Citrus Sinensis ID: 001360
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1092 | 2.2.26 [Sep-21-2011] | |||||||
| Q559T8 | 2102 | Probable serine/threonine | yes | no | 0.300 | 0.156 | 0.525 | 1e-102 | |
| Q60592 | 1734 | Microtubule-associated se | yes | no | 0.295 | 0.186 | 0.473 | 4e-85 | |
| Q6P0Q8 | 1798 | Microtubule-associated se | yes | no | 0.284 | 0.172 | 0.480 | 6e-85 | |
| Q6AX33 | 1482 | Microtubule-associated se | N/A | no | 0.278 | 0.205 | 0.481 | 2e-83 | |
| Q3U214 | 1321 | Microtubule-associated se | no | no | 0.278 | 0.230 | 0.484 | 7e-83 | |
| O15021 | 2626 | Microtubule-associated se | no | no | 0.278 | 0.115 | 0.471 | 9e-83 | |
| Q9Y2H9 | 1570 | Microtubule-associated se | no | no | 0.328 | 0.228 | 0.433 | 1e-82 | |
| Q811L6 | 2618 | Microtubule-associated se | no | no | 0.295 | 0.123 | 0.462 | 2e-82 | |
| O60307 | 1309 | Microtubule-associated se | no | no | 0.278 | 0.232 | 0.481 | 4e-82 | |
| Q9R1L5 | 1570 | Microtubule-associated se | no | no | 0.319 | 0.222 | 0.436 | 6e-82 |
| >sp|Q559T8|Y0701_DICDI Probable serine/threonine-protein kinase DDB_G0272282 OS=Dictyostelium discoideum GN=DDB_G0272282 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 372 bits (955), Expect = e-102, Method: Compositional matrix adjust.
Identities = 197/375 (52%), Positives = 241/375 (64%), Gaps = 47/375 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
I DFEIIKPISRGAFGRV+LA+K+ TGDL+AIKVLKKLD IRKN + ++ ERNIL V+
Sbjct: 1524 IADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVNHVIVERNILAMVQ 1583
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
N FVV+ FY+F D LYLVMEYL GGD SLLR +GC EE +A+ YIAE VL LEYLH
Sbjct: 1584 NEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETVLCLEYLHK 1643
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI-------------NNTIDLSGPETDG 852
IVHRDLKPDN+LI GHIKLTDFGLSKIG+I N + S T+
Sbjct: 1644 SAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDDKKMEDSGNTNTNTHFNFSTSPTNT 1703
Query: 853 IMPSDAH-----------------------YPEYQQT----DNRNRHSAVGTPDYLAPEI 885
M D+ YP+ + T + VGTPDYL+PEI
Sbjct: 1704 SMMDDSSTTGNPNGNGNTSLNSSQTNILSPYPQRKNTLKTPLKKPVKKVVGTPDYLSPEI 1763
Query: 886 LLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL--NRKIPWPCVPSDMSFE 943
LLGT HG DWW++GIIL+EF+TG PPF ++PE+IF +IL +R++ W P ++S E
Sbjct: 1764 LLGTGHGQTVDWWALGIILYEFLTGSPPFNDDTPELIFQHILHRDREMEW---PEEISSE 1820
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKA--VFVPQPESVDDTSY 1001
A+DLI + L DP +RLGANGA EVK HPFF VNWD+L Q+ +F+P+PE+ DT Y
Sbjct: 1821 AKDLILKLLNPDPYKRLGANGAYEVKTHPFFANVNWDTLIDQEMDNIFLPKPENNYDTDY 1880
Query: 1002 FLSRFSQISSGLPDD 1016
F R S DD
Sbjct: 1881 FWDRQSMYDDEAEDD 1895
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q60592|MAST2_MOUSE Microtubule-associated serine/threonine-protein kinase 2 OS=Mus musculus GN=Mast2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 317 bits (811), Expect = 4e-85, Method: Compositional matrix adjust.
Identities = 163/344 (47%), Positives = 219/344 (63%), Gaps = 21/344 (6%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
DSV + GVS P + E +DFE IK IS GA+G VFL R ++T FA+K + K
Sbjct: 433 DSV-EGRGVSQPSQKTPSE----EDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQ 487
Query: 724 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
++I +N I++ ER+IL NPFVV F SF + +L +VMEY+ GGD +LL+ +G
Sbjct: 488 NLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA 547
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
L D+ R+Y AE VLALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T
Sbjct: 548 LPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 607
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVG 901
+L Y + + D R GTP+Y+APE++L +G DWW++G
Sbjct: 608 NL--------------YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG 653
Query: 902 IILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
IIL+EF+ G PF ++PE +F +++ +I WP + +AQDL ++ L +P +RLG
Sbjct: 654 IILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDDALPPDAQDLTSKLLHQNPLERLG 713
Query: 962 ANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSR 1005
+ A EVK HPFF G++W L QKA F+PQ ES DDTSYF +R
Sbjct: 714 TSSAYEVKQHPFFMGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 757
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 316 bits (810), Expect = 6e-85, Method: Compositional matrix adjust.
Identities = 157/327 (48%), Positives = 211/327 (64%), Gaps = 16/327 (4%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
K+ S +DFE IK IS GA+G VFL R ++T FA+K + K ++I +N I++ ER+I
Sbjct: 504 KKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQNLILRNQIQQAFVERDI 563
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
L NPFVV F SF + +L +VMEY+ GGD +LL+ +G L D+ R+Y AE VLAL
Sbjct: 564 LTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCATLLKNIGALPVDMVRLYFAETVLAL 623
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T +L Y
Sbjct: 624 EYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL--------------Y 669
Query: 861 PEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
+ + D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++
Sbjct: 670 EGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 729
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
PE +F +++ +I WP + +AQDL ++ L +P +RLG A EVK HPFF G++
Sbjct: 730 PEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEVKQHPFFTGLD 789
Query: 979 WDSLALQKAVFVPQPESVDDTSYFLSR 1005
W L QKA F+PQ ES DDTSYF +R
Sbjct: 790 WTGLLRQKAEFIPQLESEDDTSYFDTR 816
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6AX33|MAST3_XENLA Microtubule-associated serine/threonine-protein kinase 3 OS=Xenopus laevis GN=mast3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (796), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 154/320 (48%), Positives = 205/320 (64%), Gaps = 16/320 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+L R + T FA+K + K ++I +N I ++ ER+IL NP
Sbjct: 398 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIHQVFVERDILTFAENP 457
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV F SF R +L +VMEY+ GGD +LL+ +G L D++R+Y AE VLALEYLH+ G
Sbjct: 458 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMSRMYFAETVLALEYLHNYG 517
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLLI GHIKLTDFGLSK+GL+N T +L Y + + D
Sbjct: 518 IVHRDLKPDNLLITSLGHIKLTDFGLSKVGLMNMTTNL--------------YEGHIEKD 563
Query: 868 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 564 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 623
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985
+++ I WP + ++QDLI R L + +RLG GA EVK H FF ++W+ L Q
Sbjct: 624 VISDDIIWPGGEEALPADSQDLITRLLRQNSLERLGTGGAQEVKQHTFFLSLDWNGLLRQ 683
Query: 986 KAVFVPQPESVDDTSYFLSR 1005
KA FVPQ E+ DDTSYF +R
Sbjct: 684 KAEFVPQLEADDDTSYFDTR 703
|
Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U214|MAST3_MOUSE Microtubule-associated serine/threonine-protein kinase 3 OS=Mus musculus GN=Mast3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 309 bits (792), Expect = 7e-83, Method: Compositional matrix adjust.
Identities = 155/320 (48%), Positives = 202/320 (63%), Gaps = 16/320 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 388 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 447
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 448 FVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVLALEYLHNYG 507
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L Y + + D
Sbjct: 508 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNL--------------YEGHIEKD 553
Query: 868 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R GTP+Y+APE++ +G DWW++G+IL+EF+ G PF ++PE +F
Sbjct: 554 AREFVDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVILYEFLVGCVPFFGDTPEELFGQ 613
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985
+++ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L
Sbjct: 614 VVSDEIMWPEGDEALPLDAQDLITRLLRQSPMDRLGTGGTHEVKQHPFFLALDWAGLLRH 673
Query: 986 KAVFVPQPESVDDTSYFLSR 1005
KA FVPQ E+ DDTSYF +R
Sbjct: 674 KAEFVPQLEAEDDTSYFDTR 693
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O15021|MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 309 bits (791), Expect = 9e-83, Method: Compositional matrix adjust.
Identities = 151/320 (47%), Positives = 206/320 (64%), Gaps = 16/320 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+ R + + FA+K + K ++I +N I++ ER+IL NP
Sbjct: 572 DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENP 631
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV + SF R +L +VMEY+ GGD +L++ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 632 FVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYG 691
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T +L Y + + D
Sbjct: 692 IVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTTNL--------------YEGHIEKD 737
Query: 868 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 738 AREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 797
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985
+++ +I WP +AQDLI L +P +RLG GA EVK H FF+ ++W+SL Q
Sbjct: 798 VISDEINWPEKDEAPPPDAQDLITLLLRQNPLERLGTGGAYEVKQHRFFRSLDWNSLLRQ 857
Query: 986 KAVFVPQPESVDDTSYFLSR 1005
KA F+PQ ES DDTSYF +R
Sbjct: 858 KAEFIPQLESEDDTSYFDTR 877
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H9|MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 308 bits (790), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 169/390 (43%), Positives = 230/390 (58%), Gaps = 31/390 (7%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S K+ +DF+ IK IS GA+G V+L R R T FA+K + K ++I +N I++ E
Sbjct: 363 SKAKKPPGENDFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVE 422
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
R+IL NPFVV F SF R +L +VMEY+ GGD +LL+ +G L ++AR+Y AE V
Sbjct: 423 RDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETV 482
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
LALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L
Sbjct: 483 LALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNL------------ 530
Query: 858 AHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
Y + + D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF
Sbjct: 531 --YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 588
Query: 916 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
++PE +F +++ I WP + EAQ LI+ L +P RLGA GA EVK H FF+
Sbjct: 589 GDTPEELFGQVISDDILWPEGDEALPTEAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFR 648
Query: 976 GVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRT 1035
++W L QKA F+P ES DDTSYF +R + SY + DT +
Sbjct: 649 DLDWTGLLRQKAEFIPHLESEDDTSYFDTRSDRY------HHVNSYDEDDTTE------- 695
Query: 1036 EMDECGDLAEFGSCPLDLSLINFSFKNLSQ 1065
+E ++ +F SC S + S + LSQ
Sbjct: 696 --EEPVEIRQFSSCSPRFSKVYSSMEQLSQ 723
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q811L6|MAST4_MOUSE Microtubule-associated serine/threonine-protein kinase 4 OS=Mus musculus GN=Mast4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 308 bits (789), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 159/344 (46%), Positives = 217/344 (63%), Gaps = 21/344 (6%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
+SVS S+ T L K R S DFE IK IS GA+G V+ R + + FA+K + K
Sbjct: 548 ESVSSSN---TSLRLRRKPRES--DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQ 602
Query: 724 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
++I +N I++ ER+IL NPFVV + SF R +L +VMEY+ GGD +L++ +G
Sbjct: 603 NLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGP 662
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
L D+AR+Y AE VLALEYLH+ GIVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T
Sbjct: 663 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTT 722
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVG 901
+L Y + + D R GTP+Y+APE++L +G DWW++G
Sbjct: 723 NL--------------YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG 768
Query: 902 IILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
IIL+EF+ G PF ++PE +F +++ +I WP +AQ+LI L +P +RLG
Sbjct: 769 IILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQELITLLLRQNPLERLG 828
Query: 962 ANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSR 1005
GA EVK H FF+ ++W+SL QKA F+PQ ES DDTSYF +R
Sbjct: 829 TGGAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDTR 872
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O60307|MAST3_HUMAN Microtubule-associated serine/threonine-protein kinase 3 OS=Homo sapiens GN=MAST3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 307 bits (786), Expect = 4e-82, Method: Compositional matrix adjust.
Identities = 154/320 (48%), Positives = 202/320 (63%), Gaps = 16/320 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 366 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 425
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 426 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARLYFAETVLALEYLHNYG 485
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L Y + + D
Sbjct: 486 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNL--------------YEGHIEKD 531
Query: 868 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R GTP+Y+APE++ +G DWW++G++L+EF+ G PF ++PE +F
Sbjct: 532 AREFIDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFFGDTPEELFGQ 591
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985
+++ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L
Sbjct: 592 VVSDEIMWPEGDEALPADAQDLITRLLRQSPLDRLGTGGTHEVKQHPFFLALDWAGLLRH 651
Query: 986 KAVFVPQPESVDDTSYFLSR 1005
KA FVPQ E+ DDTSYF +R
Sbjct: 652 KAEFVPQLEAEDDTSYFDTR 671
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9R1L5|MAST1_MOUSE Microtubule-associated serine/threonine-protein kinase 1 OS=Mus musculus GN=Mast1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 306 bits (784), Expect = 6e-82, Method: Compositional matrix adjust.
Identities = 166/380 (43%), Positives = 226/380 (59%), Gaps = 31/380 (8%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DF+ IK IS GA+G V+L R R T FA+K + K ++I +N I++ ER+IL NP
Sbjct: 375 DFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENP 434
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV F SF R +L +VMEY+ GGD +LL+ +G L ++AR+Y AE VLALEYLH+ G
Sbjct: 435 FVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETVLALEYLHNYG 494
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L Y + + D
Sbjct: 495 IVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNL--------------YEGHIEKD 540
Query: 868 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 541 AREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 600
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985
+++ I WP + +AQ LI+ L +P RLGA GA EVK H FF+ ++W L Q
Sbjct: 601 VISDDILWPEGDEALPTDAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFRDLDWTGLLRQ 660
Query: 986 KAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAE 1045
KA F+P ES DDTSYF +R + SY + DT + +E ++ +
Sbjct: 661 KAEFIPHLESEDDTSYFDTRSDRY------HHVNSYDEDDTTE---------EEPVEIRQ 705
Query: 1046 FGSCPLDLSLINFSFKNLSQ 1065
F SC S + S + LSQ
Sbjct: 706 FSSCSPRFSKVYSSMEQLSQ 725
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1092 | ||||||
| 359492673 | 1109 | PREDICTED: uncharacterized protein LOC10 | 0.982 | 0.967 | 0.699 | 0.0 | |
| 255538590 | 1106 | kinase, putative [Ricinus communis] gi|2 | 0.935 | 0.924 | 0.711 | 0.0 | |
| 145324180 | 1067 | protein kinase-like protein [Arabidopsis | 0.962 | 0.985 | 0.583 | 0.0 | |
| 7767670 | 1092 | F27F5.23 [Arabidopsis thaliana] | 0.962 | 0.962 | 0.570 | 0.0 | |
| 297852258 | 1101 | predicted protein [Arabidopsis lyrata su | 0.956 | 0.949 | 0.562 | 0.0 | |
| 145336472 | 1042 | protein kinase-like protein [Arabidopsis | 0.912 | 0.955 | 0.585 | 0.0 | |
| 110740013 | 1042 | similar to IRE homolog 1 [Arabidopsis th | 0.912 | 0.955 | 0.584 | 0.0 | |
| 302142471 | 948 | unnamed protein product [Vitis vinifera] | 0.627 | 0.722 | 0.761 | 0.0 | |
| 356529485 | 1395 | PREDICTED: uncharacterized protein LOC10 | 0.856 | 0.670 | 0.486 | 0.0 | |
| 168060390 | 1073 | predicted protein [Physcomitrella patens | 0.867 | 0.882 | 0.470 | 0.0 |
| >gi|359492673|ref|XP_002282958.2| PREDICTED: uncharacterized protein LOC100259179 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1470 bits (3805), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 771/1102 (69%), Positives = 868/1102 (78%), Gaps = 29/1102 (2%)
Query: 12 GIPSGLNRIKTRGGVSKP---------DELTESRSYGVSRPPQKHKQKTVAQGHVKLANS 62
GIP+GLNRIKTR SK D+ ESR G+SRPP K +GH K A S
Sbjct: 16 GIPTGLNRIKTRRESSKDQLNWKPDDDDKFHESRPRGISRPPANQKHN---KGHAKFAGS 72
Query: 63 FTEEVRKGKKIAQWFTSYISK-----FNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNH 117
E KGKKIA+WFTS++SK F+ V P ++S S+ K D E RTK EG H
Sbjct: 73 I-EGFHKGKKIARWFTSHLSKDSSQGFDDVPPKVQDSNSKVKAPDKEGSTRTKQWKEGKH 131
Query: 118 LNEKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAA 177
L KQS E +SS KV KGLKSFSHELGPKGGIP S+PRAHSYNDLKELL +LHSRFDAA
Sbjct: 132 LTGKQSSPEGLSSIKVPKGLKSFSHELGPKGGIPPSHPRAHSYNDLKELLGSLHSRFDAA 191
Query: 178 KEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQ 237
KEVVN EL++ D+M+ L++ DS S G++M E LLILAQQC+EMT FR CETIVQ
Sbjct: 192 KEVVNVELSSLTGDIMDALQRNDS--SPGQKMAEGLLILAQQCMEMTPSEFRIKCETIVQ 249
Query: 238 DLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVE 297
LTEKRQ CQ +KWL TRMLFILTRCTRLL FQK+SEPI EKSLH F KCLES+PAVE
Sbjct: 250 GLTEKRQHCQTAFLKWLFTRMLFILTRCTRLLRFQKDSEPIDEKSLHNFTKCLESIPAVE 309
Query: 298 TSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLDH---TSENKS 354
+W P +S DY S K++AK ++ + +VS++ E + C E D TS S
Sbjct: 310 MNWAPYSRIVDSGSDYDSNGKSDAKHELQWRNRVSSLLEQTWCRSEEPADKSGITSRKDS 369
Query: 355 VFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICE 414
+ + Q Q SQ +Q G+ + + GS HE + LDGSDSVICRICE
Sbjct: 370 MVLVQKPLSQNSQIDFLPHIEQDGDYPGKSMNSFED--GSLHEPERGLDGSDSVICRICE 427
Query: 415 EVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENS 474
E VP SHLESHSYICAYADKC+L LD+DERL KL+EILEQI ES N + SPENS
Sbjct: 428 ENVPTSHLESHSYICAYADKCDLKYLDIDERLSKLAEILEQIIESRNLNFQASFCSPENS 487
Query: 475 RTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGS-LNLRGHLGLKL 533
R Q NSA+ +G SPKISEWRNKGVEGMFED+HEMDTACIDDS+L + LNL+GH G KL
Sbjct: 488 RMQITNSAVISEGCSPKISEWRNKGVEGMFEDLHEMDTACIDDSYLTNPLNLKGHWGTKL 547
Query: 534 SGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDF 593
S YGA SSTGSMTS+SSTNTP+AGHFD FWLE N+P++LEDVQQM +LADIARCVA TD
Sbjct: 548 SQYGAPSSTGSMTSMSSTNTPRAGHFDLFWLEHNNPSKLEDVQQMADLADIARCVAGTDL 607
Query: 594 SKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSF 652
SKEGS +FLLACM DLQDVLQ++KLK+LVIDTFG RIE LLREKYILACEL D KSP S
Sbjct: 608 SKEGSCDFLLACMEDLQDVLQNTKLKSLVIDTFGGRIENLLREKYILACELADTKSPKSD 667
Query: 653 SKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTG 712
++ KE+SRL+ D+ S SS +STPLH HKERTSIDDFEIIKPISRGAFG+VFLARKRTTG
Sbjct: 668 NRIKESSRLLFDNASHSSTMSTPLHPLHKERTSIDDFEIIKPISRGAFGKVFLARKRTTG 727
Query: 713 DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772
DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN+YLVMEYLNGG
Sbjct: 728 DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNVYLVMEYLNGG 787
Query: 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
DLYSLLRK+GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHDGHIKLTDFG
Sbjct: 788 DLYSLLRKLGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHDGHIKLTDFG 847
Query: 833 LSKIGLINNTIDLSGPETDGIMPS--DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 890
LSKIGLIN+T+DLSGPETDG + D+ QQTD+R+R SAVGTPDYLAPEILLGTE
Sbjct: 848 LSKIGLINSTVDLSGPETDGSTDAFLDSLNLHTQQTDDRHRQSAVGTPDYLAPEILLGTE 907
Query: 891 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINR 950
HGYAADWWSVGIILFE ITG+PPFTAE PEIIFDNILNRKIPWP VP DMS+EAQDLINR
Sbjct: 908 HGYAADWWSVGIILFELITGVPPFTAEHPEIIFDNILNRKIPWPSVPGDMSYEAQDLINR 967
Query: 951 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQIS 1010
FLIHDP+ RLGANG +EVK HPFFKGVNWD+LALQKAVFVPQP+S DDTSYF+SR+SQI
Sbjct: 968 FLIHDPDLRLGANGLSEVKTHPFFKGVNWDTLALQKAVFVPQPDSADDTSYFVSRYSQIP 1027
Query: 1011 SGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASIN 1070
SGLPD+Q+ S S D+ D SNS EMDECGDLAEF S PL+LSLINFSFKNLSQLASIN
Sbjct: 1028 SGLPDEQDCSDSATDSSDLYSNSGLEMDECGDLAEFDSSPLNLSLINFSFKNLSQLASIN 1087
Query: 1071 HEVLVQNVKDSTRSSPAKDAGT 1092
++VL+Q KD T+ SP+K T
Sbjct: 1088 YDVLLQTGKDPTKCSPSKSRDT 1109
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255538590|ref|XP_002510360.1| kinase, putative [Ricinus communis] gi|223551061|gb|EEF52547.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1469 bits (3803), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 743/1045 (71%), Positives = 841/1045 (80%), Gaps = 23/1045 (2%)
Query: 65 EEVRKGKKIAQWFTSYISKFNI-----VSPNTENSGSEDKDVDVEDPRRTKLRHEGNHLN 119
+E KGKKI +W SY SK VS N E E K +D + RR K + NHL+
Sbjct: 60 KEFHKGKKITRWLASYFSKGTSQVTADVSSNIEKRSLEHKTLDKFEQRRIKFVNGENHLD 119
Query: 120 EKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKE 179
Q E +S SK SKGLKSFSHELGP+GGIP + PRAHSY+DLKELL + HSRFDAAKE
Sbjct: 120 GNQPSVEILSQSKASKGLKSFSHELGPRGGIPPAQPRAHSYSDLKELLGSFHSRFDAAKE 179
Query: 180 VVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDL 239
VVN+ELA+FA+D M+VLE +DS E +M EDLLILAQ C+EM FR CE IVQDL
Sbjct: 180 VVNAELASFARDAMDVLEIIDSSLQEELKMAEDLLILAQLCMEMACSQFRLKCEIIVQDL 239
Query: 240 TEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETS 299
TEKR QCQ GLVKWL TRMLFILTRCTRLL FQK++EPI EKSL K KKCLESVP+V+ S
Sbjct: 240 TEKRLQCQTGLVKWLYTRMLFILTRCTRLLQFQKDTEPIDEKSLRKLKKCLESVPSVDMS 299
Query: 300 WVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLDH---TSENKSVF 356
WV + ++DLD A QK + K+K+ GQ +S++PE C ES D TS S+
Sbjct: 300 WVANHVIDDTDLDDALNQKGDIKRKLQGQNNLSSLPEAVCCGSQESDDQSGVTSGKDSLD 359
Query: 357 IEQNFPPQKSQHYSRMQEQQ------------SHIVEGRIVEVTKSNCGSPHEQGQSLDG 404
EQ QKS++ S + +Q + + + K S EQ + LDG
Sbjct: 360 FEQKLSCQKSRNESLFEVRQFCETDKSAISNSVNNSSCSLHDQEKFLDDSLQEQERVLDG 419
Query: 405 SDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSS 464
SD VICRICEE+VPISHLESHSYICAYADKC+LNCLDVDERL L+E+LEQI ES N +
Sbjct: 420 SDLVICRICEEIVPISHLESHSYICAYADKCDLNCLDVDERLSNLAEMLEQIVESRNMNV 479
Query: 465 HPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLN 524
H GSPENSR Q+ NSA T + SPKISEWRNKGVEGMFEDIHEMDTA IDDSHL +N
Sbjct: 480 HQSHGSPENSRPQNANSATT-EACSPKISEWRNKGVEGMFEDIHEMDTAFIDDSHLPPVN 538
Query: 525 LRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADI 584
L+GHLG+KL YGA SSTGSMTS+SSTNTPKAGHFD FWLE N+P+ELEDV QMI LADI
Sbjct: 539 LKGHLGMKLCNYGAPSSTGSMTSLSSTNTPKAGHFDSFWLEHNNPSELEDVPQMINLADI 598
Query: 585 ARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACEL 643
AR VA+TD SKEGS EFLLACM DLQDVLQHSKLKALVIDTFG RIEKLLREKY+LAC++
Sbjct: 599 ARSVANTDLSKEGSYEFLLACMQDLQDVLQHSKLKALVIDTFGGRIEKLLREKYLLACDI 658
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRV 703
D KSP S SK KENSRL+LD+ SQSS +STP+HSSHKERTSIDDFEIIKPISRGAFG+V
Sbjct: 659 TDAKSPKSDSKLKENSRLLLDNASQSSAMSTPVHSSHKERTSIDDFEIIKPISRGAFGKV 718
Query: 704 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763
FLARKR TGDLFAIKVLKKLDM+RKND++RILAERNILITVRNPFVVRFFYSFTCRDNLY
Sbjct: 719 FLARKRITGDLFAIKVLKKLDMLRKNDVQRILAERNILITVRNPFVVRFFYSFTCRDNLY 778
Query: 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823
LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHD
Sbjct: 779 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHD 838
Query: 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAP 883
GHIKLTDFGLSKIGLIN+T+DL+GPET+ SDAH P + QT+ NR SAVGTPDYLAP
Sbjct: 839 GHIKLTDFGLSKIGLINSTMDLAGPETNEDEVSDAHNP-HIQTEETNRQSAVGTPDYLAP 897
Query: 884 EILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFE 943
EILLGTEHGYAADWWSVGIILFE ITGIPPFTAE PEIIFDNILNRKIPWP VP MS+E
Sbjct: 898 EILLGTEHGYAADWWSVGIILFELITGIPPFTAERPEIIFDNILNRKIPWPPVPESMSYE 957
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFL 1003
AQDLINR + +DP+QRLG+NG+AEVK++PFF+G++WD+LALQKAVFVP P+S DDTSYF+
Sbjct: 958 AQDLINRLITYDPDQRLGSNGSAEVKSYPFFRGIDWDNLALQKAVFVPSPDSADDTSYFV 1017
Query: 1004 SRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNL 1063
SRFSQ+SSG+P+D + S+SD D DSS NS EMDECGDLAEF S PL+LSLINFSFKNL
Sbjct: 1018 SRFSQMSSGMPNDCSSSHSDTDAYDSSPNSGVEMDECGDLAEFDSSPLNLSLINFSFKNL 1077
Query: 1064 SQLASINHEVLVQNVKDSTRSSPAK 1088
SQLASINH+V +Q KDS ++SP++
Sbjct: 1078 SQLASINHDVYLQTGKDSAKNSPSR 1102
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145324180|ref|NP_001077679.1| protein kinase-like protein [Arabidopsis thaliana] gi|332193965|gb|AEE32086.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1189 bits (3076), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 644/1104 (58%), Positives = 792/1104 (71%), Gaps = 53/1104 (4%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771
GD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNG
Sbjct: 693 GDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNG 752
Query: 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831
GDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDF
Sbjct: 753 GDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDF 812
Query: 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891
GLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTEH
Sbjct: 813 GLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEH 872
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
GYAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR
Sbjct: 873 GYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRL 932
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS 1011
L+H+P +RLGANGAAEVK+HPFF+GV+W++LALQKA FVPQPES++DTSYF+SRFS+ S
Sbjct: 933 LVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQKAAFVPQPESINDTSYFVSRFSESSC 992
Query: 1012 GLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINH 1071
+ N S S+ D+ D E+DEC +L +F S P LSLINFSFKNLSQLASINH
Sbjct: 993 SDTETGNNSGSNPDSGD-------ELDECTNLEKFDSPPYYLSLINFSFKNLSQLASINH 1045
Query: 1072 EVLVQNVKDSTRS---SPAKDAGT 1092
+VL+Q KD + SP K GT
Sbjct: 1046 DVLLQ--KDPAKGGGDSPFKSHGT 1067
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7767670|gb|AAF69167.1|AC007915_19 F27F5.23 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1169 bits (3025), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 644/1129 (57%), Positives = 792/1129 (70%), Gaps = 78/1129 (6%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV---------VRFFYSFTCRDNL 762
GD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+ VRFFYSFTCRDNL
Sbjct: 693 GDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLAEHLMLLMQVRFFYSFTCRDNL 752
Query: 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 822
YLVMEYLNGGDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA+
Sbjct: 753 YLVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAY 812
Query: 823 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLA 882
+GHIKLTDFGLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLA
Sbjct: 813 NGHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLA 872
Query: 883 PEILLGTEHG----------------YAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
PEILLGTEHG YAADWWS GI+LFE +TGIPPFTA PE IFDNI
Sbjct: 873 PEILLGTEHGLDTTFKSGFHEAPVNCYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNI 932
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 986
LN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK+HPFF+GV+W++LALQK
Sbjct: 933 LNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQK 992
Query: 987 AVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEF 1046
A FVPQPES++DTSYF+SRFS+ S + N S S+ D+ D E+DEC +L +F
Sbjct: 993 AAFVPQPESINDTSYFVSRFSESSCSDTETGNNSGSNPDSGD-------ELDECTNLEKF 1045
Query: 1047 GSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDSTRS---SPAKDAGT 1092
S P LSLINFSFKNLSQLASINH+VL+Q KD + SP K GT
Sbjct: 1046 DSPPYYLSLINFSFKNLSQLASINHDVLLQ--KDPAKGGGDSPFKSHGT 1092
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297852258|ref|XP_002894010.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297339852|gb|EFH70269.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1160 bits (3002), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 644/1144 (56%), Positives = 793/1144 (69%), Gaps = 99/1144 (8%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVS--KPDELTESRSYGVSRPPQKHKQKT-VAQ 54
A +N D G IPSGLNRIKTR S +P++ +++ V +PP QK V +
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGLRPEDSSDT----VVKPPFNRNQKIIVPR 57
Query: 55 GHVKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPN---TENSGSEDKDVDVEDPRRTKL 111
G+ + S +E RKG K+++W SY K++ P + + SED KL
Sbjct: 58 GYGRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSED----------IKL 106
Query: 112 RHEGNHLNEKQSLAEHVSSSKV----SKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELL 167
R G + + + + VS + + S G+KSFSHELGP+GG+ + YPR HSYNDLKELL
Sbjct: 107 R--GKNCGKDEEMIIKVSETNLPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELL 164
Query: 168 DTLHSRFDAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCL 227
+LHSRFD AKE V+ +L F DV +EKMD P E +EM E+LL +A+ C+EMTS
Sbjct: 165 GSLHSRFDVAKETVDKKLDVFVIDVKEAMEKMDPPCPEDREMAEELLDVARACMEMTSAQ 224
Query: 228 FRANCETIVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFK 287
RA CE+IV DLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK
Sbjct: 225 LRATCESIVHDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFK 284
Query: 288 KCLESVPAVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLD 347
+CLE +PA+ET W +P +S Y YQ+ A +K ++ S E + + D
Sbjct: 285 ECLERIPALETDWGSTPRVDDSGSGYPKYQRDEAGQKFKRRETESLESETTFDYVIPN-D 343
Query: 348 HTSENKS---VFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDG 404
H++ + +Q FP Q+ Q S++ +Q+ ++ + E P ++ L
Sbjct: 344 HSNNAATEGYAVAKQEFPSQEPQFDSKVVQQRFYLSD----EYEHKMLNEPVKE---LGR 396
Query: 405 SDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSS 464
SD VICRICEE VP+SHLE HSYICAYADKCE+NCLDVDERLLKL EILEQI +S + +S
Sbjct: 397 SDYVICRICEEEVPLSHLEPHSYICAYADKCEINCLDVDERLLKLEEILEQIIDSRSLNS 456
Query: 465 HPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLN 524
G ENS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ +N
Sbjct: 457 FTQAGGLENSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIN 514
Query: 525 LRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADI 584
L+ H+G K+ + SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED+Q M++L+DI
Sbjct: 515 LKSHVGAKICHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLQLMMDLSDI 573
Query: 585 ARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACEL 643
ARC A TD SKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL
Sbjct: 574 ARCGASTDLSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLYAREL 633
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRV 703
+KS K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+V
Sbjct: 634 TADKSSVGNVKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKV 684
Query: 704 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV---------VRFFY 754
FLARKRTTGD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+ VRFFY
Sbjct: 685 FLARKRTTGDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLAEHLILLMQVRFFY 744
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
SFTCRDNLYLVMEYLNGGDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLK
Sbjct: 745 SFTCRDNLYLVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLK 804
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
PDNLLIA++GHIKLTDFGLSKIGLINNTIDLSG E+D + +H+ + Q + R RHSA
Sbjct: 805 PDNLLIAYNGHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTGSHHFQKNQEEERIRHSA 864
Query: 875 VGTPDYLAPEILLGTEH------------------------GYAADWWSVGIILFEFITG 910
VGTPDYLAPEILLGTEH GYA+DWWSVGI+LFE ITG
Sbjct: 865 VGTPDYLAPEILLGTEHGLDTTLYLGFSEAIGNYIQLLGLAGYASDWWSVGIVLFELITG 924
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
IPPFTA PEIIFDNILN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK+
Sbjct: 925 IPPFTAARPEIIFDNILNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKS 984
Query: 971 HPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSS 1030
HPFF+GV+WD+LALQKA FVPQPES+ DTSYF+SRF + S+ + N S S D+ D
Sbjct: 985 HPFFQGVDWDNLALQKAAFVPQPESIADTSYFVSRFCENSASDSETDNNSGSFPDSGD-- 1042
Query: 1031 SNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQN--VKDSTRSSPAK 1088
E+DEC +L +F S P LSLINFSFKNLSQLASINH+VL+Q K SP K
Sbjct: 1043 -----ELDECTNLEKFDSPPYYLSLINFSFKNLSQLASINHDVLLQKDPAKGGGGDSPFK 1097
Query: 1089 DAGT 1092
GT
Sbjct: 1098 SHGT 1101
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145336472|ref|NP_175130.2| protein kinase-like protein [Arabidopsis thaliana] gi|332193964|gb|AEE32085.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1133 bits (2930), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 607/1037 (58%), Positives = 749/1037 (72%), Gaps = 41/1037 (3%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771
GD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNG
Sbjct: 693 GDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNG 752
Query: 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831
GDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDF
Sbjct: 753 GDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDF 812
Query: 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891
GLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTEH
Sbjct: 813 GLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEH 872
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
GYAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR
Sbjct: 873 GYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRL 932
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS 1011
L+H+P +RLGANGAAEVK+HPFF+GV+W++LALQKA FVPQPES++DTSYF+SRFS+ S
Sbjct: 933 LVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQKAAFVPQPESINDTSYFVSRFSESSC 992
Query: 1012 GLPDDQNGSYSDADTCD 1028
+ N S S+ D+ D
Sbjct: 993 SDTETGNNSGSNPDSGD 1009
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|110740013|dbj|BAF01910.1| similar to IRE homolog 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1130 bits (2922), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 606/1037 (58%), Positives = 748/1037 (72%), Gaps = 41/1037 (3%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y Q+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPECQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771
GD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNG
Sbjct: 693 GDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNG 752
Query: 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831
GDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDF
Sbjct: 753 GDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDF 812
Query: 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891
GLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTEH
Sbjct: 813 GLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEH 872
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
GYAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR
Sbjct: 873 GYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRL 932
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS 1011
L+H+P +RLGANGAAEVK+HPFF+GV+W++LALQKA FVPQPES++DTSYF+SRFS+ S
Sbjct: 933 LVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQKAAFVPQPESINDTSYFVSRFSESSC 992
Query: 1012 GLPDDQNGSYSDADTCD 1028
+ N S S+ D+ D
Sbjct: 993 SDTETGNNSGSNPDSGD 1009
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142471|emb|CBI19674.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1076 bits (2782), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 555/729 (76%), Positives = 607/729 (83%), Gaps = 44/729 (6%)
Query: 376 QSHIVEGRIVEVTKSNCGSPHEQGQSL-------DGSDSVICRICEEVVPISHLESHSYI 428
Q IV GR++ N E G L DGSDSVICRICEE VP SHLESHSYI
Sbjct: 252 QIMIVMGRVM----PNMNYSGETGYLLSLSKLGADGSDSVICRICEENVPTSHLESHSYI 307
Query: 429 CAYADKCELNCLDVDERLLKLSEILEQISES-CNSSSHPILGSPENSRTQSMNSAITYDG 487
CAYADKC+L LD+DERL KL+EILEQI ES C
Sbjct: 308 CAYADKCDLKYLDIDERLSKLAEILEQIIESRC--------------------------- 340
Query: 488 YSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGS-LNLRGHLGLKLSGYGASSSTGSMT 546
SPKISEWRNKGVEGMFED+HEMDTACIDDS+L + LNL+GH G KLS YGA SSTGSMT
Sbjct: 341 -SPKISEWRNKGVEGMFEDLHEMDTACIDDSYLTNPLNLKGHWGTKLSQYGAPSSTGSMT 399
Query: 547 SVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACM 605
S+SSTNTP+AGHFD FWLE N+P++LEDVQQM +LADIARCVA TD SKEGS +FLLACM
Sbjct: 400 SMSSTNTPRAGHFDLFWLEHNNPSKLEDVQQMADLADIARCVAGTDLSKEGSCDFLLACM 459
Query: 606 HDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDS 665
DLQDVLQ++KLK+LVIDTFG RIE LLREKYILACEL D KSP S ++ KE+SRL+ D+
Sbjct: 460 EDLQDVLQNTKLKSLVIDTFGGRIENLLREKYILACELADTKSPKSDNRIKESSRLLFDN 519
Query: 666 VSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 725
S SS +STPLH HKERTSIDDFEIIKPISRGAFG+VFLARKRTTGDLFAIKVLKKLDM
Sbjct: 520 ASHSSTMSTPLHPLHKERTSIDDFEIIKPISRGAFGKVFLARKRTTGDLFAIKVLKKLDM 579
Query: 726 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN+YLVMEYLNGGDLYSLLRK+GCLE
Sbjct: 580 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNVYLVMEYLNGGDLYSLLRKLGCLE 639
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845
EDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHDGHIKLTDFGLSKIGLIN+T+DL
Sbjct: 640 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHDGHIKLTDFGLSKIGLINSTVDL 699
Query: 846 SGPETDGIMPS--DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
SGPETDG + D+ QQTD+R+R SAVGTPDYLAPEILLGTEHGYAADWWSVGII
Sbjct: 700 SGPETDGSTDAFLDSLNLHTQQTDDRHRQSAVGTPDYLAPEILLGTEHGYAADWWSVGII 759
Query: 904 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
LFE ITG+PPFTAE PEIIFDNILNRKIPWP VP DMS+EAQDLINRFLIHDP+ RLGAN
Sbjct: 760 LFELITGVPPFTAEHPEIIFDNILNRKIPWPSVPGDMSYEAQDLINRFLIHDPDLRLGAN 819
Query: 964 GAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSD 1023
G +EVK HPFFKGVNWD+LALQKAVFVPQP+S DDTSYF+SR+SQI SGLPD+Q+ S S
Sbjct: 820 GLSEVKTHPFFKGVNWDTLALQKAVFVPQPDSADDTSYFVSRYSQIPSGLPDEQDCSDSA 879
Query: 1024 ADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDSTR 1083
D+ D SNS EMDECGDLAEF S PL+LSLINFSFKNLSQLASIN++VL+Q KD T+
Sbjct: 880 TDSSDLYSNSGLEMDECGDLAEFDSSPLNLSLINFSFKNLSQLASINYDVLLQTGKDPTK 939
Query: 1084 SSPAKDAGT 1092
SP+K T
Sbjct: 940 CSPSKSRDT 948
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529485|ref|XP_003533321.1| PREDICTED: uncharacterized protein LOC100776995 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 859 bits (2220), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 490/1008 (48%), Positives = 640/1008 (63%), Gaps = 73/1008 (7%)
Query: 137 LKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVMNVL 196
+KSFSHEL KG P + + N+L+E+L + ++FD AKE VNS+LA FA D++ +L
Sbjct: 295 IKSFSHELNSKGVWPFPFSKPRRLNNLEEILVVIRAKFDKAKEDVNSDLAIFAADLVGIL 354
Query: 197 EKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLST 256
EK + +E +EDLL+LA+ C +S F CE+IVQ+L ++RQ+ G++K L T
Sbjct: 355 EKNADTHPDWQETIEDLLVLARSCAMTSSGEFWLQCESIVQELDDRRQEHPPGMLKQLHT 414
Query: 257 RMLFILTRCTRLLLFQKES-----EPI----AEKSLHKFKKCLESVPAVETSWVPSPGTA 307
RMLFILTRCTRLL F KES EP+ + LH K + +T +A
Sbjct: 415 RMLFILTRCTRLLQFHKESGLAEDEPVFNLRQSRVLHSAGKFIPPSVGRDTK----SSSA 470
Query: 308 ESDLDYASYQKANAKKKISGQQKVSTVPE----ISDCSCSESLDHTSENKSVFIEQNFP- 362
L +S + + ++ + G +K PE +D ++ D +S + + FP
Sbjct: 471 AKALKPSSKKAFSQEQSMMGWKKDVMQPENLSIPADDDNAKLFDSSSGRNRMASWKKFPS 530
Query: 363 -----PQ-----KSQHYSRMQEQQSHIVEGRIVEVT------------------------ 388
P+ K Q+Y R++ ++ + +V
Sbjct: 531 PTGRSPKEAVQLKDQNYGRVESSKASNNKRFTSDVDLSTAKPSELLPVKDSLDHASKHQH 590
Query: 389 KSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLK 448
K + G +Q + +S+ICRICEE VP SH+E HS ICA AD+C+ L V+ERL++
Sbjct: 591 KVSWGYWGDQQNNNSEENSIICRICEEDVPTSHVEDHSRICAVADRCDQKGLSVNERLVR 650
Query: 449 LSEILEQISESCNSS-SHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDI 507
+S+ LE++ ESC + ++GSP+ ++ + + D SPK+S+W +G E M +
Sbjct: 651 ISDTLEKMMESCTQKDTQQMVGSPDVAKVSNSSMTEESDVPSPKLSDWSRRGSEDMLDCF 710
Query: 508 HEMDTACIDDSHLGS--LNLRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLE 565
E D + D G ++ + G K +SS GSMT S TP+ D
Sbjct: 711 PEADNSVFMDDLKGLPLMSCKTRFGPKSDQGMTTSSAGSMTPRSPLMTPRTSQIDLLLAG 770
Query: 566 RNHPAELEDVQQMIELADIARCVADTDFSKE-GSEFLLACMHDLQDVLQHSKLKALVIDT 624
+ +E +D+ QM ELADIARCVA+ + + +LL+C+ DL+ V+ K AL ++T
Sbjct: 771 KGAYSEHDDLPQMNELADIARCVANAPLDDDRTTSYLLSCLDDLRVVVDRRKFDALTVET 830
Query: 625 FGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERT 684
FG+RIEKL+REKY+ E++D + + S ++ ++ D V +S S P+HSS ++RT
Sbjct: 831 FGTRIEKLIREKYLQLTEMVDVEKIDTESTVDDD--ILEDDVVRSLRTS-PIHSS-RDRT 886
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
SIDDFEIIKPISRGAFGRVFLA+KRTTGDLFAIKVLKK DMIRKN +E ILAER+ILITV
Sbjct: 887 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILITV 946
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
RNPFVVRFFYSFTCR+NLYLVMEYLNGGDLYSLLR +GCL+E+VAR+YIAE+VLALEYLH
Sbjct: 947 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEEVARVYIAEVVLALEYLH 1006
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG--IMPSDAH--Y 860
SL +VHRDLKPDNLLIAHDGHIKLTDFGLSK+GLIN+T DLSGP +G ++ D +
Sbjct: 1007 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVNGTSLLEEDETDVF 1066
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
Q + R + SAVGTPDYLAPEILLGT HG+ ADWWSVG+ILFE + GIPPF AE P+
Sbjct: 1067 TSADQRERREKRSAVGTPDYLAPEILLGTGHGFTADWWSVGVILFELLVGIPPFNAEHPQ 1126
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980
IIFDNILNRKIPWP VP +MS EA DLI+R L DPNQRLG+ GA+EVK H FFK +NWD
Sbjct: 1127 IIFDNILNRKIPWPAVPEEMSPEALDLIDRLLTEDPNQRLGSKGASEVKQHVFFKDINWD 1186
Query: 981 SLALQKAVFVPQPESVDDTSYFLSRFS-QISSGL--PDDQNGSYSDAD----TCDSSSNS 1033
+LA QKA FVP ES DTSYF SR+S S G P SDAD + SN
Sbjct: 1187 TLARQKAAFVPASESALDTSYFTSRYSWNTSDGFVYPASDVEDSSDADSLSGSSSCLSNR 1246
Query: 1034 RTEMDECGDLAEFGS-CPLDLSLINFSFKNLSQLASINHEVLVQNVKD 1080
+ E DECG L EF S ++ S NFSFKNLSQLASIN++ L + KD
Sbjct: 1247 QDEGDECGGLTEFDSGTSVNYSFSNFSFKNLSQLASINYD-LTKGWKD 1293
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|168060390|ref|XP_001782179.1| predicted protein [Physcomitrella patens subsp. patens] gi|162666345|gb|EDQ53002.1| predicted protein [Physcomitrella patens subsp. patens] | Back alignment and taxonomy information |
|---|
Score = 858 bits (2217), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/1057 (47%), Positives = 653/1057 (61%), Gaps = 110/1057 (10%)
Query: 134 SKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVM 193
S +KSFSHEL P+G + R DL+E++ L +RF AK+ VN+ELA FA D++
Sbjct: 24 STDIKSFSHELDPRGVRSYEFLRPRDLLDLEEVMAALGARFHTAKDEVNAELAVFAGDLV 83
Query: 194 NVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKW 253
VLE +E +EDLLILA+ C M +FR CE IVQDL +KRQ+ +G++K
Sbjct: 84 GVLEDTTDMDPYHQERIEDLLILARDCAFMDPQVFRKECEAIVQDLDDKRQELPMGVLKR 143
Query: 254 LSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKK------CLESVPAVETSWVPSPGTA 307
L TRMLFILTRCTRLL F+KE+ + E LH+ ++ C+ES + SW G A
Sbjct: 144 LHTRMLFILTRCTRLLQFEKEN-GLDEVELHRLQQQAKTGSCIESWKKI-ISW-NEKGKA 200
Query: 308 ------ESDLDYASYQKANAKKKISGQQKVSTVPEISDC------SCSESLDHTSENKSV 355
L +S + + K++S + +S P S S ES+ S
Sbjct: 201 LLKVVRPQRLSLSSKPQEKSSKRVSDEVSISGTPTFSGITEQAVESDKESISKASGGSVS 260
Query: 356 FIEQNFPPQKS--QHYSRM--QEQQSHIVE-------GRIVEVT---------------- 388
I +++ +H+S E +SH E G +V +T
Sbjct: 261 PIHSVVADRQTSWKHFSVAPPNELKSHGGESDVETEMGSVVYITPESSQLCADGGMVISR 320
Query: 389 ---------------KSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYAD 433
+ G +Q + LD + ICRICE+ V S LE HS ICA AD
Sbjct: 321 TSEEVQRIPSSKRHQRVAWGHWTDQPEVLDDNLDFICRICEDEVATSCLEDHSRICALAD 380
Query: 434 KCELNCLDVDERLLKLSEILEQISESCNSSSHPIL--GSPENSRTQSMNSA--------- 482
+C+ LDVD+RL +++E LE+++ES S + GSP+ ++T N+
Sbjct: 381 RCDQQGLDVDDRLRRIAETLERMAESLTPKSFSLAAGGSPDTAKTSGSNNGGCSSDGALS 440
Query: 483 ---ITYDGYSPKI-SEWRNKGVEGMFEDIHEMDTACI--DDSHLGSLNLRGHLGLKL--- 533
ITY ++ K+ E KG E + ED +E+D A + D+ S+ + G K+
Sbjct: 441 ERCITYPTFTDKVWGELLRKGSEELLEDTYEIDAASMGDDNKKANSVTCKTRFGPKIEQS 500
Query: 534 --------SGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIA 585
S +SS GS+T S TP+ D +RN E++D Q+ E+ADIA
Sbjct: 501 SVPTSSPGSALAPASSAGSLTPRSPLATPRISQIDVLLSDRNGFNEIDDALQINEIADIA 560
Query: 586 RCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLD 645
RC+A ++G+E+LL+C+ D+QD+L+++K++AL + TFG RIEKL EKY E+LD
Sbjct: 561 RCIAGASPDEDGTEYLLSCLEDVQDILRYNKVEALTVATFGKRIEKLCMEKYHKFLEILD 620
Query: 646 EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFL 705
S ++ +L+ + S STP+H S+K+RT+IDDFEIIKPISRGAFGRVFL
Sbjct: 621 PNGVEVASSVGDDE--LLEDDTFHSYKSTPVHPSYKDRTTIDDFEIIKPISRGAFGRVFL 678
Query: 706 ARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765
ARKRTTGDLFAIKVLKK DMIRKN +E + AERNILI+ RNPFVVRFFYSFTC +NLYLV
Sbjct: 679 ARKRTTGDLFAIKVLKKADMIRKNAVESVKAERNILISARNPFVVRFFYSFTCAENLYLV 738
Query: 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 825
MEYLNGGD+YSLLR +GCL+E +AR+YIAELVLALE LHSLG+VHRDLKPDN+LIAHDGH
Sbjct: 739 MEYLNGGDMYSLLRTLGCLDEALARVYIAELVLALECLHSLGVVHRDLKPDNILIAHDGH 798
Query: 826 IKLTDFGLSKIGLINNTIDLSGPETDGIM------PSDAHYPEYQ-QTDNRNRHSAVGTP 878
IKLTDFGLS++GLIN+T DLSGP G M + P+++ Q R + SAVGTP
Sbjct: 799 IKLTDFGLSRVGLINSTDDLSGPAATGTMVMEESTKNQCASPKHEHQRKIRQQRSAVGTP 858
Query: 879 DYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPS 938
DYLAPEILLGT HG AADWWS G+ILFEF+TGIPPF AE P+++FDNILNR IPWP VP
Sbjct: 859 DYLAPEILLGTSHGPAADWWSTGVILFEFLTGIPPFNAEHPQVVFDNILNRHIPWPAVPE 918
Query: 939 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDD 998
MS+EAQDLI+R L DP +RLGANGAAEVKAHPFFK +NW++LA QKA F+P P+ D
Sbjct: 919 YMSYEAQDLIDRLLTEDPTERLGANGAAEVKAHPFFKDINWETLARQKAAFIPSPDGAHD 978
Query: 999 TSYFLSRFSQISS-GLPDDQNGSYSDADTCDSSSNSRTEM----DECGDLAEF---GSCP 1050
TSYF SR++ S+ G D ++ SD ++ S S S + + DE GD+AEF SC
Sbjct: 979 TSYFSSRYAWNSNEGNFDTEHFDESDDESTCSGSTSDSALVLQTDEFGDMAEFENSSSCK 1038
Query: 1051 LDLSLINFSFKNLSQLASINHEVLVQNVKDSTRSSPA 1087
S NFSFKNLSQLASIN+++L Q+ + + P+
Sbjct: 1039 YTFS--NFSFKNLSQLASINYDLLQQSERRDSPQGPS 1073
|
Source: Physcomitrella patens subsp. patens Species: Physcomitrella patens Genus: Physcomitrella Family: Funariaceae Order: Funariales Class: Bryopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1092 | ||||||
| TAIR|locus:2028285 | 1067 | AT1G45160 [Arabidopsis thalian | 0.847 | 0.866 | 0.611 | 9e-299 | |
| TAIR|locus:2088515 | 1296 | AT3G17850 [Arabidopsis thalian | 0.651 | 0.548 | 0.528 | 1.3e-222 | |
| TAIR|locus:2198012 | 1235 | AT1G48490 [Arabidopsis thalian | 0.657 | 0.581 | 0.500 | 6e-208 | |
| TAIR|locus:2167953 | 1168 | IRE "INCOMPLETE ROOT HAIR ELON | 0.841 | 0.786 | 0.459 | 2.8e-200 | |
| DICTYBASE|DDB_G0272282 | 2102 | DDB_G0272282 "MAST family prot | 0.150 | 0.078 | 0.682 | 6.6e-92 | |
| DICTYBASE|DDB_G0276157 | 1367 | pkgA "MAST family protein kina | 0.247 | 0.197 | 0.436 | 1e-91 | |
| UNIPROTKB|F1S920 | 729 | MAST3 "Uncharacterized protein | 0.305 | 0.458 | 0.468 | 1.1e-81 | |
| RGD|1310139 | 968 | Mast4 "microtubule associated | 0.309 | 0.349 | 0.460 | 1.6e-81 | |
| POMBASE|SPAPB18E9.02c | 1318 | ppk18 "serine/threonine protei | 0.179 | 0.148 | 0.492 | 5.9e-80 | |
| POMBASE|SPCC1450.11c | 1338 | cek1 "serine/threonine protein | 0.156 | 0.127 | 0.569 | 6.8e-79 |
| TAIR|locus:2028285 AT1G45160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2868 (1014.6 bits), Expect = 9.0e-299, P = 9.0e-299
Identities = 584/955 (61%), Positives = 702/955 (73%)
Query: 142 HELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVMNVLEKMDS 201
HELGP+GG+ + YPR HSYNDLKELL +LHSRFD AKE V+ +L F +DV +EKMD
Sbjct: 139 HELGPRGGVQTPYPRPHSYNDLKELLGSLHSRFDVAKETVDKKLDVFVRDVKEAMEKMDP 198
Query: 202 PSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLSTRMLFI 261
E +EM E LL +A+ C+EMTS RA CE+IVQDLT KR+QCQ GLVKWL +++LFI
Sbjct: 199 SCPEDREMAEQLLDVARACMEMTSAQLRATCESIVQDLTRKRKQCQAGLVKWLFSQLLFI 258
Query: 262 LTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDLDYASYQKANA 321
LT CTR+++FQKE+EPI E S KFK+CLE +PA+ET W +P +S Y YQ+ A
Sbjct: 259 LTHCTRVVMFQKETEPIDESSFRKFKECLERIPALETDWGSTPRVDDSGSGYPEYQRNEA 318
Query: 322 KKKISGQQKVSTVPEISDCSCSESLDHTSENKSVFIEQNFPPQKSQHYSRMQEQQSHIVE 381
+K + K S E + DH N + + + K + S + S +VE
Sbjct: 319 GQKFKRRDKESLESETA-LDYVVPNDH-GNNAA---REGYAAAKQEFPSHEPQFDSKVVE 373
Query: 382 GRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLD 441
R + +E G+ L GSD VICRICEE VP+ HLE HSYICAYADKCE+NC+D
Sbjct: 374 QRFYLSDEYEDKMSNEPGKELGGSDYVICRICEEEVPLFHLEPHSYICAYADKCEINCVD 433
Query: 442 VDERLLKLSEILEQISESCNSSSHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVE 501
VDERLLKL EILEQI +S + +S G ENS + S + +G SPKI+EWRNKG+E
Sbjct: 434 VDERLLKLEEILEQIIDSRSLNSFTQAGGLENSVLRK--SGVASEGCSPKINEWRNKGLE 491
Query: 502 GMFEDIHEMDTACIDDSHLGSLNLRGHLGLKLXXXXXXXXXXXXXXXXXXNTPKAGHFDP 561
GMFED+HEMDTA ID+S+ ++L+ H+G K NTP+ HFD
Sbjct: 492 GMFEDLHEMDTAFIDESYTYPIHLKSHVGAKFCHHATSSSTGSITSVSSTNTPRTSHFDS 551
Query: 562 FWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKAL 620
+WLER+ P E ED++ M++L+DIARC A TDFSKEGS ++++ACM D+Q VL+ KLKAL
Sbjct: 552 YWLERHCP-EQEDLRLMMDLSDIARCGASTDFSKEGSCDYIMACMQDIQAVLKQGKLKAL 610
Query: 621 VIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSH 680
VIDTFG RIEKLL EKY+ A EL +KS S KE S +L+ S +TP
Sbjct: 611 VIDTFGGRIEKLLCEKYLHARELTADKS--SVGNIKE-SEDVLEHAS-----ATP-QLLL 661
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
K+R SIDDFEIIKPISRGAFG+VFLARKRTTGD FAIKVLKKLDMIRKNDIERIL ERNI
Sbjct: 662 KDRISIDDFEIIKPISRGAFGKVFLARKRTTGDFFAIKVLKKLDMIRKNDIERILQERNI 721
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
LITVR PF+VRFFYSFTCRDNLYLVMEYLNGGDLYSLL+KVGCL+E++ARIYIAELVLAL
Sbjct: 722 LITVRYPFLVRFFYSFTCRDNLYLVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLAL 781
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLHSL IVHRDLKPDNLLIA++GHIKLTDFGLSKIGLINNTIDLSG E+D +++H+
Sbjct: 782 EYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTNSHH 841
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ Q + R RHSAVGTPDYLAPEILLGTEHGYAADWWS GI+LFE +TGIPPFTA PE
Sbjct: 842 FQKNQEEERIRHSAVGTPDYLAPEILLGTEHGYAADWWSAGIVLFELLTGIPPFTASRPE 901
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980
IFDNILN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK+HPFF+GV+W+
Sbjct: 902 KIFDNILNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKSHPFFQGVDWE 961
Query: 981 SLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDEC 1040
+LALQKA FVPQPES++DTSYF+SRFS+ S + N S S+ D+ D E+DEC
Sbjct: 962 NLALQKAAFVPQPESINDTSYFVSRFSESSCSDTETGNNSGSNPDSGD-------ELDEC 1014
Query: 1041 GDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDSTRS---SPAKDAGT 1092
+L +F S P LSLINFSFKNLSQLASINH+VL+Q KD + SP K GT
Sbjct: 1015 TNLEKFDSPPYYLSLINFSFKNLSQLASINHDVLLQ--KDPAKGGGDSPFKSHGT 1067
|
|
| TAIR|locus:2088515 AT3G17850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1829 (648.9 bits), Expect = 1.3e-222, Sum P(3) = 1.3e-222
Identities = 394/745 (52%), Positives = 484/745 (64%)
Query: 360 NFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPI 419
NFPP K H + H + + G EQ + S++CRICEE VP
Sbjct: 565 NFPPAKDSH--EHSSKHRHNI----------SWGYWGEQ-PLISEESSIMCRICEEEVPT 611
Query: 420 SHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESC-NSSSHPILGSPENSRTQS 478
+H+E HS +C ADK + L VDERL+ ++ L++I+E+ + S SP+ + +
Sbjct: 612 THVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKDSLAAAESPDGMKVSN 671
Query: 479 MNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTAC-IDDSH-LGSLNLRGHLGLKLXXX 536
+ D SP++S+W KG E M + E D + +DD L ++ R G K
Sbjct: 672 SHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSDQG 731
Query: 537 XXXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKE 596
TP+ + + + +D+ QM ELADIA+C AD +
Sbjct: 732 MTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPGDD 791
Query: 597 GS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKY 655
S FLL+C+ DL+ V+ K AL ++TFG+RIEKL+REKY+ CEL+D++ S
Sbjct: 792 QSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLSTV 851
Query: 656 KENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF 715
+ + D V +S S P+H ++RTSIDDFEIIKPISRGAFGRVFLA+KRTTGDLF
Sbjct: 852 IDEDAPLEDDVVRSLRTS-PVHP--RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 908
Query: 716 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 775
AIKVLKK DMIRKN +E ILAER+ILI VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY
Sbjct: 909 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 968
Query: 776 SLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
SLLR +GCLEED+ R+YIAE+VLALEYLHS G+VHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 969 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1028
Query: 836 IGLINNTIDLSGPETDGIMPSDAHYPEY----QQTDNRNRHSAVGTPDYLAPEILLGTEH 891
+GLIN+T DL+GP G D +Q + R + SAVGTPDYLAPEILLGT H
Sbjct: 1029 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 1088
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
G ADWWSVGIILFE I GIPPF AE P+ IFDNILNRKIPWP VP +MS EA D+I+RF
Sbjct: 1089 GATADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPHVPEEMSAEAHDIIDRF 1148
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS 1011
L DP+QRLGA GAAEVK H FFK +NWD+LA QKA FVP ES DTSYF SR+S +S
Sbjct: 1149 LTEDPHQRLGARGAAEVKQHIFFKDINWDTLARQKAAFVPASESAIDTSYFRSRYSWNTS 1208
Query: 1012 G---LPDDQNGSYSDADT------CDSSSNSRTEMDECGDLAEFGS-CPLDLSLINFSFK 1061
P + YSDAD+ C S+ + E +EC AEF S P+D S NFSFK
Sbjct: 1209 DEQFFPSGEVPDYSDADSMTNSSGCSSNHHEEGEAEECEGHAEFESGIPVDYSFSNFSFK 1268
Query: 1062 NLSQLASINHEVLVQNVKDSTRSSP 1086
NLSQLASIN+++L + KD + P
Sbjct: 1269 NLSQLASINYDLLSKGWKDEPQQIP 1293
|
|
| TAIR|locus:2198012 AT1G48490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1703 (604.5 bits), Expect = 6.0e-208, Sum P(3) = 6.0e-208
Identities = 374/747 (50%), Positives = 476/747 (63%)
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
K V I + K S + Q H+ + R ++ G H+ + S+ICRI
Sbjct: 500 KLVAISDDMAVAKLPEVSSAKASQEHMSKNRH-NISWGYWG--HQS--CISEESSIICRI 554
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESC-NSSSHPILGSP 471
CEE +P +H+E HS ICA ADK + + VDERL+ ++ LE+I+++ S + SP
Sbjct: 555 CEEEIPTTHVEDHSRICALADKYDQKGVGVDERLMAVAVTLEKITDNVIQKDSLAAVESP 614
Query: 472 ENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTAC-IDDSH-LGSLNLRGHL 529
E + + + D SPK+S+W +G E M + E D + +DD L S++ R
Sbjct: 615 EGMKISNASLTEELDVLSPKLSDWSRRGSEDMLDCFPETDNSVFMDDMGCLPSMSCRTRF 674
Query: 530 GLKLXXXXXXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVA 589
G K TP+ + + + +D QM ELADIARC A
Sbjct: 675 GPKSDQGMATSSAGSMTPRSPIPTPRPDPIELLLEGKGTFHDQDDFPQMSELADIARCAA 734
Query: 590 DT-DFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKS 648
+ + + LL+C+ DL+ V+ K AL+++TFG+RIEKL++EKY+ CEL+D++
Sbjct: 735 NAIPVDDQSIQLLLSCLEDLRVVIDRRKFDALIVETFGTRIEKLIQEKYLQLCELMDDEK 794
Query: 649 PTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARK 708
T E++ L D V +S S P+H ++R SIDDFE++K ISRGAFG V LARK
Sbjct: 795 GTIID---EDAPLE-DDVVRSLRTS-PVHL--RDRISIDDFEVMKSISRGAFGHVILARK 847
Query: 709 RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768
TTGDLFAIKVL+K DMIRKN +E ILAER+ILI RNPFVVRFFYSFTC +NLYLVMEY
Sbjct: 848 NTTGDLFAIKVLRKADMIRKNAVESILAERDILINARNPFVVRFFYSFTCSENLYLVMEY 907
Query: 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 828
LNGGD YS+LRK+GCL+E AR+YIAE+VLALEYLHS G+VHRDLKPDNLLIAHDGH+KL
Sbjct: 908 LNGGDFYSMLRKIGCLDEANARVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHVKL 967
Query: 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG 888
TDFGLSK+GLINNT DLSGP + P+ D++ SAVGTPDYLAPEILLG
Sbjct: 968 TDFGLSKVGLINNTDDLSGPVSSATSLLVEEKPKLPTLDHKR--SAVGTPDYLAPEILLG 1025
Query: 889 TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLI 948
T HG ADWWSVGIIL+EF+ GIPPF A+ P+ IFDNILNR I WP VP DMS EA+DLI
Sbjct: 1026 TGHGATADWWSVGIILYEFLVGIPPFNADHPQQIFDNILNRNIQWPPVPEDMSHEARDLI 1085
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQ 1008
+R L DP+QRLGA GAAEVK H FFK ++W++LA QKA FVP E+ DTSYF SR+S
Sbjct: 1086 DRLLTEDPHQRLGARGAAEVKQHSFFKDIDWNTLAQQKAAFVPDSENAFDTSYFQSRYSW 1145
Query: 1009 ISSG---LPDDQNGSYSDADT-CDSSSNSRTEMDE-----CGDLAEFG-SCPLDLSLINF 1058
SG P ++N S+ D+ C SS DE CG AEF S + NF
Sbjct: 1146 NYSGERCFPTNENEDSSEGDSLCGSSGRLSNHHDEGVDIPCGP-AEFETSVSENYPFDNF 1204
Query: 1059 SFKNLSQLASINHEVLVQNVKDSTRSS 1085
SFKNLSQLA IN+ ++ + KD T+ S
Sbjct: 1205 SFKNLSQLAYINYNLMSKGHKDETQPS 1231
|
|
| TAIR|locus:2167953 IRE "INCOMPLETE ROOT HAIR ELONGATION" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1918 (680.2 bits), Expect = 2.8e-200, Sum P(2) = 2.8e-200
Identities = 452/984 (45%), Positives = 608/984 (61%)
Query: 142 HELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVMNVLEKMDS 201
HEL KG P R+ + ++E++ + ++FD KE V+++L FA ++ LE
Sbjct: 201 HELNSKGVRPFPVWRSRAVGHMEEIMAAIRTKFDKQKEDVDADLGVFAGYLVTTLESTPE 260
Query: 202 PSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLSTRMLFI 261
+ E + LEDLL+ A+QC M + F CE IVQ L +KRQ+ +G +K R+LFI
Sbjct: 261 SNKELRVGLEDLLVEARQCATMPASEFWLKCEGIVQKLDDKRQELPMGGLKQAHNRLLFI 320
Query: 262 LTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDL-DYASYQKAN 320
LTRC RL+ F+KES + E L + L + V + + DL QK N
Sbjct: 321 LTRCNRLVQFRKESGYVEEHILGMHQ--LSDLGVYPEQMVEI--SRQQDLLREKEIQKIN 376
Query: 321 AKKKISGQQKVSTVPEISD---CSCSESLDHTSENKSVFIEQNFPP--QKSQHYSRMQEQ 375
K+ ++G+Q +D + + S D TS N + + P +K++ + +
Sbjct: 377 EKQNLAGKQDDQNSNSGADGVEVNTARSTDSTSSNFRMSSWKKLPSAAEKNRSLNNTPKA 436
Query: 376 QSHI-VEGRIV-EVTKSNCGSPHEQGQSLDGS---------------DSVICRICEEVVP 418
+ ++ ++ + N SP Q S D S +S+ICRICE +P
Sbjct: 437 KGESKIQPKVYGDENAENLHSPSGQPASADRSALWGFWADHQCVTYDNSMICRICEVEIP 496
Query: 419 ISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENSRTQS 478
+ H+E HS IC AD+C+L ++V+ RL +++E LE+I ES S + +S S
Sbjct: 497 VVHVEEHSRICTIADRCDLKGINVNLRLERVAESLEKILESWTPKSSVTPRAVADSARLS 556
Query: 479 MNSAITYDGYSPKISEWRNKGVEGMFEDI-HEMDTACIDDSHLGSLNLRGHLGLKLXXXX 537
NS+ D + E + + M + + +T +D+ LN+ + +
Sbjct: 557 -NSSRQED-----LDEISQRCSDDMLDCVPRSQNTFSLDE-----LNILNEMSM---TNG 602
Query: 538 XXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEG 597
TP+ D R +ELE+ QQ+ +L DIAR VA+ +
Sbjct: 603 TKDSSAGSLTPPSPATPRNSQVDLLLSGRKTISELENYQQINKLLDIARSVANVNVCGYS 662
Query: 598 S-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLD-EKSPTSFSKY 655
S +F++ + +L+ V+Q K ALV++TFG RIEKLL+EKYI C L+D EK +S +
Sbjct: 663 SLDFMIEQLDELKYVIQDRKADALVVETFGRRIEKLLQEKYIELCGLIDDEKVDSSNAMP 722
Query: 656 KENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF 715
E S D+V ++PL+ K+RTSI+DFEIIKPISRGAFGRVFLA+KR TGDLF
Sbjct: 723 DEESSADEDTVRSLR--ASPLNPRAKDRTSIEDFEIIKPISRGAFGRVFLAKKRATGDLF 780
Query: 716 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 775
AIKVLKK DMIRKN +E ILAERNILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDL+
Sbjct: 781 AIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLF 840
Query: 776 SLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
SLLR +GCL+ED+ARIYIAE+VLALEYLHS+ I+HRDLKPDNLLI DGHIKLTDFGLSK
Sbjct: 841 SLLRNLGCLDEDMARIYIAEVVLALEYLHSVNIIHRDLKPDNLLINQDGHIKLTDFGLSK 900
Query: 836 IGLINNTIDLSGPET---DGIMPSDAHYPEYQQ-TDNRNRHSAVGTPDYLAPEILLGTEH 891
+GLIN+T DLSG + G D ++ Q D+R +H+ VGTPDYLAPEILLG H
Sbjct: 901 VGLINSTDDLSGESSLGNSGFFAEDGSKAQHSQGKDSRKKHAVVGTPDYLAPEILLGMGH 960
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
G ADWWSVG+ILFE + GIPPF AE+P+ IF+NI+NR IPWP VP ++S+EA DLIN+
Sbjct: 961 GKTADWWSVGVILFEVLVGIPPFNAETPQQIFENIINRDIPWPNVPEEISYEAHDLINKL 1020
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS 1011
L +P QRLGA GA EVK H FFK +NWD+LA QKA+FVP E DTSYF+SR+ I +
Sbjct: 1021 LTENPVQRLGATGAGEVKQHHFFKDINWDTLARQKAMFVPSAEP-QDTSYFMSRY--IWN 1077
Query: 1012 GLPDDQN---GS-YSD-ADTCDSSS-NSRTEM-DECGDLAEFGSCP---LDLSLINFSFK 1061
P+D+N GS + D DTC SSS N++ E DECG LAEFG+ P + S NFSFK
Sbjct: 1078 --PEDENVHGGSDFDDLTDTCSSSSFNTQEEDGDECGSLAEFGNGPNLAVKYSFSNFSFK 1135
Query: 1062 NLSQLASINHEVLVQNVKDSTRSS 1085
NLSQLASIN++++++N K+S +S
Sbjct: 1136 NLSQLASINYDLVLKNAKESVEAS 1159
|
|
| DICTYBASE|DDB_G0272282 DDB_G0272282 "MAST family protein kinase DDB_G0272282" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 6.6e-92, Sum P(7) = 6.6e-92
Identities = 112/164 (68%), Positives = 130/164 (79%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
SS+ SI DFEIIKPISRGAFGRV+LA+K+ TGDL+AIKVLKKLD IRKN + ++ E
Sbjct: 1516 SSNTTSISIADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVNHVIVE 1575
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
RNIL V+N FVV+ FY+F D LYLVMEYL GGD SLLR +GC EE +A+ YIAE V
Sbjct: 1576 RNILAMVQNEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETV 1635
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841
L LEYLH IVHRDLKPDN+LI GHIKLTDFGLSKIG+I++
Sbjct: 1636 LCLEYLHKSAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDD 1679
|
|
| DICTYBASE|DDB_G0276157 pkgA "MAST family protein kinase PkgA" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 536 (193.7 bits), Expect = 1.0e-91, Sum P(4) = 1.0e-91
Identities = 128/293 (43%), Positives = 186/293 (63%)
Query: 564 LERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVID 623
L R++ E + +IEL +IA + KE L +H + D++++ K +
Sbjct: 676 LTRSNDIPHEKRKMIIELREIALFAVENGI-KEN----LKMIHIMNDIIKNFDPKDDNRE 730
Query: 624 TFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDS-----VSQSS------GV 672
+I+ L+ +K + A + D+ +S ++ NS IL S +SQ+
Sbjct: 731 -LAIKIQSLISDK-VNALKRADDVINSSPRIFRTNSPRILKSPREEELSQTPLGGRLRSD 788
Query: 673 STPLHSS---HKER--TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR 727
S P+H + +K + +I DFE IKPI++G +G+VFLA+K TGD++AIK LKK DMI+
Sbjct: 789 SDPVHQTQIEYKPKGVPTISDFEFIKPITKGGYGKVFLAKKIRTGDIYAIKRLKKSDMIK 848
Query: 728 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 787
KN ++ + ERNIL NPFVV+ +YSF ++ YLVMEYL GGD +SLL+ +G ++E+
Sbjct: 849 KNQLDHVKVERNILAYTSNPFVVKMYYSFQTKEYYYLVMEYLQGGDCFSLLQMLGSMDEN 908
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
+A++ IAE VLALEYLHS GIVHRD+KPDNLLI GHIKLTDFGLSK+GL++
Sbjct: 909 MAKMIIAETVLALEYLHSHGIVHRDVKPDNLLIDKKGHIKLTDFGLSKVGLLD 961
|
|
| UNIPROTKB|F1S920 MAST3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 752 (269.8 bits), Expect = 1.1e-81, Sum P(3) = 1.1e-81
Identities = 163/348 (46%), Positives = 216/348 (62%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 376 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 435
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 436 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVLALEYLHNYG 495
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L +G + D E+ D
Sbjct: 496 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLY----EGHIEKDTR--EF--VD 547
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+ GTP+Y+APE++ +G DWW++G++L+EF+ G PF ++PE +F ++
Sbjct: 548 KQ----VCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFFGDTPEELFGQVV 603
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKA 987
+ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L KA
Sbjct: 604 SDEIMWPEGDEALPADAQDLITRLLRQSPLDRLGTGGTHEVKQHPFFWTLDWAGLLRHKA 663
Query: 988 VFVPQPESVDDTSYFLSRFSQISS-GLPDDQ-NGSYSDADTCDSSSNS 1033
FVPQ E+ DDTSYF +R + G DD+ N S + SS S
Sbjct: 664 EFVPQLEAEDDTSYFDTRSERYRHLGSEDDETNDEESSTEIPQFSSCS 711
|
|
| RGD|1310139 Mast4 "microtubule associated serine/threonine kinase family member 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 757 (271.5 bits), Expect = 1.6e-81, Sum P(3) = 1.6e-81
Identities = 165/358 (46%), Positives = 227/358 (63%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
+SVS S+ T L K R S DFE IK IS GA+G V+ R + + FA+K + K
Sbjct: 301 ESVSSSN---TSLRLRRKPRES--DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQ 355
Query: 724 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
++I +N I++ ER+IL NPFVV + SF R +L +VMEY+ GGD +L++ +G
Sbjct: 356 NLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGP 415
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
L D+AR+Y AE VLALEYLH+ GIVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T
Sbjct: 416 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTT 475
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
+L +G + DA E+ D + GTP+Y+APE++L +G DWW++GII
Sbjct: 476 NLY----EGHIEKDAR--EF--LDKQ----VCGTPEYIAPEVILRQGYGKPVDWWAMGII 523
Query: 904 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
L+EF+ G PF ++PE +F +++ +I WP +AQDLI L +P +RLG
Sbjct: 524 LYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQDLITLLLRQNPLERLGTG 583
Query: 964 GAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSR---FSQISSGLPDDQN 1018
GA EVK H FF+ ++W+SL QKA F+PQ ES DDTSYF +R + + + DD N
Sbjct: 584 GAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDTRSEKYHHMETEEEDDTN 641
|
|
| POMBASE|SPAPB18E9.02c ppk18 "serine/threonine protein kinase Ppk18 (predicted)" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 490 (177.5 bits), Expect = 5.9e-80, Sum P(3) = 5.9e-80
Identities = 98/199 (49%), Positives = 138/199 (69%)
Query: 666 VSQSSGVSTPLH--SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
+S+ G+ST SS K SI D+EIIKPIS+G FG V+L+RK TTG+++AIKVL+K+
Sbjct: 541 LSRQIGISTLSSNISSGKGTPSIQDYEIIKPISKGTFGTVYLSRKNTTGEIYAIKVLRKV 600
Query: 724 DMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
DMI KN + + AER +L+ + FV + +Y+F RD LYLVME++NGGD SLL+ +
Sbjct: 601 DMISKNQVANVKAERAVLMAQEESAFVAKLYYAFQSRDYLYLVMEFMNGGDCASLLKSLY 660
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
+ E A+IYIAE+ L LE+LH LGI+HRD+KPDN+L++ GH+KL DFGLS++GL
Sbjct: 661 TIPESWAKIYIAEVALGLEHLHRLGIIHRDIKPDNILMSITGHLKLADFGLSQLGLTTRQ 720
Query: 843 IDLSGPETDGIMPSDAHYP 861
+ L + + + P P
Sbjct: 721 LRLQKGKNNILSPPSFQSP 739
|
|
| POMBASE|SPCC1450.11c cek1 "serine/threonine protein kinase Cek1" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 6.8e-79, Sum P(3) = 6.8e-79
Identities = 98/172 (56%), Positives = 130/172 (75%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
S S + T + +S E SI+D++I+KPIS+GAFG V+LA+KRTTGD FAIK+LKK +MI
Sbjct: 567 SPSPRIHTIVPNSAPEHPSINDYKILKPISKGAFGSVYLAQKRTTGDYFAIKILKKSNMI 626
Query: 727 RKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
KN + + AER IL++ +PFV + +Y+F +D LYLVMEYLNGGD SLL+ +G L+
Sbjct: 627 AKNQVINVRAERAILMSQGESPFVAKLYYTFQSKDYLYLVMEYLNGGDCGSLLKTMGVLD 686
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
D R YIAE VL L LH GI+HRD+KP+NLLI+ +GH+KLTDFGLS++G
Sbjct: 687 LDWIRTYIAETVLCLGDLHDRGIIHRDIKPENLLISQNGHLKLTDFGLSRVG 738
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1092 | |||
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-148 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-120 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-119 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-118 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-117 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-115 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-108 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-101 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-99 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-97 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-94 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-93 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-90 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-87 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-86 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-85 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-84 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-83 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-83 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-82 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-81 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-79 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-77 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-77 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-76 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-76 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-76 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-75 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-75 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-75 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-74 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-73 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-72 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-72 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-72 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-70 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-70 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-69 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-69 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-68 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-67 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-67 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-67 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-66 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-66 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-66 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-66 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-64 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-64 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-64 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-63 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-62 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-62 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-62 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-62 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-62 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-61 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-60 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-59 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-58 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-58 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-57 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-56 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-53 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-52 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-52 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-49 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-49 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-49 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-48 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-48 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-47 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-46 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-46 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-45 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-45 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-45 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-43 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-43 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-43 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-42 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-42 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-42 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-41 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-40 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-40 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-40 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-40 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-39 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-39 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-38 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-38 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-37 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-37 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-36 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-36 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-35 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-35 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-34 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-34 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-34 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-34 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-34 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-33 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-33 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-32 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-32 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-32 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-31 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-31 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-31 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-30 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-30 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-30 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-30 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-30 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-29 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-29 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-29 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-29 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-28 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-28 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-28 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-27 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-26 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-25 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-25 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-24 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-24 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-24 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-24 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-24 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-24 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-23 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-23 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-22 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-21 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-20 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-20 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-20 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-18 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-11 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 5e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 1e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-09 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-08 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-08 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 6e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-08 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-05 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| PRK09188 | 365 | PRK09188, PRK09188, serine/threonine protein kinas | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| cd05145 | 190 | cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 | 4e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-04 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 8e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.001 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.002 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 443 bits (1141), Expect = e-148
Identities = 166/285 (58%), Positives = 210/285 (73%), Gaps = 20/285 (7%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
IS+GA+GRVFLA+K++TGD++AIKV+KK DMIRKN ++++L ER+IL ++P+VV+ +Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
SF + NLYLVMEYL GGDL SLL VG L+EDVARIYIAE+VLALEYLHS GI+HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
PDN+LI +GH+KLTDFGLSK+GL+ I+L+ E + D R
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE---------------DKR----I 161
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTPDY+APE++LG H DWWS+G IL+EF+ GIPPF E+PE IF NILN KI WP
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979
S EA DLI++ L+ DP +RLGA E+K HPFFKG++W
Sbjct: 222 EDVEV-SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 369 bits (950), Expect = e-120
Identities = 131/280 (46%), Positives = 183/280 (65%), Gaps = 30/280 (10%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G+FG+V L RK+ TG L+A+KVLKK +I++ ++E L ERNIL + +PF+V+ Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
+F + LYLV+EY GG+L+S L K G E+ AR Y AE+VLALEYLHSLGI++RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
P+N+L+ DGHIKLTDFGL+K ++ ++
Sbjct: 121 PENILLDADGHIKLTDFGLAKELS---------------------------SEGSRTNTF 153
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
GTP+YLAPE+LLG +G A DWWS+G++L+E +TG PPF AE + I++ IL + +
Sbjct: 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF- 212
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
P +S EA+DLI+ L DP +RLG+ GA E+KAHPFF
Sbjct: 213 --PEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 366 bits (942), Expect = e-119
Identities = 155/291 (53%), Positives = 195/291 (67%), Gaps = 33/291 (11%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVV 750
+KPIS+GAFG V+LA+KR+TGD FAIKVLKK DMI KN + + AER I++ +P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
+ +YSF +D LYLVMEYLNGGD SL++ +G L ED A+ YIAE+VL +E LH GI+H
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
RD+KP+NLLI GH+KLTDFGLS+ GL N
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF--------------------------- 153
Query: 871 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 930
VGTPDYLAPE +LG +DWWS+G ++FEF+ G PPF AE+P+ +FDNIL+R+
Sbjct: 154 ----VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209
Query: 931 IPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980
I WP V S EA DLINR L DP +RLGANG E+K+HPFFK +NWD
Sbjct: 210 INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 367 bits (943), Expect = e-118
Identities = 149/321 (46%), Positives = 204/321 (63%), Gaps = 10/321 (3%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE+IK I RGAFG V+L R + TG ++A+KVL+K DMI++N I + AER+IL +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P++V+ +YSF ++LYLVMEY+ GGDL +LL + E+ AR YIAELVLAL+ +H L
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN---TIDLSGPETDGIMPSDAHYPEY 863
G +HRD+KPDN+LI DGHIKL DFGL K + L+ +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCK-KMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ +S VGTPDY+APE+L GT +G DWWS+G+IL+E + G PPF +++ + +
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 924 DNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981
+ I+N K P D +S EA DLI R L DP RLG+ E+K+HPFFKG++W++
Sbjct: 240 NKIINWKESL-RFPPDPPVSPEAIDLICRLLC-DPEDRLGS--FEEIKSHPFFKGIDWEN 295
Query: 982 LALQKAVFVPQPESVDDTSYF 1002
L K FVP+ S DTS F
Sbjct: 296 LRETKPPFVPELSSPLDTSNF 316
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 363 bits (934), Expect = e-117
Identities = 156/316 (49%), Positives = 209/316 (66%), Gaps = 12/316 (3%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+DFE IK IS GA+G V+L R + T FA+K + K ++I +N I+++ ER+IL N
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PFVV F SF + +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T +L +G + D +Q
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY----EGHIEKDTREFLDKQV 176
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F +
Sbjct: 177 --------CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 986
++ I WP + +AQDLI+R L +P +RLG GA EVK H FF G++W+ L QK
Sbjct: 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQK 288
Query: 987 AVFVPQPESVDDTSYF 1002
A F+PQ ES DDTSYF
Sbjct: 289 AEFIPQLESEDDTSYF 304
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 357 bits (919), Expect = e-115
Identities = 137/321 (42%), Positives = 197/321 (61%), Gaps = 39/321 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE IK + G+FGRV L R + +G +A+K+L K +++ +E +L E+ IL ++R+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF+V + SF NLYLVMEY+ GG+L+S LRK G E VAR Y A++VLALEYLHSL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+NLL+ DG+IK+TDFG +K + T
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRT------------------------ 155
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
++ GTP+YLAPEI+L +G A DWW++GI+++E + G PPF ++P I++ I
Sbjct: 156 -----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLAL 984
L K+ PS S +A+DLI L D +RLG NG ++K HP+F G++W +L L
Sbjct: 211 LEGKVR---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL-L 266
Query: 985 QKAV---FVPQPESVDDTSYF 1002
Q+ + F+P+ + DTS F
Sbjct: 267 QRKIEAPFIPKVKGPGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 342 bits (878), Expect = e-108
Identities = 143/331 (43%), Positives = 202/331 (61%), Gaps = 19/331 (5%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE IK I RGAFG V L +K+ TG ++A+K L+K +M+ K + + AER+IL N
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P+VV+ +YSF + LYL+MEYL GGD+ +LL K E+ R YIAE +LA++ +H L
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-----DLSGPETDGIMPSDAHYP 861
G +HRD+KPDNLL+ GHIKL+DFGL GL + LS P
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCT-GLKKSHRTEFYRILSHALPS-NFLDFISKP 178
Query: 862 EYQ----QTDNRNR----HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
+T RNR +S VGTPDY+APE+ L T + DWWS+G+I++E + G PP
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
Query: 914 FTAESPEIIFDNILNRKIPWPCVPSDM--SFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971
F +++P+ + I+N K P ++ S EA+DLI R + +RLG NG E+K+H
Sbjct: 239 FCSDNPQETYRKIINWKETLQ-FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296
Query: 972 PFFKGVNWDSLALQKAVFVPQPESVDDTSYF 1002
PFFKGV+W+ + + A +P+ +S+ DTS F
Sbjct: 297 PFFKGVDWEHIRERPAPIIPELKSITDTSNF 327
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 318 bits (818), Expect = e-101
Identities = 129/287 (44%), Positives = 173/287 (60%), Gaps = 34/287 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+EI++ + G+FG+V+LAR + TG L AIKV+KK + K D ERIL E IL +++P
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+VR + F D LYLVMEY GGDL+ LL+K G L ED AR Y+ +++ ALEYLHS GI
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
VHRDLKP+N+L+ DGH+KL DFGL++ Q
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR----------------------------QLDPG 150
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFDNIL 927
+ VGTP+Y+APE+LLG +G A D WS+G+IL+E +TG PPF + +F I
Sbjct: 151 EKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG 210
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
K P+P D+S EA+DLI + L+ DP +RL A E HPFF
Sbjct: 211 KPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 316 bits (811), Expect = 3e-99
Identities = 136/326 (41%), Positives = 195/326 (59%), Gaps = 24/326 (7%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
F+ IK + +G GRVFL R + TG LFA+KVL K +MI++N ++R+L E+ IL T+ +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLH 804
PF+ + SF L LVM+Y GG+L+ LL++ CL E+VAR Y AE++LALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET-----DGIMPSDAH 859
LGIV+RDLKP+N+L+ GHI L+DF LSK S E S
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSK---------QSDVEPPPVSKALRKGSRRS 171
Query: 860 YPEYQQTD------NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
++ + +S VGT +Y+APE++ G HG A DWW++GI+L+E + G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
Query: 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAHP 972
F + + F NIL +++ +P P S A+DLI + L+ DP++RLG GAAE+K HP
Sbjct: 232 FKGSNRDETFSNILKKEVTFPGSPPV-SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290
Query: 973 FFKGVNWDSLALQKAVFVPQPESVDD 998
FF+GVNW + +P+P+ D
Sbjct: 291 FFRGVNWALIRHTTPPIIPRPDDGID 316
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 313 bits (804), Expect = 2e-97
Identities = 157/370 (42%), Positives = 211/370 (57%), Gaps = 30/370 (8%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F IK I GAFG V L RK T L+A+K L+K D++ +N + AER+IL N +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
VV+ +YSF +DNLY VM+Y+ GGD+ SLL ++G EED+AR YIAEL A+E +H +G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGL---------SKIGLINN-----TIDLSGPETDGIM 854
+HRD+KPDN+LI DGHIKLTDFGL SK + +++ S E I
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS-EEWSEID 181
Query: 855 PSDAHYPEYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911
E ++ R HS VGTP+Y+APE+LL T + DWWSVG+IL+E + G
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 912 PPFTAESPEIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967
PPF A++P ++N + IP + +S EA DLI R L RLG NGA E
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIP-SQ--AKLSREASDLILR-LCCGAEDRLGKNGADE 297
Query: 968 VKAHPFFKGVNWDSLAL-QKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADT 1026
+KAHPFFKG+++ SL QKA ++P+ DTS F L D +G S
Sbjct: 298 IKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNF-DPVDP--EKLRSDDSGESSPDRN 354
Query: 1027 CDSSSNSRTE 1036
++ RTE
Sbjct: 355 VKPNNRKRTE 364
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 301 bits (774), Expect = 2e-94
Identities = 109/290 (37%), Positives = 170/290 (58%), Gaps = 12/290 (4%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVR 745
DDF+ K I G+F V LA+++ T +AIK+L K +I++ ++ + E+ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+P +++ +Y+F +NLY V+EY G+L +RK G L+E R Y AE++LALEYLHS
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
GI+HRDLKP+N+L+ D HIK+TDFG +K+ + D+ + +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVL---DPNSSPESNKGDATNIDSQIEKNR- 176
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R S VGT +Y++PE+L G ++D W++G I+++ +TG PPF + + F
Sbjct: 177 ---RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVKAHPFF 974
IL + + P + +A+DLI + L+ DP RLG N G E+KAHPFF
Sbjct: 234 ILKLEYSF---PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 301 bits (772), Expect = 2e-93
Identities = 129/320 (40%), Positives = 193/320 (60%), Gaps = 38/320 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DF+I+ + +G +G+VFLA+K+ TG++ A+K +KK + + N++ +L ER+IL T ++
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
++V+ Y+F + LYL MEY+ GGD +LL +G L ED AR Y+AE+ A++ LH LG
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDLKP+N LI GHIKLTDFGLSK + +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYA--------------------- 155
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+S VG+PDY+APE+L G + + D+WS+G +L+EF+ G PPF+ +P ++N+
Sbjct: 156 ----NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211
Query: 928 NRK--IPWPC---VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982
K + P ++S EA DLI + LI+DP++R G ++K HPFFK V+W+ L
Sbjct: 212 YWKETLQRPVYDDPRFNLSDEAWDLITK-LINDPSRRFG--SLEDIKNHPFFKEVDWNEL 268
Query: 983 ALQKAVFVPQPESVDDTSYF 1002
K FVP+ ES DT YF
Sbjct: 269 RELKPPFVPELESEIDTGYF 288
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 295 bits (757), Expect = 1e-90
Identities = 146/352 (41%), Positives = 205/352 (58%), Gaps = 52/352 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+DF +K I +GAFG V L +K+ TG ++A+K L K +M +K+ + + AER++L +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P+VV +YSF LYL+ME+L GGDL ++L K EDV R Y+AE VLA+E +H L
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLS---------------------------KIGLI 839
G +HRD+KPDN+LI GHIKL+DFGLS + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR----HSAVGTPDYLAPEILLGTEHGYAA 895
++I+L+ D I T +NR +S VGTPDY+APEI L +G
Sbjct: 181 VDSINLTMSSKDQI-----------ATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229
Query: 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP---CVPSD--MSFEAQDLINR 950
DWWS+G I+FE + G PPF +E+ + I+N W P D +S EA+DLI R
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIIN----WRETLYFPDDIHLSVEAEDLIRR 285
Query: 951 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYF 1002
LI + RLG GA E+K+HPFF+GV+WD++ +A F+PQ +S+ DTSYF
Sbjct: 286 -LITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYF 336
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 283 bits (727), Expect = 3e-87
Identities = 115/331 (34%), Positives = 186/331 (56%), Gaps = 36/331 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVR 751
K + +G+FG+V LA + T +L+A+KVLKK +++ +D+E + E+ +L PF+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
F +D L+ VMEY+NGGDL +++ G +E AR Y AE+VL L++LH GI++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK DN+L+ +GHIK+ DFG+ K G++
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILG--------------------------GVTTS 154
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTPDY+APEIL +G A DWW++G++L+E + G PF + + +F +IL ++
Sbjct: 155 -TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV- 988
+ P +S EA+ ++ FL +P +RLG G ++K HPFF+ ++WD L ++
Sbjct: 214 RY---PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKP 270
Query: 989 -FVPQPESVDDTSYFLSRFSQISSGL-PDDQ 1017
F P+ + D S F F++ L P D+
Sbjct: 271 PFKPKIKGRFDVSNFDDEFTKEKPVLTPPDE 301
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 279 bits (715), Expect = 4e-86
Identities = 129/318 (40%), Positives = 185/318 (58%), Gaps = 44/318 (13%)
Query: 688 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 743
+FE+++ + GA+G+VFL RK G L+A+KVLKK +++K E ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 744 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
VR PF+V Y+F L+L+++Y+NGG+L++ L + E R+YIAE+VLAL++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH LGI++RD+K +N+L+ +GH+ LTDFGLSK L
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL------------------------ 156
Query: 863 YQQTDNRNR-HSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE-- 917
+ R +S GT +Y+APE++ G G+ A DWWS+G++ FE +TG PFT +
Sbjct: 157 ---AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213
Query: 918 --SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
S I IL K P P MS EA+D I + L DP +RLGANGA E+K HPFF+
Sbjct: 214 QNSQSEISRRILKSKPP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
Query: 976 GVNWDSLALQ--KAVFVP 991
G++WD LA + A F P
Sbjct: 271 GIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 278 bits (712), Expect = 1e-85
Identities = 122/320 (38%), Positives = 179/320 (55%), Gaps = 37/320 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DD E IK + G FGRV L R R + +A+KV+ ++IR + + E+ +L V +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF++R F++ + LY++MEY+ GG+L+S LR G Y +E+V ALEYLHS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+N+L+ +GHIKLTDFG +K L + T L
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWTL--------------------- 158
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
GTP+YLAPE++ H A DWW++GI+++E + G PPF ++P I++ I
Sbjct: 159 --------CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLAL 984
L K+ + P + A+DLI + L+ D +RLG NGA +VK H +FK V+WD +
Sbjct: 211 LAGKLEF---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQ 267
Query: 985 QKAV--FVPQPESVDDTSYF 1002
+K VP+ DTS F
Sbjct: 268 RKLKPPIVPKVSHDGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 276 bits (707), Expect = 2e-84
Identities = 141/340 (41%), Positives = 203/340 (59%), Gaps = 39/340 (11%)
Query: 692 IKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRNP 747
+K + +G +G+VF RK T TG +FA+KVLKK ++R + D AERNIL V++P
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
F+V Y+F LYL++EYL+GG+L+ L + G ED A Y++E+ LALE+LH G
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I++RDLKP+N+L+ GH+KLTDFGL K + T+
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT----------------------- 157
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
H+ GT +Y+APEIL+ + HG A DWWS+G ++++ +TG PPFTAE+ + D IL
Sbjct: 158 ----HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 985
K+ +P ++ EA+DL+ + L +P+ RLGA AAEV++HPFF+ VNWD L +
Sbjct: 214 KGKL---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLAR 270
Query: 986 K--AVFVPQPESVDDTSYFLSRFS-QISSGLPDDQNGSYS 1022
K F P +S +D S F S+F+ Q PDD S S
Sbjct: 271 KVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSES 310
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 271 bits (694), Expect = 2e-83
Identities = 105/291 (36%), Positives = 161/291 (55%), Gaps = 36/291 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+E+++ + G+FG V+ A+ + TG + A+K+LKK + + E IL + +P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+VR +F +D+LYLVMEY GGDL+ L + G L ED A+ +++ LEYLHS GI
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRDLKP+N+L+ +G +K+ DFGL+K L +++
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSS-------------------------- 153
Query: 869 RNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAE---SPEIIFD 924
+ + VGTP Y+APE+LL G +G D WS+G+IL+E +TG PPF+ E +
Sbjct: 154 -SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR 212
Query: 925 NILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
IL + + S S EA+DLI + L DP++R A E+ HP+F
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP---TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 273 bits (700), Expect = 3e-83
Identities = 126/330 (38%), Positives = 191/330 (57%), Gaps = 42/330 (12%)
Query: 681 KERTS---IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
K TS + DFE+ + + G+FGRV +A+ + TG+ +AIK LKK ++++ ++ + E
Sbjct: 9 KPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQE 68
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
++IL+ + +PF+V SF + +Y ++E++ GG+L++ LRK G DVA+ Y AELV
Sbjct: 69 KSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV 128
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
LA EYLHS I++RDLKP+NLL+ + GH+K+TDFG +K
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK---------------------- 166
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
P+ T GTP+YLAPE++ HG A DWW++G++L+EFI G PPF +
Sbjct: 167 -KVPDRTFT-------LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218
Query: 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFK 975
+P I++ IL ++ + P+ A+DL+ L D +RLG G A+VK HP+F
Sbjct: 219 TPFRIYEKILAGRLKF---PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275
Query: 976 GVNWDSLALQKAVFVPQP---ESVDDTSYF 1002
G NWD L + P P +S DTS F
Sbjct: 276 GANWDKL-YARYYPAPIPVRVKSPGDTSNF 304
|
Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 269 bits (689), Expect = 1e-82
Identities = 104/293 (35%), Positives = 169/293 (57%), Gaps = 39/293 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ G FGRV L + ++ FA+K +KK ++ E I +E+ IL +PF+V+ +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
+F + +Y++MEY GG+L+++LR G +E AR YIA +VLA EYLH+ GI++RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR-HS 873
P+NLL+ +G++KL DFG +K + + + +
Sbjct: 121 PENLLLDSNGYVKLVDFGFAK-----------------------------KLKSGQKTWT 151
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA--ESPEIIFDNIL--NR 929
GTP+Y+APEI+L + ++ D+WS+GI+L+E +TG PPF E P I+++IL N
Sbjct: 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG 211
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWD 980
K+ + P+ + A+DLI + L +P +RLG G ++K H +F G +W+
Sbjct: 212 KLEF---PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 267 bits (684), Expect = 9e-81
Identities = 143/329 (43%), Positives = 205/329 (62%), Gaps = 18/329 (5%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE +K I RGAFG V L +K+ TG ++A+K+L+K DM+ K + I AER+IL+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+VV+ FYSF + NLYL+ME+L GGD+ +LL K L E+ + YIAE VLA++ +H L
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ-- 864
G +HRD+KPDNLL+ GH+KL+DFGL GL PSD +
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCT-GLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179
Query: 865 ---QTDNRNR----HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
+T +NR +S VGTPDY+APE+ + T + DWWS+G+I++E + G PPF +E
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 918 SPEIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+P+ + ++N K P P VP +S +A+DLI RF D R+G+NG E+K+HPF
Sbjct: 240 TPQETYRKVMNWKETLVFP-PEVP--ISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295
Query: 974 FKGVNWDSLALQKAVFVPQPESVDDTSYF 1002
F+GV+W + + A + +S+DDTS F
Sbjct: 296 FEGVDWGHIRERPAAIPIEIKSIDDTSNF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 263 bits (673), Expect = 7e-79
Identities = 148/336 (44%), Positives = 200/336 (59%), Gaps = 23/336 (6%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F IK + GAFG V LARK T L+A+K L+K D++ +N + + AER+IL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
VVR +YSF +DNLY VM+Y+ GGD+ SLL ++G ED+AR YIAEL A+E +H +G
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGL--------------SKIGLINNTIDLSGPETD--G 852
+HRD+KPDN+LI DGHIKLTDFGL S + +++D S D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 853 IMPSDAHYP-EYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
D P E + R HS VGTP+Y+APE+LL T + DWWSVG+IL+E +
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 909 TGIPPFTAESPEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAE 967
G PPF A++P ++N + P + +S EA DLI + L P RLG NGA E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADE 301
Query: 968 VKAHPFFKGVNWDS-LALQKAVFVPQPESVDDTSYF 1002
+KAHPFFK +++ S L Q A ++P+ DTS F
Sbjct: 302 IKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNF 337
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 258 bits (660), Expect = 1e-77
Identities = 135/324 (41%), Positives = 194/324 (59%), Gaps = 35/324 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFEI+K I RGAFG V + + + TG ++A+K+L K +M+++ + ER++L+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHS 805
++ Y+F +NLYLVM+Y GGDL +LL K L ED+AR Y+AE+VLA++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
LG VHRD+KPDN+L+ +GHI+L DFG S + L+ DG + S+
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLL----------ADGTVQSNV------- 162
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 920
AVGTPDY++PEIL E +G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 921 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ I+N K +P +D+S EA+DLI R LI P RLG NG + K HPFF+G++
Sbjct: 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRR-LICSPETRLGRNGLQDFKDHPFFEGID 273
Query: 979 WDSLALQKAVFVPQPESVDDTSYF 1002
WD++ A +VP+ S DTS F
Sbjct: 274 WDNIRNSTAPYVPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 2e-77
Identities = 141/328 (42%), Positives = 206/328 (62%), Gaps = 16/328 (4%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+DFE +K I RGAFG V L +K+ TG ++A+K+L+K DM+ K + I AER+IL+ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+VV+ FYSF + NLYL+ME+L GGD+ +LL K L E+ + YIAE VLA++ +H L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ-- 864
G +HRD+KPDNLL+ GH+KL+DFGL GL + +PSD +
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCT-GLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 865 ---QTDNRNRH----SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
+T RNR S VGTPDY+APE+ + T + DWWS+G+I++E + G PPF +E
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 918 SPEIIFDNILNRK---IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+P+ + ++N K I P VP +S +A+DLI RF + R+GA G E+K +PFF
Sbjct: 240 TPQETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFF 296
Query: 975 KGVNWDSLALQKAVFVPQPESVDDTSYF 1002
+GV+W+ + + A + +S+DDTS F
Sbjct: 297 EGVDWEHIRERPAAIPIEIKSIDDTSNF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 255 bits (652), Expect = 1e-76
Identities = 127/333 (38%), Positives = 180/333 (54%), Gaps = 35/333 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +G FG+V L R++ TG +A+K+LKK +I K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL YLHS +V+RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
LK +NL++ DGHIK+TDFGL K G+ +D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------SDGATMK 153
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV-- 988
+ P +S EA+ L+ L DP QRLG A E+ H FF +NW + +K
Sbjct: 214 F---PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPP 270
Query: 989 FVPQPESVDDTSYFLSRF-SQISSGLPDDQNGS 1020
F PQ S DT YF F +Q + P D+ S
Sbjct: 271 FKPQVTSETDTRYFDEEFTAQSITITPPDRYDS 303
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 253 bits (649), Expect = 3e-76
Identities = 125/344 (36%), Positives = 187/344 (54%), Gaps = 41/344 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 751
K I +G+FG+V LA+ + G +A+KVL+K +++K + + I+AERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
YSF D LY V++Y+NGG+L+ L++ E AR Y AE+ AL YLHSL I++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GH+ LTDFGL K +GI S
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGIEHSK------------TT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + ++DNILN+ +
Sbjct: 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQK--AV 988
+ ++S A+ L+ L D +RLGA + E+K H FF +NWD L +K
Sbjct: 214 R---LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPP 270
Query: 989 FVPQPESVDDTSYFLSRFSQI----SSGLPDDQN---GSYSDAD 1025
F P D +F F++ S G D S +AD
Sbjct: 271 FNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEAD 314
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 255 bits (653), Expect = 3e-76
Identities = 125/328 (38%), Positives = 187/328 (57%), Gaps = 37/328 (11%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R +DF++IK I RGAFG V L R +++ ++A+K+L K +MI+++D ER+I+
Sbjct: 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+ ++V+ Y+F LY+VMEY+ GGDL +L+ + E AR Y AE+VLAL+
Sbjct: 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDA 157
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HS+G +HRD+KPDN+L+ GH+KL DFG + + + +G++ D
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFG--------TCMKM---DANGMVRCD----- 201
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 918
+AVGTPDY++PE+L +G DWWSVG+ L+E + G PF A+S
Sbjct: 202 ----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
Query: 919 PEIIFDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ I++ K P D +S +A+DLI FL D RLG NG E+K+HPFFK
Sbjct: 252 LVGTYSKIMDHKNSL-TFPDDIEISKQAKDLICAFLT-DREVRLGRNGVDEIKSHPFFKN 309
Query: 977 --VNWDSLALQKAVFVPQPESVDDTSYF 1002
+D++ A VP+ S DTS F
Sbjct: 310 DQWTFDNIRETVAPVVPELSSDIDTSNF 337
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 1e-75
Identities = 154/382 (40%), Positives = 206/382 (53%), Gaps = 49/382 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F IK + GAFG V LA K T L+A+K L+K D++ +N + + AER+IL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
VV+ +YSF +DNLY VM+Y+ GGD+ SLL ++ E +AR YIAEL LA+E +H +G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGL---------SKIGLINNTIDLSGPETDGIMPSD-- 857
+HRD+KPDN+LI DGHIKLTDFGL SK + I D + PSD
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI-----RQDSMEPSDLW 177
Query: 858 -----------AHYPEYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
E + T R HS VGTP+Y+APE+LL + DWWSVG+I
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 904 LFEFITGIPPFTAESPE------IIFDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHD 955
LFE + G PPF A +P I ++N L+ +P +S EA DLI + L
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLH-------IPPQVKLSPEAVDLITK-LCCS 289
Query: 956 PNQRLGANGAAEVKAHPFFKGVNWDS-LALQKAVFVPQPESVDDTSYFLSRFSQISSGLP 1014
+RLG NGA ++KAHPFF V++ S + Q A +VP+ DTS F + S
Sbjct: 290 AEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDP--VEEESPWN 347
Query: 1015 DDQNGSYSDADTCDSSSNSRTE 1036
D S DT S + E
Sbjct: 348 DASGDSTRTWDTLCSPNGKHPE 369
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 2e-75
Identities = 132/333 (39%), Positives = 197/333 (59%), Gaps = 37/333 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 743
+FE++K + GA+G+VFL RK T TG L+A+KVL+K +++K +E ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 744 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
VR +PF+V Y+F L+L+++Y++GG++++ L + ED R Y E++LALE+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH LGIV+RD+K +N+L+ +GH+ LTDFGLSK E
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK--------------------------E 154
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
+ + +S GT +Y+APEI+ G HG A DWWS+GI++FE +TG PFT E
Sbjct: 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214
Query: 922 IFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVN 978
+ R + P PS + EAQDL+++ L DP +RLGA GA+E+K HPFFKG++
Sbjct: 215 TQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274
Query: 979 WDSLALQK--AVFVPQPESVDDTSYFLSRFSQI 1009
W++LAL+K F P + D F F+ +
Sbjct: 275 WEALALRKVNPPFRPSIRNELDVGNFAEEFTNL 307
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 3e-75
Identities = 120/318 (37%), Positives = 183/318 (57%), Gaps = 36/318 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +G+FG+V RKR T ++A+K ++K ++ ++++ LAER +L V PF+V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
SF + LYLV+ ++NGG+L+ L++ G + AR Y AEL+ ALE LH +++RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
P+N+L+ + GHI L DFGL K+ + + D N +
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKD-------------------------DDKTN--TF 153
Query: 875 VGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
GTP+YLAPE+LLG HGY A DWW++G++L+E +TG+PPF E+ ++ IL +
Sbjct: 154 CGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR 211
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAV--FV 990
+ P +A+DL+ L DP +RLG NGA E+K HPFF ++W L ++ F
Sbjct: 212 F---PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFK 268
Query: 991 PQPESVDDTSYFLSRFSQ 1008
P S DTS F F++
Sbjct: 269 PAVSSAIDTSNFDEEFTR 286
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 248 bits (635), Expect = 3e-74
Identities = 120/328 (36%), Positives = 178/328 (54%), Gaps = 40/328 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---R 745
F + + RG FG+V LA + TG+L+AIK LKK D+I ++++E ++ E+ I T R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+PF+V F F D++ VMEY GGDL + E A Y A +VL L+YLH
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE 119
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
IV+RDLK DNLL+ +G +K+ DFGL K +G+ D
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK---------------EGMGFGD-------- 156
Query: 866 TDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
R S GTP++LAPE+L T + A DWW +G++++E + G PF + E +FD
Sbjct: 157 -----RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSL 982
+I+N ++ +P +S EA ++ R L +P +RLG+ A +VK PFF+ +NWD L
Sbjct: 212 SIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268
Query: 983 ALQK--AVFVPQPESVDDTSYFLSRFSQ 1008
+K FVP + +D S F F+
Sbjct: 269 LARKIKPPFVPTIKGPEDVSNFDEEFTS 296
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 245 bits (626), Expect = 4e-73
Identities = 133/342 (38%), Positives = 194/342 (56%), Gaps = 48/342 (14%)
Query: 692 IKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+K + +G+FG+VFL RK T G L+A+KVLKK + + D R ER+IL V +PF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPF 59
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLG 807
+V+ Y+F LYL++++L GGDL++ L K V EEDV + Y+AEL LAL++LHSLG
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAELALALDHLHSLG 118
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I++RDLKP+N+L+ +GHIKLTDFGLSK + D
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSK----------------------------ESID 150
Query: 868 NRNR-HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ + +S GT +Y+APE++ H +ADWWS G+++FE +TG PF + + I
Sbjct: 151 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLAL 984
L K+ +P +S EAQ L+ +P RLGA +G E+K HPFF ++W+ L
Sbjct: 211 LKAKLG---MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKL-Y 266
Query: 985 QKAV---FVPQPESVDDTSYFLSRFS----QISSGLPDDQNG 1019
++ + F P DDT YF F+ + S G+P N
Sbjct: 267 RREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDSPGIPPSANA 308
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 241 bits (617), Expect = 1e-72
Identities = 106/287 (36%), Positives = 157/287 (54%), Gaps = 31/287 (10%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
FE+++ I +GAFG+V + +KR T +FA+K + K + K + +L ER IL + +PF
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V +YSF +N+YLV++ L GGDL Y L +KV E+ + +I E+VLALEYLHS G
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK-FSEEQVKFWICEIVLALEYLHSKG 120
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRD+KPDN+L+ GH+ +TDF ++ T
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATK----------------------------VTP 152
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+ S GTP Y+APE+L + A DWWS+G+ +E + G P+ S I
Sbjct: 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
++ P+ S EA D IN+ L DP +RLG N ++K HP+F
Sbjct: 213 KQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 241 bits (617), Expect = 9e-72
Identities = 121/325 (37%), Positives = 179/325 (55%), Gaps = 40/325 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DF++ + RG FG V + R++ TGD++A+KV+KK ++ + + ER+IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEYLHS 805
P++ + Y+F +DNLYLVMEY GGDL SLL R +ED+A+ Y+AELVLA+ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+G VHRD+KP+N+LI GHIKL DFG + + ++
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSA-----------------ARLTANKMV----- 158
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPPFTAESP 919
N VGTPDY+APE+L +G DWWS+G+I +E I G PF +
Sbjct: 159 ----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214
Query: 920 EIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
++NI+N R + +P P +S + DLI L+ +RLG G + HPFF +
Sbjct: 215 AKTYNNIMNFQRFLKFPEDPK-VSSDFLDLIQS-LLCGQKERLGYEG---LCCHPFFSKI 269
Query: 978 NWDSLALQKAVFVPQPESVDDTSYF 1002
+W+++ FVP +S DDTS F
Sbjct: 270 DWNNIRNSLPPFVPTLKSDDDTSNF 294
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 241 bits (617), Expect = 9e-72
Identities = 109/337 (32%), Positives = 180/337 (53%), Gaps = 36/337 (10%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 746
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GI++RDLK DN+++ +GHIK+ DFG+ K + I
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK---------------ENIFGGK--------- 156
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PPF E + +F +I
Sbjct: 157 ---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLAL 984
+ + + P +S EA + L P +RLG G +++ H FF+ ++W+ L
Sbjct: 214 MEHNVSY---PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLER 270
Query: 985 Q--KAVFVPQPESVDDTSYFLSRFSQISSGL-PDDQN 1018
+ + F P+ + F F++ L P D+
Sbjct: 271 REIQPPFKPKVKGRRSAENFDKFFTREPPVLTPPDKL 307
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 237 bits (607), Expect = 2e-70
Identities = 118/321 (36%), Positives = 187/321 (58%), Gaps = 38/321 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 753
+ +G+FG+V LAR + +G L+A+KVLKK +++ +D+E + E+ IL RN PF+ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F D L+ VME++NGGDL ++K +E AR Y AE+ AL +LH GI++RDL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K DN+L+ H+GH KL DFG+ K G+ N G S +
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFN-----------GKTTS----------------T 155
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW 933
GTPDY+APEIL +G + DWW++G++L+E + G PF AE+ + +F+ ILN ++ +
Sbjct: 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY 215
Query: 934 PCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQKAV-- 988
P+ +S +A D++ F+ +P RLG+ G + HPFFK ++W+ L ++ +
Sbjct: 216 ---PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLN-RRQIEP 271
Query: 989 -FVPQPESVDDTSYFLSRFSQ 1008
F P+ +S +D S F F +
Sbjct: 272 PFRPRIKSREDVSNFDPDFIK 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (607), Expect = 2e-70
Identities = 126/324 (38%), Positives = 185/324 (57%), Gaps = 38/324 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVR 751
I +G FG+V+ RK+ T ++A+KVL K +++ K ++ + ERNIL+ +PF+V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
+SF +LYLV +Y++GG+L+ L+K G ED A+ YIAELVLALE+LH IV+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GHI L DFGLSK L TDN+
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANL---------------------------TDNKTT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYA--ADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929
++ GT +YLAPE+LL E GY D+WS+G+++FE G PF AE + ++ NI
Sbjct: 154 NTFCGTTEYLAPEVLL-DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG 212
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQKAV 988
K+ +P + +S E + + L +P RLGA A E+K HPFF ++WD L+ ++
Sbjct: 213 KVRFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQIT 270
Query: 989 --FVPQPESVDDTSYFLSRFSQIS 1010
F P +S +D S F F+ S
Sbjct: 271 PPFKPIVDSDEDVSNFDPEFTNSS 294
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 1e-69
Identities = 116/317 (36%), Positives = 179/317 (56%), Gaps = 35/317 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 751
K + +G+FG+V LA + T + FAIK LKK ++ +D+E + ER +L +PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
F +F +++L+ VMEYLNGGDL ++ G +E AR Y AE++ L++LH GI++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK DN+L+ DGHIK+ DFG+ K +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEG---------------------------KA 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTPDY+APEIL G ++ + DWWS G++L+E + G PF E + +FD+ILN
Sbjct: 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-DR 212
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK--AVF 989
P P +S EA+D +++ DP +RLG +G +++ HPFF+G++W+ L ++ F
Sbjct: 213 PH--FPRWISKEAKDCLSKLFERDPTKRLGVDG--DIRQHPFFRGIDWERLEKREIPPPF 268
Query: 990 VPQPESVDDTSYFLSRF 1006
P+ +S D S F F
Sbjct: 269 KPKVKSPSDASNFDREF 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 2e-69
Identities = 123/319 (38%), Positives = 191/319 (59%), Gaps = 45/319 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 743
+FE++K + GA+G+VFL RK + +G L+A+KVLKK +++K E ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 744 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+R +PF+V Y+F L+L+++Y+NGG+L++ L + +E +IY E+VLALE+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH LGI++RD+K +N+L+ +GH+ LTDFGLSK E
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--------------------------E 154
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE--- 917
+ + + +S GT +Y+AP+I+ G + G+ A DWWS+G++++E +TG PFT +
Sbjct: 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214
Query: 918 -SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFF 974
S I IL + P+ P +MS A+D+I R L+ DP +RLG + A E+K HPFF
Sbjct: 215 NSQAEISRRILKSEPPY---PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271
Query: 975 KGVNWDSLALQKAVFVPQP 993
+ +NWD LA +K VP P
Sbjct: 272 QKINWDDLAAKK---VPAP 287
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 2e-68
Identities = 124/342 (36%), Positives = 184/342 (53%), Gaps = 38/342 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEYLHS +V+RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
+K +NL++ DGHIK+TDFGL K G+ +D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGI---------------------------SDGATMK 153
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV-- 988
+ P +S EA+ L+ L DP QRLG + A EV H FF +NW + +K +
Sbjct: 214 F---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 270
Query: 989 FVPQPESVDDTSYFLSRFSQISSGL-PDDQNGSYSDADTCDS 1029
F PQ S DT YF F+ S + P D+ Y +
Sbjct: 271 FKPQVTSEVDTRYFDDEFTAQSITITPPDR---YDSLGLLEL 309
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 1e-67
Identities = 133/347 (38%), Positives = 191/347 (55%), Gaps = 39/347 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +G FG+V L R++ +G +A+K+LKK +I K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
YSF +D L VMEY+NGG+L+ L + ED R Y AE+V AL+YLHS IV+RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
LK +NL++ DGHIK+TDFGL K G+ TD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------TDAATMK 153
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV-- 988
+ P +S +A+ L++ LI DPN+RLG + A E+ H FF GVNW + +K V
Sbjct: 214 F---PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPP 270
Query: 989 FVPQPESVDDTSYFLSRFS-QISSGLPDDQNGSYSDADTCDSSSNSR 1034
F PQ S DT YF F+ Q + P ++ D D D N R
Sbjct: 271 FKPQVTSETDTRYFDEEFTAQTITITPPEK----YDEDGMDCMDNER 313
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 1e-67
Identities = 111/323 (34%), Positives = 186/323 (57%), Gaps = 37/323 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 751
K + +G+FG+V LA + T +++AIKVLKK +++ +D++ + E+ IL + ++PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
F +D L+ VMEY+NGGDL +++ +E +R Y AE+ LAL +LH G+++R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK DN+L+ +GH KL DFG+ K G++N
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--------------------------- 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTPDY+APEIL E+G + DWW++G++++E + G PPF A++ + +F++IL+ +
Sbjct: 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLG----ANGAAEVKAHPFFKGVNWDSLALQ-- 985
+P +S EA ++ F+ +PN+RLG G +K HPFFK ++W L +
Sbjct: 214 LYPVW---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKI 270
Query: 986 KAVFVPQPESVDDTSYFLSRFSQ 1008
K F P+ ++ D + F F++
Sbjct: 271 KPPFKPKIKTKRDVNNFDQDFTK 293
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 229 bits (584), Expect = 3e-67
Identities = 129/324 (39%), Positives = 186/324 (57%), Gaps = 35/324 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFEIIK I RGAFG V + + + T ++A+K+L K +M+++ + ERN+L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
++ Y+F + LYLVM+Y GGDL +LL K L ED+AR YIAE+VLA+ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
L VHRD+KPDN+L+ +GHI+L DFG S + + DG + S
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQ----------DGTVQSSV------- 162
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYA-----ADWWSVGIILFEFITGIPPFTAESPE 920
AVGTPDY++PEIL E G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 921 IIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ I+N + +P +D+S EA+DLI R LI +RLG NG + K H FF+G++
Sbjct: 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQR-LICSRERRLGQNGIEDFKKHAFFEGID 273
Query: 979 WDSLALQKAVFVPQPESVDDTSYF 1002
W+++ +A ++P S DTS F
Sbjct: 274 WENIRNLEAPYIPDVSSPSDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 227 bits (579), Expect = 2e-66
Identities = 129/324 (39%), Positives = 190/324 (58%), Gaps = 35/324 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+DFEI+K I RGAFG V + + + +FA+K+L K +M+++ + ER++L+ N
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
++ Y+F +NLYLVM+Y GGDL +LL K L ED+AR Y+AE+V+A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
L VHRD+KPDN+L+ +GHI+L DFG S + L+ DG + S
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLME----------DGTVQSSV------- 162
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 920
AVGTPDY++PEIL E +G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 921 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ I+N K +P +D+S +A+DLI R LI RLG NG + K HPFF G++
Sbjct: 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRR-LICSREHRLGQNGIEDFKQHPFFTGID 273
Query: 979 WDSLALQKAVFVPQPESVDDTSYF 1002
WD++ +A ++P+ S DTS F
Sbjct: 274 WDNIRNCEAPYIPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 3e-66
Identities = 97/290 (33%), Positives = 152/290 (52%), Gaps = 33/290 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
++ + + RG+FG V+LA + TG+L A+K ++ + +E + E IL ++++P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEE-LEALEREIRILSSLQHP 59
Query: 748 FVVRFFYSFT--CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+VR++ S ++ L + +EY++GG L SLL+K G L E V R Y +++ L YLHS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
GIVHRD+K N+L+ DG +KL DFG +K T +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE--------------------- 158
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
S GTP ++APE++ G E+G AAD WS+G + E TG PP++ +
Sbjct: 159 ----GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214
Query: 926 -ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
I + P P +P +S EA+D + + L DP +R A E+ HPF
Sbjct: 215 KIGSSGEP-PEIPEHLSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 225 bits (574), Expect = 5e-66
Identities = 115/319 (36%), Positives = 184/319 (57%), Gaps = 39/319 (12%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 751
K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E+ +L + +PF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR--IYIAELVLALEYLHSLGIV 809
+ +F ++NL+ VMEYLNGGDL ++ C + D+ R Y AE++ L++LHS GIV
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
+RDLK DN+L+ DGHIK+ DFG+ K ++ DA +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENML----------------GDAKTCTF------ 156
Query: 870 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929
GTPDY+APEILLG ++ + DWWS G++L+E + G PF E +F +I
Sbjct: 157 -----CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--- 208
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK--A 987
++ PC P ++ EA+D++ + + +P +RLG G +++ HPFF+ ++W +L ++
Sbjct: 209 RMDNPCYPRWLTREAKDILVKLFVREPERRLGVKG--DIRQHPFFREIDWSALEEREIEP 266
Query: 988 VFVPQPESVDDTSYFLSRF 1006
F P+ +S +D S F F
Sbjct: 267 PFKPKVKSANDCSNFDKEF 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 9e-66
Identities = 121/342 (35%), Positives = 190/342 (55%), Gaps = 39/342 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 751
K I +G+FG+V LA++++ G +A+KVL+K +++K + I+AERN+L+ +++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
YSF + LY V++Y+NGG+L+ L++ C E AR Y AE+ A+ YLHSL I++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GH+ LTDFGL K +G+ P +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGVEPEE------------TT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + ++DNIL++ +
Sbjct: 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA-AEVKAHPFFKGVNWDSLALQKAV-- 988
+P + A DL+ L D +RLGA E+K H FF +NWD L ++
Sbjct: 214 Q---LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPP 270
Query: 989 FVPQPESVDDTSYFLSRFSQ--ISSGL---PDDQNGSYSDAD 1025
+ P D +F F+Q +SS + PD S S +
Sbjct: 271 YNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASS 312
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 5e-64
Identities = 129/328 (39%), Positives = 186/328 (56%), Gaps = 37/328 (11%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R +D+E++K I RGAFG V L R ++T ++A+K+L K +MI+++D ER+I+
Sbjct: 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+P+VV+ FY+F LY+VMEY+ GGDL +L+ + E AR Y AE+VLAL+
Sbjct: 99 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDA 157
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HS+G +HRD+KPDN+L+ GH+KL DFG +G++ D
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-----------KMNKEGMVRCD----- 201
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 918
+AVGTPDY++PE+L +G DWWSVG+ L+E + G PF A+S
Sbjct: 202 ----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
Query: 919 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ I+N K + +P +D+S EA++LI FL D RLG NG E+K H FFK
Sbjct: 252 LVGTYSKIMNHKNSLTFP-DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 309
Query: 977 VN--WDSLALQKAVFVPQPESVDDTSYF 1002
W++L A VP S DTS F
Sbjct: 310 DQWAWETLRDTVAPVVPDLSSDIDTSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 5e-64
Identities = 128/340 (37%), Positives = 186/340 (54%), Gaps = 36/340 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +G FG+V L +++ TG +A+K+LKK ++ K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHR 811
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL+YLHS +V+R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK +NL++ DGHIK+TDFGL K G+ D
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGI---------------------------KDGATM 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRL--GANGAAEVKAHPFFKGVNWDSLALQKAV- 988
+ P +S EA+ L++ L DP QRL G + A E+ H FF G+ W + +K V
Sbjct: 214 RF---PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVP 270
Query: 989 -FVPQPESVDDTSYFLSRFS-QISSGLPDDQNGSYSDADT 1026
F PQ S DT YF F+ Q+ + P DQ+ S D
Sbjct: 271 PFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMETVDN 310
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 219 bits (558), Expect = 9e-64
Identities = 120/320 (37%), Positives = 181/320 (56%), Gaps = 34/320 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 751
K I +G+FG+V LAR + +A+KVL+K +++K + + I++ERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
+SF D LY V++Y+NGG+L+ L++ C E AR Y AE+ AL YLHSL IV+R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GHI LTDFGL K + I N
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK---------------ENIEH------------NGTT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + + ++DNILN+
Sbjct: 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-- 211
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQKAV-- 988
P P +++ A+ L+ L D +RLGA + E+K H FF +NWD L +K
Sbjct: 212 PLQLKP-NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPP 270
Query: 989 FVPQPESVDDTSYFLSRFSQ 1008
F P +D +F F++
Sbjct: 271 FNPNVSGPNDLRHFDPEFTE 290
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 219 bits (558), Expect = 1e-63
Identities = 124/333 (37%), Positives = 180/333 (54%), Gaps = 42/333 (12%)
Query: 677 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIRKNDIERI 734
K + +DF I+ + G+FGRV LA + D AIK +K +I++ ++ +
Sbjct: 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKN-EDFPPVAIKRFEKSKIIKQKQVDHV 78
Query: 735 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
+ER IL + +PF V + SF LYLV+E++ GG+ ++ LR+ DV Y A
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA 138
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
++VL EYL SL IV+RDLKP+NLL+ DG IK+TDFG +K+
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV------------------ 180
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
D R ++ GTP+Y+APEILL HG AADWW++GI ++E + G PPF
Sbjct: 181 -----------VDTRT-YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHP 972
A P +I+ IL I + P + + L+ + L HD +R G GA VK HP
Sbjct: 229 YANEPLLIYQKILEGIIYF---PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285
Query: 973 FFKGVNWDSLALQKAVFVP-QP--ESVDDTSYF 1002
+F ++W SL L K V VP +P ++V D+S F
Sbjct: 286 WFGNIDWVSL-LHKNVEVPYKPKYKNVFDSSNF 317
|
Length = 340 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 216 bits (550), Expect = 1e-62
Identities = 121/345 (35%), Positives = 187/345 (54%), Gaps = 43/345 (12%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 751
K I +G+FG+V LA+++ G +A+KVL+K ++ + + + I+AERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
YSF + LY V++++NGG+L+ L++ E AR Y AE+ AL YLHS+ IV+R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GH+ LTDFGL K +GI SD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGIAQSD------------TT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE++ + DWW +G +L+E + G+PPF ++DNIL++ +
Sbjct: 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQK--AV 988
+ S A ++ L D +RLGA E++ HPFF+ ++W L +K
Sbjct: 214 ---VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPP 270
Query: 989 FVPQPESVDDTSYFLSRFSQ--------ISSGLPDDQNGSYSDAD 1025
F P E DD S F + F++ SS N S +AD
Sbjct: 271 FNPNVEGPDDISNFDAVFTEETVPYSVCFSSD-YSIVNASVLEAD 314
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 1e-62
Identities = 125/324 (38%), Positives = 183/324 (56%), Gaps = 37/324 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+D++++K I RGAFG V L R +++ ++A+K+L K +MI+++D ER+I+ +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P+VV+ F +F LY+VMEY+ GGDL +L+ + E A+ Y AE+VLAL+ +HS+
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSM 161
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
G++HRD+KPDN+L+ GH+KL DFG M D +T
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTC-------------------MKMD-------ET 195
Query: 867 DNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+AVGTPDY++PE+L +G DWWSVG+ LFE + G PF A+S
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT 255
Query: 923 FDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG--VN 978
+ I++ K P D +S A++LI FL D RLG NG E+K HPFFK N
Sbjct: 256 YSKIMDHKNSL-NFPEDVEISKHAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKNDQWN 313
Query: 979 WDSLALQKAVFVPQPESVDDTSYF 1002
WD++ A VP+ S D+S F
Sbjct: 314 WDNIRETAAPVVPELSSDIDSSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 1e-62
Identities = 119/351 (33%), Positives = 192/351 (54%), Gaps = 48/351 (13%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 751
K + +G+FG+V LA + G+ FA+K LKK ++ +D+E + E+ +L + NPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
+ +F +++L+ VME+LNGGDL ++ G + A Y AE+V L++LHS GI++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK DN+++ DGHIK+ DFG+ K + DNR
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFG--------------------------DNRAS 154
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTPDY+APEIL G ++ ++ DWWS G++L+E + G PF + + +F++I ++
Sbjct: 155 -TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---RV 210
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK--AVF 989
P P ++ E++D++ + DP +RLG G ++ HPFFK +NW +L ++ F
Sbjct: 211 DTPHYPRWITKESKDILEKLFERDPTRRLGVVG--NIRGHPFFKTINWTALEKRELDPPF 268
Query: 990 VPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDEC 1040
P+ +S D S F F L + SYSD + DS MD+
Sbjct: 269 KPKVKSPSDYSNFDREF------LSEKPRLSYSDKNLIDS-------MDQS 306
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 2e-62
Identities = 93/276 (33%), Positives = 151/276 (54%), Gaps = 34/276 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+EIIK I +G+FG+V+L R+++ G L+ +K + +M K + E L E IL + +P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKLNHP 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----LEEDVARIYIAELVLALEYL 803
+++++ SF + L +VMEY +GGDL ++K E+ + +L LAL+YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS I+HRD+KP N+ + +G +KL DFG+SK+ +++T+DL+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLA----------------- 160
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ VGTP YL+PE+ + Y +D WS+G +L+E T PF E+ +
Sbjct: 161 --------KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
IL + P P PS S E ++L++ L DP +R
Sbjct: 213 LKILKGQYP-PI-PSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 5e-62
Identities = 118/339 (34%), Positives = 188/339 (55%), Gaps = 48/339 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 753
I RG++ +V L + T ++A+KV+KK + DI+ + E+++ T N PF+V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F L+ V+E+++GGDL +++ L E+ AR Y AE+ LAL +LH GI++RDL
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K DN+L+ +GHIKLTD+G+ K +GI P D +
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCK---------------EGIRPGDT------------TST 155
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF----TAESPE-----IIFD 924
GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF +++P+ +F
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ 215
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVKAHPFFKGVNWDS 981
IL ++I +P +S +A ++ FL DP +RLG + G ++K+HPFF+ ++WD
Sbjct: 216 VILEKQIR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL 272
Query: 982 LALQKAV---FVPQPESVDDTSYFLSRFSQISSGL-PDD 1016
L QK V + P ES D F +F+ L PDD
Sbjct: 273 LE-QKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPDD 310
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 1e-61
Identities = 98/290 (33%), Positives = 149/290 (51%), Gaps = 41/290 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
FEI++ I +G FG V+ AR + TG AIKV+K + K E+I+ E IL ++P
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHP 57
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSL 806
+V+++ S+ +D L++VME+ +GG L LL+ L E EL+ LEYLHS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GI+HRD+K N+L+ DG +KL DFGLS Q +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA----------------------------QLS 149
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDN 925
D + R++ VGTP ++APE++ G + Y AD WS+GI E G PP++ P + +F
Sbjct: 150 DTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-- 207
Query: 926 ILNRKIPWPCVPSDM--SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
P + + S E +D + + L +P +R A ++ HPF
Sbjct: 208 -KIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 218 bits (556), Expect = 6e-60
Identities = 88/154 (57%), Positives = 120/154 (77%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
SI++F I+KPISRGAFG+V+L RK+ L+A+KV+KK DMI KN + ++ AER+ L
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
++PF+V +YS +N+YLVMEYL GGD+ SLL G +E++A YI+E+ LAL+YLH
Sbjct: 62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838
GI+HRDLKPDN+LI+++GHIKLTDFGLSK+ L
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 9e-59
Identities = 96/304 (31%), Positives = 149/304 (49%), Gaps = 35/304 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V + + TG ++A K L K + ++ + L E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRD 812
+F +D+L LVM +NGGDL + VG E A Y A+++ LE+LH IV+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
LKP+N+L+ G+++++D GL+ ++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLA-----------------------VELKGGKKI-----K 152
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
GTP Y+APE+L G + ++ DW+++G L+E I G PF ++ + + R +
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212
Query: 933 WPC-VPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDSLALQKAV- 988
P S EA+DL L DP +RLG G A EV+ HP FK +NW L
Sbjct: 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEP 272
Query: 989 -FVP 991
F+P
Sbjct: 273 PFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 204 bits (519), Expect = 2e-58
Identities = 111/335 (33%), Positives = 183/335 (54%), Gaps = 35/335 (10%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 746
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L ++ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GI++RDLK DN+++ +GHIK+ DFG+ K + DG+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-----------DGV------------- 156
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PF E + +F +I
Sbjct: 157 ---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLAL 984
+ + + P MS EA + + P +RLG G ++K H FF+ ++W+ L
Sbjct: 214 MEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER 270
Query: 985 QKAVFVPQPESVD-DTSYFLSRFSQISSGL-PDDQ 1017
++ +P++ D F F++ L P DQ
Sbjct: 271 KEVQPPYKPKACGRDAENFDKFFTRHPPVLTPPDQ 305
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 202 bits (514), Expect = 8e-58
Identities = 120/341 (35%), Positives = 191/341 (56%), Gaps = 50/341 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFF 753
I RG++ +V L R + ++A+KV+KK + DI+ + E+++ NPF+V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F L+LV+EY+NGGDL +++ L E+ AR Y AE+ +AL +LH GI++RDL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K DN+L+ DGHIKLTD+G+ K +G+ P D +
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCK---------------EGLGPGD------------TTST 155
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF--TAESPEI-----IFDNI 926
GTP+Y+APEIL G E+G++ DWW++G+++FE + G PF ++P++ +F I
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI 215
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLA 983
L + I +P +S +A ++ FL DP +RLG G +++K+H FF+ ++WD L
Sbjct: 216 LEKPIR---IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLE 272
Query: 984 LQKAVFVP-QPESVDDTSYFLSRF-SQISSG----LPDDQN 1018
+K V P +P+ DD Y L F +Q +S PDD++
Sbjct: 273 -KKQVTPPFKPQITDD--YGLENFDTQFTSEPVQLTPDDED 310
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 3e-57
Identities = 116/340 (34%), Positives = 187/340 (55%), Gaps = 46/340 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 753
I RG++ +V L R + T ++A+KV+KK + DI+ + E+++ N PF+V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F L+ V+EY+NGGDL +++ L E+ AR Y AE+ LAL YLH GI++RDL
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K DN+L+ +GHIKLTD+G+ K +G+ P D +
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCK---------------EGLRPGDT------------TST 155
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF----TAESP-----EIIFD 924
GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF ++++P + +F
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDS 981
IL ++I +P +S +A ++ FL DP +RLG G A+++ HPFF+ V+WD
Sbjct: 216 VILEKQIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDL 272
Query: 982 LALQKAV--FVPQPESVDDTSYFLSRFSQISSGL-PDDQN 1018
+ ++ V F P F ++F+ L PDD +
Sbjct: 273 MEQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQLTPDDDD 312
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 6e-57
Identities = 102/299 (34%), Positives = 169/299 (56%), Gaps = 33/299 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 746
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GI++RDLK DN+++ +GHIK+ DFG+ K ++ DG+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-----------DGV------------- 156
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PPF E + +F +I
Sbjct: 157 ---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLA 983
+ + + P +S EA + + P++RLG G +++ H FF+ ++WD L
Sbjct: 214 MEHNVSY---PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLE 269
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 2e-56
Identities = 95/281 (33%), Positives = 136/281 (48%), Gaps = 69/281 (24%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ G FG V+LAR + TG AIK++KK D + +E +L E IL + +P +V+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F ++LYLVMEY GG L LL++ G L ED + +++ LEYLHS GI+HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 814 KPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
KP+N+L+ D G +KL DFGLSK+ +D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLL---------------------------TSDKSLLK 151
Query: 873 SAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ VGTP Y+APE+LLG + +D WS+G+IL+E
Sbjct: 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE------------------------- 186
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
+ E +DLI + L DP +R A E+ H
Sbjct: 187 --------LP-ELKDLIRKMLQKDPEKRPSAK---EILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 5e-53
Identities = 93/295 (31%), Positives = 147/295 (49%), Gaps = 39/295 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D E +K + +G+ G V+ R + TG ++A+K + + +++L E L + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--DEEFRKQLLRELKTLRSCES 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS- 805
P+VV+ + +F + +V+EY++GG L LL+KVG + E V +++ L+YLH+
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRD+KP NLLI G +K+ DFG+SK+ + NT+D
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLD--------------------- 155
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEII-- 922
++ VGT Y++PE + G + YAAD WS+G+ L E G PF P
Sbjct: 156 ----QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211
Query: 923 FDNILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
I + P P + S E +D I+ L DP +R AAE+ HPF K
Sbjct: 212 MQAICDGPPPSLP--AEEFSPEFRDFISACLQKDPKKRP---SAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 3e-52
Identities = 99/284 (34%), Positives = 146/284 (51%), Gaps = 33/284 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I G FG+V+ A TG+L A+K ++ D K I+ I E +L +++P +V+++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELLKHPNLVKYYG 66
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
R+ +Y+ MEY +GG L LL L+E V R+Y +L+ L YLHS GIVHRD+K
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
P N+ + H+G IKL DFG + + + E Q S
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVK----------------LKNNTTTMGEEVQ-------SL 163
Query: 875 VGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFTAESPE--IIFDNILNR 929
GTP Y+APE++ G + HG AAD WS+G ++ E TG P++ E I+F
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH 223
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
K P P +S E +D ++R L DP +R A+E+ HPF
Sbjct: 224 KPPIP-DSLQLSPEGKDFLDRCLESDPKKRP---TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 8e-52
Identities = 94/289 (32%), Positives = 148/289 (51%), Gaps = 37/289 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
++ ++ I GA G V+ A R TG AIK ++ +RK + E I+ E I+ ++P
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSL 806
+V ++ S+ D L++VMEY++GG L ++ V E +A + E++ LEYLHS
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYLHSQ 135
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K DN+L++ DG +KL DFG + L+
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQ--------LT-------------------K 168
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ R+S VGTP ++APE++ ++G D WS+GI+ E G PP+ E P I
Sbjct: 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI 228
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ IP P S E +D +N+ L+ DP +R A E+ HPF K
Sbjct: 229 TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP---SAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-49
Identities = 99/312 (31%), Positives = 152/312 (48%), Gaps = 35/312 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
VV Y++ +D L LV+ +NGGDL + +G +E+ A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+N+L+ GHI+++D GL+ PE +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA-----------------------VEIPEGETI 158
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
R VGT Y+APE++ + ++ DWW +G +++E I G PF ++ + +
Sbjct: 159 RGR-----VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213
Query: 927 LNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSL- 982
R S+ S A+ + + L DP RLG GA EVKAHPFF+ N+ L
Sbjct: 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLE 273
Query: 983 -ALQKAVFVPQP 993
+ + F P P
Sbjct: 274 AGMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-49
Identities = 81/287 (28%), Positives = 143/287 (49%), Gaps = 33/287 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
++++ I RGAFG V+ TGD AIK + I++ ++ I+ E ++L +++P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V++ S D+LY+++EY G L +++K G E + +Y+ +++ L YLH G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
++HRD+K N+L DG +KL DFG++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKL---------------------------NDV 152
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+++ S VGTP ++APE++ + A+D WS+G + E +TG PP+ +P I+
Sbjct: 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
P +P +S E +D + + DPN R A ++ HP+
Sbjct: 213 QD--DHPPLPEGISPELKDFLMQCFQKDPNLRP---TAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 6e-49
Identities = 88/282 (31%), Positives = 138/282 (48%), Gaps = 35/282 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRF 752
+ G+FG V+ GD FA+K + D + ++++ E +L +++P +V++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
+ DNLY+ +E + GG L LL+K G E V R+Y +++L LEYLH VHRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
+K N+L+ +G +KL DFG++K Q +
Sbjct: 128 IKGANILVDTNGVVKLADFGMAK----------------------------QVVEFSFAK 159
Query: 873 SAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
S G+P ++APE++ +G AAD WS+G + E TG PP++ I K
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE 219
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
P +P +S EA+D I + L DP+ R AAE+ HPF
Sbjct: 220 -LPPIPDHLSDEAKDFILKCLQRDPSLRP---TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 1e-48
Identities = 105/313 (33%), Positives = 157/313 (50%), Gaps = 37/313 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
VV Y++ +D L LV+ +NGGDL + +G EE+ A Y AE++ LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
V+RDLKP+N+L+ GHI+++D GL+ KI PE + I
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKI-----------PEGESI------------ 158
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R R VGT Y+APE+L + + D+W +G +++E I G PF ++ +
Sbjct: 159 ---RGR---VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212
Query: 926 ILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSL 982
+ R + V + S EA+ + L DP QRLG GA EVK HPFF+ +N+ L
Sbjct: 213 VDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL 272
Query: 983 --ALQKAVFVPQP 993
+ FVP P
Sbjct: 273 EAGMLDPPFVPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 2e-48
Identities = 89/289 (30%), Positives = 144/289 (49%), Gaps = 34/289 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ F +++ I +G+FG V+ A + T + AIKV+ L+ +++IE I E L R+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-LEE-AEDEIEDIQQEIQFLSQCRS 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P++ +++ SF L+++MEY GG LL K G L+E + E++L LEYLH
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
G +HRD+K N+L++ +G +KL DFG+S G + +T+
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMS---------------------- 153
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
R++ VGTP ++APE++ + + AD WS+GI E G PP + P + I
Sbjct: 154 ---KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
P + S +D ++ L DP +R A E+ H F K
Sbjct: 211 PKNNPP-SLEGNKFSKPFKDFVSLCLNKDPKERPSAK---ELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 176 bits (446), Expect = 3e-48
Identities = 117/403 (29%), Positives = 180/403 (44%), Gaps = 45/403 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-N 746
+ I++ + G+FG V+LAR R A+KVL K + ++ER L E IL ++
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYL 803
P +V+ + F +LYLVMEY++GG L LL+K G L E A +A+++ ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 804 HSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
HS GI+HRD+KP+N+L+ DG +KL DFGL+K+ P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL---------------------LPDPG 156
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPFTAES- 918
+ ++VGTP Y+APE+LLG Y ++D WS+GI L+E +TG+PPF E
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 919 ---PEIIFDNILNRKIPWPCVPSDMSF------EAQDLINRFLIHDPNQRLGANGA--AE 967
IL P P S A DL+ + L DP RL ++ +
Sbjct: 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 968 VKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTC 1027
+ AH K + L + +S + ++ D + + +
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKEL 336
Query: 1028 DSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASIN 1070
+ S + L + SL S ++ S +
Sbjct: 337 APNGVSSSP-HNSSSLLLSTASSKRSSLPKISARSSPSSLSSS 378
|
Length = 384 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 103/301 (34%), Positives = 152/301 (50%), Gaps = 41/301 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 751
I RG FG V+ RK TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
Y+F D L +++ +NGGDL+ L + G E R Y AE++L LE++H+ +V+R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP N+L+ GH++++D GL+ D S +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA--------CDFS---------------------KKKP 152
Query: 872 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF---TAESPEIIFDNIL 927
H++VGT Y+APE+L G + +ADW+S+G +LF+ + G PF + I L
Sbjct: 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ 985
+ P S E + L+ L D N+RLG GA EVK HPFF+ ++W + LQ
Sbjct: 213 TMAVELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269
Query: 986 K 986
K
Sbjct: 270 K 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 3e-46
Identities = 103/313 (32%), Positives = 154/313 (49%), Gaps = 37/313 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
VV Y++ +D L LV+ +NGGDL + +G EE A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+N+L+ GHI+++D GL+ H PE Q
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA-----------------------VHVPEGQTI 158
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
R VGT Y+APE++ + ++ DWW++G +L+E I G PF +I + +
Sbjct: 159 KGR-----VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213
Query: 927 --LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDSL 982
L +++ S +A+ L L DP +RLG G A EVK HP FK +N+ L
Sbjct: 214 ERLVKEVQEE-YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRL 272
Query: 983 A--LQKAVFVPQP 993
+ + F P P
Sbjct: 273 EAGMLEPPFKPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 4e-46
Identities = 90/306 (29%), Positives = 153/306 (50%), Gaps = 36/306 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V + R TG L+A K L K + ++ E + E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 755 SFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
+F + +L LVM +NGGDL Y++ + E A Y A+++ LE+LH I++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
RDLKP+N+L+ +DG+++++D GL+ E + ++
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAV--------------------------ELKDGQSKT 154
Query: 871 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 930
+ A GTP ++APE+L G E+ ++ D++++G+ L+E I PF A ++ + R
Sbjct: 155 KGYA-GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213
Query: 931 IPWPCVPSD-MSFEAQDLINRFLIHDPNQRLG-ANGA-AEVKAHPFFKGVNWDSL--ALQ 985
+ D S ++ L DP +RLG +G ++ HP F+ +NW L +
Sbjct: 214 LNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGML 273
Query: 986 KAVFVP 991
FVP
Sbjct: 274 PPPFVP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 4e-45
Identities = 106/303 (34%), Positives = 157/303 (51%), Gaps = 45/303 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 751
I RG FG V+ RK TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
Y+F D L +++ +NGGDL+ L + G E R Y E++L LE++H+ +V+R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP N+L+ GH++++D GL+ D S +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA--------CDFS---------------------KKKP 152
Query: 872 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF----TAESPEIIFDNI 926
H++VGT Y+APE+L GT + +ADW+S+G +LF+ + G PF T + EI D +
Sbjct: 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRM 210
Query: 927 -LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLA 983
L + +P S E + L+ L D ++RLG GA EVK H FFKG++W +
Sbjct: 211 TLTVNVE---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVY 267
Query: 984 LQK 986
LQK
Sbjct: 268 LQK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 4e-45
Identities = 99/319 (31%), Positives = 147/319 (46%), Gaps = 70/319 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 744
+E ++ + G +G V+ AR + TG++ A+K ++ LD N+ E I L E ++L +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-LD----NEEEGIPSTALREISLLKEL 55
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYL 803
++P +V+ LYLV EY + DL L K G L ++ + + +L+ L Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS I+HRDLKP N+LI DG +KL DFGL++ I P + E
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI---------------PLRTYTHE- 158
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI- 921
V T Y APEILLG++H A D WSVG I E ITG P F +S EI
Sbjct: 159 -----------VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS-EID 206
Query: 922 ----IFD-----------------NILNRKIPWPCVP-----SDMSFEAQDLINRFLIHD 955
IF + +P + E DL+++ L ++
Sbjct: 207 QLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYN 266
Query: 956 PNQRLGANGAAEVKAHPFF 974
P +R+ A A + HP+F
Sbjct: 267 PAKRISAKEALK---HPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 5e-45
Identities = 88/299 (29%), Positives = 142/299 (47%), Gaps = 43/299 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 745
DD+E+I+ I GA V+ A + AIK ++D+ + ++ + E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIK---RIDLEKCQTSVDELRKEVQAMSQCN 57
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---KVGCLEEDVARIYIAELVLALEY 802
+P VV+++ SF D L+LVM YL+GG L +++ G L+E + + E++ LEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS G +HRD+K N+L+ DG +K+ DFG+S A +
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVS-----------------------ASLAD 154
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPE 920
+ R + VGTP ++APE+ + HGY AD WS GI E TG P++ P
Sbjct: 155 GGDRTRKVRKTFVGTPCWMAPEV-MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM 213
Query: 921 IIFDNILNRKIPWPCVPSDMSFEA-----QDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ L P + + ++ + +I+ L DP++R A E+ H FF
Sbjct: 214 KVLMLTLQN--DPPSLETGADYKKYSKSFRKMISLCLQKDPSKR---PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 6e-45
Identities = 97/320 (30%), Positives = 139/320 (43%), Gaps = 68/320 (21%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND--IERILAERNILITVR 745
++I+ I GA G VF A+ R TG+ A+K K+ + R + L E L +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALK---KVALRRLEGGIPNQALREIKALQACQ 57
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 804
+P+VV+ F LVMEY+ DL +LR L E + Y+ L+ + Y+H
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+ GI+HRDLKP NLLI+ DG +K+ DFGL++ + +
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLAR-----------------LFSEEEPRLYSH 159
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES----- 918
Q V T Y APE+L G D W+VG I E + G P F E+
Sbjct: 160 Q---------VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL 210
Query: 919 ---------------PE---------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIH 954
P I F ++ IP + D S EA DL+ L++
Sbjct: 211 AIVFRTLGTPNEETWPGLTSLPDYNKITFPE--SKPIPLEEIFPDASPEALDLLKGLLVY 268
Query: 955 DPNQRLGANGAAEVKAHPFF 974
DP++RL AAE HP+F
Sbjct: 269 DPSKRL---SAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 85/286 (29%), Positives = 143/286 (50%), Gaps = 47/286 (16%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
D+E+++ I +G+FG V R+++ G + K + +M K + +++++E NIL +++P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHP 59
Query: 748 FVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALE 801
+VR++ R N LY+VMEY GGDL L++K +EE+ + +L+LAL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 802 YLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
H+ ++HRDLKP N+ + + ++KL DFGL+KI
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-------------------- 159
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
D+ + VGTP Y++PE L + +D WS+G +++E PPFTA
Sbjct: 160 -------LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212
Query: 917 ESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ L KI + +P S E ++I L DP++R
Sbjct: 213 RNQL-----QLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 98/312 (31%), Positives = 150/312 (48%), Gaps = 35/312 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
VV Y++ +D L LV+ +NGGDL + +G +E A Y AEL LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+N+L+ GHI+++D GL+ PE +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA-----------------------VQIPEGETV 158
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
R VGT Y+APE++ ++ ++ DWW +G +++E I G PF + + +
Sbjct: 159 RGR-----VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213
Query: 927 LNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLA 983
R K S +A+ + L +P +RLG NGAA VK HP FK +N+ L
Sbjct: 214 DRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLE 273
Query: 984 --LQKAVFVPQP 993
+ + F P P
Sbjct: 274 ANMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 84/292 (28%), Positives = 140/292 (47%), Gaps = 42/292 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ F+I++ + G++G V+ A + TG + AIKV+ + D++ I+ E +IL +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV-----EEDLQEIIKEISILKQCDS 57
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
P++V+++ S+ +L++VMEY G D+ + K L E+ + + + LEYL
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYL 115
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS +HRD+K N+L+ +G KL DFG+S
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ--------------------------- 148
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 922
R++ +GTP ++APE++ + AD WS+GI E G PP++ P I
Sbjct: 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
F I N+ P P S E D + + L+ DP +R A ++ HPF
Sbjct: 209 F-MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEER---PSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 98/299 (32%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+D+E+I+ I G +G V+ AR TG+L AIKV+K + +D E I E ++L R+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRH 59
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIA----ELVLA 799
P +V +F S+ RD L++VMEY GG D+Y + R G L E IA E +
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQ----IAYVCRETLKG 113
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
L YLH G +HRD+K N+L+ DG +KL DFG+S + TI
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS--AQLTATI---------------- 155
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIPPFTA 916
R S +GTP ++APE + + GY D W++GI E PP
Sbjct: 156 ---------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206
Query: 917 ESPEIIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
P I P P + S D I + L DP +R A ++ HPF
Sbjct: 207 LHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR---PTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 4e-42
Identities = 70/131 (53%), Positives = 89/131 (67%), Gaps = 3/131 (2%)
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
+GTPDYLAPE+LLG HG A DWW++G+ LFEF+TGIPPF E+P+ +F NILNR IPWP
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPE 994
+S AQ+ I L DP +R G E+K HP F GV+W++L Q F+PQP+
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLK---ELKQHPLFHGVDWENLQNQTMPFIPQPD 657
Query: 995 SVDDTSYFLSR 1005
DTSYF +R
Sbjct: 658 DETDTSYFEAR 668
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 7e-42
Identities = 89/294 (30%), Positives = 144/294 (48%), Gaps = 39/294 (13%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R+ +D+F I G+ G V +A ++TG A+K K+D+ ++ E + E I+
Sbjct: 18 RSYLDNF---VKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMR 71
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALE 801
++P +V + S+ D L++VME+L GG L ++ EE +A + VL AL
Sbjct: 72 DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVLKALS 129
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
+LH+ G++HRD+K D++L+ DG +KL+DFG + +P
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA-------------QVSKEVP------ 170
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
R S VGTP ++APE++ +G D WS+GI++ E + G PP+ E P
Sbjct: 171 --------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ 222
Query: 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
I + P +S + ++R L+ DP QR AAE+ HPF
Sbjct: 223 AMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA---TAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 80/292 (27%), Positives = 140/292 (47%), Gaps = 45/292 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILITVR 745
DF+++K + +G++G V+ ++ + +A LK++D+ + ER + E IL +V
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYA---LKEVDLGSMSQKEREDAVNEIRILASVN 57
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL-----EEDVARIYIAELVLAL 800
+P ++ + +F + L +VMEY GDL + K E+++ RI+I +L+ L
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGL 116
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+ LH I+HRDLK N+L+ + +K+ D G+SK+
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKV------------------------ 152
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ +GTP Y+APE+ G + Y +D WS+G +L+E T PPF A S +
Sbjct: 153 -----LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
+ + K +P +P S + Q+ I L P R + ++ A P
Sbjct: 208 DLRYKVQRGK--YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCD---KILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 102/325 (31%), Positives = 148/325 (45%), Gaps = 77/325 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--TVRN 746
+E I I G +G+V+ AR + TG+L A LKK+ M + + I A R I + +R+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVA---LKKIRMENEKEGFPITAIREIKLLQKLRH 57
Query: 747 PFVVRFFYSFTCRD--NLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYL 803
P +VR T + ++Y+V EY++ DL LL E + Y+ +L+ L+YL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS GI+HRD+K N+LI +DG +KL DFGL++ Y +
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLAR-----------------------PYTKR 153
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP--- 919
D NR V T Y PE+LLG T +G D WSVG IL E G P F +
Sbjct: 154 NSADYTNR---VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ 210
Query: 920 -EIIFD-----NILNRKIPWPCVPSDMSF------------------------EAQDLIN 949
E IF+ N WP V S + + A DL++
Sbjct: 211 LEKIFELCGSPTDEN----WPGV-SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLD 265
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFF 974
+ L DP +R+ A+ A + H +F
Sbjct: 266 KLLTLDPKKRISADQALQ---HEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 97/301 (32%), Positives = 151/301 (50%), Gaps = 46/301 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DD E + + G G V R TG + A+K ++ L+ I + ++IL E +IL +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR-LE-INEAIQKQILRELDILHKCNS 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDV-ARIYIAELVLALEYLH 804
P++V F+ +F ++ + MEY++GG L +L++V G + E + +I +A ++ L YLH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA-VLKGLTYLH 117
Query: 805 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
I+HRD+KP N+L+ G IKL DFG+S L+N+
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ-LVNSLAK------------------- 157
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--SPEI 921
+ VGT Y+APE + G ++ +D WS+G+ L E TG P+ E P+
Sbjct: 158 ---------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208
Query: 922 IFD---NILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
IF+ I+N P P +PS S + QD +N LI DP +R E+ HPF K
Sbjct: 209 IFELLQYIVNE--PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYK---ELLEHPFIKKY 263
Query: 978 N 978
Sbjct: 264 E 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 7e-40
Identities = 88/325 (27%), Positives = 145/325 (44%), Gaps = 67/325 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITVRN 746
+E++KPI GA+G V A + TG AIK K+ + + I+ RIL E +L +R+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 747 PFVVR---FFY--SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
++ S +++Y+V E + DL+ +++ L +D + ++ +++ L+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YLHS ++HRDLKP N+L+ + +K+ DFGL++ + + G +
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD-------EDEKGFLT------ 164
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP- 919
EY V T Y APE+LL + A D WSVG I E +T P F
Sbjct: 165 EY-----------VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213
Query: 920 ---EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINRFL 952
+I + I + K P + S EA DL+ + L
Sbjct: 214 DQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKML 273
Query: 953 IHDPNQRLGANGAAEVKAHPFFKGV 977
+ DP +R+ A E AHP+ +
Sbjct: 274 VFDPKKRI---TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 8e-40
Identities = 91/317 (28%), Positives = 148/317 (46%), Gaps = 65/317 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LITVRN 746
++ + I G +G V+ AR + TG++ AIK K+ + +++ A R I L + +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIK---KIKLRFESEGIPKTALREIKLLKELNH 57
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHS 805
P +++ F + +LYLV E+++ DLY L++ L E + + Y+ +L+ L + HS
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
GI+HRDLKP+NLLI +G +KL DFGL++ Y Y
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARS----------------FGSPVRPYTHY-- 158
Query: 866 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES------ 918
V T Y APE+LLG + D WSVG I E ++ P F +S
Sbjct: 159 ---------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
Query: 919 --------------PEII---FDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPN 957
P+ + + +P P + + S +A DL+++ L +DP+
Sbjct: 210 KIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH 269
Query: 958 QRLGANGAAEVKAHPFF 974
+R+ A A AHP+F
Sbjct: 270 KRITAEQAL---AHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 4e-39
Identities = 87/285 (30%), Positives = 139/285 (48%), Gaps = 32/285 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERILAERNILITVRNPFVV 750
K + +GAFGRV+L TG A+K + K ++ + E +L +++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
+++ + L + MEY+ GG + L+ G L E V R Y +++ +EYLHS IVH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
RD+K N+L G++KL DFG SK TI SG T +
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASK---RLQTICSSG------------------TGMK- 165
Query: 871 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNR 929
S GTP +++PE++ G +G AD WSVG + E +T PP+ E+ IF +
Sbjct: 166 --SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK--IAT 221
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ P +PS +S +A++ + R + + +R A E+ H F
Sbjct: 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKR---PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 87/304 (28%), Positives = 148/304 (48%), Gaps = 36/304 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V + + TG ++A K L K + +K+ + L E+ IL V +PF+V Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGIVHRD 812
+F + +L LVM +NGGDL + VG ++ R+ Y A++ + +LHS+ IV+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
+KP+N+L+ G+ +L+D GL+ + + R
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLA-----------------------VELKDGKTITQR--- 154
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
GT Y+APEIL + Y DW+++G ++E + G PF ++ + + R +
Sbjct: 155 --AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212
Query: 933 WPCVPSDMSF--EAQDLINRFLIHDPNQRLGANGAA-EVKAHPFFKGVNWDSLALQKAVF 989
+F E++D+ FL P RLG+ + + H FFK +N+ L +A
Sbjct: 213 DEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL---EAGL 269
Query: 990 VPQP 993
+P P
Sbjct: 270 IPPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 7e-38
Identities = 96/320 (30%), Positives = 143/320 (44%), Gaps = 71/320 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LITV-R 745
+++IK + G FG V+LAR + TG+L AIK +KK + E + R + L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKK----KFYSWEECMNLREVKSLRKLNE 56
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYL 803
+P +V+ F D LY V EY+ G +LY L+ RK E V R I +++ L ++
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
H G HRDLKP+NLL++ +K+ DFGL++ E P Y +Y
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-------------EIRSRPP----YTDY 158
Query: 864 QQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF--TAESPE 920
V T Y APEILL T + D W++G I+ E T P F ++E +
Sbjct: 159 -----------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ 207
Query: 921 I--IFD-----------------NILNRKIPWPCVPSDMSF-------EAQDLINRFLIH 954
+ I + L + P P+ + EA DLI L
Sbjct: 208 LYKICSVLGTPTKQDWPEGYKLASKLGFRFP-QFAPTSLHQLIPNASPEAIDLIKDMLRW 266
Query: 955 DPNQRLGANGAAEVKAHPFF 974
DP +R A++ HP+F
Sbjct: 267 DPKKRP---TASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 73/234 (31%), Positives = 114/234 (48%), Gaps = 34/234 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD---MIRKNDIERILAERNILITVR 745
+E++ + GA+G V R + TG++ AIK K+ + ++K L E +L +R
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT----ALREVKVLRQLR 58
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ +V +F + LYLV EY+ L L G L D R YI +L+ A+ Y HS
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRD+KP+N+L++ G +KL DFG ++ L + +Y
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARA--------LRA-------RPASPLTDY-- 161
Query: 866 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918
V T Y APE+L+G T +G D W++G I+ E + G P F +S
Sbjct: 162 ---------VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 86/295 (29%), Positives = 143/295 (48%), Gaps = 39/295 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
D +EII + GAFG+V+ A+ + TG A K++ + + ++E + E +IL +
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECK 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLH 804
+P +V + ++ + L++++E+ +GG L S++ ++ L E R +++ AL +LH
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S ++HRDLK N+L+ DG +KL DFG+S
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK-------------------------- 154
Query: 865 QTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
T + R + +GTP ++APE++ + Y AD WS+GI L E PP +P
Sbjct: 155 STLQK-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ IL + P PS S D + L+ DP+ R AAE+ HPF
Sbjct: 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP---TAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 9e-37
Identities = 83/275 (30%), Positives = 139/275 (50%), Gaps = 34/275 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFEI+ I +G+FG VF ++ ++A+K + M R+ + E + E +L + +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKLDSS 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEYLH 804
+++R++ SF + L +VMEY GDL+ LL R E+ V R +I +++L L +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S I+HRD+K NL + ++K+ D G++K+ L +NT +
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTN-------------------FA 158
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
T VGTP YL+PE+ + +D W++G++L+E TG PF A + +
Sbjct: 159 NT-------IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I+ +P V S + LI++ L D QR
Sbjct: 212 KIIRGV--FPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 92/303 (30%), Positives = 136/303 (44%), Gaps = 50/303 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
FE+++ I G +G+V+ AR + TG L AIK++ I +++ E I E NIL N
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSN 61
Query: 747 -PFVVRFFYSF------TCRDNLYLVMEYLNGG---DLYSLLRKVG-CLEEDVARIYIAE 795
P + F+ +F D L+LVME GG DL LRK G L+E+ + E
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ L YLH ++HRD+K N+L+ + +KL DFG+S
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-------------------- 161
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITG 910
+ T R R++ +GTP ++APE++ E + +D WS+GI E G
Sbjct: 162 ------QLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
PP P I P P + S + D I+ LI + QR E+
Sbjct: 215 KPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQR---PFMEELLE 271
Query: 971 HPF 973
HPF
Sbjct: 272 HPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 98/319 (30%), Positives = 139/319 (43%), Gaps = 66/319 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 744
+E K + G + V+ AR + TG + AIK +K + RK + I L E +L +
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGE--RKEAKDGINFTALREIKLLQEL 59
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYL 803
++P ++ F + N+ LV E++ DL +++ K L + Y+ + LEYL
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS I+HRDLKP+NLLIA DG +KL DFGL++ S
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLAR-----------------SFGS------- 154
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP--- 919
NR V T Y APE+L G H G D WSVG I E + +P +S
Sbjct: 155 ---PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ 211
Query: 920 -EIIFDNILNRKIP--WPCVPSDMSF--------------------EAQDLINRFLIHDP 956
IF L WP V S + +A DL+ R L +P
Sbjct: 212 LGKIF-EALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270
Query: 957 NQRLGANGAAEVKAHPFFK 975
N+R+ A A E HP+F
Sbjct: 271 NKRITARQALE---HPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 90/281 (32%), Positives = 134/281 (47%), Gaps = 34/281 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +GA G V+ A TG AIK + +K E I+ E ++ ++P +V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
S+ D L++VMEYL GG L ++ + C++E E + ALE+LHS ++HRD+K
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
P +S +D +NR L D +R A E+ HPF K
Sbjct: 236 QNPEKLSAIFRDFLNRCLEMDVEKR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 79/280 (28%), Positives = 140/280 (50%), Gaps = 37/280 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 751
I RGA+G V+ + TG + A+K++ LD +D+ I E +L +R P + +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIIN-LDT-PDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
++ S+ L+++MEY GG + +L+ K G + E + I E+++AL+Y+H +G++HR
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLM-KAGPIAEKYISVIIREVLVALKYIHKVGVIHR 125
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
D+K N+L+ + G++KL DFG++ Q ++ R
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAA--------------------------LLNQNSSK-R 158
Query: 872 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 930
+ VGTP ++APE++ G + AD WS+GI ++E TG PP++ I K
Sbjct: 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK 218
Query: 931 IPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVK 969
P + + S ++ + L +P +RL A + K
Sbjct: 219 PPR--LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSK 256
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 5e-35
Identities = 95/297 (31%), Positives = 151/297 (50%), Gaps = 47/297 (15%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
RT +D+F IK I G+ G V +A +++G L A+K K+D+ ++ E + E I+
Sbjct: 19 RTYLDNF--IK-IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMR 72
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ VV + S+ D L++VME+L GG L ++ EE +A + +A L AL
Sbjct: 73 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK-ALSV 131
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH+ G++HRD+K D++L+ HDG +KL+DFG ++ +
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEV------------------- 170
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP--- 919
R S VGTP ++APE++ +G D WS+GI++ E + G PP+ E P
Sbjct: 171 ------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 224
Query: 920 -EIIFDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
++I DN+ + K PS F ++R L+ DP QR A E+ HPF
Sbjct: 225 MKMIRDNLPPKLKNLHKVSPSLKGF-----LDRLLVRDPAQRATAA---ELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 91/296 (30%), Positives = 146/296 (49%), Gaps = 39/296 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+EII + GAFG+V+ A+ + TG L A KV+ + + ++E + E IL T +P+
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYMVEIEILATCNHPY 70
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLG 807
+V+ +F L++++E+ GG + +++ ++ L E ++ +++ AL+YLHS+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRDLK N+L+ DG IKL DFG+S N L
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSA----KNVKTL---------------------- 164
Query: 868 NRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+ R S +GTP ++APE+++ T + Y AD WS+GI L E PP +P +
Sbjct: 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 223
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
I + P PS S E +D + L P R AA++ HPF V
Sbjct: 224 LLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETR---PSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 92/281 (32%), Positives = 138/281 (49%), Gaps = 34/281 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +GA G VF A TG AIK ++++ ++ E I+ E ++ ++NP +V F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIK---QINLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
SF D L++VMEYL GG L ++ + C++E E + ALE+LH+ ++HRD+K
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
P +S +D +NR L D +R A E+ HPF K
Sbjct: 236 QNPEKLSPIFRDFLNRCLEMDVEKR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 89/281 (31%), Positives = 138/281 (49%), Gaps = 34/281 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +GA G V+ A TG AIK ++++ ++ E I+ E ++ +NP +V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIK---QMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
S+ D L++VMEYL GG L ++ + C++E E + AL++LHS ++HRD+K
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
P +S +D +NR L D ++R A E+ HPF K
Sbjct: 236 QNPERLSAVFRDFLNRCLEMDVDRR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 5e-34
Identities = 100/323 (30%), Positives = 156/323 (48%), Gaps = 68/323 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRN- 746
+EI++ + +GA+G V+ A R T ++ A+K K D R D +R E L + +
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALK--KIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 747 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYL 803
P +V+ ++ +YLV EY+ DL++++R LE DV + YI +L+ AL+Y+
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA-NILE-DVHKRYIMYQLLKALKYI 123
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID-LSGPETDGIMPSDAHYPE 862
HS ++HRDLKP N+L+ D +KL DFGL++ ++ L + ++ +
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLAR------SLSELEENPENPVLT------D 171
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITG---------- 910
Y V T Y APEILLG+ Y D WSVG IL E + G
Sbjct: 172 Y-----------VATRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219
Query: 911 ---------IPPFTAE------SP--EIIFDNILNRKI-PWPCVPSDMSFEAQDLINRFL 952
I P +AE SP + D++ +R P + S +A DL+ + L
Sbjct: 220 NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLL 279
Query: 953 IHDPNQRLGANGAAEVKAHPFFK 975
+ +PN+RL A A E HP+
Sbjct: 280 VFNPNKRLTAEEALE---HPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 6e-34
Identities = 96/332 (28%), Positives = 139/332 (41%), Gaps = 91/332 (27%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVR-- 745
+E + I GA+G V+ AR TG A LKK+ + L+E I L T+R
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVA---LKKVRVP--------LSEEGIPLSTLREI 49
Query: 746 ----------NPFVVRFF-YSFTCRDN----LYLVMEYLNGGDLYSLLRKV---GCLEED 787
+P +VR R + L LV E+++ DL + L K G L +
Sbjct: 50 ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG-LPPE 107
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ + +L+ +++LHS IVHRDLKP N+L+ DG +K+ DFGL++I
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI----------- 156
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907
Y + S V T Y APE+LL + + D WSVG I E
Sbjct: 157 ------------Y-----SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
Query: 908 ITGIPPFTAESPEI-----IFDNI---------LNRKIPWPCVPS-----------DMSF 942
P F S E IFD I N +P PS ++
Sbjct: 200 FRRRPLFRGTS-EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICE 258
Query: 943 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
E DL+ + L +P++R+ A E HP+F
Sbjct: 259 EGLDLLKKMLTFNPHKRI---SAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 88/294 (29%), Positives = 150/294 (51%), Gaps = 41/294 (13%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R+ ++++ IK I G+ G V +AR++ +G A+K++ D+ ++ E + E I+
Sbjct: 20 RSLLENY--IK-IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMR 73
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALE 801
++ VV + S+ + L+++ME+L GG L ++ + EE +A + E VL AL
Sbjct: 74 DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV--CESVLQALC 131
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL-SKIGLINNTIDLSGPETDGIMPSDAHY 860
YLHS G++HRD+K D++L+ DG +KL+DFG ++I
Sbjct: 132 YLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI------------------------ 167
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
D R S VGTP ++APE++ T +G D WS+GI++ E + G PP+ ++SP
Sbjct: 168 ----SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV 223
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ + P +S +D + R L +P +R A E+ HPF
Sbjct: 224 QAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER---ATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 79/282 (28%), Positives = 134/282 (47%), Gaps = 36/282 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ +F+I K I +G F V+ A G + A+K ++ +M+ + L E ++L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALE 801
+P V+++ SF + L +V+E + GDL +++ + E Y +L ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
++HS I+HRD+KP N+ I G +KL D GL + S T
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF--------FSSKTTAA--------- 163
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 164 ----------HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 922 --IFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRL 960
+ I K +P +P+D S E +DL++R + DP +R
Sbjct: 214 YSLCKKI--EKCDYPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 86/289 (29%), Positives = 142/289 (49%), Gaps = 39/289 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA--ERNILITVRN 746
+ I+ + +GAFG L R+ L V K++++ R ++ ER A E IL +++
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLV---VWKEVNLTRLSEKERRDALNEIVILSLLQH 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLH 804
P ++ ++ F + L + MEY NGG LY + +K EE++ Y+ ++V A+ Y+H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
GI+HRD+K N+ + G IKL DFG+SKI + S+ E
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI-----------------LGSEYSMAE-- 159
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
+ VGTP Y++PE+ G ++ + +D W++G +L+E +T F A +P +
Sbjct: 160 --------TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
I+ + V S S E L++ L DP +R A EV P
Sbjct: 212 KIVQGN--YTPVVSVYSSELISLVHSLLQQDPEKR---PTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 77/280 (27%), Positives = 125/280 (44%), Gaps = 41/280 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILITV 744
E+ K + GAFG V+ + G+ A+K LK+ + E L E +I+ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKL 58
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIA-ELVLAL 800
+P +VR T + LY+V EY+ GGDL LRK G L++ + +A ++ +
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD---LLQMALQIAKGM 115
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYL S VHRDL N L+ + +K++DFGLS+ I D
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRD----------------IYEDD--- 156
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919
Y++ ++APE L + +D WS G++L+E T G P+ S
Sbjct: 157 -YYRKRGG-----GKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN 210
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
E + + + + P P + E +L+ + +DP R
Sbjct: 211 EEVLELLEDGYRL-PR-PENCPDELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 89/281 (31%), Positives = 136/281 (48%), Gaps = 34/281 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +GA G V+ A TG AI+ ++++ ++ E I+ E ++ +NP +V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIR---QMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
S+ D L++VMEYL GG L ++ + C++E E + ALE+LHS ++HRD+K
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
DN+L+ DG +KLTDFG I P + R +
Sbjct: 144 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 176
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTP ++APE++ +G D WS+GI+ E I G PP+ E+P I P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
P +S +D +NR L D +R A E+ H F K
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKR---GSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 85/289 (29%), Positives = 145/289 (50%), Gaps = 40/289 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIK------VLKKLDMIRKNDIERILAERNILITVRNPF 748
I G+FG V+L ++G+L A+K V +++ ++ + E +L +++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+V++ S D+L + +EY+ GG + +LL G EE + R ++ +++ L YLH+ GI
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L+ + G IK++DFG+SK N+ N
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLS---------------------TKTN 166
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF-TAESPEIIF---D 924
R S G+ ++APE++ T + AD WS+G ++ E +TG PF + IF +
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
N P +PS++S EA D + + D N+R AAE+ HPF
Sbjct: 227 NAS------PEIPSNISSEAIDFLEKTFEIDHNKR---PTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 74/279 (26%), Positives = 144/279 (51%), Gaps = 36/279 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--TVRN 746
+ +K I G+FG+ L + + G + V+K++++ + + ER + + + + +++
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQY---VIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLH 804
P +V++ SF NLY+VM+Y GGDLY + ++ ED + ++ LAL+++H
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+HRD+K N+ + DG IKL DFG++++ +N+T++L+
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELA------------------ 158
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
+ +GTP YL+PEI + +D W++G +L+E T F A + + +
Sbjct: 159 -------RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
I+ +P V S S++ ++L+++ +P R N
Sbjct: 212 KIIRGS--YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVN 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 94/301 (31%), Positives = 143/301 (47%), Gaps = 46/301 (15%)
Query: 689 FEIIKP--ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL-------AERN 739
F+ +K I +G +GRV+LA TTG++ A+K ++ I R +E
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
L + + +V++ T + L + +EY+ GG + S LR G EE + R + +++
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
L YLHS GI+HRDLK DNLL+ DG K++DFG+SK SD
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFGISK-------------------KSDDI 161
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPF-TA 916
Y DN S G+ ++APE++ GY+A D WS+G ++ E G P+
Sbjct: 162 Y------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
Query: 917 ESPEIIFDNILNRKIPWPCVPSD----MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
E+ +F L K P +P D +S A D +N +P+ R A E+ HP
Sbjct: 216 EAIAAMFK--LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAR---ELLQHP 270
Query: 973 F 973
F
Sbjct: 271 F 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 48/282 (17%)
Query: 690 EIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ K + GAFG V+ + A+K LK+ + IE L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKLD 59
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL------- 798
+P VV+ T + LY+VMEY+ GGDL S LRK ++ +++L+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP------KLSLSDLLSFALQIAR 113
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+EYL S +HRDL N L+ + +K++DFGLS+
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL--------------------- 152
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917
+ R + ++APE L + +D WS G++L+E T G P+
Sbjct: 153 --YDDDYYRKRGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 207
Query: 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
S E + + + N P + E DL+ + DP R
Sbjct: 208 SNEEVLEYLKNGYRLPQ--PPNCPPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 69/280 (24%), Positives = 110/280 (39%), Gaps = 43/280 (15%)
Query: 690 EIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ K + GAFG V+ A+K LK+ IE L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASE--QQIEEFLREARIMRKLD 59
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY-----IAELVLAL 800
+P +V+ T + L +VMEY+ GGDL LRK E ++ + IA +
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR---GM 116
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYL S +HRDL N L+ + +K++DFGLS+
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL----------------------- 153
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919
+ + + ++APE L + +D WS G++L+E T G P+ S
Sbjct: 154 YDDDYYKVKGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN 210
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + + P + E L+ + DP R
Sbjct: 211 AEVLEYLKKGYRLPK--PPNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 84/279 (30%), Positives = 126/279 (45%), Gaps = 47/279 (16%)
Query: 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757
G +V L T F +K L+K + ER +I P +V
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR--------ERLTIIPHCVPNMVCLHKYIV 55
Query: 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817
D+++LV+++ GG L+S + K + E+ + + AE+V+AL+ LH GIV RDL P+N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT 877
+L+ GHI+LT F E + +A +N
Sbjct: 116 ILLDDRGHIQLTYFS-------------RWSEVEDSCDGEA-------VENM-------- 147
Query: 878 PDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVP 937
Y APE+ +E A DWWS+G ILFE +TG I LN +P
Sbjct: 148 --YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLN-------IP 198
Query: 938 SDMSFEAQDLINRFLIHDPNQRLGANGAA--EVKAHPFF 974
+S EA+ L+ + L +P +RLGA A ++K+HPFF
Sbjct: 199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 76/280 (27%), Positives = 116/280 (41%), Gaps = 42/280 (15%)
Query: 693 KPISRGAFGRVFLAR---KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
K + GAFG V+ + K A+K LK+ + + + L E ++ + +P V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNV 58
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---------AL 800
VR T + LYLV+EY+ GGDL LRK + + ++ L +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYL S VHRDL N L+ D +K++DFGLS+ ++ T G +P
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK---TGGKLP----- 170
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919
R ++APE L +D WS G++L+E T G P+ S
Sbjct: 171 -------IR----------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
E + + + P P E +L+ DP R
Sbjct: 214 EEVLEYLRKGYRL-PK-PEYCPDELYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 89/321 (27%), Positives = 138/321 (42%), Gaps = 74/321 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 745
++I+ I G F V A+ R TG +AIK +KK +E++ R I R
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 746 NPFVVRF----FYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLAL 800
+P ++R F T R L LV E ++ +LY L++ + L E + Y+ +L+ +L
Sbjct: 57 HPNILRLIEVLFDRKTGR--LALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+++H GI HRD+KP+N+LI D +KL DFG + I P Y
Sbjct: 114 DHMHRNGIFHRDIKPENILI-KDDILKLADFGSCR------GIYSKPP-----------Y 155
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE-- 917
EY + T Y APE LL +G D W+VG + FE ++ P F
Sbjct: 156 TEY-----------ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204
Query: 918 --------------SPEIIFD----NILNRKIP------WPCVPSDMSFEAQDLINRFLI 953
E++ +N P + + S E DL+ + L
Sbjct: 205 LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLA 264
Query: 954 HDPNQRLGANGAAEVKAHPFF 974
+DP++R+ A A HP+F
Sbjct: 265 YDPDERITAKQALR---HPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 101/347 (29%), Positives = 148/347 (42%), Gaps = 113/347 (32%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI------LAER 738
S+D++E + I G +G V+ AR + TG++ A LKKL K + E+ L E
Sbjct: 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVA---LKKL----KMEKEKEGFPITSLREI 55
Query: 739 NILITVRNPFVVRFFYSFTCR--------DNLYLVMEYLNGGDLYSLLR---------KV 781
NIL+ +++P +V T + D +Y+VMEY+ DL SL+ +V
Sbjct: 56 NILLKLQHPNIV------TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEV 108
Query: 782 GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841
CL + +L+ + +LH I+HRDLK NLL+ + G +K+ DFGL++
Sbjct: 109 KCL--------MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR------ 154
Query: 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSV 900
EY + V T Y APE+LLG E+ A D WSV
Sbjct: 155 --------------------EYGSP-LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSV 193
Query: 901 GIILFEFITGIPPFTAESP----EIIFD-----------------------------NIL 927
G I E +T P F +S IF N L
Sbjct: 194 GCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQL 253
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+K P +S DL+NR L +DP +R+ A A + HP+F
Sbjct: 254 RKKFP----ALSLSDNGFDLLNRLLTYDPAKRISAEDALK---HPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 6e-31
Identities = 90/293 (30%), Positives = 144/293 (49%), Gaps = 37/293 (12%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R +D F IK I G+ G V +A ++ TG A+K K+D+ ++ E + E I+
Sbjct: 21 REYLDSF--IK-IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMR 74
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+ VV + S+ D L++VME+L GG L ++ EE +A + ++ ++ AL Y
Sbjct: 75 DYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSY 133
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH+ G++HRD+K D++L+ DG IKL+DFG + +P
Sbjct: 134 LHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA-------------QVSKEVP------- 173
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
R S VGTP ++APE++ +G D WS+GI++ E I G PP+ E P
Sbjct: 174 -------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
I + P +S + ++ L+ +P+QR A E+ HPF K
Sbjct: 227 MRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRA---TAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 83/290 (28%), Positives = 133/290 (45%), Gaps = 38/290 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---IERILAERNILITVRNPFVVR 751
+ GAF + AR TG L A+K + + +E + E ++ + +P ++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 752 FFYSFTCRDNLY-LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
TC D+ + L +E++ GG + LL K G +E V Y +L+ L YLH I+H
Sbjct: 68 M-LGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 811 RDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
RD+K NLLI G +++ DFG + + +G E G +
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAA--ARLAAKGTGAG-EFQGQL--------------- 168
Query: 870 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDN 925
+GT ++APE+L G ++G + D WSVG ++ E T PP+ AE +IF
Sbjct: 169 -----LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-K 222
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
I + P +P +S +D+ R L P R + E+ HP F+
Sbjct: 223 IASATTA-PSIPEHLSPGLRDVTLRCLELQPEDR---PPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 98/343 (28%), Positives = 152/343 (44%), Gaps = 78/343 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE + + G G V R +G + A K L L+ I+ +I+ E +L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARK-LIHLE-IKPAIRNQIIRELKVLHECNS 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 805
P++V F+ +F + + ME+++GG L +L+K G + E++ +I IA ++ L YL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-VLRGLTYLRE 117
Query: 806 -LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+HRD+KP N+L+ G IKL DFG+S LI++ +
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMAN-------------------- 156
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 921
S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E
Sbjct: 157 --------SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208
Query: 922 IF---------------------------------DNILNRKIPWPCVPSD-MSFEAQDL 947
+F D I+N P P +PS S E QD
Sbjct: 209 MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNE--PPPKLPSGAFSDEFQDF 266
Query: 948 INRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFV 990
+++ L +P +R E+ HPF K + + A +V
Sbjct: 267 VDKCLKKNPKERA---DLKELTKHPFIK--RAELEEVDFAGWV 304
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 95/323 (29%), Positives = 147/323 (45%), Gaps = 77/323 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERI----LAERNILIT 743
++ ++ I G +G V+ AR + TG++ A LKK IR + + E + + E ++L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVA---LKK---IRLETEDEGVPSTAIREISLLKE 54
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 801
+ +P +VR + LYLV E+L+ DL + L+ + + Y+ +L+ +
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
Y HS ++HRDLKP NLLI +G +KL DFGL++ G+ P
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF--------------GV-------P 152
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESP 919
T H V T Y APEILLG+ Y D WS+G I E + P F +S
Sbjct: 153 VRTYT-----HEVV-TLWYRAPEILLGSRQ-YSTPVDIWSIGCIFAEMVNRRPLFPGDS- 204
Query: 920 EI-----IFDNILN--RKIPWPCVPSDMSF---------------------EAQDLINRF 951
EI IF L + WP V S + + DL+++
Sbjct: 205 EIDQLFRIF-RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKM 263
Query: 952 LIHDPNQRLGANGAAEVKAHPFF 974
L++DP +R+ A A + HP+F
Sbjct: 264 LVYDPAKRISAKAALQ---HPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 86/333 (25%), Positives = 140/333 (42%), Gaps = 81/333 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIK--------------VLKKLDMIRKNDIE 732
++ I+ I GA+G V A +G AIK L++L ++R +
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 792
I+A R+IL F ++Y+VM+ L DL+ ++ L E+ R +
Sbjct: 65 NIIAIRDILRPPGADF-----------KDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYF 112
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+ +L+ L+Y+HS ++HRDLKP NLL+ D +++ DFG+++ GL ++ +
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR-GLSSSPTEHKY----- 166
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFI--- 908
EY V T Y APE+LL E+ A D WSVG I E +
Sbjct: 167 ------FMTEY-----------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209
Query: 909 ------------------TGIPP------FTAESPEIIFDNILNRK-IPWPCVPSDMSFE 943
G P ++ N+ ++ +PW + S E
Sbjct: 210 QLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPE 269
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
A DL+++ L DP +R+ A + HPF
Sbjct: 270 ALDLLSQMLQFDPEERITVEQALQ---HPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 84/287 (29%), Positives = 136/287 (47%), Gaps = 47/287 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTG-DLFAIK-------VLKKLDMIRKNDIERILAERNI 740
+ +++ + GAFG V+ RK+ G +L A+K K R I I++E I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 741 LI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNG---GDLYSLLRKVG--CLEEDVARIYIA 794
+ +R+P +VR++ +F D LY+VM+ + G G+ ++ L++ EE + I++
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV- 120
Query: 795 ELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
++VLAL YLH IVHRDL P+N+++ D + +TDFGL+K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------ 162
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
Q+ S VGT Y PEI+ +G AD W+ G IL++ T PP
Sbjct: 163 ----------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
Query: 914 FTAESPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQR 959
F + + + I+ + +P M S + D+I L D R
Sbjct: 213 FYSTNMLSLATKIVEAV--YEPLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 95/330 (28%), Positives = 139/330 (42%), Gaps = 79/330 (23%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILI 742
S+ +FE + I G +G V+ AR T+G++ A LKK+ M + D I L E +L+
Sbjct: 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVA---LKKVRMDNERDGIPISSLREITLLL 61
Query: 743 TVRNPFVVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLA 799
+R+P +V + D+++LVMEY DL SLL + E + + +L+
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
L+YLH I+HRDLK NLL+ G +K+ DFGL++
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART---------------------YG 159
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918
P T V T Y APE+LLG T + A D W+VG IL E + P +S
Sbjct: 160 LPAKPMTPK------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213
Query: 919 P----EIIFD-----------------------------NILNRKIPWPCVPSDMSFEAQ 945
++I N L K PW +S
Sbjct: 214 EIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPW------LSEAGL 267
Query: 946 DLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
L+N L++DP +R A E +FK
Sbjct: 268 RLLNFLLMYDPKKRA---TAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 6e-30
Identities = 90/300 (30%), Positives = 136/300 (45%), Gaps = 60/300 (20%)
Query: 688 DFEIIKPI--SRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ EI+K + G FG+V + + + T LF K++K + N IE V
Sbjct: 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF---NAIE---------PMVH 62
Query: 746 -----NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
NP ++ +YS T L+M+Y+ GDL+ LL+K G L E + I +LV AL
Sbjct: 63 QLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEAL 122
Query: 801 EYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
LH I+H D+K +N+L I L D+GL KI I T D
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IG---------TPSCY--D-- 167
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
GT DY +PE + G + + DWW+VG++ +E +TG PF +
Sbjct: 168 ----------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
Query: 920 EII-FDNILNR---KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
E + +++L R K+P ++S A D + L ++ N RL E+ HPF K
Sbjct: 212 EELDLESLLKRQQKKLP---FIKNVSKNANDFVQSMLKYNINYRL--TNYNEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 84/287 (29%), Positives = 141/287 (49%), Gaps = 39/287 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I +G+FG V+ T ++ AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+ R++ S+ L+++MEYL GG LL K G LEE + E++ L+YLHS
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG----------------------------QLTDT 154
Query: 869 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNI 926
+ R++ VGTP ++APE++ + + + AD WS+GI E G PP + P ++F +
Sbjct: 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--L 212
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ + P P + S ++ + L DP R A E+ H F
Sbjct: 213 IPKNSP-PTLEGQYSKPFKEFVEACLNKDPRFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 83/233 (35%), Positives = 119/233 (51%), Gaps = 29/233 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI-ERILAERNILITVR 745
+ FE++ + GA+G V R + T ++ AIK K D ++ E L E +L T++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLK 58
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+V +F R LYLV EY+ L L + + R YI +L+ A+ + H
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
IVHRD+KP+NLLI+H+ +KL DFG ++ +LS +G S+A+Y EY
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFAR--------NLS----EG---SNANYTEY-- 161
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
V T Y +PE+LLG +G A D WSVG IL E G P F ES
Sbjct: 162 ---------VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 96/330 (29%), Positives = 148/330 (44%), Gaps = 72/330 (21%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL--KK 722
S S SS S+ S+ S+ + E + I GA G V+ R TG L+A+KV+
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 723 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
D +R+ +I E IL V +P VV+ F + +++E+++GG L +
Sbjct: 112 EDTVRR----QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG--THIA 165
Query: 783 CLEE--DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
+ DVAR +++ + YLH IVHRD+KP NLLI ++K+ DFG+S+I +
Sbjct: 166 DEQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LA 219
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-----LGTEHGYAA 895
T+D P + S+VGT Y++PE + G GYA
Sbjct: 220 QTMD----------PCN---------------SSVGTIAYMSPERINTDLNHGAYDGYAG 254
Query: 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW------------PCVPSDMSFE 943
D WS+G+ + EF G PF + R+ W P P+ S E
Sbjct: 255 DIWSLGVSILEFYLGRFPFG-----------VGRQGDWASLMCAICMSQPPEAPATASRE 303
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ I+ L +P +R A ++ HPF
Sbjct: 304 FRHFISCCLQREPAKRWSAM---QLLQHPF 330
|
Length = 353 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 4e-29
Identities = 87/293 (29%), Positives = 143/293 (48%), Gaps = 39/293 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +EII + GAFG+V+ A+ + TG L A KV+ D + ++E + E +IL + +
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI---DTKSEEELEDYMVEIDILASCDH 61
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHS 805
P +V+ +F +NL++++E+ GG + +++ ++ L E R+ + + AL YLH
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK N+L DG IKL DFG+S NT +
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRTI-------------------- 157
Query: 866 TDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ R S +GTP ++APE+++ + Y AD WS+GI L E PP +P
Sbjct: 158 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM 214
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ I + P PS S E +D + + L + + R ++ HPF
Sbjct: 215 RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARW---TTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 85/302 (28%), Positives = 136/302 (45%), Gaps = 52/302 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKV--LKKLDMIRKNDIERILAERNILITV 744
+D E I + G G V + TG + A KV + +RK +IL E I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK----QILRELQIMHEC 60
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
R+P++V F+ +F +N+ + ME+++ G L + +K G + ++ +V L YL+
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 805 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
+ I+HRD+KP N+L+ G IKL DFG+S LIN+ D
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG-ELINSIAD------------------- 160
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA------- 916
+ VGT Y++PE + G ++ +D WS+GI + E G PF
Sbjct: 161 ---------TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
Query: 917 -ESPEIIFD---NILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971
+ P I D I+ P P +PS D + +D ++ L+ DP +R
Sbjct: 212 QDDPMGILDLLQQIVQE--PPPRLPSSDFPEDLRDFVDACLLKDPTER--PTPQQLCAMP 267
Query: 972 PF 973
PF
Sbjct: 268 PF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 92/328 (28%), Positives = 142/328 (43%), Gaps = 74/328 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 745
D +E ++ I G +G+V+ AR + TG L A+K +L+M + L E ++L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSE 59
Query: 746 NPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLL----RKVGC-LEEDVARIYIAE 795
+ ++VR + +LYLV EYL+ DL + R G L + ++ +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
L+ + + H G++HRDLKP NLL+ G +K+ D GL + +I +
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR----AFSIPVK-------- 166
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPP 913
H V T Y APE+LLG+ H D WSVG I E P
Sbjct: 167 --------------SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211
Query: 914 FTAESPEI-----IFDNI--LNRKIPWPCV-------------PSDMSF-------EAQD 946
F +S E+ IF + ++ WP V P D+S E D
Sbjct: 212 FPGDS-ELQQLLHIFKLLGTPTEQV-WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLD 269
Query: 947 LINRFLIHDPNQRLGANGAAEVKAHPFF 974
L+ + L +DP +R+ A A HP+F
Sbjct: 270 LLQKMLRYDPAKRISAKAALT---HPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 80/288 (27%), Positives = 136/288 (47%), Gaps = 39/288 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+E I+ + RGAFG V L R++ L IK + M + E +L + +P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER-LAAQNECQVLKLLSHPN 60
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
++ ++ +F L +VMEY GG L ++K L+ED + +++LAL ++H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 807 GIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK N+L+ H +K+ DFG+SKI LS S A
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKI--------LSS-------KSKA------- 158
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 924
++ VGTP Y++PE+ G + +D W++G +L+E + F A + P ++
Sbjct: 159 ------YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK 212
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
+ P + S + + LI L DP++R + ++ A P
Sbjct: 213 IMSGTFAP---ISDRYSPDLRQLILSMLNLDPSKRPQLS---QIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 84/286 (29%), Positives = 137/286 (47%), Gaps = 37/286 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I +G+FG VF T + AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
V +++ S+ L+++MEYL GG LLR G +E + E++ L+YLHS
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG----------------------------QLTDT 154
Query: 869 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+ R++ VGTP ++APE++ + + AD WS+GI E G PP + P + I
Sbjct: 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI- 213
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
K P + + S ++ I+ L DP+ R A E+ H F
Sbjct: 214 -PKNNPPTLTGEFSKPFKEFIDACLNKDPSFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-28
Identities = 77/286 (26%), Positives = 138/286 (48%), Gaps = 36/286 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER----ILAERNILITVRNPFVV 750
+ +GA+G V+ G L A+K ++ LD E+ + E ++L ++++ +V
Sbjct: 8 LGKGAYGTVYCGLT-NQGQLIAVKQVE-LDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 751 RFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+ Y TC D+ + + ME++ GG + S+L + G L E V Y +++ + YLH+ +
Sbjct: 66 Q--YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
VHRD+K +N+++ +G IKL DFG ++ + + L G ++ +
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG----LHGTHSNML-------------- 165
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
S GTP ++APE++ + +G +D WS+G +FE TG PP + I
Sbjct: 166 ----KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ P +P S A D + L D ++R A ++ H F
Sbjct: 222 AHRGLMPRLPDSFSAAAIDFVTSCLTRDQHER---PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 80/274 (29%), Positives = 136/274 (49%), Gaps = 33/274 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+EIIK I G+FG+++LA+ ++ + IK + M K E E +L +++P
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMKHPN 60
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCL-EEDVARIYIAELVLALEYLHSL 806
+V FF SF L++VMEY +GGDL + R+ G L ED + ++ L L+++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 807 GIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRD+K N+ ++ +G + KL DFG+++ +N++++L+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELA------------------- 159
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
++ VGTP YL+PEI + D WS+G +L+E T PF + +
Sbjct: 160 ------YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I P P + S + + LI++ P R
Sbjct: 214 ICQGYFA-PISP-NFSRDLRSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 5e-28
Identities = 95/305 (31%), Positives = 138/305 (45%), Gaps = 51/305 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +EII+ I +G +G+V+ + G L A+K+L D I D E I AE NIL ++ N
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVD-EEIEAEYNILQSLPN 77
Query: 747 -PFVVRFFYSFTCRDN-----LYLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAEL 796
P VV+F+ F D L+LV+E NGG + L L L+E + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+L L++LH+ I+HRD+K +N+L+ +G +KL DFG+S
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 176
Query: 857 DAHYPEYQQTDNR-NRHSAVGTPDYLAPEILLGTE---HGYAA--DWWSVGIILFEFITG 910
Q T R R+++VGTP ++APE++ + + Y A D WS+GI E G
Sbjct: 177 -------QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
PP P I P P I++ LI D R E
Sbjct: 230 DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE--- 286
Query: 971 HPFFK 975
HPF K
Sbjct: 287 HPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 77/234 (32%), Positives = 112/234 (47%), Gaps = 33/234 (14%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R +DFE+I+ I G +G V+ AR TG+L AIKV+K + D + E ++
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMK 61
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ +V +F S+ RD L++ ME+ GG L + G L E E + L Y
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS G +HRD+K N+L+ +GH+KL DFG+S I TI
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVS--AQITATI------------------- 160
Query: 863 YQQTDNRNRHSAVGTPDYLAPEI-LLGTEHGY--AADWWSVGIILFEFITGIPP 913
R S +GTP ++APE+ + + GY D W+VGI E PP
Sbjct: 161 ------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 78/273 (28%), Positives = 135/273 (49%), Gaps = 37/273 (13%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILITVRNPFV 749
++ + +G++G V L R RT G + V+KKL++ + ER AE+ +L +++P +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQY---VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 750 VRFFYSFTCRDN-LYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSL 806
V + S+ D LY+VM + GGDLY L+ K L E+ + ++ +AL+YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
I+HRDLK N+ + IK+ D G++++ + N D++
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMAS------------------- 160
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ +GTP Y++PE+ + Y +D W++G ++E T F A+ + I
Sbjct: 161 ------TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ K+ P +P D S E +LI L P +R
Sbjct: 215 IEGKL--PPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 95/317 (29%), Positives = 148/317 (46%), Gaps = 65/317 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F+ ++ I G +G V+ AR + TG++ A+K ++ LD + + E ++L + +P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 60
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDL--YSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+V+ + LYLV E+L+ DL + + + + + Y+ +L+ L + HS
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRDLKP NLLI +G IKL DFGL++ G+ P
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV----------------------PVRTY 157
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEI--- 921
T H V T Y APEILLG + + A D WS+G I E +T F +S EI
Sbjct: 158 T-----HEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-EIDQL 210
Query: 922 --IFDNI-LNRKIPWPCV--------------PSDMSF-------EAQDLINRFLIHDPN 957
IF + ++ WP V D S + +DL+++ L +DPN
Sbjct: 211 FRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPN 270
Query: 958 QRLGANGAAEVKAHPFF 974
+R+ A A AHPFF
Sbjct: 271 KRISAKAAL---AHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 88/289 (30%), Positives = 134/289 (46%), Gaps = 48/289 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +EII+ I +G +G+VF + G A+K+L D I D E I AE NIL + +
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL---DPIHDID-EEIEAEYNILKALSD 73
Query: 747 -PFVVRFFYSFTCRD-----NLYLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAEL 796
P VV+F+ + +D L+LV+E NGG + L L++ +EE + + E
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
++ L++LH +HRD+K +N+L+ +G +KL DFG+S
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 172
Query: 857 DAHYPEYQQTDNR-NRHSAVGTPDYLAPEIL-----LGTEHGYAADWWSVGIILFEFITG 910
Q T R R+++VGTP ++APE++ L + + D WS+GI E G
Sbjct: 173 -------QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
PP P I P P S E D I + L D +R
Sbjct: 226 DPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKR 274
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 73/279 (26%), Positives = 132/279 (47%), Gaps = 37/279 (13%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+ +++ + G+FGR L + + +A+K ++ + +E E +L +++P
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL--PKSSSAVEDSRKEAVLLAKMKHP 58
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHS 805
+V F SF +LY+VMEY +GGDL ++ + ED + ++ L ++++H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRD+K N+ + +G +KL DFG +++ L+ P Y
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--------LTSP-----GAYACTY----- 160
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
VGTP Y+ PEI + +D WS+G IL+E T PF A S + N
Sbjct: 161 ---------VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS----WKN 207
Query: 926 ILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
++ + + + +PS S+E + LI + +P R A
Sbjct: 208 LILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSA 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-27
Identities = 93/336 (27%), Positives = 144/336 (42%), Gaps = 92/336 (27%)
Query: 689 FEI------IKPISRGAFGRVFLARKRTTGDLFAIK--------------VLKKLDMIRK 728
FE+ IKPI RGA+G V A+ T + AIK L+++ ++R
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH 60
Query: 729 NDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 787
D E ++A ++I+ R F +++Y+V E L DL+ ++R L +D
Sbjct: 61 LDHENVIAIKDIMPPPHREAF-----------NDVYIVYE-LMDTDLHQIIRSSQTLSDD 108
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ ++ +L+ L+Y+HS ++HRDLKP NLL+ + +K+ DFGL++
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--------- 159
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFE 906
E M EY V T Y APE+LL +E+ A D WSVG I E
Sbjct: 160 -EKGDFM------TEY-----------VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201
Query: 907 FITGIPPFTAE--------------SP-EIIFDNILN-------RKIP-WPCVP-----S 938
+ P F + SP E I N R +P P
Sbjct: 202 LLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFP 261
Query: 939 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ A DL+ + L+ DP++R+ A HP+
Sbjct: 262 HANPLAIDLLEKMLVFDPSKRITVEEALA---HPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 82/287 (28%), Positives = 141/287 (49%), Gaps = 39/287 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I +G+FG VF T + AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
V +++ S+ L+++MEYL GG LL G L+E + E++ L+YLHS
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG----------------------------QLTDT 154
Query: 869 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNI 926
+ R++ VGTP ++APE++ + + AD WS+GI E G PP + P +++F +
Sbjct: 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF--L 212
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ + P P + + S ++ + L +P+ R A E+ H F
Sbjct: 213 IPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 51/303 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-KLDMIRKNDIERILAERNILITVR 745
D+ E++ + +G +G V+ R TG A+K ++ +LD + N +I+ E +IL
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN---QIIMELDILHKAV 57
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGD---LYSLLRKVGCLEEDVARIYIAELVLALEY 802
+P++V F+ +F +Y+ MEY++ G LY+ + EDV R +V L++
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 803 L-HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
L I+HRD+KP N+L+ +G +KL DFG+S + S +T+
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTN---------- 161
Query: 862 EYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGYA-----ADWWSVGIILFEFITGIPPFT 915
+G Y+APE I G + +D WS+G+ + E G P+
Sbjct: 162 -------------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208
Query: 916 AESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
E+ IF + I P +PS S +AQD + + L PN+R A++ HP
Sbjct: 209 PETYANIFAQL--SAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR---PTYAQLLEHP 263
Query: 973 FFK 975
+
Sbjct: 264 WLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 89/310 (28%), Positives = 135/310 (43%), Gaps = 59/310 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 744
+ + + GA G V R + TG +FA+K + N ++IL E I +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSC 56
Query: 745 RNPFVVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI------YIAEL 796
++P++V+++ +F ++ + MEY GG L S+ +KV ++ RI IAE
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKV---KKRGGRIGEKVLGKIAES 113
Query: 797 VL-ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
VL L YLHS I+HRD+KP N+L+ G +KL DFG+S L+N S T
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG-ELVN-----SLAGT----- 162
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
GT Y+APE + G + +D WS+G+ L E PF
Sbjct: 163 ------------------FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204
Query: 916 AESPEI-----IFDNILNRKIPW----PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
E + I+N P P S E +D I + L DP +R
Sbjct: 205 PEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR---PTPW 261
Query: 967 EVKAHPFFKG 976
++ HP+ K
Sbjct: 262 DMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-26
Identities = 87/286 (30%), Positives = 136/286 (47%), Gaps = 35/286 (12%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERILAERNILITVRNPFVV 750
K + +GAFGRV+L TG A K ++ ++ + E +L +++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 751 RFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+++ R L + MEY+ GG + L+ G L E V R Y +++ + YLHS I
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
VHRD+K N+L G++KL DFG SK TI +SG GI
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSG---TGI--------------- 166
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNIL 927
S GTP +++PE++ G +G AD WS+G + E +T PP+ E+ IF +
Sbjct: 167 ---RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK--I 221
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ P +PS +S A+D + + + R A E+ HPF
Sbjct: 222 ATQPTNPQLPSHISEHARDFLGCIFV-EARHR---PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-26
Identities = 77/280 (27%), Positives = 130/280 (46%), Gaps = 38/280 (13%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+F I K I RG F V+ A G A+K ++ D++ + E ++L + +P
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYL 803
V++++ SF + L +V+E + GDL +++ + E Y +L ALE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS ++HRD+KP N+ I G +KL D GL + +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGR---------------------------F 155
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY- 214
Query: 924 DNILNRKIP---WPCVPSD-MSFEAQDLINRFLIHDPNQR 959
L +KI +P +PSD S E + L+N + DP +R
Sbjct: 215 --SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 70/229 (30%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
D+E+I+ + G +G V+ AR TG+L A+K++K + +D I E ++ ++
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHC 66
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V +F S+ R+ L++ MEY GG L + G L E E + L YLHS G
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRD+K N+L+ +G +KL DFG++ I TI
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVA--AKITATI------------------------ 160
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPP 913
R S +GTP ++APE+ ++G D W+VGI E PP
Sbjct: 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 72/228 (31%), Positives = 114/228 (50%), Gaps = 31/228 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI-LAERNILITVR 745
+ +E + I G++G VF R R TG + AIK K ++ I++I L E +L ++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLK 58
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+P +V F + L+LV EY + L L + + E + + I + + A+ + H
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+HRD+KP+N+LI G IKL DFG ++I L+GP D Y +Y
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARI--------LTGPGDD--------YTDY-- 160
Query: 866 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 912
V T Y APE+L+G T++G D W++G + E +TG P
Sbjct: 161 ---------VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 89/331 (26%), Positives = 135/331 (40%), Gaps = 64/331 (19%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI- 742
+ + D+EI+ + G FG V+ AR+ TG + A LKK+ M + D I A R I I
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVA---LKKILMHNEKDGFPITALREIKIL 61
Query: 743 -TVRNPFVVRF---FYSFT-----CRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 792
+++P VV R ++Y+V Y++ DL LL L E + Y
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCY 120
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE-TD 851
+ +L+ + YLH I+HRD+K N+LI + G +K+ DFGL++ D P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP------YDGPPPNPKG 174
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 910
G Y + V T Y PE+LLG + A D W +G + E T
Sbjct: 175 GGGGGTRKYT-----------NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
Query: 911 IPPFTAESP----EIIFD-----------------NILNRKIPWPCVPS-DMSFEAQ--- 945
P +S +IF + + F
Sbjct: 224 RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE 283
Query: 946 --DLINRFLIHDPNQRLGANGAAEVKAHPFF 974
DL+++ L DP +RL A+ A HP+F
Sbjct: 284 GLDLLSKLLSLDPYKRLTASDA---LEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 90/336 (26%), Positives = 138/336 (41%), Gaps = 83/336 (24%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--T 743
+ +E + I +G FG VF AR + T + A LKK+ M + + I A R I I
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVA---LKKVLMENEKEGFPITALREIKILQL 67
Query: 744 VRNPFVVRFF---------YSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIY 792
+++ VV Y+ + + YLV E+ DL LL + V ++ ++
Sbjct: 68 LKHENVVNLIEICRTKATPYN-RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV- 124
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+ L+ L Y+H I+HRD+K N+LI DG +KL DFGL++ ++
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS------------ 172
Query: 853 IMPSDAHYPEYQQTDNRNRHSA-VGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITG 910
+ NR++ V T Y PE+LLG G D W G I+ E T
Sbjct: 173 ------------KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220
Query: 911 IPPFTAES----------------PEI--------IFDNI-----LNRKIP---WPCVPS 938
P + PE+ +F + RK+ P V
Sbjct: 221 SPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKD 280
Query: 939 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
A DLI++ L+ DP +R+ A+ A H FF
Sbjct: 281 P---HALDLIDKLLVLDPAKRIDADTALN---HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 82/276 (29%), Positives = 130/276 (47%), Gaps = 38/276 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G +G V+ AR +T AIK + + D ++ + E + +++ +V++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLE--EDVARIYIAELVLALEYLHSLGIVHR 811
S + + ME + GG L +LLR K G L+ E Y +++ L+YLH IVHR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 812 DLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
D+K DN+L+ + G +K++DFG SK GI P +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSK-------------RLAGINPCTETF---------- 169
Query: 871 RHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTA-ESPEIIFDNIL 927
GT Y+APE++ GY AD WS+G + E TG PPF P+ +
Sbjct: 170 ----TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG 225
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
KI P +P +S EA++ I R DP++R A+
Sbjct: 226 MFKIH-PEIPESLSAEAKNFILRCFEPDPDKRASAH 260
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 83/267 (31%), Positives = 127/267 (47%), Gaps = 33/267 (12%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +GAFGRV+L TG A+K ++ D + + A + ++N R
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQ-FDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 753 FYSFTC-RD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+ C RD L + ME++ GG + L+ G L E+V R Y +++ + YLHS
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRD+K N+L G++KL DFG SK TI LSG G+
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLSG---TGMK------------- 167
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNI 926
S GTP +++PE++ G +G AD WSVG + E +T PP+ E+ IF
Sbjct: 168 -----SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-- 220
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLI 953
+ + P +P +S +D + R +
Sbjct: 221 IATQPTNPVLPPHVSDHCRDFLKRIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 94/325 (28%), Positives = 146/325 (44%), Gaps = 78/325 (24%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERI----LAERNILI 742
D+ I+ I G +G V+ R + TG + A +KK IR +++ E + + E ++L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVA---MKK---IRLESEEEGVPSTAIREISLLK 54
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLA 799
+++P +V LYL+ E+L+ DL L K ++ ++ + Y+ +++
Sbjct: 55 ELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQG 113
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ + HS ++HRDLKP NLLI + G IKL DFGL++ GI P +
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR--------------AFGI-PVRVY 158
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918
E V T Y APE+LLG + D WS+G I E T P F +S
Sbjct: 159 THE------------VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206
Query: 919 PEI-----IFDNIL---NRKIPWPCVPS---------------------DMSFEAQDLIN 949
EI IF IL + WP V S ++ + DL+
Sbjct: 207 -EIDQLFRIF-RILGTPTEDV-WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLE 263
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFF 974
+ LI+DP +R+ A A HP+F
Sbjct: 264 KMLIYDPAKRISAKKALN---HPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 86/301 (28%), Positives = 144/301 (47%), Gaps = 48/301 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVR 745
DD E+I+ + RGA+G V R TG + A+K ++ + + +R+L + +I + +V
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRA--TVNSQEQKRLLMDLDISMRSVD 58
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALE 801
P+ V F+ + ++++ ME ++ L +KV + ED+ +V ALE
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTS-LDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 802 YLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
YLHS L ++HRD+KP N+LI +G +KL DFG+S
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG------------------------- 152
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEIL--LGTEHGY--AADWWSVGIILFEFITGIPPFTA 916
D+ + G Y+APE + + GY +D WS+GI + E TG P+
Sbjct: 153 ---YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY-- 207
Query: 917 ESPEIIFDNILN-RKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+S + F + + P P +P++ S E QD +N+ L + +R E+ HPFF
Sbjct: 208 DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP---ELLQHPFF 264
Query: 975 K 975
+
Sbjct: 265 E 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 69/227 (30%), Positives = 111/227 (48%), Gaps = 35/227 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
D + + + G G V+ A T + A+KV+ LD I ++I++E IL +P
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIP-LD-ITVELQKQIMSELEILYKCDSP 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+++ F+ +F + + + E+++GG L + RK+ E + RI +A +V L YL SL
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-DVYRKIP--EHVLGRIAVA-VVKGLTYLWSLK 115
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRD+KP N+L+ G +KL DFG+S Q
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVST-----------------------------QLV 146
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
N + VGT Y+APE + G ++G +D WS+GI E G P+
Sbjct: 147 NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 94/328 (28%), Positives = 142/328 (43%), Gaps = 79/328 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 744
D ++ + P+ GA+G+V A TG AIK KL ++ I +R E +L +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK---KLSRPFQSAIHAKRTYRELRLLKHM 71
Query: 745 RNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELV 797
+ V+ FT +L YLV L G DL ++++ + L +D + + +++
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNIVKCQK--LSDDHIQFLVYQIL 128
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
L+Y+HS GI+HRDLKP N+ + D +K+ DFGL++ TD M
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-------------HTDDEM--- 172
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFT 915
T V T Y APEI+L H Y D WSVG I+ E +TG F
Sbjct: 173 --------TGY------VATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFP 217
Query: 916 AESPEIIFDNILN----------RKIP----------WPCVP--------SDMSFEAQDL 947
I+N +KI P +P S + A DL
Sbjct: 218 GSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDL 277
Query: 948 INRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ + L+ DP++R+ AAE AHP+
Sbjct: 278 LEKMLVLDPDKRI---TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 90/321 (28%), Positives = 137/321 (42%), Gaps = 80/321 (24%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK--------LDMIRKNDIERILAERNILIT 743
++P+ GAFG V AR + TG AIK + K R+ + + L NI I+
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI-IS 73
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+ + F+ + +++Y V E L G DL+ LL LE+ + ++ +++ L+Y+
Sbjct: 74 LSDIFI-------SPLEDIYFVTELL-GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYV 124
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS G+VHRDLKP N+LI + +K+ DFGL++I D Y
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARI-------------------QDPQMTGY 165
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP--- 919
V T Y APEI+L ++ D WS G I E + G P F +
Sbjct: 166 -----------VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214
Query: 920 -EIIFD----------------NILN--------RKIPWPCVPSDMSFEAQDLINRFLIH 954
II D N L +P+ + A DL+ + L+
Sbjct: 215 FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVF 274
Query: 955 DPNQRLGANGAAEVKAHPFFK 975
DP +R+ AAE AHP+
Sbjct: 275 DPQKRI---SAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 90/332 (27%), Positives = 146/332 (43%), Gaps = 82/332 (24%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--DIERILAE-------- 737
D E +PI GAFG V+ G A LKK+ + +N +R+ E
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVA---LKKMPNVFQNLVSCKRVFRELKMLCFFK 57
Query: 738 -RNIL--ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
N+L + + P + F + +Y+V E + DL+ ++ L D ++++
Sbjct: 58 HDNVLSALDILQPPHIDPF------EEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLY 110
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
+++ L+YLHS GI+HRD+KP NLL+ + +K+ DFGL+++
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV------------------ 152
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPP 913
+ ++++ V T Y APEIL+G+ H A D WSVG I E +
Sbjct: 153 --------EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRIL 204
Query: 914 FTAESP----EIIFD-------------------NILNRKIPWPCVP------SDMSFEA 944
F A+SP ++I D +IL P +P S + EA
Sbjct: 205 FQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEA 264
Query: 945 QDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
L+ R L+ DP++R+ AA+ AHP+
Sbjct: 265 VHLLCRMLVFDPDKRI---SAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 71/236 (30%), Positives = 118/236 (50%), Gaps = 39/236 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVL---KKLDMIRKNDIERILAERNI--LIT 743
+E + + G++G V + + TG + AIK + M++K +A R I L
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKK------IAMREIRMLKQ 56
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+R+ +V F + LYLV E+++ L L + L+E R Y+ +++ +E+
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS I+HRD+KP+N+L++ G +KL DFG ++ L+ P Y +Y
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFART--------LAAPGEV--------YTDY 160
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918
V T Y APE+L+G T++G A D W+VG ++ E +TG P F +S
Sbjct: 161 -----------VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 72/282 (25%), Positives = 134/282 (47%), Gaps = 38/282 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ +F+I K I RG F V+ A A+K ++ +M+ + + E ++L +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALE 801
+P V+++ SF + L +V+E + GDL ++ ++ + E Y +L A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
++HS ++HRD+KP N+ I G +KL D GL +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-------------------------- 154
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
+ + HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 155 -FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 922 IFDNILNRKIP---WPCVPSD-MSFEAQDLINRFLIHDPNQR 959
L +KI +P +P++ S + ++L++ + DP+QR
Sbjct: 214 F---SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 94/332 (28%), Positives = 143/332 (43%), Gaps = 74/332 (22%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK--------KLDMIRKNDIERI 734
+ +D F+II I G +G+V+ AR + TG+L A+K ++ + IR+ I R
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 735 LAERNIL----ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVA 789
L RNI+ I + F + YLV EY++ DL LL + ED
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKD---KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118
Query: 790 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ ++ +L+ L Y H +HRD+K N+L+ + G IKL DFGL+++
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL------------- 165
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFI 908
Y ++R + V T Y PE+LLG E +G A D WS G IL E
Sbjct: 166 -------------YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 212
Query: 909 TGIPPFTAES--------------------PEII----FDNILNRKIPWPCVPSDMSF-- 942
T P F A P++I F+ + +K + + SF
Sbjct: 213 TKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIP 272
Query: 943 -EAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
A DL++ L DP++R A E P+
Sbjct: 273 TPALDLLDHMLTLDPSKRCTAE---EALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 85/289 (29%), Positives = 135/289 (46%), Gaps = 41/289 (14%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLD---MIRKNDIERILAERNILITVRNPFV 749
K + RGAFG V+L TG A+K + D ++ + E +L +R+ +
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVP-FDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 750 VRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
V+++ RD L + +EY+ GG + L+ G L E+V R Y +++ + YLHS
Sbjct: 67 VQYYGCL--RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
IVHRD+K N+L G++KL DFG SK TI +SG GI
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMSG---TGI------------ 166
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFD 924
S GTP +++PE++ G +G AD WSV + E +T PP+ E+ IF
Sbjct: 167 ------KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK 220
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ + P +P +S +D + + + + + A + HPF
Sbjct: 221 --IATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPT----AEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 69/247 (27%), Positives = 117/247 (47%), Gaps = 49/247 (19%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---R 745
FE+++ + G +G+V+ R TG L AIKV+ + +++ E I E N+L R
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73
Query: 746 NPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELV 797
N + ++ +F + D L+LVME+ G + L++ L+ED E++
Sbjct: 74 N--IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
L +LH+ ++HRD+K N+L+ + +KL DFG+S
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------------- 169
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIP 912
+ +T R R++ +GTP ++APE++ E + Y +D WS+GI E G P
Sbjct: 170 ----QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
Query: 913 PFTAESP 919
P P
Sbjct: 225 PLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 87/330 (26%), Positives = 147/330 (44%), Gaps = 83/330 (25%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-------------VLKKLDMIRKNDIER 733
++ + I GA+G V A + TG AIK L+++ ++R+ E
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 793
I+ +I+ F SF +++Y+V E + DLY L++ L D + ++
Sbjct: 65 IIGILDIIR-------PPSFESF---NDVYIVQELMET-DLYKLIKTQH-LSNDHIQYFL 112
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+++ L+Y+HS ++HRDLKP NLL+ + +K+ DFGL++I + D +G T
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLT--- 167
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGI 911
EY V T Y APEI+L GY A D WSVG IL E ++
Sbjct: 168 --------EY-----------VATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNR 207
Query: 912 PPFTAE--------------SPEII-FDNILNRK-------------IPWPCVPSDMSFE 943
P F + +P + I++ + +PW + + +
Sbjct: 208 PLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPK 267
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
A DL+++ L +P++R+ E AHP+
Sbjct: 268 ALDLLDKMLTFNPHKRITVE---EALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 92/336 (27%), Positives = 145/336 (43%), Gaps = 84/336 (25%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE I + G G VF + +G + A K++ I+ +I+ E +L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 805
P++V F+ +F + + ME+++GG L +L+K G + E + ++ IA ++ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-VIKGLTYLRE 121
Query: 806 L-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+HRD+KP N+L+ G IKL DFG+S
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----------------------------- 152
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 921
Q + +S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E+
Sbjct: 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212
Query: 922 IF-----------------------------------------DNILNRKIPWPCVPSDM 940
+F D I+N P P +PS +
Sbjct: 213 MFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE--PPPKLPSGV 270
Query: 941 -SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
E QD +N+ LI +P +R ++ H F K
Sbjct: 271 FGAEFQDFVNKCLIKNPAERADLK---QLMVHAFIK 303
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 89/324 (27%), Positives = 141/324 (43%), Gaps = 70/324 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRN 746
+E+IK + +GA+G V AR T + + + KK+ + I +R L E +L R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAI-KKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 747 --------PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ F +F + LYL E L DL+ ++R L + + +I +++
Sbjct: 61 HKNITCLYDMDIVFPGNF---NELYLYEE-LMEADLHQIIRSGQPLTDAHFQSFIYQILC 116
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+HS ++HRDLKP NLL+ D +K+ DFGL++ G N + +G
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAG----------- 164
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917
EY V T Y APEI+L + A D WSVG IL E + P F +
Sbjct: 165 FMTEY-----------VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213
Query: 918 S-----PEIIF------DNILNR-----------------KIPWPCVPSDMSFEAQDLIN 949
+I+ + L+R K P+ + + + A DL+
Sbjct: 214 DYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLE 273
Query: 950 RFLIHDPNQRLGANGAAEVKAHPF 973
+ L DP +R+ A E HP+
Sbjct: 274 KLLAFDPTKRISVEEALE---HPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 80/307 (26%), Positives = 141/307 (45%), Gaps = 50/307 (16%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
K ++D E + I G G+V+ R + TG + A+K +++ K + +RIL + ++
Sbjct: 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDV 66
Query: 741 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVL 798
++ + P++V+ + F ++++ ME L L LL+++ G + ED+ +V
Sbjct: 67 VLKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 799 ALEYL---HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
AL YL H G++HRD+KP N+L+ G++KL DFG+S G +
Sbjct: 126 ALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS-----------------GRL- 165
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL----LGTEHGYAADWWSVGIILFEFITGI 911
D++ + + G Y+APE + ++ AD WS+GI L E TG
Sbjct: 166 ----------VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
Query: 912 PPFTAESPEI-IFDNILNRKIPWPCVPSDMSF--EAQDLINRFLIHDPNQRLGANGAAEV 968
P+ E + IL P +P + F + ++ L D +R E+
Sbjct: 216 FPYKNCKTEFEVLTKILQE--EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYR---EL 270
Query: 969 KAHPFFK 975
HPF +
Sbjct: 271 LQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 94/330 (28%), Positives = 152/330 (46%), Gaps = 76/330 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--DIERILAERNILITVRN 746
++I + I +G++G V A TG+ AIK K++ + ++ D RIL E +L +R+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---KINDVFEHVSDATRILREIKLLRLLRH 58
Query: 747 PFVV---RFFYSFTCRD--NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
P +V + R+ ++Y+V E L DL+ +++ L + + ++ +L+ AL+
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
Y+H+ + HRDLKP N+L D +K+ DFGL+++ N+T P+ +
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF-NDT------------PTAIFWT 164
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAE- 917
+Y V T Y APE L G +++ A D WS+G I E +TG P F +
Sbjct: 165 DY-----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212
Query: 918 ---------------SPEII----------FDNILNRKIPWPCVPSDMSFEAQD-----L 947
SPE I + + + +K P VP F D L
Sbjct: 213 VVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP---VPFSQKFPNADPLALRL 269
Query: 948 INRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
+ R L DP R A E A P+FKG+
Sbjct: 270 LERLLAFDPKDR---PTAEEALADPYFKGL 296
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 5e-22
Identities = 89/326 (27%), Positives = 135/326 (41%), Gaps = 83/326 (25%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--------MIRKNDIERILAERNI 740
F+ ++ + G + V+ R RTTG++ A+K + LD IR+ + + L NI
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH-LDAEEGTPSTAIREISLMKELKHENI 60
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL--YSLLRKV-GCLEEDVARIYIAELV 797
VR + L LV EY++ DL Y V G L+ + + + +L+
Sbjct: 61 ---------VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPS 856
+ + H ++HRDLKP NLLI G +KL DFGL++ G+ NT
Sbjct: 111 KGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS------------ 158
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFT 915
+ V T Y AP++LLG+ + + D WSVG I+ E ITG P F
Sbjct: 159 ----------------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202
Query: 916 AESPE----IIFDNI----------------LNRKIPWPCVPSDMSF-------EAQDLI 948
+ E IF + P P D+ DL+
Sbjct: 203 GTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP-RYPPQDLQQLFPHADPLGIDLL 261
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFF 974
+R L +P R+ A+ A HP+F
Sbjct: 262 HRLLQLNPELRISAHDAL---QHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 97/325 (29%), Positives = 146/325 (44%), Gaps = 72/325 (22%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LIT 743
+D +E ++ I G +G V+ AR R T + A LKK+ + ++++ A R I L
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIA---LKKIRLEQEDEGVPSTAIREISLLKE 57
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED--VARIYIAELVLALE 801
+++ +VR LYLV EYL+ DL + ++ + + Y+ +++ +
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
Y HS ++HRDLKP NLLI + +KL DFGL++ GI P
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--------------AFGI-PVRTFT 161
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPFTAES 918
E V T Y APEILLG+ H Y+ D WSVG I E + P F +S
Sbjct: 162 HE------------VVTLWYRAPEILLGSRH-YSTPVDIWSVGCIFAEMVNQKPLFPGDS 208
Query: 919 PEI-----IFDNILN--RKIPWPCVPSDMSFEAQ---------------------DLINR 950
EI IF IL + WP V S +++ DL+++
Sbjct: 209 -EIDELFKIF-RILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSK 266
Query: 951 FLIHDPNQRLGANGAAEVKAHPFFK 975
L DP++R+ A A E H +FK
Sbjct: 267 MLRLDPSKRITARAALE---HEYFK 288
|
Length = 294 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 80/301 (26%), Positives = 136/301 (45%), Gaps = 53/301 (17%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
FE+++ + G +G+V+ R TG L AIKV+ + ++ E I E N+L +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 749 VVRFFYSFTCR-------DNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLA 799
+ +Y + D L+LVME+ G + L++ K L+E+ E++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
L +LH ++HRD+K N+L+ + +KL DFG+S
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------------------------ 159
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPF 914
+ +T R R++ +GTP ++APE++ E + + +D WS+GI E G PP
Sbjct: 160 --QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
Query: 915 TAESP-EIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
P +F L + P P + S S + Q I L+ + +QR ++ HP
Sbjct: 217 CDMHPMRALF---LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQR---PTTEQLMKHP 270
Query: 973 F 973
F
Sbjct: 271 F 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-21
Identities = 68/234 (29%), Positives = 104/234 (44%), Gaps = 44/234 (18%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER---ILAERNILITVR 745
F ++ I G+FG V+ AR T ++ AIK K+ K E+ I+ E L +R
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIK---KMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNG--GDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+P + + + +LVMEY G D+ + +K E ++A I L L YL
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK-PLQEVEIAAICHGALQ-GLAYL 131
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS +HRD+K N+L+ G +KL DFG + + + P++
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASL----------------VSPAN------ 169
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 914
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 170 ---------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 81/319 (25%), Positives = 135/319 (42%), Gaps = 69/319 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 744
+E ++ I G +G VF A+ R T ++ A+K ++ LD +D E + L E +L +
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LD----DDDEGVPSSALREICLLKEL 56
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYL 803
++ +VR + L LV EY + DL G ++ ++ + ++ +L+ L +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS ++HRDLKP NLLI +G +KL DFGL++ GI P + E
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLAR--------------AFGI-PVRCYSAE- 159
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEF--------------- 907
V T Y P++L G + + D WS G I E
Sbjct: 160 -----------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
Query: 908 -------ITGIP-----PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHD 955
+ G P P ++ P+ + V ++ +DL+ L+ +
Sbjct: 209 QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCN 268
Query: 956 PNQRLGANGAAEVKAHPFF 974
P QR+ A A + HP+F
Sbjct: 269 PVQRISAEEALQ---HPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 87/326 (26%), Positives = 137/326 (42%), Gaps = 75/326 (23%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNIL 741
++ ++ + + G++ V+ R + TG L A+K IR E + E ++L
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKE------IRLEHEEGAPFTAIREASLL 57
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLAL 800
+++ +V + L LV EYL+ DL + G L R+++ +L+ L
Sbjct: 58 KDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
Y H ++HRDLKP NLLI+ G +KL DFGL++ + PS +
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV---------------PSKTYS 161
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF----- 914
E V T Y P++LLG TE+ + D W VG I +E TG P F
Sbjct: 162 NE------------VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209
Query: 915 TAESPEIIFDNILNRKIP--WPCVPSDMSF------------------------EAQDLI 948
+ IF +L WP V S+ F ++L
Sbjct: 210 VEDQLHKIF-RVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELA 268
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFF 974
+FL ++P +R+ AAE HP+F
Sbjct: 269 LKFLQYEPKKRI---SAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 67/294 (22%), Positives = 115/294 (39%), Gaps = 53/294 (18%)
Query: 687 DDFEIIKPISRGAFGRVF--LARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNIL 741
+ +I+ + +G+FG V+ LA+ G+ AIK + + +R + L E +++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIEFLNEASVM 63
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA----------RI 791
VVR + +VME + GDL S LR E +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRS--RRPEAENNPGLGPPTLQKF 121
Query: 792 Y--IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
AE+ + YL + VHRDL N ++A D +K+ DFG+++ I T D
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYET-DYYRKG 178
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
G++P ++APE L +D WS G++L+E T
Sbjct: 179 GKGLLPV----------------------RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
Query: 910 -GIPPFTAESPEIIFDNILNRKI-PWP-CVPSDMSFEAQDLINRFLIHDPNQRL 960
P+ S E + +++ P P + +L+ ++P R
Sbjct: 217 LAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKL----LELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 5e-21
Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 42/275 (15%)
Query: 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757
GA G V A++ + G+ FA+KV+ ++ + + D R AE L+ +V+ F
Sbjct: 43 GATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA 101
Query: 758 CRDN--------LYLVMEYLNGGDLYSLLR---KVG-CLEEDVARIYIAELVLALEYLHS 805
+D + LV++Y N GDL ++ K E A + +++LA+ ++HS
Sbjct: 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS 161
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRD+K N+L+ +G +KL DFG SK + T+
Sbjct: 162 KHMIHRDIKSANILLCSNGLVKLGDFGFSK--MYAATV---------------------- 197
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 924
+D+ R + GTP Y+APEI + AD +S+G++L+E +T PF E+ E++
Sbjct: 198 SDDVGR-TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ R P +P +S E Q+++ L DP +R
Sbjct: 257 TLAGRYDP---LPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 1e-20
Identities = 72/242 (29%), Positives = 117/242 (48%), Gaps = 37/242 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE I + G G V + + +G + A K++ I+ +I+ E +L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 805
P++V F+ +F + + ME+++GG L +L++ + E++ ++ IA ++ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA-VLRGLAYLRE 121
Query: 806 L-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+HRD+KP N+L+ G IKL DFG+S
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG----------------------------- 152
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 921
Q + +S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E
Sbjct: 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212
Query: 922 IF 923
IF
Sbjct: 213 IF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-20
Identities = 84/295 (28%), Positives = 140/295 (47%), Gaps = 46/295 (15%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE------RILAERNILI 742
++II+ I +G G V+LA A LKK IR++ E R L E I
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVA---LKK---IREDLSENPLLKKRFLREAKIAA 57
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV---GCLEEDVA---------R 790
+ +P +V + + D +Y M Y+ G L SLL+ V L +++A
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 791 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG--LSKIGLINNTIDLSGP 848
I+ ++ +EY+HS G++HRDLKPDN+L+ G + + D+G + K + +D+
Sbjct: 118 IFH-KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
E I S P VGTPDY+APE LLG + D +++G+IL++ +
Sbjct: 177 ER-NICYSSMTIP----------GKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
Query: 909 TGIPPFTAES-PEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQR 959
T P+ + +I + +++ I P+ +P +S + + L DP +R
Sbjct: 226 TLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-20
Identities = 85/274 (31%), Positives = 124/274 (45%), Gaps = 43/274 (15%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA----ERNILITVRNPFVV 750
+ R F+A T G KV+ K M+ ND ER A E + L + +V
Sbjct: 75 VGRNPTTAAFVA---TRGSDPKEKVVAKFVML--ND-ERQAAYARSELHCLAACDHFGIV 128
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+ F F D L L+MEY +GGDL L++ +E + ++VLAL+ +HS
Sbjct: 129 KHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR 188
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRDLK N+ + G IKL DFG SK + ++D++
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS------------------- 229
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
S GTP YLAPE+ + AD WS+G+IL+E +T PF S I +
Sbjct: 230 ------SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283
Query: 927 LNRKI-PWPCVPSDMSFEAQDLINRFLIHDPNQR 959
L K P+PC S + L++ L +P R
Sbjct: 284 LYGKYDPFPCPVSS---GMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-20
Identities = 91/326 (27%), Positives = 141/326 (43%), Gaps = 75/326 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 744
D + +K + GA+G V A R TG AIK KL ++++ +R E +L +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 71
Query: 745 RNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
++ V+ FT +L YLVM ++ G DL L+ K L ED + + +++
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLM-KHEKLSEDRIQFLVYQMLK 129
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+H+ GI+HRDLKP NL + D +K+ DFGL++
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----------------------- 166
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917
QTD+ V T Y APE++L H D WSVG I+ E +TG P F
Sbjct: 167 ------QTDSEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219
Query: 918 --------------SPEIIFDNILN--------------RKIPWPCVPSDMSFEAQDLIN 949
+P F L RK + + + + A +++
Sbjct: 220 DHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLE 279
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFFK 975
+ L+ D R+ AAE AHP+F+
Sbjct: 280 KMLVLDAESRI---TAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 86/321 (26%), Positives = 133/321 (41%), Gaps = 60/321 (18%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERI---------LAERNILIT 743
+ G +G+V A TG + AIK +K ++ D + + L E I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 802
+++ ++ + D + LVM+ + DL ++ RK+ E V I + +++ L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCI-LLQILNGLNV 134
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH +HRDL P N+ I G K+ DFGL++ SD +
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLAR-------------RYGYPPYSDTLSKD 181
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEI 921
S V T Y APE+L+G E + +A D WSVG I E +TG P F E+ EI
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN-EI 240
Query: 922 -----IFDNILNRKIP--WP---CVPSDMSF-----------------EAQDLINRFLIH 954
IF +L WP +P F +A DL+ L
Sbjct: 241 DQLGRIF-ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299
Query: 955 DPNQRLGANGAAEVKAHPFFK 975
+P +R+ A A + H +FK
Sbjct: 300 NPLERISAKEALK---HEYFK 317
|
Length = 335 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 8e-20
Identities = 78/287 (27%), Positives = 136/287 (47%), Gaps = 43/287 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA--ERNILITVRNPFVVRF 752
+ +G+FG V+L + + +KVLK++ + N E + A E +L + +P +V+F
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE----LVLALEYLHSLGI 808
SF RD ++ EY G DL L ++ + ++ + E L+L + Y+H I
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRDLK N+ + ++ +K+ DFG+S+ L+ + DL+ T
Sbjct: 128 LHRDLKAKNIFLKNN-LLKIGDFGVSR--LLMGSCDLATTFT------------------ 166
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 928
GTP Y++PE L + +D WS+G IL+E F ++ F +++
Sbjct: 167 -------GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVL 215
Query: 929 RKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
R + P P +P S + ++ L DP+ R AAE+ +PF
Sbjct: 216 RIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRP---SAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 49/245 (20%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVR 745
IK + G FG+V L R TG+ A+K L ++D ER E IL T+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH-SGEEQHRSDFER---EIEILRTLD 64
Query: 746 NPFVVRFFYSFT--CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ +V++ +L L+MEYL G L L++ +I + L+L
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQI 118
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
++YL S +HRDL N+L+ + +K++DFGL+K ++P
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK-----------------VLPE 161
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
D Y S + + APE L ++ A+D WS G+ L+E T P +
Sbjct: 162 DKDY----YYVKEPGESPI---FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
Query: 917 ESPEI 921
E
Sbjct: 215 PPAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 9e-20
Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 63/264 (23%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
+ ++++E+IK I G FG VFL + + T + F K + + ++ + +++ E N++
Sbjct: 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRE 68
Query: 744 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELV 797
+++ +VR+ F + N LY++ME+ + GDL ++K G +EE +L+
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 798 LALEYLHSLG-------IVHRDLKPDNLL----IAHDGHI-------------KLTDFGL 833
AL Y H+L ++HRDLKP N+ I H G I K+ DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 834 SK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
SK IG+ HS VGTP Y +PE+LL
Sbjct: 189 SKNIGI-----------------------------ESMAHSCVGTPYYWSPELLLHETKS 219
Query: 893 Y--AADWWSVGIILFEFITGIPPF 914
Y +D W++G I++E +G PF
Sbjct: 220 YDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 90/326 (27%), Positives = 135/326 (41%), Gaps = 79/326 (24%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK--------KLDMIRKNDIERILAERNI 740
+E + I GA+G V+ AR +G A+K ++ L +R E L +R
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR----EVALLKR-- 55
Query: 741 LITVRNPFVVRFF----YSFTCRD-NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYI 793
L +P +VR S T R+ + LV E+++ DL + L KV L + + +
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLM 114
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+ + L++LH+ IVHRDLKP+N+L+ G +KL DFGL++I +
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT--------- 165
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
V T Y APE+LL + + D WSVG I E P
Sbjct: 166 -------------------PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 206
Query: 914 FTAESPE----IIFDNI-LNRKIPWP--------------------CVPSDMSFEAQDLI 948
F S IFD I L + WP VP ++ L+
Sbjct: 207 FCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVP-EIEESGAQLL 265
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFF 974
L +P++R+ A A + HPFF
Sbjct: 266 LEMLTFNPHKRISAFRALQ---HPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 84/332 (25%), Positives = 137/332 (41%), Gaps = 85/332 (25%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIK------------VLKKLDMIRKNDIERILAERN 739
++P+ G+ G VF A A+K L+++ +IR+ D + I+
Sbjct: 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 740 ILIT--VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
+L V +++Y+V EY+ DL ++L + G L E+ AR+++ +L+
Sbjct: 70 VLGPSGSDLTEDVGSLTEL---NSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLL 124
Query: 798 LALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
L+Y+HS ++HRDLKP N+ I D +K+ DFGL++I
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI-------------------V 165
Query: 857 DAHYPEYQQTDNRNRHSA-----VGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 910
D HY H + T Y +P +LL + A D W+ G I E +TG
Sbjct: 166 DPHY----------SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
Query: 911 IPPFTA----ESPEIIFDNI----------LNRKIPW--------PCVP-----SDMSFE 943
P F E ++I +++ L IP P P ++ E
Sbjct: 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPE 275
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
A D + + L +P RL A A HP+
Sbjct: 276 ALDFLEQILTFNPMDRLTAEEAL---MHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 81/318 (25%), Positives = 133/318 (41%), Gaps = 71/318 (22%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITVRNP 747
++ + G++ V+ R G L A+KV I E + + E ++L +++
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V ++ L V EY++ +++ G L R+++ +L+ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRDLKP NLLI++ G +KL DFGL++ I PS + E
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSI---------------PSQTYSSE----- 163
Query: 868 NRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF--TAESPEII-- 922
V T Y P++LLG T++ A D W G I E + G P F ++ E +
Sbjct: 164 -------VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216
Query: 923 ---------------FDNILNRKIPW--PCVPSDM---------SFEAQDLINRFLIHDP 956
+ N K W PC P + +A+DL ++ L+ P
Sbjct: 217 IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFP 276
Query: 957 NQRLGANGAAEVKAHPFF 974
R+ A A HP+F
Sbjct: 277 KDRISAQDAL---LHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 3e-19
Identities = 83/322 (25%), Positives = 136/322 (42%), Gaps = 69/322 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +E ++ + G++ V+ + + G L A+KV++ + + + E ++L +++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+V ++ L LV EY++ + + G L + ++++ +L+ L Y+H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
I+HRDLKP NLLI+ G +KL DFGL++ + PS + E
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSV---------------PSHTYSNE---- 163
Query: 867 DNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA-----ESPE 920
V T Y P++LLG TE+ D W VG I E I G+ F + E
Sbjct: 164 --------VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE 215
Query: 921 IIFDNILNRKIP----WPCVPSDMSFE------------------------AQDLINRFL 952
IF L P WP V S F+ A+DL ++ L
Sbjct: 216 RIF---LVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLL 272
Query: 953 IHDPNQRLGANGAAEVKAHPFF 974
P RL A A +H +F
Sbjct: 273 QCFPKNRLSAQAAL---SHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 84/308 (27%), Positives = 139/308 (45%), Gaps = 59/308 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNILI 742
+D + + I RGAFG V + +G + A+K IR E R+L + ++++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVK------RIRSTVDEKEQKRLLMDLDVVM 57
Query: 743 TVRN-PFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSL--LRKVGCLEEDV-ARIYIAEL 796
+ P++V+F+ + + ++ ME ++ Y + E++ +I +A
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA-T 116
Query: 797 VLALEYL-HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
V AL YL L I+HRD+KP N+L+ +G+IKL DFG+S G + ++I
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI------------ 162
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIP 912
+T + G Y+APE I GY +D WS+GI L+E TG
Sbjct: 163 --------AKTRD------AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKF 208
Query: 913 PFTAESPEIIFDNILN-RKIPWPCVPSD----MSFEAQDLINRFLIHDPNQRLGANGAAE 967
P+ + +FD + K P + + S + IN LI D ++R E
Sbjct: 209 PYPKWNS--VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYK---E 263
Query: 968 VKAHPFFK 975
+ HPF K
Sbjct: 264 LLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 77/274 (28%), Positives = 115/274 (41%), Gaps = 45/274 (16%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I RG FG VF R R A+K + + + + + L E IL +P +VR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEYLHSLG 807
T + +Y+VME + GGD + LR G R+ + EL+ +EYL S
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESKH 114
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL N L+ +K++DFG+S+ E DG+ S +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR------------EEEDGVYASTGGMKQ----- 157
Query: 868 NRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDN 925
P + APE L + +D WS GI+L+E F G P+ S + +
Sbjct: 158 ---------IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA 208
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I + + PC P L+ R +DP QR
Sbjct: 209 I-EQGVRLPC-PELCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 78/242 (32%), Positives = 111/242 (45%), Gaps = 43/242 (17%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFA----IKVLKKLDMIRKNDIERILAERNILITV 744
+E + I GA+G+VF AR G F ++V + + + I + R+ L T
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-LETF 61
Query: 745 RNPFVVRFF----YSFTCRDN-LYLVMEYLNGGDLYSLLRKV---GCLEEDVARIYIAEL 796
+P VVR F S T R+ L LV E+++ DL + L KV G E + + + +L
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM-MFQL 119
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-------------------- 159
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
+Q S V T Y APE+LL + + D WSVG I E P F
Sbjct: 160 ----YSFQMALT----SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211
Query: 917 ES 918
S
Sbjct: 212 SS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 88/316 (27%), Positives = 130/316 (41%), Gaps = 76/316 (24%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILITVRNP 747
+ G + VF R + T +L A+K ++ IR+ + + L NI +T+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI-VTLHD- 70
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE-DVARIYIAELVLALEYLHSL 806
++ T LV EYL+ DL L G L +I++ +L+ L Y H
Sbjct: 71 -IIHTERCLT------LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
I+HRDLKP NLLI G +KL DFGL++ + P+ + E
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSV---------------PTKTYSNE---- 163
Query: 867 DNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF----TAESPEI 921
V T Y P++LLG TE+ D W VG IL+E TG P F E +
Sbjct: 164 --------VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
Query: 922 IFDNI-LNRKIPWPCVPSDMSFE--------AQDLINR--------------FLIHDPNQ 958
IF + + WP + S+ F AQ LIN L+++
Sbjct: 216 IFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKS 275
Query: 959 RLGANGAAEVKAHPFF 974
R+ A A H +F
Sbjct: 276 RISAEAALR---HSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 7e-18
Identities = 65/255 (25%), Positives = 104/255 (40%), Gaps = 29/255 (11%)
Query: 711 TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-LYLVMEYL 769
TG AIK+L+ ++ R E + + +P +V S L+ V EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 770 NGGDLYSLLRKVGCLE-EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---H 825
G L +L G L + R+ + +++ AL H+ GIVHRDLKP N++++ G H
Sbjct: 62 PGRTLREVLAADGALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEI 885
K+ DFG+ + + +GTP Y APE
Sbjct: 121 AKVLDFGIGTLL------------------PGVRDADVATLTRT--TEVLGTPTYCAPEQ 160
Query: 886 LLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEA 944
L G +D ++ G+I E +TG S EI++ + + P P
Sbjct: 161 LRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLP--PWIAGHPL 218
Query: 945 QDLINRFLIHDPNQR 959
++ + L DP QR
Sbjct: 219 GQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 8e-18
Identities = 91/347 (26%), Positives = 144/347 (41%), Gaps = 87/347 (25%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRNPFV 749
+K + GA+G V A + TG+ AIK KL +++I +R E +L +++ V
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIK---KLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 750 VRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLE--EDVARIYIAELVLALE 801
+ FT + YLVM Y+ + L+K+ ED + + +++ L+
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
Y+HS GI+HRDLKP NL + D +K+ DFGL++ +DA
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------------HADAEMT 172
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES-- 918
Y V T Y APE++L H D WSVG I+ E +TG F +
Sbjct: 173 GY-----------VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 221
Query: 919 --------------PEII--FDNILNRKI--PWPCVPS--------DMSFEAQDLINRFL 952
PE + ++ + P P S +A DL+ + L
Sbjct: 222 DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKML 281
Query: 953 IHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDT 999
D ++RL A A E HP+F + + A + + DD+
Sbjct: 282 ELDVDKRLTATEALE---HPYFD-------SFRDADEETEQQPYDDS 318
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 67/248 (27%), Positives = 109/248 (43%), Gaps = 55/248 (22%)
Query: 689 FEIIKPISRGAFGRVFLAR--KRTTGDLFAIKVLK--KLDM-------IRKNDIERILAE 737
+EI I RG +GRV+ A+ G +AIK K K R+ + R L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-----KVGCLEEDVARIY 792
N+ +++ F+ S +YL+ +Y DL+ +++ K + + +
Sbjct: 62 ENV-VSLVEVFLEHADKS------VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH----IKLTDFGLSKIGLINNTIDLSGP 848
+ +++ + YLHS ++HRDLKP N+L+ +G +K+ D GL++ L N +
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLAD 171
Query: 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFE 906
D + V T Y APE+LLG H Y A D W++G I E
Sbjct: 172 L-DPV---------------------VVTIWYRAPELLLGARH-YTKAIDIWAIGCIFAE 208
Query: 907 FITGIPPF 914
+T P F
Sbjct: 209 LLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-17
Identities = 88/326 (26%), Positives = 137/326 (42%), Gaps = 77/326 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDIERILAERNILITV 744
+ ++ + P+ GA+G V A TG A+K L + +I +R E +L +
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHM 73
Query: 745 RNPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
++ V+ FT +++YLV +L G DL +++ K L +D + I +++
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIV-KCQKLTDDHVQFLIYQILR 131
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+HS I+HRDLKP NL + D +K+ DFGL++ TD M
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMT--- 175
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917
V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 176 --------------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
Query: 918 SPEIIFDNILN----------RKIP----------WPCVPSDMSFE---------AQDLI 948
IL +KI +P M+F A DL+
Sbjct: 222 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK-MNFANVFIGANPLAVDLL 280
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFF 974
+ L+ D ++R+ AA+ AH +F
Sbjct: 281 EKMLVLDSDKRI---TAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 40/228 (17%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
I+ + +G FG V L R + TG++ A+K L+ D ER E IL ++++
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER---EIEILKSLQHD 65
Query: 748 FVVRFFYSFTC----RDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEY 802
+V+ Y C R NL LVMEYL G L L+K L+ +Y +++ +EY
Sbjct: 66 NIVK--YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L S VHRDL N+L+ + +K+ DFGL+K+ +P D Y +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKV-----------------LPQDKEYYK 166
Query: 863 YQQTDNRNRHSAVGTPDY-LAPEILLGTEHGYAADWWSVGIILFEFIT 909
++ +P + APE L ++ A+D WS G++L+E T
Sbjct: 167 VREPGE--------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 42/228 (18%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +G FG V+ + ++ A+K + + + L E IL +P +V+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEYLHSLG 807
+ +Y+VME + GG L + LRK R+ + +L+ +EYL S
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL N L+ + +K++DFG+S+ E GI Y +D
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR------------EEEGGI---------YTVSD 152
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
+ T APE L + +D WS GI+L+E F G P+
Sbjct: 153 GLKQIPIKWT----APEALNYGRYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+++ + +LVMEY G DL + +K E ++A + L L YLHS
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGAL-QGLAYLHSH 134
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K N+L++ G +KL DFG + I + P++
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI----------------MAPAN--------- 169
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 914
VGTP ++APE++L + G D WS+GI E PP
Sbjct: 170 ------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I G+FG V+ AR T ++ AIK + + I+ E L +++P
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+ + + +LVMEY G DL + +K E ++A I L L YLHS
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGAL-QGLAYLHSH 144
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K N+L+ G +KL DFG + I P++
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASI----------------ASPAN--------- 179
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 914
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 180 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+ + ++ I +G FG V L R G A+K LK + LAE +++ T+
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKD----DSTAAQAFLAEASVMTTL 57
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEY 802
R+P +V+ + LY+V EY+ G L LR G + + ++ +EY
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
L VHRDL N+L++ D K++DFGL+K
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 38/225 (16%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I G+FG V+ A T ++ A+K + + I+ E L +++P + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 755 SFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
+ +LVMEY G DL + +K E ++A I L L YLHS ++HRD
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGAL-QGLAYLHSHNMIHRD 146
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
+K N+L+ G +KL DFG + S P +
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASK---------SSPA----------------------N 175
Query: 873 SAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 914
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRNPFV 749
+KPI GA G V A TG AIK KL +N +R E ++ V + +
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIK---KLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 750 VRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALE 801
+ FT + +L YLVME ++ L +V ++ D R+ + +++ ++
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIK 132
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
+LHS GI+HRDLKP N+++ D +K+ DFGL++ M + Y
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------------GTSFMMTP--Y- 177
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
V T Y APE++LG + D WSVG I+ E I G
Sbjct: 178 -------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 83/314 (26%), Positives = 129/314 (41%), Gaps = 72/314 (22%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNILITVRNPFVV 750
+ G + V+ R + T +L A+K IR E + E ++L +++ +V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALK------EIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIV 809
+L LV EYL+ DL L G + ++++ +L+ L Y H ++
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
HRDLKP NLLI G +KL DFGL++ I P+ + E
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSI---------------PTKTYSNE------- 164
Query: 870 NRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE----IIFD 924
V T Y P+ILLG T++ D W VG I +E TG P F + E IF
Sbjct: 165 -----VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF- 218
Query: 925 NILNRKI--PWPCVPSDMSF----------------------EAQDLINRFLIHDPNQRL 960
IL WP + S+ F + +L+++ L + +R+
Sbjct: 219 RILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI 278
Query: 961 GANGAAEVKAHPFF 974
A A + HP+F
Sbjct: 279 SAEEAMK---HPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 41/278 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +++K + G FG V++ + AIK LK+ M E LAE N++ +++
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 804
P +VR Y+ ++ +Y++ EY+ G L L+ ++ + ++ A++ + ++
Sbjct: 61 PRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HRDL+ N+L++ K+ DFGL+++ I + EY
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARL--IEDN-------------------EYT 158
Query: 865 QTDNRNRHSAVGTPDYLAPE-ILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAESPEI 921
R A + APE I GT +D WS GI+L E +T IP +PE+
Sbjct: 159 A-----REGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212
Query: 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I + L R P P + E +L+ P +R
Sbjct: 213 IQN--LERGYRMPR-PDNCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 68/235 (28%), Positives = 100/235 (42%), Gaps = 48/235 (20%)
Query: 695 ISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
+ GAFG+VFLA L A+K LK+ + D +R E +L +++ +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQHI 69
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLE--EDVA--------RIYIAE 795
VRF+ T L +V EY+ GDL LR G L EDVA + IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 796 LVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
+ + + YL SL VHRDL N L+ +K+ DFG+S+
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR------------------- 170
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
D + +Y + R P PE +L + +D WS G++L+E T
Sbjct: 171 --DIYSTDYYRVGGRTMLPIRWMP----PESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-15
Identities = 82/337 (24%), Positives = 139/337 (41%), Gaps = 84/337 (24%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
T + ++ +KPI GA G V A G A+K L + + +R E +L
Sbjct: 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKC 76
Query: 744 VRNPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 795
V + ++ FT + ++YLVME ++ L +V +E D R+ + +
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQ 131
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ N
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--------------- 176
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT------ 909
+ T V T Y APE++LG + D WSVG I+ E +
Sbjct: 177 -------FMMT------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223
Query: 910 ---------------GIPP--FTAESPEIIFDNILNRK----------IPWPCVPSD--- 939
G P F + + + NR P PS+
Sbjct: 224 GTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESER 283
Query: 940 ---MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ +A+DL+++ L+ DP++R+ + E HP+
Sbjct: 284 DKLKTSQARDLLSKMLVIDPDKRISVD---EALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 59/229 (25%), Positives = 108/229 (47%), Gaps = 33/229 (14%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 751
+K + G FG V L + R + AIK + + M ++ IE E +++ + +P +V+
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQ 63
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
+ T + LY+V E++ G L + LR + G L +D+ ++ +EYL +H
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
RDL N L++ G +K++DFG+++ L + SG A +P
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG----------AKFP--------- 164
Query: 871 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAES 918
+ PE+ +++ +D WS G++++E F G PF +S
Sbjct: 165 -------VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-15
Identities = 82/322 (25%), Positives = 136/322 (42%), Gaps = 76/322 (23%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILITV 744
++ + G + VF R + T +L A+K ++ IR+ + + L NI +T+
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-VTL 69
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYL 803
+ +V S T LV EYL+ DL + G + +I++ +++ L Y
Sbjct: 70 HD--IVHTDKSLT------LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
H ++HRDLKP NLLI G +KL DFGL++ + P+ + E
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV---------------PTKTYSNE- 164
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE-- 920
V T Y P++LLG +E+ D W VG I FE +G P F + E
Sbjct: 165 -----------VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213
Query: 921 --IIFDNI-LNRKIPWPCVPSDMSF----------------------EAQDLINRFLIHD 955
+IF + + WP + S+ F E +L+ +FL ++
Sbjct: 214 LHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYE 273
Query: 956 PNQRLGANGAAEVKAHPFFKGV 977
+R+ A E H +F+ +
Sbjct: 274 SKKRISAE---EAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 9e-15
Identities = 85/327 (25%), Positives = 134/327 (40%), Gaps = 83/327 (25%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDIERILAERNILITVRN 746
++ + P+ GA+G V A A+K L + +I R E +L +++
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHA---RRTYRELRLLKHMKH 73
Query: 747 PFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
V+ FT ++ YLV L G DL +++ K L ++ + I +L+ L
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIV-KCQKLSDEHVQFLIYQLLRGL 131
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+Y+HS GI+HRDLKP N+ + D +++ DFGL++
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR------------------------- 166
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 919
Q D+ V T Y APEI+L H D WSVG I+ E + G F P
Sbjct: 167 ----QADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF----P 217
Query: 920 EIIFDNILNRKI-----PWPCVPSDMSFE---------------------------AQDL 947
+ + L R + P P V +S E A DL
Sbjct: 218 GNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDL 277
Query: 948 INRFLIHDPNQRLGANGAAEVKAHPFF 974
+ + L+ D ++R+ A+E AHP+F
Sbjct: 278 LEKMLVLDSDKRI---SASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 35/231 (15%)
Query: 695 ISRGAFGR--VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
I + V LA+ + T L A+K + LD K D++ + E +++P ++ +
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKIN-LDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVH 810
SF LY+V + G LL+ L E + +++ AL+Y+HS G +H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH 124
Query: 811 RDLKPDNLLIAHDGHIKLTDF----GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
R +K ++L++ DG + L+ + K G +
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP------------------- 165
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPFT 915
+ S P +L+PE+L GY D +SVGI E G PF
Sbjct: 166 ----KSSVKNLP-WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 27/171 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKR---TTGD--LFAIKVLKK--LDMIRKNDIERILAERN 739
D + + + GAFG+VFL D L A+K LK+ + RK D ER E
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARK-DFER---EAE 60
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---------------CL 784
+L ++ +V+F+ T D +V EY+ GDL LR G
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 785 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ +I + ++ + YL S VHRDL N L+ +D +K+ DFG+S+
Sbjct: 121 LSQLLQIAV-QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-14
Identities = 83/337 (24%), Positives = 139/337 (41%), Gaps = 84/337 (24%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 744 VRNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 795
V + ++ FT + +L YLVME ++ L +V +E D R+ + +
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQ 127
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ T G
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------------TAGTSF 173
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI------- 908
Y V T Y APE++LG + D WSVG I+ E +
Sbjct: 174 MMTPY--------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219
Query: 909 ----------------TGIPPFTAESPEIIFDNILNRK----------IPWPCVPSD--- 939
T P F + + + + NR P P+D
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 940 ---MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ +A+DL+++ L+ DP +R+ + A + HP+
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDEALQ---HPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 77/299 (25%), Positives = 121/299 (40%), Gaps = 70/299 (23%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
I+ + G FG+V L TG++ A+K LK+ + ++N E NIL T+ +
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKR-ECGQQNT-SGWKKEINILKTLYHE 66
Query: 748 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+V+ Y C + L L+MEY+ G L L K ++ +A+L+L
Sbjct: 67 NIVK--YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQI 116
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ YLHS +HRDL N+L+ +D +K+ DFGL+K
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--------------------- 155
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
PE + R R + A E L + YA+D WS G+ L+E +T
Sbjct: 156 --AVPEGHEY-YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK-- 210
Query: 917 ESPEIIFD----------------NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+SP F+ +L R + PC P + E L+ + R
Sbjct: 211 QSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPC-PKNCPQEVYILMKNCWETEAKFR 268
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 79/298 (26%), Positives = 126/298 (42%), Gaps = 58/298 (19%)
Query: 688 DFEIIKPISRGAFGRVFLAR---KRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILI 742
D + + + GAFG+VFLA T D L A+K LK + + D +R E +L
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLT 62
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVL 798
+++ +V+F+ D L +V EY+ GDL LR G L + R EL L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 799 A------------LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846
+ + YL S VHRDL N L+ + +K+ DFG+S+
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----------- 171
Query: 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
D + +Y + H+ + ++ PE ++ + +D WS G+IL+E
Sbjct: 172 ----------DVYSTDYYRVGG---HTMLPI-RWMPPESIMYRKFTTESDVWSFGVILWE 217
Query: 907 FIT-GIPPFTAESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
T G P+ S + + I ++ P C P E D++ +P QRL
Sbjct: 218 IFTYGKQPWFQLSNTEVIECITQGRVLERPRVC-PK----EVYDIMLGCWQREPQQRL 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 8e-14
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 49/226 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+ +IK ++ G+ GRVF+A K D +K+ +K L E +L V +P
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---------GTTLIEAMLLQNVNHPS 118
Query: 749 VVR-----FFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 802
V+R + TC +V+ + + DLY+ L ++ L D A I +++ L Y
Sbjct: 119 VIRMKDTLVSGAITC-----MVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRY 172
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH+ I+HRD+K +N+ I + + D G ++ + P G+
Sbjct: 173 LHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-------FPVVAPAFLGL--------- 216
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
GT + APE+L ++ AD WS GI+LFE +
Sbjct: 217 ------------AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 44/236 (18%)
Query: 698 GAFG----RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 753
G FG V+ RK+ AIKVLK + K+ + ++ E I+ + NP++VR
Sbjct: 6 GNFGCVKKGVYKMRKKQID--VAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 754 YSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV----LALEYLHSLGI 808
C + L LVME +GG L L ++++ + EL+ + ++YL
Sbjct: 62 G--VCEAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
VHRDL N+L+ + + K++DFGLSK + D++Y
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSK----------------ALGADDSYY-------- 152
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA-ESPEII 922
+ R + + APE + + +D WS GI ++E F G P+ + PE++
Sbjct: 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM 208
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+F + + + G FG V+ + + AIK+LK D++++ D ++ E L +R+
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQK---EVQALKRLRHK 62
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELVL-ALEYLHS 805
++ F + + +Y++ E + G L + LR VA I +A V + YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+HRDL N+L+ D K+ DFGL+++ I + LS SD P Y+
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLS---------SDKKIP-YKW 170
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIP 912
T APE +D WS GI+L+E T +P
Sbjct: 171 T---------------APEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 73/303 (24%), Positives = 131/303 (43%), Gaps = 71/303 (23%)
Query: 693 KPISRGAFGRV-----FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
K + G FG+V F + R A+K+LK+ +++ +L+E N+L V +P
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE--NASSSELRDLLSEFNLLKQVNHP 63
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---KVGC-------------LEEDVARI 791
V++ + + + L L++EY G L S LR KVG L+ R
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 792 YIAELVLA--------LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
+++ ++YL + +VHRDL N+L+A +K++DFGLS+
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR-------- 175
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGI 902
+ + D+ + S P ++A E L + +D WS G+
Sbjct: 176 ------------------DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217
Query: 903 ILFEFIT-GIPPFTAESPEIIFDNI-----LNRKIPWPCVPSDMSFEAQDLINRFLIHDP 956
+L+E +T G P+ +PE +F+ + + R P + S E +L+ +P
Sbjct: 218 LLWEIVTLGGNPYPGIAPERLFNLLKTGYRMER-------PENCSEEMYNLMLTCWKQEP 270
Query: 957 NQR 959
++R
Sbjct: 271 DKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757
G +G V+ + A+K LK+ M ++E L E ++ +++P +V+ T
Sbjct: 17 GQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEED-VARIYIA-ELVLALEYLHSLGIVHRDLKP 815
Y++ E++ G+L LR+ E + V +Y+A ++ A+EYL +HRDL
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132
Query: 816 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV 875
N L+ + +K+ DFGLS++ D H+
Sbjct: 133 RNCLVGENHLVKVADFGLSRL---------------------------MTGDTYTAHAGA 165
Query: 876 GTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916
P + APE L + +D W+ G++L+E T G+ P+
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
I+ + G FG+V L R TG+ A+K LK N I + E IL + +
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE 66
Query: 748 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 802
+V+ Y C ++ + L+ME+L G L L R + Y ++ ++Y
Sbjct: 67 NIVK--YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L S VHRDL N+L+ + +K+ DFGL+K + +D Y
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-----------------IETDKEY-- 165
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
Y D+ + S V + APE L+ ++ A+D WS G+ L+E +T
Sbjct: 166 YTVKDDLD--SPVF---WYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 43/228 (18%)
Query: 695 ISRGAFGRVF---LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 751
+ +G FG VF L K A+K K+ D+ ++ I + L+E IL +P +V+
Sbjct: 3 LGKGNFGEVFKGTLKDKTPV----AVKTCKE-DLPQELKI-KFLSEARILKQYDHPNIVK 56
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----ALEYLHSLG 807
T R +Y+VME + GGD S LRK ++++ + + L + YL S
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL N L+ + +K++DFG+S+ E DGI S +Q
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR------------QEDDGIYSSSG----LKQIP 157
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
+ + APE L + +D WS GI+L+E F G+ P+
Sbjct: 158 IK----------WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
D +K + G FG V + R D+ AIK++K+ M IE E +++ + +
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMKLSHE 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSL 806
+V+ + T + +Y+V EY++ G L + LR+ G + + + + V + YL S
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
+HRDL N L+ G +K++DFGLS+ L D Y
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL------------------DDEYT----- 156
Query: 867 DNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
S+VG+ + PE+LL ++ +D W+ G++++E +
Sbjct: 157 ------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 44/234 (18%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+RTSI ++++ + G FG V+ T + A+K LK M D + LAE I+
Sbjct: 4 DRTSI---QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIM 55
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----LEE--DVARIYIAE 795
+R+P +++ + T + +Y+V E + G L L+ L + D+A A+
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQ 111
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ + YL + +HRDL N+L+ + K+ DFGL+++ I
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV----------------IKE 155
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
Y+ R A + APE L +D WS GI+L E +T
Sbjct: 156 D-----IYEA-----REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-13
Identities = 89/331 (26%), Positives = 138/331 (41%), Gaps = 77/331 (23%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-VLKKLDMIRKNDIERILAERNIL 741
R+ +++ I G+FG V+ A T + AIK VL+ D KN I+ N +
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ--DPQYKNRELLIMKNLNHI 119
Query: 742 ITVRNPFVVRFFYSFTCRDN-----LYLVMEYLNGG-----DLYSLLRKVGCLEEDVARI 791
+ F+ ++Y+ + N L +VME++ Y+ R L + ++
Sbjct: 120 NII---FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA--RNNHALPLFLVKL 174
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPET 850
Y +L AL Y+HS I HRDLKP NLLI + H +KL DFG +K +L
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK--------NLLA--- 223
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 909
+ S + + Y APE++LG T + D WS+G I+ E I
Sbjct: 224 -----------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266
Query: 910 GIPPFTAESP-------------------EIIFDNILNRKIP-------WPCVPSDMSFE 943
G P F+ +S + + N + K P P +
Sbjct: 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDD 326
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
A + I++FL ++P +RL E A PFF
Sbjct: 327 AINFISQFLKYEPLKRL---NPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-13
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 42/235 (17%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 79
Query: 744 VRNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 795
V + ++ FT + +L Y+VME ++ L +V +E D R+ + +
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQ 134
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ T + P
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY------ 185
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
V T Y APE++LG + D WSVG I+ E I G
Sbjct: 186 -------------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 54/238 (22%)
Query: 686 IDDFEI--IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
ID E+ +K + G FG V L + R D+ AIK++++ M + IE E +++
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIE----EAKVMMK 55
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ +P +V+ + T + +++V EY+ G L + LR+ E +L
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLG-------TEWLLDMCSD 108
Query: 799 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
A+EYL S G +HRDL N L+ D +K++DFGL++ L
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL----------------- 151
Query: 856 SDAHYPEYQQTDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
D Y S+ GT + PE+ + +D WS G++++E +
Sbjct: 152 -DDQYT-----------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 48/235 (20%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R S+ ++ + + G FG V++ T + A+K LK M E L E I+
Sbjct: 5 RESL---KLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMK 56
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------KVGCLEEDVARIYIAE 795
+R+ +V+ + + + +Y+V EY++ G L L+ ++ L + A+I AE
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--AE 114
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIM 854
+ YL S +HRDL N+L+ + + K+ DFGL++ LI E D
Sbjct: 115 ---GMAYLESRNYIHRDLAARNILVG-ENLVCKIADFGLAR--LI---------EDD--- 156
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
EY R A + APE +D WS GI+L E +T
Sbjct: 157 -------EYTA-----REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 65/264 (24%), Positives = 116/264 (43%), Gaps = 52/264 (19%)
Query: 685 SIDDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S D + KP+ G FG+V +A K A+K+LK D + D+ +++E
Sbjct: 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSE 70
Query: 738 RNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE----DVARIY 792
++ + ++ ++ + T LY+++EY + G+L LR D+AR+
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 793 IAELVL------------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
++ +EYL S +HRDL N+L+ + +K+ DFGL++ +N
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--VN 188
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900
N ID T+G +P ++APE L + + +D WS
Sbjct: 189 N-IDYYKKTTNGRLPV----------------------KWMAPEALFDRVYTHQSDVWSF 225
Query: 901 GIILFEFIT-GIPPFTAESPEIIF 923
G++++E T G P+ E +F
Sbjct: 226 GVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 41/223 (18%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I G FG V + TG A+K +K D+ + L E ++ + + +VR
Sbjct: 14 IGEGEFGAVL--QGEYTGQKVAVKNIK-CDVT----AQAFLEETAVMTKLHHKNLVRLL- 65
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA--LEYLHSLGIVHRD 812
+ LY+VME ++ G+L + LR G V ++ L +A +EYL S +VHRD
Sbjct: 66 GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
L N+L++ DG K++DFGL+++G +
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVG------------------------------SMGVD 155
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
++ + APE L + +D WS G++L+E F G P+
Sbjct: 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 33/240 (13%)
Query: 693 KPISRGAFGRVFLAR-KRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
K + G+FG V + G + A+K LK + + ++ L E I+ ++ + +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENL 58
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLG 807
+R Y L +V E G L LRK ++ + Y ++ + YL S
Sbjct: 59 IRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL N+L+A D +K+ DFGL + L N + H Y +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMR-ALPQN---------------EDH---YVMEE 158
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDNI 926
+ A + APE L +A+D W G+ L+E F G P+ S I I
Sbjct: 159 HLKVPFA-----WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 47/281 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++IK + G FG V++ + A+K LK M E L E I+ +R+
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTM----SPESFLEEAQIMKKLRH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------KVGCLEEDVARIYIAELVLA 799
+V+ Y+ + +Y+V EY++ G L L+ K+ L D+A A++
Sbjct: 61 DKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV-DMA----AQVAAG 114
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ Y+ + +HRDL+ N+L+ K+ DFGL++ LI +
Sbjct: 115 MAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDN----------------- 155
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918
EY R A + APE L +D WS GI+L E +T G P+ +
Sbjct: 156 --EYTA-----RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + + R PC P D +L+ + DP +R
Sbjct: 209 NREVLEQV-ERGYRMPC-PQDCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 65/264 (24%), Positives = 109/264 (41%), Gaps = 52/264 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDL-----FAIKVLKKLDMIRKNDIERILAERNIL 741
D + KP+ GAFG+V A + A+K+LK D + D+ +++E ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK--DDATEKDLSDLVSEMEMM 69
Query: 742 ITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE----DVARIYIAEL 796
+ ++ ++ T LY+V+EY G+L LR E D R L
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 797 VL------------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844
+E+L S +HRDL N+L+ D +K+ DFGL++
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--------- 180
Query: 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGII 903
D H+ +Y + R P ++APE L + + +D WS G++
Sbjct: 181 ------------DIHHIDYYRKTTNGR-----LPVKWMAPEALFDRVYTHQSDVWSFGVL 223
Query: 904 LFEFIT-GIPPFTAESPEIIFDNI 926
L+E T G P+ E +F +
Sbjct: 224 LWEIFTLGGSPYPGIPVEELFKLL 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-12
Identities = 60/230 (26%), Positives = 91/230 (39%), Gaps = 52/230 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F I++ + GA G F T + IK ++ E +IL + +P
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPS 144
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALE 801
+++ +FT L++ DLY C I I +++ A++
Sbjct: 145 IIQLKGTFTYNKFTCLILPRYKT-DLY-------CYLAAKRNIAICDILAIERSVLRAIQ 196
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YLH I+HRD+K +N+ I H G + L DFG + P D
Sbjct: 197 YLHENRIIHRDIKAENIFINHPGDVCLGDFGAA------------------CFPVDI--- 235
Query: 862 EYQQTDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
N N++ GT APE+L +G A D WS GI+LFE T
Sbjct: 236 ------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 66/250 (26%), Positives = 107/250 (42%), Gaps = 50/250 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITV 744
E IK + GAFG V+ G+ AIKVL++ + K + IL E ++ +V
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKA-NKEILDEAYVMASV 66
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLAL 800
+P VVR + L+ + + G L +R +G + IA+ +
Sbjct: 67 DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK---GM 122
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
YL +VHRDL N+L+ H+K+TDFGL+K+ L E
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL--------LDVDEK---------- 164
Query: 861 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-------GIP 912
EY + P ++A E +L + + +D WS G+ ++E +T GIP
Sbjct: 165 -EYHAEGGK-------VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
Query: 913 PFTAESPEII 922
E P+++
Sbjct: 217 --AVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 44/227 (19%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILI 742
++ + ++++ I +G FG V L R G+ A+K +K ND + LAE +++
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK-------NDATAQAFLAEASVMT 54
Query: 743 TVRNPFVVRFFYSFT-CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLA 799
+R+ +V+ + LY+V EY+ G L LR G L D + ++ A
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+EYL + VHRDL N+L++ D K++DFGL+K + S + G +P
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPV--- 163
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
+ APE L + +D WS GI+L+E
Sbjct: 164 -------------------KWTAPEALREKKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 46/235 (19%)
Query: 693 KPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+ + GAFG+VFLA L A+K LK + D R E +L +++
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLTNLQHE 67
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR------------IYIAE 795
+V+F+ D L +V EY+ GDL LR G +A ++IA+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 796 LVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
+ A + YL S VHRDL N L+ + +K+ DFG+S+
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR------------------- 168
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
D + +Y + H+ + ++ PE ++ + +D WS+G++L+E T
Sbjct: 169 --DVYSTDYYRVGG---HTMLPI-RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 35/124 (28%), Positives = 58/124 (46%), Gaps = 11/124 (8%)
Query: 716 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 775
A+K LK+ + + L E +++ + +P +VR + L LVME G L
Sbjct: 27 AVKTLKQEHI--AAGKKEFLREASVMAQLDHPCIVRLI-GVCKGEPLMLVMELAPLGPLL 83
Query: 776 SLLRKVGCLEEDVARIYIAELVL----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831
L+K ++ + EL + YL S VHRDL N+L+ + K++DF
Sbjct: 84 KYLKKRR----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDF 139
Query: 832 GLSK 835
G+S+
Sbjct: 140 GMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 71/316 (22%), Positives = 120/316 (37%), Gaps = 81/316 (25%)
Query: 687 DDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKK---LDMIRKNDIERILAER 738
++ E ++ I +GAFGRVF AR + A+K+LK+ DM + D +R E
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQR---EA 59
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------------KVGCLE 785
++ +P +V+ + L+ EY+ GDL LR +
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 786 EDVARIYIAELVL---------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ + ++ + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 837 GLINNTIDLSGPETDGI----MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
I + E D I MP PE + +
Sbjct: 180 --IYSADYYKASENDAIPIRWMP---------------------------PESIFYNRYT 210
Query: 893 YAADWWSVGIILFE-FITGIPPFTAES-PEIIF----DNILNRKIPWPCVPSDMSFEAQD 946
+D W+ G++L+E F G+ P+ + E+I+ N+L+ C P + E +
Sbjct: 211 TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLS------C-PDNCPLELYN 263
Query: 947 LINRFLIHDPNQRLGA 962
L+ P+ R
Sbjct: 264 LMRLCWSKLPSDRPSF 279
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 69/282 (24%), Positives = 117/282 (41%), Gaps = 51/282 (18%)
Query: 693 KPISRGAFGRV---FLARKRTTGDLFAIKVLKKLDMIRKNDI---ERILAERNILITVRN 746
+ G FG V K++ + A+K+LK + ND + +L E N++ + N
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTV-AVKILKNDN----NDPALKDELLREANVMQQLDN 55
Query: 747 PFVVRFFYSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV----LALE 801
P++VR C ++ LVME G L L+K + V I ELV + ++
Sbjct: 56 PYIVRMIG--ICEAESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMK 109
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YL VHRDL N+L+ + K++DFGLSK + +D +Y
Sbjct: 110 YLEETNFVHRDLAARNVLLVTQHYAKISDFGLSK-----------------ALGADENYY 152
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA-ESP 919
+ + + APE + + +D WS G++++E F G P+ +
Sbjct: 153 KAKTHGK-------WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN 205
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
E+ ++ C P E DL+ + ++R G
Sbjct: 206 EVT--QMIESGERMEC-PQRCPPEMYDLMKLCWTYGVDERPG 244
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 54/235 (22%), Positives = 104/235 (44%), Gaps = 34/235 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +++K + G FG V++ + + A+K LK M ++ L E N++ T+++
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 804
+VR + T + +Y++ EY+ G L L+ + + ++ + A++ + Y+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HRDL+ N+L++ K+ DFGL+++ D Y
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARV------------------IEDNEYTA-- 160
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918
R A + APE + +D WS GI+L+E +T G P+ S
Sbjct: 161 ------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 48/285 (16%)
Query: 692 IKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
I + RG FG VFLA+ + + L +K L+K +N E ++ + +
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSH 67
Query: 747 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDV--------ARIYIA-E 795
VVR CR+ Y+++EY + GDL LR +E + ++ + +
Sbjct: 68 KNVVRLLG--LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ L +++L + VHRDL N L++ +K++ LSK
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-------------------- 165
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
D + EY + N A+ +LAPE + + +D WS G++++E F G PF
Sbjct: 166 -DVYNSEYYKLRN-----ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
S E + + + K+ P VP L+ R +P R
Sbjct: 220 YGLSDEEVLNRLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 49/162 (30%), Positives = 71/162 (43%), Gaps = 36/162 (22%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVL-----------KKLD-MIRKNDIERILAERN 739
+K I RGA ++L GD IK + +LD IR+ ER E
Sbjct: 1 MKLIKRGAEAEIYL------GDFLGIKAVIKWRIPKRYRHPELDERIRR---ERTRREAR 51
Query: 740 ILIT-----VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
I+ V P V +N +VMEY+ G L L+ G E +++R
Sbjct: 52 IMSRARKAGVNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINSNGMEELELSR---- 102
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
E+ + LHS GI+H DL N+++ G I L DFGL++
Sbjct: 103 EIGRLVGKLHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 63/256 (24%), Positives = 109/256 (42%), Gaps = 52/256 (20%)
Query: 693 KPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV- 744
KP+ G FG+V +A K A+K+LK D K D+ +++E ++ +
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS-DATEK-DLSDLISEMEMMKMIG 81
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------CLEED---VARIYIAE 795
++ ++ + T LY+++EY + G+L LR C ++ +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 796 LV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848
LV +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------------- 188
Query: 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
D H+ +Y + R ++APE L + + +D WS G++L+E
Sbjct: 189 --------DIHHIDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236
Query: 909 T-GIPPFTAESPEIIF 923
T G P+ E +F
Sbjct: 237 TLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 59/243 (24%), Positives = 108/243 (44%), Gaps = 46/243 (18%)
Query: 695 ISRGAFGRVFLARKRT-----TGDL-FAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+ GAFG V+ +G + A+K L+K ++ + L E +++ +P
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALE------ 801
+V+ + Y++ME + GGDL S LR + + EL+ + L+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
YL + +HRDL N L++ G+ +K+ DFGL++ + + D E +G++P
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKS--DYYRKEGEGLLPV 177
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 915
++APE LL + +D WS G++++E +T G P+
Sbjct: 178 ----------------------RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215
Query: 916 AES 918
A +
Sbjct: 216 ALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 8e-11
Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 50/274 (18%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID-------DFEIIKP 694
EL D T + Y + +S+S + V + +S D + I+
Sbjct: 47 ELGDSDDVTHATDYDADE----ESLSPQTDVCQ---EPCETTSSSDPASVVRMQYNILSS 99
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
++ G+ G VF+ K GD KV+ K + R E +IL T+ + ++ +
Sbjct: 100 LTPGSEGEVFVCTKH--GDEQRKKVIVKA-VTGGKTPGR---EIDILKTISHRAIINLIH 153
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSLGIVHRDL 813
++ + + +VM DL++ + + G L + A I I +L AL YLH GI+HRD+
Sbjct: 154 AYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALAYLHGRGIIHRDV 211
Query: 814 KPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
K +N+ + + L DFG + K+ +T P +
Sbjct: 212 KTENIFLDEPENAVLGDFGAACKLDAHPDT------------PQC--------------Y 245
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
GT + +PE+L + D WS G++LFE
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
|
Length = 392 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 51/270 (18%)
Query: 692 IKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
++ + AFG+++ G L AIK LK D+ E +++ + +P
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHP 67
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL------RKVGCLEEDVARI---------- 791
+V T + ++ EYLN GDL+ L VGC ++ +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 792 YIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850
+IA ++ +EYL S VH+DL N+LI H+K++D GLS+
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR--------------- 172
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FIT 909
I +D + R + ++ ++ PE ++ + +D WS G++L+E F
Sbjct: 173 -EIYSADYY---------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF 222
Query: 910 GIPPFTAESPEIIFDNILNRKIPWPCVPSD 939
G+ P+ S + + + + R++ PC D
Sbjct: 223 GLQPYYGFSNQEVIEMVRKRQL-LPC-SED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 68/273 (24%), Positives = 112/273 (41%), Gaps = 47/273 (17%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V++ T + AIK LK M+ E L E I+ +R+ +V Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMP----EAFLQEAQIMKKLRHDKLVPL-Y 67
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLG 807
+ + +Y+V E++ G L L+ E D + + +LV + Y+ +
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLK-----EGDGKYLKLPQLVDMAAQIADGMAYIERMN 122
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL+ N+L+ + K+ DFGL++ LI + EY
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLAR--LIEDN-------------------EYTA-- 159
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 926
R A + APE L +D WS GI+L E +T G P+ + + +
Sbjct: 160 ---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
R PC P +L+ DP++R
Sbjct: 217 -ERGYRMPC-PQGCPESLHELMKLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 67/268 (25%), Positives = 112/268 (41%), Gaps = 37/268 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V++ T + AIK LK M E L E ++ +R+ +V+ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 67
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGIVHRD 812
+ + +Y+V EY++ G L L+ + ++ A++ + Y+ + VHRD
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
L+ N+L+ + K+ DFGL++ LI + EY R
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--LIEDN-------------------EYTA-----RQ 161
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKI 931
A + APE L +D WS GI+L E T G P+ + D + R
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGY 220
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQR 959
PC P + DL+ + +P +R
Sbjct: 221 RMPC-PPECPESLHDLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 55/262 (20%)
Query: 692 IKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+K + GAFG V+ G+ AIKVL++ + N + IL E ++ V +P
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 69
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI-------YIAELVLAL 800
+V R + LV + + G L +R E+ RI + ++ +
Sbjct: 70 YVCRLL-GICLTSTVQLVTQLMPYGCLLDYVR------ENKDRIGSQDLLNWCVQIAKGM 122
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
YL + +VHRDL N+L+ H+K+TDFGL+++ I+ T
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET------------------ 164
Query: 861 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA-- 916
EY + P ++A E +L + +D WS G+ ++E +T G P+
Sbjct: 165 -EYHADGGK-------VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216
Query: 917 --ESPEIIFDNILNRKIPWPCV 936
E P+++ ++P P +
Sbjct: 217 AREIPDLLEK---GERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 63/265 (23%), Positives = 109/265 (41%), Gaps = 70/265 (26%)
Query: 693 KPISRGAFGRVFLA------RKRTTGDL-FAIKVLKKLDMIRKNDIERILAERNILITV- 744
KP+ G FG+V +A + + + A+K+LK D D+ +++E ++ +
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK--DDATDKDLSDLVSEMEMMKMIG 75
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK------------------------ 780
++ ++ + T LY+++EY + G+L LR
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 781 -VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839
V C + VAR +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 136 LVSCAYQ-VAR--------GMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR---- 182
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899
D H +Y + R ++APE L + + +D WS
Sbjct: 183 -----------------DVHNIDYYKKTTNGRLPV----KWMAPEALFDRVYTHQSDVWS 221
Query: 900 VGIILFEFIT-GIPPFTAESPEIIF 923
G++L+E T G P+ E +F
Sbjct: 222 FGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 46/231 (19%)
Query: 691 IIKPISRGAFGRVFLARKRTTGD---LFAIKVLKK--LDMIRKNDIERILAERNILITVR 745
I K I G FG V R + G AIK LK + R++ L+E +I+
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD----FLSEASIMGQFD 63
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------L 798
+P ++ T + +V EY+ G L + LRK + + +LV
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK------HDGQFTVIQLVGMLRGIAS 117
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
++YL +G VHRDL N+L+ + K++DFGLS++ + + + + G +P
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPI-- 173
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
+ APE + + A+D WS GI+++E ++
Sbjct: 174 --------------------RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 35/151 (23%)
Query: 768 YLNGGDLYSLLRKVGCLEEDVAR-IYIAELVL-------ALEYLHSLGIVHRDLKPDNLL 819
Y+N G+L L++ E + + + +LV + YLH G++H+D+ N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP- 878
I + +K+TD LS+ DL P D H DN NR P
Sbjct: 150 IDEELQVKITDNALSR--------DL--------FPMDYHC----LGDNENR------PV 183
Query: 879 DYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
++A E L+ E+ A+D WS G++L+E +T
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 49/166 (29%), Positives = 66/166 (39%), Gaps = 53/166 (31%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKK-----------LD-MIRKNDIERILAERNILI 742
I++GA ++L GD +K + K LD IR+ ER E +L
Sbjct: 2 IAKGAEAIIYL------GDFLGLKAVIKERVPKSYRHPELDERIRR---ERTRNEARLLS 52
Query: 743 TVR----NPFVVRFFYSFTCRDNLYLVMEYLNGGDL--------YSLLRKVGCLEEDVAR 790
R N VV DN +VMEY+ G L LLR++G V +
Sbjct: 53 RARKAGVNTPVVYDVD----PDNKTIVMEYIEGKPLKDVIEEGNDELLREIG---RLVGK 105
Query: 791 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
LH GIVH DL N+++ D + L DFGL K
Sbjct: 106 ------------LHKAGIVHGDLTTSNIIV-RDDKLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 56/236 (23%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 693 KPISRGAFGRVFLA--RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV 750
K + G FG V++A K T A+K +K M +E LAE N++ T+++ +V
Sbjct: 12 KKLGAGQFGEVWMATYNKHTK---VAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLV 64
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGI 808
+ ++ ++ +Y++ E++ G L L+ ++ + ++ + A++ + ++
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 123
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRDL+ N+L++ K+ DFGL+++ N G A +P
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG----------AKFP------- 166
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA-ESPEII 922
+ APE + +D WS GI+L E +T G P+ +PE+I
Sbjct: 167 ---------IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 42/237 (17%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILIT 743
+F+ IK + GAFG V+ G+ AIK L++ + N + IL E ++ +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 65
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI----AELVLA 799
V NP V R + L+ + + G L +R+ ++++ Y+ ++
Sbjct: 66 VDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKG 121
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ YL +VHRDL N+L+ H+K+TDFGL+K+ L E
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL--------LGADEK--------- 164
Query: 860 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
EY + P ++A E +L + + +D WS G+ ++E +T G P+
Sbjct: 165 --EYHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 58/235 (24%), Positives = 96/235 (40%), Gaps = 41/235 (17%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERI--LAER 738
I K I G FG V R + G AIK LK +D +R+ L E
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA----GSSDKQRLDFLTEA 56
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV- 797
+I+ +P ++R T + ++ EY+ G L LR+ + + ++
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLR 113
Query: 798 ---LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
++YL + VHRDL N+L+ + K++DFGLS+ +
Sbjct: 114 GIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR----------------LE 157
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
S+A Y T + T APE + + A+D WS GI+++E ++
Sbjct: 158 DSEATY-----TTKGGKIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 67/280 (23%), Positives = 117/280 (41%), Gaps = 53/280 (18%)
Query: 683 RTSIDDFEIIKPISRGAFGRV-----FLARKRTTGDLFAIKVLKKLDMIR-KNDIERILA 736
+ ++ + GAFG+V +R + AIK LK+ + + + +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ--- 57
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL------RKVGCLEEDVAR 790
E ++ +++P +V T ++ EYL GDL+ L VG D
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 791 ---------IYIAELVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
++IA + A +EYL S VHRDL N L+ +K++DFGLS+
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY-- 175
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900
S +Y R + ++ ++ PE +L + +D WS
Sbjct: 176 ---------------SADYY--------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212
Query: 901 GIILFE-FITGIPPFTAESPEIIFDNILNRKIPWPCVPSD 939
G++L+E F G+ P+ S + + + I +R++ PC P D
Sbjct: 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-LPC-PED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 9/154 (5%)
Query: 687 DDFEIIKPISRGAFGRVFLA-RKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 743
+D + + I G FG V+ + A+K K + E+ L E I+
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQ 63
Query: 744 VRNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALE 801
+P +V+ +N +++VME G+L S L+ L+ +Y +L AL
Sbjct: 64 FDHPHIVKLIG--VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
YL S VHRD+ N+L++ +KL DFGLS+
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 62/258 (24%), Positives = 112/258 (43%), Gaps = 56/258 (21%)
Query: 693 KPISRGAFGRVFLAR----KRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITV- 744
KP+ G FG+V A ++ D A+K+LK D D+ +++E ++ +
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK--DNATDKDLADLISEMELMKLIG 75
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR------------------KVGCLEE 786
++ ++ T LY+++EY G+L LR + ++
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 787 DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846
V+ Y ++ +EYL S +HRDL N+L+ D +K+ DFGL++ G+ + ID
Sbjct: 136 LVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR-GV--HDIDYY 190
Query: 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
++G +P ++APE L + + +D WS GI+++E
Sbjct: 191 KKTSNGRLPV----------------------KWMAPEALFDRVYTHQSDVWSFGILMWE 228
Query: 907 FIT-GIPPFTAESPEIIF 923
T G P+ E +F
Sbjct: 229 IFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 63/255 (24%), Positives = 112/255 (43%), Gaps = 42/255 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ K + GAFG+V A K A+K+LK ++ E +++E I+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP--TAHSSEREALMSELKIM 92
Query: 742 ITVRNPF-VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVL 798
+ N +V + T + ++ EY GDL + LR+ L + + ++
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+ +L S +HRDL N+L+ H G I K+ DFGL++ IM +D
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLAR----------------DIM-ND 194
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA 916
++Y + +A ++APE + + + +D WS GI+L+E F G P+
Sbjct: 195 SNYV--------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY-- 244
Query: 917 ESPEIIFDNILNRKI 931
P + D+ + I
Sbjct: 245 --PGMPVDSKFYKLI 257
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-09
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 44/218 (20%)
Query: 714 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 773
L A+K+L+ + KN L E I+ +++P ++R D L ++ EY+ GD
Sbjct: 48 LVAVKMLR--EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 774 LYSLLR----KVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAH 822
L L + + DV I + L+ ++YL SL VHRDL N L+
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK 165
Query: 823 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLA 882
+ IK+ DFG+S+ + + +Y + R AV +++
Sbjct: 166 NYTIKIADFGMSR---------------------NLYSGDYYRIQGR----AVLPIRWMS 200
Query: 883 PE-ILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
E ILLG + A+D W+ G+ L+E +T E P
Sbjct: 201 WESILLG-KFTTASDVWAFGVTLWEILT----LCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 17/166 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 745
+D + I G FG+V AR + G + + + K+D E +L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI-------------- 791
+P ++ + R LYL +EY G+L LRK LE D A
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 792 --YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ A++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 48/233 (20%)
Query: 714 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 773
L A+K+L+ KN L E IL +++P ++R D L ++ EY+ GD
Sbjct: 48 LVAVKILRP--DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 774 LYSLLRKVGCLEEDV------------------ARIYIA-ELVLALEYLHSLGIVHRDLK 814
L L +++ + +++A ++ ++YL SL VHRDL
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
N L+ + IK+ DFG+S+ + + +Y + R A
Sbjct: 166 TRNCLVGENLTIKIADFGMSR---------------------NLYAGDYYRIQGR----A 200
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAESPEIIFDN 925
V ++A E +L + A+D W+ G+ L+E + P+ + E + +N
Sbjct: 201 VLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 55/237 (23%), Positives = 105/237 (44%), Gaps = 39/237 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +++ I G FG V+L AIK +++ M ++ IE E +++ + +
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGAMSEEDFIE----EAQVMMKLSH 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHS 805
P +V+ + T R + LV E++ G L LR + G ++ ++ + YL S
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRDL N L+ + +K++DFG+++ L D Y
Sbjct: 119 SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL------------------DDQYT---- 156
Query: 866 TDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAES 918
S+ GT + +PE+ +++ +D WS G++++E F G P+ S
Sbjct: 157 -------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-09
Identities = 58/225 (25%), Positives = 89/225 (39%), Gaps = 64/225 (28%)
Query: 672 VSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK------------- 718
V PL R S DDF++ + G FG F + D +
Sbjct: 130 VGAPLADGANSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRV 189
Query: 719 VLKKLDMIR--------------KNDIERILAERNILITV-RNPFVVR-------FFYSF 756
VLK+++M R K E + E + + RNP +F S
Sbjct: 190 VLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSN 249
Query: 757 TC-----RDNLYLVMEYLNGGDLYSLLR-KVG----CLEE-------------------D 787
T + + +LV ++ + L L K+G CLEE +
Sbjct: 250 TADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
V + + +++ L LH +GIVHRD+KP+NLL+ DG +K+ DFG
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 7e-09
Identities = 61/251 (24%), Positives = 111/251 (44%), Gaps = 52/251 (20%)
Query: 695 ISRGAFGRVFLARKRTTGDL--FAIKVLK----KLDMIRKNDIERILAERNILITVRNPF 748
+ RG +G V+ A+++ D +A+K ++ + R+ + R L N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA------ 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---------KVGCLEEDVARIYIAELVLA 799
+ + F S + R ++L+ +Y DL+ +++ K L + + + +++
Sbjct: 63 LQKVFLSHSDR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YLH+ ++HRDLKP N+L+ + G +K+ D G ++ L N+ + P D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLK---PLAD---- 171
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF 914
V T Y APE+LLG H A D W++G I E +T P F
Sbjct: 172 ---------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
Query: 915 TAESPEIIFDN 925
+I N
Sbjct: 217 HCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 70/293 (23%), Positives = 121/293 (41%), Gaps = 56/293 (19%)
Query: 689 FEIIKPISRGAFGRV---FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
F + + + +G FG V L + + A+K+LK D+ +DIE L E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA-DIFSSSDIEEFLREAACMKEFD 59
Query: 746 NPFVVRFF-YSFTCRDNLYL-----VMEYLNGGDLYS--LLRKVG----CLEEDVARIYI 793
+P V++ S R L ++ ++ GDL++ L+ ++G L ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
++ +EYL S +HRDL N ++ + + + DFGLSK I
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK----------------KI 163
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 911
D Y+Q A P +LA E L + +D W+ G+ ++E +T G
Sbjct: 164 YSGDY----YRQG------CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
Query: 912 PPFTA-ESPEI----IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
P+ E+ EI I N L + P D + +L+ + +P R
Sbjct: 214 TPYAGVENSEIYNYLIKGNRLKQ-------PPDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 58/255 (22%), Positives = 93/255 (36%), Gaps = 70/255 (27%)
Query: 690 EIIKPISRGAFGRVFLA-----------------RKRTTGDLFAIKVLKK-LDMIRKNDI 731
++ + G FG V L L A+KVL+ + D
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAP-VLVAVKVLRPDASDNAREDF 66
Query: 732 ERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------- 780
+ E IL + +P + R T L ++MEY+ GDL L+K
Sbjct: 67 LK---EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 781 -----VGCLEEDVARIYIAELVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
L +Y+A + + + YL SL VHRDL N L+ + IK+ DFG
Sbjct: 124 SKSLSFSTL------LYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFG-- 175
Query: 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 894
M + + +Y + R A ++A E +L +
Sbjct: 176 -------------------MSRNLYSSDYYRVQGR----APLPIRWMAWESVLLGKFTTK 212
Query: 895 ADWWSVGIILFEFIT 909
+D W+ G+ L+E +T
Sbjct: 213 SDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 45/169 (26%), Positives = 63/169 (37%), Gaps = 53/169 (31%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----------LDM-IRKNDIERILAERN 739
+ I +GA ++L D + + K LD +R+ ER E
Sbjct: 1 MDLIKQGAEAIIYL------TDFLGLPAVVKERIPKRYRHPELDEKLRR---ERTRREAR 51
Query: 740 ILITVR----NPFVVRFFYSFTCRDNLYLVMEYLNGGDL--------YSLLRKVGCLEED 787
IL R +V DN +VMEY+ G L LLR+VG
Sbjct: 52 ILAKAREAGVPVPIVYDVDP----DNGLIVMEYIEGELLKDALEEARPDLLREVG---RL 104
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
V + LH GIVH DL N++++ G I DFGL +
Sbjct: 105 VGK------------LHKAGIVHGDLTTSNIILS-GGRIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 66/234 (28%), Positives = 107/234 (45%), Gaps = 33/234 (14%)
Query: 690 EIIKPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
E++ I RG V LAR + TG+ ++ + L+ + + E ++ +P
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHP 59
Query: 748 FVVRFFYSFTCRDNLYLV---MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYL 803
+V + +F + L++V M Y + DL G E +A YI + VL AL+Y+
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIA--YILQGVLKALDYI 117
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGL-SKIGLINNTIDLSGPETDGIMPSDAHYPE 862
H +G VHR +K ++LI+ DG + L+ GL S + +IN H
Sbjct: 118 HHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMIN------------------HGQR 157
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPF 914
+ + ++S P +L+PE+L GY A D +SVGI E G PF
Sbjct: 158 LRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-08
Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 34/139 (24%)
Query: 773 DLYSLL----RKVGCLE-EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827
DLY+ L R +G + VAR +L+ A++Y+H GI+HRD+K +N+L+ I
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVAR----QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC 300
Query: 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 887
L DFG + G + HY GT D APE+L
Sbjct: 301 LGDFGAACF-------------ARGSWSTPFHY------------GIAGTVDTNAPEVLA 335
Query: 888 GTEHGYAADWWSVGIILFE 906
G + + D WS G+++FE
Sbjct: 336 GDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 714 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 773
L A+K+L+ + K L E I+ ++NP ++R D L ++ EY+ GD
Sbjct: 46 LVAVKMLRA--DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 774 LYSLL-----RKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIA 821
L L ++ + IA L+ ++YL SL VHRDL N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 822 HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL 881
+ IK+ DFG+S+ + + +Y + R AV ++
Sbjct: 164 NHYTIKIADFGMSR---------------------NLYSGDYYRIQGR----AVLPIRWM 198
Query: 882 APEILLGTEHGYAADWWSVGIILFEFITGIP--PFTAESPEIIFDN 925
A E +L + A+D W+ G+ L+E T P++ S E + +N
Sbjct: 199 AWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 41/244 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKV-LKKL-DMIRKNDIERILAERNILIT 743
D +++ + GAFG V+ R GD ++V +K L + + D L E I+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 744 VRNPFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALE 801
+ +VR SF R ++++E + GGDL S LR+ E + + + +L+ A +
Sbjct: 66 FNHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 802 ------YLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDG 852
YL +HRD+ N L+ G K+ DFG+++
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----------------- 167
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGI 911
D + Y + R A+ ++ PE L D WS G++L+E F G
Sbjct: 168 ----DIYRASYYRKGGR----AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGY 219
Query: 912 PPFT 915
P+
Sbjct: 220 MPYP 223
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 33/220 (15%)
Query: 703 VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT---VRNPFVVRFFYSFTCR 759
V+LAR TG L +++ D+ + E + A +N ++ R+P ++ + FT
Sbjct: 16 VYLARHTPTGTLVTVRIT---DLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTG 71
Query: 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817
L+++ ++ G SLL+ + E + + + L YLH G +HR++K +
Sbjct: 72 SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131
Query: 818 LLIAHDGHIKLTDFGLSKI-GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 876
+LI+ DG + L+ GLS + L+ N G + + +P++ S
Sbjct: 132 ILISGDGLVSLS--GLSHLYSLVRN-----GQKAKVVY----DFPQF---------STSV 171
Query: 877 TPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPF 914
P +L+PE+L +GY +D +SVGI E TG PF
Sbjct: 172 LP-WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 21/168 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITV 744
+D + I G FG+V A + G AIK+LK + +ND E +L +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKL 59
Query: 745 -RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI------------ 791
+P ++ + R LY+ +EY G+L LRK LE D A
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 792 ----YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ +++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 6e-08
Identities = 47/160 (29%), Positives = 63/160 (39%), Gaps = 42/160 (26%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLK-----KLD-MIRKNDIERILAERNILITVRN-- 746
I +GA + + +V K +LD +R ER AE +L R
Sbjct: 341 IGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRT---ERTRAEARLLSEARRAG 397
Query: 747 ---PFVVRFFYSFTCRDNLYLVMEYLNGGDLY-------SLLRKVGCLEEDVARIYIAEL 796
P + Y + +VMEY+ G DL L+RKVG E VA+
Sbjct: 398 VPTPVI----YDVD-PEEKTIVMEYIGGKDLKDVLEGNPELVRKVG---EIVAK------ 443
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
LH GIVH DL N ++ D + L DFGL K
Sbjct: 444 ------LHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 9e-08
Identities = 61/251 (24%), Positives = 110/251 (43%), Gaps = 52/251 (20%)
Query: 695 ISRGAFGRVFLARKRTTGDL--FAIKVLK----KLDMIRKNDIERILAERNILITVRNPF 748
+ RG +G V+ A+++ D +A+K ++ + R+ + R L N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVIS------ 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---------KVGCLEEDVARIYIAELVLA 799
+ + F S R ++L+ +Y DL+ +++ K L + + + +++
Sbjct: 63 LQKVFLSHADR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YLH+ ++HRDLKP N+L+ + G +K+ D G ++ L N+ + P D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLK---PLAD---- 171
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF 914
V T Y APE+LLG H A D W++G I E +T P F
Sbjct: 172 ---------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
Query: 915 TAESPEIIFDN 925
+I N
Sbjct: 217 HCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-07
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 43/242 (17%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL-DMIRKNDIERILAERNILIT 743
S F+I+ + G FG+V A R + A+K+++ + R IE E+
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQAD 186
Query: 744 VRNPF----VVRFFYSFTCRDNLYLVM-EYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ F + R+F + T ++ +VM +Y G L + K G ++A+++
Sbjct: 187 PADRFPLMKIQRYFQNET--GHMCIVMPKY--GPCLLDWIMKHGPFSHR----HLAQIIF 238
Query: 799 ----ALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
AL+Y H+ L ++H DLKP+N+L+ + +D P T+
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETS----------------DTVVD---PVTNRA 279
Query: 854 MPSDAHYPEYQQ----TDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
+P D D R+ +A V T Y +PE++LG Y+ D WS+G I++E
Sbjct: 280 LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339
Query: 909 TG 910
TG
Sbjct: 340 TG 341
|
Length = 467 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 64/260 (24%), Positives = 106/260 (40%), Gaps = 71/260 (27%)
Query: 687 DDFEIIKPISRGAFGRVF--LARKRTTGDL---FAIKVLKKLDMIRKNDIERI--LAERN 739
+ +++ + +G+FG V+ AR G+ A+K + + +R ERI L E +
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR----ERIEFLNEAS 61
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR--------- 790
++ VVR + +VME + GDL S LR L +
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR---SLRPEAENNPGRPPPTL 118
Query: 791 ----IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846
AE+ + YL++ VHRDL N ++AHD +K+ DFG+++ D+
Sbjct: 119 QEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIY 170
Query: 847 GPETD-------GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899
ETD G++P ++APE L ++D WS
Sbjct: 171 --ETDYYRKGGKGLLPV----------------------RWMAPESLKDGVFTTSSDMWS 206
Query: 900 VGIILFEFITGIPPFTAESP 919
G++L+E + AE P
Sbjct: 207 FGVVLWEITS-----LAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 21/160 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 751
I G FG+V AR + G AIK +K + K+D E +L + +P ++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI----------------YIAE 795
+ R LYL +EY G+L LRK LE D A + A+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 695 ISRGAFGRVFLARKRTTG---DLFAIKVLKK--LDMIRKNDIERILAERNILITVRNPFV 749
I G FG V R + G AIK LK + R++ L+E +I+ +P +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD----FLSEASIMGQFDHPNI 67
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEY 802
+ T + ++ E++ G L S LR ++ + + +LV ++Y
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLR------QNDGQFTVIQLVGMLRGIAAGMKY 121
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L + VHRDL N+L+ + K++DFGLS+ L ++T D P
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF-LEDDTSD----------------PT 164
Query: 863 YQQTDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
Y S++G + APE + + A+D WS GI+++E ++
Sbjct: 165 YT--------SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-07
Identities = 64/276 (23%), Positives = 113/276 (40%), Gaps = 51/276 (18%)
Query: 657 ENSRLILDSVSQSSGVSTPLHSSHKERTS--IDDFEIIKPISRGAFGRVFL-ARKRTTGD 713
+ S L D + PL + + + F +I + GAFG++F+ A + +T +
Sbjct: 116 DASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEE 175
Query: 714 LFAIKVLKKLDMIRKNDIERILA-------------ERNILITVR--NPFVVRFFYSFTC 758
A + + + K ER++A E IL R + +++
Sbjct: 176 AEARRGVNSTNQ-GKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRS 234
Query: 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-----ARIYIAELVLALEYLHSLGIVHRDL 813
N Y++ + + DLYS + +D R + +L+ A+EY+H ++HRD+
Sbjct: 235 EANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDI 293
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K +N+ + DG I L DFG MP +++ +
Sbjct: 294 KLENIFLNCDGKIVLGDFGT-------------------AMP-------FEKEREAFDYG 327
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
VGT +PEIL G + D WS G+IL + ++
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 16/158 (10%)
Query: 693 KPISRGAFGRVF---LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
K + G FG V L++ + A+K +K LD+ ++IE L+E + +P V
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 750 VRFF-YSFTCRDNLYL-----VMEYLNGGDLYSLL--RKVGCLEEDVAR----IYIAELV 797
++ F + ++ ++ GDL+S L ++G L E + ++ ++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
L +EYL + +HRDL N ++ D + + DFGLSK
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 17/151 (11%)
Query: 691 IIKPISRGAFGRVFLARKRTTGDLFAIKV----LKKLDMIRKNDIERILAERNILITVRN 746
IK + G RV+L T + + +K+ K D R+ I ++LA + + +
Sbjct: 2 SIKLLKGGLTNRVYLLG--TKDEDYVLKINPSREKGADREREVAILQLLARKGLPV---- 55
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P V+ S YL+ME++ G L +V E++ +AEL+ L L L
Sbjct: 56 PKVL---ASGESDGWSYLLMEWIEG----ETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
+ H DL P N+L+ + + D+ + G
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 50/231 (21%)
Query: 693 KPISRGAFGRVFLARKRTTGD---LFAIKVLKK-LDMIRKNDIERILAERNILITVRNPF 748
K I G FG VF + G AIK LK ++ D L+E +I+ +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDF---LSEASIMGQFSHHN 67
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDL----------YSLLRKVGCLEEDVARIYIAELVL 798
++R T ++ EY+ G L +S + VG L A
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAA--------- 118
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
++YL + VHRDL N+L+ + K++DFGLS++ + + + + + G +P
Sbjct: 119 GMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV--LEDDPEGTYTTSGGKIPI-- 174
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
+ APE + + A+D WS GI+++E ++
Sbjct: 175 --------------------RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 59/246 (23%), Positives = 104/246 (42%), Gaps = 48/246 (19%)
Query: 692 IKPISRGAFGRVF----LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+K + GAFG V+ + T AIK+L + + N + E I+ ++ +P
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN--VEFMDEALIMASMDHP 69
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI----YIAELVLALEYL 803
+VR + LV + + G LL V ++++ + ++ + YL
Sbjct: 70 HLVRLL-GVCLSPTIQLVTQLMPHG---CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
+VHRDL N+L+ H+K+TDFGL+++ L G E EY
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARL--------LEGDEK-----------EY 166
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-------GIPPFTA 916
N ++A E + + + +D WS G+ ++E +T GIP T
Sbjct: 167 ------NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TR 218
Query: 917 ESPEII 922
E P+++
Sbjct: 219 EIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-05
Identities = 49/188 (26%), Positives = 74/188 (39%), Gaps = 36/188 (19%)
Query: 675 PLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---I 731
PL + DDF + K + GAFG V+ + + K K + + + +
Sbjct: 120 PLEGLFRPSFKKDDFVLGKKLGEGAFGVVY----KASLVNKQSKKEGKYVLKKATEYGAV 175
Query: 732 ERILAERNILITVRNPFVVRFFYSFTC------RDNLYLVMEYLNGGDLYSL-------- 777
E + ER + N F Y F D +LV Y L L
Sbjct: 176 EIWMNER-VRRACPN-SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPY 233
Query: 778 ------LRKVGCL------EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DG 824
L KV L E + + + +++ AL+ LHS GIVHRD+KP N++ + G
Sbjct: 234 NVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG 293
Query: 825 HIKLTDFG 832
K+ D G
Sbjct: 294 SFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 64/263 (24%), Positives = 104/263 (39%), Gaps = 64/263 (24%)
Query: 695 ISRGAFGRVFLARKRTTGDLF---------AIKVLKKLDMIRKNDIERILAERNILITVR 745
I +G FG V+ G L A+K L ++ + ++E+ L E I+
Sbjct: 3 IGKGHFGCVY------HGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFS 54
Query: 746 NPFVVRFFYSFTCRDNLYLV-MEYLNGGDLYSLLRK----------VGCLEEDVARIYIA 794
+P V+ + LV + Y+ GDL + +R +G VA+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG-FGLQVAK---- 109
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
+EYL S VHRDL N ++ +K+ DFGL++
Sbjct: 110 ----GMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLAR------------------- 146
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912
D + EY N H+ P ++A E L + +D WS G++L+E +T G P
Sbjct: 147 --DIYDKEYYSVHN---HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
Query: 913 PFTAESPEIIFDNILN-RKIPWP 934
P+ I +L R++ P
Sbjct: 202 PYPDVDSFDITVYLLQGRRLLQP 224
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 46.3 bits (111), Expect = 2e-05
Identities = 25/72 (34%), Positives = 37/72 (51%), Gaps = 7/72 (9%)
Query: 764 LVMEYLNGGDLYS-LLRKVGCLEEDVARIY--IAELVLALEYLHSLGIVHRDLKPDNLLI 820
LVME++ G + + L+ V L ED +Y I EL+ L G+VH DL N+L+
Sbjct: 92 LVMEFIGGDGIPAPRLKDVR-LLEDPEELYDQILELMRKL--YREAGLVHGDLSEYNILV 148
Query: 821 AHDGHIKLTDFG 832
DG + + D
Sbjct: 149 -DDGKVYIIDVP 159
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 32/238 (13%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKL--DMIRKNDIERILAERNILITVRNPFV 749
+K + G FG V GD I V K D + + I + ++ + ++
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGI 808
VR +L LV + G L +R+ L+ + ++ + YL +
Sbjct: 72 VRLL-GICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
VHR+L N+L+ D +++ DFG+ +D YP+ D
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGV----------------------ADLLYPD----DK 164
Query: 869 RNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 924
+ +S TP ++A E +L + + +D WS G+ ++E ++ G P+ P + D
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 60/245 (24%), Positives = 101/245 (41%), Gaps = 53/245 (21%)
Query: 693 KPISRGAFGRVF--LAR---KRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILITVR 745
+ + +G+FG V+ +A+ K AIK + + +R ERI L E +++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR----ERIEFLNEASVMKEFN 67
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA---------RIYIA-E 795
VVR + ++ME + GDL S LR + E+ I +A E
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ + YL++ VHRDL N ++A D +K+ DFG+++
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------------------- 167
Query: 856 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ +TD + P +++PE L +D WS G++L+E T
Sbjct: 168 ------DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----- 216
Query: 915 TAESP 919
AE P
Sbjct: 217 LAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 54/241 (22%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 716 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 775
AIK LK D E E + +++P +V T L ++ Y + DL+
Sbjct: 39 AIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLH 96
Query: 776 SLL------RKVGCLEEDVARI----------YIAELVLALEYLHSLGIVHRDLKPDNLL 819
L VG ++D + ++ +E+L S +VH+DL N+L
Sbjct: 97 EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156
Query: 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 879
+ ++K++D GL + + L G + ++P
Sbjct: 157 VFDKLNVKISDLGLFREVYAADYYKLMG---NSLLPI----------------------R 191
Query: 880 YLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDNILNRKIPWPCVPS 938
+++PE ++ + +D WS G++L+E F G+ P+ S + + + I NR++ PC P
Sbjct: 192 WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV-LPC-PD 249
Query: 939 D 939
D
Sbjct: 250 D 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 67/298 (22%), Positives = 115/298 (38%), Gaps = 72/298 (24%)
Query: 693 KPISRGAFGRVFL--ARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILIT 743
I G FG+V L A + + +K L+ +L +++ R L N+L
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 744 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAEL 796
+ C ++ LV+E+ GDL + LR ++DV + E+
Sbjct: 61 LGQ-----------CIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
L +LH +H DL N + D +K+ D+GL+
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLAL--------------------- 148
Query: 857 DAHYPE-YQQTDNRNRHSAVGTPDYLAPEI-------LLGTEHGYAADWWSVGIILFE-F 907
YPE Y T + + +LAPE+ LL + ++ WS+G+ ++E F
Sbjct: 149 -EQYPEDYYITKDCH----AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203
Query: 908 ITGIPPFTAESPEIIFDNIL---NRKIPWPCVP---SDMSFEAQDLINRFLIHDPNQR 959
P+ S E + ++ + K+P P + SD +E + +F DP R
Sbjct: 204 TAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE----VMQFCWLDPETR 257
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIK----VLKKLDMIRKNDIERILAERNILITVRNPFVV 750
+ +G F ++F +R GD + +LK LD +N E +++ + + +V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHSLGIV 809
+ C D +V EY+ G L + L+K L ++ +A +L AL +L G+
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122
Query: 810 HRDLKPDNLLIAHDGH--------IKLTDFGLS 834
H ++ N+L+ + IKL+D G+S
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 30/134 (22%)
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+E+L S VHRDL N+L+A +K+ DFGL++ IM D+
Sbjct: 249 GMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----------------DIM-HDS 291
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAE 917
+Y ++ S ++APE + + +D WS GI+L+E F G P+
Sbjct: 292 NYV--------SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY--- 340
Query: 918 SPEIIFDNILNRKI 931
P +I D+ KI
Sbjct: 341 -PGMIVDSTFYNKI 353
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 19/90 (21%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
R +Y F + L + + +++ C + + + + +++ LEY+H GI H
Sbjct: 98 RMYYRFILLEKLVE--------NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISH 149
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
D+KP+N+++ + + D+G++ +I+
Sbjct: 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIH 179
|
Length = 294 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 32/124 (25%), Positives = 57/124 (45%), Gaps = 26/124 (20%)
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
Y ++ +E+L S +HRDL N+L++ + +K+ DFGL++ D+
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR--------DI------ 224
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITG 910
Y+ D + SA ++APE + + +D WS G++L+E F G
Sbjct: 225 -----------YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 273
Query: 911 IPPF 914
P+
Sbjct: 274 ASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 18/37 (48%), Positives = 21/37 (56%), Gaps = 1/37 (2%)
Query: 799 ALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLS 834
AL LH GI H DL KP N L+ DG + DF L+
Sbjct: 123 ALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159
|
Length = 365 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 31/143 (21%)
Query: 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
DLY +KV LE+ + Y ++ +E+L S +HRDL N+L++ + +K+ DFG
Sbjct: 170 DLY---KKVLTLEDLIC--YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 224
Query: 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
L++ D+ + D + DA P ++APE + +
Sbjct: 225 LAR--------DIY-KDPDYVRKGDARLPL----------------KWMAPETIFDRVYT 259
Query: 893 YAADWWSVGIILFE-FITGIPPF 914
+D WS G++L+E F G P+
Sbjct: 260 IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|240168 cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 4e-04
Identities = 41/169 (24%), Positives = 66/169 (39%), Gaps = 40/169 (23%)
Query: 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---RNI--------LI 742
IS G V+ AR G+ A+K+ K + K+ + I + R+ L+
Sbjct: 4 CISTGKEANVYHAR-TGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLV 62
Query: 743 TV------RN-----------PFVVRFFYSFTCRDNLYLVMEYL-NGGDLYSLLRKVGCL 784
RN P + + N+ LVME++ + G L+ V
Sbjct: 63 FAWAEKEFRNLKRLYEAGVPVPEPI------LLKKNV-LVMEFIGDDGSPAPRLKDVPLE 115
Query: 785 EEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
EE+ +Y ++V + L G+VH DL N+L HDG + D
Sbjct: 116 EEEAEELY-EQVVEQMRRLYQEAGLVHGDLSEYNILY-HDGKPYIIDVS 162
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and chromosome maintenance. The biological substrates for RIO1 are unknown. The function of RIO3 is also unknown. Length = 190 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 40/187 (21%), Positives = 61/187 (32%), Gaps = 47/187 (25%)
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
A + L L L HR K N+L+ DG +KL G PE
Sbjct: 21 AVCLQCLGALREL---HRQAKSGNILLTWDGLLKL--DGSVAF---------KTPEQSR- 65
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
P ++APE++ G + AD +S+GI L+E + P
Sbjct: 66 ----------------------PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
Query: 914 FTAESP-----EIIFDNILNRKIPWPCVPSDMS--FEAQDLINRFLIHDPNQRLGANGAA 966
+ E EI+ + + +S +D + P +R AN
Sbjct: 104 YNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAAN--- 160
Query: 967 EVKAHPF 973
AH
Sbjct: 161 HYLAHCR 167
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-04
Identities = 41/147 (27%), Positives = 64/147 (43%), Gaps = 28/147 (19%)
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+E+L S VHRDL N+LI +K+ DFGL++ IM D++
Sbjct: 252 MEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR----------------DIM-RDSN 294
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918
Y ++ S ++APE + + +D WS GI+L+E T G P+
Sbjct: 295 YI--------SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346
Query: 919 PEIIFDNILNR--KIPWPCVPSDMSFE 943
F N + R ++ P SD +E
Sbjct: 347 MNEQFYNAIKRGYRMAKPAHASDEIYE 373
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 27/176 (15%)
Query: 735 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYI 793
LAE L + +VR T + + +V EY++ G L S LRK G L +
Sbjct: 54 LAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGML 113
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
L ++YL +G VH+ L +L+ D K++ F E
Sbjct: 114 PGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR-------------RLQEDK-- 158
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
S+A Y T + + APE + A+D WS GI+++E ++
Sbjct: 159 --SEAIY-----TTMSGKSPVLWA----APEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 8e-04
Identities = 21/67 (31%), Positives = 36/67 (53%), Gaps = 6/67 (8%)
Query: 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824
VMEY++G +LY + R + ED + E++ + + GI+H DL N+L+ D
Sbjct: 109 VMEYIDGVELYRV-RVL----EDPEEVL-DEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162
Query: 825 HIKLTDF 831
I + D+
Sbjct: 163 KIYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 36/158 (22%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKV-LKKLDMIRKNDIERILAERNILITVRNPFVVR 751
K + G FG V + + + V K+ + ++++E L+E + +P V+R
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 752 FFYSFTCRDNL--------YLVMEYLNGGDLYSLL--RKVG----CLEEDVARIYIAELV 797
C + +++ ++ GDL+S L ++G L + ++ ++
Sbjct: 65 LIG--VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+EYL S +HRDL N ++ + ++ + DFGLSK
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 26/116 (22%)
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ +L S +HRDL N+L+ H K+ DFGL++ I N +++ ++ +A
Sbjct: 227 MSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD--IRN-------DSNYVVKGNAR 277
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
P ++APE + + + +D WS GI+L+E F G P+
Sbjct: 278 LP----------------VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 49/229 (21%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
ISRG G + + G F +K + ++ I ++I + +++P +V+
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD-------MGKLQHPNIVKLIG 750
Query: 755 SFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH---SLGIV 809
CR YL+ EY+ G +L +LR + I IA+ AL +LH S +V
Sbjct: 751 --LCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAK---ALRFLHCRCSPAVV 805
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
+L P+ ++I DG D ++ L P TD +
Sbjct: 806 VGNLSPEKIII--DG----KDEPHLRLSL----------------------PGLLCTDTK 837
Query: 870 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
S+ Y+APE + +D + G+IL E +TG P AE
Sbjct: 838 CFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882
|
Length = 968 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 22/80 (27%), Positives = 34/80 (42%), Gaps = 6/80 (7%)
Query: 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818
L + L LL ++ L E + + L+ AL L +VH DL P NL
Sbjct: 123 LKLLRQLAAALRRLVAAELLDRLAELWERLLA-ALLALLPALP----LVLVHGDLHPGNL 177
Query: 819 LIAHDGHIK-LTDFGLSKIG 837
L+ G + + DF + +G
Sbjct: 178 LVDPGGRVTGVIDFEDAGLG 197
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 24/69 (34%), Positives = 36/69 (52%), Gaps = 7/69 (10%)
Query: 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSLGIVHRDLKPDNLLIAH 822
+VMEY+ G +LY L V +E I + +L + + GIVH DL N+L+
Sbjct: 184 VVMEYIEGVELYRLRLDVENPDE------ILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237
Query: 823 DGHIKLTDF 831
DG I + D+
Sbjct: 238 DGDIVVIDW 246
|
Length = 304 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1092 | |||
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.6 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.88 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.72 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.65 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.59 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.55 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.51 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.39 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.22 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.19 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.17 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.13 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.08 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.02 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.99 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.97 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.89 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.87 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.81 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.79 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.75 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.51 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.48 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.37 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.37 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.23 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.12 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.07 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.99 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.93 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.85 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.84 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.79 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 95.83 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.82 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.81 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.8 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.77 | |
| PLN02236 | 344 | choline kinase | 95.76 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.26 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.2 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.11 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.07 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.66 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.55 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.15 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.62 | |
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 92.34 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.25 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 92.09 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 90.73 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 89.56 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 89.26 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 88.21 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 87.84 |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-79 Score=729.41 Aligned_cols=1021 Identities=35% Similarity=0.438 Sum_probs=788.4
Q ss_pred CCCcccccccccCCCC-CCccccccccccCCCCCc---ccccccccccchhcc-hhhH-HHHHhhchH--HHHHH-----
Q 001360 12 GIPSGLNRIKTRGGVS-KPDELTESRSYGVSRPPQ---KHKQKTVAQGHVKLA-NSFT-EEVRKGKKI--AQWFT----- 78 (1092)
Q Consensus 12 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~--~~~~~----- 78 (1092)
-+++|+|+|||+-.-. -+-.|..- -+.|+|- -.||+-|+.|+...| |.|. -.-+++-|+ .+|..
T Consensus 80 p~e~df~~IklisngAygavylvrh---~~trqrfa~kiNkq~lilRnilt~a~npfvvgDc~tllk~~g~lPvdmvla~ 156 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRH---KETRQRFAMKINKQNLILRNILTFAGNPFVVGDCATLLKNIGPLPVDMVLAV 156 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeec---cccccchhhcccccchhhhccccccCCcceechhhhhcccCCCCcchhhHHh
Confidence 4678999999974221 11111100 1223332 257888888877665 5554 223444444 34443
Q ss_pred hhcccceecCCCCCCCCCCCCCCCcCCccccccccccccchhhhHHHHhhhcccccCCccccccccCCCCCCCCCCccCC
Q 001360 79 SYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNHLNEKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAH 158 (1092)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (1092)
.|.-.+.||-+.--+.+.+-+-+ -+.||-..| ..|.+|.-..- -+.+-++++|+||++.||.-.--+.+++
T Consensus 157 Eylh~ygivhrdlkpdnllIT~m-----GhiKlTDfg---Lsk~GLms~at-nl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 157 EYLHSYGIVHRDLKPDNLLITSM-----GHIKLTDFG---LSKKGLMSLAT-NLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred HhhccCCeecCCCCCCcceeeec-----ccccccchh---hhhhhhhhccc-hhhhcchHHHHHHhhhccccCCccccCh
Confidence 37777889988777666554433 234444443 56777765554 6778899999999999998888889999
Q ss_pred CcCCHH--------HHHHHHHHHHHHHHHhhhhh-----HhhhHHHHHHHHhhcCCCCchhhhHHHHHHHHHHHhhhhhc
Q 001360 159 SYNDLK--------ELLDTLHSRFDAAKEVVNSE-----LATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTS 225 (1092)
Q Consensus 159 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (1092)
.|+..+ +.+|.|+.+|.-.++-|..+ +|+|+.|.+...|+++-.-.|-++++++||..+-+|..||.
T Consensus 228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 999999 99999999999999999999 99999999999999998899999999999999999999999
Q ss_pred chhhhhhhHHHHhhHHh---HhcCcchHHHHhhhhhHHHhHhhhHHhhccccccchhcc--chhhHhhhcccCCcccccc
Q 001360 226 CLFRANCETIVQDLTEK---RQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEK--SLHKFKKCLESVPAVETSW 300 (1092)
Q Consensus 226 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 300 (1092)
=-||+-||-|+|.||.+ ||+|+-+.++|...+|+||+|||+|+-+|.+|...+++- ..++|.-|.+-..++..+|
T Consensus 308 ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfdTRs~Ryh~~~se~~~~ees~~~~~qFsscs~r~~kv~ss~ 387 (1205)
T KOG0606|consen 308 GALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFDTRSDRYHHFESEDTGDEESSLEFRQFSSCSPRFSKVYSSW 387 (1205)
T ss_pred hhhhhhhccceeecccchhhhhhccccccccccccchhhcccchheeeccccCCccccccccccccccccccccccccch
Confidence 99999999999999999 999999999999999999999999999999999999888 6789999999999999999
Q ss_pred cC-------CCCccccchhhHHHHhhhccccccccc--cccccccccccCccCccccccccccceeccCCCCccccchhh
Q 001360 301 VP-------SPGTAESDLDYASYQKANAKKKISGQQ--KVSTVPEISDCSCSESLDHTSENKSVFIEQNFPPQKSQHYSR 371 (1092)
Q Consensus 301 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (1092)
-- .+-.-++...+-.++- +-.++. +...-|++..-.-+..+++..+| -.--|.|.+-++-
T Consensus 388 ~~l~~~~t~~~~~~~~~~~~~~~~~-----~~~g~k~~~~~~sp~~~kl~~st~~ss~s~~------~~~s~~~~~~~~~ 456 (1205)
T KOG0606|consen 388 ESLAQLETATPREKSSQSSQGEVSP-----SSAGQKDSWKSNSPESSKLELSTALSSVSPN------HPGSPSKSLTSAA 456 (1205)
T ss_pred hhhhccccccccccccccccccccC-----CccccccccccCChhhhhccccchhhhcccc------cCCCccccccchh
Confidence 65 1111111111111110 111111 12222322222222122222222 0122223332221
Q ss_pred h----h------hhccccccce------EEEEeecC-------C--------------CCCCcCCCCCCCCCceeeeecc
Q 001360 372 M----Q------EQQSHIVEGR------IVEVTKSN-------C--------------GSPHEQGQSLDGSDSVICRICE 414 (1092)
Q Consensus 372 ~----~------~~~~~~~~~~------~~~~~~~~-------~--------------~~~~~~~~~~~~~~~~~~~~~~ 414 (1092)
- + --.+++..+| ++.-++.. | ...|..-+.+..+|+.||||||
T Consensus 457 s~~~~~~~~s~~~~ds~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~d~s~~~~~~r~~~~~v~~~d~~i~~~~e 536 (1205)
T KOG0606|consen 457 STLRTALRTSSPSEDSKIFPLRAPPPPSSYASEEPESPKPKFSVSPESGQPGDDSEALDRSRLWSKCVGTSDSGICRICE 536 (1205)
T ss_pred hhhccccccCCCCCCccccccCCCCCccccccCCCCCCCcccccCCCCCCcccchhhhccccccccccccCCcccccccc
Confidence 1 1 1123333443 22111110 1 1345566889999999999999
Q ss_pred ccccccccccccccccccccccccccchhhhHHhHHHHHHHHHhhcc--CCCCCCCCCCcccccccCccceeccCCCccc
Q 001360 415 EVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCN--SSSHPILGSPENSRTQSMNSAITYDGYSPKI 492 (1092)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 492 (1092)
.++|..|.|.|++||+++++|+.+|++++.|+.|+.+.++++..|.. ++.+| .|+|..+..+ +...-++..| +.
T Consensus 537 ~~~p~~~~e~~~~~~~~~~ks~~~s~e~~~~~~kv~ks~s~~alS~~i~s~~~~-~~~~l~s~lS--~~~~sS~p~S-rd 612 (1205)
T KOG0606|consen 537 AEGPRLHSENHSRICKHQAKSELNSIEVKSRLRKVNKSLSASALSLMINSSDTP-TGGPLCSPLS--PRSLSSNPSS-RD 612 (1205)
T ss_pred cccccccccCcchHHHhhhhcccCccccccchhhHHHHHHhhhcccccccccCC-cccccccccC--CCCCCCCccc-Cc
Confidence 99999999999999999999999999999999999999999877654 33444 4667776663 5556677777 99
Q ss_pred hhhhccCcchhhhccccccccccccCCCc--ceeecccccccccCCCCcCCCCcccccCCCCCCCCCCCcccccccCCCC
Q 001360 493 SEWRNKGVEGMFEDIHEMDTACIDDSHLG--SLNLRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPA 570 (1092)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~s~t~~~~~~~p~~~~~~~~~~~~~~~~ 570 (1092)
+.|+|+++++|+++.+.++.. +.+..+| .+.++-..|-+. .|.-.++.++-+..||..+|...+.|+||.++-++-
T Consensus 613 sspsrd~s~~~~~~~ppI~i~-~~~~~yGft~~airVy~Gd~d-~ytvhh~v~sv~egsPA~~agls~~DlIthvnge~v 690 (1205)
T KOG0606|consen 613 SSPSRDSSAAMLSLRPPITIH-FSGKKYGFTLRAIRVYMGDKD-VYTVHHSVGSVEEGSPAFEAGLSAGDLITHVNGEPV 690 (1205)
T ss_pred cccccccchhhcCcCCceeee-ccccccCceeeeEEEecCCcc-cceeeeeeeeecCCCCccccCCCccceeEeccCccc
Confidence 999999999999999977654 4555677 667778889888 888899999999999999999999999999999999
Q ss_pred chhhHHhhhhhhh--hhhhhhhhhhhccchhhHh-hhccchHHHHhhcccceEeccchh-HHHHHHhhhhhHhhhhhccc
Q 001360 571 ELEDVQQMIELAD--IARCVADTDFSKEGSEFLL-ACMHDLQDVLQHSKLKALVIDTFG-SRIEKLLREKYILACELLDE 646 (1092)
Q Consensus 571 ~~~d~~~~~~~~~--~~~~i~~~~~~ke~~~~l~-~~~~~~~~~~~~~~~~~lvid~fg-~rI~kllr~k~il~~~lL~~ 646 (1092)
+-.+.+||++|.+ ++++++.+--.++.+-+.. +|..+.+-+|.+.+.+..++++|+ .|+.++++..+.-.|+++..
T Consensus 691 ~gl~H~ev~~Lll~~gn~v~~~ttplenTSik~g~arr~~~k~~m~~R~kk~~~~E~~~~rr~~kLlr~~~~q~~~l~~~ 770 (1205)
T KOG0606|consen 691 HGLVHTEVMELLLKSGNKVTLRTTPLENTSIKSGPARRDSYKAVMARRKKKALVPETFGIRRIEKLLRKISKQDCELLHT 770 (1205)
T ss_pred chhhHHHHHHHHHhcCCeeEEEeeccccchhhhhHHHHHHHHHHHhhcccccccccccccccHHHHHHHHHhhhhhhhcc
Confidence 9999999999999 9999999999999995555 999999999999999999999999 78999999888877776554
Q ss_pred CCCCcccccccchhhhhcccccCCCCCCCCCCCccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc
Q 001360 647 KSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726 (1092)
Q Consensus 647 ksp~sfSk~~ens~llldsls~ssg~~tp~~ss~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~ 726 (1092)
......+ ....--+. .......|..+.. -+...++|.+.+.+-+|+||.++.+....+|...++|+..+..+.
T Consensus 771 ~~s~~ss----~eS~pgdp--~~sls~sP~sp~~-yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i 843 (1205)
T KOG0606|consen 771 SRSFLSS----SESLPGDP--TRSLSASPRSPTK-YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKI 843 (1205)
T ss_pred ccccccc----cccCCCCc--ccccccCCCCccc-ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhh
Confidence 3321000 00000000 0001111222222 457889999999999999999999999999999999999988888
Q ss_pred chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc
Q 001360 727 RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806 (1092)
Q Consensus 727 kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~ 806 (1092)
..++.+.++.+..++....+|.++..+..|.....++|+|+|+.||+|...|++.++.+++.++.++..++.+++|||..
T Consensus 844 ~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~ 923 (1205)
T KOG0606|consen 844 RTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS 923 (1205)
T ss_pred ccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc
Confidence 88888889999999888899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCeeeecCCCceEecCCCcEEEEecC-CcccccccccccCCCCCCCCCC---CCCCCCCcccccCcCCccCccCCCCCCC
Q 001360 807 GIVHRDLKPDNLLIAHDGHIKLTDFG-LSKIGLINNTIDLSGPETDGIM---PSDAHYPEYQQTDNRNRHSAVGTPDYLA 882 (1092)
Q Consensus 807 GIIHRDLKPeNILLD~nG~VKLsDFG-LAk~~~~n~s~dls~~~t~g~~---p~~~~~~~~~~~~~~~~~s~vGTp~YmA 882 (1092)
.++|||++|.|+|+..+|+.+++||| +.+.+..+...+++++...+.. ....+-+.............+||+.|.|
T Consensus 924 ~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~la 1003 (1205)
T KOG0606|consen 924 LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLA 1003 (1205)
T ss_pred hhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccC
Confidence 99999999999999999999999999 5555555555555543332221 1122222333333455677899999999
Q ss_pred hhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc
Q 001360 883 PEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962 (1092)
Q Consensus 883 PEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa 962 (1092)
||.+.+...+..+|||++|++++|.++|.+||....++.+++.|.++..+||.-+...++++++++.++|..+|.+|.++
T Consensus 1004 Pe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1004 PEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred CcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred ccHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCC-CCCCCCCcchhhccC
Q 001360 963 NGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADT-CDSSSNSRTEMDECG 1041 (1092)
Q Consensus 963 ~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st-~~ss~~~~~em~e~~ 1041 (1092)
.++.+.+.||||++++|+.|..+...|+|.+.+..|++||.+.|......+.....+..+...+ +......+.++
T Consensus 1084 ~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~s~~dtS~~~~r~~~~~~~e~~sg~s~~~~~~s~~~~~~~~~pe~---- 1159 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLALQKAEFVPQPESTQDTSYFESRFSEESQDETVSGSSSGSKLDSPDESPECTTPEL---- 1159 (1205)
T ss_pred ccccccccCCccCCCCccccccccCccCCCCCCCCccchhhcccccccccccccCCCcccCccCccccccccCccc----
Confidence 8888999999999999999999999999999999999999999885543333322222222211 22222222222
Q ss_pred CccccCCCCCCCcccCceeecchhhhccchhhhhh
Q 001360 1042 DLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQ 1076 (1092)
Q Consensus 1042 ~f~e~~~~~~d~~Fig~tyk~~~~~~~~~~~~~~~ 1076 (1092)
+..-.-++.|+||+||+..+|.+|||+++++
T Consensus 1160 ----~~~~~~~~sl~~~~~k~~s~l~s~~p~~~l~ 1190 (1205)
T KOG0606|consen 1160 ----KPAMCGNLSLINFSFKNLSQLASINPDKLLQ 1190 (1205)
T ss_pred ----cCCcCccccccccCccChhhccccChHhhcC
Confidence 2222237789999999999999999999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-78 Score=687.01 Aligned_cols=373 Identities=46% Similarity=0.796 Sum_probs=319.2
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
++..++|+++++||+|+||.||+|+.+.||.+||||+|+|..+..++++++++.|++||...++||||+||++||+.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||||||++|||++++|.+.+.|+++.+++|+++++.||+.||++|||||||||+|+|||..||+||+|||||+.....+.
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999975444333
Q ss_pred ccCCC------CCCCCCC----C----------CCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhh
Q 001360 843 IDLSG------PETDGIM----P----------SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902 (1092)
Q Consensus 843 ~dls~------~~t~g~~----p----------~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGV 902 (1092)
++... ....... + ....+..|+.+++..+++++|||.|||||||.+.+|+..||||||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 33211 0000000 1 12233567778888899999999999999999999999999999999
Q ss_pred hHHHHHhCCCCCCCCChHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcc
Q 001360 903 ILFEFITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 903 ILYEMLTGk~PF~~~s~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd 980 (1092)
||||||.|+|||+++++.+++++|++.. +.+|. ...++++|+|||.+||+ ||.+|++.+|+.||++||||++|+|+
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 9999999999999999999999999865 67774 46789999999999999 99999999999999999999999999
Q ss_pred hhhhccCCccCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCcchhhccCCccccCCCCCCCcccCcee
Q 001360 981 SLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSF 1060 (1092)
Q Consensus 981 ~L~~~~pPfiP~~~s~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~ss~~~~~em~e~~~f~e~~~~~~d~~Fig~ty 1060 (1092)
.|...+|||+|.+.++.|++||+.+ +......+.. ..+..|+. |. .+...+...+|-+|+||||
T Consensus 455 ~l~~~~apfvP~v~~~~DT~yFddF-~e~~~~~~~~-----------~~~~~~~k-~~---~~~~~~~~~~~~~FvgfTy 518 (550)
T KOG0605|consen 455 HLREMPAPFVPQVNSELDTQYFDDF-PEEDSMTPTA-----------DKSGPSRK-ML---SMVDTNNSSKDINFVGFTY 518 (550)
T ss_pred hhhcCCCCCCCCCCCcccccccccC-cccccCcccc-----------cccccchh-hh---hcccccCCcccccccceee
Confidence 9999999999999999999999963 3332211111 11112221 11 1122224567888999999
Q ss_pred ecchhhhccchhh
Q 001360 1061 KNLSQLASINHEV 1073 (1092)
Q Consensus 1061 k~~~~~~~~~~~~ 1073 (1092)
|+|+++.+-+...
T Consensus 519 k~~~~~~~~~~~~ 531 (550)
T KOG0605|consen 519 KNFDGLNKANSLL 531 (550)
T ss_pred ecccccccccccc
Confidence 9999999887764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-70 Score=603.41 Aligned_cols=303 Identities=49% Similarity=0.911 Sum_probs=284.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
....++|+++++||+|+||+||+|+.++|++.||||+++|..+..+.+.+++.+|+.||.+++||+||+++++||+.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|||+||+.||+|+.+|++.+.|++..+++|+++|+.||.|||++|||||||||+|||||.+|||+|+|||||+...
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~---- 176 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL---- 176 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999532
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.....+.++|||+.|||||++.+.+|+..+||||||++|||||+|.+||.+.+...+
T Consensus 177 -----------------------~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~ 233 (357)
T KOG0598|consen 177 -----------------------KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM 233 (357)
T ss_pred -----------------------cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH
Confidence 223445679999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC-cccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCc
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDT 999 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpS-a~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dt 999 (1092)
+++|+.++...+ |..++.+++|||+++|.+||++|++ ..++.+|++||||++++|+.+.++ .|||+|......|+
T Consensus 234 ~~~I~~~k~~~~--p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~ 311 (357)
T KOG0598|consen 234 YDKILKGKLPLP--PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDT 311 (357)
T ss_pred HHHHhcCcCCCC--CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCcccc
Confidence 999999986554 4679999999999999999999997 457999999999999999999877 79999999999999
Q ss_pred cccccccccCCCCCC
Q 001360 1000 SYFLSRFSQISSGLP 1014 (1092)
Q Consensus 1000 s~Fds~fs~~~s~l~ 1014 (1092)
++|+.+|+...+...
T Consensus 312 ~~Fd~eft~~~~~~~ 326 (357)
T KOG0598|consen 312 SNFDNEFTSYTVDYS 326 (357)
T ss_pred ccccHHHHhccccCC
Confidence 999999998855443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-66 Score=554.01 Aligned_cols=289 Identities=43% Similarity=0.837 Sum_probs=276.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
..+++|+++++||.|+||+|.+++.+.+|..||||++++..+.+-.++++..+|..+|+.+.||++++|++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
|||||++||.|+.+|++.++|++..++||++||+.||+|||+++||||||||+|||||++|++||+|||+|+..
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v------ 194 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV------ 194 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999853
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
...+++.||||.|+|||++..++|+.++|||||||++|||+.|++||...++..+|
T Consensus 195 ------------------------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY 250 (355)
T KOG0616|consen 195 ------------------------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY 250 (355)
T ss_pred ------------------------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH
Confidence 22367899999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC--cccHHHHHcCCCCCCCCcchhhhc--cCCccC-CCCCCCC
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVP-QPESVDD 998 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpS--a~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP-~~~s~~D 998 (1092)
++|+.+++.|| ..++.+++|||+++|++|-.+|.+ .+|..+|++||||++++|..+..+ ++||+| ....+.|
T Consensus 251 ~KI~~~~v~fP---~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gd 327 (355)
T KOG0616|consen 251 EKILEGKVKFP---SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGD 327 (355)
T ss_pred HHHHhCcccCC---cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCcc
Confidence 99999999998 799999999999999999999988 458999999999999999999877 789988 6778899
Q ss_pred ccccccc
Q 001360 999 TSYFLSR 1005 (1092)
Q Consensus 999 ts~Fds~ 1005 (1092)
+++|+..
T Consensus 328 tsnfd~y 334 (355)
T KOG0616|consen 328 TSNFDDY 334 (355)
T ss_pred ccccccc
Confidence 9999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-65 Score=595.69 Aligned_cols=303 Identities=38% Similarity=0.766 Sum_probs=285.4
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD 760 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~ 760 (1092)
.+..+++|.++++||+|+||+|+++..+.+++.||||+++|..+..+++++..+.|.+|+.... ||++++||.+||+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4688999999999999999999999999999999999999999999999999999999998886 999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
++|+||||+.||| +.+++..+.|++..+++|+++|+.||.|||++||||||||.+|||||.+||+||+|||||+.+.
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-- 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-- 519 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC--
Confidence 9999999999999 4455566889999999999999999999999999999999999999999999999999999642
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.....+.++||||.|||||++.++.|+.++|||||||+|||||+|..||.+++.+
T Consensus 520 -------------------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe 574 (694)
T KOG0694|consen 520 -------------------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE 574 (694)
T ss_pred -------------------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 1234678999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCC
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESV 996 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~ 996 (1092)
+++..|++..+.+| ..+|.++.++|++||++||++|++. .++.+|+.||||+.|+|+.|.++ +|||+|...++
T Consensus 575 e~FdsI~~d~~~yP---~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~ 651 (694)
T KOG0694|consen 575 EVFDSIVNDEVRYP---RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGP 651 (694)
T ss_pred HHHHHHhcCCCCCC---CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCCh
Confidence 99999999998877 7999999999999999999999995 57999999999999999999887 89999999999
Q ss_pred CCccccccccccCCCCCCC
Q 001360 997 DDTSYFLSRFSQISSGLPD 1015 (1092)
Q Consensus 997 ~Dts~Fds~fs~~~s~l~~ 1015 (1092)
.|.+|||.+|+.....+.+
T Consensus 652 ~D~snFd~eFt~e~p~Lt~ 670 (694)
T KOG0694|consen 652 EDVSNFDEEFTSEKPALTP 670 (694)
T ss_pred hhhcccchhhhcCCCccCC
Confidence 9999999999999777765
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-65 Score=610.84 Aligned_cols=296 Identities=44% Similarity=0.773 Sum_probs=275.6
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
+.++..+||+++++||+|+||.|.+|+++.|+++||||++.|.++.++.+...|..|++||...+.+|||+|+++|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 44677899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
++|||||||+||||..++.+.+.+++.+++||+++|+.||..||++|+|||||||+|||||.+|||||+|||.|-....
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~- 227 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA- 227 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998864221
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHHHhCCCCCC
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
+........||||.|++||+|.. +.|+..||||||||+|||||+|..||+
T Consensus 228 -------------------------dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 228 -------------------------DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred -------------------------CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 12334567899999999999963 458999999999999999999999999
Q ss_pred CCChHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCCccCCC
Q 001360 916 AESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQP 993 (1092)
Q Consensus 916 ~~s~~ei~~kIl~~--~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~ 993 (1092)
.++-.++|.+|++. .+.||. ...+|.++++||.++++ +|..|+|.+|+.+|+.||||.|++|+.++...|||+|.+
T Consensus 283 adslveTY~KIm~hk~~l~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPev 360 (1317)
T KOG0612|consen 283 ADSLVETYGKIMNHKESLSFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEV 360 (1317)
T ss_pred HHHHHHHHHHHhchhhhcCCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcC
Confidence 99999999999986 677773 45699999999999999 899999999999999999999999999999999999999
Q ss_pred CCCCCcccccc
Q 001360 994 ESVDDTSYFLS 1004 (1092)
Q Consensus 994 ~s~~Dts~Fds 1004 (1092)
.+.+||+||+.
T Consensus 361 ssd~DTsnFd~ 371 (1317)
T KOG0612|consen 361 SSDDDTSNFDV 371 (1317)
T ss_pred CCCCccccccc
Confidence 99999999954
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-64 Score=560.69 Aligned_cols=412 Identities=33% Similarity=0.551 Sum_probs=344.1
Q ss_pred hhhhhhhhhhhhhhhhccchhhHhhhccchH--HHHhhcc---cceEeccchhHHHHHHhhhhhHhhhhhcccCCCCccc
Q 001360 579 IELADIARCVADTDFSKEGSEFLLACMHDLQ--DVLQHSK---LKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFS 653 (1092)
Q Consensus 579 ~~~~~~~~~i~~~~~~ke~~~~l~~~~~~~~--~~~~~~~---~~~lvid~fg~rI~kllr~k~il~~~lL~~ksp~sfS 653 (1092)
-++.++|+.|++.|||+| +.+|+|+.+ +++.+.. ......+.|...+... |..|.. ..|.
T Consensus 96 ~~r~~~~~~i~~~~l~~~----~~~~~~~~s~~~~v~~~~~~l~~~~~~~lf~~~~~~~--------~~~L~~---~pF~ 160 (591)
T KOG0986|consen 96 DERKDKARQILDAYLMKE----LLACLPQFSSKDLVTHVQEHLLEKPPKDLFQPLARAI--------CAYLRG---DPFQ 160 (591)
T ss_pred ccchhhHHHHHHHHhhcc----ccccCCCcchhhhhHHHhhhccccCchhhhHHHHHHH--------HHHhcc---chHh
Confidence 356789999999999999 999999984 5555542 2223445555544433 333322 1222
Q ss_pred ccccchhhhhcccccCCCCCCCCCCCccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHH
Q 001360 654 KYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 733 (1092)
Q Consensus 654 k~~ens~llldsls~ssg~~tp~~ss~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~ 733 (1092)
.|.... ..+++.++.. .+...+..+.|+..++||+||||+||-++.+.||+.||+|.+.|..+.++.....
T Consensus 161 ~f~~S~--yf~rFlQWK~-------lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~m 231 (591)
T KOG0986|consen 161 EFLESD--YFTRFLQWKW-------LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETM 231 (591)
T ss_pred HhHHHH--HHHHHHHHHH-------HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHH
Confidence 222111 1122222211 1224467789999999999999999999999999999999999999888888999
Q ss_pred HHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeee
Q 001360 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHR 811 (1092)
Q Consensus 734 ~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHR 811 (1092)
.++|..||.+++.|+||.|-++|++.+.++|||..|+||||..+|.+.+ .|++..++||++||++||++||+.+||+|
T Consensus 232 aLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYR 311 (591)
T KOG0986|consen 232 ALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYR 311 (591)
T ss_pred hhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeec
Confidence 9999999999999999999999999999999999999999999999887 79999999999999999999999999999
Q ss_pred ecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC
Q 001360 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891 (1092)
Q Consensus 812 DLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y 891 (1092)
||||+|||||+.|||+|+|+|||.... ........+||.+|||||++.+..|
T Consensus 312 DLKPeNILLDd~GhvRISDLGLAvei~----------------------------~g~~~~~rvGT~GYMAPEvl~ne~Y 363 (591)
T KOG0986|consen 312 DLKPENILLDDHGHVRISDLGLAVEIP----------------------------EGKPIRGRVGTVGYMAPEVLQNEVY 363 (591)
T ss_pred cCChhheeeccCCCeEeeccceEEecC----------------------------CCCccccccCcccccCHHHHcCCcc
Confidence 999999999999999999999998532 1233445699999999999999999
Q ss_pred CccceeechhhhHHHHHhCCCCCCCCC----hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccH
Q 001360 892 GYAADWWSVGIILFEFITGIPPFTAES----PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGA 965 (1092)
Q Consensus 892 t~ksDVWSLGVILYEMLTGk~PF~~~s----~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga 965 (1092)
+.++|||||||+||||+.|+.||.... .+++-+++++....+| ..+|+++++|++.+|++||.+|+|. +++
T Consensus 364 ~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~---~kFS~eakslc~~LL~Kdp~~RLGcrg~ga 440 (591)
T KOG0986|consen 364 DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS---DKFSEEAKSLCEGLLTKDPEKRLGCRGEGA 440 (591)
T ss_pred cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc---cccCHHHHHHHHHHHccCHHHhccCCCcCc
Confidence 999999999999999999999997643 4577888888887777 7999999999999999999999993 589
Q ss_pred HHHHcCCCCCCCCcchhhhc--cCCccCCCCC-----CCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCcchhh
Q 001360 966 AEVKAHPFFKGVNWDSLALQ--KAVFVPQPES-----VDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMD 1038 (1092)
Q Consensus 966 ~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s-----~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~ss~~~~~em~ 1038 (1092)
.++++||||+++||..+... .|||+|.+.. ..|+..|+ +-.++.++++|..+|..|.|+..+++|+++|.
T Consensus 441 ~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs---~VKGV~ld~~D~~fy~~F~tg~vsipWQnE~~ 517 (591)
T KOG0986|consen 441 QEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFS---TVKGVKLDDTDTDFYKNFATGSVSIPWQNEMI 517 (591)
T ss_pred chhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhcc---cccceecccccHHHHHhccCCcccchHHHHHH
Confidence 99999999999999999887 8999999864 56666654 23488899999999999999999999999999
Q ss_pred ccCCccccCC
Q 001360 1039 ECGDLAEFGS 1048 (1092)
Q Consensus 1039 e~~~f~e~~~ 1048 (1092)
|+++|.+.+-
T Consensus 518 ET~~f~elnv 527 (591)
T KOG0986|consen 518 ETECFEELNV 527 (591)
T ss_pred HhhhHHHhhc
Confidence 9999998744
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-62 Score=527.33 Aligned_cols=310 Identities=41% Similarity=0.745 Sum_probs=293.0
Q ss_pred CCccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001360 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (1092)
Q Consensus 678 ss~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfq 757 (1092)
+..+.++.+++|+++++||+|.||+|.+|+.+.+|+.||||+++|.-+..+.++.+.+.|-++|+..+||++..|-++|+
T Consensus 159 ~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 159 AKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred ccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 34556788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
..+.+|+||||+.||+|+.+|.+...|+++.+++|.++|+.||.|||+++||+||||.+|+|||.+|||||+|||||+..
T Consensus 239 t~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999953
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
. .......++||||.|+|||++....|+.++|||.+||+||||++|+.||+..
T Consensus 319 I---------------------------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 319 I---------------------------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred c---------------------------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 2 2345667899999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC--cccHHHHHcCCCCCCCCcchhhhc--cCCccCCC
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 993 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpS--a~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~ 993 (1092)
+...++..|+.+.+.|| ..++++++.|+..+|.+||.+|++ .++|.||.+|+||.+++|+.+..+ .|||+|++
T Consensus 372 dh~kLFeLIl~ed~kFP---r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqV 448 (516)
T KOG0690|consen 372 DHEKLFELILMEDLKFP---RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQV 448 (516)
T ss_pred chhHHHHHHHhhhccCC---ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCc
Confidence 99999999999999988 799999999999999999999999 468999999999999999998766 89999999
Q ss_pred CCCCCccccccccccCCCCCCCCC
Q 001360 994 ESVDDTSYFLSRFSQISSGLPDDQ 1017 (1092)
Q Consensus 994 ~s~~Dts~Fds~fs~~~s~l~~~d 1017 (1092)
.+..|+.|||.+|+.++.++.+-+
T Consensus 449 tSetDTryFD~EFT~q~v~lTPP~ 472 (516)
T KOG0690|consen 449 TSETDTRYFDEEFTSQPVTLTPPD 472 (516)
T ss_pred ccccchhhhhhhhhcceeEecCCC
Confidence 999999999999999988876544
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-60 Score=541.52 Aligned_cols=320 Identities=45% Similarity=0.746 Sum_probs=277.8
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
.++...-|..++.||-|+||+|.+++..+|...||||.|+|.+++.++++.++..|++||...+++|||+||++|++.++
T Consensus 624 aKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 624 AKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred hhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 34566779999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+|+||+|++||||+.+|.+.+.|+|+.++||++++.+||+++|++|+|||||||+|||||.+|||||+|||||+-+. .
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR--W 781 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR--W 781 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce--e
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998532 1
Q ss_pred ccc--CCCCCCCCCCCCCCCCCcc---------------cccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhH
Q 001360 842 TID--LSGPETDGIMPSDAHYPEY---------------QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (1092)
Q Consensus 842 s~d--ls~~~t~g~~p~~~~~~~~---------------~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVIL 904 (1092)
+.+ ..+........+-..+++| .+..+..+.+.+||+.|+|||++...+|+..|||||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 111 1111000000000001111 12234456788999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchh
Q 001360 905 FEFITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982 (1092)
Q Consensus 905 YEMLTGk~PF~~~s~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L 982 (1092)
|||+.|++||...++.++..+|++.. +.+| ....+|.++.+||.++++ ++++|+|.++++++++||||++|||..+
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~-~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfssl 939 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWRNFLHIP-YQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSL 939 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehhhccccc-cccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhh
Confidence 99999999999999988887777643 3343 236899999999999888 9999999999999999999999999999
Q ss_pred hhccCCccCCCCCCCCccccccc
Q 001360 983 ALQKAVFVPQPESVDDTSYFLSR 1005 (1092)
Q Consensus 983 ~~~~pPfiP~~~s~~Dts~Fds~ 1005 (1092)
+.+++||+|.+..+.|++||+..
T Consensus 940 Rkq~ApYIP~ItHptDTSNFdpv 962 (1034)
T KOG0608|consen 940 RKQRAPYIPRITHPTDTSNFDPV 962 (1034)
T ss_pred hhccCCcCccccCCCccccCCcC
Confidence 99999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-58 Score=527.19 Aligned_cols=287 Identities=39% Similarity=0.751 Sum_probs=260.9
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~ 760 (1092)
++....||.+.+.||.|+|++|++|+.+.+++.||||++.|..+.+++.+..+..|.++|.+| .||.||+||..|+|+.
T Consensus 68 ~kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 68 EKKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred ccCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 367889999999999999999999999999999999999999999999999999999999999 7999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|+|+||+++|+|.++|.+.|.|++..+|+|++||+.||+|||++|||||||||+|||||.+||+||+|||-|+.+...
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999975321
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.... .+ +...........++|||..|++||+|.....++.+|+|+||||||.|+.|.+||.+.+.-
T Consensus 228 ~~~~-------------~~-~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 228 QKSQ-------------EN-PVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred hccc-------------cC-ccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 1100 00 000000111246799999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCC
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAV 988 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pP 988 (1092)
.++++|+.-.+.|| ..+++.++|||+++|..||.+|+| +.+|++||||.+|+|+.|..+.||
T Consensus 294 liFqkI~~l~y~fp---~~fp~~a~dLv~KLLv~dp~~Rlt---~~qIk~HpFF~~Vdw~nlw~~~PP 355 (604)
T KOG0592|consen 294 LIFQKIQALDYEFP---EGFPEDARDLIKKLLVRDPSDRLT---SQQIKAHPFFEGVDWENLWQQTPP 355 (604)
T ss_pred HHHHHHHHhcccCC---CCCCHHHHHHHHHHHccCcccccc---HHHHhhCcccccCChhhhhhcCCC
Confidence 99999999999988 799999999999999999999999 789999999999999999988543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-59 Score=518.67 Aligned_cols=335 Identities=35% Similarity=0.700 Sum_probs=305.6
Q ss_pred CccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeec
Q 001360 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFT 757 (1092)
Q Consensus 679 s~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfq 757 (1092)
+....+...+|.++.+||+|+||+|.++..+.|.+.||||+++|..+...++++..+.|.++|.... -|++|+|+.+|+
T Consensus 341 ~~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 341 SKRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred CcccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence 3445678899999999999999999999999999999999999988888888999999999998775 789999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
+-+.+|+||||+.||+|+.+++..+.|.|..+.+|+++|+-||-+||++|||+||||.+|||||.+|||||+|||+++..
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
. .....+.++||||.|||||++..++|+.++||||+||+|||||.|++||.++
T Consensus 501 i---------------------------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 501 I---------------------------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred c---------------------------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 2 1244567899999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCC
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 993 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~ 993 (1092)
+..++++.|......+| ..+|.++.++++.+|.+.|.+|++. .+-.+|..||||+.|||+.+... +|||.|.+
T Consensus 554 DE~elF~aI~ehnvsyP---KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 554 DEDELFQAIMEHNVSYP---KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred CHHHHHHHHHHccCcCc---ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcc
Confidence 99999999999998887 7999999999999999999999994 46789999999999999999887 89999999
Q ss_pred CCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCcchhhccCCccccCCCCCCCcccCceeecchhhhcc
Q 001360 994 ESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASI 1069 (1092)
Q Consensus 994 ~s~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~ss~~~~~em~e~~~f~e~~~~~~d~~Fig~tyk~~~~~~~~ 1069 (1092)
..-.+.+||+..|+.....+++.|.-++.. .++ -.|+||||.|.+.+..+
T Consensus 631 k~~r~~eNFD~~Ft~~~~~lTPpD~~v~~n----------------------ldq----~eF~gFsfvNpefv~~~ 680 (683)
T KOG0696|consen 631 KCGRDAENFDKFFTREPTDLTPPDKLVMMN----------------------LDQ----SEFEGFSFVNPEFVKPI 680 (683)
T ss_pred ccCCchhhhhHHHhcCCCCCCCchHHHHhc----------------------Cch----hhcCceeeeChhhcCCC
Confidence 999999999999999988887766443321 111 23899999999998765
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-59 Score=515.97 Aligned_cols=315 Identities=40% Similarity=0.714 Sum_probs=272.3
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
.+.++.|++++.||+|.-|+||+|+.+.++..+|||++.|..+..++...++..|.+||+.++||+++.||..|+.++..
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 46678999999999999999999999999999999999999998889999999999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
|+|||||+||+|..+++++ ..|++..++||+++++.||+|||-+|||+|||||+||||-++|||.|+||.|+......
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999999876 47999999999999999999999999999999999999999999999999998754221
Q ss_pred ccccCC-CCC------------CCCCCCC---C-C-----------CCCcc-cccCcCCccCccCCCCCCChhhhcCCCC
Q 001360 841 NTIDLS-GPE------------TDGIMPS---D-A-----------HYPEY-QQTDNRNRHSAVGTPDYLAPEILLGTEH 891 (1092)
Q Consensus 841 ~s~dls-~~~------------t~g~~p~---~-~-----------~~~~~-~~~~~~~~~s~vGTp~YmAPEVL~g~~Y 891 (1092)
.+.-.+ .+. ...+.+. . . ..++. .........++|||-.|+|||++.|.++
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 111000 000 0001110 0 0 00111 1223356778999999999999999999
Q ss_pred CccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC-cccHHHHHc
Q 001360 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKA 970 (1092)
Q Consensus 892 t~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpS-a~ga~EIL~ 970 (1092)
+.++|||+|||+|||||+|..||.+.+..+++.+|+...+.||..+ .++..++|||+++|.+||.+|++ ..||.||++
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 9999999999999999999999999999999999999999999755 78999999999999999999999 568999999
Q ss_pred CCCCCCCCcchhhhccCCccCCCCCCCC
Q 001360 971 HPFFKGVNWDSLALQKAVFVPQPESVDD 998 (1092)
Q Consensus 971 HPFFkgIdWd~L~~~~pPfiP~~~s~~D 998 (1092)
||||+|++|.-++...||++|.+.....
T Consensus 392 HpFF~gVnWaLir~~~PP~iP~~~d~~~ 419 (459)
T KOG0610|consen 392 HPFFEGVNWALIRCARPPEIPKPVDGGL 419 (459)
T ss_pred CccccCCChhheeccCCCcCCCccccCc
Confidence 9999999999777779999998865433
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-55 Score=483.43 Aligned_cols=351 Identities=40% Similarity=0.737 Sum_probs=280.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765555566778899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998753211100000
Q ss_pred CCCCCC-----------CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC
Q 001360 847 GPETDG-----------IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 847 ~~~t~g-----------~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
...... ..........|.........+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 000000 000000111122222223456789999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCCccCCC
Q 001360 916 AESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQP 993 (1092)
Q Consensus 916 ~~s~~ei~~kIl~~~l--~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~ 993 (1092)
+.++.+.+..+..... .+|. ...+++++++||.+||. +|.+|++...+.+++.||||++++|+.+....+++.|..
T Consensus 241 ~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 318 (364)
T cd05599 241 SDNPQETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPEL 318 (364)
T ss_pred CCCHHHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCCC
Confidence 9999888888876543 3332 23579999999999997 999999877799999999999999999888889999999
Q ss_pred CCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCcchhhccCCccccCCCCCCCcccCceeecch
Q 001360 994 ESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLS 1064 (1092)
Q Consensus 994 ~s~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~ss~~~~~em~e~~~f~e~~~~~~d~~Fig~tyk~~~ 1064 (1092)
.+..|.++|+.+ .......+... . .. .-....+||.|+||||++|+
T Consensus 319 ~~~~~~~~~~~~-~~~~~~~~~~~-----------~--~~-----------~~~~~~~~~~~~~~~~~~~~ 364 (364)
T cd05599 319 KSITDTSNFDDF-EEIDLDVPTSP-----------G--PP-----------RGKIKSKDLAFIGYTYKRFE 364 (364)
T ss_pred CCchhhhhcccc-ccccccccCCC-----------c--cc-----------cccccccCCCCCCCeeeCCC
Confidence 888898888753 22221111100 0 00 01123569999999999986
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-55 Score=483.51 Aligned_cols=352 Identities=39% Similarity=0.699 Sum_probs=274.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||+||+|+++.+++.||||++++...........+.+|+.++..++||||+++++.|++...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998766555566778899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999753211100000
Q ss_pred CCCCCCCCCCCCC---------CCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 847 GPETDGIMPSDAH---------YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 847 ~~~t~g~~p~~~~---------~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
.... ...+.+.. ...+...........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.
T Consensus 161 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLN-HSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccc-ccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0000 00010000 0111111222335679999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCCccCCCCC
Q 001360 918 SPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPES 995 (1092)
Q Consensus 918 s~~ei~~kIl~~--~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s 995 (1092)
++.+.+.++... .+.+|. ...+++++++||.+|++ +|.+|++..++.+|++||||++++|+.+...+++..+...+
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~ 317 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKS 317 (363)
T ss_pred CHHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCCCCCCccCCC
Confidence 999999988864 344442 23578999999999886 77777655459999999999999999998776555556667
Q ss_pred CCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCcchhhccCCccccCCCCCCCcccCceeecch
Q 001360 996 VDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLS 1064 (1092)
Q Consensus 996 ~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~ss~~~~~em~e~~~f~e~~~~~~d~~Fig~tyk~~~ 1064 (1092)
..|+++|+...... ...+ .. ..+ . -.+....+.+|.|+||||+.|+
T Consensus 318 ~~~~~~~~~~~~~~-~~~~-~~----------~~~-~----------~~~~~~~~~~~~~~~~~~~~~~ 363 (363)
T cd05628 318 IDDTSNFDEFPDSD-ILKP-TV----------ATS-N----------HPETDYKNKDWVFINYTYKRFE 363 (363)
T ss_pred cchhhccCCCCccc-cccc-cc----------ccc-C----------CcccccCcCCcccCCceeecCC
Confidence 77888876532111 0000 00 000 0 0123446779999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-54 Score=481.58 Aligned_cols=317 Identities=43% Similarity=0.799 Sum_probs=259.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|..++|||||+++++|.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998765555666788999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC-
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL- 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl- 845 (1092)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++..........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999964211000000
Q ss_pred ---CC--CCCC------CC--------CCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHH
Q 001360 846 ---SG--PETD------GI--------MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906 (1092)
Q Consensus 846 ---s~--~~t~------g~--------~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYE 906 (1092)
.. .... .. .........|.........+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 00 0000 00 00000001111111112235789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhh
Q 001360 907 FITGIPPFTAESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 984 (1092)
Q Consensus 907 MLTGk~PF~~~s~~ei~~kIl~~--~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~ 984 (1092)
|++|.+||.+.+..+.+..+... .+.+|. ...++.++++||.+||+ +|.+|++...+.+++.||||++++|+.+..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~ 318 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTIRQ 318 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHcc
Confidence 99999999999888888888763 334442 23588999999999998 888887555699999999999999999988
Q ss_pred ccCCccCCCCCCCCccccccc
Q 001360 985 QKAVFVPQPESVDDTSYFLSR 1005 (1092)
Q Consensus 985 ~~pPfiP~~~s~~Dts~Fds~ 1005 (1092)
..+|+.|......+..+|...
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~ 339 (377)
T cd05629 319 IRAPFIPQLKSITDTSYFPTD 339 (377)
T ss_pred CCCCcccCCCCccccccCCcc
Confidence 889999999888888877654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-54 Score=478.46 Aligned_cols=316 Identities=44% Similarity=0.734 Sum_probs=258.0
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
.|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|+.++|||||++++.|.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999987666566677889999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+............
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999986321100000000
Q ss_pred C------CCCCCC-----CCCCC----C-----CcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001360 848 P------ETDGIM-----PSDAH----Y-----PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (1092)
Q Consensus 848 ~------~t~g~~-----p~~~~----~-----~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEM 907 (1092)
. ...... +.... . ............+.+||+.|+|||++.+..|+.++|||||||+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 0 000000 00000 0 00000111223457899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhh-h
Q 001360 908 ITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA-L 984 (1092)
Q Consensus 908 LTGk~PF~~~s~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~-~ 984 (1092)
++|++||.+.++.+....+.... ..+|. ...+++++.+||.+|+. +|.+|++..++.++++||||++++|.... .
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~ 319 (382)
T cd05625 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPP-QAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFKTIDFSSDLRQ 319 (382)
T ss_pred HhCCCCCCCCCHHHHHHHHHccCCCcCCCC-cccCCHHHHHHHHHHcc-CHhHcCCCCCHHHHhcCCCcCCcChHHHHhc
Confidence 99999999998888887777643 33332 24689999999999864 99999987779999999999999998744 3
Q ss_pred ccCCccCCCCCCCCccccccc
Q 001360 985 QKAVFVPQPESVDDTSYFLSR 1005 (1092)
Q Consensus 985 ~~pPfiP~~~s~~Dts~Fds~ 1005 (1092)
..+|+.|....+.|+++|+..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~ 340 (382)
T cd05625 320 QSAPYIPKITHPTDTSNFDPV 340 (382)
T ss_pred CCCCccCcCCCcchhhhcCCC
Confidence 478999999999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-55 Score=502.82 Aligned_cols=256 Identities=35% Similarity=0.650 Sum_probs=245.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
..|+..+.||+|||++||.++...+|+.||+|++.|..+.+..+.+.+.+|++|.+.++|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
|+|..|+|+.++++...++|.++++|+.||+.||.|||+++|||||||..||+|+++.+|||+|||||....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le-------- 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE-------- 169 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec--------
Confidence 999999999999999999999999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
.+..+..+.||||.|+||||+...+++..+||||+||+||-||+|+|||...+-.+++.+|
T Consensus 170 -------------------~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I 230 (592)
T KOG0575|consen 170 -------------------YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI 230 (592)
T ss_pred -------------------CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH
Confidence 2345667899999999999999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
....+.+| ..+|.+|+|||.+||..||.+||+ +.+|+.|+||+
T Consensus 231 k~~~Y~~P---~~ls~~A~dLI~~lL~~~P~~Rps---l~~vL~h~Ff~ 273 (592)
T KOG0575|consen 231 KLNEYSMP---SHLSAEAKDLIRKLLRPNPSERPS---LDEVLDHPFFK 273 (592)
T ss_pred HhcCcccc---cccCHHHHHHHHHHhcCCcccCCC---HHHHhcCHhhh
Confidence 99999988 699999999999999999999999 88999999993
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-54 Score=472.44 Aligned_cols=350 Identities=39% Similarity=0.720 Sum_probs=275.4
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||+||+|+.+.+|+.||||++++...........+.+|+.++..++||||+++++.|++.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998766555666788999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||||+.+|++||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998743211100000
Q ss_pred CC----CCCC----CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 847 GP----ETDG----IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 847 ~~----~t~g----~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
.. .... .+........+.........+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00 0000 000000001111222233456799999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCCccCCCCCC
Q 001360 919 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESV 996 (1092)
Q Consensus 919 ~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~ 996 (1092)
+...+.++.... +.+|. ...++.++++||.+|+. ||.+|++..++.++++||||++++|..+....++..+...+.
T Consensus 241 ~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~~ 318 (360)
T cd05627 241 PQETYRKVMNWKETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKSI 318 (360)
T ss_pred HHHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCCCCccCCCc
Confidence 999988887643 33442 13479999999999875 999999977899999999999999999877755544556677
Q ss_pred CCccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCcchhhccCCccccCCCCCCCcccCceeecch
Q 001360 997 DDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLS 1064 (1092)
Q Consensus 997 ~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~ss~~~~~em~e~~~f~e~~~~~~d~~Fig~tyk~~~ 1064 (1092)
.|.++|+.. +. ++..... .. -.+-....++|.|-||+|++|+
T Consensus 319 ~~~~~~~~~-~~-------~~~~~~~-----~~-------------~~~~~~~~~~~~~~~~~~~~~~ 360 (360)
T cd05627 319 DDTSNFDEF-PE-------SDILQPA-----EN-------------TIEPDYKSKDWVFLNYTYKRFE 360 (360)
T ss_pred chhhhcCCC-Cc-------ccccCCC-----cc-------------ccccccCcCCcccCCceeecCC
Confidence 888887542 11 1100000 00 0022345679999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-55 Score=487.11 Aligned_cols=266 Identities=36% Similarity=0.609 Sum_probs=237.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc----hhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR----KNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~k----k~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
...+.|.+.+.||+|+||.|.+|..+.||+.||||++++..... ......+.+|++||++++|||||+++++|...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 45567888999999999999999999999999999998865443 22345578999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC---CcEEEEecCCccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKI 836 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n---G~VKLsDFGLAk~ 836 (1092)
+..|||||||.||+|++.+...+.+.+...+.|++|++.||.|||++||+||||||+|||+..+ -.+||+|||+|++
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999999999999999999999999999999999999999999999999999876 7899999999996
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC---CccceeechhhhHHHHHhCCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y---t~ksDVWSLGVILYEMLTGk~P 913 (1092)
.. ......+.||||.|.|||++.+.++ ..++|+|||||+||-+|+|++|
T Consensus 329 ~g----------------------------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 329 SG----------------------------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred cc----------------------------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 31 1234568999999999999998764 4588999999999999999999
Q ss_pred CCCCChHH-HHHHHhhcCCCC-CCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcc
Q 001360 914 FTAESPEI-IFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 914 F~~~s~~e-i~~kIl~~~l~f-P~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd 980 (1092)
|.+..... +.+.|..+.+.| |.....+|.++.+||.+||..||++||+ +.|+|+||||+.+.-.
T Consensus 381 FS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s---~~eaL~hpW~~~~~~~ 446 (475)
T KOG0615|consen 381 FSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPS---ADEALNHPWFKDAPCL 446 (475)
T ss_pred cccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcC---HHHHhcChhhhccccc
Confidence 99877665 899999998876 3456789999999999999999999999 8899999999977543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-53 Score=470.23 Aligned_cols=315 Identities=43% Similarity=0.685 Sum_probs=253.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
..|++++.||+|+||+||+|+++.+++.||||++++...........+.+|+.+|..++|||||+++++|.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998876666677888999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++||+|.+++.+.+.+++..++.+++||+.||.|||+.||+||||||+||||+.+|++||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998642110000000
Q ss_pred CCC----CCCCCCC----C------------CCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHH
Q 001360 847 GPE----TDGIMPS----D------------AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906 (1092)
Q Consensus 847 ~~~----t~g~~p~----~------------~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYE 906 (1092)
... .....+. . ...............+.+||+.|||||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 000 0000000 0 0000000011112346789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHHHhccCCcC--CCCCcccHHHHHcCCCCCCCCcchh
Q 001360 907 FITGIPPFTAESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPN--QRLGANGAAEVKAHPFFKGVNWDSL 982 (1092)
Q Consensus 907 MLTGk~PF~~~s~~ei~~kIl~~--~l~fP~ip~~lS~eakDLI~kcL~kDP~--KRpSa~ga~EIL~HPFFkgIdWd~L 982 (1092)
|++|.+||...++.+....+... ...+|. ...+++++++||.+||+.+++ .|++ +.++++||||++++|...
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~~---~~~~l~hp~f~~~~~~~~ 316 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPP-QVKLSPEAVDLITKLCCSAEERLGRNG---ADDIKAHPFFSEVDFSSD 316 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCC-CCCCCHHHHHHHHHHccCcccccCCCC---HHHHhcCcccCCCChhHH
Confidence 99999999998887777777643 333332 236899999999997765444 4888 889999999999999875
Q ss_pred hh-ccCCccCCCCCCCCccccccc
Q 001360 983 AL-QKAVFVPQPESVDDTSYFLSR 1005 (1092)
Q Consensus 983 ~~-~~pPfiP~~~s~~Dts~Fds~ 1005 (1092)
.. .++|+.|....+.++++|+..
T Consensus 317 ~~~~~~~~~p~~~~~~~~~~~~~~ 340 (381)
T cd05626 317 IRTQPAPYVPKISHPMDTSNFDPV 340 (381)
T ss_pred hhcCCCCccCcCCCcchhhhcCCC
Confidence 43 477899999999999988653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-55 Score=472.31 Aligned_cols=309 Identities=37% Similarity=0.730 Sum_probs=282.7
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCe
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~ 761 (1092)
...+++|+++++||+|+|++|.+++++.|.+.||||+++|.-+...+++.-+..|..+..+. +||++|.|+.+|+++..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 35678999999999999999999999999999999999987776777788899999998876 59999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+++|.||++||+|+.++++...++++.+++|.++|+.||.|||++|||+||||.+|+|||..||+||+|+|+|+.+.
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l--- 402 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--- 402 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999642
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC-----
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA----- 916 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~----- 916 (1092)
.+...+.++||||.|+|||++.+..|++++|||+|||+||||+.|+.||.-
T Consensus 403 ------------------------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n 458 (593)
T KOG0695|consen 403 ------------------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN 458 (593)
T ss_pred ------------------------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC
Confidence 234556789999999999999999999999999999999999999999952
Q ss_pred ---CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc---ccHHHHHcCCCCCCCCcchhhhc--cCC
Q 001360 917 ---ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAV 988 (1092)
Q Consensus 917 ---~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa---~ga~EIL~HPFFkgIdWd~L~~~--~pP 988 (1092)
.+...+++-|+..++.+| ..+|-.+..+++..|.+||.+|++. -+..+++.||||+.++|+.+.++ .||
T Consensus 459 ~d~ntedylfqvilekqirip---rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~pp 535 (593)
T KOG0695|consen 459 PDMNTEDYLFQVILEKQIRIP---RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPP 535 (593)
T ss_pred cccchhHHHHHHHhhhccccc---ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCC
Confidence 234567888888888877 7899999999999999999999982 37899999999999999999877 799
Q ss_pred ccCCCCCCCCccccccccccCCCCCCCCCCCCC
Q 001360 989 FVPQPESVDDTSYFLSRFSQISSGLPDDQNGSY 1021 (1092)
Q Consensus 989 fiP~~~s~~Dts~Fds~fs~~~s~l~~~d~~s~ 1021 (1092)
|.|...+..+..+|+..|+...+++.+++.+..
T Consensus 536 f~p~i~~d~~l~~fd~qft~e~~qltpdd~d~i 568 (593)
T KOG0695|consen 536 FQPQITDDYGLDNFDTQFTSEPVQLTPDDEDAI 568 (593)
T ss_pred CCCccccccCccccccccccCCcccCCCCHHHH
Confidence 999999999999999999999999988776544
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-53 Score=459.03 Aligned_cols=290 Identities=42% Similarity=0.764 Sum_probs=257.8
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GG 772 (1092)
+.||+|+||.||+|+++.+|+.||||++++...........+.+|+.+|..++||||++++++|...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555566778899999999999999999999999999999999999999
Q ss_pred cHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 001360 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (1092)
Q Consensus 773 SL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g 852 (1092)
+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~------------- 147 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS------------- 147 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-------------
Confidence 9999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCC
Q 001360 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932 (1092)
Q Consensus 853 ~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~ 932 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||...+...++..+......
T Consensus 148 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~ 213 (323)
T cd05571 148 --------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213 (323)
T ss_pred --------------CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 011223568999999999999999999999999999999999999999999988888888887766
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 001360 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1008 (1092)
Q Consensus 933 fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1008 (1092)
+| ..++.++.+||.+||.+||++||+. ..+.++++||||.+++|..+... .+|+.|...+..|+.+|+..++.
T Consensus 214 ~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (323)
T cd05571 214 FP---RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTA 290 (323)
T ss_pred CC---CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccccc
Confidence 65 6899999999999999999999952 24899999999999999988755 67889998888999999877666
Q ss_pred CCCC
Q 001360 1009 ISSG 1012 (1092)
Q Consensus 1009 ~~s~ 1012 (1092)
....
T Consensus 291 ~~~~ 294 (323)
T cd05571 291 QSIT 294 (323)
T ss_pred CCcc
Confidence 5433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=451.44 Aligned_cols=289 Identities=42% Similarity=0.809 Sum_probs=258.1
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
....++|++.+.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.+|..++||||+++++++.+.+.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 34578999999999999999999999999999999999876555555677899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~---- 169 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---- 169 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC----
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
....+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.++..+
T Consensus 170 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 223 (329)
T PTZ00263 170 --------------------------DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223 (329)
T ss_pred --------------------------CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH
Confidence 011245799999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD 998 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~D 998 (1092)
+..+..+.+.+| ..++..+++||.+||+.||.+|++. ..+.+++.||||++++|..+..+ .+|+.+......+
T Consensus 224 ~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (329)
T PTZ00263 224 YEKILAGRLKFP---NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGD 300 (329)
T ss_pred HHHHhcCCcCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCccc
Confidence 999988877665 6789999999999999999999983 45899999999999999988655 4566666666667
Q ss_pred cccccc
Q 001360 999 TSYFLS 1004 (1092)
Q Consensus 999 ts~Fds 1004 (1092)
..+|..
T Consensus 301 ~~~~~~ 306 (329)
T PTZ00263 301 TSNFEK 306 (329)
T ss_pred chhccC
Confidence 777654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-52 Score=450.34 Aligned_cols=315 Identities=46% Similarity=0.809 Sum_probs=260.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||+||+|++..+|+.||||++++...........+.+|+.+|..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998766555566788999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998753211100000
Q ss_pred --CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 847 --GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 847 --~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
........+...................+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 000000000000000001111223345789999999999999999999999999999999999999999999888888
Q ss_pred HHhh--cCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCCcccc
Q 001360 925 NILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYF 1002 (1092)
Q Consensus 925 kIl~--~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~Dts~F 1002 (1092)
++.. ....+|.. ..+++++.+||.+||. ||.+|++ .+.++++||||++++|+......+|++|...+..+..+|
T Consensus 241 ~i~~~~~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~--s~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (350)
T cd05573 241 KIINWKESLRFPPD-PPVSPEAIDLICRLLC-DPEDRLG--SFEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDTSNF 316 (350)
T ss_pred HHhccCCcccCCCC-CCCCHHHHHHHHHHcc-ChhhcCC--CHHHHhcCCCcCCCCHHHHhhCCCCcCCCCCCchhhhhc
Confidence 8887 44555532 3379999999999998 9999998 377999999999999999887789999999888888887
Q ss_pred ccc
Q 001360 1003 LSR 1005 (1092)
Q Consensus 1003 ds~ 1005 (1092)
+..
T Consensus 317 ~~~ 319 (350)
T cd05573 317 DDF 319 (350)
T ss_pred CCC
Confidence 663
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-54 Score=485.40 Aligned_cols=294 Identities=35% Similarity=0.692 Sum_probs=276.3
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
...+.+++.+.+||-||||.|=+++.+.....+|+|+++|..+....+.+++..|.+||..+++|+||+||-.|.+..++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 45678999999999999999999998876667999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||+||-|-||+|++.|+..+.|++..++||++.++.|++|||.+|||+|||||+|+|||.+|.+||.|||+|+..
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki----- 570 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI----- 570 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999963
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
....+++++||||.|.|||++++++++.++|+||||+++||||+|.|||.+.++..+
T Consensus 571 -----------------------~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt 627 (732)
T KOG0614|consen 571 -----------------------GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT 627 (732)
T ss_pred -----------------------ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence 235677899999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC--cccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD 998 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpS--a~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~D 998 (1092)
|..|+.+--.+ .+|..++..+.+||++++..+|.+|++ .+++.||+.|.||.++||+.|..+ +||++|.+.++.|
T Consensus 628 Yn~ILkGid~i-~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD 706 (732)
T KOG0614|consen 628 YNLILKGIDKI-EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTD 706 (732)
T ss_pred HHHHHhhhhhh-hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCccc
Confidence 99999864322 234899999999999999999999999 689999999999999999999887 8999999999999
Q ss_pred ccccccc
Q 001360 999 TSYFLSR 1005 (1092)
Q Consensus 999 ts~Fds~ 1005 (1092)
++||+.+
T Consensus 707 ~s~Fd~~ 713 (732)
T KOG0614|consen 707 VSNFDNF 713 (732)
T ss_pred chhccCC
Confidence 9999986
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=444.47 Aligned_cols=291 Identities=36% Similarity=0.742 Sum_probs=256.1
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LYLVM 766 (1092)
+|++++.||+|+||+||+|+++.+++.||||++++...........+..|..++..+ .||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 689999999999999999999999999999999875544455566788888888877 4899999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~------- 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW------- 153 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...++..+
T Consensus 154 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i 213 (323)
T cd05616 154 --------------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213 (323)
T ss_pred --------------------CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011223467999999999999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccc
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 1002 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~F 1002 (1092)
......+| ..++.++.+||.+||++||.+|++. ....+++.||||+.++|+.+..+ .+|+.|... ..|..+|
T Consensus 214 ~~~~~~~p---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 289 (323)
T cd05616 214 MEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKAC-GRDAENF 289 (323)
T ss_pred HhCCCCCC---CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC-Cchhhhc
Confidence 88877665 6799999999999999999999984 35789999999999999998765 678888764 4777777
Q ss_pred ccccccC
Q 001360 1003 LSRFSQI 1009 (1092)
Q Consensus 1003 ds~fs~~ 1009 (1092)
+..|...
T Consensus 290 ~~~~~~~ 296 (323)
T cd05616 290 DKFFTRH 296 (323)
T ss_pred CchhccC
Confidence 7766644
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=444.68 Aligned_cols=292 Identities=36% Similarity=0.751 Sum_probs=256.6
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccCCeeEEEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H-PNIVkL~~sfqde~~LYLVM 766 (1092)
+|++++.||+|+||.||+|+++.+++.||||++++...........+..|..++..+.| ++|++++++|...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999987655455567788999999999976 56889999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~------- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF------- 153 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++..+
T Consensus 154 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (324)
T cd05587 154 --------------------GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213 (324)
T ss_pred --------------------CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011123467999999999999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccc
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 1002 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~F 1002 (1092)
......+| ..++.++.+||.+||.+||.+|++. ....++++||||+.++|..+... .+++.|......+.++|
T Consensus 214 ~~~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (324)
T cd05587 214 MEHNVSYP---KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENF 290 (324)
T ss_pred HcCCCCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchhhhc
Confidence 88776655 6789999999999999999999984 34589999999999999988655 57788888777888888
Q ss_pred ccccccC
Q 001360 1003 LSRFSQI 1009 (1092)
Q Consensus 1003 ds~fs~~ 1009 (1092)
+..+...
T Consensus 291 ~~~~~~~ 297 (324)
T cd05587 291 DKFFTRE 297 (324)
T ss_pred CcccccC
Confidence 7754333
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=441.73 Aligned_cols=285 Identities=42% Similarity=0.791 Sum_probs=255.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||+|+||.||+|.++.+|+.||+|++.............+.+|+.+|+.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998655444456678899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~-------- 152 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------- 152 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc--------
Confidence 999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....+..+
T Consensus 153 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i 210 (291)
T cd05612 153 ----------------------DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210 (291)
T ss_pred ----------------------CCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0112457999999999999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC--cccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccc
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 1002 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpS--a~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~F 1002 (1092)
..+...+| ..++..+++||++||..||.+|++ ...+.+++.||||+.++|..+... .|++.|......|+.+|
T Consensus 211 ~~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 287 (291)
T cd05612 211 LAGKLEFP---RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNF 287 (291)
T ss_pred HhCCcCCC---ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCccccccc
Confidence 88877766 678999999999999999999996 235889999999999999987655 67778888888888887
Q ss_pred cc
Q 001360 1003 LS 1004 (1092)
Q Consensus 1003 ds 1004 (1092)
++
T Consensus 288 ~~ 289 (291)
T cd05612 288 DD 289 (291)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=445.19 Aligned_cols=287 Identities=40% Similarity=0.783 Sum_probs=250.2
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieI-L~~L~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||+|+||+||+|+++.+|+.||+|++.+...........+..|..+ ++.++||||+++++.|...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999987554444555667777664 5779999999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~------------ 148 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE------------ 148 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc------------
Confidence 99999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l 931 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 213 (323)
T cd05575 149 ---------------HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213 (323)
T ss_pred ---------------CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 01122346799999999999999999999999999999999999999999999999999888766
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCc-ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 001360 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1008 (1092)
Q Consensus 932 ~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa-~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1008 (1092)
.++ ..++.++.+||.+||++||.+||++ ....+++.||||..++|..+... .+|+.|......+...|+..+.+
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (323)
T cd05575 214 RLK---PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTE 290 (323)
T ss_pred CCC---CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhcCccccc
Confidence 544 6789999999999999999999995 35789999999999999988655 67888888888888887765554
Q ss_pred C
Q 001360 1009 I 1009 (1092)
Q Consensus 1009 ~ 1009 (1092)
.
T Consensus 291 ~ 291 (323)
T cd05575 291 E 291 (323)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-51 Score=441.63 Aligned_cols=284 Identities=41% Similarity=0.819 Sum_probs=255.1
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001360 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1092)
Q Consensus 695 LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL 774 (1092)
||+|+||+||+|+++.+++.||+|++++...........+.+|+.+|.+++||||++++++|...+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999876555566678889999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 001360 775 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854 (1092)
Q Consensus 775 ~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~ 854 (1092)
.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--------------- 145 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--------------- 145 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc---------------
Confidence 99999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCC
Q 001360 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934 (1092)
Q Consensus 855 p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP 934 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++..+......+|
T Consensus 146 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 213 (312)
T cd05585 146 ------------DDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP 213 (312)
T ss_pred ------------CCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC
Confidence 01112346899999999999999999999999999999999999999999999999999988876665
Q ss_pred CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 001360 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1008 (1092)
Q Consensus 935 ~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1008 (1092)
..+++++++||.+||..||.+||+...+.+++.||||+..+|..+... .+++.|...+..++++|+..++.
T Consensus 214 ---~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (312)
T cd05585 214 ---DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTR 286 (312)
T ss_pred ---CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCccccc
Confidence 679999999999999999999999878999999999999999876544 67888888888888888876554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-51 Score=444.37 Aligned_cols=286 Identities=39% Similarity=0.766 Sum_probs=249.7
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieI-L~~L~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||+|+||+||+|+++.+|+.||+|++.+...........+..|..+ ++.++||||+++++.|...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999987544444555667777664 6779999999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~------------ 148 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA------------ 148 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC------------
Confidence 99999998888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l 931 (1092)
........+||+.|||||++.+..|+.++|||||||++|||++|.+||...+..++++.+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~ 213 (325)
T cd05604 149 ---------------QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL 213 (325)
T ss_pred ---------------CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 01122356799999999999999999999999999999999999999999999999999888765
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCc-ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 001360 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1008 (1092)
Q Consensus 932 ~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa-~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1008 (1092)
.++ ...+.++.+||.+||.+||.+||+. ..+.+++.||||++++|..+... .+|+.|......+.++|+..+..
T Consensus 214 ~~~---~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (325)
T cd05604 214 VLR---PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTE 290 (325)
T ss_pred cCC---CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCCcccc
Confidence 544 5689999999999999999999995 46789999999999999987655 67888888888888888765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-51 Score=449.55 Aligned_cols=290 Identities=40% Similarity=0.772 Sum_probs=258.1
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TG-k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
......++|++.+.||+|+||.||+|+++.++ ..||+|++.+...........+.+|+.+|..++|||||++++++.+.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 34567889999999999999999999976655 68999999876555556677899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~- 182 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD- 182 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC-
Confidence 9999999999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
....+.+||+.|||||++.+..++.++|||||||++|||++|.+||.+.++
T Consensus 183 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 183 -----------------------------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred -----------------------------CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 012346799999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCC
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES 995 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s 995 (1092)
..++..+..+...+| ..+++++++||++||..||.+|++. ..+.++++||||++++|..+... .+|+.|....
T Consensus 234 ~~~~~~i~~~~~~~p---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 234 LLIYQKILEGIIYFP---KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred HHHHHHHhcCCCCCC---CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 999999988876665 6789999999999999999999852 35899999999999999987655 6788888877
Q ss_pred CCCccccc
Q 001360 996 VDDTSYFL 1003 (1092)
Q Consensus 996 ~~Dts~Fd 1003 (1092)
..+.++|.
T Consensus 311 ~~~~~~~~ 318 (340)
T PTZ00426 311 VFDSSNFE 318 (340)
T ss_pred CcchhhcC
Confidence 77766664
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-51 Score=444.79 Aligned_cols=287 Identities=43% Similarity=0.789 Sum_probs=254.6
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GG 772 (1092)
+.||+|+||.||+++.+.+|+.||+|++++...........+.+|+.+|+.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555566788899999999999999999999999999999999999999
Q ss_pred cHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 001360 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (1092)
Q Consensus 773 SL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g 852 (1092)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~------------- 147 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT------------- 147 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC-------------
Confidence 9999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCC
Q 001360 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932 (1092)
Q Consensus 853 ~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~ 932 (1092)
........+||+.|+|||++.+..++.++|||||||++|||++|..||...+...+...+......
T Consensus 148 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ 213 (328)
T cd05593 148 --------------DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213 (328)
T ss_pred --------------cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCcc
Confidence 011123467999999999999999999999999999999999999999998888888888777666
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 001360 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1008 (1092)
Q Consensus 933 fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1008 (1092)
+| ..++.++.+||.+||.+||.+|++. ..+.++++||||.+++|..+... .+|+.|...+..+..+|+..|+.
T Consensus 214 ~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (328)
T cd05593 214 FP---RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTA 290 (328)
T ss_pred CC---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCccccc
Confidence 55 6899999999999999999999852 35899999999999999987655 67888888888888888876655
Q ss_pred C
Q 001360 1009 I 1009 (1092)
Q Consensus 1009 ~ 1009 (1092)
.
T Consensus 291 ~ 291 (328)
T cd05593 291 Q 291 (328)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=448.83 Aligned_cols=316 Identities=46% Similarity=0.761 Sum_probs=254.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||+||+|+.+.+|+.||+|++.+...........+.+|+.+|..++||||+++++.|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765555556778899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|............
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998632100000000
Q ss_pred CC----CCCCCCCCCC-------CCC-----cccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC
Q 001360 847 GP----ETDGIMPSDA-------HYP-----EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910 (1092)
Q Consensus 847 ~~----~t~g~~p~~~-------~~~-----~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTG 910 (1092)
.. ......+... ... .............+||+.|||||++.+..|+.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00 0000000000 000 0000011122356899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhh-hccC
Q 001360 911 IPPFTAESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA-LQKA 987 (1092)
Q Consensus 911 k~PF~~~s~~ei~~kIl~~~l--~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~-~~~p 987 (1092)
++||.+.++.+....+..... .+|. ...++.++.+||.+|+. +|.+|++...+.++++||||++++|..+. ...+
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~l~~-~p~~R~~~~t~~ell~h~~~~~~~~~~~~~~~~~ 318 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLHIPS-QAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKA 318 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccccCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhCCCCcCCCCHHHHhhcCCC
Confidence 999999988887777765432 2231 24689999999999875 99999965559999999999999999885 3477
Q ss_pred CccCCCCCCCCcccccc
Q 001360 988 VFVPQPESVDDTSYFLS 1004 (1092)
Q Consensus 988 PfiP~~~s~~Dts~Fds 1004 (1092)
|+.|....+.++++|+.
T Consensus 319 ~~~~~~~~~~~~~~~~~ 335 (376)
T cd05598 319 PYIPKITHPTDTSNFDP 335 (376)
T ss_pred CCCCcCCCcchhhhcCC
Confidence 88998888888888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-51 Score=441.69 Aligned_cols=287 Identities=41% Similarity=0.745 Sum_probs=251.2
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||+|+||+||+|+.+.+|+.||+|++++...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544556677889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~----- 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN----- 155 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC-----
Confidence 999999999999876 67999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc------CCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL------GTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~------g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
........+||+.|+|||++. +..|+.++|||||||++|||++|..||...+.
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 156 ---------------------KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred ---------------------CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 001123357999999999997 45678999999999999999999999999888
Q ss_pred HHHHHHHhhcC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCCccCCCCCCC
Q 001360 920 EIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVD 997 (1092)
Q Consensus 920 ~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~ 997 (1092)
...+.+++... ..+|. ...++.++.+||.+||+ ||.+||+ +.++++||||+.++|..+....+++.|......
T Consensus 215 ~~~~~~i~~~~~~~~~~~-~~~~~~~~~~li~~ll~-~p~~R~t---~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (330)
T cd05601 215 AKTYNNIMNFQRFLKFPE-DPKVSSDFLDLIQSLLC-GQKERLG---YEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDD 289 (330)
T ss_pred HHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-ChhhCCC---HHHHhCCCCcCCCCHHHHhhCCCCccCcCCCcc
Confidence 88888887643 33443 23589999999999998 9999999 889999999999999999888888999888888
Q ss_pred Ccccccc
Q 001360 998 DTSYFLS 1004 (1092)
Q Consensus 998 Dts~Fds 1004 (1092)
|.++|..
T Consensus 290 ~~~~~~~ 296 (330)
T cd05601 290 DTSNFDE 296 (330)
T ss_pred hhhhcCC
Confidence 8877754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-51 Score=441.23 Aligned_cols=286 Identities=38% Similarity=0.776 Sum_probs=251.7
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||+|+||+||+|+++.+|+.||+|++++...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999999999999999999876555556677788999999876 799999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~------------ 148 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL------------ 148 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc------------
Confidence 99999998888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l 931 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|++||...+....+..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05591 149 ---------------NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213 (321)
T ss_pred ---------------CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 01112346799999999999999999999999999999999999999999999999999988776
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc----cHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccc
Q 001360 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN----GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSR 1005 (1092)
Q Consensus 932 ~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~----ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~ 1005 (1092)
.+| ..++.++.+||.+||..||.+|++.. .+.++++||||.+++|..+... .++|.|......+..+|++.
T Consensus 214 ~~p---~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (321)
T cd05591 214 LYP---VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQD 290 (321)
T ss_pred CCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhhcCCc
Confidence 655 67899999999999999999999532 4889999999999999988655 57788888777777777765
Q ss_pred ccc
Q 001360 1006 FSQ 1008 (1092)
Q Consensus 1006 fs~ 1008 (1092)
+..
T Consensus 291 ~~~ 293 (321)
T cd05591 291 FTK 293 (321)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-51 Score=443.92 Aligned_cols=292 Identities=41% Similarity=0.748 Sum_probs=257.6
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GG 772 (1092)
+.||+|+||.||+|+.+.+|..||+|++++...........+.+|+.++..++||||++++++|...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998755545556778889999999999999999999999999999999999999
Q ss_pred cHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 001360 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (1092)
Q Consensus 773 SL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g 852 (1092)
+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~------------- 147 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS------------- 147 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC-------------
Confidence 9999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCC
Q 001360 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932 (1092)
Q Consensus 853 ~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~ 932 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+....+..+......
T Consensus 148 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 213 (323)
T cd05595 148 --------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213 (323)
T ss_pred --------------CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Confidence 011123467999999999999999999999999999999999999999999988888888877766
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 001360 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1008 (1092)
Q Consensus 933 fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1008 (1092)
+| ..+++++.+||.+||..||.+|++. ..+.++++||||.+++|..+... .||+.|...+..+..+|+..++.
T Consensus 214 ~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (323)
T cd05595 214 FP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTA 290 (323)
T ss_pred CC---CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCccccc
Confidence 55 6889999999999999999999952 35999999999999999987655 57889999999999998887766
Q ss_pred CCCCCC
Q 001360 1009 ISSGLP 1014 (1092)
Q Consensus 1009 ~~s~l~ 1014 (1092)
.....+
T Consensus 291 ~~~~~~ 296 (323)
T cd05595 291 QSITIT 296 (323)
T ss_pred CCccCC
Confidence 644433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=442.37 Aligned_cols=293 Identities=37% Similarity=0.733 Sum_probs=249.4
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||+|+||.||+|+++.+++.||+|++++...........+..|..++..+ +||||++++++|.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876554455667788999999988 699999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~------------ 148 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR------------ 148 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc------------
Confidence 99999998888999999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC---------ChHHH
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---------SPEII 922 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~---------s~~ei 922 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|+.||... .....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05588 149 ---------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213 (329)
T ss_pred ---------------CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH
Confidence 011223568999999999999999999999999999999999999999632 12335
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc---cHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVD 997 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~---ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~ 997 (1092)
+..+......+| ..++.++.+||.+||..||.+|+++. .+.++++||||..++|+.+... .|++.|......
T Consensus 214 ~~~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
T cd05588 214 FQVILEKQIRIP---RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDR 290 (329)
T ss_pred HHHHHcCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCcc
Confidence 556666655544 68899999999999999999999852 4889999999999999988654 567788887777
Q ss_pred CccccccccccCCCCCCC
Q 001360 998 DTSYFLSRFSQISSGLPD 1015 (1092)
Q Consensus 998 Dts~Fds~fs~~~s~l~~ 1015 (1092)
+..+|...+.......++
T Consensus 291 ~~~~~~~~~~~~~~~~~p 308 (329)
T cd05588 291 DLDNFDPQFTDEPVQLTP 308 (329)
T ss_pred hhhhcCCccccCccccCC
Confidence 778887766555444443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=440.60 Aligned_cols=285 Identities=43% Similarity=0.802 Sum_probs=253.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||.||+|++..+|+.||+|++++...........+.+|+.+|..++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444456778899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~-------- 152 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-------- 152 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccc--------
Confidence 999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
......+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+..+.+..+
T Consensus 153 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i 210 (333)
T cd05600 153 ----------------------TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210 (333)
T ss_pred ----------------------cccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH
Confidence 0223567999999999999999999999999999999999999999999988888777
Q ss_pred hhcC--CCCCCCC---CCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCCccc
Q 001360 927 LNRK--IPWPCVP---SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSY 1001 (1092)
Q Consensus 927 l~~~--l~fP~ip---~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~Dts~ 1001 (1092)
.... +..|... ..++.++.+||.+||..+|.+|++ +.++++||||++++|..+....||+.|......+..+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s---~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (333)
T cd05600 211 KYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS---LEDIKNHPFFKEVDWNELRELKPPFVPELESEIDTGY 287 (333)
T ss_pred HhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCC---HHHHHhCcccCCCCHHHHhhCCCCCCCCCCCcchhhh
Confidence 6532 2223211 256899999999999999999999 8899999999999999988778899999888877777
Q ss_pred ccc
Q 001360 1002 FLS 1004 (1092)
Q Consensus 1002 Fds 1004 (1092)
|+.
T Consensus 288 ~~~ 290 (333)
T cd05600 288 FDD 290 (333)
T ss_pred ccC
Confidence 754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=441.73 Aligned_cols=287 Identities=39% Similarity=0.780 Sum_probs=254.0
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||+|+||+||+|+++.+++.||+|++++...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999875544555677788999999876 699999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~------------ 148 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF------------ 148 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc------------
Confidence 99999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l 931 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~ 213 (320)
T cd05590 149 ---------------NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213 (320)
T ss_pred ---------------CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC
Confidence 01122346799999999999999999999999999999999999999999999999999988776
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCc---ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccc
Q 001360 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRF 1006 (1092)
Q Consensus 932 ~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa---~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~f 1006 (1092)
.+| ..++.++.+||.+||++||.+||++ .+..++++||||++++|+.+..+ .|||.|...+..|.++|+..+
T Consensus 214 ~~~---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (320)
T cd05590 214 VYP---TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDF 290 (320)
T ss_pred CCC---CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccc
Confidence 655 6789999999999999999999995 34589999999999999987655 688999999999999988754
Q ss_pred ccC
Q 001360 1007 SQI 1009 (1092)
Q Consensus 1007 s~~ 1009 (1092)
...
T Consensus 291 ~~~ 293 (320)
T cd05590 291 IKE 293 (320)
T ss_pred ccC
Confidence 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=439.77 Aligned_cols=292 Identities=38% Similarity=0.727 Sum_probs=249.7
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||+|+||+||+|+.+.+++.||+|++++...........+.+|+.++.++ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555677889999999888 599999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~------------ 148 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG------------ 148 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC-------ChHHHHH
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-------SPEIIFD 924 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~-------s~~ei~~ 924 (1092)
........+||+.|+|||++.+..|+.++|||||||+||||++|..||... ....++.
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 213 (327)
T cd05617 149 ---------------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213 (327)
T ss_pred ---------------CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH
Confidence 011223568999999999999999999999999999999999999999532 2334555
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc---ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCc
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDT 999 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa---~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dt 999 (1092)
.+......+| ..++..+.+||.+||.+||.+|++. .+..+++.||||++++|+.+... .++|.|......+.
T Consensus 214 ~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (327)
T cd05617 214 VILEKPIRIP---RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGL 290 (327)
T ss_pred HHHhCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCCcch
Confidence 6655555544 6789999999999999999999984 35789999999999999988755 67889988888788
Q ss_pred cccccccccCCCCCC
Q 001360 1000 SYFLSRFSQISSGLP 1014 (1092)
Q Consensus 1000 s~Fds~fs~~~s~l~ 1014 (1092)
++|+..+...+....
T Consensus 291 ~~~~~~~~~~~~~~~ 305 (327)
T cd05617 291 ENFDTQFTSEPVQLT 305 (327)
T ss_pred hhcCCccccCcccCC
Confidence 888776554443333
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=440.02 Aligned_cols=293 Identities=37% Similarity=0.733 Sum_probs=248.0
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||+|+||+||+|+.+.+++.||+|++++...........+.+|+.++.++ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876544555667788999998876 799999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~------------ 148 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR------------ 148 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC---------ChHHH
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---------SPEII 922 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~---------s~~ei 922 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||... ....+
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05618 149 ---------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213 (329)
T ss_pred ---------------CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH
Confidence 011223468999999999999999999999999999999999999999521 12345
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc---ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVD 997 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa---~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~ 997 (1092)
...+......+| ..++.++.+||.+||..||.+||++ .++.++++||||++++|+.+... .+++.|......
T Consensus 214 ~~~i~~~~~~~p---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
T cd05618 214 FQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEF 290 (329)
T ss_pred HHHHhcCCCCCC---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCcc
Confidence 556666665555 6889999999999999999999984 24789999999999999987654 678888887777
Q ss_pred CccccccccccCCCCCCC
Q 001360 998 DTSYFLSRFSQISSGLPD 1015 (1092)
Q Consensus 998 Dts~Fds~fs~~~s~l~~ 1015 (1092)
+..+|+..+........+
T Consensus 291 ~~~~~~~~~~~~~~~~~~ 308 (329)
T cd05618 291 GLDNFDAQFTNEPVQLTP 308 (329)
T ss_pred cchhcCcccccCCccCCC
Confidence 777777655554444433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=450.71 Aligned_cols=259 Identities=32% Similarity=0.573 Sum_probs=235.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe-
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN- 761 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~- 761 (1092)
.+..++++.++.||+|..|+||+|+++.|++.||+|++.- ..+.....++.+|++++..++||+||++|++|.....
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 4567799999999999999999999999999999999942 2345567889999999999999999999999999995
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
++|+||||.||+|.+++...+.++|.....++.++++||.|||. ++||||||||+||||+..|.|||||||.++...
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv-- 230 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV-- 230 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh--
Confidence 99999999999999999999999999999999999999999995 999999999999999999999999999988531
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC---
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--- 917 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~--- 917 (1092)
+..+.+++||..|||||.+.+..|+.++||||||+.++||++|+.||...
T Consensus 231 ---------------------------nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~ 283 (364)
T KOG0581|consen 231 ---------------------------NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP 283 (364)
T ss_pred ---------------------------hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC
Confidence 12457899999999999999999999999999999999999999999874
Q ss_pred --ChHHHHHHHhhcCCCCCCCCCC-CCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 918 --SPEIIFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 918 --s~~ei~~kIl~~~l~fP~ip~~-lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
+..+++..|+.+.. |.+|.. +|+++++||..||++||.+|++ +.++++|||++..
T Consensus 284 ~~~~~~Ll~~Iv~~pp--P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s---~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 284 YLDIFELLCAIVDEPP--PRLPEGEFSPEFRSFVSCCLRKDPSERPS---AKQLLQHPFIKKF 341 (364)
T ss_pred CCCHHHHHHHHhcCCC--CCCCcccCCHHHHHHHHHHhcCCcccCCC---HHHHhcCHHHhhc
Confidence 67788888888654 445566 9999999999999999999999 8899999999864
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=436.18 Aligned_cols=289 Identities=40% Similarity=0.782 Sum_probs=250.4
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||+|+||+||+|+++.+++.||+|++++...........+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999999875544445566677788887654 799999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~------------ 148 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC------------
Confidence 99999998888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l 931 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~ 213 (316)
T cd05592 149 ---------------GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP 213 (316)
T ss_pred ---------------CCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 01122356899999999999999999999999999999999999999999999888888876554
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccccccC
Q 001360 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQI 1009 (1092)
Q Consensus 932 ~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~~ 1009 (1092)
.+ +..++.++.+||.+||..||.+||+. ..+++.||||+.++|..+... .|++.|......+.++|+..|+..
T Consensus 214 ~~---~~~~~~~~~~ll~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (316)
T cd05592 214 HF---PRWISKEAKDCLSKLFERDPTKRLGV--DGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNE 288 (316)
T ss_pred CC---CCCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccc
Confidence 44 47789999999999999999999983 358899999999999987655 678888888888999998776665
Q ss_pred CCCC
Q 001360 1010 SSGL 1013 (1092)
Q Consensus 1010 ~s~l 1013 (1092)
...+
T Consensus 289 ~~~~ 292 (316)
T cd05592 289 KVRL 292 (316)
T ss_pred cccC
Confidence 4333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=436.12 Aligned_cols=290 Identities=39% Similarity=0.784 Sum_probs=253.7
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||+|+||+||+|+++.+++.||+|++++...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876555555677788999999888 699999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~------------ 148 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL------------ 148 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc------------
Confidence 99999998888999999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l 931 (1092)
........+||+.|+|||++.+..|+.++|+|||||++|+|++|+.||.+.+...++..+.....
T Consensus 149 ---------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~ 213 (318)
T cd05570 149 ---------------GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV 213 (318)
T ss_pred ---------------CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 01122346799999999999999999999999999999999999999999998888888887766
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccccc
Q 001360 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1007 (1092)
Q Consensus 932 ~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs 1007 (1092)
.+| ..++.++.+||.+||..||.+||++ ....+++.||||+.++|..+... .+|+.|......+.++|+..|.
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (318)
T cd05570 214 RYP---RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFT 290 (318)
T ss_pred CCC---CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCchhc
Confidence 555 6789999999999999999999993 22389999999999999877655 6788888888888888877655
Q ss_pred cCCCC
Q 001360 1008 QISSG 1012 (1092)
Q Consensus 1008 ~~~s~ 1012 (1092)
...+.
T Consensus 291 ~~~~~ 295 (318)
T cd05570 291 KEKPV 295 (318)
T ss_pred cCccc
Confidence 44433
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=434.92 Aligned_cols=291 Identities=36% Similarity=0.743 Sum_probs=253.9
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LYLVM 766 (1092)
+|++.+.||+|+||+||+|+++.+|+.||||++++...........+..|..++..+. ||+|++++++|.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999998755444556677888999998886 578889999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~------- 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV------- 153 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC-------
Confidence 9999999999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...+++.+
T Consensus 154 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (323)
T cd05615 154 --------------------DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213 (323)
T ss_pred --------------------CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011123467999999999999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc--cHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccc
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 1002 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~--ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~F 1002 (1092)
......+| ..++.++.+||.+||.+||.+|++.. ...++++||||++++|..+... .+|+.|.... ....+|
T Consensus 214 ~~~~~~~p---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 289 (323)
T cd05615 214 MEHNVSYP---KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCG-KGAENF 289 (323)
T ss_pred HhCCCCCC---ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCC-Cchhhc
Confidence 88776655 67899999999999999999999843 4789999999999999988766 5788886544 346677
Q ss_pred ccccccC
Q 001360 1003 LSRFSQI 1009 (1092)
Q Consensus 1003 ds~fs~~ 1009 (1092)
+..+...
T Consensus 290 ~~~~~~~ 296 (323)
T cd05615 290 DKFFTRG 296 (323)
T ss_pred Ccccccc
Confidence 7665444
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-50 Score=433.37 Aligned_cols=287 Identities=40% Similarity=0.775 Sum_probs=248.5
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~Eie-IL~~L~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||+|+||.||+|+++.+|+.||+|++.+...........+..|+. +++.++||||+++++.|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998755444445566666665 57889999999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~------------ 148 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE------------ 148 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l 931 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+...++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05603 149 ---------------PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213 (321)
T ss_pred ---------------CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 01112346799999999999999999999999999999999999999999998889988888766
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCc-ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 001360 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1008 (1092)
Q Consensus 932 ~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa-~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1008 (1092)
.+| ...+.++.+||.+||++||.+|++. ..+.++++||||..++|..+... .+++.|......+...|+..++.
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (321)
T cd05603 214 QLP---GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQ 290 (321)
T ss_pred CCC---CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCCcccc
Confidence 555 6789999999999999999999984 46789999999999999987654 57778877777777777765544
Q ss_pred C
Q 001360 1009 I 1009 (1092)
Q Consensus 1009 ~ 1009 (1092)
.
T Consensus 291 ~ 291 (321)
T cd05603 291 E 291 (321)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=444.75 Aligned_cols=292 Identities=41% Similarity=0.743 Sum_probs=246.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..++||||++++++|.+...+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 45678999999999999999999999999999999998765555556677889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~---- 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE---- 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc----
Confidence 999999999999998654 589999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC----CCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~----Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
.......+.+||+.|||||++.+.. |+.++|||||||+||||++|.+||.+.+.
T Consensus 195 ----------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 195 ----------------------TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred ----------------------CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 0011223568999999999997643 78899999999999999999999999998
Q ss_pred HHHHHHHhhcC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcc--hhhhccCCccCCCCC
Q 001360 920 EIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD--SLALQKAVFVPQPES 995 (1092)
Q Consensus 920 ~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd--~L~~~~pPfiP~~~s 995 (1092)
...+..|.... +.+|. ...++..+++||.+||. ++.+|++..++.++++||||++..|+ .+....+|+.|...+
T Consensus 253 ~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~-~~~~r~~R~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~ 330 (370)
T cd05621 253 VGTYSKIMDHKNSLNFPE-DVEISKHAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSS 330 (370)
T ss_pred HHHHHHHHhCCcccCCCC-cccCCHHHHHHHHHHcc-CchhccCCCCHHHHhcCcccCCCCcChHhcCCCCCCcCCCCCC
Confidence 88888888643 34442 23579999999999998 44444433338999999999987665 444447788998888
Q ss_pred CCCcccccc
Q 001360 996 VDDTSYFLS 1004 (1092)
Q Consensus 996 ~~Dts~Fds 1004 (1092)
..|.++|+.
T Consensus 331 ~~~~~~~~~ 339 (370)
T cd05621 331 DIDSSNFDD 339 (370)
T ss_pred cchhhhcCC
Confidence 888888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=437.31 Aligned_cols=286 Identities=42% Similarity=0.773 Sum_probs=249.6
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 695 LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L---~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
||+|+||+||+|+++.+|+.||+|++.+...........+..|..++... .||||++++..|.....+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999876555555666777888888766 699999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~------------ 148 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT------------ 148 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC------------
Confidence 99999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 930 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~ 930 (1092)
........+||+.|||||++.+. .|+.++|||||||++|||++|+.||...+..+++..+..+.
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 213 (330)
T cd05586 149 ---------------DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213 (330)
T ss_pred ---------------CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC
Confidence 01122356899999999999764 58999999999999999999999999999999999988877
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc-ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccccc
Q 001360 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1007 (1092)
Q Consensus 931 l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa-~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs 1007 (1092)
..+|. ..++.++.+||.+||..||.+||+. ..+.+++.||||+.++|+.+... .+|+.|......+.++|+..|.
T Consensus 214 ~~~~~--~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (330)
T cd05586 214 VRFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFT 291 (330)
T ss_pred CCCCC--ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcCcccc
Confidence 77663 4689999999999999999999974 36899999999999999987655 6788888888888888876554
Q ss_pred cC
Q 001360 1008 QI 1009 (1092)
Q Consensus 1008 ~~ 1009 (1092)
..
T Consensus 292 ~~ 293 (330)
T cd05586 292 NS 293 (330)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=443.35 Aligned_cols=292 Identities=40% Similarity=0.704 Sum_probs=250.7
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
....++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45678999999999999999999999999999999999876555555667788999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||++||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~--- 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA--- 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC---
Confidence 999999999999998865 4689999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC----CCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~----~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
.........+||+.|||||++.+. .++.++|||||||++|||++|.+||.+.+
T Consensus 195 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 195 -----------------------NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred -----------------------CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 001112346899999999999754 37899999999999999999999999999
Q ss_pred hHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHHHhccCCcCC--CCCcccHHHHHcCCCCCCCCcchh--hhccCCccCC
Q 001360 919 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVKAHPFFKGVNWDSL--ALQKAVFVPQ 992 (1092)
Q Consensus 919 ~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~kcL~kDP~K--RpSa~ga~EIL~HPFFkgIdWd~L--~~~~pPfiP~ 992 (1092)
....+..|.... +.+|. ...+|.++++||.+||..+|.+ |++ +.++++||||++.+|... ....+|+.|.
T Consensus 252 ~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s---~~ell~h~~~~~~~~~~~~~~~~~~~~~p~ 327 (370)
T cd05596 252 LVGTYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNG---VDEIKSHPFFKNDQWTFDNIRETVAPVVPE 327 (370)
T ss_pred HHHHHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCC---HHHHhcCcccCCCChhhHHhcCCCcCccCc
Confidence 988999988754 34442 2357999999999999988987 887 889999999999888754 3446788998
Q ss_pred CCCCCCccccccc
Q 001360 993 PESVDDTSYFLSR 1005 (1092)
Q Consensus 993 ~~s~~Dts~Fds~ 1005 (1092)
..+..+.++|+..
T Consensus 328 ~~~~~~~~~~~~~ 340 (370)
T cd05596 328 LSSDIDTSNFDDI 340 (370)
T ss_pred CCCcchhhhcCCc
Confidence 8888888887653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-50 Score=434.24 Aligned_cols=286 Identities=41% Similarity=0.782 Sum_probs=247.2
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~Eie-IL~~L~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||+|+||+||+|+++.+++.||+|++.+...........+..|.. +++.++||||++++++|...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999998755444444455666655 46778999999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~------------ 148 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE------------ 148 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc------------
Confidence 99999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l 931 (1092)
........+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 213 (325)
T cd05602 149 ---------------HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 213 (325)
T ss_pred ---------------CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc
Confidence 01122356899999999999999999999999999999999999999999999999988887765
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCc-ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 001360 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1008 (1092)
Q Consensus 932 ~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa-~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1008 (1092)
.++ ..++.++.+||.+||++||.+|++. +...++++|+||..++|+.+... .+++.|......+...|+..++.
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (325)
T cd05602 214 QLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTE 290 (325)
T ss_pred CCC---CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhcCCcccc
Confidence 544 5789999999999999999999995 35779999999999999988655 56778887777777777765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=433.45 Aligned_cols=287 Identities=46% Similarity=0.853 Sum_probs=246.6
Q ss_pred EEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 692 IKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k---~TGk~VAIKvLkK~ei~k-k~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
++.||+|+||.||+|+.. .+++.||+|++++..... ......+.+|+.+|..++||||+++++.|...+.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999864 578999999998754322 2345678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
|++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-------- 152 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-------- 152 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--------
Confidence 999999999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl 927 (1092)
........+||+.|+|||++.+..++.++|||||||++|||++|++||...+.......+.
T Consensus 153 -------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~ 213 (323)
T cd05584 153 -------------------EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213 (323)
T ss_pred -------------------CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 0112234679999999999999999999999999999999999999999999888888888
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC--cccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccc
Q 001360 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFL 1003 (1092)
Q Consensus 928 ~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpS--a~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fd 1003 (1092)
.+...+| ..+++++.+||.+||.+||.+||+ ...+.+++.||||+..+|..+... .+|+.+...+..+.+.|+
T Consensus 214 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (323)
T cd05584 214 KGKLNLP---PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFD 290 (323)
T ss_pred cCCCCCC---CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcC
Confidence 8776655 678999999999999999999994 234889999999999999887654 566777776667776666
Q ss_pred ccccc
Q 001360 1004 SRFSQ 1008 (1092)
Q Consensus 1004 s~fs~ 1008 (1092)
..++.
T Consensus 291 ~~~~~ 295 (323)
T cd05584 291 SKFTR 295 (323)
T ss_pred chhcc
Confidence 55443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=425.48 Aligned_cols=275 Identities=33% Similarity=0.615 Sum_probs=236.8
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
.|++.+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.+|..++||||++++++|.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999987655444455678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE------ 154 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC------
Confidence 99999999888653 3589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH----H
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE----I 921 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~----e 921 (1092)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||...+.. .
T Consensus 155 ----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05631 155 ----------------------GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE 212 (285)
T ss_pred ----------------------CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence 01112457999999999999999999999999999999999999999876543 2
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCC
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 993 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~ 993 (1092)
+...+......+ +..++.++.+||++||..||.+||+. .++.++++||||.+++|+.+... +|||+|.+
T Consensus 213 ~~~~~~~~~~~~---~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05631 213 VDRRVKEDQEEY---SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPDP 285 (285)
T ss_pred HHHHhhcccccC---CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCCC
Confidence 333333333333 46789999999999999999999984 35899999999999999999887 88999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=432.77 Aligned_cols=291 Identities=44% Similarity=0.806 Sum_probs=250.4
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||+||+++.+.+++.||+|++.+...........+.+|+.++..++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998766555566777899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD----- 155 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC-----
Confidence 99999999999976 457999999999999999999999999999999999999999999999999998642100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
........+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+..
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 214 (331)
T cd05597 156 ---------------------GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred ---------------------CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH
Confidence 0011123579999999999973 45788999999999999999999999999888
Q ss_pred HHHHHHhhcC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCC
Q 001360 921 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDD 998 (1092)
Q Consensus 921 ei~~kIl~~~--l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~D 998 (1092)
+.+..+.... ..+|.....++.++++||++||+. |.+|++...+.++++||||.+++|..+....+++.|...+..+
T Consensus 215 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~-~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (331)
T cd05597 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTD 293 (331)
T ss_pred HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccC-cccccCCCCHHHHhcCCCCCCCCHHHHhhCCCCccCcCCCcch
Confidence 8888887643 344443456899999999999985 5565554459999999999999999998888889998888888
Q ss_pred cccccc
Q 001360 999 TSYFLS 1004 (1092)
Q Consensus 999 ts~Fds 1004 (1092)
+++|+.
T Consensus 294 ~~~~~~ 299 (331)
T cd05597 294 TSNFDV 299 (331)
T ss_pred hhhcCC
Confidence 877754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=432.76 Aligned_cols=290 Identities=40% Similarity=0.753 Sum_probs=252.9
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH---hcCCCceEEEeeeeccCCeeEEE
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI---TVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~---~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
|++++.||+|+||.||+|.++.+|+.||||++++.........+.+.+|++++. .++||||++++++|.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999998765555556677888877764 56799999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||++||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~------ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG------ 153 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC------
Confidence 999999999988854 5799999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
........+||+.|||||++.+..++.++|||||||++|||++|..||.+.+..+.+..
T Consensus 154 ---------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~ 212 (324)
T cd05589 154 ---------------------FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS 212 (324)
T ss_pred ---------------------CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 01122356899999999999999999999999999999999999999999999999988
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc--cHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccc
Q 001360 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSY 1001 (1092)
Q Consensus 926 Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~--ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~ 1001 (1092)
+......+| ..++.++.+||.+||..||.+||+.. .+.++++||||++++|..+... .+|+.|......|.++
T Consensus 213 i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 289 (324)
T cd05589 213 IVNDEVRYP---RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSN 289 (324)
T ss_pred HHhCCCCCC---CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcchhhh
Confidence 888776655 67899999999999999999999732 5899999999999999987654 6788888888888888
Q ss_pred cccccccC
Q 001360 1002 FLSRFSQI 1009 (1092)
Q Consensus 1002 Fds~fs~~ 1009 (1092)
|...+...
T Consensus 290 ~~~~~~~~ 297 (324)
T cd05589 290 FDEEFTSE 297 (324)
T ss_pred cCcccccc
Confidence 77654443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=430.65 Aligned_cols=290 Identities=42% Similarity=0.779 Sum_probs=249.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||+||+++.+.+++.||+|++.+...........+..|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998755555556667889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~----- 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED----- 155 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-----
Confidence 99999999999987 467999999999999999999999999999999999999999999999999998642100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
........+||+.|||||++. ...|+.++|||||||++|||++|+.||...+..
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~ 214 (332)
T cd05623 156 ---------------------GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (332)
T ss_pred ---------------------CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH
Confidence 011122457999999999986 346889999999999999999999999999999
Q ss_pred HHHHHHhhcC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCC
Q 001360 921 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDD 998 (1092)
Q Consensus 921 ei~~kIl~~~--l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~D 998 (1092)
+.+.++.... ..+|.....++.++++||++||+.++ +|++...+.++++||||.+++|+.+....+|++|...++.+
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~-~r~~r~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 293 (332)
T cd05623 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSRE-HRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTD 293 (332)
T ss_pred HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChh-hhcCCCCHHHHhCCCCcCCCCHHHHhhCCCCccCCCCCCcc
Confidence 9998887754 34454445789999999999998644 45444458999999999999999998888899998887777
Q ss_pred ccccc
Q 001360 999 TSYFL 1003 (1092)
Q Consensus 999 ts~Fd 1003 (1092)
.+++.
T Consensus 294 ~~~~~ 298 (332)
T cd05623 294 TSNFD 298 (332)
T ss_pred cccCC
Confidence 77653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-50 Score=434.90 Aligned_cols=288 Identities=42% Similarity=0.763 Sum_probs=254.1
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GG 772 (1092)
+.||+|+||+||+|+++.+|+.||+|++++...........+.+|+.++..++||||++++++|...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555556778889999999999999999999999999999999999999
Q ss_pred cHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 773 SL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
+|..++.+...+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~------------ 148 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK------------ 148 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC------------
Confidence 999999888889999999999999999999997 7999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l 931 (1092)
........+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+...+...+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~ 213 (325)
T cd05594 149 ---------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 213 (325)
T ss_pred ---------------CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC
Confidence 01112345799999999999999999999999999999999999999999988888888887776
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccccc
Q 001360 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1007 (1092)
Q Consensus 932 ~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs 1007 (1092)
.+| ..+++++.+||.+||.+||++|++. ..+.++++||||.++.|...... .+|+.|...+..++.+|+..+.
T Consensus 214 ~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (325)
T cd05594 214 RFP---RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFT 290 (325)
T ss_pred CCC---CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCchhh
Confidence 665 6789999999999999999999852 24899999999999999987654 5788888888889999987766
Q ss_pred cCC
Q 001360 1008 QIS 1010 (1092)
Q Consensus 1008 ~~~ 1010 (1092)
...
T Consensus 291 ~~~ 293 (325)
T cd05594 291 AQM 293 (325)
T ss_pred cCc
Confidence 553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=442.29 Aligned_cols=294 Identities=43% Similarity=0.747 Sum_probs=250.6
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
..+..++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..++||||+++++.+.+...
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34567899999999999999999999999999999999987655555566778899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~-- 194 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-- 194 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc--
Confidence 99999999999999998654 589999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC----CCccceeechhhhHHHHHhCCCCCCCC
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~----Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
.........+||+.|||||++.+.. |+.++|||||||++|||++|.+||...
T Consensus 195 ------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 195 ------------------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred ------------------------CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 0011223568999999999997643 789999999999999999999999999
Q ss_pred ChHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCc--chhhhccCCccCCC
Q 001360 918 SPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW--DSLALQKAVFVPQP 993 (1092)
Q Consensus 918 s~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdW--d~L~~~~pPfiP~~ 993 (1092)
+....+.+|.... ..+|. ...++.++++||.+||. +|.+|++..++.+|++||||++..| ..+....+|++|..
T Consensus 251 ~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~ 328 (371)
T cd05622 251 SLVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDL 328 (371)
T ss_pred CHHHHHHHHHcCCCcccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcCcccCCCChhHHhcCCCCCCCCCCC
Confidence 9988999988754 44443 34689999999999998 7777766556999999999998655 45555578888888
Q ss_pred CCCCCcccccc
Q 001360 994 ESVDDTSYFLS 1004 (1092)
Q Consensus 994 ~s~~Dts~Fds 1004 (1092)
.+..+.++|+.
T Consensus 329 ~~~~~~~~~~~ 339 (371)
T cd05622 329 SSDIDTSNFDD 339 (371)
T ss_pred CCcchhhhcCC
Confidence 77777777653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=433.02 Aligned_cols=284 Identities=37% Similarity=0.754 Sum_probs=246.2
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||+|+||.||+|+++.+|+.||+|++++...........+..|..++... +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999875443344566778888888764 899999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|..++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~------------ 148 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc------------
Confidence 99999998888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l 931 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+...++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (316)
T cd05620 149 ---------------GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP 213 (316)
T ss_pred ---------------CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 01122356799999999999999999999999999999999999999999998888888876654
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 001360 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1008 (1092)
Q Consensus 932 ~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1008 (1092)
.+| ..++.++++||.+||..||.+|++. ..++++||||++++|..+... .+|+.|....+.+.++|+..+..
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~dP~~R~~~--~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (316)
T cd05620 214 HYP---RWITKESKDILEKLFERDPTRRLGV--VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLS 287 (316)
T ss_pred CCC---CCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccccc
Confidence 444 6789999999999999999999983 357999999999999987554 57888888888888888765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=449.27 Aligned_cols=260 Identities=34% Similarity=0.645 Sum_probs=239.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
...+|.+.+.||+|+||+||+|+++.++..||||.+.+... .+...+.+..|+.+|+.++|||||.|++++.+.+.+||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 46799999999999999999999999999999999987654 45667889999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC------CcEEEEecCCccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD------GHIKLTDFGLSKIGL 838 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n------G~VKLsDFGLAk~~~ 838 (1092)
|||||.||||.+||++.+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+...
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999875 358999999999631
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
......+.||+|.|||||++..+.|+.|+|+||+|+|+|+|++|++||...+
T Consensus 167 ----------------------------~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 167 ----------------------------PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred ----------------------------chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 2445678999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
+.+++..+..+....|.++..++....+|+..+|+++|..|.+ ..+-..|+|...
T Consensus 219 ~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~---~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 219 PKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRIS---FEDFFDHPFLAA 273 (429)
T ss_pred HHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCc---hHHhhhhhhccc
Confidence 9999999988877777778889999999999999999999998 567778888754
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=431.36 Aligned_cols=291 Identities=42% Similarity=0.755 Sum_probs=250.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998755555556677889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
||++||+|.+++.+ ...+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----- 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD----- 155 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC-----
Confidence 99999999999987 467999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
........+||+.|||||++.+ ..++.++|||||||++|||++|+.||...+..
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 156 ---------------------GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred ---------------------CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 0011123579999999999976 46789999999999999999999999999988
Q ss_pred HHHHHHhhcC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCC
Q 001360 921 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDD 998 (1092)
Q Consensus 921 ei~~kIl~~~--l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~D 998 (1092)
+.+..+.... .++|.....++.++++||.+||+.+ .+|++...+.++++||||++++|+.+....+|+.|....+.+
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~-~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p~~~~~~~ 293 (331)
T cd05624 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSR-ERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSD 293 (331)
T ss_pred HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCc-hhhcCCCCHHHHhcCCCcCCCCHHHHhhCCCCccCCCCCcch
Confidence 8888887644 3444434567999999999999954 466655569999999999999999998888999998887777
Q ss_pred cccccc
Q 001360 999 TSYFLS 1004 (1092)
Q Consensus 999 ts~Fds 1004 (1092)
.++|+.
T Consensus 294 ~~~~~~ 299 (331)
T cd05624 294 TSNFDV 299 (331)
T ss_pred hhhcCC
Confidence 777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-50 Score=451.08 Aligned_cols=261 Identities=39% Similarity=0.684 Sum_probs=237.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK--NDIERILAERNILITVR-NPFVVRFFYSFTCRD 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk--~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~ 760 (1092)
...+.|++.+.||+|+||+|++|++..+|..||+|++.+...... ...+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 567899999999999999999999999999999998876532211 34566778999999999 999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC-CcEEEEecCCcccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n-G~VKLsDFGLAk~~~~ 839 (1092)
.+|+||||+.||+|++++.+.+++.|..++.|++||+.|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999998521
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-C-CccceeechhhhHHHHHhCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-H-GYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Y-t~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
.......++||||.|+|||++.+.. | +.++||||+||+||.|++|+.||...
T Consensus 173 --------------------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 173 --------------------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred --------------------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 1123456899999999999999988 8 58999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCC-CHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~l-S~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
+...++.+|..+.+.+| ..+ |+++++||.+||..||.+|++ +.+|+.||||+..
T Consensus 227 ~~~~l~~ki~~~~~~~p---~~~~S~~~~~Li~~mL~~~P~~R~t---~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 227 NVPNLYRKIRKGEFKIP---SYLLSPEARSLIEKMLVPDPSTRIT---LLEILEHPWFQKE 281 (370)
T ss_pred cHHHHHHHHhcCCccCC---CCcCCHHHHHHHHHHcCCCcccCCC---HHHHhhChhhccC
Confidence 99999999999999888 667 999999999999999999999 8899999999863
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=427.49 Aligned_cols=289 Identities=45% Similarity=0.821 Sum_probs=244.5
Q ss_pred CeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCee
Q 001360 688 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k---~TGk~VAIKvLkK~ei~k-k~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~L 762 (1092)
+|++++.||+|+||.||+|+.. .+|+.||+|++++..... ....+.+..|+.+|..++ ||||++++++|...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 578999999998654322 234567889999999995 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~--- 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS--- 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCC----
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE---- 917 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~---- 917 (1092)
.........+||+.|||||++.+. .++.++|||||||++|||++|..||...
T Consensus 158 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 214 (332)
T cd05614 158 -----------------------EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214 (332)
T ss_pred -----------------------cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC
Confidence 011122356899999999999875 4789999999999999999999999643
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc--cHHHHHcCCCCCCCCcchhhhc--cCCccCCC
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 993 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~--ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~ 993 (1092)
....+...+......+ +..++..+.+||.+||..||++||++. .+.++++||||++++|..+... .+++.|..
T Consensus 215 ~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~ 291 (332)
T cd05614 215 TQSEVSRRILKCDPPF---PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSI 291 (332)
T ss_pred CHHHHHHHHhcCCCCC---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 2344555555555444 467899999999999999999999755 6999999999999999987654 67788888
Q ss_pred CCCCCccccccc
Q 001360 994 ESVDDTSYFLSR 1005 (1092)
Q Consensus 994 ~s~~Dts~Fds~ 1005 (1092)
....+..+|...
T Consensus 292 ~~~~~~~~~~~~ 303 (332)
T cd05614 292 RNELDVGNFAEE 303 (332)
T ss_pred CCcchhhhcCcc
Confidence 777777777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=428.02 Aligned_cols=286 Identities=38% Similarity=0.755 Sum_probs=248.8
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||+|+||+||+|+++.+++.||||++++...........+..|..++... +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999875433344556677888888764 899999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~------------ 148 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l 931 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..++++.+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~ 213 (316)
T cd05619 149 ---------------GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP 213 (316)
T ss_pred ---------------CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 01112346799999999999999999999999999999999999999999998888888766554
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccccccC
Q 001360 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQI 1009 (1092)
Q Consensus 932 ~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~~ 1009 (1092)
.+| ..++.++++||.+||++||.+||++. .+++.||||+.++|..+... .+++.|...+..+.++|+..+.+.
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~~P~~R~~~~--~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (316)
T cd05619 214 CYP---RWLTREAKDILVKLFVREPERRLGVK--GDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNE 288 (316)
T ss_pred CCC---ccCCHHHHHHHHHHhccCHhhcCCCh--HHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChhhhcC
Confidence 444 67899999999999999999999932 48999999999999987654 688999999999999998876554
Q ss_pred C
Q 001360 1010 S 1010 (1092)
Q Consensus 1010 ~ 1010 (1092)
.
T Consensus 289 ~ 289 (316)
T cd05619 289 K 289 (316)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=426.29 Aligned_cols=283 Identities=43% Similarity=0.790 Sum_probs=245.8
Q ss_pred EeeccCCCeEEEEEEE---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 001360 693 KPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~---k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm 769 (1092)
+.||+|+||.||+++. +.+|+.||+|++++... .......+.+|+.+|.+++||||++++++|.+.+.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 6799999999999986 35789999999986443 2234456788999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCC
Q 001360 770 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849 (1092)
Q Consensus 770 ~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~ 849 (1092)
+||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~----------- 149 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI----------- 149 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccC-----------
Confidence 999999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhc
Q 001360 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929 (1092)
Q Consensus 850 t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~ 929 (1092)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+...
T Consensus 150 ----------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~ 213 (318)
T cd05582 150 ----------------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213 (318)
T ss_pred ----------------CCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence 0011233568999999999999999999999999999999999999999999988888888877
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCccc--HHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccc
Q 001360 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSR 1005 (1092)
Q Consensus 930 ~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~g--a~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~ 1005 (1092)
...+| ..+++++.+||.+||+.||.+||++.+ +.+++.||||+.++|..+... .+++.|......+..+++..
T Consensus 214 ~~~~p---~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (318)
T cd05582 214 KLGMP---QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPE 290 (318)
T ss_pred CCCCC---CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCCCcchhhhcCcc
Confidence 76655 678999999999999999999999766 899999999999999987654 56777776666666665554
Q ss_pred c
Q 001360 1006 F 1006 (1092)
Q Consensus 1006 f 1006 (1092)
+
T Consensus 291 ~ 291 (318)
T cd05582 291 F 291 (318)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=455.58 Aligned_cols=261 Identities=34% Similarity=0.625 Sum_probs=244.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..+-|++.+.||+|+-|.|.+|++..||+..|||++.+...........+.+|+-||+.+.||||++||+.+.+...+|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 45678999999999999999999999999999999998765666677889999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|+||++||.|+++|.+.|.|++.++..|+.||+.|+.|+|..+|+||||||+|+|||..++|||+|||+|.+-
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe------- 162 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE------- 162 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc-------
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999752
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
.......+.||+|.|.|||++.|.+| +.++||||.|||||.||+|+.||.+++...++
T Consensus 163 ---------------------~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LL 221 (786)
T KOG0588|consen 163 ---------------------VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLL 221 (786)
T ss_pred ---------------------cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHH
Confidence 22344567899999999999999999 68999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCc
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdW 979 (1092)
.++..+.+.+| ..+|.+++|||.+||.+||.+|++ .++|++|||+.+..-
T Consensus 222 lKV~~G~f~MP---s~Is~eaQdLLr~ml~VDp~~RiT---~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 222 LKVQRGVFEMP---SNISSEAQDLLRRMLDVDPSTRIT---TEEILKHPFLSGYTS 271 (786)
T ss_pred HHHHcCcccCC---CcCCHHHHHHHHHHhccCcccccc---HHHHhhCchhhcCCC
Confidence 99999999888 899999999999999999999999 889999999987543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=445.63 Aligned_cols=257 Identities=36% Similarity=0.626 Sum_probs=237.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
+++|-+.+.||+|+||.||+|+.+.|.+.||||.+.|... .+.++..+.+|++|++.++|||||.++++|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 3678899999999999999999999999999999988654 345688899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
+||+.| +|+.+|...+.++|+.++.++.+++.||.|||+++|+|||+||.||||+..|++|+||||+|+....+
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~----- 153 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN----- 153 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-----
Confidence 999987 99999999999999999999999999999999999999999999999999999999999999953211
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
.....+..|||.|||||++.+++|+..+|+||||||+|||++|+|||+..+..++.+.
T Consensus 154 ----------------------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~ 211 (808)
T KOG0597|consen 154 ----------------------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKS 211 (808)
T ss_pred ----------------------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHH
Confidence 1223457899999999999999999999999999999999999999999999999999
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 926 Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
|+.....+| ...+.++..|++.+|.+||.+|++ -.+++.|||.++.
T Consensus 212 I~~d~v~~p---~~~S~~f~nfl~gLL~kdP~~Rlt---W~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 212 ILKDPVKPP---STASSSFVNFLQGLLIKDPAQRLT---WTDLLGHPFWKGK 257 (808)
T ss_pred HhcCCCCCc---ccccHHHHHHHHHHhhcChhhccc---HHHHhcChHHhhh
Confidence 999998887 689999999999999999999999 6799999999863
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=402.50 Aligned_cols=275 Identities=34% Similarity=0.618 Sum_probs=233.9
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
.|++.+.||+|+||+||++....+++.||+|++.+...........+.+|+.+++.++||||+++++.+...+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999986554444445667899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||+++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE------ 154 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC------
Confidence 99999999888654 4589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......
T Consensus 155 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05605 155 ----------------------GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212 (285)
T ss_pred ----------------------CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH
Confidence 0111245799999999999999999999999999999999999999988765433322
Q ss_pred ----HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc--cHHHHHcCCCCCCCCcchhhhc--cCCccCCC
Q 001360 926 ----ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 993 (1092)
Q Consensus 926 ----Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~--ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~ 993 (1092)
+...... ++..++..+.+||.+||..||.+||+.. .+.+++.||||...+|..+... .|||.|.|
T Consensus 213 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05605 213 VERRVKEDQEE---YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPDP 285 (285)
T ss_pred HHHHhhhcccc---cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCCC
Confidence 2222222 3367899999999999999999999533 5889999999999999988765 56888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=402.44 Aligned_cols=267 Identities=33% Similarity=0.631 Sum_probs=226.6
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001360 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1092)
Q Consensus 695 LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL 774 (1092)
||+|+||+||+|.++.+|+.||+|++.+...........+..|+.+|+.++||||++++++|.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999876554445567788999999999999999999999999999999999999999
Q ss_pred HHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCC
Q 001360 775 YSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (1092)
Q Consensus 775 ~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t 850 (1092)
.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~----------- 149 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD----------- 149 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCC-----------
Confidence 988753 34689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh----HHHHHHH
Q 001360 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNI 926 (1092)
Q Consensus 851 ~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~----~ei~~kI 926 (1092)
.........||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ......+
T Consensus 150 ----------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 213 (280)
T cd05608 150 ----------------GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213 (280)
T ss_pred ----------------CCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh
Confidence 00112345799999999999999999999999999999999999999986543 3334444
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc--cHHHHHcCCCCCCCCcchhhhc--cCCccC
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVP 991 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~--ga~EIL~HPFFkgIdWd~L~~~--~pPfiP 991 (1092)
......+ +..++.++.+|+.+||+.||.+||+.. .+.++++||||++++|..+... ++||.|
T Consensus 214 ~~~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~ 279 (280)
T cd05608 214 LNDSVTY---PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279 (280)
T ss_pred cccCCCC---cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence 4444333 367899999999999999999999742 4899999999999999987664 456655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=401.30 Aligned_cols=305 Identities=51% Similarity=0.889 Sum_probs=261.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||.||++.++.+++.||+|.+.+...........+.+|++++..++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998755444455678889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.........+.
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998743211110000
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
. ..... ...........|++.|+|||.+.+..++.++|+|||||++|||++|..||.+.++.+....+
T Consensus 161 ~----~~~~~--------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 161 E----GHIEK--------DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred c----ccccc--------chhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0 00000 00011122357899999999999889999999999999999999999999999988888888
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCCccccc
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFL 1003 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~Dts~Fd 1003 (1092)
......+|..+..++.++.+||.+||..||.+||+..++.++++||||...+|..+......++|.+...++.+||+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (305)
T cd05609 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESEDDTSYFD 305 (305)
T ss_pred HhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCCCCCCCccccccCC
Confidence 88776666655578999999999999999999999888999999999999999998888888999998888888764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=397.03 Aligned_cols=284 Identities=48% Similarity=0.874 Sum_probs=253.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||+|+||.||++.+..+++.||+|++++...........+.+|+++|++++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998766555566788999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||+++|+|.+++.+.+.+++..+..++.||+.||.|||+.||+||||+|.|||++.+|.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~-------- 152 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-------- 152 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccC--------
Confidence 999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
......+|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+
T Consensus 153 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 210 (290)
T cd05580 153 ----------------------GRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210 (290)
T ss_pred ----------------------CCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0023457999999999999888999999999999999999999999988888888888
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccc
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 1002 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~F 1002 (1092)
..+...+| ..++..++++|.+||..||.+|++. ..+.++++||||+.++|..+... .+|+.|......+.+.|
T Consensus 211 ~~~~~~~~---~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (290)
T cd05580 211 LEGKVRFP---SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNF 287 (290)
T ss_pred hcCCccCC---ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCCccccccc
Confidence 87766555 6789999999999999999999952 35899999999999999988655 67888877777777666
Q ss_pred c
Q 001360 1003 L 1003 (1092)
Q Consensus 1003 d 1003 (1092)
+
T Consensus 288 ~ 288 (290)
T cd05580 288 D 288 (290)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=418.67 Aligned_cols=261 Identities=35% Similarity=0.600 Sum_probs=222.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--eeE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--NLY 763 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~--~LY 763 (1092)
..++...+.||+|+||.||++..+.+|..+|||.+.... ....+.+.+|+.+|.+++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456888999999999999999999999999999887542 122677899999999999999999999865555 699
Q ss_pred EEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-CCcEEEEecCCcccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~n~ 841 (1092)
++|||++||+|.+++.+.+ .|++..++.|++||+.||.|||++|||||||||+||||+. +|.+||+|||+++....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~-- 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES-- 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc--
Confidence 9999999999999999887 7999999999999999999999999999999999999999 79999999999885310
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCC-CCh
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTA-ESP 919 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~-~s~ 919 (1092)
............|||.|||||++.+. ..+.++|||||||++.||+||++||.. ...
T Consensus 171 ----------------------~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~ 228 (313)
T KOG0198|consen 171 ----------------------KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE 228 (313)
T ss_pred ----------------------ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch
Confidence 00112233467899999999999963 234599999999999999999999987 455
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
....-.|.... ..|.+|..+|.++++||.+||.+||.+||+ |.++|.|||.+..
T Consensus 229 ~~~~~~ig~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpt---a~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 229 AEALLLIGRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPT---AEELLEHPFLKQN 282 (313)
T ss_pred HHHHHHHhccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcC---HHHHhhChhhhcc
Confidence 55455555444 456788999999999999999999999999 8899999999753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-48 Score=405.38 Aligned_cols=261 Identities=36% Similarity=0.666 Sum_probs=244.4
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.....++++|++.+.||+|-||.||+|+.+.++..||+|++.|..+........+.+|++|-..++||||+++|++|.+.
T Consensus 15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 34457889999999999999999999999999999999999998887777777899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHH--hhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLk--k~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
...||++||.++|+|+..|. ....|++..+..|++|++.||.|+|..+||||||||+|+|++..|.+||+|||-+...
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999999999 6678999999999999999999999999999999999999999999999999987641
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
+..+..+.|||..|.+||+..+..++..+|+|++|++.||+|+|.+||...
T Consensus 175 -----------------------------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 175 -----------------------------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred -----------------------------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 123456789999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
+..++|++|....+.+| ..++.+++|||.+||.++|.+|+. ..+++.|||..
T Consensus 226 ~~~etYkrI~k~~~~~p---~~is~~a~dlI~~ll~~~p~~r~~---l~~v~~hpwI~ 277 (281)
T KOG0580|consen 226 SHSETYKRIRKVDLKFP---STISGGAADLISRLLVKNPIERLA---LTEVMDHPWIV 277 (281)
T ss_pred hhHHHHHHHHHccccCC---cccChhHHHHHHHHhccCcccccc---HHHHhhhHHHH
Confidence 99999999999998888 799999999999999999999998 88999999975
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=396.07 Aligned_cols=267 Identities=33% Similarity=0.597 Sum_probs=225.3
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001360 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1092)
Q Consensus 695 LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL 774 (1092)
||+|+||+||+++.+.+|+.||+|++.+...........+..|+++|.+++||||+++++.|.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765544334455667799999999999999999999999999999999999999
Q ss_pred HHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 001360 775 YSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (1092)
Q Consensus 775 ~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g 852 (1092)
.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~------------- 147 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD------------- 147 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC-------------
Confidence 98886543 488899999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh----HHHHHHHhh
Q 001360 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNILN 928 (1092)
Q Consensus 853 ~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~----~ei~~kIl~ 928 (1092)
........||+.|+|||++.+..++.++|+|||||++|||++|+.||..... .++...+..
T Consensus 148 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05607 148 ---------------GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212 (277)
T ss_pred ---------------CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc
Confidence 0111234699999999999998899999999999999999999999976432 344455554
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc-cHHHHHcCCCCCCCCcchhhhc--cCCccC
Q 001360 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVKAHPFFKGVNWDSLALQ--KAVFVP 991 (1092)
Q Consensus 929 ~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~-ga~EIL~HPFFkgIdWd~L~~~--~pPfiP 991 (1092)
....++ ...++.++++||.+||.+||.+||++. ...+++.||||++++|..+... .+||+|
T Consensus 213 ~~~~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 213 DEVKFE--HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred cccccc--cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCCC
Confidence 444433 256899999999999999999999953 3478999999999999998866 667765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=427.11 Aligned_cols=270 Identities=37% Similarity=0.675 Sum_probs=230.6
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch-----------hHHHHHHHHHHHHHhcCCCc
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-----------NDIERILAERNILITVRNPF 748 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk-----------~~ie~~l~EieIL~~L~HPN 748 (1092)
...+..+++|++++.||+|.||+|.+|+...+++.||||++.|...... ..++.+.+|+.||++++|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 4456788999999999999999999999999999999999987543221 23578999999999999999
Q ss_pred eEEEeeeeccC--CeeEEEEeecCCCcHHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc
Q 001360 749 VVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 825 (1092)
Q Consensus 749 IVkL~~sfqde--~~LYLVMEYm~GGSL~dlLkk~g~-LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~ 825 (1092)
||+|+.+..+. +.+|||+|||..|.+...= .... +++.+++.|+++++.||+|||.+|||||||||+|+||+.+|+
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 99999998775 4699999999999885432 2334 999999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC---CC-Cccceeechh
Q 001360 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EH-GYAADWWSVG 901 (1092)
Q Consensus 826 VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~---~Y-t~ksDVWSLG 901 (1092)
|||+|||.+...... .. ..........+|||.|||||...+. .| +.+.||||||
T Consensus 249 VKIsDFGVs~~~~~~---------------~~-------~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalG 306 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQG---------------SD-------EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALG 306 (576)
T ss_pred EEeeccceeeecccC---------------Cc-------cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhh
Confidence 999999988643110 00 0001112237999999999999873 23 6889999999
Q ss_pred hhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 902 IILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 902 VILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
|+||.|+.|+.||.++...+++.+|++..+.||..+ .+..+++|||.+||++||.+|++ +.+|+.|||...
T Consensus 307 VTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~p-e~~e~~kDli~~lL~KdP~~Ri~---l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 307 VTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENP-EINEDLKDLIKRLLEKDPEQRIT---LPDIKLHPWVTR 377 (576)
T ss_pred hhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcc-cccHHHHHHHHHHhhcChhheee---hhhheecceecc
Confidence 999999999999999999999999999999999643 68999999999999999999999 889999999753
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=394.08 Aligned_cols=276 Identities=35% Similarity=0.631 Sum_probs=232.5
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.++..++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999987555444455678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 768 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|++||+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE------ 154 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC------
Confidence 999999999986543 589999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH---HH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE---II 922 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~---ei 922 (1092)
.......+||+.|+|||++.+..++.++|+|||||++|+|++|++||...... ..
T Consensus 155 ----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~ 212 (285)
T cd05630 155 ----------------------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212 (285)
T ss_pred ----------------------CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 01112357999999999999999999999999999999999999999865432 22
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc--cHHHHHcCCCCCCCCcchhhhc--cCCccCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 993 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~--ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~ 993 (1092)
...+.... . ...+..+++++++||.+||+.||.+||+.+ .+.++++||||+.++|..+... +|+|+|.|
T Consensus 213 ~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05630 213 VERLVKEV-Q-EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP 285 (285)
T ss_pred HHhhhhhh-h-hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCCC
Confidence 22222211 1 123467899999999999999999999843 5889999999999999977653 67888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=390.94 Aligned_cols=258 Identities=34% Similarity=0.496 Sum_probs=215.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||+|+||+||+|+++.+++.||+|+++.... .......+.+|+.++..++||||++++++|...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976432 2334567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~------- 152 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE------- 152 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc-------
Confidence 9999987776655556799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
.........+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+
T Consensus 153 -------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 153 -------------------GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred -------------------cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0011122457999999999999999999999999999999999999999987654443333
Q ss_pred hhc-------------------CCCCCCC----------CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 927 LNR-------------------KIPWPCV----------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 927 l~~-------------------~l~fP~i----------p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
... ...+|.. ...+|.++.+||++||++||++||+ +.++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s---~~~~l~hp~f 287 (287)
T cd07848 214 QKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL---TEQCLNHPAF 287 (287)
T ss_pred HHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 221 0111110 1237889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=419.51 Aligned_cols=261 Identities=40% Similarity=0.669 Sum_probs=238.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LY 763 (1092)
....|++.+.||+|.||.||+|+.+.||+.||+|++.|...........+.+|+.||+++. |||||.+++.|++...+|
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4467999999999999999999999999999999999877766666788999999999999 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC----CcEEEEecCCcccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n----G~VKLsDFGLAk~~~~ 839 (1092)
+|||++.||+|++.+.+. .+++..+..++.|++.|+.|||+.||+||||||+|+|+... +.+|++|||++....
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~- 190 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK- 190 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc-
Confidence 999999999999999877 49999999999999999999999999999999999999643 579999999998631
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
........||||.|+|||++.+.+|+..+|+||+||++|.||+|.+||.+.+.
T Consensus 191 ---------------------------~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 191 ---------------------------PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred ---------------------------CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 13345678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 920 EIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~i-p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
..++.+|..+.+.|+.- ...++..+++||++||..||.+|++ +.++|+|||+++.
T Consensus 244 ~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~t---a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 244 FEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLT---AAQALQHPWIKSI 299 (382)
T ss_pred hHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCC---HHHHhcCccccCC
Confidence 99999999998876542 3568999999999999999999999 8899999998765
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=413.66 Aligned_cols=249 Identities=30% Similarity=0.552 Sum_probs=224.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEee-eeccCCe
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY-SFTCRDN 761 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~-sfqde~~ 761 (1092)
.....+|++++.||+|+||+||+|+...+|..+|.|.++ -.+......+.+..|+.+|++++|||||++|+ .|..+..
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 456778999999999999999999999999999999997 55667777889999999999999999999998 6666555
Q ss_pred -eEEEEeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHH--cC--CeeeecCCCceEecCCCcEEEEecC
Q 001360 762 -LYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHS--LG--IVHRDLKPDNLLIAHDGHIKLTDFG 832 (1092)
Q Consensus 762 -LYLVMEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs--~G--IIHRDLKPeNILLD~nG~VKLsDFG 832 (1092)
++||||||.+|||..+++. ...++|..++.|+.|++.||.++|. .. |+||||||.||+|+.+|.|||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 9999999999999999864 3569999999999999999999999 44 9999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCC
Q 001360 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912 (1092)
Q Consensus 833 LAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~ 912 (1092)
|++++. .....+.+.||||.||+||++.+.+|+.++|||||||++|||+.-.+
T Consensus 174 L~r~l~---------------------------s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~ 226 (375)
T KOG0591|consen 174 LGRFLS---------------------------SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQS 226 (375)
T ss_pred hHhHhc---------------------------chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCC
Confidence 999742 12334578999999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCC-CCCCHHHHHHHHHhccCCcCCCCC
Q 001360 913 PFTAESPEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLG 961 (1092)
Q Consensus 913 PF~~~s~~ei~~kIl~~~l~fP~ip-~~lS~eakDLI~kcL~kDP~KRpS 961 (1092)
||.+++-.++.++|.++.++ .+| ...|.++..||.-|+..||..||+
T Consensus 227 PF~g~n~~~L~~KI~qgd~~--~~p~~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 227 PFYGDNLLSLCKKIEQGDYP--PLPDEHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred CcccccHHHHHHHHHcCCCC--CCcHHHhhhHHHHHHHHHccCCcccCCC
Confidence 99999999999999998653 344 678999999999999999999998
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=405.24 Aligned_cols=259 Identities=28% Similarity=0.488 Sum_probs=219.4
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
+.|+.+..+|+|+||+||+|++++||+.||||.+...+. ...-.+-.++|+++|++++|||+|.|..+|.....++||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 568999999999999999999999999999999875432 2333456789999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||.. ++.+-|.+. ..++++.++.|+.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+...
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~------- 152 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS------- 152 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc-------
Confidence 99987 555555544 569999999999999999999999999999999999999999999999999999632
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
.+.......|.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+-|.+.+..+..-
T Consensus 153 --------------------~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy 212 (396)
T KOG0593|consen 153 --------------------APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY 212 (396)
T ss_pred --------------------CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH
Confidence 12333456789999999999998 789999999999999999999999999988765544
Q ss_pred HHhh-------------------cCCCCCCC---------CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 925 NILN-------------------RKIPWPCV---------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 925 kIl~-------------------~~l~fP~i---------p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
.|.. ..+.+|.. .+.++.-+.||+++||..||++|++ .++++.||||.+
T Consensus 213 ~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s---c~qll~H~yFd~ 289 (396)
T KOG0593|consen 213 LIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS---CEQLLHHPYFDG 289 (396)
T ss_pred HHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc---HHHHhcChHHHH
Confidence 4432 11223331 1356778999999999999999999 889999999965
Q ss_pred C
Q 001360 977 V 977 (1092)
Q Consensus 977 I 977 (1092)
+
T Consensus 290 ~ 290 (396)
T KOG0593|consen 290 F 290 (396)
T ss_pred H
Confidence 3
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=403.57 Aligned_cols=261 Identities=33% Similarity=0.551 Sum_probs=237.4
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..+.|++.++||+|.|+.||++.++.||+.+|+|++.-..+. ....+.+.+|++|-..++|||||+|...+......||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~-~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc-cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 456899999999999999999999999999999999754443 3467889999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC---CCcEEEEecCCcccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFGLAk~~~~n~ 841 (1092)
|+|+|.||+|..-+-..-.++|..+-.|++||+.||.|+|.+||||||+||+|+||-+ ..-+||+|||+|...
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l---- 163 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV---- 163 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe----
Confidence 9999999999887777677999999999999999999999999999999999999964 346999999999743
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
........++|||.|||||++...+|+..+|||+-|||||-||.|++||.+++...
T Consensus 164 ------------------------~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r 219 (355)
T KOG0033|consen 164 ------------------------NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 219 (355)
T ss_pred ------------------------CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH
Confidence 12344567899999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 922 i~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
+|+.|..+.+.+|. ..+.+++++++||++||..||.+|++ +.|.|+|||.++-
T Consensus 220 lye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt---a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 220 LYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT---ADEALKHPWICNR 273 (355)
T ss_pred HHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc---HHHHhCCchhcch
Confidence 99999999998876 45789999999999999999999999 8899999999864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=389.68 Aligned_cols=307 Identities=43% Similarity=0.806 Sum_probs=250.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||+|+||.||+|....+++.||+|.+.+...........+.+|+++|..++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765554456778999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 767 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
||+.||+|.+++.+. ..+++..++.++.|++.||.|||++|++|+||||+|||++.+|.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 569999999999999999999999999999999999999999999999999987432111000
Q ss_pred CCCCCCCCCCC--CCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 845 LSGPETDGIMP--SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 845 ls~~~t~g~~p--~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
........... ...................+||..|+|||++.+..++.++||||||+++|+|++|..||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 00000000000 0000000111112233457899999999999998999999999999999999999999999988888
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC-cccHHHHHcCCCCCCCCcchhhhccCCccCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPE 994 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpS-a~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~~ 994 (1092)
+..+......++. ...++.++.+||.+||..||++||+ ...+.+++.||||++++|..+....+|-+|.+.
T Consensus 241 ~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (316)
T cd05574 241 FSNILKKEVTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPD 312 (316)
T ss_pred HHHHhcCCccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCcc
Confidence 8888777666653 2237999999999999999999999 456889999999999999999888777777654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=390.21 Aligned_cols=257 Identities=28% Similarity=0.500 Sum_probs=215.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
.+++|++++.||.|+||.||+|+.+.++..||+|+++.... ......+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 35789999999999999999999999999999999875332 2234567899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~---- 155 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV---- 155 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC----
Confidence 9999975 9999887654 578999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
........+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.
T Consensus 156 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~ 212 (288)
T cd07871 156 -----------------------PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212 (288)
T ss_pred -----------------------CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0111233578999999999876 5689999999999999999999999998887666
Q ss_pred HHHHhhcC-------------------CCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 923 FDNILNRK-------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 923 ~~kIl~~~-------------------l~fP~--------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
...+.... ..+|. ....++.+++|||++||+.||.+||| +.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t---~~~~l~hp~f 288 (288)
T cd07871 213 LHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS---AEAALRHSYF 288 (288)
T ss_pred HHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC---HHHHhcCCCC
Confidence 55543210 01111 11357889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=414.73 Aligned_cols=254 Identities=31% Similarity=0.585 Sum_probs=238.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
...|++.+.||+|.||+|.++.....|+.||||.|+|..+..+++.-++.+|++||..++||||+++|.+|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35799999999999999999999899999999999999999999999999999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||..+|+|++|+.+.+.|++.+++.+++||+.|+.|+|+++++|||||.+|||||.|+++||+||||+-..
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly-------- 203 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY-------- 203 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh--------
Confidence 999999999999999999999999999999999999999999999999999999999999999999998642
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
.......++||+|.|.+||+++|.+| +..+|-|||||+||-|+.|..||.+.+...+.+
T Consensus 204 --------------------~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr 263 (668)
T KOG0611|consen 204 --------------------ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR 263 (668)
T ss_pred --------------------ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH
Confidence 12334568999999999999999999 689999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.|.++.+.-|. -+.++.-||++||.+||++|.+ +.+|..|-|.
T Consensus 264 QIs~GaYrEP~----~PSdA~gLIRwmLmVNP~RRAT---ieDiAsHWWv 306 (668)
T KOG0611|consen 264 QISRGAYREPE----TPSDASGLIRWMLMVNPERRAT---IEDIASHWWV 306 (668)
T ss_pred HhhcccccCCC----CCchHHHHHHHHHhcCcccchh---HHHHhhhhee
Confidence 99999887653 4567899999999999999999 8899999996
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=392.11 Aligned_cols=261 Identities=29% Similarity=0.517 Sum_probs=212.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++++.||.|+||+||+|+.+.+|+.||+|+++.... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999975432 22234678899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||+. |+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----- 155 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV----- 155 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC-----
Confidence 99996 5888877654 5689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh-HHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 922 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~-~ei 922 (1092)
........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+... ...
T Consensus 156 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 213 (303)
T cd07869 156 ----------------------PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213 (303)
T ss_pred ----------------------CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 0111234578999999999876 4588999999999999999999999987543 232
Q ss_pred HHHHhhc--C---CCCCC------------------------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCC
Q 001360 923 FDNILNR--K---IPWPC------------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1092)
Q Consensus 923 ~~kIl~~--~---l~fP~------------------------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPF 973 (1092)
...+... . ..+|. .....++++++||.+||+.||.+||| +.++++|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s---~~~~l~h~~ 290 (303)
T cd07869 214 LERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS---AQAALSHEY 290 (303)
T ss_pred HHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC---HHHHhcCcc
Confidence 3222210 0 00000 00124578999999999999999999 889999999
Q ss_pred CCCCCc
Q 001360 974 FKGVNW 979 (1092)
Q Consensus 974 FkgIdW 979 (1092)
|+++.+
T Consensus 291 f~~~~~ 296 (303)
T cd07869 291 FSDLPP 296 (303)
T ss_pred cccCCh
Confidence 998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=385.80 Aligned_cols=275 Identities=35% Similarity=0.613 Sum_probs=234.2
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
.|+..+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+++|..++|+||+.+++.|...+.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37889999999999999999999999999999987554444445667899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE------ 154 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC------
Confidence 99999999888654 3699999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
........||+.|+|||++.+..++.++|+|||||++|||++|..||...........
T Consensus 155 ----------------------~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~ 212 (285)
T cd05632 155 ----------------------GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212 (285)
T ss_pred ----------------------CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0111245799999999999999999999999999999999999999988765443333
Q ss_pred Hh----hcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc--cHHHHHcCCCCCCCCcchhhhc--cCCccCCC
Q 001360 926 IL----NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 993 (1092)
Q Consensus 926 Il----~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~--ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~ 993 (1092)
+. ..... ++..++.++.+||.+||..||.+||+.. .+.+++.||||+.++|+.+... .|+|+|.|
T Consensus 213 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05632 213 VDRRVLETEEV---YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP 285 (285)
T ss_pred HHHhhhccccc---cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCCC
Confidence 32 22222 3367889999999999999999999943 4789999999999999987655 67888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=425.74 Aligned_cols=256 Identities=35% Similarity=0.575 Sum_probs=227.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
..|.....||+|+.|.||.++...+++.||||.+..... ...+-+++|+.+|+..+|+|||+++.+|...+.+|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 467888899999999999999999999999999976443 23456899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
|||+||+|.+.+.. ..++|.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+..
T Consensus 350 Eym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~------- 421 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE------- 421 (550)
T ss_pred eecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc-------
Confidence 99999999998865 4599999999999999999999999999999999999999999999999999985321
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
...+..+.+|||.|||||++....|+.++||||||+++.||+-|.+||..+++......|
T Consensus 422 --------------------~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI 481 (550)
T KOG0578|consen 422 --------------------EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 481 (550)
T ss_pred --------------------ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH
Confidence 122456789999999999999999999999999999999999999999998887766666
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
.....+--..+..+|++++||+.+||+.|+.+|++ |.|+|.||||+-
T Consensus 482 a~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ras---A~eLL~HpFl~~ 528 (550)
T KOG0578|consen 482 ATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRAS---AKELLEHPFLKM 528 (550)
T ss_pred hhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCC---HHHHhcChhhhh
Confidence 65433322346889999999999999999999999 889999999954
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=392.01 Aligned_cols=263 Identities=30% Similarity=0.487 Sum_probs=213.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----Cee
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-----DNL 762 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde-----~~L 762 (1092)
.|++.+.||+|+||.||+|+++.+|..||||+++... ........+.+|+.+|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 4899999999999999999999999999999987432 2233456788999999999999999999887543 358
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~- 157 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT- 157 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc-
Confidence 99999995 6999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.........+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..
T Consensus 158 -----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~ 214 (338)
T cd07859 158 -----------------------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214 (338)
T ss_pred -----------------------CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH
Confidence 00011234679999999999876 67899999999999999999999999876643
Q ss_pred HHHHHHhh--------------------------cC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCC
Q 001360 921 IIFDNILN--------------------------RK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1092)
Q Consensus 921 ei~~kIl~--------------------------~~--l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HP 972 (1092)
.....+.. .. .++......+++++.+||.+||..||++||+ +.++++||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~e~l~hp 291 (338)
T cd07859 215 HQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT---AEEALADP 291 (338)
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC---HHHHhcCc
Confidence 32221110 00 0111111346788999999999999999999 88999999
Q ss_pred CCCCCCc
Q 001360 973 FFKGVNW 979 (1092)
Q Consensus 973 FFkgIdW 979 (1092)
||+++..
T Consensus 292 ~f~~~~~ 298 (338)
T cd07859 292 YFKGLAK 298 (338)
T ss_pred hhhhcCc
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=407.76 Aligned_cols=270 Identities=31% Similarity=0.519 Sum_probs=234.8
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
.+....++|++..+||.|.-++||+|+...++..||||++.-... ....+.+.+|+..|..++||||++++.+|..+.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc--~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC--NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh--hhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 455778999999999999999999999999999999999975332 234788999999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+|+||.||.+|++.++++.. ..|+|..+..+++++++||.|||++|.||||||+.||||+.+|.|||+|||.+....
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999999999864 459999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
.+. . .......+++|||.|||||++.. .+|+.|+||||||++..||.+|..||..
T Consensus 178 ~~G----------------------~-R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k 234 (516)
T KOG0582|consen 178 DSG----------------------D-RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK 234 (516)
T ss_pred ccC----------------------c-eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence 110 0 00111167899999999999765 5899999999999999999999999999
Q ss_pred CChHHHHHHHhhcCCCCCCC-------CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 917 ESPEIIFDNILNRKIPWPCV-------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~i-------p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
..+.++.-..+++..+.+.. ...++..++.+|..||.+||.+||+ |.++|+|+||+...
T Consensus 235 ~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt---AskLlkh~FFk~~k 300 (516)
T KOG0582|consen 235 YPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT---ASKLLKHAFFKKAK 300 (516)
T ss_pred CChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCC---HHHHhccHHHhhcc
Confidence 99999888888887764431 1346778999999999999999999 88999999998753
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=408.21 Aligned_cols=258 Identities=31% Similarity=0.505 Sum_probs=222.9
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcE-EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDL-FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~-VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.+.+...++.+.+.||+|+||+||+|.++ |.. ||+|++......... ...|.+|+.+|.+++|||||++++++...
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34456677788888999999999999997 555 999999876554444 78899999999999999999999999998
Q ss_pred C-eeEEEEeecCCCcHHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHcC-CeeeecCCCceEecCCC-cEEEEecCCc
Q 001360 760 D-NLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLG-IVHRDLKPDNLLIAHDG-HIKLTDFGLS 834 (1092)
Q Consensus 760 ~-~LYLVMEYm~GGSL~dlLkk--~g~LsE~~ar~yaaQIL~ALeYLHs~G-IIHRDLKPeNILLD~nG-~VKLsDFGLA 834 (1092)
. .++||||||++|+|..++.+ ...++...+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 8 79999999999999999988 578999999999999999999999999 99999999999999998 9999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc--CCCCCccceeechhhhHHHHHhCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--GTEHGYAADWWSVGIILFEFITGIP 912 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~--g~~Yt~ksDVWSLGVILYEMLTGk~ 912 (1092)
+..... ........||+.|||||++. ...|+.++||||||++||||+||..
T Consensus 192 r~~~~~---------------------------~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~ 244 (362)
T KOG0192|consen 192 REKVIS---------------------------KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEI 244 (362)
T ss_pred eeeccc---------------------------cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCC
Confidence 852100 01122368999999999999 6699999999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 913 PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
||.+..+.+....+..+..+ |.+|..+++.+..||.+||..||.+||++.++...|
T Consensus 245 Pf~~~~~~~~~~~v~~~~~R-p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l 300 (362)
T KOG0192|consen 245 PFEDLAPVQVASAVVVGGLR-PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRL 300 (362)
T ss_pred CCCCCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence 99999987777777655443 556677999999999999999999999965554444
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=415.03 Aligned_cols=262 Identities=33% Similarity=0.531 Sum_probs=226.7
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--C
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 760 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde--~ 760 (1092)
....+.|+.++.||+|.||.||+|++..||+.||+|.++... .+.....-..+|+.||++++||||++|.+...+. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 456778999999999999999999999999999999987533 2344456678999999999999999999988877 6
Q ss_pred eeEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
.+|||+|||+. ||.-++...+ .|++.+++.||.||+.||+|||.+||+|||||.+|||||.+|.+||+|||||++...
T Consensus 192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 79999999988 9999998754 699999999999999999999999999999999999999999999999999996321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
.........|.|.+|.|||.|+| ..|+.++|+||.||||.||++|++.|.+.+
T Consensus 271 --------------------------~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 271 --------------------------SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred --------------------------CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 11223456889999999999998 579999999999999999999999999999
Q ss_pred hHHHHHHHhhc-----CCCCC-----C----------------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCC
Q 001360 919 PEIIFDNILNR-----KIPWP-----C----------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1092)
Q Consensus 919 ~~ei~~kIl~~-----~l~fP-----~----------------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HP 972 (1092)
..+...+|..- .-.|| . .-..++..+.+|+..||+.||.+|.+ |.+.|.|+
T Consensus 325 EveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t---A~~aL~se 401 (560)
T KOG0600|consen 325 EVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT---ASSALQSE 401 (560)
T ss_pred HHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc---HHHHhcCc
Confidence 98888888751 11122 1 11357899999999999999999999 88999999
Q ss_pred CCC
Q 001360 973 FFK 975 (1092)
Q Consensus 973 FFk 975 (1092)
||.
T Consensus 402 yF~ 404 (560)
T KOG0600|consen 402 YFT 404 (560)
T ss_pred ccc
Confidence 994
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=391.09 Aligned_cols=259 Identities=28% Similarity=0.456 Sum_probs=220.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..++|++++.||+|+||.||+++++.+|..||+|+++... .......+.+|+++|.+++||||+++++++...+.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4579999999999999999999999999999999987531 23445679999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc-CCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~----- 155 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----- 155 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc-----
Confidence 999999999999998888899999999999999999999986 69999999999999999999999999986421
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++.
T Consensus 156 ------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 211 (331)
T cd06649 156 ------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE 211 (331)
T ss_pred ------------------------ccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 01122457999999999999999999999999999999999999999876654433
Q ss_pred HHHh----------------------------------------------hcCCCCCCC-CCCCCHHHHHHHHHhccCCc
Q 001360 924 DNIL----------------------------------------------NRKIPWPCV-PSDMSFEAQDLINRFLIHDP 956 (1092)
Q Consensus 924 ~kIl----------------------------------------------~~~l~fP~i-p~~lS~eakDLI~kcL~kDP 956 (1092)
..+. ... .|.. ...++.++++||.+||.+||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~~P 289 (331)
T cd06649 212 AIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEP--PPKLPNGVFTPDFQEFVNKCLIKNP 289 (331)
T ss_pred HHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCC--CcCCCCccccHHHHHHHHHHccCCc
Confidence 2211 110 0111 12478899999999999999
Q ss_pred CCCCCcccHHHHHcCCCCCCCCc
Q 001360 957 NQRLGANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 957 ~KRpSa~ga~EIL~HPFFkgIdW 979 (1092)
++||+ +.++++||||+....
T Consensus 290 ~~Rpt---~~ell~h~~~~~~~~ 309 (331)
T cd06649 290 AERAD---LKMLMNHTFIKRSEV 309 (331)
T ss_pred ccCCC---HHHHhcChHHhhccc
Confidence 99999 889999999986543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=417.30 Aligned_cols=259 Identities=32% Similarity=0.503 Sum_probs=222.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC-e
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD-N 761 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~-~ 761 (1092)
...+.|.+++.||.|+||.||+|+.+.+|..||||.+++. .... +...-++|+.-|++++ |||||+|++.+.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~K-f~s~-ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKK-FYSW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhh-hccH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 4567899999999999999999999999999999999763 3332 2334478999999999 999999999999988 8
Q ss_pred eEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
+|+|||||.. +|+++++.. ..|++..++.|+.||+.||+|+|++|+.||||||+|||+..+..|||+|||||+...
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~-- 161 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR-- 161 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--
Confidence 9999999976 999999765 469999999999999999999999999999999999999989999999999999632
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
........|-|.+|+|||+|+. ..|+.++|+||+||||+|+++-++-|.|.+.
T Consensus 162 --------------------------SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 162 --------------------------SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred --------------------------cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 1222345789999999999886 5679999999999999999999999999988
Q ss_pred HHHHHHHhh-------------------cCCCCCCC--------CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCC
Q 001360 920 EIIFDNILN-------------------RKIPWPCV--------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1092)
Q Consensus 920 ~ei~~kIl~-------------------~~l~fP~i--------p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HP 972 (1092)
.+..-+|.. ..+.||.. -+..+.++.+||.+||.+||.+||+ |.++|+||
T Consensus 216 ~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT---A~~al~~p 292 (538)
T KOG0661|consen 216 IDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT---ASQALQHP 292 (538)
T ss_pred HHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc---HHHHhcCc
Confidence 777666653 12333432 2348999999999999999999999 88999999
Q ss_pred CCCC
Q 001360 973 FFKG 976 (1092)
Q Consensus 973 FFkg 976 (1092)
||+.
T Consensus 293 ffq~ 296 (538)
T KOG0661|consen 293 FFQV 296 (538)
T ss_pred cccc
Confidence 9974
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=425.59 Aligned_cols=316 Identities=51% Similarity=0.941 Sum_probs=264.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
+++|++++.||+|+||+||+|.+..+++.||||++++...........+..|+.++..++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876666666678899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc--
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-- 843 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~-- 843 (1092)
|||+.||+|.+++...+.+++..++.|+.||+.||.|||.+|||||||||+||||+.+|++||+|||+++........
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~~ 162 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMM 162 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCccccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999998743210000
Q ss_pred cC---------------------------------------------------------C-----C----C---------
Q 001360 844 DL---------------------------------------------------------S-----G----P--------- 848 (1092)
Q Consensus 844 dl---------------------------------------------------------s-----~----~--------- 848 (1092)
++ . . +
T Consensus 163 ~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (669)
T cd05610 163 DILTTPSMAKPKNDYSRTPGQVLSLISSLGFNTPVGEKDQGSVNSGQNNGTSSVRTGTSHPLLMINKESLPMSLKLSKSC 242 (669)
T ss_pred ccccCccccCccccccCCCCceeeeeeecCcCCccccccccccccccccccccccccCCCCcccccccccccccHhhhhc
Confidence 00 0 0 0
Q ss_pred ----CCCCCCCC--------------------------------------------------------------------
Q 001360 849 ----ETDGIMPS-------------------------------------------------------------------- 856 (1092)
Q Consensus 849 ----~t~g~~p~-------------------------------------------------------------------- 856 (1092)
......+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (669)
T cd05610 243 LETSESSPSLPVRSLTPNLLKSRKRPEASTSSTHSCMTNSLSSCESECCSSNLKLLEQASSPSQSPRWSVDEGNIISEGE 322 (669)
T ss_pred cccccCCCCCCccccCcccccccccCCcccccchhhhhhhhhhccccccCcchhhhhhccCCCCCccccccCCCCccccc
Confidence 00000000
Q ss_pred --------------------------------------------------------------------------------
Q 001360 857 -------------------------------------------------------------------------------- 856 (1092)
Q Consensus 857 -------------------------------------------------------------------------------- 856 (1092)
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (669)
T cd05610 323 KSEKGSVKRSFELVEKSPCQELLQSKKTNAEYKRGCSITETNGNQSTGLTMEIQSLNLSKHKSRPKFLAGNEKRTGPKKK 402 (669)
T ss_pred ccccCCccccccccccChHHHHhcccccccccccceeeccccccccccceeecchhhhhhhhcCchhhhccccccCcccC
Confidence
Q ss_pred -----------C---------------------------------CC-------CCccc-------c-------------
Q 001360 857 -----------D---------------------------------AH-------YPEYQ-------Q------------- 865 (1092)
Q Consensus 857 -----------~---------------------------------~~-------~~~~~-------~------------- 865 (1092)
. .. ...|. .
T Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (669)
T cd05610 403 SNPVVAKNLMCELDDDGEKDGKYSNSSTSCGDDREIVLKLSLNSDSSFPEMSKNAVAFRSYNSPINVSNVSEPSTMSSLD 482 (669)
T ss_pred CCcchhhhhhccccccccccCCccccccccCccHHHhhhhhhccccccccccccceeeeccCchhhccccCCCCcccccc
Confidence 0 00 00000 0
Q ss_pred -------------------------------------------------cCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001360 866 -------------------------------------------------TDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 896 (1092)
Q Consensus 866 -------------------------------------------------~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksD 896 (1092)
.........+||+.|||||++.+..|+.++|
T Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~D 562 (669)
T cd05610 483 AMKMSGSQSGSYPAITPTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVD 562 (669)
T ss_pred hhhccccccCCCcccCCCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHH
Confidence 0000012247899999999999999999999
Q ss_pred eechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 897 WWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 897 VWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
||||||+||||++|.+||.+......+..++...+++|.....++..+.+++.+||..||.+||+ +.+++.||||..
T Consensus 563 iwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~dP~~R~t---a~e~l~h~~~~~ 639 (669)
T cd05610 563 WWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAG---LKELKQHPLFHG 639 (669)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhHCcC---HHHHHhCHhhcC
Confidence 99999999999999999999999999999998888888766788999999999999999999999 889999999999
Q ss_pred CCcchhhhccCCccCCCCCCCCcccccc
Q 001360 977 VNWDSLALQKAVFVPQPESVDDTSYFLS 1004 (1092)
Q Consensus 977 IdWd~L~~~~pPfiP~~~s~~Dts~Fds 1004 (1092)
++|..+.....+|.|.+....|+.||+.
T Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (669)
T cd05610 640 VDWENLQNQTMPFIPQPDDETDTSYFEA 667 (669)
T ss_pred CCHHHhcccCCCCCCCCCCccccccccc
Confidence 9999999999999999988888888865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=376.81 Aligned_cols=255 Identities=33% Similarity=0.517 Sum_probs=209.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeec-----
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFT----- 757 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~-TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L---~HPNIVkL~~sfq----- 757 (1092)
++|++++.||+|+||+||+|++.. +|..||+|+++.... .......+.+|+.++..+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 478899999875332 222334566777777665 6999999999875
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcc
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 835 (1092)
....+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999996 5999998754 358999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC
Q 001360 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 836 ~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
.... ........||+.|+|||++.+..++.++|||||||++|||++|.+||.
T Consensus 159 ~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 159 IYSF----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred eccC----------------------------CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 4210 112234679999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHhhcCC-----CCC-------------------CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 916 AESPEIIFDNILNRKI-----PWP-------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 916 ~~s~~ei~~kIl~~~l-----~fP-------------------~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
+.+..+.+..|..... .+| .+...++..+++||.+||+.||++||+ +.++++|
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~~~l~h 287 (290)
T cd07862 211 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSALSH 287 (290)
T ss_pred CCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC---HHHHhcC
Confidence 9888777777654210 111 011357888999999999999999999 8899999
Q ss_pred CCC
Q 001360 972 PFF 974 (1092)
Q Consensus 972 PFF 974 (1092)
|||
T Consensus 288 p~f 290 (290)
T cd07862 288 PYF 290 (290)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=370.23 Aligned_cols=257 Identities=60% Similarity=1.052 Sum_probs=224.9
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~-~L~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||.|+||.||+|.+..+|+.||+|++++...........+..|..++. ..+||||+++++++...+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999999999999999998655443444455566665554 45899999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||+++...
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------------- 148 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL------------- 148 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecc-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999887421
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l 931 (1092)
......|++.|+|||.+.+..++.++||||||+++|+|++|.+||...+...++..+.....
T Consensus 149 ------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 210 (260)
T cd05611 149 ------------------ENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI 210 (260)
T ss_pred ------------------ccccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence 01234688999999999988899999999999999999999999999888888888777665
Q ss_pred CCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcc
Q 001360 932 PWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 932 ~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd 980 (1092)
.++. ....++.++.++|.+||..||++||++.++.+++.||||++++|+
T Consensus 211 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 211 NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 5443 234689999999999999999999998889999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=393.06 Aligned_cols=264 Identities=30% Similarity=0.502 Sum_probs=235.0
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc-----cchhHHHHHHHHHHHHHhcC-CCceEEEeeee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----IRKNDIERILAERNILITVR-NPFVVRFFYSF 756 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei-----~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sf 756 (1092)
.-....|+..+.||+|..+.|.++.++.||+.+|+|++.-... .-..-.+..++|+.||+++. ||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 3456678888999999999999999999999999999864221 12233456788999999986 99999999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 757 TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 757 qde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
+.+..+++|+|.|+.|.|+|+|...-.+++..++.+|+|+..|++|||.++||||||||+|||+|++.++||+|||+|+.
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc------CCCCCccceeechhhhHHHHHhC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL------GTEHGYAADWWSVGIILFEFITG 910 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~------g~~Yt~ksDVWSLGVILYEMLTG 910 (1092)
. .++.+....||||+|+|||.+. ..+|+..+|+||+|||||.||.|
T Consensus 173 l----------------------------~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaG 224 (411)
T KOG0599|consen 173 L----------------------------EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAG 224 (411)
T ss_pred c----------------------------CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcC
Confidence 3 2344556789999999999985 35789999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 911 IPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 911 k~PF~~~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.+||.......+.+.|+.+++.|.. -..++|.+++|||++||++||.+|++ +.|+|+||||..+
T Consensus 225 cpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rit---ake~LaHpff~q~ 289 (411)
T KOG0599|consen 225 CPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRIT---AKEALAHPFFIQI 289 (411)
T ss_pred CCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhccc---HHHHhcChHHHHH
Confidence 9999999999999999999987753 23578999999999999999999999 8899999999654
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=373.74 Aligned_cols=266 Identities=36% Similarity=0.664 Sum_probs=224.8
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001360 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1092)
Q Consensus 695 LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL 774 (1092)
||.|+||+||+|....+|+.||+|++.+...........+.+|+.+|+.++||||+++++.|...+.+|+||||++||+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999875544444566778999999999999999999999999999999999999999
Q ss_pred HHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 001360 775 YSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (1092)
Q Consensus 775 ~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g 852 (1092)
.+++.+.. .+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------------- 147 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------------- 147 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-------------
Confidence 99998765 799999999999999999999999999999999999999999999999998864210
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh----HHHHHHHhh
Q 001360 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNILN 928 (1092)
Q Consensus 853 ~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~----~ei~~kIl~ 928 (1092)
........|+..|+|||++.+..++.++|+|||||++|+|++|+.||..... ..+...+..
T Consensus 148 ---------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05577 148 ---------------GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212 (277)
T ss_pred ---------------CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc
Confidence 0111234688999999999988899999999999999999999999977654 333333333
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc-c-cHHHHHcCCCCCCCCcchhhhc--cCCccC
Q 001360 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-N-GAAEVKAHPFFKGVNWDSLALQ--KAVFVP 991 (1092)
Q Consensus 929 ~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa-~-ga~EIL~HPFFkgIdWd~L~~~--~pPfiP 991 (1092)
.... .+..+++++.+||.+||..||.+||+. + .+.+++.||||+.++|..+... .|||.|
T Consensus 213 ~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 213 MAVE---YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred cccc---CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence 3322 346789999999999999999999962 2 4889999999999999887554 566655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=391.33 Aligned_cols=261 Identities=31% Similarity=0.510 Sum_probs=218.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----ee
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----NL 762 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~-----~L 762 (1092)
+|++++.||+|+||.||+|.+..+|+.||||.+.+. .........+.+|+.+|..++||||+++++++...+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 588999999999999999999999999999998653 222334567889999999999999999999998877 79
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-- 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-- 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC--
Confidence 99999996 589999888888999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.++..
T Consensus 157 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 212 (372)
T cd07853 157 ------------------------ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212 (372)
T ss_pred ------------------------ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH
Confidence 01112234689999999999874 57999999999999999999999999887766
Q ss_pred HHHHHhh-----------------------cCCCCC------CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCC
Q 001360 922 IFDNILN-----------------------RKIPWP------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1092)
Q Consensus 922 i~~kIl~-----------------------~~l~fP------~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HP 972 (1092)
....|.. .....| .+....++++.+||.+||+.||.+||+ +.++++||
T Consensus 213 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t---~~e~l~hp 289 (372)
T cd07853 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS---AADALAHP 289 (372)
T ss_pred HHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC---HHHHhcCH
Confidence 5554432 111111 122456889999999999999999999 88999999
Q ss_pred CCCCCCc
Q 001360 973 FFKGVNW 979 (1092)
Q Consensus 973 FFkgIdW 979 (1092)
||++..+
T Consensus 290 ~~~~~~~ 296 (372)
T cd07853 290 YLDEGRL 296 (372)
T ss_pred hhCCCcc
Confidence 9998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=375.27 Aligned_cols=260 Identities=38% Similarity=0.673 Sum_probs=213.4
Q ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH---hcCCCceEEEeeeeccCCeeEEEEeecC
Q 001360 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI---TVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (1092)
Q Consensus 694 ~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~---~L~HPNIVkL~~sfqde~~LYLVMEYm~ 770 (1092)
.||+|+||.||++....+|+.||+|++.+.............+|..++. ..+||||+.+++.+...+.+|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999998754433333344455554444 3479999999999999999999999999
Q ss_pred CCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCC
Q 001360 771 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (1092)
Q Consensus 771 GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t 850 (1092)
||+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~------------ 148 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS------------ 148 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecc------------
Confidence 99999999888889999999999999999999999999999999999999999999999999986311
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeechhhhHHHHHhCCCCCCCCCh---HHHHHHH
Q 001360 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFDNI 926 (1092)
Q Consensus 851 ~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~---~ei~~kI 926 (1092)
........||+.|+|||++. +..++.++|+|||||++|||++|..||..... .......
T Consensus 149 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 211 (279)
T cd05633 149 -----------------KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211 (279)
T ss_pred -----------------ccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh
Confidence 00112346999999999987 46689999999999999999999999975432 2222222
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC--cccHHHHHcCCCCCCCCcchhhhc
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ 985 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpS--a~ga~EIL~HPFFkgIdWd~L~~~ 985 (1092)
...... ++..++.++.+||.+||..||.+|++ ...+.++++||||++++|......
T Consensus 212 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 269 (279)
T cd05633 212 LTVNVE---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQ 269 (279)
T ss_pred hcCCcC---CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcC
Confidence 222222 34678999999999999999999995 234889999999999999987644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=372.00 Aligned_cols=254 Identities=30% Similarity=0.498 Sum_probs=208.1
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeeccC-----
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCR----- 759 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L---~HPNIVkL~~sfqde----- 759 (1092)
+|++++.||+|+||+||+|+++.+|+.||+|.++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 48999999999999999999999999999999875322 122223456677777655 799999999988653
Q ss_pred CeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
..+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 458999999985 899888764 34899999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
.. ........||+.|+|||++.+..++.++|||||||++|||++|++||.+.
T Consensus 159 ~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 159 SC----------------------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cC----------------------------cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 10 01112357899999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHhhcC-----CCCC-------------------CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCC
Q 001360 918 SPEIIFDNILNRK-----IPWP-------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1092)
Q Consensus 918 s~~ei~~kIl~~~-----l~fP-------------------~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPF 973 (1092)
.......++.... ..+| .....++.++.+||.+||+.||.+||+ +.+++.|||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~~l~hp~ 287 (288)
T cd07863 211 SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS---AFRALQHPF 287 (288)
T ss_pred CHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC---HHHHhcCCC
Confidence 7766665554310 0111 011357888999999999999999999 889999999
Q ss_pred C
Q 001360 974 F 974 (1092)
Q Consensus 974 F 974 (1092)
|
T Consensus 288 f 288 (288)
T cd07863 288 F 288 (288)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=405.58 Aligned_cols=257 Identities=30% Similarity=0.415 Sum_probs=210.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 759 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde---- 759 (1092)
....+|++++.||+|+||.||+|.+..+++.||||++.+.. ....+|+.+|+.++|||||+++++|...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 34568999999999999999999999999999999885422 2245799999999999999998876432
Q ss_pred ----CeeEEEEeecCCCcHHHHHH----hhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC-cEEEEe
Q 001360 760 ----DNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTD 830 (1092)
Q Consensus 760 ----~~LYLVMEYm~GGSL~dlLk----k~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsD 830 (1092)
..+|+||||+++ +|.+++. ....+++..++.|+.||+.||.|||++|||||||||+||||+.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 247899999986 6776664 345799999999999999999999999999999999999999765 699999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHh
Q 001360 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFIT 909 (1092)
Q Consensus 831 FGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLT 909 (1092)
||+|+.... .......+||+.|||||++.+. .|+.++|||||||+||||++
T Consensus 215 FGla~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt 266 (440)
T PTZ00036 215 FGSAKNLLA----------------------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266 (440)
T ss_pred cccchhccC----------------------------CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 999974210 1112346789999999998764 68999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhhc-----------------CCCCCC---------CCCCCCHHHHHHHHHhccCCcCCCCCcc
Q 001360 910 GIPPFTAESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (1092)
Q Consensus 910 Gk~PF~~~s~~ei~~kIl~~-----------------~l~fP~---------ip~~lS~eakDLI~kcL~kDP~KRpSa~ 963 (1092)
|.+||.+.+..+...++... .+.+|. +|...+.++.+||.+||++||.+||+
T Consensus 267 G~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t-- 344 (440)
T PTZ00036 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN-- 344 (440)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC--
Confidence 99999998776665555431 111221 23457889999999999999999999
Q ss_pred cHHHHHcCCCCCCCCc
Q 001360 964 GAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 964 ga~EIL~HPFFkgIdW 979 (1092)
+.++++||||..+..
T Consensus 345 -a~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 345 -PIEALADPFFDDLRD 359 (440)
T ss_pred -HHHHhCChhHHhhhc
Confidence 889999999987654
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=362.26 Aligned_cols=260 Identities=31% Similarity=0.503 Sum_probs=224.2
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~--kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
++|++.+.||.|+||.||+|....+++.||+|.+...... .......+.+|+.++.+++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998754322 22345678999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
||||++|++|.+++.+.+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~--- 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC--- 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc---
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
..........|++.|+|||++.+..++.++|+||||+++|||++|++||...+......
T Consensus 159 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 217 (263)
T cd06625 159 ---------------------SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF 217 (263)
T ss_pred ---------------------cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH
Confidence 00011124568899999999999889999999999999999999999998877766665
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.+...... +.++..++.++.+||.+||..+|.+||+ +.++++||||
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 263 (263)
T cd06625 218 KIATQPTN-PQLPSHVSPDARNFLRRTFVENAKKRPS---AEELLRHFFV 263 (263)
T ss_pred HHhccCCC-CCCCccCCHHHHHHHHHHhhcCcccCCC---HHHHhhCCCC
Confidence 55544333 3355788999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=404.51 Aligned_cols=261 Identities=34% Similarity=0.585 Sum_probs=238.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
...=|.+-+.||+|.|+.|.++++.-||..||||++.|..+.. -...++++|++.|+.+.|||||+||.+..+...+||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 3456888999999999999999999999999999999876543 345789999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEec-CCCcEEEEecCCccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD-~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+|+-.+|||++||.++. .+.|+.++.|++||+.||.|+|+..+|||||||+|+++. +-|-|||+|||++-.+
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf----- 169 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF----- 169 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC-----
Confidence 999999999999998874 699999999999999999999999999999999999875 5689999999987532
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCC-ccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG-YAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt-~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
.++....+.||+..|-|||+++|..|+ .++||||||||||-|++|++||...+..+
T Consensus 170 -----------------------~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 170 -----------------------QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred -----------------------CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 235566789999999999999999996 68999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcc
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd 980 (1092)
+.-+|+..++..| ..+|.+++|||..||.+||++|.+ +++|..|+|++.+|-.
T Consensus 227 TLTmImDCKYtvP---shvS~eCrdLI~sMLvRdPkkRAs---lEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 227 TLTMIMDCKYTVP---SHVSKECRDLIQSMLVRDPKKRAS---LEEIVSTSWLQAGDRG 279 (864)
T ss_pred hhhhhhcccccCc---hhhhHHHHHHHHHHHhcCchhhcc---HHHHhccccccCCCCC
Confidence 9999999999877 799999999999999999999998 8899999999987653
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=388.07 Aligned_cols=257 Identities=31% Similarity=0.490 Sum_probs=211.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
....++|+.++.||+|+||+||+|+++.+|+.||||++.+.. .......+.+|+.+|+.++||||++++++|...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 455788999999999999999999999999999999986532 233456789999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||+.+|+|... ..+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~--- 220 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ--- 220 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc---
Confidence 999999999998653 3456778888999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
........+||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 221 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 221 ------------------------TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred ------------------------ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 0011234579999999999843 23457899999999999999999999754
Q ss_pred ChHH---HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 918 SPEI---IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 918 s~~e---i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
...+ ....+... ..+..+..++.++++||.+||..||++||+ +.++++||||.+.
T Consensus 277 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt---~~ell~hp~~~~~ 334 (353)
T PLN00034 277 RQGDWASLMCAICMS--QPPEAPATASREFRHFISCCLQREPAKRWS---AMQLLQHPFILRA 334 (353)
T ss_pred CCccHHHHHHHHhcc--CCCCCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccccC
Confidence 3322 22222221 123345678999999999999999999999 8899999999874
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=361.60 Aligned_cols=265 Identities=62% Similarity=1.119 Sum_probs=230.7
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001360 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1092)
Q Consensus 695 LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL 774 (1092)
||.|+||.||+|++..+|+.||+|++.+...........+.+|++++.+++||||+++++.+.....+|+||||++||+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999876555556678899999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 001360 775 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854 (1092)
Q Consensus 775 ~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~ 854 (1092)
.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~---------- 150 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN---------- 150 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc----------
Confidence 9999888889999999999999999999999999999999999999999999999999987532110000
Q ss_pred CCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCC
Q 001360 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934 (1092)
Q Consensus 855 p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP 934 (1092)
............+++.|+|||++.+..++.++|+||||+++|+|++|..||........+..+..+...+|
T Consensus 151 ---------~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 221 (265)
T cd05579 151 ---------LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221 (265)
T ss_pred ---------cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence 00001122345689999999999988899999999999999999999999999999888888887766665
Q ss_pred CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCc
Q 001360 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 935 ~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdW 979 (1092)
.. ..++..+.+||.+||+.+|.+||++..+.++++||||++++|
T Consensus 222 ~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 222 ED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred cc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 32 225899999999999999999999877899999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=377.88 Aligned_cols=258 Identities=33% Similarity=0.536 Sum_probs=221.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
..|..++.||+|.||.||+|++..||+.||||.++..+.. ..--...++|+..|+.++||||+.|.++|....++.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 4688899999999999999999999999999999865332 222346789999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||+. ||...++.. -.|+...++.|+.++++||+|||.+.|+||||||.|+||+.+|.+||+|||||+.+..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~------ 153 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS------ 153 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC------
Confidence 99987 999999755 4699999999999999999999999999999999999999999999999999996431
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
+.......|-|.+|.|||.+.| +.|+..+|+||.|||+.||+.|.|-|.+.+..+...
T Consensus 154 ---------------------p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~ 212 (318)
T KOG0659|consen 154 ---------------------PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS 212 (318)
T ss_pred ---------------------CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH
Confidence 1111223489999999999987 579999999999999999999999999999888877
Q ss_pred HHhhc-----CCCCCC--------------------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 925 NILNR-----KIPWPC--------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 925 kIl~~-----~l~fP~--------------------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
.|... .-.||. +-...+.++.||+.+||.+||.+|++ +.+.++|+||+.
T Consensus 213 ~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit---a~qaL~~~yf~~ 286 (318)
T KOG0659|consen 213 KIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT---ASQALKHPYFKS 286 (318)
T ss_pred HHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhccc---HHHHhcchhhhc
Confidence 77651 112222 11346788999999999999999999 889999999975
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=362.51 Aligned_cols=257 Identities=39% Similarity=0.787 Sum_probs=225.4
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001360 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1092)
Q Consensus 695 LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL 774 (1092)
||.|+||.||+|+...+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||||+++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999999999999999876555555667899999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 001360 775 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854 (1092)
Q Consensus 775 ~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~ 854 (1092)
.+++.+...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~--------------- 145 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS--------------- 145 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc---------------
Confidence 99998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC--hHHHHHHHhhcCCC
Q 001360 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--PEIIFDNILNRKIP 932 (1092)
Q Consensus 855 p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s--~~ei~~kIl~~~l~ 932 (1092)
.......+|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... +...+..+..+...
T Consensus 146 -------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 212 (262)
T cd05572 146 -------------GQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK 212 (262)
T ss_pred -------------ccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC
Confidence 001234578999999999998889999999999999999999999998777 67777777742222
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcc
Q 001360 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 933 fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd 980 (1092)
+..|...+.++.+||.+||..||.+||+. ..+.++++||||++.+|+
T Consensus 213 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 213 -LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred -CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 22345668999999999999999999982 358899999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=388.74 Aligned_cols=265 Identities=33% Similarity=0.514 Sum_probs=224.6
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR- 759 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde- 759 (1092)
...-.+++|+.+..|+.|+||.||+|+++.|++.||+|.++-.. .+..---.-++|+.+|.+++|||||.+-......
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 34567889999999999999999999999999999999987532 2222233468999999999999999998766543
Q ss_pred -CeeEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 760 -DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 760 -~~LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
+.+|||||||+. ||..++.+.+ +|...+++.++.|++.||+|||.++|+||||||+|+|+...|.+||+|||||+..
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 469999999988 9999998876 8999999999999999999999999999999999999999999999999999852
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
. .........+.|.+|.|||.+++ ..|+.++|+||+|||+.|||+++|-|.+
T Consensus 228 g---------------------------sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G 280 (419)
T KOG0663|consen 228 G---------------------------SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG 280 (419)
T ss_pred c---------------------------CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC
Confidence 1 12233456789999999999997 5699999999999999999999999999
Q ss_pred CChHHHHHHHhhc-----CCCCCC--------------CC---------C-CCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 917 ESPEIIFDNILNR-----KIPWPC--------------VP---------S-DMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 917 ~s~~ei~~kIl~~-----~l~fP~--------------ip---------~-~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
.+..+...+|... .-.||. .| . .++....+|+..+|.+||.+|+| |.+
T Consensus 281 ~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t---A~~ 357 (419)
T KOG0663|consen 281 KSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT---AED 357 (419)
T ss_pred CchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc---HHH
Confidence 9988888887651 111221 11 1 26799999999999999999999 889
Q ss_pred HHcCCCCCCC
Q 001360 968 VKAHPFFKGV 977 (1092)
Q Consensus 968 IL~HPFFkgI 977 (1092)
.|+|.||...
T Consensus 358 ~L~h~~F~e~ 367 (419)
T KOG0663|consen 358 GLKHEYFRET 367 (419)
T ss_pred hhcccccccC
Confidence 9999999863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=381.36 Aligned_cols=260 Identities=24% Similarity=0.365 Sum_probs=207.7
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 755 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~s 755 (1092)
+.+..++|++.+.||+|+||.||+|.+ +.+++.||+|+++... .......+.+|+.+|..+ +|||||+++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 345667899999999999999999975 2446789999987532 234456789999999999 89999999998
Q ss_pred eccCC-eeEEEEeecCCCcHHHHHHhh-----------------------------------------------------
Q 001360 756 FTCRD-NLYLVMEYLNGGDLYSLLRKV----------------------------------------------------- 781 (1092)
Q Consensus 756 fqde~-~LYLVMEYm~GGSL~dlLkk~----------------------------------------------------- 781 (1092)
+...+ .+|+||||++||+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 87654 589999999999999999752
Q ss_pred ---------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 001360 782 ---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (1092)
Q Consensus 782 ---------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g 852 (1092)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~----------- 228 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP----------- 228 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc-----------
Confidence 237778889999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCC
Q 001360 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKI 931 (1092)
Q Consensus 853 ~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l 931 (1092)
.........+|+.|||||++.+..|+.++|||||||+||||++ |.+||.+......+...+....
T Consensus 229 --------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 294 (338)
T cd05102 229 --------------DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT 294 (338)
T ss_pred --------------chhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC
Confidence 0011123456789999999999999999999999999999997 9999988654433333333222
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 932 ~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
. +..+..+++++.+||.+||..||.+||++.++.+.+
T Consensus 295 ~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l 331 (338)
T cd05102 295 R-MRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331 (338)
T ss_pred C-CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 2 223567899999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=375.81 Aligned_cols=260 Identities=27% Similarity=0.500 Sum_probs=215.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..++|++++.||+|+||.||+|+.+.+++.||+|+++.... ......+.+|+.++++++||||+++++++...+.+|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 35789999999999999999999999999999999875432 2233457789999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---- 156 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV---- 156 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC----
Confidence 9999975 888888654 4589999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.
T Consensus 157 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 213 (309)
T cd07872 157 -----------------------PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213 (309)
T ss_pred -----------------------CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 0011123468999999999875 4689999999999999999999999998776555
Q ss_pred HHHHhhc-------------------CCCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 923 FDNILNR-------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 923 ~~kIl~~-------------------~l~fP~--------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
...+... ...+|. ....++.++++||.+||+.||.+||+ +.+++.||||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~ 290 (309)
T cd07872 214 LHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS---AEEAMKHAYFR 290 (309)
T ss_pred HHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC---HHHHhcChhhh
Confidence 4444321 011111 11357889999999999999999999 88999999998
Q ss_pred CC
Q 001360 976 GV 977 (1092)
Q Consensus 976 gI 977 (1092)
++
T Consensus 291 ~~ 292 (309)
T cd07872 291 SL 292 (309)
T ss_pred hc
Confidence 64
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=382.28 Aligned_cols=257 Identities=31% Similarity=0.511 Sum_probs=218.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..++|++.+.||.|+||.||+++++.+|..+|+|+++... .......+.+|+++|..++||||++++++|.+.+.+|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 4578999999999999999999999999999999887531 23445678999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc-CCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||++||+|.+++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~----- 155 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----- 155 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh-----
Confidence 999999999999999888899999999999999999999975 79999999999999999999999999986421
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......+.
T Consensus 156 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 211 (333)
T cd06650 156 ------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE 211 (333)
T ss_pred ------------------------hhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH
Confidence 00112357999999999999989999999999999999999999999865543332
Q ss_pred HHH--------------------------------------------hhcCCCCCCCC-CCCCHHHHHHHHHhccCCcCC
Q 001360 924 DNI--------------------------------------------LNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQ 958 (1092)
Q Consensus 924 ~kI--------------------------------------------l~~~l~fP~ip-~~lS~eakDLI~kcL~kDP~K 958 (1092)
..+ .+... |.++ ..++.++++||.+||++||.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~ 289 (333)
T cd06650 212 LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAE 289 (333)
T ss_pred HHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCccc
Confidence 111 11110 1111 236789999999999999999
Q ss_pred CCCcccHHHHHcCCCCCCC
Q 001360 959 RLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 959 RpSa~ga~EIL~HPFFkgI 977 (1092)
||+ +.+++.||||+..
T Consensus 290 Rpt---~~ell~h~~~~~~ 305 (333)
T cd06650 290 RAD---LKQLMVHAFIKRS 305 (333)
T ss_pred CcC---HHHHhhCHHHhcC
Confidence 999 8899999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=395.31 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=210.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+...+|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+++|++++|||||+++++|......|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 445789999999999999999999999999999996532 34678999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+|||++. ++|..++.....+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++....
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~---- 234 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD---- 234 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc----
Confidence 9999995 69999998888899999999999999999999999999999999999999999999999999864210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-----
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES----- 918 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s----- 918 (1092)
.........+||+.|+|||++.+..|+.++|||||||++|||++|..||....
T Consensus 235 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~ 292 (391)
T PHA03212 235 ----------------------INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGD 292 (391)
T ss_pred ----------------------ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccccc
Confidence 00112234689999999999999999999999999999999999998875432
Q ss_pred --hHHHHHHHhh--------------------------cCCCCCCC------CCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 919 --PEIIFDNILN--------------------------RKIPWPCV------PSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 919 --~~ei~~kIl~--------------------------~~l~fP~i------p~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
.......++. .....|.. ...++.++.+||.+||+.||.+||+
T Consensus 293 ~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt--- 369 (391)
T PHA03212 293 CDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS--- 369 (391)
T ss_pred CchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC---
Confidence 1111111111 00000000 0135678999999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 001360 965 AAEVKAHPFFKGV 977 (1092)
Q Consensus 965 a~EIL~HPFFkgI 977 (1092)
+.++++||||+.+
T Consensus 370 a~elL~hp~f~~~ 382 (391)
T PHA03212 370 AEALLDFAAFQDI 382 (391)
T ss_pred HHHHhcChhhccC
Confidence 8899999999764
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=368.12 Aligned_cols=260 Identities=38% Similarity=0.650 Sum_probs=215.4
Q ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH---HHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 001360 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI---LITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (1092)
Q Consensus 694 ~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieI---L~~L~HPNIVkL~~sfqde~~LYLVMEYm~ 770 (1092)
.||+|+||.||+|.+..+|+.||+|++.+...........+..|..+ +....||+|+.+++.|...+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987544333333334455444 344579999999999999999999999999
Q ss_pred CCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCC
Q 001360 771 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (1092)
Q Consensus 771 GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t 850 (1092)
||+|..++.+.+.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~------------ 148 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS------------ 148 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccC------------
Confidence 99999999888889999999999999999999999999999999999999999999999999986321
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCC---ChHHHHHHH
Q 001360 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE---SPEIIFDNI 926 (1092)
Q Consensus 851 ~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~---s~~ei~~kI 926 (1092)
.......+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||... ........+
T Consensus 149 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 211 (278)
T cd05606 149 -----------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211 (278)
T ss_pred -----------------ccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh
Confidence 001123579999999999975 46899999999999999999999999876 333333333
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc--cHHHHHcCCCCCCCCcchhhhc
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ 985 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~--ga~EIL~HPFFkgIdWd~L~~~ 985 (1092)
......+ +..++.++.+||.+||..||.+||... .+.++++||||++++|+.+...
T Consensus 212 ~~~~~~~---~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~ 269 (278)
T cd05606 212 LTMAVEL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269 (278)
T ss_pred hccCCCC---CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhc
Confidence 3333333 356799999999999999999999422 4889999999999999988655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=382.71 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=212.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~---- 760 (1092)
..++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||+++++.|....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 4689999999999999999999999999999999987532 23344567889999999999999999998876543
Q ss_pred --eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 --~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+|+||||+.+ +|..++.. .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 57999999975 77777753 48889999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 178 ~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 178 T----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred C----------------------------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 0 011234579999999999999999999999999999999999999999888
Q ss_pred hHHHHHHHhhcCC----------------------CC--------------C---CCCCCCCHHHHHHHHHhccCCcCCC
Q 001360 919 PEIIFDNILNRKI----------------------PW--------------P---CVPSDMSFEAQDLINRFLIHDPNQR 959 (1092)
Q Consensus 919 ~~ei~~kIl~~~l----------------------~f--------------P---~ip~~lS~eakDLI~kcL~kDP~KR 959 (1092)
..+.+.+++.... .+ + ......+.++++||.+||+.||.+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 309 (364)
T cd07875 230 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309 (364)
T ss_pred HHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccC
Confidence 7666665543100 00 0 0011235688999999999999999
Q ss_pred CCcccHHHHHcCCCCCC
Q 001360 960 LGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 960 pSa~ga~EIL~HPFFkg 976 (1092)
|+ +.++++||||..
T Consensus 310 ~t---~~e~L~hp~~~~ 323 (364)
T cd07875 310 IS---VDEALQHPYINV 323 (364)
T ss_pred CC---HHHHhcCccccc
Confidence 99 889999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=381.76 Aligned_cols=258 Identities=28% Similarity=0.469 Sum_probs=211.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~--- 760 (1092)
...++|++++.||+|+||.||+|.++.+|..||+|++.+.. ........+.+|+.++..++||||++++++|....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 34689999999999999999999999999999999997542 23344567889999999999999999999886553
Q ss_pred ---eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 761 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 761 ---~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999976 6666664 34889999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
.. ........||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.
T Consensus 174 ~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 174 CT----------------------------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cc----------------------------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 10 11123457999999999999999999999999999999999999999877
Q ss_pred ChHHHHHHHhh----------------------cCCCCCC-----------------CCCCCCHHHHHHHHHhccCCcCC
Q 001360 918 SPEIIFDNILN----------------------RKIPWPC-----------------VPSDMSFEAQDLINRFLIHDPNQ 958 (1092)
Q Consensus 918 s~~ei~~kIl~----------------------~~l~fP~-----------------ip~~lS~eakDLI~kcL~kDP~K 958 (1092)
+....+..+.. ....++. .....+.++++||.+||+.||.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 305 (359)
T cd07876 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDK 305 (359)
T ss_pred CHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCccc
Confidence 65443322221 1111110 11224678999999999999999
Q ss_pred CCCcccHHHHHcCCCCCC
Q 001360 959 RLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 959 RpSa~ga~EIL~HPFFkg 976 (1092)
||+ +.++++||||..
T Consensus 306 R~t---~~e~l~hp~~~~ 320 (359)
T cd07876 306 RIS---VDEALRHPYITV 320 (359)
T ss_pred CCC---HHHHhcCchhhh
Confidence 999 889999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=400.75 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=206.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC------CCceEEEeeeec
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR------NPFVVRFFYSFT 757 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~------HPNIVkL~~sfq 757 (1092)
...++|++++.||+|+||+||+|.+..+++.||||++++.. .....+..|+.++..++ |++|++++++|.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34578999999999999999999999999999999997532 12334556777777665 456899998887
Q ss_pred cC-CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCC-----------
Q 001360 758 CR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDG----------- 824 (1092)
Q Consensus 758 de-~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG----------- 824 (1092)
.. ..+|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+||||+.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 65 4689999988 77999999888899999999999999999999998 5999999999999998766
Q ss_pred -----cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeec
Q 001360 825 -----HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899 (1092)
Q Consensus 825 -----~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWS 899 (1092)
.+||+|||++... .......+||+.|||||++.+..|+.++||||
T Consensus 281 ~~~~~~vkl~DfG~~~~~------------------------------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 330 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDE------------------------------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWS 330 (467)
T ss_pred CCCCceEEECCCCccccC------------------------------ccccccccCCccccCcHHhhcCCCCcHHHHHH
Confidence 4999999987531 11123568999999999999999999999999
Q ss_pred hhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCC------------------------CC---------------CCCC
Q 001360 900 VGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP------------------------CV---------------PSDM 940 (1092)
Q Consensus 900 LGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP------------------------~i---------------p~~l 940 (1092)
|||++|||++|++||.+.+..+....+......+| .. ....
T Consensus 331 lGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (467)
T PTZ00284 331 MGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR 410 (467)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhc
Confidence 99999999999999988776554443322110000 00 0011
Q ss_pred CHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 941 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 941 S~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
++.+.|||.+||++||.+||+ +.++++||||...
T Consensus 411 ~~~~~dli~~mL~~dP~~R~t---a~e~L~Hp~~~~~ 444 (467)
T PTZ00284 411 DDLLCDLIYGLLHYDRQKRLN---ARQMTTHPYVLKY 444 (467)
T ss_pred hHHHHHHHHHhCCcChhhCCC---HHHHhcCcccccc
Confidence 456789999999999999999 8899999999753
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=353.89 Aligned_cols=254 Identities=28% Similarity=0.534 Sum_probs=220.0
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-CeeEEEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-DNLYLVM 766 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde-~~LYLVM 766 (1092)
+|++++.||+|+||.||+++++.+++.||+|.+..... .....+.+.+|+.++++++||||+++++.+... ..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999999875332 334566788999999999999999999888754 4689999
Q ss_pred eecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 767 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
||+++++|.+++... ..+++..+..++.+++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~----- 154 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN----- 154 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc-----
Confidence 999999999999763 4589999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
.........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+......
T Consensus 155 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~ 212 (257)
T cd08223 155 ----------------------QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212 (257)
T ss_pred ----------------------cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0011234568999999999999999999999999999999999999999888777776
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.+..+.. +..+..+++++.+||.+||..||.+||+ +.+++.||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 257 (257)
T cd08223 213 RIIEGKL--PPMPKDYSPELGELIATMLSKRPEKRPS---VKSILRQPYI 257 (257)
T ss_pred HHHhcCC--CCCccccCHHHHHHHHHHhccCcccCCC---HHHHhcCCCC
Confidence 7666544 3345778999999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=366.82 Aligned_cols=268 Identities=33% Similarity=0.574 Sum_probs=228.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..+.|++++.||.|+||.||+|+...++..||+|++... .......+.+|+.+++.++||||+++++.+.....+|+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 346799999999999999999999999999999998753 33456778899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||++||+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~---- 162 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK---- 162 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc----
Confidence 9999999999888764 45689999999999999999999999999999999999999999999999998763110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
.........|++.|+|||++. ...++.++|||||||++|||++|.+||...+
T Consensus 163 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 163 -----------------------TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred -----------------------cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 011122456899999999985 3457889999999999999999999999888
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhc
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~ 985 (1092)
+...+.++.....+....+..++.++.+||.+||..||.+||+ +.++++||||..++|......
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~~~~~~ 283 (292)
T cd06644 220 PMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPS---AAQLLEHPFVSSVTSNRPLRE 283 (292)
T ss_pred HHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccccccchhHHH
Confidence 7776666655443322235678899999999999999999999 889999999999999875443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=352.75 Aligned_cols=254 Identities=30% Similarity=0.529 Sum_probs=223.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|.+.+.||+|+||.||+|.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 58999999999999999999999999999999875433 34456788999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|++|++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||+++....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~------ 153 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD------ 153 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccC------
Confidence 99999999999764 5689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
.........|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......
T Consensus 154 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08529 154 ---------------------NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212 (256)
T ss_pred ---------------------ccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 00111245689999999999999999999999999999999999999998888887777
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 926 Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
+..+.. +.++..++.++.++|.+||+.+|++||+ +.+++.|||+
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 256 (256)
T cd08529 213 IIRGVF--PPVSQMYSQQLAQLIDQCLTKDYRQRPD---TFQLLRNPSL 256 (256)
T ss_pred HHcCCC--CCCccccCHHHHHHHHHHccCCcccCcC---HHHHhhCCCC
Confidence 766543 3344578899999999999999999999 8899999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=360.51 Aligned_cols=255 Identities=38% Similarity=0.664 Sum_probs=215.6
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEY 768 (1092)
|++.+.||+|+||+||+++...+++.||+|++........ ......+|+.++.+++||||+++++++.+...+|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 7899999999999999999999999999999987543322 233445699999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCC
Q 001360 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848 (1092)
Q Consensus 769 m~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~ 848 (1092)
+.+++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~---------- 149 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS---------- 149 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 9999999999988899999999999999999999999999999999999999999999999999986410
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeechhhhHHHHHhCCCCCCCCC---hHHHHH
Q 001360 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAES---PEIIFD 924 (1092)
Q Consensus 849 ~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s---~~ei~~ 924 (1092)
..........||+.|+|||++. +..++.++||||||+++|+|++|..||.... ......
T Consensus 150 -----------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~ 212 (260)
T PF00069_consen 150 -----------------ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE 212 (260)
T ss_dssp -----------------STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred -----------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence 0112334567999999999998 7889999999999999999999999999873 333443
Q ss_pred HHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
+........+. .....+.++.+||.+||..||++||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~l~~~~~~ 260 (260)
T PF00069_consen 213 KILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPS---AEELLKHPWF 260 (260)
T ss_dssp HHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTT---HHHHHTSGGG
T ss_pred hcccccccccccccchhHHHHHHHHHHHccCChhHCcC---HHHHhcCCCC
Confidence 33332211110 01223489999999999999999999 8899999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=404.89 Aligned_cols=257 Identities=30% Similarity=0.509 Sum_probs=229.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
..|+.+..||+|+||.||+|.+..+++.||+|++.-.. .+.+++.+.+|+.+|.++++|||.++|++|.....++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 45778899999999999999999999999999997533 3456888999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
|||.||++.++|+....+.+..+..++++++.||.|||..+.||||||+.|||+..+|.+||+|||.+....
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~-------- 162 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT-------- 162 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee--------
Confidence 999999999999988888999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
.......+++|||.||||||+.+.+|+.++||||||++.+||++|.|||....+......|
T Consensus 163 -------------------~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI 223 (467)
T KOG0201|consen 163 -------------------NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI 223 (467)
T ss_pred -------------------chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec
Confidence 1123347899999999999999999999999999999999999999999998885444334
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
-+.. .|.+...+|+.+++||..||.+||+.||+ |.++|+|+|.+..
T Consensus 224 pk~~--PP~L~~~~S~~~kEFV~~CL~k~P~~Rps---A~~LLKh~FIk~a 269 (467)
T KOG0201|consen 224 PKSA--PPRLDGDFSPPFKEFVEACLDKNPEFRPS---AKELLKHKFIKRA 269 (467)
T ss_pred cCCC--CCccccccCHHHHHHHHHHhhcCcccCcC---HHHHhhhHHHHhc
Confidence 3333 35556789999999999999999999999 8999999999874
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=379.13 Aligned_cols=256 Identities=29% Similarity=0.471 Sum_probs=211.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC------
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------ 759 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde------ 759 (1092)
.+.|++++.||+|+||+||+|.+..+++.||+|++.+.. ........+.+|+.+|+.++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 478999999999999999999999999999999987532 2223456678999999999999999999888644
Q ss_pred CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
..+|++|+++ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~- 169 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD- 169 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC-
Confidence 3479999998 779988775 4569999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+
T Consensus 170 -----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 170 -----------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred -----------------------------CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 01124579999999999987 568999999999999999999999998876
Q ss_pred hHHHHHHHhhcCC--------------------CCCC--------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 919 PEIIFDNILNRKI--------------------PWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 919 ~~ei~~kIl~~~l--------------------~fP~--------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
..+....+..... .++. .....++.+.+||.+||..||.+||+ +.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s---~~ell~ 297 (343)
T cd07878 221 YIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS---ASEALA 297 (343)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC---HHHHhc
Confidence 6554444432100 0011 11245678899999999999999999 889999
Q ss_pred CCCCCCC
Q 001360 971 HPFFKGV 977 (1092)
Q Consensus 971 HPFFkgI 977 (1092)
||||...
T Consensus 298 hp~~~~~ 304 (343)
T cd07878 298 HPYFSQY 304 (343)
T ss_pred Ccchhcc
Confidence 9999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=364.60 Aligned_cols=274 Identities=46% Similarity=0.847 Sum_probs=229.4
Q ss_pred CeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 001360 688 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIR-KNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k---~TGk~VAIKvLkK~ei~k-k~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~L 762 (1092)
+|++.+.||+|+||.||+++.. .+++.||||++++..... .....++.+|+.++.++ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 467899999998644322 23456788999999999 599999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||+++|+|.+++.....+++..++.++.|++.||.|||+.|++||||||.|||++.++.++|+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-- 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc--
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998742110
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC--CCccceeechhhhHHHHHhCCCCCCCCC--
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES-- 918 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~--Yt~ksDVWSLGVILYEMLTGk~PF~~~s-- 918 (1092)
........+|++.|+|||.+.+.. ++.++|+||||+++|||++|..||....
T Consensus 159 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 214 (288)
T cd05583 159 ------------------------EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214 (288)
T ss_pred ------------------------cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc
Confidence 011122456899999999987654 7889999999999999999999996543
Q ss_pred --hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhc--cCCcc
Q 001360 919 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFV 990 (1092)
Q Consensus 919 --~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~--~pPfi 990 (1092)
..++.+.+.....+. +..++.++.+||.+||+.||++||++.++.++++||||+.++|+.+... .++|.
T Consensus 215 ~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 287 (288)
T cd05583 215 NSQSEISRRILKSKPPF---PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPFK 287 (288)
T ss_pred chHHHHHHHHHccCCCC---CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhhccCCCCC
Confidence 234444444444333 4678899999999999999999999989999999999999999988766 34443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=398.08 Aligned_cols=259 Identities=29% Similarity=0.406 Sum_probs=224.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTT-GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~T-Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
...|.+.+.||+|+||.||+|....+ +..||+|.+... .......+.+|+.+|..++|||||+++++|...+.+||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999998877 788999976432 33445678899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 765 VMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999988754 346899999999999999999999999999999999999999999999999999752100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..
T Consensus 223 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~ 277 (478)
T PTZ00267 223 -------------------------VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR 277 (478)
T ss_pred -------------------------cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0011234568999999999999999999999999999999999999999999888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
+++..+..+... ..+..++.++.+||.+||..||++||+ +.+++.|||++.+
T Consensus 278 ~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps---~~~~l~~~~~~~~ 329 (478)
T PTZ00267 278 EIMQQVLYGKYD--PFPCPVSSGMKALLDPLLSKNPALRPT---TQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHhCCCC--CCCccCCHHHHHHHHHHhccChhhCcC---HHHHHhCHHHHHH
Confidence 888888776543 234678999999999999999999999 8899999999643
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=357.73 Aligned_cols=262 Identities=27% Similarity=0.468 Sum_probs=221.9
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD---MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~e---i~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
+|++.+.||+|+||+||+|.. .+|+.+|+|.++... .........+.+|+++|+.++||||+++++++.+.+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 578899999999999999986 478999999886432 1223445678999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
||||++||+|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL-- 157 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999874211000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
. ...........||+.|+|||++.+..++.++|+|||||++|+|++|..||...+......
T Consensus 158 -~------------------~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~ 218 (265)
T cd06631 158 -H------------------GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218 (265)
T ss_pred -c------------------ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH
Confidence 0 000111234569999999999999899999999999999999999999998877655555
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.+.......|.++..++.++.+||.+||..+|.+||+ +.+++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~ 265 (265)
T cd06631 219 YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS---ALQLLRHDFL 265 (265)
T ss_pred HhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 5554434455566789999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=386.58 Aligned_cols=261 Identities=33% Similarity=0.540 Sum_probs=219.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-----CCe
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-----RDN 761 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd-----e~~ 761 (1092)
..|..++.||+|+||.|+.+.++.||+.||||.+.. .+...-..++.++|+.+|+.++|+||+.+++.+.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 456668999999999999999999999999998763 24455678899999999999999999999998876 345
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+|+|+|+|. -||...++....+++..++++++||+.||.|+|+.||+||||||.|+|++.+..+||+|||||+.....
T Consensus 101 vYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~- 178 (359)
T KOG0660|consen 101 VYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF- 178 (359)
T ss_pred eEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence 999999995 499999988888999999999999999999999999999999999999999999999999999953210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.........+.|.+|.|||++.. ..|+.++||||+||||.|||+|++-|.+.+.-
T Consensus 179 ------------------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v 234 (359)
T KOG0660|consen 179 ------------------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV 234 (359)
T ss_pred ------------------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH
Confidence 01122345688999999998864 68999999999999999999999999997754
Q ss_pred HHHHHHhh-----------------------c-----CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCC
Q 001360 921 IIFDNILN-----------------------R-----KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1092)
Q Consensus 921 ei~~kIl~-----------------------~-----~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HP 972 (1092)
...+.|+. . +.+|..+-+..++.+.||+.+||..||.+|+| ++|.|+||
T Consensus 235 ~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit---a~eAL~hP 311 (359)
T KOG0660|consen 235 HQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT---AEEALAHP 311 (359)
T ss_pred HHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC---HHHHhcCh
Confidence 44444332 1 11122223578999999999999999999999 88999999
Q ss_pred CCCCC
Q 001360 973 FFKGV 977 (1092)
Q Consensus 973 FFkgI 977 (1092)
||...
T Consensus 312 Yl~~~ 316 (359)
T KOG0660|consen 312 YLAPY 316 (359)
T ss_pred hhhhh
Confidence 99764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=399.86 Aligned_cols=264 Identities=29% Similarity=0.478 Sum_probs=227.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-- 760 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~-- 760 (1092)
....++|++.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|..++|+||++++..|...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3456799999999999999999999999999999999976433 3455677889999999999999999987775432
Q ss_pred ------eeEEEEeecCCCcHHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEe
Q 001360 761 ------NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 830 (1092)
Q Consensus 761 ------~LYLVMEYm~GGSL~dlLkk~----g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsD 830 (1092)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||||+.++++||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 378999999999999998653 4689999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC
Q 001360 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910 (1092)
Q Consensus 831 FGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTG 910 (1092)
||+++..... .........+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 187 FGls~~~~~~-------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG 241 (496)
T PTZ00283 187 FGFSKMYAAT-------------------------VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241 (496)
T ss_pred cccCeecccc-------------------------ccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9998752100 001112356899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 911 k~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
+.||.+.+..+++..+..+... .++..+++++.+||.+||..||.+||+ +.++++|||++..
T Consensus 242 ~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~RPs---~~ell~~p~~~~~ 303 (496)
T PTZ00283 242 KRPFDGENMEEVMHKTLAGRYD--PLPPSISPEMQEIVTALLSSDPKRRPS---SSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccChhhCcC---HHHHHhCHHHHHh
Confidence 9999999988888888776543 245789999999999999999999999 8899999998753
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=362.95 Aligned_cols=260 Identities=33% Similarity=0.576 Sum_probs=224.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++++.||.|+||.||+|.+..++..||+|+++.. .......+.+|+.++++++||||+++++.+.....+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 46799999999999999999999989999999998643 344567788999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||+++|+|.+++.+. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~----- 155 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS----- 155 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc-----
Confidence 9999999999998764 4699999999999999999999999999999999999999999999999998764210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
.........||+.|+|||++. ...++.++|+|||||++|||++|++||...+.
T Consensus 156 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 156 ----------------------TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred ----------------------cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 011123457999999999985 34567899999999999999999999998888
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
......+.....+....+..++.++.+||.+||..||.+||+ +.++++||||....
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~~ 269 (280)
T cd06611 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT---AAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcC---HHHHhcChhhcccc
Confidence 777777766544333335678999999999999999999999 88999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=355.56 Aligned_cols=260 Identities=32% Similarity=0.525 Sum_probs=220.8
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc------hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR------KNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~k------k~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
|.+...||.|+||.||+|.+..+++.||+|.+....... ....+.+.+|+.++.+++||||+++++++...+.+
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 677889999999999999999899999999887543221 23346788999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999875321000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
............|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+....
T Consensus 162 ---------------------~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 220 (267)
T cd06628 162 ---------------------STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA 220 (267)
T ss_pred ---------------------cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH
Confidence 00001112345689999999999988899999999999999999999999988766555
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
...+... ..|.++..++.++.+||.+||+.||.+||+ +.++++||||
T Consensus 221 ~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 267 (267)
T cd06628 221 IFKIGEN--ASPEIPSNISSEAIDFLEKTFEIDHNKRPT---AAELLKHPFL 267 (267)
T ss_pred HHHHhcc--CCCcCCcccCHHHHHHHHHHccCCchhCcC---HHHHhhCCCC
Confidence 5554432 234455788999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=366.49 Aligned_cols=261 Identities=27% Similarity=0.503 Sum_probs=216.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
.+++|++++.||.|+||.||+|+++.+++.||+|.++.... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 46789999999999999999999999999999999875332 2234467789999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||++ ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~---- 156 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI---- 156 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC----
Confidence 999997 5898888754 4689999999999999999999999999999999999999999999999999864210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.........+++.|+|||++.+ ..++.++|||||||++|||++|++||...+..+.
T Consensus 157 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~ 213 (301)
T cd07873 157 -----------------------PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213 (301)
T ss_pred -----------------------CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0011123467899999999876 4578899999999999999999999998876655
Q ss_pred HHHHhhc-------------------CCCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 923 FDNILNR-------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 923 ~~kIl~~-------------------~l~fP~--------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
...+... ...+|. ....+++++++||.+||+.||.+||+ +.++++||||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t---~~eil~h~~f~ 290 (301)
T cd07873 214 LHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS---AEEAMKHPYFH 290 (301)
T ss_pred HHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC---HHHHhcCcccc
Confidence 5443321 011111 11357889999999999999999999 88999999998
Q ss_pred CCC
Q 001360 976 GVN 978 (1092)
Q Consensus 976 gId 978 (1092)
...
T Consensus 291 ~~~ 293 (301)
T cd07873 291 CLG 293 (301)
T ss_pred ccc
Confidence 653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=360.65 Aligned_cols=257 Identities=32% Similarity=0.500 Sum_probs=216.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.++..++||||+++++.+...+.+|
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 34568999999999999999999999999999999987532 234456788999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+||||+++|+|.+++...+.+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~---- 158 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA---- 158 (267)
T ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC----
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999864210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.........||+.|+|||++. ...++.++|+|||||++|+|++|.+||....+.
T Consensus 159 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~ 215 (267)
T cd06645 159 -----------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred -----------------------cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch
Confidence 001123457999999999985 456889999999999999999999999876654
Q ss_pred HHHHHHhhcCCCCCCC--CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCC
Q 001360 921 IIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~i--p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPF 973 (1092)
.....+.......+.. ...++..+.+||.+||..||++||+ +.+++.|||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~ll~~~~ 267 (267)
T cd06645 216 RALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT---AEKLLQHPF 267 (267)
T ss_pred hhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcC---HHHHhcCCC
Confidence 4443333333322221 1257789999999999999999999 889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=352.79 Aligned_cols=260 Identities=32% Similarity=0.543 Sum_probs=221.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||.|+||+||+|....++..+|+|++...... .....+.+|+.+|+.++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 4799999999999999999999989999999998754332 25678999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 767 EYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~---g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||++|++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~- 157 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD- 157 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc-
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999875321000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.........+|++.|+|||++... .++.++|+|||||++|+|++|+.||...+....
T Consensus 158 ----------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 215 (267)
T cd06610 158 ----------------------RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV 215 (267)
T ss_pred ----------------------ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh
Confidence 000122456799999999999876 789999999999999999999999998887766
Q ss_pred HHHHhhcCCC-CCCC--CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 923 FDNILNRKIP-WPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 923 ~~kIl~~~l~-fP~i--p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
+..+...... ++.. ...++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~ll~~p~~ 267 (267)
T cd06610 216 LMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT---AEELLKHKFF 267 (267)
T ss_pred HHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcC---HHHHhhCCCC
Confidence 6666554321 2211 1367899999999999999999999 8899999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=357.21 Aligned_cols=255 Identities=40% Similarity=0.739 Sum_probs=222.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|++.+.||.|+||.||+|++..+++.||+|++.+...........+.+|++++++++||||+++++.+.....+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987665555667889999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
|+.|++|..++.+...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~-------- 152 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP-------- 152 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC--------
Confidence 999999999998877899999999999999999999999999999999999999999999999998864210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh---HHHHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFD 924 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~---~ei~~ 924 (1092)
........|+..|+|||++.+..++.++|+||||+++|+|++|..||...+. ..+..
T Consensus 153 --------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (258)
T cd05578 153 --------------------DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212 (258)
T ss_pred --------------------CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence 0011235688999999999988899999999999999999999999988773 33333
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
...... +..+..++.++.++|.+||..||.+||+.. +.++++||||
T Consensus 213 ~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~-~~~l~~~~~~ 258 (258)
T cd05578 213 KQETAD---VLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258 (258)
T ss_pred Hhcccc---ccCcccCcHHHHHHHHHHccCChhHcCCcc-HHHHhcCCCC
Confidence 322222 334577899999999999999999999943 4899999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=378.04 Aligned_cols=258 Identities=27% Similarity=0.451 Sum_probs=211.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~--- 760 (1092)
...++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 34689999999999999999999999999999999987532 23344567889999999999999999999886543
Q ss_pred ---eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 761 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 761 ---~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
.+|+||||+.+ +|...+.. .+++..+..++.|++.||.|||++||+||||||+||||+.+|.+||+|||+++..
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 57999999976 67776653 4889999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
.. .......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.
T Consensus 170 ~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 170 GT----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred CC----------------------------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 10 11123457999999999999999999999999999999999999999887
Q ss_pred ChHHHHHHHhhc----------------------C-----CCCCC------------CCCCCCHHHHHHHHHhccCCcCC
Q 001360 918 SPEIIFDNILNR----------------------K-----IPWPC------------VPSDMSFEAQDLINRFLIHDPNQ 958 (1092)
Q Consensus 918 s~~ei~~kIl~~----------------------~-----l~fP~------------ip~~lS~eakDLI~kcL~kDP~K 958 (1092)
+..+.+..++.. . ..+|. .+...+.++++||.+||..||.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 301 (355)
T cd07874 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchh
Confidence 754444332211 0 00000 11224678899999999999999
Q ss_pred CCCcccHHHHHcCCCCCC
Q 001360 959 RLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 959 RpSa~ga~EIL~HPFFkg 976 (1092)
||+ +.++++||||..
T Consensus 302 Rps---~~ell~hp~~~~ 316 (355)
T cd07874 302 RIS---VDEALQHPYINV 316 (355)
T ss_pred cCC---HHHHhcCcchhc
Confidence 999 889999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=367.66 Aligned_cols=243 Identities=20% Similarity=0.225 Sum_probs=210.2
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCeeEEEEee
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLYLVMEY 768 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd----e~~LYLVMEY 768 (1092)
..||+|++|.||+|.. +|+.||||++++.........+.+.+|+.+|.+++|||||++++++.+ ...+|+||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999987 589999999987544444446788899999999999999999999877 3578999999
Q ss_pred cCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc-CCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 769 m~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
++||+|.+++.+...+++.....++.+++.||.|||+. +++||||||+|||++.+|.+||+|||+++...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~--------- 174 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS--------- 174 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc---------
Confidence 99999999999888899999999999999999999984 99999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+++..
T Consensus 175 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~ 233 (283)
T PHA02988 175 ---------------------SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233 (283)
T ss_pred ---------------------cccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 01123578999999999976 6899999999999999999999999999998888888
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 926 Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
+......++ ++...+.++++||.+||+.||.+||++.++.+.
T Consensus 234 i~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 234 IINKNNSLK-LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HHhcCCCCC-CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 876654433 445789999999999999999999995544433
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=360.78 Aligned_cols=256 Identities=33% Similarity=0.557 Sum_probs=219.5
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEY 768 (1092)
|++++.||.|+||.||+|++..++..+|+|.+.... ......+.+|+.++..++||||+++++.|......|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 688899999999999999999999999999886432 34567788999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 769 LNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 769 m~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
+++|+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~-------- 155 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-------- 155 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--------
Confidence 999999988765 45799999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.........||+.|+|||++. +..++.++|||||||++|||++|.+||...+....
T Consensus 156 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 216 (282)
T cd06643 156 -------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV 216 (282)
T ss_pred -------------------cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH
Confidence 001123457899999999984 34578899999999999999999999998887777
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
...+.....+....+..++.++++||.+||..||.+||+ +.++++||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~ 268 (282)
T cd06643 217 LLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWT---TTQLLQHPFVTVN 268 (282)
T ss_pred HHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCCCEecc
Confidence 666655443322335678999999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.77 Aligned_cols=256 Identities=31% Similarity=0.514 Sum_probs=216.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||+|+||.||++++..+|..||+|.++.. ........+.+|++++.+++||||++++++|.+.+.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 4799999999999999999999999999999988642 12344567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
||++||+|.+++.+.+.+++..++.++.|++.||.|||+ .+|+||||||+|||++.+|.+||+|||++....
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------- 151 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------- 151 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc-------
Confidence 999999999999988889999999999999999999997 599999999999999999999999999886321
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
.......+|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......
T Consensus 152 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 209 (308)
T cd06615 152 ----------------------DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209 (308)
T ss_pred ----------------------ccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHh
Confidence 0012345799999999999888899999999999999999999999976654433322
Q ss_pred HhhcCC----------------------------------CCCCCC-CCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 926 ILNRKI----------------------------------PWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 926 Il~~~l----------------------------------~fP~ip-~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
+..... ..|..+ ..++.++++||.+||..||++||+ +.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~ 286 (308)
T cd06615 210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD---LKELTK 286 (308)
T ss_pred hcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC---HHHHhc
Confidence 211100 001111 236789999999999999999999 889999
Q ss_pred CCCCCC
Q 001360 971 HPFFKG 976 (1092)
Q Consensus 971 HPFFkg 976 (1092)
||||.+
T Consensus 287 ~~~~~~ 292 (308)
T cd06615 287 HPFIKR 292 (308)
T ss_pred Chhhhh
Confidence 999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=380.27 Aligned_cols=261 Identities=31% Similarity=0.536 Sum_probs=221.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCC----
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRD---- 760 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPN-IVkL~~sfqde~---- 760 (1092)
...|+.++.||+|+||+||+|+.+.+|+.||+|+++-... .+..-....+|+-+|+.++|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~-~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE-EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc-ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 4568888899999999999999999999999999874322 1223345689999999999999 999999999988
Q ss_pred --eeEEEEeecCCCcHHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCc
Q 001360 761 --NLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1092)
Q Consensus 761 --~LYLVMEYm~GGSL~dlLkk~g----~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 834 (1092)
.+|+||||+.- ||..++.... .++...++.+++||+.||+|||+++|+||||||+||||+.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999976 9999998765 5788899999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
+... -+.......++|.+|.|||++.+. .|+..+|+||+|||++||+++++-
T Consensus 168 ra~~---------------------------ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 168 RAFS---------------------------IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred HHhc---------------------------CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence 8421 012224567899999999999986 799999999999999999999999
Q ss_pred CCCCChHHHHHHHhh-----cCCCCCC-------------CC---------CCCCHHHHHHHHHhccCCcCCCCCcccHH
Q 001360 914 FTAESPEIIFDNILN-----RKIPWPC-------------VP---------SDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~-----~~l~fP~-------------ip---------~~lS~eakDLI~kcL~kDP~KRpSa~ga~ 966 (1092)
|.+.+..+...+|.. ....||. .+ +..++++.+|+.+||+++|.+|++ |.
T Consensus 221 FpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S---a~ 297 (323)
T KOG0594|consen 221 FPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS---AK 297 (323)
T ss_pred CCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC---HH
Confidence 999998877777764 1122322 11 233468999999999999999999 88
Q ss_pred HHHcCCCCCCCC
Q 001360 967 EVKAHPFFKGVN 978 (1092)
Q Consensus 967 EIL~HPFFkgId 978 (1092)
.++.||||....
T Consensus 298 ~al~h~yf~~~~ 309 (323)
T KOG0594|consen 298 GALTHPYFSELP 309 (323)
T ss_pred HHhcChhhcccc
Confidence 999999998763
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=356.97 Aligned_cols=257 Identities=29% Similarity=0.474 Sum_probs=216.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++.+.||+|+||.||+|+.+.+|+.||+|++.... ......+.+|+.++..++||||+++++++...+.+|
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence 34568999999999999999999999999999999986432 234456889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+||||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~---- 158 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA---- 158 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc----
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.........|++.|+|||.+. ...++.++|+|||||++|||++|.+||....+.
T Consensus 159 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 159 -----------------------TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred -----------------------cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 001122457899999999985 345788999999999999999999999776655
Q ss_pred HHHHHHhhcCCCCCCC--CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCC
Q 001360 921 IIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~i--p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPF 973 (1092)
.....+.......+.. ...++..+.+||++||..||++||+ +.+|++|+|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~l~ 267 (267)
T cd06646 216 RALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT---AERLLTHLF 267 (267)
T ss_pred hhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC---HHHHhcCCC
Confidence 4443433333332221 2357899999999999999999999 889999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.79 Aligned_cols=269 Identities=43% Similarity=0.819 Sum_probs=225.1
Q ss_pred CeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 001360 688 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIR-KNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k---~TGk~VAIKvLkK~ei~k-k~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~L 762 (1092)
+|++.+.||.|+||.||+|+.. .+|..||+|++++..... ....+++.+|+.+|..+ +||||++++++|.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999875 478999999997643322 23456788999999999 599999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||+++|+|.+++.....+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-- 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCC--
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAES-- 918 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s-- 918 (1092)
.........|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....
T Consensus 159 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 214 (290)
T cd05613 159 ------------------------EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214 (290)
T ss_pred ------------------------cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc
Confidence 0111234679999999999875 357889999999999999999999997543
Q ss_pred --hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc
Q 001360 919 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 985 (1092)
Q Consensus 919 --~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~ 985 (1092)
...+...+.....++ +..+++.+.+|+.+||..||.+||+. ..+.+++.||||..++|+.+...
T Consensus 215 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 282 (290)
T cd05613 215 NSQAEISRRILKSEPPY---PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAK 282 (290)
T ss_pred ccHHHHHHHhhccCCCC---CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhhc
Confidence 234444444444443 36789999999999999999999863 35899999999999999887543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=360.39 Aligned_cols=268 Identities=23% Similarity=0.355 Sum_probs=220.7
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfq 757 (1092)
.+..++|++.+.||+|+||.||+|..+. .+..||+|.++... .......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4567899999999999999999997653 34589999886433 2233456889999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEE
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKVG----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~g----------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VK 827 (1092)
+....|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999997532 345677888999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001360 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (1092)
Q Consensus 828 LsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEM 907 (1092)
|+|||+++...... .........++..|+|||.+.+..++.++|+|||||++|||
T Consensus 160 L~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el 214 (288)
T cd05061 160 IGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214 (288)
T ss_pred ECcCCccccccccc-------------------------cccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHH
Confidence 99999987421000 00011223467889999999988999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc---CCCCCCCCc
Q 001360 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA---HPFFKGVNW 979 (1092)
Q Consensus 908 LT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~---HPFFkgIdW 979 (1092)
++ |.+||.+....+....+..+.. +..+..++..+++||.+||+.||.+||++.++.+.+. ||||++++|
T Consensus 215 ~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 215 TSLAEQPYQGLSNEQVLKFVMDGGY--LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 98 8999999888888777765533 2234677899999999999999999999655544433 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.47 Aligned_cols=255 Identities=31% Similarity=0.518 Sum_probs=209.5
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|++++.||.|+||.||+|+.+.+|..||+|+++... ........+.+|+.++..++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 5899999999999999999999999999999986532 222334678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 768 YLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~---g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 153 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI----- 153 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC-----
Confidence 997 5898888643 4689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
.........|++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+.....
T Consensus 154 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~ 211 (285)
T cd07861 154 ----------------------PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211 (285)
T ss_pred ----------------------CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 0011123467899999999875 45789999999999999999999999877654333
Q ss_pred HHHhhcC------------------CCCC--------CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 924 DNILNRK------------------IPWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 924 ~kIl~~~------------------l~fP--------~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
..+.... ..++ .....+++++++||.+||+.||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~~ll~~~~~ 285 (285)
T cd07861 212 FRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS---AKKALNHPYF 285 (285)
T ss_pred HHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC---HHHHhcCCCC
Confidence 2221100 0000 012357899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.67 Aligned_cols=252 Identities=28% Similarity=0.478 Sum_probs=212.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||.||+|.+..+++.||+|++.+.. .......+.+|+.+|.+++||||+++++.|...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 47899999999999999999999999999999987532 2334567899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||+++|+|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+|.+||+|||++....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~-------- 146 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-------- 146 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc--------
Confidence 99999999654 357889999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh-------
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP------- 919 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~------- 919 (1092)
.......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.....
T Consensus 147 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 205 (279)
T cd06619 147 ---------------------NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP 205 (279)
T ss_pred ---------------------cccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch
Confidence 0112245799999999999999999999999999999999999999965321
Q ss_pred HHHHHHHhhcCC-CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 920 EIIFDNILNRKI-PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 920 ~ei~~kIl~~~l-~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
......+..... ..+ ....++++.+||.+||+.||.+||+ +.+++.||||...+
T Consensus 206 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~---~~eil~~~~~~~~~ 260 (279)
T cd06619 206 LQLLQCIVDEDPPVLP--VGQFSEKFVHFITQCMRKQPKERPA---PENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHHhccCCCCCC--CCcCCHHHHHHHHHHhhCChhhCCC---HHHHhcCccccccc
Confidence 233333332221 111 2457889999999999999999999 88999999998664
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=382.87 Aligned_cols=262 Identities=23% Similarity=0.363 Sum_probs=215.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~--TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
..+|++++.||.|+||.||+|.... ++..||+|.+.+.. ...+|+++|+.++|||||+++++|.....+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 4579999999999999999997643 46789999876422 2457999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+|||++. ++|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.....
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~--- 238 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH--- 238 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc---
Confidence 9999996 589999977788999999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh---H
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP---E 920 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~---~ 920 (1092)
.........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+... .
T Consensus 239 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~ 296 (392)
T PHA03207 239 ----------------------PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296 (392)
T ss_pred ----------------------cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH
Confidence 001122356899999999999999999999999999999999999999976542 1
Q ss_pred HHHHHHhh----cCCCCCC----------------------C-----CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 921 IIFDNILN----RKIPWPC----------------------V-----PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 921 ei~~kIl~----~~l~fP~----------------------i-----p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
..+..++. ....+|. + ...++.++++||.+||+.||++||+ +.+++
T Consensus 297 ~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps---a~e~l 373 (392)
T PHA03207 297 SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS---AQDIL 373 (392)
T ss_pred HHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC---HHHHh
Confidence 22222221 0111110 0 1235778999999999999999999 88999
Q ss_pred cCCCCCCCCcchhhh
Q 001360 970 AHPFFKGVNWDSLAL 984 (1092)
Q Consensus 970 ~HPFFkgIdWd~L~~ 984 (1092)
.||||....|+.+..
T Consensus 374 ~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 374 SLPLFTKEPINLLNI 388 (392)
T ss_pred hCchhhccchhhhcC
Confidence 999999998887753
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=393.90 Aligned_cols=257 Identities=31% Similarity=0.538 Sum_probs=233.8
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe-eEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-LYL 764 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~-LYL 764 (1092)
.++|..++.||+|+||.+++++++..++.|++|.+.-..... .......+|+.+++++.|||||.+++.|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 578999999999999999999999999999999998655433 344578999999999999999999999999998 999
Q ss_pred EEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||+||+||+|.+.+.+.. -|+++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.|||.|||+|+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~---- 157 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN---- 157 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC----
Confidence 999999999999997654 59999999999999999999999999999999999999999999999999999631
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.....+.+.+|||.||.||++.+.+|+.++|||||||++|||++-+++|...+...+
T Consensus 158 -----------------------~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 158 -----------------------PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred -----------------------CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 112245688999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
..+|.+..+ ..+|...+.+++.||+.||.++|..||+ +.++|.+|...
T Consensus 215 i~ki~~~~~--~Plp~~ys~el~~lv~~~l~~~P~~RPs---a~~LL~~P~l~ 262 (426)
T KOG0589|consen 215 ILKINRGLY--SPLPSMYSSELRSLVKSMLRKNPEHRPS---ALELLRRPHLL 262 (426)
T ss_pred HHHHhhccC--CCCCccccHHHHHHHHHHhhcCCccCCC---HHHHhhChhhh
Confidence 999998873 2356899999999999999999999999 88999998876
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=353.23 Aligned_cols=262 Identities=29% Similarity=0.499 Sum_probs=218.0
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc---hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR---KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~k---k~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
+|+..+.||+|+||.||+|....+++.||+|++....... ......+.+|+.+|++++||||+++++.+.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999987543211 2245788999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC-cEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~-- 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG-- 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc--
Confidence 999999999999998888899999999999999999999999999999999999998876 59999999987421000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
...........||..|+|||++.+..++.++|+|||||++|+|++|..||.........
T Consensus 159 ---------------------~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 217 (268)
T cd06630 159 ---------------------TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL 217 (268)
T ss_pred ---------------------ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH
Confidence 00001122356899999999999889999999999999999999999999765543333
Q ss_pred HHHhh--cCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 924 DNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 924 ~kIl~--~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
..+.. .....+.++..+++++.++|.+||..+|.+||+ +.++++||||+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~ll~~~~~~ 268 (268)
T cd06630 218 ALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPP---SRELLKHPVFR 268 (268)
T ss_pred HHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcC---HHHHhcCcccC
Confidence 32221 111224455678999999999999999999999 88999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=351.70 Aligned_cols=260 Identities=29% Similarity=0.483 Sum_probs=219.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cee
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 762 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~e--i~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde--~~L 762 (1092)
.+|++.+.||+|+||.||+|.+..+|..||||.+.... .........+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 58999999999999999999999999999999886422 12234567889999999999999999999998764 468
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||++||+|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~- 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC- 160 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc-
Confidence 8999999999999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
..........||..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 161 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 217 (265)
T cd06652 161 -----------------------LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217 (265)
T ss_pred -----------------------ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH
Confidence 000112335699999999999988899999999999999999999999988766665
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
...+.... ..+..|..++..+.++|.+||. +|++||+ +.+++.|||+.
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~---~~~il~~~~~~ 265 (265)
T cd06652 218 IFKIATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPS---ADELLRHTFVH 265 (265)
T ss_pred HHHHhcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCC---HHHHhcCcccC
Confidence 55544332 2344567788999999999996 9999999 88999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=353.51 Aligned_cols=260 Identities=30% Similarity=0.483 Sum_probs=218.2
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCee
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNL 762 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei--~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd--e~~L 762 (1092)
.+|+..+.||+|+||.||+|....+|..||+|+++.... ........+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478999999999999999999999999999999875432 123456678999999999999999999998875 3578
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|++|||+++++|.+++.+.+.+++.....++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~- 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC- 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
..........|+..|+|||.+.+..++.++|+|||||++|||++|++||........
T Consensus 161 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~ 217 (266)
T cd06651 161 -----------------------MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217 (266)
T ss_pred -----------------------ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH
Confidence 000111235689999999999988899999999999999999999999987766555
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
...+.... ..|.++..+++.+++|| +||..+|++||+ +.++++||||+
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~---~~eil~hp~~~ 265 (266)
T cd06651 218 IFKIATQP-TNPQLPSHISEHARDFL-GCIFVEARHRPS---AEELLRHPFAQ 265 (266)
T ss_pred HHHHhcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCcC---HHHHhcCcccc
Confidence 55444332 23455677899999999 677789999999 88999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=350.16 Aligned_cols=254 Identities=31% Similarity=0.568 Sum_probs=218.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++.+.||.|+||.||+|.++.++..||+|.++... ....+.+|+++++.++||||+++++.+.+...+|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 368999999999999999999999989999999986532 267899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~----- 151 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD----- 151 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhccc-----
Confidence 999999999999975 45689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
.........|+..|+|||++.+..++.++|||||||++|+|++|++||....+.....
T Consensus 152 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~ 209 (256)
T cd06612 152 ----------------------TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF 209 (256)
T ss_pred ----------------------CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh
Confidence 0011233558999999999999999999999999999999999999998877655544
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.+..........+..++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~il~~~~~ 256 (256)
T cd06612 210 MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPS---AIQLLQHPFI 256 (256)
T ss_pred hhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcC---HHHHhcCCCC
Confidence 4433322222233567889999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=353.44 Aligned_cols=257 Identities=30% Similarity=0.480 Sum_probs=213.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||+|+||.||+|+.+.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999875432 2223456789999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 152 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG------- 152 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCC-------
Confidence 9999999888887777899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
.........|+..|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....
T Consensus 153 --------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~ 212 (286)
T cd07847 153 --------------------PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL 212 (286)
T ss_pred --------------------CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 0001123468899999999876 5578999999999999999999999988765443333
Q ss_pred Hhhc-------------------CCCCCC---------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 926 ILNR-------------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 926 Il~~-------------------~l~fP~---------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
+... ....|. ....++..+.+||.+||..||++||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~eil~~~~f 286 (286)
T cd07847 213 IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS---CEELLEHPYF 286 (286)
T ss_pred HHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC---HHHHhcCCCC
Confidence 2210 000111 01356888999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=354.57 Aligned_cols=255 Identities=29% Similarity=0.505 Sum_probs=212.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC----
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR---- 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde---- 759 (1092)
..+.|++.+.||+|+||.||+|..+.+++.||+|++.... .....+.+|+.++.++ +||||+++++.|...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 3457889999999999999999999999999999987532 2345688999999998 699999999998753
Q ss_pred --CeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcc
Q 001360 760 --DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1092)
Q Consensus 760 --~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 835 (1092)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4689999999999999999863 468999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhC
Q 001360 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITG 910 (1092)
Q Consensus 836 ~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Yt~ksDVWSLGVILYEMLTG 910 (1092)
.... .........||+.|+|||++. +..|+.++|||||||++|||++|
T Consensus 160 ~~~~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g 212 (272)
T cd06637 160 QLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212 (272)
T ss_pred eccc---------------------------ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhC
Confidence 4210 001123467999999999986 34688899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 911 k~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
..||....+......+....... ..+..++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~~ 272 (272)
T cd06637 213 APPLCDMHPMRALFLIPRNPAPR-LKSKKWSKKFQSFIESCLVKNHSQRPT---TEQLMKHPFI 272 (272)
T ss_pred CCCccccCHHHHHHHHhcCCCCC-CCCCCcCHHHHHHHHHHcCCChhhCCC---HHHHhhCCCC
Confidence 99998776655554444332221 123567899999999999999999999 8899999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=349.04 Aligned_cols=255 Identities=35% Similarity=0.548 Sum_probs=219.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++.+.||.|+||.||+|....+++.||+|++.... ......+.+|+.+++.++||||+++++++.+...+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 368999999999999999999999999999999997532 23567889999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.+|.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~----- 153 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA----- 153 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh-----
Confidence 9999999999999876 7899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC---CCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~---~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
.........|+..|+|||++.+. .++.++|+|||||++|||++|.+||...++..
T Consensus 154 ----------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 154 ----------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred ----------------------hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 00112245789999999999876 88999999999999999999999999887666
Q ss_pred HHHHHhhcCCCCCC--CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCC
Q 001360 922 IFDNILNRKIPWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1092)
Q Consensus 922 i~~kIl~~~l~fP~--ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPF 973 (1092)
....+....+..+. .+...+.++.+||.+||..||..||+ +.+++.|||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~ 262 (262)
T cd06613 212 ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT---ATKLLQHPF 262 (262)
T ss_pred HHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCC---HHHHhcCCC
Confidence 55555444332221 23456788999999999999999999 889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.75 Aligned_cols=257 Identities=30% Similarity=0.530 Sum_probs=216.2
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||.||+|++..+|..||+|.++.. ........+.+|++++.+++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 4789999999999999999999999999999988642 23344577899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 767 EYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~---g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||++|++|..++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~---- 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---- 154 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence 999999999988763 379999999999999999999997 599999999999999999999999999986321
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC------CCCccceeechhhhHHHHHhCCCCCCC
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~------~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
.......+|++.|+|||++.+. .++.++|+|||||++|+|++|..||..
T Consensus 155 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 155 -------------------------ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred -------------------------CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 0011234689999999998653 357899999999999999999999987
Q ss_pred CChHHHHHHHhh-cCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 917 ESPEIIFDNILN-RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 917 ~s~~ei~~kIl~-~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
......+..+.. .....+.++..++.++.+||.+||..+|.+||+ +.+++.||||...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~~~~~~~~ 268 (286)
T cd06622 210 ETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPT---YAQLLEHPWLVKY 268 (286)
T ss_pred cchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCC---HHHHhcChhhhhc
Confidence 665554443221 111223345679999999999999999999999 8899999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=346.93 Aligned_cols=254 Identities=29% Similarity=0.536 Sum_probs=222.9
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|++.+.||+|+||.||+++...+|+.||+|.+..... .......+.+|+.++++++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999875433 23345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 768 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~------ 153 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS------ 153 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc------
Confidence 999999999987643 578999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....
T Consensus 154 ---------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08218 154 ---------------------TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK 212 (256)
T ss_pred ---------------------chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH
Confidence 00111235689999999999988899999999999999999999999998888888888
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 926 Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
++.+.. +..+..++.++.++|.+||..+|.+||+ +.+++.||||
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~vl~~~~~ 256 (256)
T cd08218 213 IIRGSY--PPVSSHYSYDLRNLVSQLFKRNPRDRPS---VNSILEKNFI 256 (256)
T ss_pred HhcCCC--CCCcccCCHHHHHHHHHHhhCChhhCcC---HHHHhhCcCC
Confidence 776653 3345788999999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=368.73 Aligned_cols=264 Identities=22% Similarity=0.358 Sum_probs=210.9
Q ss_pred EEEeeccC--CCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001360 691 IIKPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1092)
Q Consensus 691 ilr~LGkG--gFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEY 768 (1092)
++++||+| +||+||+++.+.+|+.||+|.++.... .......+.+|+.+++.++|||||+++++|..++.+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999865322 234456778899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 769 LNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 769 m~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++++|||.+...... .
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~-~---- 155 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH-G---- 155 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccc-c----
Confidence 9999999999653 45899999999999999999999999999999999999999999999999875421100 0
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
. ... .........+++..|+|||++.+ ..|+.++|||||||++|||++|+.||..........
T Consensus 156 -~--------~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 220 (327)
T cd08227 156 -Q--------RLR------VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (327)
T ss_pred -c--------ccc------ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 0 000 00011123467889999999976 468999999999999999999999998765544443
Q ss_pred HHhhcCCCC-------------------------------------------CCCCCCCCHHHHHHHHHhccCCcCCCCC
Q 001360 925 NILNRKIPW-------------------------------------------PCVPSDMSFEAQDLINRFLIHDPNQRLG 961 (1092)
Q Consensus 925 kIl~~~l~f-------------------------------------------P~ip~~lS~eakDLI~kcL~kDP~KRpS 961 (1092)
....+..+. ......+++++.+||.+||+.||.+||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 300 (327)
T cd08227 221 EKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS 300 (327)
T ss_pred HHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC
Confidence 333221110 0011235778999999999999999999
Q ss_pred cccHHHHHcCCCCCCCC
Q 001360 962 ANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 962 a~ga~EIL~HPFFkgId 978 (1092)
+.++++||||+.+.
T Consensus 301 ---~~ell~~p~f~~~~ 314 (327)
T cd08227 301 ---ASTLLNHSFFKQIK 314 (327)
T ss_pred ---HHHHhcChhhhhcc
Confidence 88999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=351.28 Aligned_cols=278 Identities=40% Similarity=0.756 Sum_probs=231.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LYLV 765 (1092)
++|++.+.||+|+||.||+|..+.+|+.||+|++.+...........+.+|+.++.++. ||||+++++.+...+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765555556678899999999999 99999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||+++|+|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||||+||+++.+|+++|+|||++..........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~- 159 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE- 159 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc-
Confidence 9999999999999988899999999999999999999999999999999999999999999999999987532111000
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
........... .............|++.|+|||++.+..++.++|+||||+++|+|++|..||...+....+..
T Consensus 160 --~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 160 --SNKGDATNIDS----QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred --cCCCCCccccc----cccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 00000000000 000112234456799999999999988899999999999999999999999998887777777
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc-cHHHHHcCCCC
Q 001360 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVKAHPFF 974 (1092)
Q Consensus 926 Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~-ga~EIL~HPFF 974 (1092)
+......+| ..+++.+.+||.+||..||.+||++. ...++++||||
T Consensus 234 ~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSFP---PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCCCC---CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 776665555 67899999999999999999999931 12899999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=365.31 Aligned_cols=250 Identities=25% Similarity=0.441 Sum_probs=194.0
Q ss_pred EEeeccCCCeEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCeeEEEEe
Q 001360 692 IKPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLVME 767 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~--TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd--e~~LYLVME 767 (1092)
.+.||+|+||+||+|+++. +++.||+|.++.... ...+.+|+.+|++++||||+++++.|.. ...+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 3579999999999999763 678999999865322 2446789999999999999999998854 456899999
Q ss_pred ecCCCcHHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe----cCCCcEEEEecCCc
Q 001360 768 YLNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLS 834 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~---------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL----D~nG~VKLsDFGLA 834 (1092)
|+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9864 888887532 258999999999999999999999999999999999999 45689999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
+...... .........+||+.|+|||++.+ ..|+.++|||||||++|||++|++|
T Consensus 160 ~~~~~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 215 (317)
T cd07868 160 RLFNSPL------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred eccCCCC------------------------ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 7421000 00112234689999999999987 4589999999999999999999999
Q ss_pred CCCCCh---------HHHHHHHhhc-CC----------CCCC------------------------CCCCCCHHHHHHHH
Q 001360 914 FTAESP---------EIIFDNILNR-KI----------PWPC------------------------VPSDMSFEAQDLIN 949 (1092)
Q Consensus 914 F~~~s~---------~ei~~kIl~~-~l----------~fP~------------------------ip~~lS~eakDLI~ 949 (1092)
|..... ......+... .. .+|. .....+.++.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 295 (317)
T cd07868 216 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 295 (317)
T ss_pred ccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHH
Confidence 975332 1112222110 00 0000 01123567999999
Q ss_pred HhccCCcCCCCCcccHHHHHcCCCC
Q 001360 950 RFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 950 kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
+||+.||.+||| +.++++||||
T Consensus 296 ~mL~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07868 296 KLLTMDPIKRIT---SEQAMQDPYF 317 (317)
T ss_pred HHhccCcccCCC---HHHHhcCCCC
Confidence 999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.60 Aligned_cols=254 Identities=31% Similarity=0.536 Sum_probs=223.9
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
.|++++.||.|+||.||.++...+++.+++|.+..... .......+.+|+++|++++||||+++++++.+.+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 48999999999999999999999999999999875432 33456678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|+++|+|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~----- 154 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE----- 154 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc-----
Confidence 99999999999765 46899999999999999999999999999999999999999999999999998743110
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
........||+.|+|||++.+..++.++|+||||+++|||++|..||...+..+....
T Consensus 155 ----------------------~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08221 155 ----------------------YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK 212 (256)
T ss_pred ----------------------cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 0012345789999999999988899999999999999999999999999888888888
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 926 Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
+..+... ..+..++.++.++|.+||..+|.+||+ +.++++|||+
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~s---~~~ll~~~~l 256 (256)
T cd08221 213 IVQGNYT--PVVSVYSSELISLVHSLLQQDPEKRPT---ADEVLDQPLL 256 (256)
T ss_pred HHcCCCC--CCccccCHHHHHHHHHHcccCcccCCC---HHHHhhCcCC
Confidence 8766543 234678999999999999999999999 8899999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=354.01 Aligned_cols=257 Identities=33% Similarity=0.579 Sum_probs=222.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||.|+||.||+|++..+++.||+|++.... .......+.+|+++++.++||||+++++++.+...+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 46889999999999999999999999999999987533 2334567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||+++|+|.+++... .+++..+..++.|++.||.|||+.+++||||+|+||+++.+|.++|+|||+++....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~------- 150 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS------- 150 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecc-------
Confidence 999999999998765 789999999999999999999999999999999999999999999999999875310
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
.........|++.|+|||++.+..++.++|||||||++|+|++|.+||...++......+
T Consensus 151 --------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 210 (274)
T cd06609 151 --------------------TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210 (274)
T ss_pred --------------------cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh
Confidence 001123457899999999999988999999999999999999999999887776666655
Q ss_pred hhcCCCCCCCCCC-CCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 927 LNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 927 l~~~l~fP~ip~~-lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
..... |..+.. ++.++.++|.+||..||.+||+ +.+++.||||.+..
T Consensus 211 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt---~~~il~~~~~~~~~ 258 (274)
T cd06609 211 PKNNP--PSLEGNKFSKPFKDFVSLCLNKDPKERPS---AKELLKHKFIKKAK 258 (274)
T ss_pred hhcCC--CCCcccccCHHHHHHHHHHhhCChhhCcC---HHHHhhChhhcCCC
Confidence 55432 222334 8899999999999999999999 88999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=360.07 Aligned_cols=257 Identities=34% Similarity=0.542 Sum_probs=219.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
...|++++.||.|+||.||+|....++..||+|.+..... .....+.+|+.+++.++||||+++++.|.....+|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4689999999999999999999999999999999875432 2356788999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||++||+|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~------ 168 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 168 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc------
Confidence 999999999999864 4689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|++||...++......
T Consensus 169 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~ 227 (296)
T cd06654 169 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (296)
T ss_pred ---------------------cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH
Confidence 00111235789999999999988899999999999999999999999988876544433
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 926 Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
+.....+....+..++..+.+||.+||..||++||+ +.+++.||||..
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~eil~~~~~~~ 275 (296)
T cd06654 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (296)
T ss_pred HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcC---HHHHhhChhhhc
Confidence 333222222234678899999999999999999999 889999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=357.23 Aligned_cols=255 Identities=30% Similarity=0.524 Sum_probs=208.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
.|++.+.||+|+||.||+|+++.+|+.||+|.++.... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48999999999999999999999999999999975322 22234567889999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 768 YLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 768 Ym~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
|+.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~------- 151 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI------- 151 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC-------
Confidence 9975 78887765 46799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCC-CCCChHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPF-TAESPEIIFD 924 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF-~~~s~~ei~~ 924 (1092)
.........+|+.|+|||++.+. .++.++|||||||++|||++|..|| .+.+..+.+.
T Consensus 152 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~ 211 (284)
T cd07839 152 --------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 211 (284)
T ss_pred --------------------CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHH
Confidence 00111234678999999998774 4789999999999999999988875 4455444444
Q ss_pred HHhhc-----------------CCCCCC---------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~-----------------~l~fP~---------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.+... ...++. ....+++++++||.+||..||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~~il~h~~f 284 (284)
T cd07839 212 RIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS---AEEALQHPYF 284 (284)
T ss_pred HHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC---HHHHhcCCCC
Confidence 43221 000111 11357899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=355.72 Aligned_cols=255 Identities=23% Similarity=0.375 Sum_probs=216.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TG-----k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd 758 (1092)
+..++|++++.||+|+||.||+|.....+ ..||+|.++... .......+.+|+.++..++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34678999999999999999999986555 689999886432 23445678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 822 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~----------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~ 822 (1092)
....|++|||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999999999999764 45788899999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhh
Q 001360 823 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902 (1092)
Q Consensus 823 nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGV 902 (1092)
++.+||+|||+++...... .........+|+.|+|||.+.+..++.++|||||||
T Consensus 160 ~~~~~L~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~ 214 (283)
T cd05048 160 GLTVKISDFGLSRDIYSAD-------------------------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGV 214 (283)
T ss_pred CCcEEECCCcceeeccccc-------------------------cccccCCCcccccccCHHHhccCcCchhhhHHHHHH
Confidence 9999999999987431100 001122346789999999999889999999999999
Q ss_pred hHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 903 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 903 ILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
++|||++ |..||.+.+..++...+..... +..+..++.++.+|+.+||..||.+||+ +.+|++
T Consensus 215 il~el~~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~l~~~c~~~~p~~Rp~---~~~i~~ 278 (283)
T cd05048 215 VLWEIFSYGLQPYYGFSNQEVIEMIRSRQL--LPCPEDCPARVYALMIECWNEIPARRPR---FKDIHT 278 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCcccCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 9999998 9999999998888888776543 2345789999999999999999999999 445543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=393.79 Aligned_cols=299 Identities=24% Similarity=0.370 Sum_probs=236.1
Q ss_pred hhhhhcccCCCCcccccccchhhhhcccccCCCC---CCCCCC---CccccccCCCeEEEEeeccCCCeEEEEEEECCCC
Q 001360 639 LACELLDEKSPTSFSKYKENSRLILDSVSQSSGV---STPLHS---SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTG 712 (1092)
Q Consensus 639 l~~~lL~~ksp~sfSk~~ens~llldsls~ssg~---~tp~~s---s~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TG 712 (1092)
+.+..++...+.....+..+...+...+...... ..|... ...+.+....+++++.||+|-||+||+|.+.. .
T Consensus 152 ~~~~~~F~~l~~lv~~~~~~~~gl~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~ 230 (468)
T KOG0197|consen 152 IDERELFSSLQQLVNYYSKNADGLCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNG-S 230 (468)
T ss_pred CCHHHhhhhHHHHHhhhhccCcchhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcC-C
Confidence 3334444444444444554444444444333322 112211 34455666678888999999999999999974 3
Q ss_pred cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHh--hcCCCHHHHH
Q 001360 713 DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK--VGCLEEDVAR 790 (1092)
Q Consensus 713 k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk--~g~LsE~~ar 790 (1092)
..||+|.++...+ ..+.|.+|+++|++++|++||+||+++..++.+|||||||+.|+|.++|+. ...+...+..
T Consensus 231 ~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll 306 (468)
T KOG0197|consen 231 TKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLL 306 (468)
T ss_pred CcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHH
Confidence 4799999986543 345688999999999999999999999999999999999999999999987 4579999999
Q ss_pred HHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCC
Q 001360 791 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870 (1092)
Q Consensus 791 ~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~ 870 (1092)
.++.||+.||+||+++++|||||-..||||++++.+||+|||||+....+.+..
T Consensus 307 ~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~-------------------------- 360 (468)
T KOG0197|consen 307 DFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA-------------------------- 360 (468)
T ss_pred HHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee--------------------------
Confidence 999999999999999999999999999999999999999999999532221110
Q ss_pred ccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHH
Q 001360 871 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLIN 949 (1092)
Q Consensus 871 ~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~ 949 (1092)
....--...|.|||.+....++.++|||||||+||||+| |+.||.+.+..++.+.+-.+ +++|. |..+|+++.+||.
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-yRlp~-P~~CP~~vY~lM~ 438 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-YRLPR-PEGCPDEVYELMK 438 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-CcCCC-CCCCCHHHHHHHH
Confidence 011123467999999999999999999999999999999 99999999999999887654 45553 6899999999999
Q ss_pred HhccCCcCCCCCcccHHHHHc
Q 001360 950 RFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 950 kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
.||..+|++|||+......+.
T Consensus 439 ~CW~~~P~~RPtF~~L~~~l~ 459 (468)
T KOG0197|consen 439 SCWHEDPEDRPTFETLREVLE 459 (468)
T ss_pred HHhhCCcccCCCHHHHHHHHH
Confidence 999999999999765544443
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=348.24 Aligned_cols=256 Identities=32% Similarity=0.537 Sum_probs=214.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC---
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD--- 760 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~--- 760 (1092)
..++|++.+.||.|+||.||+|..+.+++.||+|++.... .....+.+|+.++.++ .||||++++++|....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 4589999999999999999999999999999999987533 2346788999999998 6999999999997644
Q ss_pred ---eeEEEEeecCCCcHHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCC
Q 001360 761 ---NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1092)
Q Consensus 761 ---~LYLVMEYm~GGSL~dlLkk~----g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGL 833 (1092)
.+|+||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999998653 4799999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHHH
Q 001360 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFI 908 (1092)
Q Consensus 834 Ak~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Yt~ksDVWSLGVILYEML 908 (1092)
+..... .........||+.|+|||++.. ..++.++|+|||||+||+|+
T Consensus 160 ~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~ 212 (275)
T cd06608 160 SAQLDS---------------------------TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212 (275)
T ss_pred ceeccc---------------------------chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence 874210 0111234569999999999854 34678999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 909 TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 909 TGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
+|++||...........+.....+.-..+..++.++++||.+||..||.+||+ +.+++.|||+
T Consensus 213 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~ll~~~~~ 275 (275)
T cd06608 213 DGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPF---MEELLEHPFI 275 (275)
T ss_pred hCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcC---HHHHhcCCCC
Confidence 99999987776666656555432211122347889999999999999999999 8899999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=352.31 Aligned_cols=258 Identities=32% Similarity=0.504 Sum_probs=211.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeec----
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFT---- 757 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfq---- 757 (1092)
....++|++++.||+|+||.||+|..+.+++.||+|+++... .....+.+|+.++..+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 346689999999999999999999999999999999886532 2235677899999999 6999999999873
Q ss_pred -cCCeeEEEEeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecC
Q 001360 758 -CRDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832 (1092)
Q Consensus 758 -de~~LYLVMEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFG 832 (1092)
..+.+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 45679999999999999998753 3468899999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHH
Q 001360 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEF 907 (1092)
Q Consensus 833 LAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Yt~ksDVWSLGVILYEM 907 (1092)
+++.... .........||+.|+|||++.. ..|+.++|||||||++|||
T Consensus 170 ~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el 222 (286)
T cd06638 170 VSAQLTS---------------------------TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222 (286)
T ss_pred ceeeccc---------------------------CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHH
Confidence 9874210 0111234569999999999853 4578899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 908 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 908 LTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
++|..||....+......+..........+..++.++.+||.+||..||.+||+ +.++++|+||
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~~~~ 286 (286)
T cd06638 223 GDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT---VSDLLQHVFI 286 (286)
T ss_pred hcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCC---HHHHhhcccC
Confidence 999999988766554444333221111123456889999999999999999999 8899999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=359.11 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=207.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRT----------------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~----------------TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPN 748 (1092)
..++|++.+.||+|+||.||+|.+.. ++..||+|+++... .......+.+|+.+|.+++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 34689999999999999999998643 34579999987532 3445677899999999999999
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhc-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 001360 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-------------------CLEEDVARIYIAELVLALEYLHSLGIV 809 (1092)
Q Consensus 749 IVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g-------------------~LsE~~ar~yaaQIL~ALeYLHs~GII 809 (1092)
|+++++++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999986532 356778889999999999999999999
Q ss_pred eeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC
Q 001360 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT 889 (1092)
Q Consensus 810 HRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~ 889 (1092)
||||||+|||++.++.+||+|||+++...... .........+|+.|||||++.+.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~ 215 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGD-------------------------YYRIQGRAVLPIRWMAWECILMG 215 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCc-------------------------eeEecCcCCCCccccCHHHHhcC
Confidence 99999999999999999999999987421000 00111234578899999999988
Q ss_pred CCCccceeechhhhHHHHHh--CCCCCCCCChHHHHHHHhh---c--CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc
Q 001360 890 EHGYAADWWSVGIILFEFIT--GIPPFTAESPEIIFDNILN---R--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962 (1092)
Q Consensus 890 ~Yt~ksDVWSLGVILYEMLT--Gk~PF~~~s~~ei~~kIl~---~--~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa 962 (1092)
.++.++|||||||++|||++ |..||...+..+....+.. . ...++..+..++..+.+||.+||..||.+||++
T Consensus 216 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 295 (304)
T cd05096 216 KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295 (304)
T ss_pred CCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence 99999999999999999986 6789988776665554422 1 111222346788999999999999999999995
Q ss_pred ccHHHH
Q 001360 963 NGAAEV 968 (1092)
Q Consensus 963 ~ga~EI 968 (1092)
.++..+
T Consensus 296 ~~i~~~ 301 (304)
T cd05096 296 SDIHAF 301 (304)
T ss_pred HHHHHH
Confidence 544333
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=378.13 Aligned_cols=252 Identities=33% Similarity=0.555 Sum_probs=212.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----e
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----N 761 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~-----~ 761 (1092)
=.|+-.+++|.|+||.||+|....+++.||||.+-.... .-.+|.++|..++|||||+|.++|.... .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 358889999999999999999999999999997754322 2246899999999999999998886432 3
Q ss_pred eEEEEeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC-CcEEEEecCCccc
Q 001360 762 LYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKI 836 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n-G~VKLsDFGLAk~ 836 (1092)
+.+|||||+. +|..+++. ...++.-.++.|+.||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+.
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 5689999987 99999874 4678999999999999999999999999999999999999976 8999999999996
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
.. .+....+...|..|+|||.+.| ..|+.+.||||.||+|.||+-|++-|.
T Consensus 176 L~----------------------------~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp 227 (364)
T KOG0658|consen 176 LV----------------------------KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP 227 (364)
T ss_pred ec----------------------------cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC
Confidence 42 1223346678999999999987 579999999999999999999999999
Q ss_pred CCChHHHHHHHhhc-----------------CCCCCC---------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 916 AESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 916 ~~s~~ei~~kIl~~-----------------~l~fP~---------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+++..+....|++- ...+|. +...+++++.||+.++|.++|.+|.+ +.+++
T Consensus 228 G~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~---~~~~l 304 (364)
T KOG0658|consen 228 GDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS---ALEAL 304 (364)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC---HHHHh
Confidence 99887776666541 112222 23567999999999999999999999 89999
Q ss_pred cCCCCCCC
Q 001360 970 AHPFFKGV 977 (1092)
Q Consensus 970 ~HPFFkgI 977 (1092)
.||||..+
T Consensus 305 ~h~fFdel 312 (364)
T KOG0658|consen 305 AHPFFDEL 312 (364)
T ss_pred cchhhHHh
Confidence 99999765
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.80 Aligned_cols=254 Identities=33% Similarity=0.574 Sum_probs=220.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCeeEEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLV 765 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd--e~~LYLV 765 (1092)
+|++++.||.|+||.||+|.+..+|..||+|++..... .....+.+.+|+.+++.++||||+++++.+.. ...+|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999876443 34456778999999999999999999987754 4568999
Q ss_pred EeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHH-----HcCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 766 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLH-----SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLH-----s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
|||+++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999975 357899999999999999999999 89999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
... .........|++.|+|||++.+..++.++|+||||+++|+|++|..||..
T Consensus 160 ~~~---------------------------~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 160 LGH---------------------------DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred ccC---------------------------CcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 210 00112235689999999999988899999999999999999999999998
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.+...+.+.+..+.. +.++..++.++.+|+.+||..+|.+||+ +.+|++|||+
T Consensus 213 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp~---~~~il~~~~~ 265 (265)
T cd08217 213 RNQLQLASKIKEGKF--RRIPYRYSSELNEVIKSMLNVDPDKRPS---TEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHhcCCC--CCCccccCHHHHHHHHHHccCCcccCCC---HHHHhhCCCC
Confidence 887777777665543 4456788999999999999999999999 8899999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=352.62 Aligned_cols=255 Identities=21% Similarity=0.273 Sum_probs=213.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k---~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
..++|++.+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.+|.+++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 4568999999999999999999875 346789999987532 23445678999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
+|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999999764 57899999999999999999999999999999999999999999999999986531100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~ 919 (1092)
.........+|+.|+|||++.+..++.++|||||||++|||++ |..||...+.
T Consensus 161 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 161 --------------------------AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred --------------------------chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 0001123346788999999999999999999999999999775 9999999888
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.++...+..+. ..| .+..++..+.+++.+||..+|.+||++.++.+++
T Consensus 215 ~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l 262 (266)
T cd05064 215 QDVIKAVEDGF-RLP-APRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262 (266)
T ss_pred HHHHHHHHCCC-CCC-CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence 88777765542 223 3577899999999999999999999955554443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=352.18 Aligned_cols=257 Identities=32% Similarity=0.522 Sum_probs=214.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC----
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR---- 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde---- 759 (1092)
..++|++.+.||+|+||.||+|..+.+++.||+|++.... .....+.+|+.++.++ +||||++++++|...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 4688999999999999999999999999999999986532 2235677899999998 799999999988754
Q ss_pred -CeeEEEEeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCc
Q 001360 760 -DNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1092)
Q Consensus 760 -~~LYLVMEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 834 (1092)
..+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 358999999999999998863 356899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-----CCCccceeechhhhHHHHHh
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----EHGYAADWWSVGIILFEFIT 909 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-----~Yt~ksDVWSLGVILYEMLT 909 (1092)
..... ........+|++.|+|||++... .++.++|||||||++|||++
T Consensus 176 ~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~ 228 (291)
T cd06639 176 AQLTS---------------------------TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228 (291)
T ss_pred hhccc---------------------------ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhh
Confidence 74210 00111235689999999998643 36789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 910 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 910 Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
|++||....+......+..........+...+..+.+||.+||..||++||+ +.++++||||+
T Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~ 291 (291)
T cd06639 229 GDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS---VTHLLEHPFIK 291 (291)
T ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcC---HHHHhcCcccC
Confidence 9999998877666555554432211123467789999999999999999999 88999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.26 Aligned_cols=249 Identities=28% Similarity=0.522 Sum_probs=216.6
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|++.+.||.|+||.||+++++.+++.||+|.++... .....+.+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999987533 23456778899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|+++|+|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~------ 152 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS------ 152 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc------
Confidence 99999999988643 4589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
.........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 153 ---------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 211 (255)
T cd08219 153 ---------------------PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211 (255)
T ss_pred ---------------------cccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence 01112245789999999999998999999999999999999999999999888877777
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 926 Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
+..+... .++..++..+.+||.+||..||.+||+ +.+++.
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~ 251 (255)
T cd08219 212 VCQGSYK--PLPSHYSYELRSLIKQMFKRNPRSRPS---ATTILS 251 (255)
T ss_pred HhcCCCC--CCCcccCHHHHHHHHHHHhCCcccCCC---HHHHhh
Confidence 7665433 235678999999999999999999999 667765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.42 Aligned_cols=255 Identities=34% Similarity=0.566 Sum_probs=219.7
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei--~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.|+..+.||+|+||+||+|....++..||+|.+..... ........+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 36778899999999999999998999999999875432 2234567889999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~------ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE------ 154 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc------
Confidence 99999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
........|++.|+|||.+.... ++.++|+|||||++|+|++|.+||..........
T Consensus 155 ----------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~ 212 (258)
T cd06632 155 ----------------------FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF 212 (258)
T ss_pred ----------------------cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH
Confidence 00123456899999999998766 8999999999999999999999998776555444
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.+... ...+.++..++.++.+||.+||..+|.+||+ +.+++.|||+
T Consensus 213 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 258 (258)
T cd06632 213 KIGRS-KELPPIPDHLSDEAKDFILKCLQRDPSLRPT---AAELLEHPFV 258 (258)
T ss_pred HHHhc-ccCCCcCCCcCHHHHHHHHHHhhcCcccCcC---HHHHhcCCCC
Confidence 44331 2334556788999999999999999999999 8899999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=354.27 Aligned_cols=257 Identities=30% Similarity=0.482 Sum_probs=214.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||.||+|.++.+++.||+|++.+.... ....+.+.+|+++|..++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4799999999999999999999999999999998764332 234566889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++++.|..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~------- 152 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA------- 152 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC-------
Confidence 9999999988877666799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
.........|+..|+|||++.+ ..++.++|||||||++|||++|.+||......+....
T Consensus 153 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~ 212 (286)
T cd07846 153 --------------------PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH 212 (286)
T ss_pred --------------------CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 0011223568999999999876 4578899999999999999999999987765444333
Q ss_pred Hhhc-------------------CCCCCC---------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 926 ILNR-------------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 926 Il~~-------------------~l~fP~---------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
+... ....|. ....++..+.+||.+||..||.+||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~~~~ 286 (286)
T cd07846 213 IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS---SSQLLHHEFF 286 (286)
T ss_pred HHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh---HHHHhcCCCC
Confidence 3321 011111 12367889999999999999999999 7899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=359.73 Aligned_cols=258 Identities=34% Similarity=0.548 Sum_probs=218.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
..+|++++.||.|+||.||+|....+|+.||+|.+..... ...+.+.+|+.+++.++||||++++++|...+.+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3689999999999999999999999999999999865332 2346688999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||++||+|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~----- 168 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE----- 168 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC-----
Confidence 999999999999865 46899999999999999999999999999999999999999999999999998642100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
........|++.|+|||.+.+..++.++|+|||||++|+|++|.+||...++......
T Consensus 169 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~ 226 (297)
T cd06656 169 ----------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (297)
T ss_pred ----------------------ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee
Confidence 0111234689999999999998899999999999999999999999987765443333
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 926 Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
+.....+....+..++..+++||.+||..||.+||+ +.+++.||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 275 (297)
T cd06656 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGS---AKELLQHPFLKLA 275 (297)
T ss_pred eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhccc
Confidence 333222222234678899999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=342.47 Aligned_cols=253 Identities=30% Similarity=0.502 Sum_probs=220.7
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|++.+.||.|+||.||+|....+++.||+|.+..... .......+.+|+.+|+.++||||+++++.+...+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999976443 33456789999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC-cEEEEecCCccccccccccc
Q 001360 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~n~s~d 844 (1092)
|++|++|.+++... ..+++..+..++.+++.||.|||++||+|+||||+||+++.++ .+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~----- 154 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS----- 154 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC-----
Confidence 99999999999764 3589999999999999999999999999999999999998654 589999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
........|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+......
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 211 (256)
T cd08220 155 -----------------------KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211 (256)
T ss_pred -----------------------CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 111223568999999999998889999999999999999999999999888877777
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.+..... +.++..++.++.+||.+||..||.+||+ +.++++||||
T Consensus 212 ~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~ll~~p~~ 256 (256)
T cd08220 212 KIMSGTF--APISDRYSPDLRQLILSMLNLDPSKRPQ---LSQIMAQPIC 256 (256)
T ss_pred HHHhcCC--CCCCCCcCHHHHHHHHHHccCChhhCCC---HHHHhhCCCC
Confidence 7765433 2234678999999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=373.22 Aligned_cols=284 Identities=30% Similarity=0.505 Sum_probs=235.2
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeecCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
+.||.|+||.|--+....||..||||++.|.. -....++.+|++++..++ |+||++|+.+|+++.++|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 47999999999999999999999999998853 345678999999999996 99999999999999999999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc---EEEEecCCcccccccccccCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGP 848 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~---VKLsDFGLAk~~~~n~s~dls~~ 848 (1092)
|.|..+|.++..|++.++..+..+|+.||.|||.+||.||||||+|||-..-.+ ||||||.|......++. .+ +
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~--~s-p 237 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND--CS-P 237 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC--CC-C
Confidence 999999999999999999999999999999999999999999999999876554 89999999764322221 11 1
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCC-----
Q 001360 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAES----- 918 (1092)
Q Consensus 849 ~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s----- 918 (1092)
. ......+.||+..|||||++. ...|+.+||.||||||+|-||+|++||.+.=
T Consensus 238 a-----------------stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 238 A-----------------STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred C-----------------CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 0 112235789999999999873 2578999999999999999999999996531
Q ss_pred ----------hHHHHHHHhhcCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccC
Q 001360 919 ----------PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKA 987 (1092)
Q Consensus 919 ----------~~ei~~kIl~~~l~fP~i-p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~p 987 (1092)
...++..|..+.+.||.- ...+|.+++|||+.+|.+|+..|++ +..+++|||++.+.-+.-. ..|
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls---a~~vlnhPw~~~~~~ekal-ptp 376 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS---AAQVLNHPWVQRCAPEKAL-PTP 376 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh---hhhccCCccccccchhccC-CCC
Confidence 467899999999999963 3568999999999999999999999 8899999999987544221 233
Q ss_pred CccCCCCCCCCccccc
Q 001360 988 VFVPQPESVDDTSYFL 1003 (1092)
Q Consensus 988 PfiP~~~s~~Dts~Fd 1003 (1092)
+.+-...+..+.+.|.
T Consensus 377 ~v~~r~~s~~~lslfa 392 (463)
T KOG0607|consen 377 QVLQRNSSTMDLSLFA 392 (463)
T ss_pred cccccCccchhhHHHH
Confidence 3333333333555554
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=358.02 Aligned_cols=257 Identities=35% Similarity=0.565 Sum_probs=221.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
..|++.+.||.|+||.||+|.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 56999999999999999999999999999999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||+++|+|..++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||++.....
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~------- 167 (296)
T cd06655 96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP------- 167 (296)
T ss_pred EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc-------
Confidence 99999999998865 4689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...++......+
T Consensus 168 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~ 227 (296)
T cd06655 168 --------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227 (296)
T ss_pred --------------------ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 001112356899999999999888999999999999999999999999988776555555
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.....+....+..+++.+.+||.+||..||.+||+ +.+++.||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~il~~~~~~~~ 275 (296)
T cd06655 228 ATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKLA 275 (296)
T ss_pred HhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCC---HHHHhhChHhhhc
Confidence 44333222234678999999999999999999999 8899999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.04 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=212.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc----
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC---- 758 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqd---- 758 (1092)
...+.|++.+.||.|+||.||+|++..+++.||+|++.... .....+..|+.++.++ +||||++++++|..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 34578999999999999999999999999999999986532 3445688899999988 69999999999853
Q ss_pred --CCeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCc
Q 001360 759 --RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1092)
Q Consensus 759 --e~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 834 (1092)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 45789999999999999999753 45888899999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHh
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFIT 909 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Yt~ksDVWSLGVILYEMLT 909 (1092)
..... ........+|++.|+|||++. +..|+.++|+|||||++|||++
T Consensus 169 ~~~~~---------------------------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~ 221 (282)
T cd06636 169 AQLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE 221 (282)
T ss_pred hhhhc---------------------------cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHh
Confidence 74210 001123467999999999986 3568889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 910 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 910 Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
|.+||....+......+..... ....+..++.++.+||.+||..||.+||+ +.+|+.||||
T Consensus 222 g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~---~~ell~~~~~ 282 (282)
T cd06636 222 GAPPLCDMHPMRALFLIPRNPP-PKLKSKKWSKKFIDFIEGCLVKNYLSRPS---TEQLLKHPFI 282 (282)
T ss_pred CCCCccccCHHhhhhhHhhCCC-CCCcccccCHHHHHHHHHHhCCChhhCcC---HHHHhcCCCC
Confidence 9999987766554444333221 11123568899999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=343.75 Aligned_cols=258 Identities=35% Similarity=0.593 Sum_probs=223.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||.|+||.||+|+...+|+.||+|++...... .....+.+|+.++..++||||+++++++.....+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4799999999999999999999999999999998764321 44677899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~------ 152 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN------ 152 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceeccc------
Confidence 999999999999888889999999999999999999999 9999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC---ChHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---SPEII 922 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~---s~~ei 922 (1092)
.........|+..|+|||.+.+..++.++|+||||+++|+|++|..||... ...+.
T Consensus 153 ---------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 211 (264)
T cd06623 153 ---------------------TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211 (264)
T ss_pred ---------------------CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH
Confidence 011112456899999999999989999999999999999999999999877 44555
Q ss_pred HHHHhhcCCCCCCCCCC-CCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~-lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
...+..... +..+.. ++..+.++|.+||..+|++||+ +.+++.||||+.++
T Consensus 212 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~ll~~~~~~~~~ 263 (264)
T cd06623 212 MQAICDGPP--PSLPAEEFSPEFRDFISACLQKDPKKRPS---AAELLQHPFIKKAD 263 (264)
T ss_pred HHHHhcCCC--CCCCcccCCHHHHHHHHHHccCChhhCCC---HHHHHhCHHHHhcc
Confidence 555554322 223455 8899999999999999999999 88999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=349.20 Aligned_cols=258 Identities=30% Similarity=0.510 Sum_probs=209.1
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCceEEEeeeeccCCeeEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieI-L~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
++|++.+.||+|+||.||+|+++.+|+.||+|++++... .. ....+..|..+ ++..+||||+++++++.....+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999876422 22 23445556665 5667899999999999999999999
Q ss_pred EeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHc-CCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 766 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
|||++ |+|.+++.. ...+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99997 588877754 24689999999999999999999997 999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC----CCCCccceeechhhhHHHHHhCCCCCCC
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g----~~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
........|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 157 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 ---------------------------SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ---------------------------ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 001123468999999999865 4578899999999999999999999975
Q ss_pred C-ChHHHHHHHhhc-CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcc
Q 001360 917 E-SPEIIFDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 917 ~-s~~ei~~kIl~~-~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd 980 (1092)
. ...+....+... ...+| ...+|.++.+||.+||..+|.+||+ +.+++.||||....+.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~ 270 (283)
T cd06617 210 WKTPFQQLKQVVEEPSPQLP--AEKFSPEFQDFVNKCLKKNYKERPN---YPELLQHPFFELHLSK 270 (283)
T ss_pred cccCHHHHHHHHhcCCCCCC--ccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhhhcccc
Confidence 3 233333333332 22222 2457899999999999999999999 7899999999886654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=373.62 Aligned_cols=253 Identities=27% Similarity=0.415 Sum_probs=203.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
....+|++++.||+|+||.||+|++..++..||+|+..+. ....|+.+|.+++|||||++++++......|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 3456799999999999999999999999999999975432 2356899999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
+||||+. |+|.+++.+ ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++....
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 209 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--- 209 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence 9999995 588888865 45699999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCC-CCCCCCh--
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP-PFTAESP-- 919 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~-PF~~~s~-- 919 (1092)
........||+.|+|||++.+..|+.++|||||||++|||+++.. +|.....
T Consensus 210 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~ 264 (357)
T PHA03209 210 -------------------------APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTP 264 (357)
T ss_pred -------------------------CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcH
Confidence 011234579999999999999999999999999999999998544 4443211
Q ss_pred -------HHHHHHHhhc----CCCCCC---------------------------CCCCCCHHHHHHHHHhccCCcCCCCC
Q 001360 920 -------EIIFDNILNR----KIPWPC---------------------------VPSDMSFEAQDLINRFLIHDPNQRLG 961 (1092)
Q Consensus 920 -------~ei~~kIl~~----~l~fP~---------------------------ip~~lS~eakDLI~kcL~kDP~KRpS 961 (1092)
......++.. ...+|. ....++.++.+||.+||+.||.+||+
T Consensus 265 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt 344 (357)
T PHA03209 265 EEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS 344 (357)
T ss_pred HHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC
Confidence 0111111110 001110 01245778889999999999999999
Q ss_pred cccHHHHHcCCCCCCC
Q 001360 962 ANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 962 a~ga~EIL~HPFFkgI 977 (1092)
+.++++||||+.+
T Consensus 345 ---a~e~l~hp~f~~~ 357 (357)
T PHA03209 345 ---AEEILNYPMFAQL 357 (357)
T ss_pred ---HHHHhcCchhccC
Confidence 8899999999864
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=396.56 Aligned_cols=261 Identities=33% Similarity=0.580 Sum_probs=234.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
+-|+++..||-|+||+||++..+.++-..|-|+|. .....+.+.++-|++||..++||+||+|++.|..++.+||+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 34688899999999999999999999999999875 345678899999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||.||-+..++-.- ..|++.+++.+++|++.||+|||+++|||||||..|||++.+|.|+|+|||.+....
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~------- 181 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK------- 181 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-------
Confidence 999999998877665 469999999999999999999999999999999999999999999999999875310
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.......++.|||+|||||++. ..+|++++||||||++|.||..+.||-...++.
T Consensus 182 --------------------~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM 241 (1187)
T KOG0579|consen 182 --------------------STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM 241 (1187)
T ss_pred --------------------hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH
Confidence 1234556899999999999974 578999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcc
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd 980 (1092)
.+..+|.....+-...|..++..+.||+.+||.+||..||+ +.+|++||||.++.-.
T Consensus 242 RVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~---aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 242 RVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPP---AAQLLKHPFVQNAPSN 298 (1187)
T ss_pred HHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCC---HHHHhhCcccccCCcc
Confidence 99999988776655567899999999999999999999999 8899999999976544
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=374.44 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=212.9
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~T-----Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~ 753 (1092)
..+....++|++.+.||+|+||.||+|++..+ +..||+|+++... .......+.+|+.+|+.+ +|||||+++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 34456678999999999999999999986544 3579999997543 233456789999999999 899999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhh----------------------------------------------------
Q 001360 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKV---------------------------------------------------- 781 (1092)
Q Consensus 754 ~sfqde~~LYLVMEYm~GGSL~dlLkk~---------------------------------------------------- 781 (1092)
++|...+.+|+||||+++|+|.+++...
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 9999999999999999999999998642
Q ss_pred ------------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 782 ------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 782 ------------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~-- 266 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-- 266 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc--
Confidence 136788899999999999999999999999999999999999999999999987421000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 922 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei 922 (1092)
.........+++.|||||++.+..|+.++|||||||++|||++ |+.||........
T Consensus 267 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~ 323 (374)
T cd05106 267 -----------------------NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK 323 (374)
T ss_pred -----------------------ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH
Confidence 0001112345678999999999999999999999999999997 9999988766555
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+..+.......+ .+..+++++.+||.+||+.||.+||++.++.+.+
T Consensus 324 ~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 324 FYKMVKRGYQMS-RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred HHHHHHcccCcc-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 545554443322 3456789999999999999999999965555443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.22 Aligned_cols=251 Identities=28% Similarity=0.477 Sum_probs=211.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||.|+||.||+|+.+.+++.||||.++............+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999987655555666778899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 767 EYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 767 EYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~--- 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--- 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc---
Confidence 99999999988853 34588999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC--hH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--PE 920 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s--~~ 920 (1092)
.........|++.|+|||.+.+..++.++|+||||+++|||++|..||.... ..
T Consensus 159 ------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 214 (267)
T cd08228 159 ------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF 214 (267)
T ss_pred ------------------------hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH
Confidence 0011123568999999999999889999999999999999999999997654 34
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
.....+.....+ +..+...+..+.+||.+||..+|.+||++.++
T Consensus 215 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~v 258 (267)
T cd08228 215 SLCQKIEQCDYP-PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258 (267)
T ss_pred HHHHHHhcCCCC-CCChhhcCHHHHHHHHHHCCCCcccCcCHHHH
Confidence 445544433221 22234678899999999999999999994433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=351.02 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=214.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
..++|.+.+.||+|+||.||+|.... ++..||+|++++.. .......+.+|+++|..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35679999999999999999998753 46789999987532 233457899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVG--------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 825 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g--------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~ 825 (1092)
..+|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++|++||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997643 4788899999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHH
Q 001360 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 905 (1092)
Q Consensus 826 VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILY 905 (1092)
+||+|||+++...... .........+++.|+|||++.+..++.++|||||||++|
T Consensus 161 ~kl~d~g~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (280)
T cd05049 161 VKIGDFGMSRDVYTTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215 (280)
T ss_pred EEECCcccceecccCc-------------------------ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHH
Confidence 9999999987421000 001112345688999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 906 EFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 906 EMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
||++ |..||...+..+....+..+.... .+..++.++.+||.+||..||.+||++.++.+.
T Consensus 216 e~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 277 (280)
T cd05049 216 EIFTYGKQPWYGLSNEEVIECITQGRLLQ--RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHER 277 (280)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 9998 999999888888888877655433 346789999999999999999999995544443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.46 Aligned_cols=259 Identities=34% Similarity=0.521 Sum_probs=215.7
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~--kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
+|++.+.||.|+||.||+|....+|+.||+|.++..... .......+..|+.++..++||||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999999999999999999865433 122345677899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.+|.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~----- 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS----- 154 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC-----
Confidence 9999 899999998766 799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
.........+++.|+|||.+.+ ..++.++|+|||||++|||++|.+||.+.+..+.+
T Consensus 155 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~ 212 (298)
T cd07841 155 ----------------------PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL 212 (298)
T ss_pred ----------------------CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH
Confidence 0011123457889999999865 46789999999999999999999999887766655
Q ss_pred HHHhhcCC-----CC---------------C-----CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 924 DNILNRKI-----PW---------------P-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 924 ~kIl~~~l-----~f---------------P-----~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.++..... .+ + ......+.++.+||.+||..||++||+ +.+++.||||++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~e~l~~~~~~~~ 288 (298)
T cd07841 213 GKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT---ARQALEHPYFSND 288 (298)
T ss_pred HHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC---HHHHhhCccccCC
Confidence 55542100 00 0 011345788999999999999999999 8899999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=346.40 Aligned_cols=259 Identities=32% Similarity=0.529 Sum_probs=215.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-------RKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~-------kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
.|.+.+.||.|+||.||+|....+|+.||+|.++..... .....+.+.+|+.++..++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478889999999999999999999999999988642111 1223467889999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC--CCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~--Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
..........|+..|+|||++.... ++.++|+||||+++|+|++|..||....
T Consensus 162 -------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 162 -------------------------YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred -------------------------ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 0011123456899999999998754 7899999999999999999999998766
Q ss_pred hHHHHHHHhhcC--CCCC-CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 919 PEIIFDNILNRK--IPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 919 ~~ei~~kIl~~~--l~fP-~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.......+.... ..++ .....++.++.+||.+||..||.+||+ +.++++||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~ 272 (272)
T cd06629 217 AIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT---ARELLQHPFI 272 (272)
T ss_pred hHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC---HHHHhhCCCC
Confidence 554444433322 1222 122356899999999999999999999 8899999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=345.17 Aligned_cols=256 Identities=31% Similarity=0.472 Sum_probs=210.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...+.+.....||+|+||.||+|.+..++..||+|.+.... ......+.+|+.++..++||||+++++++...+.+|
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34555666678999999999999999999999999886532 345667899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhh-cCC--CHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-CCcEEEEecCCcccccc
Q 001360 764 LVMEYLNGGDLYSLLRKV-GCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~-g~L--sE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~ 839 (1092)
+||||+++++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999999999999764 455 88889999999999999999999999999999999986 67999999999864210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC--CCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~--~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
. ........|++.|+|||++.+. .++.++|+||||+++|+|++|.+||...
T Consensus 162 ~---------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 162 I---------------------------NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred C---------------------------CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 0 0111234589999999998764 4789999999999999999999999764
Q ss_pred ChHH--HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 918 SPEI--IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 918 s~~e--i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.... .+...... ..+.++..+++++++||.+||..+|.+||+ +.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 268 (268)
T cd06624 215 GEPQAAMFKVGMFK--IHPEIPESLSAEAKNFILRCFEPDPDKRAS---AHDLLQDPFL 268 (268)
T ss_pred cChhhhHhhhhhhc--cCCCCCcccCHHHHHHHHHHcCCCchhCCC---HHHHHhCCCC
Confidence 4322 22111111 223455788999999999999999999999 8899999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=348.35 Aligned_cols=254 Identities=34% Similarity=0.576 Sum_probs=218.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||.|+||.||+|.++.+++.+|+|.+.+... ......+.+|+++++.++||||+++++.+.....+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 478899999999999999999999999999999876432 245567899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.+|.+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~----- 153 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN----- 153 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH-----
Confidence 999999999999876 789999999999999999999999 9999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC-----Ch
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-----SP 919 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~-----s~ 919 (1092)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||... ..
T Consensus 154 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 209 (265)
T cd06605 154 ------------------------SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209 (265)
T ss_pred ------------------------HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH
Confidence 0011267899999999999999999999999999999999999999764 23
Q ss_pred HHHHHHHhhcCCCCCCCCCC-CCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 920 EIIFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~-lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
.+..+.+..... |..+.. ++.++.+||.+||..||.+||+ +.+++.||||+.
T Consensus 210 ~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~~~ 262 (265)
T cd06605 210 FELLQYIVNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRERPS---YKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHhcCCC--CCCChhhcCHHHHHHHHHHcCCCchhCcC---HHHHhhCchhhc
Confidence 344444444322 223333 8899999999999999999999 889999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.22 Aligned_cols=257 Identities=36% Similarity=0.580 Sum_probs=215.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|++.+.||.|+||.||+|++..+|..||+|++..... .......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999999976432 23345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 768 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
|+ +++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~------ 152 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE------ 152 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC------
Confidence 99 99999998653 56899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
.........||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+....+..
T Consensus 153 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 212 (286)
T cd07832 153 --------------------EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212 (286)
T ss_pred --------------------CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH
Confidence 00112345799999999998754 468999999999999999999999988777666555
Q ss_pred HhhcC-------------------CCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 926 ILNRK-------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 926 Il~~~-------------------l~fP~--------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
++..- ..++. .....+.++.+||.+||..||.+||+ +.+++.||||.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~---~~~~l~h~~~~ 286 (286)
T cd07832 213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS---AAEALRHPYFT 286 (286)
T ss_pred HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC---HHHHhhCcCcC
Confidence 44310 01111 11356789999999999999999999 88999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=340.67 Aligned_cols=259 Identities=37% Similarity=0.616 Sum_probs=216.5
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|++.+.||+|+||.||+|....+++.||+|+++..... ......+.+|+.+++.++||||+++++.+...+.+|+|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 488999999999999999999989999999999765432 4577889999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
|+++++|.+++.+.+.+++..++.++.+++.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~----- 154 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT----- 154 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC-----
Confidence 999999999998877899999999999999999999999999999999999999999999999999875311000
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC---CCccceeechhhhHHHHHhCCCCCCCCCh-HHHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFTAESP-EIIF 923 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~---Yt~ksDVWSLGVILYEMLTGk~PF~~~s~-~ei~ 923 (1092)
..........|++.|+|||++.+.. ++.++|+||||+++|+|++|+.||..... ....
T Consensus 155 ------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~ 216 (264)
T cd06626 155 ------------------TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216 (264)
T ss_pred ------------------cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH
Confidence 0000022356899999999998766 88999999999999999999999976533 2222
Q ss_pred HHHhhc-CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 924 DNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 924 ~kIl~~-~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
..+... ...+|. ...++..+.+||.+||+.||.+||+ +.+++.|||+
T Consensus 217 ~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~---~~~i~~~~~~ 264 (264)
T cd06626 217 FHVGAGHKPPIPD-SLQLSPEGKDFLDRCLESDPKKRPT---ASELLQHPFV 264 (264)
T ss_pred HHHhcCCCCCCCc-ccccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 222222 222221 1234899999999999999999999 8899999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=348.67 Aligned_cols=258 Identities=33% Similarity=0.544 Sum_probs=215.4
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||.|+||.||+|.++.+++.||+|+++.... .......+.+|+++++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999875332 2334577899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++++.+..++.+...+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~------ 153 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR------ 153 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC------
Confidence 99999888777776677999999999999999999999999999999999999999999999999998752100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
........+|++.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+....
T Consensus 154 --------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 213 (288)
T cd07833 154 --------------------PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213 (288)
T ss_pred --------------------ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 00112345789999999999887 889999999999999999999999987765443333
Q ss_pred Hhhc-------------------CCCCCC----------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 926 ILNR-------------------KIPWPC----------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 926 Il~~-------------------~l~fP~----------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
+... ...++. .+..++.++.+||.+||..||++||+ +.+++.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~f 288 (288)
T cd07833 214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT---CDELLQHPYF 288 (288)
T ss_pred HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc---HHHHhcCCCC
Confidence 2210 000110 12345889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=390.40 Aligned_cols=261 Identities=33% Similarity=0.574 Sum_probs=239.6
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
........|.+.++||+|.|++|.++++..||..||||++.|..... .....+.+|+++|+.++|||||++|.+.....
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 34456789999999999999999999999999999999999866543 34456899999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|+||||+.+|++++++.+++.+.+..++.++.|++.|++|||+++|||||||.+||||+.+.++||+|||++.++.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999998642
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
......++||+|.|.|||++.+..| +..+|+||||+++|-|+.|..||.+.+-
T Consensus 207 --------------------------~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l 260 (596)
T KOG0586|consen 207 --------------------------YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL 260 (596)
T ss_pred --------------------------ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc
Confidence 1234467899999999999999888 6899999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
.++..+.+.+++.+| ..++.++++||+++|..+|.+|++ +.+|..|.|...
T Consensus 261 k~Lr~rvl~gk~rIp---~~ms~dce~lLrk~lvl~Pskr~~---~dqim~~~W~n~ 311 (596)
T KOG0586|consen 261 KELRPRVLRGKYRIP---FYMSCDCEDLLRKFLVLNPSKRGP---CDQIMKDRWRND 311 (596)
T ss_pred ccccchheeeeeccc---ceeechhHHHHHHhhccCccccCC---HHHhhhhcccch
Confidence 999999999988876 689999999999999999999999 889999999853
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.03 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=218.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..++|++++.||+|+||+||++.+..+|+.||+|++.... .......+.+|++++..++||||+++++++.....+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4578999999999999999999999999999999986532 23345778999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||+++|+|.+++.+.+.+++..++.++.+++.||.|||+ .|++||||||+||+++.++.++|+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~----- 155 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI----- 155 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh-----
Confidence 99999999999999888889999999999999999999997 599999999999999999999999999976321
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH---
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE--- 920 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~--- 920 (1092)
.......+||..|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 156 ------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~ 211 (284)
T cd06620 156 ------------------------NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211 (284)
T ss_pred ------------------------hhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh
Confidence 00112357999999999998888999999999999999999999999865542
Q ss_pred --------HHHHHHhhcCCCCCCCC-CCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 921 --------IIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 921 --------ei~~kIl~~~l~fP~ip-~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
+....+..... +.++ ..++.++.+||.+||..||.+||+ +.++++||||..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~e~~~~~~~~~ 271 (284)
T cd06620 212 QDDPMGILDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDPTERPT---PQQLCAMPPFIQ 271 (284)
T ss_pred hhhhhHHHHHHHHHhhccC--CCCCchhcCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccc
Confidence 23333333221 1122 237889999999999999999999 889999999954
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.96 Aligned_cols=257 Identities=32% Similarity=0.519 Sum_probs=209.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe----
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN---- 761 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~---- 761 (1092)
++|++.+.||.|+||.||+|.+..+|+.||+|+++... ........+.+|+.++..+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 47999999999999999999999999999999886532 22233467888999999995 6999999999987766
Q ss_pred -eEEEEeecCCCcHHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-CCcEEEEecCCc
Q 001360 762 -LYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLS 834 (1092)
Q Consensus 762 -LYLVMEYm~GGSL~dlLkk~-----g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLA 834 (1092)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 898888643 35799999999999999999999999999999999999998 899999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
+.... .........+++.|+|||++.+ ..++.++|||||||++|+|++|.+|
T Consensus 159 ~~~~~---------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 159 RAFSI---------------------------PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred eecCC---------------------------CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 74210 0011123367899999999875 4578999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcC-----CCC------------CC--------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 914 FTAESPEIIFDNILNRK-----IPW------------PC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~~~-----l~f------------P~--------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
|.+.+......++.... ..+ +. ....++.++.+||.+||.+||.+||+ +.++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~---~~ei 288 (295)
T cd07837 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS---AKAA 288 (295)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC---HHHH
Confidence 99877665555443310 000 10 01357899999999999999999999 8899
Q ss_pred HcCCCCC
Q 001360 969 KAHPFFK 975 (1092)
Q Consensus 969 L~HPFFk 975 (1092)
+.||||+
T Consensus 289 l~~~~~~ 295 (295)
T cd07837 289 LTHPYFD 295 (295)
T ss_pred hcCCCcC
Confidence 9999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=340.18 Aligned_cols=250 Identities=52% Similarity=0.959 Sum_probs=223.3
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001360 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1092)
Q Consensus 695 LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL 774 (1092)
||.|+||.||++.+..+++.||+|++++...........+..|+.+++.++||||+++++.+.....+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999887665566778899999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 001360 775 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854 (1092)
Q Consensus 775 ~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~ 854 (1092)
.+++.....+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~-------------- 146 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE-------------- 146 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccC--------------
Confidence 999988888999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCC
Q 001360 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934 (1092)
Q Consensus 855 p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP 934 (1092)
........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+...+...+......+|
T Consensus 147 -------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 213 (250)
T cd05123 147 -------------GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP 213 (250)
T ss_pred -------------CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 0122345789999999999988889999999999999999999999988888888888877655544
Q ss_pred CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 935 ~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
..++.++.+||.+||..||.+||++..+.++++||||
T Consensus 214 ---~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 214 ---EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 6779999999999999999999995445899999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=369.08 Aligned_cols=255 Identities=32% Similarity=0.529 Sum_probs=222.3
Q ss_pred ccCCCeEEE-EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc---
Q 001360 684 TSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC--- 758 (1092)
Q Consensus 684 i~~~dFeil-r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqd--- 758 (1092)
..+++|.+- ++||-|-.|+|..|.++.||+.+|+|++.. ....++|+++.-... |||||.+++.|..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 356777765 589999999999999999999999998863 345778999887765 9999999987754
Q ss_pred -CCeeEEEEeecCCCcHHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC---CCcEEEEecC
Q 001360 759 -RDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFG 832 (1092)
Q Consensus 759 -e~~LYLVMEYm~GGSL~dlLkk~g~--LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFG 832 (1092)
...+.+|||+|+||+|+..++.++. |+|.++..++.||..|+.|||+++|.||||||+|+|... |..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 4568999999999999999988764 999999999999999999999999999999999999975 4579999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCC
Q 001360 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912 (1092)
Q Consensus 833 LAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~ 912 (1092)
+|+... ......+.|-||.|.|||++....|+.+||+||||||||-||+|++
T Consensus 210 FAK~t~----------------------------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyP 261 (400)
T KOG0604|consen 210 FAKETQ----------------------------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261 (400)
T ss_pred cccccC----------------------------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCC
Confidence 998521 1223456899999999999999999999999999999999999999
Q ss_pred CCCCCC----hHHHHHHHhhcCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 913 PFTAES----PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 913 PF~~~s----~~ei~~kIl~~~l~fP~i-p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
||+... ...+..+|..+.+.||.- ...+|.+++|+|++||..+|.+|++ +.+++.|||..+.
T Consensus 262 PFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT---I~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 262 PFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT---IEEVMDHPWINQY 328 (400)
T ss_pred cccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee---HHHhhcCchhccc
Confidence 998765 467889999999999862 2458999999999999999999999 8899999998754
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=349.83 Aligned_cols=255 Identities=33% Similarity=0.538 Sum_probs=210.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|++++.||.|+||.||+|+++.+|+.||||.++... ........+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 5899999999999999999999999999999886532 222334578899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 768 YLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 768 Ym~GGSL~dlLkk--~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|+. ++|..++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~------ 152 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV------ 152 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhccc------
Confidence 996 589888865 35689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
.........+++.|+|||++.+.. ++.++|||||||++|||++|+.||...+......
T Consensus 153 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 211 (284)
T cd07860 153 ---------------------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211 (284)
T ss_pred ---------------------CccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 001112345789999999987644 6889999999999999999999998877654444
Q ss_pred HHhhcC------------------CCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNRK------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~~------------------l~fP~--------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
++.... ..++. +...++.++++||.+||..||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~~l~~~~f 284 (284)
T cd07860 212 RIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS---AKAALAHPFF 284 (284)
T ss_pred HHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC---HHHHhcCCCC
Confidence 333210 00110 12357889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=344.80 Aligned_cols=255 Identities=21% Similarity=0.361 Sum_probs=216.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+...+|.+.+.||.|+||.||+|.++.+++.||+|++.+.. .....+.+|++++..++||||+++++++.....+|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 45678999999999999999999999999999999987532 23567889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999999753 358899999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..
T Consensus 159 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 212 (263)
T cd05052 159 --------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212 (263)
T ss_pred --------------------------eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 000112234678999999999999999999999999999998 99999998888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
+.+..+.... . +..+..++.++.+||.+||..||++||++.++.+.++
T Consensus 213 ~~~~~~~~~~-~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 213 QVYELLEKGY-R-MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred HHHHHHHCCC-C-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 8877775532 2 2235778999999999999999999999666655543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=342.98 Aligned_cols=247 Identities=24% Similarity=0.404 Sum_probs=209.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++.+.||+|+||.||+++++. +..+|+|.+++... ....+.+|+.+|++++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 4689999999999999999998864 56799998865432 235688899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||++||+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~---- 153 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD---- 153 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC----
Confidence 999999999999975 356899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~ 923 (1092)
.........++..|+|||++.+..++.++|+||||+++|||++ |++||...+..+..
T Consensus 154 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~ 211 (256)
T cd05114 154 ----------------------EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV 211 (256)
T ss_pred ----------------------ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 0001112346678999999998899999999999999999999 99999999888888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
..+..+... ..+...+.++.+||.+||..||.+||++.++
T Consensus 212 ~~i~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l 251 (256)
T cd05114 212 EMISRGFRL--YRPKLASMTVYEVMYSCWHEKPEGRPTFAEL 251 (256)
T ss_pred HHHHCCCCC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 888765432 2245678899999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=370.54 Aligned_cols=261 Identities=23% Similarity=0.344 Sum_probs=210.4
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~ 754 (1092)
.+....++|++.+.||+|+||+||+|++ ..++..||+|+++.... ....+.+.+|+.+|..+ +|||||++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 4455667899999999999999999974 34577899999975332 23456789999999999 8999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhhc----------------------------------------------------
Q 001360 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVG---------------------------------------------------- 782 (1092)
Q Consensus 755 sfqde~~LYLVMEYm~GGSL~dlLkk~g---------------------------------------------------- 782 (1092)
+|......|+||||++||+|.+++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999986421
Q ss_pred -----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 783 -----------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 783 -----------------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 367788899999999999999999999999999999999999999999999874211
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s 918 (1092)
.. .........+++.|+|||++.+..++.++|||||||++|||++ |.+||....
T Consensus 267 ~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 267 DS-------------------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred cc-------------------------cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 00 0001112346778999999999999999999999999999998 999998776
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
....+.+++...... ..+...+.++.+||.+||..||++||++.++.+.+
T Consensus 322 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l 371 (375)
T cd05104 322 VDSKFYKMIKEGYRM-LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371 (375)
T ss_pred chHHHHHHHHhCccC-CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 544444444443322 23456789999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=349.29 Aligned_cols=257 Identities=30% Similarity=0.551 Sum_probs=207.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..++|++.+.||.|+||.||+|..+.+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999875321 1223456789999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||+.+ +|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 155 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV---- 155 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC----
Confidence 9999985 999988764 4689999999999999999999999999999999999999999999999999863110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC-hHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES-PEI 921 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s-~~e 921 (1092)
.........+++.|+|||++.+ ..++.++|||||||++|+|++|++||.... ..+
T Consensus 156 -----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~ 212 (291)
T cd07844 156 -----------------------PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED 212 (291)
T ss_pred -----------------------CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 0001122357899999999876 568899999999999999999999997665 222
Q ss_pred HHHHHhhc-------------------CCCCCC--------CCCCCC--HHHHHHHHHhccCCcCCCCCcccHHHHHcCC
Q 001360 922 IFDNILNR-------------------KIPWPC--------VPSDMS--FEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1092)
Q Consensus 922 i~~kIl~~-------------------~l~fP~--------ip~~lS--~eakDLI~kcL~kDP~KRpSa~ga~EIL~HP 972 (1092)
....+... ...++. ....++ .++.+||.+||+.||.+||+ +.+++.||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps---~~e~l~~~ 289 (291)
T cd07844 213 QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS---AAEAMKHP 289 (291)
T ss_pred HHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC---HHHHhcCC
Confidence 22222110 000000 001344 88999999999999999999 88999999
Q ss_pred CC
Q 001360 973 FF 974 (1092)
Q Consensus 973 FF 974 (1092)
||
T Consensus 290 ~f 291 (291)
T cd07844 290 YF 291 (291)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=354.61 Aligned_cols=261 Identities=33% Similarity=0.486 Sum_probs=214.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cee
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 762 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde--~~L 762 (1092)
..++|++.+.||.|+||.||+|..+.+|+.||+|+++.... .......+.+|+.++.+++||||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 56789999999999999999999999999999999875332 222234567899999999999999999998765 568
Q ss_pred EEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~-- 160 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL-- 160 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC--
Confidence 999999975 888888753 5689999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.........+++.|+|||++.+ ..++.++|+|||||++|||++|.+||...+..
T Consensus 161 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~ 215 (309)
T cd07845 161 -------------------------PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI 215 (309)
T ss_pred -------------------------ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0011122356889999999876 56799999999999999999999999998887
Q ss_pred HHHHHHhhcC-------------------CCCCCC--------CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCC
Q 001360 921 IIFDNILNRK-------------------IPWPCV--------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1092)
Q Consensus 921 ei~~kIl~~~-------------------l~fP~i--------p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPF 973 (1092)
+.+..+.... ...+.. ...+++++.+||.+||+.||.+||+ +.+++.|||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t---~~~il~h~~ 292 (309)
T cd07845 216 EQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT---AEEALESSY 292 (309)
T ss_pred HHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC---HHHHhcChh
Confidence 7776665421 011100 0235889999999999999999999 889999999
Q ss_pred CCCC
Q 001360 974 FKGV 977 (1092)
Q Consensus 974 FkgI 977 (1092)
|++.
T Consensus 293 f~~~ 296 (309)
T cd07845 293 FKEK 296 (309)
T ss_pred hccC
Confidence 9753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=354.24 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=210.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~--VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~ 760 (1092)
+..++|++.+.||+|+||.||+|.++.++.. +|+|.++. .........+.+|+.++.++ +||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 5678999999999999999999999888765 46666543 23344567888999999999 8999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g----------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG 824 (1092)
.+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999997543 478899999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhH
Q 001360 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (1092)
Q Consensus 825 ~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVIL 904 (1092)
.+||+|||++..... ........+++.|+|||++.+..++.++|||||||++
T Consensus 162 ~~kl~dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 213 (303)
T cd05088 162 VAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213 (303)
T ss_pred cEEeCccccCcccch----------------------------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHH
Confidence 999999999863100 0001122356789999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 905 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 905 YEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
|||++ |.+||...+..+.+..+... .. +..+..++.++.+||.+||..+|.+||+ +.+++.+
T Consensus 214 ~ellt~g~~p~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~ 276 (303)
T cd05088 214 WEIVSLGGTPYCGMTCAELYEKLPQG-YR-LEKPLNCDDEVYDLMRQCWREKPYERPS---FAQILVS 276 (303)
T ss_pred HHHHhcCCCCcccCChHHHHHHHhcC-Cc-CCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 99998 99999988888777766443 22 1234567899999999999999999999 5555543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=339.66 Aligned_cols=254 Identities=29% Similarity=0.520 Sum_probs=219.1
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|++.+.||+|+||.||+|..+.+|..||+|.+..... .....+.+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58999999999999999999999999999999876432 22345678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc-EEEEecCCccccccccccc
Q 001360 768 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~-VKLsDFGLAk~~~~n~s~d 844 (1092)
|+++++|.+++.+.. .+++..+..++.|++.||.|||+++|+|+||||+||+++.++. +||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~----- 154 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND----- 154 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC-----
Confidence 999999999997643 4799999999999999999999999999999999999998865 69999998864210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
.........|++.|+|||++.+..++.++|+|||||++|||++|..||...+......
T Consensus 155 ----------------------~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 212 (257)
T cd08225 155 ----------------------SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212 (257)
T ss_pred ----------------------CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 0111123468999999999998889999999999999999999999999888777776
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.+..... +.++..++.++.++|.+||..+|++||+ +.++++||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll~~~~~ 257 (257)
T cd08225 213 KICQGYF--APISPNFSRDLRSLISQLFKVSPRDRPS---ITSILKRPFL 257 (257)
T ss_pred HHhcccC--CCCCCCCCHHHHHHHHHHhccChhhCcC---HHHHhhCCCC
Confidence 6665543 3334678899999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=340.00 Aligned_cols=254 Identities=30% Similarity=0.506 Sum_probs=215.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||.|+||.||+|....+|+.||+|.++............+.+|+.++++++|+||+++++++...+..|+||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999998655555556788999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 767 EYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 767 EYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||+++|+|..++.. ...+++..+..++.+++.||.|||+.||+||||||+||+++.+|.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 99999999999864 245899999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC--hH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--PE 920 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s--~~ 920 (1092)
........|++.|+|||++.+..++.++|+|||||++|+|++|+.||.... ..
T Consensus 160 -------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08224 160 -------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred -------------------------CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH
Confidence 011223568999999999999999999999999999999999999997653 33
Q ss_pred HHHHHHhhcCCCCCCCCC-CCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 921 IIFDNILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~-~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.....+..+.. +..+. .++.++.++|.+||..+|++||++.++.+.+
T Consensus 215 ~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 215 SLCKKIEKCDY--PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred HHHhhhhcCCC--CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 44445444322 22233 6888999999999999999999965555544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=349.70 Aligned_cols=256 Identities=31% Similarity=0.551 Sum_probs=220.3
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
.|...+.||.|+||.||++....+++.+|+|+++.. .....+.+.+|+.++..++||||+++++++...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 455567999999999999999989999999988642 22345668899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
|++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~-------- 167 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-------- 167 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc--------
Confidence 9999999999877 6789999999999999999999999999999999999999999999999998763210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl 927 (1092)
.........|++.|+|||++.+..++.++|+|||||++|||++|..||...++......+.
T Consensus 168 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~ 228 (285)
T cd06648 168 -------------------EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR 228 (285)
T ss_pred -------------------CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 0011123568999999999998889999999999999999999999999888877777776
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 928 ~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
....+....+..++..+.+||.+||..+|.+||+ +.+++.||||+..
T Consensus 229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~ 275 (285)
T cd06648 229 DNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT---AAELLNHPFLAKA 275 (285)
T ss_pred hcCCCCCcccccCCHHHHHHHHHHcccChhhCcC---HHHHccCcccccC
Confidence 6533332223447899999999999999999999 8899999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=349.33 Aligned_cols=250 Identities=33% Similarity=0.539 Sum_probs=203.5
Q ss_pred CCCeEEEEee--ccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCceEEEeeeeccCCee
Q 001360 686 IDDFEIIKPI--SRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 686 ~~dFeilr~L--GkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~-L~HPNIVkL~~sfqde~~L 762 (1092)
.++|++.+.+ |.|+||.||+++.+.++..||+|++.+..... .|..+... .+||||+++++.|...+.+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3456666665 99999999999999999999999987543211 12222222 2699999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC-cEEEEecCCcccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~n~ 841 (1092)
|+||||++||+|.+++.+...+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||+++...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~--- 161 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG--- 161 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC---
Confidence 99999999999999998877899999999999999999999999999999999999999998 99999999986421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 162 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 162 ----------------------------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred ----------------------------CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 0112468999999999999999999999999999999999999998654433
Q ss_pred HHHH-HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 922 IFDN-ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 922 i~~k-Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
+... +.......+..+..+++.+.+||.+||+.||.+|++ .+.++++||||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~--~~~~~l~h~~~~~ 267 (267)
T PHA03390 214 LDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLT--NYNEIIKHPFLKI 267 (267)
T ss_pred hhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCc--hHHHHhcCCcccC
Confidence 2111 111111111233578999999999999999999996 2589999999974
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=334.60 Aligned_cols=254 Identities=36% Similarity=0.658 Sum_probs=224.2
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|++.+.||.|+||.||++.+..++..||+|++..... .......+.+|+++++.++|||++++++.+......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999999999999999875432 33456778999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 768 YLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~----g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
|+++++|.+++.+. ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~---- 155 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS---- 155 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc----
Confidence 99999999999764 6799999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+...+.
T Consensus 156 -----------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 212 (258)
T cd08215 156 -----------------------TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212 (258)
T ss_pred -----------------------CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence 001123457899999999999989999999999999999999999999988888877
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
..+.... ++.++..++.++.++|.+||..+|.+||+ +.+++.||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 258 (258)
T cd08215 213 LKILKGQ--YPPIPSQYSSELRNLVSSLLQKDPEERPS---IAQILQSPFI 258 (258)
T ss_pred HHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCCCC
Confidence 7776654 33445688999999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=361.84 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=211.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~---- 760 (1092)
..++|++++.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4578999999999999999999999999999999986532 23334566788999999999999999999886543
Q ss_pred --eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 --~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+|+||||+.+ +|.+.+... +++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 57999999965 888887654 8999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 170 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 170 T----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred C----------------------------CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 0 011223568999999999999999999999999999999999999998877
Q ss_pred hHHHHHHHhhcC----------------------C-----C---------CCC----CCCCCCHHHHHHHHHhccCCcCC
Q 001360 919 PEIIFDNILNRK----------------------I-----P---------WPC----VPSDMSFEAQDLINRFLIHDPNQ 958 (1092)
Q Consensus 919 ~~ei~~kIl~~~----------------------l-----~---------fP~----ip~~lS~eakDLI~kcL~kDP~K 958 (1092)
....+.++...- . . ++. .+...+..+++||.+||+.||.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 301 (353)
T cd07850 222 HIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301 (353)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhh
Confidence 655554443210 0 0 000 01234667899999999999999
Q ss_pred CCCcccHHHHHcCCCCCC
Q 001360 959 RLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 959 RpSa~ga~EIL~HPFFkg 976 (1092)
||+ +.+++.||||+.
T Consensus 302 R~t---~~eiL~~~~~~~ 316 (353)
T cd07850 302 RIS---VDDALQHPYINV 316 (353)
T ss_pred CcC---HHHHhcChhHhh
Confidence 999 889999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=353.34 Aligned_cols=249 Identities=24% Similarity=0.427 Sum_probs=192.3
Q ss_pred EeeccCCCeEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCeeEEEEee
Q 001360 693 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLVMEY 768 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~--TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd--e~~LYLVMEY 768 (1092)
..||+|+||+||+|+.+. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++.. ...+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999764 56899999886532 23457789999999999999999998853 5678999999
Q ss_pred cCCCcHHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe----cCCCcEEEEecCCcc
Q 001360 769 LNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLSK 835 (1092)
Q Consensus 769 m~GGSL~dlLkk~---------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL----D~nG~VKLsDFGLAk 835 (1092)
+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.+|.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 875 888877532 248899999999999999999999999999999999999 567899999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCC
Q 001360 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 836 ~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
...... .........+||+.|+|||++.+ ..++.++|||||||++|||++|.+||
T Consensus 161 ~~~~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 161 LFNSPL------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ccCCCc------------------------ccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 421000 00111234679999999999987 45899999999999999999999999
Q ss_pred CCCChH---------HHHHHHhhc--------------CCCC---------------------CCCCCCCCHHHHHHHHH
Q 001360 915 TAESPE---------IIFDNILNR--------------KIPW---------------------PCVPSDMSFEAQDLINR 950 (1092)
Q Consensus 915 ~~~s~~---------ei~~kIl~~--------------~l~f---------------------P~ip~~lS~eakDLI~k 950 (1092)
...... .....+... ...+ +......+..+.+||.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 296 (317)
T cd07867 217 HCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQK 296 (317)
T ss_pred ccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHH
Confidence 754321 111111100 0000 00112345678999999
Q ss_pred hccCCcCCCCCcccHHHHHcCCCC
Q 001360 951 FLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 951 cL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
||+.||.+||+ +.++++||||
T Consensus 297 ~l~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07867 297 LLTMDPTKRIT---SEQALQDPYF 317 (317)
T ss_pred HhccCcccccC---HHHHhcCCCC
Confidence 99999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=344.92 Aligned_cols=255 Identities=29% Similarity=0.491 Sum_probs=214.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++.+.||+|+||.||+|+.+.+|+.||||.+.+...........+.+|+.+++.++||||++++++|...+.+|+||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999988765555566678999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 767 EYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 767 EYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||++|++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC--
Confidence 99999999998863 346899999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh--H
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP--E 920 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~--~ 920 (1092)
.......+|++.|+|||++.+..++.++|+||||+++|+|++|..||.+... .
T Consensus 160 -------------------------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08229 160 -------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred -------------------------CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH
Confidence 0111235689999999999998999999999999999999999999976543 3
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.....+.....+ +..+..++.++++||.+||..||.+||++..+.+.+
T Consensus 215 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~ 262 (267)
T cd08229 215 SLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVA 262 (267)
T ss_pred HHhhhhhcCCCC-CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHH
Confidence 444444433221 222346889999999999999999999955444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=349.74 Aligned_cols=261 Identities=31% Similarity=0.486 Sum_probs=212.8
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
+++|++.+.||.|+||+||+|.++.+|+.||+|.++.... .......+.+|+++++.++||||+++++++.+...+|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999998865432 223346688999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-CCcEEEEecCCccccccccc
Q 001360 766 MEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~--LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~n~s 842 (1092)
|||++ ++|.+++..... +++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~--- 155 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI--- 155 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCC---
Confidence 99996 588888765443 578888999999999999999999999999999999985 55799999999864210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
.........|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+
T Consensus 156 ------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~ 211 (294)
T PLN00009 156 ------------------------PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID 211 (294)
T ss_pred ------------------------CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0011123468899999999876 457899999999999999999999999877665
Q ss_pred HHHHHhhcC-C--------------------CCCC-----CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 922 IFDNILNRK-I--------------------PWPC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 922 i~~kIl~~~-l--------------------~fP~-----ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
...++.... . .++. ....+++++.+||.+||..||.+||+ +.+++.||||.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~~l~~~~~~ 288 (294)
T PLN00009 212 ELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT---ARAALEHEYFK 288 (294)
T ss_pred HHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC---HHHHhcCchHh
Confidence 555543210 0 0000 12357889999999999999999999 88999999998
Q ss_pred CCC
Q 001360 976 GVN 978 (1092)
Q Consensus 976 gId 978 (1092)
+++
T Consensus 289 ~~~ 291 (294)
T PLN00009 289 DLG 291 (294)
T ss_pred HHh
Confidence 753
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.73 Aligned_cols=257 Identities=38% Similarity=0.612 Sum_probs=220.6
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeEEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYLV 765 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde--~~LYLV 765 (1092)
+|+..+.||+|+||.||+|....+++.|++|++...... ......+.+|+.++++++||||+++++.+... ..+|+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 488899999999999999999999999999998764432 45678899999999999999999999999988 899999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET--- 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc---
Confidence 99999999999998888899999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-hHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 924 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s-~~ei~~ 924 (1092)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ......
T Consensus 157 ----------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 214 (260)
T cd06606 157 ----------------------GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214 (260)
T ss_pred ----------------------cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 001234578999999999998889999999999999999999999998766 233333
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.+.. ....+.++..++..+.+||.+||..||.+||+ +.+++.||||
T Consensus 215 ~~~~-~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 260 (260)
T cd06606 215 KIGS-SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT---ADELLQHPFL 260 (260)
T ss_pred hccc-cCCCcCCCcccCHHHHHHHHHhCcCChhhCCC---HHHHhhCCCC
Confidence 3322 22334456788999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=346.53 Aligned_cols=254 Identities=22% Similarity=0.387 Sum_probs=211.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEEC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKR----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k----~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
..++|++.+.||+|+||+||+|... .++..||+|.++... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999863 456789999987532 3345567889999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV-----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~-----------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n 823 (1092)
..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 247888889999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhh
Q 001360 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (1092)
Q Consensus 824 G~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVI 903 (1092)
+.+||+|||+++...... .........++..|+|||++.+..++.++|||||||+
T Consensus 161 ~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 215 (283)
T cd05090 161 LHVKISDLGLSREIYSAD-------------------------YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVV 215 (283)
T ss_pred CcEEeccccccccccCCc-------------------------ceecccCCCccceecChHHhccCCCCchhhhHHHHHH
Confidence 999999999987431100 0011233456788999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 904 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 904 LYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
+|||++ |.+||.+.++..+...+..... +..+..++..+.+||.+||+.||.+||+++++.+
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 278 (283)
T cd05090 216 LWEIFSFGLQPYYGFSNQEVIEMVRKRQL--LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHT 278 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 999998 9999998887777766655432 2245778999999999999999999999554433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=347.57 Aligned_cols=263 Identities=34% Similarity=0.572 Sum_probs=226.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..+.|++.+.||.|+||.||+|.+..++..||+|+++.... ....+.+|++++..++||||+++++.+......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 34568899999999999999999998899999999975332 45678899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||++|++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||+++.+|.+||+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~---- 168 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK---- 168 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc----
Confidence 999999999999998876 899999999999999999999999999999999999999999999999998763210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||...++....
T Consensus 169 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~ 225 (286)
T cd06614 169 -----------------------EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225 (286)
T ss_pred -----------------------chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 001122346889999999999888999999999999999999999999988776666
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcch
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~ 981 (1092)
..+..........+..++.++++||.+||+.+|.+||+ +.+++.||||+...|..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~~~~~ 280 (286)
T cd06614 226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS---AEELLQHPFLKKACPKE 280 (286)
T ss_pred HHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcC---HHHHhhChHhhccCchH
Confidence 66554433221122348899999999999999999999 88999999999876653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=340.73 Aligned_cols=254 Identities=23% Similarity=0.377 Sum_probs=214.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+..++|++++.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++||||+++++.+...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 56689999999999999999999865 56779999876432 23567899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 156 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN- 156 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC-
Confidence 999999999999999753 45888899999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
.........++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 157 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 211 (261)
T cd05072 157 -------------------------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211 (261)
T ss_pred -------------------------ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence 0001112346788999999998889999999999999999998 99999988887
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
.....+... ..+|. +..++.++.+||.+||..+|++||+++.+.++++
T Consensus 212 ~~~~~~~~~-~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 212 DVMSALQRG-YRMPR-MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred HHHHHHHcC-CCCCC-CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 777776544 33332 3568899999999999999999999766665553
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=342.35 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=213.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~T-----Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfq 757 (1092)
++..++|++.+.||+|+||.||+|..+.. +..||+|.+.... .......+.+|+.+|..++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 35567999999999999999999998644 4789999986432 2234567889999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhh----------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEE
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~----------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VK 827 (1092)
.....|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 999999999999999999999643 2367788999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001360 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (1092)
Q Consensus 828 LsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEM 907 (1092)
|+|||+++...... .........||..|+|||.+.+..++.++|+|||||++|||
T Consensus 160 l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 214 (277)
T cd05032 160 IGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214 (277)
T ss_pred ECCcccchhhccCc-------------------------ccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHh
Confidence 99999987431100 00111234578899999999988899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 908 LT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
++ |.+||...+.....+.+.... .+..+..++.++.+||.+||+.+|.+||++.++.+
T Consensus 215 ~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 215 ATLAEQPYQGLSNEEVLKFVIDGG--HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred hccCCCCCccCCHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 98 999999988888877776432 23345678999999999999999999999544433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.71 Aligned_cols=259 Identities=29% Similarity=0.490 Sum_probs=218.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cee
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 762 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~e--i~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde--~~L 762 (1092)
.+|++.+.||+|+||.||+|.++.+|+.||+|++.... .........+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999885422 12234567889999999999999999999998764 468
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
++||||+++++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++..... .
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-~ 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI-C 160 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc-c
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998742100 0
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
..........||+.|+|||++.+..++.++|+|||||++|+|++|++||........
T Consensus 161 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 217 (264)
T cd06653 161 -----------------------MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217 (264)
T ss_pred -----------------------ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH
Confidence 000111235689999999999998899999999999999999999999988776665
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
...+..... .+.+|..+++++.++|.+||. +|.+||+ +.+++.|||.
T Consensus 218 ~~~~~~~~~-~~~~p~~~~~~~~~~i~~~l~-~~~~r~~---~~~~~~~~~~ 264 (264)
T cd06653 218 IFKIATQPT-KPMLPDGVSDACRDFLKQIFV-EEKRRPT---AEFLLRHPFV 264 (264)
T ss_pred HHHHHcCCC-CCCCCcccCHHHHHHHHHHhc-CcccCcc---HHHHhcCCCC
Confidence 555543332 244568899999999999999 6899999 7799999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=348.15 Aligned_cols=258 Identities=31% Similarity=0.527 Sum_probs=221.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
..|+.++.||.|+||.||+|.++.++..||+|++.... .......+.+|+.++..+.||||+++++++.+...+|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999999999999999987533 2345678899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||++||+|.+++.. +.+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~------- 153 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD------- 153 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC-------
Confidence 99999999999865 5689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
.........|+..|+|||++.+..++.++|+|||||++|||++|.+||...++......+
T Consensus 154 --------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06640 154 --------------------TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213 (277)
T ss_pred --------------------CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh
Confidence 001112346899999999999888999999999999999999999999988776666554
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCc
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdW 979 (1092)
.... .|.++..++..+.+||.+||..+|.+||+ +.+++.||||.....
T Consensus 214 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~ 261 (277)
T cd06640 214 PKNN--PPTLTGEFSKPFKEFIDACLNKDPSFRPT---AKELLKHKFIVKNAK 261 (277)
T ss_pred hcCC--CCCCchhhhHHHHHHHHHHcccCcccCcC---HHHHHhChHhhhcch
Confidence 3332 23345678889999999999999999999 889999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=346.80 Aligned_cols=254 Identities=30% Similarity=0.510 Sum_probs=212.3
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|++.+.||.|+||.||+|++..+|..||+|+++.... ......+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999975432 2234567889999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 768 YLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~---g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|+++ +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~----- 152 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI----- 152 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC-----
Confidence 9985 898888654 3589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
........++|+.|+|||++.+. .++.++|+|||||++|+|++|++||.+.+..+.+
T Consensus 153 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 210 (284)
T cd07836 153 ----------------------PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210 (284)
T ss_pred ----------------------CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 00111234688999999998764 5788999999999999999999999988776666
Q ss_pred HHHhhcC------------------CCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 924 DNILNRK------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 924 ~kIl~~~------------------l~fP~--------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
..+.... ..+|. +...++.++.++|.+||+.||.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~f 284 (284)
T cd07836 211 LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS---AHDALQHPWF 284 (284)
T ss_pred HHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 5554310 00110 11246788999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=345.64 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=211.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd 758 (1092)
...++|++.+.||+|+||.||+|.++. ++..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999998652 35689999886532 22345668899999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEE
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKVG----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 828 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~g----------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKL 828 (1092)
....|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||+.|++||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999997532 3567788889999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHH
Q 001360 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (1092)
Q Consensus 829 sDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEML 908 (1092)
+|||+++...... . ........+++.|||||++.+..++.++|||||||++|||+
T Consensus 161 ~dfg~~~~~~~~~---------------------~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 215 (277)
T cd05062 161 GDFGMTRDIYETD---------------------Y----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215 (277)
T ss_pred CCCCCccccCCcc---------------------e----eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHH
Confidence 9999987421000 0 00111235688999999999989999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 909 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 909 T-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
+ |..||.+.+.......+..... +..+..++..+.+||.+||+.||.+||+ +.+++.
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~ 273 (277)
T cd05062 216 TLAEQPYQGMSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPS---FLEIIS 273 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 9 7999999888888777766543 2335778999999999999999999999 445543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=384.41 Aligned_cols=253 Identities=32% Similarity=0.533 Sum_probs=214.5
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-C-----CceEEEeeeeccCCe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-N-----PFVVRFFYSFTCRDN 761 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-H-----PNIVkL~~sfqde~~ 761 (1092)
.|+++++||+|+||.|.+|.+..|++.||||++++.. ........|+.||..++ | -|||+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 7999999999999999999999999999999998643 44566788999999987 3 499999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC--cEEEEecCCcccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKIG 837 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG--~VKLsDFGLAk~~ 837 (1092)
+|||+|++.- +|+++|+.. ..|+...++.++.||+.||.+||++||||+||||+||||..-+ .|||+|||.|.+.
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999999965 999999865 4699999999999999999999999999999999999997644 6999999999852
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
....++.+-+..|.|||+++|.+|+.+.|+||||||++||++|.|.|.+.
T Consensus 342 ------------------------------~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 ------------------------------SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ------------------------------CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 12233667789999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhc--------------------C-C-------------------------------CCC-C-------CC
Q 001360 918 SPEIIFDNILNR--------------------K-I-------------------------------PWP-C-------VP 937 (1092)
Q Consensus 918 s~~ei~~kIl~~--------------------~-l-------------------------------~fP-~-------ip 937 (1092)
+..+.+..|+.- . . ..| . .+
T Consensus 392 ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~ 471 (586)
T KOG0667|consen 392 NEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLP 471 (586)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcc
Confidence 887776666430 0 0 001 0 00
Q ss_pred CCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 938 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 938 ~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
..-...+.|||.+||..||.+|++ +.+.|+||||.+..
T Consensus 472 ~~~~~~F~dflk~~L~~dP~~R~t---p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 472 KADDKLFIDFLKRCLEWDPAERIT---PAQALNHPFLTGTS 509 (586)
T ss_pred cccHHHHHHHHHHHhccCchhcCC---HHHHhcCccccccc
Confidence 012345789999999999999999 77999999998653
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=344.95 Aligned_cols=256 Identities=29% Similarity=0.561 Sum_probs=216.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCeeEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~---HPNIVkL~~sfqde~~LYL 764 (1092)
.|++++.||.|+||.||+|.+..+|+.||+|+++... .......+.+|+.+++.+. ||||+++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5788999999999999999999999999999987532 2345567889999999987 9999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~---- 154 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN---- 154 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC----
Confidence 9999999999999865 47899999999999999999999999999999999999999999999999998742110
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
........|++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.........
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 211 (277)
T cd06917 155 -----------------------SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211 (277)
T ss_pred -----------------------ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh
Confidence 011233579999999999875 45789999999999999999999999887765555
Q ss_pred HHHhhcCCCCCCCCC-CCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 924 DNILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~-~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
..+... ..|.++. .++.++.+||.+||..||.+||+ +.+++.||||+...
T Consensus 212 ~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~il~~~~~~~~~ 262 (277)
T cd06917 212 MLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLS---AEELLKSKWIKAHS 262 (277)
T ss_pred hccccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCcC---HHHHhhChHhhccc
Confidence 443332 2233333 37889999999999999999999 88999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=348.39 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=215.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.-.+|.+.+.||.|+||+||++... .++..||+|.+++.. ......+.+|+.+|.+++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3468999999999999999999853 345679999887532 34566789999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhc-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcE
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVG-------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 826 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g-------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~V 826 (1092)
+.+|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999997554 38999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHH
Q 001360 827 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906 (1092)
Q Consensus 827 KLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYE 906 (1092)
||+|||+++...... .........|++.|+|||++.+..++.++|+|||||++|+
T Consensus 160 kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~ 214 (288)
T cd05093 160 KIGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214 (288)
T ss_pred EeccCCccccccCCc-------------------------eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHH
Confidence 999999987421000 0011123456889999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 907 FIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 907 MLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
|++ |.+||...........+..+... ..+..++.++.+|+.+||+.||.+||++.++...++
T Consensus 215 l~t~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 215 IFTYGKQPWYQLSNNEVIECITQGRVL--QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 998 99999998888888888776532 234678899999999999999999999665555443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=332.76 Aligned_cols=254 Identities=31% Similarity=0.611 Sum_probs=222.2
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|++.+.||+|+||.||++++..+++.||+|.+.+... .......+.+|++++.+++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999987543 23456789999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
|+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~------- 152 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV------- 152 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC-------
Confidence 9999999999988888999999999999999999999999999999999999999999999999998752100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl 927 (1092)
........|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.
T Consensus 153 --------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 153 --------------------SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212 (254)
T ss_pred --------------------cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 011234568999999999988889999999999999999999999998777655554444
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 928 ~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.. ..+.++..++..+.++|.+||..+|++||+ +.+++.||||
T Consensus 213 ~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~~ 254 (254)
T cd06627 213 QD--DHPPLPEGISPELKDFLMQCFQKDPNLRPT---AKQLLKHPWI 254 (254)
T ss_pred cc--CCCCCCCCCCHHHHHHHHHHHhCChhhCcC---HHHHhcCCCC
Confidence 32 233455788999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=343.12 Aligned_cols=251 Identities=31% Similarity=0.499 Sum_probs=205.9
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccC--CeeEEE
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR--DNLYLV 765 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde--~~LYLV 765 (1092)
|++++.||+|+||.||+|..+.+++.||+|++++... . .......+|+.++.++. ||||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-S-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-C-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6789999999999999999999999999999875322 1 12234567888898885 99999999999988 889999
Q ss_pred EeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||+++ +|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++. |.+||+|||+++....
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~----- 151 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS----- 151 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc-----
Confidence 999975 88888765 357899999999999999999999999999999999999999 9999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
........+|+.|+|||++.. ..++.++|||||||++|||++|.+||.+.+..+..
T Consensus 152 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~ 208 (282)
T cd07831 152 -----------------------KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208 (282)
T ss_pred -----------------------CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH
Confidence 001122468899999998754 45688999999999999999999999988776655
Q ss_pred HHHhhc------------------CCCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 924 DNILNR------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 924 ~kIl~~------------------~l~fP~--------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
..+... ...+|. ....++.++.+||.+||.+||.+||+ +.+++.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~~l~~~~~ 282 (282)
T cd07831 209 AKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT---AKQALRHPYF 282 (282)
T ss_pred HHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC---HHHHhhCCCC
Confidence 544321 111111 11356899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=355.06 Aligned_cols=256 Identities=31% Similarity=0.541 Sum_probs=218.5
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
.|+....||.|+||.||+|....+++.||+|++..... .....+.+|+.++..++||||++++++|...+.+|+|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 34455579999999999999998999999999865332 234668899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
|+++++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~-------- 169 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-------- 169 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc--------
Confidence 9999999987754 5689999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl 927 (1092)
........+|++.|+|||++.+..++.++|+|||||++|||++|+.||...++.+....+.
T Consensus 170 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 230 (297)
T cd06659 170 -------------------DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230 (297)
T ss_pred -------------------ccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 0011234679999999999999899999999999999999999999999888777766665
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 928 ~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.........+..++..+.++|.+||+.+|.+||+ +.++++||||...
T Consensus 231 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps---~~~ll~~~~~~~~ 277 (297)
T cd06659 231 DSPPPKLKNAHKISPVLRDFLERMLTREPQERAT---AQELLDHPFLLQT 277 (297)
T ss_pred ccCCCCccccCCCCHHHHHHHHHHhcCCcccCcC---HHHHhhChhhccC
Confidence 4433333334568899999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=380.68 Aligned_cols=254 Identities=25% Similarity=0.338 Sum_probs=206.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
....|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+++|++++|||||++++++......|+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 3457999999999999999999999999999999532 1235689999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
|||++. |+|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-- 314 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW-- 314 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc--
Confidence 999995 6898888654 469999999999999999999999999999999999999999999999999987521000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-----
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES----- 918 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s----- 918 (1092)
........+||+.|||||++.+..|+.++|||||||+||||++|..|+....
T Consensus 315 -----------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~ 371 (461)
T PHA03211 315 -----------------------STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDER 371 (461)
T ss_pred -----------------------ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCccccc
Confidence 0011234679999999999999999999999999999999999886654321
Q ss_pred ---hHHHHHHHhhcCCC---CCCC----------------------------CCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 919 ---PEIIFDNILNRKIP---WPCV----------------------------PSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 919 ---~~ei~~kIl~~~l~---fP~i----------------------------p~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
...+.+.|...... ++.. ...++.++.+||.+||+.||.+||+
T Consensus 372 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs--- 448 (461)
T PHA03211 372 RPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS--- 448 (461)
T ss_pred CCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC---
Confidence 22333333322211 1100 0135668999999999999999999
Q ss_pred HHHHHcCCCCCC
Q 001360 965 AAEVKAHPFFKG 976 (1092)
Q Consensus 965 a~EIL~HPFFkg 976 (1092)
+.|+|+||||+.
T Consensus 449 a~elL~hp~f~~ 460 (461)
T PHA03211 449 AAELLRLPLFQS 460 (461)
T ss_pred HHHHhhCcccCC
Confidence 889999999974
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=355.50 Aligned_cols=257 Identities=31% Similarity=0.534 Sum_probs=217.4
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
+.|.....||.|+||.||++....++..||||.+.... ....+.+.+|+.++..++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 44555678999999999999999999999999886422 334567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~------- 170 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK------- 170 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc-------
Confidence 99999999998854 5689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
........+||+.|+|||++.+..++.++|+|||||++|||++|+.||...+....+..+
T Consensus 171 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 230 (292)
T cd06658 171 --------------------EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230 (292)
T ss_pred --------------------ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 001113457899999999999889999999999999999999999999988877666555
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
..............+..+.+||.+||..||.+||+ +.++++||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~~~~ 278 (292)
T cd06658 231 RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT---AQELLQHPFLKLA 278 (292)
T ss_pred HhcCCCccccccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhhcc
Confidence 43321111122457889999999999999999999 8899999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=403.11 Aligned_cols=263 Identities=31% Similarity=0.523 Sum_probs=218.7
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--C
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 760 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde--~ 760 (1092)
....++|++++.||+|+||+||+|+++.++..||+|++..... .......+..|+.+|..++|||||+++++|... .
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 4567899999999999999999999999999999999975433 344567889999999999999999999988553 5
Q ss_pred eeEEEEeecCCCcHHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHc-------CCeeeecCCCceEecC-------
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSL-------GIVHRDLKPDNLLIAH------- 822 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~----g~LsE~~ar~yaaQIL~ALeYLHs~-------GIIHRDLKPeNILLD~------- 822 (1092)
.+||||||+++|+|.++|... +.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 699999999999999999753 5799999999999999999999985 4999999999999964
Q ss_pred ----------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CC
Q 001360 823 ----------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TE 890 (1092)
Q Consensus 823 ----------nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~ 890 (1092)
.+.+||+|||+++.... .......+||+.|+|||++.+ ..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~----------------------------~s~~~s~vGTp~YmAPEvL~ge~~~ 219 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGI----------------------------ESMAHSCVGTPYYWSPELLLHETKS 219 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccc----------------------------cccccccCCCccccCHHHHhccCCC
Confidence 34599999999874210 011234679999999999965 45
Q ss_pred CCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 891 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 891 Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
|+.++||||||||||||++|.+||...+....+..++.....+|. ...+.++.+||..||..+|.+||+ +.++|.
T Consensus 220 ~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi--~~~S~eL~dLI~~~L~~dPeeRPS---a~QlL~ 294 (1021)
T PTZ00266 220 YDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPI--KGKSKELNILIKNLLNLSAKERPS---ALQCLG 294 (1021)
T ss_pred CCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCc--CCCCHHHHHHHHHHhcCChhHCcC---HHHHhc
Confidence 889999999999999999999999876554444444444333332 457899999999999999999999 889999
Q ss_pred CCCCCCCCc
Q 001360 971 HPFFKGVNW 979 (1092)
Q Consensus 971 HPFFkgIdW 979 (1092)
||||+.+..
T Consensus 295 h~~ik~i~~ 303 (1021)
T PTZ00266 295 YQIIKNVGP 303 (1021)
T ss_pred cHHHhhcCC
Confidence 999987643
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=353.27 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=208.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~----VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
+...+|++++.||+|+||+||+|++..+|.. ||+|+++... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 4567899999999999999999998776664 8999886422 234456788999999999999999999988764
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
..++|+||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 578999999999999999864 468889999999999999999999999999999999999999999999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
... .........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 161 ~~~-------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 161 ADE-------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred CCC-------------------------cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 100 0001112345778999999999999999999999999999997 99999988
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
...++... +.....+| .+..++.++.++|.+||..||.+||+ +.+++.+
T Consensus 216 ~~~~~~~~-~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps---~~~l~~~ 264 (316)
T cd05108 216 PASEISSI-LEKGERLP-QPPICTIDVYMIMVKCWMIDADSRPK---FRELIIE 264 (316)
T ss_pred CHHHHHHH-HhCCCCCC-CCCCCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 77665543 34333333 24678899999999999999999999 4455543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=347.63 Aligned_cols=256 Identities=29% Similarity=0.481 Sum_probs=205.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++.+.||+|+||.||+|..+.+|+.||+|++..... ......+.+|+.+|+.++|+||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999875432 22234567899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~----- 155 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI----- 155 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC-----
Confidence 99996 577777654 35688889999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChH-HH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE-II 922 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~-ei 922 (1092)
.........+++.|+|||++.+ ..++.++|+|||||++|||++|.+||...+.. +.
T Consensus 156 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~ 213 (291)
T cd07870 156 ----------------------PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213 (291)
T ss_pred ----------------------CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH
Confidence 0011123467999999999876 45788999999999999999999999765432 22
Q ss_pred HHHHhhc-CC------------------CCCC--------C--CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCC
Q 001360 923 FDNILNR-KI------------------PWPC--------V--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1092)
Q Consensus 923 ~~kIl~~-~l------------------~fP~--------i--p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPF 973 (1092)
...+... .. .++. + ....+.++.+||.+||..||.+||+ +.+++.|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t---~~~~l~h~~ 290 (291)
T cd07870 214 LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS---AQDALLHPY 290 (291)
T ss_pred HHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC---HHHHhcCCC
Confidence 2221110 00 0000 0 0123678999999999999999999 889999999
Q ss_pred C
Q 001360 974 F 974 (1092)
Q Consensus 974 F 974 (1092)
|
T Consensus 291 ~ 291 (291)
T cd07870 291 F 291 (291)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=348.14 Aligned_cols=257 Identities=33% Similarity=0.501 Sum_probs=212.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLY 763 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde--~~LY 763 (1092)
.++|++.+.||.|+||.||+|.++.+++.||+|.++..... ......+.+|+.++.+++||||+++++++... ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46899999999999999999999999999999999754322 22344577899999999999999999998877 8899
Q ss_pred EEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++.+|.+||+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~--- 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS--- 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccC---
Confidence 99999975 9999887644 589999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
.........+++.|+|||++.+. .++.++|+||||+++|||++|.+||...+...
T Consensus 159 ------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~ 214 (293)
T cd07843 159 ------------------------PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214 (293)
T ss_pred ------------------------CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 00111234678999999998764 46889999999999999999999999887766
Q ss_pred HHHHHhhcCC-------------------CC---------CCCCCC-CCHHHHHHHHHhccCCcCCCCCcccHHHHHcCC
Q 001360 922 IFDNILNRKI-------------------PW---------PCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1092)
Q Consensus 922 i~~kIl~~~l-------------------~f---------P~ip~~-lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HP 972 (1092)
...++..... .+ ..++.. +++.+.+||.+||+.||++||+ +.|++.||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t---~~ell~~~ 291 (293)
T cd07843 215 QLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS---AEDALKHP 291 (293)
T ss_pred HHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC---HHHHhcCC
Confidence 6555432100 00 001222 5889999999999999999999 88999999
Q ss_pred CC
Q 001360 973 FF 974 (1092)
Q Consensus 973 FF 974 (1092)
||
T Consensus 292 ~f 293 (293)
T cd07843 292 YF 293 (293)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.79 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=207.5
Q ss_pred eEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe----
Q 001360 689 FEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN---- 761 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~T---Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~---- 761 (1092)
|++.+.||+|+||.||+|....+ +..||+|.++.. .........+.+|+.+|+.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-IHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC-cCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 57889999999999999987653 478999998753 3334556789999999999999999999988766554
Q ss_pred --eEEEEeecCCCcHHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCC
Q 001360 762 --LYLVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1092)
Q Consensus 762 --LYLVMEYm~GGSL~dlLkk~------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGL 833 (1092)
.++||||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999998543 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCC
Q 001360 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912 (1092)
Q Consensus 834 Ak~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~ 912 (1092)
++....... ........++..|+|||++.+..++.++|||||||++|||++ |.+
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 160 SKKIYSGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred eeecccccc-------------------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 875321000 001112335678999999988899999999999999999999 999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 913 PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
||.+....+++..+..+.. +..+..++.++.++|.+||..||.+||++.++..
T Consensus 215 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 215 PYPGVENHEIYDYLRHGNR--LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred CCCCCCHHHHHHHHHcCCC--CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999888888877765532 2345788999999999999999999999444433
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.02 Aligned_cols=263 Identities=30% Similarity=0.452 Sum_probs=208.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~--- 760 (1092)
..+++|++.+.||+|+||.||+|..+.+++.||||++..... .......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 346789999999999999999999999999999999865322 2223345678999999999999999999876654
Q ss_pred -----eeEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCc
Q 001360 761 -----NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1092)
Q Consensus 761 -----~LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 834 (1092)
..|+||||+.+ +|.+++.+.. .+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 88 NRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred cCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999965 8888886653 6899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
........ ..........|++.|+|||++.+. .++.++|+||||+++|||++|++|
T Consensus 167 ~~~~~~~~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~ 223 (310)
T cd07865 167 RAFSLSKN-----------------------SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI 223 (310)
T ss_pred ccccCCcc-----------------------cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCC
Confidence 74311000 001112345689999999998764 478899999999999999999999
Q ss_pred CCCCChHHHHHHHhh--cCC-----------------CCCCC----------CCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 914 FTAESPEIIFDNILN--RKI-----------------PWPCV----------PSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~--~~l-----------------~fP~i----------p~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
|.+.++......+.. +.. .+|.. +...+..+.+||.+||..||.+||+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t--- 300 (310)
T cd07865 224 MQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID--- 300 (310)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC---
Confidence 988776544333222 100 01100 0123567889999999999999999
Q ss_pred HHHHHcCCCC
Q 001360 965 AAEVKAHPFF 974 (1092)
Q Consensus 965 a~EIL~HPFF 974 (1092)
+.++++||||
T Consensus 301 ~~e~l~h~~f 310 (310)
T cd07865 301 ADTALNHDFF 310 (310)
T ss_pred HHHHhcCCCC
Confidence 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=350.25 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=215.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
..|++.+.||+|+||+||+|....+|+.||+|++.............+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45899999999999999999999999999999997654444555678899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
||+.| +|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.+|.+||+|||++....
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~------- 166 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------- 166 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC-------
Confidence 99975 77777653 4578999999999999999999999999999999999999999999999999886421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
......|++.|+|||++. ...++.++||||||+++|||++|.+||.+.+....
T Consensus 167 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~ 222 (307)
T cd06607 167 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (307)
T ss_pred ------------------------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH
Confidence 012346889999999985 35688999999999999999999999988877665
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
...+.....+ ...+..++.++.+||.+||..||.+||+ +.+++.||||..
T Consensus 223 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~ 272 (307)
T cd06607 223 LYHIAQNDSP-TLSSNDWSDYFRNFVDSCLQKIPQDRPS---SEELLKHRFVLR 272 (307)
T ss_pred HHHHhcCCCC-CCCchhhCHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcc
Confidence 5554433221 1113457889999999999999999999 889999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=333.31 Aligned_cols=247 Identities=29% Similarity=0.430 Sum_probs=212.6
Q ss_pred EeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 001360 693 KPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~T---Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm 769 (1092)
+.||+|+||.||+|..... +..||+|+++..... .....+.+|+.++..++||||+++++++.+...+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 889999999764332 25678999999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 770 NGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 770 ~GGSL~dlLkk~---------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 77999999999999999999999999999999999999999999999999998753210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~ 919 (1092)
.. ........+++.|+|||.+.+..++.++|+|||||++|||++ |..||.....
T Consensus 159 ~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 159 DY-------------------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred cc-------------------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 00 011234568899999999998899999999999999999999 6999999988
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
.++...+.... .+..+..++.++.++|.+||+.||.+||+ +.+++.|
T Consensus 214 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~l~~~ 260 (262)
T cd00192 214 EEVLEYLRKGY--RLPKPEYCPDELYELMLSCWQLDPEDRPT---FSELVER 260 (262)
T ss_pred HHHHHHHHcCC--CCCCCccCChHHHHHHHHHccCCcccCcC---HHHHHHh
Confidence 88888877632 12345778999999999999999999999 6666643
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=358.48 Aligned_cols=263 Identities=29% Similarity=0.441 Sum_probs=214.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCee
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNL 762 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd----e~~L 762 (1092)
++|++.+.||.|+||.||+|..+.+|+.||+|++.+.. ........+.+|+.+|..++||||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 68999999999999999999999999999999987532 223345678889999999999999999988763 3468
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 59999998778899999999999999999999999999999999999999999999999999874211000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
.........+||..|+|||++.+ ..++.++|||||||++|||++|++||.+.+...
T Consensus 163 -----------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~ 219 (334)
T cd07855 163 -----------------------EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH 219 (334)
T ss_pred -----------------------CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH
Confidence 00111234579999999999876 568999999999999999999999998876544
Q ss_pred HHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCC
Q 001360 922 IFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1092)
Q Consensus 922 i~~kIl~~----------------------------~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPF 973 (1092)
....+... ..++......++.++.+||.+||+.||.+||+ +.+++.|||
T Consensus 220 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~~l~~~~ 296 (334)
T cd07855 220 QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT---VEQALQHPF 296 (334)
T ss_pred HHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC---HHHHHhChh
Confidence 33322210 00111112457899999999999999999999 889999999
Q ss_pred CCCC
Q 001360 974 FKGV 977 (1092)
Q Consensus 974 FkgI 977 (1092)
|++.
T Consensus 297 ~~~~ 300 (334)
T cd07855 297 LAQY 300 (334)
T ss_pred hhhc
Confidence 9854
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=327.49 Aligned_cols=250 Identities=38% Similarity=0.650 Sum_probs=215.6
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|++.+.||.|+||.||++....+++.|++|++..... .....+.+|+.++..++||+|+++++.+......|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999998999999999976432 356788999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 768 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
|++|++|.+++... ..+++..+..++.|++.||.|||.+|++|+||+|+||+++.++.++|+|||++.....
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~------- 150 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD------- 150 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccc-------
Confidence 99999999999776 5799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+
T Consensus 151 ---------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 209 (253)
T cd05122 151 ---------------------TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI 209 (253)
T ss_pred ---------------------cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Confidence 00023457899999999999888999999999999999999999999887655444444
Q ss_pred hhcCCCCCCCCC--CCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCC
Q 001360 927 LNRKIPWPCVPS--DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1092)
Q Consensus 927 l~~~l~fP~ip~--~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPF 973 (1092)
..... +..+. .++..+.++|.+||..||.+||+ +.+++.|||
T Consensus 210 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~~~l~~~~ 253 (253)
T cd05122 210 ATNGP--PGLRNPEKWSDEFKDFLKKCLQKNPEKRPT---AEQLLKHPF 253 (253)
T ss_pred HhcCC--CCcCcccccCHHHHHHHHHHccCChhhCCC---HHHHhcCCC
Confidence 33222 22222 34899999999999999999999 889999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=346.87 Aligned_cols=263 Identities=26% Similarity=0.434 Sum_probs=212.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LYL 764 (1092)
.++|+..+.||+|+||.||++.+..+|+.||+|.+.+... ......+.+|+.++.++. ||||+++++++......|+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 3577888899999999999999999999999999875432 244567889999999996 9999999999999999999
Q ss_pred EEeecCCCcHHHHH---H--hhcCCCHHHHHHHHHHHHHHHHHHHHc-CCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 765 VMEYLNGGDLYSLL---R--KVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 765 VMEYm~GGSL~dlL---k--k~g~LsE~~ar~yaaQIL~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
+|||+.+ +|.++. . ....+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999864 554433 2 235799999999999999999999975 99999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC---CCCccceeechhhhHHHHHhCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~---~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
. ........||+.|+|||++.+. .++.++|||||||++|||++|++||.
T Consensus 160 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 160 D----------------------------SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred c----------------------------CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 0 0111234689999999999876 68999999999999999999999997
Q ss_pred CCCh-HHHHHHHhhcCC-CCC-CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchh
Q 001360 916 AESP-EIIFDNILNRKI-PWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982 (1092)
Q Consensus 916 ~~s~-~ei~~kIl~~~l-~fP-~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L 982 (1092)
.... .+....+..... .++ ..+..++.++.+||.+||..||.+||+ +.+++.||||+...|...
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~i~~~~~~~~~~~~~~ 278 (288)
T cd06616 212 KWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK---YKELLEHPFIKDYEERNV 278 (288)
T ss_pred hcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcChhhhchhhcch
Confidence 6542 222233322221 111 112357899999999999999999999 889999999998766543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=343.57 Aligned_cols=258 Identities=31% Similarity=0.486 Sum_probs=213.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYL 764 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde--~~LYL 764 (1092)
++|+..+.||.|+||.||+|....+++.||+|.+..... ......+.+|+++++.++||||++++++|.+. ..+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 479999999999999999999999999999999875322 24457789999999999999999999988654 36899
Q ss_pred EEeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 765 VMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
||||++||+|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999988753 34589999999999999999999999999999999999999999999999999864210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC---
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--- 917 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~--- 917 (1092)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 158 ----------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (287)
T cd06621 158 ----------------------------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209 (287)
T ss_pred ----------------------------cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence 0011345788999999999999999999999999999999999999865
Q ss_pred --ChHHHHHHHhhcCC-CCCCCC---CCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 918 --SPEIIFDNILNRKI-PWPCVP---SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 918 --s~~ei~~kIl~~~l-~fP~ip---~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
.+.+....+..... .++..+ ...++.+.+||.+||..||.+||+ +.+++.||||+...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~eil~~~~~~~~~ 273 (287)
T cd06621 210 PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT---PWDMLEHPWIKAQM 273 (287)
T ss_pred CCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCC---HHHHHhCccccccc
Confidence 33444444443221 111111 235678999999999999999999 88999999997653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.81 Aligned_cols=257 Identities=31% Similarity=0.536 Sum_probs=218.8
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
.|+.++.||+|+||.||+|.+..++..||+|+++.... ......+.+|+.+++.++||||++++++|...+.+|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 46677889999999999999999999999999875332 2345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
|+++|+|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.....
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~-------- 153 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-------- 153 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccC--------
Confidence 9999999998864 5689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl 927 (1092)
.........|+..|+|||++.+..++.++|+|||||++|||++|..||....+......+.
T Consensus 154 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 214 (277)
T cd06642 154 -------------------TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP 214 (277)
T ss_pred -------------------cchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh
Confidence 0011123568999999999999899999999999999999999999998776665555443
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCc
Q 001360 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 928 ~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdW 979 (1092)
... .+..+..++.++.+||.+||..+|.+||+ +.++++||||....+
T Consensus 215 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~ 261 (277)
T cd06642 215 KNS--PPTLEGQYSKPFKEFVEACLNKDPRFRPT---AKELLKHKFITRYTK 261 (277)
T ss_pred cCC--CCCCCcccCHHHHHHHHHHccCCcccCcC---HHHHHHhHHHHHHhh
Confidence 332 23344668899999999999999999999 889999999976443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=343.98 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=210.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCC----------------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTG----------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TG----------------k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPN 748 (1092)
..++|++++.||+|+||.||+|....++ ..||+|.+.... .......+.+|++++.+++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCC
Confidence 4568999999999999999999876544 468999987533 2345678899999999999999
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCc
Q 001360 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (1092)
Q Consensus 749 IVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g-----------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeN 817 (1092)
|+++++++...+.+|+||||+++++|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999998765 68999999999999999999999999999999999
Q ss_pred eEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001360 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (1092)
Q Consensus 818 ILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDV 897 (1092)
||++.++.++|+|||+++...... .........+|+.|||||++.+..++.++||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSD-------------------------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215 (296)
T ss_pred eeecCCCceEEccccceeecccCc-------------------------ceeecCcCCCCceecCHHHhhcCCCCccchh
Confidence 999999999999999987421100 0011224467889999999998889999999
Q ss_pred echhhhHHHHHh--CCCCCCCCChHHHHHHHhhc-----CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 898 WSVGIILFEFIT--GIPPFTAESPEIIFDNILNR-----KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 898 WSLGVILYEMLT--Gk~PF~~~s~~ei~~kIl~~-----~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
|||||++|||++ |..||...+...++..+... .......+..++.++.+||.+||+.||.+||++.++
T Consensus 216 ~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el 290 (296)
T cd05051 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290 (296)
T ss_pred hhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence 999999999998 78999887777776665432 111111245678999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.85 Aligned_cols=259 Identities=28% Similarity=0.481 Sum_probs=207.0
Q ss_pred CeEEEEeeccCCCeEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLY 763 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~--TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde--~~LY 763 (1092)
.|++.+.||+|+||.||+|..+. ++..||+|.+.+...........+.+|+.++..++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999999864333333456778899999999999999999999988 7899
Q ss_pred EEEeecCCCcHHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC----CCcEEEEecCCc
Q 001360 764 LVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLS 834 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~-----g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~----nG~VKLsDFGLA 834 (1092)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. +|.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 777776432 36899999999999999999999999999999999999999 999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
+...... .........+||+.|+|||++.+ ..++.++|+|||||++|+|++|++|
T Consensus 160 ~~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 160 RLFNAPL------------------------KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred cccCCCc------------------------ccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 7531100 00112234578999999999876 4588999999999999999999999
Q ss_pred CCCCChHH---------HHHHHhh--------------------------cCCCCCC------CC--CCCCHHHHHHHHH
Q 001360 914 FTAESPEI---------IFDNILN--------------------------RKIPWPC------VP--SDMSFEAQDLINR 950 (1092)
Q Consensus 914 F~~~s~~e---------i~~kIl~--------------------------~~l~fP~------ip--~~lS~eakDLI~k 950 (1092)
|.+..... ....++. ....++. .+ ...+.++.++|.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 295 (316)
T cd07842 216 FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295 (316)
T ss_pred CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH
Confidence 98654322 1111110 0011110 00 1567789999999
Q ss_pred hccCCcCCCCCcccHHHHHcCCCC
Q 001360 951 FLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 951 cL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
||..||.+||+ +.+++.||||
T Consensus 296 ~l~~~P~~Rps---~~eil~~~~f 316 (316)
T cd07842 296 LLEYDPTKRIT---AEEALEHPYF 316 (316)
T ss_pred HhcCCcccCcC---HHHHhcCCCC
Confidence 99999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=342.23 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=214.6
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TG-----k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~ 754 (1092)
...+..++|++.+.||+|+||.||++.++..+ ..+|+|.+.... .......+.+|+.++.++ +||||+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 44567789999999999999999999986443 789999987532 234456789999999999 7999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCce
Q 001360 755 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (1092)
Q Consensus 755 sfqde~~LYLVMEYm~GGSL~dlLkk~----------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNI 818 (1092)
++.....+|+||||+++|+|..++... +.+++..+..++.|++.||.|||++||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999999642 4588899999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001360 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (1092)
Q Consensus 819 LLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVW 898 (1092)
|++.++.+||+|||+++...... .........+++.|+|||++.+..++.++|||
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 218 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHID-------------------------YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVW 218 (293)
T ss_pred EEcCCCeEEeCcccccccccccc-------------------------ceeccCCCCCCccccCHHHhccCCcCccccee
Confidence 99999999999999987421000 00011122356789999999999999999999
Q ss_pred chhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 899 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 899 SLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
||||++|||++ |..||......+++..+..... +..+...+.++.+|+.+||..||.+||+ +.++++
T Consensus 219 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~eil~ 286 (293)
T cd05053 219 SFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR--MEKPQNCTQELYHLMRDCWHEVPSQRPT---FKQLVE 286 (293)
T ss_pred ehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcC---HHHHHH
Confidence 99999999997 9999999888888877665432 2234678899999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.03 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=207.5
Q ss_pred eeccCCCeEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 694 PISRGAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 694 ~LGkGgFGtVyLar~--k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
.||+|+||.||+|.+ +.++..||+|+++... ......+.+.+|+.++..++||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999965 4568899999986432 23445678899999999999999999999875 4567999999999
Q ss_pred CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 772 GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
|+|.+++.+...+++..+..++.|++.||.|||++||+||||||.|||++.++.+||+|||+++......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~---------- 149 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---------- 149 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 930 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~ 930 (1092)
..........+++.|+|||.+....++.++|+|||||++|||++ |.+||...+...+...+..+.
T Consensus 150 --------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~ 215 (257)
T cd05116 150 --------------NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE 215 (257)
T ss_pred --------------CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC
Confidence 00001122345789999999988889999999999999999998 999999888888877776543
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 931 l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
. +..|..++.++++||.+||+.||++||++..+.+.|.
T Consensus 216 ~--~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~ 253 (257)
T cd05116 216 R--MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253 (257)
T ss_pred C--CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence 2 3345789999999999999999999999665555554
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.09 Aligned_cols=255 Identities=31% Similarity=0.534 Sum_probs=219.9
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
-|++++.||.|+||.||+|.+..++..||+|++..... ......+.+|+.++..++||||+++++++...+.+|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 47788999999999999999998999999998865332 2345678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
|+++|+|..++.. +.+++..+..++.|++.||.|||+.|++|+||||+||+++.+|.++|+|||++.....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~-------- 153 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-------- 153 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceeccc--------
Confidence 9999999999865 4689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl 927 (1092)
.........|+..|+|||.+.+..++.++|+|||||++|+|++|.+||...........+.
T Consensus 154 -------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 214 (277)
T cd06641 154 -------------------TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP 214 (277)
T ss_pred -------------------chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh
Confidence 0011123568999999999988888999999999999999999999998877766666654
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 928 ~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
... .+.++..++.++.++|.+||..+|.+||+ +.++++||||...
T Consensus 215 ~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~~~~ 259 (277)
T cd06641 215 KNN--PPTLEGNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFIVRF 259 (277)
T ss_pred cCC--CCCCCcccCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhhh
Confidence 433 23345678899999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=342.41 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=212.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 45789999999999999999999987 7789999988642 2233456789999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC---cEEEE
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVG-------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLT 829 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g-------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLs 829 (1092)
...|+||||++||+|.+++...+ .+++..+..++.||+.||.|||+++++||||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999997653 488999999999999999999999999999999999998765 59999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh
Q 001360 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909 (1092)
Q Consensus 830 DFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT 909 (1092)
|||+++...... + ........+++.|+|||++.+..++.++|||||||++|||++
T Consensus 162 dfg~~~~~~~~~---------------------~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 216 (277)
T cd05036 162 DFGMARDIYRAS---------------------Y----YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216 (277)
T ss_pred cCccccccCCcc---------------------c----eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHc
Confidence 999987421000 0 000112234578999999999899999999999999999997
Q ss_pred -CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 910 -GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 910 -Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
|..||...+...+...+..... +..+..++..+.+||.+||+.||++||+ +.++++|
T Consensus 217 ~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rps---~~~vl~~ 274 (277)
T cd05036 217 LGYMPYPGRTNQEVMEFVTGGGR--LDPPKGCPGPVYRIMTDCWQHTPEDRPN---FATILER 274 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcC---HHHHHHH
Confidence 9999999888777766654321 2234678999999999999999999999 5566654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.76 Aligned_cols=258 Identities=33% Similarity=0.551 Sum_probs=217.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++.+.||.|+||.||++....++..||+|.+.... ....+.+.+|+.+++.++||||+++++.|...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 478999999999999999999998899999999986432 23456789999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||+++|+|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~------ 167 (293)
T cd06647 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 167 (293)
T ss_pred EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc------
Confidence 9999999999998653 588999999999999999999999999999999999999999999999998763210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......
T Consensus 168 ---------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~ 226 (293)
T cd06647 168 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (293)
T ss_pred ---------------------cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee
Confidence 00111234689999999999988899999999999999999999999988766544333
Q ss_pred Hhhc-CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 926 ILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 926 Il~~-~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
+... ...++ .+..++..+++||.+||..+|.+||+ +.+++.||||+...
T Consensus 227 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~h~~~~~~~ 276 (293)
T cd06647 227 IATNGTPELQ-NPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKIAK 276 (293)
T ss_pred hhcCCCCCCC-CccccCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhcCc
Confidence 3222 22222 23457889999999999999999999 88999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=356.60 Aligned_cols=257 Identities=31% Similarity=0.478 Sum_probs=213.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~---- 760 (1092)
..++|++++.||+|+||.||+|....+|..||||++.+.. ........+.+|+.+|+.++||||++++++|....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567999999999999999999999999999999986532 22334567889999999999999999999987764
Q ss_pred --eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 --~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 358999999 7799888764 579999999999999999999999999999999999999999999999999986321
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
.......|++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.
T Consensus 170 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 170 ------------------------------SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ------------------------------cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 01123467999999999876 45889999999999999999999999987
Q ss_pred ChHHHHHHHhhcCCC----------------------------CCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 918 SPEIIFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~----------------------------fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+....+..+...... +......+++++.+||.+||+.||.+||+ +.+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t---~~~~l 296 (343)
T cd07880 220 DHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT---AAEAL 296 (343)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC---HHHHh
Confidence 765555444332111 01112467889999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001360 970 AHPFFKGV 977 (1092)
Q Consensus 970 ~HPFFkgI 977 (1092)
.||||+..
T Consensus 297 ~~~~~~~~ 304 (343)
T cd07880 297 AHPYFEEF 304 (343)
T ss_pred cCccHhhh
Confidence 99999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.64 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=205.2
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GG 772 (1092)
+.||+|+||.||+|+++.+|+.||+|.+.+. ........+.+|+++|+.++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 3699999999999999999999999988642 23345577999999999999999999999999999999999999999
Q ss_pred cHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 773 DLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 773 SL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
+|.+++.+.+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-~---------- 147 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEED-G---------- 147 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccc-c----------
Confidence 9999997644 589999999999999999999999999999999999999999999999999863210 0
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 930 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~ 930 (1092)
. . ........++..|+|||.+.+..++.++|||||||++|||++ |.+||...+.......+....
T Consensus 148 -~------~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~ 213 (252)
T cd05084 148 -V------Y-------ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV 213 (252)
T ss_pred -c------c-------cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC
Confidence 0 0 000011123567999999998889999999999999999998 999998887776666655432
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 931 l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.. ..+...+..+.+||.+||+.||++||++.++.+.+
T Consensus 214 -~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 250 (252)
T cd05084 214 -RL-PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250 (252)
T ss_pred -CC-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 22 23467889999999999999999999955554433
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.88 Aligned_cols=253 Identities=33% Similarity=0.526 Sum_probs=210.0
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeeccCCe----
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCRDN---- 761 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L---~HPNIVkL~~sfqde~~---- 761 (1092)
|++.+.||.|+||.||+|+++.+++.||+|+++.... .......+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7889999999999999999998999999999975332 222345567788877666 59999999999998877
Q ss_pred -eEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 762 -LYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 762 -LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
+|++|||+.+ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+|||++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8999887643 58999999999999999999999999999999999999999999999999986421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
. ........|++.|+|||++.+..++.++|+|||||++|||++|.+||...+
T Consensus 159 ~----------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 159 F----------------------------EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred C----------------------------CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 0 011123458899999999999999999999999999999999999999988
Q ss_pred hHHHHHHHhhc-----CCCCCC-------------------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 919 PEIIFDNILNR-----KIPWPC-------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 919 ~~ei~~kIl~~-----~l~fP~-------------------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
..+.+.++... ...++. ....++..+.+||.+||+.||.+||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~---~~~il~~~~~ 287 (287)
T cd07838 211 EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS---AFEALQHPYF 287 (287)
T ss_pred hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC---HHHHhcCcCC
Confidence 87777666541 011110 01245678899999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=382.50 Aligned_cols=268 Identities=24% Similarity=0.331 Sum_probs=202.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCC-cEEEEEE--------------eecccccchhHHHHHHHHHHHHHhcCCCce
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKV--------------LKKLDMIRKNDIERILAERNILITVRNPFV 749 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TG-k~VAIKv--------------LkK~ei~kk~~ie~~l~EieIL~~L~HPNI 749 (1092)
..++|++++.||+|+||+||+|..+... ..++.|. +.+...........+.+|+.+|.+++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999999865432 2222221 111111122345668899999999999999
Q ss_pred EEEeeeeccCCeeEEEEeecCCCcHHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC
Q 001360 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (1092)
Q Consensus 750 VkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~-----g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG 824 (1092)
|++++++...+..|+||+++. ++|..++... .......++.++.||+.||.|||++|||||||||+||||+.+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 999999999999999999995 5788877542 2234567888999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhH
Q 001360 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (1092)
Q Consensus 825 ~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVIL 904 (1092)
.+||+|||+++.... .........+||+.|+|||++.+..|+.++|||||||+|
T Consensus 305 ~vkL~DFGla~~~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 358 (501)
T PHA03210 305 KIVLGDFGTAMPFEK--------------------------EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358 (501)
T ss_pred CEEEEeCCCceecCc--------------------------ccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHH
Confidence 999999999974210 001122346899999999999999999999999999999
Q ss_pred HHHHhCCCC-CCCC--ChHHHHHHHhhc----CCCCCC----------------C---------CCCCCHHHHHHHHHhc
Q 001360 905 FEFITGIPP-FTAE--SPEIIFDNILNR----KIPWPC----------------V---------PSDMSFEAQDLINRFL 952 (1092)
Q Consensus 905 YEMLTGk~P-F~~~--s~~ei~~kIl~~----~l~fP~----------------i---------p~~lS~eakDLI~kcL 952 (1092)
|||++|..| |... .+...+.+++.. ...+|. . ...++.++.++|.+||
T Consensus 359 ~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL 438 (501)
T PHA03210 359 LDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKML 438 (501)
T ss_pred HHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHh
Confidence 999998754 4322 222222222210 001110 0 1235678889999999
Q ss_pred cCCcCCCCCcccHHHHHcCCCCCCCCcchh
Q 001360 953 IHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982 (1092)
Q Consensus 953 ~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L 982 (1092)
++||.+||+ +.|++.||||.......+
T Consensus 439 ~~DP~~Rps---a~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 439 TFDWHLRPG---AAELLALPLFSAEEEEEI 465 (501)
T ss_pred ccCcccCcC---HHHHhhChhhhcCCchHH
Confidence 999999999 889999999998776654
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=332.11 Aligned_cols=252 Identities=30% Similarity=0.521 Sum_probs=221.3
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+|++.+.||.|+||.||+++++.+++.||+|.+.+... .......+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58999999999999999999999999999999976443 23456678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 768 YLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 768 Ym~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
|+++++|..++.+ ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~---- 155 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK---- 155 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc----
Confidence 9999999999866 35689999999999999999999999999999999999999999999999999875210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.....
T Consensus 156 -------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (256)
T cd08530 156 -------------------------NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210 (256)
T ss_pred -------------------------CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0112346889999999999999999999999999999999999999998887777
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
..+.... ++.++..++.+++++|.+||..+|.+||+ +.++++||+.
T Consensus 211 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~p~~ 256 (256)
T cd08530 211 YKVQRGK--YPPIPPIYSQDLQNFIRSMLQVKPKLRPN---CDKILASPAV 256 (256)
T ss_pred HHHhcCC--CCCCchhhCHHHHHHHHHHcCCCcccCCC---HHHHhcCCCC
Confidence 7665544 34445678999999999999999999999 8899999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.65 Aligned_cols=261 Identities=30% Similarity=0.506 Sum_probs=209.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----C
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-----D 760 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde-----~ 760 (1092)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.++.+++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 368999999999999999999999999999999986422 233456788999999999999999999876544 3
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|+||||+.+ +|..++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 58999999975 88888754 56999999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
. .........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 160 ~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~ 215 (336)
T cd07849 160 H------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215 (336)
T ss_pred c------------------------cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0 00111234579999999998765 5689999999999999999999999987654
Q ss_pred HHHHHHHhh---------------c-------------CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 920 EIIFDNILN---------------R-------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 920 ~ei~~kIl~---------------~-------------~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
......+.. . ..+++......+.++.+||.+||+.||.+||+ +.+++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~e~l~h 292 (336)
T cd07849 216 LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT---VEEALAH 292 (336)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC---HHHHhcC
Confidence 333322211 0 00000011346788999999999999999999 8899999
Q ss_pred CCCCCC
Q 001360 972 PFFKGV 977 (1092)
Q Consensus 972 PFFkgI 977 (1092)
|||+..
T Consensus 293 p~~~~~ 298 (336)
T cd07849 293 PYLEQY 298 (336)
T ss_pred cccccc
Confidence 999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=337.20 Aligned_cols=255 Identities=24% Similarity=0.309 Sum_probs=213.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~T---Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
.++|++.+.||+|+||.||+|+++.+ ...||+|+++... .......+.+|+.++..++||||+++++++...+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46899999999999999999998754 4589999886532 334456788999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
|+||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~- 159 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS- 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc-
Confidence 9999999999999999764 46899999999999999999999999999999999999999999999999999853100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
..........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 160 ------------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~ 215 (266)
T cd05033 160 ------------------------EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215 (266)
T ss_pred ------------------------ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence 00001112345788999999999899999999999999999998 99999888887
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.....+.... ..| .+...+..+.+|+.+||..+|++||++.++.+.+
T Consensus 216 ~~~~~~~~~~-~~~-~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 216 DVIKAVEDGY-RLP-PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred HHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 7777776542 222 2467899999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.89 Aligned_cols=260 Identities=30% Similarity=0.462 Sum_probs=213.8
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~----- 760 (1092)
.+.|++++.||+|+||+||+|++..+|+.||||.+++.. ........+.+|+.+|..++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 357999999999999999999999999999999987532 23334567788999999999999999998876543
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|+||||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~- 160 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE- 160 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC-
Confidence 4899999996 68999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
.........||..|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+.
T Consensus 161 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 214 (337)
T cd07858 161 --------------------------KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214 (337)
T ss_pred --------------------------CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence 0011224568999999999875 4688999999999999999999999987664
Q ss_pred HHHHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 920 EIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 920 ~ei~~kIl~~----------------------------~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
......+... ...+......+++++.+||.+||+.||.+||+ +.++++|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps---~~ell~h 291 (337)
T cd07858 215 VHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT---VEEALAH 291 (337)
T ss_pred HHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC---HHHHHcC
Confidence 4333322210 00011122468899999999999999999999 8899999
Q ss_pred CCCCCC
Q 001360 972 PFFKGV 977 (1092)
Q Consensus 972 PFFkgI 977 (1092)
|||+.+
T Consensus 292 ~~~~~~ 297 (337)
T cd07858 292 PYLASL 297 (337)
T ss_pred cchhhh
Confidence 999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.46 Aligned_cols=254 Identities=21% Similarity=0.329 Sum_probs=212.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~T-----Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
...+|++.+.||+|+||.||+|....+ +..||||+++... .......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 456788999999999999999987543 5789999987432 233456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~----------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n 823 (1092)
..+++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 247888899999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhh
Q 001360 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (1092)
Q Consensus 824 G~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVI 903 (1092)
+.+||+|||+++...... .........+++.|+|||++.+..++.++|||||||+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 215 (283)
T cd05091 161 LNVKISDLGLFREVYAAD-------------------------YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVV 215 (283)
T ss_pred CceEecccccccccccch-------------------------heeeccCccCCccccCHHHHhcCCCCcchhHHHHHHH
Confidence 999999999987421100 0011123456889999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 904 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 904 LYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
+|||++ |.+||.+....+....+...... ..+..++.++.+|+.+||+.+|.+||+ +.+|+.
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RP~---~~~i~~ 278 (283)
T cd05091 216 LWEVFSYGLQPYCGYSNQDVIEMIRNRQVL--PCPDDCPAWVYTLMLECWNEFPSRRPR---FKDIHS 278 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHhCCCcccCCC---HHHHHH
Confidence 999998 99999998888888888776542 235789999999999999999999999 445543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.23 Aligned_cols=254 Identities=31% Similarity=0.530 Sum_probs=210.9
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEY 768 (1092)
|++++.||.|++|.||+|.++.+|..||+|++..... .......+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999875432 223346688999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 769 LNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 769 m~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
++ ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~------- 151 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV------- 151 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCC-------
Confidence 95 69999997765 689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
.........+++.|+|||++.+. .++.++|+|||||++|+|++|++||...+......+
T Consensus 152 --------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 211 (283)
T cd07835 152 --------------------PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211 (283)
T ss_pred --------------------CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 00111234578999999988764 578899999999999999999999988776544443
Q ss_pred HhhcC--------------------------CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 926 ILNRK--------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 926 Il~~~--------------------------l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
+.... .........++.++.+||.+||+.||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~ 283 (283)
T cd07835 212 IFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS---AKAALQHPYF 283 (283)
T ss_pred HHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC---HHHHhcCCCC
Confidence 32210 0001123467889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=339.46 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=209.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk----~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
+..++|++++.||.|+||+||+|++..+|. .||+|+++... .......+.+|+.++..+.||||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 456789999999999999999999887776 48999886532 33445678899999999999999999998875
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
...+++|||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 4578999999999999999764 569999999999999999999999999999999999999999999999999987531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
... .........+++.|+|||.+.+..++.++|||||||++|||++ |.+||...
T Consensus 161 ~~~-------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 161 IDE-------------------------TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred ccc-------------------------ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 000 0000112345788999999999999999999999999999998 99999887
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
....+...+..+. ..+ .+...+.++.++|.+||..||++||+ +.+++
T Consensus 216 ~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~---~~~l~ 262 (279)
T cd05109 216 PAREIPDLLEKGE-RLP-QPPICTIDVYMIMVKCWMIDSECRPR---FRELV 262 (279)
T ss_pred CHHHHHHHHHCCC-cCC-CCccCCHHHHHHHHHHcCCChhhCcC---HHHHH
Confidence 7776666554432 222 34678999999999999999999999 44554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=337.12 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=205.6
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC------C
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------D 760 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk--~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde------~ 760 (1092)
|.+.+.||+|+||.||+|+...++. .||+|.++.. .......+.+.+|..++..++||||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC-cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3467889999999999999987775 6999988653 23455678899999999999999999999865322 2
Q ss_pred eeEEEEeecCCCcHHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 834 (1092)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 478999999999999887422 34889999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~P 913 (1092)
+....... ........+++.|+|||++.+..++.++|||||||++|||++ |.+|
T Consensus 160 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 160 KKIYNGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred cccCcccc-------------------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 75210000 001122346788999999999999999999999999999999 8999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
|.+.....++..+..+... ..+..++..+.++|.+||+.||.+||++.++.+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 215 YPGVENSEIYDYLRQGNRL--KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9988888888777665431 2346788999999999999999999995444433
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.51 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=215.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
...+|++.+.||.|+||.||+|..+. +..+|+|++.+... .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 44679999999999999999999987 89999999876432 234568899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~--- 156 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE--- 156 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC---
Confidence 99999999999999753 4689999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~e 921 (1092)
.........+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+
T Consensus 157 ------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~ 212 (261)
T cd05148 157 ------------------------DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212 (261)
T ss_pred ------------------------ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 0001113346788999999998899999999999999999998 899999988888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
++..+... ...+ .+..+++.+.++|.+||+.||.+||++.++.+.|
T Consensus 213 ~~~~~~~~-~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 213 VYDQITAG-YRMP-CPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred HHHHHHhC-CcCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 88877754 2222 3468899999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=336.23 Aligned_cols=249 Identities=23% Similarity=0.401 Sum_probs=208.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
..+|++.+.||+|+||.||+|+++ ++..+|+|++.+... ....+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 457899999999999999999886 467899999875432 234678899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~--- 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--- 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc---
Confidence 9999999999999753 468999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~ 923 (1092)
........++..|+|||.+.+..++.++|+|||||++|||++ |.+||...+..+..
T Consensus 155 -----------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 211 (256)
T cd05059 155 -----------------------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211 (256)
T ss_pred -----------------------ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH
Confidence 000111234568999999999999999999999999999999 89999988887777
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
..+.... .. ..+...+.++.+|+.+||..+|++||+ +.++++
T Consensus 212 ~~~~~~~-~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~~~l~ 253 (256)
T cd05059 212 ESVSAGY-RL-YRPKLAPTEVYTIMYSCWHEKPEDRPA---FKKLLS 253 (256)
T ss_pred HHHHcCC-cC-CCCCCCCHHHHHHHHHHhcCChhhCcC---HHHHHH
Confidence 7765442 21 234568999999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=334.15 Aligned_cols=248 Identities=26% Similarity=0.423 Sum_probs=208.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee-ccCCee
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF-TCRDNL 762 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sf-qde~~L 762 (1092)
+...+|++.+.||+|+||.||++... |..||+|.++.. .....+.+|+.++++++||||+++++++ .....+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 45678999999999999999999765 788999988642 2345788999999999999999999865 455679
Q ss_pred EEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
|+||||+++|+|.+++.+.+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 154 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 154 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-
Confidence 99999999999999997654 488999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~ 919 (1092)
......++..|+|||++.+..++.++|||||||++|||++ |++||...+.
T Consensus 155 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~ 205 (256)
T cd05082 155 -----------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred -----------------------------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 0112345678999999999899999999999999999997 9999998888
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
..+...+..+. . +..+..++..+.+||.+||..||.+||++.++.+.+.
T Consensus 206 ~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 206 KDVVPRVEKGY-K-MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254 (256)
T ss_pred HHHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence 77777765442 2 2334678999999999999999999999655554443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=355.09 Aligned_cols=257 Identities=32% Similarity=0.481 Sum_probs=210.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~----- 760 (1092)
.++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.. ........+.+|+.++..++||||++++++|....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 368999999999999999999999999999999987532 22233456889999999999999999999887553
Q ss_pred -eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 761 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 -~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
.+|+||||+.+ +|..++. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~- 168 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD- 168 (342)
T ss_pred ceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC-
Confidence 46999999964 7776652 368999999999999999999999999999999999999999999999999986310
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus 169 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 169 -----------------------------AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred -----------------------------CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 01123468999999999876 468899999999999999999999999877
Q ss_pred hHHHHHHHhhcC-----------------------CCCC-----CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 919 PEIIFDNILNRK-----------------------IPWP-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 919 ~~ei~~kIl~~~-----------------------l~fP-----~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
....+..+.... ..++ ......+.++.+||.+||+.||.+||+ +.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~---~~e~l~ 296 (342)
T cd07879 220 YLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT---ATEALE 296 (342)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC---HHHHhc
Confidence 655554443310 0000 011246788999999999999999999 889999
Q ss_pred CCCCCCCCc
Q 001360 971 HPFFKGVNW 979 (1092)
Q Consensus 971 HPFFkgIdW 979 (1092)
||||+++.+
T Consensus 297 h~~f~~~~~ 305 (342)
T cd07879 297 HPYFDSFRD 305 (342)
T ss_pred Ccchhhccc
Confidence 999988754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=366.23 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=213.4
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEee
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFY 754 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~T-----Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~ 754 (1092)
.+....++|++++.||+|+||.||+|.+... +..||||+++... .....+.+.+|+.+|.++. |||||++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 3445678899999999999999999987533 3479999996532 2344578999999999996 999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhh-----------------------------------------------------
Q 001360 755 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------------------------------------------------- 781 (1092)
Q Consensus 755 sfqde~~LYLVMEYm~GGSL~dlLkk~----------------------------------------------------- 781 (1092)
++.....+|||||||++|+|.++|.+.
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999988642
Q ss_pred -------------------------------------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCce
Q 001360 782 -------------------------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (1092)
Q Consensus 782 -------------------------------------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNI 818 (1092)
..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 1367788889999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001360 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (1092)
Q Consensus 819 LLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVW 898 (1092)
|++.++.+||+|||+++...... .........|++.|+|||++.+..++.++|||
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 323 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDS-------------------------NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVW 323 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccc-------------------------cccccCCcCCCcceEChhhhcCCCCCchhhHH
Confidence 99999999999999987421100 00112234678899999999999999999999
Q ss_pred chhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 899 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 899 SLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
||||++|||++ |..||............+.....++ .+..++.++.+||.+||..||++||++.++.+++.
T Consensus 324 SlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 324 SYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred HHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 99999999997 9999987655444433344433333 35678999999999999999999999776666654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=334.86 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=212.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+..++|++.+.||+|+||.||+|... +++.||+|.++.... ....+.+|+.++++++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 45578999999999999999999975 457899999875432 2456889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 156 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED- 156 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC-
Confidence 9999999999999997654 6899999999999999999999999999999999999999999999999998753100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
.........++..|+|||++.+..++.++|+||||+++|||++ |+.||.+.+..
T Consensus 157 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 211 (261)
T cd05068 157 -------------------------IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA 211 (261)
T ss_pred -------------------------cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0000111223568999999998899999999999999999999 99999998888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.+...+... ...+ .+...+..+.+|+.+||..+|.+||+++++...+
T Consensus 212 ~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l 258 (261)
T cd05068 212 EVLQQVDQG-YRMP-CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKL 258 (261)
T ss_pred HHHHHHHcC-CCCC-CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 777776544 2222 2467889999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=335.99 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=210.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++++.||+|+||+||+|++.. +..||+|.++.... ....+.+|+.++.+++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4689999999999999999998764 45699998875432 235688999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.....
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~---- 153 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD---- 153 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC----
Confidence 9999999999999764 46899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~ 923 (1092)
. ........++..|+|||++.+..++.++|+|||||++|+|++ |..||...+.....
T Consensus 154 -----------------~-----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~ 211 (256)
T cd05113 154 -----------------E-----YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV 211 (256)
T ss_pred -----------------c-----eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH
Confidence 0 000112346678999999998889999999999999999998 99999988888888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
..+..+.... .+...+..+.+++.+||..||.+||+ +.+|+.
T Consensus 212 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~---~~~ll~ 253 (256)
T cd05113 212 EKVSQGLRLY--RPHLASEKVYAIMYSCWHEKAEERPT---FQQLLS 253 (256)
T ss_pred HHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCcccCCC---HHHHHH
Confidence 8877654332 24567899999999999999999999 556654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=341.38 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=212.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
...+|.+.+.||+|+||.||+|... .++..+|+|.+.+. .......+.+|++++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3468899999999999999999753 34678999988653 234567899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhc---------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVG---------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g---------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG 824 (1092)
...|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999997653 478899999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhH
Q 001360 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (1092)
Q Consensus 825 ~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVIL 904 (1092)
.+||+|||+++...... .........+++.|+|||++.+..++.++|||||||++
T Consensus 160 ~~kL~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (280)
T cd05092 160 VVKIGDFGMSRDIYSTD-------------------------YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVL 214 (280)
T ss_pred CEEECCCCceeEcCCCc-------------------------eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHH
Confidence 99999999987421000 00111234567899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 905 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 905 YEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
|||++ |.+||...........+..+... ..+..+++.+.+||.+||+.||.+||+++++.+.+
T Consensus 215 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 215 WEIFTYGKQPWYQLSNTEAIECITQGREL--ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred HHHHcCCCCCCccCCHHHHHHHHHcCccC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 99998 99999888887777777655321 23467899999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=334.94 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=209.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+..++|++++.||+|+||.||+|... .+..+|+|.++.... ....+.+|+.++++++||||+++++.+. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 45678999999999999999999876 567799999875432 2356889999999999999999998875 45689
Q ss_pred EEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~- 155 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN- 155 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc-
Confidence 999999999999999753 35899999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
.........++..|+|||++.+..++.++|+||||+++|||++ |.+||.+.+..
T Consensus 156 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 156 -------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred -------------------------ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0001112345678999999998889999999999999999999 99999998888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
++...+... ...+ .+...+..+.+||.+||.+||.+||++..+.+.+
T Consensus 211 ~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 211 EVLEQVERG-YRMP-CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred HHHHHHHcC-CCCC-CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 877777654 2222 3467889999999999999999999965554444
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=351.68 Aligned_cols=262 Identities=31% Similarity=0.471 Sum_probs=220.5
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----ee
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----NL 762 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~-----~L 762 (1092)
+|++.+.||.|+||.||+|+...+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 4899999999999999999999999999999987532 22345577899999999999999999999998876 79
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||+++ +|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~- 157 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE- 157 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc-
Confidence 999999984 899999887789999999999999999999999999999999999999999999999999987521000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
..........||+.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+
T Consensus 158 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~ 214 (330)
T cd07834 158 -----------------------DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214 (330)
T ss_pred -----------------------cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 000112345689999999999887 88999999999999999999999999988777
Q ss_pred HHHHHhhcCCC----------------------------CCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCC
Q 001360 922 IFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1092)
Q Consensus 922 i~~kIl~~~l~----------------------------fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPF 973 (1092)
.+..+...... +......++.++.+||.+||++||.+||+ +.+++.|||
T Consensus 215 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~~~~ 291 (330)
T cd07834 215 QLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT---ADEALAHPY 291 (330)
T ss_pred HHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC---HHHHHhCcc
Confidence 76666542110 01112347889999999999999999999 889999999
Q ss_pred CCCCC
Q 001360 974 FKGVN 978 (1092)
Q Consensus 974 FkgId 978 (1092)
|+++.
T Consensus 292 ~~~~~ 296 (330)
T cd07834 292 LAQLH 296 (330)
T ss_pred HHhhc
Confidence 98643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=341.61 Aligned_cols=269 Identities=30% Similarity=0.479 Sum_probs=210.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~---- 760 (1092)
.+++|++.+.||.|+||.||+|+++.+++.||+|++..... .......+.+|+++++.++||||+++++.+....
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 36899999999999999999999999999999999875432 1222345678999999999999999998875433
Q ss_pred ----eeEEEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcc
Q 001360 761 ----NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1092)
Q Consensus 761 ----~LYLVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 835 (1092)
.+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 47999999975 77777654 4579999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCC
Q 001360 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 836 ~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
........ .... ............||+.|+|||++.+ ..++.++|||||||++|||++|++||
T Consensus 164 ~~~~~~~~-----------~~~~-----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 164 PYDGPPPN-----------PKGG-----GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred hccCCCcc-----------cccC-----CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 43210000 0000 0001122345678999999999875 45889999999999999999999999
Q ss_pred CCCChHHHHHHHhhcCC-----CC------CC---------C-------CCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 915 TAESPEIIFDNILNRKI-----PW------PC---------V-------PSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 915 ~~~s~~ei~~kIl~~~l-----~f------P~---------i-------p~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
.+.+.......+..... .+ +. . ...++.++.+||.+||..||.+||+ +.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~e 304 (311)
T cd07866 228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT---ASD 304 (311)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC---HHH
Confidence 98877665555443100 00 00 0 0234578899999999999999999 889
Q ss_pred HHcCCCC
Q 001360 968 VKAHPFF 974 (1092)
Q Consensus 968 IL~HPFF 974 (1092)
++.||||
T Consensus 305 ll~~~~f 311 (311)
T cd07866 305 ALEHPYF 311 (311)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=343.09 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=206.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk--~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LY 763 (1092)
++|++.+.||+|+||.||+|..+.++. .+|+|.++. .........+.+|+.++.++ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc--cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999887765 468887763 22334456789999999999 6999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEE
Q 001360 764 LVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g----------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VK 827 (1092)
+||||+++|+|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997542 478899999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001360 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (1092)
Q Consensus 828 LsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEM 907 (1092)
|+|||++..... ........++..|+|||++.+..++.++|||||||++|||
T Consensus 160 l~dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 160 IADFGLSRGEEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred ECCcCCCccccc----------------------------eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 999999763100 0001112235679999999998999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 908 LT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
++ |.+||...........+..+. . +..+..++.++.+||.+||..||.+||++.+
T Consensus 212 ~t~g~~pf~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 267 (297)
T cd05089 212 VSLGGTPYCGMTCAELYEKLPQGY-R-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQ 267 (297)
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 97 999999998888888776542 2 2234678999999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=341.60 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=213.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
...+|.+.+.||+|+||.||+|+... ++..+|+|.++... ......+.+|+.++.+++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 45679999999999999999998643 45679999876432 23446788999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g----------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n 823 (1092)
+.+++||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997543 37889999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhh
Q 001360 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (1092)
Q Consensus 824 G~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVI 903 (1092)
+.+||+|||+++...... .........|++.|+|||++.+..++.++|||||||+
T Consensus 160 ~~~~l~dfg~a~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 214 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 214 (291)
T ss_pred CcEEECCCCcccccCCCc-------------------------eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHH
Confidence 999999999987421000 0011223567899999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 904 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 904 LYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+|||++ |.+||...+..+....+..+... ..+..++..+.+||.+||+.||.+||++.++.+.+
T Consensus 215 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 215 LWEIFTYGKQPWFQLSNTEVIECITQGRVL--ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHhCCCCC--CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 999998 99999988888877777655432 23466889999999999999999999965555444
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=373.07 Aligned_cols=257 Identities=35% Similarity=0.581 Sum_probs=225.1
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GG 772 (1092)
++||.|.||+||-|+++.+|+.||||+|.|.++..++ ...+++|+.||+.++||.||.|-..|++.+.+++|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 6899999999999999999999999999998876554 48899999999999999999999999999999999999965
Q ss_pred cHHHHHH--hhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC---cEEEEecCCcccccccccccCCC
Q 001360 773 DLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 773 SL~dlLk--k~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
|+..++- +.++|++...+|++.||+.||.|||-+||+|+||||+||||.... .+||||||+|++..+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-------- 719 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-------- 719 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--------
Confidence 7766663 568899999999999999999999999999999999999997643 799999999997421
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl 927 (1092)
.....+.+|||.|+|||++..++|+.+-|+||+|||+|--|.|..||..+ +++-+.|.
T Consensus 720 --------------------ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQ 777 (888)
T KOG4236|consen 720 --------------------KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQ 777 (888)
T ss_pred --------------------hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhh
Confidence 22345789999999999999999999999999999999999999999754 45666777
Q ss_pred hcCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC-Ccchhhh
Q 001360 928 NRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV-NWDSLAL 984 (1092)
Q Consensus 928 ~~~l~fP~i-p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI-dWd~L~~ 984 (1092)
+..+-+|.- ...+++++.|||..+|++.-.+|.+ +...+.|||+++. -|-.|+.
T Consensus 778 NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRys---vdk~lsh~Wlq~yq~w~DLRe 833 (888)
T KOG4236|consen 778 NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYS---VDKSLSHPWLQDYQTWLDLRE 833 (888)
T ss_pred ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcc---hHhhccchhhhcchHHHHHHH
Confidence 776666543 2579999999999999999999999 7789999999974 4655543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=356.58 Aligned_cols=258 Identities=25% Similarity=0.362 Sum_probs=207.2
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 755 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~s 755 (1092)
|.+.-++|++.+.||.|+||.||+|.... +++.||+|+++... .......+..|+.++.++ +||||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 34556789999999999999999997543 45789999987432 234456788999999999 79999999998
Q ss_pred eccC-CeeEEEEeecCCCcHHHHHHhh-----------------------------------------------------
Q 001360 756 FTCR-DNLYLVMEYLNGGDLYSLLRKV----------------------------------------------------- 781 (1092)
Q Consensus 756 fqde-~~LYLVMEYm~GGSL~dlLkk~----------------------------------------------------- 781 (1092)
+... ..+|++|||+++|+|.+++...
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 7654 5689999999999999998642
Q ss_pred --------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCC
Q 001360 782 --------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853 (1092)
Q Consensus 782 --------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~ 853 (1092)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~------------ 227 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------ 227 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc------------
Confidence 257889999999999999999999999999999999999999999999999987531100
Q ss_pred CCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCC
Q 001360 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIP 932 (1092)
Q Consensus 854 ~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~ 932 (1092)
.........|+..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+...+.....
T Consensus 228 -------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 294 (337)
T cd05054 228 -------------DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR 294 (337)
T ss_pred -------------chhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC
Confidence 0011123456788999999999999999999999999999998 99999876654444444443322
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 933 fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
+..+...++++.+++.+||+.+|++||++.++.+
T Consensus 295 -~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~ 328 (337)
T cd05054 295 -MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVE 328 (337)
T ss_pred -CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2234678899999999999999999999444333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.59 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=217.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
..|+..+.||+|+||.||+|++..+|..||+|++.+...........+.+|+.+++.++|||++++++++...+..|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34888999999999999999999999999999997654444455678999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
||++| +|.+++.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------- 176 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------- 176 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-------
Confidence 99975 78777754 4568999999999999999999999999999999999999999999999999876311
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
......|++.|+|||++. +..++.++|||||||++|||++|.+||...+....
T Consensus 177 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 232 (317)
T cd06635 177 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232 (317)
T ss_pred ------------------------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 012346899999999984 35688999999999999999999999988877776
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
...+........ ....++..+++||.+||..+|.+||+ +.+++.|||+..
T Consensus 233 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~ 282 (317)
T cd06635 233 LYHIAQNESPTL-QSNEWSDYFRNFVDSCLQKIPQDRPT---SEELLKHMFVLR 282 (317)
T ss_pred HHHHHhccCCCC-CCccccHHHHHHHHHHccCCcccCcC---HHHHHhChhhhc
Confidence 666665543322 23567889999999999999999999 889999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.06 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=212.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk---~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
..++|+..+.||+|+||.||+|..+.++. .+|+|.++... .......+.+|+.++..++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 45689999999999999999999876665 79999886532 23345678999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.|+||||+++|+|.+++... +.+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999999764 57899999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~ 919 (1092)
. ..........+++.|+|||++.+..++.++|||||||++|||++ |+.||...+.
T Consensus 161 ~------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 161 P------------------------EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred c------------------------ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 0 00000111234568999999998889999999999999999997 9999998888
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
..+...+.... ..| .+..++.++.+|+.+||..+|++||++.++.+.
T Consensus 217 ~~~~~~i~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 217 HEVMKAINDGF-RLP-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred HHHHHHHhcCC-CCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88877776542 333 235678999999999999999999995544443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=339.31 Aligned_cols=257 Identities=22% Similarity=0.377 Sum_probs=213.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
..++|++.+.||+|+||.||+|.... ++..||+|++.... .......+.+|+.++.+++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45789999999999999999998753 67899999987532 233456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhc----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVG----------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g----------------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeN 817 (1092)
..+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997432 36788889999999999999999999999999999
Q ss_pred eEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001360 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (1092)
Q Consensus 818 ILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDV 897 (1092)
||++.++.+||+|||++....... .........+++.|+|||++.+..++.++||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSAD-------------------------YYKASENDAIPIRWMPPESIFYNRYTTESDV 215 (288)
T ss_pred eEecCCCceEECccccceecccCc-------------------------cccccCCCccChhhcCHHHHhcCCCCchhHH
Confidence 999999999999999986421000 0000112235678999999999999999999
Q ss_pred echhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 898 WSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
|||||++|||++ |..||.+.+..+....+..+... ..+..++.++.+||.+||+.||.+||++.++...|+
T Consensus 216 ~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 216 WAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL--SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 999999999997 88999988888888777665432 234678899999999999999999999666655554
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.89 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=206.3
Q ss_pred EeeccCCCeEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 001360 693 KPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TG---k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm 769 (1092)
+.||+|+||.||+|.+..++ ..||+|.+...... .....+.+|+.+++.++|||||++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876555 78999998765432 35567899999999999999999999876 45689999999
Q ss_pred CCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCC
Q 001360 770 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849 (1092)
Q Consensus 770 ~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~ 849 (1092)
++|+|.+++.+...+++..+..++.|++.||.|||..|++||||||+|||++.++.+||+|||+++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~------- 150 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD------- 150 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc-------
Confidence 9999999998888899999999999999999999999999999999999999999999999999874311000
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhh
Q 001360 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 928 (1092)
Q Consensus 850 t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~ 928 (1092)
.........++..|+|||.+.+..++.++|+|||||++|||++ |.+||...+..++...+..
T Consensus 151 -----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05060 151 -----------------YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES 213 (257)
T ss_pred -----------------ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 0000111234678999999999899999999999999999998 9999998888777777655
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 929 ~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
... ...+..++..+++||.+||..||.+||++.++.+++.
T Consensus 214 ~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~ 253 (257)
T cd05060 214 GER--LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253 (257)
T ss_pred CCc--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 432 2235678999999999999999999999665555543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.86 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=207.4
Q ss_pred eeccCCCeEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 694 PISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 694 ~LGkGgFGtVyLar~k--~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
.||+|+||.||+|.++ .++..||+|++.... .....+.+.+|+.++++++||||++++++++. +.+|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999775 445679999986532 33445678999999999999999999998864 578999999999
Q ss_pred CcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCC
Q 001360 772 GDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (1092)
Q Consensus 772 GSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t 850 (1092)
|+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 150 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS-------- 150 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcc--------
Confidence 999999874 45789999999999999999999999999999999999999999999999999874211000
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhc
Q 001360 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNR 929 (1092)
Q Consensus 851 ~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~ 929 (1092)
.........+++.|+|||++.+..++.++|+|||||++|||++ |..||...........+..+
T Consensus 151 ----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 214 (257)
T cd05115 151 ----------------YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG 214 (257)
T ss_pred ----------------ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC
Confidence 0000112234678999999998889999999999999999996 99999998887777666554
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 930 ~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.. +..+...++++.+||.+||..||++||++.++.+.++.-||
T Consensus 215 ~~--~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~~ 257 (257)
T cd05115 215 KR--LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYYY 257 (257)
T ss_pred CC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhcC
Confidence 32 22457789999999999999999999998777777766654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=335.05 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=212.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk---~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
..+|++.+.||+|+||.||+|+++.++. .+|+|.++... .......+.+|+.++..++||||+++++++...+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999875543 79999886532 233456889999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
|+||||++||+|.+++.+. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999765 468999999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
..........+++.|+|||.+.+..++.++|+|||||++|||++ |..||...+..
T Consensus 161 ------------------------~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 161 ------------------------EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred ------------------------ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 00001112234678999999998899999999999999999886 99999988887
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+....+... ...| .+..++..+.+|+.+||+++|.+||+++++.+++
T Consensus 217 ~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 263 (267)
T cd05066 217 DVIKAIEEG-YRLP-APMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263 (267)
T ss_pred HHHHHHhCC-CcCC-CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHH
Confidence 777777654 2333 2457889999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.17 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=209.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~-------TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~ 754 (1092)
.+..++|.+.+.||+|+||.||+|++.. ++..||+|.+++.. .......+.+|+.++..+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4455789999999999999999998643 23579999987532 234456788999999999 7999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCce
Q 001360 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (1092)
Q Consensus 755 sfqde~~LYLVMEYm~GGSL~dlLkk~g----------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNI 818 (1092)
++...+.+|+||||+++|+|.+++.... .++...+..++.|++.||.|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999997642 478889999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001360 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (1092)
Q Consensus 819 LLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVW 898 (1092)
|++.++.+||+|||+++....... ........+++.|+|||++.+..++.++|||
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 226 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDY-------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226 (307)
T ss_pred EEcCCCcEEECCCcccccccccch-------------------------hhccccCCCccceeChHHhccCCCCcHHHHH
Confidence 999999999999999874210000 0001112345789999999998999999999
Q ss_pred chhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 899 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 899 SLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
||||++|||++ |..||...+..++...+.... . +..+..++.++++||.+||..+|.+||++.++
T Consensus 227 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 292 (307)
T cd05098 227 SFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-R-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292 (307)
T ss_pred HHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC-C-CCCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 99999999998 999999888877777765443 2 22346789999999999999999999995443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.01 Aligned_cols=259 Identities=24% Similarity=0.349 Sum_probs=212.9
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~-------TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~ 753 (1092)
+....++|.+.+.||+|+||.||+|+... .+..||+|+++... .......+.+|+.++..+ +||||++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 34556789999999999999999998642 34579999887532 234567789999999999 599999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCc
Q 001360 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (1092)
Q Consensus 754 ~sfqde~~LYLVMEYm~GGSL~dlLkk~----------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeN 817 (1092)
+++.....+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 9999999999999999999999999753 247888899999999999999999999999999999
Q ss_pred eEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001360 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (1092)
Q Consensus 818 ILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDV 897 (1092)
||++.++.+||+|||+++...... .........+++.|||||++.+..++.++||
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDID-------------------------YYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219 (314)
T ss_pred EEEcCCCcEEEccccccccccccc-------------------------cccccccCCCCccccCHHHHccCCcCccchh
Confidence 999999999999999987421000 0000112234578999999999999999999
Q ss_pred echhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 898 WSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
|||||++|||++ |..||.+.+..+++..+..... +..+..++.++++||.+||..||.+||++.++.+.+
T Consensus 220 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR--MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 999999999999 9999999888888887765432 223467889999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=342.17 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=208.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCC--------------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTG--------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 751 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TG--------------k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVk 751 (1092)
.++|++.+.||+|+||.||+|++..++ ..||+|.++.. ........+.+|+++|.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 468999999999999999999875432 35999998753 23345567899999999999999999
Q ss_pred EeeeeccCCeeEEEEeecCCCcHHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceE
Q 001360 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819 (1092)
Q Consensus 752 L~~sfqde~~LYLVMEYm~GGSL~dlLkk~g------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNIL 819 (1092)
+++++.....+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999986532 3678888999999999999999999999999999999
Q ss_pred ecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeec
Q 001360 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899 (1092)
Q Consensus 820 LD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWS 899 (1092)
++.++.+||+|||++....... .........+++.|+|||++.+..++.++||||
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 216 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD-------------------------YYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216 (295)
T ss_pred EcCCCcEEecccccccccccCc-------------------------ceeccCcCcCceeecChhhhccCCcCchhhHHH
Confidence 9999999999999987421000 001112345678999999999889999999999
Q ss_pred hhhhHHHHHh--CCCCCCCCChHHHHHHHhh-----cCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 900 VGIILFEFIT--GIPPFTAESPEIIFDNILN-----RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 900 LGVILYEMLT--Gk~PF~~~s~~ei~~kIl~-----~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
|||++|+|++ |..||...+..+....+.. ....+...+..+++.+.+||.+||..||.+||+++++.+.|
T Consensus 217 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 217 FGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9999999988 7789988777666555432 12222333456789999999999999999999965554443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.30 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=209.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+..++|++.+.||+|+||.||+|++..+ ..||+|++++... ....+.+|++++..++||||+++++.+.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 3456799999999999999999988765 4699999875332 23568899999999999999999988754 5689
Q ss_pred EEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~- 155 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN- 155 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc-
Confidence 999999999999999763 35789999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
.........|+..|+|||++.+..++.++|+|||||++|||++ |.+||.+....
T Consensus 156 -------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~ 210 (262)
T cd05071 156 -------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210 (262)
T ss_pred -------------------------ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence 0001123346788999999998899999999999999999999 89999988888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.+...+.... ..+ .+..++..+.+||.+||..||++||++.++.+.+
T Consensus 211 ~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l 257 (262)
T cd05071 211 EVLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 257 (262)
T ss_pred HHHHHHhcCC-CCC-CccccCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 8777765542 222 2457889999999999999999999966665554
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.99 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=215.4
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEY 768 (1092)
|...+.||+|+||+||+|+...+|..||+|++.............+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999999765544455667889999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 769 LNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 769 m~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--------- 172 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--------- 172 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---------
Confidence 96 478777765 4568999999999999999999999999999999999999999999999999875310
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
......|++.|+|||++. ...++.++|+|||||++|+|++|.+||...+......
T Consensus 173 ----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~ 230 (313)
T cd06633 173 ----------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230 (313)
T ss_pred ----------------------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 112356899999999984 3567889999999999999999999998887666555
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
.+.....+.. ....++..+++||.+||+++|.+||+ +.+++.||||+...
T Consensus 231 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rp~---~~~~l~~~~~~~~~ 280 (313)
T cd06633 231 HIAQNDSPTL-QSNEWTDSFRGFVDYCLQKIPQERPA---SAELLRHDFVRRDR 280 (313)
T ss_pred HHHhcCCCCC-CccccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCc
Confidence 5554432211 12457788999999999999999999 88999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=344.62 Aligned_cols=259 Identities=23% Similarity=0.366 Sum_probs=213.3
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~ 754 (1092)
.+....++|++.+.||+|+||.||++.. ..++..||+|++++.. .....+.+.+|+.+++++ +||||+++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 3456677899999999999999999975 3345689999987532 234457789999999999 7999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecC
Q 001360 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832 (1092)
Q Consensus 755 sfqde~~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFG 832 (1092)
++...+.+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999999997543 38999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CC
Q 001360 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 911 (1092)
Q Consensus 833 LAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk 911 (1092)
+++...... .........+++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 187 ~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~ 241 (302)
T cd05055 187 LARDIMNDS-------------------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241 (302)
T ss_pred ccccccCCC-------------------------ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCC
Confidence 987421100 0001122356789999999999999999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 912 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 912 ~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
+||........+..........+ .+...+.++.+||.+||..+|++||++.++.+
T Consensus 242 ~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 242 NPYPGMPVDSKFYKLIKEGYRMA-QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCcCCCCchHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99988776665555555443322 34567899999999999999999999554433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.10 Aligned_cols=248 Identities=27% Similarity=0.405 Sum_probs=211.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+..++|++.+.||.|+||.||+|... |+.||+|.++.... ...++.+|+.++..++||||+++++.+.+....|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 35678999999999999999999875 88999999875432 4678999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~-- 154 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ-- 154 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc--
Confidence 9999999999999998765 699999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
......++..|+|||.+.+..++.++|+||||+++|||++ |..||...+..
T Consensus 155 ----------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 206 (256)
T cd05039 155 ----------------------------GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred ----------------------------ccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0012234668999999988889999999999999999997 99999988877
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
++...+.... . +..+..+++++.+||.+||..+|.+||++.++.+.+
T Consensus 207 ~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 207 DVVPHVEKGY-R-MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253 (256)
T ss_pred HHHHHHhcCC-C-CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 7776655432 2 223467899999999999999999999955444443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.17 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=214.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~T-----Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
.++|++++.||.|+||+||+|+.+.+ .+.||+|.+.... .......+.+|+++|++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 46899999999999999999997643 4679999876432 2234677899999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhc---------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEec
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVG---------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g---------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDF 831 (1092)
..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999998665 6899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-C
Q 001360 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 910 (1092)
Q Consensus 832 GLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-G 910 (1092)
|+++..... .........+++.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 162 ~~~~~~~~~--------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~ 215 (275)
T cd05046 162 SLSKDVYNS--------------------------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215 (275)
T ss_pred ccccccCcc--------------------------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 998632100 0011123456788999999988888999999999999999998 8
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 911 k~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
..||...........+..+...++. +..++..+.++|.+||..||.+||+ +.+++.
T Consensus 216 ~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~i~~~l~~~p~~Rp~---~~~~l~ 271 (275)
T cd05046 216 ELPFYGLSDEEVLNRLQAGKLELPV-PEGCPSRLYKLMTRCWAVNPKDRPS---FSELVS 271 (275)
T ss_pred CCCccccchHHHHHHHHcCCcCCCC-CCCCCHHHHHHHHHHcCCCcccCCC---HHHHHH
Confidence 9999888877878777766665553 4578899999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.41 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=209.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+..++|++++.||+|+||.||+|..+ +++.||+|.+.+... ....+.+|+.+++.++||||+++++++. .+.+|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999865 578899999875432 3457889999999999999999998874 45789
Q ss_pred EEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~- 155 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN- 155 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC-
Confidence 999999999999998753 35889999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
.........++..|+|||++.+..++.++|+||||+++|||++ |++||.+.+..
T Consensus 156 -------------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 210 (260)
T cd05067 156 -------------------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP 210 (260)
T ss_pred -------------------------CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence 0001123346789999999998889999999999999999999 99999988877
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+....+... ...+ .+...+.++.+||.+||..+|++||++..+..++
T Consensus 211 ~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 211 EVIQNLERG-YRMP-RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred HHHHHHHcC-CCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence 777666443 2222 3467889999999999999999999965555544
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.42 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=210.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk---~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
..+|++.+.||+|+||.||+|..+.+++ .||||++++. ........+..|+.+++.++||||+++++++.+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4679999999999999999999987665 6999998753 2344567899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
|+||||+++|+|.+++... +.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999999753 568999999999999999999999999999999999999999999999999987421100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
. .+.+ .......++..|+|||++.+..++.++|||||||++|||++ |..||...+..
T Consensus 161 ~-----------------~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~ 218 (269)
T cd05065 161 S-----------------DPTY-----TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218 (269)
T ss_pred c-----------------cccc-----ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence 0 0000 00011123567999999999999999999999999999886 99999988888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
.....+... ..+| .+..++..+.+++.+||..+|.+||+++++
T Consensus 219 ~~~~~i~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 261 (269)
T cd05065 219 DVINAIEQD-YRLP-PPMDCPTALHQLMLDCWQKDRNARPKFGQI 261 (269)
T ss_pred HHHHHHHcC-CcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 777776443 3333 235788999999999999999999995443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.49 Aligned_cols=255 Identities=35% Similarity=0.579 Sum_probs=212.1
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeEEEE
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYLVM 766 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde--~~LYLVM 766 (1092)
|++.+.||.|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++.+... ..+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 688999999999999999999999999999998653 2333456788999999999999999999999988 8899999
Q ss_pred eecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
||+++ +|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+|||++.+|.+||+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~---- 154 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN---- 154 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC----
Confidence 99975 899888765 579999999999999999999999999999999999999999999999999987431100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
........++..|+|||.+.+ ..++.++||||||+++|||++|++||...+......
T Consensus 155 ----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~ 212 (287)
T cd07840 155 ----------------------SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE 212 (287)
T ss_pred ----------------------cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 011123457889999998775 467899999999999999999999999888766666
Q ss_pred HHhhcC-----CCCCCC-----------------------CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNRK-----IPWPCV-----------------------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~~-----l~fP~i-----------------------p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.+.... ..++.. ...++.++.++|.+||..||.+||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~~l~~~~~ 287 (287)
T cd07840 213 KIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS---ADQALQHEYF 287 (287)
T ss_pred HHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC---HHHHhhCcCC
Confidence 554311 011110 1113889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=329.51 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=212.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+..++|++.+.||+|+||.||+|... .+..||||.+..... ....+.+|+.++++++||||+++++++.....+|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 56689999999999999999999976 457899999875432 2456889999999999999999999999989999
Q ss_pred EEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++.....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD- 156 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch-
Confidence 9999999999999997653 6899999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
.........++..|+|||.+.+..++.++|+|||||++|||++ |+.||.+.+..
T Consensus 157 -------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 211 (261)
T cd05034 157 -------------------------EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211 (261)
T ss_pred -------------------------hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 0000112235678999999999899999999999999999998 99999988888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.....+.... ..+ .+...+.++.+++.+||..+|.+||+++++.+.+
T Consensus 212 ~~~~~~~~~~-~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l 258 (261)
T cd05034 212 EVLEQVERGY-RMP-RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258 (261)
T ss_pred HHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 8777776542 222 2456789999999999999999999965555444
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=375.61 Aligned_cols=250 Identities=33% Similarity=0.516 Sum_probs=214.4
Q ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCc
Q 001360 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 773 (1092)
Q Consensus 694 ~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGS 773 (1092)
+||+|.||+||.|+++.|....|||.+.... ....+-+..|+.+.+.++|.|||++.+++...+.+-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 7999999999999999999999999886432 3456778899999999999999999999999999999999999999
Q ss_pred HHHHHHh-hcCC--CHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-CCcEEEEecCCcccccccccccCCCCC
Q 001360 774 LYSLLRK-VGCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPE 849 (1092)
Q Consensus 774 L~dlLkk-~g~L--sE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~n~s~dls~~~ 849 (1092)
|.++|+. .|++ +|...-+|.+||+.||.|||.+.|||||||-+|+||+. .|.+||+|||-++..-
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA----------- 727 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA----------- 727 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc-----------
Confidence 9999974 5787 88999999999999999999999999999999999975 7999999999988531
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCC-hHHHHHHH
Q 001360 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFDNI 926 (1092)
Q Consensus 850 t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s-~~ei~~kI 926 (1092)
.-...+.++.||..|||||++-. .+|+.++|||||||++.||.||+|||.... ++...-++
T Consensus 728 ----------------ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV 791 (1226)
T KOG4279|consen 728 ----------------GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV 791 (1226)
T ss_pred ----------------cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh
Confidence 11223467889999999999975 479999999999999999999999997654 33222222
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
- .-..-|.+|..+|.+++.||.+|+..||.+||+ |.++|..||++.-
T Consensus 792 G-myKvHP~iPeelsaeak~FilrcFepd~~~R~s---A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 792 G-MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPS---AKDLLQDPFLQHN 838 (1226)
T ss_pred c-ceecCCCCcHHHHHHHHHHHHHHcCCCcccCcc---HHHhccCcccccC
Confidence 1 111235567899999999999999999999999 8899999999754
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.87 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=211.8
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEEC-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKR-------TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k-------~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~ 753 (1092)
+....++|++.+.||+|+||.||+|++. .++..||+|.++.. ........+.+|+.++..+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3466789999999999999999999853 23457999988643 2234567889999999999 799999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCc
Q 001360 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (1092)
Q Consensus 754 ~sfqde~~LYLVMEYm~GGSL~dlLkk~----------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeN 817 (1092)
+++.....+|+||||+++|+|.+++.+. ..++...+..++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 9999999999999999999999999763 246778888999999999999999999999999999
Q ss_pred eEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001360 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (1092)
Q Consensus 818 ILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDV 897 (1092)
||++.++.+||+|||+++...... .........+++.|+|||++.+..|+.++||
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 222 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNID-------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222 (304)
T ss_pred EEEcCCCcEEECCCccceeccccc-------------------------ccccccCCCCCceeeCchhhccCCCCchhhH
Confidence 999999999999999987431100 0011123356788999999999899999999
Q ss_pred echhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 898 WSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
|||||++|+|++ |..||.+.+..++...+..... +..+..++.++++||.+||..+|.+||++.++
T Consensus 223 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 289 (304)
T cd05101 223 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289 (304)
T ss_pred HHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 999999999998 8999999888888887755432 12346789999999999999999999995443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=350.86 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=206.7
Q ss_pred EeeccC--CCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 001360 693 KPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (1092)
Q Consensus 693 r~LGkG--gFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~ 770 (1092)
..||+| +||+||++++..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|...+.+|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 999999999999999999999875432 23456788999999999999999999999999999999999999
Q ss_pred CCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCC
Q 001360 771 GGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848 (1092)
Q Consensus 771 GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~ 848 (1092)
+|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~------ 156 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ------ 156 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc------
Confidence 99999999764 3489999999999999999999999999999999999999999999999986542110000
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC--CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 849 ~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~--~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
.... .........++..|||||++.+. .|+.++|||||||++|||++|.+||...........+
T Consensus 157 ------~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 222 (328)
T cd08226 157 ------KAKV--------VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222 (328)
T ss_pred ------cccc--------cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Confidence 0000 00001123467789999999763 5789999999999999999999999887655554443
Q ss_pred hhcCCCCC--------------------------------------------CCCCCCCHHHHHHHHHhccCCcCCCCCc
Q 001360 927 LNRKIPWP--------------------------------------------CVPSDMSFEAQDLINRFLIHDPNQRLGA 962 (1092)
Q Consensus 927 l~~~l~fP--------------------------------------------~ip~~lS~eakDLI~kcL~kDP~KRpSa 962 (1092)
+......| ..+..+++.+.+||++||+.||.+||+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt- 301 (328)
T cd08226 223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS- 301 (328)
T ss_pred hcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC-
Confidence 33211101 011235678999999999999999999
Q ss_pred ccHHHHHcCCCCCCC
Q 001360 963 NGAAEVKAHPFFKGV 977 (1092)
Q Consensus 963 ~ga~EIL~HPFFkgI 977 (1092)
+.++++||||+.+
T Consensus 302 --a~e~l~~~~~~~~ 314 (328)
T cd08226 302 --ASSLLSHAFFKQV 314 (328)
T ss_pred --HHHHhhCHHHHHH
Confidence 8899999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.63 Aligned_cols=251 Identities=19% Similarity=0.302 Sum_probs=204.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~----VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
+..++|++++.||+|+||+||+|.+..+|.. +|+|.+... ........+..|+.++..++||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 3457899999999999999999999888874 566665421 12234467788888999999999999999875 4
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
...++||||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 5678999999999999999764 578999999999999999999999999999999999999999999999999987531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
... .........|+..|+|||++.+..|+.++|||||||++|||++ |..||.+.
T Consensus 161 ~~~-------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 161 PDD-------------------------KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred CCC-------------------------cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 100 0011123457789999999998899999999999999999998 99999988
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
.+..+.+.+..+... ..+...+.++.+++.+||..||.+||++.+
T Consensus 216 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~e 260 (279)
T cd05111 216 RPHEVPDLLEKGERL--AQPQICTIDVYMVMVKCWMIDENVRPTFKE 260 (279)
T ss_pred CHHHHHHHHHCCCcC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 877666555444322 224567889999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=349.14 Aligned_cols=257 Identities=30% Similarity=0.454 Sum_probs=210.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 759 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde---- 759 (1092)
...++|++++.||+|+||.||+|....+|+.||+|++++.. ......+.+.+|+.++.+++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 34588999999999999999999999999999999987532 2233456788999999999999999999887643
Q ss_pred --CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 760 --DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 760 --~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
...|++++++ |++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++..
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3478899887 7799888754 46999999999999999999999999999999999999999999999999998631
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus 171 ~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 171 D------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred c------------------------------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0 01123568999999999876 5688999999999999999999999987
Q ss_pred CChHHHHHHHhhcCC-----------------------CCC-----CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 917 ESPEIIFDNILNRKI-----------------------PWP-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l-----------------------~fP-----~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
.+.......+..... ..| ......++++.+||.+||+.||.+||+ +.++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~ 297 (345)
T cd07877 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQA 297 (345)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC---HHHH
Confidence 765554443322110 001 111245788999999999999999999 8899
Q ss_pred HcCCCCCC
Q 001360 969 KAHPFFKG 976 (1092)
Q Consensus 969 L~HPFFkg 976 (1092)
+.||||+.
T Consensus 298 l~h~~f~~ 305 (345)
T cd07877 298 LAHAYFAQ 305 (345)
T ss_pred hcChhhhh
Confidence 99999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.29 Aligned_cols=260 Identities=33% Similarity=0.502 Sum_probs=211.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~--- 760 (1092)
...++|++.+.||.|+||.||+|.++.+|+.||+|+++.... .......+.+|+.++..++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456789999999999999999999999999999999875432 2233456778999999999999999999887765
Q ss_pred -------eeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecC
Q 001360 761 -------NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832 (1092)
Q Consensus 761 -------~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFG 832 (1092)
.+|+||||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999986 777777653 469999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCC
Q 001360 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGI 911 (1092)
Q Consensus 833 LAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk 911 (1092)
++...... .........+++.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 162 ~~~~~~~~--------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 162 LARLYNSE--------------------------ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred ccccccCC--------------------------cccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 98743110 0011122356889999999875 45789999999999999999999
Q ss_pred CCCCCCChHHHHHHHhhc---CC--CCCC----------------------CCCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 912 PPFTAESPEIIFDNILNR---KI--PWPC----------------------VPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 912 ~PF~~~s~~ei~~kIl~~---~l--~fP~----------------------ip~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
+||...+..+....+... .. .+|. ....++..+.+||.+||..||.+||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~--- 292 (302)
T cd07864 216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT--- 292 (302)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC---
Confidence 999887766555554431 00 0110 01246899999999999999999999
Q ss_pred HHHHHcCCCC
Q 001360 965 AAEVKAHPFF 974 (1092)
Q Consensus 965 a~EIL~HPFF 974 (1092)
+.+++.||||
T Consensus 293 ~~~il~~~~~ 302 (302)
T cd07864 293 AEEALNSPWL 302 (302)
T ss_pred HHHHhcCCCC
Confidence 8899999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.95 Aligned_cols=254 Identities=28% Similarity=0.494 Sum_probs=215.6
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei--~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.|.+.+.||+|+||.||++.+..++..+++|+++.... ........+..|+.++..++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 48899999999999999999988888888888765432 1233445677899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 766 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
|||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||+++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999998864 346899999999999999999999999999999999999975 67999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus 159 --------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~ 212 (260)
T cd08222 159 --------------------------CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212 (260)
T ss_pred --------------------------cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 011223568899999999988889999999999999999999999998877777
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
....+..+. .|..+..++.++.+||.+||..||++||+ +.+++.||||
T Consensus 213 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 260 (260)
T cd08222 213 VVLRIVEGP--TPSLPETYSRQLNSIMQSMLNKDPSLRPS---AAEILRNPFI 260 (260)
T ss_pred HHHHHHcCC--CCCCcchhcHHHHHHHHHHhcCChhhCcC---HHHHhhCCCC
Confidence 766665543 33445778899999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.94 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=199.5
Q ss_pred EeeccCCCeEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 001360 693 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~--TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~ 770 (1092)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.....+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997543 34578888765422 23345678899999999999999999999999999999999999
Q ss_pred CCcHHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 771 GGDLYSLLRKVG-----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 771 GGSL~dlLkk~g-----~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---- 154 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED---- 154 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch----
Confidence 999999997643 34677888999999999999999999999999999999999999999999986321000
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-------CCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-------~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
.........+++.|+|||++.. ..++.++|||||||++|||++ |.+||...
T Consensus 155 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 155 ---------------------YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ---------------------heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 0001123456788999999753 356789999999999999999 88999888
Q ss_pred ChHHHHHHHhhc-CCC--CCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 918 SPEIIFDNILNR-KIP--WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 918 s~~ei~~kIl~~-~l~--fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
...+....+... ..+ -|.++..++....+++..||. ||.+||++.++.+++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-dp~~Rpt~~~v~~~l~~ 269 (269)
T cd05042 214 SDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELLTY 269 (269)
T ss_pred CHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHhc-CcccccCHHHHHHHhcC
Confidence 776666555443 222 233456788999999999995 99999997777777655
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=350.78 Aligned_cols=257 Identities=32% Similarity=0.483 Sum_probs=215.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe---
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--- 761 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~--- 761 (1092)
..++|++.+.||.|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4578999999999999999999999999999999986532 223345678889999999999999999988877665
Q ss_pred ---eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 762 ---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 762 ---LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
+|+|+||+ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6699998865 569999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
.......||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.
T Consensus 170 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 170 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ------------------------------ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 01123468899999999875 46789999999999999999999999988
Q ss_pred ChHHHHHHHhhcCCC----------------------------CCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 918 SPEIIFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~----------------------------fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+....+..+...... ++......+.++.+||.+||..||.+||+ +.+++
T Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt---~~ell 296 (343)
T cd07851 220 DHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT---AAEAL 296 (343)
T ss_pred ChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC---HHHHh
Confidence 776666655432100 01111346889999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001360 970 AHPFFKGV 977 (1092)
Q Consensus 970 ~HPFFkgI 977 (1092)
.||||+..
T Consensus 297 ~h~~~~~~ 304 (343)
T cd07851 297 AHPYLAEY 304 (343)
T ss_pred cCCCcccc
Confidence 99999853
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=328.37 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=207.0
Q ss_pred EeeccCCCeEEEEEEECC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 001360 693 KPISRGAFGRVFLARKRT-TGD--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~-TGk--~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm 769 (1092)
+.||+|+||.||+|.+.. .++ .||+|.+...... .....+.+|+.++.+++||||+++++.+.. ..+|+||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999865 333 6999999764432 567789999999999999999999999988 8899999999
Q ss_pred CCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 770 NGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 770 ~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~------ 151 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE------ 151 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccc------
Confidence 9999999997754 68999999999999999999999999999999999999999999999999987531100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kI 926 (1092)
. .+ .......++..|+|||.+.+..++.++|+|||||++|||++ |..||...+..++...+
T Consensus 152 ----------~---~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 152 ----------D---HY-----VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred ----------c---ce-----ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 0 00 01113467889999999999999999999999999999998 99999988888877777
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
......++ .+..++..+.+|+.+||..+|++||++.++.+.
T Consensus 214 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 254 (257)
T cd05040 214 DKEGERLE-RPEACPQDIYNVMLQCWAHNPADRPTFAALREF 254 (257)
T ss_pred HhcCCcCC-CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHH
Confidence 65433332 346788999999999999999999995544443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=330.30 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=207.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..++|++.+.||.|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++||||+++++++. .+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 446799999999999999999988654 4699998865332 2356888999999999999999998875 456899
Q ss_pred EEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~-- 155 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN-- 155 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC--
Confidence 999999999999997643 4788999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~e 921 (1092)
.........++..|+|||++.+..++.++|+|||||++|||++ |.+||.+....+
T Consensus 156 ------------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 211 (260)
T cd05069 156 ------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE 211 (260)
T ss_pred ------------------------cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 0001112346788999999998889999999999999999999 999999988887
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
....+... ...+ .+..++..+.+||.+||.+||.+||+++.+.+.+
T Consensus 212 ~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 212 VLEQVERG-YRMP-CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred HHHHHHcC-CCCC-CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 77776554 2222 3467899999999999999999999965554443
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.30 Aligned_cols=274 Identities=28% Similarity=0.404 Sum_probs=215.9
Q ss_pred CCeE-EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchh-----------HHHHHHHHHHHHHhcCCCceEEEee
Q 001360 687 DDFE-IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-----------DIERILAERNILITVRNPFVVRFFY 754 (1092)
Q Consensus 687 ~dFe-ilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~-----------~ie~~l~EieIL~~L~HPNIVkL~~ 754 (1092)
+.|. +.+.||.|+||+||+|.++.+|+.||+|+++........ ....+.+|+.++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 457799999999999999999999999998764332210 0124778999999999999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCc
Q 001360 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1092)
Q Consensus 755 sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 834 (1092)
+|...+.+|+||||+. |+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999997 599999988888999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
............ ... .. ...........+++.|+|||++.+. .++.++|+|||||++|||++|.+|
T Consensus 167 ~~~~~~~~~~~~--------~~~-~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 167 RRYGYPPYSDTL--------SKD-ET----MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred eecccccccccc--------ccc-cc----ccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 753211100000 000 00 0011122345689999999998764 468999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcC-----CCCCC--------------------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 914 FTAESPEIIFDNILNRK-----IPWPC--------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~~~-----l~fP~--------------------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
|.+.+..+....+.... ..||. .....+.++.+||.+||..||.+||+ +.++
T Consensus 234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~~~ 310 (335)
T PTZ00024 234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS---AKEA 310 (335)
T ss_pred CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC---HHHH
Confidence 99888777666554310 00110 11345788999999999999999999 8899
Q ss_pred HcCCCCCCC
Q 001360 969 KAHPFFKGV 977 (1092)
Q Consensus 969 L~HPFFkgI 977 (1092)
+.||||++.
T Consensus 311 l~~~~~~~~ 319 (335)
T PTZ00024 311 LKHEYFKSD 319 (335)
T ss_pred hcCcccCCC
Confidence 999999854
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=363.86 Aligned_cols=256 Identities=30% Similarity=0.535 Sum_probs=224.2
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
.-|.++..||.|+||.||++.++.+|+++|||.+.- ..+.+.+..|+.||++++.|+||++|++|-....+|+||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 458899999999999999999999999999997753 346788999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||..|+..+.++- ..+|++.++..+++..+.||+|||...-||||||..||||+.+|+.||+|||.|..+.
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT------- 180 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT------- 180 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh-------
Confidence 99999999999974 4679999999999999999999999999999999999999999999999999886421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
....+.++..|||.|||||++..-+|+.++||||||++..||..|++||.+..+....-.
T Consensus 181 --------------------DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM 240 (502)
T KOG0574|consen 181 --------------------DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM 240 (502)
T ss_pred --------------------hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe
Confidence 112345688999999999999999999999999999999999999999998777554444
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 926 Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
|-....+--.-|...|.++.|||++||.+.|++|-+ |.++++|||.++.
T Consensus 241 IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~T---A~~L~~H~FiknA 289 (502)
T KOG0574|consen 241 IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKT---ALRLCEHTFIKNA 289 (502)
T ss_pred ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHH---HHHHhhhhhhcCC
Confidence 433332211135678999999999999999999998 8999999999864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=345.36 Aligned_cols=261 Identities=31% Similarity=0.456 Sum_probs=209.6
Q ss_pred CeEEEEeeccCCCeEEEEEEECCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc----CC
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTT--GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC----RD 760 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~T--Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqd----e~ 760 (1092)
+|++.+.||+|+||.||+|+...+ +..||+|++... .........+.+|+.++.++ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNV-FSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccc-cccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 489999999999999999999988 899999998642 22233456788999999999 59999999986432 24
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|++|||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5889999986 599999988888999999999999999999999999999999999999999999999999998742110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
.. .........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.
T Consensus 159 ~~-----------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~ 215 (332)
T cd07857 159 PG-----------------------ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY 215 (332)
T ss_pred cc-----------------------cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH
Confidence 00 00111234679999999998865 5789999999999999999999999987665
Q ss_pred HHHHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 920 EIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 920 ~ei~~kIl~~----------------------------~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
......++.. ...++......+..+.+||.+||+.||.+||+ +.+++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~~ll~~ 292 (332)
T cd07857 216 VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS---VEEALEH 292 (332)
T ss_pred HHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC---HHHHhcC
Confidence 4433332221 01112222346889999999999999999999 8899999
Q ss_pred CCCCC
Q 001360 972 PFFKG 976 (1092)
Q Consensus 972 PFFkg 976 (1092)
|||+.
T Consensus 293 ~~~~~ 297 (332)
T cd07857 293 PYLAI 297 (332)
T ss_pred hhhhh
Confidence 99954
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=324.61 Aligned_cols=249 Identities=28% Similarity=0.433 Sum_probs=212.1
Q ss_pred eEEEEeeccCCCeEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TG----k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
|++.+.||.|+||.||++++..++ ..||+|+++.... ......+..|+.++..++||||+++++.+.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467789999999999999998766 8999999965432 2256789999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~--LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||||+++++|.+++..... +++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD- 157 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc-
Confidence 9999999999999976544 9999999999999999999999999999999999999999999999999987531100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~e 921 (1092)
.+. .....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+...
T Consensus 158 -------------------~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 158 -------------------YYK------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred -------------------ccc------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 000 001227889999999988889999999999999999998 899999988888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
+...+...... ..+...+.++.+++.+||..||.+||+ +.+++.
T Consensus 213 ~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll~ 256 (258)
T smart00219 213 VLEYLKKGYRL--PKPENCPPEIYKLMLQCWAEDPEDRPT---FSELVE 256 (258)
T ss_pred HHHHHhcCCCC--CCCCcCCHHHHHHHHHHCcCChhhCcC---HHHHHh
Confidence 88887665432 234668999999999999999999999 556553
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=338.01 Aligned_cols=261 Identities=28% Similarity=0.503 Sum_probs=212.0
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD 760 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~ 760 (1092)
.....++|++.+.||.|+||+||+|.+..+++.||||.+++... ......+..|+.++.+.. ||||+++++++.+..
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 35677899999999999999999999999999999999976432 233456677777776665 999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++....
T Consensus 88 ~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99999999854 77777765 3568999999999999999999997 599999999999999999999999999986421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC----CCccceeechhhhHHHHHhCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~----Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
. ........|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||
T Consensus 167 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 218 (296)
T cd06618 167 D----------------------------SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY 218 (296)
T ss_pred C----------------------------CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCC
Confidence 0 00112235889999999987553 788999999999999999999999
Q ss_pred CCCCh-HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 915 TAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 915 ~~~s~-~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
..... .+....+.............++.++.+||.+||..||.+||+ +.+++.||||..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~ 278 (296)
T cd06618 219 KNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPK---YRELLQHPFIRR 278 (296)
T ss_pred CcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhc
Confidence 76433 345555554432211112347899999999999999999999 889999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=332.08 Aligned_cols=254 Identities=36% Similarity=0.561 Sum_probs=212.7
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEY 768 (1092)
|++.+.||.|+||.||+|+...+++.||+|++.... ........+..|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999998643 2233456778899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 769 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 769 m~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
++ ++|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||+++....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~-------- 150 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI-------- 150 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCC--------
Confidence 98 5999999876 5799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
.........++..|+|||++.+. .++.++|+|||||++|||++|.+||...+..+.+.++
T Consensus 151 -------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 151 -------------------PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred -------------------CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 00011234567889999999876 7899999999999999999999999888766555544
Q ss_pred hhc------------------CCCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 927 LNR------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 927 l~~------------------~l~fP~--------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
... ...++. ....++..+.++|.+||..||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~~l~~p~~ 282 (282)
T cd07829 212 FQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS---AKEALKHPYF 282 (282)
T ss_pred HHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCC---HHHHhhCcCC
Confidence 321 011111 01235789999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.32 Aligned_cols=254 Identities=34% Similarity=0.563 Sum_probs=212.1
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEY 768 (1092)
|++.+.||.|++|.||+|....+|+.+|+|.++.... .......+.+|+.+|+.++||||+++++.+.+...+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6778999999999999999998999999999875432 223456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 769 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 769 m~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
+++ +|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||.+......
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~------- 151 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP------- 151 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC-------
Confidence 975 888888764 57999999999999999999999999999999999999999999999999988742100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
........++..|+|||.+.+. .++.++|+||||+++|+|++|++||...+..+...++
T Consensus 152 --------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 152 --------------------VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred --------------------cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0011224588999999999876 7899999999999999999999999887766655554
Q ss_pred hhcC-------------------CCCC--------CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 927 LNRK-------------------IPWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 927 l~~~-------------------l~fP--------~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.... ..++ .....++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~ll~~~~~ 283 (283)
T cd05118 212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT---AEQALAHPYF 283 (283)
T ss_pred HHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC---HHHHhhCCCC
Confidence 3210 0000 112346889999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=340.45 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=205.5
Q ss_pred eeccC--CCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 694 PISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 694 ~LGkG--gFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
.||+| ++|.||+++.+.+|+.||+|+++... ........+.+|+.+++.++||||++++++|...+..|++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34444 55667777777799999999997643 2345678899999999999999999999999999999999999999
Q ss_pred CcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCC
Q 001360 772 GDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849 (1092)
Q Consensus 772 GSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~ 849 (1092)
|+|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~------- 156 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK------- 156 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccc-------
Confidence 9999999764 4589999999999999999999999999999999999999999999999998874311000
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001360 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1092)
Q Consensus 850 t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl 927 (1092)
.............++..|+|||++.+ ..|+.++|+|||||++|||++|..||.............
T Consensus 157 -------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~ 223 (314)
T cd08216 157 -------------RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV 223 (314)
T ss_pred -------------cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 00001112234568899999999976 468899999999999999999999998766544332222
Q ss_pred hcCCC-------CCC------------------------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 928 NRKIP-------WPC------------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 928 ~~~l~-------fP~------------------------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
.+..+ +|. .+..++.++.+||.+||+.||++||+ +.++++||||+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~~p~~~~ 300 (314)
T cd08216 224 RGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS---ASQLLNHSFFKQ 300 (314)
T ss_pred hccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC---HHHHhcCchHhh
Confidence 11100 000 11234578999999999999999999 889999999986
Q ss_pred CC
Q 001360 977 VN 978 (1092)
Q Consensus 977 Id 978 (1092)
+.
T Consensus 301 ~~ 302 (314)
T cd08216 301 CK 302 (314)
T ss_pred hc
Confidence 53
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=337.07 Aligned_cols=256 Identities=24% Similarity=0.377 Sum_probs=206.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRT----------------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~----------------TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNI 749 (1092)
.++|++.+.||+|+||.||+|++.. ++..||+|+++... .......+.+|+.+|..++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3579999999999999999986543 34579999987532 23445688999999999999999
Q ss_pred EEEeeeeccCCeeEEEEeecCCCcHHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCce
Q 001360 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (1092)
Q Consensus 750 VkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g-----------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNI 818 (1092)
+++++++...+..|+||||+++|+|.+++.+.. .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999997643 366778999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001360 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (1092)
Q Consensus 819 LLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVW 898 (1092)
|++.++.+||+|||+++...... .........+++.|+|||+..+..++.++|+|
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Diw 216 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGD-------------------------YYRIQGRAVLPIRWMSWESILLGKFTTASDVW 216 (296)
T ss_pred EEcCCCCEEeccCcccccccCCc-------------------------ceeccCcCcCccccCCHHHHhcCCccchhhhh
Confidence 99999999999999987421000 00011223457889999999888899999999
Q ss_pred chhhhHHHHHh--CCCCCCCCChHHHHHHHhh------cCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 899 SVGIILFEFIT--GIPPFTAESPEIIFDNILN------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 899 SLGVILYEMLT--Gk~PF~~~s~~ei~~kIl~------~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
||||++|||++ |..||...+..+....... ....+| .+..++..+.+||.+||..||.+||++.++.++|
T Consensus 217 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 217 AFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLP-KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred HHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 99999999998 7899988776665543321 111122 2456789999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=325.99 Aligned_cols=249 Identities=22% Similarity=0.384 Sum_probs=209.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
..+|++.+.||.|+||.||+|.+. .+..+|+|.+.+... ....+.+|+++++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 468999999999999999999886 477899998875332 234688899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||+++|+|.+++... +.+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---- 153 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD---- 153 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC----
Confidence 9999999999999764 56899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~ 923 (1092)
.........++..|+|||++.+..++.++|+||||+++|||++ |.+||.......+.
T Consensus 154 ----------------------~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 211 (256)
T cd05112 154 ----------------------QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211 (256)
T ss_pred ----------------------cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 0001112345678999999998889999999999999999998 99999988887777
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
..+..+...+ .+...+..+.+|+.+||..+|++||+ +.++++
T Consensus 212 ~~~~~~~~~~--~~~~~~~~~~~l~~~~l~~~p~~Rp~---~~~~l~ 253 (256)
T cd05112 212 ETINAGFRLY--KPRLASQSVYELMQHCWKERPEDRPS---FSLLLH 253 (256)
T ss_pred HHHhCCCCCC--CCCCCCHHHHHHHHHHcccChhhCCC---HHHHHH
Confidence 7765543222 23567899999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=335.78 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=208.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 688 DFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
+|++.+.||+|+||.||+|.... ....+|+|.+.+.. .......+.+|+.++..++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 23579999886532 233457789999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhh------------------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCce
Q 001360 763 YLVMEYLNGGDLYSLLRKV------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~------------------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNI 818 (1092)
|+||||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2477888999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001360 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (1092)
Q Consensus 819 LLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVW 898 (1092)
|++.++.+||+|||+++...... .........++..|+|||++.+..++.++|||
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEED-------------------------SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred EEcCCCcEEeccccccccccCcc-------------------------chhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 99999999999999987421100 00011233567889999999988999999999
Q ss_pred chhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 899 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 899 SLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
|||+++|||++ |..||.+..+..+...+... ..++ .+..++.++.+||.+||+.||.+||++.++.+.+
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG-YRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 99999999998 99999988888777665433 2322 3567899999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.27 Aligned_cols=253 Identities=32% Similarity=0.543 Sum_probs=213.0
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 001360 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~ 770 (1092)
....||+|+||.||++..+.+|..||+|.+... .......+.+|+.++..++||||+++++.|...+..|+||||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 346799999999999999999999999987532 23345678899999999999999999999999999999999999
Q ss_pred CCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCC
Q 001360 771 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (1092)
Q Consensus 771 GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t 850 (1092)
+++|.+++.. +.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~----------- 168 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK----------- 168 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc-----------
Confidence 9999998754 5689999999999999999999999999999999999999999999999998763210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 001360 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 930 (1092)
Q Consensus 851 ~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~ 930 (1092)
.........||+.|+|||.+.+..++.++|+||||+++|+|++|.+||.+.........+....
T Consensus 169 ----------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 232 (292)
T cd06657 169 ----------------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL 232 (292)
T ss_pred ----------------ccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Confidence 0011123568999999999988888999999999999999999999999887766655544322
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 931 l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.........++..+.++|.+||..||.+||+ +.+++.||||...
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~---~~~ll~~~~~~~~ 276 (292)
T cd06657 233 PPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 276 (292)
T ss_pred CcccCCcccCCHHHHHHHHHHHhCCcccCcC---HHHHhcChHHhcc
Confidence 1111112457899999999999999999999 8899999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=331.45 Aligned_cols=240 Identities=25% Similarity=0.397 Sum_probs=200.0
Q ss_pred eeccCCCeEEEEEEECCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecC
Q 001360 694 PISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLN 770 (1092)
Q Consensus 694 ~LGkGgFGtVyLar~k~TGk--~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LYLVMEYm~ 770 (1092)
.||+|+||.||+|+.+.+|. .+|+|.++.. ........+.+|+.++.++ +||||+++++++.....+|+||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 68999999999999988876 4688877642 2334556789999999999 79999999999999999999999999
Q ss_pred CCcHHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCc
Q 001360 771 GGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1092)
Q Consensus 771 GGSL~dlLkk~g----------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 834 (1092)
+|+|.+++.... .+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999997543 4788899999999999999999999999999999999999999999999997
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~P 913 (1092)
..... ........+++.|+|||++.+..++.++|+|||||++|||++ |..|
T Consensus 160 ~~~~~----------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~p 211 (270)
T cd05047 160 RGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211 (270)
T ss_pred cccch----------------------------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 52100 000111234678999999998899999999999999999997 9999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
|.+.+..+.+..+.... .. ..+..++.++.+|+.+||..||.+||++.++
T Consensus 212 f~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (270)
T cd05047 212 YCGMTCAELYEKLPQGY-RL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261 (270)
T ss_pred ccccCHHHHHHHHhCCC-CC-CCCCcCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 99888877777765532 21 2345688999999999999999999995433
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=330.10 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=196.1
Q ss_pred EeeccCCCeEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 001360 693 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~--TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~ 770 (1092)
+.||+|+||.||+|.... ++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 368999999999998653 456799998865432 2334578899999999999999999999999999999999999
Q ss_pred CCcHHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 771 GGDLYSLLRKVG-----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 771 GGSL~dlLkk~g-----~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
+|+|.+++.... .+++..++.++.|++.||.|||+.|++||||||+|||++.++++||+|||+++......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~---- 154 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED---- 154 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc----
Confidence 999999997532 35667788899999999999999999999999999999999999999999986321000
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-------CCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-------EHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-------~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
.........|++.|+|||++.+. .++.++|+|||||++|||++ |.+||...
T Consensus 155 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 155 ---------------------YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred ---------------------eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 00011235678999999998642 35789999999999999996 99999887
Q ss_pred ChHHHHHHHhhc-CC--CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 918 SPEIIFDNILNR-KI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 918 s~~ei~~kIl~~-~l--~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
...+........ .. +.|.+....+..+.++|.+|+ .+|++||+++++...|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 214 SDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred ChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 766654443332 22 223333467889999999999 5899999965554444
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=343.13 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=212.5
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEE
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTT-------GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 751 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~T-------Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVk 751 (1092)
.++.+...+|++.+.||+|+||.||+|++... +..||+|+++.. ........+.+|+.++.++ +||||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 34455667899999999999999999986432 236899988642 2334567889999999999 7999999
Q ss_pred EeeeeccCCeeEEEEeecCCCcHHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCC
Q 001360 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 815 (1092)
Q Consensus 752 L~~sfqde~~LYLVMEYm~GGSL~dlLkk~g----------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKP 815 (1092)
+++++...+.+|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 9999999999999999999999999997532 367788888999999999999999999999999
Q ss_pred CceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001360 816 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (1092)
Q Consensus 816 eNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ks 895 (1092)
+|||++.++.+||+|||+++...... .........++..|+|||++.+..++.++
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 217 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNID-------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQS 217 (334)
T ss_pred ceEEEcCCCcEEECCcccceeccccc-------------------------ccccccCCCcCceEcCHHHhccCCcCchh
Confidence 99999999999999999987421000 00011123356789999999999999999
Q ss_pred eeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 896 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 896 DVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
|||||||++|||++ |..||.+.+..+.+..+..... +..+...+.++.+||.+||..+|.+||+ +.+++.+
T Consensus 218 Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~ell~~ 289 (334)
T cd05100 218 DVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTHELYMIMRECWHAVPSQRPT---FKQLVED 289 (334)
T ss_pred hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcccChhhCcC---HHHHHHH
Confidence 99999999999998 8999999888888877765432 2234678899999999999999999999 4455543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=345.52 Aligned_cols=259 Identities=28% Similarity=0.452 Sum_probs=209.2
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-------
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------- 759 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde------- 759 (1092)
.+|++.+.||.|+||.||+|..+.+|+.||+|++..... .....+.+|+++|+.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 689999999999999999999999999999999865432 4557788999999999999999999776554
Q ss_pred -------CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-CCcEEEEec
Q 001360 760 -------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDF 831 (1092)
Q Consensus 760 -------~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDF 831 (1092)
..+|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35899999997 589888754 56999999999999999999999999999999999999985 567899999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhC
Q 001360 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 910 (1092)
Q Consensus 832 GLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTG 910 (1092)
|+++.... .. .........+||..|+|||++.+ ..++.++|+|||||++|+|++|
T Consensus 160 g~~~~~~~--~~----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g 215 (342)
T cd07854 160 GLARIVDP--HY----------------------SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215 (342)
T ss_pred ccceecCC--cc----------------------ccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhC
Confidence 99874210 00 00001122468999999998765 5688999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcC----------------------C---CC--CCCCCCCCHHHHHHHHHhccCCcCCCCCcc
Q 001360 911 IPPFTAESPEIIFDNILNRK----------------------I---PW--PCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (1092)
Q Consensus 911 k~PF~~~s~~ei~~kIl~~~----------------------l---~f--P~ip~~lS~eakDLI~kcL~kDP~KRpSa~ 963 (1092)
..||...++......++... . .. ......++.++.+||.+||+.||.+||+
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-- 293 (342)
T cd07854 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT-- 293 (342)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC--
Confidence 99998877655554443210 0 00 0012357889999999999999999999
Q ss_pred cHHHHHcCCCCCCC
Q 001360 964 GAAEVKAHPFFKGV 977 (1092)
Q Consensus 964 ga~EIL~HPFFkgI 977 (1092)
+.+++.||||+..
T Consensus 294 -~~ell~h~~~~~~ 306 (342)
T cd07854 294 -AEEALMHPYMSCY 306 (342)
T ss_pred -HHHHhCCCccccc
Confidence 8899999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=349.08 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=204.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSF 756 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sf 756 (1092)
....++|++.+.||+|+||+||+|++ ..+++.||||+++... .......+.+|+.+|.++ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 34567899999999999999999985 3467899999997532 234456788999999999 689999999887
Q ss_pred ccC-CeeEEEEeecCCCcHHHHHHhh------------------------------------------------------
Q 001360 757 TCR-DNLYLVMEYLNGGDLYSLLRKV------------------------------------------------------ 781 (1092)
Q Consensus 757 qde-~~LYLVMEYm~GGSL~dlLkk~------------------------------------------------------ 781 (1092)
... ..+|+||||+++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 4689999999999999998642
Q ss_pred -------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCC
Q 001360 782 -------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848 (1092)
Q Consensus 782 -------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~ 848 (1092)
..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~------- 233 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------- 233 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc-------
Confidence 136777888899999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHh
Q 001360 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNIL 927 (1092)
Q Consensus 849 ~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl 927 (1092)
.........+++.|+|||++.+..++.++|||||||++|+|++ |..||............+
T Consensus 234 ------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 295 (343)
T cd05103 234 ------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295 (343)
T ss_pred ------------------chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH
Confidence 0001112346778999999999999999999999999999997 999998765433333333
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 928 ~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
..... +..+...++++.+++.+||+.||.+||+ +.+|++|
T Consensus 296 ~~~~~-~~~~~~~~~~~~~~~~~cl~~~p~~Rps---~~eil~~ 335 (343)
T cd05103 296 KEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 335 (343)
T ss_pred hccCC-CCCCCCCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 32222 2234567889999999999999999999 5566654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=330.91 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=210.4
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk----~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
...+|++.+.||+|+||+||+|.++.+|. .+|+|.+++... ......+.+|+.+|..++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45789999999999999999999887765 589998865432 3456778899999999999999999999887 7
Q ss_pred eeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
..++||||+++|+|.+++.+. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 899999999999999999764 4689999999999999999999999999999999999999999999999999875310
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s 918 (1092)
.. . ........+++.|+|||.+....++.++|+|||||++|||++ |..||.+..
T Consensus 162 ~~----------------~---------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 162 DE----------------K---------EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred cc----------------c---------ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 00 0 000112234678999999988899999999999999999998 999999998
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
..++...+..+.. ++ .+...+.++.+++.+||..||.+||++..+
T Consensus 217 ~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l 261 (279)
T cd05057 217 AVEIPDLLEKGER-LP-QPPICTIDVYMVLVKCWMIDAESRPTFKEL 261 (279)
T ss_pred HHHHHHHHhCCCC-CC-CCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 8888877765432 22 245678999999999999999999995433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=385.25 Aligned_cols=266 Identities=26% Similarity=0.396 Sum_probs=207.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
+++|++.+.||+|+||.||+|++..+|+.||||++++..........++.+|+.++..++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999999764333344567799999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCc
Q 001360 766 MEYLNGGDLYSLLRKV-----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~-----------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 834 (1092)
|||++||+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998642 23455667888999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
+........ . .....................+||+.|||||++.+..++.++|||||||++|||++|..||
T Consensus 161 k~i~~~~~~-~--------~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 161 IFKKLEEED-L--------LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred eeccccccc-c--------cccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 853110000 0 0000000000000111223468999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHH-HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC
Q 001360 915 TAESPEIIFDN-ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961 (1092)
Q Consensus 915 ~~~s~~ei~~k-Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpS 961 (1092)
.......+... .......+. ....+++.+.+++.+||..||++|++
T Consensus 232 ~~~~~~ki~~~~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~s 278 (932)
T PRK13184 232 RRKKGRKISYRDVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYS 278 (932)
T ss_pred CCcchhhhhhhhhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcC
Confidence 87655433222 111111111 12467899999999999999999988
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=330.83 Aligned_cols=252 Identities=35% Similarity=0.528 Sum_probs=207.9
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEe
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LYLVME 767 (1092)
|++.+.||.|+||+||+|+...+++.||||.+.+... ........+|+..+.+++ ||||+++++.+.+.+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999999999999999875322 122334567899999999 9999999999999999999999
Q ss_pred ecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 768 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|+ +|+|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++....
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~------ 151 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS------ 151 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC------
Confidence 99 789999987764 789999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
........|+..|+|||++.+ ..++.++|+||||+++|||++|++||...+..+.+.
T Consensus 152 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~ 209 (283)
T cd07830 152 ----------------------RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209 (283)
T ss_pred ----------------------CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence 001123468999999998854 557899999999999999999999998877665554
Q ss_pred HHhhcC-------------------CCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 925 NILNRK-------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 925 kIl~~~-------------------l~fP~--------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
++.... ..++. .....+.++.+||.+||+.||.+||+ +.+++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~ei~~~~~~ 283 (283)
T cd07830 210 KICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT---ASQALQHPYF 283 (283)
T ss_pred HHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC---HHHHhhCCCC
Confidence 443210 00010 01233688999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=344.80 Aligned_cols=256 Identities=33% Similarity=0.527 Sum_probs=210.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-CCeeE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RDNLY 763 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd-e~~LY 763 (1092)
..++|++++.||.|+||.||+|..+.+|+.||+|++.+.. ........+.+|+.++..++||||++++++|.. ...+|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 5678999999999999999999999999999999886532 223345678899999999999999999999876 56789
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+||||+ +++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~----- 159 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD----- 159 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC-----
Confidence 999998 5689888764 468889999999999999999999999999999999999999999999999886310
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|++||........
T Consensus 160 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~ 214 (328)
T cd07856 160 -------------------------PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214 (328)
T ss_pred -------------------------CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 01123467899999999866 5789999999999999999999999987765333
Q ss_pred HHHHhh----------------------------cCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 923 FDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 923 ~~kIl~----------------------------~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
+..+.+ ...++......++.++.++|.+||+.+|.+||+ +.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~ell~~~~~ 291 (328)
T cd07856 215 FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS---AAEALAHPYL 291 (328)
T ss_pred HHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC---HHHHhcCCcc
Confidence 222111 001111112357889999999999999999999 8899999999
Q ss_pred CC
Q 001360 975 KG 976 (1092)
Q Consensus 975 kg 976 (1092)
..
T Consensus 292 ~~ 293 (328)
T cd07856 292 AP 293 (328)
T ss_pred cc
Confidence 63
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.71 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=209.8
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
.+..++|++.+.||+|+||.||+|... .+..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 345678999999999999999999865 45679999886532 245678899999999999999999999888 778
Q ss_pred EEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999999999763 35788889999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~ 919 (1092)
. ........++..|+|||++.+..++.++|+|||||++|+|++ |++||...+.
T Consensus 156 ~--------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 156 E--------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred C--------------------------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 0 001112346678999999998889999999999999999998 9999998887
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
..+...+... ...+ .+...+.++.+++.+||..+|++||+...+.++|
T Consensus 210 ~~~~~~~~~~-~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L 257 (260)
T cd05073 210 PEVIRALERG-YRMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257 (260)
T ss_pred HHHHHHHhCC-CCCC-CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 7777666544 2222 2467889999999999999999999966555554
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=339.72 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=214.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
..|+..+.||.|+||.||+|+.+.++..+|+|.+.............+.+|+.+++.++|||++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34778899999999999999999999999999987543334445667889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
||+. |+|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+|||++.+|.+||+|||++....
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~------- 166 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec-------
Confidence 9997 588777754 4568999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
......||+.|+|||++. ...++.++|||||||++|+|++|..||...+....
T Consensus 167 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 222 (308)
T cd06634 167 ------------------------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (308)
T ss_pred ------------------------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH
Confidence 012346899999999985 34678899999999999999999999988776555
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
...+.....+.. .+..++..+.+||.+||..+|.+||+ +.+++.||||...
T Consensus 223 ~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~---~~~ll~~~~~~~~ 273 (308)
T cd06634 223 LYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRE 273 (308)
T ss_pred HHHHhhcCCCCc-CcccccHHHHHHHHHHhhCCcccCCC---HHHHhhCcccccc
Confidence 555544433221 13568899999999999999999999 8899999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.96 Aligned_cols=232 Identities=34% Similarity=0.542 Sum_probs=195.0
Q ss_pred CCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHH
Q 001360 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL 777 (1092)
Q Consensus 698 GgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL~dl 777 (1092)
|.||+||+|+++.+|+.||+|.+++.. .+.+|...+....||||+++++++...+..|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997642 123455555566799999999999999999999999999999999
Q ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCC
Q 001360 778 LRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857 (1092)
Q Consensus 778 Lkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~ 857 (1092)
+.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~------------------- 136 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE------------------- 136 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccc-------------------
Confidence 9888889999999999999999999999999999999999999999999999999875321
Q ss_pred CCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCC
Q 001360 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVP 937 (1092)
Q Consensus 858 ~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip 937 (1092)
.......++..|+|||.+.+..++.++|+|||||++|||++|+.||...... + ..... ..+|
T Consensus 137 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~-~~~~ 198 (237)
T cd05576 137 -----------DSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTT-LNIP 198 (237)
T ss_pred -----------cccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccc-cCCc
Confidence 0112345678899999998888999999999999999999999988643221 0 11111 1234
Q ss_pred CCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCC
Q 001360 938 SDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFF 974 (1092)
Q Consensus 938 ~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFF 974 (1092)
..++..+++||.+||+.||.+||++ ..+.++++||||
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 6789999999999999999999995 346899999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=345.49 Aligned_cols=266 Identities=33% Similarity=0.527 Sum_probs=214.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC--
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD-- 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~-- 760 (1092)
...++|++.+.||.|+||.||+|.+..+|+.+|+|.+.+.. ........+.+|+.++.++ +||||++++++|...+
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 34678999999999999999999999899999999886532 2233456678899999999 9999999999886543
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|+||||+. ++|..++.+. .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 6899999997 4999988765 7899999999999999999999999999999999999999999999999998753210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
.. ..........+||+.|+|||++.+ ..++.++|+|||||++|+|++|++||.+...
T Consensus 161 ~~----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 161 EE----------------------NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred cc----------------------cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 00 000112234579999999998865 4578999999999999999999999987765
Q ss_pred HHHHHHHhhcC----------------------------CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 920 EIIFDNILNRK----------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 920 ~ei~~kIl~~~----------------------------l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
.....++.... ..+......++.++.+||.+||+.||.+||+ +.++++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps---~~~il~~ 295 (337)
T cd07852 219 LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT---AEEALEH 295 (337)
T ss_pred HHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC---HHHHhhC
Confidence 55444332211 0111112347899999999999999999999 8899999
Q ss_pred CCCCCC
Q 001360 972 PFFKGV 977 (1092)
Q Consensus 972 PFFkgI 977 (1092)
|||+..
T Consensus 296 ~~~~~~ 301 (337)
T cd07852 296 PYVAQF 301 (337)
T ss_pred hhhhhh
Confidence 999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=366.51 Aligned_cols=261 Identities=27% Similarity=0.467 Sum_probs=211.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~ 761 (1092)
.+.-..|++++.||+||.++||+|...+ ...||+|.+.- .......+..+.+|+..|.+++ |.+||+||++-..++.
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~-~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVL-LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHH-hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 4556789999999999999999998754 45677775543 2334556788999999999997 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~-LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
+||||||=. -||..+|++... ++...+++|..|++.|+.++|+.||||.||||.|+|+- .|.+||+|||+|.....+
T Consensus 435 lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 435 LYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 999999864 499999987754 44468999999999999999999999999999999995 699999999999853211
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-----------CCccceeechhhhHHHHHh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----------HGYAADWWSVGIILFEFIT 909 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-----------Yt~ksDVWSLGVILYEMLT 909 (1092)
. -.....+.|||+.||+||.+.... .+.++||||||||||+|++
T Consensus 513 T-------------------------TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY 567 (677)
T KOG0596|consen 513 T-------------------------TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY 567 (677)
T ss_pred c-------------------------cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh
Confidence 1 122345689999999999996543 3578999999999999999
Q ss_pred CCCCCCCCC-hHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 910 GIPPFTAES-PEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 910 Gk~PF~~~s-~~ei~~kIl~~--~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
|++||..-. ...-+..|..- .++||.++.. .++.++++.||.+||++||+ +.++|+|||+..+
T Consensus 568 gktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~s---i~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 568 GKTPFGQIINQIAKLHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWS---IPELLQHPFLQIQ 633 (677)
T ss_pred cCCchHHHHHHHHHHHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCC---cHHHhcCcccccc
Confidence 999997643 23334444443 4577765543 34999999999999999999 8899999999753
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=330.19 Aligned_cols=253 Identities=26% Similarity=0.371 Sum_probs=198.3
Q ss_pred eEEEEeeccCCCeEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cee
Q 001360 689 FEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 762 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~----k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde--~~L 762 (1092)
|++++.||+|+||+||++.. ..++..||+|+++... .......+.+|+++|+.++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 48999999999999988753 3568899999987532 223456788999999999999999999987654 468
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~- 161 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH- 161 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc-
Confidence 9999999999999999764 59999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH--
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-- 920 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~-- 920 (1092)
..........++..|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 162 -----------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 218 (283)
T cd05080 162 -----------------------EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE 218 (283)
T ss_pred -----------------------hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh
Confidence 0000011234667899999999888999999999999999999999998653321
Q ss_pred HH------------HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 921 II------------FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 921 ei------------~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
++ ...........+ .+..++.++.+|+.+||..||.+||++.++.+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l 278 (283)
T cd05080 219 EMIGPKQGQMTVVRLIELLERGMRLP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278 (283)
T ss_pred hhhcccccccchhhhhhhhhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 00 111111111212 3467889999999999999999999955544443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=366.70 Aligned_cols=260 Identities=29% Similarity=0.458 Sum_probs=225.9
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCc---E-EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGD---L-FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 756 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk---~-VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sf 756 (1092)
.|.+.-++-.+.+.||+|+||+||+|+.+..+. . ||+|..+......+.++..+++|.++|++++|||||++||+.
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456677788888999999999999999876433 3 899998865556788899999999999999999999999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcc
Q 001360 757 TCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1092)
Q Consensus 757 qde~~LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 835 (1092)
..+..+|+|||+|+||+|.++|++.+ .++..+...|+.+.+.||+|||++++|||||-..|+|++.++.+||+||||++
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999999999999887 49999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCC
Q 001360 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914 (1092)
Q Consensus 836 ~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF 914 (1092)
... .+.. ......-...|+|||.+...-|+.++|||||||++||+++ |..||
T Consensus 311 ~~~-----------------------~~~~----~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py 363 (474)
T KOG0194|consen 311 AGS-----------------------QYVM----KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPY 363 (474)
T ss_pred CCc-----------------------ceee----ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCC
Confidence 531 0000 0001134678999999999999999999999999999999 89999
Q ss_pred CCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 915 ~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
.+....++..+|....++.+ .|...+.++..++.+||..||++||++..+...
T Consensus 364 ~g~~~~~v~~kI~~~~~r~~-~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~ 416 (474)
T KOG0194|consen 364 PGMKNYEVKAKIVKNGYRMP-IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKK 416 (474)
T ss_pred CCCCHHHHHHHHHhcCccCC-CCCCCHHHHHHHHHHhccCChhhccCHHHHHHH
Confidence 99999999999977776655 356888999999999999999999996554443
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=325.97 Aligned_cols=246 Identities=25% Similarity=0.406 Sum_probs=206.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+..++|++.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++..++||||+++++++... .+|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 74 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY 74 (254)
T ss_pred ccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence 3457899999999999999999864 68899999886421 345788999999999999999999998754 579
Q ss_pred EEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.+|.+||+|||++.....
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~-- 152 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM-- 152 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc--
Confidence 9999999999999997654 478999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
......++..|+|||.+.+..++.++|+|||||++|||++ |++||...+..
T Consensus 153 ----------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 204 (254)
T cd05083 153 ----------------------------GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK 204 (254)
T ss_pred ----------------------------cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 0011234568999999998899999999999999999998 99999998887
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+....+..+. ..+ .+..++.++.+||.+||..+|.+||+++++.+.+
T Consensus 205 ~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 251 (254)
T cd05083 205 EVKECVEKGY-RME-PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251 (254)
T ss_pred HHHHHHhCCC-CCC-CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 7776665442 222 2467889999999999999999999965555444
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.13 Aligned_cols=242 Identities=25% Similarity=0.365 Sum_probs=201.5
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GG 772 (1092)
+.||+|+||.||+|... ++..||+|+++... .......+.+|++++..++||||+++++.+......|+||||+++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999865 68899999886532 2333457889999999999999999999999999999999999999
Q ss_pred cHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 773 DLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 773 SL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~----------- 146 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG----------- 146 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc-----------
Confidence 999998753 46889999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 930 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~ 930 (1092)
. ........+++.|+|||++.+..++.++|+||||+++|+|++ |..||.......+...+....
T Consensus 147 -~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~ 211 (250)
T cd05085 147 -I--------------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY 211 (250)
T ss_pred -c--------------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence 0 000112234678999999998889999999999999999998 999999888777776665432
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 931 l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
. +..+..++..+.+|+.+||..+|++||++.++
T Consensus 212 -~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 244 (250)
T cd05085 212 -R-MSCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244 (250)
T ss_pred -C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 1 22346789999999999999999999995443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=328.50 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=204.2
Q ss_pred EeeccCCCeEEEEEEECCCC------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 693 KPISRGAFGRVFLARKRTTG------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TG------k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
+.||+|+||.||+|+.+..+ ..||+|.+.+.. .......+.+|+.+|+.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36999999999999986544 689999886532 1234567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC-----cEEEEecCCc
Q 001360 767 EYLNGGDLYSLLRKV-------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-----HIKLTDFGLS 834 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~-------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG-----~VKLsDFGLA 834 (1092)
||++||+|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+|||++.++ .+||+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999743 3478889999999999999999999999999999999999888 8999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~P 913 (1092)
+....... ........++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 159 ~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 159 RDIYKSDY-------------------------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred cccccccc-------------------------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 74211000 001123356789999999999999999999999999999998 9999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
|...+..+....+..+.. +..+..++..+.+||.+||..+|.+||++.++.+.++
T Consensus 214 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 214 YPALNNQEVLQHVTAGGR--LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CcccCHHHHHHHHhcCCc--cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 998887777766654321 1234678899999999999999999999665555443
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.48 Aligned_cols=244 Identities=26% Similarity=0.361 Sum_probs=204.3
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GG 772 (1092)
+.||.|+||.||+|.... ++.||+|.++.... ......+.+|++++++++||||+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 369999999999999887 99999998876433 245678999999999999999999999999999999999999999
Q ss_pred cHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001360 773 DLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1092)
Q Consensus 773 SL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~ 851 (1092)
+|.+++.+. ..+++..+..++.+++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~---------- 147 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI---------- 147 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc----------
Confidence 999999753 468899999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 001360 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 930 (1092)
Q Consensus 852 g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~ 930 (1092)
+ ........++..|+|||++.+..++.++|+|||||++|||++ |..||...........+....
T Consensus 148 -----------~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~ 212 (251)
T cd05041 148 -----------Y----TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY 212 (251)
T ss_pred -----------c----eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC
Confidence 0 000012234678999999998899999999999999999999 899999888777776665432
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 931 l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
..+ .+..++.++.+||.+||..+|.+||+ +.+++
T Consensus 213 -~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~---~~ell 246 (251)
T cd05041 213 -RMP-APQLCPEEIYRLMLQCWAYDPENRPS---FSEIY 246 (251)
T ss_pred -CCC-CCccCCHHHHHHHHHHhccChhhCcC---HHHHH
Confidence 222 34678899999999999999999999 44554
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=369.06 Aligned_cols=251 Identities=28% Similarity=0.437 Sum_probs=222.4
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEY 768 (1092)
|.-++.||.|+||-||-+++..+.++||||.+.-.-.........++.|+..|.+++|||+|.+-++|.-+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66778999999999999999999999999998765555556678899999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 769 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 769 m~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
|-| +-.|+|.-+ .++.+.++..++.+.+.||.|||+.+.||||||..||||++.|.|||+|||.|.+.
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~---------- 176 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM---------- 176 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc----------
Confidence 965 777877643 46899999999999999999999999999999999999999999999999988742
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
..+.+++|||.||||||++. +.|+-++||||||++..||.-.+||+.+.+.....-
T Consensus 177 ---------------------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY 235 (948)
T KOG0577|consen 177 ---------------------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 235 (948)
T ss_pred ---------------------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH
Confidence 24568999999999999974 679999999999999999999999999998877666
Q ss_pred HHhhcCCC-CCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 925 NILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 925 kIl~~~l~-fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
.|-.+..+ ++ .+.+|..+..||..||++-|.+||+ .++++.|+|...
T Consensus 236 HIAQNesPtLq--s~eWS~~F~~Fvd~CLqKipqeRpt---se~ll~H~fv~R 283 (948)
T KOG0577|consen 236 HIAQNESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPT---SEELLKHRFVLR 283 (948)
T ss_pred HHHhcCCCCCC--CchhHHHHHHHHHHHHhhCcccCCc---HHHHhhcchhcc
Confidence 66655433 33 3678999999999999999999999 889999999854
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.92 Aligned_cols=257 Identities=20% Similarity=0.314 Sum_probs=211.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC- 758 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd- 758 (1092)
+..++|++.+.||+|+||.||+|.+.. ++..||+|.++.. ........+.+|..+|+.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345789999999999999999999876 3578999988642 344567888999999999999999999997655
Q ss_pred CCeeEEEEeecCCCcHHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEe
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKV--------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 830 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~--------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsD 830 (1092)
....++++||+++|+|.+++... ..+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 56789999999999999999753 3588999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-
Q 001360 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT- 909 (1092)
Q Consensus 831 FGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT- 909 (1092)
||+++....... ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 161 ~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~ 215 (280)
T cd05043 161 NALSRDLFPMDY-------------------------HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL 215 (280)
T ss_pred CCCcccccCCce-------------------------EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcC
Confidence 999874211000 000112346778999999999899999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 910 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 910 Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
|++||...++.++...+..+ ..++ .+..+++++.+++.+||..||++||++.++.+.+
T Consensus 216 g~~p~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 216 GQTPYVEIDPFEMAAYLKDG-YRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred CCCCcCcCCHHHHHHHHHcC-CCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 99999988887777665543 2322 2456789999999999999999999965554443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=356.39 Aligned_cols=259 Identities=24% Similarity=0.344 Sum_probs=211.1
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEee
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFY 754 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~ 754 (1092)
.+.+..++|.+.+.||+|+||.||+|++. .+++.||+|+++... .......+.+|+.+|.++. |||||++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 35677788999999999999999999964 345689999997532 2334557889999999998 999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhhc----------------------------------------------------
Q 001360 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVG---------------------------------------------------- 782 (1092)
Q Consensus 755 sfqde~~LYLVMEYm~GGSL~dlLkk~g---------------------------------------------------- 782 (1092)
++.....+|+||||+++|+|.+++.+.+
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999996431
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCC
Q 001360 783 ----------------------------------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816 (1092)
Q Consensus 783 ----------------------------------------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPe 816 (1092)
.+++..+..++.||+.||.|||+.||+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 2566678889999999999999999999999999
Q ss_pred ceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001360 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 896 (1092)
Q Consensus 817 NILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksD 896 (1092)
|||++.++.+||+|||+++...... .........|++.|||||++.+..++.++|
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 323 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDS-------------------------NYISKGSTFLPLKWMAPESIFNNLYTTLSD 323 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccccc-------------------------ccccCCCcCCCCceeChHHhcCCCCCcHhH
Confidence 9999999999999999987421000 001112346789999999999888999999
Q ss_pred eechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 897 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 897 VWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
||||||++|||++ |..||......+.....+......+ .|..++.++.+||.+||..+|.+||++.++..
T Consensus 324 vwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 324 VWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999998 8999987665555444444433322 35678999999999999999999999544433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=325.74 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=198.3
Q ss_pred EeeccCCCeEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec-cCCeeEEEEee
Q 001360 693 KPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT-CRDNLYLVMEY 768 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~---TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfq-de~~LYLVMEY 768 (1092)
+.||+|+||.||+|.+.. .+..||+|.+... ........+.+|+.+++.++||||+++++.+. .+...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998754 3457999987542 23345678889999999999999999999765 45568999999
Q ss_pred cCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 769 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 769 m~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~----- 153 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY----- 153 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc-----
Confidence 9999999999764 3467777888999999999999999999999999999999999999999999874211000
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kI 926 (1092)
..........+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...+
T Consensus 154 ------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~ 215 (262)
T cd05058 154 ------------------YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL 215 (262)
T ss_pred ------------------eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 00011123356789999999998899999999999999999999 57788888877777766
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
..+.. +..+..++..+.+++.+||..+|++||++.++..
T Consensus 216 ~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 216 LQGRR--LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred hcCCC--CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 55432 2234567899999999999999999999544433
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.14 Aligned_cols=250 Identities=25% Similarity=0.352 Sum_probs=206.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~T---Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
..++|.+.+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 456799999999999999999987654 3468999876432 23456788999999999999999999998876 45
Q ss_pred eEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.|+||||+++|+|.+++.+.. .+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 789999999999999997644 5899999999999999999999999999999999999999999999999998743110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~ 919 (1092)
. ........+++.|+|||.+....++.++|+|||||++|||++ |..||...+.
T Consensus 161 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 161 S--------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred c--------------------------ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 0 000112235678999999988899999999999999999996 9999998887
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
.+....+.++.. +..+..++.++.+||.+||..+|.+||++.++
T Consensus 215 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 258 (270)
T cd05056 215 NDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258 (270)
T ss_pred HHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 777766655432 12346889999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=372.41 Aligned_cols=343 Identities=29% Similarity=0.435 Sum_probs=251.9
Q ss_pred hhhhhhhhhhhhhhhhccchhhHhhhccchHHHHhhcccceEeccchhHHHHHHhhhhhHhhh----------hhcccCC
Q 001360 579 IELADIARCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILAC----------ELLDEKS 648 (1092)
Q Consensus 579 ~~~~~~~~~i~~~~~~ke~~~~l~~~~~~~~~~~~~~~~~~lvid~fg~rI~kllr~k~il~~----------~lL~~ks 648 (1092)
.++.+.|+..+...+++--.-||..-.....++.+|.-...+-.+... .+.....+.... ..+....
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~---~r~~~~~fkp~~~~e~~~~~fd~eft~~~ 284 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELE---ARSRPPPFKPGSITERDVAQFDPEFTSQV 284 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHh---hcCCCCCCCCcccchhhhhhcCchhccCC
Confidence 357788888888888888777777766777788888877666333111 111111110000 0000000
Q ss_pred CCccc---ccccchhhhhcccccCCCCCCCCCCCccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc
Q 001360 649 PTSFS---KYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 725 (1092)
Q Consensus 649 p~sfS---k~~ens~llldsls~ssg~~tp~~ss~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei 725 (1092)
|.... ...++.....+ .+-.....-...+.....++|++...+|.|+|+.|..+.+..+++.+|+|++.+..
T Consensus 285 P~dsp~~~~~~s~~~if~g----~sfva~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~- 359 (612)
T KOG0603|consen 285 PADSPLLSASGSDHTIFSG----PSFVAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA- 359 (612)
T ss_pred cccCCCCCCCccccchhcC----CCccChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccccc-
Confidence 10000 00000000000 00000000000112235788999999999999999999999999999999998752
Q ss_pred cchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH
Q 001360 726 IRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804 (1092)
Q Consensus 726 ~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLH 804 (1092)
....+|+.++... +||||+++++.+.+..+.|+|||++.||.|.+.+.....+. ..+..|++||+.|+.|||
T Consensus 360 ------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH 432 (612)
T KOG0603|consen 360 ------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLH 432 (612)
T ss_pred ------cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHH
Confidence 1234566666555 59999999999999999999999999999999988776666 788889999999999999
Q ss_pred HcCCeeeecCCCceEe-cCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCh
Q 001360 805 SLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAP 883 (1092)
Q Consensus 805 s~GIIHRDLKPeNILL-D~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAP 883 (1092)
.+|||||||||+|||+ ++.|+++|+|||.++... ....+.|-|..|.||
T Consensus 433 ~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~------------------------------~~~~tp~~t~~y~AP 482 (612)
T KOG0603|consen 433 EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE------------------------------RSCDTPALTLQYVAP 482 (612)
T ss_pred hcCeeecCCChhheeecCCCCcEEEEEechhhhCc------------------------------hhhcccchhhcccCh
Confidence 9999999999999999 699999999999987421 113456789999999
Q ss_pred hhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH-HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc
Q 001360 884 EILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962 (1092)
Q Consensus 884 EVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~-ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa 962 (1092)
|++...+|+.+|||||||++||+||+|+.||...... ++..+|..+.. ...+|.+++|||++||+.||.+||+
T Consensus 483 Evl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~-----s~~vS~~AKdLl~~LL~~dP~~Rl~- 556 (612)
T KOG0603|consen 483 EVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF-----SECVSDEAKDLLQQLLQVDPALRLG- 556 (612)
T ss_pred hhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc-----ccccCHHHHHHHHHhccCChhhCcC-
Confidence 9999999999999999999999999999999876555 66666544432 3789999999999999999999999
Q ss_pred ccHHHHHcCCCC
Q 001360 963 NGAAEVKAHPFF 974 (1092)
Q Consensus 963 ~ga~EIL~HPFF 974 (1092)
+.+++.||||
T Consensus 557 --~~~i~~h~w~ 566 (612)
T KOG0603|consen 557 --ADEIGAHPWF 566 (612)
T ss_pred --hhhhccCcch
Confidence 7899999999
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=332.44 Aligned_cols=245 Identities=32% Similarity=0.509 Sum_probs=202.5
Q ss_pred EEEEeeccCCCeEEEEEEEC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 690 EIIKPISRGAFGRVFLARKR----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 690 eilr~LGkGgFGtVyLar~k----~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
++.+.||.|+||.||+|.+. ..+..|+||+++. .......+.+.+|++++.+++||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeeccccccccccccccccccccccccccccc
Confidence 57789999999999999998 4467899999954 23344578899999999999999999999999988889999
Q ss_pred EeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 766 MEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
|||+++|+|.++|... ..+++.....++.||+.||.|||+++|+|++|+|.|||++.++.+||+|||++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~--- 156 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK--- 156 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---
Confidence 9999999999999886 67999999999999999999999999999999999999999999999999998752100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 922 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei 922 (1092)
..........+...|+|||++.+..++.++||||||++||||++ |+.||...+..++
T Consensus 157 ----------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~ 214 (259)
T PF07714_consen 157 ----------------------SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI 214 (259)
T ss_dssp ----------------------SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred ----------------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 00111233457788999999998889999999999999999999 7899999988888
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ 963 (1092)
...+..+.. +..+..++..+.+||..||..||.+||++.
T Consensus 215 ~~~~~~~~~--~~~~~~~~~~~~~li~~C~~~~p~~RPs~~ 253 (259)
T PF07714_consen 215 IEKLKQGQR--LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQ 253 (259)
T ss_dssp HHHHHTTEE--TTSBTTSBHHHHHHHHHHT-SSGGGS--HH
T ss_pred ccccccccc--ceeccchhHHHHHHHHHHcCCChhhCcCHH
Confidence 888855433 223577899999999999999999999943
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=366.23 Aligned_cols=256 Identities=20% Similarity=0.340 Sum_probs=214.7
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
..|.+..+++.+...||+|.||+||+|+|-. .||||+++.... ...+.+.|++|+.++++-+|-||+-+.|++...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 5667888999999999999999999999974 499999986544 455889999999999999999999999998877
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.. .||+.+|.|-+|+.+|+-. ..|.....+.|++||++||.|||.++|||||||..||+|.+++.|||+||||+..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 76 9999999999999999744 469999999999999999999999999999999999999999999999999987411
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
. | .........-|...|||||++.. .+|++.+|||||||++|||++|..||.
T Consensus 540 --------------~---------w--~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 540 --------------R---------W--SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred --------------e---------e--ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 0 1 11222334568999999999974 478999999999999999999999999
Q ss_pred CCChHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 916 AESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 916 ~~s~~ei~~kIl~~~l--~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
..+.+++.-.+-.+.+ ....+....+.++++|+..||.+++++||.+..+
T Consensus 595 i~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~i 646 (678)
T KOG0193|consen 595 IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQL 646 (678)
T ss_pred CCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHH
Confidence 7776666655444421 2222345678899999999999999999995433
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=330.98 Aligned_cols=237 Identities=24% Similarity=0.392 Sum_probs=194.0
Q ss_pred EeeccCCCeEEEEEEECCCCcE-------EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 693 KPISRGAFGRVFLARKRTTGDL-------FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~-------VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
+.||+|+||.||+|.++.++.. ||+|.+.+.. ....+.+.+|..+|+.++||||+++++++...+..|+|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 3699999999999998765543 8888775422 34456788999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc--------EEEEecCCccc
Q 001360 766 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--------IKLTDFGLSKI 836 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~--------VKLsDFGLAk~ 836 (1092)
|||+++|+|..++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++. +|++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997654 5899999999999999999999999999999999999988765 68999998753
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhC-CCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG-IPPF 914 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTG-k~PF 914 (1092)
.. ......|++.|+|||++.+ ..++.++|||||||++|||++| .+||
T Consensus 158 ~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 158 VL-------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred cC-------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 10 1123568899999999986 4579999999999999999998 5777
Q ss_pred CCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 915 ~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
...++..... +......+| ...+.++.+||.+||+.||++||+ +.+|++
T Consensus 207 ~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~~il~ 255 (258)
T cd05078 207 SALDSQKKLQ-FYEDRHQLP---APKWTELANLINQCMDYEPDFRPS---FRAIIR 255 (258)
T ss_pred hhccHHHHHH-HHHccccCC---CCCcHHHHHHHHHHhccChhhCCC---HHHHHH
Confidence 7666554433 333333333 567789999999999999999999 556554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=328.78 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=201.1
Q ss_pred CCeEEEEeeccCCCeEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--C
Q 001360 687 DDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 760 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~----k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde--~ 760 (1092)
.-|++++.||+|+||.||+|+. +.++..||+|.++... .......+.+|+.+|+.+.||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3478999999999999999984 4578899999986432 234456789999999999999999999988775 5
Q ss_pred eeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
.+|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 689999999999999999764 3589999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s- 918 (1092)
.. ..........|+..|+|||++.+..++.++|+|||||++|||+++..|+....
T Consensus 162 ~~------------------------~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 162 DK------------------------EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred Cc------------------------cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence 00 00011123567888999999998889999999999999999999877653211
Q ss_pred -------------hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 919 -------------PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 919 -------------~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
........+......+ .+..++..+.+||.+||+.||.+||+ +.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~ 278 (284)
T cd05079 218 LFLKMIGPTHGQMTVTRLVRVLEEGKRLP-RPPNCPEEVYQLMRKCWEFQPSKRTT---FQNLIE 278 (284)
T ss_pred hhhhhcccccccccHHHHHHHHHcCccCC-CCCCCCHHHHHHHHHHccCCcccCcC---HHHHHH
Confidence 1111111222222222 34678999999999999999999999 445543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=398.81 Aligned_cols=259 Identities=36% Similarity=0.588 Sum_probs=220.5
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+++....||.|.||.||-|...+||...|||-++-.... ......+.+|..+|..++|||+|++|+.-...+.+||.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 345566899999999999999999999999988754443 5567778999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
||.||+|.+++...+..++...+.|..|++.|+.|||+.|||||||||.||||+.+|.+|++|||.|.... ++.-++
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~-~~~~~~-- 1391 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK-NNAQTM-- 1391 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEec-CchhcC--
Confidence 99999999999988889999999999999999999999999999999999999999999999999997532 111011
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCCCCChH-HHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPE-IIF 923 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~-ei~ 923 (1092)
.......+|||.|||||++.+ .+.+.++|||||||++.||+||+.||...+.+ .+.
T Consensus 1392 --------------------~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM 1451 (1509)
T KOG4645|consen 1392 --------------------PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM 1451 (1509)
T ss_pred --------------------CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH
Confidence 122336789999999999986 46788999999999999999999999765542 333
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
-++-.+. -|.+|..+|.+.+|||.+||..||++|++ +.+|+.|.|-+
T Consensus 1452 y~V~~gh--~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~---~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1452 YHVAAGH--KPQIPERLSSEGRDFLEHCLEQDPKMRWT---ASQLLEHAFGK 1498 (1509)
T ss_pred hHHhccC--CCCCchhhhHhHHHHHHHHHhcCchhhhH---HHHHHHhhccc
Confidence 3333332 25566889999999999999999999998 77999999865
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=325.96 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=199.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CC
Q 001360 687 DDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RD 760 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~----k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd--e~ 760 (1092)
.+|++++.||+|+||.||+|.. ..++..||+|.+... .......+.+|+++|..++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 5799999999999999999984 457889999998653 23456778999999999999999999987643 34
Q ss_pred eeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
.+|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999999764 4689999999999999999999999999999999999999999999999999875311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
... . ........++..|+|||++.+..++.++|||||||++|||++|..|+.....
T Consensus 161 ~~~--------------------~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 216 (284)
T cd05081 161 DKE--------------------Y----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA 216 (284)
T ss_pred CCc--------------------c----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch
Confidence 000 0 0001112345569999999988999999999999999999998877643321
Q ss_pred HH---------------HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 920 EI---------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 920 ~e---------------i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
.. ....++.....+| .+..++.++.+||.+||..+|++||++.++..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 217 EFMRMMGNDKQGQMIVYHLIELLKNNGRLP-APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hhhhhcccccccccchHHHHHHHhcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 10 0111222222222 34678899999999999999999999544433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=365.09 Aligned_cols=248 Identities=26% Similarity=0.420 Sum_probs=214.5
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
+-|.+.++...-++-||.|+-|-||+|+.+ ++.||||.++.. + ..++.-|++|+||||+.+.++|...
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el---k-------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---K-------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh---h-------hhhHHHHHhccCcceeeEeeeecCC
Confidence 344556666667788999999999999987 789999976531 2 2356678899999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
..+|||||||+.|-|+..|+....++......+..+|+.||.|||.+.|||||||.-||||..+..|||+|||-++...
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~- 263 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS- 263 (904)
T ss_pred ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999887421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
+.....+++||..|||||++...+.+.++|||||||+|||||||..||.+.+.
T Consensus 264 ---------------------------~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 264 ---------------------------DKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred ---------------------------hhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch
Confidence 12334679999999999999999999999999999999999999999988776
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
..++--+-.+-+.+| .|..+++-++=||+.||.-.|..||+ ..+|+.|
T Consensus 317 sAIIwGVGsNsL~Lp-vPstcP~GfklL~Kqcw~sKpRNRPS---Frqil~H 364 (904)
T KOG4721|consen 317 SAIIWGVGSNSLHLP-VPSTCPDGFKLLLKQCWNSKPRNRPS---FRQILLH 364 (904)
T ss_pred heeEEeccCCccccc-CcccCchHHHHHHHHHHhcCCCCCcc---HHHHHHH
Confidence 655544444545555 46889999999999999999999999 6667766
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.48 Aligned_cols=250 Identities=31% Similarity=0.512 Sum_probs=208.8
Q ss_pred CeEEEEeeccCCCeEEEEEEECC-CCcEEEEEEeeccc-------ccchhHHHHHHHHHHHHHh-cCCCceEEEeeeecc
Q 001360 688 DFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLD-------MIRKNDIERILAERNILIT-VRNPFVVRFFYSFTC 758 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~-TGk~VAIKvLkK~e-------i~kk~~ie~~l~EieIL~~-L~HPNIVkL~~sfqd 758 (1092)
+|++.+.||+|+||.||+|.++. +++.+|+|.+.... .........+.+|+.++.+ ++||||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 68899999886432 1223445667889988865 789999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcEEEEecCC
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGL 833 (1092)
.+..|+||||++|++|.+++.. ...+++..+..++.|++.||.|||+ .|++|+||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCC
Q 001360 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 834 Ak~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
+..... ........|+..|+|||++.+..++.++|+||||+++|||++|.+|
T Consensus 161 ~~~~~~----------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 161 AKQKQP----------------------------ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred eeeccc----------------------------ccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCc
Confidence 874210 0012345689999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHH
Q 001360 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~ 966 (1092)
|...........+...... |.....++.++.+||.+||..||.+||++.++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~ 264 (269)
T cd08528 213 FYSTNMLSLATKIVEAVYE-PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264 (269)
T ss_pred ccccCHHHHHHHHhhccCC-cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHH
Confidence 9888777777776655433 222346789999999999999999999954443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.78 Aligned_cols=251 Identities=21% Similarity=0.339 Sum_probs=204.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk----~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
+..++|+.++.||+|+||.||+|++..+|. .+|+|.+.... .......+.+|+.++..++||||+++++.+...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 456789999999999999999999987776 46888776432 233345688999999999999999999988754
Q ss_pred CeeEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 5789999999999999997654 58999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
... .........++..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 161 ~~~-------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 161 GDE-------------------------KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred Ccc-------------------------cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 000 0011122456789999999999999999999999999999997 99999887
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
........+..+ ..++ .+...+..+.++|.+||..+|++||++.+
T Consensus 216 ~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~ 260 (303)
T cd05110 216 PTREIPDLLEKG-ERLP-QPPICTIDVYMVMVKCWMIDADSRPKFKE 260 (303)
T ss_pred CHHHHHHHHHCC-CCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 766655544333 2323 24567889999999999999999999543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=367.64 Aligned_cols=253 Identities=26% Similarity=0.483 Sum_probs=219.9
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe--eEEEE
Q 001360 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--LYLVM 766 (1092)
Q Consensus 690 eilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei-~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~--LYLVM 766 (1092)
++-.+||+|+|-+||+|.+..+|..||--.++-.++ ......+++..|+.+|+.|+|||||++|+++.+..+ +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 455689999999999999999999888655543332 234567899999999999999999999999998876 88999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcC--CeeeecCCCceEecC-CCcEEEEecCCcccccccccc
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~G--IIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
|++..|+|..|+++++.++...++.|++||+.||.|||++. |||||||-+||+|+. -|.|||+|+|||+...
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r----- 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR----- 197 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh-----
Confidence 99999999999999999999999999999999999999985 999999999999975 4899999999998631
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC-CChHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEII 922 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~-~s~~ei 922 (1092)
...+.+.+|||.|||||++. ..|+..+||||||++|.||+|+..||.. .++.++
T Consensus 198 ------------------------~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI 252 (632)
T KOG0584|consen 198 ------------------------KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI 252 (632)
T ss_pred ------------------------ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH
Confidence 22344589999999999998 7899999999999999999999999964 678999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
|+++..+..+-. +..--.+++++||.+||.. ...||+ +.|+|.||||..-
T Consensus 253 YKKV~SGiKP~s-l~kV~dPevr~fIekCl~~-~~~R~s---a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 253 YKKVTSGIKPAA-LSKVKDPEVREFIEKCLAT-KSERLS---AKELLKDPFFDED 302 (632)
T ss_pred HHHHHcCCCHHH-hhccCCHHHHHHHHHHhcC-chhccC---HHHHhhChhhccc
Confidence 999998865422 1223368999999999997 999999 8999999999764
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=324.94 Aligned_cols=238 Identities=22% Similarity=0.280 Sum_probs=192.3
Q ss_pred EeeccCCCeEEEEEEECCC------------CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 693 KPISRGAFGRVFLARKRTT------------GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~T------------Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
+.||+|+||.||+|..... ...+|+|++.... ......+..|+.++..++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999986422 2358888876432 334557888999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc-------EEEEecC
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-------IKLTDFG 832 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~-------VKLsDFG 832 (1092)
..|+||||+++|+|..++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +|++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999999888754 56999999999999999999999999999999999999987664 8999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeechhhhHHHHH-hC
Q 001360 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFI-TG 910 (1092)
Q Consensus 833 LAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Yt~ksDVWSLGVILYEML-TG 910 (1092)
++.... ......||+.|+|||++. +..++.++|||||||++|||+ .|
T Consensus 158 ~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~ 206 (262)
T cd05077 158 IPITVL-------------------------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNG 206 (262)
T ss_pred CCcccc-------------------------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 876321 012346889999999987 467899999999999999998 58
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 911 k~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
..||......+... +........ ...+.++.+||.+||..||.+||+ ..+|+.+
T Consensus 207 ~~p~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~li~~cl~~dp~~Rp~---~~~il~~ 260 (262)
T cd05077 207 EIPLKDKTLAEKER-FYEGQCMLV---TPSCKELADLMTHCMNYDPNQRPF---FRAIMRD 260 (262)
T ss_pred CCCCCCcchhHHHH-HHhcCccCC---CCChHHHHHHHHHHcCCChhhCcC---HHHHHHh
Confidence 99998766544432 223322222 345688999999999999999999 5566643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=321.36 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=204.8
Q ss_pred eEEEEeeccCCCeEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001360 689 FEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~---TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~----- 760 (1092)
|++.++||+|+||.||+|.++. ++..||||++... .......+.+.+|+.+|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD-IFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccc-cCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6778899999999999998653 5789999998653 334445678899999999999999999999886542
Q ss_pred -eeEEEEeecCCCcHHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCC
Q 001360 761 -NLYLVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1092)
Q Consensus 761 -~LYLVMEYm~GGSL~dlLkk~------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGL 833 (1092)
..++++||+.+|+|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247899999999999887532 2478889999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCC
Q 001360 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912 (1092)
Q Consensus 834 Ak~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~ 912 (1092)
++...... .........+++.|++||.+.+..++.++|||||||++|||++ |.+
T Consensus 160 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 160 SKKIYSGD-------------------------YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred cccccCCc-------------------------ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCC
Confidence 87421100 0001122346788999999999999999999999999999999 999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 913 PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
||.+.+...++..+..... +..+...+..+.+|+.+||..+|.+||++.++.+.
T Consensus 215 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 215 PYAGVENSEIYNYLIKGNR--LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9998888887777765432 11235678999999999999999999995544433
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=319.36 Aligned_cols=234 Identities=24% Similarity=0.313 Sum_probs=192.1
Q ss_pred EeeccCCCeEEEEEEECCCC----------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 693 KPISRGAFGRVFLARKRTTG----------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TG----------k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
+.||+|+||.||+|.+..++ ..+++|++.... .....+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36999999999999998777 347778765432 125778899999999999999999999888 778
Q ss_pred EEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC-------cEEEEecCCc
Q 001360 763 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-------HIKLTDFGLS 834 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG-------~VKLsDFGLA 834 (1092)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 789999999999999999999999999999999999999888 8999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC--CCCccceeechhhhHHHHHh-CC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFIT-GI 911 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~--~Yt~ksDVWSLGVILYEMLT-Gk 911 (1092)
.... ......++..|+|||++.+. .++.++|+|||||++|||++ |.
T Consensus 156 ~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~ 204 (259)
T cd05037 156 ITVL-------------------------------SREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204 (259)
T ss_pred cccc-------------------------------cccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCC
Confidence 7421 01234577889999999876 78999999999999999999 68
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 912 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 912 ~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.||...+......... .....| ......+.+||.+||..+|.+||+ +.+++
T Consensus 205 ~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt---~~~il 255 (259)
T cd05037 205 EPLSTLSSSEKERFYQ-DQHRLP---MPDCAELANLINQCWTYDPTKRPS---FRAIL 255 (259)
T ss_pred CCcccCCchhHHHHHh-cCCCCC---CCCchHHHHHHHHHhccChhhCCC---HHHHH
Confidence 8887776444333332 222222 223488999999999999999999 44544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=373.44 Aligned_cols=262 Identities=25% Similarity=0.391 Sum_probs=225.5
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEee
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~ 754 (1092)
....+...+.++.+.||+|+||+||+|+... ....||||.++... ..+....|.+|+++|..++|||||+|+|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 3445677888999999999999999998642 34689999998643 3446788999999999999999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe
Q 001360 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVG--------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 820 (1092)
Q Consensus 755 sfqde~~LYLVMEYm~GGSL~dlLkk~g--------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL 820 (1092)
.+..++.+|||+|||..|||..+|+... .|+..+...++.||+.||+||-++.+|||||-..|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 9999999999999999999999997431 27888999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeech
Q 001360 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900 (1092)
Q Consensus 821 D~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSL 900 (1092)
.++-.|||+||||++......+. + ......-...|||||.++..+|+.++||||+
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYY---------------------k----~~~~t~lPIRWMppEsIly~kFTteSDVWs~ 691 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYY---------------------K----VRGNTLLPIRWMPPESILYGKFTTESDVWSF 691 (774)
T ss_pred ccceEEEecccccchhhhhhhhh---------------------c----ccCCceeeeecCCHHHhhcCcccchhhhhhh
Confidence 99999999999999854321111 0 0011223578999999999999999999999
Q ss_pred hhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 901 GIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 901 GVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
||+|||+++ |+.||++.+.++..+.|.++++ ++ .|..+|.++.+||..||+.+|.+||++.++.-+|+
T Consensus 692 GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~-~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~ 760 (774)
T KOG1026|consen 692 GVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LS-CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ 760 (774)
T ss_pred hhhhhhhhccccCcccccchHHHHHHHHcCCc-cc-CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence 999999998 9999999999999999999887 55 47899999999999999999999999766655554
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=322.64 Aligned_cols=248 Identities=19% Similarity=0.291 Sum_probs=195.4
Q ss_pred eeccCCCeEEEEEEECCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001360 694 PISRGAFGRVFLARKRTTG--DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 694 ~LGkGgFGtVyLar~k~TG--k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
.||+|+||.||+++....+ ..+++|.++... .......+.+|+.++..++||||+++++.+.+....|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 5999999999999864332 345566554322 233467899999999999999999999999999999999999999
Q ss_pred CcHHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 772 GDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 772 GSL~dlLkk~----g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
|+|.+++.+. ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~------- 152 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE------- 152 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc-------
Confidence 9999999754 23566778889999999999999999999999999999999999999999987631100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-------CCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-------~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~ 919 (1092)
.........+|++.|+|||++.. ..++.++|||||||++|||++ |.+||...+.
T Consensus 153 ------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 214 (268)
T cd05086 153 ------------------DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214 (268)
T ss_pred ------------------hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 00011124578999999999853 245789999999999999997 6889988887
Q ss_pred HHHHHHHhhcC-C--CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 920 EIIFDNILNRK-I--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 920 ~ei~~kIl~~~-l--~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.+.+..+..+. . .-|.++..+++.+.+++..|| .+|.+||+++++.+.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 215 REVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred HHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 77777765542 1 224445668899999999999 5899999955544443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=321.99 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=205.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--C
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--R 759 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd--e 759 (1092)
..+|++++.||+|+||.||+|++.. ++..||+|++++.... .....+.+|+.+++.+.||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 3578899999999999999998653 4789999999764322 356789999999999999999999998877 5
Q ss_pred CeeEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
...|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 57999999999999999997654 68999999999999999999999999999999999999999999999999987531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
.... . ........++..|+|||.+.+..++.++|+|||||++|||++|..||....
T Consensus 161 ~~~~-------------------~-----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 161 EDKD-------------------Y-----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred cCCc-------------------c-----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 0000 0 000112345667999999998899999999999999999999999987543
Q ss_pred hHH--------------HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 919 PEI--------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 919 ~~e--------------i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
... ....++.....++. +..++.++.+|+.+||..+|.+||++.++.+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 217 AEFLRMIGIAQGQMIVTRLLELLKEGERLPR-PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred chhccccccccccccHHHHHHHHHcCCcCCC-CccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 221 11222333333332 456788999999999999999999955554443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=327.45 Aligned_cols=237 Identities=25% Similarity=0.335 Sum_probs=192.0
Q ss_pred eeccCCCeEEEEEEECCCC------------------------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce
Q 001360 694 PISRGAFGRVFLARKRTTG------------------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749 (1092)
Q Consensus 694 ~LGkGgFGtVyLar~k~TG------------------------k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNI 749 (1092)
.||+|+||.||+|....++ ..||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 5999999999999854221 358888886432 2344678889999999999999
Q ss_pred EEEeeeeccCCeeEEEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC----
Q 001360 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---- 824 (1092)
Q Consensus 750 VkL~~sfqde~~LYLVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG---- 824 (1092)
+++++++......|+||||+++|+|..++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++..|
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999875 46789999999999999999999999999999999999998654
Q ss_pred ---cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeech
Q 001360 825 ---HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSV 900 (1092)
Q Consensus 825 ---~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSL 900 (1092)
.+||+|||++.... ......|++.|+|||.+.+ ..++.++|+|||
T Consensus 159 ~~~~~kl~d~g~~~~~~-------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~sl 207 (274)
T cd05076 159 TSPFIKLSDPGVSFTAL-------------------------------SREERVERIPWIAPECVPGGNSLSTAADKWSF 207 (274)
T ss_pred ccceeeecCCccccccc-------------------------------cccccccCCcccCchhhcCCCCCCcHHHHHHH
Confidence 48999999875311 0012357888999999875 568999999999
Q ss_pred hhhHHHHH-hCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 901 GIILFEFI-TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 901 GVILYEML-TGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
||++|||+ +|..||....+.+... +......+| ...++++.+||.+||+.+|.+||+ +.+++++
T Consensus 208 G~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps---~~~il~~ 272 (274)
T cd05076 208 GTTLLEICFDGEVPLKERTPSEKER-FYEKKHRLP---EPSCKELATLISQCLTYEPTQRPS---FRTILRD 272 (274)
T ss_pred HHHHHHHHhCCCCCccccChHHHHH-HHHhccCCC---CCCChHHHHHHHHHcccChhhCcC---HHHHHHh
Confidence 99999995 6999998877655433 233333333 456678999999999999999999 5666643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=334.96 Aligned_cols=261 Identities=29% Similarity=0.505 Sum_probs=219.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~ 761 (1092)
...+++.+.+..||.|+.|.|++++.+.+|...|||.+++.. .+++..+++..++++.+.+ +|+||+.|++|..+..
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 355778889999999999999999999999999999998743 5667789999999887776 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
.++.||.|.. -+..+|++ .++++|..+-.+...++.||.||.. +||||||+||+|||+|..|+|||||||++-....
T Consensus 166 V~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 166 VFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 9999999954 55666654 3679999999999999999999975 5999999999999999999999999999865321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
........|-+.|||||-+.- ..|+..+||||||++++||.||..||.+
T Consensus 245 ----------------------------SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 245 ----------------------------SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred ----------------------------ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 122234579999999999863 4799999999999999999999999988
Q ss_pred CC-hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 917 ES-PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 917 ~s-~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.+ .-++..+|++...+.-.....+|+.+++|+..||++|+.+||. ..++++|||....
T Consensus 297 c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~---Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 297 CKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPK---YNKLLEHPFIKRY 355 (391)
T ss_pred CCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcc---hHHHhcCcceeec
Confidence 54 5677778887554322122458999999999999999999998 6799999999653
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.18 Aligned_cols=259 Identities=15% Similarity=0.236 Sum_probs=193.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhH--------HHHHHHHHHHHHhcCCCceEEE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKND--------IERILAERNILITVRNPFVVRF 752 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~T---Gk~VAIKvLkK~ei~kk~~--------ie~~l~EieIL~~L~HPNIVkL 752 (1092)
+..+.|++.+.||+|+||+||+|++..+ +..+|+|+..........+ ......+...+..+.|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3446899999999999999999999887 6677887643211110000 0112233344566789999999
Q ss_pred eeeeccCC----eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEE
Q 001360 753 FYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 828 (1092)
Q Consensus 753 ~~sfqde~----~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKL 828 (1092)
++++.... ..|++||++.. ++.+.+.....+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765544 34788888754 77777766666788999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHH
Q 001360 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (1092)
Q Consensus 829 sDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEML 908 (1092)
+|||+|+....+.. .. . ..........||+.|+|||++.+..|+.++|||||||+||||+
T Consensus 168 ~DFGla~~~~~~~~----------------~~-~---~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~ 227 (294)
T PHA02882 168 IDYGIASHFIIHGK----------------HI-E---YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227 (294)
T ss_pred EEcCCceeeccCCc----------------cc-c---cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999985321100 00 0 0011223457999999999999999999999999999999999
Q ss_pred hCCCCCCCCCh-H--------HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 909 TGIPPFTAESP-E--------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 909 TGk~PF~~~s~-~--------ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
+|.+||.+... . +....+..+...+ ...+.++.++++.||..+|.+||+++.+.+
T Consensus 228 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 228 GIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI----KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 99999987632 2 2233444443333 356789999999999999999999554433
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=346.50 Aligned_cols=263 Identities=27% Similarity=0.358 Sum_probs=206.3
Q ss_pred CCCCccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeee
Q 001360 676 LHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS 755 (1092)
Q Consensus 676 ~~ss~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~s 755 (1092)
.++..+...++++|..-..||+|+||.||+|...+ |..||||.+....... ...|.+|+.+|.+++|||+|+|+|+
T Consensus 64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 34555667788999999999999999999999865 4899999776533211 3459999999999999999999999
Q ss_pred eccCC-eeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcC---CeeeecCCCceEecCCCcEEEE
Q 001360 756 FTCRD-NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLG---IVHRDLKPDNLLIAHDGHIKLT 829 (1092)
Q Consensus 756 fqde~-~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~G---IIHRDLKPeNILLD~nG~VKLs 829 (1092)
|.+.+ ..+||+|||++|+|.++|.... .++|.....|+.+++.||+|||... ||||||||+|||||++...||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99999 5999999999999999998654 8999999999999999999999864 9999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCc-cCCCCCCChhhhcCCCCCccceeechhhhHHHHH
Q 001360 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (1092)
Q Consensus 830 DFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~-vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEML 908 (1092)
|||||+..... .....+. .||.+|+|||++..+..+.++|||||||+|.||+
T Consensus 220 DFGLa~~~~~~---------------------------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEli 272 (361)
T KOG1187|consen 220 DFGLAKLGPEG---------------------------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELI 272 (361)
T ss_pred CccCcccCCcc---------------------------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHH
Confidence 99999753210 0001112 7999999999999888999999999999999999
Q ss_pred hCCCCCCCCC---h---HHHHHHHhhc-CC---CCCCCC-CCCC--HH---HHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 909 TGIPPFTAES---P---EIIFDNILNR-KI---PWPCVP-SDMS--FE---AQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 909 TGk~PF~~~s---~---~ei~~kIl~~-~l---~fP~ip-~~lS--~e---akDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+|+.|..... . .+.....+.. .+ --|.+. ...+ .+ +..+..+|++.+|.+||+..++.+.|
T Consensus 273 tgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 273 TGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred hCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 9998886432 1 1111112221 11 011111 2222 22 45677899999999999976655555
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=366.36 Aligned_cols=253 Identities=27% Similarity=0.466 Sum_probs=208.0
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeec-cC-
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFT-CR- 759 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfq-de- 759 (1092)
.+.-..+++.+.|.+|||+.||+|+....|..||+|.+-.. .+.....+.+|+++|++|+ |||||.++++.. ..
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 45566788999999999999999999988899999987542 5677889999999999998 999999998432 11
Q ss_pred -----CeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcC--CeeeecCCCceEecCCCcEEEEe
Q 001360 760 -----DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTD 830 (1092)
Q Consensus 760 -----~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~G--IIHRDLKPeNILLD~nG~VKLsD 830 (1092)
-.++|.||||.||.|-+++.+. ..|++.++..|+.++++|+.+||... |||||||-|||||+.+|+.||||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 2378999999999999999743 56999999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh---cCCCCCccceeechhhhHHHH
Q 001360 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILFEF 907 (1092)
Q Consensus 831 FGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL---~g~~Yt~ksDVWSLGVILYEM 907 (1092)
||.|..... .+ ...+-..+. ...-...-|+.|+|||++ .+.+.+.|+|||+|||+||-|
T Consensus 190 FGSatt~~~-------~~-------~~~~e~~~v----e~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkL 251 (738)
T KOG1989|consen 190 FGSATTKIL-------SP-------TSAQEVNYV----EEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKL 251 (738)
T ss_pred ccccccccC-------CC-------ccHHHHHHH----HHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHH
Confidence 998873210 00 000000000 001123469999999987 467789999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC
Q 001360 908 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961 (1092)
Q Consensus 908 LTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpS 961 (1092)
++...||..... ..|+++.+.||.. +..+..+++||+.||+.||.+||+
T Consensus 252 Cy~t~PFe~sg~----laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPn 300 (738)
T KOG1989|consen 252 CYFTTPFEESGK----LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPN 300 (738)
T ss_pred HHhCCCcCcCcc----eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCC
Confidence 999999987643 3688999999964 578999999999999999999999
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=364.67 Aligned_cols=276 Identities=41% Similarity=0.734 Sum_probs=249.5
Q ss_pred eeccCCCeEEEEEEE---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeec
Q 001360 694 PISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYL 769 (1092)
Q Consensus 694 ~LGkGgFGtVyLar~---k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LYLVMEYm 769 (1092)
++|.|+||.|++++. .+.|..||||++++.....+... +...|..++..++ ||++|++++.|+.+..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998864 34578999999998766554444 7888999999998 999999999999999999999999
Q ss_pred CCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCC
Q 001360 770 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849 (1092)
Q Consensus 770 ~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~ 849 (1092)
.||+|+..+.+...+.+...++|.++++.|++++|+.||||||+|++||+++.+||+|+.|||+++.....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~--------- 150 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE--------- 150 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh---------
Confidence 99999999999999999999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhc
Q 001360 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929 (1092)
Q Consensus 850 t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~ 929 (1092)
...|||..|||||++. ++...+||||||+++|||++|..||.. ++...|+..
T Consensus 151 ----------------------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~ 202 (612)
T KOG0603|consen 151 ----------------------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA 202 (612)
T ss_pred ----------------------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh
Confidence 1129999999999998 788999999999999999999999988 788888888
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccc
Q 001360 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSR 1005 (1092)
Q Consensus 930 ~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~ 1005 (1092)
.+.+| ..++.++++++..++.++|.+|++. .++.+|++|+||..++|+.+..+ +|||+|....+.|+.+|+.+
T Consensus 203 ~~~~p---~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~e 279 (612)
T KOG0603|consen 203 ELEMP---RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPE 279 (612)
T ss_pred ccCCc---hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCch
Confidence 87776 7899999999999999999999995 68999999999999999988766 78999999999999999998
Q ss_pred cccCC
Q 001360 1006 FSQIS 1010 (1092)
Q Consensus 1006 fs~~~ 1010 (1092)
|+...
T Consensus 280 ft~~~ 284 (612)
T KOG0603|consen 280 FTSQV 284 (612)
T ss_pred hccCC
Confidence 87763
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=372.04 Aligned_cols=273 Identities=31% Similarity=0.483 Sum_probs=211.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------ 758 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd------ 758 (1092)
-..+|+.+..||+||||.||+|+++-+|..||||.|.-.. .......+.+|+.+|++++|||||++|.++..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4678999999999999999999999999999999887533 45567789999999999999999999864300
Q ss_pred --------------------------------------------------------------------------------
Q 001360 759 -------------------------------------------------------------------------------- 758 (1092)
Q Consensus 759 -------------------------------------------------------------------------------- 758 (1092)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeeEEEEeecCCCcHHHHHHhhcCC-CHHHHHHHHHHHHHHHHHHH
Q 001360 759 -------------------------R--------DNLYLVMEYLNGGDLYSLLRKVGCL-EEDVARIYIAELVLALEYLH 804 (1092)
Q Consensus 759 -------------------------e--------~~LYLVMEYm~GGSL~dlLkk~g~L-sE~~ar~yaaQIL~ALeYLH 804 (1092)
+ ..+||-||||+.-.|.+++...... ....++.+++||+.||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1268999999996666666554433 47788999999999999999
Q ss_pred HcCCeeeecCCCceEecCCCcEEEEecCCccccccc-ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCh
Q 001360 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN-NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAP 883 (1092)
Q Consensus 805 s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n-~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAP 883 (1092)
++|||||||||.||+||.+++|||+|||+|+....+ ..++.. .. ..............+.+||..|+||
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~-~~---------~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQD-LS---------FSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhc-cC---------ccccccCCCCcccccccceeeeecH
Confidence 999999999999999999999999999999863211 011100 00 0000111122245678999999999
Q ss_pred hhhcCCC---CCccceeechhhhHHHHHhCCCCCCC-CChHHHHHHHhhcCCCCC-CCCCCCCHHHHHHHHHhccCCcCC
Q 001360 884 EILLGTE---HGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQ 958 (1092)
Q Consensus 884 EVL~g~~---Yt~ksDVWSLGVILYEMLTGk~PF~~-~s~~ei~~kIl~~~l~fP-~ip~~lS~eakDLI~kcL~kDP~K 958 (1092)
|++.+.. |+.|+|+||||||+|||+. ||.. +....+...+..+.+++| .+...--+....+|++||..||.+
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCcc
Confidence 9998754 9999999999999999984 6754 344556666666666655 112333456778999999999999
Q ss_pred CCCcccHHHHHcCCCCC
Q 001360 959 RLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 959 RpSa~ga~EIL~HPFFk 975 (1092)
||| |.++|++.||-
T Consensus 862 RPt---A~eLL~s~llp 875 (1351)
T KOG1035|consen 862 RPT---ATELLNSELLP 875 (1351)
T ss_pred CCC---HHHHhhccCCC
Confidence 999 99999999997
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=365.87 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=214.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk-----~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd 758 (1092)
......++.+.||+|+||.||.|....... .||||.+++ ..+.++...|++|..+|+.++|||||++.+.+.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 445678899999999999999999865433 399998876 4456788999999999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEec
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKV-------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~-------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDF 831 (1092)
....+|++|||.||||..+|++. ..++......++.+|++|++||+++++|||||-..|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999876 24888999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-C
Q 001360 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 910 (1092)
Q Consensus 832 GLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-G 910 (1092)
|||+......+. ... .. ..-...|||||.+..+.++.++|||||||+|||+++ |
T Consensus 847 GlArDiy~~~yy--------------------r~~-~~----a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG 901 (1025)
T KOG1095|consen 847 GLARDIYDKDYY--------------------RKH-GE----AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLG 901 (1025)
T ss_pred chhHhhhhchhe--------------------ecc-Cc----cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCC
Confidence 999943211110 000 00 122468999999999999999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc
Q 001360 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962 (1092)
Q Consensus 911 k~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa 962 (1092)
..||.+.+..++....+.+. +++ .|..++..+.+||..||+.+|++||++
T Consensus 902 ~~PY~~~~n~~v~~~~~~gg-RL~-~P~~CP~~ly~lM~~CW~~~pe~RP~F 951 (1025)
T KOG1095|consen 902 ATPYPSRSNFEVLLDVLEGG-RLD-PPSYCPEKLYQLMLQCWKHDPEDRPSF 951 (1025)
T ss_pred CCCCCCcchHHHHHHHHhCC-ccC-CCCCCChHHHHHHHHHccCChhhCccH
Confidence 99999999999988666654 333 358999999999999999999999994
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=296.27 Aligned_cols=243 Identities=50% Similarity=0.851 Sum_probs=209.3
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHH
Q 001360 699 AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL 778 (1092)
Q Consensus 699 gFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL~dlL 778 (1092)
+||.||+|....+|+.+|+|++........ ...+.+|+.++++++|+||+++++.+......+++|||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999999999999999976443221 578899999999999999999999999999999999999999999999
Q ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCC
Q 001360 779 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858 (1092)
Q Consensus 779 kk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~ 858 (1092)
.....++...+..++.+++.+|.|||+.||+|+||+|.||+++.++.++|+|||++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~------------------- 139 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDP------------------- 139 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecc-------------------
Confidence 8766689999999999999999999999999999999999999999999999999875210
Q ss_pred CCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC-CChHHHHHHHhhcCCCCCCCC
Q 001360 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNRKIPWPCVP 937 (1092)
Q Consensus 859 ~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~-~s~~ei~~kIl~~~l~fP~ip 937 (1092)
........|++.|++||.+.+..++.++|+||||+++|+|++|..||.. .+...+.+.+.......+...
T Consensus 140 ---------~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (244)
T smart00220 140 ---------GGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPE 210 (244)
T ss_pred ---------ccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcccc
Confidence 0022345688999999999988899999999999999999999999988 666666666655544433222
Q ss_pred CCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 938 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 938 ~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
..++.++.+++.+||..+|.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~~~~~~~ 244 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLT---AEEALQHPFF 244 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccC---HHHHhhCCCC
Confidence 228899999999999999999999 8899999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=307.13 Aligned_cols=259 Identities=30% Similarity=0.533 Sum_probs=217.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
..|.-++.||+|.||+||+++.+++++.||+|.++-.+ ..+.--...++|+-+|+.++|.|||++++....+..+.+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 35667789999999999999999999999999987533 22333467899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||.. +|..+... .+.++.+.++.++.|++.||.|+|++++.||||||.|+||+.+|.+||+|||+++.+..
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi------ 153 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI------ 153 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC------
Confidence 99965 88777754 46799999999999999999999999999999999999999999999999999985310
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHh-CCCCCCCCChHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~ 923 (1092)
+.+-....+.|.+|.+|.++.+. -|+.+.|+||.|||+.|+.. |++.|.+.+..+..
T Consensus 154 ---------------------pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql 212 (292)
T KOG0662|consen 154 ---------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212 (292)
T ss_pred ---------------------ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH
Confidence 11122345789999999999874 58999999999999999987 89999999988888
Q ss_pred HHHhhc-----CCCCCC------------CC---------CCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 924 DNILNR-----KIPWPC------------VP---------SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 924 ~kIl~~-----~l~fP~------------ip---------~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.+|... .-.||. +| +.++...+||++++|..+|.+|++ |++.++||||.+.
T Consensus 213 krif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris---aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 213 KRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS---AEAALQHPYFSDF 289 (292)
T ss_pred HHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC---HHHHhcCcccccc
Confidence 887641 112222 22 345667889999999999999999 7889999999764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=346.82 Aligned_cols=264 Identities=25% Similarity=0.344 Sum_probs=184.5
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCC----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeee--
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTT----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS-- 755 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~T----Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~s-- 755 (1092)
.....++|++.+.||+|+||.||+|++..+ +..||+|.+.... ..+....|. +....+.+++.+...
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e~--l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNER--VRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHHH--HHhhchhhHHHHHHhhh
Confidence 345678999999999999999999999988 9999999876422 111112221 122222222222222
Q ss_pred ----eccCCeeEEEEeecCCCcHHHHHHhhcC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCeee
Q 001360 756 ----FTCRDNLYLVMEYLNGGDLYSLLRKVGC--------------------LEEDVARIYIAELVLALEYLHSLGIVHR 811 (1092)
Q Consensus 756 ----fqde~~LYLVMEYm~GGSL~dlLkk~g~--------------------LsE~~ar~yaaQIL~ALeYLHs~GIIHR 811 (1092)
......+|+||||+.+|+|.+++..... ..+..++.++.||+.||.|||++|||||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 2455679999999999999999875321 1234466789999999999999999999
Q ss_pred ecCCCceEecC-CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-
Q 001360 812 DLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT- 889 (1092)
Q Consensus 812 DLKPeNILLD~-nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~- 889 (1092)
||||+||||+. ++.+||+|||+|+.... .........+||+.|||||.+...
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~--------------------------~~~~~~~~~~~t~~Y~APE~~~~~~ 333 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRV--------------------------GINYIPKEFLLDPRYAAPEQYIMST 333 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCcccccc--------------------------ccccCCcccccCCCccChHHhhccC
Confidence 99999999986 68999999999974210 001122356899999999976432
Q ss_pred ---------------------CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhh-cCCCC------------CC
Q 001360 890 ---------------------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN-RKIPW------------PC 935 (1092)
Q Consensus 890 ---------------------~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~-~~l~f------------P~ 935 (1092)
.++.++|||||||+||||+++..|+.. ....+..++. ....+ +.
T Consensus 334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 411 (566)
T PLN03225 334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPD 411 (566)
T ss_pred CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchh
Confidence 244567999999999999997665432 2222222211 11100 00
Q ss_pred ------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001360 936 ------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983 (1092)
Q Consensus 936 ------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~ 983 (1092)
+....+..+++||.+||++||.+||+ +.++|+||||++..+..+.
T Consensus 412 ~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t---a~e~L~Hpff~~~~~~~~~ 462 (566)
T PLN03225 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS---AKAALAHPYFDREGLLGLS 462 (566)
T ss_pred hhhhhhhccccchHHHHHHHHHccCCcccCCC---HHHHhCCcCcCCCCccccc
Confidence 01122345679999999999999999 8899999999998876443
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.39 Aligned_cols=264 Identities=29% Similarity=0.492 Sum_probs=209.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-C
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-R 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk----~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd-e 759 (1092)
....|+.+..||+|.||.||+|..++++. .||||.++.... ...-.....+|+.+++.++|||||.|..+|.. +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 45679999999999999999997665543 799998865321 12223567889999999999999999999988 7
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC----CcEEEEe
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTD 830 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-----g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n----G~VKLsD 830 (1092)
..+||++||.+. ||...++-+ ..++...++.++.||+.|+.|||++.|+||||||.||||..+ |.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 789999999987 999988633 368999999999999999999999999999999999999877 8999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHh
Q 001360 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 909 (1092)
Q Consensus 831 FGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLT 909 (1092)
||+++... +. + .+-......|.|.+|.|||.++| ..|+.++|+||+|||+.|||+
T Consensus 180 lGlaR~~~--~p----------l------------kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 180 LGLARLFN--NP----------L------------KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred ccHHHHhh--cc----------c------------cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence 99999642 10 0 01112245788999999999998 568999999999999999999
Q ss_pred CCCCCCCCCh---------HHHHHHHhh-----cCCCCCCC---C--------------------------CCCCHHHHH
Q 001360 910 GIPPFTAESP---------EIIFDNILN-----RKIPWPCV---P--------------------------SDMSFEAQD 946 (1092)
Q Consensus 910 Gk~PF~~~s~---------~ei~~kIl~-----~~l~fP~i---p--------------------------~~lS~eakD 946 (1092)
-.|-|.+... .+...+|++ ..-.||.+ | ..-++.+.+
T Consensus 236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~ 315 (438)
T KOG0666|consen 236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALD 315 (438)
T ss_pred cCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHH
Confidence 9998876431 233444443 11123321 0 113556889
Q ss_pred HHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 947 LINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 947 LI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
|+.+||++||.+|++ +.+.++|+||...
T Consensus 316 LL~klL~yDP~kRIt---a~qAleh~yF~~d 343 (438)
T KOG0666|consen 316 LLQKLLTYDPIKRIT---AEQALEHPYFTED 343 (438)
T ss_pred HHHHHhccCchhhcc---HHHHhcccccccC
Confidence 999999999999999 8889999999754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=332.85 Aligned_cols=256 Identities=30% Similarity=0.533 Sum_probs=211.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--C----ceEEEeeeec
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--P----FVVRFFYSFT 757 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H--P----NIVkL~~sfq 757 (1092)
...+.|+++..+|+|.||+|..+.+..++..||||+++... ...+..+-|+++|.++.+ | .+|++.++|.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 34678999999999999999999999999999999998643 234556789999999842 2 5888999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-------------
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH------------- 822 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~------------- 822 (1092)
-.++.|||+|.+ |-+++++|.+.. +|+...++.+++|++.+++|||+++++|-||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999998 559999998754 6899999999999999999999999999999999999842
Q ss_pred -------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001360 823 -------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (1092)
Q Consensus 823 -------nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ks 895 (1092)
+-+|||+|||.|++. .....+.+-|..|.|||++++-+++..|
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~------------------------------~e~hs~iVsTRHYRAPEViLgLGwS~pC 290 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFD------------------------------HEHHSTIVSTRHYRAPEVILGLGWSQPC 290 (415)
T ss_pred ceeccCCCcceEEEecCCccee------------------------------ccCcceeeeccccCCchheeccCcCCcc
Confidence 336899999998852 1222567899999999999999999999
Q ss_pred eeechhhhHHHHHhCCCCCCCCChHH---HHHHHhh------------------cCCCCCCCC-----------------
Q 001360 896 DWWSVGIILFEFITGIPPFTAESPEI---IFDNILN------------------RKIPWPCVP----------------- 937 (1092)
Q Consensus 896 DVWSLGVILYEMLTGk~PF~~~s~~e---i~~kIl~------------------~~l~fP~ip----------------- 937 (1092)
||||+||||+|+.+|...|...+..+ +.++|+. +.+.||...
T Consensus 291 DvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~ 370 (415)
T KOG0671|consen 291 DVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKK 370 (415)
T ss_pred CceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHH
Confidence 99999999999999999998876544 5555543 223333210
Q ss_pred -----CCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 938 -----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 938 -----~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
..--.++.|||++||.+||.+|+| +.|+|.||||+..
T Consensus 371 ~~~~~d~e~~~LfDLl~~mL~fDP~~RiT---l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 371 YMLQDDLEHVQLFDLLRRMLEFDPARRIT---LREALSHPFFARL 412 (415)
T ss_pred HhccCcHHHhHHHHHHHHHHccCcccccc---HHHHhcCHHhhcC
Confidence 011234779999999999999999 8899999999864
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=317.50 Aligned_cols=264 Identities=26% Similarity=0.354 Sum_probs=212.9
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
..+.-+.|++.+.||.|||+-||+|+...+++.||+|.+... ..++.+..++|++..++++||||++++++...+..
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 346678999999999999999999999999999999988643 35678899999999999999999999987765544
Q ss_pred -----eEEEEeecCCCcHHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHcC--CeeeecCCCceEecCCCcEEEEe
Q 001360 762 -----LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTD 830 (1092)
Q Consensus 762 -----LYLVMEYm~GGSL~dlLkk~----g~LsE~~ar~yaaQIL~ALeYLHs~G--IIHRDLKPeNILLD~nG~VKLsD 830 (1092)
.||+++|...|+|.+.+... ..+++.++..|+.+|++||++||... ++||||||.|||+...+.++|.|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 99999999999999998643 36999999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHH
Q 001360 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEF 907 (1092)
Q Consensus 831 FGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Yt~ksDVWSLGVILYEM 907 (1092)
||.++.... .+.+ ..+-. .-+....-..|..|.|||.+.- ...+.++|||||||+||+|
T Consensus 173 ~GS~~~a~i----~i~~---------~~~a~-----~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~ 234 (302)
T KOG2345|consen 173 LGSATQAPI----QIEG---------SRQAL-----RLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAM 234 (302)
T ss_pred ccCccccce----Eeec---------hHHHH-----HHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHH
Confidence 999875321 0000 00000 0011122346889999999864 3457899999999999999
Q ss_pred HhCCCCCCCCC--hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 908 ITGIPPFTAES--PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 908 LTGk~PF~~~s--~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
+.|..||...- ...+.-.+.+.++.||.- ...|..+..||+.||++||.+||+ +.+++.
T Consensus 235 mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~---i~~ll~ 295 (302)
T KOG2345|consen 235 MFGESPFERIYQQGGSLALAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPT---IPELLS 295 (302)
T ss_pred HHcCCcchHHhhcCCeEEEeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCC---HHHHHH
Confidence 99999996321 122233455677888864 448999999999999999999999 556654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=346.49 Aligned_cols=253 Identities=34% Similarity=0.476 Sum_probs=200.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC------
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD------ 760 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~------ 760 (1092)
..+..-+.||+||||.||+++++.||+.||||.+++.. .....+...+|+++|++++|||||++++.-.+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 34567788999999999999999999999999998744 3345678889999999999999999998766654
Q ss_pred eeEEEEeecCCCcHHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC--CC--cEEEEecCC
Q 001360 761 NLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DG--HIKLTDFGL 833 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk---~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~--nG--~VKLsDFGL 833 (1092)
...+|||||+||||+..|.+ ...|++.+.+.++..++.||.|||++|||||||||.||++-. +| .-||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 36799999999999999974 346999999999999999999999999999999999999853 34 369999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeechhhhHHHHHhCCC
Q 001360 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIP 912 (1092)
Q Consensus 834 Ak~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Yt~ksDVWSLGVILYEMLTGk~ 912 (1092)
|+... +.....+.+||+.|.+||++. .+.|+..+|.|||||++|+++||..
T Consensus 171 Arel~----------------------------d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~l 222 (732)
T KOG4250|consen 171 ARELD----------------------------DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGEL 222 (732)
T ss_pred cccCC----------------------------CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCC
Confidence 99532 223456899999999999999 4889999999999999999999999
Q ss_pred CCCCCCh-----HHHHHHHhh--------------cCCC----CCCCCCCCCHHHH----HHHHHhccCCcCCCC--Cc-
Q 001360 913 PFTAESP-----EIIFDNILN--------------RKIP----WPCVPSDMSFEAQ----DLINRFLIHDPNQRL--GA- 962 (1092)
Q Consensus 913 PF~~~s~-----~ei~~kIl~--------------~~l~----fP~ip~~lS~eak----DLI~kcL~kDP~KRp--Sa- 962 (1092)
||..... +.++..+.. +.+. +|. |..++.... ..+..+|..+|.+|. +.
T Consensus 223 PF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~ 301 (732)
T KOG4250|consen 223 PFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFD 301 (732)
T ss_pred CCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcc
Confidence 9964321 233333322 1221 222 345555433 456778899999998 42
Q ss_pred ---ccHHHHHc
Q 001360 963 ---NGAAEVKA 970 (1092)
Q Consensus 963 ---~ga~EIL~ 970 (1092)
....+||+
T Consensus 302 ~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 302 RFFAEVDDILN 312 (732)
T ss_pred hHHHHHHHHHh
Confidence 33556654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=345.95 Aligned_cols=258 Identities=33% Similarity=0.542 Sum_probs=223.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc-----
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC----- 758 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqd----- 758 (1092)
..+-|++..+||.|.+|.||+++.+.+|+..|+|++.... ...+.+..|.+||+... |||++.+|++|..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 4567999999999999999999999999999999986432 34456788999998775 9999999998854
Q ss_pred CCeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
.+.+|||||||.||+..|++++. ..+.|+.+..++++++.||.+||++.+||||||-.|||++.+|.|||+|||++..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 45699999999999999999754 5799999999999999999999999999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHHHhCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGI 911 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Yt~ksDVWSLGVILYEMLTGk 911 (1092)
.. ....+..+.+|||.|||||++.- ..|+..+|+||||++..||.-|.
T Consensus 173 ld---------------------------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~ 225 (953)
T KOG0587|consen 173 LD---------------------------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGA 225 (953)
T ss_pred ee---------------------------cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCC
Confidence 21 12445678999999999999853 35788999999999999999999
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 912 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 912 ~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
||+.+..+....-.|-....+-..-|...+.++.|||..||.+|-.+||+ ..+++.|||.+.
T Consensus 226 PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~---~~~ll~hpFi~e 287 (953)
T KOG0587|consen 226 PPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS---TEELLKHPFITE 287 (953)
T ss_pred CCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcc---hhhhccCCcccc
Confidence 99999998877777765544333335778999999999999999999999 889999999974
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=327.42 Aligned_cols=267 Identities=29% Similarity=0.467 Sum_probs=218.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccc----ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD----MIRKNDIERILAERNILITVRNPFVVRFFYSFTCR- 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~e----i~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde- 759 (1092)
-.+.|-++..||+|||++||++.+....++||+|+-.-.. ..+.+..++..+|.+|.+.++||.||++|++|.-+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3467888999999999999999999999999999864322 22344567889999999999999999999999754
Q ss_pred CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc--CCeeeecCCCceEecC---CCcEEEEecCCc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--GIVHRDLKPDNLLIAH---DGHIKLTDFGLS 834 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~--GIIHRDLKPeNILLD~---nG~VKLsDFGLA 834 (1092)
+.+|-|+|||+|.||..||+.+..+++.+++.++.||+.||.||... -|||-||||.||||-. .|.|||+||||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 56899999999999999999999999999999999999999999977 5999999999999954 578999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC----CCCccceeechhhhHHHHHhC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITG 910 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~----~Yt~ksDVWSLGVILYEMLTG 910 (1092)
++...... + . ......+....||.+|++||.|.-. ..+.++||||+|||+|.+|+|
T Consensus 621 KIMdddSy-~----~---------------vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYG 680 (775)
T KOG1151|consen 621 KIMDDDSY-N----S---------------VDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYG 680 (775)
T ss_pred hhccCCcc-C----c---------------ccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhcc
Confidence 97432111 0 0 0112344567899999999988633 357899999999999999999
Q ss_pred CCCCCCCCh-HHHH--HHHhh-cCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 911 IPPFTAESP-EIIF--DNILN-RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 911 k~PF~~~s~-~ei~--~kIl~-~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
+.||..... .++. ..|++ ..+.||. .+.++.++++||++||++--+.|.. +.++..||||.
T Consensus 681 rKPFGhnqsQQdILqeNTIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~D---V~qLA~dpyll 745 (775)
T KOG1151|consen 681 RKPFGHNQSQQDILQENTILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRID---VQQLACDPYLL 745 (775)
T ss_pred CCCCCCchhHHHHHhhhchhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhh---HHHHccCcccc
Confidence 999976543 2332 22333 3556764 3578999999999999999999987 88999999995
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.25 Aligned_cols=260 Identities=27% Similarity=0.457 Sum_probs=212.3
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCceEEEeeeeccCCe
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~-L~HPNIVkL~~sfqde~~ 761 (1092)
....++.+-+..||.|+||+|++-.++.+|+..|||.++.... ..+..+++.|.+...+ -++||||++|+..-.+..
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 4566778888899999999999999999999999999986543 4556778888876555 469999999999999999
Q ss_pred eEEEEeecCCCcHHHHHH-----hhcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcEEEEecCCcc
Q 001360 762 LYLVMEYLNGGDLYSLLR-----KVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLk-----k~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 835 (1092)
.||.||+|.- +|..+-+ +...++|...-.+....+.||+||-. ..||||||||+|||||..|.|||||||+|-
T Consensus 138 cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 138 CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence 9999999964 5543322 34579999999999999999999985 589999999999999999999999999986
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc--CCCCCccceeechhhhHHHHHhCCCC
Q 001360 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--GTEHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 836 ~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~--g~~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
.... ......-+|-..|||||-+. +.+|+.++|+||||++|||+.||+.|
T Consensus 217 qLv~----------------------------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fP 268 (361)
T KOG1006|consen 217 QLVD----------------------------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFP 268 (361)
T ss_pred hHHH----------------------------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCC
Confidence 4210 11122346889999999986 35799999999999999999999999
Q ss_pred CCCCCh-HHHHHHHhhcCCCCCCCCC---CCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 914 FTAESP-EIIFDNILNRKIPWPCVPS---DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 914 F~~~s~-~ei~~kIl~~~l~fP~ip~---~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
|..-+. .+....++.+..+.-..+. ..+..+..+|.-||.+|-..||. ..+++.+||++.
T Consensus 269 yr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpk---y~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 269 YRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPK---YDDLKKFPFYRM 332 (361)
T ss_pred cchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcc---hhhhhcCchhhh
Confidence 987543 4455556666654433333 38899999999999999999999 679999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=327.88 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=193.0
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEEC----------------CCCcEEEEEEeecccccc-----------hhHHHHH
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKR----------------TTGDLFAIKVLKKLDMIR-----------KNDIERI 734 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k----------------~TGk~VAIKvLkK~ei~k-----------k~~ie~~ 734 (1092)
.+...++|++.+.||+|+||+||+|... ..++.||||.++...... ....+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 3467889999999999999999999752 235689999886422110 0011233
Q ss_pred HHHHHHHHhcCCCce-----EEEeeeecc--------CCeeEEEEeecCCCcHHHHHHhh--------------------
Q 001360 735 LAERNILITVRNPFV-----VRFFYSFTC--------RDNLYLVMEYLNGGDLYSLLRKV-------------------- 781 (1092)
Q Consensus 735 l~EieIL~~L~HPNI-----VkL~~sfqd--------e~~LYLVMEYm~GGSL~dlLkk~-------------------- 781 (1092)
..|+.++.+++|.++ ++++++|.. ....||||||+++|+|.+++...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 457777777776554 556665543 34689999999999999998642
Q ss_pred ----cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCC
Q 001360 782 ----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857 (1092)
Q Consensus 782 ----g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~ 857 (1092)
..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~----------------- 362 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG----------------- 362 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccC-----------------
Confidence 12356678889999999999999999999999999999999999999999998642100
Q ss_pred CCCCcccccCcCCccCccCCCCCCChhhhcCCC--------------------CC--ccceeechhhhHHHHHhCCC-CC
Q 001360 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--------------------HG--YAADWWSVGIILFEFITGIP-PF 914 (1092)
Q Consensus 858 ~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~--------------------Yt--~ksDVWSLGVILYEMLTGk~-PF 914 (1092)
.........+|+.|+|||++.... |+ .+.|+||+||++|+|++|.. ||
T Consensus 363 ---------~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 363 ---------INFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred ---------CccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 000111234589999999986432 22 24799999999999999875 77
Q ss_pred CCCC-----------hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCc---CCCCCcccHHHHHcCCCCCC
Q 001360 915 TAES-----------PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP---NQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 915 ~~~s-----------~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP---~KRpSa~ga~EIL~HPFFkg 976 (1092)
.... ....++.+....+.++. ...+++.++|||.+||.++| .+|+| +.++|+||||..
T Consensus 434 ~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~-~d~~s~~~~dLi~~LL~~~~~~~~~RlS---a~eaL~Hp~f~~ 505 (507)
T PLN03224 434 ANIRLFNTELRQYDNDLNRWRMYKGQKYDFSL-LDRNKEAGWDLACKLITKRDQANRGRLS---VGQALSHRFFLP 505 (507)
T ss_pred cchhhhhhHHhhccchHHHHHhhcccCCCccc-ccccChHHHHHHHHHhccCCCCcccCCC---HHHHhCCCCcCC
Confidence 5421 11223333334555552 35689999999999999876 68999 889999999953
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=316.76 Aligned_cols=263 Identities=31% Similarity=0.447 Sum_probs=211.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC------
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------ 759 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde------ 759 (1092)
.+.|+-+..||+|.||+||+|+.+.+|+.||+|++--. -.+...-...++|+++|..++|+|++.++..|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme-neKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME-NEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh-ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 45677788999999999999999999999999854211 11222334578999999999999999998776543
Q ss_pred --CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 760 --DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 760 --~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
..+|+||.+|+. ||.-+|.+. ..|+...++.++.++..||.|+|.+.|+|||+||.|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 348999999987 999999766 6799999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
+.... ..........+.|.+|.+||.++| ..|+.+.|+|..||||.||.+|.+-|.
T Consensus 174 fs~~~-----------------------n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 174 FSTSK-----------------------NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred eeccc-----------------------ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 42110 001112345688999999999987 579999999999999999999999999
Q ss_pred CCChHHHHHHHhh--c---CCCCCCC---------------------------CCCCCHHHHHHHHHhccCCcCCCCCcc
Q 001360 916 AESPEIIFDNILN--R---KIPWPCV---------------------------PSDMSFEAQDLINRFLIHDPNQRLGAN 963 (1092)
Q Consensus 916 ~~s~~ei~~kIl~--~---~l~fP~i---------------------------p~~lS~eakDLI~kcL~kDP~KRpSa~ 963 (1092)
+.+.......|.. + +-.||.. |-.-.+++.||+.+||..||.+|+.
T Consensus 231 gnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~-- 308 (376)
T KOG0669|consen 231 GNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID-- 308 (376)
T ss_pred CChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc--
Confidence 9887766555532 1 1122220 1123568999999999999999999
Q ss_pred cHHHHHcCCCCCC
Q 001360 964 GAAEVKAHPFFKG 976 (1092)
Q Consensus 964 ga~EIL~HPFFkg 976 (1092)
+.++++|.||..
T Consensus 309 -ad~alnh~~F~k 320 (376)
T KOG0669|consen 309 -ADQALNHDFFWK 320 (376)
T ss_pred -hHhhhchhhhhc
Confidence 789999999953
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=328.90 Aligned_cols=258 Identities=22% Similarity=0.360 Sum_probs=220.5
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.+|++.-.+..+...||.|.||.||.|.|+.-.-.||||.++... ..++.|+.|..+|+.++|||+|+|+++|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 677788888999999999999999999999989999999997644 3678899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
..+|||+|||..|+|.+||++.. .++.-....++.||..||+||..+++|||||-..|+|+.++..|||+||||++++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999998764 3666666777779999999999999999999999999999999999999999974
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~ 916 (1092)
..+.++ ++ ....-...|.|||-|....++.++|||+|||+|||+.| |..||.+
T Consensus 416 tgDTYT--------------AH------------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 416 TGDTYT--------------AH------------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred cCCcee--------------cc------------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 221110 00 01123567999999999999999999999999999998 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.+..++|..+-+ .+.+. -|..+++.+..||+.||+++|..||++.++-+.+
T Consensus 470 idlSqVY~LLEk-gyRM~-~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqaf 520 (1157)
T KOG4278|consen 470 IDLSQVYGLLEK-GYRMD-GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAF 520 (1157)
T ss_pred ccHHHHHHHHhc-ccccc-CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHH
Confidence 999998876544 44443 3689999999999999999999999954443333
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=348.54 Aligned_cols=270 Identities=51% Similarity=0.865 Sum_probs=230.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|+.++.|..|+||-||+++++.+.+.+|+| ++|..++-++ ||.....|++|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn----------ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN----------ILTFAGNPFVV------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc----------cccccCCccee-------------
Confidence 45679999999999999999999999999999995 4443322111 55566677777
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||=.++++..+.++.+. +.|++|||+.||+|||+||+|.||..-||+|++|||+++.+.+..+.
T Consensus 136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 67788888878777554 88999999999999999999999999999999999999987654332
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
.+.. + ++.. ....-.....||||.|+||||+..++|+..+|||++|+|+||.+.|..||.++++++++
T Consensus 200 nl~e----g------~I~k--~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf 267 (1205)
T KOG0606|consen 200 NLKE----G------HIEK--DTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 267 (1205)
T ss_pred hhhh----c------chHH--HHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH
Confidence 1111 1 1100 11122334579999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCCccccc
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFL 1003 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~Dts~Fd 1003 (1092)
..++...+.||.-...++++++++|.+||..+|..|++..++.++++|+||+.+||..|..+++.|+|...+.+|++||+
T Consensus 268 g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfd 347 (1205)
T KOG0606|consen 268 GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFD 347 (1205)
T ss_pred hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccccchhhc
Confidence 99999999999877789999999999999999999999889999999999999999999999999999999999999999
Q ss_pred cc
Q 001360 1004 SR 1005 (1092)
Q Consensus 1004 s~ 1005 (1092)
.+
T Consensus 348 TR 349 (1205)
T KOG0606|consen 348 TR 349 (1205)
T ss_pred cc
Confidence 75
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=334.76 Aligned_cols=254 Identities=25% Similarity=0.346 Sum_probs=220.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk---~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
++..+...+-++||.|.||+|+.|+.+..|+ .||||.++.. ..+.+...|+.|..||-+++||||++|-++....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 4566778999999999999999999987774 7999999753 3456778899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
..+.||+|||++|+|..+|+++ +.|+..+..-+++.|+.||.||-++|+|||||-..|||++.+-.+|++||||+++..
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999999999865 579999999999999999999999999999999999999999999999999999642
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCcc---CCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV---GTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~v---GTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF 914 (1092)
. . ....++.. -...|.|||.+...+++.++||||+|++|||.++ |..||
T Consensus 783 d-d--------------------------~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 783 D-D--------------------------PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred c-C--------------------------CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 1 1 01111222 2478999999999999999999999999999776 99999
Q ss_pred CCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 915 ~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
.+.+.++.++.|..+ +.+|. |.++|..+..|+..||++|-.+||.+.++..
T Consensus 836 WdmSNQdVIkaIe~g-yRLPp-PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 836 WDMSNQDVIKAIEQG-YRLPP-PMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred cccchHHHHHHHHhc-cCCCC-CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 999999999888654 45553 6899999999999999999999999554433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=321.90 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=210.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
..-+...+.+.||+|-||+|.+|.... +..||+|+++... ..+....|..|+.+|.+++|||||.|+++|..++.++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 445667888999999999999998753 6899999998643 3455688999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+|||||++|+|.+++.++. .+.......++.||+.||+||.+.++|||||.+.|+|+|.++++||+|||+++-.....
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999999998873 33455566699999999999999999999999999999999999999999998432111
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh--CCCCCCCCCh
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAESP 919 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT--Gk~PF~~~s~ 919 (1092)
+. ......+-...|||||.+.-++++.++|+|+||++||||++ ...||...+.
T Consensus 692 yy-------------------------~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 692 YY-------------------------RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred ce-------------------------eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 10 11123456789999999999999999999999999999865 7899998888
Q ss_pred HHHHHHHhh-----cCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 920 EIIFDNILN-----RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 920 ~ei~~kIl~-----~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
++..++.-. +.-.++..|.-++..+..||.+||.+|..+||+++.
T Consensus 747 e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~ 796 (807)
T KOG1094|consen 747 EQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQ 796 (807)
T ss_pred HHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHH
Confidence 777766432 122234456789999999999999999999999543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=346.16 Aligned_cols=241 Identities=23% Similarity=0.322 Sum_probs=186.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
..|.....||+|+||.||+|+.+.+|..||+|.++..... ...|+.++.+++|||||++++++.+.+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3466677899999999999999999999999988653321 124578899999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH---SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLH---s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||+++|+|.++++. +++..+..++.|++.||.||| +.+|+||||||+|||++.++..++. ||......
T Consensus 763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~----- 833 (968)
T PLN00113 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC----- 833 (968)
T ss_pred eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-----
Confidence 99999999999964 888999999999999999999 6699999999999999999888876 66543210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh----
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP---- 919 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~---- 919 (1092)
......||+.|||||++.+..|+.++|||||||++|||++|+.||.....
T Consensus 834 --------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~ 887 (968)
T PLN00113 834 --------------------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS 887 (968)
T ss_pred --------------------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCc
Confidence 01123689999999999999999999999999999999999999954321
Q ss_pred -HHHHHHHhhc-CC---CCCCC------CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 920 -EIIFDNILNR-KI---PWPCV------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 920 -~ei~~kIl~~-~l---~fP~i------p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.+..+..... .. .-|.+ +.....++.+++.+||..||++||++.++.+.+
T Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 948 (968)
T PLN00113 888 IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948 (968)
T ss_pred HHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence 1111111100 00 00111 111223577899999999999999955444433
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=321.61 Aligned_cols=256 Identities=32% Similarity=0.525 Sum_probs=213.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC------CCceEEEeeeec
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR------NPFVVRFFYSFT 757 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~------HPNIVkL~~sfq 757 (1092)
.--+.|.+....|+|-|++|..|.+..-|..||||+|+..+++.+ .=+.|++||++|+ --++++||-.|.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K----tGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK----TGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh----hhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 345689999999999999999999999999999999998665433 3467999999996 248999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC-cEEEEecCC
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGL 833 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~g---~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGL 833 (1092)
..+++|||+|-+. -+|..+|++.| .|....++.|+.|+..||..|-+.||+|.||||+|||+++.. .+||||||.
T Consensus 505 hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 9999999999985 49999999876 478889999999999999999999999999999999999754 689999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCC
Q 001360 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 834 Ak~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
|.....+. ...+..+..|.|||+++|.+|++..|+||+||+||||.||+..
T Consensus 584 A~~~~ene-----------------------------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 584 ASFASENE-----------------------------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred cccccccc-----------------------------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence 87542211 1223456789999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCC--------------------------------------C-C-----------------
Q 001360 914 FTAESPEIIFDNILNRKIPWPC--------------------------------------V-P----------------- 937 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~~~l~fP~--------------------------------------i-p----------------- 937 (1092)
|.+.+...|.+..+.-+-+||. + |
T Consensus 635 FpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~de 714 (752)
T KOG0670|consen 635 FPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDE 714 (752)
T ss_pred cCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCch
Confidence 9999887777655543333332 0 0
Q ss_pred -CCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 938 -SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 938 -~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
..+-..+++|+.+||..||++|++ +.+.|.||||.+
T Consensus 715 q~~~~~~~rdLLdkml~LdP~KRit---~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 715 QPKIVQQLRDLLDKMLILDPEKRIT---VNQALKHPFITE 751 (752)
T ss_pred hHHHHHHHHHHHHHHhccChhhcCC---HHHHhcCCcccC
Confidence 011235789999999999999999 778899999964
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=321.57 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=214.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCC-c--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTG-D--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TG-k--~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
+..++..+++.||.|.||.|++|.|+..+ + .||||+++..... .....|++|+.+|.+++|||+++||+...+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 55667788899999999999999997543 3 6999999864432 267889999999999999999999999888 7
Q ss_pred eeEEEEeecCCCcHHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk--~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+.||||+++.|+|.+.|++ .+.|.......|+.||+.||.||..+++|||||-..||||-....|||+||||.+.+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 78899999999999999987 3568889999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
.+. ..| . ......-...|.|||.|....++.++|+|++||+||||++ |..||.+.
T Consensus 264 ~ne----------------d~Y---v-----m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 264 ENE----------------DMY---V-----MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred CCC----------------cce---E-----ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence 211 010 0 1111224568999999999999999999999999999998 89999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
...++.++|-.+ -.+| -|..++.++.+++.+||..+|++||++..+
T Consensus 320 ~g~qIL~~iD~~-erLp-RPk~csedIY~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 320 RGIQILKNIDAG-ERLP-RPKYCSEDIYQIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred CHHHHHHhcccc-ccCC-CCCCChHHHHHHHHHhccCCccccccHHHH
Confidence 999999998743 3333 258999999999999999999999995543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=316.70 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=207.3
Q ss_pred CeEEEEeeccCCCeEEEEEEECCC----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTT----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~T----Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...+.+.||.|-||.||.|....- .-.||||..++.. ..+..+.|+.|.-+|+.++|||||+|+|.+.+. ..|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 345567899999999999987432 3369999887643 334578899999999999999999999998765 589
Q ss_pred EEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||||+++-|.|..||+.. ..++......|+.||+.||.|||+..+|||||-..|||+.+.--|||+||||++......+
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 999999999999999854 5789999999999999999999999999999999999999999999999999986421111
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~e 921 (1092)
..+....-..-|||||.++-..++.++|||-|||+|||+|. |..||.+....+
T Consensus 547 --------------------------YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 547 --------------------------YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred --------------------------hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 11112233568999999999999999999999999999987 999999988888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHH
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~ 966 (1092)
..-.|-++. +.| .|+.+++.+..|+.+||.+||.+||.+.++.
T Consensus 601 VI~~iEnGe-RlP-~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 601 VIGHIENGE-RLP-CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred eEEEecCCC-CCC-CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 877776653 223 3589999999999999999999999964433
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=300.01 Aligned_cols=255 Identities=29% Similarity=0.469 Sum_probs=210.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~---- 760 (1092)
....|.-++.+|.|+- .|..+-+.-+++.||+|.+... ........+..+|..++..+.|+||++++.+|.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 3457888899999998 7888888888999999988664 444555678899999999999999999999997665
Q ss_pred --eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 --~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
..|+|||||.. +|...+. -.++....++++.|+++|+.|||+.||+||||||+||++..++.+||.|||+|+...
T Consensus 93 ~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 93 FQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 47999999965 8888876 347888899999999999999999999999999999999999999999999997310
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
..-.....+.|..|.|||++.+.+|...+||||+|||+.||++|..-|.+.+
T Consensus 170 ----------------------------~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 170 ----------------------------TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD 221 (369)
T ss_pred ----------------------------cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch
Confidence 0112345789999999999999999999999999999999999999999887
Q ss_pred hHHHHHHHhhc---------------------------CCC----CCC--C------CCCCCHHHHHHHHHhccCCcCCC
Q 001360 919 PEIIFDNILNR---------------------------KIP----WPC--V------PSDMSFEAQDLINRFLIHDPNQR 959 (1092)
Q Consensus 919 ~~ei~~kIl~~---------------------------~l~----fP~--i------p~~lS~eakDLI~kcL~kDP~KR 959 (1092)
..+.+.+|... ... ||. + +..-+..++||+.+||..||++|
T Consensus 222 ~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~R 301 (369)
T KOG0665|consen 222 HIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKR 301 (369)
T ss_pred HHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhc
Confidence 66655555320 001 111 0 11224568999999999999999
Q ss_pred CCcccHHHHHcCCCCC
Q 001360 960 LGANGAAEVKAHPFFK 975 (1092)
Q Consensus 960 pSa~ga~EIL~HPFFk 975 (1092)
++ +.++|.||||+
T Consensus 302 is---v~daL~HPY~~ 314 (369)
T KOG0665|consen 302 IS---VDDALRHPYIK 314 (369)
T ss_pred cc---HHHHhcCCeee
Confidence 99 88999999998
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=325.43 Aligned_cols=245 Identities=32% Similarity=0.437 Sum_probs=197.1
Q ss_pred EEeeccCCCeE-EEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeec
Q 001360 692 IKPISRGAFGR-VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYL 769 (1092)
Q Consensus 692 lr~LGkGgFGt-VyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LYLVMEYm 769 (1092)
-+++|.|+-|+ ||+|... |+.||||.+-. .....+.+|+..|+..+ |||||++|+.-++...+||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35789999985 7999875 88999996632 34456789999999886 999999999999999999999999
Q ss_pred CCCcHHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC---CC--cEEEEecCCccccccc
Q 001360 770 NGGDLYSLLRKVGC----LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DG--HIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 770 ~GGSL~dlLkk~g~----LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~---nG--~VKLsDFGLAk~~~~n 840 (1092)
.. +|.+++...+. ......+..+.|++.||++||+.+||||||||.||||+. +| .++|+|||+|+....+
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 76 99999987411 111345778999999999999999999999999999986 34 6899999999863211
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC-CCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG-IPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTG-k~PF~~~s~ 919 (1092)
.+ .-....+..||-+|+|||++....-..++|||||||++|+.++| ..||...-.
T Consensus 665 ~s------------------------S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~ 720 (903)
T KOG1027|consen 665 KS------------------------SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE 720 (903)
T ss_pred cc------------------------hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH
Confidence 10 01124567899999999999998888899999999999999995 999976533
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
. --+|+++....-.+......++.|||.+||..||..||+ |.++|.||||
T Consensus 721 R--~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPs---a~~VL~HPlF 770 (903)
T KOG1027|consen 721 R--QANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPS---ATDVLNHPLF 770 (903)
T ss_pred h--hhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCC---HHHHhCCCcc
Confidence 2 235666655443333333339999999999999999999 8899999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=288.80 Aligned_cols=254 Identities=33% Similarity=0.551 Sum_probs=207.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC--
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD-- 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~-- 760 (1092)
-..++|++.+.+|+|-|++||.|....+++.++||+++.. ..+.+.+|+.||..+. ||||++|++...+..
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 3678999999999999999999999999999999999753 3466899999999998 999999999988765
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC-CcEEEEecCCcccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n-G~VKLsDFGLAk~~~~ 839 (1092)
...||+||+.+.|...+- ..|+...+++|+.|++.||.|+|++||+|||+||.|++||.. -.++|+|+|||.+-.
T Consensus 109 tpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH- 184 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH- 184 (338)
T ss_pred CchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC-
Confidence 478999999997776554 458889999999999999999999999999999999999964 479999999998632
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCC-CC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT-AE 917 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~-~~ 917 (1092)
++....-.+.+..|--||.+.. +.|+++-|+|||||++..|+..+.||. +.
T Consensus 185 ---------------------------p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 185 ---------------------------PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred ---------------------------CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 1233345677888999999875 678999999999999999999998874 44
Q ss_pred ChHHHHHHHhh-------------cCC----------------CCCC-----CCCCCCHHHHHHHHHhccCCcCCCCCcc
Q 001360 918 SPEIIFDNILN-------------RKI----------------PWPC-----VPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (1092)
Q Consensus 918 s~~ei~~kIl~-------------~~l----------------~fP~-----ip~~lS~eakDLI~kcL~kDP~KRpSa~ 963 (1092)
+..+..-+|.. -.+ +|.. -..-.++++.||+.++|.+|..+|||
T Consensus 238 dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT-- 315 (338)
T KOG0668|consen 238 DNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT-- 315 (338)
T ss_pred CCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc--
Confidence 43332222211 111 1110 11235799999999999999999999
Q ss_pred cHHHHHcCCCCCCC
Q 001360 964 GAAEVKAHPFFKGV 977 (1092)
Q Consensus 964 ga~EIL~HPFFkgI 977 (1092)
|.|.+.||||..+
T Consensus 316 -akEam~HpyF~~~ 328 (338)
T KOG0668|consen 316 -AKEAMAHPYFAPV 328 (338)
T ss_pred -hHHHhcCchHHHH
Confidence 8899999999754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=319.91 Aligned_cols=261 Identities=31% Similarity=0.506 Sum_probs=226.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
-..++|+++..+|.|+||.||+++++.+++..|+|+++-. -.....-+..|+-+++.++|||||.+|+.|.-.+.+|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 3457999999999999999999999999999999999742 2345667788999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
++||||.||+|.+.-+-.+++++.++.+++++.+.||+|||+.|-+|||||-.|||+++.|.+||+|||.+....
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit----- 163 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT----- 163 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh-----
Confidence 999999999999998888999999999999999999999999999999999999999999999999999875310
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh---cCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL---~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.--.+..++.|||.|||||+. ...+|+..||+|++|+...|+---++|-....+.
T Consensus 164 ----------------------ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 164 ----------------------ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred ----------------------hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 012334578999999999986 3578999999999999999999989998777777
Q ss_pred HHHHHHhhcCCCCCCC--CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 921 IIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~i--p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.....+.+..+.-|.. +...++.+.+|++.+|.++|++||+ ++.+|.|||....
T Consensus 222 r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpt---aeklL~h~fvs~~ 277 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPT---AEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCC---hhhheeceeeccc
Confidence 6666555555443432 3568899999999999999999999 7788999999754
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=300.30 Aligned_cols=263 Identities=27% Similarity=0.404 Sum_probs=201.3
Q ss_pred cCCCCCCCCCCCccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH--hcC
Q 001360 668 QSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--TVR 745 (1092)
Q Consensus 668 ~ssg~~tp~~ss~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~--~L~ 745 (1092)
..+|...|+ ...+....+..+.+.||+|.||+||+|+|+ |+.||||++... +.....+|.+|-+ .++
T Consensus 195 SGSGSGlpl---LVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLR 263 (513)
T KOG2052|consen 195 SGSGSGLPL---LVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLR 263 (513)
T ss_pred CCCCCCchh---HhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhc
Confidence 344444554 455677889999999999999999999998 899999998653 3456777887775 469
Q ss_pred CCceEEEeeeeccCC----eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeeec
Q 001360 746 NPFVVRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDL 813 (1092)
Q Consensus 746 HPNIVkL~~sfqde~----~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~--------GIIHRDL 813 (1092)
|+||+.++++-..+. .+|||++|.+.|+|+|||.+ ..++.+....++..++.||+|||.. .|.||||
T Consensus 264 HENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl 342 (513)
T KOG2052|consen 264 HENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL 342 (513)
T ss_pred cchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence 999999987765443 49999999999999999987 6788899999999999999999964 4999999
Q ss_pred CCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC--
Q 001360 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-- 891 (1092)
Q Consensus 814 KPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-- 891 (1092)
|..|||+.++|.+-|+|+|||....... + .-....+..|||-.|||||+|...-.
T Consensus 343 KSKNILVKkn~~C~IADLGLAv~h~~~t---------~--------------~idi~~N~rVGTKRYMAPEvLdetin~~ 399 (513)
T KOG2052|consen 343 KSKNILVKKNGTCCIADLGLAVRHDSDT---------D--------------TIDIPPNPRVGTKRYMAPEVLDETINMK 399 (513)
T ss_pred ccccEEEccCCcEEEeeceeeEEecccC---------C--------------cccCCCCCccceeeccChHHhhhhcChh
Confidence 9999999999999999999997432110 0 01123456799999999999965321
Q ss_pred ----CccceeechhhhHHHHHhC----------CCCCCCCC-----hHHHHHHHhhcCCCCCCCCCCCC-H----HHHHH
Q 001360 892 ----GYAADWWSVGIILFEFITG----------IPPFTAES-----PEIIFDNILNRKIPWPCVPSDMS-F----EAQDL 947 (1092)
Q Consensus 892 ----t~ksDVWSLGVILYEMLTG----------k~PF~~~s-----~~ei~~kIl~~~l~fP~ip~~lS-~----eakDL 947 (1092)
-..+||||||.+|||++.. .+||++.. .+++.+-+.-.++. |.+|.... . .+..|
T Consensus 400 ~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~R-P~ipnrW~s~~~l~~m~kl 478 (513)
T KOG2052|consen 400 HFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLR-PNIPNRWKSDPALRVMAKL 478 (513)
T ss_pred hhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccC-CCCCcccccCHHHHHHHHH
Confidence 2468999999999999763 47887532 34444444444433 44444332 2 35578
Q ss_pred HHHhccCCcCCCCCcccHHHHH
Q 001360 948 INRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 948 I~kcL~kDP~KRpSa~ga~EIL 969 (1092)
|+.||..||.-|++ |..|+
T Consensus 479 MkeCW~~Np~aRlt---ALriK 497 (513)
T KOG2052|consen 479 MKECWYANPAARLT---ALRIK 497 (513)
T ss_pred HHHhhcCCchhhhH---HHHHH
Confidence 99999999999999 54444
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=295.18 Aligned_cols=261 Identities=30% Similarity=0.504 Sum_probs=214.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~----- 760 (1092)
..+.+.-+.||.|+||.||-+.+..+|+.||+|.+... ..+-...+++.+|..+|.-++|.||+...+..+...
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 34566678999999999999999999999999987642 223334678999999999999999999888777654
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|+|+|+|.. ||...+.....++.+.++-+++||++||+|||+.||.||||||.|+|+++|..+|||||||++.-
T Consensus 131 EiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARve--- 206 (449)
T KOG0664|consen 131 ELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTW--- 206 (449)
T ss_pred HHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccccc---
Confidence 47899999976 99998888888999999999999999999999999999999999999999999999999999852
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
..........-+.|..|.|||+++| ..|+..+||||+|||+.|+|-.+..|...++
T Consensus 207 -----------------------e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 207 -----------------------DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred -----------------------chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 1122333344678999999999998 5689999999999999999999999998887
Q ss_pred HHHHHHHhh-----------------------cCCCCCCC--------CCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 920 EIIFDNILN-----------------------RKIPWPCV--------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 920 ~ei~~kIl~-----------------------~~l~fP~i--------p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
.+..+.|.. +...-|.+ +..-..++.+++..+|..||++|++ ..+.
T Consensus 264 iqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris---~~~A 340 (449)
T KOG0664|consen 264 IEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS---VEEA 340 (449)
T ss_pred HHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc---Hhhh
Confidence 666555532 22222322 2234567889999999999999998 7788
Q ss_pred HcCCCCCCC
Q 001360 969 KAHPFFKGV 977 (1092)
Q Consensus 969 L~HPFFkgI 977 (1092)
+.|++....
T Consensus 341 ~~~~~~~e~ 349 (449)
T KOG0664|consen 341 LQHRYLEEG 349 (449)
T ss_pred ccccccccc
Confidence 999998654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=311.03 Aligned_cols=259 Identities=28% Similarity=0.413 Sum_probs=212.1
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEE
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRF 752 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~-------TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL 752 (1092)
.+.+..++..+.+.||.|+||.|++|..+. ....||||.++.... ..+.+.+..|+.+|+.+. |||||.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 455666677788899999999999997431 145799999876443 267788999999999985 9999999
Q ss_pred eeeeccCCeeEEEEeecCCCcHHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCC
Q 001360 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816 (1092)
Q Consensus 753 ~~sfqde~~LYLVMEYm~GGSL~dlLkk~g----------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPe 816 (1092)
.+++.....+++|+||+..|+|..+|+..+ .++......++.||+.|++||++..+|||||-..
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998765 4888899999999999999999999999999999
Q ss_pred ceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccC--CCCCCChhhhcCCCCCcc
Q 001360 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG--TPDYLAPEILLGTEHGYA 894 (1092)
Q Consensus 817 NILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vG--Tp~YmAPEVL~g~~Yt~k 894 (1092)
||||..+..+||+|||||+....... .......| ...|||||.+....|+.+
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~--------------------------y~~~~~~~~LP~kWmApEsl~~~~ft~k 501 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDY--------------------------YRTKSSAGTLPVKWMAPESLFDRVFTSK 501 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCc--------------------------eEecCCCCccceeecCHHHhccCccccc
Confidence 99999999999999999984211000 00011122 234999999999999999
Q ss_pred ceeechhhhHHHHHh-CCCCCCCCC-hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 895 ADWWSVGIILFEFIT-GIPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 895 sDVWSLGVILYEMLT-Gk~PF~~~s-~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+||||+||+||||++ |..||.+.. ..++++.+..+. .. ..|..+++++.++++.||..+|++||++.+..+.+
T Consensus 502 SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~-r~-~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 502 SDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGN-RM-EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred chhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCC-CC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 999999999999999 999999866 667776555443 22 23578899999999999999999999965554433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=308.04 Aligned_cols=206 Identities=29% Similarity=0.525 Sum_probs=183.5
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchh-----HHHHHHHHHHHHHhcC---CCceEEEe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-----DIERILAERNILITVR---NPFVVRFF 753 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~-----~ie~~l~EieIL~~L~---HPNIVkL~ 753 (1092)
......+|..++.+|.|+||.|++|.++.+...|+||.|.|.++.... ..-.+-.|+.||..++ |+||++++
T Consensus 556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 345677899999999999999999999999999999999987654322 2234667999999998 99999999
Q ss_pred eeeccCCeeEEEEeec-CCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecC
Q 001360 754 YSFTCRDNLYLVMEYL-NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832 (1092)
Q Consensus 754 ~sfqde~~LYLVMEYm-~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFG 832 (1092)
++|++++++||+||-. +|-||++++..+..++|.+++.+++|++.|+++||+.||||||||-+|+.++.+|-+||+|||
T Consensus 636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred heeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 9999999999999975 467999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCC
Q 001360 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 911 (1092)
Q Consensus 833 LAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk 911 (1092)
.|... ....-..++||.+|.|||++.|.+| +..-|||+||++||.++...
T Consensus 716 saa~~-----------------------------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyke 766 (772)
T KOG1152|consen 716 SAAYT-----------------------------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKE 766 (772)
T ss_pred chhhh-----------------------------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEecc
Confidence 88642 1223356899999999999999988 78899999999999999999
Q ss_pred CCCCC
Q 001360 912 PPFTA 916 (1092)
Q Consensus 912 ~PF~~ 916 (1092)
.||++
T Consensus 767 npyyn 771 (772)
T KOG1152|consen 767 NPYYN 771 (772)
T ss_pred CCCcC
Confidence 99975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=246.17 Aligned_cols=212 Identities=44% Similarity=0.742 Sum_probs=185.6
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001360 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1092)
Q Consensus 695 LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL 774 (1092)
||.|++|.||+++...+|+.+++|++....... ....+.+|+.++..+.|++|+++++++......+++|||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987543211 357799999999999999999999999999999999999999999
Q ss_pred HHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-CCcEEEEecCCcccccccccccCCCCCCCC
Q 001360 775 YSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (1092)
Q Consensus 775 ~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~n~s~dls~~~t~g 852 (1092)
.+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~------------ 146 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD------------ 146 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC------------
Confidence 9999876 57899999999999999999999999999999999999999 899999999998742100
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001360 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1092)
Q Consensus 853 ~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l 931 (1092)
........++..|++||.+... .++.+.|+|+||++||+|
T Consensus 147 ---------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------ 187 (215)
T cd00180 147 ---------------KSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------ 187 (215)
T ss_pred ---------------cchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------
Confidence 0012335688999999999887 888999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCC
Q 001360 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1092)
Q Consensus 932 ~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HP 972 (1092)
..+.+++.+||..||.+||+ +.++++|+
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~---~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPS---AKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcC---HHHHhhCC
Confidence 57899999999999999999 77888775
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=256.05 Aligned_cols=214 Identities=46% Similarity=0.752 Sum_probs=184.9
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEY 768 (1092)
|.+.+.||.|+||.||+|....+++.+|+|.+...... .....+.+|+..+..++|+|++++++++......|+++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 57789999999999999999988999999999764322 2567889999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 769 LNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 769 m~GGSL~dlLkk~g~-LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
+++++|.+++..... +++..+..++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~------ 152 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL------ 152 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc------
Confidence 999999999987766 8999999999999999999999999999999999999999999999999987531100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh-cCCCCCccceeechhhhHHHHHhCCCCCCC--CChHHHHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-LGTEHGYAADWWSVGIILFEFITGIPPFTA--ESPEIIFD 924 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL-~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~--~s~~ei~~ 924 (1092)
........|+..|++||.+ ....++.++|+|+||+++|+|++|++||.. .+...+.+
T Consensus 153 --------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~ 212 (225)
T smart00221 153 --------------------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSD 212 (225)
T ss_pred --------------------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHH
Confidence 0012345688999999999 667788899999999999999999999987 44457777
Q ss_pred HHhhcC
Q 001360 925 NILNRK 930 (1092)
Q Consensus 925 kIl~~~ 930 (1092)
.|..+.
T Consensus 213 ~~~~~~ 218 (225)
T smart00221 213 VWSFGV 218 (225)
T ss_pred HHhcCC
Confidence 777665
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=292.19 Aligned_cols=133 Identities=29% Similarity=0.479 Sum_probs=115.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----C---CceEEEeee
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----N---PFVVRFFYS 755 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-----H---PNIVkL~~s 755 (1092)
..-..|-+.+.||.|.|++||+|.+..+.+.||||+.+.... ..+..+.|+.+|++++ | .+||+|++.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 334789999999999999999999999999999999986543 3456788999999874 2 479999999
Q ss_pred eccC----CeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHc-CCeeeecCCCceEec
Q 001360 756 FTCR----DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIA 821 (1092)
Q Consensus 756 fqde----~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~-GIIHRDLKPeNILLD 821 (1092)
|... .++|||+|++ |-+|..+|++. ..++...++.|++||+.||.|||.. ||||-||||+||||-
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9764 4799999999 66999999764 5699999999999999999999975 999999999999994
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=269.70 Aligned_cols=218 Identities=28% Similarity=0.517 Sum_probs=181.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCe
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~ 761 (1092)
.+..++...+..||+|+||.|-+.++..+|...|+|.++. ....+...+.++|+++..+. .+|++|.+|+.+.....
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~--tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRA--TVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehh--hcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 4556777788899999999999999999999999999874 23455677888999887655 69999999999999999
Q ss_pred eEEEEeecCCCcHHHHH----HhhcCCCHHHHHHHHHHHHHHHHHHHHc-CCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 762 LYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlL----kk~g~LsE~~ar~yaaQIL~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
+|+.||.|.. +|..+- .+.+.++|..+-.++..++.||.|||++ .+||||+||+||||+.+|+||+||||++-.
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999999965 765443 4557899999999999999999999975 899999999999999999999999999864
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC----CCCCccceeechhhhHHHHHhCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFITGIP 912 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g----~~Yt~ksDVWSLGVILYEMLTGk~ 912 (1092)
+.. ........|--.|||||.+.. .+|+.++||||||++|+||.+++.
T Consensus 199 L~d----------------------------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~ 250 (282)
T KOG0984|consen 199 LVD----------------------------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRF 250 (282)
T ss_pred ehh----------------------------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccc
Confidence 310 011112458889999999853 489999999999999999999999
Q ss_pred CCCC-CChHHHHHHHhhcCC
Q 001360 913 PFTA-ESPEIIFDNILNRKI 931 (1092)
Q Consensus 913 PF~~-~s~~ei~~kIl~~~l 931 (1092)
||.. .++-+..+.++....
T Consensus 251 PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 251 PYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred cccccCCHHHHHHHHhcCCC
Confidence 9975 567777888877643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=288.97 Aligned_cols=244 Identities=26% Similarity=0.408 Sum_probs=191.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCceEEEeeeeccCC--
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRD-- 760 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~--L~HPNIVkL~~sfqde~-- 760 (1092)
.....++++.||+|.||.||+|+.. ++.||||++.. .+.+.+.+|.+|.+. ++|+||+++++.-.-..
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 3567788899999999999999976 69999998863 456789999999875 57999999997765544
Q ss_pred --eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc---------CCeeeecCCCceEecCCCcEEEE
Q 001360 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---------GIVHRDLKPDNLLIAHDGHIKLT 829 (1092)
Q Consensus 761 --~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~---------GIIHRDLKPeNILLD~nG~VKLs 829 (1092)
.++||++|.+.|+|.+||..+ .+++.....++..+++||+|||.. .|+|||||..||||.+++.+-|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 689999999999999999764 689999999999999999999964 59999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-C-----ccceeechhhh
Q 001360 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-G-----YAADWWSVGII 903 (1092)
Q Consensus 830 DFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t-----~ksDVWSLGVI 903 (1092)
|||||..+.. . .....+...+||..|||||+|.+.-. . ...||||+|.+
T Consensus 359 DFGLAl~~~p----------------~---------~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLV 413 (534)
T KOG3653|consen 359 DFGLALRLEP----------------G---------KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLV 413 (534)
T ss_pred ccceeEEecC----------------C---------CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHH
Confidence 9999986421 0 01122344799999999999987421 1 46899999999
Q ss_pred HHHHHhCC------------CCCCC-----CChHHHHHHHhhcCCCCCCCCCC-----CCHHHHHHHHHhccCCcCCCCC
Q 001360 904 LFEFITGI------------PPFTA-----ESPEIIFDNILNRKIPWPCVPSD-----MSFEAQDLINRFLIHDPNQRLG 961 (1092)
Q Consensus 904 LYEMLTGk------------~PF~~-----~s~~ei~~kIl~~~l~fP~ip~~-----lS~eakDLI~kcL~kDP~KRpS 961 (1092)
||||++.- +||.. .+-+++...++..+.+ |.+|.. --.-+++.|..||..||+-|+|
T Consensus 414 LWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~R-P~~p~~W~~h~~~~~l~et~EeCWDhDaeARLT 492 (534)
T KOG3653|consen 414 LWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQR-PKIPDAWRKHAGMAVLCETIEECWDHDAEARLT 492 (534)
T ss_pred HHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccC-CCChhhhhcCccHHHHHHHHHHHcCCchhhhhh
Confidence 99999853 24431 2234555555544322 333322 2345889999999999999999
Q ss_pred cc
Q 001360 962 AN 963 (1092)
Q Consensus 962 a~ 963 (1092)
+.
T Consensus 493 A~ 494 (534)
T KOG3653|consen 493 AG 494 (534)
T ss_pred hH
Confidence 54
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=297.96 Aligned_cols=246 Identities=22% Similarity=0.338 Sum_probs=207.5
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk----~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
.++..++||.|+||+||+|.|...|+ +||||++.... .......++.|+-+|.+++|||+++|++++.... +-
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 34566799999999999999976654 78999887643 3344678999999999999999999999998877 88
Q ss_pred EEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||++||++|.|.+|++.+ +.+-......|..||++||.|||.++++||||-..|+|+..-.++||.|||+++.....
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d-- 851 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD-- 851 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc--
Confidence 999999999999999865 56888889999999999999999999999999999999999999999999999863210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~e 921 (1092)
. ....+....-.+.|||=|.+....|+.++|||||||++||++| |..|+.+....+
T Consensus 852 --------------~---------~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 852 --------------E---------KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE 908 (1177)
T ss_pred --------------c---------ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence 0 0111222334578999999999999999999999999999999 999999998888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ 963 (1092)
+-+.+..+. +++ .|+..+-++.-++.+||..|+..||++.
T Consensus 909 I~dlle~ge-RLs-qPpiCtiDVy~~mvkCwmid~~~rp~fk 948 (1177)
T KOG1025|consen 909 IPDLLEKGE-RLS-QPPICTIDVYMVMVKCWMIDADSRPTFK 948 (1177)
T ss_pred hhHHHhccc-cCC-CCCCccHHHHHHHHHHhccCcccCccHH
Confidence 776655443 344 3578999999999999999999999953
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=280.89 Aligned_cols=284 Identities=26% Similarity=0.416 Sum_probs=208.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR 759 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~---TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde 759 (1092)
...+.|..+..||.|+|+.||++.... .++.||+|.+.... ...++.+|+++|..+. +.||+++.+++...
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 345678999999999999999998877 78899999886533 3466999999999996 89999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-CCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~ 838 (1092)
+...+||||++..+..++... ++...++.|++.++.||.++|.+|||||||||+|+|.+. -+.-.|+|||||....
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999999888888765 678899999999999999999999999999999999985 4678999999997211
Q ss_pred ccc----cccCCCCCC---CCCCCC-----CCC-CCcc----cccCcCCccCccCCCCCCChhhhcCC-CCCccceeech
Q 001360 839 INN----TIDLSGPET---DGIMPS-----DAH-YPEY----QQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSV 900 (1092)
Q Consensus 839 ~n~----s~dls~~~t---~g~~p~-----~~~-~~~~----~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSL 900 (1092)
... +-..+.+.. .+.... ... -..+ ....+.......||++|.|||++..- ..+.++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 000000000 000000 000 0001 11233445567899999999999864 45889999999
Q ss_pred hhhHHHHHhCCCCCCCCCh--------------HHHHHHH-hhcC------CCCCC------------------------
Q 001360 901 GIILFEFITGIPPFTAESP--------------EIIFDNI-LNRK------IPWPC------------------------ 935 (1092)
Q Consensus 901 GVILYEMLTGk~PF~~~s~--------------~ei~~kI-l~~~------l~fP~------------------------ 935 (1092)
|||+.-+++++.||..... .++.+-. +.+. -.+|.
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 9999999999999954221 1110000 0011 00000
Q ss_pred ----CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 936 ----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 936 ----ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
.....+..+.||+.+||..||.+|++ |++.|.||||...+
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRit---AEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRIT---AEDALKHPFFDEAD 388 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhccc---HHHHhcCcCCcchh
Confidence 01234568999999999999999999 88999999998543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-27 Score=235.08 Aligned_cols=260 Identities=40% Similarity=0.709 Sum_probs=208.6
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC-ceEEEeeeeccCCeeEEEEe
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP-FVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HP-NIVkL~~sfqde~~LYLVME 767 (1092)
|.+.+.||.|+||.||++.+. ..+|+|.+.+...........+.+|..++..+.|+ +|++++..+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 78999999876554444578899999999999988 79999999988888899999
Q ss_pred ecCCCcHHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC-cEEEEecCCcccccccccc
Q 001360 768 YLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g---~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~n~s~ 843 (1092)
|+.++++.+++.... .+++.....++.|++.++.|+|..|++||||||+|||++..+ .++++|||+++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~- 157 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS- 157 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc-
Confidence 999999998877665 799999999999999999999999999999999999999998 799999999874211000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCCCCCh-
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESP- 919 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~- 919 (1092)
.. .........+||+.|+|||.+.+ ..+....|+||+|++++++++|..||.....
T Consensus 158 ---------------~~-----~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~ 217 (384)
T COG0515 158 ---------------TS-----SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217 (384)
T ss_pred ---------------cc-----cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 00 00013456789999999999988 5788999999999999999999999887763
Q ss_pred ---HHHHHHHhhcCCC-CCC-CCCCC----CHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 920 ---EIIFDNILNRKIP-WPC-VPSDM----SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 920 ---~ei~~kIl~~~l~-fP~-ip~~l----S~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
......+.....+ ... ..... ...+.+++.+++..+|..|.+ ..+...++|..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~---~~~~~~~~~~~ 279 (384)
T COG0515 218 SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS---SSSDLSHDLLA 279 (384)
T ss_pred ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCC---HHHHhhchHhh
Confidence 4555555544433 211 11111 257999999999999999998 44555554443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-29 Score=303.40 Aligned_cols=224 Identities=16% Similarity=0.185 Sum_probs=154.7
Q ss_pred cCC-CceEEEeeee-------ccCCeeEEEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecC
Q 001360 744 VRN-PFVVRFFYSF-------TCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814 (1092)
Q Consensus 744 L~H-PNIVkL~~sf-------qde~~LYLVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLK 814 (1092)
++| +||++++++| .....++++|||+ +++|.++|.. ...+++..++.|+.||+.||.|||++||||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 444 5777777777 2334678889988 5699999975 3569999999999999999999999999999999
Q ss_pred CCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCC-----CC---CCCcccc-cCcCCccCccCCCCCCChhh
Q 001360 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS-----DA---HYPEYQQ-TDNRNRHSAVGTPDYLAPEI 885 (1092)
Q Consensus 815 PeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~-----~~---~~~~~~~-~~~~~~~s~vGTp~YmAPEV 885 (1092)
|+||||+..|.+|++|||++..........+..... |.... .. ....... .........+||+.|||||+
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~Df-G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREI-GSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCccccccc-ccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999888888888888776421110000000000 00000 00 0000000 00011223579999999999
Q ss_pred hcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 886 LLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 886 L~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
+.+..|+.++|||||||+||||++|.+||.... .....+..... |.....-.+.+.+++.+||..||.+||+ +
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~L~~~P~~Rps---~ 259 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQILLNWPKEASFCLWLLHPEPSCRPS---M 259 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--ChhhhhcCHHHHHHHHHhCCCChhhCcC---h
Confidence 999999999999999999999999999976432 12222222211 1111122456789999999999999999 8
Q ss_pred HHHHcCCCCCC
Q 001360 966 AEVKAHPFFKG 976 (1092)
Q Consensus 966 ~EIL~HPFFkg 976 (1092)
.++++||||..
T Consensus 260 ~eil~h~~~~~ 270 (793)
T PLN00181 260 SELLQSEFINE 270 (793)
T ss_pred HHHhhchhhhh
Confidence 89999999975
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=255.13 Aligned_cols=241 Identities=27% Similarity=0.390 Sum_probs=190.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe-eeeccCCee
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF-YSFTCRDNL 762 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~-~sfqde~~L 762 (1092)
..+.|.+.+.||.|-||.+.+|+++.++..+++|.+.+.. ..+..|.+|..---.+ .|.||+.-| ..|++.+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 3578999999999999999999999999999999998643 2456788887654444 489999988 568999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC--CCcEEEEecCCccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~--nG~VKLsDFGLAk~~~~n 840 (1092)
.++|||++.|||..-+.. ..+-|...+.+++|++.||.|||+.++||||||.+||||-. ...|||||||+.+...
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-- 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-- 174 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--
Confidence 999999999999988765 44788999999999999999999999999999999999953 3489999999976421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC---C--CCccceeechhhhHHHHHhCCCCCC
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---E--HGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~---~--Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
......--+..|-|||+.... . .....|+|.||+++|.+|+|.+||.
T Consensus 175 ----------------------------~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 175 ----------------------------TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred ----------------------------ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 000111235678999987542 2 3678999999999999999999997
Q ss_pred CCC----hHHHHHHHhhc-CCCCCCCCCCCCHHHHHHHHHhccCCcCCCC
Q 001360 916 AES----PEIIFDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960 (1092)
Q Consensus 916 ~~s----~~ei~~kIl~~-~l~fP~ip~~lS~eakDLI~kcL~kDP~KRp 960 (1092)
... +---+.+...+ ....|.....+++.+..+.++-|..+|++|-
T Consensus 227 ka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drc 276 (378)
T KOG1345|consen 227 KASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRC 276 (378)
T ss_pred hhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccc
Confidence 432 22223333332 2344555567899999999999999999983
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=232.92 Aligned_cols=161 Identities=25% Similarity=0.281 Sum_probs=130.0
Q ss_pred CcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCC
Q 001360 772 GDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (1092)
Q Consensus 772 GSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t 850 (1092)
|+|.+++... ..+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~----------- 61 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP----------- 61 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-----------
Confidence 7899999874 45999999999999999999999998 999999999999999 999875210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh-HHHHHHHhhc
Q 001360 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNILNR 929 (1092)
Q Consensus 851 ~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~-~ei~~kIl~~ 929 (1092)
....||+.|||||++.+..|+.++|||||||++|||++|.+||..... ......+...
T Consensus 62 ---------------------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 120 (176)
T smart00750 62 ---------------------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG 120 (176)
T ss_pred ---------------------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH
Confidence 112689999999999999999999999999999999999999976543 2333343332
Q ss_pred CCCC-C---CCCCCCCH--HHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 930 KIPW-P---CVPSDMSF--EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 930 ~l~f-P---~ip~~lS~--eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
.... + ..+..++. ++++||.+||..||.+||+ +.+++.|+|+.
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~---~~~ll~~~~~~ 169 (176)
T smart00750 121 MPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA---ANHYLAHCRAL 169 (176)
T ss_pred hccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC---HHHHHHHHHHH
Confidence 2111 1 01123344 6999999999999999999 88999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-26 Score=271.76 Aligned_cols=265 Identities=27% Similarity=0.388 Sum_probs=207.5
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeec---ccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK---LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 690 eilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK---~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
.....+|.|+||.|+.+......+.++.|..+. .....+.....+..|.-+-..+.|||++.....+++....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999999988877777777776542 11112222233667777778889999999888888877777779
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
|||++ ||+.++...+.+....+..++.|++.|+.|||..||.||||||+|+|+..+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~------ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP------ 473 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC------
Confidence 99999 99999998888999999999999999999999999999999999999999999999999998764210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCC-ccceeechhhhHHHHHhCCCCCCCCChHHH--H
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG-YAADWWSVGIILFEFITGIPPFTAESPEII--F 923 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt-~ksDVWSLGVILYEMLTGk~PF~~~s~~ei--~ 923 (1092)
|. ........++|+..|+|||++.+..|+ ..+||||.|++++.|++|+.||......+. +
T Consensus 474 ----------------~e-~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~ 536 (601)
T KOG0590|consen 474 ----------------WE-KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK 536 (601)
T ss_pred ----------------cc-hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh
Confidence 00 111344578999999999999999996 578999999999999999999975443322 1
Q ss_pred HHHhhcCCC----CCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcch
Q 001360 924 DNILNRKIP----WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981 (1092)
Q Consensus 924 ~kIl~~~l~----fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~ 981 (1092)
......... .-.+...++...+.+|.+||+.||.+|.+ +.+|++.+||+.+.-..
T Consensus 537 ~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t---i~~i~~d~W~~~i~~c~ 595 (601)
T KOG0590|consen 537 TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT---IEQILNDEWIRSIECCH 595 (601)
T ss_pred hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec---HHHHhhChHhhhcceEE
Confidence 111111110 01123567889999999999999999999 88999999999876443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=242.25 Aligned_cols=256 Identities=20% Similarity=0.269 Sum_probs=205.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC- 758 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk-----~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd- 758 (1092)
....+++...+-+|.||.||.|.|++... .+-+|.++. ....-++..++.|.-+|..+.|||+..+.+....
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~--~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ--HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh--cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 34567788889999999999998875432 344555543 2244567889999999999999999999877654
Q ss_pred CCeeEEEEeecCCCcHHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEe
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKV--------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 830 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~--------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsD 830 (1092)
....+.++.++.-|+|..+|... ..++..+...++.|++.|++|||+.||||.||-..|.+||+.-.|||+|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence 45688899999999999999722 2467778888999999999999999999999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-
Q 001360 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT- 909 (1092)
Q Consensus 831 FGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT- 909 (1092)
=.|++-... .+.+. .. ..-.....||+||.+.+..|+..+|+|||||+||||+|
T Consensus 440 saLSRDLFP----------------~DYhc--LG-------DnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtl 494 (563)
T KOG1024|consen 440 SALSRDLFP----------------GDYHC--LG-------DNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTL 494 (563)
T ss_pred chhccccCc----------------ccccc--cC-------CCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhc
Confidence 999885321 11111 00 01123567999999999999999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 910 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 910 Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
|+.||...+|.++...+..+. ++. .|.++|+++..++--||..+|++||+..++...|
T Consensus 495 g~~PyaeIDPfEm~~ylkdGy-Rla-QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 495 GKLPYAEIDPFEMEHYLKDGY-RLA-QPFNCPDELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred CCCCccccCHHHHHHHHhccc-eec-CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 999999999999998877653 322 2578999999999999999999999966554444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=241.58 Aligned_cols=178 Identities=22% Similarity=0.158 Sum_probs=134.5
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECC-CCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEE-Eeeee
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVR-FFYSF 756 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~-TGk~VAIKvLkK~ei--~kk~~ie~~l~EieIL~~L~HPNIVk-L~~sf 756 (1092)
..+...++|++.+.||+|+||+||+|+++. ++..||||++..... ........+.+|+++|.+++|+||+. ++..
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 345667889999999999999999999876 688889998753211 12334567899999999999999985 5432
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeec-CCCceEecCCCcEEEEecCCcc
Q 001360 757 TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLSK 835 (1092)
Q Consensus 757 qde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDL-KPeNILLD~nG~VKLsDFGLAk 835 (1092)
...||||||++|++|.. +.. .. ...++.+++.||.|||++||+|||| ||+|||++.+|.+||+|||+|+
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 45799999999999973 211 11 1467889999999999999999999 9999999999999999999998
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC
Q 001360 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG 888 (1092)
Q Consensus 836 ~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g 888 (1092)
..... ...+ .........+.+|++.|+|||.+..
T Consensus 161 ~~~~~--------~~~~-----------~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRR--------GALY-----------RIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccC--------cchh-----------hhhhhhhhhhhhccCccCCcccCCh
Confidence 63210 0000 0000111236789999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-23 Score=227.13 Aligned_cols=259 Identities=22% Similarity=0.288 Sum_probs=193.6
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhcC----CCceEEEeeee-ccCCe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDMIRKNDIERILAERNILITVR----NPFVVRFFYSF-TCRDN 761 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TG-k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~----HPNIVkL~~sf-qde~~ 761 (1092)
.|.+.+.||+|+||.||+|....++ ..+|+|+........ ...+..|+.+|..+. .+++..++..+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988764 689999876532211 115677888888876 36889999888 57778
Q ss_pred eEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC-----CcEEEEecCCc
Q 001360 762 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-----GHIKLTDFGLS 834 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n-----G~VKLsDFGLA 834 (1092)
-||||+.+ |-+|.++.... +.|+...+..++.|++.+|++||+.|+|||||||+|+++... -.+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999988 77999988654 479999999999999999999999999999999999999865 36999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
+...... ..+ .. ....+.....+.||..|.++.+..+...+...|+||++.++.||+.|..||
T Consensus 175 r~~~~~~--------~~~-----~~----~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 175 RRFKYVG--------DSG-----GN----LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred ccccccC--------CCC-----cc----cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 8321000 000 00 001111134567999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhh---cCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 915 TAESPEIIFDNILN---RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 915 ~~~s~~ei~~kIl~---~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
.+........++.. .....+ .....+.+...+...+-..+...+|.......+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 238 EALEMTDLKSKFEKDPRKLLTDR-FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred ccccccchHHHHHHHhhhhcccc-ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 77654322222222 111110 123455677777777777788888885544444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-22 Score=205.71 Aligned_cols=141 Identities=24% Similarity=0.195 Sum_probs=110.8
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhH-----------------------HHHHHHHHHHHHhcCCCc
Q 001360 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-----------------------IERILAERNILITVRNPF 748 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~-----------------------ie~~l~EieIL~~L~HPN 748 (1092)
...||+|+||.||+|... +|+.||||+++......... ......|..+|.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999987 89999999998643211110 123345999999998766
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHH-HHcCCeeeecCCCceEecCCCcEE
Q 001360 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLIAHDGHIK 827 (1092)
Q Consensus 749 IVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYL-Hs~GIIHRDLKPeNILLD~nG~VK 827 (1092)
|...+... . ...||||||++|+++...+.+.+.+++..+..++.|++.+|.|| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~-~-~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPIL-L-KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEE-e-cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 53322221 1 22389999999988876655567899999999999999999999 799999999999999998 58899
Q ss_pred EEecCCccc
Q 001360 828 LTDFGLSKI 836 (1092)
Q Consensus 828 LsDFGLAk~ 836 (1092)
|+|||+|..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=211.70 Aligned_cols=217 Identities=24% Similarity=0.414 Sum_probs=179.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LYL 764 (1092)
--.|++.+.||.|+||++++|...-+++.||||.-.. +.+...+..|.+.-+.|. .+.|...|++.+...+-.|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 3479999999999999999999999999999996542 223455667777777665 7999999999999988899
Q ss_pred EEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC-----cEEEEecCCccccc
Q 001360 765 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-----HIKLTDFGLSKIGL 838 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG-----~VKLsDFGLAk~~~ 838 (1092)
|||++ |-+|.|+..=.+ .|+...+..++.|++.-|+|+|.+.+|+|||||+|+||..-| .|.|+|||+|+.-
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y- 179 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY- 179 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh-
Confidence 99998 668888876544 699999999999999999999999999999999999998644 5899999999953
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC-
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE- 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~- 917 (1092)
.+|.+...+|... ..+..||..||+--..+|...+...|+=|||-++++.|.|..||.+.
T Consensus 180 -------rDp~TkqHIPYrE------------~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 180 -------RDPKTKQHIPYRE------------HKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred -------cCccccccCcccc------------ccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 2344443333322 24567999999999888999999999999999999999999999874
Q ss_pred --ChHHHHHHHhh
Q 001360 918 --SPEIIFDNILN 928 (1092)
Q Consensus 918 --s~~ei~~kIl~ 928 (1092)
+..+-|++|-.
T Consensus 241 A~tnK~kYeKIGe 253 (449)
T KOG1165|consen 241 ADTNKEKYEKIGE 253 (449)
T ss_pred CcchHHHHHHhcc
Confidence 45566666654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-21 Score=203.76 Aligned_cols=279 Identities=23% Similarity=0.319 Sum_probs=210.7
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccC
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR 759 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde 759 (1092)
++.+..+.|++++.||.|+||.+|+|....+|..||||+-.+.. ...++.-|..+-..++ ...|..+..++...
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 34467789999999999999999999999999999999765422 2234677888888887 46788888888888
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC---cEEEEecCCcc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSK 835 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLsDFGLAk 835 (1092)
.+-.|||+++ |.+|.++..-. ..|+...+...+-|++.-|+|+|.+++|||||||+|+|+.-+- .+.|+|||||+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 8899999998 67998888643 4689999999999999999999999999999999999997543 58899999998
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC
Q 001360 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 836 ~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
..... .+ ..+++ -.......||..|.+--...+...+...|+=|+|.+|.++..|..||.
T Consensus 163 ky~d~--------~t------~~HIp------yre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 163 KYRDI--------RT------RQHIP------YREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred hhccc--------cc------cccCc------cccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 53211 11 11111 112234679999998888877778889999999999999999999998
Q ss_pred CCC---hHHHHHHHhhcCCCCCC--CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH-------HcCCCCCCCCcchhh
Q 001360 916 AES---PEIIFDNILNRKIPWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV-------KAHPFFKGVNWDSLA 983 (1092)
Q Consensus 916 ~~s---~~ei~~kIl~~~l~fP~--ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI-------L~HPFFkgIdWd~L~ 983 (1092)
+.. ..+-+++|...+...|. +-..+|.++.-.+.-|=..--++-|...-+.++ ++|.+=--.||+.+.
T Consensus 223 glka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lk 302 (341)
T KOG1163|consen 223 GLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLK 302 (341)
T ss_pred ccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHH
Confidence 865 45667778776654432 235778888888888866555555653222222 233333336898887
Q ss_pred hc
Q 001360 984 LQ 985 (1092)
Q Consensus 984 ~~ 985 (1092)
++
T Consensus 303 qk 304 (341)
T KOG1163|consen 303 QK 304 (341)
T ss_pred HH
Confidence 55
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-21 Score=196.65 Aligned_cols=141 Identities=25% Similarity=0.169 Sum_probs=111.8
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch-----------------------hHHHHHHHHHHHHHhcCCCc
Q 001360 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-----------------------NDIERILAERNILITVRNPF 748 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk-----------------------~~ie~~l~EieIL~~L~HPN 748 (1092)
.+.||+|+||.||+|... +|+.||||+++....... .....+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 899999999986421100 00223467899999999988
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcEE
Q 001360 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIK 827 (1092)
Q Consensus 749 IVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~VK 827 (1092)
|......... ..||||||++|+++.........++...+..++.|++.+|.+||. .||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 7443322222 248999999998665443345668888999999999999999999 9999999999999998 89999
Q ss_pred EEecCCccc
Q 001360 828 LTDFGLSKI 836 (1092)
Q Consensus 828 LsDFGLAk~ 836 (1092)
|+|||+++.
T Consensus 158 liDFG~a~~ 166 (190)
T cd05145 158 IIDVSQAVE 166 (190)
T ss_pred EEEccccee
Confidence 999999975
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=204.76 Aligned_cols=175 Identities=17% Similarity=0.177 Sum_probs=136.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhcCCCceEEEeeeec
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER------ILAERNILITVRNPFVVRFFYSFT 757 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~------~l~EieIL~~L~HPNIVkL~~sfq 757 (1092)
.-.++|+++++||.|+||.||++.. ++..||+|+++......+..... +.+|+..+.++.||+|..+..++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4457899999999999999999755 46789999997644333333344 578999999999999999988866
Q ss_pred cC--------CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEE
Q 001360 758 CR--------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 829 (1092)
Q Consensus 758 de--------~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLs 829 (1092)
+. ...||||||++|.+|.++. .+++. ...+++.+|..||..|++||||||+|||++.+| ++|+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 54 3589999999999998773 23332 356999999999999999999999999999999 9999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHH
Q 001360 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (1092)
Q Consensus 830 DFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEML 908 (1092)
|||..+..... .....+++...|+.++|+||||+++.-+.
T Consensus 177 Dfg~~~~~~e~---------------------------------------~a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQR---------------------------------------KAKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccch---------------------------------------hhHHHHHHHhHhcccccccceeEeehHHH
Confidence 99987632100 00011556677888999999999876543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=206.92 Aligned_cols=234 Identities=28% Similarity=0.389 Sum_probs=151.9
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-----------CceE-----E
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-----------PFVV-----R 751 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H-----------PNIV-----k 751 (1092)
.+...+.||.|+|+.||.|++..||+.+|+|++.-.........+.+.+|.-....+.+ ..++ +
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45777899999999999999999999999999875554444566667666644333221 1222 1
Q ss_pred Ee---eeeccCC--------eeEEEEeecCCCcHHHHHH---hhcCC---CHHHHHH-HHHHHHHHHHHHHHcCCeeeec
Q 001360 752 FF---YSFTCRD--------NLYLVMEYLNGGDLYSLLR---KVGCL---EEDVARI-YIAELVLALEYLHSLGIVHRDL 813 (1092)
Q Consensus 752 L~---~sfqde~--------~LYLVMEYm~GGSL~dlLk---k~g~L---sE~~ar~-yaaQIL~ALeYLHs~GIIHRDL 813 (1092)
+- .++.... +.+++|+-+. +||.+++. ..... ....++. +..|++..+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 0111111 3477888885 48888764 22222 1223433 3479999999999999999999
Q ss_pred CCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC----
Q 001360 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---- 889 (1092)
Q Consensus 814 KPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~---- 889 (1092)
||+|+|++.+|.++|+||+..... +........+..|.+||.....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~------------------------------g~~~~~~~~~~~~~PPe~~~~~~~~~ 221 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRA------------------------------GTRYRCSEFPVAFTPPELESCAGQFG 221 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEET------------------------------TEEEEGGGS-TTTS-HHHHHHHTSCH
T ss_pred ceeeEEEcCCCCEEEcChHHHeec------------------------------CceeeccCCCcccCChhhhhhhcccC
Confidence 999999999999999999876531 0011113455789999987542
Q ss_pred ----CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCC
Q 001360 890 ----EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959 (1092)
Q Consensus 890 ----~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KR 959 (1092)
.++.+.|.|+||+++|.|.+|..||....+...... .|.... .+|..+++||.+||++||.+|
T Consensus 222 ~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 222 QNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 468899999999999999999999987654322221 233333 788999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=209.84 Aligned_cols=272 Identities=28% Similarity=0.409 Sum_probs=189.0
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCc-----------------------------------EEEEEEeeccccc
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGD-----------------------------------LFAIKVLKKLDMI 726 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk-----------------------------------~VAIKvLkK~ei~ 726 (1092)
.+..+++|++...||+|.-..||-++....|. +.|||.+-..+..
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 35788999999999999999999987654221 3455554332222
Q ss_pred chhHHHHHH----HHH------HHH--------H--------hcCCCceEEEeeeeccC---------------------
Q 001360 727 RKNDIERIL----AER------NIL--------I--------TVRNPFVVRFFYSFTCR--------------------- 759 (1092)
Q Consensus 727 kk~~ie~~l----~Ei------eIL--------~--------~L~HPNIVkL~~sfqde--------------------- 759 (1092)
. ...+++ +|. ..+ + ..+|||||+++.+|.+.
T Consensus 232 s--~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 232 S--GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred C--chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 1 112222 111 011 0 13599999999888652
Q ss_pred ------CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe--cCCC--cEEEE
Q 001360 760 ------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDG--HIKLT 829 (1092)
Q Consensus 760 ------~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL--D~nG--~VKLs 829 (1092)
..+|+||...+. +|..++-.. ..+....+.+++|+++|+.|||++||.|||+|.+|||| |.++ .+.|+
T Consensus 310 ~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred cccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 238999998876 899998654 35667788899999999999999999999999999998 4444 57899
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC--C----Cccceeechhhh
Q 001360 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--H----GYAADWWSVGII 903 (1092)
Q Consensus 830 DFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~--Y----t~ksDVWSLGVI 903 (1092)
|||.|-. ..+....+ | +..+ ....-|...-||||+....+ . -.++|.|+.|.+
T Consensus 388 DFGCcLA-d~~hGlql---------p----y~S~-------~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~Gal 446 (598)
T KOG4158|consen 388 DFGCCLA-DDNHGLQL---------P----YESD-------EVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGAL 446 (598)
T ss_pred ccceeee-cccccccc---------c----cccc-------cccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhh
Confidence 9998752 11111111 1 1111 12234777889999987532 1 248999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCc
Q 001360 904 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 904 LYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdW 979 (1092)
.||++....||++.....+-.+.. ..-.+|.+|..+++.+++|+..+|+.||.+|++.+=|..+++--.|..-+|
T Consensus 447 aYEIfg~~NPFY~rGem~L~~r~Y-qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 447 AYEIFGRSNPFYKRGEMLLDTRTY-QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGED 521 (598)
T ss_pred HHHHhccCCcccccchheechhhh-hhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchH
Confidence 999999999999854332221111 222456678999999999999999999999999776666665544444344
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-20 Score=195.11 Aligned_cols=202 Identities=22% Similarity=0.269 Sum_probs=144.1
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchh-HHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEe
Q 001360 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 690 eilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~-~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LYLVME 767 (1092)
.+...|++|+||+||++.. .+..++.+.+.......+. ....+.+|+++|+++. |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999998765 5777887766654332221 2235789999999996 5889998875 45799999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeec-CCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDL-KPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
|+.|.+|...+.. . ...++.|++.+|.++|.+||+|||| ||+|||++.+|.++|+|||+|........
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~---- 147 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR---- 147 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch----
Confidence 9999998755422 1 1346789999999999999999999 79999999999999999999974311000
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
.. ..+ ....-......-..+++.|++|+.-.- ..--...+|++.|+-+|.|+|+..|+.+++
T Consensus 148 ------~~---r~L-~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 ------WM---RLL-AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ------HH---HHH-HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00 000 000000001122347899999986432 223357899999999999999999987654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-20 Score=200.06 Aligned_cols=251 Identities=21% Similarity=0.330 Sum_probs=200.8
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
.+...+..++..|.....|+.|+|+|. |..++.|++.-.+. .......|..|.-.|+-+.||||+.+++.+....++
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred CcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 356677888889999999999999997 44566787764332 233345688888889999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcC--CeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~G--IIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+|..||+-|+|+..|+... ..+..++..++.+++.|+.|||+.. |.---|....++||++-+.+|+ .+-+++.
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs- 340 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS- 340 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee-
Confidence 99999999999999998764 3677888999999999999999984 3344678888999998877765 1111210
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCC---ccceeechhhhHHHHHhCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt---~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
|+ .....-.|.||+||.+..++-+ .++|+|||.+++||+.|...||.
T Consensus 341 ------------------------fq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfa 390 (448)
T KOG0195|consen 341 ------------------------FQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFA 390 (448)
T ss_pred ------------------------ee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccc
Confidence 00 0122346899999999876653 58999999999999999999999
Q ss_pred CCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 916 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 916 ~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
..++.+.--+|--..+. +.+|+.++.....|+.-|+..||.+||.++.+.-||
T Consensus 391 dlspmecgmkialeglr-v~ippgis~hm~klm~icmnedpgkrpkfdmivpil 443 (448)
T KOG0195|consen 391 DLSPMECGMKIALEGLR-VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPIL 443 (448)
T ss_pred cCCchhhhhhhhhcccc-ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhH
Confidence 99998888777766665 456799999999999999999999999976655554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-20 Score=225.80 Aligned_cols=244 Identities=27% Similarity=0.405 Sum_probs=183.9
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~e-i~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
+|...+.||.+.|=+|.+|++.+ |. |+||++-+.. ...-....+-+.|++ ...+++||++.+.-.-......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 78889999999999999998764 44 8899987654 222223334444555 66678999999988888888899999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
+|+.. +|+|.|....-+..-+.++|+.||+.||.-+|+.||+|+|||.+||||+.=+.+.|+||..-|...
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY-------- 171 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTY-------- 171 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCcc--------
Confidence 99987 999999988889999999999999999999999999999999999999999999999998655321
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-----------CCccceeechhhhHHHHHh-CCCCC
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----------HGYAADWWSVGIILFEFIT-GIPPF 914 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-----------Yt~ksDVWSLGVILYEMLT-Gk~PF 914 (1092)
-|+.+ |. .+.-|-.. ..--..|+|||-+.... .+.+.||||+||+++||++ |.|||
T Consensus 172 LPeDN---Pa--df~fFFDT-------SrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF 239 (1431)
T KOG1240|consen 172 LPEDN---PA--DFTFFFDT-------SRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF 239 (1431)
T ss_pred CCCCC---cc--cceEEEec-------CCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence 01110 00 11111111 11224699999986522 4578899999999999998 89999
Q ss_pred CC-----------CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 915 TA-----------ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 915 ~~-----------~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
.- .+++...++|- +..++.||..|++.||.+|++ |++.|+.
T Consensus 240 ~LSQL~aYr~~~~~~~e~~Le~Ie-------------d~~~Rnlil~Mi~rdPs~RlS---AedyL~~ 291 (1431)
T KOG1240|consen 240 TLSQLLAYRSGNADDPEQLLEKIE-------------DVSLRNLILSMIQRDPSKRLS---AEDYLQK 291 (1431)
T ss_pred cHHHHHhHhccCccCHHHHHHhCc-------------CccHHHHHHHHHccCchhccC---HHHHHHh
Confidence 42 22333333331 125789999999999999999 6677754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.3e-19 Score=186.32 Aligned_cols=136 Identities=18% Similarity=0.204 Sum_probs=108.5
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-----CCCceEEEeeeeccCC---ee
Q 001360 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-----RNPFVVRFFYSFTCRD---NL 762 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-----~HPNIVkL~~sfqde~---~L 762 (1092)
-.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.++..+ +||||+++|++++++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 346899999999995 6666665 688886532 22346789999999999 5799999999999874 33
Q ss_pred E-EEEee--cCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHH-HHHHHcCCeeeecCCCceEecCC----CcEEEEecCCc
Q 001360 763 Y-LVMEY--LNGGDLYSLLRKVGCLEEDVARIYIAELVLAL-EYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLS 834 (1092)
Q Consensus 763 Y-LVMEY--m~GGSL~dlLkk~g~LsE~~ar~yaaQIL~AL-eYLHs~GIIHRDLKPeNILLD~n----G~VKLsDFGLA 834 (1092)
| +|||| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+-+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 78999 558999999976 457666 35678888888 99999999999999999999743 37999995544
Q ss_pred c
Q 001360 835 K 835 (1092)
Q Consensus 835 k 835 (1092)
+
T Consensus 157 ~ 157 (210)
T PRK10345 157 S 157 (210)
T ss_pred c
Confidence 3
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.3e-19 Score=179.85 Aligned_cols=137 Identities=31% Similarity=0.373 Sum_probs=114.0
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~k-----k~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+.||+|++|.||+|.+ +|..+++|+........ ......+.+|+.++..+.|++|+....++.+....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 57789999765322211 1123567889999999999988776666667778899999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
|++|++|.+++..... ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865432 7778899999999999999999999999999999 88999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-20 Score=221.01 Aligned_cols=263 Identities=27% Similarity=0.414 Sum_probs=210.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEEC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k-~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LY 763 (1092)
...|.+.+.||+|+|+.|-+.... .+...+|+|.+.... .......++..|..+-..+. |+|++.+++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 567889999999999999988764 345567777665433 23445566777888888887 999999999999999999
Q ss_pred EEEeecCCCcHHHHH-Hhhc-CCCHHHHHHHHHHHHHHHHHHH-HcCCeeeecCCCceEecCCC-cEEEEecCCcccccc
Q 001360 764 LVMEYLNGGDLYSLL-RKVG-CLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLI 839 (1092)
Q Consensus 764 LVMEYm~GGSL~dlL-kk~g-~LsE~~ar~yaaQIL~ALeYLH-s~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~ 839 (1092)
++++|..||+++..+ .... ..+...+.+|+.|+..++.|+| ..++.||||||+|.+++..+ .+|++|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999998 5554 6788889999999999999999 99999999999999999999 999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccC-CCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG-TPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vG-Tp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
. ..........+| ++.|+|||.+.+..| +...|+||.|+++.-|++|..||...
T Consensus 178 ~------------------------~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 178 K------------------------NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred c------------------------CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 0 111233445678 999999999998644 78899999999999999999999765
Q ss_pred ChHHH-HHHHhhcC-CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 918 SPEII-FDNILNRK-IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 918 s~~ei-~~kIl~~~-l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
..... +....... ..-......++..+.+++.++|..+|..|.+ ..++..+||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s---~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 234 SRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS---IEELKLDNWLSS 291 (601)
T ss_pred ccccccceeecccccccccCccccCChhhhhcccccccCCchhccc---cccccccccccc
Confidence 43321 11111111 1011124678999999999999999999999 779999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-18 Score=184.06 Aligned_cols=144 Identities=24% Similarity=0.144 Sum_probs=114.6
Q ss_pred CeEEEEeeccCCCeEEEEEE-ECCCCcEEEEEEeecccccc---------------------hhHHHHHHHHHHHHHhcC
Q 001360 688 DFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIR---------------------KNDIERILAERNILITVR 745 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar-~k~TGk~VAIKvLkK~ei~k---------------------k~~ie~~l~EieIL~~L~ 745 (1092)
.|.+.+.||+|+||.||+|. +..+|+.||||+++...... ......+..|..++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 66789999999997532110 001134568999999997
Q ss_pred CC--ceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcC-CeeeecCCCceEecC
Q 001360 746 NP--FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG-IVHRDLKPDNLLIAH 822 (1092)
Q Consensus 746 HP--NIVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~G-IIHRDLKPeNILLD~ 822 (1092)
+. .+.+++.. ...||||||++|++|..++.....+....+..++.||+.+|.+||+.| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34444442 235899999999888776544556677778899999999999999999 99999999999999
Q ss_pred CCcEEEEecCCccc
Q 001360 823 DGHIKLTDFGLSKI 836 (1092)
Q Consensus 823 nG~VKLsDFGLAk~ 836 (1092)
++.++|+|||++..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=168.98 Aligned_cols=133 Identities=29% Similarity=0.322 Sum_probs=106.8
Q ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001360 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1092)
Q Consensus 694 ~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~-----kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEY 768 (1092)
.||+|+||.||+|.+ +|..+++|+....... ......++.+|++++..+.|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 4788999986542211 112346778999999999887654444444456677999999
Q ss_pred cCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 769 m~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||+++.
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765321 7788999999999999999999999999999 89999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.9e-18 Score=206.70 Aligned_cols=198 Identities=24% Similarity=0.387 Sum_probs=159.7
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeecc
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTC 758 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~---HPNIVkL~~sfqd 758 (1092)
..+....|.|-+.||+|+||+||+|...+ |+.||+|+=+....+. |.--.+++.+|+ -+-|..++.++.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34566789999999999999999999877 9999999876543322 222223444444 3456667777777
Q ss_pred CCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-------CCcEEEEec
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-------DGHIKLTDF 831 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~-------nG~VKLsDF 831 (1092)
.+.-+||+||.+.|+|.+++...+.+++..+.+++.|++..|++||..+|||+||||+|+||.. +--++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 7888999999999999999998889999999999999999999999999999999999999953 335899999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCC
Q 001360 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911 (1092)
Q Consensus 832 GLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk 911 (1092)
|-+--+. +.+ +...-...++|-.+--+|+..|.++++.+|.|.|..+++-||.|+
T Consensus 846 G~siDm~--------------lfp-----------~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMK--------------LFP-----------DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeee--------------EcC-----------CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 9764210 111 112334568899999999999999999999999999999999985
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-17 Score=169.83 Aligned_cols=137 Identities=21% Similarity=0.205 Sum_probs=107.6
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch-------------------hHHHHHHHHHHHHHhcCCC--
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-------------------NDIERILAERNILITVRNP-- 747 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk-------------------~~ie~~l~EieIL~~L~HP-- 747 (1092)
|.+.+.||.|+||.||++... +|+.||||+++....... .....+..|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 667789999999999999875 799999999765321000 0112367788899888877
Q ss_pred ceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEE
Q 001360 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (1092)
Q Consensus 748 NIVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VK 827 (1092)
.++..+. ....++||||++|++|..+... .....++.+++.++.++|+.||+||||||+|||++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4444443 2456899999999998765431 34567788999999999999999999999999999999999
Q ss_pred EEecCCccc
Q 001360 828 LTDFGLSKI 836 (1092)
Q Consensus 828 LsDFGLAk~ 836 (1092)
|+|||++..
T Consensus 166 liDfg~~~~ 174 (198)
T cd05144 166 IIDWPQMVS 174 (198)
T ss_pred EEECCcccc
Confidence 999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.1e-17 Score=191.90 Aligned_cols=140 Identities=26% Similarity=0.235 Sum_probs=112.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc-----cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----IRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei-----~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
...|...+.||+|+||+||++.+... .+++|+...... ......+++.+|++++..++|++|+..+.++.+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 34456678999999999999987543 344443322111 11123467889999999999999988777777777
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
..++||||++|++|.+++. ....++.+++.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 8899999999999999885 346788999999999999999999999999999 688999999999985
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=160.80 Aligned_cols=137 Identities=23% Similarity=0.275 Sum_probs=98.9
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHH---------------------HHHHHHHHHHhcCCC--c
Q 001360 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE---------------------RILAERNILITVRNP--F 748 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie---------------------~~l~EieIL~~L~HP--N 748 (1092)
.+.||+|+||+||+|... +|+.||||+++........... ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 7999999998753321111111 113566666666543 2
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcHHHH-HHhhcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcE
Q 001360 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSL-LRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHI 826 (1092)
Q Consensus 749 IVkL~~sfqde~~LYLVMEYm~GGSL~dl-Lkk~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~V 826 (1092)
+.+.++. ...++||||++||.+... +.... .. ..++.++.+++.++.++|. .||+||||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4444443 235899999999654321 21111 11 6678899999999999999 9999999999999999 9999
Q ss_pred EEEecCCccc
Q 001360 827 KLTDFGLSKI 836 (1092)
Q Consensus 827 KLsDFGLAk~ 836 (1092)
+|+|||.+..
T Consensus 154 ~liDfg~a~~ 163 (187)
T cd05119 154 YIIDVPQAVE 163 (187)
T ss_pred EEEECccccc
Confidence 9999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.8e-17 Score=188.81 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=162.7
Q ss_pred CeEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEee-------eec
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY-------SFT 757 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~T---Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~-------sfq 757 (1092)
...+.+..+.+++|.++..+...+ ...++-+..+ ..+........+++-.+....|-+..-+.. .+.
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~---~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRAD---VDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhh---ccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 344555666667776665554433 2223222211 111122333444544444444333322222 111
Q ss_pred -----cCCeeEEEEeecCCCcHHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEE
Q 001360 758 -----CRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 829 (1092)
Q Consensus 758 -----de~~LYLVMEYm~GGSL~dlLkk~g---~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLs 829 (1092)
...++||.|++|.-++|.++|.... ..+......++.|++.|++| +|.+|||+||.||....+..+||.
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 1235899999999999999997443 35667788899999999999 999999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh
Q 001360 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909 (1092)
Q Consensus 830 DFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT 909 (1092)
||||..-..... ..+ .........+||..||+||.+.+..|+.++||||||+||||+++
T Consensus 399 DFgl~ts~~~~~----------~~~-----------~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 399 DFGLVTSQDKDE----------TVA-----------PAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhheeecccCC----------ccc-----------chhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 999976321000 000 11223456789999999999999999999999999999999997
Q ss_pred -CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 910 -GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 910 -Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
=..+|. ...++.-+..+.++ |.+ ..--++..+|+.+||...|.+||+ +.+.--|+|.
T Consensus 458 ~f~T~~e---r~~t~~d~r~g~ip-~~~-~~d~p~e~~ll~~lls~~p~~RP~---~~~~~~~~~~ 515 (516)
T KOG1033|consen 458 QFSTQFE---RIATLTDIRDGIIP-PEF-LQDYPEEYTLLQQLLSPSPEERPS---AIEVALHEFL 515 (516)
T ss_pred HhccHHH---HHHhhhhhhcCCCC-hHH-hhcCcHHHHHHHHhcCCCcccCch---HHHHhhhhhc
Confidence 223322 22333333344333 111 111245668999999999999996 5565556553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-15 Score=143.04 Aligned_cols=132 Identities=23% Similarity=0.304 Sum_probs=112.4
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccCCeeEEEEee
Q 001360 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDNLYLVMEY 768 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H--PNIVkL~~sfqde~~LYLVMEY 768 (1092)
+++.||.|.++.||++... +..+++|.+..... ...+.+|..++..+.+ +++++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4578999999999999975 37899998865322 4568889999999976 5899999988888889999999
Q ss_pred cCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc---CCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 769 m~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~---GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
++|+.+..+ +......++.+++.+|.+||.. +++|+||+|.|||++..+.++++|||+++.
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877654 4456667788999999999985 799999999999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.2e-15 Score=158.78 Aligned_cols=137 Identities=21% Similarity=0.353 Sum_probs=105.7
Q ss_pred Eeec-cCCCeEEEEEEECCCCcEEEEEEeeccccc----------chhHHHHHHHHHHHHHhcCCCce--EEEeeeeccC
Q 001360 693 KPIS-RGAFGRVFLARKRTTGDLFAIKVLKKLDMI----------RKNDIERILAERNILITVRNPFV--VRFFYSFTCR 759 (1092)
Q Consensus 693 r~LG-kGgFGtVyLar~k~TGk~VAIKvLkK~ei~----------kk~~ie~~l~EieIL~~L~HPNI--VkL~~sfqde 759 (1092)
..|| .||.|+||.+... +..++||.+.+.... ......++.+|+.++..+.|++| +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 7888888888764 778999988643211 11234578899999999998774 5666554332
Q ss_pred Ce----eEEEEeecCC-CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCc
Q 001360 760 DN----LYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1092)
Q Consensus 760 ~~----LYLVMEYm~G-GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 834 (1092)
.. .++||||++| .+|.+++.. ..+++.. +.+|+.+|.+||+.||+||||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 3599999998 689888865 4455543 568999999999999999999999999999999999999988
Q ss_pred cc
Q 001360 835 KI 836 (1092)
Q Consensus 835 k~ 836 (1092)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 74
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.2e-15 Score=174.50 Aligned_cols=205 Identities=24% Similarity=0.314 Sum_probs=156.9
Q ss_pred HHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCC-eeeecCCCce
Q 001360 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGI-VHRDLKPDNL 818 (1092)
Q Consensus 741 L~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GI-IHRDLKPeNI 818 (1092)
|+.+.|.|+.++++.+.+....++|.+||..|+|.+.+... -.++.-....++++|+.||.|||.-.| .|+-+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35688999999999999999999999999999999999873 357777777788999999999998866 9999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-------C
Q 001360 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-------H 891 (1092)
Q Consensus 819 LLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-------Y 891 (1092)
++|....+||+|||+..+... + . .........-...|.|||.+.+.. -
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~----------~-------~--------~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~ 135 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEE----------T-------A--------EPEAHHPIRKALLWTAPELLRGALSQSLESAL 135 (484)
T ss_pred eeeeeEEEEechhhhcccccc----------c-------c--------cccccchhHHHHhccCHHHhcccccccccccc
Confidence 999999999999999765210 0 0 000001111235799999998742 3
Q ss_pred CccceeechhhhHHHHHhCCCCCCCC----ChHHHHHHHhh-cC-CCCCCCC--CCCCHHHHHHHHHhccCCcCCCCCcc
Q 001360 892 GYAADWWSVGIILFEFITGIPPFTAE----SPEIIFDNILN-RK-IPWPCVP--SDMSFEAQDLINRFLIHDPNQRLGAN 963 (1092)
Q Consensus 892 t~ksDVWSLGVILYEMLTGk~PF~~~----s~~ei~~kIl~-~~-l~fP~ip--~~lS~eakDLI~kcL~kDP~KRpSa~ 963 (1092)
+.+.|+||||++++|+++...||... .+.++..++.. +. ...|.+. ..+.+++..++..||..+|.+||+..
T Consensus 136 ~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~ 215 (484)
T KOG1023|consen 136 TQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIE 215 (484)
T ss_pred cccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHH
Confidence 56799999999999999999999763 33456656555 22 1233332 14566899999999999999999966
Q ss_pred cHHHHHc
Q 001360 964 GAAEVKA 970 (1092)
Q Consensus 964 ga~EIL~ 970 (1092)
.+...+.
T Consensus 216 ~i~~~~~ 222 (484)
T KOG1023|consen 216 QIRSKLL 222 (484)
T ss_pred HHHhhhh
Confidence 5555443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.5e-13 Score=163.19 Aligned_cols=143 Identities=23% Similarity=0.398 Sum_probs=96.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc--------------------------cc-----hhHHHHH
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------------------------IR-----KNDIERI 734 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei--------------------------~k-----k~~ie~~ 734 (1092)
..+|+. +.||.|++|+||+|+.+.+|+.||||++++.-. .+ .+....+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456777 799999999999999998899999999974310 00 0112233
Q ss_pred HHHHHHHHhc------C----CCceEEEeeeecc-CCeeEEEEeecCCCcHHHH--HHhhc----CCCHHHHHHHHHHHH
Q 001360 735 LAERNILITV------R----NPFVVRFFYSFTC-RDNLYLVMEYLNGGDLYSL--LRKVG----CLEEDVARIYIAELV 797 (1092)
Q Consensus 735 l~EieIL~~L------~----HPNIVkL~~sfqd-e~~LYLVMEYm~GGSL~dl--Lkk~g----~LsE~~ar~yaaQIL 797 (1092)
.+|++.+... . +...+.+-..|.+ ....+|||||+.|+.+.++ +...+ .+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 4444444332 1 2222222222211 2335799999999999774 33333 244445555555554
Q ss_pred HHHHHHHHcCCeeeecCCCceEecCCC----cEEEEecCCccc
Q 001360 798 LALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKI 836 (1092)
Q Consensus 798 ~ALeYLHs~GIIHRDLKPeNILLD~nG----~VKLsDFGLAk~ 836 (1092)
..|++|+|+||.||+++.+| .+++.|||++..
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 58999999999999999988 999999999874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.6e-12 Score=148.25 Aligned_cols=138 Identities=24% Similarity=0.308 Sum_probs=94.9
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--c------------------------h-h----H------HHHHH
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--R------------------------K-N----D------IERIL 735 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~--k------------------------k-~----~------ie~~l 735 (1092)
+.||.|++|.||+|+.+ +|+.||||+.+..-.. . . . - .-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999976 6899999998642100 0 0 0 0 01244
Q ss_pred HHHHHHHhcC-----CCceE--EEeeeeccCCeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHH-HHHHHHHc
Q 001360 736 AERNILITVR-----NPFVV--RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVL-ALEYLHSL 806 (1092)
Q Consensus 736 ~EieIL~~L~-----HPNIV--kL~~sfqde~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~-ALeYLHs~ 806 (1092)
+|...+.++. +++|. ++|..+ ....+|||||++|++|.++.... ..++ ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4555555442 34332 333222 33468999999999998876532 1222 2334555555 47789999
Q ss_pred CCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 807 GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
|++|+|+||.||+++.+|.++|+|||++..
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 999999999999999999999999999875
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.2e-12 Score=126.31 Aligned_cols=128 Identities=18% Similarity=0.290 Sum_probs=96.1
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce-EEEeeeeccCCeeEEEEeecC
Q 001360 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDNLYLVMEYLN 770 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNI-VkL~~sfqde~~LYLVMEYm~ 770 (1092)
++.|+.|.++.||+++.. |..|++|+...... ....+..|..++..+.+.++ .+++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999864 78899998754321 12235678888888765443 34554433 34589999999
Q ss_pred CCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCC-----eeeecCCCceEecCCCcEEEEecCCccc
Q 001360 771 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI-----VHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 771 GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GI-----IHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
|.++... . .....++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+..
T Consensus 75 G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887643 0 1123456799999999999985 9999999999999 67899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.5e-12 Score=153.03 Aligned_cols=263 Identities=25% Similarity=0.258 Sum_probs=192.8
Q ss_pred CCCeEEEEeecc--CCCeEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC
Q 001360 686 IDDFEIIKPISR--GAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD 760 (1092)
Q Consensus 686 ~~dFeilr~LGk--GgFGtVyLar~--k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~ 760 (1092)
-..|.+...+|. |.+|.||.+.. ..++..+|+|.=+. .......-.+=++|..-..+++ |++.|+.+..+...+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 345677788999 99999999998 88899999996322 1111122233455666666665 999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhcC-CCHHHHHHHHHHHHH----HHHHHHHcCCeeeecCCCceEecCC-CcEEEEecCCc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVL----ALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLS 834 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~-LsE~~ar~yaaQIL~----ALeYLHs~GIIHRDLKPeNILLD~n-G~VKLsDFGLA 834 (1092)
.+|+-+|++. .+|..+...... +++..++.++.+... ||.++|..+++|-|+||.||++..+ ..++++|||+.
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 9999999985 688888877655 888899999999999 9999999999999999999999999 88999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
......+ +.. . .......-|..-|++||++.+ -++...|+++||.++.+-.+|..++
T Consensus 271 ~~i~~~~------------------~~~---~-~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 271 SKISDGN------------------FSS---V-FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred EEccCCc------------------ccc---c-eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence 7432111 000 0 001122357788999999875 5889999999999999998887665
Q ss_pred CCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 915 ~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
...-... +..+-+..++ ..+-...+.++...+..|+..+|..|++ +..+++|++.....
T Consensus 328 ~~g~~~~-W~~~r~~~ip-~e~~~~~s~~l~~~~~~~~d~~~~~~~~---~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 328 SVGKNSS-WSQLRQGYIP-LEFCEGGSSSLRSVTSQMLDEDPRLRLT---AQILTALNVIHSKL 386 (524)
T ss_pred cCCCCCC-ccccccccCc-hhhhcCcchhhhhHHHHhcCcchhhhhH---HHHHhccccccchh
Confidence 4331000 0011111111 1122345667777999999999999999 78899999987543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.4e-12 Score=153.16 Aligned_cols=251 Identities=26% Similarity=0.247 Sum_probs=187.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEEC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k-~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~ 761 (1092)
....+|..+..||.|.|+.|+.+..+ .++..|++|.+.+...... +...-+.|+.+...+. |.+++.++..+...++
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~-~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA-SDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH-hhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 45678999999999999999998876 6788999998876433322 2333456666666664 9999999999998899
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC-CcEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n-G~VKLsDFGLAk~~~~n 840 (1092)
.|+-.|||.++++...+.-...+.+...+....|++.|+.++|+..++|+|+||+||++..+ +..++.|||..+.+...
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 99999999999988777655678889999999999999999999999999999999999886 78899999987621100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCC--ChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL--APEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~Ym--APEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
.....++-.++ +|+......+..++|++|||.-++|.++|.+-=...
T Consensus 421 ------------------------------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~- 469 (524)
T KOG0601|consen 421 ------------------------------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG- 469 (524)
T ss_pred ------------------------------cccccccccccccchhhccccccccccccccccccccccccCcccCccc-
Confidence 01122333444 444555677889999999999999999986421111
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.....|..+..+.. .....++..+.+.++..++..|+. +.++..|+=|
T Consensus 470 --~~~~~i~~~~~p~~---~~~~~~~q~~~kv~~~~~~~~~~l---~~~l~~~~~~ 517 (524)
T KOG0601|consen 470 --VQSLTIRSGDTPNL---PGLKLQLQVLLKVMINPDRKRRPS---AVELSLHSEF 517 (524)
T ss_pred --ccceeeecccccCC---CchHHhhhhhhhhhcCCccccchh---hhhhcccchh
Confidence 11222333433322 334488999999999999999998 6666666555
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.7e-11 Score=124.84 Aligned_cols=139 Identities=22% Similarity=0.165 Sum_probs=100.2
Q ss_pred EeeccCCCeEEEEEEECC------CCcEEEEEEeecccc-------------------cchhHHHHH----HHHHHHHHh
Q 001360 693 KPISRGAFGRVFLARKRT------TGDLFAIKVLKKLDM-------------------IRKNDIERI----LAERNILIT 743 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~------TGk~VAIKvLkK~ei-------------------~kk~~ie~~----l~EieIL~~ 743 (1092)
..||.|--+.||.|.... .+..+|||+.+-... .+.+....+ .+|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 357999998762110 011112233 389999988
Q ss_pred cC--CCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHH-HHcCCeeeecCCCceEe
Q 001360 744 VR--NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLI 820 (1092)
Q Consensus 744 L~--HPNIVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYL-Hs~GIIHRDLKPeNILL 820 (1092)
+. .-++.+.+++ ..-+|||||+.++.+..-.-+...+++.....+..+++.+|..| |+.||||+||+|.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 75 2445555543 45689999997755533222333466666777889999999999 89999999999999999
Q ss_pred cCCCcEEEEecCCccc
Q 001360 821 AHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 821 D~nG~VKLsDFGLAk~ 836 (1092)
+ +|.+.|+|||.+..
T Consensus 159 ~-~~~v~iIDF~qav~ 173 (197)
T cd05146 159 H-DGKVWFIDVSQSVE 173 (197)
T ss_pred E-CCcEEEEECCCcee
Confidence 6 57899999998863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-10 Score=137.63 Aligned_cols=169 Identities=21% Similarity=0.362 Sum_probs=128.4
Q ss_pred EEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhcCC
Q 001360 705 LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 784 (1092)
Q Consensus 705 Lar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~L 784 (1092)
.|..+.++.+|.+.+.+...- .....+.+-+.-|+.++||||++++..+..+..+|||+|-+. .|..++.+.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--
Confidence 456677888999888865332 335567778889999999999999999999999999999985 5777777654
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcc
Q 001360 785 EEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863 (1092)
Q Consensus 785 sE~~ar~yaaQIL~ALeYLH-s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~ 863 (1092)
......-+.||+.||.||| +.+++|.+|.-+-|+++..|+.||++|-++.... +..+
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~-------------~~~~-------- 160 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS-------------GFNA-------- 160 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc-------------cCCc--------
Confidence 6666777889999999998 5689999999999999999999999999875311 0000
Q ss_pred cccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC
Q 001360 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910 (1092)
Q Consensus 864 ~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTG 910 (1092)
......---.|..|+.+.... ...|.|-|||+++|++.|
T Consensus 161 ------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 ------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 000111112356666543322 567999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.4e-10 Score=116.82 Aligned_cols=140 Identities=20% Similarity=0.256 Sum_probs=104.9
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccC---CeeEEEEe
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCR---DNLYLVME 767 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H--PNIVkL~~sfqde---~~LYLVME 767 (1092)
+.||.|.++.||++...+ |..|++|+....... .....+..|..++..+.+ ..+.+++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 678999999999998753 688999987654321 124567889999999875 3456666665553 26789999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS------------------------------------------ 805 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs------------------------------------------ 805 (1092)
|++|+++.+.+.. ..+++.....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 345666666677777777777773
Q ss_pred --------------cCCeeeecCCCceEecC--CCcEEEEecCCccc
Q 001360 806 --------------LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKI 836 (1092)
Q Consensus 806 --------------~GIIHRDLKPeNILLD~--nG~VKLsDFGLAk~ 836 (1092)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 67789999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.2e-10 Score=127.55 Aligned_cols=210 Identities=24% Similarity=0.334 Sum_probs=147.0
Q ss_pred HHHHhcCCCceEEEeeeeccCC-----eeEEEEeecCCCcHHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHcC--
Q 001360 739 NILITVRNPFVVRFFYSFTCRD-----NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLG-- 807 (1092)
Q Consensus 739 eIL~~L~HPNIVkL~~sfqde~-----~LYLVMEYm~GGSL~dlLkk~----g~LsE~~ar~yaaQIL~ALeYLHs~G-- 807 (1092)
+-|-.+.|-|||+++.++.+.. ...+++|||..|+|..+|++. ..+.....+.|+.||+.||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3455667999999998876654 478999999999999999864 35778888899999999999999985
Q ss_pred CeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc
Q 001360 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 887 (1092)
Q Consensus 808 IIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~ 887 (1092)
|||+.+..+-|++..+|-||+.---.... +.. .............|-++|.|||.=.
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~----------------------h~s-~~~~~~~Ek~~~~~~~g~~a~~sg~ 255 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDST----------------------HPS-VNSTREAEKSVNTSLPGFSAPESGT 255 (458)
T ss_pred cccCCcchhheeecCCceEEecccCcccc----------------------chh-hhhhhHhhhhccccCCccccCCcCc
Confidence 99999999999999999888752211110 000 0001111122334678999999765
Q ss_pred CCCCCccceeechhhhHHHHHhCCCC-CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHH
Q 001360 888 GTEHGYAADWWSVGIILFEFITGIPP-FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (1092)
Q Consensus 888 g~~Yt~ksDVWSLGVILYEMLTGk~P-F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~ 966 (1092)
....+-.+|||+||....||..|..- -.+.+....-..|.+-.+-. .. .--+++|.+||+-.|..||+ +.
T Consensus 256 ~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l---en---~lqr~~i~kcl~~eP~~rp~---ar 326 (458)
T KOG1266|consen 256 TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL---EN---GLQRGSITKCLEGEPNGRPD---AR 326 (458)
T ss_pred ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec---cC---ccccCcCcccccCCCCCCcc---hh
Confidence 55667789999999999999987653 33332222222221111100 01 12357899999999999999 88
Q ss_pred HHHcCCCCCCCCcc
Q 001360 967 EVKAHPFFKGVNWD 980 (1092)
Q Consensus 967 EIL~HPFFkgIdWd 980 (1092)
+++.||..-++--.
T Consensus 327 ~llfHpllfeVhsl 340 (458)
T KOG1266|consen 327 LLLFHPLLFEVHSL 340 (458)
T ss_pred hhhcCceeeecchH
Confidence 99999988665443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.7e-09 Score=113.48 Aligned_cols=134 Identities=29% Similarity=0.311 Sum_probs=98.0
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEee-c----ccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLK-K----LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLk-K----~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
..+++|+-+.+|.+.+. |..+.+|.=. | ..+..+-...+..+|..+|.++.--.|..-+-++.+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999775 5556666432 2 112222234567889999988864333332334456677789999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
|++|-.|.+.+... . -.++..+-.-+.-||..||||+||.++||++...+ +.++||||+.+
T Consensus 80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888765 1 34566777778889999999999999999997554 99999999985
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.3e-08 Score=106.99 Aligned_cols=144 Identities=24% Similarity=0.253 Sum_probs=105.0
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEe-----ecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVL-----KKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~TGk~VAIKvL-----kK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.+..|-+|+-+.|+++.+. |+.+.||.- +...+..+-...+..+|.++|.++.--.|.--.-+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 6778899999999999875 888888842 222222233456788999999887633332222345566666899
Q ss_pred EeecCC-CcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC---cEEEEecCCccc
Q 001360 766 MEYLNG-GDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 836 (1092)
Q Consensus 766 MEYm~G-GSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLsDFGLAk~ 836 (1092)
|||++| -++.+++.... .........++..|-..|.-||.++|||+||..+||||..+| .+-|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 47788886543 222333367788999999999999999999999999998766 358999999864
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.6e-09 Score=127.95 Aligned_cols=170 Identities=20% Similarity=0.323 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHc-CCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCcc
Q 001360 794 AELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872 (1092)
Q Consensus 794 aQIL~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~ 872 (1092)
.+++.||.|+|.. ++||+.|-|++|.++.+|.+||+.|+++..... . ....+..|. .....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~--~-------------~~~p~~~yd---~~lp~ 167 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANG--P-------------TEYPFSEYD---PPLPL 167 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCC--C-------------CccccccCC---CCCCh
Confidence 3556999999976 899999999999999999999999998763211 0 011111111 11122
Q ss_pred CccCCCCCCChhhhcCCCCCccceeechhhhHHHHH-hCCCCCCCCChHHHHHHHh-hcCCCCCCCCCCCCHHHHHHHHH
Q 001360 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI-TGIPPFTAESPEIIFDNIL-NRKIPWPCVPSDMSFEAQDLINR 950 (1092)
Q Consensus 873 s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEML-TGk~PF~~~s~~ei~~kIl-~~~l~fP~ip~~lS~eakDLI~k 950 (1092)
...-...|.|||++.+...+.++|+|||||++|-+. .|+.-|...+....+..-. ......-.....++.++++=|.+
T Consensus 168 ~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 168 LLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred hhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHH
Confidence 233457899999999988899999999999999998 4666665554333332221 12222222347899999999999
Q ss_pred hccCCcCCCCCcccHHHHHcCCCCCCCCcchhhh
Q 001360 951 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 984 (1092)
Q Consensus 951 cL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~ 984 (1092)
+|..++..||+ +..++..|||.+..-..|+.
T Consensus 248 ~l~~~~~~rp~---~~~l~~~~ff~D~~~~aLrf 278 (700)
T KOG2137|consen 248 LLNGDSAVRPT---LDLLLSIPFFSDPGLKALRF 278 (700)
T ss_pred HhcCCcccCcc---hhhhhcccccCCchhhhhhh
Confidence 99999999997 88999999999876655543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=2e-07 Score=102.73 Aligned_cols=131 Identities=15% Similarity=0.140 Sum_probs=90.7
Q ss_pred EEEEEECCCCcEEEEEEeecccc---cch-----hHHHHHHHHHHHHHhcC-----CCceEEEeeeecc--CCeeEEEEe
Q 001360 703 VFLARKRTTGDLFAIKVLKKLDM---IRK-----NDIERILAERNILITVR-----NPFVVRFFYSFTC--RDNLYLVME 767 (1092)
Q Consensus 703 VyLar~k~TGk~VAIKvLkK~ei---~kk-----~~ie~~l~EieIL~~L~-----HPNIVkL~~sfqd--e~~LYLVME 767 (1092)
|+.+.. .|+.|.||....... .+. .-...+.+|...+.++. -|.+|-+...-.. ...-|||||
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 445544 367788886532211 000 11124678888887763 3444443211111 234789999
Q ss_pred ecCCC-cHHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-------CCcEEEEecCCcc
Q 001360 768 YLNGG-DLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-------DGHIKLTDFGLSK 835 (1092)
Q Consensus 768 Ym~GG-SL~dlLkk--~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~-------nG~VKLsDFGLAk 835 (1092)
++++- +|.+++.. ....+......++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99886 79888864 234566778889999999999999999999999999999985 4689999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.8e-07 Score=107.08 Aligned_cols=202 Identities=20% Similarity=0.234 Sum_probs=146.3
Q ss_pred CeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----CeeEEEEeecCC-CcH
Q 001360 700 FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----DNLYLVMEYLNG-GDL 774 (1092)
Q Consensus 700 FGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde----~~LYLVMEYm~G-GSL 774 (1092)
-.+.|++....+|..|++|.++-.+....+ ....-+++++++.|+|||++..+|.+. ..++||++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 347899999999999999998533322221 233456789999999999999999843 358999999986 577
Q ss_pred HHHHHh---------------hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 775 YSLLRK---------------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 775 ~dlLkk---------------~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
+++--. ....+|..++.|+.|+..||.++|+.|+.-+-|.|.+||++.+-.++|+-.|+..+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 766521 12468899999999999999999999999999999999999888888887776543210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCC-CCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP-FTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~P-F~~~s 918 (1092)
+ . + |-+.++ .+-|.=.||.+++.|.||..- +..+.
T Consensus 446 d---------------------------~-------~-------~~le~~---Qq~D~~~lG~ll~aLAt~~~ns~~~d~ 481 (655)
T KOG3741|consen 446 D---------------------------P-------T-------EPLESQ---QQNDLRDLGLLLLALATGTENSNRTDS 481 (655)
T ss_pred C---------------------------C-------C-------cchhHH---hhhhHHHHHHHHHHHhhcccccccccc
Confidence 0 0 1 111111 245777899999999998532 33333
Q ss_pred hHHH-HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCC
Q 001360 919 PEII-FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 958 (1092)
Q Consensus 919 ~~ei-~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~K 958 (1092)
.+.. .+.| ....+.+++++|.-+...++.+
T Consensus 482 ~~~s~~~~I----------~~~yS~D~rn~v~yl~s~~~~~ 512 (655)
T KOG3741|consen 482 TQSSHLTRI----------TTTYSTDLRNVVEYLESLNFRE 512 (655)
T ss_pred hHHHHHHHh----------hhhhhHHHHHHHHHHHhcCccc
Confidence 3333 2222 2456788999999999888884
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.3e-07 Score=97.55 Aligned_cols=127 Identities=25% Similarity=0.280 Sum_probs=81.9
Q ss_pred EEEEEEECCCCcEEEEEEeecccc-----------------------cchhHHHHHHHHHHHHHhcCCC--ceEEEeeee
Q 001360 702 RVFLARKRTTGDLFAIKVLKKLDM-----------------------IRKNDIERILAERNILITVRNP--FVVRFFYSF 756 (1092)
Q Consensus 702 tVyLar~k~TGk~VAIKvLkK~ei-----------------------~kk~~ie~~l~EieIL~~L~HP--NIVkL~~sf 756 (1092)
.||.|... .|..+|+|+.+.... ..........+|.+.|.++..- ++.+.+.+.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38888864 578999998753110 0111234578899999999754 456665442
Q ss_pred ccCCeeEEEEeecC--CCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHH-HHHcCCeeeecCCCceEecCCCcEEEEecCC
Q 001360 757 TCRDNLYLVMEYLN--GGDLYSLLRKVGCLEEDVARIYIAELVLALEY-LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1092)
Q Consensus 757 qde~~LYLVMEYm~--GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeY-LHs~GIIHRDLKPeNILLD~nG~VKLsDFGL 833 (1092)
.-+|||||+. |..+..+... . ++......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~-~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV-D-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC-G-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc-c-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3479999998 6555443322 1 2244556677788886665 579999999999999999876 899999998
Q ss_pred ccc
Q 001360 834 SKI 836 (1092)
Q Consensus 834 Ak~ 836 (1092)
+..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 863
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.3e-07 Score=94.95 Aligned_cols=106 Identities=29% Similarity=0.364 Sum_probs=82.2
Q ss_pred HHHHHHHHHHHHhcC-----CCceEEEeeeecc-CCeeEEEEeecCCC-cHHHHHHhhcCCCHHHHHHHHHHHHHHHHHH
Q 001360 731 IERILAERNILITVR-----NPFVVRFFYSFTC-RDNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYL 803 (1092)
Q Consensus 731 ie~~l~EieIL~~L~-----HPNIVkL~~sfqd-e~~LYLVMEYm~GG-SL~dlLkk~g~LsE~~ar~yaaQIL~ALeYL 803 (1092)
.....+|...+..+. -|-.|-+...-.. ...-|||||+++|- +|.+++.....++......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 345777877776664 3444443221111 12458999999984 7999998755577788889999999999999
Q ss_pred HHcCCeeeecCCCceEecCCC---cEEEEecCCccc
Q 001360 804 HSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 836 (1092)
Q Consensus 804 Hs~GIIHRDLKPeNILLD~nG---~VKLsDFGLAk~ 836 (1092)
|..||+|+|++|.|||++.++ .+.|+||+-++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999998774
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.7e-08 Score=120.27 Aligned_cols=243 Identities=22% Similarity=0.222 Sum_probs=163.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCCeeEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPN-IVkL~~sfqde~~LYL 764 (1092)
...+....-+++|+++++++.+...+...+ .+++.. .....-++++|.+++||| .+..++.++.++..++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~--------~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQ--------TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeecc--------chhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 345566677899999999988776554444 554432 144566889999999999 8888888888999999
Q ss_pred EEeecCCC-cHHHHH-HhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 765 VMEYLNGG-DLYSLL-RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 765 VMEYm~GG-SL~dlL-kk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
+|+++.+| +..... ...-.|.+-+.....+.-+++++|||+.-=+||| |||..+ +..|+.||+.....
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L----- 381 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQL----- 381 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCccc-----
Confidence 99999887 221111 1111233444455666778899999998778999 888754 77899999976531
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.+.....+..||+.++|||+.....+....|.|++|+--.+|.-|-+|-... ...
T Consensus 382 -----------------------~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~ 436 (829)
T KOG0576|consen 382 -----------------------TRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAV 436 (829)
T ss_pred -----------------------CcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccc
Confidence 1111346788999999999999999999999999999777888887775441 111
Q ss_pred HHHHhhcCCCCCCCCC--CC-CHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 923 FDNILNRKIPWPCVPS--DM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~--~l-S~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
...+-++. .-|.+.. .. +..-.++...|+..-|..|+. ....+.|.+|.+
T Consensus 437 ~~~~g~~p-~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv---~mgacfsKvfng 489 (829)
T KOG0576|consen 437 LPMIGNGP-NSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKV---HMGACFSKVFNG 489 (829)
T ss_pred cCCCCCCC-CccccchhhhcCcccccCCcccccCCCCCCCcc---hhhHHHHHHhcc
Confidence 11111110 0000000 00 011124667788888888777 556677888876
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=5e-06 Score=96.05 Aligned_cols=231 Identities=17% Similarity=0.247 Sum_probs=148.3
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEE--------EeeeeccCCee
Q 001360 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR--------FFYSFTCRDNL 762 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVk--------L~~sfqde~~L 762 (1092)
.+.||+|+-+.+|-.-.- +. .+-|++.+...-.. ..-+..|... .||-+-. ||+. .....+
T Consensus 16 gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~i 85 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVI 85 (637)
T ss_pred CccccCCccceeeecchh--hc-hhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCC-Ccccee
Confidence 467999999999965432 22 33477765432111 1122233333 3553322 1221 112236
Q ss_pred EEEEeecCCCcHHHHHH-------hhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcc
Q 001360 763 YLVMEYLNGGDLYSLLR-------KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLk-------k~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 835 (1092)
-+.|..++|-.--..+. ....+.+..+...+++|+.+...||..|.+-+|+.++|+|+.+++.|.|.|=..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 78888887743222221 12347788899999999999999999999999999999999999999999754221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhC
Q 001360 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITG 910 (1092)
Q Consensus 836 ~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Yt~ksDVWSLGVILYEMLTG 910 (1092)
+. .........+|.+.|.+||.-. +..-+...|-|.|||++|++|.|
T Consensus 166 i~----------------------------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~g 217 (637)
T COG4248 166 IN----------------------------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFG 217 (637)
T ss_pred ec----------------------------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhc
Confidence 10 1122234578999999999865 23446789999999999999986
Q ss_pred -CCCCCCCC-------hHHHHHHHhhcC-----------CCCCCC--CCCCCHHHHHHHHHhccC--CcCCCCCc
Q 001360 911 -IPPFTAES-------PEIIFDNILNRK-----------IPWPCV--PSDMSFEAQDLINRFLIH--DPNQRLGA 962 (1092)
Q Consensus 911 -k~PF~~~s-------~~ei~~kIl~~~-----------l~fP~i--p~~lS~eakDLI~kcL~k--DP~KRpSa 962 (1092)
+.||.+.. +-++ .|-.+. .+-|.- ..-++++++.|..+|+.. ++.-||++
T Consensus 218 grHPysGI~~~~~ap~p~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a 290 (637)
T COG4248 218 GRHPYSGIPLISDAPNPLET--DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA 290 (637)
T ss_pred CCCCCCcccccCCCCCcchh--hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence 99997632 2221 222211 111110 134788999999999984 24579994
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.8e-05 Score=79.60 Aligned_cols=138 Identities=28% Similarity=0.380 Sum_probs=82.4
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--ceEEEeeee---ccCCeeEEEE
Q 001360 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYSF---TCRDNLYLVM 766 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HP--NIVkL~~sf---qde~~LYLVM 766 (1092)
++.|+.|..+.||++.... ..|++|+.... .....+.+|..++..+... .+.+++... ......|++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999998764 58999986542 3456677888888777522 245555433 2233479999
Q ss_pred eecCCCcHHH----------------HHH---hh--c--CCCHHH------HHHH---------------HHHHHH-HHH
Q 001360 767 EYLNGGDLYS----------------LLR---KV--G--CLEEDV------ARIY---------------IAELVL-ALE 801 (1092)
Q Consensus 767 EYm~GGSL~d----------------lLk---k~--g--~LsE~~------ar~y---------------aaQIL~-ALe 801 (1092)
++++|..+.. .+. .. . .+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987777 111 11 0 001000 0000 111222 333
Q ss_pred HHHH-------cCCeeeecCCCceEec-CCCcEEEEecCCccc
Q 001360 802 YLHS-------LGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKI 836 (1092)
Q Consensus 802 YLHs-------~GIIHRDLKPeNILLD-~nG~VKLsDFGLAk~ 836 (1092)
.++. ..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 3332 3599999999999999 677778999998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.8e-05 Score=85.82 Aligned_cols=141 Identities=21% Similarity=0.309 Sum_probs=91.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhc---CCCceEEEee
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER------ILAERNILITV---RNPFVVRFFY 754 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~------~l~EieIL~~L---~HPNIVkL~~ 754 (1092)
+..++|++++++-......|.+..- +|+.|++|..+......+..... ..+++..+.++ .--....+|.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 4557889999998888777777654 47899999876532211111111 12233333333 2222222222
Q ss_pred -----eeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEE
Q 001360 755 -----SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 829 (1092)
Q Consensus 755 -----sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLs 829 (1092)
.+.-....+|||||++|..|.++.. +++. +...++.+|.-||+.|+.|+|..|.|++++.++ +++.
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence 2222334568999999988866532 3332 345677889999999999999999999998555 9999
Q ss_pred ecCCcc
Q 001360 830 DFGLSK 835 (1092)
Q Consensus 830 DFGLAk 835 (1092)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.3e-05 Score=84.44 Aligned_cols=139 Identities=14% Similarity=0.203 Sum_probs=100.3
Q ss_pred ccCCCeEEEEEEECCCCcEEEEEEeecc---cccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccC----CeeEEEE
Q 001360 696 SRGAFGRVFLARKRTTGDLFAIKVLKKL---DMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCR----DNLYLVM 766 (1092)
Q Consensus 696 GkGgFGtVyLar~k~TGk~VAIKvLkK~---ei~kk~~ie~~l~EieIL~~L~H--PNIVkL~~sfqde----~~LYLVM 766 (1092)
|+||-+-|+..... |+.|-+|.-... ..........|.+|...|..+.. -.+.+...+-... -.-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 57888889887754 446777865411 11113356779999999988852 2244444221111 1368999
Q ss_pred eecCC-CcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc--EEEEecCCccc
Q 001360 767 EYLNG-GDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKI 836 (1092)
Q Consensus 767 EYm~G-GSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~--VKLsDFGLAk~ 836 (1092)
|-+.| -+|.+++.+. ...+......++.+++.+|.-||+.|+.|+|+-+.|||++.+|. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98864 5888888664 34567777889999999999999999999999999999987777 99999997764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.13 E-value=9.1e-06 Score=90.12 Aligned_cols=136 Identities=24% Similarity=0.243 Sum_probs=97.2
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeecc-------ccc----------ch--hHHHHHHHHHHHHHhcCCC--c
Q 001360 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL-------DMI----------RK--NDIERILAERNILITVRNP--F 748 (1092)
Q Consensus 690 eilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~-------ei~----------kk--~~ie~~l~EieIL~~L~HP--N 748 (1092)
.+...||-|--+.||.|... .|..+|||.=+-. ... .. -......+|.++|.++... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45578999999999999876 5899999964311 000 00 1123457788899888643 4
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEE
Q 001360 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 828 (1092)
Q Consensus 749 IVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKL 828 (1092)
|.+-++ .+.-.+||||+.|-.|...- ++......++..|+.-+.-+-..||||+|+.+-|||++.+|.+.+
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 444443 24568999999997665432 234444555666666666666899999999999999999999999
Q ss_pred EecCCcc
Q 001360 829 TDFGLSK 835 (1092)
Q Consensus 829 sDFGLAk 835 (1092)
+||--+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9998765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.3e-05 Score=101.32 Aligned_cols=238 Identities=24% Similarity=0.256 Sum_probs=160.3
Q ss_pred eccCCCeEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe----eEEEE
Q 001360 695 ISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN----LYLVM 766 (1092)
Q Consensus 695 LGkGgFGtVyLar~k~TG----k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~----LYLVM 766 (1092)
|..-.+|+|+++++..-- .++-++.=.-.....+.++.....|...+.++.|+|++.++.+-..... +.+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 556677777777663210 0111110000011122344555667778888999999999877654432 34556
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCC---ceEecCCCcEEEE--ecCCcccccccc
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD---NLLIAHDGHIKLT--DFGLSKIGLINN 841 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPe---NILLD~nG~VKLs--DFGLAk~~~~n~ 841 (1092)
++++.-++...+...+..+...++.+..++++||.|+|+....|.=|-.. +-..+..+.+.++ ||+.++....
T Consensus 266 ~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d-- 343 (1351)
T KOG1035|consen 266 EICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD-- 343 (1351)
T ss_pred hhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCC--
Confidence 88999999999999999999999999999999999999996666665554 4455566777777 8887764321
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc--ceeechhhhHHHHHhCCCCCC-CCC
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA--ADWWSVGIILFEFITGIPPFT-AES 918 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~k--sDVWSLGVILYEMLTGk~PF~-~~s 918 (1092)
.....+..-+..|.|||.+....+..+ .|+|.+|.....+..|..+-. ...
T Consensus 344 --------------------------~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~ 397 (1351)
T KOG1035|consen 344 --------------------------NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV 397 (1351)
T ss_pred --------------------------cccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc
Confidence 111223344567888998887766654 699999999999988754311 111
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
+ .+..+.....+..+++.+|+..++++|++ +.+++.|||.+-
T Consensus 398 ~-------------~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~---~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 398 P-------------VSLLDVLSTSELLDALPKCLDEDSEERLS---ALELLTHPFLRF 439 (1351)
T ss_pred h-------------hhhhccccchhhhhhhhhhcchhhhhccc---hhhhhhchhccc
Confidence 1 11111222237788999999999999999 889999999864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.7e-05 Score=81.87 Aligned_cols=135 Identities=16% Similarity=0.120 Sum_probs=83.3
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--ceEEEeeeeccCCeeEEEEeecC
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYSFTCRDNLYLVMEYLN 770 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HP--NIVkL~~sfqde~~LYLVMEYm~ 770 (1092)
..||.|..+.||+. .|..+++|...... ....+.+|.+++..+..- .+.+.+++..+.+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999974 24567788775421 234468899999887532 24566666677777899999999
Q ss_pred CCc-HH--------------HHH-------Hhh--cCCCHHH-HHHHHHH----------HHH-HHHHHHH----cCCee
Q 001360 771 GGD-LY--------------SLL-------RKV--GCLEEDV-ARIYIAE----------LVL-ALEYLHS----LGIVH 810 (1092)
Q Consensus 771 GGS-L~--------------dlL-------kk~--g~LsE~~-ar~yaaQ----------IL~-ALeYLHs----~GIIH 810 (1092)
|.+ +. ..+ +.. ....... ...+..+ +.. ...+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 11 111 100 0011000 0011000 111 1222221 24789
Q ss_pred eecCCCceEecCCCcEEEEecCCcccc
Q 001360 811 RDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 811 RDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
+|+.|.||+++.+| +.|+||+.+..+
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCcC
Confidence 99999999999888 999999988753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.9e-05 Score=93.00 Aligned_cols=139 Identities=25% Similarity=0.312 Sum_probs=87.4
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccc--------------------------cch-----hHHHH------HH
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------------------------IRK-----NDIER------IL 735 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei--------------------------~kk-----~~ie~------~l 735 (1092)
..|+.++-|.||.|+.+. |+.||||+.+..-. ... +-.+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999875 99999999753100 000 00111 23
Q ss_pred HHHHHHHhcC-----CCceEEEeeeeccCCeeEEEEeecCCCcHHHHH--HhhcCCCHHHHHHHHHHHHHH-HHHHHHcC
Q 001360 736 AERNILITVR-----NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLA-LEYLHSLG 807 (1092)
Q Consensus 736 ~EieIL~~L~-----HPNIVkL~~sfqde~~LYLVMEYm~GGSL~dlL--kk~g~LsE~~ar~yaaQIL~A-LeYLHs~G 807 (1092)
+|..-+.+++ .|+|.--.-+.+-...-.|+|||+.|-.+.+.. .. ..++...+ +..++.+ +.-+=..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHHHhcC
Confidence 4444444432 343322111222233457999999998888774 44 34553222 2222222 22333479
Q ss_pred CeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 808 IIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
++|.|..|.||+++.+|++-+.|||+...
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceec
Confidence 99999999999999999999999998764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00014 Score=78.05 Aligned_cols=128 Identities=27% Similarity=0.390 Sum_probs=92.6
Q ss_pred CCeEEEEeeccCCC-eEEEEEEECCCCcEEEEEEeeccccc---------ch---------hHHHHHHHHHHHHHhcC--
Q 001360 687 DDFEIIKPISRGAF-GRVFLARKRTTGDLFAIKVLKKLDMI---------RK---------NDIERILAERNILITVR-- 745 (1092)
Q Consensus 687 ~dFeilr~LGkGgF-GtVyLar~k~TGk~VAIKvLkK~ei~---------kk---------~~ie~~l~EieIL~~L~-- 745 (1092)
.+++.++.||.|.- |.||+++.. |+.||+|+++.-... .. ....-|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 79999999999999 999999875 889999994321110 00 12345778887766654
Q ss_pred -CCce--EEEeeeeccC------------------CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH
Q 001360 746 -NPFV--VRFFYSFTCR------------------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804 (1092)
Q Consensus 746 -HPNI--VkL~~sfqde------------------~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLH 804 (1092)
+..+ |+.|++..-. ....||.||++... .+.. .-+.+|..-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 4455 9999887322 12468899887643 1222 23567888899999
Q ss_pred HcCCeeeecCCCceEecCCCcEEEEecCCc
Q 001360 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1092)
Q Consensus 805 s~GIIHRDLKPeNILLD~nG~VKLsDFGLA 834 (1092)
+.||+-+|+++.|.. +| ||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---CC--EEEecccC
Confidence 999999999999987 33 89999953
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.89 E-value=9e-05 Score=78.91 Aligned_cols=135 Identities=15% Similarity=0.121 Sum_probs=82.4
Q ss_pred eeccCCC-eEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeecCC
Q 001360 694 PISRGAF-GRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1092)
Q Consensus 694 ~LGkGgF-GtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LYLVMEYm~G 771 (1092)
.|-.|.. ..||++... +..+.+|+..... ...+.+|+.++..+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3444555 789998653 4678888775432 234667888887774 34455677777666678999999999
Q ss_pred CcHHHHH----------------HhhcCC-------CHH------HHHHHHH----------------HHHHHHHHHH--
Q 001360 772 GDLYSLL----------------RKVGCL-------EED------VARIYIA----------------ELVLALEYLH-- 804 (1092)
Q Consensus 772 GSL~dlL----------------kk~g~L-------sE~------~ar~yaa----------------QIL~ALeYLH-- 804 (1092)
.+|.... .+-..+ ... .....+. .+...+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 7765331 100011 100 0000000 0111122221
Q ss_pred -----HcCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 805 -----SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 805 -----s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 23489999999999999988889999998865
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=2e-06 Score=109.77 Aligned_cols=256 Identities=19% Similarity=0.125 Sum_probs=164.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCC-cEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRD- 760 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TG-k~VAIKvLkK~ei--~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~- 760 (1092)
....+++.--+|-|.+++ +++.... ..+.+|+.+..+. ..+-..+..+.|++-++...|++++..+.-.....
T Consensus 1227 ~~e~~EV~l~i~~~~~~R---~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s 1303 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFR---NKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSES 1303 (2724)
T ss_pred Hhhhhheeeecccceeec---cchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCC
Confidence 345666666666665553 3332111 1234555543222 22334456677778778889999998776554433
Q ss_pred -eeEEEEeecCCCcHHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHcC-----CeeeecCCCceEecCCCcEEEEe
Q 001360 761 -NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTD 830 (1092)
Q Consensus 761 -~LYLVMEYm~GGSL~dlLkk~----g~LsE~~ar~yaaQIL~ALeYLHs~G-----IIHRDLKPeNILLD~nG~VKLsD 830 (1092)
..|.+++|+.+|.+++.|.+. ..+....+.....+.+.+..-+|... .+|++||+-|.+|..+..+|+.+
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence 479999999999999999764 23444444444555588888888652 78999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC
Q 001360 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910 (1092)
Q Consensus 831 FGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTG 910 (1092)
+|+.++- + .........++++.|++|++.+.-.++.+.|+|..|+-+|+.-.|
T Consensus 1384 ~gLdKIk--n-------------------------p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1384 GGLDKIK--N-------------------------PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccccccc--C-------------------------chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 9999831 0 111223456789999999999999999899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 911 k~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
.+||.......+...|.++. +-.++.--|.++-.+...+|-..-..||+ -..++.-+.|.
T Consensus 1437 n~~fi~flq~~Lkgiidn~t--f~sIe~l~pgdaNve~~~~Ll~K~~~rp~---q~isls~d~~a 1496 (2724)
T KOG1826|consen 1437 NAYFIFFLQPALKGIIDNHT--FFSIEKLKPGDANVEALHRLLWKYMERPG---QYISLSRDHFA 1496 (2724)
T ss_pred cHHHHHHHHHHHcCcccccc--cccccccCCCcccHHHHHHHHHHhhhcch---hhhhccccccc
Confidence 88874332222222222211 11122222333333333333334556887 44556666654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=7.5e-05 Score=89.73 Aligned_cols=137 Identities=25% Similarity=0.355 Sum_probs=85.9
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccc----------------------------cchhHHHH------HHHHH
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM----------------------------IRKNDIER------ILAER 738 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei----------------------------~kk~~ie~------~l~Ei 738 (1092)
+.||.-+.|.|++|+.+. |+.||||+-+..-. .-.+-.+. |.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 479999999999999987 99999998653100 00000112 23333
Q ss_pred HHHH----hcCCCc------eEEEeeeeccCCeeEEEEeecCCCcHHHH--HHhhcCCCHHHHHHHHHHHHHHHH-HHHH
Q 001360 739 NILI----TVRNPF------VVRFFYSFTCRDNLYLVMEYLNGGDLYSL--LRKVGCLEEDVARIYIAELVLALE-YLHS 805 (1092)
Q Consensus 739 eIL~----~L~HPN------IVkL~~sfqde~~LYLVMEYm~GGSL~dl--Lkk~g~LsE~~ar~yaaQIL~ALe-YLHs 805 (1092)
+-.. .+.|-+ |.++|..+.. .-.|+||||+|.-+.+. |.+.+ ++...+.. .+..+.. -|=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~---~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRG-ISPHDILN---KLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcC-CCHHHHHH---HHHHHHHHHHHh
Confidence 3222 233444 5555544433 35799999999866544 44444 44443322 2333222 2234
Q ss_pred cCCeeeecCCCceEecC----CCcEEEEecCCccc
Q 001360 806 LGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKI 836 (1092)
Q Consensus 806 ~GIIHRDLKPeNILLD~----nG~VKLsDFGLAk~ 836 (1092)
.|++|.|-.|.|||+.. ++.+.+-|||+...
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 68999999999999984 56899999999875
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00016 Score=79.75 Aligned_cols=138 Identities=25% Similarity=0.225 Sum_probs=91.8
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchh-------------------H--HHHHHHHHHHHHhcC--CCc
Q 001360 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-------------------D--IERILAERNILITVR--NPF 748 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~-------------------~--ie~~l~EieIL~~L~--HPN 748 (1092)
...|+.|--+.||+|.. .++..+|+|+++......+. + ..-...|..-|.++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34788888889999975 45889999998642211111 1 112345666666653 222
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCc-HHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcE
Q 001360 749 VVRFFYSFTCRDNLYLVMEYLNGGD-LYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHI 826 (1092)
Q Consensus 749 IVkL~~sfqde~~LYLVMEYm~GGS-L~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~V 826 (1092)
+.+-+.++ .-.|||||+.... -.-.|.. -.+...++..+..+++..+.-|-. .++||+||..-|||+. +|.+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 23333322 2359999996531 1111211 123344788888899999998877 8999999999999999 8999
Q ss_pred EEEecCCccc
Q 001360 827 KLTDFGLSKI 836 (1092)
Q Consensus 827 KLsDFGLAk~ 836 (1092)
.|+|||-|..
T Consensus 206 ~iID~~QaV~ 215 (268)
T COG1718 206 YIIDVSQAVT 215 (268)
T ss_pred EEEECccccc
Confidence 9999998863
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00024 Score=89.51 Aligned_cols=145 Identities=20% Similarity=0.357 Sum_probs=90.4
Q ss_pred EEEeeccCCCeEEEEEEECCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCce--EEEeeeeccC---Cee
Q 001360 691 IIKPISRGAFGRVFLARKRTTG--DLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFV--VRFFYSFTCR---DNL 762 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~TG--k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNI--VkL~~sfqde---~~L 762 (1092)
.++.|+.|.+..+|+......+ ..|++|+........ ....+.+|..+|+.+. |++| .+++.++.+. ...
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3577899999999998875432 467777654322211 2345779999999885 5554 7777777664 457
Q ss_pred EEEEeecCCCcHHH--------------------HHH---hhc----CC---------CHHHHHHHHH------------
Q 001360 763 YLVMEYLNGGDLYS--------------------LLR---KVG----CL---------EEDVARIYIA------------ 794 (1092)
Q Consensus 763 YLVMEYm~GGSL~d--------------------lLk---k~g----~L---------sE~~ar~yaa------------ 794 (1092)
|+||||++|..+.+ .|. ... .+ ...++..+..
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 99999999854211 111 100 00 0112221111
Q ss_pred ---HHHHHHHHHHH-----------cCCeeeecCCCceEecCC-Cc-EEEEecCCcccc
Q 001360 795 ---ELVLALEYLHS-----------LGIVHRDLKPDNLLIAHD-GH-IKLTDFGLSKIG 837 (1092)
Q Consensus 795 ---QIL~ALeYLHs-----------~GIIHRDLKPeNILLD~n-G~-VKLsDFGLAk~~ 837 (1092)
.+...+.+|.. ..+||+|++|.|||++.+ +. +-|.||+++..+
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12233556643 249999999999999853 33 579999999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00045 Score=73.73 Aligned_cols=73 Identities=16% Similarity=0.165 Sum_probs=44.6
Q ss_pred EEeeccCCCe-EEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC---ceEEEeeeeccC---CeeEE
Q 001360 692 IKPISRGAFG-RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP---FVVRFFYSFTCR---DNLYL 764 (1092)
Q Consensus 692 lr~LGkGgFG-tVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HP---NIVkL~~sfqde---~~LYL 764 (1092)
++.|+.|+.. .||++ +..+++|+.+.. .....+.+|..+|..+... -+.++++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567877777 58876 234677865431 1234688899988776521 233444433332 23589
Q ss_pred EEeecCCCcH
Q 001360 765 VMEYLNGGDL 774 (1092)
Q Consensus 765 VMEYm~GGSL 774 (1092)
||++++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999999665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00047 Score=72.93 Aligned_cols=131 Identities=24% Similarity=0.336 Sum_probs=93.0
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEY 768 (1092)
.+..+.||+|.+|.||+|.++ |..+|+|+-+... -...+..|.++|..+.--++..=.+.+- .-++.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhh
Confidence 456678999999999999987 6789999765432 2456888999999988655543322222 12455999
Q ss_pred cCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecC-CCceEecCCCcEEEEecCCccc
Q 001360 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK-PDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 769 m~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLK-PeNILLD~nG~VKLsDFGLAk~ 836 (1092)
+.|-.|.++-... + +.-+..++.+---|-..||-|..|. |..++|..++.+.|+||.-|++
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9998887765421 1 2223345566555677899999994 7777777777999999998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0022 Score=68.55 Aligned_cols=130 Identities=23% Similarity=0.254 Sum_probs=90.3
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccc-------------cchhHHHHHHHHHHHHHhcC------CCceEEEe
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-------------IRKNDIERILAERNILITVR------NPFVVRFF 753 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei-------------~kk~~ie~~l~EieIL~~L~------HPNIVkL~ 753 (1092)
..||+|+.=.||.- . .+....||+++.... ..........+|+.-...+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46999999999853 2 244467898876540 01112344556665544444 78999999
Q ss_pred eeeccCCeeEEEEeecCCC------cHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC---
Q 001360 754 YSFTCRDNLYLVMEYLNGG------DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--- 824 (1092)
Q Consensus 754 ~sfqde~~LYLVMEYm~GG------SL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG--- 824 (1092)
|..+++..+-+|+|.+.+. +|.+++.+ +.+++ .. ...+-.-..||-+++|+.+||+|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999999999987542 57888854 44665 22 22334455688899999999999999997533
Q ss_pred -cEEEEe
Q 001360 825 -HIKLTD 830 (1092)
Q Consensus 825 -~VKLsD 830 (1092)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0015 Score=68.97 Aligned_cols=137 Identities=18% Similarity=0.238 Sum_probs=80.2
Q ss_pred EEeeccCCCeEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeec
Q 001360 692 IKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYL 769 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~-TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LYLVMEYm 769 (1092)
++.|..|-...||++.... .++.|++|+...... ......+|..++..+. +..+.++++.+.. .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 4678888889999997543 356888997754211 1112346888888774 3334455544432 4799999
Q ss_pred CCCcHHHH--------------HHh---hc-CC----------C-HHHHHHHHHH----------------------HHH
Q 001360 770 NGGDLYSL--------------LRK---VG-CL----------E-EDVARIYIAE----------------------LVL 798 (1092)
Q Consensus 770 ~GGSL~dl--------------Lkk---~g-~L----------s-E~~ar~yaaQ----------------------IL~ 798 (1092)
+|-++... |.+ .. .. . ...+..|... +..
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 98664211 111 00 11 0 1122222111 111
Q ss_pred HHHHH----H----HcCCeeeecCCCceEecC-CCcEEEEecCCccc
Q 001360 799 ALEYL----H----SLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKI 836 (1092)
Q Consensus 799 ALeYL----H----s~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~ 836 (1092)
.+..| - ..+++|+|+.|.|||++. ++.+.|+||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 11111 1 136999999999999998 57899999998874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00086 Score=70.66 Aligned_cols=98 Identities=23% Similarity=0.263 Sum_probs=79.1
Q ss_pred HHHHHHHHhcCC-CceEEEeeeeccCCeeEEEEeecCCCcHHHH---HHhhcCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 001360 735 LAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL---LRKVGCLEEDVARIYIAELVLALEYLHS---LG 807 (1092)
Q Consensus 735 l~EieIL~~L~H-PNIVkL~~sfqde~~LYLVMEYm~GGSL~dl---Lkk~g~LsE~~ar~yaaQIL~ALeYLHs---~G 807 (1092)
.+|.-+|+.+.+ +++.+++|+|- -++|.||...+++... +......++.....++.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888875 69999999983 3679999988766421 2222346888999999999999999998 35
Q ss_pred CeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 808 IIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
+.-.|++|+|+-++++|++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 78899999999999999999999997653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0088 Score=70.21 Aligned_cols=80 Identities=18% Similarity=0.163 Sum_probs=54.6
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cc---hhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCeeEE
Q 001360 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IR---KNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei-~k---k~~ie~~l~EieIL~~L~---HPNIVkL~~sfqde~~LYL 764 (1092)
.+.||.|.+..||++.....++.++||.-..... .. .-..++...|.+.|..+. ..++.++|.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999864335899997431100 00 124567788888888763 3456777665 4456789
Q ss_pred EEeecCCCc
Q 001360 765 VMEYLNGGD 773 (1092)
Q Consensus 765 VMEYm~GGS 773 (1092)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0057 Score=68.49 Aligned_cols=78 Identities=12% Similarity=0.036 Sum_probs=54.3
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC---CceEEEeeeecc---CCeeE
Q 001360 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTC---RDNLY 763 (1092)
Q Consensus 690 eilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H---PNIVkL~~sfqd---e~~LY 763 (1092)
.-.+.||.|..+.||..... +..+.+|..+.. .....+.+|...|+.+.- -.|.++++.+.+ .+..|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS--QGNPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcC--CCCEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34568999999999988643 234667764321 122468889999887752 357777776654 35689
Q ss_pred EEEeecCCCcH
Q 001360 764 LVMEYLNGGDL 774 (1092)
Q Consensus 764 LVMEYm~GGSL 774 (1092)
||||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0027 Score=68.61 Aligned_cols=133 Identities=20% Similarity=0.209 Sum_probs=75.6
Q ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCCeeEEEEeecCCC
Q 001360 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYLVMEYLNGG 772 (1092)
Q Consensus 694 ~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPN-IVkL~~sfqde~~LYLVMEYm~GG 772 (1092)
.+..|-.+.+|++. .+|..|++|+....... -. -...+|..+|+.+..-. ..++++... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~--~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA--LG-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccc--cc-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 35567788899887 34677888875432110 00 12466888888775322 223333332 36899999986
Q ss_pred cHHH--------------HHHh---hc----CCCH-HHHHHHHHHH---------HHHHHHHHH--------cCCeeeec
Q 001360 773 DLYS--------------LLRK---VG----CLEE-DVARIYIAEL---------VLALEYLHS--------LGIVHRDL 813 (1092)
Q Consensus 773 SL~d--------------lLkk---~g----~LsE-~~ar~yaaQI---------L~ALeYLHs--------~GIIHRDL 813 (1092)
.+.. .+.+ .. .++. ..+..|..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5431 1111 11 1111 1222322222 111222221 24899999
Q ss_pred CCCceEecCCCcEEEEecCCccc
Q 001360 814 KPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 814 KPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
.|.|||++.++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0046 Score=68.14 Aligned_cols=75 Identities=12% Similarity=0.109 Sum_probs=47.3
Q ss_pred EEeeccCCCeEEEEEEECC------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccCCeeEE
Q 001360 692 IKPISRGAFGRVFLARKRT------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~------TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H-PNIVkL~~sfqde~~LYL 764 (1092)
++.|..|-...||++.... +++.|++|+..... .......+|..++..+.. .-..++++.+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4566677777899887543 25789999876422 112345678878777752 223345555542 36
Q ss_pred EEeecCCCcH
Q 001360 765 VMEYLNGGDL 774 (1092)
Q Consensus 765 VMEYm~GGSL 774 (1092)
||||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999998665
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.02 Score=63.71 Aligned_cols=30 Identities=33% Similarity=0.469 Sum_probs=26.4
Q ss_pred CCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 807 GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
|+||+|+.|.|||++.+...-|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 899999999999998665568999998864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.016 Score=64.43 Aligned_cols=141 Identities=22% Similarity=0.217 Sum_probs=82.5
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeee------eccCC
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYS------FTCRD 760 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H--PNIVkL~~s------fqde~ 760 (1092)
...++.++.|.-..||++... +..|++|+.+... ....+..|.+++..+.. -.+.+++.. ....+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEeC--CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 445677888888899998642 3457889775421 12334556666666632 113333321 12245
Q ss_pred eeEEEEeecCCCcHH-----------HHH---Hhh-cCCC---------HHHHH--------------HHHHHHHHHHHH
Q 001360 761 NLYLVMEYLNGGDLY-----------SLL---RKV-GCLE---------EDVAR--------------IYIAELVLALEY 802 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~-----------dlL---kk~-g~Ls---------E~~ar--------------~yaaQIL~ALeY 802 (1092)
..|++|+|++|..+. ..+ +.. ..++ ..... .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999985431 111 110 0110 00000 011123345666
Q ss_pred HHH-------cCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 803 LHS-------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 803 LHs-------~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
+.. .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 643 5899999999999999988779999998864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.011 Score=64.75 Aligned_cols=139 Identities=19% Similarity=0.168 Sum_probs=83.4
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--ceEEEeee------eccCCe
Q 001360 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYS------FTCRDN 761 (1092)
Q Consensus 690 eilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HP--NIVkL~~s------fqde~~ 761 (1092)
.-++.|..|....+|++... +..+++|+... .....+..|..++..+.+- .+.+++.. ....+.
T Consensus 17 ~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 17 LSFEGISAGIENTNYFVTTD--SGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred hheecccCccccceEEEEeC--CCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 33667888888899998643 45788998764 1124466677777766421 24444332 123455
Q ss_pred eEEEEeecCCCcHHH----H-------H---Hhh-cCCCH--------HHHH------------HHHHHHHHHHHHHHH-
Q 001360 762 LYLVMEYLNGGDLYS----L-------L---RKV-GCLEE--------DVAR------------IYIAELVLALEYLHS- 805 (1092)
Q Consensus 762 LYLVMEYm~GGSL~d----l-------L---kk~-g~LsE--------~~ar------------~yaaQIL~ALeYLHs- 805 (1092)
.|+||+|++|..+.. . | +.. ..+.. .... .....+..++.++..
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 789999999865421 1 1 100 00100 0000 011123344555553
Q ss_pred ------cCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 806 ------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 806 ------~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
.+++|+|+.|.|||++.++.+.|.||+.+..
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999887789999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.0082 Score=51.62 Aligned_cols=35 Identities=37% Similarity=0.702 Sum_probs=29.0
Q ss_pred CCCCcchhhhc--cCCccCCCCCCCCccccccccccC
Q 001360 975 KGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQI 1009 (1092)
Q Consensus 975 kgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~~ 1009 (1092)
++++|+.|..+ .|||+|...+..|+++|+..|...
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~ 37 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEE 37 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCC
Confidence 47999999755 799999999999999998755444
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.047 Score=63.59 Aligned_cols=76 Identities=21% Similarity=0.207 Sum_probs=48.8
Q ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeec-ccc---cchhHHHHHHHHHHHHHhcC--CC-ceEEEeeeeccCCeeEEEE
Q 001360 694 PISRGAFGRVFLARKRTTGDLFAIKVLKK-LDM---IRKNDIERILAERNILITVR--NP-FVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 694 ~LGkGgFGtVyLar~k~TGk~VAIKvLkK-~ei---~kk~~ie~~l~EieIL~~L~--HP-NIVkL~~sfqde~~LYLVM 766 (1092)
.||-|....||++.....++.++||.-.. ... .-+-...+..-|...|.... .| .+.++|.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999754346899985321 111 11234566777888887664 35 45555433 445566999
Q ss_pred eecCC
Q 001360 767 EYLNG 771 (1092)
Q Consensus 767 EYm~G 771 (1092)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99965
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.11 Score=57.21 Aligned_cols=30 Identities=27% Similarity=0.522 Sum_probs=26.5
Q ss_pred cCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 806 ~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
.+++|+|+.+.|||++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.065 Score=61.47 Aligned_cols=124 Identities=18% Similarity=0.243 Sum_probs=73.2
Q ss_pred CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccCC--eeEEEEeecCCCcH-------------
Q 001360 712 GDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRD--NLYLVMEYLNGGDL------------- 774 (1092)
Q Consensus 712 Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H--PNIVkL~~sfqde~--~LYLVMEYm~GGSL------------- 774 (1092)
++.+++. ... ............+|..+|+.+.- .-+...++.+.++. ..|.||+|+.|..+
T Consensus 48 ~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~ 125 (321)
T COG3173 48 GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQF 125 (321)
T ss_pred CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHH
Confidence 6777777 321 12222344556678888877653 23445566666665 67999999998422
Q ss_pred -----HHHHHh---h-----------cCCCHHHHHHHHHHH--------------HHHHHHHHHc--------CCeeeec
Q 001360 775 -----YSLLRK---V-----------GCLEEDVARIYIAEL--------------VLALEYLHSL--------GIVHRDL 813 (1092)
Q Consensus 775 -----~dlLkk---~-----------g~LsE~~ar~yaaQI--------------L~ALeYLHs~--------GIIHRDL 813 (1092)
.+.|.. . +.+...+...+..+. ..-..+|+.+ .++|+|+
T Consensus 126 ~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~ 205 (321)
T COG3173 126 ALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDY 205 (321)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCc
Confidence 111211 0 001111111222222 2234555543 3899999
Q ss_pred CCCceEecCCCcEEEEecCCcccc
Q 001360 814 KPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 814 KPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
.+.||+|+..+-+=|.||+++.++
T Consensus 206 ~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 206 RPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ccCCEEEeCCCeeEEEeccccccC
Confidence 999999999999999999999864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.011 Score=67.88 Aligned_cols=136 Identities=16% Similarity=0.199 Sum_probs=91.2
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----------------chhHH--HHHHHHHHHHHhcC-CCc
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----------------RKNDI--ERILAERNILITVR-NPF 748 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~-----------------kk~~i--e~~l~EieIL~~L~-HPN 748 (1092)
+.+...||-|--+.||.|-.. .|..+++|.-+-.... ..-.. -...+|...|+.+. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456788999999999999875 5889999953211100 00011 12456777777774 322
Q ss_pred -eEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEE
Q 001360 749 -VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (1092)
Q Consensus 749 -IVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VK 827 (1092)
|.+.+ +-+.-++|||++.|-.|...-+- .+ +..+...+..-|.-|..+|+||+|..--||+|+.+++++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 22222 23457899999999777544321 11 122334555566778899999999999999999999999
Q ss_pred EEecCCcc
Q 001360 828 LTDFGLSK 835 (1092)
Q Consensus 828 LsDFGLAk 835 (1092)
++||--+.
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99998653
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.065 Score=61.42 Aligned_cols=137 Identities=19% Similarity=0.245 Sum_probs=77.5
Q ss_pred EEeeccCCCeEEEEEEECC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccCCeeEEEE
Q 001360 692 IKPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H-PNIVkL~~sfqde~~LYLVM 766 (1092)
+..|-.|-.-.+|++.... +++.|.+|+..... ...+. -.+|..++..+.. .--.++++.+... .|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 3455557778899887532 34688899876421 11122 2568888777753 2223445555332 589
Q ss_pred eecCCCcHHHH--------------HH---hhc------CCCHHHHHHHHHHH-----------------HHHHHHHH--
Q 001360 767 EYLNGGDLYSL--------------LR---KVG------CLEEDVARIYIAEL-----------------VLALEYLH-- 804 (1092)
Q Consensus 767 EYm~GGSL~dl--------------Lk---k~g------~LsE~~ar~yaaQI-----------------L~ALeYLH-- 804 (1092)
+|++|-+|... +. ... ......+..++.++ ...+..|.
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987655211 11 101 01122232332211 11122221
Q ss_pred ------HcCCeeeecCCCceEecC-CCcEEEEecCCccc
Q 001360 805 ------SLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKI 836 (1092)
Q Consensus 805 ------s~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~ 836 (1092)
...++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 225899999999999986 47899999998874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.1 Score=61.04 Aligned_cols=136 Identities=31% Similarity=0.329 Sum_probs=90.3
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch-------------------h--HH--HHHHHHHHHHHhcCC-
Q 001360 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-------------------N--DI--ERILAERNILITVRN- 746 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk-------------------~--~i--e~~l~EieIL~~L~H- 746 (1092)
+-..|..|--+-||.|... +|..+|||+++-.-+.-+ + .. .-...|++-|.+++.
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3356888888999999864 688899999863211110 0 01 112346666776653
Q ss_pred ----CceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH-HcCCeeeecCCCceEec
Q 001360 747 ----PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIA 821 (1092)
Q Consensus 747 ----PNIVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLH-s~GIIHRDLKPeNILLD 821 (1092)
|--+-| ..-.|||+|+.......=.-+...++...++.+-.+++.-|.-|- ..++||.||.--|+|+
T Consensus 227 GIP~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 227 GIPCPEPILL-------KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY- 298 (520)
T ss_pred CCCCCCceee-------ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-
Confidence 222222 123699999954221111113345777888888888888888875 5689999999999998
Q ss_pred CCCcEEEEecCCcc
Q 001360 822 HDGHIKLTDFGLSK 835 (1092)
Q Consensus 822 ~nG~VKLsDFGLAk 835 (1092)
.+|.+.|+|-+-+.
T Consensus 299 hdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 299 HDGKLYIIDVSQSV 312 (520)
T ss_pred ECCEEEEEEccccc
Confidence 47999999998775
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.13 Score=57.35 Aligned_cols=31 Identities=39% Similarity=0.677 Sum_probs=26.1
Q ss_pred CCeeeecCCCceEecCCCc-EEEEecCCcccc
Q 001360 807 GIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIG 837 (1092)
Q Consensus 807 GIIHRDLKPeNILLD~nG~-VKLsDFGLAk~~ 837 (1092)
.++|+|+.|.|||++.++. .-|.||+.+..+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997565 569999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.2 Score=56.53 Aligned_cols=75 Identities=21% Similarity=0.301 Sum_probs=47.4
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCeeEEEE
Q 001360 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 690 eilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~---HPNIVkL~~sfqde~~LYLVM 766 (1092)
+-.+.||.|....+|+.. .+++.|.+|+-.. .....+..|..-|+.+. --.+.+.+.+....+.-||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 456789999999999887 6688899997652 22345777888887773 345667777777777779999
Q ss_pred eecCCC
Q 001360 767 EYLNGG 772 (1092)
Q Consensus 767 EYm~GG 772 (1092)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.2 Score=59.38 Aligned_cols=77 Identities=21% Similarity=0.168 Sum_probs=50.9
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cch---hHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCeeE
Q 001360 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRK---NDIERILAERNILITVR---NPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei-~kk---~~ie~~l~EieIL~~L~---HPNIVkL~~sfqde~~LY 763 (1092)
..+.||.|....||++... +..|+||.-..... ... ....+...|...|..+. ..++.++|.+.. +.-+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4678999999999999863 45688886431111 111 13455566677776654 246777877766 4467
Q ss_pred EEEeecCC
Q 001360 764 LVMEYLNG 771 (1092)
Q Consensus 764 LVMEYm~G 771 (1092)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999977
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.17 Score=57.53 Aligned_cols=141 Identities=16% Similarity=0.189 Sum_probs=76.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce-EEEeeeeccCCee
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDNL 762 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~T---Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNI-VkL~~sfqde~~L 762 (1092)
+++++.. |..|=...+|++..... +..|.+|+...... ..-.-.+|..+++.+..-.+ .++++++...
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~----~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G--- 86 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD----YVIDRERELQAIKYLSAAGFGAKLLGVFGNG--- 86 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcC----eEechHHHHHHHHHHHhcCCCCceeEEeCCc---
Confidence 4555544 44477778898875432 23788897754211 11112467777777753222 3445555322
Q ss_pred EEEEeecCCCcHHH--------------HHH---hhc-C----C-CHHHHHHHHHHH----------------------H
Q 001360 763 YLVMEYLNGGDLYS--------------LLR---KVG-C----L-EEDVARIYIAEL----------------------V 797 (1092)
Q Consensus 763 YLVMEYm~GGSL~d--------------lLk---k~g-~----L-sE~~ar~yaaQI----------------------L 797 (1092)
+|.+|++|-.|.. .++ ... . + ....+..|..++ .
T Consensus 87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~ 165 (330)
T PLN02421 87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR 165 (330)
T ss_pred -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence 5899997755411 111 111 0 1 122233333222 1
Q ss_pred HHHHHHH----Hc----CCeeeecCCCceEecC-CCcEEEEecCCccc
Q 001360 798 LALEYLH----SL----GIVHRDLKPDNLLIAH-DGHIKLTDFGLSKI 836 (1092)
Q Consensus 798 ~ALeYLH----s~----GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~ 836 (1092)
.-+..+. .. -++|.|+-+.|||++. ++.++++||..|..
T Consensus 166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1122221 11 2799999999999975 57899999999864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.55 E-value=0.49 Score=53.01 Aligned_cols=30 Identities=17% Similarity=0.204 Sum_probs=28.1
Q ss_pred CCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 807 GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.25 Score=58.44 Aligned_cols=78 Identities=22% Similarity=0.185 Sum_probs=51.8
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeec-ccc--cchhHHHHHHHHHHHHHhcC--CC-ceEEEeeeeccCCeeEEE
Q 001360 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK-LDM--IRKNDIERILAERNILITVR--NP-FVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK-~ei--~kk~~ie~~l~EieIL~~L~--HP-NIVkL~~sfqde~~LYLV 765 (1092)
++.||-|.-.-||++.....++.++||.-.. ... .-.-..++..-|.++|+... .| .+.++|.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6789999999999999854456788885321 110 11234577788888888764 34 45556543 45556789
Q ss_pred EeecCC
Q 001360 766 MEYLNG 771 (1092)
Q Consensus 766 MEYm~G 771 (1092)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999865
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.62 E-value=0.45 Score=55.82 Aligned_cols=30 Identities=27% Similarity=0.309 Sum_probs=25.1
Q ss_pred cCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 806 ~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
..++|.|+-+.|||.+. +.++++||-.|..
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 46799999999999764 5599999998863
|
|
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=92.34 E-value=0.051 Score=45.42 Aligned_cols=22 Identities=27% Similarity=0.193 Sum_probs=15.8
Q ss_pred CCCCCCccccccccccCCCCCC
Q 001360 993 PESVDDTSYFLSRFSQISSGLP 1014 (1092)
Q Consensus 993 ~~s~~Dts~Fds~fs~~~s~l~ 1014 (1092)
+.+..|++||+..|+.+...++
T Consensus 2 v~~~~DtsnFD~eFt~~~~~~t 23 (48)
T PF00433_consen 2 VKSETDTSNFDPEFTEEPPVDT 23 (48)
T ss_dssp -SSTT-GTTSCHHHHTSSSSS-
T ss_pred CCchhhhhhcCcccccCCCCCC
Confidence 4678999999999998865544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.25 E-value=2.3 Score=55.79 Aligned_cols=31 Identities=32% Similarity=0.518 Sum_probs=26.4
Q ss_pred cCCeeeecCCCceEecCCC--cEE-EEecCCccc
Q 001360 806 LGIVHRDLKPDNLLIAHDG--HIK-LTDFGLSKI 836 (1092)
Q Consensus 806 ~GIIHRDLKPeNILLD~nG--~VK-LsDFGLAk~ 836 (1092)
.++||.|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 565 999998763
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.09 E-value=0.33 Score=57.00 Aligned_cols=72 Identities=26% Similarity=0.400 Sum_probs=52.8
Q ss_pred CCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc-CCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
..++|++|++. |+.+.- + ..-..+++..++.+.+..+.-+... .+-|||+...||||+ +|+|.|+||-+|+.
T Consensus 298 ~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 34678888876 445432 1 1224456666677777766666654 689999999999999 99999999999985
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.73 E-value=0.48 Score=57.56 Aligned_cols=163 Identities=21% Similarity=0.276 Sum_probs=100.2
Q ss_pred HHHHHHHHHHHhcCCCceEEEeeeeccC-CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 001360 732 ERILAERNILITVRNPFVVRFFYSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810 (1092)
Q Consensus 732 e~~l~EieIL~~L~HPNIVkL~~sfqde-~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIH 810 (1092)
..++--..+++.+.|+|..++..+-... ....+|||++. -+|.++++.+. +-.. ++. .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~-------s~~-------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDE-------SLL-------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchh-------hhc-------ccccce
Confidence 3466677888999999999988765543 34789999995 59999987654 2111 111 122222
Q ss_pred eecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC
Q 001360 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 890 (1092)
Q Consensus 811 RDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ 890 (1092)
-| .++++| -++. + ..+..|
T Consensus 91 -----~~-------~~~~td-~~~t---------------------------~-------~~~~~~-------------- 109 (725)
T KOG1093|consen 91 -----LN-------IIYITD-HFLT---------------------------K-------YPSPIG-------------- 109 (725)
T ss_pred -----eh-------hhhccc-cccc---------------------------c-------CCCCCC--------------
Confidence 12 223344 1100 0 011112
Q ss_pred CCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCC----------CCCCCCHHHHHHHHHhccCCcCCCC
Q 001360 891 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPC----------VPSDMSFEAQDLINRFLIHDPNQRL 960 (1092)
Q Consensus 891 Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~----------ip~~lS~eakDLI~kcL~kDP~KRp 960 (1092)
.++||||+|.++.|+..|..-|......+..+.|..-... +. +.-.++....++..+|+...|..||
T Consensus 110 --pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~-d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~ 186 (725)
T KOG1093|consen 110 --PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTD-DQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP 186 (725)
T ss_pred --cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccC-chhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc
Confidence 3999999999999999998777666555555444432110 10 1123455677889999999999999
Q ss_pred CcccHHHHHcCCCCCCC
Q 001360 961 GANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 961 Sa~ga~EIL~HPFFkgI 977 (1092)
. ..++.+|+-|..+
T Consensus 187 l---~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 187 L---PMELSKRCSFTEV 200 (725)
T ss_pred c---hhHHhcCccHHHH
Confidence 6 4567777777543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=89.56 E-value=1.2 Score=49.66 Aligned_cols=100 Identities=17% Similarity=0.168 Sum_probs=66.1
Q ss_pred EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHH
Q 001360 715 FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794 (1092)
Q Consensus 715 VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaa 794 (1092)
..+|.++.....- ...-+.++.++++++. .|++|..- ....+-+|+|+|---.. .. ..++.
T Consensus 88 L~lKKi~slp~~~--~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~~----~N~i~ 148 (308)
T PF07387_consen 88 LFLKKIRSLPCCI--NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------NF----SNFIT 148 (308)
T ss_pred hhhhhccCCCccc--chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------ch----hHHHH
Confidence 4466665443321 2345688899998886 47887632 33346799999843211 00 11122
Q ss_pred HHHHHHHHHHH--cCCeeeecCCCceEecCCCcEEEEecCC
Q 001360 795 ELVLALEYLHS--LGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1092)
Q Consensus 795 QIL~ALeYLHs--~GIIHRDLKPeNILLD~nG~VKLsDFGL 833 (1092)
-=+.+|.-.|+ .+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 22466777884 3799999999999999999999999874
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.26 E-value=9.4 Score=43.56 Aligned_cols=29 Identities=28% Similarity=0.416 Sum_probs=24.8
Q ss_pred cCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 806 ~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
.++||+|+.+.|||++ + .+.|+||+-+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3689999999999995 4 578999998874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=88.21 E-value=0.1 Score=62.67 Aligned_cols=75 Identities=28% Similarity=0.476 Sum_probs=61.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
...++|+....+|.|+||+|+-++.+.++..||||.|.-.. ......++++|..-+.++.|++|++++..|....
T Consensus 46 r~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn--~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~ 120 (516)
T KOG1033|consen 46 REANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKN--REESRSRVLREVSSLAEFEHPGIKRYFHAWYERP 120 (516)
T ss_pred hhhccccccccccccCccccCCccccccchhhHHHHhcccc--hhhhhhhhhccccchhhhcccchhhheeceecCC
Confidence 45688999999999999999999999888899999875322 2234467888999999999999999998876544
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.84 E-value=0.42 Score=55.52 Aligned_cols=50 Identities=28% Similarity=0.466 Sum_probs=36.0
Q ss_pred HHHHHHHHHHHHHHHHHHH----cCCeeeecCCCceEecCCC------------------cEEEEecCCccc
Q 001360 787 DVARIYIAELVLALEYLHS----LGIVHRDLKPDNLLIAHDG------------------HIKLTDFGLSKI 836 (1092)
Q Consensus 787 ~~ar~yaaQIL~ALeYLHs----~GIIHRDLKPeNILLD~nG------------------~VKLsDFGLAk~ 836 (1092)
+-+++++.||+.-.-.+-. .+++|-||||+||||-... .++|.||.++.+
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 4577888888776645533 3699999999999995432 346777777764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1092 | ||||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-65 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-65 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-59 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-59 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-59 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-59 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-59 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-58 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-58 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-58 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-58 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-58 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-58 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-58 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-58 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-58 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-58 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-58 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-58 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-58 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-58 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-58 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-58 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-58 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-58 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-58 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-58 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-58 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-58 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-58 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-58 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-58 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-58 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-58 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-58 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-58 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-58 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-58 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-58 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-57 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-57 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-57 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-57 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-57 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-57 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-57 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-57 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-57 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-57 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-57 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-57 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-57 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-57 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-57 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-57 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-57 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-57 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-57 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-57 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-57 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-57 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-57 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-57 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-57 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-57 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-57 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-57 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-57 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-57 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-57 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-57 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-57 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-56 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-56 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-56 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-56 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-56 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-56 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-55 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-55 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-55 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-54 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-54 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-53 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-53 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-52 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-52 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-52 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-51 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-51 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-51 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-50 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-50 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-50 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-50 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-50 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-50 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-50 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-50 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-50 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-50 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-50 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-50 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-50 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-50 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-50 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-50 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-50 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-50 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-50 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-50 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-50 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-41 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-41 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-41 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-41 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-41 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-41 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-41 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-40 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-40 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-40 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-40 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-40 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-40 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-40 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-40 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-40 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-40 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-39 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-39 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-39 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-39 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-39 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-39 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-39 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-39 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-39 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-39 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-39 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-39 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-39 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-39 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-39 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-38 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-38 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-38 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-38 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-38 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-38 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-38 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-38 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-38 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-37 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-35 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-35 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-35 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-34 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-34 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-34 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-34 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-34 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-33 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-33 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-33 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-33 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-33 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-33 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-32 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-32 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-31 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-31 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-31 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-31 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-31 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-31 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-31 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-31 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-31 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-31 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-31 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-31 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-31 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-31 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-30 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-30 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-30 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-30 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-30 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-30 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-30 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-30 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-30 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-30 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-30 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-30 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-30 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-30 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-30 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-30 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-30 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-29 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-29 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-29 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-29 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-29 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-29 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-29 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-29 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-29 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-29 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-29 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-28 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-28 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-28 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-28 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-28 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-28 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-27 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-27 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-27 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-27 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-27 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-27 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-27 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-26 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-26 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-26 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-26 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-26 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-26 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-26 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-26 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-26 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-26 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-26 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-26 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-25 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-25 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-25 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-25 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-25 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-25 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-25 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-25 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-25 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-25 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-25 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-25 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-24 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-24 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-24 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-24 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-24 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-24 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-24 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-24 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-24 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-24 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-24 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-24 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-24 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-24 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-24 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-24 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-24 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-24 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-24 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-24 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-24 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-24 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-24 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-23 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-23 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-23 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-23 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-23 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-23 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-23 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-23 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-23 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-23 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-23 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-22 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-22 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-22 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-22 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-22 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-22 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-22 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-22 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-22 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-22 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-22 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-22 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-22 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-22 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-22 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-22 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-22 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-22 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-21 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-21 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-21 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-21 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-21 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-21 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-21 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-21 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-21 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-21 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-21 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-21 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-21 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-20 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-20 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-20 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-20 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-20 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-20 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-20 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-20 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-20 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-20 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-20 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-20 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-20 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-20 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-20 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-19 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-19 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-19 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-19 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-19 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-18 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-18 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-18 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-18 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-18 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-18 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-18 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-18 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-18 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-18 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-18 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-17 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-17 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-16 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-16 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-15 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-15 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-15 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-15 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-15 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-15 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-14 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-14 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-14 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-14 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-14 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-14 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-14 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-14 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-14 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-14 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-14 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-14 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-14 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-14 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-14 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-14 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-14 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-14 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-14 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 9e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-13 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 7e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 9e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-08 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 6e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-08 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 7e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-07 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 7e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-06 |
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1092 | |||
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-143 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-139 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-135 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-134 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-132 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-131 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-131 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-130 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-130 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-129 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-128 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-127 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-126 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-126 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-124 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-123 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-121 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-121 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-117 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-115 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-113 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-112 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-105 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-105 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-91 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-90 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-85 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 5e-85 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 6e-83 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-82 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-78 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-76 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-74 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-73 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 6e-73 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-72 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-72 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-72 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-71 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-71 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-71 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-70 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-70 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-70 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-70 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 6e-70 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-69 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 6e-69 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 6e-69 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 7e-69 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 8e-69 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 8e-69 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-68 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-68 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-68 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-68 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 4e-68 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-68 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 5e-68 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 7e-68 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-67 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-67 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-67 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-67 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 9e-67 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-66 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-66 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-66 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-65 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-65 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-65 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 4e-65 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-65 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-64 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-64 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-64 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-64 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 9e-64 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-63 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-63 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-63 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-63 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-63 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 6e-63 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-62 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-62 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-62 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 8e-62 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 8e-62 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-61 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-61 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 8e-60 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-59 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-58 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-57 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-57 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-56 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 7e-56 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 8e-56 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-55 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-55 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 7e-55 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-54 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 7e-54 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-52 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-52 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 9e-52 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-51 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 7e-51 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-50 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-50 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-50 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-50 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-49 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-45 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 6e-45 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-44 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-44 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-44 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-43 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-43 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-43 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-43 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-43 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-43 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-43 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-43 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 5e-43 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 6e-43 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 8e-43 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-42 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-42 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-42 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 4e-42 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 7e-42 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-41 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-41 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 4e-41 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-40 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-40 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 5e-40 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 6e-40 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-39 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-39 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-39 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 8e-38 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 9e-38 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-37 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 6e-37 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 8e-37 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-36 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-36 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 5e-36 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 5e-36 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 8e-36 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-35 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-35 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-35 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 7e-35 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-34 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-34 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 4e-34 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 6e-34 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 7e-34 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 7e-34 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-33 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-33 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-33 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-33 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-32 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 8e-31 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-26 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 6e-25 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 8e-25 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-24 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-24 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-24 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-23 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-23 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-23 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-22 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-22 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-21 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-21 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-21 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-21 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 4e-21 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 8e-21 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 9e-21 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-20 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-20 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-20 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-20 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 7e-20 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-19 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-19 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-19 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-19 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-19 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-19 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-19 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 7e-19 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 9e-19 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-18 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-18 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-18 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-18 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-18 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-18 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-18 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 5e-18 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 5e-18 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-18 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-17 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-17 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-17 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 5e-17 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 7e-17 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 7e-17 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-16 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-16 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-16 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-16 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-16 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-16 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-16 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-16 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-16 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-16 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 5e-16 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-16 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-15 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-12 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-13 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 7e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-08 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-05 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 2e-07 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 1e-04 |
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 435 bits (1120), Expect = e-143
Identities = 133/462 (28%), Positives = 212/462 (45%), Gaps = 68/462 (14%)
Query: 617 LKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPL 676
++ LV+D +E LL L + E + ++ K + + +
Sbjct: 2 MQQLVLDPGFLGLEPLLD----LLLGVHQELGASELAQDKYVADFL-------QWAEPIV 50
Query: 677 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 736
+ R DDFEI+K I RGAF V + + + TG ++A+K++ K DM+++ ++
Sbjct: 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAE 795
ER++L+ ++ + ++F + LYLVMEY GGDL +LL K G + ++AR Y+AE
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+V+A++ +H LG VHRD+KPDN+L+ GHI+L DFG + T+
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV------------ 218
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-------HGYAADWWSVGIILFEFI 908
AVGTPDYL+PEIL +G DWW++G+ +E
Sbjct: 219 --------------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
Query: 909 TGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
G PF A+S + I++ K + P V + EA+D I R L P RLG GA
Sbjct: 265 YGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRGGAG 323
Query: 967 EVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADT 1026
+ + HPFF G++WD L F P E DT F ++ G + +D
Sbjct: 324 DFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLT---AMVSGGGETLSDI 380
Query: 1027 CDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLAS 1068
+ + L + +S+ ++ S
Sbjct: 381 REGAPLGV-----------------HLPFVGYSYSCMALRDS 405
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 426 bits (1097), Expect = e-139
Identities = 134/423 (31%), Positives = 213/423 (50%), Gaps = 46/423 (10%)
Query: 615 SKLKALVIDTFGSRIEKLLREKYIL--ACELLDEKSPTSFSKYKENSRLILDSVSQSSGV 672
+L+ ++D + + +L L DE + + + K +
Sbjct: 7 RQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYL-------EWA 59
Query: 673 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 732
+ R +DFEI+K I RGAFG V + + + +FA+K+L K +M+++ +
Sbjct: 60 KPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA 119
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARI 791
ER++L+ + ++ Y+F +NLYLVM+Y GGDL +LL K L E++AR
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF 179
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
Y+AE+V+A++ +H L VHRD+KPDN+L+ +GHI+L DFG + + T+
Sbjct: 180 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ------- 232
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFE 906
AVGTPDY++PEIL E +G DWWS+G+ ++E
Sbjct: 233 -------------------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
Query: 907 FITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964
+ G PF AES + I+N K +P +D+S A+DLI R LI RLG NG
Sbjct: 274 MLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRR-LICSREHRLGQNG 332
Query: 965 AAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRF--SQISSGLPDDQNGSYS 1022
+ K HPFF G++WD++ +A ++P+ S DTS F + S +P + ++S
Sbjct: 333 IEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFS 392
Query: 1023 DAD 1025
Sbjct: 393 GHH 395
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 409 bits (1055), Expect = e-135
Identities = 117/326 (35%), Positives = 186/326 (57%), Gaps = 40/326 (12%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ S+ DF+I++ + G+FGRV L R R G +A+KVLKK ++R +E ER +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
V +PF++R + +F ++++M+Y+ GG+L+SLLRK VA+ Y AE+ LALEY
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS I++RDLKP+N+L+ +GHIK+TDFG +K + + T
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY-VPDVT-------------------- 160
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
++ GTPDY+APE++ + + DWWS GI+++E + G PF +
Sbjct: 161 ---------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 980
++ ILN ++ + P + + +DL++R + D +QRLG NG +VK HP+FK V W+
Sbjct: 212 YEKILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268
Query: 981 SLALQKAV---FVPQPESVD-DTSYF 1002
L L + + + P + DTS F
Sbjct: 269 KL-LSRNIETPYEPPIQQGQGDTSQF 293
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-134
Identities = 101/327 (30%), Positives = 172/327 (52%), Gaps = 31/327 (9%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
+ + + + +DF+ K + G+F V LAR+ T +AIK+L+K
Sbjct: 7 EPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR 66
Query: 724 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
+I++N + + ER+++ + +PF V+ +++F + LY + Y G+L +RK+G
Sbjct: 67 HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 126
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
+E R Y AE+V ALEYLH GI+HRDLKP+N+L+ D HI++TDFG +K+
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS----- 181
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
++ +S VGT Y++PE+L ++D W++G I
Sbjct: 182 --------------------PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 221
Query: 904 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
+++ + G+PPF A + +IF I+ + + P +A+DL+ + L+ D +RLG
Sbjct: 222 IYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCE 278
Query: 964 ---GAAEVKAHPFFKGVNWDSLALQKA 987
G +KAHPFF+ V W++L Q
Sbjct: 279 EMEGYGPLKAHPFFESVTWENLHQQTP 305
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 402 bits (1036), Expect = e-132
Identities = 134/345 (38%), Positives = 198/345 (57%), Gaps = 40/345 (11%)
Query: 671 GVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIR 727
G S + E+ + FE+++ + +G +G+VF RK T TG +FA+KVLKK ++R
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 728 K-NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE 786
D AERNIL V++PF+V Y+F LYL++EYL+GG+L+ L + G E
Sbjct: 61 NAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 787 DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846
D A Y+AE+ +AL +LH GI++RDLKP+N+++ H GH+KLTDFGL K +
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-------- 172
Query: 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
D H+ GT +Y+APEIL+ + H A DWWS+G ++++
Sbjct: 173 -------------------HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYD 213
Query: 907 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NG 964
+TG PPFT E+ + D IL K+ P ++ EA+DL+ + L + RLGA
Sbjct: 214 MLTGAPPFTGENRKKTIDKILKCKLNL---PPYLTQEARDLLKKLLKRNAASRLGAGPGD 270
Query: 965 AAEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1006
A EV+AHPFF+ +NW+ L L + V F P +S +D S F S+F
Sbjct: 271 AGEVQAHPFFRHINWEEL-LARKVEPPFKPLLQSEEDVSQFDSKF 314
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 404 bits (1039), Expect = e-131
Identities = 127/338 (37%), Positives = 183/338 (54%), Gaps = 37/338 (10%)
Query: 673 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 732
++ R +D+E++K I RGAFG V L R ++T ++A+K+L K +MI+++D
Sbjct: 55 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 114
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 792
ER+I+ +P+VV+ FY+F LY+VMEY+ GGDL +L+ + E AR Y
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFY 173
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
AE+VLAL+ +HS+G +HRD+KPDN+L+ GH+KL DFG
Sbjct: 174 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM----------------- 216
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFI 908
+ + +AVGTPDY++PE+L +G DWWSVG+ L+E +
Sbjct: 217 ---------KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267
Query: 909 TGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
G PF A+S + I+N K + +P D+S EA++LI FL D RLG NG
Sbjct: 268 VGDTPFYADSLVGTYSKIMNHKNSLTFPDDN-DISKEAKNLICAFL-TDREVRLGRNGVE 325
Query: 967 EVKAHPFFKGVNWDSLALQKAV--FVPQPESVDDTSYF 1002
E+K H FFK W L+ V VP S DTS F
Sbjct: 326 EIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNF 363
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 400 bits (1031), Expect = e-131
Identities = 117/327 (35%), Positives = 185/327 (56%), Gaps = 39/327 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ +D F+ IK + G+FGRV L + + +G+ +A+K+L K +++ IE L E+ I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
L V PF+V+ +SF NLY+VMEY+ GG+++S LR++G E AR Y A++VL
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLHSL +++RDLKP+NLLI G+I++TDFG +K + T
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRT------------------ 195
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ GTP+ LAPEI+L + A DWW++G++++E G PPF A+ P
Sbjct: 196 -----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVN 978
I++ I++ K+ + PS S + +DL+ L D +R G NG ++K H +F +
Sbjct: 245 QIYEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
Query: 979 WDSLALQKAV---FVPQPESVDDTSYF 1002
W ++ Q+ V F+P+ + DTS F
Sbjct: 302 WIAI-YQRKVEAPFIPKFKGPGDTSNF 327
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 400 bits (1029), Expect = e-130
Identities = 121/348 (34%), Positives = 186/348 (53%), Gaps = 36/348 (10%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
+ + L S DF +K I +G+FG+V LAR + +A+KVL+K
Sbjct: 15 PAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKK 74
Query: 724 DMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
+++K + + I++ERN+L+ V++PF+V +SF D LY V++Y+NGG+L+ L++
Sbjct: 75 AILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER 134
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
C E AR Y AE+ AL YLHSL IV+RDLKP+N+L+ GHI LTDFGL K +
Sbjct: 135 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI---- 190
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
N + GTP+YLAPE+L + DWW +G
Sbjct: 191 -----------------------EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227
Query: 903 ILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+L+E + G+PPF + + ++DNILN+ + +++ A+ L+ L D +RLGA
Sbjct: 228 VLYEMLYGLPPFYSRNTAEMYDNILNKPLQL---KPNITNSARHLLEGLLQKDRTKRLGA 284
Query: 963 -NGAAEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1006
+ E+K+H FF +NWD L + K + F P +D +F F
Sbjct: 285 KDDFMEIKSHVFFSLINWDDL-INKKITPPFNPNVSGPNDLRHFDPEF 331
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 398 bits (1024), Expect = e-130
Identities = 122/337 (36%), Positives = 185/337 (54%), Gaps = 40/337 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERI 734
E+ FE++K + +G+FG+VFL +K + L+A+KVLKK ++ D R
Sbjct: 15 KEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-ATLKVRDRVRT 73
Query: 735 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
ER+IL+ V +PF+V+ Y+F LYL++++L GGDL++ L K E+ + Y+A
Sbjct: 74 KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 133
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
EL LAL++LHSLGI++RDLKP+N+L+ +GHIKLTDFGLSK +
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI---------------- 177
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ +S GT +Y+APE++ H +ADWWS G+++FE +TG PF
Sbjct: 178 -----------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHP 972
+ + IL K+ P +S EAQ L+ +P RLGA +G E+K H
Sbjct: 227 QGKDRKETMTMILKAKLGM---PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS 283
Query: 973 FFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1006
FF ++W+ L ++ + F P +DT YF F
Sbjct: 284 FFSTIDWNKL-YRREIHPPFKPATGRPEDTFYFDPEF 319
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 396 bits (1019), Expect = e-129
Identities = 127/357 (35%), Positives = 193/357 (54%), Gaps = 37/357 (10%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ +++DF+ +K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
R+PF+ Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS +V+RD+K +NL++ DGHIK+TDFGL K G+
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI------------------------ 156
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+D + GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +
Sbjct: 157 ---SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 980
F+ IL +I + P +S EA+ L+ L DP QRLG + A EV H FF +NW
Sbjct: 214 FELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270
Query: 981 SLALQKAV---FVPQPESVDDTSYFLSRFSQISSGL-PDDQNGSYSDADTCDSSSNS 1033
+ +QK + F PQ S DT YF F+ S + P D+ S +
Sbjct: 271 DV-VQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQE 326
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 393 bits (1012), Expect = e-128
Identities = 129/374 (34%), Positives = 200/374 (53%), Gaps = 46/374 (12%)
Query: 645 DEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVF 704
S + + ++ + T + H E+ I++FE++K + GA+G+VF
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF 71
Query: 705 LARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILITVRN-PFVVRFFYSFTCR 759
L RK + TG L+A+KVLKK +++K E ER +L +R PF+V Y+F
Sbjct: 72 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131
Query: 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819
L+L+++Y+NGG+L++ L + E +IY+ E+VLALE+LH LGI++RD+K +N+L
Sbjct: 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
Query: 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 879
+ +GH+ LTDFGLSK + + + + GT +
Sbjct: 192 LDSNGHVVLTDFGLSKEFVAD--------------------------ETERAYDFCGTIE 225
Query: 880 YLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE----SPEIIFDNILNRKIPW 933
Y+AP+I+ G + G+ A DWWS+G++++E +TG PFT + S I IL + P+
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285
Query: 934 PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV--- 988
P +MS A+DLI R L+ DP +RLG A E+K H FF+ +NWD L K V
Sbjct: 286 ---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL-AAKKVPAP 341
Query: 989 FVPQPESVDDTSYF 1002
F P D S F
Sbjct: 342 FKPVIRDELDVSNF 355
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 391 bits (1007), Expect = e-127
Identities = 125/347 (36%), Positives = 195/347 (56%), Gaps = 38/347 (10%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
+SS + + R ID+FE I+ + +G+FG+V LAR + TGDL+A+KVLKK ++
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 727 RKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
+ +D+E + E+ IL RN PF+ + F F D L+ VME++NGGDL ++K +
Sbjct: 63 QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD 122
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845
E AR Y AE++ AL +LH GI++RDLK DN+L+ H+GH KL DFG+ K G+
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI------- 175
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 905
+ + GTPDY+APEIL +G A DWW++G++L+
Sbjct: 176 --------------------CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215
Query: 906 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--- 962
E + G PF AE+ + +F+ ILN ++ + P+ + +A ++ F+ +P RLG+
Sbjct: 216 EMLCGHAPFEAENEDDLFEAILNDEVVY---PTWLHEDATGILKSFMTKNPTMRLGSLTQ 272
Query: 963 NGAAEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1006
G + HPFFK ++W L + + F P+ +S +D S F F
Sbjct: 273 GGEHAILRHPFFKEIDWAQL-NHRQIEPPFRPRIKSREDVSNFDPDF 318
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 388 bits (999), Expect = e-126
Identities = 117/333 (35%), Positives = 185/333 (55%), Gaps = 37/333 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S + + I+DF + K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E
Sbjct: 8 PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 738 RNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
+ +L +PF+ F +F ++NL+ VMEYLNGGDL ++ + A Y AE+
Sbjct: 68 KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+L L++LHS GIV+RDLK DN+L+ DGHIK+ DFG+ K +
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM------------------ 169
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
+ ++ GTPDY+APEILLG ++ ++ DWWS G++L+E + G PF
Sbjct: 170 ---------LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ E +F +I + P + EA+DL+ + + +P +RLG G +++ HP F+
Sbjct: 221 QDEEELFHSIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGVRG--DIRQHPLFRE 275
Query: 977 VNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1006
+NW+ L +K + F P+ +S D S F F
Sbjct: 276 INWEEL-ERKEIDPPFRPKVKSPFDCSNFDKEF 307
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 388 bits (999), Expect = e-126
Identities = 106/344 (30%), Positives = 182/344 (52%), Gaps = 38/344 (11%)
Query: 669 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK 728
++ VS ++ +++R + DF + + +G+FG+V L+ ++ T +L+A+K+LKK +I+
Sbjct: 2 TNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61
Query: 729 NDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 787
+D+E + E+ +L PF+ + F D LY VMEY+NGGDL +++VG +E
Sbjct: 62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 121
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
A Y AE+ + L +L S GI++RDLK DN+++ +GHIK+ DFG+ K +
Sbjct: 122 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--------- 172
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907
D + GTPDY+APEI+ +G + DWW+ G++L+E
Sbjct: 173 ------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214
Query: 908 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGA 965
+ G PF E + +F +I+ + + P MS EA + + P +RLG G
Sbjct: 215 LAGQAPFEGEDEDELFQSIMEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGE 271
Query: 966 AEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1006
++K H FF+ ++W+ L +K + + P+ + F F
Sbjct: 272 RDIKEHAFFRYIDWEKL-ERKEIQPPYKPKACG-RNAENFDRFF 313
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 382 bits (983), Expect = e-124
Identities = 115/343 (33%), Positives = 181/343 (52%), Gaps = 47/343 (13%)
Query: 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
+ + DF++++ I RG++ +V L R + T ++A+KV+KK + DI+ + E++
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 740 ILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ N PF+V F L+ V+EY+NGGDL +++ L E+ AR Y AE+ L
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
AL YLH GI++RDLK DN+L+ +GHIKLTD+G+ K GL
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-------------------- 161
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT--- 915
+ GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF
Sbjct: 162 -------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214
Query: 916 ------AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAA 966
+ + +F IL ++I P +S +A ++ FL DP +RLG G A
Sbjct: 215 SSDNPDQNTEDYLFQVILEKQIRIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFA 271
Query: 967 EVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1006
+++ HPFF+ V+WD + QK V F P F S+F
Sbjct: 272 DIQGHPFFRNVDWDMM-EQKQVVPPFKPNISGEFGLDNFDSQF 313
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 384 bits (987), Expect = e-123
Identities = 129/379 (34%), Positives = 198/379 (52%), Gaps = 38/379 (10%)
Query: 634 REKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIK 693
RE++ A + + + + + S + + L + K R ++++FE +K
Sbjct: 96 REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSL-AKPKHRVTMNEFEYLK 154
Query: 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 753
+ +G FG+V L +++ TG +A+K+LKK ++ K+++ L E +L R+PF+
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRD 812
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL+YLHS +V+RD
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
LK +NL++ DGHIK+TDFGL K G+ D
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------KDGATMK 307
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 367
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV-- 988
+ P + EA+ L++ L DP QRLG A E+ H FF G+ W + +K +
Sbjct: 368 F---PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV-YEKKLSP 423
Query: 989 -FVPQPESVDDTSYFLSRF 1006
F PQ S DT YF F
Sbjct: 424 PFKPQVTSETDTRYFDEEF 442
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 378 bits (972), Expect = e-121
Identities = 119/381 (31%), Positives = 193/381 (50%), Gaps = 48/381 (12%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 701
D PT+ + Y + + + + ++T + DF++++ I RG++
Sbjct: 8 HHHDYDIPTTENLYFQGA-MGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66
Query: 702 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRD 760
+V L R + T ++A++V+KK + DI+ + E+++ N PF+V F
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126
Query: 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 820
L+ V+EY+NGGDL +++ L E+ AR Y AE+ LAL YLH GI++RDLK DN+L+
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
+GHIKLTD+G+ K GL + GTP+Y
Sbjct: 187 DSEGHIKLTDYGMCKEGL---------------------------RPGDTTSTFCGTPNY 219
Query: 881 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT---------AESPEIIFDNILNRKI 931
+APEIL G ++G++ DWW++G+++FE + G PF + + +F IL ++I
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQKAV 988
P +S +A ++ FL DP +RLG G A+++ HPFF+ V+WD + QK V
Sbjct: 280 RIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM-EQKQV 335
Query: 989 ---FVPQPESVDDTSYFLSRF 1006
F P F S+F
Sbjct: 336 VPPFKPNISGEFGLDNFDSQF 356
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 377 bits (969), Expect = e-121
Identities = 101/413 (24%), Positives = 187/413 (45%), Gaps = 53/413 (12%)
Query: 673 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 732
S P E + D FEI++ I +G+FG+V + +K T ++A+K + K + +N++
Sbjct: 1 SMPPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR 60
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 792
+ E I+ + +PF+V +YSF +++++V++ L GGDL L++ +E+ +++
Sbjct: 61 NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF 120
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
I ELV+AL+YL + I+HRD+KPDN+L+ GH+ +TDF ++ +
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML--------------- 165
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFIT 909
+ GT Y+APE+ G + +A DWWS+G+ +E +
Sbjct: 166 -------------PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
Query: 910 GIPPF---TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
G P+ ++ S + I + + PS S E L+ + L +P+QR +
Sbjct: 213 GRRPYHIRSSTSSKEIVHTFETTVVTY---PSAWSQEMVSLLKKLLEPNPDQRFS--QLS 267
Query: 967 EVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF---SQISSGLPDDQNG- 1019
+V+ P+ +NWD++ QK + F+P F I P +
Sbjct: 268 DVQNFPYMNDINWDAV-FQKRLIPGFIPNK----GRLNCDPTFELEEMILESKPLHKKKK 322
Query: 1020 --SYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASIN 1070
+ + D S+ + E D + + +N F ++
Sbjct: 323 RLAKKEKDMRKCDSSQTCLLQEHLDSVQKEFIIFNREKVNRDFNKRQPNLALE 375
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 375 bits (964), Expect = e-117
Identities = 109/371 (29%), Positives = 189/371 (50%), Gaps = 38/371 (10%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 701
+E+ F + K ++ +S ++ +++R + DF + + +G+FG
Sbjct: 296 SEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFG 355
Query: 702 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRD 760
+V L+ ++ T +L+A+K+LKK +I+ +D+E + E+ +L PF+ + F D
Sbjct: 356 KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415
Query: 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 820
LY VMEY+NGGDL +++VG +E A Y AE+ + L +L S GI++RDLK DN+++
Sbjct: 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
+GHIK+ DFG+ K + D + GTPDY
Sbjct: 476 DSEGHIKIADFGMCKENI---------------------------WDGVTTKTFCGTPDY 508
Query: 881 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDM 940
+APEI+ +G + DWW+ G++L+E + G PF E + +F +I+ + + P M
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---PKSM 565
Query: 941 SFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV---FVPQPES 995
S EA + + P +RLG G ++K H FF+ ++W+ L +K + + P+ S
Sbjct: 566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL-ERKEIQPPYKPKA-S 623
Query: 996 VDDTSYFLSRF 1006
+ F F
Sbjct: 624 GRNAENFDRFF 634
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 367 bits (944), Expect = e-115
Identities = 98/381 (25%), Positives = 170/381 (44%), Gaps = 46/381 (12%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ D F + + RG FG VF + + TG L+A K L K + ++ + + E+ I
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAEL 796
L V + F+V Y+F + +L LVM +NGGD+ Y++ +E A Y A++
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
V LE+LH I++RDLKP+N+L+ DG+++++D GL+
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK------------------ 340
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
GTP ++APE+LLG E+ ++ D++++G+ L+E I PF A
Sbjct: 341 ---------AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
Query: 917 E----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKA 970
+ + +L + + + P S ++D L DP +RLG ++
Sbjct: 392 RGEKVENKELKQRVLEQAVTY---PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448
Query: 971 HPFFKGVNWDSLALQK--AVFVPQPESVDDTSYF-LSRFSQI--SSGLPDDQNGSYSDAD 1025
HP F+ ++W L FVP +V + + FS + + D + +
Sbjct: 449 HPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKGVAFEKADTE-FFQEFA 507
Query: 1026 TCDSSSNSRTEMDECGDLAEF 1046
+ + EM E G +
Sbjct: 508 SGTCPIPWQEEMIETGVFGDL 528
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 364 bits (937), Expect = e-113
Identities = 113/393 (28%), Positives = 175/393 (44%), Gaps = 56/393 (14%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 701
E+ F K+ E+ + + + +++DF + + I RG FG
Sbjct: 152 EICQNLRGDVFQKFIESDK--------FTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFG 203
Query: 702 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTC 758
V+ RK TG ++A+K L K + K L ER +L V PF+V Y+F
Sbjct: 204 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263
Query: 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818
D L +++ +NGGDL+ L + G E R Y AE++L LE++H+ +V+RDLKP N+
Sbjct: 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323
Query: 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP 878
L+ GH++++D GL+ H++VGT
Sbjct: 324 LLDEHGHVRISDLGLACDFSKKKP-----------------------------HASVGTH 354
Query: 879 DYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFDNILNRKIPWP 934
Y+APE+L G + +ADW+S+G +LF+ + G PF I L +
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL- 413
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQK--AVFV 990
P S E + L+ L D N+RLG GA EVK PFF+ ++W + LQK +
Sbjct: 414 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 471
Query: 991 PQPESVD-----DTSYFLSRFSQISSGLPDDQN 1018
P V+ D F ++ L DQ
Sbjct: 472 PPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQE 504
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 359 bits (924), Expect = e-112
Identities = 126/489 (25%), Positives = 197/489 (40%), Gaps = 64/489 (13%)
Query: 633 LREKYILACELLDEKSPTSFSKYKENSRLILDSVSQ--------SSGVSTPLHSSHKERT 684
+ + + C E+ P ++E +RL + +S S + L ER
Sbjct: 121 VPRQLVTNCTQRLEQGPCK-DLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQ 179
Query: 685 --SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ + F + + +G FG V + R TG ++A K L+K + ++ L E+ IL
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLAL 800
V + FVV Y++ +D L LV+ +NGGDL + +G E A Y AE+ L
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
E LH IV+RDLKP+N+L+ GHI+++D GL+ TI
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI----------------- 342
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--- 917
VGT Y+APE++ + ++ DWW++G +L+E I G PF
Sbjct: 343 -----------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391
Query: 918 -SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFF 974
E + + + S +A+ L ++ L DP +RLG A EVK HP F
Sbjct: 392 IKREEVERLVKEVPEEY---SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 975 KGVNWDSLALQKAV--FVPQPESVD--DTSYFLSRFSQISSGL-PDDQNGSYSDADTCDS 1029
K +N+ L F P P+++ D + L P DQ+ Y T
Sbjct: 449 KKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVELEPTDQD-FYQKFATGSV 507
Query: 1030 SSNSRTEMDECGDLAEF------GSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDSTR 1083
+ EM E E GS P DL + + +
Sbjct: 508 PIPWQNEMVETECFQELNVFGLDGSVPPDLDWKGQP--PAPPKKGLLQRLFSRQDSSGNS 565
Query: 1084 SSPAKDAGT 1092
S ++ T
Sbjct: 566 SDSEEELPT 574
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 329 bits (846), Expect = e-105
Identities = 95/308 (30%), Positives = 152/308 (49%), Gaps = 35/308 (11%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER 738
S K + +++DFEI +P+ +G FG V+LAR++ + + A+KVL K + + ++ E
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
I +R+P ++R + F +YL++EY G +Y L+K+ +E YI EL
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
AL Y HS ++HRD+KP+NLL+ G +K+ DFG S
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----------------------- 157
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
+ R GT DYL PE++ G H D WS+G++ +EF+ G PPF A +
Sbjct: 158 ------HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ + I + + P ++ A+DLI+R L H+P+QR EV HP+ +
Sbjct: 212 YQETYKRISRVEFTF---PDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITANS 265
Query: 979 WDSLALQK 986
Q
Sbjct: 266 SKPSNCQN 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 329 bits (847), Expect = e-105
Identities = 94/302 (31%), Positives = 153/302 (50%), Gaps = 35/302 (11%)
Query: 674 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 733
T L K + +IDDF+I +P+ +G FG V+LAR++ + A+KVL K + ++ +
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 793
+ E I +R+P ++R + F R +YL++E+ G+LY L+K G +E + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
EL AL Y H ++HRD+KP+NLL+ + G +K+ DFG S
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
+ R + GT DYL PE++ G H D W G++ +EF+ G+PP
Sbjct: 163 -----------HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
Query: 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
F + S I+N + + P +S ++DLI++ L + P QRL V HP+
Sbjct: 212 FDSPSHTETHRRIVNVDLKF---PPFLSDGSKDLISKLLRYHPPQRL---PLKGVMEHPW 265
Query: 974 FK 975
K
Sbjct: 266 VK 267
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 5e-91
Identities = 72/361 (19%), Positives = 141/361 (39%), Gaps = 76/361 (21%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
D +S S + ++ I+D+ II+ +++G F ++ L K +A+K +K
Sbjct: 8 DILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKS 65
Query: 724 DMIRK--------------NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769
+ +K + + E I+ ++N + + T D +Y++ EY+
Sbjct: 66 LLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYM 125
Query: 770 NGGDLYSLLRKVGCLE--------EDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLI 820
+ L+ V + I ++ + Y+H+ I HRD+KP N+L+
Sbjct: 126 ENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185
Query: 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
+G +KL+DFG S+ ++ + GT ++
Sbjct: 186 DKNGRVKLSDFGESEY-----------------------------MVDKKIKGSRGTYEF 216
Query: 881 LAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAE-SPEIIFDNILNRKIPWPCVP 937
+ PE +G D WS+GI L+ + PF+ + S +F+NI + I +P
Sbjct: 217 MPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR 276
Query: 938 SD----------------MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981
+ +S E D + FL +P +R+ + + H + N +
Sbjct: 277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI---TSEDALKHEWLADTNIED 333
Query: 982 L 982
L
Sbjct: 334 L 334
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 4e-90
Identities = 89/312 (28%), Positives = 146/312 (46%), Gaps = 38/312 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DFE I + +GAFG+V AR +AIK ++ + + IL+E +L ++ +
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNH 61
Query: 747 PFVVRFFYSFTCRDN-------------LYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 792
+VVR++ ++ R N L++ MEY G LY L+ + D
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+++ AL Y+HS GI+HRDLKP N+ I ++K+ DFGL+K ++ ++D+ ++
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN--VHRSLDILKLDSQN 179
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 911
+ S N SA+GT Y+A E+L GT H D +S+GII FE I
Sbjct: 180 LPGSS-----------DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226
Query: 912 PPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
P T I + + I +P + + +I + HDPN+R GA +
Sbjct: 227 PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP---GARTLLN 283
Query: 971 HPFFKGVNWDSL 982
+ + D +
Sbjct: 284 SGWLPVKHQDEV 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 2e-85
Identities = 86/336 (25%), Positives = 131/336 (38%), Gaps = 43/336 (12%)
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHS-SHKERTSIDDFEIIKPISRGAFGR 702
L ++ S ++ R + S + +P + S E F+ + + G++G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72
Query: 703 VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761
VF R + G L+A+K K D R LAE V ++P VR ++
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131
Query: 762 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 820
LYL E G L G L E Y+ + +LAL +LHS G+VH D+KP N+ +
Sbjct: 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL 190
Query: 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
G KL DFGL L G P Y
Sbjct: 191 GPRGRCKLGDFGLLVE--------LGTAGA--------------------GEVQEGDPRY 222
Query: 881 LAPEILLGTEHGYAADWWSVGIILFEFITGIP-PFTAESPEIIFDNILNRKIPWPCVPSD 939
+APE+L G +G AAD +S+G+ + E + P E + + L P +
Sbjct: 223 MAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP-----PEFTAG 276
Query: 940 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+S E + ++ L DP R A + A P +
Sbjct: 277 LSSELRSVLVMMLEPDPKLRATAE---ALLALPVLR 309
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 5e-85
Identities = 81/298 (27%), Positives = 148/298 (49%), Gaps = 34/298 (11%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER 738
+ I+DF++ + +G+F V+ A TG AIK++ K M + ++R+ E
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELV 797
I +++P ++ + F + +YLV+E + G++ L+ +V E+ AR ++ +++
Sbjct: 63 KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+ YLHS GI+HRDL NLL+ + +IK+ DFGL+
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA----------------------- 159
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
+ + ++ GTP+Y++PEI + HG +D WS+G + + + G PPF +
Sbjct: 160 TQL----KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215
Query: 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ + + ++ +PS +S EA+DLI++ L +P RL + V HPF
Sbjct: 216 TVKNTLNKVVLADYE---MPSFLSIEAKDLIHQLLRRNPADRL---SLSSVLDHPFMS 267
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 6e-83
Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 33/295 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ S + + + +G F + F T ++FA K++ K +++ + E++ E +I
Sbjct: 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
++ + VV F F D +++V+E L L ++ L E AR Y+ ++VL
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+YLH ++HRDLK NL + D +K+ DFGL+ +
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA------TKV----------------- 165
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ D + GTP+Y+APE+L H + D WS+G I++ + G PPF +
Sbjct: 166 ----EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ I + P ++ A LI + L DP R E+ FF
Sbjct: 222 ETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARP---TINELLNDEFFT 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 1e-82
Identities = 75/311 (24%), Positives = 133/311 (42%), Gaps = 33/311 (10%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 724
++ + + + S + + + +G F + F T ++FA K++ K
Sbjct: 19 GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78
Query: 725 MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 784
+++ + E++ E +I ++ + VV F F D +++V+E L L ++ L
Sbjct: 79 LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL 138
Query: 785 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844
E AR Y+ ++VL +YLH ++HRDLK NL + D +K+ DFGL+ +
Sbjct: 139 TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA------TKV- 191
Query: 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
+ D + GTP+Y+APE+L H + D WS+G I+
Sbjct: 192 --------------------EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231
Query: 905 FEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964
+ + G PPF + + I + P ++ A LI + L DP R
Sbjct: 232 YTLLVGKPPFETSCLKETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARP---T 285
Query: 965 AAEVKAHPFFK 975
E+ FF
Sbjct: 286 INELLNDEFFT 296
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 260 bits (665), Expect = 3e-78
Identities = 79/310 (25%), Positives = 149/310 (48%), Gaps = 37/310 (11%)
Query: 668 QSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR 727
SSGV + + + S++ + ++ I G+FG+ L + G + IK + M
Sbjct: 7 HSSGVDLGTENLYFQ--SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS 64
Query: 728 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLE 785
K + E E +L +++P +V++ SF +LY+VM+Y GGDL+ + +K +
Sbjct: 65 K-EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845
ED + ++ LAL+++H I+HRD+K N+ + DG ++L DFG++++ +N+T++L
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVEL 181
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 905
+ + +GTP YL+PEI + +D W++G +L+
Sbjct: 182 A-------------------------RACIGTPYYLSPEICENKPYNNKSDIWALGCVLY 216
Query: 906 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
E T F A S + + I++ P V S++ + L+++ +P R N
Sbjct: 217 ELCTLKHAFEAGSMKNLVLKIISGSF--PPVSLHYSYDLRSLVSQLFKRNPRDRPSVN-- 272
Query: 966 AEVKAHPFFK 975
+ F
Sbjct: 273 -SILEKGFIA 281
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 2e-76
Identities = 80/325 (24%), Positives = 131/325 (40%), Gaps = 49/325 (15%)
Query: 667 SQSSGVSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 724
SSGV + + + S+ + I+K I G +VF ++AIK + +
Sbjct: 6 HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL-E 63
Query: 725 MIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
++ E L ++ + ++R + +Y+VME DL S L+K
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK 122
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
++ + Y ++ A+ +H GIVH DLKP N LI DG +KL DFG++
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIAN------- 174
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----------EH 891
M D T + + S VGT +Y+ PE + +
Sbjct: 175 ----------QMQPD--------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINR 950
+D WS+G IL+ G PF +I I++ P + QD++
Sbjct: 217 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKC 275
Query: 951 FLIHDPNQRLGANGAAEVKAHPFFK 975
L DP QR+ E+ AHP+ +
Sbjct: 276 CLKRDPKQRISIP---ELLAHPYVQ 297
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 6e-74
Identities = 83/303 (27%), Positives = 142/303 (46%), Gaps = 44/303 (14%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
+ +D+E++ I G++GR R+++ G + K L M + + +++E N+L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRE 61
Query: 744 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELV 797
+++P +VR++ R N LY+VMEY GGDL S++ K L+E+ + +L
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 798 LALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
LAL+ H ++HRDLKP N+ + ++KL DFGL++I +N+ +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFA------ 173
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912
+ VGTP Y++PE + + +D WS+G +L+E +P
Sbjct: 174 -------------------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
Query: 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
PFTA S + + I K +P S E ++I R L R E+ +P
Sbjct: 215 PFTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRP---SVEEILENP 269
Query: 973 FFK 975
Sbjct: 270 LIL 272
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 4e-73
Identities = 95/298 (31%), Positives = 146/298 (48%), Gaps = 47/298 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
F ++ + GAF VFL ++R TG LFA+K +KK R + +E E +L +++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKH 65
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+V + + YLVM+ ++GG+L+ + + G E A + I +++ A++YLH
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
GIVHRDLKP+NLL + I +TDFGLSK+ E +GIM
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM------------EQNGIM--------- 164
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+A GTP Y+APE+L + A D WS+G+I + + G PPF E+ +F
Sbjct: 165 --------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF 216
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ I W + S A+D I L DPN+R + +HP+ G
Sbjct: 217 EKIKEGYYEFESPFWDDI----SESAKDFICHLLEKDPNERY---TCEKALSHPWIDG 267
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 6e-73
Identities = 75/302 (24%), Positives = 122/302 (40%), Gaps = 47/302 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-- 745
+ I+K I G +VF ++AIK + + ++ E L ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQH 67
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ ++R + +Y+VME DL S L+K ++ + Y ++ A+ +H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
GIVH DLKP N LI DG +KL DFG++ M D
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIAN-----------------QMQPD-------- 160
Query: 866 TDNRNRHSAVGTPDYLAPEILLGT-----------EHGYAADWWSVGIILFEFITGIPPF 914
T + + S VGT +Y+ PE + + +D WS+G IL+ G PF
Sbjct: 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220
Query: 915 TAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+I I++ P + QD++ L DP QR+ E+ AHP+
Sbjct: 221 QQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIP---ELLAHPY 276
Query: 974 FK 975
+
Sbjct: 277 VQ 278
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 1e-72
Identities = 82/344 (23%), Positives = 134/344 (38%), Gaps = 49/344 (14%)
Query: 648 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFL 705
S + + R +DS + SS E S+ + I+K I G +VF
Sbjct: 15 SGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQ 74
Query: 706 ARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLY 763
++AIK + + ++ E L ++ + ++R + +Y
Sbjct: 75 VLNEK-KQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132
Query: 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823
+VME DL S L+K ++ + Y ++ A+ +H GIVH DLKP N LI D
Sbjct: 133 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VD 190
Query: 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAP 883
G +KL DFG++ M D T + + S VG +Y+ P
Sbjct: 191 GMLKLIDFGIAN-----------------QMQPD--------TTSVVKDSQVGAVNYMPP 225
Query: 884 EILLGT-----------EHGYAADWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKI 931
E + + +D WS+G IL+ G PF +I I++
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
P + QD++ L DP QR+ E+ AHP+ +
Sbjct: 286 EIE-FPDIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQ 325
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 1e-72
Identities = 69/308 (22%), Positives = 130/308 (42%), Gaps = 39/308 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ DFE I+ + RG FG VF A+ + +AIK ++ + + E+++ E L +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLE 61
Query: 746 NPFVVRFFYSFTCRDN------------LYLVMEYLNGGDLYSLLRK---VGCLEEDVAR 790
+P +VR+F ++ ++ LY+ M+ +L + + E V
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 791 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850
++ A+E+LHS G++HRDLKP N+ D +K+ DFGL ++
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQD-------- 171
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
+ VGT Y++PE + G + + D +S+G+ILFE +
Sbjct: 172 -----EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY- 225
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
P T ++ R + +P + + ++ L P +R A +
Sbjct: 226 -PFSTQMERVRTLTDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI---NIIE 279
Query: 971 HPFFKGVN 978
+ F+ ++
Sbjct: 280 NAVFEDLD 287
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 2e-72
Identities = 82/310 (26%), Positives = 140/310 (45%), Gaps = 44/310 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D ++ + + +G+FG V L + + TG A+KV+ K + +K D E +L E +L + +
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ + F + YLV E GG+L+ + E A I +++ + Y+H
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
IVHRDLKP+NLL+ D +I++ DFGLS
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--------------------------- 178
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
++ +GT Y+APE+L G + D WS G+IL+ ++G PPF + I
Sbjct: 179 -FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 236
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ K W V S A+DLI + L + P+ R+ A + H + +
Sbjct: 237 KKVEKGKYTFELPQWKKV----SESAKDLIRKMLTYVPSMRI---SARDALDHEWIQTYT 289
Query: 979 WDSLALQKAV 988
+ +++
Sbjct: 290 KEQISVDVPS 299
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 1e-71
Identities = 83/319 (26%), Positives = 141/319 (44%), Gaps = 50/319 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D++++ + + +GAF V +TTG FA K++ + D +++ E I +++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 64
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +VR S YLV + + GG+L+ + E A I +++ ++ Y HS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
GIVHR+LKP+NLL+A +KL DFGL+ ++
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE------VN------------------- 159
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
D+ H GTP YL+PE+L + D W+ G+IL+ + G PPF E ++
Sbjct: 160 ---DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 216
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
I W V + EA+ LI+ L +P +R+ A + P+
Sbjct: 217 AQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVNPKKRI---TADQALKVPWICN-- 267
Query: 979 WDSLALQKAVFVPQPESVD 997
+ A + + ++VD
Sbjct: 268 ----RERVASAIHRQDTVD 282
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-71
Identities = 81/356 (22%), Positives = 137/356 (38%), Gaps = 74/356 (20%)
Query: 668 QSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL--KKLD 724
S L+ + + + I +G++G V +A + T + AIK++ K+
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 725 MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 784
I D+ERI E ++ + +P + R + + + LVME +GG L L
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 785 E----------------------------------------EDVARIYIAELVLALEYLH 804
E + + ++ AL YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 805 SLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+ GI HRD+KP+N L + + IKL DFGLSK + +
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE-----------------------FYK 222
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPE 920
+ + GTP ++APE+L T Y D WS G++L + G PF +
Sbjct: 223 LNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA 282
Query: 921 IIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+LN+K+ + + +S A+DL++ L + ++R A HP+
Sbjct: 283 DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF---DAMRALQHPWIS 335
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 3e-71
Identities = 82/298 (27%), Positives = 132/298 (44%), Gaps = 45/298 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I+ + +G+FG V + R T +A+KV+ K + D IL E +L + +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINK-ASAKNKDTSTILREVELLKKLDH 80
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ F + Y+V E GG+L+ + K E A I ++ + Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
IVHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------------------------- 173
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
N +GT Y+APE+L GT + D WS G+IL+ ++G PPF ++ I
Sbjct: 174 -FQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ K W + S +A+DLI + L P+ R+ A + HP+ +
Sbjct: 232 KRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQK 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 1e-70
Identities = 82/321 (25%), Positives = 137/321 (42%), Gaps = 45/321 (14%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
S++ + T D +++ + + +GAF V +TTG FA K++
Sbjct: 6 SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT- 64
Query: 724 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
+ D +++ E I +++P +VR S YLV + + GG+L+ +
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLIN 840
E A I +++ ++ Y HS GIVHR+LKP+NLL+A +KL DFGL+
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---- 180
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900
++ D+ H GTP YL+PE+L + D W+
Sbjct: 181 --VN----------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 216
Query: 901 GIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHD 955
G+IL+ + G PPF E ++ I W V + EA+ LI+ L +
Sbjct: 217 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVN 272
Query: 956 PNQRLGANGAAEVKAHPFFKG 976
P +R+ A + P+
Sbjct: 273 PKKRI---TADQALKVPWICN 290
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 2e-70
Identities = 82/300 (27%), Positives = 132/300 (44%), Gaps = 45/300 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I+ + +G+FG V + R T +A+KV+ K K D IL E +L + +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ F + Y+V E GG+L+ + K E A I ++ + Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
IVHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------------------------- 173
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
N +GT Y+APE+L G + D WS G+IL+ ++G PPF ++ I
Sbjct: 174 -FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ K W + S +A+DLI + L P+ R+ A + HP+ + +
Sbjct: 232 KRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYS 284
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 2e-70
Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 41/296 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D F + + GAFG V L +R++G IK + K + +E+I AE +L ++ +
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDH 79
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLY----SLLRKVGCLEEDVARIYIAELVLALEY 802
P +++ F F N+Y+VME GG+L S + L E + +++ AL Y
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 803 LHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
HS +VH+DLKP+N+L IK+ DFGL+++
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL----------------------- 176
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
+ + +A GT Y+APE+ + + D WS G++++ +TG PFT S
Sbjct: 177 -----FKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
E + ++ + ++ +A DL+ + L DP +R AA+V H +FK
Sbjct: 231 EEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHHEWFK 283
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-70
Identities = 75/300 (25%), Positives = 129/300 (43%), Gaps = 36/300 (12%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
++ +F I K I RG F V+ A G A+K ++ D++
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71
Query: 727 RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---- 782
+ E ++L + +P V++++ SF + L +V+E + GDL +++
Sbjct: 72 DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
+ E Y +L ALE++HS ++HRD+KP N+ I G +KL D GL + ++
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSK 189
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
HS VGTP Y++PE + + + +D WS+G
Sbjct: 190 TTA-------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGC 224
Query: 903 ILFEFITGIPPFTAESPEI--IFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQR 959
+L+E PF + + + I P +PSD S E + L+N + DP +R
Sbjct: 225 LLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEELRQLVNMCINPDPEKR 282
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 6e-70
Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 47/298 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I RG++G V +A ++ T A K + K + D++R E I+ ++ +
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P ++R + +F ++YLVME GG+L+ + E A + +++ A+ Y H L
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
+ HRDLKP+N L D +KL DFGL+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--------------------------- 158
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ + VGTP Y++P++L G +G D WS G++++ + G PPF+A + +
Sbjct: 159 -FKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM 216
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
I W V S +A+ LI R L P QR+ + + H +F+
Sbjct: 217 LKIREGTFTFPEKDWLNV----SPQAESLIRRLLTKSPKQRI---TSLQALEHEWFEK 267
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 3e-69
Identities = 89/342 (26%), Positives = 152/342 (44%), Gaps = 49/342 (14%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK 722
+ Q +TP ++ + + ++ +K + GA+G V L R + T AIK+++K
Sbjct: 13 NLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRK 72
Query: 723 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
+ + ++L E +L + +P +++ + F + N YLVME GG+L+ +
Sbjct: 73 -TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM 131
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLI 839
E A + I +++ + YLH IVHRDLKP+NLL+ D IK+ DFGLS +
Sbjct: 132 KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--- 188
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899
+ + +GT Y+APE+L ++ D WS
Sbjct: 189 -------------------------FENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWS 222
Query: 900 VGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIH 954
+G+ILF + G PPF ++ + I + K W V S A+DLI + L
Sbjct: 223 IGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV----SEGAKDLIKQMLQF 278
Query: 955 DPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESV 996
D +R+ A + HP+ K + + +P +
Sbjct: 279 DSQRRI---SAQQALEHPWIKE---MCSKKESGIELPSLANA 314
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 6e-69
Identities = 63/312 (20%), Positives = 122/312 (39%), Gaps = 63/312 (20%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ DF+ I+ I G FG+VF A+ R G + IK ++ N+ E+ E L
Sbjct: 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK------RVKYNN-EKAEREVKAL 58
Query: 742 ITVRNPFVVRFFYSF----------------TCRDNLYLVMEYLNGGDLYSLL--RKVGC 783
+ + +V + + + L++ ME+ + G L + R+
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
L++ +A ++ ++Y+HS +++RDLKP N+ + +K+ DFGL + N
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDG 176
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
R + GT Y++PE + ++G D +++G+I
Sbjct: 177 K--------------------------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 210
Query: 904 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
L E + TA F ++ + I + + L+ + L P R +
Sbjct: 211 LAELLH--VCDTAFETSKFFTDLRDGII-----SDIFDKKEKTLLQKLLSKKPEDRPNTS 263
Query: 964 GAAEVKAHPFFK 975
E+
Sbjct: 264 ---EILRTLTVW 272
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 6e-69
Identities = 81/306 (26%), Positives = 138/306 (45%), Gaps = 48/306 (15%)
Query: 684 TSIDDF-EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERN 739
+ ++D E+ + + G F V R++ TG +A K +KK + E I E N
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
IL +R+P ++ F + ++ L++E ++GG+L+ L + L ED A ++ +++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YLHS I H DLKP+N+++ + IKL DFG++ I +
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKN-------- 170
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
GTP+++APEI+ G AD WS+G+I + ++G PF
Sbjct: 171 ------------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212
Query: 916 AESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
E+ + NI + S A+D I R L+ DP +R+ A+
Sbjct: 213 GETKQETLTNISAVNYDFDEEYFSNT----SELAKDFIRRLLVKDPKRRM---TIAQSLE 265
Query: 971 HPFFKG 976
H + K
Sbjct: 266 HSWIKA 271
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 7e-69
Identities = 77/320 (24%), Positives = 138/320 (43%), Gaps = 54/320 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR----------KNDIERILA 736
+ + ++ + GA+G V L +++ AIKV+KK + + E I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
E ++L ++ +P +++ F F + YLV E+ GG+L+ + +E A + ++
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+ + YLH IVHRD+KP+N+L+ + +IK+ DFGLS
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF----------------- 198
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
+ + +GT Y+APE+L ++ D WS G+I++ + G PP
Sbjct: 199 -----------FSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246
Query: 914 FTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
F ++ + I + K W + S EA++LI L +D N+R A E
Sbjct: 247 FGGQNDQDIIKKVEKGKYYFDFNDWKNI----SDEAKELIKLMLTYDYNKRC---TAEEA 299
Query: 969 KAHPFFKGVNWDSLALQKAV 988
+ K + +
Sbjct: 300 LNSRWIKKYANNINKSDQKT 319
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 8e-69
Identities = 85/326 (26%), Positives = 137/326 (42%), Gaps = 49/326 (15%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 724
S S G L + + D +E+ + I +G F V R TG FA+K++
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 725 MIRKN--DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY----SLL 778
E + E +I +++P +V +++ LY+V E+++G DL
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 779 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSK 835
E VA Y+ +++ AL Y H I+HRD+KP +L+A +KL FG++
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181
Query: 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895
+ SG G VGTP ++APE++ +G
Sbjct: 182 Q------LGESGLVAGGR---------------------VGTPHFMAPEVVKREPYGKPV 214
Query: 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINR 950
D W G+ILF ++G PF +F+ I+ K W + S A+DL+ R
Sbjct: 215 DVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI----SESAKDLVRR 269
Query: 951 FLIHDPNQRLGANGAAEVKAHPFFKG 976
L+ DP +R+ E HP+ K
Sbjct: 270 MLMLDPAERI---TVYEALNHPWLKE 292
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 8e-69
Identities = 85/299 (28%), Positives = 145/299 (48%), Gaps = 36/299 (12%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S E+ I ++ ++K I +G F +V LAR TG AIK++ K + ++++ E
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFRE 64
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
I+ + +P +V+ F LYL+MEY +GG+++ L G ++E AR ++V
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
A++Y H IVHRDLK +NLL+ D +IK+ DFG S
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---------------------- 162
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 916
+ T + G P Y APE+ G + G D WS+G+IL+ ++G PF
Sbjct: 163 ------EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
++ + + + +L K +P MS + ++L+ RFL+ +P +R ++ +
Sbjct: 217 QNLKELRERVLRGKYR---IPFYMSTDCENLLKRFLVLNPIKRG---TLEQIMKDRWIN 269
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-68
Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 47/316 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILIT 743
D ++I + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
V + V+ + R ++ L++E ++GG+L+ L + L E+ A +I +++ + YL
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 804 HSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
H+ I H DLKP+N+++ HIKL DFGL+ I
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE----------------IEDGVEF 175
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
+ GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 176 K------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223
Query: 920 EIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ NI + + S A+D I + L+ + +RL E HP+
Sbjct: 224 QETLANITSVSYDFDEEFFSHT----SELAKDFIRKLLVKETRKRL---TIQEALRHPWI 276
Query: 975 KGVNWDSLALQKAVFV 990
V+ +++ V
Sbjct: 277 TPVDNQQAMVRRESVV 292
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-68
Identities = 77/298 (25%), Positives = 136/298 (45%), Gaps = 43/298 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+++++ + + +GAF V K G +A ++ + D +++ E I +++
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARICRLLKH 69
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +VR S + + YL+ + + GG+L+ + E A I +++ A+ + H +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
G+VHR+LKP+NLL+A +KL DFGL+
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAI---------------------------E 162
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ + + GTP YL+PE+L +G D W+ G+IL+ + G PPF E ++
Sbjct: 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY 222
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
I W V + EA+DLIN+ L +P++R+ AAE HP+
Sbjct: 223 QQIKAGAYDFPSPEWDTV----TPEAKDLINKMLTINPSKRI---TAAEALKHPWISH 273
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-68
Identities = 69/337 (20%), Positives = 121/337 (35%), Gaps = 76/337 (22%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ TS + + + +GA VF R + TGDLFAIKV + +R ++ + E +
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEV 60
Query: 741 LITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAE 795
L + + +V+ F T + L+ME+ G LY++L + L E I + +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
+V + +L GIVHR++KP N++ KLTDFG ++
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------------- 165
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--------LGTEHGYAADWWSVGII 903
D+ S GT +YL P++ ++G D WS+G+
Sbjct: 166 -------------LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 904 LFEFITGIPPFTAESPEIIFDNILNRKI--------------------------PWPCVP 937
+ TG PF ++ + I +
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS 272
Query: 938 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ ++ L D + G + + A
Sbjct: 273 RGLQVLLTPVLANILEADQEKCWGFD---QFFAETSD 306
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-68
Identities = 81/314 (25%), Positives = 131/314 (41%), Gaps = 53/314 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDI----ERILAERNI 740
+++E + + RG V + T +A+K++ ++ E L E +I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 741 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
L V P +++ ++ +LV + + G+L+ L + L E R + L+
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ LH L IVHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ----------------------- 173
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPP 913
GTP YLAPEI+ + +G D WS G+I++ + G PP
Sbjct: 174 -----LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
Query: 914 FTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
F ++ I++ W S +DL++RFL+ P +R A E
Sbjct: 229 FWHRKQMLMLRMIMSGNYQFGSPEWDDY----SDTVKDLVSRFLVVQPQKRY---TAEEA 281
Query: 969 KAHPFFKGVNWDSL 982
AHPFF+ + +
Sbjct: 282 LAHPFFQQYVVEEV 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 4e-68
Identities = 79/316 (25%), Positives = 140/316 (44%), Gaps = 47/316 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILIT 743
D ++ + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+++P V+ + + ++ L++E + GG+L+ L + L E+ A ++ +++ + YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 804 HSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
HSL I H DLKP+N+++ IK+ DFGL+ I +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK----------------IDFGNEF 174
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
+ GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 175 ------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222
Query: 920 EIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ N+ + S A+D I R L+ DP +R+ + HP+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNT----SALAKDFIRRLLVKDPKKRM---TIQDSLQHPWI 275
Query: 975 KGVNWDSLALQKAVFV 990
K + +KA V
Sbjct: 276 KPKDTQQALSRKASAV 291
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 4e-68
Identities = 87/303 (28%), Positives = 145/303 (47%), Gaps = 45/303 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----LDMIRKNDIERILAERNIL 741
D++ + K + GA G V LA +R T AI+++ K + + E IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
+ +P +++ F ++ Y+V+E + GG+L+ + L+E ++Y +++LA++
Sbjct: 195 KKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 802 YLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
YLH GI+HRDLKP+N+L++ D IK+TDFG SKI
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---------------------- 291
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPPFT 915
+ + GTP YLAPE+L+ A D WS+G+ILF ++G PPF+
Sbjct: 292 ------LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345
Query: 916 AES-PEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ D I + K + +++S +A DL+ + L+ DP R E HP+
Sbjct: 346 EHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALRHPW 402
Query: 974 FKG 976
+
Sbjct: 403 LQD 405
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 5e-68
Identities = 92/326 (28%), Positives = 146/326 (44%), Gaps = 60/326 (18%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK--------- 728
S + ++ + + I +G++G V LA +A+KVL K +IR+
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 729 --------------NDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGG 772
IE++ E IL + +P VV+ D+LY+V E +N G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
+ + L ED AR Y +L+ +EYLH I+HRD+KP NLL+ DGHIK+ DFG
Sbjct: 124 PVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
+S + + + VGTP ++APE L T
Sbjct: 183 VSNE---------------------------FKGSDALLSNTVGTPAFMAPESLSETRKI 215
Query: 893 Y---AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLIN 949
+ A D W++G+ L+ F+ G PF E + I ++ + +P P D++ + +DLI
Sbjct: 216 FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP-DIAEDLKDLIT 274
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFFK 975
R L +P R+ E+K HP+
Sbjct: 275 RMLDKNPESRI---VVPEIKLHPWVT 297
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 7e-68
Identities = 91/316 (28%), Positives = 144/316 (45%), Gaps = 53/316 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----LDMIRKNDIERILAERNIL 741
D++ + K + GA G V LA +R T AIK++ K + + E IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
+ +P +++ F D Y+V+E + GG+L+ + L+E ++Y +++LA++
Sbjct: 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 802 YLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
YLH GI+HRDLKP+N+L++ D IK+TDFG SKI
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---------------------- 166
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFT 915
+ + GTP YLAPE+L+ + A D WS+G+ILF ++G PPF+
Sbjct: 167 ------LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220
Query: 916 AES-PEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969
+ D I + K W V S +A DL+ + L+ DP R E
Sbjct: 221 EHRTQVSLKDQITSGKYNFIPEVWAEV----SEKALDLVKKLLVVDPKARF---TTEEAL 273
Query: 970 AHPFFKGVNWDSLALQ 985
HP+ + +
Sbjct: 274 RHPWLQDEDMKRKFQD 289
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-67
Identities = 95/301 (31%), Positives = 143/301 (47%), Gaps = 49/301 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D FE+ + RGA V+ +++ T +A+KVLKK D + + E +L+ + +
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSH 107
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ F + LV+E + GG+L+ + + G E A + +++ A+ YLH
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
GIVHRDLKP+NLL A D +K+ DFGLSKI E +M
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-----------EHQVLM--------- 207
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-II 922
+ GTP Y APEIL G +G D WSVGII + + G PF E + +
Sbjct: 208 --------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259
Query: 923 FDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
F ILN + W V S A+DL+ + ++ DP +RL + HP+ G
Sbjct: 260 FRRILNCEYYFISPWWDEV----SLNAKDLVRKLIVLDPKKRL---TTFQALQHPWVTGK 312
Query: 978 N 978
Sbjct: 313 A 313
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 1e-67
Identities = 79/299 (26%), Positives = 139/299 (46%), Gaps = 35/299 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S H R I + + + G FG+V + + TG A+K+L + + + + +I E
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
L R+P +++ + + + ++VMEY++GG+L+ + K G +EE AR +++
Sbjct: 62 IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
A++Y H +VHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--------------------- 160
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 916
+D ++ G+P+Y APE++ G G D WS G+IL+ + G PF
Sbjct: 161 -------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
E +F I +P ++ L+ L DP +R +++ H +FK
Sbjct: 214 EHVPTLFKKIRGGVFY---IPEYLNRSVATLLMHMLQVDPLKRA---TIKDIREHEWFK 266
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-67
Identities = 70/298 (23%), Positives = 131/298 (43%), Gaps = 47/298 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I + + RG FG V + ++ + K +K + D + E +IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHS 805
++ SF + L ++ E+++G D++ + L E Y+ ++ AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 806 LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
I H D++P+N++ IK+ +FG ++ + P D
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ----------------LKPGDNF---- 160
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
P+Y APE+ A D WS+G +++ ++GI PF AE+ + I
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+NI+N + + + S EA D ++R L+ + R+ A+E HP+ K
Sbjct: 213 ENIMNAEYTFDEEAFKEI----SIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQ 263
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-67
Identities = 81/324 (25%), Positives = 143/324 (44%), Gaps = 47/324 (14%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERIL 735
+ K++ D ++I + + G F V R+++TG +A K +KK E I
Sbjct: 4 TFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE 63
Query: 736 AERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 795
E +IL V +P ++ + R ++ L++E ++GG+L+ L + L E+ A +I +
Sbjct: 64 REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETD 851
++ + YLH+ I H DLKP+N+++ HIKL DFGL+
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------------- 168
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911
I + GTP+++APEI+ G AD WS+G+I + ++G
Sbjct: 169 -IEDGVEFK------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
Query: 912 PPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
PF ++ + NI + S A+D I + L+ + +RL
Sbjct: 216 SPFLGDTKQETLANITAVSYDFDEEFFSQT----SELAKDFIRKLLVKETRKRL---TIQ 268
Query: 967 EVKAHPFFKGVNWDSLALQKAVFV 990
E HP+ V+ +++ V
Sbjct: 269 EALRHPWITPVDTQQAMVRRESVV 292
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 9e-67
Identities = 88/347 (25%), Positives = 136/347 (39%), Gaps = 52/347 (14%)
Query: 646 EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFL 705
+ + + QS G L + ++ I RG V
Sbjct: 53 NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR 112
Query: 706 ARKRTTGDLFAIKVLKKLDMIRKND-----IERILAERNILITVRN-PFVVRFFYSFTCR 759
R TG FA+K+++ + E E +IL V P ++ S+
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172
Query: 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819
++LV + + G+L+ L + L E R + L+ A+ +LH+ IVHRDLKP+N+L
Sbjct: 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL 232
Query: 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 879
+ + I+L+DFG S + P + GTP
Sbjct: 233 LDDNMQIRLSDFGFSCH----------------LEPGEKLR------------ELCGTPG 264
Query: 880 YLAPEILLGTE------HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-- 931
YLAPEIL + +G D W+ G+ILF + G PPF ++ I+ +
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324
Query: 932 ---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
W S +DLI+R L DP RL A + HPFF+
Sbjct: 325 SSPEWDDR----SSTVKDLISRLLQVDPEARL---TAEQALQHPFFE 364
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 2e-66
Identities = 45/352 (12%), Positives = 100/352 (28%), Gaps = 87/352 (24%)
Query: 670 SGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 729
+G + S ER + + A + TG+ F + V + N
Sbjct: 58 TGQPFRVESELGERPR--TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 115
Query: 730 DIE-------------------------RILAERNILITVRNPFVVRFFYSFTCRD--NL 762
I+ R + +++ + ++R +
Sbjct: 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175
Query: 763 YLVMEYLN------GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816
+ + + G L S L +++ L LH G+VH L+P
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 235
Query: 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 876
++++ G + LT F + R +
Sbjct: 236 DIVLDQRGGVFLTGFEHLV-------------------------------RDGARVVSSV 264
Query: 877 TPDYLAPEILL-----------GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
+ + PE+ T ++ D W++G++++ P T ++ +
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW 324
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
I ++ + L+ FL + RL + P ++ +
Sbjct: 325 IFRS-------CKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQL 366
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-66
Identities = 84/323 (26%), Positives = 139/323 (43%), Gaps = 55/323 (17%)
Query: 668 QSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
Q+ GV + + H+ D +E+ + I G++ + T FA+K++ K
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---- 57
Query: 727 RKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
K D E IL+ P ++ + +Y+V E + GG+L + +
Sbjct: 58 SKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS 114
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH----IKLTDFGLSKIGLINN 841
E A + + +EYLH+ G+VHRDLKP N+L + I++ DFG +K
Sbjct: 115 EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL---- 170
Query: 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 901
+ +N + T +++APE+L + A D WS+G
Sbjct: 171 -----------------------RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLG 207
Query: 902 IILFEFITGIPPFTA---ESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLI 953
++L+ +TG PF ++PE I I + K W V S A+DL+++ L
Sbjct: 208 VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV----SDTAKDLVSKMLH 263
Query: 954 HDPNQRLGANGAAEVKAHPFFKG 976
DP+QRL AA V HP+
Sbjct: 264 VDPHQRL---TAALVLRHPWIVH 283
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 3e-66
Identities = 82/328 (25%), Positives = 134/328 (40%), Gaps = 48/328 (14%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 725
S + T + + + K + RG F V ++TG +A K LKK
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK-RR 66
Query: 726 IRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVG 782
++ IL E +L + P V+ + + L++EY GG+++SL
Sbjct: 67 RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE 126
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLI 839
+ E+ I +++ + YLH IVH DLKP N+L++ G IK+ DFG+S+
Sbjct: 127 MVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--- 183
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899
I +GTP+YLAPEIL A D W+
Sbjct: 184 ---IG----------------------HACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 900 VGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIH 954
+GII + +T PF E + + NI + + V S A D I L+
Sbjct: 219 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV----SQLATDFIQSLLVK 274
Query: 955 DPNQRLGANGAAEVKAHPFFKGVNWDSL 982
+P +R A +H + + ++++L
Sbjct: 275 NPEKRP---TAEICLSHSWLQQWDFENL 299
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 1e-65
Identities = 68/325 (20%), Positives = 119/325 (36%), Gaps = 73/325 (22%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ TS + + + +GA VF R + TGDLFAIKV + +R ++ + E +L
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61
Query: 742 ITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAEL 796
+ + +V+ F T + L+ME+ G LY++L + L E I + ++
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
V + +L GIVHR++KP N++ KLTDFG ++
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---------------- 165
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--------LGTEHGYAADWWSVGIIL 904
D+ S GT +YL P++ ++G D WS+G+
Sbjct: 166 ------------LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
Query: 905 FEFITGIPPFTAESPEIIFDNILNRKI--------------------------PWPCVPS 938
+ TG PF ++ + I +
Sbjct: 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273
Query: 939 DMSFEAQDLINRFLIHDPNQRLGAN 963
+ ++ L D + G +
Sbjct: 274 GLQVLLTPVLANILEADQEKCWGFD 298
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 2e-65
Identities = 82/334 (24%), Positives = 135/334 (40%), Gaps = 56/334 (16%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVR 751
KP+ G+F + + FA+K+ I K E L P +V+
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKI------ISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
F + + +LVME LNGG+L+ ++K E A + +LV A+ ++H +G+VHR
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 812 DLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
DLKP+NLL + IK+ DFG +++ + DN
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARL---------------------------KPPDN 163
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-------SPEI 921
+ + T Y APE+L + + D WS+G+IL+ ++G PF + S
Sbjct: 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE 223
Query: 922 IFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
I I W V S EA+DLI L DPN+RL + ++ + + +
Sbjct: 224 IMKKIKKGDFSFEGEAWKNV----SQEAKDLIQGLLTVDPNKRL---KMSGLRYNEWLQD 276
Query: 977 VNWDSLALQKAVFVPQPESVDDTSYFLSRFSQIS 1010
+ S + + + F +
Sbjct: 277 GSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFN 310
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 4e-65
Identities = 74/295 (25%), Positives = 136/295 (46%), Gaps = 39/295 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+GI HRD+KP+NLL+ ++K++DFGL+ + NN L
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-------------------- 163
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF-TAESPEIIF 923
+ GT Y+APE+L E H D WS GI+L + G P+ +
Sbjct: 164 -----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
Query: 924 DNILNRK---IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ +K PW + L+++ L+ +P+ R+ ++K ++
Sbjct: 219 SDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 266
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 5e-65
Identities = 71/340 (20%), Positives = 138/340 (40%), Gaps = 47/340 (13%)
Query: 646 EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRVF 704
KY D + ++ S+ D ++I++ + GAFG V
Sbjct: 9 HHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVH 68
Query: 705 LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764
++ TG +F K + + K ++ E +I+ + +P ++ +F + + L
Sbjct: 69 RCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINLHDAFEDKYEMVL 125
Query: 765 VMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH- 822
++E+L+GG+L+ + + + E Y+ + L+++H IVH D+KP+N++
Sbjct: 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK 185
Query: 823 -DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL 881
+K+ DFGL+ + P + T ++
Sbjct: 186 KASSVKIIDFGLATK----------------LNPDEIV------------KVTTATAEFA 217
Query: 882 APEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCV 936
APEI+ G+ D W++G++ + ++G+ PF E N+ + V
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 277
Query: 937 PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
S EA+D I L +P +RL + HP+ KG
Sbjct: 278 ----SPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKG 310
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-64
Identities = 83/339 (24%), Positives = 133/339 (39%), Gaps = 52/339 (15%)
Query: 669 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK---LDM 725
G TP ++ + + +G FG VF + T AIKV+ + L
Sbjct: 13 PPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW 72
Query: 726 IRKNDIERILAERNILITVRN----PFVVRFFYSFTCRDNLYLVMEY-LNGGDLYSLLRK 780
+D E +L V P V+R F ++ LV+E L DL+ + +
Sbjct: 73 SPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE 132
Query: 781 VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLI 839
G L E +R + ++V A+++ HS G+VHRD+K +N+LI G KL DFG +
Sbjct: 133 KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--- 189
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWW 898
D Y GT Y PE + + H A W
Sbjct: 190 ---------------LHDEPY-----------TDFDGTRVYSPPEWISRHQYHALPATVW 223
Query: 899 SVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 958
S+GI+L++ + G PF + IL ++ P+ +S + LI R L P+
Sbjct: 224 SLGILLYDMVCGDIPFERD------QEILEAELH---FPAHVSPDCCALIRRCLAPKPSS 274
Query: 959 RLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVD 997
R E+ P+ + + + L + P P +
Sbjct: 275 RP---SLEEILLDPWMQ-TPAEDVPLNPSKGGPAPLAWS 309
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 3e-64
Identities = 77/339 (22%), Positives = 136/339 (40%), Gaps = 48/339 (14%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-- 722
++ + + E + + P+ GAFG V+ A + +K +KK
Sbjct: 2 ALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEK 61
Query: 723 ---LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME-YLNGGDLYSLL 778
I + ++ E IL V + +++ F + LVME + +G DL++ +
Sbjct: 62 VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI 121
Query: 779 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838
+ L+E +A +LV A+ YL I+HRD+K +N++IA D IKL DFG +
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY-- 179
Query: 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADW 897
+ ++ GT +Y APE+L+G G +
Sbjct: 180 --------------------------LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEM 213
Query: 898 WSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPN 957
WS+G+ L+ + PF + + I P +S E L++ L P
Sbjct: 214 WSLGVTLYTLVFEENPFCE------LEETVEAAIH---PPYLVSKELMSLVSGLLQPVPE 264
Query: 958 QRLGANGAAEVKAHPFF-KGVNWDSLALQKAVFVPQPES 995
+R ++ P+ + VN ++ V +PES
Sbjct: 265 RRT---TLEKLVTDPWVTQPVNLADYTWEEVFRVNKPES 300
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 4e-64
Identities = 75/343 (21%), Positives = 140/343 (40%), Gaps = 47/343 (13%)
Query: 645 DEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRV 703
D + K D+ + + D ++I + + GAFG V
Sbjct: 114 DVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVV 173
Query: 704 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763
+R TG+ FA K + ++D E + E + +R+P +V +F + +
Sbjct: 174 HRVTERATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 764 LVMEYLNGGDLYS-LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 822
++ E+++GG+L+ + + + ED A Y+ ++ L ++H VH DLKP+N++
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290
Query: 823 --DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
+KL DFGL+ ++ GT ++
Sbjct: 291 KRSNELKLIDFGLTA----------------------------HLDPKQSVKVTTGTAEF 322
Query: 881 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPC 935
APE+ G GY D WSVG++ + ++G+ PF E+ + N+ + +
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382
Query: 936 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ S + +D I + L+ DPN R+ + HP+ N
Sbjct: 383 I----SEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGN 418
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 5e-64
Identities = 68/300 (22%), Positives = 120/300 (40%), Gaps = 36/300 (12%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
++ R + + RG+FG V + + TG A+K ++ L++ R ++
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFRVEELV----- 102
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
+ +P +V + + + + ME L GG L L++++GCL ED A Y+ + +
Sbjct: 103 --ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
LEYLH+ I+H D+K DN+L++ DG L DFG + L +
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC--------LQPDGLGKSLL- 211
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
GT ++APE+++G D WS ++ + G P+T
Sbjct: 212 -------------TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258
Query: 917 ESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ I + P +P + I L +P R A E++
Sbjct: 259 YFRGPLCL-KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA---SAMELRRKVGKA 314
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 9e-64
Identities = 81/348 (23%), Positives = 150/348 (43%), Gaps = 42/348 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+GI HRD+KP+NLL+ ++K++DFGL+ + NN L
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-------------------- 163
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF--TAESPEII 922
+ GT Y+APE+L E H D WS GI+L + G P+ ++S +
Sbjct: 164 -----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
Query: 923 FDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF-KGVNW 979
D PW + L+++ L+ +P+ R+ ++K ++ K +
Sbjct: 219 SDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKPLKK 271
Query: 980 DSL--ALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDAD 1025
+ + P FS ++S +G +
Sbjct: 272 GAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHH 319
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-63
Identities = 69/302 (22%), Positives = 138/302 (45%), Gaps = 46/302 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+ + G FG+V + TG A K++K D E + E +++ + +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT---RGMKDKEEVKNEISVMNQLDHA 146
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+++ + +F ++++ LVMEY++GG+L+ ++ + L E +++ ++ + ++H +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 807 GIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+H DLKP+N+L + IK+ DFGL++
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARR---------------------------- 238
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
GTP++LAPE++ + D WSVG+I + ++G+ PF ++ +
Sbjct: 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298
Query: 925 NILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979
NIL + + + S EA++ I++ LI + + R+ A+E HP+
Sbjct: 299 NILACRWDLEDEEFQDI----SEEAKEFISKLLIKEKSWRI---SASEALKHPWLSDHKL 351
Query: 980 DS 981
S
Sbjct: 352 HS 353
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 2e-63
Identities = 77/320 (24%), Positives = 133/320 (41%), Gaps = 49/320 (15%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK---L 723
+ +T L ++ +++ + G FG V+ + + AIK ++K
Sbjct: 23 PCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 82
Query: 724 DMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDNLYLVMEYLNG-GDLYSLLRK 780
D + R+ E +L V + V+R F D+ L++E DL+ + +
Sbjct: 83 DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 142
Query: 781 VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLI 839
G L+E++AR + +++ A+ + H+ G++HRD+K +N+LI + G +KL DFG +
Sbjct: 143 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--- 199
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWW 898
D Y GT Y PE + HG +A W
Sbjct: 200 ---------------LKDTVY-----------TDFDGTRVYSPPEWIRYHRYHGRSAAVW 233
Query: 899 SVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 958
S+GI+L++ + G PF E E I + +S E Q LI L P+
Sbjct: 234 SLGILLYDMVCGDIPF--EHDEEIIRGQVF-------FRQRVSSECQHLIRWCLALRPSD 284
Query: 959 RLGANGAAEVKAHPFFKGVN 978
R E++ HP+ + V
Sbjct: 285 RP---TFEEIQNHPWMQDVL 301
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 2e-63
Identities = 83/296 (28%), Positives = 143/296 (48%), Gaps = 36/296 (12%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ I + I + + G+FG+V LA T A+K + + + + + R+ E +
Sbjct: 3 ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
L +R+P +++ + T ++ +V+EY GG+L+ + + + ED R + +++ A+
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EY H IVHRDLKP+NLL+ + ++K+ DFGLS I
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI------------------------ 157
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESP 919
TD ++ G+P+Y APE++ G G D WS GI+L+ + G PF E
Sbjct: 158 ----MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+F + + +P +S AQ LI R ++ DP QR+ E++ P+F
Sbjct: 214 PNLFKKVNSCVYV---MPDFLSPGAQSLIRRMIVADPMQRI---TIQEIRRDPWFN 263
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 3e-63
Identities = 68/300 (22%), Positives = 117/300 (39%), Gaps = 37/300 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 745
+F ++ I G FG VF KR G ++AIK KK D + L E + +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQ 69
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALE 801
+ VVR+F ++ D++ + EY NGG L + R + +E + + ++ L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-----DLSGPETDGIMPS 856
Y+HS+ +VH D+KP N+ I+ + +N + DL G +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL------GHV-- 181
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFT 915
T + G +LA E+L H AD +++ + + P
Sbjct: 182 ---------TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232
Query: 916 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ I R+ P +P +S E +L+ + DP +R A + H
Sbjct: 233 NGDQ---WHEI--RQGRLPRIPQVLSQEFTELLKVMIHPDPERRP---SAMALVKHSVLL 284
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-63
Identities = 103/394 (26%), Positives = 165/394 (41%), Gaps = 52/394 (13%)
Query: 666 VSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 725
+ ++ + PL D ++ +K I G FG L R + T +L A+K +++
Sbjct: 1 MDRAPVTTGPLDMPIMHD--SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA 58
Query: 726 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
I +N ++R E ++R+P +VRF +L ++MEY +GG+LY + G
Sbjct: 59 IDEN-VQR---EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS 114
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNTI 843
ED AR + +L+ + Y HS+ I HRDLK +N L+ + +K+ DFG SK
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS------- 167
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGI 902
P S VGTP Y+APE+LL E G AD WS G+
Sbjct: 168 -----SVLHSQP----------------KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGV 206
Query: 903 ILFEFITGIPPFTAESPEIIFDNILNR------KIPWPCVPSDMSFEAQDLINRFLIHDP 956
L+ + G PF + + R IP +S E LI+R + DP
Sbjct: 207 TLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP---DDIRISPECCHLISRIFVADP 263
Query: 957 NQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS--GLP 1014
R+ E+K H +F N + + ++ Q + + L QI S +P
Sbjct: 264 ATRI---SIPEIKTHSWFL-KNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIP 319
Query: 1015 DDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGS 1048
+N D T + + + + + S
Sbjct: 320 AVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDS 353
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 6e-63
Identities = 63/378 (16%), Positives = 105/378 (27%), Gaps = 77/378 (20%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID----DFEIIKPISR 697
+LL + +E + V + P ++ + + ++++P+
Sbjct: 13 DLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRV 72
Query: 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF---- 753
G VFL R + FA+KV ++++ER+ +
Sbjct: 73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132
Query: 754 ----------------------YSFTCRDNLYLVMEYLNG--GDLYSLLRKV----GCLE 785
N L+M + L+S L V G
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845
I A+L+ L S G+VH PDNL I DG + L D
Sbjct: 193 ILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---------- 242
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGII 903
++ Y E L +A + W +G+
Sbjct: 243 --------------------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282
Query: 904 LFEFITGIPPFTAESPEIIFDNILN-----RKIPWP-CVPSDMSFEAQDLINRFLIHDPN 957
++ PF +P I + + + LI RFL D
Sbjct: 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRR 342
Query: 958 QRLGANGAAEVKAHPFFK 975
+RL E P F
Sbjct: 343 RRL---LPLEAMETPEFL 357
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-62
Identities = 75/299 (25%), Positives = 138/299 (46%), Gaps = 35/299 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
H R I + + + G FG+V + + TG A+K+L + + + + +I E
Sbjct: 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
L R+P +++ + + ++++VMEY++GG+L+ + K G L+E +R +++
Sbjct: 67 IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
++Y H +VHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--------------------- 165
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 916
+D ++ G+P+Y APE++ G G D WS G+IL+ + G PF
Sbjct: 166 -------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ +F I + P ++ L+ L DP +R +++ H +FK
Sbjct: 219 DHVPTLFKKICDGIFY---TPQYLNPSVISLLKHMLQVDPMKRA---TIKDIREHEWFK 271
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-62
Identities = 82/320 (25%), Positives = 139/320 (43%), Gaps = 60/320 (18%)
Query: 687 DDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
D +++ + + GA RV T +A+K+++K ++ + R E +L +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQ 68
Query: 746 N-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
V+ F D YLV E + GG + S + K E A + + ++ AL++LH
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 805 SLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
+ GI HRDLKP+N+L H +K+ DF L I L+G +
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG------IKLNGDCSP---------- 172
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTA 916
+ G+ +Y+APE++ + + D WS+G+IL+ ++G PPF
Sbjct: 173 ----ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228
Query: 917 E---------------SPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDP 956
++F++I K W + S A+DLI++ L+ D
Sbjct: 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI----SCAAKDLISKLLVRDA 284
Query: 957 NQRLGANGAAEVKAHPFFKG 976
QRL AA+V HP+ +G
Sbjct: 285 KQRL---SAAQVLQHPWVQG 301
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 224 bits (571), Expect = 4e-62
Identities = 77/335 (22%), Positives = 124/335 (37%), Gaps = 66/335 (19%)
Query: 677 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 736
S + +E+ + + G FG V + TG+ AIK ++ ++ KN ER
Sbjct: 4 RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKN-RERWCL 61
Query: 737 ERNILITVRNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEED 787
E I+ + +P VV D L MEY GGDL L + L+E
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTID 844
R ++++ AL YLH I+HRDLKP+N+++ K+ D G +K
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-------- 173
Query: 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
VGT YLAPE+L ++ D+WS G +
Sbjct: 174 --------------------LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213
Query: 905 FEFITGIPPFTAESPEIIFDNILNRK--------------------IPWPC-VPSDMSFE 943
FE ITG PF + + + K +P P + ++ +
Sbjct: 214 FECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGK 273
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ + L+ QR + F+ ++
Sbjct: 274 LERWLQCMLMWHQRQR---GTDPQNPNVGCFQALD 305
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 8e-62
Identities = 74/297 (24%), Positives = 130/297 (43%), Gaps = 39/297 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE-RILAERNILITV 744
I + + + G++G+V T A+K+LKK + R + E + E +L +
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 745 RNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLAL 800
R+ V++ + +Y+VMEY G + +L V A Y +L+ L
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLHS GIVH+D+KP NLL+ G +K++ G++ +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA------EALH---------------- 160
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES 918
+ ++ G+P + PEI G + G+ D WS G+ L+ TG+ PF ++
Sbjct: 161 ---PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+F+NI +P D DL+ L ++P +R +++ H +F+
Sbjct: 218 IYKLFENIGKGSYA---IPGDCGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWFR 268
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 216 bits (550), Expect = 8e-62
Identities = 50/368 (13%), Positives = 102/368 (27%), Gaps = 76/368 (20%)
Query: 670 SGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 729
+G + S ER + + A + TG+ F + V + N
Sbjct: 63 TGQPFRVESELGERPR--TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 120
Query: 730 DIERILAERNI---LITVRNP------------------------FVVRFFYSFTCRDNL 762
I+++ E L ++N VR +
Sbjct: 121 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 180
Query: 763 YLVMEYLNG------GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816
+ + + L S L +++ L LH G+VH L+P
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240
Query: 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 876
++++ G + LT F + P
Sbjct: 241 DIVLDQRGGVFLTGFEHLVR-----------DGASAVSPI---------------GRGFA 274
Query: 877 TPDYLAPEILLGTEHG-----YAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
P+ A +L +H +A D W++G+ ++ P T ++ + I
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS-- 332
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVP 991
++ + L+ FL + RL + P ++ + + A
Sbjct: 333 -----CKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQLRTELSAALPLYQTD 384
Query: 992 QPESVDDT 999
+ +
Sbjct: 385 GEPTREGG 392
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-61
Identities = 57/299 (19%), Positives = 103/299 (34%), Gaps = 37/299 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+ I+ + G F V L G +A+K + + D E E ++ +P
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHP 86
Query: 748 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLA 799
++R +L++ + G L++ + ++ L ED + +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
LE +H+ G HRDLKP N+L+ +G L D G + +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ---------------ACIHVEGS 191
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPPFTA 916
D + T Y APE+ H D WS+G +L+ + G P+
Sbjct: 192 RQALTLQDWAAQR---CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 917 ESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ + ++ P S L+N + DP+QR + +
Sbjct: 249 VFQKGDSVALAVQNQLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIP---LLLSQLEA 303
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 6e-61
Identities = 83/330 (25%), Positives = 136/330 (41%), Gaps = 67/330 (20%)
Query: 669 SSGVSTPLHSSHKERTSI-DDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
SSG+ ++ ++ DD+++ K + G G+V R TG A+K+L
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA 68
Query: 727 RKNDIERILAERNILITVRN-PFVVRFFYSF----TCRDNLYLVMEYLNGGDLYS--LLR 779
R+ E + P +V + + L ++ME + GG+L+S R
Sbjct: 69 RQ--------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER 120
Query: 780 KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKI 836
E A + ++ A+++LHS I HRD+KP+NLL D +KLTDFG +K
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 896
T + TP Y+APE+L ++ + D
Sbjct: 181 -----------------------------TTQNALQTPCYTPYYVAPEVLGPEKYDKSCD 211
Query: 897 WWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI----------PWPCVPSDMSFEAQD 946
WS+G+I++ + G PPF + + + I + R+I W V S +A+
Sbjct: 212 MWSLGVIMYILLCGFPPFYSNTGQAISPGMK-RRIRLGQYGFPNPEWSEV----SEDAKQ 266
Query: 947 LINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
LI L DP +RL + HP+
Sbjct: 267 LIRLLLKTDPTERL---TITQFMNHPWINQ 293
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 8e-60
Identities = 86/289 (29%), Positives = 134/289 (46%), Gaps = 43/289 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G +G V+ R + AIK + + D + + E + +++ +V++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLE--EDVARIYIAELVLALEYLHSLGIVHR 811
SF+ + + ME + GG L +LLR K G L+ E Y +++ L+YLH IVHR
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 812 DLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
D+K DN+LI + G +K++DFG SK L+G N
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKR--------LAG-------------------INPC 179
Query: 871 RHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFT--AESPEIIFDNI 926
+ GT Y+APEI+ GY AAD WS+G + E TG PPF E +F +
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KV 238
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
K+ P +P MS EA+ I + DP++R A ++ F K
Sbjct: 239 GMFKVH-PEIPESMSAEAKAFILKCFEPDPDKRA---CANDLLVDEFLK 283
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-59
Identities = 47/336 (13%), Positives = 94/336 (27%), Gaps = 76/336 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ + GAF +V+ A + F +KV K + L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERL 121
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----CLEEDVARIYIAEL 796
++F+ + ++ LV E + G L + + + + + + +
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAH-----------DGHIKLTDFGLSKIGLINNTIDL 845
+ +E +H I+H D+KPDN ++ + + L D G S ID+
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS--------IDM 233
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 905
I + T + E+L Y D++ V ++
Sbjct: 234 KLFPKGTIF-----------------TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVY 276
Query: 906 EFITGIPPFTAESPEI------------------IFDNILNRKIPWPCVPSDMSFEAQDL 947
+ G F +LN +P + DL
Sbjct: 277 CMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLN-------IPDCHHLPSLDL 329
Query: 948 INRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983
+ + L Q + + +
Sbjct: 330 LRQKLKKVFQQHYTNKI--RALRNRLIVLLLECKRS 363
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-58
Identities = 84/349 (24%), Positives = 138/349 (39%), Gaps = 63/349 (18%)
Query: 648 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEII-KPISRGAFGRVFLA 706
P + + ++ Q K+ IDD+++ + + G G+V
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 707 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRF--FY--SFTCRDN 761
+ T + FA+K+L+ R+ E + P +VR Y + R
Sbjct: 82 FNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 762 LYLVMEYLNGGDLYS--LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819
L +VME L+GG+L+S R E A + + A++YLHS+ I HRD+KP+NLL
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 820 IAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 876
+ +KLTDFG +K + + +
Sbjct: 194 YTSKRPNAILKLTDFGFAKE-----------TTSHNSL-----------------TTPCY 225
Query: 877 TPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI----IFDNILNRKI- 931
TP Y+APE+L ++ + D WS+G+I++ + G PPF + + I +
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285
Query: 932 ----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
W V S E + LI L +P QR+ E HP+
Sbjct: 286 FPNPEWSEV----SEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 327
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-57
Identities = 59/288 (20%), Positives = 120/288 (41%), Gaps = 41/288 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I RG+F V+ T A L+ + K++ +R E +L +++P +VRF+
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQ-DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 755 SFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--I 808
S+ + + LV E + G L + L++ ++ V R + +++ L++LH+ I
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 809 VHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDLK DN+ I G +K+ D GL+
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLAT-----------------------------LKR 183
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+ +GTP+++APE + ++ + D ++ G+ + E T P++ +
Sbjct: 184 ASFAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ E +++I + + ++R ++ H FF+
Sbjct: 243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQ 287
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 4e-57
Identities = 66/349 (18%), Positives = 123/349 (35%), Gaps = 80/349 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFA-------------------IKVLKKLD--- 724
DFE I+ + RG FG VF A+ + +A +K L KL+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 725 ---------------------------------MIRKNDIERILAERNILITVRNPFVVR 751
+ + ++ + + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYLHSLGI 808
+ + LY+ M+ +L + + + E V ++ A+E+LHS G+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRDLKP N+ D +K+ DFGL ++ + T
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQDEEEQTVLTP-------------MPAY 230
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 928
VGT Y++PE + G + + D +S+G+ILFE + T I ++
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDV-- 286
Query: 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
R + +P + + + ++ L P +R A ++ + F+ +
Sbjct: 287 RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT---DIIENAIFENL 332
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-56
Identities = 85/314 (27%), Positives = 139/314 (44%), Gaps = 43/314 (13%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S+ + DD+E+ + I GA V A + AIK + L+ + ++ +L E
Sbjct: 6 SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-LEKCQ-TSMDELLKE 63
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--------KVGCLEEDVA 789
+ +P +V ++ SF +D L+LVM+ L+GG + +++ K G L+E
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 790 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ E++ LEYLH G +HRD+K N+L+ DG +++ DFG+S + D
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS--AFLATGGD----- 176
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGYAADWWSVGIILFEFI 908
T N+ R + VGTP ++APE + + + AD WS GI E
Sbjct: 177 ---------------ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221
Query: 909 TGIPPFTAESPEIIFDNILNRKIP-------WPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
TG P+ P + L P + + +I+ L DP +R
Sbjct: 222 TGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP- 280
Query: 962 ANGAAEVKAHPFFK 975
AAE+ H FF+
Sbjct: 281 --TAAELLRHKFFQ 292
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 7e-56
Identities = 67/310 (21%), Positives = 103/310 (33%), Gaps = 46/310 (14%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
+ F + GA G + A+K I E
Sbjct: 15 ETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKR------ILPECFSFADRE 67
Query: 738 RNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAE 795
+L P V+R+F + R Y+ +E L + +K + +
Sbjct: 68 VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQ 126
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPET 850
L +LHSL IVHRDLKP N+LI+ ++DFGL K
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK--------------- 171
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEF 907
+ + +R R GT ++APE+L Y D +S G + +
Sbjct: 172 --------KLAVGRHSFSR-RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
I+ G PF + + A++LI + + DP +R A
Sbjct: 223 ISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP---SAK 279
Query: 967 EVKAHPFFKG 976
V HPFF
Sbjct: 280 HVLKHPFFWS 289
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-56
Identities = 81/290 (27%), Positives = 142/290 (48%), Gaps = 36/290 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ I G+ G V LAR++ +G A+K++ D+ ++ E + E I+ ++
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQH 101
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
VV + S+ + L+++ME+L GG L ++ +V EE +A + ++ AL YLH+
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATV-CEAVLQALAYLHAQ 160
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
G++HRD+K D++L+ DG +KL+DFG Q +
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCA----------------------------QIS 192
Query: 867 DNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
+ R S VGTP ++APE++ + + D WS+GI++ E + G PP+ ++SP
Sbjct: 193 KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ + P +S +D + R L+ DP +R A E+ HPF
Sbjct: 253 LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA---TAQELLDHPFLL 299
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-55
Identities = 89/290 (30%), Positives = 139/290 (47%), Gaps = 36/290 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I +GA G V+ A TG AI+ ++++ ++ E I+ E ++ +N
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIR---QMNLQQQPKKELIINEILVMRENKN 76
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +V + S+ D L++VMEYL GG L ++ + E +A + E + ALE+LHS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSN 135
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K DN+L+ DG +KLTDFG Q T
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------------------------QIT 167
Query: 867 DNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
++ R + VGTP ++APE++ +G D WS+GI+ E I G PP+ E+P
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
I P P +S +D +NR L D +R A E+ H F K
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAK---ELLQHQFLK 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-55
Identities = 70/323 (21%), Positives = 124/323 (38%), Gaps = 65/323 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ K + G+ G V G A+K + + + L E +L +
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKR------MLIDFCDIALMEIKLLTESDD 67
Query: 747 -PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-------ARIYIAELVL 798
P V+R++ S T LY+ +E +L L+ +E++ + ++
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAH-------------DGHIKLTDFGLSKIGLINNTIDL 845
+ +LHSL I+HRDLKP N+L++ + I ++DFGL K
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK--------- 177
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-------GYAADWW 898
Q + N ++ GT + APE+L + + + D +
Sbjct: 178 --------------LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 899 SVGIILFEFIT-GIPPFTAESPEI--IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHD 955
S+G + + ++ G PF + I I + + EA DLI++ + HD
Sbjct: 224 SMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283
Query: 956 PNQRLGANGAAEVKAHPFFKGVN 978
P +R A +V HP F +
Sbjct: 284 PLKRP---TAMKVLRHPLFWPKS 303
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 7e-55
Identities = 83/290 (28%), Positives = 141/290 (48%), Gaps = 37/290 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ F ++ I +G+FG VF T + AIK++ L+ +++IE I E +L +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEA-EDEIEDIQQEITVLSQCDS 79
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P+V +++ S+ L+++MEYL GG LL G L+E + E++ L+YLHS
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE 138
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
+HRD+K N+L++ G +KL DFG++ G + +T
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQI---------------------- 174
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDN 925
R++ VGTP ++APE++ + + AD WS+GI E G PP + P +++F
Sbjct: 175 ---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-- 229
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
L K P + + S ++ + L +P+ R A E+ H F
Sbjct: 230 -LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFIL 275
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-54
Identities = 76/321 (23%), Positives = 135/321 (42%), Gaps = 43/321 (13%)
Query: 663 LDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK 722
S + +G T + + I+D E + + G G+V+ R R TG + A+K ++
Sbjct: 3 SGSSGKQTGYLTI--GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR- 59
Query: 723 LDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV 781
K + +RIL + ++++ + P++V+ F +F ++++ ME + R
Sbjct: 60 RS-GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ 118
Query: 782 GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
G + E + +V AL YL G++HRD+KP N+L+ G IKL DFG+S
Sbjct: 119 GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG----- 173
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-----LGTEHGYAA 895
+ D++ + + G Y+APE + ++ A
Sbjct: 174 -----------------------RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRA 210
Query: 896 DWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIH 954
D WS+GI L E TG P+ + + +L + P S + Q + L
Sbjct: 211 DVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTK 270
Query: 955 DPNQRLGANGAAEVKAHPFFK 975
D +R ++ H F K
Sbjct: 271 DHRKRP---KYNKLLEHSFIK 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 7e-54
Identities = 84/298 (28%), Positives = 145/298 (48%), Gaps = 41/298 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +EI+ + GAFG+V+ A+ + TG L A KV+ + + ++E + E IL T +
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATCDH 75
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
P++V+ ++ L++++E+ GG + +++ ++ L E ++ +++ AL +LHS
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK N+L+ +G I+L DFG+S T+
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQ--------------------- 172
Query: 866 TDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP- 919
R S +GTP ++APE+++ T + Y AD WS+GI L E PP +P
Sbjct: 173 ----KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 228
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
++ I P PS S E +D + L +P R AA++ HPF +
Sbjct: 229 RVLL-KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRP---SAAQLLEHPFVSSI 282
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-52
Identities = 76/316 (24%), Positives = 120/316 (37%), Gaps = 84/316 (26%)
Query: 681 KERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
K+ IDD+++ + + G G+V + T + FA+K+L+ R+ E
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 62
Query: 740 ILITVRN-PFVVRFFYSF----TCRDNLYLVMEYLNGGDLYS--LLRKVGCLEEDVARIY 792
+ P +VR + R L +VME L+GG+L+S R E A
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ + A++YLHS+ I HRD+KP+NLL + +KLTDFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG----------------- 165
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
A E G ++ + D WS+G+I++ +
Sbjct: 166 -------------------------------FAKET-TGEKYDKSCDMWSLGVIMYILLC 193
Query: 910 GIPPFTAESPEI----IFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
G PPF + + I + W V S E + LI L +P QR+
Sbjct: 194 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV----SEEVKMLIRNLLKTEPTQRM 249
Query: 961 GANGAAEVKAHPFFKG 976
E HP+
Sbjct: 250 ---TITEFMNHPWIMQ 262
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-52
Identities = 82/292 (28%), Positives = 138/292 (47%), Gaps = 40/292 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ F++++ + G++G V+ A + TG + AIK + ++D++ I+ E +I+ +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ-----VPVESDLQEIIKEISIMQQCDS 83
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
P VV+++ S+ +L++VMEY G + ++R L ED + + LEYLH
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+ +HRD+K N+L+ +GH KL DFG++ Q
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAG----------------------------QL 175
Query: 866 TDNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIF 923
TD R++ +GTP ++APE++ + AD WS+GI E G PP+ P IF
Sbjct: 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF 235
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
I P P S D + + L+ P QR A ++ HPF +
Sbjct: 236 -MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRA---TATQLLQHPFVR 283
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 9e-52
Identities = 87/335 (25%), Positives = 138/335 (41%), Gaps = 80/335 (23%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
DDFE I + G G VF + +G + A K++ L+ I+ +I+ E +L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LE-IKPAIRNQIIRELQVLHEC 88
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
+P++V F+ +F + + ME+++GG L +L+K G + E + ++ L YL
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 805 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
I+HRD+KP N+L+ G IKL DFG+S G + +++
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSM-------------------- 186
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES----- 918
+S VGT Y++PE L GT + +D WS+G+ L E G P
Sbjct: 187 -------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239
Query: 919 ----------------------------------PEIIFD---NILNRKIP-WPCVPSDM 940
P IF+ I+N P P
Sbjct: 240 LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVF 297
Query: 941 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
S E QD +N+ LI +P +R ++ H F K
Sbjct: 298 SLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIK 329
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-51
Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 46/302 (15%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-T 743
DD E I + RGA+G V R +G + A+K ++ + + +R+L + +I + T
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-AT-VNSQEQKRLLMDLDISMRT 62
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGG--DLY-SLLRKVGCLEEDVARIYIAELVLAL 800
V PF V F+ + ++++ ME ++ Y ++ K + ED+ +V AL
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 801 EYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
E+LHS L ++HRD+KP N+LI G +K+ DFG+S
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG------------------------ 158
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG----YAADWWSVGIILFEFITGIPPFT 915
D+ + G Y+APE + + +D WS+GI + E P+
Sbjct: 159 ----YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214
Query: 916 A-ESPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ +P ++ P P +P+D S E D ++ L + +R E+ HPF
Sbjct: 215 SWGTPFQQLKQVVEE--PSPQLPADKFSAEFVDFTSQCLKKNSKERP---TYPELMQHPF 269
Query: 974 FK 975
F
Sbjct: 270 FT 271
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 7e-51
Identities = 67/313 (21%), Positives = 130/313 (41%), Gaps = 46/313 (14%)
Query: 676 LHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL 735
+ + +D + + I RGA+G V + +G + A+K ++ + + + +++L
Sbjct: 11 ISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-ST-VDEKEQKQLL 68
Query: 736 AERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKV--GCLEEDVAR 790
+ ++++ + P++V+F+ + + ++ ME ++ Y + V + E++
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 791 IYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
V AL +L L I+HRD+KP N+L+ G+IKL DFG+S
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG-------------- 174
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG----YAADWWSVGIILF 905
Q D+ + G Y+APE + + +D WS+GI L+
Sbjct: 175 --------------QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
Query: 906 EFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSF--EAQDLINRFLIHDPNQRLGA 962
E TG P+ + ++ P + F + +N L D ++R
Sbjct: 221 ELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP-- 278
Query: 963 NGAAEVKAHPFFK 975
E+ HPF
Sbjct: 279 -KYKELLKHPFIL 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 1e-50
Identities = 66/301 (21%), Positives = 111/301 (36%), Gaps = 42/301 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
+ + ++ G F V+ A+ +G +A+K L + + I + E + + P
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMKKLSGHP 86
Query: 748 FVVRFFYSFTCRDN--------LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELV 797
+V+F + + L+ E G + L + G L D +
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 798 LALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
A++++H I+HRDLK +NLL+++ G IKL DFG + +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT------------TISHYPDY 194
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILFEFITGIP 912
S + + R+ TP Y PEI+ G D W++G IL+
Sbjct: 195 SWSAQRRALVEEEITRN---TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
Query: 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
PF + I+N K P + LI L +P +RL EV
Sbjct: 252 PFEDGAKL----RIVNGKYSIPPHDT-QYTVFHSLIRAMLQVNPEERLSIA---EVVHQL 303
Query: 973 F 973
Sbjct: 304 Q 304
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-50
Identities = 71/293 (24%), Positives = 111/293 (37%), Gaps = 40/293 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ + +LVMEY G L L+E + L YLHS
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K N+L++ G +KL DFG +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSA-----------------------------SIM 204
Query: 867 DNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESP-EII 922
N S VGTP ++APE IL E Y D WS+GI E PP + +
Sbjct: 205 APAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ +I + P S ++ ++ L P R + + H F
Sbjct: 263 Y-HIAQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVL 310
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-50
Identities = 62/338 (18%), Positives = 119/338 (35%), Gaps = 73/338 (21%)
Query: 687 DDFEIIKPISRGA--FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+E++ I +G V LAR + TG+ ++ + L+ + + E ++
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLF 83
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEY 802
+P +V + +F + L++V ++ G L+ + + E + ++ AL+Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+H +G VHR +K ++LI+ DG + L+ + + +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSN--LSMISHGQ------------------ 183
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPF------ 914
Q+ + +V +L+PE+L GY +D +SVGI E G PF
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243
Query: 915 -------------------------------------TAESPEIIFDNILNRKIPWPCVP 937
++S N P
Sbjct: 244 QMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYH 303
Query: 938 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
S + + L +P+ R A+ + H FFK
Sbjct: 304 RTFSPHFHHFVEQCLQRNPDARP---SASTLLNHSFFK 338
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-49
Identities = 77/304 (25%), Positives = 134/304 (44%), Gaps = 51/304 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 745
FE+++ + G +G+V+ R TG L AIKV+ + ++ E I E N+L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 746 NPFVVRFFYSF------TCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELV 797
+ + ++ +F D L+LVME+ G + L++ K L+E+ E++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
L +LH ++HRD+K N+L+ + +KL DFG+S ++ T+
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVG------------- 184
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-----GYAADWWSVGIILFEFITGIP 912
R++ +GTP ++APE++ E+ + +D WS+GI E G P
Sbjct: 185 ------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 913 PFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971
P P +F I P S + Q I L+ + +QR ++ H
Sbjct: 233 PLCDMHPMRALF-LIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQRP---ATEQLMKH 287
Query: 972 PFFK 975
PF +
Sbjct: 288 PFIR 291
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 6e-45
Identities = 62/274 (22%), Positives = 115/274 (41%), Gaps = 17/274 (6%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D + + +G FG+ R TG++ +K L + D + L E ++ + +
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEH 66
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALEYLHS 805
P V++F L + EY+ GG L +++ + R+ A+ + + YLHS
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+ I+HRDL N L+ + ++ + DFGL+++ + + P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARL--MVDEKTQPEGLRSLKKP---------- 174
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
D + R++ VG P ++APE++ G + D +S GI+L E I + P +
Sbjct: 175 -DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ R P + + R DP +R
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 80/326 (24%), Positives = 136/326 (41%), Gaps = 70/326 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILITV 744
+ +E I I G++G VF R R TG + AIK K + + + +A R +L +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYL 803
++P +V F + L+LV EY + + L + + E + + + + A+ +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
H +HRD+KP+N+LI IKL DFG +++ L+GP +Y +
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARL--------LTGP--------SDYYDDE 162
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI- 921
V T Y +PE+L+G G D W++G + E ++G+P + +S ++
Sbjct: 163 -----------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS-DVD 210
Query: 922 ----IFDNIL------------------NRKIPWPCVPSD-------MSFEAQDLINRFL 952
I L KIP P +S+ A L+ L
Sbjct: 211 QLYLIR-KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCL 269
Query: 953 IHDPNQRLGANGAAEVKAHPFFKGVN 978
DP +RL HP+F+ +
Sbjct: 270 HMDPTERLTCEQLLH---HPYFENIR 292
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-44
Identities = 81/352 (23%), Positives = 142/352 (40%), Gaps = 75/352 (21%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
+Q+ G + S+ TSID + I + G +G V+ A T + AIK ++ L+
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LE-- 70
Query: 727 RKNDIERI----LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
++ E + + E ++L +++ ++ L+L+ EY DL + K
Sbjct: 71 --HEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP 127
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-----AHDGHIKLTDFGLSKIG 837
+ V + ++ +L+ + + HS +HRDLKP NLL+ + +K+ DFGL++
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-- 185
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAAD 896
+ + H + T Y PEILLG+ H + D
Sbjct: 186 ------------------------AFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVD 220
Query: 897 WWSVGIILFEFITGIPPFTAESPEI-----IFD-----------------NILNRKIPWP 934
WS+ I E + P F +S EI IF+ + +
Sbjct: 221 IWSIACIWAEMLMKTPLFPGDS-EIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFR 279
Query: 935 ------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980
+ + + E DL+ L DP +R+ A A E HP+F ++D
Sbjct: 280 GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE---HPYFSHNDFD 328
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 43/308 (13%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFA 716
+ T + + DD +I + I G+FG V A G A
Sbjct: 7 HHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVA 64
Query: 717 IKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYS 776
+K+L + D + L E I+ +R+P +V F + T NL +V EYL+ G LY
Sbjct: 65 VKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 777 LLRKVGCLEE--DVARIYIA-ELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDF 831
LL K G E+ + R+ +A ++ + YLH+ IVHR+LK NLL+ +K+ DF
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183
Query: 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891
GLS++ + + + SA GTP+++APE+L
Sbjct: 184 GLSRL---------------------------KASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
+D +S G+IL+E T P+ +P + + + +P +++ + +I
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-LEIPRNLNPQVAAIIEGC 275
Query: 952 LIHDPNQR 959
++P +R
Sbjct: 276 WTNEPWKR 283
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 85/326 (26%), Positives = 139/326 (42%), Gaps = 71/326 (21%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNIL 741
++ + ++ I G +G V+ A+ G+ FA+K ++ L+ + E I + E +IL
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIR-LE----KEDEGIPSTTIREISIL 54
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLAL 800
+++ +V+ + + L LV E+L+ DL LL LE A+ ++ +L+ +
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
Y H ++HRDLKP NLLI +G +K+ DFGL++
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR------------------------- 148
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 919
+ + H V T Y AP++L+G++ D WSVG I E + G P F S
Sbjct: 149 -AFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS- 205
Query: 920 EI-----IFD-----------------NILNRKIPWPCVP-----SDMSFEAQDLINRFL 952
E IF + +P + DL+++ L
Sbjct: 206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265
Query: 953 IHDPNQRLGANGAAEVKAHPFFKGVN 978
DPNQR+ A A E H +FK N
Sbjct: 266 KLDPNQRITAKQALE---HAYFKENN 288
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-43
Identities = 77/314 (24%), Positives = 118/314 (37%), Gaps = 56/314 (17%)
Query: 689 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+E+ I+ G G ++LA + G +K L + +AER L V +P
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL--VHSGDAEAQAMAMAERQFLAEVVHP 139
Query: 748 FVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+V+ F Y+VMEY+ G L L A Y+ E++ AL Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSY 197
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS+G+V+ DLKP+N+++ + +KL D G I+ G
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS------RINSFG--------------- 235
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
GTP + APEI+ A D ++VG L +P +
Sbjct: 236 ----------YLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-- 282
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982
L P S+ L+ R + DP QR A E+ A GV + +
Sbjct: 283 ---GLPEDDPVLKTYD--SYGR--LLRRAIDPDPRQRFTT--AEEMSAQ--LTGVLREVV 331
Query: 983 ALQKAVFVPQPESV 996
A V P ++
Sbjct: 332 AQDTGVPRPGLSTI 345
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 67/288 (23%), Positives = 116/288 (40%), Gaps = 47/288 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA----ERNILI 742
++ E K I +G FG V R + AIK L D + ++ E I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALE 801
+ +P +V+ + + +VME++ GDLY L + ++ + ++ L +E
Sbjct: 79 NLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 802 YLHSLG--IVHRDLKPDNLLIAHDG-----HIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
Y+ + IVHRDL+ N+ + K+ DFGLS+ +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------------SVHSVS 184
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIP 912
+G ++APE + E Y AD +S +IL+ +TG
Sbjct: 185 ------------------GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
Query: 913 PFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
PF S +I F N++ + P +P D +++I DP +R
Sbjct: 227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-43
Identities = 79/335 (23%), Positives = 131/335 (39%), Gaps = 86/335 (25%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NI 740
++ +E + + G F V+ AR + T + AIK +K D A R +
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLA 799
L + +P ++ +F + N+ LV +++ DL +++ L + Y+ +
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
LEYLH I+HRDLKP+NLL+ +G +KL DFGL+K
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK------------------------ 160
Query: 860 YPEYQQTDNRNRHSAVGTPD-----------YLAPEILLGTEH-GYAADWWSVGIILFEF 907
+ G+P+ Y APE+L G G D W+VG IL E
Sbjct: 161 --------------SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 206
Query: 908 ITGIPPFTAESPEI-----IFDNIL---NRKI--------------PWPCVP-----SDM 940
+ +P +S ++ IF+ L + +P +P S
Sbjct: 207 LLRVPFLPGDS-DLDQLTRIFE-TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAA 264
Query: 941 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ DLI + +P R+ A A + +F
Sbjct: 265 GDDLLDLIQGLFLFNPCARITATQALK---MKYFS 296
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 70/292 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ E+ + + RGAFG V A+ R AIK ++ +++ + + E L V +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----ESERKAFIVELRQLSRVNH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE-----------DVARIYIAE 795
P +V+ + + C + + LVMEY GG LY++L L ++
Sbjct: 61 PNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ----- 113
Query: 796 LVLALEYLHSL---GIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETD 851
+ YLHS+ ++HRDLKP NLL+ G +K+ DFG + +
Sbjct: 114 ---GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-------------DIQ 157
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911
M T + G+ ++APE+ G+ + D +S GIIL+E IT
Sbjct: 158 THM-----------T------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
Query: 912 PPF--TAESPEIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
PF I + N R P + ++ + L+ R DP+QR
Sbjct: 201 KPFDEIGGPAFRIMWAVHNGTR----PPLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 66/311 (21%), Positives = 118/311 (37%), Gaps = 46/311 (14%)
Query: 666 VSQSSGVSTPLHSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFAIK 718
+S S S P +S + + +++I + I +G FG+V+ R G++ AI+
Sbjct: 6 LSLLSARSFPRKAS-QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEV-AIR 61
Query: 719 VLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL 778
++ ++ ++ E R+ VV F + +L ++ G LYS++
Sbjct: 62 LIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 779 RKVGCLEEDVARIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
R + + IA E+V + YLH+ GI+H+DLK N+ +G + +TDFGL I
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSIS 179
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---- 893
+ G +LAPEI+
Sbjct: 180 GVLQAGRREDKLR----------------------IQNGWLCHLAPEIIRQLSPDTEEDK 217
Query: 894 -----AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLI 948
+D +++G I +E PF + E I + P M E D++
Sbjct: 218 LPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP-NLSQIGMGKEISDIL 276
Query: 949 NRFLIHDPNQR 959
+ +R
Sbjct: 277 LFCWAFEQEER 287
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-43
Identities = 77/345 (22%), Positives = 135/345 (39%), Gaps = 70/345 (20%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILI 742
S++ +E + + G++G V R + TG + A +KK + + + +A R +L
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVA---IKKFLESDDDKMVKKIAMREIKLLK 79
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALE 801
+R+ +V + YLV E+++ + L L+ V + Y+ +++ +
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
+ HS I+HRD+KP+N+L++ G +KL DFG ++ L+ P
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART--------LAAP-----GEVYDDE- 184
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE 920
V T Y APE+L+G G A D W++G ++ E G P F +S +
Sbjct: 185 -------------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS-D 230
Query: 921 I-----IFDNILNRKIP--WPCVPS-----------------------DMSFEAQDLINR 950
I I L IP +S DL +
Sbjct: 231 IDQLYHIM-MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK 289
Query: 951 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPES 995
L DP++R H FF+ + Q+ Q ++
Sbjct: 290 CLHIDPDKRPFCAELLH---HDFFQMDGFAERFSQELQLKVQKDA 331
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-43
Identities = 83/340 (24%), Positives = 133/340 (39%), Gaps = 91/340 (26%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------IRKNDIERIL 735
+S F+ ++ + G + V+ +TTG A+K +K LD IR
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIR-------- 52
Query: 736 AERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC------LEEDVA 789
E +++ +++ +VR + + L LV E+++ DL + LE ++
Sbjct: 53 -EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110
Query: 790 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ + +L+ L + H I+HRDLKP NLLI G +KL DFGL++
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-------------- 156
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFI 908
GI P + E V T Y AP++L+G+ + D WS G IL E I
Sbjct: 157 AFGI-PVNTFSSE------------VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203
Query: 909 TGIPPFTAESPEI-----IFD----------------------------NILNRKIPWPC 935
TG P F + + IFD L + +
Sbjct: 204 TGKPLFPGTN-DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT 262
Query: 936 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ D ++ L +P+ RL A A HP+F
Sbjct: 263 KEP-LDGNLMDFLHGLLQLNPDMRLSAKQALH---HPWFA 298
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-43
Identities = 83/330 (25%), Positives = 139/330 (42%), Gaps = 72/330 (21%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAER 738
+ ++ ++ ++ + G +G V+ A+ G + A+K ++ LD + E I + E
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIR-LD----AEDEGIPSTAIREI 70
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELV 797
++L + +P +V L LV E++ DL +L + L++ +IY+ +L+
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+ + H I+HRDLKP NLLI DG +KL DFGL++
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR---------------------- 167
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTA 916
+ H V T Y AP++L+G++ + D WS+G I E ITG P F
Sbjct: 168 ----AFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 917 ESPEI-----IFD-----------------NILNRKIP-WPCVP-----SDMSFEAQDLI 948
+ + IF R + P E DL+
Sbjct: 223 VT-DDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLL 281
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ L DPN+R+ A A HP+FK ++
Sbjct: 282 SNMLCFDPNKRISARDAMN---HPYFKDLD 308
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-43
Identities = 80/332 (24%), Positives = 124/332 (37%), Gaps = 78/332 (23%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL---AERNI- 740
+ +E + I GA+G V+ AR +G A LK + + L R +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVA---LKSVRVPNGGGGGGGLPISTVREVA 63
Query: 741 ----LITVRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVA 789
L +P VVR + LV E+++ DL + L K L +
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122
Query: 790 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ + + + L++LH+ IVHRDLKP+N+L+ G +KL DFGL++
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR------IYSYQMAL 176
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
T V T Y APE+LL + + D WSVG I E
Sbjct: 177 T----------------------PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
Query: 910 GIPPFTAESPEI-----IFDNIL----------NRKIPWPCVP-----------SDMSFE 943
P F S E IFD ++ + +P P +M
Sbjct: 215 RKPLFCGNS-EADQLGKIFD-LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEES 272
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
L+ L +P++R+ A A + H +
Sbjct: 273 GAQLLLEMLTFNPHKRISAFRALQ---HSYLH 301
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-43
Identities = 82/329 (24%), Positives = 134/329 (40%), Gaps = 75/329 (22%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNIL 741
+ +E ++ I G +G VF A+ R T ++ A+K ++ LD +D E + L E +L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LD----DDDEGVPSSALREICLL 55
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLAL 800
+++ +VR L LV E+ + DL L+ ++ + ++ +L+ L
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+ HS ++HRDLKP NLLI +G +KL +FGL++ GI P +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR--------------AFGI-PVRCYS 159
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFIT-GIPPFTAES 918
E V T Y P++L G + + D WS G I E G P F
Sbjct: 160 AE------------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 919 PEI-----IFDNIL---NRKIPWPCVPS---------------------DMSFEAQDLIN 949
IF +L + WP + ++ +DL+
Sbjct: 208 -VDDQLKRIFR-LLGTPTEEQ-WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ 264
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
L +P QR+ A A + HP+F
Sbjct: 265 NLLKCNPVQRISAEEALQ---HPYFSDFC 290
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 86/335 (25%), Positives = 142/335 (42%), Gaps = 88/335 (26%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DD+++++ + RG + VF A T + +K+LK + ++I E IL +R
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRG 89
Query: 747 -PFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
P ++ S LV E++N D L + L + R Y+ E++ A
Sbjct: 90 GPNIITLADIVKDPVSR----TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKA 142
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y HS+GI+HRD+KP N++I H+ ++L D+GL++ P +
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---------HPGQE------- 186
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF--- 914
Y V + + PE+L+ + Y+ D WS+G +L I PF
Sbjct: 187 -YNVR-----------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234
Query: 915 ---------------TAESPEII----------FDNILNR--KIPW-PCVPSD----MSF 942
T + + I F++IL R + W V S+ +S
Sbjct: 235 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 294
Query: 943 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
EA D +++ L +D RL A A E HP+F V
Sbjct: 295 EALDFLDKLLRYDHQSRLTAREAME---HPYFYTV 326
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 65/297 (21%), Positives = 125/297 (42%), Gaps = 44/297 (14%)
Query: 677 HSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 729
H H R + DD+EI + I G+FG V+ + GD+ A+K+L
Sbjct: 7 HHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAP-TPQ 62
Query: 730 DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA 789
++ E +L R+ ++ F ++ L +V ++ G LY L E
Sbjct: 63 QLQAFKNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKK 121
Query: 790 RIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848
I IA + ++YLH+ I+HRDLK +N+ + D +K+ DFGL+
Sbjct: 122 LIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE------------ 169
Query: 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILF 905
+ + + + G+ ++APE++ + + +D ++ GI+L+
Sbjct: 170 -------------KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLY 216
Query: 906 EFITGIPPFTAESP-EIIFDNIL--NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
E +TG P++ + + I + + + V S+ + L+ L ++R
Sbjct: 217 ELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 80/330 (24%), Positives = 129/330 (39%), Gaps = 84/330 (25%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------IRKNDIERILAE 737
++ + + + G + V+ + + T +L A+K ++ L+ IR E
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAPCTAIR---------E 50
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAEL 796
++L +++ +V +L LV EYL+ DL L G + ++++ +L
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ L Y H ++HRDLKP NLLI G +KL DFGL++ S P
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA--------KSIP-------- 153
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFT 915
+ + V T Y P+ILLG+ D W VG I +E TG P F
Sbjct: 154 -----------TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202
Query: 916 AESPEI-----IFDNIL---NRKIPWPCVPS----------------------DMSFEAQ 945
+ IF IL + WP + S + +
Sbjct: 203 GST-VEEQLHFIFR-ILGTPTEET-WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGA 259
Query: 946 DLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
DL+ + L + R+ A A + HPFF
Sbjct: 260 DLLTKLLQFEGRNRISAEDAMK---HPFFL 286
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-42
Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 30/278 (10%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILI 742
T + + + + RG G V+ A + A+K++ + R+ E
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAG 89
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ P VV LY+ M +NG DL ++LR+ G L A + ++ AL+
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
H+ G HRD+KP+N+L++ D L DFG++ + + T
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKL------T------------ 190
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
Q + VGT Y+APE + Y AD +++ +L+E +TG PP+ + ++
Sbjct: 191 --QLG-----NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243
Query: 923 FDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQR 959
+ +N+ IP P V + +I R + +P R
Sbjct: 244 GAH-INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 7e-42
Identities = 86/335 (25%), Positives = 134/335 (40%), Gaps = 86/335 (25%)
Query: 685 SIDDFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKNDIER----ILAERN 739
+ +E + I GA+G+VF AR + G A LK++ + + R
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVA---LKRVRV----QTGEEGMPLSTIRE 61
Query: 740 I-----LITVRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEED 787
+ L T +P VVR F L LV E+++ DL + L KV + +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ + +L+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I S
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI--------YSF 172
Query: 848 PETDGIMPSDAHY-PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
V T Y APE+LL + + D WSVG I E
Sbjct: 173 QMA---------LTSV------------VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 211
Query: 907 FITGIPPFTAESPEI-----IFDNIL----------NRKIPWPCVP-----------SDM 940
P F S ++ I D ++ + +P +D+
Sbjct: 212 MFRRKPLFRGSS-DVDQLGKILD-VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI 269
Query: 941 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+DL+ + L +P +R+ A A HP+F+
Sbjct: 270 DELGKDLLLKCLTFNPAKRISAYSALS---HPYFQ 301
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-41
Identities = 89/337 (26%), Positives = 131/337 (38%), Gaps = 81/337 (24%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----------IRKNDIER 733
+ +E + I +G FG VF AR R TG A LKK+ M +R+ I +
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVA---LKKVLMENEKEGFPITALREIKILQ 71
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 792
+L N+ + + + C+ ++YLV ++ DL LL V +
Sbjct: 72 LLKHENV-VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETD 851
+ L+ L Y+H I+HRD+K N+LI DG +KL DFGL+ L
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL------------- 176
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITG 910
++ Y T NR V T Y PE+LLG G D W G I+ E T
Sbjct: 177 ---AKNSQPNRY--T-NR-----VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225
Query: 911 IPPFTAESPEI-----IFDNIL---NRKIPWPCVPS------------------------ 938
P + E I + ++ WP V +
Sbjct: 226 SPIMQGNT-EQHQLALIS-QLCGSITPEV-WPNVDNYELYEKLELVKGQKRKVKDRLKAY 282
Query: 939 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
A DLI++ L+ DP QR+ ++ A H FF
Sbjct: 283 VRDPYALDLIDKLLVLDPAQRIDSDDALN---HDFFW 316
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 30/274 (10%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILITVRNP 747
++I+ + G V+LA AIK + + K + ++R E + + +
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V D YLVMEY+ G L + G L D A + +++ +++ H +
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRD+KP N+LI + +K+ DFG++K L ++ +
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLTQTN-------------------- 170
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+GT Y +PE G D +S+GI+L+E + G PPF E+ I +
Sbjct: 171 -----HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI 225
Query: 928 NRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQR 959
+P V D+ ++I R D R
Sbjct: 226 QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-41
Identities = 84/340 (24%), Positives = 140/340 (41%), Gaps = 82/340 (24%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-VLKKLDMIRKNDIERILAERN 739
+ R +D F++ + +G FG V L ++++TG AIK V+ D +N R L
Sbjct: 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--QDPRFRN---RELQIMQ 71
Query: 740 ILITVRNPFVVR---FFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGC----LEEDV 788
L + +P +V+ +FY+ RD L +VMEY+ L+ R +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130
Query: 789 ARIYIAELVLALEYLH--SLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDL 845
++++ +L+ ++ LH S+ + HRD+KP N+L+ DG +KL DFG +K
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK---------- 180
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIIL 904
+ Y + + Y APE++ G + A D WSVG I
Sbjct: 181 -------KLSPSEPNVAY-----------ICSRYYRAPELIFGNQHYTTAVDIWSVGCIF 222
Query: 905 FEFITGIPPFTAESP-----EII----------FDNILN----------RKIPW----PC 935
E + G P F ++ EI+ + + IPW
Sbjct: 223 AEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD 282
Query: 936 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ EA DL++ L + P +R+ E HP+F
Sbjct: 283 HSLKDAKEAYDLLSALLQYLPEERM---KPYEALCHPYFD 319
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-40
Identities = 89/334 (26%), Positives = 132/334 (39%), Gaps = 81/334 (24%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+R + K I G+FG V+ A+ +G+L AIK K+ D E I+
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KV----LQDKRFKNRELQIM 101
Query: 742 ITVRNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGC----LEEDVARI 791
+ + +VR FFYS + + L LV++Y+ +Y + R L ++
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPET 850
Y+ +L +L Y+HS GI HRD+KP NLL+ +KL DFG +K
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--------------- 205
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 909
+ Y + + Y APE++ G T++ + D WS G +L E +
Sbjct: 206 --QLVRGEPNVSY-----------ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252
Query: 910 GIPPFTAESP-----EII----------------------FDNILNRKIPWP-CVPSDMS 941
G P F +S EII F I + PW
Sbjct: 253 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI--KAHPWTKVFRPRTP 310
Query: 942 FEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
EA L +R L + P RL E AH FF
Sbjct: 311 PEAIALCSRLLEYTPTARL---TPLEACAHSFFD 341
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 67/285 (23%), Positives = 112/285 (39%), Gaps = 45/285 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-LDMIRKNDIERILAERNILITVR 745
+ + + I G FG+V+ A GD A+K + D IE + E + ++
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+P ++ NL LVME+ GG L +L + D+ + ++ + YLH
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHD 123
Query: 806 LG---IVHRDLKPDNLLIAHDGH--------IKLTDFGLSKIGLINNTIDLSGPETDGIM 854
I+HRDLK N+LI +K+TDFGL++
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE------------------ 165
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ SA G ++APE++ + +D WS G++L+E +TG PF
Sbjct: 166 -----------WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + K+ +PS L+ DP+ R
Sbjct: 215 RGIDGLAVAYGVAMNKLA-LPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-40
Identities = 71/277 (25%), Positives = 125/277 (45%), Gaps = 31/277 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILITVRNP 747
+E+ + + G V LAR A+KVL+ D+ R R E + +P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHP 72
Query: 748 FVVRFF----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+V + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
H GI+HRD+KP N++I+ +K+ DFG+++ + ++ ++
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVT----------------- 174
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 922
QT + +GT YL+PE G +D +S+G +L+E +TG PPFT +SP +
Sbjct: 175 -QTA-----AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ ++ IP +S + ++ + L +P R
Sbjct: 229 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-39
Identities = 79/326 (24%), Positives = 133/326 (40%), Gaps = 61/326 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 745
DF++ + GA+G V A + TG++ AIK K++ K R L E IL +
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFK 67
Query: 746 NPFVVRFFYSFT--CRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
+ ++ F +N +Y++ E + DL+ ++ L +D + +I + + A+
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQTLRAV 125
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+ LH ++HRDLKP NLLI + +K+ DFGL++I + + M
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM------ 179
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES- 918
E+ V T Y APE++L ++ A D WS G IL E P F
Sbjct: 180 VEF-----------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 919 ---------------PEIIFDNILN-------------RKIPWPCVPSDMSFEAQDLINR 950
+ I + P + ++ + DL+ R
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288
Query: 951 FLIHDPNQRLGANGAAEVKAHPFFKG 976
L+ DP +R+ A E HP+ +
Sbjct: 289 MLVFDPAKRI---TAKEALEHPYLQT 311
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 56/296 (18%), Positives = 103/296 (34%), Gaps = 56/296 (18%)
Query: 678 SSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL 735
+ H ID + ++ G ++ R + G+ +KVLK D
Sbjct: 2 NKHSG---IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFN 55
Query: 736 AERNILITVRNPFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA-RIY 792
E L +P V+ + + L+ ++ G LY++L + D + +
Sbjct: 56 EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115
Query: 793 IA-ELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
A ++ + +LH+L I L +++I D +++ +
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------------- 161
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFE 906
+Q + P ++APE L +AD WS ++L+E
Sbjct: 162 ------------SFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWE 203
Query: 907 FITGIPPFTAESP-EIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+T PF S EI L R P +P +S L+ + DP +R
Sbjct: 204 LVTREVPFADLSNMEIGMKVALEGLR----PTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-39
Identities = 93/327 (28%), Positives = 137/327 (41%), Gaps = 82/327 (25%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+ K I G+FG VF A+ + + AIK K+ D E I+ V++P
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIK---KV----LQDKRFKNRELQIMRIVKHPN 93
Query: 749 VVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVL 798
VV FFYS + + L LV+EY+ +Y R + + ++Y+ +L+
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 799 ALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+L Y+HS+GI HRD+KP NLL+ G +KL DFG +KI ++ +
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI----------------LIAGE 196
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 916
Y + + Y APE++ G T + D WS G ++ E + G P F
Sbjct: 197 P-NVSY-----------ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244
Query: 917 ESP-----EII----------------------FDNILNRKIPWP-CVPSDMSFEAQDLI 948
ES EII F I R P+ +A DLI
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQI--RPHPFSKVFRPRTPPDAIDLI 302
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFFK 975
+R L + P+ RL A E HPFF
Sbjct: 303 SRLLEYTPSARL---TAIEALCHPFFD 326
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-38
Identities = 81/358 (22%), Positives = 134/358 (37%), Gaps = 113/358 (31%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+ + K + G+FG V +G FA+K K+ D E +I+ + +
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALK---KV----LQDPRYKNRELDIMKVLDHVN 61
Query: 749 VVRFFYSFTCRDN--------------------------------------LYLVMEYLN 770
+++ F + L ++MEY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV- 120
Query: 771 GGDLYSLLRKVGC----LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGH 825
L+ +L+ + ++ IYI +L A+ ++HSLGI HRD+KP NLL+ + D
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEI 885
+KL DFG +K + Y + + Y APE+
Sbjct: 181 LKLCDFGSAK-----------------KLIPSEPSVAY-----------ICSRFYRAPEL 212
Query: 886 LLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP-----EII----------------- 922
+LG TE+ + D WS+G + E I G P F+ E+ II
Sbjct: 213 MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH 272
Query: 923 -----FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
F + + W + P A DL+ + L ++P+ R+ E AHPFF
Sbjct: 273 YTEVRFPTL--KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHPFF 325
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-38
Identities = 83/331 (25%), Positives = 130/331 (39%), Gaps = 75/331 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---------RN 739
+ +KP+ G G VF A AIK K+ + ++ L E N
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 740 I-----LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
I ++ + S T +++Y+V EY+ DL ++L + G L E+ AR+++
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ-GPLLEEHARLFMY 127
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+L+ L+Y+HS ++HRDLKP NL I D +K+ DFGL++I D
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI-------------MDPH 174
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 912
H E + T Y +P +LL + A D W+ G I E +TG
Sbjct: 175 YSHKGHLSEG-----------LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
Query: 913 PFTAESP----EIIFD-------------------NILN----RKIPWPCVPSDMSFEAQ 945
F ++I + I N P + +S EA
Sbjct: 224 LFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAV 283
Query: 946 DLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
D + + L P RL A E +HP+
Sbjct: 284 DFLEQILTFSPMDRL---TAEEALSHPYMSI 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-37
Identities = 81/327 (24%), Positives = 132/327 (40%), Gaps = 76/327 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
+ + GA+G V A + +G+ AIK KL +++I R E +L +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK---KLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 745 RNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
++ V+ F + N YLVM ++ DL ++ E+ + + +++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLK 137
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+HS G+VHRDLKP NL + D +K+ DFGL++ +DA
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------------------HADA 178
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917
Y V T Y APE++L H D WSVG I+ E +TG F +
Sbjct: 179 EMTGY-----------VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227
Query: 918 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 949
I + + + + + S +A DL+
Sbjct: 228 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLE 287
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ L D ++RL AA+ HPFF+
Sbjct: 288 KMLELDVDKRL---TAAQALTHPFFEP 311
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-37
Identities = 79/354 (22%), Positives = 127/354 (35%), Gaps = 74/354 (20%)
Query: 648 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLAR 707
S T + LI S S SG PL +RT +++K I +G +G V++ +
Sbjct: 1 SMTYIPPGESLRDLIEQSQSSGSGSGLPLLV---QRTIAKQIQMVKQIGKGRYGEVWMGK 57
Query: 708 KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV--RNPFVVRFF----YSFTCRDN 761
R G+ A+KV + E I TV R+ ++ F
Sbjct: 58 WR--GEKVAVKVFFT------TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109
Query: 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDL 813
LYL+ +Y G LY L+ + + ++ V L +LH+ I HRDL
Sbjct: 110 LYLITDYHENGSLYDYLKSTTLDAKSMLKL-AYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K N+L+ +G + D GL+ E D ++
Sbjct: 169 KSKNILVKKNGTCCIADLGLAVK------FISDTNEVDIPP-----------------NT 205
Query: 874 AVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGI----------PPFTAE 917
VGT Y+ PE+L + + AD +S G+IL+E P+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 918 SP-----EIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
P E + + + +K P + + L+ H+P RL A
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-37
Identities = 79/325 (24%), Positives = 131/325 (40%), Gaps = 67/325 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 745
+ + I GA+G V A AIK K+ +R L E IL+ R
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFR 83
Query: 746 NPFVVRFFYSFT--CRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
+ ++ + +Y+V + + DLY LL+ L D ++ +++ L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT-QHLSNDHICYFLYQILRGL 141
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+Y+HS ++HRDLKP NLL+ +K+ DFGL+++ D
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-------------ADPDHDHTGFL 188
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 919
EY V T Y APEI+L ++ + D WSVG IL E ++ P F +
Sbjct: 189 TEY-----------VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 920 ----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINRF 951
I I+N K+PW + + +A DL+++
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKG 976
L +P++R+ + AHP+ +
Sbjct: 298 LTFNPHKRI---EVEQALAHPYLEQ 319
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 66/334 (19%), Positives = 114/334 (34%), Gaps = 77/334 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--------DIERILAER 738
+ + + IS G++G V + G AIK + + +R+L E
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 739 NILITVRNPFVVRFFYSFTCRDN-----LYLVMEYLNGGDLYSLLR-KVGCLEEDVARIY 792
+L +P ++ F + LYLV E + DL ++ + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+ ++L L LH G+VHRDL P N+L+A + I + DF L++ D
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-----------EDTADA 188
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 911
Y V Y APE+++ + D WS G ++ E
Sbjct: 189 NK------THY-----------VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
Query: 912 PPFTAESP----EIIFD-----------NILN--------------RKIPWPCVPSDMSF 942
F + I + + W V
Sbjct: 232 ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADP 291
Query: 943 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
A DLI + L +P +R+ + HP+F+
Sbjct: 292 VALDLIAKMLEFNPQRRI---STEQALRHPYFES 322
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-36
Identities = 83/326 (25%), Positives = 134/326 (41%), Gaps = 75/326 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
+ ++ + P+ GA+G V A TG A+K KL ++ I R E +L +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 745 RNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
++ V+ F + +YLV + G DL ++++ L +D + I +++
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILR 143
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+HS I+HRDLKP NL + D +K+ DFGL++ T M
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTADEM---- 186
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917
Y V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 187 --TGY-----------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
Query: 918 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 949
++I I + K+ + V + A DL+
Sbjct: 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFFK 975
+ L+ D ++R+ AA+ AH +F
Sbjct: 294 KMLVLDSDKRI---TAAQALAHAYFA 316
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-36
Identities = 83/327 (25%), Positives = 135/327 (41%), Gaps = 75/327 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
+ ++P+ GA+G V A TG AIK KL ++++ R E +L +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 81
Query: 745 RNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
R+ V+ + + YLVM ++ G DL L++ L ED + + +++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLK 139
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L Y+H+ GI+HRDLKP NL + D +K+ DFGL++ +D+
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------------QADS 180
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917
Y V T Y APE++L + D WSVG I+ E ITG F
Sbjct: 181 EMTGY-----------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229
Query: 918 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 949
+ I + + K + + ++ S A +L+
Sbjct: 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 289
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ L+ D QR+ A E AHP+F+
Sbjct: 290 KMLVLDAEQRV---TAGEALAHPYFES 313
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-36
Identities = 75/354 (21%), Positives = 123/354 (34%), Gaps = 104/354 (29%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 745
+E++K I +G+FG+V A A+K+++ + E IL +R
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ----AAEEIRILEHLRKQD 154
Query: 746 ---NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLAL 800
V+ +FT R+++ + E L +LY L++K + R + ++ L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+ LH I+H DLKP+N+L+ G IK+ DFG S
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS------------------CYEHQR 255
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF---- 914
Y Y Q+ R Y APE++LG +G D WS+G IL E +TG P
Sbjct: 256 VYT-YIQS----RF-------YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303
Query: 915 ------------------------------------------TAESPEIIFDNILNRKIP 932
T ++ + +R+
Sbjct: 304 EGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGK 363
Query: 933 WPCVPSDMSFEAQ----------DLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
P + D + + L DP R+ A HP+ +
Sbjct: 364 LRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA---LRHPWLRR 414
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-36
Identities = 70/322 (21%), Positives = 118/322 (36%), Gaps = 68/322 (21%)
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRV 703
LD + + K+ LI D + SG PL +RT + + I +G FG V
Sbjct: 5 LDRPFISEGTTLKD---LIYDMTTSGSGSGLPLLV---QRTIARTIVLQESIGKGRFGEV 58
Query: 704 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRDN 761
+ + R G+ A+K+ + E I T +R+ ++ F + +
Sbjct: 59 WRGKWR--GEEVAVKIF------SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110
Query: 762 ----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS--------LGIV 809
L+LV +Y G L+ L + E + ++ L +LH I
Sbjct: 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
HRDLK N+L+ +G + D GL+ + T +
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVR-----------------------HDSATDTIDI 206
Query: 870 NRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ VGT Y+APE+L + E AD +++G++ +E
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY--- 263
Query: 924 DNILNRKIPWP-CVPSDMSFEA 944
++P+ VPSD S E
Sbjct: 264 ------QLPYYDLVPSDPSVEE 279
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 62/283 (21%), Positives = 107/283 (37%), Gaps = 62/283 (21%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+RT D +++ + +G +G V+ + G+ A+K+ D + E +
Sbjct: 3 QRTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIF------SSRDEKSWFRETELY 54
Query: 742 ITV--RNPFVVRFF----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 795
TV R+ ++ F S L+L+ Y G LY L+ RI +
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLS 113
Query: 796 LVLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ L +LH I HRDLK N+L+ +G + D GL+ +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----------- 162
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVG 901
+ + + + VGT Y+APE+L T + D W+ G
Sbjct: 163 ------------HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG 210
Query: 902 IILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 943
++L+E + + + K P+ VP+D SFE
Sbjct: 211 LVLWEVARRMVS---------NGIVEDYKPPFYDVVPNDPSFE 244
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-35
Identities = 87/358 (24%), Positives = 134/358 (37%), Gaps = 74/358 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
D +EI I G++G V A + + AIK K+ + ++ I+ RIL E IL +
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRL 109
Query: 745 RNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
+ VV+ D LY+V+E D L R L E + + L++
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
++Y+HS GI+HRDLKP N L+ D +K+ DFGL++ + P + +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES 918
+ + R V T Y APE++L E+ A D WS+G I E + I A
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 919 P-----------------------------------EIIFD------------------- 924
+IF+
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
Query: 925 NILNRKIPWPCVP-----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
+ S +A L+ R L+ +PN+R+ N HPFFK V
Sbjct: 349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA---HPFFKEV 403
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-35
Identities = 75/363 (20%), Positives = 137/363 (37%), Gaps = 101/363 (27%)
Query: 678 SSHKERTSIDDFEIIKP-ISRGAFGRVFLARKR--TTGDLFAIKVLKKLDM----IRKND 730
SS +ER D FE + RG +G V+ A+++ +A+K ++ + R+
Sbjct: 12 SSERER-VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA 70
Query: 731 IERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC------- 783
+ R L N+ I+++ F+ ++L+ +Y DL+ +++
Sbjct: 71 LLRELKHPNV-ISLQKVFLSH------ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKP 122
Query: 784 --LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIG 837
L + + + +++ + YLH+ ++HRDLKP N+L+ + G +K+ D G +++
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL- 181
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAAD 896
+ P D V T Y APE+LLG H A D
Sbjct: 182 --------------------FNSPLKPLADLDPV---VVTFWYRAPELLLGARHYTKAID 218
Query: 897 WWSVGIILFEFITGIPPFTAESPEIIFDNILNR----KI------P----WPCVPS---- 938
W++G I E +T P F +I N + +I P W +
Sbjct: 219 IWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEH 278
Query: 939 --------------------------DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
+A L+ + L DP +R+ + A + P
Sbjct: 279 STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ---DP 335
Query: 973 FFK 975
+F
Sbjct: 336 YFL 338
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-35
Identities = 72/346 (20%), Positives = 120/346 (34%), Gaps = 81/346 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 745
F +I+ + G FGRV L + +A+KV++ + E +IL ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT----RSAKIEADILKKIQNDD 92
Query: 746 --NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 801
N +V++ F D++ L+ E L G LY ++ + + ++Y E++ AL
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI-------- 853
YL + + H DLKP+N+L+ K I + ++ GI
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD--GKKIQIYRTKSTGIKLIDFGCA 209
Query: 854 -MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912
SD H T R Y APE++L ++D WS G +L E TG
Sbjct: 210 TFKSDYHGS-IINT----RQ-------YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
Query: 913 PFTAES----------------PEII----------FDNILNRKIPWPCVPSDMSF---- 942
F ++ + N K+ WP S ++
Sbjct: 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV 317
Query: 943 -------------EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
D + L DP R + H F +
Sbjct: 318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK---HKFLE 360
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 74/337 (21%), Positives = 129/337 (38%), Gaps = 84/337 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
++ +KPI GA G V A AIK KL +N R E ++ V
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 745 RNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ ++ FT + + +Y+VME + +L +++ L+ + + +++
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 138
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+++LHS GI+HRDLKP N+++ D +K+ DFGL++ T +M
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMM---- 183
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF---- 914
Y V T Y APE++LG + D WSVG I+ E I G F
Sbjct: 184 --TPY-----------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
Query: 915 ---------------TAESPEIIFDNILN--------RKIPW------------PCVPSD 939
E + + + +
Sbjct: 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 290
Query: 940 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ +A+DL+++ L+ D ++R+ E HP+
Sbjct: 291 KASQARDLLSKMLVIDASKRI---SVDEALQHPYINV 324
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-34
Identities = 84/356 (23%), Positives = 142/356 (39%), Gaps = 78/356 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
D++ I I RG++G V+LA + T AIK K++ + ++ I+ RIL E IL +
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK---KVNRMFEDLIDCKRILREITILNRL 82
Query: 745 RNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
++ +++R + D LY+V+E DL L + L E+ + + L+L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
++H GI+HRDLKP N L+ D +K+ DFGL++ ++ + P +
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 860 YPEYQQ-TDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917
+Q T + V T Y APE++L E+ + D WS G I E + + +
Sbjct: 202 KNLKKQLTSH------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 918 SP--------------------------------EIIFD-----------NILN------ 928
IIF+ NI
Sbjct: 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315
Query: 929 -------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
+ I +S + +L+ L +PN+R+ + HP+ K V
Sbjct: 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRI---TIDQALDHPYLKDV 368
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-34
Identities = 74/357 (20%), Positives = 123/357 (34%), Gaps = 107/357 (29%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP- 747
+ +++ + G F V+LA+ A+K+++ K E E +L V +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDAD 76
Query: 748 ----------FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 791
+++ F + + +V E L G +L +L++K + +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 792 YIAELVLALEYLHS-LGIVHRDLKPDNLLIAH------DGHIKLTDFGLSKIGLINNTID 844
+L+L L+Y+H GI+H D+KP+N+L+ IK+ D G +
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---------- 185
Query: 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
D HY QT R Y +PE+LLG G AD WS ++
Sbjct: 186 ---------CWYDEHYTNSIQT----RE-------YRSPEVLLGAPWGCGADIWSTACLI 225
Query: 905 FEFITGIPPFTAESPEI-------------------------------IFDNILNRKI-- 931
FE ITG F + F++ +
Sbjct: 226 FELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNIS 285
Query: 932 ---PWP---CVPSDMSFEAQ------DLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
WP + F D ++ L DP +R A G HP+ K
Sbjct: 286 KLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN---HPWLKD 339
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-34
Identities = 87/340 (25%), Positives = 149/340 (43%), Gaps = 64/340 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
+E++K + +GA+G V+ + R TG++ A+K K+ +N + R E IL +
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTEL 65
Query: 745 RN-PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
+V ++ +YLV +Y+ DL++++R LE + + +L+ ++
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA-NILEPVHKQYVVYQLIKVIK 123
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YLHS G++HRD+KP N+L+ + H+K+ DFGLS+ + + + P + +
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP- 919
+ TD V T Y APEILLG T++ D WS+G IL E + G P F S
Sbjct: 184 QPILTD------YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237
Query: 920 ---EIIFD-------------------NILNRKIPWPCVP-------------------- 937
E I ++ +
Sbjct: 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297
Query: 938 -SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+D + EA DL+++ L +PN+R+ A + HPF
Sbjct: 298 KADCNEEALDLLDKLLQFNPNKRI---SANDALKHPFVSI 334
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 33/286 (11%), Positives = 70/286 (24%), Gaps = 60/286 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+ ++ + + A A+ + ++ + ++ L+ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
V R R +V E++ GG L + R + L A + H G+
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRA-MQSLAAAADAAHRAGV 150
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
P + ++ DG + L
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA------------------------------------ 174
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 928
+ D +G L+ + P
Sbjct: 175 -----------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
Query: 929 RKIPWPCVPS----DMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
P P+ D+ F+ + R + D R + ++
Sbjct: 217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQ 262
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 75/337 (22%), Positives = 131/337 (38%), Gaps = 84/337 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
++ +KPI GA G V A AIK KL +N R E ++ V
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 745 RNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ ++ FT + +YLVME + +L +++ L+ + + +++
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 175
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+++LHS GI+HRDLKP N+++ D +K+ DFGL++ T +M
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMM---- 220
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF---- 914
Y V T Y APE++LG + D WSVG I+ E + F
Sbjct: 221 --TPY-----------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
Query: 915 ---------------TAESPEIIFDNILN--------RKIPWPCV------------PSD 939
E + + + N + +P +
Sbjct: 268 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 327
Query: 940 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ +A+DL+++ L+ DP +R+ + HP+
Sbjct: 328 KASQARDLLSKMLVIDPAKRI---SVDDALQHPYINV 361
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 74/238 (31%), Positives = 110/238 (46%), Gaps = 39/238 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-KLDMIRKNDIE-RILAERNILITVRN 746
+EI I +G+FG+V A R + AIK++K K + + IE R+L N T
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLH 804
++V F R++L LV E L +LY LLR + ++ R + ++ AL +L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 805 S--LGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+ L I+H DLKP+N+L+ + IK+ DFG S Y
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS------------------CQLGQRIY 216
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
Y Q+ R Y +PE+LLG + A D WS+G IL E TG P F+ +
Sbjct: 217 Q-YIQS----RF-------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 71/352 (20%), Positives = 108/352 (30%), Gaps = 95/352 (26%)
Query: 689 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKK--------------LDMIRKNDIER 733
+EI+ + G FG+V A+K+++ L I++ D E
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 791
+ V F ++ + E L G + + L++ R
Sbjct: 81 ---KFLC---------VLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRH 127
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT-----IDLS 846
+L AL +LH + H DLKP+N+L + L + S D
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
+ H T RH Y PE++L D WS+G ILFE
Sbjct: 188 S----ATFDHEHHTT-IVAT----RH-------YRPPEVILELGWAQPCDVWSIGCILFE 231
Query: 907 FITGIPPFTAES---------------PEIIFDNILNRK------IPWPCVPSD------ 939
+ G F P + +K + W SD
Sbjct: 232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE 291
Query: 940 --------------MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
+ DL+ R L DP QR+ A HPFF G+
Sbjct: 292 NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL---HPFFAGL 340
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 70/354 (19%), Positives = 116/354 (32%), Gaps = 99/354 (27%)
Query: 689 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKK--------------LDMIRKNDIER 733
+EI+ + GAFG+V + G A+K++K L+ + D
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 791
V+ F ++ +V E L G Y +++ G D R
Sbjct: 76 ---TFRC---------VQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRK 122
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT-----IDLS 846
++ ++ +LHS + H DLKP+N+L + + + + + +D
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF- 181
Query: 847 GPETDG--IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
G + H T RH Y APE++L D WS+G IL
Sbjct: 182 -----GSATYDDEHHST-LVST----RH-------YRAPEVILALGWSQPCDVWSIGCIL 224
Query: 905 FEFITGIPPFTAES---------------PEIIFDNILNRK------IPWPCVPSDMSF- 942
E+ G F P+ + RK + W S +
Sbjct: 225 IEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYV 284
Query: 943 -------------------EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
DLI + L +DP +R+ A + HPFF +
Sbjct: 285 SRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK---HPFFDLL 335
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 59/282 (20%), Positives = 103/282 (36%), Gaps = 58/282 (20%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-- 743
+D+ ++++ I RG +G V+ A+KV + + + E+NI
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANR------QNFINEKNIYRVPL 63
Query: 744 VRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ + + RF + R LVMEY G L L R+ +
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSVTR 122
Query: 799 ALEYLHS---------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
L YLH+ I HRDL N+L+ +DG ++DFGLS
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR------------- 169
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-------EHGYAADWWSVGI 902
+ ++ S VGT Y+APE+L G D +++G+
Sbjct: 170 ------LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 903 ILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 943
I +E + +++ ++ + V + +FE
Sbjct: 224 IYWEIFMR------CTDLFPGESVPEYQMAFQTEVGNHPTFE 259
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 53/300 (17%), Positives = 107/300 (35%), Gaps = 69/300 (23%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-- 724
SSGV + ++ ++++ +RG FG V+ A+ + A+K+ D
Sbjct: 7 HHSSGVDLGT-ENLYFQS--MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ 61
Query: 725 -MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLR 779
+ ++ L +++ +++F + + L+L+ + G L L+
Sbjct: 62 SWQNEYEVY-------SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 780 KVGCLEEDVARIYIAELVLALEYLHS----------LGIVHRDLKPDNLLIAHDGHIKLT 829
++ I + L YLH I HRD+K N+L+ ++ +
Sbjct: 115 ANVVSWNELCHIAE-TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--- 886
DFGL+ + + H VGT Y+APE+L
Sbjct: 174 DFGLALKFEAGKSAG-------------------------DTHGQVGTRRYMAPEVLEGA 208
Query: 887 LGTEHGY--AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 943
+ + D +++G++L+E + E +P+ + S E
Sbjct: 209 INFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--------YMLPFEEEIGQHPSLE 260
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 60/276 (21%), Positives = 104/276 (37%), Gaps = 49/276 (17%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-- 746
+ +I+ + G F V+L+ A+KV+K ++ E L E +L +VRN
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSD 94
Query: 747 ------PFVVRFFYSFT---------CRDNLYLVMEYLNGGDLYSLLRK--VGCLEEDVA 789
VV+ F C +V E L G L + K L
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHIC-----MVFEVL-GHHLLKWIIKSNYQGLPLPCV 148
Query: 790 RIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848
+ I +++ L+YLH+ I+H D+KP+N+L++ + + + SG
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 849 ETDGIM------------PSDAHYPEYQQTD-------NRNRHSAVGTPDYLAPEILLGT 889
P +A + + D +++ + T Y + E+L+G+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS 268
Query: 890 EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
+ AD WS + FE TG F S E +
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 62/254 (24%), Positives = 102/254 (40%), Gaps = 38/254 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
F + K I G FG + L + T + AIK+ K+ ++ E + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP-----MKSRAPQLHLEYRFYKQLGSGD 65
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 805
+ + +Y C +V+E L G L L + V I I +L+ +EY+HS
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAI-QLISRMEYVHS 123
Query: 806 LGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+++RD+KP+N LI G+ I + DF L+K ID + H
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE-----YIDPETKK---------HI 169
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAE 917
P R S GT Y++ LG E D ++G + F+ G P A+
Sbjct: 170 PY------REHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223
Query: 918 SPEIIFDNILNRKI 931
+ + + I + K
Sbjct: 224 TLKERYQKIGDTKR 237
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 56/257 (21%), Positives = 98/257 (38%), Gaps = 38/257 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
+++ + I G+FG +F AIK R++D ++ E +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCT 66
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 805
+ +Y + LV++ L G L LL G + VA +++ ++ +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAK-QMLARVQSIHE 124
Query: 806 LGIVHRDLKPDNLLI-----AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+V+RD+KPDN LI + I + DFG+ K T H
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT--------------KQHI 170
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAE 917
P R + + GT Y++ LG E D ++G + F+ G P A
Sbjct: 171 PY------REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224
Query: 918 SPEIIFDNILNRKIPWP 934
+ + ++ I +K P
Sbjct: 225 TNKQKYERIGEKKQSTP 241
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 58/252 (23%), Positives = 96/252 (38%), Gaps = 36/252 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
+ + + I G+FG ++L G+ AIK+ K ++ E I ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-----VKTKHPQLHIESKIYKMMQGGV 65
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 805
+ + D +VME L G L L + V + +++ +EY+HS
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD-QMISRIEYIHS 123
Query: 806 LGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HRD+KPDN L+ + + DFGL+K D + H P
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK-----KYRDARTHQ---------HIP- 168
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAESP 919
R + GT Y + LG E D S+G +L F G P A +
Sbjct: 169 -----YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 223
Query: 920 EIIFDNILNRKI 931
++ I +K+
Sbjct: 224 RQKYERISEKKM 235
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 31/231 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+D + + I RG FG VF R R L A+K ++ + + L E IL +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSH 171
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHS 805
P +VR T + +Y+VME + GGD + LR G + + + +EYL S
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+HRDL N L+ +K++DFG+S+ +
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSR-----------------EEADGVYAA---- 270
Query: 866 TDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
P + APE L + +D WS GI+L+E + G P+
Sbjct: 271 -----SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 64/257 (24%), Positives = 101/257 (39%), Gaps = 49/257 (19%)
Query: 668 QSSGVSTPLHSSHKERTSI--DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLK 721
G L + T + I+ + G FG+V L T D + A+K LK
Sbjct: 10 HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK 69
Query: 722 KLDMIRKNDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLR 779
E +IL T+ + ++++ +L LVMEY+ G L L
Sbjct: 70 --ADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP 127
Query: 780 KVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
+ I +A+L+L + YLH+ +HRDL N+L+ +D +K+ DFG
Sbjct: 128 R--------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179
Query: 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
L+K + + DG P + APE L +
Sbjct: 180 LAK--AVPEGHEYYRVREDGDSPV----------------------FWYAPECLKEYKFY 215
Query: 893 YAADWWSVGIILFEFIT 909
YA+D WS G+ L+E +T
Sbjct: 216 YASDVWSFGVTLYELLT 232
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 48/237 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ ++ + +G FG V + R + TG++ A+K L+ D E IL
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILK 66
Query: 743 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 798
++++ +V++ R NL L+MEYL G L L+K RI +L+
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYT 120
Query: 799 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+EYL + +HRDL N+L+ ++ +K+ DFGL+K +
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK-----------------V 163
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
+P D + ++ + +P + APE L ++ A+D WS G++L+E T
Sbjct: 164 LPQDKEF--FKVKEPGE------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 65/254 (25%), Positives = 110/254 (43%), Gaps = 49/254 (19%)
Query: 672 VSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDM 725
VS ++ + T + + I+ + G FG+V L R GD A+K LK
Sbjct: 4 VSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PE 61
Query: 726 IRKNDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
N I + E IL + + +V++ + + + L+ME+L G L L K
Sbjct: 62 SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--- 118
Query: 784 LEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ +I + + + ++YL S VHRDL N+L+ + +K+ DFGL+K
Sbjct: 119 ---NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK- 174
Query: 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAA 895
+ +D Y Y D+R+ +P + APE L+ ++ A+
Sbjct: 175 ----------------AIETDKEY--YTVKDDRD------SPVFWYAPECLMQSKFYIAS 210
Query: 896 DWWSVGIILFEFIT 909
D WS G+ L E +T
Sbjct: 211 DVWSFGVTLHELLT 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 51/262 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ ++ + +G FG V + R + TG++ A+K L+ D E IL
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILK 97
Query: 743 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 798
++++ +V++ R NL L+MEYL G L L+K RI +L+
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK------HKERIDHIKLLQYT 151
Query: 799 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+EYL + +HRDL N+L+ ++ +K+ DFGL+K +
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK-----------------V 194
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912
+P D Y Y+ + +P + APE L ++ A+D WS G++L+E T I
Sbjct: 195 LPQDKEY--YKVKEPGE------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246
Query: 913 PFTAESPEIIFDNILNRKIPWP 934
++SP F ++
Sbjct: 247 K--SKSPPAEFMRMIGN-DKQG 265
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 57/253 (22%), Positives = 91/253 (35%), Gaps = 45/253 (17%)
Query: 681 KERTSIDD-----FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK------------- 722
E +DD + + K I G FG ++LA + A V+K
Sbjct: 26 PEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELK 85
Query: 723 -LDMIRKNDIERILAERNILITVRNPFVVRF-FYSFTCRDNLYLVMEYLNGGDLYSLLRK 780
+ K D + ER L + P F R ++VME L G DL + +
Sbjct: 86 FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ 144
Query: 781 VGCL-EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIG 837
G + V ++ I ++ LEY+H VH D+K NLL+ + + L D+GLS
Sbjct: 145 NGTFKKSTVLQLGI-RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897
N Y E R GT ++ + + G +D
Sbjct: 204 CPNGN--------------HKQYQE------NPRKGHNGTIEFTSLDAHKGVALSRRSDV 243
Query: 898 WSVGIILFEFITG 910
+G + ++ G
Sbjct: 244 EILGYCMLRWLCG 256
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 68/265 (25%), Positives = 106/265 (40%), Gaps = 49/265 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILI 742
+ I + +G FG V L R GD L A+K L+ ++ D E IL
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF---QREIQILK 79
Query: 743 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 798
+ + F+V++ R +L LVMEYL G L L++ AR+ + L+L
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR------HRARLDASRLLLYS 133
Query: 799 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+EYL S VHRDL N+L+ + H+K+ DFGL+K +
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK-----------------L 176
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 911
+P D Y Y + +P + APE L +D WS G++L+E T
Sbjct: 177 LPLDKDY--YVVREPG------QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228
Query: 912 PPFTAESPEIIFDNILNRKIPWPCV 936
+ + + +
Sbjct: 229 KSCSPSAEFLRMMGCERDVPALSRL 253
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-21
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 47/237 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + + +G FG V++ T + AIK LK M E L E ++ +R+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 238
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
+V+ + + + +Y+V EY++ G L L+ E + + +LV
Sbjct: 239 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASG 292
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ Y+ + VHRDL+ N+L+ + K+ DFGL++
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR---------------------LIE 331
Query: 860 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
EY P + APE L +D WS GI+L E T G P+
Sbjct: 332 DNEYTARQGAK------FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 48/241 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILI 742
+F+ IK + GAFG V+ G+ AIK L++ + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 798
+V NP V R + L+ + + G L +R+ I L+
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQ 125
Query: 799 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YL +VHRDL N+L+ H+K+TDFGL+K ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-----------------LLG 168
Query: 856 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913
++ Y + P ++A E +L + + +D WS G+ ++E +T G P
Sbjct: 169 AEEKE--YHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 914 F 914
+
Sbjct: 220 Y 220
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 2e-21
Identities = 60/255 (23%), Positives = 101/255 (39%), Gaps = 36/255 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
F + + I G+FG ++L T + AIK+ K ++L E I ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-----VKTKHPQLLYESKIYRILQGGT 63
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 805
+ + D LVM+ L G L L + V + +++ +E++HS
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD-QMINRVEFVHS 121
Query: 806 LGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HRD+KPDN L+ + + DFGL+K D S + H P
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-----KYRDTSTHQ---------HIPY 167
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT---AESP 919
R + GT Y + LG E D S+G +L F+ G P+ A +
Sbjct: 168 ------RENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
Query: 920 EIIFDNILNRKIPWP 934
+ ++ I +K+
Sbjct: 222 KQKYEKISEKKVATS 236
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 54/232 (23%), Positives = 98/232 (42%), Gaps = 35/232 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D + + G +G V+ + A+K LK+ M ++E L E ++ +++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIA-ELVLALEYLH 804
P +V+ T Y++ E++ G+L LR+ E +Y+A ++ A+EYL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HR+L N L+ + +K+ DFGLS++ D Y
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-----------MTGD----------TYT 374
Query: 865 QTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
P + APE L + +D W+ G++L+E T G+ P+
Sbjct: 375 AHAGAK------FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-21
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 47/237 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + + +G FG V++ T + AIK LK M E L E ++ +R+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 321
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
+V+ + + + +Y+V EY++ G L L+ E + + +LV
Sbjct: 322 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASG 375
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ Y+ + VHRDL+ N+L+ + K+ DFGL++
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR---------------------LIE 414
Query: 860 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
EY P + APE L +D WS GI+L E T G P+
Sbjct: 415 DNEYTARQGAK------FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 61/277 (22%), Positives = 109/277 (39%), Gaps = 57/277 (20%)
Query: 679 SHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRK 728
S + + ++D I + + +G FG V A+ + F A+K+LK D+I
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA-DIIAS 66
Query: 729 NDIERILAERNILITVRNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
+DIE L E + +P V + + +++ ++ GDL++ L
Sbjct: 67 SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 783 CLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
E + + LV +EYL S +HRDL N ++A D + + DFGLS+
Sbjct: 127 IGENP-FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN---RHSAVGTPDYLAPEILLGTEHG 892
I D Y+Q + +LA E L +
Sbjct: 186 ----------------KIYSGD----YYRQGCASKLPVK--------WLALESLADNLYT 217
Query: 893 YAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 928
+D W+ G+ ++E +T G P+ I++ ++
Sbjct: 218 VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-21
Identities = 46/276 (16%), Positives = 87/276 (31%), Gaps = 50/276 (18%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDD-----FEIIKPISRGAFGRVFLARKRTTGDL----- 714
+ S L I D +++ PI +G FG ++LA ++ +
Sbjct: 8 QAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAP 67
Query: 715 FAIKVLKK-----------LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763
+KV K + + L + P Y
Sbjct: 68 CVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY-WGSGLHDKNGKSY 126
Query: 764 --LVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819
++M+ G DL + + V ++ + ++ LEY+H VH D+K NLL
Sbjct: 127 RFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSL-RILDILEYIHEHEYVHGDIKASNLL 184
Query: 820 I--AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT 877
+ + + L D+GL+ Y + GT
Sbjct: 185 LNYKNPDQVYLVDYGLAYRYCPEGV--------------HKAYAA------DPKRCHDGT 224
Query: 878 PDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
++ + + G D +G + +++TG P
Sbjct: 225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 55/242 (22%), Positives = 90/242 (37%), Gaps = 48/242 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 743
D +++ + G+FG V +G A+K LK + + ++ + E N + +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ + ++R Y + +V E G L LRK + L
Sbjct: 78 LDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQV 130
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ YL S +HRDL NLL+A +K+ DFGL + + +
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA----------------LPQN 174
Query: 857 DAHYPEYQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912
D HY P + APE L +A+D W G+ L+E T G
Sbjct: 175 DDHY-----------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
Query: 913 PF 914
P+
Sbjct: 224 PW 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 18/157 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++ I G FG V L + AIK +++ M E + E +++ + +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKLSH 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
P +V+ + + + LV E++ G L LR L+
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEG 116
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ YL ++HRDL N L+ + IK++DFG+++
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 38/152 (25%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D + + G +G V+ + A+K LK+ M ++E L E ++ +++
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 68
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 804
P +V+ T Y++ E++ G+L LR+ E + ++ A+EYL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+HRDL N L+ + +K+ DFGLS++
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 687 DDFEI--------IKPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILA 736
+ + K + G FG V + + A+K+LK + + +LA
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLA 67
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
E N++ + NP++VR ++ LVME G L L++ +++ + ++
Sbjct: 68 EANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ ++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 7e-20
Identities = 38/151 (25%), Positives = 78/151 (51%), Gaps = 6/151 (3%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
++ ++K + G FG V L + + D+ A+K++K+ M + E ++ + +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKLSH 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHS 805
P +V+F+ + +Y+V EY++ G L + LR G E + + ++ + +L S
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+HRDL N L+ D +K++DFG+++
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 58/253 (22%), Positives = 100/253 (39%), Gaps = 48/253 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILI 742
+F+ IK + GAFG V+ G+ AIK L++ + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 798
+V NP V R + L+ + + G L +R+ I L+
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQ 125
Query: 799 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YL +VHRDL N+L+ H+K+TDFGL+K ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-----------------LLG 168
Query: 856 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913
++ Y + P ++A E +L + + +D WS G+ ++E +T G P
Sbjct: 169 AEEKE--YHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 914 FTAESPEIIFDNI 926
+ I +
Sbjct: 220 YDGIPASEISSIL 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 34/152 (22%), Positives = 80/152 (52%), Gaps = 8/152 (5%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++++ + G FG V++ + A+K LK+ M + LAE N++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIA-ELVLALEYLH 804
+VR + T ++ +Y++ EY+ G L L+ ++ + + + +A ++ + ++
Sbjct: 68 QRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+HRDL+ N+L++ K+ DFGL+++
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +K + G FG V + R D+ AIK++K+ M + + E +++ + +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNLSH 78
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
+V+ + T + ++++ EY+ G L + LR++ R +L+ A
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEA 132
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+EYL S +HRDL N L+ G +K++DFGLS+
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 65/253 (25%), Positives = 100/253 (39%), Gaps = 45/253 (17%)
Query: 675 PLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKN 729
P + I+ I K I G G V R R G AIK LK +
Sbjct: 35 PGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ER 92
Query: 730 DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA 789
L+E +I+ +P ++R T +V EY+ G L + LR
Sbjct: 93 QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD------G 146
Query: 790 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
+ I +LV + YL LG VHRDL N+L+ + K++DFGLS+ ++ +
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR--VLEDD 204
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
D + T G +P + T APE + A+D WS G+
Sbjct: 205 PDAAYTTTGGKIP-------IRWT---------------APEAIAFRTFSSASDVWSFGV 242
Query: 903 ILFEFIT-GIPPF 914
+++E + G P+
Sbjct: 243 VMWEVLAYGERPY 255
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 34/165 (20%), Positives = 69/165 (41%), Gaps = 19/165 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF-------AIKVLKKLDMIRKNDIERILAERN 739
+D + + +G F ++F +R GD +KVL K +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF---FEAAS 64
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVL 798
++ + + +V + C D LV E++ G L + L+K + ++ +A +L
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGH--------IKLTDFGLSK 835
A+ +L ++H ++ N+L+ + IKL+D G+S
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 58/273 (21%), Positives = 102/273 (37%), Gaps = 55/273 (20%)
Query: 659 SRLILDSVSQSSGVSTPLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF- 715
+ + + S + + E + + K I G FG V+ +T+
Sbjct: 17 TENLYFQGAMGSDPNQAVLKFTTEIHPSCV---TRQKVIGAGEFGEVYKGMLKTSSGKKE 73
Query: 716 ---AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772
AIK LK + L E I+ + ++R + + ++ EY+ G
Sbjct: 74 VPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG 131
Query: 773 DLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGH 825
L LR+ + +LV ++YL ++ VHRDL N+L+ +
Sbjct: 132 ALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV 185
Query: 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT--P-DYLA 882
K++DFGLS++ D Y + G P + A
Sbjct: 186 CKVSDFGLSRV------------------LEDDPEATY---------TTSGGKIPIRWTA 218
Query: 883 PEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
PE + + A+D WS GI+++E +T G P+
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-19
Identities = 35/157 (22%), Positives = 79/157 (50%), Gaps = 18/157 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++ K + G FG V++A + A+K +K M +E LAE N++ T+++
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 242
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
+V+ T ++ +Y++ E++ G L L+ ++ ++ + +L+
Sbjct: 243 DKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKS-----DEGSKQPLPKLIDFSAQIAEG 296
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ ++ +HRDL+ N+L++ K+ DFGL+++
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 48/255 (18%), Positives = 97/255 (38%), Gaps = 53/255 (20%)
Query: 675 PLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRK 728
+ + T + +K + G FG V G+ IKV++ D +
Sbjct: 2 AMKVLARIFKETEL---RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGR 56
Query: 729 NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV 788
+ + + ++ + +VR +L LV +YL G L +R+
Sbjct: 57 QSFQAVTDHMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQ------HR 109
Query: 789 ARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841
+ L+ + YL G+VHR+L N+L+ +++ DFG++
Sbjct: 110 GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD------ 163
Query: 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSV 900
++P D ++ + TP ++A E + ++ + +D WS
Sbjct: 164 -----------LLPPDDKQ--LLYSEAK-------TPIKWMALESIHFGKYTHQSDVWSY 203
Query: 901 GIILFEFIT-GIPPF 914
G+ ++E +T G P+
Sbjct: 204 GVTVWELMTFGAEPY 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 46/197 (23%), Positives = 77/197 (39%), Gaps = 26/197 (13%)
Query: 663 LDSVSQSSGVSTPLHSSHKE--RTSIDDFEI-------IKPISRGAFGRVFLARKRTTGD 713
+ S S+ L E + ++D I K + G FG V +
Sbjct: 1 MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG 60
Query: 714 LF---AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-----YSFTCRDNLYLV 765
A+K +K D + +IE L+E + +P V+R S ++
Sbjct: 61 TSLKVAVKTMKL-DNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVI 119
Query: 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNL 818
+ ++ GDL++ L LE I + L+ +EYL + +HRDL N
Sbjct: 120 LPFMKYGDLHTYLLYSR-LETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNC 178
Query: 819 LIAHDGHIKLTDFGLSK 835
++ D + + DFGLSK
Sbjct: 179 MLRDDMTVCVADFGLSK 195
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-18
Identities = 46/273 (16%), Positives = 92/273 (33%), Gaps = 52/273 (19%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDL--------FAIKVLKK--------LDMIRKNDIE 732
+++ +R G ++ A +T F++K+ K R
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNL-YLVMEYLNGGDLYSLLRKVGCL---EEDV 788
++ + L + + +D +LV+ L G L S L E V
Sbjct: 104 QVNKWKK-LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSV 161
Query: 789 ARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNTIDLS 846
++ L+ ALE+LH VH ++ +N+ + + L +G +
Sbjct: 162 LQVAC-RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR---------- 210
Query: 847 GPETDGIMPSDAH--YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
PS H Y E +R G ++++ ++ G +D S+G +
Sbjct: 211 ------YCPSGKHVAYVE------GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258
Query: 905 FEFITGIPP---FTAESPEIIFDNILNRKIPWP 934
+++ G P + +I+ P P
Sbjct: 259 LKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP 291
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 61/242 (25%), Positives = 97/242 (40%), Gaps = 50/242 (20%)
Query: 687 DDFEIIK-PISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 743
D+ I + G FG V R AIKVLK+ K D E ++ E I+
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQ 66
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ NP++VR + L LVME GG L+ L I ++ +
Sbjct: 67 LDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQV 119
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
++YL VHRDL N+L+ + + K++DFGLSK +
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA----------------LGAD 163
Query: 857 DAHYPEYQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912
D++Y + P + APE + + +D WS G+ ++E ++ G
Sbjct: 164 DSYY-----------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
Query: 913 PF 914
P+
Sbjct: 213 PY 214
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 54/266 (20%), Positives = 103/266 (38%), Gaps = 57/266 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 741
+ + + + +G+FG V+ K D AIK + + +R + L E +++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 82
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVL 798
VVR + ++ME + GDL S LR +A +++++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 799 -------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
+ YL++ VHRDL N ++A D +K+ DFG+++
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR---------------- 186
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYL-----APEILLGTEHGY--AADWWSVGIIL 904
D + +Y + + L +PE L + + +D WS G++L
Sbjct: 187 -----DIYETDYYRKGGKGL---------LPVRWMSPESLK--DGVFTTYSDVWSFGVVL 230
Query: 905 FEFIT-GIPPFTAESPEIIFDNILNR 929
+E T P+ S E + ++
Sbjct: 231 WEIATLAEQPYQGLSNEQVLRFVMEG 256
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 66/256 (25%), Positives = 103/256 (40%), Gaps = 50/256 (19%)
Query: 673 STPLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIR 727
+ +H KE T+I I K + G FG V R + AIK LK
Sbjct: 32 TQTVHEFAKELDATNI---SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-- 86
Query: 728 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 787
+ L E +I+ +P ++R T + +V EY+ G L S LRK
Sbjct: 87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD----- 141
Query: 788 VARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
A+ + +LV ++YL +G VHRDL N+LI + K++DFGL ++
Sbjct: 142 -AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV---- 196
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWS 899
D Y + P + +PE + + A+D WS
Sbjct: 197 --------------LEDDPEAAYTTRGGK-------IPIRWTSPEAIAYRKFTSASDVWS 235
Query: 900 VGIILFEFIT-GIPPF 914
GI+L+E ++ G P+
Sbjct: 236 YGIVLWEVMSYGERPY 251
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 19/160 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILIT 743
+D + + + G FG V+ A+K KK + E+ ++E I+
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKN 69
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ +P +V+ + +++ME G+L L + + + LVL
Sbjct: 70 LDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNK------NSLKVLTLVLYSLQI 122
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
A+ YL S+ VHRD+ N+L+A +KL DFGLS+
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 26/170 (15%)
Query: 684 TSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIER 733
+S D+EI + I G FG V + + AIK K E+
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREK 62
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 793
L E + +P +V+ + ++++ME G+L S L+ + +
Sbjct: 63 FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK------YSLDL 115
Query: 794 AELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
A L+L AL YL S VHRD+ N+L++ + +KL DFGLS+
Sbjct: 116 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++++ I +G FG V L R A+K +K + LAE +++ +R+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-----FLAEASVMTQLRH 73
Query: 747 PFVVRFFYSFT-CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELV-LALEYL 803
+V+ + LY+V EY+ G L LR G + + V A+EYL
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
VHRDL N+L++ D K++DFGL+K
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 56/254 (22%), Positives = 98/254 (38%), Gaps = 49/254 (19%)
Query: 690 EIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ I RG FG V+ A+K L ++ I ++ + L E I+ +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSH 85
Query: 747 PFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRK----------VGCLEEDVARIYIAE 795
P V+ + +V+ Y+ GDL + +R +G VA+
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAK----- 139
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
++YL S VHRDL N ++ +K+ DFGL++ + + +T +P
Sbjct: 140 ---GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 195
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
V ++A E L + +D WS G++L+E +T G PP+
Sbjct: 196 -------------------V---KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
Query: 915 TAESPEIIFDNILN 928
+ I +L
Sbjct: 234 PDVNTFDITVYLLQ 247
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 55/302 (18%), Positives = 109/302 (36%), Gaps = 60/302 (19%)
Query: 647 KSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 706
K+ + ++ + + +D + + + + S + I RG FG V+
Sbjct: 50 KAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGP-SSLIVHFNEVIGRGHFGCVYHG 108
Query: 707 RKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTCRDNL 762
A+K L ++ I ++ + L E I+ +P V+ +
Sbjct: 109 TLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166
Query: 763 YLVMEYLNGGDLYSLLRK----------VGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
+V+ Y+ GDL + +R +G VA+ +++L S VHRD
Sbjct: 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAK--------GMKFLASKKFVHRD 217
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN---- 868
L N ++ +K+ DFGL++ + + +
Sbjct: 218 LAARNCMLDEKFTVKVADFGLARD----------------MYDKE--FDSVHNKTGAKLP 259
Query: 869 -RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 926
+ ++A E L + +D WS G++L+E +T G PP+ + I +
Sbjct: 260 VK----------WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
Query: 927 LN 928
L
Sbjct: 310 LQ 311
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 6e-18
Identities = 56/246 (22%), Positives = 100/246 (40%), Gaps = 36/246 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILIT 743
+ E+ + I G FG V + + AIK K + E+ L E +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEALTMRQ 447
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEY 802
+P +V+ + ++++ME G+L S L+ L+ +Y +L AL Y
Sbjct: 448 FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L S VHRD+ N+L++ + +KL DFGLS+ + ++
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDST------------------Y 546
Query: 863 YQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920
Y+ + + P ++APE + A+D W G+ ++E + G+ PF
Sbjct: 547 YKASKGK-------LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599
Query: 921 IIFDNI 926
+ I
Sbjct: 600 DVIGRI 605
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 45/169 (26%), Positives = 75/169 (44%), Gaps = 24/169 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 741
D + + + GAFG+VFLA + L A+K LK + + D E +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF---QREAELL 71
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVARIY 792
+++ +V+F+ D L +V EY+ GDL LR G + +
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 793 IAELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
+++++ + YL S VHRDL N L+ + +K+ DFG+S
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-17
Identities = 66/296 (22%), Positives = 111/296 (37%), Gaps = 51/296 (17%)
Query: 634 REKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEII- 692
+ + P + + + +D+ S S P K+ D +I
Sbjct: 281 QRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA 340
Query: 693 -KPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
+ G FG V R AIKVLK+ K D E ++ E I+ + NP++
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYI 398
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEY 802
VR + L LVME GG L+ L I ++ + ++Y
Sbjct: 399 VRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKY 451
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L VHR+L N+L+ + + K++DFGLSK + D++Y
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA----------------LGADDSYY-- 493
Query: 863 YQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
+ P + APE + + +D WS G+ ++E ++ G P+
Sbjct: 494 ---------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 48/168 (28%), Positives = 72/168 (42%), Gaps = 23/168 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 741
D + + GAFG+VFLA + L A+K LK+ + D E +L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF---QREAELL 97
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK--------VGCLEEDVARIYI 793
+++ +VRFF T L +V EY+ GDL LR G + + +
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 794 AELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
+L+ + YL L VHRDL N L+ +K+ DFG+S
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 31/178 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ + K + G FG+V A R A+K+LK+ ++ +L+E N+L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--ELRDLLSEFNVL 80
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------------VGCL 784
V +P V++ + + + L L++EY G L LR+
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 785 EEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
D + + +L+ ++YL + +VHRDL N+L+A +K++DFGLS+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-17
Identities = 48/168 (28%), Positives = 70/168 (41%), Gaps = 21/168 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV 744
+D + I G FG+V AR + G AIK +K+ K+D E +L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKL 82
Query: 745 -RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL--- 800
+P ++ + R LYL +EY G+L LRK LE D A L
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 801 -------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 70/281 (24%), Positives = 108/281 (38%), Gaps = 63/281 (22%)
Query: 653 SKYKENSRLILDSVSQSSGVSTPLHS-SHKE-RTSIDDFEIIKPISRGAFGRVFLARKRT 710
SKY + + I D++S S V + + + ++F+ I G FG+V+ R
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 711 TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTC--RDNLYLVME 767
G A+K IE E L R+P +V + C R+ + L+ +
Sbjct: 63 -GAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGF---CDERNEMILIYK 115
Query: 768 YLNGGDLYSLLRKVGCLEED---VARIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHD 823
Y+ G+L L R+ I L YLH+ I+HRD+K N+L+ +
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN 175
Query: 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH--SAV-GTPDY 880
K+TDFG+SK G E QT H + V GT Y
Sbjct: 176 FVPKITDFGISKKG-----------------------TELDQT-----HLSTVVKGTLGY 207
Query: 881 LAPEILLGTEHGYA--------ADWWSVGIILFEFITGIPP 913
+ PE Y +D +S G++LFE +
Sbjct: 208 IDPE--------YFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-16
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++++ I +G FG V L R G+ A+K +K + LAE +++ +R+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA-----FLAEASVMTQLRH 245
Query: 747 PFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELV-LALEYL 803
+V+ + LY+V EY+ G L LR G + + V A+EYL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
VHRDL N+L++ D K++DFGL+K
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 52/259 (20%), Positives = 95/259 (36%), Gaps = 46/259 (17%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAER 738
ER + I +G FG V+ AIK L ++ ++ +E L E
Sbjct: 19 ERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ--QVEAFLREG 73
Query: 739 NILITVRNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
++ + +P V+ + ++++ Y+ GDL +R + +L+
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ------RNPTVKDLI 127
Query: 798 L-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850
+EYL VHRDL N ++ +K+ DFGL++ +++
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD-ILDREYYSVQQHR 186
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT- 909
+P V + A E L +D WS G++L+E +T
Sbjct: 187 HARLP-------------------V---KWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224
Query: 910 GIPPFTAESPEIIFDNILN 928
G PP+ P + +
Sbjct: 225 GAPPYRHIDPFDLTHFLAQ 243
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 40/234 (17%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER-ILAERNILITVRNPFVVRFF 753
+ G FG V+ + A+K L + I ++++ E ++ ++ +V
Sbjct: 39 MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 754 -YSFTCRDNLYLVMEYLNGGDLYS-LLRKVGCLEED-VARIYIAELVLA--LEYLHSLGI 808
+S D+L LV Y+ G L L G R IA A + +LH
Sbjct: 97 GFSSD-GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA-QGAANGINFLHENHH 154
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L+ K++DFGL++ ++ QT
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARAS-----------------------EKFAQTVM 191
Query: 869 RNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+R VGT Y+APE L G T +D +S G++L E ITG+P
Sbjct: 192 TSR--IVGTTAYMAPEALRGEITPK---SDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 26/173 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF-------AIKVLKKLDMIRKNDIERILAERN 739
D + KP+ GAFG+V +A A+K+LK + D+ +++E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 92
Query: 740 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVA 789
++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 790 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
++ +LV +EYL S +HRDL N+L+ + +K+ DFGL++
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 24/203 (11%)
Query: 654 KYKENSRLILDSVSQSSGVSTPLHSSHKERTSI--DDFEIIKPISRGAFGRVFLA----- 706
KY+ ++I S P + E+ ++ + K + GAFG+V A
Sbjct: 11 KYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL 70
Query: 707 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLV 765
K A+K+LK + E +++E I+ + +V + T + ++
Sbjct: 71 GKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128
Query: 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL--------------EYLHSLGIVHR 811
EY GDL + LR+ + E IA + +L S +HR
Sbjct: 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR 188
Query: 812 DLKPDNLLIAHDGHIKLTDFGLS 834
D+ N+L+ + K+ DFGL+
Sbjct: 189 DVAARNVLLTNGHVAKIGDFGLA 211
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 36/169 (21%), Positives = 60/169 (35%), Gaps = 23/169 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNIL 741
++ + FG+V+ AIK LK E E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEAMLR 66
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL- 800
+++P VV T L ++ Y + GDL+ L + + + AL
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 801 ---------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
EYL S +VH+DL N+L+ ++K++D GL
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 42/172 (24%), Positives = 73/172 (42%), Gaps = 26/172 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ K + GAFG+V A K A+K+LK + + E +++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 742 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------VGCLEEDVA 789
+ N +V + T ++ EY GDL + LR+ +E+D
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 790 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
+ + +L+ + +L S +HRDL N+L+ H K+ DFGL+
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 44/178 (24%), Positives = 68/178 (38%), Gaps = 31/178 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ E ++ I GAFGRVF AR + A+K+LK+ + E ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 104
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------------VGCL 784
NP +V+ + L+ EY+ GDL LR
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 785 EEDVARIYIAELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ AE + + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 26/173 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
D + KP+ G FG+V +A K A+K+LK + D+ +++E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 138
Query: 740 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVA 789
++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 790 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
++ +LV +EYL S +HRDL N+L+ + +K+ DFGL++
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 39/164 (23%), Positives = 71/164 (43%), Gaps = 17/164 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF----AIKVLKKLDMIRKNDIERILAERNIL 741
+ +I+ + GAFG V+ + D A+K L ++ + D L E I+
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 87
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LAL 800
+ +VR +++ME + GGDL S LR+ + + + +L+ +A
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 801 ------EYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 835
+YL +HRD+ N L+ G K+ DFG+++
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 37/164 (22%), Positives = 69/164 (42%), Gaps = 17/164 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF----AIKVLKKLDMIRKNDIERILAERNIL 741
+ +I+ + GAFG V+ + D A+K L ++ + D L E I+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 128
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV---- 797
+ +VR ++++E + GGDL S LR+ + + + +L+
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 798 ---LALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 835
+YL +HRD+ N L+ G K+ DFG+++
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 25/172 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
D ++ KP+ RGAFG+V A K T A+K+LK+ + +++E IL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 742 ITV-RNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRK---------VGCLEEDVAR 790
I + + VV + T L +++E+ G+L + LR V +
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 791 IYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ + L+ +E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 26/173 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
D + KP+ GAFG+V LA K A+K+LK + D+ +++E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 126
Query: 740 ILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVA 789
++ + ++ + T LY+++EY + G+L L+
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 790 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
++ +LV +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 31/177 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ E K + GAFG+V A K A+K+LK+ + E +++E ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMM 102
Query: 742 ITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------------VGCL 784
+ + +V + T +YL+ EY GDL + LR
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 785 EEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
EED+ + +L+ +E+L VHRDL N+L+ H +K+ DFGL+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 79.5 bits (195), Expect = 4e-15
Identities = 101/726 (13%), Positives = 194/726 (26%), Gaps = 240/726 (33%)
Query: 396 HEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKL--SEIL 453
H +D ++++ E A +C DV + + E +
Sbjct: 1 HHHHHHMDFETGEHQYQYKDILS--VFED-------AFVDNFDCKDVQDMPKSILSKEEI 51
Query: 454 EQISESCNSSSHP------ILGSPENSRTQSMNSAITYDGYSPKISEWRNK-----GVEG 502
+ I S ++ S +L E + + + + Y +S + + +
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKFLMSPIKTEQRQPSMMTR 110
Query: 503 MFEDIHEM---DTACIDDSHLGS----LNLRGHLGLKLS-----------GYGASSSTGS 544
M+ + + D ++ L LR L L+L G G +
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL-LELRPAKNVLIDGVLGSGKTWVALD 169
Query: 545 MTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLAC 604
S F FWL ++ C + + + L
Sbjct: 170 --VCLSYKVQCKMDFKIFWL------------------NLKNCNSPETVLEMLQKLLYQI 209
Query: 605 MHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILD 664
+ HS L I + + + +LL+ K Y+ N L+L
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK-----------------PYE-NCLLVLL 251
Query: 665 SV------------------SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 706
+V ++ V+ L ++ S+D
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS-------MTLT----- 299
Query: 707 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV----RFFYSFTCR--- 759
L K LD R D L + NP +
Sbjct: 300 -PDEVKSLLL----KYLDC-RPQD----LPREVLTT---NPRRLSIIAESIRDGLATWDN 346
Query: 760 ------DNLYLVME----YLNGGDLYSLLRKVGCLEEDVARIYIAELVLA---------- 799
D L ++E L + + ++ +I ++L+
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA---HIPTILLSLIWFDVIKSD 403
Query: 800 ----LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ LH +V + K + I +++L ++ L + +D
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISI-PSIYLELKVKLENEYALHRSIVD----------- 451
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI------T 909
HY + D+ D L P Y + I
Sbjct: 452 ---HYNIPKTFDS----------DDLIPP----YLDQY----------FYSHIGHHLKNI 484
Query: 910 GIPPFTAESPEIIFD-NILNRKI-----PWPCVPSDMSFEAQDLIN--RFLI-HDP-NQR 959
P + D L +KI W S ++ Q L ++ +DP +R
Sbjct: 485 EHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN-TLQQLKFYKPYICDNDPKYER 543
Query: 960 LGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQI-SSGLPDDQN 1018
L VN A+ F+P+ E + S+++ + L +
Sbjct: 544 L----------------VN----AILD--FLPKIE----ENLICSKYTDLLRIALMAEDE 577
Query: 1019 GSYSDA 1024
+ +A
Sbjct: 578 AIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.4 bits (174), Expect = 1e-12
Identities = 77/597 (12%), Positives = 166/597 (27%), Gaps = 169/597 (28%)
Query: 606 HDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDE--KSPTSFSKYKENSRLIL 663
+ +D+L A V + ++ + + IL+ E +D S + + +
Sbjct: 16 YQYKDILSVF-EDAFVDNFDCKDVQDMPKS--ILSKEEIDHIIMSKDA----VSGTLRLF 68
Query: 664 DSV--SQSSGVSTPLHSSHKERTSIDDFEII------KPISRGAFGRVFL-ARKRTTGDL 714
++ Q V + + +++ + + R+++ R R D
Sbjct: 69 WTLLSKQEEMVQKFVEEVLR-----INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND- 122
Query: 715 FAIKVLKKLDMIRKNDIERI-------------------------LAE---RNILITVRN 746
+V K ++ R ++ +A + + +
Sbjct: 123 --NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKM 180
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
F + F+ + ++ V+E L L + D + + L L
Sbjct: 181 DFKI-FWLNLKNCNSPETVLEMLQ--KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237
Query: 807 GIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLI----NNTIDLSGPETDGIMPSDA 858
+ + + LL+ + + KI L+ D T + D
Sbjct: 238 -LKSKPY-ENCLLVLLNVQNAKAWNAFNLS-CKI-LLTTRFKQVTDFLSAATTTHISLDH 293
Query: 859 HYPEYQQTDNRN-------------RHSAVGT-PDYLAPEILLGTE-HGYAADW------ 897
H + ++ + T P L+ ++ A W
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS---IIAESIRDGLATWDNWKHV 350
Query: 898 --WSVGIILFEFITGIPPFTAESPEI-----IFDNILNRKIP-------WP-CVPSDMSF 942
+ I+ + + P AE ++ +F + IP W + SD+
Sbjct: 351 NCDKLTTIIESSLNVLEP--AEYRKMFDRLSVFPP--SAHIPTILLSLIWFDVIKSDVMV 406
Query: 943 EAQDLINRFL-----------IHDPNQRLGANGAAEVKAH-------PFFKGVNWDSLAL 984
L L I L E H K + D L
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI- 465
Query: 985 QKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGS--------YSDAD--------TCD 1028
P +D YF +S I L + ++ + D
Sbjct: 466 --------PPYLDQ--YF---YSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDST 512
Query: 1029 SSSNSRTEMDECGDLAEFG-----SCP----LDLSLINFSFKNLSQLASINHEVLVQ 1076
+ + S + ++ L + + P L ++++F K L + L++
Sbjct: 513 AWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLR 569
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 5e-05
Identities = 68/541 (12%), Positives = 139/541 (25%), Gaps = 162/541 (29%)
Query: 38 YGVSRPPQKHKQKTVAQ--------------GHVK--LA----NSFTEEVRKGKKIAQWF 77
Y VSR K + G K +A S+ + + KI W
Sbjct: 129 YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-WL 187
Query: 78 T--------SYISKFNIVSPNTENSGSEDKDVDVEDPRRT-----KLRHEGNHLNEKQSL 124
+ + + + + + D R +LR + L
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 125 A--EHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDL--KELLDTLHSRFDAAKEV 180
+V ++K +F +L K LL T RF K+V
Sbjct: 248 LVLLNVQNAKA---WNAF---------------------NLSCKILLTT---RF---KQV 277
Query: 181 VNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLT 240
+ A + L+ + E+ +L + ++ QDL
Sbjct: 278 TDFLSAATTTHI--SLDHHSMTLTP-DEVKS---LLL-KYLDCR-----------PQDL- 318
Query: 241 EKRQQCQVG--LVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVET 298
R+ + ++ + L +K + L +
Sbjct: 319 -PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC------DKLTTIIESSLNVL----- 366
Query: 299 SWVPSPGTAESDLDYASYQK-----ANAKKKISGQQKVSTVPEI----SDCSCSESLDHT 349
E + + +A I + + + S + +
Sbjct: 367 ---------EPAEYRKMFDRLSVFPPSA--HIP-----TILLSLIWFDVIKSDVMVVVNK 410
Query: 350 SENKSVFIEQNFPPQKSQH--YSRMQEQQSHIVE--GRIVEVTKSNCGSPHEQGQSLDGS 405
S+ +Q S Y ++ + + IV+ +
Sbjct: 411 LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD-DLIPPYL 469
Query: 406 DSVICRICEEVVPISHLESHSYICAYADKCEL-NCLDVDERLLKLSEILEQISESCNSSS 464
D SH+ H + ++ L + +D R L+ ++I
Sbjct: 470 DQYFY---------SHIGHHLKNIEHPERMTLFRMVFLDFRFLE-----QKIRHD----- 510
Query: 465 HPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGV-EGMFEDI----HEMDTACIDDSH 519
+ N+ +N+ Y P I + N E + I +++ I +
Sbjct: 511 ----STAWNASGSILNTLQQLKFYKPYICD--NDPKYERLVNAILDFLPKIEENLICSKY 564
Query: 520 L 520
Sbjct: 565 T 565
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.1 bits (173), Expect = 4e-13
Identities = 45/219 (20%), Positives = 71/219 (32%), Gaps = 56/219 (25%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL-----KKLDMIRKNDIERILAERN 739
+ + + I G FG VF AIK++ ++ + E IL E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 740 IL-----------------ITVRNPFVVRFFY----------------------SFTCRD 760
I I + + V+ Y F D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 761 NLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNL 818
L++V+E+ GG DL + K+ A+ + +L +L SL HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 819 LIAHDGHIKLTDFGLSKI------GLINNTIDLSGPETD 851
L+ KL K GL + ID + +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 7e-13
Identities = 66/246 (26%), Positives = 100/246 (40%), Gaps = 58/246 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D+F + RG FG+V+ R G L A+K LK+ + + +++ E ++ +
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKE-ERTQGGELQ-FQTEVEMISMAVH 86
Query: 747 PFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-----ARIYIAELVLA 799
++R F C LV Y+ G + S LR E R IA L A
Sbjct: 87 RNLLRL-RGF-CMTPTERLLVYPYMANGSVASCLR--ERPESQPPLDWPKRQRIA-LGSA 141
Query: 800 --LEYLH---SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
L YLH I+HRD+K N+L+ + + DFGL+K+ +T
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT------------ 189
Query: 855 PSDAHYPEYQQTDNRNRH--SAV-GTPDYLAPEILLGTEHGYA---ADWWSVGIILFEFI 908
H +AV GT ++APE L G + D + G++L E I
Sbjct: 190 -----------------HVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELI 229
Query: 909 TGIPPF 914
TG F
Sbjct: 230 TGQRAF 235
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 39/186 (20%), Positives = 71/186 (38%), Gaps = 14/186 (7%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
D ++ KP+ RGAFG+V A K T A+K+LK + ++ +++E IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKIL 79
Query: 742 ITVRN-PFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
I + + VV + T L +++E+ G+L + LR + + Y +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----KRNEFVPYKTKGARF 135
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDA 858
+ +G + DLK I + F K + + D +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 859 HYPEYQ 864
+Q
Sbjct: 196 ICYSFQ 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 27/115 (23%), Positives = 48/115 (41%), Gaps = 28/115 (24%)
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR------------------------- 241
Query: 861 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913
+ + + R P ++APE + + +D WS G++L+E + G P
Sbjct: 242 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 34/149 (22%), Positives = 57/149 (38%), Gaps = 21/149 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLK-----KLD-MIRKNDIERILAERNILITVRNPF 748
I +GA + + +V K +LD IRK R E L V++
Sbjct: 344 IGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRK---SRTAREARYLALVKDFG 400
Query: 749 V-VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+ + + DN ++M Y+NG ++ + + I + LH
Sbjct: 401 IPAPYIFDVD-LDNKRIMMSYINGKLAKDVIEDNLDIAYKIGEI--------VGKLHKND 451
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
++H DL N + D + + DFGL KI
Sbjct: 452 VIHNDLTTSNFIF--DKDLYIIDFGLGKI 478
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 28/169 (16%), Positives = 54/169 (31%), Gaps = 30/169 (17%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM------------- 725
+D I K + G VF +K K
Sbjct: 84 RLVRSGKVDA--IGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGD 140
Query: 726 IRKNDIERILAER--NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
+ + + A L ++ V + + N ++ME ++ +LY +
Sbjct: 141 LHFSVLAIRSARNEFRALQKLQGLAVPKVYA---WEGNA-VLMELIDAKELYRVR----- 191
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
E+ + ++ + + GIVH DL N+L+ + I + DF
Sbjct: 192 -VENPDEVL-DMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFP 237
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1092 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.05 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.34 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.16 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.97 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.83 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.22 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.13 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.85 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.76 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.75 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.65 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.41 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.3 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.86 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.81 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.7 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.36 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.99 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.24 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-66 Score=573.06 Aligned_cols=280 Identities=36% Similarity=0.722 Sum_probs=256.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
+...++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+++|++++|||||++|++|++.+.+
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34567899999999999999999999999999999999987666666778999999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|||||||+||+|.++|.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~-- 185 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-- 185 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999853110
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.......+.||||.|||||++.+..|+.++|||||||+||||++|++||.+.+..++
T Consensus 186 -----------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~ 242 (311)
T 4aw0_A 186 -----------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI 242 (311)
T ss_dssp -----------------------TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -----------------------CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 112234578999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCccc---HHHHHcCCCCCCCCcchhhhccCCcc
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG---AAEVKAHPFFKGVNWDSLALQKAVFV 990 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~g---a~EIL~HPFFkgIdWd~L~~~~pPfi 990 (1092)
+.+|++..+.+| ..+|+++++||.+||++||.+|||+.+ ..+|++||||++++|+.|..+.||.+
T Consensus 243 ~~~i~~~~~~~p---~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 243 FAKIIKLEYDFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp HHHHHHTCCCCC---TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred HHHHHcCCCCCC---cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 999999988776 689999999999999999999999653 46799999999999999988877654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-66 Score=615.41 Aligned_cols=402 Identities=33% Similarity=0.534 Sum_probs=302.4
Q ss_pred hhhhhhhhhhhhhhhhccchhhHhhhccchH-HHH----hhcccceEeccchhHHHHHH---hhhhhHhhhhhcccCCCC
Q 001360 579 IELADIARCVADTDFSKEGSEFLLACMHDLQ-DVL----QHSKLKALVIDTFGSRIEKL---LREKYILACELLDEKSPT 650 (1092)
Q Consensus 579 ~~~~~~~~~i~~~~~~ke~~~~l~~~~~~~~-~~~----~~~~~~~lvid~fg~rI~kl---lr~k~il~~~lL~~ksp~ 650 (1092)
.++...|+.||++|+++| .++|.+.+. .+. .......+..+.|....... +...
T Consensus 99 ~~r~~~~~~i~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~lf~~~~~~~~~~l~~~-------------- 160 (689)
T 3v5w_A 99 EERVARSREIFDSYIMKE----LLACSHPFSKSATEHVQGHLGKKQVPPDLFQPYIEEICQNLRGD-------------- 160 (689)
T ss_dssp HHHHHHHHHHHTSHHHHH----HHSSSSCCCHHHHHHHHHHHHTTCCCTTTTHHHHHHHHHHHTTH--------------
T ss_pred hhHHHHHHHHHHHhcchh----hhhccCccchHHHHHHHHhhhhccCChHHHHHHHHHHHHHhccC--------------
Confidence 445678999999999999 677777655 222 22223445566666543332 1111
Q ss_pred cccccccchhhhhcccccCCCCCCCCCCCccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhH
Q 001360 651 SFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND 730 (1092)
Q Consensus 651 sfSk~~ens~llldsls~ssg~~tp~~ss~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ 730 (1092)
.|+.+...... ....+.... .....+++++|+++++||+|+||+||+|+++.+|+.||||++++..+.....
T Consensus 161 ~f~~~~~s~~~--~r~~q~k~~------e~~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~ 232 (689)
T 3v5w_A 161 VFQKFIESDKF--TRFCQWKNV------ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG 232 (689)
T ss_dssp HHHHHHHSHHH--HHHHHHHHH------HTTCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC
T ss_pred cccccccChhH--HHHHhcccc------ccCCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhh
Confidence 11111111100 000010000 0112457889999999999999999999999999999999999876655555
Q ss_pred HHHHHHHHHH---HHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcC
Q 001360 731 IERILAERNI---LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807 (1092)
Q Consensus 731 ie~~l~EieI---L~~L~HPNIVkL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~G 807 (1092)
...+.+|+.+ +..++|||||+++++|++.+.+|||||||+||+|+++|.+.+.|++..+++|++||+.||+|||++|
T Consensus 233 ~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g 312 (689)
T 3v5w_A 233 ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 312 (689)
T ss_dssp HHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 6666666554 4566899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc
Q 001360 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 887 (1092)
Q Consensus 808 IIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~ 887 (1092)
||||||||+||||+.+|++||+|||+|+... .....+.||||.|||||++.
T Consensus 313 IiHRDLKPeNILld~~G~vKL~DFGlA~~~~-----------------------------~~~~~t~~GTp~YmAPEvl~ 363 (689)
T 3v5w_A 313 VVYRDLKPANILLDEHGHVRISDLGLACDFS-----------------------------KKKPHASVGTHGYMAPEVLQ 363 (689)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECS-----------------------------SCCCCSCCSCGGGCCHHHHS
T ss_pred ccccCCchHHeEEeCCCCEEecccceeeecC-----------------------------CCCCCCccCCcCccCHHHHh
Confidence 9999999999999999999999999998521 12245689999999999997
Q ss_pred -CCCCCccceeechhhhHHHHHhCCCCCCCC---ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc-
Q 001360 888 -GTEHGYAADWWSVGIILFEFITGIPPFTAE---SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA- 962 (1092)
Q Consensus 888 -g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~---s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa- 962 (1092)
+.+|+.++|||||||+||||++|++||.+. +..+++..+....+.+| ..+|+++++||.+||++||.+|+|.
T Consensus 364 ~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p---~~~S~~a~dLI~~lL~~dP~~Rl~~~ 440 (689)
T 3v5w_A 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---DSFSPELRSLLEGLLQRDVNRRLGCL 440 (689)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCGGGCTTCS
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC---ccCCHHHHHHHHHHccCCHhHCCCCC
Confidence 468999999999999999999999999764 44567778888877766 7899999999999999999999994
Q ss_pred -ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCC-----ccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCc
Q 001360 963 -NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD-----TSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSR 1034 (1092)
Q Consensus 963 -~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~D-----ts~Fds~fs~~~s~l~~~d~~s~s~~st~~ss~~~~ 1034 (1092)
.++.+|++||||+++||+.+..+ .|||+|.+....+ +++|+.+++.. ..+.+.+...+.++++ ..+..|+
T Consensus 441 ~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~~~fD~~~fd~e~~~~-~~~~~~d~~~f~~Fs~-~~~~~~q 518 (689)
T 3v5w_A 441 GRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKG-IKLLDSDQELYRNFPL-TISERWQ 518 (689)
T ss_dssp SSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTTBCCC---------CC-CCCCHHHHTTTTTCCE-ECHHHHH
T ss_pred CCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCcCCCCCCccCCccccCC-CCCCchHHHHHhCCCc-cCccchh
Confidence 57999999999999999999776 7999998766554 45555544332 2333334455566654 3344566
Q ss_pred chhhcc
Q 001360 1035 TEMDEC 1040 (1092)
Q Consensus 1035 ~em~e~ 1040 (1092)
.+|.++
T Consensus 519 ~e~~et 524 (689)
T 3v5w_A 519 QEVAET 524 (689)
T ss_dssp HHHHTT
T ss_pred hhhhhh
Confidence 666554
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-65 Score=558.77 Aligned_cols=277 Identities=42% Similarity=0.785 Sum_probs=244.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k---~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
...++|++++.||+|+||+||+|++. .+++.||||++++..... ....++.+|+.+|++++|||||+++++|++.+
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 44578999999999999999999984 468899999998754432 23346889999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|||||||+||+|.++|.+.+.+++..++.|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+...
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~-- 177 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI-- 177 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999998421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..
T Consensus 178 -------------------------~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~ 232 (304)
T 3ubd_A 178 -------------------------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK 232 (304)
T ss_dssp ----------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------------------------CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH
Confidence 0112345689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccC
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVP 991 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP 991 (1092)
+++.+|.+..+.+| ..+|+++++||.+||++||++|||+ ..+.|+++||||+++||+.+..+ .|||+|
T Consensus 233 ~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 233 ETMTMILKAKLGMP---QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp HHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred HHHHHHHcCCCCCC---CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 99999999887766 6899999999999999999999995 35789999999999999999766 689987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-60 Score=527.68 Aligned_cols=303 Identities=40% Similarity=0.771 Sum_probs=268.8
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~ 760 (1092)
..+.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..+ +|||||+++++|++.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 346789999999999999999999999999999999999886655666778899999999988 6999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+||||||++||+|.+++.+.+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~-- 175 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI-- 175 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC--
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999997421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus 176 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 230 (353)
T 3txo_A 176 -------------------------CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230 (353)
T ss_dssp -------------------------C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------------------------cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH
Confidence 0122345678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc---ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCC
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES 995 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa---~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s 995 (1092)
+++..|......+| ..++.++++||.+||++||.+||++ .++.+|++||||++++|+.+..+ .|||+|...+
T Consensus 231 ~~~~~i~~~~~~~p---~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~ 307 (353)
T 3txo_A 231 DLFEAILNDEVVYP---TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKS 307 (353)
T ss_dssp HHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred HHHHHHHcCCCCCC---CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCC
Confidence 99999999988776 6799999999999999999999995 45689999999999999998765 7999999999
Q ss_pred CCCccccccccccCCCCCC
Q 001360 996 VDDTSYFLSRFSQISSGLP 1014 (1092)
Q Consensus 996 ~~Dts~Fds~fs~~~s~l~ 1014 (1092)
..|+++|+..|+.....+.
T Consensus 308 ~~~~~~f~~~~~~~~~~~~ 326 (353)
T 3txo_A 308 REDVSNFDPDFIKEEPVLT 326 (353)
T ss_dssp TTCCTTSCHHHHTSCCCCC
T ss_pred cccccccCcccccCCCcCC
Confidence 9999999999887654433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-60 Score=535.15 Aligned_cols=304 Identities=37% Similarity=0.741 Sum_probs=270.1
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCe
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~ 761 (1092)
.+..++|++++.||+|+||+||+|+++.+++.||||++++...........+.+|+.+|.++ +|||||+++++|++.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45678999999999999999999999999999999999987666666677889999999887 79999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+||||||++||+|.+++.+.+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~--- 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--- 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC---
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc---
Confidence 99999999999999999998999999999999999999999999999999999999999999999999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC----
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---- 917 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~---- 917 (1092)
.......+.+||+.|+|||++.+..|+.++|||||||+||||++|++||...
T Consensus 205 ------------------------~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~ 260 (396)
T 4dc2_A 205 ------------------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260 (396)
T ss_dssp ------------------------CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--
T ss_pred ------------------------cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccc
Confidence 0122345679999999999999999999999999999999999999999642
Q ss_pred -----ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc---ccHHHHHcCCCCCCCCcchhhhc--cC
Q 001360 918 -----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KA 987 (1092)
Q Consensus 918 -----s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa---~ga~EIL~HPFFkgIdWd~L~~~--~p 987 (1092)
....++..|....+.+| ..++.++++||.+||++||.+||++ .++.+|++||||++++|+.+..+ .|
T Consensus 261 ~~~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~p 337 (396)
T 4dc2_A 261 NPDQNTEDYLFQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP 337 (396)
T ss_dssp ----CCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCC
T ss_pred ccchhhHHHHHHHHhccccCCC---CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCC
Confidence 34557788888877766 6899999999999999999999996 36899999999999999998766 79
Q ss_pred CccCCCCCCCCccccccccccCCCCCCCC
Q 001360 988 VFVPQPESVDDTSYFLSRFSQISSGLPDD 1016 (1092)
Q Consensus 988 PfiP~~~s~~Dts~Fds~fs~~~s~l~~~ 1016 (1092)
||+|...+..|+++|++.|+..+..+.+.
T Consensus 338 p~~p~~~~~~d~~~fd~~~~~~~~~~~~~ 366 (396)
T 4dc2_A 338 PFKPNISGEFGLDNFDSQFTNEPVQLTPD 366 (396)
T ss_dssp SCCCCCCSSTTGGGSCHHHHTSCCCCCCC
T ss_pred CCcCCCCCccchhhcChhhccCCCccCCC
Confidence 99999999999999999998886655543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-60 Score=517.51 Aligned_cols=256 Identities=34% Similarity=0.614 Sum_probs=220.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46799999999999999999999999999999999988766556667889999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
||||| +|+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~------ 163 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT------ 163 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC------
Confidence 99999 78999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
......+.+||+.|||||++.+..| +.++|||||||++|||++|++||.+.+...++
T Consensus 164 ----------------------~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~ 221 (275)
T 3hyh_A 164 ----------------------DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF 221 (275)
T ss_dssp ---------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ----------------------CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 1112346799999999999999886 58999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
+.|.++.+.+| ..+|+++++||.+||++||++||| +.|+++||||+
T Consensus 222 ~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hpw~k 267 (275)
T 3hyh_A 222 KNISNGVYTLP---KFLSPGAAGLIKRMLIVNPLNRIS---IHEIMQDDWFK 267 (275)
T ss_dssp HHHHHTCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHCHHHH
T ss_pred HHHHcCCCCCC---CCCCHHHHHHHHHHccCChhHCcC---HHHHHcCcccc
Confidence 99999887766 689999999999999999999999 88999999996
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=515.37 Aligned_cols=301 Identities=41% Similarity=0.755 Sum_probs=272.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++||||++++++|++.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45789999999999999999999999999999999998765555566788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+||||++||+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~----- 156 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI----- 156 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC-----
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc-----
Confidence 999999999999999998999999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+...++
T Consensus 157 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 214 (337)
T 1o6l_A 157 ----------------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214 (337)
T ss_dssp ----------------------CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ----------------------cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH
Confidence 0112234678999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCc
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDT 999 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dt 999 (1092)
..|....+.+| ..+++++++||.+||++||.+||+. .++.++++||||++++|+.+..+ .|||+|.+.+..|+
T Consensus 215 ~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~ 291 (337)
T 1o6l_A 215 ELILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDT 291 (337)
T ss_dssp HHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCC
T ss_pred HHHHcCCCCCC---CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchh
Confidence 99998887766 6899999999999999999999963 35999999999999999998765 79999999999999
Q ss_pred cccccccccCCCCCC
Q 001360 1000 SYFLSRFSQISSGLP 1014 (1092)
Q Consensus 1000 s~Fds~fs~~~s~l~ 1014 (1092)
++|+..|+.......
T Consensus 292 ~~f~~~~~~~~~~~~ 306 (337)
T 1o6l_A 292 RYFDDEFTAQSITIT 306 (337)
T ss_dssp TTSCHHHHTSCCC--
T ss_pred hcccchhccCccCcC
Confidence 999998887654443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-60 Score=527.89 Aligned_cols=257 Identities=32% Similarity=0.537 Sum_probs=231.2
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
..|++++.||+|+||+||+|+++.+|+.||||++++.... ..+.+.+|+.+|+.++|||||++|++|++.+.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4699999999999999999999999999999999865432 3456889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
|||+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~-------- 221 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-------- 221 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecC--------
Confidence 99999999999875 679999999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
.......+.|||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++..|
T Consensus 222 -------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 282 (346)
T 4fih_A 222 -------------------KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 282 (346)
T ss_dssp -------------------SSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred -------------------CCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 0112345689999999999999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.....+....+..+|+++++||.+||++||++||| +.|+|+||||+..
T Consensus 283 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---a~e~l~Hp~~~~~ 330 (346)
T 4fih_A 283 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 330 (346)
T ss_dssp HHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGC
T ss_pred HcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhcCC
Confidence 87654333334679999999999999999999999 8899999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-60 Score=521.24 Aligned_cols=299 Identities=34% Similarity=0.722 Sum_probs=268.1
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~ 760 (1092)
.+...++|++++.||+|+||+||+|+++.+|+.||||++++...........+..|+.+|..+ +||||++++++|++.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 346788999999999999999999999999999999999886655556678899999999987 7999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|+||||++||+|.+++.+.+.+++..+++|+.||+.||.|||++|||||||||+||||+.+|++||+|||+++...
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~-- 172 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-- 172 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc--
Confidence 999999999999999999988999999999999999999999999999999999999999999999999999997421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..
T Consensus 173 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 227 (353)
T 2i0e_A 173 -------------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227 (353)
T ss_dssp -------------------------CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------------------------cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH
Confidence 0112235678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCC
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESV 996 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~ 996 (1092)
+++..|+...+.+| ..++.++++||.+||++||.+||+. .++.+|++||||++++|+.+..+ .|||+|...+.
T Consensus 228 ~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~ 304 (353)
T 2i0e_A 228 ELFQSIMEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR 304 (353)
T ss_dssp HHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC
T ss_pred HHHHHHHhCCCCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc
Confidence 99999999887766 6899999999999999999999985 46899999999999999998665 79999999888
Q ss_pred CCccccccccccCCC
Q 001360 997 DDTSYFLSRFSQISS 1011 (1092)
Q Consensus 997 ~Dts~Fds~fs~~~s 1011 (1092)
|+++|+.+|+....
T Consensus 305 -~~~~f~~~~~~~~~ 318 (353)
T 2i0e_A 305 -NAENFDRFFTRHPP 318 (353)
T ss_dssp ---CHHHHHHHHSCC
T ss_pred -chhhccchhccCCc
Confidence 99999998877643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-60 Score=529.98 Aligned_cols=259 Identities=27% Similarity=0.511 Sum_probs=229.4
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
.+++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|++++|||||++|++|++.+.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 46799999999999999999999999999999999987554 34567889999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|||||+||+|.++|... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--- 177 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--- 177 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH---
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC---
Confidence 99999999999999754 3579999999999999999999999999999999999999999999999999985310
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..++
T Consensus 178 ------------------------~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~ 233 (350)
T 4b9d_A 178 ------------------------TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233 (350)
T ss_dssp ------------------------HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 11223467899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
+.+|+.+.+ |.++..+|+++++||.+||++||.+||+ +.++++||||+.
T Consensus 234 ~~~i~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~l~hp~~~~ 282 (350)
T 4b9d_A 234 VLKIISGSF--PPVSLHYSYDLRSLVSQLFKRNPRDRPS---VNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSHHHHT
T ss_pred HHHHHcCCC--CCCCccCCHHHHHHHHHHccCChhHCcC---HHHHhcCHHhhc
Confidence 999998865 3346789999999999999999999999 889999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-59 Score=520.55 Aligned_cols=300 Identities=39% Similarity=0.756 Sum_probs=250.2
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCceEEEeeeeccC
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieI-L~~L~HPNIVkL~~sfqde 759 (1092)
......++|++++.||+|+||+||+|+++.+++.||||++++..........++.+|..+ ++.++|||||+++++|++.
T Consensus 32 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp CTTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CCCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 345678899999999999999999999999999999999998777666677788888887 4678999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
+.+|+||||++||+|.+++.+.+.+++..+++|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999974210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 192 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 244 (373)
T 2r5t_A 192 ---------------------------HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244 (373)
T ss_dssp ---------------------------CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH
T ss_pred ---------------------------CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 11233567899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc-ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCC
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESV 996 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa-~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~ 996 (1092)
.+++..|+...+.+| ..++.++++||.+||++||.+||++ +++.+|++||||++++|+.+..+ .|||+|...+.
T Consensus 245 ~~~~~~i~~~~~~~~---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~ 321 (373)
T 2r5t_A 245 AEMYDNILNKPLQLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGP 321 (373)
T ss_dssp HHHHHHHHHSCCCCC---SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC-
T ss_pred HHHHHHHHhcccCCC---CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCc
Confidence 999999999877766 6899999999999999999999996 46889999999999999998765 79999999999
Q ss_pred CCccccccccccCC
Q 001360 997 DDTSYFLSRFSQIS 1010 (1092)
Q Consensus 997 ~Dts~Fds~fs~~~ 1010 (1092)
.|+++|+..|+...
T Consensus 322 ~d~~~f~~~~~~~~ 335 (373)
T 2r5t_A 322 NDLRHFDPEFTEEP 335 (373)
T ss_dssp --------------
T ss_pred chhhhcCccccccc
Confidence 99999998776653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-59 Score=534.53 Aligned_cols=334 Identities=36% Similarity=0.656 Sum_probs=280.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
+...++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++|||||+++++|++.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999876555455556689999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
|||||||+||+|.+++.+ .+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~-- 227 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-- 227 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc--
Confidence 999999999999999987 47899999999999999999999999999999999999999999999999999975311
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCC
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
.........+||+.|||||++. ...|+.++|||||||+||||++|++||.+
T Consensus 228 ------------------------~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 228 ------------------------DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp ------------------------TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ------------------------CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 0111234568999999999997 56789999999999999999999999999
Q ss_pred CChHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHHHhccCCcCC--CCCcccHHHHHcCCCCCCCCcchhhhccCCccCC
Q 001360 917 ESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQ 992 (1092)
Q Consensus 917 ~s~~ei~~kIl~~--~l~fP~ip~~lS~eakDLI~kcL~kDP~K--RpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~ 992 (1092)
.+..+++.+|+.. .+.+|.....+++++++||++||+.+|++ |++ +.++++||||++++|+.+....|||+|.
T Consensus 284 ~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~---~~eil~Hpff~~i~w~~l~~~~~p~~P~ 360 (437)
T 4aw2_A 284 ESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNG---IEDFKKHPFFSGIDWDNIRNCEAPYIPE 360 (437)
T ss_dssp SSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTT---THHHHTSGGGTTCCTTTGGGSCCSCCCC
T ss_pred CChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCC---HHHHhCCCccCCCCHHHHhhCCCCCCCc
Confidence 9999999999864 45667655679999999999999988776 766 8899999999999999998889999999
Q ss_pred CCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCcchhhccCCccccCCCCCCCcccCceeecchhhhccc
Q 001360 993 PESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASIN 1070 (1092)
Q Consensus 993 ~~s~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~ss~~~~~em~e~~~f~e~~~~~~d~~Fig~tyk~~~~~~~~~ 1070 (1092)
..++.|+++|+.++......... .... .......+++|.||||++++.+..-+
T Consensus 361 ~~~~~d~~~fd~~~~~~~~~~~~----------------~~~~---------~~~~~~~~~~f~~~~~~~~~~~~~~~ 413 (437)
T 4aw2_A 361 VSSPTDTSNFDVDDDCLKNSETM----------------PPPT---------HTAFSGHHLPFVGFTYTSSCVLSDRS 413 (437)
T ss_dssp CSSTTCCTTSCCC-------------------------------------------CCTTGGGTTCCEESSCTTSTTS
T ss_pred CCCccchhhcCCcccccccccCC----------------CCCc---------cccccccCccccCCCcCCchhhccCC
Confidence 99999999998764332111000 0000 00112347899999999999886655
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-59 Score=529.48 Aligned_cols=296 Identities=40% Similarity=0.739 Sum_probs=257.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
+...++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++|||||+++++|++.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999876655555667789999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
||||||++||+|.+++.+.+ .+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+++....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~-- 214 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA-- 214 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC--
Confidence 99999999999999998764 799999999999999999999999999999999999999999999999999975310
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-------CCCCCccceeechhhhHHHHHhCCCCC
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-------GTEHGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-------g~~Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
.........+||+.|+|||++. +..|+.++|||||||++|||++|++||
T Consensus 215 ------------------------~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 270 (412)
T 2vd5_A 215 ------------------------DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270 (412)
T ss_dssp ------------------------TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------------------------CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence 0011234578999999999997 356899999999999999999999999
Q ss_pred CCCChHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCCccCC
Q 001360 915 TAESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQ 992 (1092)
Q Consensus 915 ~~~s~~ei~~kIl~~--~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~ 992 (1092)
.+.+..+++.+|+.. .+.+|..+..+|+++++||++||+ +|.+|++..++.+|++||||++++|+.+....|||+|.
T Consensus 271 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~ 349 (412)
T 2vd5_A 271 YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPD 349 (412)
T ss_dssp CCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC
T ss_pred CCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCc
Confidence 999999999999863 355665567899999999999999 99999876679999999999999999998889999999
Q ss_pred CCCCCCccccccc
Q 001360 993 PESVDDTSYFLSR 1005 (1092)
Q Consensus 993 ~~s~~Dts~Fds~ 1005 (1092)
..+..|++||+..
T Consensus 350 ~~~~~d~~~f~~~ 362 (412)
T 2vd5_A 350 FEGATDTCNFDLV 362 (412)
T ss_dssp -----CCSSCC--
T ss_pred CCCcccccccCcc
Confidence 9999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=508.12 Aligned_cols=299 Identities=37% Similarity=0.749 Sum_probs=268.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCe
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~ 761 (1092)
....++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|.++ +|||||+++++|++...
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 35678999999999999999999999999999999999987766677788899999999988 89999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+|+||||++||+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~--- 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--- 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC---
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc---
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC-----
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA----- 916 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~----- 916 (1092)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||..
T Consensus 162 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 217 (345)
T 3a8x_A 162 ------------------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217 (345)
T ss_dssp ------------------------CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--
T ss_pred ------------------------CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccc
Confidence 011223467899999999999999999999999999999999999999975
Q ss_pred ----CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc---ccHHHHHcCCCCCCCCcchhhhc--cC
Q 001360 917 ----ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KA 987 (1092)
Q Consensus 917 ----~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa---~ga~EIL~HPFFkgIdWd~L~~~--~p 987 (1092)
.....++..+......+| ..++.++++||.+||++||.+||++ .++.++++||||++++|+.+..+ .|
T Consensus 218 ~~~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~ 294 (345)
T 3a8x_A 218 NPDQNTEDYLFQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP 294 (345)
T ss_dssp -----CHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred ccccccHHHHHHHHHcCCCCCC---CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCC
Confidence 344567778888777666 6899999999999999999999996 35789999999999999998765 78
Q ss_pred CccCCCCCCCCccccccccccCCC
Q 001360 988 VFVPQPESVDDTSYFLSRFSQISS 1011 (1092)
Q Consensus 988 PfiP~~~s~~Dts~Fds~fs~~~s 1011 (1092)
||+|...+..|+++|+..|+....
T Consensus 295 p~~p~~~~~~~~~~~~~~~~~~~~ 318 (345)
T 3a8x_A 295 PFKPNISGEFGLDNFDSQFTNEPV 318 (345)
T ss_dssp SCCCCCCTTTCGGGSCHHHHTSCS
T ss_pred CcCCCCCCcchhhhcCcccccCcc
Confidence 999999999999999988776643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-59 Score=515.29 Aligned_cols=296 Identities=39% Similarity=0.747 Sum_probs=246.5
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~ 760 (1092)
.....++|++++.||+|+||+||+|+++.+|+.||||++++...........+..|+.+|..+ +||||++++++|++.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 346789999999999999999999999999999999999876554455677889999999887 8999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|+||||++||+|.+++.+.+.+++..+++|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 170 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999974210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus 171 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (345)
T 1xjd_A 171 --------------------------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 224 (345)
T ss_dssp --------------------------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------------------------CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH
Confidence 012235678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCC
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD 998 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~D 998 (1092)
+++..|......+| ..++.++++||.+||+.||.+||++. .+|++||||++++|+.+..+ .|||+|...++.|
T Consensus 225 ~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dp~~R~~~~--~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d 299 (345)
T 1xjd_A 225 ELFHSIRMDNPFYP---RWLEKEAKDLLVKLFVREPEKRLGVR--GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFD 299 (345)
T ss_dssp HHHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSBTTB--SCGGGSGGGTTCCHHHHHTTCSCC-----------
T ss_pred HHHHHHHhCCCCCC---cccCHHHHHHHHHHhcCCHhHcCCCh--HHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcch
Confidence 99999998876665 68999999999999999999999943 28999999999999998765 7999999999999
Q ss_pred ccccccccccC
Q 001360 999 TSYFLSRFSQI 1009 (1092)
Q Consensus 999 ts~Fds~fs~~ 1009 (1092)
+++|+..|.+.
T Consensus 300 ~~~f~~~~~~~ 310 (345)
T 1xjd_A 300 CSNFDKEFLNE 310 (345)
T ss_dssp -----------
T ss_pred hhhcchhhccc
Confidence 99999877654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=528.66 Aligned_cols=257 Identities=32% Similarity=0.537 Sum_probs=231.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
+.|++++.||+|+||+||+|+++.+|+.||||++++.... ..+.+.+|+.+|+.++|||||++|++|.+.+.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 5699999999999999999999999999999999865432 3456889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
|||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~-------- 298 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-------- 298 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECC--------
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECC--------
Confidence 99999999999864 579999999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
.......+.|||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++..|
T Consensus 299 -------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 359 (423)
T 4fie_A 299 -------------------KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 359 (423)
T ss_dssp -------------------SSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred -------------------CCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 1112345689999999999999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.....+....+..+|+++++||.+||++||.+||+ +.|+|+||||+..
T Consensus 360 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---a~ell~Hp~~~~~ 407 (423)
T 4fie_A 360 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 407 (423)
T ss_dssp HHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGC
T ss_pred HcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHHhcCC
Confidence 87654433345689999999999999999999999 8899999999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=523.11 Aligned_cols=295 Identities=42% Similarity=0.711 Sum_probs=260.3
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
+...++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++|||||+++++|++...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 45678999999999999999999999999999999999876555455556788999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||||||++||+|.+++.+ ..+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~--- 220 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK--- 220 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT---
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc---
Confidence 999999999999999875 5699999999999999999999999999999999999999999999999999975210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC----CCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~----Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
.......+.+||+.|+|||++.+.. |+.++|||||||+||||++|++||.+.+
T Consensus 221 -----------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 221 -----------------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp -----------------------TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----------------------CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 0111234678999999999998766 8899999999999999999999999999
Q ss_pred hHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHHHhccCCcCC--CCCcccHHHHHcCCCCCCCCcchhhhc--cCCccCC
Q 001360 919 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQ 992 (1092)
Q Consensus 919 ~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~kcL~kDP~K--RpSa~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~ 992 (1092)
...++.+|+... +.+|. ...++.++++||.+||+.+|.+ |++ +.+|++||||++++|+.+..+ .|||+|.
T Consensus 278 ~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~lL~~~~~rlgR~~---~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~ 353 (410)
T 3v8s_A 278 LVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRNG---VEEIKRHLFFKNDQWAWETLRDTVAPVVPD 353 (410)
T ss_dssp HHHHHHHHHTHHHHCCCCT-TCCCCHHHHHHHHHHSSCGGGCTTSSC---HHHHHTSGGGCCSSCCSTTGGGSCCSCCCC
T ss_pred hhhHHHHHHhccccccCCC-cccccHHHHHHHHHHccChhhhCCCCC---HHHHhcCccccCCCHHHHhhcccCCCCCCc
Confidence 999999998753 45553 3579999999999999988877 777 899999999999999876554 8999999
Q ss_pred CCCCCCcccccccccc
Q 001360 993 PESVDDTSYFLSRFSQ 1008 (1092)
Q Consensus 993 ~~s~~Dts~Fds~fs~ 1008 (1092)
..+..|+++|+..+..
T Consensus 354 ~~~~~d~~~fd~~~~~ 369 (410)
T 3v8s_A 354 LSSDIDTSNFDDLEED 369 (410)
T ss_dssp CSSTTCCTTSCCCCSC
T ss_pred CCCccchhhcCCcccc
Confidence 9999999999876443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=503.04 Aligned_cols=253 Identities=24% Similarity=0.453 Sum_probs=221.1
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCeeEE
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLYL 764 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd----e~~LYL 764 (1092)
|++.+.||+|+||+||+|+++.++..||+|++.+... .....+.+.+|+.+|++++|||||++|++|.+ ...+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 4778899999999999999999999999999986543 34557889999999999999999999999875 456899
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcC--CeeeecCCCceEecC-CCcEEEEecCCcccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~G--IIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~n~ 841 (1092)
|||||+||+|.++|.+.+.+++..++.|+.||+.||.|||++| ||||||||+||||+. +|++||+|||+|+...
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~--- 183 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC---
Confidence 9999999999999999999999999999999999999999999 999999999999984 8999999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-hH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s-~~ 920 (1092)
.....+.+|||.|||||++.+ .|+.++|||||||+||||+||++||.+.+ ..
T Consensus 184 --------------------------~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~ 236 (290)
T 3fpq_A 184 --------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA 236 (290)
T ss_dssp --------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred --------------------------CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH
Confidence 112346799999999999875 69999999999999999999999997654 45
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
.++..+..+..+ +.++..+++++++||.+||++||.+||| +.++++||||+.
T Consensus 237 ~~~~~i~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~s---~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 237 QIYRRVTSGVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHTTTCCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC-
T ss_pred HHHHHHHcCCCC-CCCCccCCHHHHHHHHHHccCChhHCcC---HHHHhcCccccC
Confidence 666666555432 3345678999999999999999999999 889999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=550.45 Aligned_cols=303 Identities=34% Similarity=0.722 Sum_probs=273.1
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR 759 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde 759 (1092)
...+.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+..|+.+|..+ +||||++++++|++.
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 3456789999999999999999999999999999999999876555556678899999999987 699999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
+.+||||||++||+|.+++.+.+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~- 493 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI- 493 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC-
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc-
Confidence 9999999999999999999998999999999999999999999999999999999999999999999999999998421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+.
T Consensus 494 --------------------------~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~ 547 (674)
T 3pfq_A 494 --------------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547 (674)
T ss_dssp --------------------------CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --------------------------cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence 011234567999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCC
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES 995 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s 995 (1092)
.+++..|+...+.+| ..+++++++||.+||++||.+||++ +++.+|++||||++++|+.+..+ .|||+|.+.+
T Consensus 548 ~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~ 624 (674)
T 3pfq_A 548 DELFQSIMEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG 624 (674)
T ss_dssp HHHHHHHHSSCCCCC---TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG
T ss_pred HHHHHHHHhCCCCCC---ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC
Confidence 999999999888776 6899999999999999999999995 56799999999999999999766 7999999988
Q ss_pred CCCccccccccccCCCCCC
Q 001360 996 VDDTSYFLSRFSQISSGLP 1014 (1092)
Q Consensus 996 ~~Dts~Fds~fs~~~s~l~ 1014 (1092)
.|+++|+.+|+..+..+.
T Consensus 625 -~~~~~f~~~~~~~~~~~~ 642 (674)
T 3pfq_A 625 -RNAENFDRFFTRHPPVLT 642 (674)
T ss_dssp -GGHHHHTTTTTSSCSSCC
T ss_pred -CchhhcCchhccCCCccC
Confidence 999999999887755443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-58 Score=515.39 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=229.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
+...+.|++.+.||+|+||+||+|+++.+|+.||||++++... ..+|+.+|+.++|||||++|++|++.+.+
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3456789999999999999999999999999999999986432 24699999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC-cEEEEecCCcccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~n~ 841 (1092)
|||||||+||+|.++|.+.+.|++..++.|+.||+.||.|||++|||||||||+||||+.+| ++||+|||+|+......
T Consensus 126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999998 69999999998532110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
. ........+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+
T Consensus 206 ~----------------------~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 263 (336)
T 4g3f_A 206 L----------------------GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263 (336)
T ss_dssp ------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC
T ss_pred c----------------------ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 0 000112345789999999999999999999999999999999999999999998888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH-------------HcCCCCCCC
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV-------------KAHPFFKGV 977 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI-------------L~HPFFkgI 977 (1092)
++.+|.....+++.++..+|+++++||.+||++||.+||| +.|+ ++|||+...
T Consensus 264 ~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---a~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 264 LCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS---AMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp CHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcC---HHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 8999998877766677899999999999999999999999 5555 468887653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=487.27 Aligned_cols=289 Identities=40% Similarity=0.759 Sum_probs=254.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
..+++|++++.||+|+||+||+|+.+.+|+.||||++++.........+.+.+|+.+|..++||||++++++|++...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45789999999999999999999999999999999998765544556788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~----- 157 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----- 157 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC-----
Confidence 999999999999999998899999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+...++
T Consensus 158 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 212 (318)
T 1fot_A 158 -------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 212 (318)
T ss_dssp -------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred -------------------------CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1224568999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCC-CCCC
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPE-SVDD 998 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~-s~~D 998 (1092)
.+|+...+.+| ..++.++++||.+||..||.+||+. .++.++++||||++++|+.+..+ .|||.|... ...|
T Consensus 213 ~~i~~~~~~~p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~d 289 (318)
T 1fot_A 213 EKILNAELRFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGD 289 (318)
T ss_dssp HHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC------
T ss_pred HHHHhCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCCccc
Confidence 99999887766 6899999999999999999999963 25889999999999999998765 789999987 4889
Q ss_pred ccccccc
Q 001360 999 TSYFLSR 1005 (1092)
Q Consensus 999 ts~Fds~ 1005 (1092)
+++|+..
T Consensus 290 ~~~f~~~ 296 (318)
T 1fot_A 290 TSQFDKY 296 (318)
T ss_dssp -------
T ss_pred hhhcCCC
Confidence 9999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=493.23 Aligned_cols=288 Identities=40% Similarity=0.781 Sum_probs=266.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++||||++++++|.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 45789999999999999999999999999999999998766555566788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+||||++||+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~----- 192 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----- 192 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-----
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc-----
Confidence 999999999999999998899999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+++
T Consensus 193 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 247 (350)
T 1rdq_E 193 -------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247 (350)
T ss_dssp -------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred -------------------------CCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH
Confidence 1124568999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC--cccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCc
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDT 999 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpS--a~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dt 999 (1092)
..|..+.+.+| ..++.++++||.+||+.||.+||+ ..++.+|++||||++++|+.+..+ .|||+|...++.|+
T Consensus 248 ~~i~~~~~~~p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~ 324 (350)
T 1rdq_E 248 EKIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDT 324 (350)
T ss_dssp HHHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCC
T ss_pred HHHHcCCCCCC---CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccc
Confidence 99999887766 689999999999999999999998 346899999999999999998765 79999999999999
Q ss_pred ccccc
Q 001360 1000 SYFLS 1004 (1092)
Q Consensus 1000 s~Fds 1004 (1092)
++|+.
T Consensus 325 ~~f~~ 329 (350)
T 1rdq_E 325 SNFDD 329 (350)
T ss_dssp TTSCC
T ss_pred ccccc
Confidence 99984
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-56 Score=502.82 Aligned_cols=264 Identities=29% Similarity=0.413 Sum_probs=226.4
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------CC
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------RD 760 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd------e~ 760 (1092)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+++|+.+|+.++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 57999999999999999999999999999999997643 334556789999999999999999999998754 46
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|||||||. |+|.+++.+.+.+++..++.|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7999999995 689999999899999999999999999999999999999999999999999999999999999853110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
. ........+.+||+.|||||++.+. .|+.++||||||||+|||++|++||.+.+.
T Consensus 212 ~-----------------------~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~ 268 (398)
T 4b99_A 212 P-----------------------AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 268 (398)
T ss_dssp ---------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred c-----------------------cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH
Confidence 0 0112234568999999999999875 569999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCC--------------------C--------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 920 EIIFDNILNRKIPWP--------------------C--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP--------------------~--------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
.+++..|.......+ . +...++++++|||.+||++||.+||| |.|+|+|
T Consensus 269 ~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---a~e~L~H 345 (398)
T 4b99_A 269 VHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS---AAAALRH 345 (398)
T ss_dssp HHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC---HHHHTTS
T ss_pred HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC---HHHHhcC
Confidence 888888865321111 0 11357999999999999999999999 8899999
Q ss_pred CCCCCCC
Q 001360 972 PFFKGVN 978 (1092)
Q Consensus 972 PFFkgId 978 (1092)
|||+...
T Consensus 346 p~f~~~~ 352 (398)
T 4b99_A 346 PFLAKYH 352 (398)
T ss_dssp GGGTTTC
T ss_pred HhhCcCC
Confidence 9998764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=524.18 Aligned_cols=334 Identities=29% Similarity=0.556 Sum_probs=284.3
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
....++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++|||||+++++|++...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 35678999999999999999999999999999999999876655556678899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~----g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
|+||||++||+|.+++... ..+++..+++|+.||+.||.|||++|||||||||+||||+.+|++||+|||+++...
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999999764 369999999999999999999999999999999999999999999999999998521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC-
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE- 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~- 917 (1092)
. ........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.
T Consensus 341 ~---------------------------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 A---------------------------GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp T---------------------------TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred C---------------------------CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 0 011223568999999999999999999999999999999999999999875
Q ss_pred ---ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc--cHHHHHcCCCCCCCCcchhhhc--cCCcc
Q 001360 918 ---SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFV 990 (1092)
Q Consensus 918 ---s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~--ga~EIL~HPFFkgIdWd~L~~~--~pPfi 990 (1092)
....++..+......+| ..+++++++||.+||++||.+||+.. ++.+|++||||++++|+.+..+ .|||+
T Consensus 394 ~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~ 470 (543)
T 3c4z_A 394 EKVENKELKQRVLEQAVTYP---DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFV 470 (543)
T ss_dssp CCCCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred cchhHHHHHHHHhhcccCCC---cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCC
Confidence 45778888888777666 78999999999999999999999953 5799999999999999998765 79999
Q ss_pred CCCCC-----CCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCcchhhccCCccccCCC
Q 001360 991 PQPES-----VDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSC 1049 (1092)
Q Consensus 991 P~~~s-----~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~ss~~~~~em~e~~~f~e~~~~ 1049 (1092)
|.+.. ..|+.+|+. .....++..+..++.+++++..+..|+.+|.++++|.+++..
T Consensus 471 P~~~~~~~~~~~d~~~f~~---~~~~~~~~~~~~~f~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (543)
T 3c4z_A 471 PDSRTVYAKNIQDVGAFST---VKGVAFEKADTEFFQEFASGTCPIPWQEEMIETGVFGDLNVW 531 (543)
T ss_dssp CCSSSCCSCC----CCCC------CCCCCHHHHHHHHHHCCEECHHHHHHHHHHTTHHHHHTCS
T ss_pred CCccccccCCchhhhhccc---cCCCCCCcchhhHhhcCCCCCCChhHHHhhhccccHHHhcCC
Confidence 98753 445555543 223344444556677777777778899999999999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-56 Score=486.67 Aligned_cols=271 Identities=26% Similarity=0.443 Sum_probs=207.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~----- 760 (1092)
+++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|++++|||||++|++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 357999999999999999999999999999999997543 3445678999999999999999999999997654
Q ss_pred -------eeEEEEeecCCCcHHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEe
Q 001360 761 -------NLYLVMEYLNGGDLYSLLRKVGC---LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 830 (1092)
Q Consensus 761 -------~LYLVMEYm~GGSL~dlLkk~g~---LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsD 830 (1092)
.+|||||||+||+|.+++...+. .++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999987654 44567889999999999999999999999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC
Q 001360 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910 (1092)
Q Consensus 831 FGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTG 910 (1092)
||+|+......... ... ..........+.|||+.|||||++.+..|+.++|||||||+||||++
T Consensus 162 FGla~~~~~~~~~~-------~~~--------~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~- 225 (299)
T 4g31_A 162 FGLVTAMDQDEEEQ-------TVL--------TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY- 225 (299)
T ss_dssp CCCC-----------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS-
T ss_pred CccceecCCCcccc-------ccc--------cccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc-
Confidence 99998642111000 000 00011123356799999999999999999999999999999999996
Q ss_pred CCCCCCCCh-HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcch
Q 001360 911 IPPFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981 (1092)
Q Consensus 911 k~PF~~~s~-~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~ 981 (1092)
||.+... ......+... .+|......++.+.+||.+||++||.+||+ +.++++||||++++|..
T Consensus 226 --Pf~~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 226 --PFSTQMERVRTLTDVRNL--KFPPLFTQKYPCEYVMVQDMLSPSPMERPE---AINIIENAVFEDLDFPG 290 (299)
T ss_dssp --CCSSHHHHHHHHHHHHTT--CCCHHHHHHCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGCCC----
T ss_pred --CCCCccHHHHHHHHHhcC--CCCCCCcccCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhCCCCCCC
Confidence 8865432 2233333333 344333456778899999999999999999 88999999999999853
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=498.16 Aligned_cols=298 Identities=41% Similarity=0.769 Sum_probs=252.9
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
.+...++|++++.||+|+||.||+|+++.+|+.||||++++...........+.+|+.+|..++||||++++++|.+.+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 34567899999999999999999999999999999999987655555667788999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
+||||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+||||+.+|++||+|||+|+...
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~-- 300 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-- 300 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC--
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc--
Confidence 99999999999999999998999999999999999999999998 999999999999999999999999999987421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.........+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+..
T Consensus 301 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 355 (446)
T 4ejn_A 301 -------------------------KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 355 (446)
T ss_dssp -------------------------C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------------------------CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH
Confidence 0112234578999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCC
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESV 996 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~ 996 (1092)
.++..+......+| ..+++++.+||.+||.+||.+||+. ..+.++++||||++++|+.+..+ .|||+|.+.+.
T Consensus 356 ~~~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~ 432 (446)
T 4ejn_A 356 KLFELILMEEIRFP---RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSE 432 (446)
T ss_dssp HHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSST
T ss_pred HHHHHHHhCCCCCC---ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCc
Confidence 99999998887766 6899999999999999999999931 24899999999999999998666 78999999999
Q ss_pred CCccccccccccC
Q 001360 997 DDTSYFLSRFSQI 1009 (1092)
Q Consensus 997 ~Dts~Fds~fs~~ 1009 (1092)
.|+++|+++|+.+
T Consensus 433 ~~~~~~~~~~~~~ 445 (446)
T 4ejn_A 433 TDTRYFDEEFTAQ 445 (446)
T ss_dssp TCCTTC-------
T ss_pred cchhhcchhhhcC
Confidence 9999999988754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-55 Score=472.89 Aligned_cols=297 Identities=43% Similarity=0.814 Sum_probs=241.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k---~TGk~VAIKvLkK~ei~k-k~~ie~~l~EieIL~~L~HPNIVkL~~sfqd 758 (1092)
.+..++|++++.||+|+||.||+|++. .+|+.||+|++++..... ......+.+|+.+|+.++||||++++++|.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 456789999999999999999999985 689999999998754322 2345678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
. ........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 173 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 173 H---------------------------DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp ---------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c---------------------------CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 0 0112345689999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc--cHHHHHcCCCCCCCCcchhhhc--cCCccCCCC
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPE 994 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~--ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~ 994 (1092)
...++..+......+| ..++.++++||.+||..||.+||++. .+.++++||||++++|+.+... .|||.|...
T Consensus 226 ~~~~~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~ 302 (327)
T 3a62_A 226 RKKTIDKILKCKLNLP---PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQ 302 (327)
T ss_dssp HHHHHHHHHHTCCCCC---TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC--
T ss_pred HHHHHHHHHhCCCCCC---CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcC
Confidence 9999999998877665 68999999999999999999999754 6999999999999999988665 789999999
Q ss_pred CCCCccccccccccC
Q 001360 995 SVDDTSYFLSRFSQI 1009 (1092)
Q Consensus 995 s~~Dts~Fds~fs~~ 1009 (1092)
+..|.++|+..|...
T Consensus 303 ~~~~~~~~~~~~~~~ 317 (327)
T 3a62_A 303 SEEDVSQFDSKFTRQ 317 (327)
T ss_dssp ---------------
T ss_pred Chhhhhhcchhhhcc
Confidence 999999998876654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-55 Score=512.15 Aligned_cols=265 Identities=28% Similarity=0.507 Sum_probs=239.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.. ....+.+.+|+.+|+.++|||||+++++|++...+||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 4579999999999999999999999999999999997643 3345778999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC--CcEEEEecCCcccccccc
Q 001360 765 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n--G~VKLsDFGLAk~~~~n~ 841 (1092)
|||||+||+|+++|.+ .+.|++..++.|++||+.||.|||++|||||||||+||||+.+ |++||+|||+|+...
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~--- 308 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 308 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC---
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc---
Confidence 9999999999999964 4689999999999999999999999999999999999999854 899999999998531
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
......+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+
T Consensus 309 -------------------------~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~ 363 (573)
T 3uto_A 309 -------------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 363 (573)
T ss_dssp -------------------------TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred -------------------------CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 1122346799999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001360 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983 (1092)
Q Consensus 922 i~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~ 983 (1092)
++..|....+.++. .+..+|+++++||.+||++||.+||+ +.|+|+||||+..+|....
T Consensus 364 ~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t---~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 364 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp HHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTSCCCCTTTT
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcCcCCCCCCCch
Confidence 99999988776653 23579999999999999999999999 8899999999998886543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=521.17 Aligned_cols=330 Identities=32% Similarity=0.542 Sum_probs=276.7
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
.+..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|..++|||||+++++|++.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 35678999999999999999999999999999999999886655556678899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~--LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
||||||++||+|.+++...+. +++..+++|+.||+.||.|||++|||||||||+||||+.+|++||+|||+++...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~-- 337 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-- 337 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc--
Confidence 999999999999999987654 9999999999999999999999999999999999999999999999999997521
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC--
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-- 918 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s-- 918 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 338 --------------------------~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~ 391 (576)
T 2acx_A 338 --------------------------EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391 (576)
T ss_dssp --------------------------TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC
T ss_pred --------------------------cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc
Confidence 0112234689999999999999999999999999999999999999998753
Q ss_pred --hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc--cHHHHHcCCCCCCCCcchhhhc--cCCccCC
Q 001360 919 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQ 992 (1092)
Q Consensus 919 --~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~--ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~ 992 (1092)
...+...+......+| ..+++++++||.+||++||.+||+.. ++.++++||||++++|+.+..+ .|||+|.
T Consensus 392 ~~~~~i~~~i~~~~~~~p---~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~ 468 (576)
T 2acx_A 392 IKREEVERLVKEVPEEYS---ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPD 468 (576)
T ss_dssp CCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred hhHHHHHHHhhcccccCC---ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCC
Confidence 4667777777666655 78999999999999999999999743 6899999999999999999765 7899998
Q ss_pred CCC-----CCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCcchhhccCCcccc
Q 001360 993 PES-----VDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEF 1046 (1092)
Q Consensus 993 ~~s-----~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~ss~~~~~em~e~~~f~e~ 1046 (1092)
+.. ..|..+|.. ..+..++..+..++.++.++..+.+|+.+|.++++|.++
T Consensus 469 ~~~~~~~~~~d~~~f~~---~~~~~~~~~~~~~f~~f~~~~~~~~~~~e~~~~~~~~~l 524 (576)
T 2acx_A 469 PQAIYCKDVLDIEQFST---VKGVELEPTDQDFYQKFATGSVPIPWQNEMVETECFQEL 524 (576)
T ss_dssp CCCCCC--------------------CHHHHHHHHHHCCEECHHHHHHHHHHTTHHHHH
T ss_pred ccccccCCcccHhhccc---cCCCCCCccHHHHHhhhccCCCCcccchhhhhcchhhhh
Confidence 753 344444433 234455556666777777777778899999999888643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=482.01 Aligned_cols=281 Identities=28% Similarity=0.424 Sum_probs=211.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCe
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k---~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~ 761 (1092)
.+.|++.+.||+|+||+||+|+++ .+++.||||++.+.. ...++.+|+++|..+ +|||||+++++|++.+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 357999999999999999999875 467899999886532 345688999999998 59999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC-CcEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n-G~VKLsDFGLAk~~~~n 840 (1092)
+|||||||+||+|.+++. .+++.+++.|+.||+.||+|||++|||||||||+||||+.+ |++||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999999999984 59999999999999999999999999999999999999877 89999999999853211
Q ss_pred ccc--cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 841 NTI--DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 841 ~s~--dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
... +............... ............+.+||+.|||||++.+. .|+.++||||+||++|||++|++||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNK-CSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp SCGGGGGC---------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccc-ccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 100 0000000000000000 00001122334567999999999999875 5899999999999999999999999644
Q ss_pred -ChHHHHHHHhh--------------------------------------cCCCCC-------------CCCCCCCHHHH
Q 001360 918 -SPEIIFDNILN--------------------------------------RKIPWP-------------CVPSDMSFEAQ 945 (1092)
Q Consensus 918 -s~~ei~~kIl~--------------------------------------~~l~fP-------------~ip~~lS~eak 945 (1092)
+..+....|.. .....| .....+|++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 33343333321 000011 01246899999
Q ss_pred HHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 946 DLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 946 DLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
|||++||++||.+||| |.|+|+||||++++
T Consensus 331 DLl~~lL~~dP~~R~t---a~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 331 DLLDKLLDLNPASRIT---AEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHTCSCTTTSCC---HHHHHTSGGGTTC-
T ss_pred HHHHHHCcCChhHCcC---HHHHhcCcccCCCC
Confidence 9999999999999999 88999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=472.35 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=218.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd 758 (1092)
+..++|.+.+.||+|+||+||+|++. .+|..||||++++. .....+.|.+|+++|++++|||||++|++|.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 45578999999999999999999975 35789999999753 34556789999999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhhc-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKVG-------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 825 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~g-------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~ 825 (1092)
.+.+|||||||+||+|.++|.+.+ .+++..+..++.||+.||.|||+++||||||||+||||+.+++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 999999999999999999997643 5999999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHH
Q 001360 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 905 (1092)
Q Consensus 826 VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILY 905 (1092)
+||+|||+|+...... ........+||+.|||||++.+..|+.++|||||||+||
T Consensus 167 ~Ki~DFGla~~~~~~~-------------------------~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~ 221 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 221 (299)
T ss_dssp EEECCCSCHHHHTGGG-------------------------CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred EEECCcccceecCCCC-------------------------ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHH
Confidence 9999999998532110 011223467999999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 906 EFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 906 EMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
||+| |++||.+.+..++...+..+.. +..|..+|+++.+||.+||+.||++||++.++
T Consensus 222 Ellt~G~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i 280 (299)
T 4asz_A 222 EIFTYGKQPWYQLSNNEVIECITQGRV--LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI 280 (299)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9998 9999999999999999888753 23457899999999999999999999994433
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-54 Score=470.52 Aligned_cols=265 Identities=21% Similarity=0.314 Sum_probs=218.7
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
..|++..++|++.+.||+|+||+||+|+++. .||||+++... ......+.|.+|+.+|++++|||||++++++. .
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~ 103 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-K 103 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-C
Confidence 3456788999999999999999999998653 59999997543 34556788999999999999999999999875 4
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
+.+|||||||+||+|.++|... +.+++..+..++.||+.||.|||+++||||||||+||||+.++++||+|||+|+...
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 6789999999999999999764 579999999999999999999999999999999999999999999999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
.. .......+.+||+.|||||++.+ ..|+.++|||||||+||||+||++||.
T Consensus 184 ~~-------------------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 184 RW-------------------------SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp -----------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cC-------------------------CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 10 01122345789999999999974 358999999999999999999999999
Q ss_pred CCChHHHHHHHhhcCCCC---CCCCCCCCHHHHHHHHHhccCCcCCCCCcccH---HHHHcCCCC
Q 001360 916 AESPEIIFDNILNRKIPW---PCVPSDMSFEAQDLINRFLIHDPNQRLGANGA---AEVKAHPFF 974 (1092)
Q Consensus 916 ~~s~~ei~~kIl~~~l~f---P~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga---~EIL~HPFF 974 (1092)
+.+.......++...... +.++..+++++.+||.+||+.||++||++.++ .+.++|+|-
T Consensus 239 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 239 HINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp TCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 877766655555544433 34567899999999999999999999995543 355677764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=476.62 Aligned_cols=282 Identities=31% Similarity=0.685 Sum_probs=251.1
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
...+..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|..++|||||+++++|++..
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34567889999999999999999999999999999999998766555667788999999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|+||||+.||+|.+++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+++...
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~-- 166 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-- 166 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc--
Confidence 999999999999999999998899999999999999999999999999999999999999999999999999997521
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||...
T Consensus 167 --------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 167 --------------------------RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp --------------------------TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred --------------------------CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 1122346789999999999974 46899999999999999999999999753
Q ss_pred ---ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhc--cCCccCC
Q 001360 918 ---SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQ 992 (1092)
Q Consensus 918 ---s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~ 992 (1092)
....++..+......+| ..++.++.+||.+||..||.+||+ .+.++++||||++++|+.+..+ .|||+|.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~s--~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~ 295 (384)
T 4fr4_A 221 SSTSSKEIVHTFETTVVTYP---SAWSQEMVSLLKKLLEPNPDQRFS--QLSDVQNFPYMNDINWDAVFQKRLIPGFIPN 295 (384)
T ss_dssp TTSCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC--SHHHHHTSGGGTTCCHHHHHTTCSCCCCCCS
T ss_pred CCccHHHHHHHHhhcccCCC---CcCCHHHHHHHHHHhcCCHhHhcc--cHHHHHcChhhhcCCHHHHHhCCCCCCCCCC
Confidence 44566666666666655 689999999999999999999998 3789999999999999998766 7899998
Q ss_pred CCC
Q 001360 993 PES 995 (1092)
Q Consensus 993 ~~s 995 (1092)
...
T Consensus 296 ~~~ 298 (384)
T 4fr4_A 296 KGR 298 (384)
T ss_dssp CCS
T ss_pred CCC
Confidence 643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=469.78 Aligned_cols=252 Identities=27% Similarity=0.384 Sum_probs=214.0
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfq 757 (1092)
.+..++|.+.+.||+|+||+||+|+++ .++..||||++++. .....+.|.+|+++|.+++|||||++|++|.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 355678999999999999999999975 36889999999753 3455678999999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhh---------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKV---------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 822 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~---------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~ 822 (1092)
+.+.+|||||||+||+|.++|.+. +.+++.++..|+.||+.||.|||+++||||||||+||||+.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 999999999999999999999754 35899999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhh
Q 001360 823 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902 (1092)
Q Consensus 823 nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGV 902 (1092)
++++||+|||+|+..... .........+||+.|||||++.+..|+.++|||||||
T Consensus 194 ~~~~Ki~DFGla~~~~~~-------------------------~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gv 248 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYST-------------------------DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 248 (329)
T ss_dssp TTEEEECCCC-----------------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CCcEEEcccccceeccCC-------------------------CcceecCcccccccccChhhhcCCCCCccccccchHH
Confidence 999999999999853210 0011223568999999999999999999999999999
Q ss_pred hHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 903 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 903 ILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
+||||+| |++||.+.+..+++..|..+.. +..|..+++++.+||.+||+.||++||++.+
T Consensus 249 vl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~e 309 (329)
T 4aoj_A 249 VLWEIFTYGKQPWYQLSNTEAIDCITQGRE--LERPRACPPEVYAIMRGCWQREPQQRHSIKD 309 (329)
T ss_dssp HHHHHHTTSCCTTCSSCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCcccccHHHHHHHHHHcCcChhHCcCHHH
Confidence 9999999 9999999999999988887642 2345789999999999999999999999443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=464.40 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=221.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd 758 (1092)
+..+++++++.||+|+||+||+|++. .+++.||||+++... .....+.|.+|+.+|.+++|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 56678999999999999999999974 367899999997532 23345789999999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 822 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~----------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~ 822 (1092)
.+.+|||||||++|+|.++|... ..+++..+..++.||+.||.|||+++||||||||+||||+.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 99999999999999999999653 35899999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhh
Q 001360 823 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902 (1092)
Q Consensus 823 nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGV 902 (1092)
++++||+|||+|+..... .........+||+.|||||++.+..|+.++|||||||
T Consensus 181 ~~~~Ki~DFGlar~~~~~-------------------------~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGv 235 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAA-------------------------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 235 (308)
T ss_dssp GGCEEECCSCCBCGGGGG-------------------------GCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred CCCEEECCcccceeccCC-------------------------CceeEecccccCCcccCHHHHhCCCCCccchhhhHHH
Confidence 999999999999853211 1112234568999999999999999999999999999
Q ss_pred hHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 903 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 903 ILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+||||+| |.+||.+.+..++...|..+.. +..|..+++++.+||.+||..||.+||++.++.+.|
T Consensus 236 vl~El~t~g~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 236 VLWEVFSYGLQPYCGYSNQDVVEMIRNRQV--LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp HHHHHHTTTCCTTTTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9999998 8999999999999998877643 224688999999999999999999999955554444
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=465.36 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=217.7
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEee
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFY 754 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TG-----k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H-PNIVkL~~ 754 (1092)
+|.+..++|++.+.||+|+||+||+|++..++ +.||||+++... .....+.+.+|+.+|.++.| ||||++++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 45677789999999999999999999987543 689999997543 33456789999999999975 99999999
Q ss_pred eeccC-CeeEEEEeecCCCcHHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCc
Q 001360 755 SFTCR-DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (1092)
Q Consensus 755 sfqde-~~LYLVMEYm~GGSL~dlLkk~----------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeN 817 (1092)
+|... +.+|||||||+||+|.++|++. ..+++..+..|+.||+.||.|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 98664 5799999999999999999753 348999999999999999999999999999999999
Q ss_pred eEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001360 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (1092)
Q Consensus 818 ILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDV 897 (1092)
|||+.++++||+|||+|+..... .......+.+||+.|||||++.+..|+.++||
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~-------------------------~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDV 270 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKD-------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 270 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTC-------------------------TTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred eeeCCCCCEEECcchhhhhcccC-------------------------CCceeeccccccccccCHHHHhcCCCCCcccE
Confidence 99999999999999999853110 00112345789999999999999999999999
Q ss_pred echhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 898 WSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
|||||+||||+| |.+||.+.+..+.+.+++..... +..|..+++++.+||.+||+.||.+||+ +.+|++|
T Consensus 271 wS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~-~~~p~~~~~~~~~li~~c~~~dP~~RPt---~~eil~~ 341 (353)
T 4ase_A 271 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 341 (353)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred eehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC-CCCCccCCHHHHHHHHHHcCcChhHCcC---HHHHHHH
Confidence 999999999998 99999987755444444443333 2346789999999999999999999999 5666665
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=443.71 Aligned_cols=261 Identities=31% Similarity=0.575 Sum_probs=237.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
....++|++++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 4567899999999999999999999999999999999987543 445677899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~---- 165 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT---- 165 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS----
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC----
Confidence 9999999999999999998999999999999999999999999999999999999999999999999999987421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCC-ccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG-YAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt-~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
........+||+.|+|||++.+..|. .++|||||||++|||++|.+||.+.+..+
T Consensus 166 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 221 (328)
T 3fe3_A 166 ------------------------VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221 (328)
T ss_dssp ------------------------SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------------------------CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 01123457899999999999988875 89999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
+...+..+...+| ..+++++.+||.+||..||.+||+ +.++++||||+...
T Consensus 222 ~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t---~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 222 LRERVLRGKYRIP---FYMSTDCENLLKRFLVLNPIKRGT---LEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHCCCCCC---TTSCHHHHHHHHHHCCSSTTTSCC---HHHHTTCTTTTTTC
T ss_pred HHHHHHhCCCCCC---CCCCHHHHHHHHHHCCCChhHCcC---HHHHhcCHhhcCCC
Confidence 9999999887766 678999999999999999999999 88999999998653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=454.03 Aligned_cols=284 Identities=30% Similarity=0.495 Sum_probs=247.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk---~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
..+.|++++.||+|+||+||+|+++.+|+.||+|++++...... ...+.+.+|+.+|..++||||++++++|.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 45679999999999999999999999999999999987543221 135678999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC----cEEEEecCCcccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIG 837 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG----~VKLsDFGLAk~~ 837 (1092)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999999888999999999999999999999999999999999999998877 7999999999752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
. ........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.
T Consensus 170 ~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 170 E----------------------------DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp C----------------------------TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred C----------------------------CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 1 011224568999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhccCCccCCCCCC
Q 001360 918 SPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESV 996 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~ 996 (1092)
+..+++..|....+.++. .+..++.++++||.+||..||.+||+ +.++++||||++++|....... .+.
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~l~hp~~~~~~~~~~~~~~-------~~~ 291 (361)
T 2yab_A 222 TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLT---IQEALRHPWITPVDTQQAMVRR-------ESV 291 (361)
T ss_dssp SHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSTTTSCSSHHHHHHHH-------TCB
T ss_pred CHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcC---HHHHhcCcCcCCCchhhhhhcc-------cch
Confidence 999999999888776652 23578999999999999999999999 8899999999999998654432 223
Q ss_pred CCcccccccc
Q 001360 997 DDTSYFLSRF 1006 (1092)
Q Consensus 997 ~Dts~Fds~f 1006 (1092)
.+..+|..++
T Consensus 292 ~~~~~~~~~~ 301 (361)
T 2yab_A 292 VNLENFKKQY 301 (361)
T ss_dssp CCHHHHHHHT
T ss_pred hhHHHHHHHH
Confidence 4455565543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=443.17 Aligned_cols=292 Identities=42% Similarity=0.795 Sum_probs=245.0
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITV-RNPFVVRFFYSF 756 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k---~TGk~VAIKvLkK~ei~-kk~~ie~~l~EieIL~~L-~HPNIVkL~~sf 756 (1092)
.....++|++++.||+|+||+||+|++. .+|+.||||++++.... .......+.+|+.+|..+ .||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3466789999999999999999999984 58999999999764432 122345677899999999 699999999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 757 TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 757 qde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
.....+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999974
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
... .........+||+.|+|||++.+ ..++.++|||||||+||||++|..||
T Consensus 209 ~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf 262 (355)
T 1vzo_A 209 FVA--------------------------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262 (355)
T ss_dssp CCG--------------------------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccc--------------------------CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 211 01122345689999999999986 45789999999999999999999999
Q ss_pred CCC----ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc--cHHHHHcCCCCCCCCcchhhhc--c
Q 001360 915 TAE----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--K 986 (1092)
Q Consensus 915 ~~~----s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~--ga~EIL~HPFFkgIdWd~L~~~--~ 986 (1092)
... ....+...+......+| ..++..+++||.+||..||.+||+.. .+.++++||||+.++|+.+..+ +
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~ 339 (355)
T 1vzo_A 263 TVDGEKNSQAEISRRILKSEPPYP---QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 339 (355)
T ss_dssp SCTTSCCCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred ccCCccchHHHHHHHHhccCCCCC---cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCC
Confidence 754 34556666666654444 78999999999999999999999532 4999999999999999998877 6
Q ss_pred CCccCCCCCCCCcccc
Q 001360 987 AVFVPQPESVDDTSYF 1002 (1092)
Q Consensus 987 pPfiP~~~s~~Dts~F 1002 (1092)
+||.|...+..|.++|
T Consensus 340 ~p~~p~~~~~~d~~~~ 355 (355)
T 1vzo_A 340 APFKPVIRDELDVSNF 355 (355)
T ss_dssp CSCCCCCCC-CCC---
T ss_pred CCCCCccccccccccC
Confidence 8999999888888876
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=425.73 Aligned_cols=268 Identities=28% Similarity=0.497 Sum_probs=236.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk---~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
..+.|++.+.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|+.+|..++||||++++++|.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34679999999999999999999999999999999986543221 135778999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC----cEEEEecCCcccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIG 837 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG----~VKLsDFGLAk~~ 837 (1092)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999998888899999999999999999999999999999999999999888 8999999999752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
.. .......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.
T Consensus 169 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 169 DF----------------------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp CT----------------------------TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CC----------------------------CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 10 11123467999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001360 918 SPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~ 983 (1092)
+..+....+......++. .+..++.++++||.+||..||.+||+ +.++++||||++.+|....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~~~~~ 284 (326)
T 2y0a_A 221 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQAL 284 (326)
T ss_dssp SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTSCCSHHHHH
T ss_pred CHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCC---HHHHhcCCCccCCcchhhh
Confidence 998888888877665542 12568999999999999999999999 8899999999999887643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=421.38 Aligned_cols=258 Identities=34% Similarity=0.543 Sum_probs=227.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++++.||+|+||+||+|++..+|+.||+|++..... ...+.+.+|+.+++.++||||++++++|...+.+|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 4679999999999999999999999999999999975433 2346688999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||++||+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~------ 168 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 168 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS------
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC------
Confidence 9999999999999764 699999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.......
T Consensus 169 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 227 (297)
T 3fxz_A 169 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (297)
T ss_dssp ---------------------TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred ---------------------cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 01123456899999999999999999999999999999999999999999888777777
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 926 Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
+.....+....+..++..+.+||.+||..||.+||+ +.++++||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~h~~~~~~ 276 (297)
T 3fxz_A 228 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHQFLKIA 276 (297)
T ss_dssp HHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGC
T ss_pred HHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhccc
Confidence 665544333345789999999999999999999999 8899999999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=411.09 Aligned_cols=260 Identities=28% Similarity=0.484 Sum_probs=218.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
+++|++++.||+|+||+||+|+++.+|+.||+|+++... ........+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC-CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 468999999999999999999999999999999998644 2344567789999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHH-hhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLk-k~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||+.+ +|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~------ 152 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG------ 152 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC------
Confidence 999986 5555554 46789999999999999999999999999999999999999999999999999997521
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeechhhhHHHHHhCCCC-CCCCChHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPP-FTAESPEII 922 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Yt~ksDVWSLGVILYEMLTGk~P-F~~~s~~ei 922 (1092)
.........+||+.|+|||++.+.. |+.++|||||||++|||++|..| |.+.+..+.
T Consensus 153 ---------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~ 211 (292)
T 3o0g_A 153 ---------------------IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_dssp ---------------------SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred ---------------------CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 0111223467999999999998765 89999999999999999987766 666666666
Q ss_pred HHHHhhcCC-----------------CC---------CCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 923 FDNILNRKI-----------------PW---------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 923 ~~kIl~~~l-----------------~f---------P~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
...+..... ++ ......++.++++||.+||+.||.+||+ +.++++||||++
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~ 288 (292)
T 3o0g_A 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS---AEEALQHPYFSD 288 (292)
T ss_dssp HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGTT
T ss_pred HHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC---HHHHhcCccccc
Confidence 666643100 00 1122458899999999999999999999 889999999987
Q ss_pred C
Q 001360 977 V 977 (1092)
Q Consensus 977 I 977 (1092)
+
T Consensus 289 ~ 289 (292)
T 3o0g_A 289 F 289 (292)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=432.80 Aligned_cols=259 Identities=31% Similarity=0.533 Sum_probs=232.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|+.+|..++|||||+++++|.+.+.+|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4679999999999999999999999999999999986543 345567899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC---cEEEEecCCccccccccc
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLsDFGLAk~~~~n~s 842 (1092)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~---- 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---- 182 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT----
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec----
Confidence 99999999999998888899999999999999999999999999999999999998654 59999999987421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+...+
T Consensus 183 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 238 (362)
T 2bdw_A 183 ------------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 238 (362)
T ss_dssp ------------------------TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ------------------------CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 01112356899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 923 FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 923 ~~kIl~~~l~fP~i-p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
+..+..+.+.+|.. ...+++++++||.+||..||.+||+ +.++++||||.+
T Consensus 239 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~~~~ 290 (362)
T 2bdw_A 239 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT---ADQALKVPWICN 290 (362)
T ss_dssp HHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSHHHHT
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCcccCC
Confidence 99999887776632 1468999999999999999999999 889999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=410.29 Aligned_cols=260 Identities=35% Similarity=0.644 Sum_probs=233.7
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
....+++|++.+.||+|+||+||+|+++.++..||+|++.+...........+.+|+.++..++||||+++++++.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 34677899999999999999999999999999999999977554444446778999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+|+||||+++|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~--- 160 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 160 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC---
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999886321
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
.......+||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus 161 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 214 (279)
T 3fdn_A 161 --------------------------SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214 (279)
T ss_dssp ---------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred --------------------------cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH
Confidence 111234579999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
....+......+| ..++.++.+||.+||..||.+||+ +.++++||||++
T Consensus 215 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~h~~~~~ 263 (279)
T 3fdn_A 215 TYKRISRVEFTFP---DFVTEGARDLISRLLKHNPSQRPM---LREVLEHPWITA 263 (279)
T ss_dssp HHHHHHHTCCCCC---TTSCHHHHHHHHHHCCSSGGGSCC---HHHHHHCHHHHH
T ss_pred HHHHHHhCCCCCC---CcCCHHHHHHHHHHhccChhhCCC---HHHHhhCccccC
Confidence 9988888776665 678999999999999999999999 889999999965
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=430.94 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=191.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----ee
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----NL 762 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~----~L 762 (1092)
.+|.+.+.||+|+||+||+|++ +|+.||||+++... ........|+..+.+++|||||++++++...+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999988 48999999986532 11122334555567889999999999998764 58
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeeecCCCceEecCCCcEEEEecCCc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~--------GIIHRDLKPeNILLD~nG~VKLsDFGLA 834 (1092)
|||||||+||+|.++|++ ..+++..+..++.|++.||.|||++ +||||||||+||||+.+|++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999976 4689999999999999999999987 9999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC------CCCccceeechhhhHHHHH
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFI 908 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~------~Yt~ksDVWSLGVILYEML 908 (1092)
+....... .........+||+.|||||++.+. .|+.++|||||||+||||+
T Consensus 156 ~~~~~~~~-----------------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~ 212 (303)
T 3hmm_A 156 VRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp EEEETTTT-----------------------EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccCCCC-----------------------ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHH
Confidence 85321100 001123356899999999999764 3678999999999999999
Q ss_pred hCCCCCCCC---------------ChHHHHHHHhhcCCCCCCCCCC-----CCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 909 TGIPPFTAE---------------SPEIIFDNILNRKIPWPCVPSD-----MSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 909 TGk~PF~~~---------------s~~ei~~kIl~~~l~fP~ip~~-----lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
||.+||... ....+...+....+. |.+|.. .+..+.+||.+||..||++|||+.++.+
T Consensus 213 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~r-p~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HCCCCCCccccccccchhcccccchHHHHHHHHhcccCC-CCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 998766321 223444445444432 333322 3357889999999999999999554443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=436.99 Aligned_cols=258 Identities=32% Similarity=0.571 Sum_probs=228.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
..+++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+...+|
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 35689999999999999999999999999999999998654333334567899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~----- 159 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT----- 159 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT-----
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc-----
Confidence 999999 78999999988999999999999999999999999999999999999999999999999999987421
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.....+
T Consensus 160 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 216 (336)
T 3h4j_B 160 -----------------------DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216 (336)
T ss_dssp -----------------------TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC
T ss_pred -----------------------CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH
Confidence 1122345689999999999998877 7899999999999999999999998776666
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
+..+......+| ..+++++.+||.+||..||.+||+ +.++++||||+.
T Consensus 217 ~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 264 (336)
T 3h4j_B 217 FKKVNSCVYVMP---DFLSPGAQSLIRRMIVADPMQRIT---IQEIRRDPWFNV 264 (336)
T ss_dssp BCCCCSSCCCCC---TTSCHHHHHHHHTTSCSSGGGSCC---HHHHTTCHHHHT
T ss_pred HHHHHcCCCCCc---ccCCHHHHHHHHHHcCCChhHCcC---HHHHHhChhhcc
Confidence 666555554444 789999999999999999999999 889999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=420.18 Aligned_cols=265 Identities=29% Similarity=0.520 Sum_probs=220.0
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
....++|++++.||+|+||+||+|++. +|+.||+|+++... ........+.+|+.+|+.++||||+++++++.+...+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 345689999999999999999999985 59999999997542 2333457788999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~-- 171 (311)
T 3niz_A 95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-- 171 (311)
T ss_dssp EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS--
T ss_pred EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC--
Confidence 999999985 888887654 4599999999999999999999999999999999999999999999999999975210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
........+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..
T Consensus 172 -------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (311)
T 3niz_A 172 -------------------------PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226 (311)
T ss_dssp -------------------------CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred -------------------------CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence 0112234579999999999986 56899999999999999999999999987776
Q ss_pred HHHHHHhhc--CC---CCC----------------------CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCC
Q 001360 921 IIFDNILNR--KI---PWP----------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1092)
Q Consensus 921 ei~~kIl~~--~l---~fP----------------------~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPF 973 (1092)
+....+... .. .++ .+...+++++.+||.+||+.||.+||+ +.++++|||
T Consensus 227 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~ 303 (311)
T 3niz_A 227 DQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS---ARDAMNHPY 303 (311)
T ss_dssp THHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC---HHHHHTSGG
T ss_pred HHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC---HHHHhcCcc
Confidence 666655431 00 000 012357889999999999999999999 889999999
Q ss_pred CCCCCcc
Q 001360 974 FKGVNWD 980 (1092)
Q Consensus 974 FkgIdWd 980 (1092)
|++++++
T Consensus 304 f~~~~~~ 310 (311)
T 3niz_A 304 FKDLDPQ 310 (311)
T ss_dssp GTTSCTT
T ss_pred cccCCcc
Confidence 9998864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=438.77 Aligned_cols=292 Identities=30% Similarity=0.420 Sum_probs=209.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-----C
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-----R 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd-----e 759 (1092)
..++|++++.||+|+||+||+|+++.+|+.||||++.+. ........++.+|+.+|..++|||||+++++|.. .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 457899999999999999999999999999999999753 3345567889999999999999999999999843 3
Q ss_pred CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
..+|+||||+ +|+|.+++.....+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 5799999998 579999999888899999999999999999999999999999999999999999999999999986421
Q ss_pred cccccCCCCCCCCCCCCC--CCCCcc--cccCcCCccCccCCCCCCChhhhc-CCCCCccceeechhhhHHHHHh-----
Q 001360 840 NNTIDLSGPETDGIMPSD--AHYPEY--QQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFIT----- 909 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~--~~~~~~--~~~~~~~~~s~vGTp~YmAPEVL~-g~~Yt~ksDVWSLGVILYEMLT----- 909 (1092)
....... ....+.. .....+ ...........+||+.|+|||++. +..|+.++||||||||||||++
T Consensus 209 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 209 PENGNSQ----LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTCCCC----CC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred ccccccc----cccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 1100000 0000000 000000 001122345679999999999874 5679999999999999999999
Q ss_pred ------CCCCCCCCCh--------------------HHHHHHHhh--c--------------------------CCCCCC
Q 001360 910 ------GIPPFTAESP--------------------EIIFDNILN--R--------------------------KIPWPC 935 (1092)
Q Consensus 910 ------Gk~PF~~~s~--------------------~ei~~kIl~--~--------------------------~l~fP~ 935 (1092)
|.+||.+.+. .+....|.. + ...+..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 7788876541 111222211 0 001111
Q ss_pred CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhc
Q 001360 936 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1092)
Q Consensus 936 ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~ 985 (1092)
....+++++.+||.+||..||.+||+ +.|+|+||||+++.|......
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t---~~e~L~Hp~f~~~~~~~~e~~ 411 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRIT---INECLAHPFFKEVRIAEVETN 411 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGTTTCCGGGCCC
T ss_pred HCCCCCHHHHHHHHHHhccCccccCC---HHHHhcCHhhhhcCCCccCCC
Confidence 12456999999999999999999999 889999999999999877544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=436.58 Aligned_cols=262 Identities=30% Similarity=0.507 Sum_probs=227.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LY 763 (1092)
..++|++++.||+|+||+||+|+++.+|+.||||++++... ...+|+++|.++ +||||++++++|.+...+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 35679999999999999999999999999999999986432 234688888887 7999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC----CcEEEEecCCcccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n----G~VKLsDFGLAk~~~~ 839 (1092)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+... +.+||+|||+++....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999999988899999999999999999999999999999999999998543 3599999999985311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC---
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA--- 916 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~--- 916 (1092)
......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+
T Consensus 173 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 225 (342)
T 2qr7_A 173 ---------------------------ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225 (342)
T ss_dssp ---------------------------TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT
T ss_pred ---------------------------CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc
Confidence 01123457899999999999988899999999999999999999999986
Q ss_pred CChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhc
Q 001360 917 ESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~ 985 (1092)
.+..+++..+..+.+.++. .+..+++++++||.+||..||.+||+ +.++++||||. +|+.+...
T Consensus 226 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~~il~hp~~~--~~~~~~~~ 290 (342)
T 2qr7_A 226 DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT---AALVLRHPWIV--HWDQLPQY 290 (342)
T ss_dssp SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCC---HHHHTTSHHHH--TGGGSCCS
T ss_pred CCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCCeec--Cccccccc
Confidence 4677888888887776553 23578999999999999999999999 88999999994 57766443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=430.18 Aligned_cols=274 Identities=22% Similarity=0.347 Sum_probs=225.1
Q ss_pred ccCCCeEEEEeeccC--CCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 684 TSIDDFEIIKPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 684 i~~~dFeilr~LGkG--gFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
...++|++++.||+| +||+||+|+++.+|+.||||+++... ........+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 456789999999999 99999999999999999999998643 334567788999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999876 6799999999999999999999999999999999999999999999999999864321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
.... ...........+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.
T Consensus 181 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 181 HGQR--------------------QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp TTEE--------------------CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccc--------------------ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 1000 0001112234589999999999987 67999999999999999999999999887
Q ss_pred ChHHHHHHHhhcCCC-------------------------------------------CCCCCCCCCHHHHHHHHHhccC
Q 001360 918 SPEIIFDNILNRKIP-------------------------------------------WPCVPSDMSFEAQDLINRFLIH 954 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~-------------------------------------------fP~ip~~lS~eakDLI~kcL~k 954 (1092)
+.......++.+..+ ....+..+++++.+||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 320 (389)
T 3gni_B 241 PATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320 (389)
T ss_dssp CSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCS
T ss_pred CHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhc
Confidence 765555544432211 0012356889999999999999
Q ss_pred CcCCCCCcccHHHHHcCCCCCCCCcch
Q 001360 955 DPNQRLGANGAAEVKAHPFFKGVNWDS 981 (1092)
Q Consensus 955 DP~KRpSa~ga~EIL~HPFFkgIdWd~ 981 (1092)
||.+||+ +.++++||||+.+.|..
T Consensus 321 dP~~Rpt---a~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 321 NPDARPS---ASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp CTTTSCC---HHHHTTSGGGGGC---C
T ss_pred CcccCCC---HHHHhcCHHHHHHhhcc
Confidence 9999999 88999999999887754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=408.35 Aligned_cols=260 Identities=35% Similarity=0.654 Sum_probs=234.7
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
.....++|++.+.||+|+||.||+|++..++..||+|++.+...........+.+|+.++..++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 44667899999999999999999999999999999999976544333445678999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~--- 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP--- 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS---
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc---
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999986421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
.......+||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus 166 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 219 (284)
T 2vgo_A 166 --------------------------SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219 (284)
T ss_dssp --------------------------SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred --------------------------ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH
Confidence 011234679999999999999999999999999999999999999999999888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
....+......+| ..++.++++||.+||..||.+||+ +.++++||||+.
T Consensus 220 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~h~~~~~ 268 (284)
T 2vgo_A 220 THRRIVNVDLKFP---PFLSDGSKDLISKLLRYHPPQRLP---LKGVMEHPWVKA 268 (284)
T ss_dssp HHHHHHTTCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC---HHHHHTCHHHHH
T ss_pred HHHHHhccccCCC---CcCCHHHHHHHHHHhhcCHhhCCC---HHHHhhCHHHHh
Confidence 8888888776655 678999999999999999999999 889999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=441.69 Aligned_cols=260 Identities=29% Similarity=0.536 Sum_probs=232.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++++.||+|+||+||+|.++.+|+.||+|++.+... .......+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999986543 334567789999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEec---CCCcEEEEecCCccccccccc
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD---~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~--- 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--- 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT---
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC---
Confidence 99999999999999989999999999999999999999999999999999999998 468899999999974210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+...+
T Consensus 166 ------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~ 221 (444)
T 3soa_A 166 ------------------------EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 221 (444)
T ss_dssp ------------------------TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 01122356899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 923 FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 923 ~~kIl~~~l~fP~i-p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
+..+..+.+.+|.. ...+++++++||.+||..||.+||+ +.++++||||++
T Consensus 222 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~e~L~hp~~~~ 273 (444)
T 3soa_A 222 YQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT---AAEALKHPWISH 273 (444)
T ss_dssp HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSCTTHH
T ss_pred HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCC---HHHHhcCccccC
Confidence 99999887776642 2478999999999999999999999 889999999964
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=401.82 Aligned_cols=266 Identities=30% Similarity=0.509 Sum_probs=236.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..++|++.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.++.+++||||+++++++.+....|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 35789999999999999999999999999999999976443 44556788999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc---EEEEecCCcccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINN 841 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~---VKLsDFGLAk~~~~n~ 841 (1092)
||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~--- 159 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--- 159 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc---
Confidence 9999999999999998889999999999999999999999999999999999999987665 9999999987421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+...
T Consensus 160 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 214 (284)
T 3kk8_A 160 -------------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214 (284)
T ss_dssp -------------------------SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH
Confidence 0111234679999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchh
Q 001360 922 IFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982 (1092)
Q Consensus 922 i~~kIl~~~l~fP~i-p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L 982 (1092)
....+..+...+|.. ...+++++.+||.+||..||.+||+ +.++++||||++..+...
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~~~ 273 (284)
T 3kk8_A 215 LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT---ADQALKVPWICNRERVAS 273 (284)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSHHHHSCCCGGG
T ss_pred HHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCC---HHHHhcCccccCChhHHh
Confidence 999888877665532 2478999999999999999999999 889999999988766543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=424.56 Aligned_cols=258 Identities=27% Similarity=0.489 Sum_probs=230.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..++|++.+.||+|+||+||+|+++.+|+.||+|+++.. ......+.+|+.+|..++||||++++++|.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 357899999999999999999999999999999998643 2345678899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC--CCcEEEEecCCcccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~--nG~VKLsDFGLAk~~~~n~ 841 (1092)
||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~--- 155 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC---
Confidence 999999999999997654 6999999999999999999999999999999999999997 7899999999997521
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 156 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 210 (321)
T 1tki_A 156 -------------------------PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp -------------------------TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred -------------------------CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence 0112234679999999999999889999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 922 i~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
+...+......++. ....++.++++||.+||..||.+||+ +.++++||||+..
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~ 264 (321)
T 1tki_A 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHSC
T ss_pred HHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcC---HHHHhcChhhccC
Confidence 99999988776552 12478999999999999999999999 8899999999753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=415.41 Aligned_cols=270 Identities=29% Similarity=0.480 Sum_probs=238.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk---~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
..+.|++.+.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|+.+|..++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 34679999999999999999999999999999999986543221 135778999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC----cEEEEecCCcccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIG 837 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG----~VKLsDFGLAk~~ 837 (1092)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999999999888899999999999999999999999999999999999999988 8999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 170 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 170 ED----------------------------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp CT----------------------------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred Cc----------------------------cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 10 11123457999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhc
Q 001360 918 SPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~ 985 (1092)
+..+....+......++. .+..++..+.+||.+||..||.+||+ +.++++||||.+++|.....+
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~hp~~~~~~~~~~~~~ 287 (321)
T 2a2a_A 222 TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLT---IQEALRHPWITPVDNQQAMVR 287 (321)
T ss_dssp SHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCC---HHHHHHSTTTSCSSHHHHHHH
T ss_pred CHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcC---HHHHhcCccccCCCccccccc
Confidence 999888888877655442 22568999999999999999999999 889999999999998875543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=409.46 Aligned_cols=260 Identities=30% Similarity=0.518 Sum_probs=216.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
+++|++++.||+|+||+||+|++ .+|+.||+|+++.... .......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 36899999999999999999998 6799999999975432 223346788999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----- 152 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI----- 152 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc-----
Confidence 999986 999998764 6799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
........+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+..
T Consensus 153 ----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 210 (288)
T 1ob3_A 153 ----------------------PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210 (288)
T ss_dssp -------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ----------------------cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 01112345799999999999764 5899999999999999999999999998887776
Q ss_pred HHHhhc--C---CCC---------------------CCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 924 DNILNR--K---IPW---------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 924 ~kIl~~--~---l~f---------------------P~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
..+... . ..+ ......+++++.+||.+||..||.+||+ +.++++||||++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 211 MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT---AKQALEHAYFKEN 287 (288)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGGC-
T ss_pred HHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC---HHHHhcCcchhhc
Confidence 666531 0 001 1122458999999999999999999999 8899999999865
Q ss_pred C
Q 001360 978 N 978 (1092)
Q Consensus 978 d 978 (1092)
+
T Consensus 288 n 288 (288)
T 1ob3_A 288 N 288 (288)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=412.32 Aligned_cols=260 Identities=35% Similarity=0.622 Sum_probs=221.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc-----------------------hhHHHHHHHHHHH
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----------------------KNDIERILAERNI 740 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~k-----------------------k~~ie~~l~EieI 740 (1092)
...++|++.+.||+|+||.||+|+++.+|+.||||++.+..... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 45689999999999999999999999999999999997654322 1224568999999
Q ss_pred HHhcCCCceEEEeeeecc--CCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCce
Q 001360 741 LITVRNPFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (1092)
Q Consensus 741 L~~L~HPNIVkL~~sfqd--e~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNI 818 (1092)
|+.++||||+++++++.+ ...+|+||||+++|+|.+++. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999987 568999999999999988653 45799999999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC---CCccc
Q 001360 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAA 895 (1092)
Q Consensus 819 LLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~---Yt~ks 895 (1092)
|++.+|.+||+|||+++.... ........+||+.|+|||++.+.. ++.++
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 221 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKG---------------------------SDALLSNTVGTPAFMAPESLSETRKIFSGKAL 221 (298)
T ss_dssp EECTTSCEEECCCTTCEECSS---------------------------SSCEECCCCSCGGGCCGGGCCTTCCCEESHHH
T ss_pred EECCCCCEEEecCCCcccccc---------------------------ccccccCCcCCccccChhhhccCCCCCCCchh
Confidence 999999999999999875210 011123467999999999998765 37889
Q ss_pred eeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 896 DVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
|||||||++|||++|..||...+...+...+......+|. ...+++++.+||.+||..||.+||+ +.++++||||+
T Consensus 222 Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~R~s---~~e~l~hp~~~ 297 (298)
T 2zv2_A 222 DVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD-QPDIAEDLKDLITRMLDKNPESRIV---VPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-SSCCCHHHHHHHHHHTCSCTTTSCC---HHHHTTCHHHH
T ss_pred hhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCC-ccccCHHHHHHHHHHhhcChhhCCC---HHHHhcCcccc
Confidence 9999999999999999999999888888888877776664 3578999999999999999999999 88999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=420.23 Aligned_cols=267 Identities=27% Similarity=0.419 Sum_probs=218.0
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
.....++|++++.||+|+||+||+|++..+|+.||||+++... ........+.+|+.+|+.++||||+++++++.+.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc-cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 3456789999999999999999999999999999999997543 233345667899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEec-----CCCcEEEEecCCccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-----HDGHIKLTDFGLSKI 836 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD-----~nG~VKLsDFGLAk~ 836 (1092)
+|+||||+.| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999985 9999999888999999999999999999999999999999999999994 555699999999975
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
... ........+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.
T Consensus 187 ~~~---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 187 FGI---------------------------PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp HC--------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCC---------------------------cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 310 01122345789999999999874 58999999999999999999999999
Q ss_pred CCChHHHHHHHhhcCC-----CCC-------------CC---------CCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 916 AESPEIIFDNILNRKI-----PWP-------------CV---------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 916 ~~s~~ei~~kIl~~~l-----~fP-------------~i---------p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
+.+..+....+..... .++ .. +..+++++.+||.+||+.||.+||+ +.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~ 316 (329)
T 3gbz_A 240 GDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS---AKNA 316 (329)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC---HHHH
T ss_pred CCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC---HHHH
Confidence 9988777777654210 011 00 0127899999999999999999999 8899
Q ss_pred HcCCCCCCCCcc
Q 001360 969 KAHPFFKGVNWD 980 (1092)
Q Consensus 969 L~HPFFkgIdWd 980 (1092)
++||||++++|+
T Consensus 317 l~hp~f~~~~~~ 328 (329)
T 3gbz_A 317 LEHPYFSHNDFD 328 (329)
T ss_dssp HTSGGGSSSCSC
T ss_pred hCCcccCCCCCC
Confidence 999999999996
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=428.68 Aligned_cols=265 Identities=30% Similarity=0.503 Sum_probs=226.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK--NDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk--~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
...+.|++.+.||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+.+|..++|||||+++++|.+.+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 344679999999999999999999999999999999975432211 235778999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc---EEEEecCCc
Q 001360 762 LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLS 834 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~----g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~---VKLsDFGLA 834 (1092)
+|+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999999888654 25899999999999999999999999999999999999987665 999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
+.... ........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||
T Consensus 181 ~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 233 (351)
T 3c0i_A 181 IQLGE---------------------------SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233 (351)
T ss_dssp EECCT---------------------------TSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eEecC---------------------------CCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCC
Confidence 75310 011123568999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCc
Q 001360 915 TAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 915 ~~~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdW 979 (1092)
.+. ...++..+..+...++. ....++.++++||.+||..||.+||+ +.++++||||++.++
T Consensus 234 ~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 234 YGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERIT---VYEALNHPWLKERDR 295 (351)
T ss_dssp CSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHTHHH
T ss_pred CCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcChhhcCCcc
Confidence 875 45677777777655431 12468999999999999999999999 889999999987543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=425.23 Aligned_cols=282 Identities=30% Similarity=0.523 Sum_probs=215.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC--
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD-- 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~-- 760 (1092)
...++|++++.||+|+||.||+|.++.+|+.||||++.+. .........+.+|+.+|..+. |||||+++++|...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 3467899999999999999999999999999999998653 334556778899999999997 999999999997554
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|+|||||. |+|..++.. +.+++..++.++.||+.||.|||+.||+||||||+||||+.+|++||+|||+|+.....
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7999999997 599999876 57999999999999999999999999999999999999999999999999999853211
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
.... .... . ........ ...........+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+.
T Consensus 163 ~~~~--~~~~--~-~~~~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 163 RRVT--NNIP--L-SINENTEN-FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp CCCC--CCGG--G-CCC----------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccc--cccc--c-cccccccc-cccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0000 0000 0 00000000 0011223455789999999999987 6799999999999999999999999999988
Q ss_pred HHHHHHHhhcCCCCCC---------------------------------------------CCCCCCHHHHHHHHHhccC
Q 001360 920 EIIFDNILNRKIPWPC---------------------------------------------VPSDMSFEAQDLINRFLIH 954 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~---------------------------------------------ip~~lS~eakDLI~kcL~k 954 (1092)
...+..|+.. +.+|. .+..+++++.+||.+||+.
T Consensus 237 ~~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 MNQLERIIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 8877777531 11110 0126789999999999999
Q ss_pred CcCCCCCcccHHHHHcCCCCCCCC
Q 001360 955 DPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 955 DP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
||.+||| +.++++||||+.+.
T Consensus 316 dP~~R~t---~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 316 NPNKRIS---ANDALKHPFVSIFH 336 (388)
T ss_dssp SGGGSCC---HHHHTTSTTTTTTC
T ss_pred CcccCCC---HHHHhCCHHHHHhc
Confidence 9999999 88999999998653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=416.24 Aligned_cols=263 Identities=29% Similarity=0.469 Sum_probs=209.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++++.||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|+.++|||||++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 568999999999999999999999999999999997543 222346788999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 766 MEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
|||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99998 5999998764 3589999999999999999999999999999999999999999999999999975210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+
T Consensus 161 ---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 161 ---------------------------PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp ---------------------------CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ---------------------------CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 0111234579999999999986 468999999999999999999999999998
Q ss_pred hHHHHHHHhhcCC-----CC--------------------------CCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 919 PEIIFDNILNRKI-----PW--------------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 919 ~~ei~~kIl~~~l-----~f--------------------------P~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
..+....+..... .+ +..+..++.++.+||.+||+.||.+||+ +.+
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~e 290 (317)
T 2pmi_A 214 DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS---AKQ 290 (317)
T ss_dssp HHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC---HHH
T ss_pred hHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC---HHH
Confidence 8877777654100 00 0012357899999999999999999999 889
Q ss_pred HHcCCCCCCCCcch
Q 001360 968 VKAHPFFKGVNWDS 981 (1092)
Q Consensus 968 IL~HPFFkgIdWd~ 981 (1092)
+++||||++..|..
T Consensus 291 ~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 291 ALHHPWFAEYYHHA 304 (317)
T ss_dssp HTTSGGGGGGCC--
T ss_pred HhCChhhhcccchh
Confidence 99999999876653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=404.90 Aligned_cols=265 Identities=28% Similarity=0.451 Sum_probs=220.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++++.||+|+||+||+|++..+|+.||+|++.+.. ........+.+|+.++.+++||||+++++++.+.+.+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 478999999999999999999999999999999987643 2334467788999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||+++++|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~------ 154 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG------ 154 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC------
Confidence 99999999999998888899999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+...
T Consensus 155 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (311)
T 4agu_A 155 ---------------------PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY 213 (311)
T ss_dssp --------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ---------------------cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0111234579999999999986 678999999999999999999999999988766655
Q ss_pred HHhhc-------------------CCCCCCC---------CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 925 NILNR-------------------KIPWPCV---------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 925 kIl~~-------------------~l~fP~i---------p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
.+... ....|.. ...++.++.+||.+||..||.+||+ +.++++||||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~ 290 (311)
T 4agu_A 214 LIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT---CEQLLHHPYFEN 290 (311)
T ss_dssp HHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC---HHHHHTSGGGTT
T ss_pred HHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC---HHHHhcChHHHh
Confidence 44321 1111110 1368899999999999999999999 889999999999
Q ss_pred CCcch
Q 001360 977 VNWDS 981 (1092)
Q Consensus 977 IdWd~ 981 (1092)
+.|..
T Consensus 291 ~~~~~ 295 (311)
T 4agu_A 291 IREIE 295 (311)
T ss_dssp CC---
T ss_pred ccCHH
Confidence 87764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=418.81 Aligned_cols=262 Identities=27% Similarity=0.486 Sum_probs=221.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..++|++++.||+|+||+||+|+++.+|+.||||++...... ...+.+.+|+.+++.++|||||++++++.+.+..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 467999999999999999999999999999999999754322 234568899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---- 158 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN---- 158 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET----
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC----
Confidence 9999999999999988888999999999999999999999999999999999999999999999999999753211
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChH-HH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE-II 922 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~PF~~~s~~-ei 922 (1092)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.. ..
T Consensus 159 ---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 217 (323)
T 3tki_A 159 ---------------------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (323)
T ss_dssp ---------------------TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH
T ss_pred ---------------------CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 01122345789999999999988776 78999999999999999999999876553 33
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
+..+.......+ ....++.++.+||.+||..||.+||+ +.++++||||+..
T Consensus 218 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t---~~eil~h~~~~~~ 268 (323)
T 3tki_A 218 YSDWKEKKTYLN-PWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHTTCTTST-TGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCC
T ss_pred HHHHhcccccCC-ccccCCHHHHHHHHHHccCChhhCcC---HHHHhhChhhccc
Confidence 333333332222 23568999999999999999999999 8899999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=444.50 Aligned_cols=260 Identities=28% Similarity=0.568 Sum_probs=236.0
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
....++|++.+.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45678999999999999999999999999999999999875544444567899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~---- 167 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---- 167 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc----
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999997521
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
......+.+||+.|+|||++.+..| +.++|||||||++|||++|.+||.+.+...
T Consensus 168 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 223 (476)
T 2y94_A 168 ------------------------DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223 (476)
T ss_dssp ------------------------TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH
T ss_pred ------------------------ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH
Confidence 0112345689999999999998776 789999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
++.++..+....| ..+++++.+||.+||..||.+||+ +.++++||||+.
T Consensus 224 ~~~~i~~~~~~~p---~~~s~~~~~Li~~~L~~dP~~Rpt---~~eil~hp~~~~ 272 (476)
T 2y94_A 224 LFKKICDGIFYTP---QYLNPSVISLLKHMLQVDPMKRAT---IKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHHTTCCCCC---TTCCHHHHHHHHHHTCSSTTTSCC---HHHHHTCHHHHT
T ss_pred HHHHHhcCCcCCC---ccCCHHHHHHHHHHcCCCchhCcC---HHHHHhCHHhhh
Confidence 9999988876655 679999999999999999999999 889999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=403.13 Aligned_cols=260 Identities=31% Similarity=0.592 Sum_probs=204.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
.+++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 45789999999999999999999999999999999986544334446789999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~---- 164 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM---- 164 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC----
Confidence 99999999999999875 5799999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
........+||+.|+|||++.+..++.++|||||||++|||++|.+||...+.....
T Consensus 165 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 221 (278)
T 3cok_A 165 -----------------------PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL 221 (278)
T ss_dssp --------------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---
T ss_pred -----------------------CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH
Confidence 011123467999999999999999999999999999999999999999988777776
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
..+......+| ..++.++.+||.+||..||.+||+ +.++++||||...
T Consensus 222 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~ 269 (278)
T 3cok_A 222 NKVVLADYEMP---SFLSIEAKDLIHQLLRRNPADRLS---LSSVLDHPFMSRN 269 (278)
T ss_dssp --CCSSCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSTTTC--
T ss_pred HHHhhcccCCc---cccCHHHHHHHHHHcccCHhhCCC---HHHHhcCccccCC
Confidence 66665555444 678999999999999999999999 8899999999754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=420.38 Aligned_cols=257 Identities=34% Similarity=0.564 Sum_probs=215.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++++.||+|+||+||+|+++.+|+.||||++.+.... .+.+.+|+.+++.++|||||+++++|.+...+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 4568899999999999999999999999999999999764332 245789999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc--EEEEecCCcccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINN 841 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~--VKLsDFGLAk~~~~n~ 841 (1092)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++...
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~--- 169 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--- 169 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc---
Confidence 99999999999999998889999999999999999999999999999999999999987765 9999999987321
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc-ceeechhhhHHHHHhCCCCCCCCCh-
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA-ADWWSVGIILFEFITGIPPFTAESP- 919 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~k-sDVWSLGVILYEMLTGk~PF~~~s~- 919 (1092)
........+||+.|+|||++.+..|..+ +|||||||++|+|++|++||.+...
T Consensus 170 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 170 -------------------------LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp ------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred -------------------------ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence 0112234679999999999998888655 8999999999999999999987543
Q ss_pred ---HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 920 ---EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 920 ---~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
......+......+|. ...+++++++||.+||..||.+||+ +.++++||||..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~~ 280 (361)
T 3uc3_A 225 RDYRKTIQRILSVKYSIPD-DIRISPECCHLISRIFVADPATRIS---IPEIKTHSWFLK 280 (361)
T ss_dssp CCHHHHHHHHHTTCCCCCT-TSCCCHHHHHHHHHHSCSCTTTSCC---HHHHHTSHHHHT
T ss_pred HHHHHHHHHHhcCCCCCCC-cCCCCHHHHHHHHHHccCChhHCcC---HHHHHhCcchhc
Confidence 4555666666666553 3468999999999999999999999 889999999953
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=401.08 Aligned_cols=261 Identities=29% Similarity=0.494 Sum_probs=236.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45678999999999999999999999999999999998766666667788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~---- 167 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY---- 167 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS----
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc----
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
........+||+.|+|||++.+..++.++||||||+++|+|++|..||......+.+
T Consensus 168 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 224 (294)
T 2rku_A 168 -----------------------DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY 224 (294)
T ss_dssp -----------------------TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred -----------------------CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 011123467999999999999999999999999999999999999999999988888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
..+......+| ..++.++.+||.+||..||.+||+ +.++++||||...
T Consensus 225 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~~~~~~~ 272 (294)
T 2rku_A 225 LRIKKNEYSIP---KHINPVAASLIQKMLQTDPTARPT---INELLNDEFFTSG 272 (294)
T ss_dssp HHHHTTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHHHTS
T ss_pred HHHhhccCCCc---cccCHHHHHHHHHHcccChhhCcC---HHHHhhChheecC
Confidence 88877766555 688999999999999999999999 7799999999754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=440.08 Aligned_cols=266 Identities=30% Similarity=0.522 Sum_probs=236.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...+.|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|.+++|||||+++++|.+...+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34568999999999999999999999999999999998765555556788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe---cCCCcEEEEecCCccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL---D~nG~VKLsDFGLAk~~~~n 840 (1092)
+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 180 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-- 180 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC--
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc--
Confidence 999999999999999988899999999999999999999999999999999999999 567899999999987521
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..
T Consensus 181 --------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 233 (484)
T 3nyv_A 181 --------------------------ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY 233 (484)
T ss_dssp --------------------------CCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------------------------cccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH
Confidence 0112234679999999999987 6999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcch
Q 001360 921 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~ 981 (1092)
++...+..+.+.++. ....+++++++||.+||++||.+||+ +.++++||||+...+..
T Consensus 234 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 234 DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRIS---ARDALDHEWIQTYTKEQ 292 (484)
T ss_dssp HHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSHHHHHHTC--
T ss_pred HHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcC---HHHHhhChhhccccccc
Confidence 999999988766542 12468999999999999999999999 88999999998765543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=399.16 Aligned_cols=269 Identities=30% Similarity=0.489 Sum_probs=232.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc------cchhHHHHHHHHHHHHHhcC-CCceEEEeeee
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM------IRKNDIERILAERNILITVR-NPFVVRFFYSF 756 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei------~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sf 756 (1092)
...++|++.+.||+|+||.||+|+++.+|+.||||+++.... ......+.+.+|+.+|.++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 456899999999999999999999999999999999975431 11233567889999999996 99999999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 757 TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 757 qde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
.....+|+||||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc------CCCCCccceeechhhhHHHHHhC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL------GTEHGYAADWWSVGIILFEFITG 910 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~------g~~Yt~ksDVWSLGVILYEMLTG 910 (1092)
.. ........+||+.|+|||++. ...++.++||||||+++|+|++|
T Consensus 174 ~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g 225 (298)
T 1phk_A 174 LD----------------------------PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225 (298)
T ss_dssp CC----------------------------TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred cC----------------------------CCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHC
Confidence 21 011223467999999999985 45688999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001360 911 IPPFTAESPEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983 (1092)
Q Consensus 911 k~PF~~~s~~ei~~kIl~~~l~fP~i-p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~ 983 (1092)
..||...+.......+..+...++.. ...++.++.+||.+||..||.+||+ +.++++||||++..|+.+.
T Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 226 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCTTC-----
T ss_pred CCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCC---HHHHHhChHhhhccchhhc
Confidence 99999999988888888877665431 2468999999999999999999999 8899999999998887654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=398.64 Aligned_cols=260 Identities=29% Similarity=0.554 Sum_probs=225.3
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
.+..++|++.+.||+|+||.||+|+++.+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 45678999999999999999999999999999999999865443344567889999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~--- 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--- 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC---
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
.......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+...
T Consensus 164 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 218 (276)
T 2h6d_A 164 -------------------------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218 (276)
T ss_dssp --------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence 111234579999999999988766 689999999999999999999999999888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
++..+......+| ..++.++.+||.+||..||.+||+ +.++++||||+.
T Consensus 219 ~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps---~~~~l~h~~~~~ 267 (276)
T 2h6d_A 219 LFKKIRGGVFYIP---EYLNRSVATLLMHMLQVDPLKRAT---IKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHSHHHHT
T ss_pred HHHHhhcCcccCc---hhcCHHHHHHHHHHccCChhhCCC---HHHHHhChhhcc
Confidence 8888877765554 678999999999999999999999 889999999964
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=408.50 Aligned_cols=271 Identities=30% Similarity=0.528 Sum_probs=219.5
Q ss_pred cCCCeEEE-EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 001360 685 SIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 685 ~~~dFeil-r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~L 762 (1092)
..+.|++. +.||+|+||+||+|+++.+|+.||||++++.. ......+.+|+.+|.++ +||||+++++++.+.+.+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 34678886 78999999999999999999999999997643 23456789999999885 799999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc---EEEEecCCcccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLI 839 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~---VKLsDFGLAk~~~~ 839 (1092)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999999998889999999999999999999999999999999999999998776 99999999874321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHHHhCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
.... ...........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||
T Consensus 167 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 226 (316)
T 2ac3_A 167 NGDC--------------------SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226 (316)
T ss_dssp -----------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcc--------------------ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCC
Confidence 1000 0000112235679999999999975 45889999999999999999999999
Q ss_pred CCCC---------------hHHHHHHHhhcCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 915 TAES---------------PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 915 ~~~s---------------~~ei~~kIl~~~l~fP~i-p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
.+.. ...++..+..+...+|.. ...++.++++||.+||..||.+||+ +.++++||||++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 227 VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS---AAQVLQHPWVQGCA 303 (316)
T ss_dssp CCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSTTCC---
T ss_pred cccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCC---HHHHhcChhhcCCC
Confidence 8764 245667777776665521 1368999999999999999999999 88999999999877
Q ss_pred cch
Q 001360 979 WDS 981 (1092)
Q Consensus 979 Wd~ 981 (1092)
|..
T Consensus 304 ~~~ 306 (316)
T 2ac3_A 304 PEN 306 (316)
T ss_dssp ---
T ss_pred Ccc
Confidence 654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=418.01 Aligned_cols=260 Identities=35% Similarity=0.581 Sum_probs=215.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...+.|++.+.||+|+||.||+|+++.+++.||||++++.. ..+.+.+|+.+|.+++||||++++++|.+...+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 44577999999999999999999999999999999997532 3456789999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC---CCcEEEEecCCccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFGLAk~~~~n 840 (1092)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~-- 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-- 202 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC--
Confidence 99999999999999998888999999999999999999999999999999999999976 8999999999987421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||......
T Consensus 203 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 256 (349)
T 2w4o_A 203 --------------------------HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256 (349)
T ss_dssp ------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred --------------------------cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 011123467999999999999999999999999999999999999999876654
Q ss_pred -HHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCc
Q 001360 921 -IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 921 -ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdW 979 (1092)
.++..+......++. ....++.++++||.+||..||.+||+ +.++++||||.+..+
T Consensus 257 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 257 QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT---TFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTTSTTC
T ss_pred HHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCcc
Confidence 477777776654432 23578999999999999999999999 889999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=425.25 Aligned_cols=262 Identities=25% Similarity=0.472 Sum_probs=231.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...+.|++++.||+|+||+||+|.++.+|+.||+|++.+.. ......+.+|+.+|..++|||||+++++|.+...+|
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999997543 234567889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC--CCcEEEEecCCccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~--nG~VKLsDFGLAk~~~~n 840 (1092)
+||||+.||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~- 203 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 203 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC-
Confidence 9999999999999997654 6999999999999999999999999999999999999974 57899999999975210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus 204 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 256 (387)
T 1kob_A 204 ---------------------------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256 (387)
T ss_dssp ---------------------------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred ---------------------------CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH
Confidence 11123457999999999999999999999999999999999999999999998
Q ss_pred HHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCc
Q 001360 921 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdW 979 (1092)
+....+......++. ....+++++++||.+||..||.+||+ +.++++||||++..+
T Consensus 257 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 257 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSCCT
T ss_pred HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC---HHHHhhCccccCCcc
Confidence 888888877665442 23578999999999999999999999 889999999987644
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=401.22 Aligned_cols=259 Identities=32% Similarity=0.533 Sum_probs=223.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...+.|++.+.||+|+||+||+|+++.+|..||+|++.+... ....+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 445789999999999999999999999999999999986432 234577899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe---cCCCcEEEEecCCccc
Q 001360 764 LVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~----g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL---D~nG~VKLsDFGLAk~ 836 (1092)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999999998643 679999999999999999999999999999999999999 4568899999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
... .......+||+.|+|||++. ..++.++|||||||++|||++|..||.+
T Consensus 177 ~~~----------------------------~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 177 FKS----------------------------DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp --------------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCC----------------------------cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 210 11123467999999999986 5689999999999999999999999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
.+..+....+......++.....+++++.+||.+||..||.+||+ +.++++||||+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~f~~ 284 (285)
T 3is5_A 228 TSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPS---AAQVLHHEWFKQ 284 (285)
T ss_dssp SSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCC---HHHHHTSGGGGC
T ss_pred CCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcC---HHHHhcCHHhhc
Confidence 998888888777665555444568999999999999999999999 889999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=403.82 Aligned_cols=262 Identities=29% Similarity=0.440 Sum_probs=215.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhc---CCCceEEEeeeecc
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR--KNDIERILAERNILITV---RNPFVVRFFYSFTC 758 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~k--k~~ie~~l~EieIL~~L---~HPNIVkL~~sfqd 758 (1092)
...++|++++.||+|+||+||+|+++.+|+.||||+++...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 44679999999999999999999999999999999997533211 11123556677777665 49999999999987
Q ss_pred CC-----eeEEEEeecCCCcHHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEec
Q 001360 759 RD-----NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831 (1092)
Q Consensus 759 e~-----~LYLVMEYm~GGSL~dlLkk~g~--LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDF 831 (1092)
.. .+|+||||+. |+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 5899999997 599999987654 999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCC
Q 001360 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911 (1092)
Q Consensus 832 GLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk 911 (1092)
|+++... ........+||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 165 g~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 216 (308)
T 3g33_A 165 GLARIYS----------------------------YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216 (308)
T ss_dssp SCTTTST----------------------------TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSS
T ss_pred ccccccC----------------------------CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCC
Confidence 9987421 011224568999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhhcCC-----CCCC-------------------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 912 PPFTAESPEIIFDNILNRKI-----PWPC-------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 912 ~PF~~~s~~ei~~kIl~~~l-----~fP~-------------------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
+||.+.+..+....+..... .|+. ....+++++.+||.+||+.||.+||+ +.+
T Consensus 217 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e 293 (308)
T 3g33_A 217 PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS---AFR 293 (308)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC---HHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC---HHH
Confidence 99999998888877764211 1110 11357899999999999999999999 889
Q ss_pred HHcCCCCCCC
Q 001360 968 VKAHPFFKGV 977 (1092)
Q Consensus 968 IL~HPFFkgI 977 (1092)
+++||||+..
T Consensus 294 ~l~h~~~~~~ 303 (308)
T 3g33_A 294 ALQHSYLHKD 303 (308)
T ss_dssp HHTSTTC---
T ss_pred HhcCccccCC
Confidence 9999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=414.88 Aligned_cols=270 Identities=29% Similarity=0.465 Sum_probs=226.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~--kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
..++|++.+.||+|+||+||+|+++.++..||+|++.+.... .....+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 356899999999999999999999999999999999864322 344567899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHh----------------------------------------hcCCCHHHHHHHHHHHHHHHHH
Q 001360 763 YLVMEYLNGGDLYSLLRK----------------------------------------VGCLEEDVARIYIAELVLALEY 802 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk----------------------------------------~g~LsE~~ar~yaaQIL~ALeY 802 (1092)
|+||||++||+|.+++.. ...+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 999999999999999852 1124677888999999999999
Q ss_pred HHHcCCeeeecCCCceEecCCC--cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCC
Q 001360 803 LHSLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880 (1092)
Q Consensus 803 LHs~GIIHRDLKPeNILLD~nG--~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~Y 880 (1092)
||++||+||||||+||||+.++ .+||+|||+++....... .........+||+.|
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y 240 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN-----------------------GEYYGMTTKAGTPYF 240 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC-----------------------C--------CCCGGG
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCc-----------------------cccccccccCCCccc
Confidence 9999999999999999998777 899999999975321000 011123456799999
Q ss_pred CChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcC
Q 001360 881 LAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPN 957 (1092)
Q Consensus 881 mAPEVL~g--~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~ 957 (1092)
+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+....+......++. ....+++++.+||.+||..||.
T Consensus 241 ~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp CCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred cCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence 99999975 67899999999999999999999999999999999888887765542 1124799999999999999999
Q ss_pred CCCCcccHHHHHcCCCCCCCCcc
Q 001360 958 QRLGANGAAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 958 KRpSa~ga~EIL~HPFFkgIdWd 980 (1092)
+||+ +.++++||||+++.|.
T Consensus 321 ~Rps---~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 321 ERFD---AMRALQHPWISQFSDK 340 (345)
T ss_dssp TSCC---HHHHHHSHHHHTTSSC
T ss_pred HCCC---HHHHhcChhhccChHh
Confidence 9999 8899999999987654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=409.68 Aligned_cols=261 Identities=29% Similarity=0.494 Sum_probs=236.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 45678999999999999999999999999999999998766666667788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~---- 193 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY---- 193 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS----
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc----
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999875210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||......+.+
T Consensus 194 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 250 (335)
T 2owb_A 194 -----------------------DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY 250 (335)
T ss_dssp -----------------------TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred -----------------------CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH
Confidence 011223467999999999999999999999999999999999999999999988888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
..+......+| ..++.++.+||.+||..||.+||+ +.++++||||...
T Consensus 251 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps---~~ell~~~~~~~~ 298 (335)
T 2owb_A 251 LRIKKNEYSIP---KHINPVAASLIQKMLQTDPTARPT---INELLNDEFFTSG 298 (335)
T ss_dssp HHHHHTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHHHTS
T ss_pred HHHhcCCCCCC---ccCCHHHHHHHHHHccCChhHCcC---HHHHhcCccccCC
Confidence 88887776655 688999999999999999999999 7799999999754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=393.48 Aligned_cols=256 Identities=30% Similarity=0.545 Sum_probs=228.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.+.|++.+.||+|+||.||+|+++.++..||+|++.+... ...+.+.+|+.+|..++||||+++++++.+...+|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 4579999999999999999999999999999999976432 2356789999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe---cCCCcEEEEecCCccccccccc
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL---D~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~---- 160 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK---- 160 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc----
Confidence 9999999999999988899999999999999999999999999999999999999 788999999999987421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
........+||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+.
T Consensus 161 ------------------------~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 215 (277)
T 3f3z_A 161 ------------------------PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV 215 (277)
T ss_dssp ------------------------TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ------------------------CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 01122346799999999998764 89999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 923 FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 923 ~~kIl~~~l~fP~i-p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
...+..+...+|.. ...+++++.+||.+||..||.+||+ +.++++||||+.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~~~l~h~~~~~ 267 (277)
T 3f3z_A 216 MLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRIT---SLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHTTSHHHHH
T ss_pred HHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhc
Confidence 99988887665521 1268999999999999999999999 889999999964
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=418.19 Aligned_cols=260 Identities=31% Similarity=0.487 Sum_probs=217.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~---- 760 (1092)
..+.|++++.||+|+||.||+|.++.+|+.||||++.+. .........+.+|+.+|+.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 357899999999999999999999999999999998653 234455678999999999999999999999998764
Q ss_pred --eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 --~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 469999999 8899999876 679999999999999999999999999999999999999999999999999997421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.
T Consensus 180 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 180 ------------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp ------------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 01234689999999999987 68999999999999999999999999998
Q ss_pred ChHHHHHHHhhcC----------------------------CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 918 SPEIIFDNILNRK----------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 918 s~~ei~~kIl~~~----------------------------l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+..+.+..|.... ..+..+....++++.+||.+||+.||.+||+ +.+++
T Consensus 230 ~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t---~~e~l 306 (367)
T 1cm8_A 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---AGEAL 306 (367)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC---HHHHH
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC---HHHHh
Confidence 8877766665311 1122234567999999999999999999999 88999
Q ss_pred cCCCCCCCCcc
Q 001360 970 AHPFFKGVNWD 980 (1092)
Q Consensus 970 ~HPFFkgIdWd 980 (1092)
+||||+.+.+.
T Consensus 307 ~hp~f~~~~~~ 317 (367)
T 1cm8_A 307 AHPYFESLHDT 317 (367)
T ss_dssp HSGGGTTTC--
T ss_pred cChHHHhhcCC
Confidence 99999987554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=436.03 Aligned_cols=263 Identities=31% Similarity=0.540 Sum_probs=231.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++++.||+|+||+||+|+++.+|+.||||++.+.... ......+.+|+.+|++++|||||++++++.+...+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 4567899999999999999999999999999999999764332 234677899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEec---CCCcEEEEecCCccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD---~nG~VKLsDFGLAk~~~~n 840 (1092)
+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 176 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC-
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC-
Confidence 9999999999999999889999999999999999999999999999999999999995 456899999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
.......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..
T Consensus 177 ---------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 228 (486)
T 3mwu_A 177 ---------------------------NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (486)
T ss_dssp ---------------------------C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ---------------------------CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 112234679999999999986 5999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCc
Q 001360 921 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdW 979 (1092)
++...+..+.+.++. ....+|+++++||.+||+.||.+||+ +.++++||||+....
T Consensus 229 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT---ATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHHHCHHHHHTCC
T ss_pred HHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCHhhccCcc
Confidence 999999888766542 12468999999999999999999999 889999999986543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=408.02 Aligned_cols=258 Identities=28% Similarity=0.452 Sum_probs=220.8
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----CCceEEEee
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----NPFVVRFFY 754 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-----HPNIVkL~~ 754 (1092)
.......++|++++.||+|+||+||+|++..+|+.||||++++. ......+..|+.+|..+. |||||++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 33445678999999999999999999999999999999999742 234566788999999986 999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC----------
Q 001360 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---------- 822 (1092)
Q Consensus 755 sfqde~~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~---------- 822 (1092)
+|...+.+|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++|||||||||+||||+.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 999999999999999 899999998654 5999999999999999999999999999999999999975
Q ss_pred ---------------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc
Q 001360 823 ---------------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 887 (1092)
Q Consensus 823 ---------------nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~ 887 (1092)
++.+||+|||+++... ......+||+.|+|||++.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~------------------------------~~~~~~~gt~~y~aPE~~~ 232 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKS------------------------------DYHGSIINTRQYRAPEVIL 232 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETT------------------------------SCCCSCCSCGGGCCHHHHT
T ss_pred hcccccccccccccCCCCEEEEeccCceecC------------------------------CCCcCccCcccccCcHHHc
Confidence 7899999999997421 1123467999999999999
Q ss_pred CCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCC--------------------------CC-----
Q 001360 888 GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP--------------------------CV----- 936 (1092)
Q Consensus 888 g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP--------------------------~i----- 936 (1092)
+..|+.++|||||||++|||++|++||...+..+....+.....++| ..
T Consensus 233 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 312 (360)
T 3llt_A 233 NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSIN 312 (360)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHH
T ss_pred CCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchh
Confidence 99999999999999999999999999999887777666654322222 10
Q ss_pred ------------CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 937 ------------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 937 ------------p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
+...++.+.+||.+||+.||.+||+ +.++++||||+
T Consensus 313 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---a~elL~hp~f~ 360 (360)
T 3llt_A 313 SIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS---PAELLKHKFLE 360 (360)
T ss_dssp HHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGC
T ss_pred hhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC---HHHHhcCcccC
Confidence 0112377889999999999999999 88999999995
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=435.32 Aligned_cols=258 Identities=27% Similarity=0.455 Sum_probs=214.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~--- 760 (1092)
...++|++++.||+|+||+||+|+++.+|+.||||++.+. .........+.+|+.+|+.++|||||+++++|....
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 3468899999999999999999999999999999999764 334556778999999999999999999999997653
Q ss_pred ---eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 761 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 761 ---~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
.+||||||+.+ +|.+.+.. .+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+++..
T Consensus 138 ~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 138 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred cCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 57999999976 57666643 4999999999999999999999999999999999999999999999999999742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
. ........+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.
T Consensus 215 ~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 215 G----------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp ------------------------------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C----------------------------CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 011234578999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCC----------------------CCCC------CCCC-----------CCHHHHHHHHHhccCCcCC
Q 001360 918 SPEIIFDNILNRKI----------------------PWPC------VPSD-----------MSFEAQDLINRFLIHDPNQ 958 (1092)
Q Consensus 918 s~~ei~~kIl~~~l----------------------~fP~------ip~~-----------lS~eakDLI~kcL~kDP~K 958 (1092)
+..+.+.+|+.... .+.. ++.. .++++++||.+||..||.+
T Consensus 267 ~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 346 (464)
T 3ttj_A 267 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346 (464)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhh
Confidence 88777777654210 0000 0000 1578999999999999999
Q ss_pred CCCcccHHHHHcCCCCCC
Q 001360 959 RLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 959 RpSa~ga~EIL~HPFFkg 976 (1092)
||+ +.++++||||+.
T Consensus 347 R~t---a~e~L~Hp~~~~ 361 (464)
T 3ttj_A 347 RIS---VDDALQHPYINV 361 (464)
T ss_dssp SCC---HHHHHTSTTTGG
T ss_pred CCC---HHHHhcChhhhh
Confidence 999 889999999984
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=407.37 Aligned_cols=257 Identities=30% Similarity=0.534 Sum_probs=225.8
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
.|+..+.||+|+||.||+|+.+.+|+.||||+++... ....+.+.+|+.+|..++||||+++++++...+.+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4788889999999999999999999999999997543 2345678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
|++||+|.+++.+ ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~-------- 193 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-------- 193 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--------
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc--------
Confidence 9999999999865 5699999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl 927 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||...+.......+.
T Consensus 194 -------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~ 254 (321)
T 2c30_A 194 -------------------DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 254 (321)
T ss_dssp -------------------SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred -------------------CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 0111235689999999999999999999999999999999999999999999888888877
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 928 ~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
....+....+..+++++.+||.+||..||.+||+ +.++++||||....
T Consensus 255 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~ 302 (321)
T 2c30_A 255 DSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT---AQELLDHPFLLQTG 302 (321)
T ss_dssp HSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGGGCC
T ss_pred cCCCCCcCccccCCHHHHHHHHHHccCChhhCcC---HHHHhcChhhccCC
Confidence 6544322233568999999999999999999999 88999999997643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=404.62 Aligned_cols=268 Identities=26% Similarity=0.441 Sum_probs=212.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~----- 760 (1092)
.++|++++.||+|+||.||+|+++.+|+.||||+++... .....+.+.+|+.+|++++|||||+++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 467999999999999999999999999999999997543 3345678999999999999999999999886543
Q ss_pred ----------------------------------------------------eeEEEEeecCCCcHHHHHHhhcC---CC
Q 001360 761 ----------------------------------------------------NLYLVMEYLNGGDLYSLLRKVGC---LE 785 (1092)
Q Consensus 761 ----------------------------------------------------~LYLVMEYm~GGSL~dlLkk~g~---Ls 785 (1092)
.+|+||||++||+|.+++..... .+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 38999999999999999987543 55
Q ss_pred HHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccc
Q 001360 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865 (1092)
Q Consensus 786 E~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~ 865 (1092)
+..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++......... .. .. ..
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~-------~~------~~--~~ 227 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ-------TV------LT--PM 227 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------------------------
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhc-------cc------cc--cc
Confidence 66789999999999999999999999999999999999999999999998532110000 00 00 00
Q ss_pred cCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHH
Q 001360 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQ 945 (1092)
Q Consensus 866 ~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eak 945 (1092)
.........+||+.|+|||++.+..|+.++|||||||++|||++|..|+.. .......+... .+|......++++.
T Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL--KFPLLFTQKYPQEH 303 (332)
T ss_dssp ----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT--CCCHHHHHHCHHHH
T ss_pred cccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc--CCCcccccCChhHH
Confidence 001223456899999999999999999999999999999999999877532 22233333333 33332345678899
Q ss_pred HHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 946 DLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 946 DLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
+||.+||..||.+||+ +.++++||||+++
T Consensus 304 ~li~~~l~~~p~~Rps---~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPE---ATDIIENAIFENL 332 (332)
T ss_dssp HHHHHHHCSSGGGSCC---HHHHHHSTTCCCC
T ss_pred HHHHHHccCCCCcCCC---HHHHhhchhhhcC
Confidence 9999999999999999 8899999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=398.96 Aligned_cols=264 Identities=31% Similarity=0.539 Sum_probs=230.2
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk---~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
++|++.+.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|+.+|.+++||||+++++++.+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999986543221 13577899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC----cEEEEecCCcccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGLI 839 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG----~VKLsDFGLAk~~~~ 839 (1092)
+||||+++++|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999999888999999999999999999999999999999999999999877 899999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.
T Consensus 165 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 165 ----------------------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp -----------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ----------------------------CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 0112345799999999999999999999999999999999999999999998
Q ss_pred HHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcch
Q 001360 920 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~ 981 (1092)
.+....+......++. .+..++..+.+||.+||..||.+||+ +.++++||||+.+.+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 217 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMT---IAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCC---HHHHHHCHHHHHHHHCC
T ss_pred HHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcC---HHHHHhCHHHHHHHHHh
Confidence 8888888776554431 22568899999999999999999999 88999999998765543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=421.44 Aligned_cols=291 Identities=28% Similarity=0.434 Sum_probs=219.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 759 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde---- 759 (1092)
...++|++++.||+|+||+||+|+++.+|+.||||++++. ........++.+|+.+|+.++|||||++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 3467899999999999999999999999999999999753 33445677899999999999999999999999876
Q ss_pred -CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 -~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
..+|+||||+. |+|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.+|.+||+|||+|+...
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 57999999986 5999999988889999999999999999999999999999999999999999999999999998642
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh-cCCCCCccceeechhhhHHHHHh--------
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-LGTEHGYAADWWSVGIILFEFIT-------- 909 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL-~g~~Yt~ksDVWSLGVILYEMLT-------- 909 (1092)
.............. .................+||+.|+|||++ .+..|+.++|||||||+||||++
T Consensus 181 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 181 SEKDTNIVNDLEEN-----EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp -----------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccc-----ccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 11100000000000 00000000111234678999999999987 45679999999999999999998
Q ss_pred ---CCCCCCCCCh-----------------HHHHHHHhh------------------------cCCCCC----CCCCCCC
Q 001360 910 ---GIPPFTAESP-----------------EIIFDNILN------------------------RKIPWP----CVPSDMS 941 (1092)
Q Consensus 910 ---Gk~PF~~~s~-----------------~ei~~kIl~------------------------~~l~fP----~ip~~lS 941 (1092)
|+++|.+.+. ......|.. .....+ .....++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 4555554331 111111111 011100 0114689
Q ss_pred HHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhh
Q 001360 942 FEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 984 (1092)
Q Consensus 942 ~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~ 984 (1092)
+++.+||.+||+.||.+||+ +.++++||||+++.|.....
T Consensus 336 ~~~~dLl~~mL~~dP~~R~t---a~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRIT---IDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCC---HHHHHTCGGGTTTCCTTTC-
T ss_pred HHHHHHHHHHhcCCcccCCC---HHHHhcChhhhhccCcccCc
Confidence 99999999999999999999 88999999999999987654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=433.08 Aligned_cols=262 Identities=29% Similarity=0.491 Sum_probs=228.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch----------hHHHHHHHHHHHHHhcCCCceEEEe
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK----------NDIERILAERNILITVRNPFVVRFF 753 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk----------~~ie~~l~EieIL~~L~HPNIVkL~ 753 (1092)
...++|++++.||+|+||+||+|+++.+++.||+|++++...... ...+.+.+|+.+|+.++|||||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 456789999999999999999999999999999999987543221 3456789999999999999999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC---cEEEEe
Q 001360 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTD 830 (1092)
Q Consensus 754 ~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLsD 830 (1092)
++|.+...+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999999999889999999999999999999999999999999999999999876 699999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC
Q 001360 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910 (1092)
Q Consensus 831 FGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTG 910 (1092)
||+++... ........+||+.|+|||++.+ .|+.++|||||||++|+|++|
T Consensus 193 fg~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g 243 (504)
T 3q5i_A 193 FGLSSFFS----------------------------KDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243 (504)
T ss_dssp CTTCEECC----------------------------TTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCEEcC----------------------------CCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhC
Confidence 99997521 0112235679999999999874 699999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 911 IPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 911 k~PF~~~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.+||.+.+..++...+..+.+.++. ....+|+++++||.+||+.||.+||+ +.++++||||+..
T Consensus 244 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 244 YPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT---AEEALNSRWIKKY 308 (504)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCC---HHHHhcCHhhhhc
Confidence 9999999999999999988766542 12578999999999999999999999 8899999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=401.65 Aligned_cols=257 Identities=35% Similarity=0.608 Sum_probs=228.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++.+.||+|+||+||+|+++.+|+.||+|+++.... .....+.+|+.+|..++||||+++++++.+...+|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 4679999999999999999999999999999999986432 2335688999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe---cCCCcEEEEecCCccccccccc
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL---D~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~---- 160 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---- 160 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC----
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC----
Confidence 9999999999999988899999999999999999999999999999999999999 788999999999987411
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+...+
T Consensus 161 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 215 (304)
T 2jam_A 161 -------------------------NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL 215 (304)
T ss_dssp -------------------------CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred -------------------------CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 0112345799999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 923 FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 923 ~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
...+..+...++. .+..+++++.+||.+||..||.+||+ +.++++||||++.
T Consensus 216 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~ 268 (304)
T 2jam_A 216 FEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYT---CEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCC---HHHHHTSHHHHSS
T ss_pred HHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCccccCC
Confidence 9888887665542 34678999999999999999999999 8899999999763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=408.85 Aligned_cols=267 Identities=30% Similarity=0.467 Sum_probs=230.9
Q ss_pred cCCCeEEE-EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCee
Q 001360 685 SIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 685 ~~~dFeil-r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~L 762 (1092)
..+.|.+. +.||+|+||+||+|+++.+|+.||+|++++... .......+.+|+.++..+. ||||++++++|.+...+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 34567777 899999999999999999999999999986443 2334577899999999995 69999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC---CCcEEEEecCCcccc
Q 001360 763 YLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIG 837 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFGLAk~~ 837 (1092)
|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. +|.+||+|||+++..
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999999998643 67999999999999999999999999999999999999998 789999999999752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
. ........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.
T Consensus 185 ~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 185 G----------------------------HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp -------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C----------------------------CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 011123467999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001360 918 SPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~ 983 (1092)
+..+.+..+......++. ....++..+.+||.+||..||.+||+ +.++++||||++++|+.+.
T Consensus 237 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 237 DNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPT---AEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp SHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTCGGGCCCCTTCC-
T ss_pred CchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcC---HHHHhCCHhhccccccccc
Confidence 998888888776555442 23578999999999999999999999 8899999999999998764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=394.64 Aligned_cols=257 Identities=23% Similarity=0.416 Sum_probs=219.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCe
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDN 761 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd----e~~ 761 (1092)
...|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+|+.++||||++++++|.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3458999999999999999999999999999999976443 44567889999999999999999999998865 456
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcC--CeeeecCCCceEec-CCCcEEEEecCCccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~G--IIHRDLKPeNILLD-~nG~VKLsDFGLAk~~~ 838 (1092)
+|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 8999999999999999998889999999999999999999999999 99999999999998 78999999999986421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
.......+||+.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 184 -----------------------------~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 184 -----------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp -----------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred -----------------------------ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 111234579999999998875 59999999999999999999999998854
Q ss_pred h-HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 919 P-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 919 ~-~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
. ...+..+..+. ..+..+...++++.+||.+||..||.+||+ +.++++||||++.
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~h~~f~~~ 289 (290)
T 1t4h_A 234 NAAQIYRRVTSGV-KPASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQEE 289 (290)
T ss_dssp SHHHHHHHHTTTC-CCGGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC--
T ss_pred cHHHHHHHHhccC-CccccCCCCCHHHHHHHHHHccCChhhCCC---HHHHhhCcccccC
Confidence 4 45555544433 223345677899999999999999999999 8899999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=431.46 Aligned_cols=260 Identities=32% Similarity=0.562 Sum_probs=225.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.+.|++++.||+|+||+||+|+++.++..||+|++++.... ......+.+|+.+|+.++|||||+++++|.+...+|+|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45799999999999999999999999999999999875432 22356789999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC---CcEEEEecCCccccccccc
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n---G~VKLsDFGLAk~~~~n~s 842 (1092)
|||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+++...
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~---- 190 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE---- 190 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB----
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC----
Confidence 9999999999999988999999999999999999999999999999999999999764 559999999997531
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
........+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..++
T Consensus 191 ------------------------~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 245 (494)
T 3lij_A 191 ------------------------NQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI 245 (494)
T ss_dssp ------------------------TTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ------------------------CCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 011224568999999999986 4699999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 923 FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 923 ~~kIl~~~l~fP~i-p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
...+..+.+.++.. ...+++++++||.+||+.||.+||+ +.++++||||+...
T Consensus 246 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 246 LRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS---AQQALEHPWIKEMC 299 (494)
T ss_dssp HHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTCHHHHHHH
T ss_pred HHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCcc---HHHHhcCcccccCc
Confidence 99999887765531 2468999999999999999999999 88999999997643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=389.14 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=214.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LYL 764 (1092)
.++|++++.||+|+||+||+|+++.+|+.||+|++++... .......+.+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4689999999999999999999999999999999986432 234567788999999999 89999999999999999999
Q ss_pred EEeecCCCcHHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC----------------
Q 001360 765 VMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---------------- 824 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~----g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG---------------- 824 (1092)
||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999999999765 6699999999999999999999999999999999999998544
Q ss_pred ---cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeech
Q 001360 825 ---HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSV 900 (1092)
Q Consensus 825 ---~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSL 900 (1092)
.+||+|||++.... ......||+.|+|||++.+. .++.++|||||
T Consensus 169 ~~~~~kl~Dfg~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRIS-------------------------------SPQVEEGDSRFLANEVLQENYTHLPKADIFAL 217 (289)
T ss_dssp -CCCEEECCCTTCEETT-------------------------------CSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred CceEEEEcccccccccC-------------------------------CccccCCCccccChhHhcCCCCCCchhhHHHH
Confidence 79999999987421 01234599999999999876 56789999999
Q ss_pred hhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 901 GIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 901 GVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
||++|+|++|.+||.... ....+..+.. +.++..+++++.+||.+||..||.+||+ +.++++||||.+.
T Consensus 218 G~il~~l~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 218 ALTVVCAAGAEPLPRNGD---QWHEIRQGRL--PRIPQVLSQEFTELLKVMIHPDPERRPS---AMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHHHTTCCCCCSSSH---HHHHHHTTCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTCTTC---
T ss_pred HHHHHHHhcCCCCCcchh---HHHHHHcCCC--CCCCcccCHHHHHHHHHHhCCCcccCCC---HHHHhhChHhhhh
Confidence 999999999998876543 3344444433 4456789999999999999999999999 8899999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=412.54 Aligned_cols=264 Identities=30% Similarity=0.499 Sum_probs=226.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+..++|++++.||+|+||+||+|++..+|..||+|+++... .......+.+|+.+|..++||||+++++++.+.+.+|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 45678999999999999999999999999999999997642 3455678999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc-CCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
+||||++||+|.+++.+.+.+++..+..++.|++.||.|||+. ||+||||||+||||+.+|++||+|||+++...
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~---- 183 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 183 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc----
Confidence 9999999999999999988999999999999999999999996 99999999999999999999999999987421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..++
T Consensus 184 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 238 (360)
T 3eqc_A 184 -------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238 (360)
T ss_dssp -------------------------HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH
T ss_pred -------------------------cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0112346799999999999999999999999999999999999999987765443
Q ss_pred HH------------------------------------------HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCC
Q 001360 923 FD------------------------------------------NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960 (1092)
Q Consensus 923 ~~------------------------------------------kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRp 960 (1092)
.. .+.....+ ...+..++.++.+||.+||..||.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rp 317 (360)
T 3eqc_A 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERA 317 (360)
T ss_dssp HHHHC------------------------------CCCHHHHHHHHHHSCCC-CCCTTTSCHHHHHHHHHHHCSSTTTSC
T ss_pred HHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCC-CCCcccccHHHHHHHHHHhhcChhhCC
Confidence 22 22222211 111245799999999999999999999
Q ss_pred CcccHHHHHcCCCCCCCCcchh
Q 001360 961 GANGAAEVKAHPFFKGVNWDSL 982 (1092)
Q Consensus 961 Sa~ga~EIL~HPFFkgIdWd~L 982 (1092)
+ +.++++||||++.+|+.+
T Consensus 318 t---~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 318 D---LKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp C---HHHHHTSHHHHHHHHSCC
T ss_pred C---HHHHhhChHhhcchHhhh
Confidence 9 889999999988776654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=412.43 Aligned_cols=261 Identities=28% Similarity=0.515 Sum_probs=214.8
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
+++|++++.||+|+||+||+|+++.+|+.||+|+++.... ......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 4689999999999999999999999999999999875321 11122456799999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||+. |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~----- 152 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI----- 152 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC-----
Confidence 99997 59999887654 599999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+..
T Consensus 153 ----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 210 (324)
T 3mtl_A 153 ----------------------PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL 210 (324)
T ss_dssp --------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ----------------------CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0112234578999999999987 57899999999999999999999999999888777
Q ss_pred HHHhhcC-----CCCCC----------------------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 924 DNILNRK-----IPWPC----------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 924 ~kIl~~~-----l~fP~----------------------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
..+.... ..+|. ....+++++.+||.+||+.||.+||+ +.++++||||.+
T Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~ 287 (324)
T 3mtl_A 211 HFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS---AEDAMKHPFFLS 287 (324)
T ss_dssp HHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSGGGGG
T ss_pred HHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC---HHHHhcChhhhh
Confidence 7665421 01111 11357899999999999999999999 889999999987
Q ss_pred CCc
Q 001360 977 VNW 979 (1092)
Q Consensus 977 IdW 979 (1092)
+..
T Consensus 288 ~~~ 290 (324)
T 3mtl_A 288 LGE 290 (324)
T ss_dssp GCS
T ss_pred ccc
Confidence 654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=397.71 Aligned_cols=265 Identities=32% Similarity=0.566 Sum_probs=227.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..+.|++++.||+|+||.||+|+++.+|+.||+|++.... ......+.+|+.+|..++||||+++++++...+.+|+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 4568999999999999999999999999999999987532 3346788999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 169 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK---- 169 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH----
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc----
Confidence 9999999999999876 45699999999999999999999999999999999999999999999999998763210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
........+||+.|+|||++. +..++.++|||||||++|+|++|.+||...+
T Consensus 170 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 170 -----------------------TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp -----------------------HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -----------------------cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 011123457999999999984 6778999999999999999999999999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchh
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L 982 (1092)
.......+.....+....+..++.++.+||.+||..||.+||+ +.++++||||+++.|...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~ 287 (302)
T 2j7t_A 227 PMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPS---AAQLLEHPFVSSITSNKA 287 (302)
T ss_dssp HHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCC---HHHHTTSTTTTTCCCCHH
T ss_pred HHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCC---HHHHhcChHHhhhccchh
Confidence 8888877777654433345678999999999999999999999 889999999999988753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=412.33 Aligned_cols=255 Identities=30% Similarity=0.515 Sum_probs=203.1
Q ss_pred CCeEEE---EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCee
Q 001360 687 DDFEII---KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 687 ~dFeil---r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~L 762 (1092)
++|++. +.||+|+||+||+|+++.+|+.||||++.+. ....+.+|+.+|..+. ||||++++++|.+...+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 456665 7899999999999999999999999999752 3456788999999997 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC---cEEEEecCCcccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKIGLI 839 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLsDFGLAk~~~~ 839 (1092)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999999999999988999999999999999999999999999999999999998766 899999999974210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s- 918 (1092)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+
T Consensus 162 ---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 162 ---------------------------DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp -------------------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred ---------------------------CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 1112345689999999999999999999999999999999999999998644
Q ss_pred ------hHHHHHHHhhcCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 919 ------PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 919 ------~~ei~~kIl~~~l~fP~i-p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
..++...+..+...++.. ...+++++++||.+||..||.+||+ +.++++||||++.
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~h~w~~~~ 277 (325)
T 3kn6_A 215 SLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK---MSGLRYNEWLQDG 277 (325)
T ss_dssp ---CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCC---TTTSTTCGGGCTT
T ss_pred ccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCC---HHHHhcChhhccC
Confidence 356777777776655421 1358999999999999999999999 7789999999763
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=420.03 Aligned_cols=260 Identities=27% Similarity=0.506 Sum_probs=223.3
Q ss_pred CeEE--EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 688 DFEI--IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 688 dFei--lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.|++ .+.||+|+||.||+|++..+|+.||+|+++... ....+.+.+|+.+|.+++|||||+++++|.+.+.+|||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3444 678999999999999999999999999997643 24557789999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe--cCCCcEEEEecCCccccccccc
Q 001360 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL--D~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~--- 241 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--- 241 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT---
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC---
Confidence 9999999999988754 469999999999999999999999999999999999999 5678999999999985210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.
T Consensus 242 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 296 (373)
T 2x4f_A 242 -------------------------REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296 (373)
T ss_dssp -------------------------TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred -------------------------ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 1112345799999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcch
Q 001360 923 FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981 (1092)
Q Consensus 923 ~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~ 981 (1092)
...++.....++. ....+++++++||.+||+.||.+||+ +.++++||||++..|..
T Consensus 297 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps---~~e~l~hp~~~~~~~~~ 353 (373)
T 2x4f_A 297 LNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRIS---ASEALKHPWLSDHKLHS 353 (373)
T ss_dssp HHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHCHHHHH
T ss_pred HHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCC---HHHHhcCcCcCCCchhh
Confidence 9999887665442 22568999999999999999999999 88999999999876543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=423.05 Aligned_cols=254 Identities=31% Similarity=0.524 Sum_probs=212.2
Q ss_pred ccCCCeEEE-EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hcCCCceEEEeeeecc---
Q 001360 684 TSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTC--- 758 (1092)
Q Consensus 684 i~~~dFeil-r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~-~L~HPNIVkL~~sfqd--- 758 (1092)
...++|.+. +.||+|+||+||+|+++.+|+.||||++++. ..+.+|+.++. ..+||||++++++|..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 456789887 7899999999999999999999999999642 34667888874 4579999999998875
Q ss_pred -CCeeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC---CCcEEEEecC
Q 001360 759 -RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFG 832 (1092)
Q Consensus 759 -e~~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFG 832 (1092)
...+|||||||+||+|.+++...+ .+++..++.++.||+.||.|||++|||||||||+||||+. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 667999999999999999998754 5999999999999999999999999999999999999998 7899999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCC
Q 001360 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912 (1092)
Q Consensus 833 LAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~ 912 (1092)
+++.... .....+.+||+.|+|||++.+..|+.++|||||||+||||++|.+
T Consensus 210 ~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 261 (400)
T 1nxk_A 210 FAKETTS----------------------------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261 (400)
T ss_dssp TCEECC---------------------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCC----------------------------CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 9984210 112245789999999999999999999999999999999999999
Q ss_pred CCCCCChH----HHHHHHhhcCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 913 PFTAESPE----IIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 913 PF~~~s~~----ei~~kIl~~~l~fP~i-p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
||.+.+.. .+...+..+.+.+|.. ...++.++++||.+||..||.+||+ +.++++||||.+
T Consensus 262 pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 327 (400)
T 1nxk_A 262 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQ 327 (400)
T ss_dssp SCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHT
T ss_pred CCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCccccC
Confidence 99876543 2556666666665531 2468999999999999999999999 889999999964
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=396.88 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=218.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++++.||+|+||.||+|++..++..||+|++.............+.+|+.++..++||||+++++++.+.+.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 45678999999999999999999999999999999997765556666788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 163 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE---- 163 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc----
Confidence 9999999999999999989999999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
.........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+.....
T Consensus 164 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~ 221 (294)
T 4eqm_A 164 ----------------------TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA 221 (294)
T ss_dssp ---------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH
T ss_pred ----------------------ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 0011223467999999999999999999999999999999999999999999887776
Q ss_pred HHHhhcCCCCC--CCCCCCCHHHHHHHHHhccCCcCCCCC
Q 001360 924 DNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLG 961 (1092)
Q Consensus 924 ~kIl~~~l~fP--~ip~~lS~eakDLI~kcL~kDP~KRpS 961 (1092)
.+......+.. ..+..+++.+.++|.+||..||.+||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~ 261 (294)
T 4eqm_A 222 IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK 261 (294)
T ss_dssp HHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCS
T ss_pred HHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccc
Confidence 66665543321 134678999999999999999999995
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=407.63 Aligned_cols=265 Identities=26% Similarity=0.390 Sum_probs=223.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe--
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-- 761 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~-- 761 (1092)
...++|++.+.||+|+||.||+|++..+|+.||||+++............+.+|+.++.+++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 346789999999999999999999999999999999987655555667789999999999999999999999887654
Q ss_pred --eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 762 --LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 762 --LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 499999999999999999888999999999999999999999999999999999999999999999999999874311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
.. .........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.
T Consensus 169 ~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 169 SG------------------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp -------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cc------------------------cccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 00 001122346799999999999999999999999999999999999999999998
Q ss_pred HHHHHHHhhcCCCCC-CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 920 EIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP-~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
......+.......+ .....++.++.+||.+||..||.+||+ +.+++.|+|++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~ 278 (311)
T 3ork_A 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ---TAAEMRADLVR 278 (311)
T ss_dssp HHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChh---hHHHHHHHHHH
Confidence 887777766544322 123568999999999999999999999 66888899875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=412.72 Aligned_cols=273 Identities=27% Similarity=0.408 Sum_probs=217.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~---- 760 (1092)
..++|++++.||+|+||.||+|++..+|+.||||++.+.. ........+.+|+.+|+.++||||++++++|....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 4578999999999999999999999999999999997532 33455678899999999999999999999998765
Q ss_pred --eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 --~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+|+||||+.+ +|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999975 7888885 458999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 179 ----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 179 ----------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ---------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----------------------------cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0111234689999999999999999999999999999999999999999998
Q ss_pred hHHHHHHHhhcCCC-C------------------CCC--------------CC------CCCHHHHHHHHHhccCCcCCC
Q 001360 919 PEIIFDNILNRKIP-W------------------PCV--------------PS------DMSFEAQDLINRFLIHDPNQR 959 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~-f------------------P~i--------------p~------~lS~eakDLI~kcL~kDP~KR 959 (1092)
..+.+..++..... . |.. +. ..+.++++||.+||+.||.+|
T Consensus 231 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 310 (371)
T 2xrw_A 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310 (371)
T ss_dssp HHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhC
Confidence 88777776643110 0 000 00 015789999999999999999
Q ss_pred CCcccHHHHHcCCCCCCCCcchhhhccCCccCC
Q 001360 960 LGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQ 992 (1092)
Q Consensus 960 pSa~ga~EIL~HPFFkgIdWd~L~~~~pPfiP~ 992 (1092)
|+ +.++++||||+...........+|+.|.
T Consensus 311 ~t---~~e~l~hp~~~~~~~~~~~~~~~~~~~~ 340 (371)
T 2xrw_A 311 IS---VDEALQHPYINVWYDPSEAEAPPPKIPD 340 (371)
T ss_dssp CC---HHHHHHSHHHHTTCCHHHHTCCCCCCCT
T ss_pred CC---HHHHhCCcchhhhcCccccCCCCCCCCC
Confidence 99 8899999999754332222224444443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=414.36 Aligned_cols=252 Identities=27% Similarity=0.449 Sum_probs=218.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch-----hHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-----NDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk-----~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
..++|++++.||+|+||+||+|+++.+|+.||||++++...... .....+.+|+.+|..++||||++++++|.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 34689999999999999999999999999999999987543221 1344677899999999999999999999999
Q ss_pred CeeEEEEeecCCC-cHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GG-SL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
+.+|+||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999999777 999999988899999999999999999999999999999999999999999999999999997521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
........+||+.|+|||++.+..+ +.++|||||||++|||++|..||...
T Consensus 182 ----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 182 ----------------------------RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp ----------------------------TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred ----------------------------CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 0112235679999999999998877 88999999999999999999999763
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
. .+....... +..+++++.+||.+||..||.+||+ +.++++||||+.
T Consensus 234 ~------~~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~Rps---~~ell~hp~~~~ 280 (335)
T 3dls_A 234 E------ETVEAAIHP---PYLVSKELMSLVSGLLQPVPERRTT---LEKLVTDPWVTQ 280 (335)
T ss_dssp G------GGTTTCCCC---SSCCCHHHHHHHHHHTCSSGGGSCC---HHHHHHCTTTTC
T ss_pred H------HHHhhccCC---CcccCHHHHHHHHHHccCChhhCcC---HHHHhcCccccC
Confidence 2 222333332 3678999999999999999999999 889999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=390.54 Aligned_cols=261 Identities=28% Similarity=0.489 Sum_probs=223.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.++|++++.||+|+||.||+|+++.+|+.||+|+++.... ....+.+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 4689999999999999999999999999999999975432 23457789999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---- 159 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---- 159 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT----
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc----
Confidence 9999999999999887889999999999999999999999999999999999999999999999999987532100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChH-HHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE-IIF 923 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~PF~~~s~~-ei~ 923 (1092)
........+||+.|+|||++.+..+ +.++|||||||++|||++|..||...... ..+
T Consensus 160 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 218 (276)
T 2yex_A 160 ---------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218 (276)
T ss_dssp ---------------------EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH
T ss_pred ---------------------chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence 0112235679999999999988765 78999999999999999999999876543 334
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
..+.......+ ....++.++.+||.+||..||.+||+ +.++++||||++.
T Consensus 219 ~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 268 (276)
T 2yex_A 219 SDWKEKKTYLN-PWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHTTCTTST-TGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCC
T ss_pred HHhhhcccccC-chhhcCHHHHHHHHHHCCCCchhCCC---HHHHhcCccccCh
Confidence 44433332222 23568999999999999999999999 8899999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=399.23 Aligned_cols=257 Identities=30% Similarity=0.464 Sum_probs=213.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc--CC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC--RD 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqd--e~ 760 (1092)
...++|++++.||+|+||+||+|++..+|+.||||+++.. ....+.+|+.+|..++ ||||+++++++.+ ..
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 4567899999999999999999999999999999998742 2466889999999997 9999999999988 66
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC-cEEEEecCCcccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~ 839 (1092)
..|+||||+.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 107 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 7999999999999999875 389999999999999999999999999999999999999777 899999999975210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCC-
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE- 917 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~- 917 (1092)
.......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||...
T Consensus 184 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 235 (330)
T 3nsz_A 184 ----------------------------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235 (330)
T ss_dssp ----------------------------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ----------------------------CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 112234679999999999987 67899999999999999999999999543
Q ss_pred ChHHHHHH-------------HhhcCCCCC---------------------CCCCCCCHHHHHHHHHhccCCcCCCCCcc
Q 001360 918 SPEIIFDN-------------ILNRKIPWP---------------------CVPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (1092)
Q Consensus 918 s~~ei~~k-------------Il~~~l~fP---------------------~ip~~lS~eakDLI~kcL~kDP~KRpSa~ 963 (1092)
+..+.... +......++ ..+..+++++.+||.+||..||.+||+
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-- 313 (330)
T 3nsz_A 236 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT-- 313 (330)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC--
T ss_pred chHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC--
Confidence 22222211 111111111 011237999999999999999999999
Q ss_pred cHHHHHcCCCCCCCCcc
Q 001360 964 GAAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 964 ga~EIL~HPFFkgIdWd 980 (1092)
+.++++||||+++.|+
T Consensus 314 -a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 314 -AREAMEHPYFYTVVKD 329 (330)
T ss_dssp -HHHHHTSGGGTTCC--
T ss_pred -HHHHhcCccHhhhccC
Confidence 8899999999999876
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=394.37 Aligned_cols=263 Identities=28% Similarity=0.486 Sum_probs=224.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcCCCceEEEeeee--ccCCee
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRNPFVVRFFYSF--TCRDNL 762 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~k-k~~ie~~l~EieIL~~L~HPNIVkL~~sf--qde~~L 762 (1092)
.++|++.+.||+|+||.||+|.+..+++.||+|++++..... ......+.+|+.++..++||||+++++++ .....+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999998643321 24567899999999999999999999998 445679
Q ss_pred EEEEeecCCCcHHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk--~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
|+||||+.+| |.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999886 7777765 356999999999999999999999999999999999999999999999999998752100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC--CccceeechhhhHHHHHhCCCCCCCCC
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH--GYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y--t~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
..........||+.|+|||++.+... +.++|||||||++|||++|..||.+.+
T Consensus 163 -------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 163 -------------------------AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp -------------------------CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -------------------------ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 00112234579999999999987543 789999999999999999999999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcc
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd 980 (1092)
...+...+......+| ..+++++.+||.+||..||.+||+ +.++++||||+.....
T Consensus 218 ~~~~~~~i~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 218 IYKLFENIGKGSYAIP---GDCGPPLSDLLKGMLEYEPAKRFS---IRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHHHHHHHHHCCCCCC---SSSCHHHHHHHHHHTCSSTTTSCC---HHHHHHSHHHHSCCCC
T ss_pred HHHHHHHHhcCCCCCC---CccCHHHHHHHHHHccCChhhCCC---HHHHhcCcccccCCCC
Confidence 9999988888776655 688999999999999999999999 8899999999876543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=405.78 Aligned_cols=267 Identities=29% Similarity=0.417 Sum_probs=220.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde----- 759 (1092)
..++|++++.||+|+||+||+|+++.+|+.||+|++..... .......+.+|+.+|..++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 45789999999999999999999999999999999865432 223345678999999999999999999998874
Q ss_pred ---CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcc
Q 001360 760 ---DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1092)
Q Consensus 760 ---~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 835 (1092)
+.+|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999985 777777654 579999999999999999999999999999999999999999999999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCC
Q 001360 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 836 ~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
...... ..........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||
T Consensus 173 ~~~~~~-----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 229 (351)
T 3mi9_A 173 AFSLAK-----------------------NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229 (351)
T ss_dssp ECCCCS-----------------------SSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccc-----------------------cccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 531100 001122345689999999999986 56899999999999999999999999
Q ss_pred CCCChHHHHHHHhhcCCCCCC-CCCC----------------------------CCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 915 TAESPEIIFDNILNRKIPWPC-VPSD----------------------------MSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 915 ~~~s~~ei~~kIl~~~l~fP~-ip~~----------------------------lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
.+.+.......+......++. .... .++++.+||.+||+.||.+||+ +
T Consensus 230 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~ 306 (351)
T 3mi9_A 230 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID---S 306 (351)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC---H
T ss_pred CCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC---H
Confidence 999888877776652211110 0001 2778999999999999999999 8
Q ss_pred HHHHcCCCCCCCCc
Q 001360 966 AEVKAHPFFKGVNW 979 (1092)
Q Consensus 966 ~EIL~HPFFkgIdW 979 (1092)
.++++||||....+
T Consensus 307 ~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 307 DDALNHDFFWSDPM 320 (351)
T ss_dssp HHHHTSGGGGSSSC
T ss_pred HHHhCCCCcCCCCC
Confidence 89999999976543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=409.35 Aligned_cols=259 Identities=32% Similarity=0.537 Sum_probs=227.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-c----hhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-R----KNDIERILAERNILITV-RNPFVVRFFYSFTCR 759 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~-k----k~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde 759 (1092)
.++|++.+.||+|+||.||+|+++.+|+.||||+++..... . ....+.+.+|+.++.++ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 46799999999999999999999999999999999754311 1 12245688999999999 799999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
..+|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~- 251 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE- 251 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC-
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC-
Confidence 9999999999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC------CCCCccceeechhhhHHHHHhCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG------TEHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g------~~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
........+||+.|+|||++.+ ..|+.++|||||||++|||++|..|
T Consensus 252 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~p 304 (365)
T 2y7j_A 252 ---------------------------PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304 (365)
T ss_dssp ---------------------------TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ---------------------------CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCC
Confidence 0112234689999999999863 3688999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 914 FTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
|...+...+...+..+...++. ....++.++.+||.+||..||.+||+ +.++++||||+
T Consensus 305 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~ 364 (365)
T 2y7j_A 305 FWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT---AEQALQHPFFE 364 (365)
T ss_dssp SCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGC
T ss_pred CCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCcccC
Confidence 9999988888888887665442 12467899999999999999999999 88999999996
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=399.94 Aligned_cols=255 Identities=29% Similarity=0.417 Sum_probs=210.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~L 762 (1092)
...++|++++.||+|+||+||+|+++.+|+.||||++..... ..........|+..+..+ +|||||+++++|.+.+.+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 344789999999999999999999999999999999865432 233444556666666555 899999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
|+||||+ +|+|.+++...+ .+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~-- 209 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT-- 209 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc--
Confidence 9999999 669999887654 599999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+..
T Consensus 210 --------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--- 259 (311)
T 3p1a_A 210 --------------------------AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--- 259 (311)
T ss_dssp -------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---
T ss_pred --------------------------CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---
Confidence 111234569999999999886 79999999999999999999977765532
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
....+..+..+ +.++..+++++.+||.+||+.||.+||+ +.++++||||+.
T Consensus 260 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~~~~ 310 (311)
T 3p1a_A 260 GWQQLRQGYLP-PEFTAGLSSELRSVLVMMLEPDPKLRAT---AEALLALPVLRQ 310 (311)
T ss_dssp HHHHHTTTCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGSC
T ss_pred HHHHHhccCCC-cccccCCCHHHHHHHHHHcCCChhhCcC---HHHHHhCccccC
Confidence 23344333322 2234678999999999999999999999 889999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=405.83 Aligned_cols=266 Identities=29% Similarity=0.458 Sum_probs=217.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR--KNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~k--k~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
...++|++++.||+|+||.||+|+++.+|+.||||+++...... ......+.+|+.+|..++||||++++++|.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999999999999999997533221 1123467899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
+|+||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~- 164 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS- 164 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS-
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC-
Confidence 9999999986 898888765 4689999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
........+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+.
T Consensus 165 --------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~ 218 (346)
T 1ua2_A 165 --------------------------PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 218 (346)
T ss_dssp --------------------------CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --------------------------CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 01122346899999999999764 589999999999999999999999999998
Q ss_pred HHHHHHHhhcC-----CCCCC---------------C-----CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 920 EIIFDNILNRK-----IPWPC---------------V-----PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 920 ~ei~~kIl~~~-----l~fP~---------------i-----p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.+.+..+.... ..||. . ...++.++++||.+||..||.+||+ +.++++||||
T Consensus 219 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~h~~f 295 (346)
T 1ua2_A 219 LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQALKMKYF 295 (346)
T ss_dssp HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC---HHHHHTSGGG
T ss_pred HHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC---HHHHhcChhh
Confidence 88887776521 11111 0 1456799999999999999999999 8899999999
Q ss_pred CCCCcc
Q 001360 975 KGVNWD 980 (1092)
Q Consensus 975 kgIdWd 980 (1092)
++..|.
T Consensus 296 ~~~~~~ 301 (346)
T 1ua2_A 296 SNRPGP 301 (346)
T ss_dssp TSSSCC
T ss_pred hcCCCC
Confidence 876554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=416.24 Aligned_cols=258 Identities=31% Similarity=0.455 Sum_probs=213.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------ 758 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd------ 758 (1092)
....|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+++|+.++|||||+++++|..
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34579999999999999999999999999999999875322 13469999999999999999988843
Q ss_pred CCeeEEEEeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC-CcEEEEecCC
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGL 833 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n-G~VKLsDFGL 833 (1092)
...+|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 2347899999986 66666543 4679999999999999999999999999999999999999965 6789999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCC
Q 001360 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIP 912 (1092)
Q Consensus 834 Ak~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~ 912 (1092)
++.... .......+||+.|+|||++.+. .|+.++|||||||+||||++|++
T Consensus 204 a~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~ 255 (420)
T 1j1b_A 204 AKQLVR----------------------------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255 (420)
T ss_dssp CEECCT----------------------------TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hhhccc----------------------------CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 985210 1112346899999999999765 79999999999999999999999
Q ss_pred CCCCCChHHHHHHHhhc-----------------CCCCCC---------CCCCCCHHHHHHHHHhccCCcCCCCCcccHH
Q 001360 913 PFTAESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (1092)
Q Consensus 913 PF~~~s~~ei~~kIl~~-----------------~l~fP~---------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~ 966 (1092)
||.+.+..+.+..|+.. .+.+|. ++..+++++.+||.+||.+||.+||+ +.
T Consensus 256 pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t---~~ 332 (420)
T 1j1b_A 256 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT---PL 332 (420)
T ss_dssp SSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC---HH
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC---HH
Confidence 99998877666665431 122332 23467899999999999999999999 88
Q ss_pred HHHcCCCCCCCCcch
Q 001360 967 EVKAHPFFKGVNWDS 981 (1092)
Q Consensus 967 EIL~HPFFkgIdWd~ 981 (1092)
++++||||+++.+..
T Consensus 333 e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 333 EACAHSFFDELRDPN 347 (420)
T ss_dssp HHHTSGGGGGGGCTT
T ss_pred HHhCCHhhccccccc
Confidence 999999998765543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=414.85 Aligned_cols=258 Identities=30% Similarity=0.463 Sum_probs=205.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC------
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------ 759 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde------ 759 (1092)
.++|++++.||+|+||.||+|.+..+|+.||||++.+. .........+.+|+.+|+.++||||++++++|...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 47899999999999999999999999999999998653 23345567889999999999999999999998764
Q ss_pred CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
..+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~- 183 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA- 183 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc-
Confidence 5689999999 7899998865 679999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+
T Consensus 184 -----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 184 -----------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -----------------------------ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01234689999999999987 678999999999999999999999999988
Q ss_pred hHHHHHHHhhcC----------------------------CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 919 PEIIFDNILNRK----------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 919 ~~ei~~kIl~~~----------------------------l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
..+....|.... ..++......++++.+||.+||+.||.+||+ +.++++
T Consensus 235 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t---~~e~L~ 311 (367)
T 2fst_X 235 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQALA 311 (367)
T ss_dssp HHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHT
T ss_pred HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC---HHHHhc
Confidence 877766665310 0011112357899999999999999999999 889999
Q ss_pred CCCCCCCCc
Q 001360 971 HPFFKGVNW 979 (1092)
Q Consensus 971 HPFFkgIdW 979 (1092)
||||+....
T Consensus 312 hp~~~~~~~ 320 (367)
T 2fst_X 312 HAYFAQYHD 320 (367)
T ss_dssp SGGGTTTCC
T ss_pred ChhhhhccC
Confidence 999987644
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=406.22 Aligned_cols=267 Identities=28% Similarity=0.441 Sum_probs=224.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++++.||+|+||.||+|++..+|+.||+|++.... ........+.+|+.+|..++||||+++++++.+.+.+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 45689999999999999999999999999999999987543 23444567889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 176 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA---- 176 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC----
Confidence 9999999999999888778899999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 177 -----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 233 (331)
T 4aaa_A 177 -----------------------PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ 233 (331)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred -----------------------CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 01122345799999999999875 789999999999999999999999999887666
Q ss_pred HHHHhhc-------------------CCCCCCC---------CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 923 FDNILNR-------------------KIPWPCV---------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 923 ~~kIl~~-------------------~l~fP~i---------p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
...+... ...+|.. ...+++++.+||.+||..||.+||+ +.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~f 310 (331)
T 4aaa_A 234 LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF---CAELLHHDFF 310 (331)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHH
T ss_pred HHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC---HHHHhcCchh
Confidence 6555421 1112211 1357899999999999999999999 7799999999
Q ss_pred CCCCcch
Q 001360 975 KGVNWDS 981 (1092)
Q Consensus 975 kgIdWd~ 981 (1092)
+...|..
T Consensus 311 ~~~~~~~ 317 (331)
T 4aaa_A 311 QMDGFAE 317 (331)
T ss_dssp HGGGHHH
T ss_pred ccCChhh
Confidence 8776654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=426.03 Aligned_cols=266 Identities=33% Similarity=0.578 Sum_probs=216.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~-----kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
..++|++.+.||+|+||+||+|.++.+++.||||++.+.... .......+.+|+.+|.+++|||||++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 457899999999999999999999999999999999865432 11223357899999999999999999999854
Q ss_pred CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC---cEEEEecCCccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 836 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLsDFGLAk~ 836 (1092)
+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++.
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 55899999999999999998888999999999999999999999999999999999999997654 599999999975
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
.. ........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+|
T Consensus 292 ~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p 343 (419)
T 3i6u_A 292 LG----------------------------ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343 (419)
T ss_dssp CC---------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cC----------------------------CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 21 0112235689999999999864 6788999999999999999999999
Q ss_pred CCCCCh-HHHHHHHhhcCCCCC-CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchh
Q 001360 914 FTAESP-EIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982 (1092)
Q Consensus 914 F~~~s~-~ei~~kIl~~~l~fP-~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L 982 (1092)
|..... ..+...+..+...++ .....+++++.+||.+||..||.+||+ +.++++||||++.+|...
T Consensus 344 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~~~~~~ 411 (419)
T 3i6u_A 344 FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TEEALRHPWLQDEDMKRK 411 (419)
T ss_dssp SCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGCCHHHHHH
T ss_pred CCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcC---HHHHhCCcccCChhHHHH
Confidence 987543 344455555554432 223568999999999999999999999 889999999998877653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=409.18 Aligned_cols=256 Identities=30% Similarity=0.495 Sum_probs=213.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-----
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----- 758 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd----- 758 (1092)
...++|++++.||+|+||+||+|++..+|+.||||++...... ..+|+.+|+.++|||||+++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 4567899999999999999999999999999999998753221 2369999999999999999999843
Q ss_pred ---------------------------------CCeeEEEEeecCCCcHHHHHH----hhcCCCHHHHHHHHHHHHHHHH
Q 001360 759 ---------------------------------RDNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLALE 801 (1092)
Q Consensus 759 ---------------------------------e~~LYLVMEYm~GGSL~dlLk----k~g~LsE~~ar~yaaQIL~ALe 801 (1092)
...+|+||||++| +|.+.+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3458999999985 7777665 3467999999999999999999
Q ss_pred HHHHcCCeeeecCCCceEec-CCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCC
Q 001360 802 YLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880 (1092)
Q Consensus 802 YLHs~GIIHRDLKPeNILLD-~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~Y 880 (1092)
|||++||+||||||+|||++ .++.+||+|||+++.... .......+||+.|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~----------------------------~~~~~~~~~t~~y 207 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP----------------------------SEPSVAYICSRFY 207 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT----------------------------TSCCCCCCCCSSC
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC----------------------------CCCCcCcccCCCc
Confidence 99999999999999999998 689999999999985310 1122356789999
Q ss_pred CChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhc-----------------CCCCCC-------
Q 001360 881 LAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR-----------------KIPWPC------- 935 (1092)
Q Consensus 881 mAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~-----------------~l~fP~------- 935 (1092)
+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+....++.. ...+|.
T Consensus 208 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (383)
T 3eb0_A 208 RAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287 (383)
T ss_dssp CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHH
T ss_pred cCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHH
Confidence 999999875 4899999999999999999999999999887777766541 112222
Q ss_pred --CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 936 --VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 936 --ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
++..+++++.+||.+||..||.+||+ +.++++||||+.+.
T Consensus 288 ~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 288 KILPEGTPSLAIDLLEQILRYEPDLRIN---PYEAMAHPFFDHLR 329 (383)
T ss_dssp HHSCTTCCHHHHHHHHHHCCSSGGGSCC---HHHHHTSGGGHHHH
T ss_pred hhCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcCHHHHHHH
Confidence 34568999999999999999999999 88999999998653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=405.92 Aligned_cols=268 Identities=25% Similarity=0.504 Sum_probs=232.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchh--------------HHHHHHHHHHHHHhcCCCc
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--------------DIERILAERNILITVRNPF 748 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~--------------~ie~~l~EieIL~~L~HPN 748 (1092)
....++|++++.||+|+||.||+|++ +|+.||+|++......... ....+.+|+.++..++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 35578999999999999999999998 8999999999864332211 1278999999999999999
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcHHHH------HHh--hcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceE
Q 001360 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSL------LRK--VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLL 819 (1092)
Q Consensus 749 IVkL~~sfqde~~LYLVMEYm~GGSL~dl------Lkk--~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNIL 819 (1092)
|+++++++.+.+.+|+||||++||+|.++ +.. ...+++..++.++.||+.||.|||+ .||+||||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999998 665 5679999999999999999999999 99999999999999
Q ss_pred ecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCc-ccee
Q 001360 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGY-AADW 897 (1092)
Q Consensus 820 LD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~-ksDV 897 (1092)
++.+|.+||+|||++..... .......||+.|+|||++.+. .++. ++||
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 235 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVD-----------------------------KKIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235 (348)
T ss_dssp ECTTSCEEECCCTTCEECBT-----------------------------TEECSSCSCGGGCCGGGGSSCCCEEHHHHHH
T ss_pred EcCCCcEEEecccccccccc-----------------------------ccccCCCCCcCccCchhhcCCCCCCcchhhH
Confidence 99999999999999875210 122346799999999999887 6766 9999
Q ss_pred echhhhHHHHHhCCCCCCCCCh-HHHHHHHhhcCCCCCCC----------------CCCCCHHHHHHHHHhccCCcCCCC
Q 001360 898 WSVGIILFEFITGIPPFTAESP-EIIFDNILNRKIPWPCV----------------PSDMSFEAQDLINRFLIHDPNQRL 960 (1092)
Q Consensus 898 WSLGVILYEMLTGk~PF~~~s~-~ei~~kIl~~~l~fP~i----------------p~~lS~eakDLI~kcL~kDP~KRp 960 (1092)
|||||++|||++|..||...+. .++...+......+|.. ...++.++.+||.+||+.||.+||
T Consensus 236 ~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 315 (348)
T 2pml_X 236 WSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315 (348)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCC
Confidence 9999999999999999998777 78888887776665521 156899999999999999999999
Q ss_pred CcccHHHHHcCCCCCCCCcchhhh
Q 001360 961 GANGAAEVKAHPFFKGVNWDSLAL 984 (1092)
Q Consensus 961 Sa~ga~EIL~HPFFkgIdWd~L~~ 984 (1092)
+ +.++++||||++.+|..+..
T Consensus 316 s---~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 316 T---SEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp C---HHHHHTSGGGTTCCHHHHHH
T ss_pred C---HHHHhcCccccCCCHHHHHH
Confidence 9 88999999999999987654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=393.33 Aligned_cols=265 Identities=29% Similarity=0.521 Sum_probs=223.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++++.||+|+||.||+|.++.+|+.||+|++.... ....+.+|+.+|..++||||+++++++...+.+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999997532 3456889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHH-hhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 764 LVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLk-k~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
+||||+++|+|.+++. ....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--- 177 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT---
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh---
Confidence 9999999999999997 456799999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus 178 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 233 (314)
T 3com_A 178 ------------------------TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233 (314)
T ss_dssp ------------------------TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ------------------------hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 01122346799999999999999999999999999999999999999998887766
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~ 983 (1092)
...+..........+..++.++.+||.+||..||.+||+ +.++++||||++..+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~~ll~~~~~~~~~~~~~~ 291 (314)
T 3com_A 234 IFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT---ATQLLQHPFVRSAKGVSIL 291 (314)
T ss_dssp HHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCC---HHHHTTSHHHHTCCCGGGG
T ss_pred HHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhcCCcchHH
Confidence 655555433222234568999999999999999999999 8899999999987766543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=399.86 Aligned_cols=273 Identities=27% Similarity=0.416 Sum_probs=221.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 759 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde----- 759 (1092)
..++|++.+.||+|+||.||+|++..+|+.||||+++.. ........+.+|+.+|..++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 457899999999999999999999999999999999643 2344567788999999999999999999887654
Q ss_pred CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
..+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 67999999997 599999876 5799999999999999999999999999999999999999999999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
..... .............+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+
T Consensus 165 ~~~~~-----------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 165 SAADN-----------------SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp --------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccc-----------------cCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 10000 000000112335689999999999875 678999999999999999999999999988
Q ss_pred hHHHHHHHhhc--C----------------------CCCCC-----CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 919 PEIIFDNILNR--K----------------------IPWPC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 919 ~~ei~~kIl~~--~----------------------l~fP~-----ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.......+... . ..++. ....+++++.+||.+||..||.+||+ +.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell 304 (353)
T 2b9h_A 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT---AKEAL 304 (353)
T ss_dssp HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC---HHHHH
T ss_pred cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC---HHHHh
Confidence 76655544321 0 00110 12468999999999999999999999 88999
Q ss_pred cCCCCCCCCcch
Q 001360 970 AHPFFKGVNWDS 981 (1092)
Q Consensus 970 ~HPFFkgIdWd~ 981 (1092)
+||||+...+..
T Consensus 305 ~hp~~~~~~~~~ 316 (353)
T 2b9h_A 305 EHPYLQTYHDPN 316 (353)
T ss_dssp TSGGGTTTCCTT
T ss_pred cCccccccCCcc
Confidence 999999887654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=389.60 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=205.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
.+..++|++++.||+|+||+||+|++..+|+.||+|+++... ........+..+...++.++||||+++++++.+.+.+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 356689999999999999999999999999999999997542 2223334445555567888999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHc-CCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 763 YLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
|+||||++| +|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 88777753 46799999999999999999999998 9999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh----cCCCCCccceeechhhhHHHHHhCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL----LGTEHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL----~g~~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
.. ........||+.|+|||++ .+..++.++|||||||++|+|++|..|
T Consensus 161 ~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (290)
T 3fme_A 161 VD----------------------------DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212 (290)
T ss_dssp -------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred cc----------------------------cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 10 1112334799999999996 556789999999999999999999999
Q ss_pred CCC-CChHHHHHHHhhcCC-CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 914 FTA-ESPEIIFDNILNRKI-PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 914 F~~-~s~~ei~~kIl~~~l-~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
|.. .........+..... ..+ +..+++++.+||.+||..||.+||+ +.++++||||+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt---~~e~l~hp~f~~ 272 (290)
T 3fme_A 213 YDSWGTPFQQLKQVVEEPSPQLP--ADKFSAEFVDFTSQCLKKNSKERPT---YPELMQHPFFTL 272 (290)
T ss_dssp SCCCSCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTSHHHHH
T ss_pred ccccCchHHHHHHHhccCCCCcc--cccCCHHHHHHHHHHhhcChhhCcC---HHHHHhCccccc
Confidence 986 344444444444332 222 3578999999999999999999999 889999999964
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=394.60 Aligned_cols=274 Identities=30% Similarity=0.498 Sum_probs=201.9
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
..+..++|++.+.||+|+||.||+|++..+|+.||+|++..... ......+.+|+.++..++||||+++++++...+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 34667899999999999999999999988999999998865322 2345678899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHh--------hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCC
Q 001360 762 LYLVMEYLNGGDLYSLLRK--------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk--------~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGL 833 (1092)
+|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999974 35699999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCC
Q 001360 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 912 (1092)
Q Consensus 834 Ak~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~ 912 (1092)
+........ ..........+||+.|+|||++.+ ..++.++|||||||++|||++|..
T Consensus 168 ~~~~~~~~~----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 225 (303)
T 2vwi_A 168 SAFLATGGD----------------------ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225 (303)
T ss_dssp HHHCC-------------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hheeccCCC----------------------ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 875311000 001112235689999999999976 578999999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCC-------CCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchh
Q 001360 913 PFTAESPEIIFDNILNRKIP-------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982 (1092)
Q Consensus 913 PF~~~s~~ei~~kIl~~~l~-------fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L 982 (1092)
||.................+ .+.....++.++.+||.+||..||.+||+ +.++++||||+...+..+
T Consensus 226 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~ 299 (303)
T 2vwi_A 226 PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT---AAELLRHKFFQKAKNKEF 299 (303)
T ss_dssp TTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCC---HHHHHTSTTC--------
T ss_pred CCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcC---HHHHhhChhhhcCCCCcc
Confidence 99988776665555443221 11233568899999999999999999999 889999999998766543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=404.57 Aligned_cols=261 Identities=28% Similarity=0.485 Sum_probs=219.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----C
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-----D 760 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde-----~ 760 (1092)
.++|++++.||+|+||.||+|++..++..||||++.... .......+.+|+.+|.+++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 368999999999999999999999999999999997532 344567889999999999999999999998765 3
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 6899999997 599999865 56999999999999999999999999999999999999999999999999999853210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
. .........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+.
T Consensus 182 ~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 182 H------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp G------------------------CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred C------------------------CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 0 00112245689999999998765 5589999999999999999999999999887
Q ss_pred HHHHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 920 EIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 920 ~ei~~kIl~~----------------------------~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
.+....+... ..+++.....+++++.+||.+||..||.+||+ +.++++|
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~h 314 (364)
T 3qyz_A 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---VEQALAH 314 (364)
T ss_dssp GGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTS
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC---HHHHhcC
Confidence 7666665431 01111122567899999999999999999999 8899999
Q ss_pred CCCCCC
Q 001360 972 PFFKGV 977 (1092)
Q Consensus 972 PFFkgI 977 (1092)
|||+..
T Consensus 315 p~~~~~ 320 (364)
T 3qyz_A 315 PYLEQY 320 (364)
T ss_dssp GGGTTT
T ss_pred cchhhc
Confidence 999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=423.36 Aligned_cols=251 Identities=16% Similarity=0.200 Sum_probs=208.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHH---HHHHhcCCCceEEEe-------e
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER---NILITVRNPFVVRFF-------Y 754 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~Ei---eIL~~L~HPNIVkL~-------~ 754 (1092)
..++|++.+.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+ .+|..++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 356899999999999999999999999999999999876555566778899999 455566899999998 5
Q ss_pred eeccCC-----------------eeEEEEeecCCCcHHHHHHhhcCCCH-------HHHHHHHHHHHHHHHHHHHcCCee
Q 001360 755 SFTCRD-----------------NLYLVMEYLNGGDLYSLLRKVGCLEE-------DVARIYIAELVLALEYLHSLGIVH 810 (1092)
Q Consensus 755 sfqde~-----------------~LYLVMEYm~GGSL~dlLkk~g~LsE-------~~ar~yaaQIL~ALeYLHs~GIIH 810 (1092)
++.+.+ ..||||||+ +|+|.+++.+.+.+++ ..+..++.||+.||.|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 554443 389999999 6899999988766666 777789999999999999999999
Q ss_pred eecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-
Q 001360 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT- 889 (1092)
Q Consensus 811 RDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~- 889 (1092)
|||||+||||+.+|.+||+|||+++.. .......+| +.|+|||++.+.
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~------------------------------~~~~~~~~g-~~y~aPE~~~~~~ 278 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRD------------------------------GARVVSSVS-RGFEPPELEARRA 278 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEET------------------------------TCEEECCCC-TTCCCHHHHHHHT
T ss_pred CCCCHHHEEEcCCCCEEEEechhheec------------------------------CCcccCCCC-cCccChhhhcccc
Confidence 999999999999999999999998741 112235678 999999999987
Q ss_pred ----------CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCC
Q 001360 890 ----------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959 (1092)
Q Consensus 890 ----------~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KR 959 (1092)
.|+.++|||||||+||||++|+.||.+.+.......+... ...+++++.+||.+||..||.+|
T Consensus 279 ~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dp~~R 351 (377)
T 3byv_A 279 TISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS-------CKNIPQPVRALLEGFLRYPKEDR 351 (377)
T ss_dssp STHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSS-------CCCCCHHHHHHHHHHTCSSGGGC
T ss_pred cccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhh-------ccCCCHHHHHHHHHHcCCCchhC
Confidence 8999999999999999999999999877655544444332 25688999999999999999999
Q ss_pred CCcccHHHHHcCCCCCCC
Q 001360 960 LGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 960 pSa~ga~EIL~HPFFkgI 977 (1092)
|+ +.++++||||+++
T Consensus 352 pt---~~e~l~hp~f~~~ 366 (377)
T 3byv_A 352 LL---PLQAMETPEYEQL 366 (377)
T ss_dssp CC---HHHHHTSHHHHHH
T ss_pred CC---HHHHhhChHHHHH
Confidence 99 8899999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=386.42 Aligned_cols=259 Identities=31% Similarity=0.538 Sum_probs=225.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec--cCCee
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT--CRDNL 762 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfq--de~~L 762 (1092)
..++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|+.++++++||||+++++++. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 45789999999999999999999999999999999976433 3455678999999999999999999999874 46789
Q ss_pred EEEEeecCCCcHHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHcC-----CeeeecCCCceEecCCCcEEEEecCC
Q 001360 763 YLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g----~LsE~~ar~yaaQIL~ALeYLHs~G-----IIHRDLKPeNILLD~nG~VKLsDFGL 833 (1092)
|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.| |+||||||+|||++.+|.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999999997643 4999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCC
Q 001360 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 834 Ak~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
++.... .........||+.|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 163 ~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 215 (279)
T 2w5a_A 163 ARILNH---------------------------DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215 (279)
T ss_dssp HHHC------------------------------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred heeecc---------------------------ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 874210 00112245799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
|...+...+...+..+.. +.++..++.++.+||.+||..||.+||+ +.++++|+||.+
T Consensus 216 ~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~~~~~~ 273 (279)
T 2w5a_A 216 FTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRPS---VEEILENPLILE 273 (279)
T ss_dssp SCCSSHHHHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTCCG
T ss_pred CcccCHHHHHHHHhhccc--ccCCcccCHHHHHHHHHHcCCCcccCCC---HHHHHhChhhhh
Confidence 999998888888877654 3345789999999999999999999999 889999999964
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=406.17 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=224.1
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
+.|++++.||+|+||+||+|++..+|+.||||++.............+.+|+.+|.+++|||||++++++.+.+.+|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999998654444555678999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~------- 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 205 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC-------
Confidence 9997 588888754 4679999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.....+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+.+....
T Consensus 206 ------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 261 (348)
T 1u5q_A 206 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 261 (348)
T ss_dssp ------------------------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ------------------------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 112457999999999995 46789999999999999999999999999888777
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
...+.....+.. .+..++..+.+||.+||..||.+||+ +.++++||||...
T Consensus 262 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps---~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 262 LYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHHHSCCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHSC
T ss_pred HHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcC---HHHHhhChhhhcc
Confidence 777766544322 24678999999999999999999999 8899999999654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=401.58 Aligned_cols=260 Identities=28% Similarity=0.430 Sum_probs=214.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccCCe
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDN 761 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H--PNIVkL~~sfqde~~ 761 (1092)
+..+.|++++.||+|+||.||+|.+. +++.||||++.... ........+.+|+.+|..++| |||+++++++.+...
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 34567999999999999999999874 68999999997643 344556789999999999986 999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+|+||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+ +|.+||+|||+++.....
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~- 160 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD- 160 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc-
Confidence 999999 56889999999988999999999999999999999999999999999999997 689999999999753110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----------CCCCccceeechhhhHHHHHhC
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----------TEHGYAADWWSVGIILFEFITG 910 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----------~~Yt~ksDVWSLGVILYEMLTG 910 (1092)
.........+||+.|+|||++.+ ..|+.++|||||||++|||++|
T Consensus 161 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 216 (343)
T 3dbq_A 161 ------------------------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216 (343)
T ss_dssp ---------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHS
T ss_pred ------------------------cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence 00112235689999999999975 6789999999999999999999
Q ss_pred CCCCCCCCh-HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 911 IPPFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 911 k~PF~~~s~-~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
.+||..... ......++..... ..++...+.++.+||.+||..||.+||+ +.++++||||+.
T Consensus 217 ~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~ 279 (343)
T 3dbq_A 217 KTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQI 279 (343)
T ss_dssp SCTTTTCCSHHHHHHHHHCTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHS
T ss_pred CCcchhhhhHHHHHHHHhcCCcc-cCCcccCCHHHHHHHHHHcCCChhHCCC---HHHHHhCccccc
Confidence 999987543 3444444443332 2234677899999999999999999999 889999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=405.90 Aligned_cols=259 Identities=30% Similarity=0.426 Sum_probs=219.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee--
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL-- 762 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L-- 762 (1092)
..++|.+.+.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||++++++|...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 3478999999999999999999999999999999997533 3445567889999999999999999999999888765
Q ss_pred ----EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 763 ----YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 763 ----YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
|+||||+. |+|.+++. ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 58888874 349999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.
T Consensus 196 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 196 ------------------------------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp ----------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------------------------cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 11234679999999999987 78899999999999999999999999998
Q ss_pred ChHHHHHHHhhcCC----------------------------CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 918 SPEIIFDNILNRKI----------------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 918 s~~ei~~kIl~~~l----------------------------~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+..+....++.... .++..+..+++++.+||.+||+.||.+||+ +.+++
T Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell 322 (371)
T 4exu_A 246 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT---AAQAL 322 (371)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC---HHHHH
T ss_pred ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC---HHHHh
Confidence 88777766654110 001112467899999999999999999999 88999
Q ss_pred cCCCCCCCCcc
Q 001360 970 AHPFFKGVNWD 980 (1092)
Q Consensus 970 ~HPFFkgIdWd 980 (1092)
+||||+.+...
T Consensus 323 ~hp~f~~~~~~ 333 (371)
T 4exu_A 323 THPFFEPFRDP 333 (371)
T ss_dssp TSGGGTTTCCG
T ss_pred cCcccccCCCc
Confidence 99999976544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=402.65 Aligned_cols=264 Identities=34% Similarity=0.600 Sum_probs=218.8
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~-----kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+.... .......+.+|+.+|..++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46799999999999999999999999999999999764321 1223456889999999999999999999987665
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc---EEEEecCCcccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIG 837 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~---VKLsDFGLAk~~ 837 (1092)
+|+||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988889999999999999999999999999999999999999987665 999999998752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
.. .......+||+.|+|||++. ...|+.++|||||||++|+|++|..||
T Consensus 168 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 219 (322)
T 2ycf_A 168 GE----------------------------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219 (322)
T ss_dssp CC----------------------------CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cc----------------------------ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 10 11123457999999999984 467899999999999999999999999
Q ss_pred CCCChH-HHHHHHhhcCCCC-CCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcch
Q 001360 915 TAESPE-IIFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981 (1092)
Q Consensus 915 ~~~s~~-ei~~kIl~~~l~f-P~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~ 981 (1092)
...... .+...+..+...+ |..+..++.++.+||.+||..||.+||+ +.++++||||++.+|..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~~~l~h~~~~~~~~~~ 285 (322)
T 2ycf_A 220 SEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TEEALRHPWLQDEDMKR 285 (322)
T ss_dssp CSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGCCHHHHH
T ss_pred cccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCC---HHHHhhCcCcCCHHHHH
Confidence 875543 3444555554433 2223568999999999999999999999 88999999999877653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=393.18 Aligned_cols=265 Identities=28% Similarity=0.486 Sum_probs=222.1
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc--
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC-- 758 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqd-- 758 (1092)
.....++|++++.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3456789999999999999999999999999999999997532 2346788999999998 79999999999977
Q ss_pred ----CCeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecC
Q 001360 759 ----RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832 (1092)
Q Consensus 759 ----e~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFG 832 (1092)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence 46799999999999999999864 579999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHH
Q 001360 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEF 907 (1092)
Q Consensus 833 LAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Yt~ksDVWSLGVILYEM 907 (1092)
++..... ........+||+.|+|||++. +..++.++|||||||++|+|
T Consensus 175 ~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l 227 (326)
T 2x7f_A 175 VSAQLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227 (326)
T ss_dssp TTC----------------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHH
T ss_pred CceecCc---------------------------CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHH
Confidence 9874210 011123467999999999997 56789999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcch
Q 001360 908 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981 (1092)
Q Consensus 908 LTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~ 981 (1092)
++|..||...+.......+.....+. ..+..++..+.+||.+||..||.+||+ +.++++||||++..+..
T Consensus 228 ~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~hp~~~~~~~~~ 297 (326)
T 2x7f_A 228 AEGAPPLCDMHPMRALFLIPRNPAPR-LKSKKWSKKFQSFIESCLVKNHSQRPA---TEQLMKHPFIRDQPNER 297 (326)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHSCCCC-CSCSCSCHHHHHHHHHHCCSSGGGSCC---HHHHHTSHHHHCCTTHH
T ss_pred HhCCCCCCCCcHHHHHHHhhcCcccc-CCccccCHHHHHHHHHHhccChhhCCC---HHHHhhChHHhhCcccc
Confidence 99999999988877776666554332 124678999999999999999999999 88999999999876654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=391.99 Aligned_cols=264 Identities=32% Similarity=0.477 Sum_probs=220.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEEC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeec---
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFT--- 757 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k-~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L---~HPNIVkL~~sfq--- 757 (1092)
..++|++++.||+|+||.||+|++. .+|+.||+|+++..... ......+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4578999999999999999999995 67899999999754321 11223456677777665 8999999999987
Q ss_pred --cCCeeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCC
Q 001360 758 --CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1092)
Q Consensus 758 --de~~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGL 833 (1092)
....+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5667999999998 59999998653 499999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCC
Q 001360 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 834 Ak~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
++... ........+||+.|+|||++.+..++.++|||||||++|+|++|.+|
T Consensus 167 ~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 218 (326)
T 1blx_A 167 ARIYS----------------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218 (326)
T ss_dssp CCCCC----------------------------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccc----------------------------CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCC
Confidence 87421 01122346799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcC-----CCC-------------------CCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 914 FTAESPEIIFDNILNRK-----IPW-------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~~~-----l~f-------------------P~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
|.+.+.......++... ..| ..+...++.++++||.+||..||.+||+ +.+++
T Consensus 219 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l 295 (326)
T 1blx_A 219 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSAL 295 (326)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC---HHHHH
T ss_pred CCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC---HHHHh
Confidence 99998887777765410 001 1123568999999999999999999999 88999
Q ss_pred cCCCCCCCCcch
Q 001360 970 AHPFFKGVNWDS 981 (1092)
Q Consensus 970 ~HPFFkgIdWd~ 981 (1092)
+||||+++++..
T Consensus 296 ~hp~~~~~~~~~ 307 (326)
T 1blx_A 296 SHPYFQDLERCK 307 (326)
T ss_dssp TSGGGTTCCCCC
T ss_pred cCccccccchhh
Confidence 999999887653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=395.09 Aligned_cols=257 Identities=30% Similarity=0.457 Sum_probs=214.3
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
..+..++|++.+.||+|+||+||+|++ +|..||||++.+... .......+.+|+.+|.+++||||+++++++.+...
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 346678999999999999999999987 488999999976433 44556789999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHcC--CeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGC---LEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~---LsE~~ar~yaaQIL~ALeYLHs~G--IIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
+|+||||++||+|.+++.+.+. +++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999999987653 999999999999999999999999 99999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
... ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 189 ~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~ 241 (309)
T 3p86_A 189 KAS---------------------------TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241 (309)
T ss_dssp ----------------------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred ccc---------------------------cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 210 01122356799999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.+..+....+...... +.++..+++++.+||.+||..||.+||++.++.+.+
T Consensus 242 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L 293 (309)
T 3p86_A 242 LNPAQVVAAVGFKCKR-LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293 (309)
T ss_dssp SCHHHHHHHHHHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9988887776544332 234578999999999999999999999955444433
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=390.38 Aligned_cols=264 Identities=31% Similarity=0.545 Sum_probs=230.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.++++++||||+++++++.+...+|
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345689999999999999999999999999999999976443 2345678999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC---CcEEEEecCCccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n---G~VKLsDFGLAk~~~~n 840 (1092)
+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~- 176 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC-
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC-
Confidence 999999999999999888899999999999999999999999999999999999999764 4799999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
........||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..
T Consensus 177 ---------------------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (287)
T 2wei_A 177 ---------------------------NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (287)
T ss_dssp ---------------------------CSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ---------------------------CCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 1112345689999999998764 899999999999999999999999999998
Q ss_pred HHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcc
Q 001360 921 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd 980 (1092)
++...+..+...++. ....++.++.+||.+||..||.+||+ +.++++||||+...|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT---ATQCLEHPWIQKYSSE 286 (287)
T ss_dssp HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHSHHHHHHCCC
T ss_pred HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcC---HHHHhcCHHHhccccC
Confidence 888888887665442 12468999999999999999999999 8899999999876654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=403.05 Aligned_cols=256 Identities=27% Similarity=0.413 Sum_probs=209.7
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--------CCceEEEee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--------NPFVVRFFY 754 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~--------HPNIVkL~~ 754 (1092)
....++|++++.||+|+||+||+|++..+|+.||||++++. ......+.+|+.+|..++ ||||+++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 34568899999999999999999999999999999999753 344567889999999885 788999999
Q ss_pred eec----cCCeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHc-CCeeeecCCCceEecCCC---
Q 001360 755 SFT----CRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDG--- 824 (1092)
Q Consensus 755 sfq----de~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~-GIIHRDLKPeNILLD~nG--- 824 (1092)
+|. ....+|+||||+ +|+|.+++... +.+++..++.++.||+.||.|||++ |||||||||+||||+.+|
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 998 566899999999 55777776554 5699999999999999999999998 999999999999999876
Q ss_pred ----------------------------------------------cEEEEecCCcccccccccccCCCCCCCCCCCCCC
Q 001360 825 ----------------------------------------------HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858 (1092)
Q Consensus 825 ----------------------------------------------~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~ 858 (1092)
.+||+|||+++...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~-------------------- 247 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH-------------------- 247 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT--------------------
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc--------------------
Confidence 79999999987521
Q ss_pred CCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh------HHHHHHHhh--cC
Q 001360 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP------EIIFDNILN--RK 930 (1092)
Q Consensus 859 ~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~------~ei~~kIl~--~~ 930 (1092)
......+||+.|+|||++.+..|+.++|||||||+||||++|.+||...+. ......+.. +.
T Consensus 248 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 317 (397)
T 1wak_A 248 ----------KHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK 317 (397)
T ss_dssp ----------BCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCS
T ss_pred ----------ccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCC
Confidence 112345799999999999999999999999999999999999999986542 222222211 10
Q ss_pred CC-------------------CC------------------CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCC
Q 001360 931 IP-------------------WP------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1092)
Q Consensus 931 l~-------------------fP------------------~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPF 973 (1092)
.+ +. ..+...+.++.+||.+||+.||.+||+ +.++++|||
T Consensus 318 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~ 394 (397)
T 1wak_A 318 VPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT---AAECLRHPW 394 (397)
T ss_dssp CCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC---HHHHHTSGG
T ss_pred CChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC---HHHHhhCcc
Confidence 00 00 011234567899999999999999999 889999999
Q ss_pred CCC
Q 001360 974 FKG 976 (1092)
Q Consensus 974 Fkg 976 (1092)
|++
T Consensus 395 ~~~ 397 (397)
T 1wak_A 395 LNS 397 (397)
T ss_dssp GGC
T ss_pred ccC
Confidence 963
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=397.75 Aligned_cols=258 Identities=29% Similarity=0.433 Sum_probs=218.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe----
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN---- 761 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~---- 761 (1092)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999997532 344456788999999999999999999999988764
Q ss_pred --eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 762 --LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 762 --LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
+|+||||+. |+|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~- 177 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD- 177 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC-
Confidence 499999997 58888774 359999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 178 -----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 178 -----------------------------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp -----------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred -----------------------------CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01224579999999999987 678999999999999999999999999988
Q ss_pred hHHHHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 919 PEIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 919 ~~ei~~kIl~~----------------------------~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
..+....+... ...++.....+++++.+||.+||..||.+||+ +.++++
T Consensus 229 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~ 305 (353)
T 3coi_A 229 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT---AAQALT 305 (353)
T ss_dssp HHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC---HHHHHT
T ss_pred HHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC---HHHHhc
Confidence 77666555431 11233344578999999999999999999999 889999
Q ss_pred CCCCCCCCcc
Q 001360 971 HPFFKGVNWD 980 (1092)
Q Consensus 971 HPFFkgIdWd 980 (1092)
||||+.+...
T Consensus 306 hp~f~~~~~~ 315 (353)
T 3coi_A 306 HPFFEPFRDP 315 (353)
T ss_dssp SGGGTTTCCG
T ss_pred CcchhhccCc
Confidence 9999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=408.92 Aligned_cols=259 Identities=31% Similarity=0.451 Sum_probs=212.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~---- 760 (1092)
...+|++++.||+|+||+||+|++..++. ||+|.+.+.... ..+|+.+|+.++|||||+++++|....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 34579999999999999999999987766 788877543221 236999999999999999999985443
Q ss_pred --eeEEEEeecCCCcHHHHH---HhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEec-CCCcEEEEecCCc
Q 001360 761 --NLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGLS 834 (1092)
Q Consensus 761 --~LYLVMEYm~GGSL~dlL---kk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD-~nG~VKLsDFGLA 834 (1092)
.+|+||||++++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+ .+|++||+|||+|
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 489999999875433332 2346799999999999999999999999999999999999999 7999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
+.... .......+||+.|+|||++.+. .|+.++|||||||++|||++|++|
T Consensus 190 ~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 241 (394)
T 4e7w_A 190 KILIA----------------------------GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPL 241 (394)
T ss_dssp EECCT----------------------------TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccC----------------------------CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 85310 1122356799999999999765 589999999999999999999999
Q ss_pred CCCCChHHHHHHHhhc-----------------CCCCCC---------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 914 FTAESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~~-----------------~l~fP~---------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
|.+.+..+....|... ...+|. ++..+++++.+||.+||++||.+||+ +.+
T Consensus 242 f~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e 318 (394)
T 4e7w_A 242 FPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT---AIE 318 (394)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC---HHH
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC---HHH
Confidence 9999877766665541 111221 23458899999999999999999999 889
Q ss_pred HHcCCCCCCCCcchh
Q 001360 968 VKAHPFFKGVNWDSL 982 (1092)
Q Consensus 968 IL~HPFFkgIdWd~L 982 (1092)
+++||||+++.|...
T Consensus 319 ~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 319 ALCHPFFDELRTGEA 333 (394)
T ss_dssp HHTSGGGSTTTSSCC
T ss_pred HhcChhhhhhccccc
Confidence 999999999887654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=389.79 Aligned_cols=265 Identities=29% Similarity=0.437 Sum_probs=215.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec-------
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT------- 757 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfq------- 757 (1092)
..++|++++.||+|+||.||+|++..+|+.||+|++... .......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 357899999999999999999999999999999998753 3456678899999999999999999998874
Q ss_pred -------cCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEec-CCCcEEEE
Q 001360 758 -------CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLT 829 (1092)
Q Consensus 758 -------de~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD-~nG~VKLs 829 (1092)
....+|+||||+. |+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999997 699999864 6799999999999999999999999999999999999997 56799999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHH
Q 001360 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFI 908 (1092)
Q Consensus 830 DFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEML 908 (1092)
|||+++...... ..........||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 164 Dfg~~~~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 219 (320)
T 2i6l_A 164 DFGLARIMDPHY------------------------SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219 (320)
T ss_dssp CCTTCBCC--------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH
T ss_pred cCccccccCCCc------------------------ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH
Confidence 999987521000 00112234578999999999876 67899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhhcCCC----------------------CC-----CCCCCCCHHHHHHHHHhccCCcCCCCC
Q 001360 909 TGIPPFTAESPEIIFDNILNRKIP----------------------WP-----CVPSDMSFEAQDLINRFLIHDPNQRLG 961 (1092)
Q Consensus 909 TGk~PF~~~s~~ei~~kIl~~~l~----------------------fP-----~ip~~lS~eakDLI~kcL~kDP~KRpS 961 (1092)
+|..||.+.+..+....+...... .+ .....++.++++||.+||+.||.+||+
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 999999998887777666543211 01 112468999999999999999999999
Q ss_pred cccHHHHHcCCCCCCCCcch
Q 001360 962 ANGAAEVKAHPFFKGVNWDS 981 (1092)
Q Consensus 962 a~ga~EIL~HPFFkgIdWd~ 981 (1092)
+.++++||||+..+|..
T Consensus 300 ---~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 300 ---AEEALSHPYMSIYSFPM 316 (320)
T ss_dssp ---HHHHHTSHHHHTTCC--
T ss_pred ---HHHHhCCcccccccCcc
Confidence 88999999999887754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=394.58 Aligned_cols=275 Identities=23% Similarity=0.334 Sum_probs=207.8
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk---~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.+..++|++.+.||+|+||+||+|+++.++. .||||+++.... .....+.+.+|+.++++++||||+++++++...
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 4566789999999999999999999887765 899999975432 344578899999999999999999999999887
Q ss_pred Cee------EEEEeecCCCcHHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEE
Q 001360 760 DNL------YLVMEYLNGGDLYSLLRKVG------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (1092)
Q Consensus 760 ~~L------YLVMEYm~GGSL~dlLkk~g------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VK 827 (1092)
... |+||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 665 99999999999999997543 599999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001360 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (1092)
Q Consensus 828 LsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEM 907 (1092)
|+|||+++...... .........||+.|+|||++.+..|+.++|||||||++|||
T Consensus 178 l~Dfg~a~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 232 (323)
T 3qup_A 178 VADFGLSRKIYSGD-------------------------YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232 (323)
T ss_dssp ECCCCC------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred Eeeccccccccccc-------------------------cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHH
Confidence 99999997531100 01112234578899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc----ccHHHHHcCCCCCCCCcchh
Q 001360 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA----NGAAEVKAHPFFKGVNWDSL 982 (1092)
Q Consensus 908 LT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa----~ga~EIL~HPFFkgIdWd~L 982 (1092)
++ |.+||.+.+..++...+...... ..+..+++++.+||.+||..||.+||++ ..+.+++.|||+....++.+
T Consensus 233 l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 233 MTRGQTPYAGIENAEIYNYLIGGNRL--KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred HhCCCCCccccChHHHHHHHhcCCCC--CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 99 99999999988888887765432 2347899999999999999999999994 34778999999988776655
Q ss_pred hhc
Q 001360 983 ALQ 985 (1092)
Q Consensus 983 ~~~ 985 (1092)
...
T Consensus 311 ~~~ 313 (323)
T 3qup_A 311 YIN 313 (323)
T ss_dssp ---
T ss_pred CCC
Confidence 443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=416.80 Aligned_cols=261 Identities=22% Similarity=0.271 Sum_probs=201.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc--CCCceEEEeeeec------
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV--RNPFVVRFFYSFT------ 757 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L--~HPNIVkL~~sfq------ 757 (1092)
..+|++.+.||+|+||+||+|+++.+|+.||||++++...........+.+|+.++..+ +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 44699999999999999999999999999999999986655556677888886555444 6999998664442
Q ss_pred -cC-----------------CeeEEEEeecCCCcHHHHHHhhc-CCCHHHH------HHHHHHHHHHHHHHHHcCCeeee
Q 001360 758 -CR-----------------DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVA------RIYIAELVLALEYLHSLGIVHRD 812 (1092)
Q Consensus 758 -de-----------------~~LYLVMEYm~GGSL~dlLkk~g-~LsE~~a------r~yaaQIL~ALeYLHs~GIIHRD 812 (1092)
.. ..+||||||++ |+|.+++...+ .+++... ..++.||+.||.|||++||||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 21 34899999999 89999998753 3444444 45669999999999999999999
Q ss_pred cCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CC
Q 001360 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TE 890 (1092)
Q Consensus 813 LKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~ 890 (1092)
|||+||||+.+|.+||+|||+++... .......||+.|+|||++.+ ..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~------------------------------~~~~~~~~t~~y~aPE~~~~~~~~ 269 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVG------------------------------TRGPASSVPVTYAPREFLNASTAT 269 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETT------------------------------CEEEGGGSCGGGCCHHHHTCSEEE
T ss_pred CCHHHEEECCCCCEEEEecceeeecC------------------------------CCccCccCCcCCcChhhccCCCCC
Confidence 99999999999999999999998421 11114567899999999987 78
Q ss_pred CCccceeechhhhHHHHHhCCCCCCCCChHHH--HHH-----HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc
Q 001360 891 HGYAADWWSVGIILFEFITGIPPFTAESPEII--FDN-----ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (1092)
Q Consensus 891 Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei--~~k-----Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ 963 (1092)
|+.++|||||||+||||++|++||.+..+... +.. .......++. ...+++++.+||.+||..||.+||+
T Consensus 270 ~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt-- 346 (371)
T 3q60_A 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS-CTPLPDFVKTLIGRFLNFDRRRRLL-- 346 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTT-SSCCCHHHHHHHHHHTCSSTTTCCC--
T ss_pred cCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhh-ccCCCHHHHHHHHHHcCCChhhCCC--
Confidence 99999999999999999999999987744211 111 0112223332 3578999999999999999999999
Q ss_pred cHHHHHcCCCCCCCCcch
Q 001360 964 GAAEVKAHPFFKGVNWDS 981 (1092)
Q Consensus 964 ga~EIL~HPFFkgIdWd~ 981 (1092)
+.++++||||+++.|..
T Consensus 347 -~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 347 -PLEAMETPEFLQLQNEI 363 (371)
T ss_dssp -HHHHTTSHHHHHHHHHH
T ss_pred -HHHHhcCHHHHHHHHHH
Confidence 88999999999887764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=401.73 Aligned_cols=262 Identities=28% Similarity=0.442 Sum_probs=205.9
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
....+++|++.+.||+|+||+||+|+++.+|+.||||++.+.... .....+++..+..++||||++++++|.....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 345678999999999999999999999999999999998654322 2346678888899999999999999865443
Q ss_pred -------eEEEEeecCCCcHHHHH----HhhcCCCHHHHHHHHHHHHHHHHHHH--HcCCeeeecCCCceEecC-CCcEE
Q 001360 762 -------LYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALEYLH--SLGIVHRDLKPDNLLIAH-DGHIK 827 (1092)
Q Consensus 762 -------LYLVMEYm~GGSL~dlL----kk~g~LsE~~ar~yaaQIL~ALeYLH--s~GIIHRDLKPeNILLD~-nG~VK 827 (1092)
+|+||||++++ |...+ .....+++..++.++.||+.||.||| ++||+||||||+||||+. +|.+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence 89999999874 44433 34567999999999999999999999 999999999999999997 89999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeechhhhHHH
Q 001360 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFE 906 (1092)
Q Consensus 828 LsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Yt~ksDVWSLGVILYE 906 (1092)
|+|||+++... ........+||+.|+|||++.+.. |+.++|||||||++||
T Consensus 173 l~Dfg~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~e 224 (360)
T 3e3p_A 173 LCDFGSAKKLS----------------------------PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224 (360)
T ss_dssp ECCCTTCBCCC----------------------------TTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred EeeCCCceecC----------------------------CCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHH
Confidence 99999997421 011223467999999999997654 8999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhhcCC-------------------------C----CCCCCCCCCHHHHHHHHHhccCCcC
Q 001360 907 FITGIPPFTAESPEIIFDNILNRKI-------------------------P----WPCVPSDMSFEAQDLINRFLIHDPN 957 (1092)
Q Consensus 907 MLTGk~PF~~~s~~ei~~kIl~~~l-------------------------~----fP~ip~~lS~eakDLI~kcL~kDP~ 957 (1092)
|++|.+||.+.+....+..+..... + ++..+...++++.+||.+||+.||.
T Consensus 225 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 304 (360)
T 3e3p_A 225 MMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE 304 (360)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGG
T ss_pred HHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCcc
Confidence 9999999999988777777654100 0 1122234678999999999999999
Q ss_pred CCCCcccHHHHHcCCCCCCCCc
Q 001360 958 QRLGANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 958 KRpSa~ga~EIL~HPFFkgIdW 979 (1092)
+||+ +.++++||||+++.+
T Consensus 305 ~Rpt---~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 305 ERMK---PYEALCHPYFDELHD 323 (360)
T ss_dssp GSCC---HHHHTTSGGGGGGGC
T ss_pred ccCC---HHHHhcCccccccCC
Confidence 9999 889999999988654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=392.21 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=215.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEE-CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC------ceEEEeeee
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARK-RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP------FVVRFFYSF 756 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~-k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HP------NIVkL~~sf 756 (1092)
...++|++++.||+|+||+||+|.+ +.+|+.||+|+++.. ......+.+|+.++..++|+ +|++++++|
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 4457999999999999999999998 567899999999753 23456788999999888755 599999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC------------
Q 001360 757 TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH------------ 822 (1092)
Q Consensus 757 qde~~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~------------ 822 (1092)
...+.+|+||||+ +|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999999 889999998765 6899999999999999999999999999999999999987
Q ss_pred -------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001360 823 -------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (1092)
Q Consensus 823 -------nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ks 895 (1092)
++.+||+|||+++... ......+||+.|+|||++.+..|+.++
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 215 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDD------------------------------EHHSTLVSTRHYRAPEVILALGWSQPC 215 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETT------------------------------SCCCSSCSCGGGCCHHHHTTSCCCTHH
T ss_pred cccccccCCCceEeeCcccccCc------------------------------cccccccCCccccChHHhhCCCCCcch
Confidence 6789999999987421 112346799999999999999999999
Q ss_pred eeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCC-----------------------------------------
Q 001360 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP----------------------------------------- 934 (1092)
Q Consensus 896 DVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP----------------------------------------- 934 (1092)
|||||||++|||++|.+||...+..+....+.....++|
T Consensus 216 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (339)
T 1z57_A 216 DVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM 295 (339)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGC
T ss_pred hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhc
Confidence 999999999999999999998887665544432111111
Q ss_pred CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 935 ~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
..+...++++.+||.+||..||.+||+ +.++++||||+.+
T Consensus 296 ~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~ 335 (339)
T 1z57_A 296 LSQDVEHERLFDLIQKMLEYDPAKRIT---LREALKHPFFDLL 335 (339)
T ss_dssp SCCSHHHHHHHHHHHHHTCSSTTTSCC---HHHHTTSGGGGGG
T ss_pred ccchhhHHHHHHHHHHHhCcCcccccC---HHHHhcCHHHHHH
Confidence 011223578899999999999999999 8899999999865
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=394.25 Aligned_cols=262 Identities=27% Similarity=0.437 Sum_probs=218.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc------eEEEeeee
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF------VVRFFYSF 756 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TG-k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPN------IVkL~~sf 756 (1092)
...++|++++.||+|+||+||+|.+..++ ..||+|++++. ......+.+|+.+|+.+.|++ ++.+++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 44689999999999999999999998877 68999999753 234567888999999887655 99999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe--------------
Q 001360 757 TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-------------- 820 (1092)
Q Consensus 757 qde~~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL-------------- 820 (1092)
...+.+|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 9999999999999 667777776553 69999999999999999999999999999999999999
Q ss_pred -----cCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001360 821 -----AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (1092)
Q Consensus 821 -----D~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ks 895 (1092)
+.++.+||+|||+++... ......+||+.|+|||++.+..|+.++
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 220 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDH------------------------------EHHTTIVATRHYRPPEVILELGWAQPC 220 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETT------------------------------SCCCSSCSCGGGCCHHHHTTCCCCTHH
T ss_pred ccccccCCCcEEEeecCcccccc------------------------------ccccCCcCCCcccCCeeeecCCCCCcc
Confidence 668899999999987421 112346799999999999999999999
Q ss_pred eeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCC----------------------------------------
Q 001360 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPC---------------------------------------- 935 (1092)
Q Consensus 896 DVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~---------------------------------------- 935 (1092)
|||||||++|||++|.+||...+..+....+.....++|.
T Consensus 221 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (355)
T 2eu9_A 221 DVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYM 300 (355)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGC
T ss_pred chHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccc
Confidence 9999999999999999999988876655544332111110
Q ss_pred -CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001360 936 -VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983 (1092)
Q Consensus 936 -ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~ 983 (1092)
.....+.++.+||.+||..||.+||+ +.++++||||++++|+...
T Consensus 301 ~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~~~~~~~~ 346 (355)
T 2eu9_A 301 LQDSLEHVQLFDLMRRMLEFDPAQRIT---LAEALLHPFFAGLTPEERS 346 (355)
T ss_dssp SCCSHHHHHHHHHHHHHTCSSTTTSCC---HHHHTTSGGGGGCCHHHHC
T ss_pred cccchhHHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcCCChhhcc
Confidence 01122458899999999999999999 8899999999999987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=408.06 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=217.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--CCceEEEeeeeccCCee
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~--HPNIVkL~~sfqde~~L 762 (1092)
....|++++.||+|+||+||+|.+.. ++.||||++.+... .......+.+|+.+|..+. |||||++++++...+.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34569999999999999999999865 99999999976433 4456788999999999997 59999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||||| +.+|+|.+++.+...+++..++.++.||+.||.|||++|||||||||+||||+ +|.+||+|||+++.....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~-- 207 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD-- 207 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC--
Confidence 99999 56889999999888999999999999999999999999999999999999995 689999999999753110
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----------CCCCccceeechhhhHHHHHhCC
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----------TEHGYAADWWSVGIILFEFITGI 911 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----------~~Yt~ksDVWSLGVILYEMLTGk 911 (1092)
.........+||+.|+|||++.+ ..|+.++|||||||+||||++|.
T Consensus 208 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~ 264 (390)
T 2zmd_A 208 -----------------------TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264 (390)
T ss_dssp -----------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSS
T ss_pred -----------------------CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCC
Confidence 00112235689999999999975 36899999999999999999999
Q ss_pred CCCCCCC-hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 912 PPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 912 ~PF~~~s-~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
+||.... .......++.....++ .+...+.++.+||.+||..||.+||+ +.++++||||+..
T Consensus 265 ~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~~~~~ 327 (390)
T 2zmd_A 265 TPFQQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQIQ 327 (390)
T ss_dssp CTTTTCCCHHHHHHHHHCTTSCCC-CCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHSC
T ss_pred CcchhhhHHHHHHHHHhCccccCC-CCccchHHHHHHHHHHcccChhhCCC---HHHHhhCcCcccc
Confidence 9998754 3455556665443322 34667899999999999999999999 8899999999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=386.20 Aligned_cols=256 Identities=30% Similarity=0.534 Sum_probs=226.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.+.|++++.||+|+||.||+|++..+|+.||+|++..... ......+.+|+.++..++||||+++++++.+...+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 4569999999999999999999999999999999976432 23567899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||++||+|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~------ 171 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD------ 171 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT------
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc------
Confidence 999999999999865 6799999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~k 925 (1092)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........
T Consensus 172 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 230 (303)
T 3a7i_A 172 ---------------------TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 230 (303)
T ss_dssp ---------------------TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred ---------------------cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH
Confidence 01122356799999999999999999999999999999999999999999888877776
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 926 Il~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
+..... +.++..++.++.+||.+||..||.+||+ +.++++||||..
T Consensus 231 ~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~ 276 (303)
T 3a7i_A 231 IPKNNP--PTLEGNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFILR 276 (303)
T ss_dssp HHHSCC--CCCCSSCCHHHHHHHHHHCCSSGGGSCC---HHHHTTCHHHHH
T ss_pred hhcCCC--CCCccccCHHHHHHHHHHcCCChhhCcC---HHHHhhChhhhc
Confidence 665543 3345789999999999999999999999 889999999953
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=402.74 Aligned_cols=255 Identities=23% Similarity=0.349 Sum_probs=218.7
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEEC-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKR-------TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k-------~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~ 753 (1092)
+....++|++.+.||+|+||+||+|++. .++..||||+++.. ........+.+|+.+|..+ +|||||+++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 4456789999999999999999999975 34568999999754 2345677899999999999 899999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCc
Q 001360 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (1092)
Q Consensus 754 ~sfqde~~LYLVMEYm~GGSL~dlLkk~g----------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeN 817 (1092)
++|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++|||||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999998653 47899999999999999999999999999999999
Q ss_pred eEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001360 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (1092)
Q Consensus 818 ILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDV 897 (1092)
|||+.+|++||+|||+++..... ..........||+.|+|||++.+..|+.++||
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~-------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv 288 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNI-------------------------DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 288 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCC-------------------------CTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHH
T ss_pred EEECCCCCEEEccccCCcccCcc-------------------------cceecccCCCcccceECHhHhcCCCCCcHHHH
Confidence 99999999999999999853110 00111234568899999999999999999999
Q ss_pred echhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 898 WSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
|||||++|||++ |..||.+.+..+++..+..+.. +..+..++.++.+||.+||..||.+||++.++
T Consensus 289 wslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el 355 (370)
T 2psq_A 289 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 355 (370)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 999999999999 9999999988888877766532 33457899999999999999999999994433
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=411.09 Aligned_cols=256 Identities=27% Similarity=0.455 Sum_probs=217.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc------CCCceEEEeeeec
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV------RNPFVVRFFYSFT 757 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L------~HPNIVkL~~sfq 757 (1092)
....+|++++.||+|+||+||+|++..+++.||||+++.. ......+.+|+.+|..+ +||||++++++|.
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 4457899999999999999999999999999999999753 23445677888888876 5789999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc--EEEEecCC
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGL 833 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~--VKLsDFGL 833 (1092)
....+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++|||||||||+||||+.+|. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999996 59999997654 4999999999999999999999999999999999999999987 99999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCC
Q 001360 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 834 Ak~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
++.. .....+.+||+.|+|||++.+..|+.++|||||||+||||++|.+|
T Consensus 249 a~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~p 298 (429)
T 3kvw_A 249 SCYE------------------------------HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL 298 (429)
T ss_dssp CEET------------------------------TCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ceec------------------------------CCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCC
Confidence 8742 1122356899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcC-C-------------------CCCC------------------------------------CC
Q 001360 914 FTAESPEIIFDNILNRK-I-------------------PWPC------------------------------------VP 937 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~~~-l-------------------~fP~------------------------------------ip 937 (1092)
|.+.+..+....+.... . .+|. ++
T Consensus 299 f~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 378 (429)
T 3kvw_A 299 LPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK 378 (429)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTT
T ss_pred CCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhcc
Confidence 99988877666554310 0 0000 11
Q ss_pred CCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 938 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 938 ~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
...++++.+||.+||+.||.+||+ +.++++||||+..
T Consensus 379 ~~~~~~~~dli~~~L~~dP~~Rpt---a~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 379 GCDDPLFLDFLKQCLEWDPAVRMT---PGQALRHPWLRRR 415 (429)
T ss_dssp TCCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSTTTC--
T ss_pred ccchHHHHHHHHHHCCCChhhCCC---HHHHhCChhhccC
Confidence 234788999999999999999999 8899999999853
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=393.64 Aligned_cols=256 Identities=26% Similarity=0.413 Sum_probs=213.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--ee
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--NL 762 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~--~L 762 (1092)
..+.|++.+.||+|+||+||+|+++.+|+.||||++++.... ...+.+.+|+.+|++++||||+++++++.... .+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 456799999999999999999999999999999999864432 33567889999999999999999999987765 78
Q ss_pred EEEEeecCCCcHHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe----cCCCcEEEEecCCcc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGC---LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLSK 835 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~---LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL----D~nG~VKLsDFGLAk 835 (1092)
|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999986543 9999999999999999999999999999999999999 888899999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc--------CCCCCccceeechhhhHHHH
Q 001360 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--------GTEHGYAADWWSVGIILFEF 907 (1092)
Q Consensus 836 ~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~--------g~~Yt~ksDVWSLGVILYEM 907 (1092)
.... .......+||+.|+|||++. +..|+.++|||||||++|||
T Consensus 165 ~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el 216 (319)
T 4euu_A 165 ELED----------------------------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (319)
T ss_dssp ECCT----------------------------TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHH
T ss_pred ecCC----------------------------CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHH
Confidence 5210 11223467999999999987 57889999999999999999
Q ss_pred HhCCCCCCCCC----hHHHHHHHhhcCC-------------------CCC---CCCCCCCHHHHHHHHHhccCCcCCCCC
Q 001360 908 ITGIPPFTAES----PEIIFDNILNRKI-------------------PWP---CVPSDMSFEAQDLINRFLIHDPNQRLG 961 (1092)
Q Consensus 908 LTGk~PF~~~s----~~ei~~kIl~~~l-------------------~fP---~ip~~lS~eakDLI~kcL~kDP~KRpS 961 (1092)
++|..||.... ..++...++.+.. .+| .++..++..+.+||.+||+.||.+||+
T Consensus 217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s 296 (319)
T 4euu_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296 (319)
T ss_dssp HHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred HhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc
Confidence 99999997433 3445555554332 111 112345678999999999999999999
Q ss_pred cccHHHHHcCCC
Q 001360 962 ANGAAEVKAHPF 973 (1092)
Q Consensus 962 a~ga~EIL~HPF 973 (1092)
+.++++||-
T Consensus 297 ---~~ell~h~~ 305 (319)
T 4euu_A 297 ---FDQFFAETS 305 (319)
T ss_dssp ---HHHHHHHHH
T ss_pred ---HHHhhhccH
Confidence 889998863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=396.69 Aligned_cols=252 Identities=19% Similarity=0.299 Sum_probs=208.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~----VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
+..++|++++.||+|+||+||+|++..+|+. ||+|++.... .......+.+|+.++..++||||+++++++. .
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 4568999999999999999999999988886 5556554321 1223345778999999999999999999886 4
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
..+|+||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 6689999999999999999864 579999999999999999999999999999999999999999999999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
.. ..........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.
T Consensus 167 ~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 221 (325)
T 3kex_A 167 PD-------------------------DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221 (325)
T ss_dssp CC-------------------------TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cc-------------------------cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc
Confidence 10 00112234578899999999999999999999999999999999 99999998
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
...++...+...... ..+..++.++.+||.+||..||.+||++.++
T Consensus 222 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 267 (325)
T 3kex_A 222 RLAEVPDLLEKGERL--AQPQICTIDVYMVMVKCWMIDENIRPTFKEL 267 (325)
T ss_dssp CTTHHHHHHHTTCBC--CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHH
T ss_pred CHHHHHHHHHcCCCC--CCCCcCcHHHHHHHHHHcCCChhhCcCHHHH
Confidence 888887777665322 2346788899999999999999999994433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=397.75 Aligned_cols=260 Identities=26% Similarity=0.381 Sum_probs=215.6
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEE-----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar-----~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~ 754 (1092)
.+.+..++|++.+.||+|+||.||+|+ ...+++.||||++++.. .....+.+.+|+.+|.++ +|||||++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 345677899999999999999999999 45667899999997532 344567899999999999 7999999999
Q ss_pred eeccCCe-eEEEEeecCCCcHHHHHHhhcC--------------------------------------------------
Q 001360 755 SFTCRDN-LYLVMEYLNGGDLYSLLRKVGC-------------------------------------------------- 783 (1092)
Q Consensus 755 sfqde~~-LYLVMEYm~GGSL~dlLkk~g~-------------------------------------------------- 783 (1092)
++.+.+. +|+||||++||+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 9887654 9999999999999999986543
Q ss_pred ----------------CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 784 ----------------LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 784 ----------------LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~------- 246 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD------- 246 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC-------
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc-------
Confidence 899999999999999999999999999999999999999999999999999742100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kI 926 (1092)
..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+..........
T Consensus 247 ------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 308 (359)
T 3vhe_A 247 ------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308 (359)
T ss_dssp ------------------TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred ------------------ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH
Confidence 00112234678999999999999999999999999999999998 99999887755444444
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
+..... +..+..+++++.+||.+||..||.+||+ +.++++|
T Consensus 309 ~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 349 (359)
T 3vhe_A 309 LKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 349 (359)
T ss_dssp HHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHcCCC-CCCCCCCCHHHHHHHHHHccCChhhCCC---HHHHHHH
Confidence 443322 2235789999999999999999999999 5555544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=380.53 Aligned_cols=273 Identities=31% Similarity=0.516 Sum_probs=214.2
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--------
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-------- 758 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd-------- 758 (1092)
++|++++.||+|+||.||+|++..+|+.||||+++.. ......+.+|+.++..++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 5799999999999999999999999999999999652 3456788999999999999999999998754
Q ss_pred -----CCeeEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecC
Q 001360 759 -----RDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832 (1092)
Q Consensus 759 -----e~~LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFG 832 (1092)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 456899999999999999998544 57889999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCC
Q 001360 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGI 911 (1092)
Q Consensus 833 LAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk 911 (1092)
+++...... .... ..... ...........+||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 162 ~~~~~~~~~--~~~~-------~~~~~----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-- 226 (303)
T 1zy4_A 162 LAKNVHRSL--DILK-------LDSQN----LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226 (303)
T ss_dssp CCSCTTC--------------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--
T ss_pred chhhccccc--chhc-------ccccc----ccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--
Confidence 987532100 0000 00000 00011223456899999999999865 68999999999999999998
Q ss_pred CCCCC-CChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchh
Q 001360 912 PPFTA-ESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982 (1092)
Q Consensus 912 ~PF~~-~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L 982 (1092)
||.. .+.......+......+|. ++...+..+++||.+||..||.+||+ +.++++||||+...++..
T Consensus 227 -p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~ 295 (303)
T 1zy4_A 227 -PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG---ARTLLNSGWLPVKHQDEV 295 (303)
T ss_dssp -CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCC---HHHHHHSSCSCCCCHHHH
T ss_pred -ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcC---HHHHhCCCCcCCCChHHH
Confidence 5643 3345556666555444442 44667888999999999999999999 889999999998777654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=393.27 Aligned_cols=261 Identities=23% Similarity=0.404 Sum_probs=210.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+..++|++.+.||+|+||+||+|.++.+|+.||+|++.+. .......+.+|+.+|..++||||+++++++.+.+.+|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4568999999999999999999999999999999988642 3456778999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999987 46799999999999999999999999999999999999999999999999999985321110
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
. ..................+||+.|+|||++.+..|+.++|||||||++|||++|..||........
T Consensus 164 ~-------------~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~ 230 (310)
T 3s95_A 164 Q-------------PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230 (310)
T ss_dssp -----------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT
T ss_pred c-------------ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH
Confidence 0 000000111122334467899999999999999999999999999999999999999976432110
Q ss_pred -----HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 923 -----FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 923 -----~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
........ .+..+++++.+||.+||..||.+||++.++
T Consensus 231 ~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 273 (310)
T 3s95_A 231 DFGLNVRGFLDRY-----CPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273 (310)
T ss_dssp TSSBCHHHHHHHT-----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHhhhhhcccccc-----CCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 11111111 236788899999999999999999994433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=406.10 Aligned_cols=261 Identities=21% Similarity=0.317 Sum_probs=223.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfq 757 (1092)
.+..++|++++.||+|+||+||+|++ ..++..||||+++.. ........+.+|+.+|.+++|||||++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 45568899999999999999999994 456789999999643 23455667899999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC---cEE
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKVG-------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIK 827 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~g-------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG---~VK 827 (1092)
+....|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||||+.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999998653 489999999999999999999999999999999999999665 499
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001360 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (1092)
Q Consensus 828 LsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEM 907 (1092)
|+|||+++...... .........||+.|+|||++.+..|+.++|||||||+||||
T Consensus 225 L~DFG~a~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el 279 (367)
T 3l9p_A 225 IGDFGMARDIYRAG-------------------------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279 (367)
T ss_dssp ECCCHHHHHHHHHS-------------------------SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ECCCcccccccccc-------------------------ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 99999997432110 01122346789999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 908 LT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
++ |.+||...+..++...+..+... ..+..++.++.+||.+||..||.+||+ +.+|++|.++-
T Consensus 280 lt~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps---~~eil~~l~~~ 343 (367)
T 3l9p_A 280 FSLGYMPYPSKSNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPN---FAIILERIEYC 343 (367)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCCCHhHCcC---HHHHHHHHHHH
Confidence 98 99999999999988888776532 234789999999999999999999999 77888876653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=379.28 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=218.4
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
..+.+..++|++++.||+|+||.||+|++. ++..||+|+++.... ....+.+|+.+|..++||||+++++++.+.
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 345577889999999999999999999886 577899999976432 235688999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
..+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999999999999999986 4679999999999999999999999999999999999999999999999999987531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
.. .........||+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 172 ~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 172 DD--------------------------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp CH--------------------------HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cc--------------------------ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 10 0112234567889999999999999999999999999999998 99999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
+.......+....... .+...++.+.+||.+||..||.+||+ +.++++|
T Consensus 226 ~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~ 274 (283)
T 3gen_A 226 TNSETAEHIAQGLRLY--RPHLASEKVYTIMYSCWHEKADERPT---FKILLSN 274 (283)
T ss_dssp CHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred ChhHHHHHHhcccCCC--CCCcCCHHHHHHHHHHccCChhHCcC---HHHHHHH
Confidence 9988888887664332 24778999999999999999999999 5555543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=382.79 Aligned_cols=260 Identities=30% Similarity=0.421 Sum_probs=214.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|.....||+|+||.||+|++..++..||+|++.... ......+.+|+.++..++||||+++++++...+.+|
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 44556666678999999999999999999999999997643 234567899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-CCcEEEEecCCcccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g---~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~ 839 (1092)
+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. +|.+||+|||+++....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999999998652 4678899999999999999999999999999999999998 89999999999875210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC--CCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~--~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
.........||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 176 ---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 176 ---------------------------INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp --------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred ---------------------------CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 01112345799999999999764 3889999999999999999999999764
Q ss_pred ChH-HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 918 SPE-IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 918 s~~-ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
... .......... ..+.++..++.++.+||.+||..||.+||+ +.++++||||+..
T Consensus 229 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~ 285 (295)
T 2clq_A 229 GEPQAAMFKVGMFK-VHPEIPESMSAEAKAFILKCFEPDPDKRAC---ANDLLVDEFLKVS 285 (295)
T ss_dssp SSHHHHHHHHHHHC-CCCCCCTTSCHHHHHHHHHTTCSSTTTSCC---HHHHHTSGGGCC-
T ss_pred CchhHHHHhhcccc-ccccccccCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhhc
Confidence 432 2222211111 123345789999999999999999999999 8899999999854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=377.85 Aligned_cols=254 Identities=21% Similarity=0.357 Sum_probs=219.4
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
+.+..++|++++.||+|+||.||+|++. +++.||+|++.+... ..+.+.+|+.+|.+++||||+++++++.+...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 4466789999999999999999999987 477899999976432 23568899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
+|+||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999999999754 46899999999999999999999999999999999999999999999999999753110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~ 919 (1092)
.........||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+.
T Consensus 160 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~ 213 (269)
T 4hcu_A 160 --------------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213 (269)
T ss_dssp --------------------------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred --------------------------ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH
Confidence 0112234567889999999999999999999999999999999 9999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
.++...+...... ..+..+++++.+||.+||..||.+||+ +.++++|
T Consensus 214 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~ 260 (269)
T 4hcu_A 214 SEVVEDISTGFRL--YKPRLASTHVYQIMNHCWRERPEDRPA---FSRLLRQ 260 (269)
T ss_dssp HHHHHHHHTTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHhcCccC--CCCCcCCHHHHHHHHHHccCCcccCcC---HHHHHHH
Confidence 9888888766332 234778999999999999999999999 5555543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=389.17 Aligned_cols=258 Identities=23% Similarity=0.373 Sum_probs=221.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfq 757 (1092)
....++|++++.||+|+||.||+|++. .+++.||+|++++.. .......+.+|+.+|..++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 456789999999999999999999987 355899999997532 3445678999999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhh------------------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeec
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKV------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~------------------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDL 813 (1092)
+.+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999764 56899999999999999999999999999999
Q ss_pred CCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCc
Q 001360 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY 893 (1092)
Q Consensus 814 KPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ 893 (1092)
||+|||++.+|.+||+|||+++...... .........||+.|+|||++.+..|+.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~ 255 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSAD-------------------------YYKADGNDAIPIRWMPPESIFYNRYTT 255 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGG-------------------------CBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred CcceEEECCCCeEEEeecCCCcccccCc-------------------------cccccCCCcccceecChhhhccCCcCc
Confidence 9999999999999999999987531100 011123456899999999999999999
Q ss_pred cceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 894 AADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 894 ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
++|||||||++|||++ |..||.+.+..++...+..+.. +..+..++.++.+||.+||..||.+||++.++.+.+
T Consensus 256 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 256 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCc--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 9999999999999999 9999999999888888877654 234578999999999999999999999955444444
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=384.21 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=220.9
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeee
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS 755 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~s 755 (1092)
.+....++|++.+.||+|+||.||+|.+ +.++..||+|+++... .......+.+|+.+|..++||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 4456678999999999999999999998 3456899999997532 34566789999999999999999999999
Q ss_pred eccCCeeEEEEeecCCCcHHHHHHhhcC------------------------CCHHHHHHHHHHHHHHHHHHHHcCCeee
Q 001360 756 FTCRDNLYLVMEYLNGGDLYSLLRKVGC------------------------LEEDVARIYIAELVLALEYLHSLGIVHR 811 (1092)
Q Consensus 756 fqde~~LYLVMEYm~GGSL~dlLkk~g~------------------------LsE~~ar~yaaQIL~ALeYLHs~GIIHR 811 (1092)
+.+.+.+|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999986543 8999999999999999999999999999
Q ss_pred ecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC
Q 001360 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891 (1092)
Q Consensus 812 DLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y 891 (1092)
||||+|||++.++.+||+|||+++...... .........||+.|+|||++.+..+
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~ 229 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEED-------------------------SYVKRSQGRIPVKWMAIESLFDHIY 229 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTS-------------------------CEECSSCCCSCGGGCCHHHHHHCEE
T ss_pred ccchheEEEcCCCCEEEccccccccccccc-------------------------cceeccCCCCcccccChhhhcCCCc
Confidence 999999999999999999999987531100 0111234568899999999999999
Q ss_pred CccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 892 GYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 892 t~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
+.++|||||||++|||++ |..||.+.+...+...+..... +..+..+++++.+||.+||..||.+||+ +.++++
T Consensus 230 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~l~~ 304 (314)
T 2ivs_A 230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR--MERPDNCSEEMYRLMLQCWKQEPDKRPV---FADISK 304 (314)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc--CCCCccCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 999999999999999999 9999999988888877766532 2345789999999999999999999999 445443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=386.66 Aligned_cols=273 Identities=21% Similarity=0.297 Sum_probs=228.5
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEee
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~ 754 (1092)
..+.+..++|++.+.||+|+||.||+|+++ .+++.||+|++.+.. .......+.+|+.+|+.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 445677789999999999999999999876 357899999997532 3345567899999999999999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhh----------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC
Q 001360 755 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (1092)
Q Consensus 755 sfqde~~LYLVMEYm~GGSL~dlLkk~----------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG 824 (1092)
++.+.+..|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999999999753 3568999999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhH
Q 001360 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (1092)
Q Consensus 825 ~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVIL 904 (1092)
.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++
T Consensus 176 ~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 230 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230 (322)
T ss_dssp CEEECCTTCCCGGGGGG-------------------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred eEEECcCcccccccccc-------------------------ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHH
Confidence 99999999987532110 01122345689999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC---CCCCCCCcc
Q 001360 905 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH---PFFKGVNWD 980 (1092)
Q Consensus 905 YEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H---PFFkgIdWd 980 (1092)
|||++ |..||.+.+..++...+..+.. +..+..++.++.+||.+||..||.+||++.++.+.+.. ++|+.++|.
T Consensus 231 ~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~ 308 (322)
T 1p4o_A 231 WEIATLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY 308 (322)
T ss_dssp HHHHHTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred HHHHhcCCCccccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccc
Confidence 99999 8999999998888888877654 23357899999999999999999999994433333322 666665554
Q ss_pred h
Q 001360 981 S 981 (1092)
Q Consensus 981 ~ 981 (1092)
.
T Consensus 309 ~ 309 (322)
T 1p4o_A 309 Y 309 (322)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=389.70 Aligned_cols=270 Identities=22% Similarity=0.313 Sum_probs=219.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LY 763 (1092)
..++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.+ +||||+++++++.+.+..|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 45789999999999999999999999999999999875432 23578899999999 8999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc-----EEEEecCCcccc
Q 001360 764 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIG 837 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~-----VKLsDFGLAk~~ 837 (1092)
+||||+ +|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++..
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 99999999864 67999999999999999999999999999999999999999887 999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
..... . ...........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 161 ~~~~~--------~------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 161 IDPET--------K------------KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp BCTTT--------C------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ecCCC--------C------------ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 21100 0 000111234678999999999999999999999999999999999999999874
Q ss_pred ---ChHHHHHHHhhcCCCCCC--CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc-------CCCCCCCCcch
Q 001360 918 ---SPEIIFDNILNRKIPWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA-------HPFFKGVNWDS 981 (1092)
Q Consensus 918 ---s~~ei~~kIl~~~l~fP~--ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~-------HPFFkgIdWd~ 981 (1092)
...+.+..+.......|. ....++ ++.+||.+||..||.+||++..+.+++. .++...++|+.
T Consensus 221 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 221 KADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp CCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred ccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 344556665543332221 113355 9999999999999999999665555443 34556688873
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=391.16 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=219.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk---~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.+..++|++.+.||+|+||+||+|+++.+|. .||||+++... .......+.+|+.+|..++||||+++++++.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4567899999999999999999999986665 59999997532 345567899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
+.+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999999755 579999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
... ..........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.
T Consensus 203 ~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 203 DDP------------------------DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp ----------------------------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cCc------------------------cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 100 00111223457889999999999999999999999999999999 99999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
...++...+..+. ..+ .+..+++++.+||.+||..||.+||++.++.+.|
T Consensus 259 ~~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 259 TNRDVISSVEEGY-RLP-APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp CHHHHHHHHHTTC-CCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHcCC-CCC-CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9988888877653 222 3578999999999999999999999955444433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=394.58 Aligned_cols=261 Identities=25% Similarity=0.402 Sum_probs=211.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc--------cchhHHHHHHHHHHHHHhcCCCceEEEeee
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------IRKNDIERILAERNILITVRNPFVVRFFYS 755 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei--------~kk~~ie~~l~EieIL~~L~HPNIVkL~~s 755 (1092)
...++|++.+.||+|+||.||+|.+.. |..||||++.+... ......+.+.+|+.+|..++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 446789999999999999999999865 99999999865322 122335789999999999999999999999
Q ss_pred ec-----cCCeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEE
Q 001360 756 FT-----CRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 829 (1092)
Q Consensus 756 fq-----de~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLs 829 (1092)
|. ....+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 84 3446899999998 5888888754 469999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHH
Q 001360 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFI 908 (1092)
Q Consensus 830 DFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEML 908 (1092)
|||+++... ........+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 177 Dfg~~~~~~----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 228 (362)
T 3pg1_A 177 DFNLAREDT----------------------------ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228 (362)
T ss_dssp CTTC-------------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred ecCcccccc----------------------------cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH
Confidence 999987421 0112234679999999999987 67899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhhcC------------------------CCCC-----CCCCCCCHHHHHHHHHhccCCcCCC
Q 001360 909 TGIPPFTAESPEIIFDNILNRK------------------------IPWP-----CVPSDMSFEAQDLINRFLIHDPNQR 959 (1092)
Q Consensus 909 TGk~PF~~~s~~ei~~kIl~~~------------------------l~fP-----~ip~~lS~eakDLI~kcL~kDP~KR 959 (1092)
+|++||.+.+..+....+.... ...+ ..+...++.+.+||.+||..||.+|
T Consensus 229 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 308 (362)
T 3pg1_A 229 NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308 (362)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhC
Confidence 9999999988777766664310 0111 1124578999999999999999999
Q ss_pred CCcccHHHHHcCCCCCCC
Q 001360 960 LGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 960 pSa~ga~EIL~HPFFkgI 977 (1092)
|+ +.++++||||+.+
T Consensus 309 pt---~~ell~hp~f~~~ 323 (362)
T 3pg1_A 309 IS---TEQALRHPYFESL 323 (362)
T ss_dssp CC---HHHHHTSGGGTTT
T ss_pred CC---HHHHHcCchhhhc
Confidence 99 8899999999876
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=393.11 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=221.1
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcC--CCceEEEeeee
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVR--NPFVVRFFYSF 756 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk---~~ie~~l~EieIL~~L~--HPNIVkL~~sf 756 (1092)
.....++|++.+.||+|+||.||+|++..+|+.||||++++...... .....+.+|+.++.++. ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 34567889999999999999999999999999999999986543221 12245678999999996 59999999999
Q ss_pred ccCCeeEEEEeecCC-CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEec-CCCcEEEEecCCc
Q 001360 757 TCRDNLYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGLS 834 (1092)
Q Consensus 757 qde~~LYLVMEYm~G-GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD-~nG~VKLsDFGLA 834 (1092)
...+.+|+||||+.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999999986 89999999888999999999999999999999999999999999999999 7899999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~P 913 (1092)
+... ........||+.|+|||++.+..+ +.++|||||||++|||++|..|
T Consensus 198 ~~~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 248 (320)
T 3a99_A 198 ALLK-----------------------------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248 (320)
T ss_dssp EECC-----------------------------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccc-----------------------------cccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCC
Confidence 7521 011234579999999999987665 7889999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcch
Q 001360 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~ 981 (1092)
|.... .+......++ ..+++++.+||.+||..||.+||+ +.++++||||+++.+..
T Consensus 249 f~~~~------~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~hp~~~~~~~~~ 304 (320)
T 3a99_A 249 FEHDE------EIIRGQVFFR---QRVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDVLLPQ 304 (320)
T ss_dssp CCSHH------HHHHCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSCCCHH
T ss_pred CCChh------hhhccccccc---ccCCHHHHHHHHHHccCChhhCcC---HHHHhcCHhhcCccCcc
Confidence 97642 2334444433 678999999999999999999999 88999999999886654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=374.41 Aligned_cols=253 Identities=21% Similarity=0.345 Sum_probs=218.1
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
.+..++|++++.||+|+||.||+|+++ ++..||+|+++.... ....+.+|+.++.+++||||+++++++.+...+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 356689999999999999999999886 567899999976432 235688999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~- 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD- 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT-
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh-
Confidence 99999999999999998765 4999999999999999999999999999999999999999999999999998753110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
.........||+.|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus 158 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (268)
T 3sxs_A 158 -------------------------QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS 212 (268)
T ss_dssp -------------------------CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred -------------------------hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH
Confidence 0111234457888999999999899999999999999999999 99999999988
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
.....+....... .+...++++.+||.+||..||.+||+ +.++++|
T Consensus 213 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~ 258 (268)
T 3sxs_A 213 EVVLKVSQGHRLY--RPHLASDTIYQIMYSCWHELPEKRPT---FQQLLSS 258 (268)
T ss_dssp HHHHHHHTTCCCC--CCTTSCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHcCCCCC--CCCcChHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 8888877665332 24678999999999999999999999 5555543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=393.48 Aligned_cols=254 Identities=27% Similarity=0.462 Sum_probs=209.1
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----------CCceEE
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----------NPFVVR 751 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-----------HPNIVk 751 (1092)
....++|++++.||+|+||+||+|++..+|+.||||++++. ......+.+|+.++.++. ||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 35568999999999999999999999999999999999753 234566888999998876 899999
Q ss_pred EeeeeccCC----eeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHc-CCeeeecCCCceEec---
Q 001360 752 FFYSFTCRD----NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIA--- 821 (1092)
Q Consensus 752 L~~sfqde~----~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~-GIIHRDLKPeNILLD--- 821 (1092)
+++++.... .+|+||||+ +|+|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+||||+
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999998755 799999999 89999999864 4599999999999999999999998 999999999999995
Q ss_pred ---CCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001360 822 ---HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (1092)
Q Consensus 822 ---~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVW 898 (1092)
..+.+||+|||+++... ......+||+.|+|||++.+..|+.++|||
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 219 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYD------------------------------EHYTNSIQTREYRSPEVLLGAPWGCGADIW 219 (373)
T ss_dssp TTTTEEEEEECCCTTCEETT------------------------------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHH
T ss_pred CCcCcceEEEcccccccccC------------------------------CCCCCCCCCccccCcHHHhCCCCCchHhHH
Confidence 44589999999987421 112235799999999999999999999999
Q ss_pred chhhhHHHHHhCCCCCCCCCh------HHHHHHHhh------------------------------------------cC
Q 001360 899 SVGIILFEFITGIPPFTAESP------EIIFDNILN------------------------------------------RK 930 (1092)
Q Consensus 899 SLGVILYEMLTGk~PF~~~s~------~ei~~kIl~------------------------------------------~~ 930 (1092)
||||++|||++|.+||...+. ......+.. ..
T Consensus 220 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (373)
T 1q8y_A 220 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK 299 (373)
T ss_dssp HHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhc
Confidence 999999999999999986542 222222221 11
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 931 l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.. ++..++.++.+||.+||+.||.+||+ +.++++||||++.
T Consensus 300 ~~---~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~ 340 (373)
T 1q8y_A 300 YK---FSKDEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDT 340 (373)
T ss_dssp TC---CCHHHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTC
T ss_pred cc---CCcchHHHHHHHHHHHhccCccccCC---HHHHhhChhhhcc
Confidence 11 12455778999999999999999999 8899999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=373.41 Aligned_cols=251 Identities=27% Similarity=0.439 Sum_probs=207.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~k-k~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
+..++|++.+.||+|+||.||+|++. |+.||+|+++...... ....+.+.+|+.++..++||||+++++++.+.+.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 45789999999999999999999975 8899999987643222 23457789999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcC---CeeeecCCCceEecC--------CCcEEEEec
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG---IVHRDLKPDNLLIAH--------DGHIKLTDF 831 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~G---IIHRDLKPeNILLD~--------nG~VKLsDF 831 (1092)
|+||||++||+|.+++. ...+++..+..++.|++.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999985 457999999999999999999999999 999999999999986 788999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCC
Q 001360 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911 (1092)
Q Consensus 832 GLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk 911 (1092)
|+++... ........||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 161 g~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 211 (271)
T 3dtc_A 161 GLAREWH-----------------------------RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211 (271)
T ss_dssp CC------------------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCC
T ss_pred Ccccccc-----------------------------cccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9987421 01112457999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 912 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 912 ~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
.||.+.+.......+.......+ .+..+++++.+||.+||..||.+||+ +.++++
T Consensus 212 ~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~ 266 (271)
T 3dtc_A 212 VPFRGIDGLAVAYGVAMNKLALP-IPSTCPEPFAKLMEDCWNPDPHSRPS---FTNILD 266 (271)
T ss_dssp CTTTTSCHHHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred CCCCCCCHHHHHHhhhcCCCCCC-CCcccCHHHHHHHHHHhcCCcccCcC---HHHHHH
Confidence 99999888888777776665543 46789999999999999999999999 445543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=371.71 Aligned_cols=249 Identities=19% Similarity=0.304 Sum_probs=216.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--C
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 760 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde--~ 760 (1092)
.+..++|++.+.||+|+||.||+|++. |+.||+|+++... ......+.+.+|+.+|.+++||||+++++++.+. .
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 456789999999999999999999985 8899999997643 2344567899999999999999999999999887 7
Q ss_pred eeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcC--CeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~G--IIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.+|.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 8999999999999999998765 4899999999999999999999999 99999999999999999999999998652
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCc---cceeechhhhHHHHHhCCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~---ksDVWSLGVILYEMLTGk~P 913 (1092)
. .....+||+.|+|||++.+..++. ++|||||||++|||++|..|
T Consensus 163 ~--------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 210 (271)
T 3kmu_A 163 F--------------------------------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210 (271)
T ss_dssp T--------------------------------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCT
T ss_pred e--------------------------------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 1 112357899999999999866554 79999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 914 F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
|.+.+.......+...... +.++..+++++.+||.+||..||.+||++.++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 211 FADLSNMEIGMKVALEGLR-PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TTTSCHHHHHHHHHHSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccChHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999988887777766544 3356789999999999999999999999544443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=404.22 Aligned_cols=262 Identities=25% Similarity=0.454 Sum_probs=197.4
Q ss_pred CCeEE-EEeeccCCCeEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee--ccCCe
Q 001360 687 DDFEI-IKPISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF--TCRDN 761 (1092)
Q Consensus 687 ~dFei-lr~LGkGgFGtVyLar~k--~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sf--qde~~ 761 (1092)
+.|++ .+.||+|+||+||+|+++ .+++.||||++.+... ...+.+|+.+|+.++|||||+++++| .....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 34665 357999999999999977 4688999999975432 24578999999999999999999999 45778
Q ss_pred eEEEEeecCCCcHHHHHHhhc---------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe----cCCCcEEE
Q 001360 762 LYLVMEYLNGGDLYSLLRKVG---------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKL 828 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g---------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL----D~nG~VKL 828 (1092)
+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999997 48888886332 49999999999999999999999999999999999999 77899999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHH
Q 001360 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEF 907 (1092)
Q Consensus 829 sDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEM 907 (1092)
+|||+++..... ..........+||+.|+|||++.+. .|+.++|||||||+||||
T Consensus 174 ~Dfg~a~~~~~~------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 229 (405)
T 3rgf_A 174 ADMGFARLFNSP------------------------LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229 (405)
T ss_dssp CCTTCCC----------------------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHH
T ss_pred EECCCceecCCC------------------------CcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHH
Confidence 999999753100 0001223457899999999999874 589999999999999999
Q ss_pred HhCCCCCCCCCh---------HHHHHHHhhc-CCC----CCC------------------------------CCCCCCHH
Q 001360 908 ITGIPPFTAESP---------EIIFDNILNR-KIP----WPC------------------------------VPSDMSFE 943 (1092)
Q Consensus 908 LTGk~PF~~~s~---------~ei~~kIl~~-~l~----fP~------------------------------ip~~lS~e 943 (1092)
++|.+||.+... .+....|+.. ..+ |+. .....+.+
T Consensus 230 l~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (405)
T 3rgf_A 230 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309 (405)
T ss_dssp HHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSH
T ss_pred HhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHH
Confidence 999999976553 2333333321 000 000 01123778
Q ss_pred HHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcch
Q 001360 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981 (1092)
Q Consensus 944 akDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~ 981 (1092)
+.+||.+||+.||.+||+ +.++++||||.+..|..
T Consensus 310 ~~~Ll~~~L~~dP~~R~t---a~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 310 AFHLLQKLLTMDPIKRIT---SEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp HHHHHHHHSCSSGGGSCC---HHHHHTSGGGTSSSCCC
T ss_pred HHHHHHHHccCCcccCCC---HHHHhcChhhccCCCCc
Confidence 999999999999999999 88999999999876654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=399.25 Aligned_cols=259 Identities=32% Similarity=0.469 Sum_probs=215.0
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CC-----ceEEEeeee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NP-----FVVRFFYSF 756 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HP-----NIVkL~~sf 756 (1092)
....++|++.+.||+|+||+||+|+++.+|+.||||++++. ......+..|+.++..+. |+ +|++++++|
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 34578999999999999999999999999999999999753 234566778888888875 44 599999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH--HcCCeeeecCCCceEec--CCCcEEEEe
Q 001360 757 TCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLH--SLGIVHRDLKPDNLLIA--HDGHIKLTD 830 (1092)
Q Consensus 757 qde~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLH--s~GIIHRDLKPeNILLD--~nG~VKLsD 830 (1092)
...+.+|+||||+. |+|.+++... +.+++..++.++.||+.||.||| +.|||||||||+||||+ .++.+||+|
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999996 4999999865 46999999999999999999999 57999999999999995 478899999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC
Q 001360 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910 (1092)
Q Consensus 831 FGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTG 910 (1092)
||+++... ......+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 205 FG~a~~~~------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 254 (382)
T 2vx3_A 205 FGSSCQLG------------------------------QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254 (382)
T ss_dssp CTTCEETT------------------------------CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccCceecc------------------------------cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99997421 112346899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCC---------------C------------------CCC------------------
Q 001360 911 IPPFTAESPEIIFDNILNRKIPWPC---------------V------------------PSD------------------ 939 (1092)
Q Consensus 911 k~PF~~~s~~ei~~kIl~~~l~fP~---------------i------------------p~~------------------ 939 (1092)
++||.+.+..+....+.......|. + +..
T Consensus 255 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 334 (382)
T 2vx3_A 255 EPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGR 334 (382)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGT
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCcc
Confidence 9999999888777776542110000 0 000
Q ss_pred ----------CCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCc
Q 001360 940 ----------MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 940 ----------lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdW 979 (1092)
.++++++||.+||+.||.+||| +.++++||||+...|
T Consensus 335 ~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt---a~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 335 RAGESGHTVADYLKFKDLILRMLDYDPKTRIQ---PYYALQHSFFKKTAD 381 (382)
T ss_dssp TTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC---HHHHTTSGGGCC---
T ss_pred ccccccccchhhHHHHHHHHHhcCCChhhCCC---HHHHhcCcccccCCC
Confidence 0147899999999999999999 889999999987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=384.93 Aligned_cols=261 Identities=24% Similarity=0.370 Sum_probs=212.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++++...+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 35678999999999999999999999999999999999875554555568899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 187 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE-- 187 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc--
Confidence 999999999999999998889999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
........+||+.|+|||++.+..++.++||||||+++|||++|..||.+.+...+
T Consensus 188 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (309)
T 2h34_A 188 ------------------------KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243 (309)
T ss_dssp ---------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH
T ss_pred ------------------------ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH
Confidence 01112345799999999999999999999999999999999999999998877655
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCC-CcccHHHHH
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL-GANGAAEVK 969 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRp-Sa~ga~EIL 969 (1092)
...+..........+..++.++.+||.+||..||.+|| ++.++.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l 291 (309)
T 2h34_A 244 GAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAA 291 (309)
T ss_dssp HHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred HHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHH
Confidence 54444333222234578899999999999999999999 654444444
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=388.67 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=215.9
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~ 754 (1092)
.+.+..++|++.+.||+|+||.||+|++. .++..||+|+++... .......+.+|+.+|.++ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 45567789999999999999999999973 456789999997532 233457789999999999 8999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhhc-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeee
Q 001360 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------------------CLEEDVARIYIAELVLALEYLHSLGIVHR 811 (1092)
Q Consensus 755 sfqde~~LYLVMEYm~GGSL~dlLkk~g-----------------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHR 811 (1092)
++...+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999997653 37899999999999999999999999999
Q ss_pred ecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC
Q 001360 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891 (1092)
Q Consensus 812 DLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y 891 (1092)
||||+||||+.+|.+||+|||+++..... ..........||+.|+|||++.+..|
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~-------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~ 251 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSD-------------------------SNYVVRGNARLPVKWMAPESLFEGIY 251 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGC-------------------------TTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccC-------------------------ccceeccCccCccCccCHHHhccCCC
Confidence 99999999999999999999998753210 00112234568999999999999999
Q ss_pred CccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 892 GYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 892 t~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
+.++|||||||++|||++ |..||.+......+..++......+ .+..+++++.+||.+||..||.+||++.++.+
T Consensus 252 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 327 (344)
T 1rjb_A 252 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD-QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327 (344)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999998 9999998876666666665544433 45778999999999999999999999443333
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=379.40 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=218.6
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~ 753 (1092)
..+....++|++.+.||+|+||.||+|++ ..+++.||+|+++... .....+.+.+|+.+|.++ +||||++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 44556778999999999999999999985 4567899999997543 234567899999999999 899999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhhc------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCC
Q 001360 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 815 (1092)
Q Consensus 754 ~sfqde~~LYLVMEYm~GGSL~dlLkk~g------------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKP 815 (1092)
+++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 99999999999999999999999998654 489999999999999999999999999999999
Q ss_pred CceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001360 816 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (1092)
Q Consensus 816 eNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ks 895 (1092)
+|||++.++.+||+|||+++..... ..........||+.|+|||++.+..++.++
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 228 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKND-------------------------SNYVVKGNARLPVKWMAPESIFNCVYTFES 228 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSC-------------------------TTSEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred ceEEEcCCCCEEEcccccccccccc-------------------------ccceeccCCCCcceeeChHHhcCCCCChHH
Confidence 9999999999999999998742100 001112345688999999999999999999
Q ss_pred eeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 896 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 896 DVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
|||||||++|||++ |..||.+.........++......+ .+..++.++.+||.+||..||.+||++.++.+
T Consensus 229 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC-CcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999 9999998776555555555443322 35678999999999999999999999444333
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=374.89 Aligned_cols=272 Identities=19% Similarity=0.259 Sum_probs=219.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~L 762 (1092)
...++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+|+.++..+ +||+|+++++++......
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 45678999999999999999999999999999999987533 223578899999999 799999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc-----EEEEecCCccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKI 836 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~-----VKLsDFGLAk~ 836 (1092)
|+||||+ +|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|. +||+|||+++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 999999998754 5999999999999999999999999999999999999988776 99999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
...... . ...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 161 ~~~~~~--------~------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 220 (298)
T 1csn_A 161 YRDPVT--------K------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 220 (298)
T ss_dssp SBCTTT--------C------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccc--------c------------ccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcch
Confidence 321100 0 00001223457899999999999999999999999999999999999999987
Q ss_pred C---ChHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH-------cCCCCCCCCcch
Q 001360 917 E---SPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK-------AHPFFKGVNWDS 981 (1092)
Q Consensus 917 ~---s~~ei~~kIl~~~l--~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL-------~HPFFkgIdWd~ 981 (1092)
. .....+..+..... +.+.....+++++.+||.+||..||.+||++.++.+.+ ........+|+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 221 LKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp CCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred hhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 4 34455555544321 22223357899999999999999999999965444433 234455566654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=376.45 Aligned_cols=258 Identities=21% Similarity=0.351 Sum_probs=222.8
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
..+.+..++|++.+.||+|+||.||+|.++.++..||+|+++.. ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 35567788999999999999999999999999999999999753 23567789999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
..+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999999864 45999999999999999999999999999999999999999999999999998752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~ 916 (1092)
.. ..........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.+
T Consensus 162 ~~--------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 162 TG--------------------------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp CS--------------------------SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cC--------------------------CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 10 00112234567899999999999999999999999999999999 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.+...+...+..... +..+..+++++.+||.+||..||.+||++.++.+.+
T Consensus 216 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l 266 (288)
T 3kfa_A 216 IDLSQVYELLEKDYR--MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266 (288)
T ss_dssp CCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHhccCC--CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence 888877777655422 223578999999999999999999999955554444
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=373.37 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=211.0
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhH----HHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND----IERILAERNILITVRNPFVVRFFYSFTC 758 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~----ie~~l~EieIL~~L~HPNIVkL~~sfqd 758 (1092)
....++|++.+.||+|+||+||+|++..+++.||+|++.......... ...+.+|+.++..++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 356789999999999999999999999999999999997644332222 2678999999999999999999999987
Q ss_pred CCeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcC--CeeeecCCCceEecCCCc-----EEEEe
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGH-----IKLTD 830 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~G--IIHRDLKPeNILLD~nG~-----VKLsD 830 (1092)
.. ++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||++| |+||||||+|||++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 66 7999999999999988654 46999999999999999999999999 999999999999998886 99999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc--CCCCCccceeechhhhHHHHH
Q 001360 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--GTEHGYAADWWSVGIILFEFI 908 (1092)
Q Consensus 831 FGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~--g~~Yt~ksDVWSLGVILYEML 908 (1092)
||+++... ......+||+.|+|||++. ...|+.++|||||||++|||+
T Consensus 173 fg~~~~~~------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~ 222 (287)
T 4f0f_A 173 FGLSQQSV------------------------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222 (287)
T ss_dssp CTTCBCCS------------------------------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH
T ss_pred CCcccccc------------------------------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH
Confidence 99987321 1123467999999999994 456789999999999999999
Q ss_pred hCCCCCCCCChHHH--HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 909 TGIPPFTAESPEII--FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 909 TGk~PF~~~s~~ei--~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
+|..||...+.... ...+...... +.++..+++++.+||.+||..||.+||++.++.+.
T Consensus 223 ~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 223 TGEGPFDEYSYGKIKFINMIREEGLR-PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp HSSCTTTTCCCCHHHHHHHHHHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCccccccHHHHHHHHhccCCC-CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999987654333 4444444333 34567899999999999999999999995544443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=377.79 Aligned_cols=246 Identities=22% Similarity=0.352 Sum_probs=208.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCC-------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTG-------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 756 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TG-------k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sf 756 (1092)
+..++|++.+.||+|+||+||+|+++.++ ..||+|++.+.. ....+.+.+|+.+|..++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 45678999999999999999999998877 469999987533 34567799999999999999999999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc--------EE
Q 001360 757 TCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--------IK 827 (1092)
Q Consensus 757 qde~~LYLVMEYm~GGSL~dlLkk~g~-LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~--------VK 827 (1092)
.+.+..|+||||++||+|.+++.+.+. +++..+..++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 999999999999999999999999999999999999999887 99
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHH
Q 001360 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFE 906 (1092)
Q Consensus 828 LsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYE 906 (1092)
|+|||++.... ......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 162 l~Dfg~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~e 210 (289)
T 4fvq_A 162 LSDPGISITVL-------------------------------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWE 210 (289)
T ss_dssp ECCCCSCTTTS-------------------------------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHH
T ss_pred eccCccccccc-------------------------------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHH
Confidence 99999986421 1123568999999999987 779999999999999999
Q ss_pred HHhC-CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 907 FITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 907 MLTG-k~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
|++| .+||...+..... .+......+| ...+.++.+||.+||..||.+||+ +.++++
T Consensus 211 l~~g~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~ 268 (289)
T 4fvq_A 211 ICSGGDKPLSALDSQRKL-QFYEDRHQLP---APKAAELANLINNCMDYEPDHRPS---FRAIIR 268 (289)
T ss_dssp HHTTTCCTTTTSCHHHHH-HHHHTTCCCC---CCSSCTTHHHHHHHSCSSGGGSCC---HHHHHH
T ss_pred HHcCCCCCccccchHHHH-HHhhccCCCC---CCCCHHHHHHHHHHcCCChhHCcC---HHHHHH
Confidence 9995 5555555554443 3334433333 567889999999999999999999 445554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=378.54 Aligned_cols=262 Identities=27% Similarity=0.470 Sum_probs=204.0
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
....++|++++.||+|+||.||+|+++.+|+.||||++..... .......+..+..++..++||||+++++++.+.+.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 4567899999999999999999999999999999999976432 222334445555678888999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHc-CCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
|+||||+ ++.+..++.. .+.+++..++.++.||+.||.|||+. ||+||||||+|||++.+|.+||+|||+++....
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~- 177 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD- 177 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC-
Confidence 9999999 5566665544 46799999999999999999999995 999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCC
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
........||+.|+|||++. +..++.++|||||||++|||++|..||.
T Consensus 178 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (318)
T 2dyl_A 178 ---------------------------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230 (318)
T ss_dssp ------------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ---------------------------CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence 11123457999999999994 4578899999999999999999999998
Q ss_pred C-CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 916 A-ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 916 ~-~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
. ....+....+.....+.......++.++.+||.+||..||.+||+ +.++++||||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 231 NCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK---YNKLLEHSFIKRY 290 (318)
T ss_dssp TCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC---HHHHTTSHHHHHH
T ss_pred CCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcC---HHHHhhCHHHHhc
Confidence 7 455566666666544322223468999999999999999999999 8899999999753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=398.85 Aligned_cols=258 Identities=27% Similarity=0.398 Sum_probs=219.9
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
.+.+..++|++.+.||+|+||+||+|+++.+|+.||||+++.. ........+.+|+.+|+.++|||||++++++...+
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 4456778999999999999999999999999999999998753 23445567889999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
.+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999999999998764 599999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s 918 (1092)
.. + ........+|+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+
T Consensus 266 ~~---------------------~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 266 GV---------------------Y----AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp SE---------------------E----ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred Cc---------------------e----eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 00 0 001112346788999999998899999999999999999998 999999998
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
..++...+..+. .+| .|..+++++.+||.+||..||.+||++.++.+
T Consensus 321 ~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 321 NQQTREFVEKGG-RLP-CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHTTC-CCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 888777765543 222 35778999999999999999999999554433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=391.26 Aligned_cols=259 Identities=24% Similarity=0.354 Sum_probs=222.0
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEE
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTT-------GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 751 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~T-------Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVk 751 (1092)
..+.+..++|++.+.||+|+||+||+|++..+ +..||+|+++.. ........+.+|+.++..+ +|||||+
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 34566778999999999999999999997543 357999999764 2345667899999999999 8999999
Q ss_pred EeeeeccCCeeEEEEeecCCCcHHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCC
Q 001360 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 815 (1092)
Q Consensus 752 L~~sfqde~~LYLVMEYm~GGSL~dlLkk~g----------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKP 815 (1092)
+++++.+.+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999998754 499999999999999999999999999999999
Q ss_pred CceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001360 816 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (1092)
Q Consensus 816 eNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ks 895 (1092)
+||||+.+|.+||+|||+++..... ..........||+.|+|||++.+..++.++
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~-------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 274 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHI-------------------------DYYKKTTNGRLPVKWMAPEALFDRIYTHQS 274 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCC-------------------------CTTCCCTTCCCGGGGSCHHHHHSCCCCHHH
T ss_pred ceEEEcCCCcEEEcccCcccccccc-------------------------cccccccCCCCCcceeCHHHhcCCCCCchh
Confidence 9999999999999999999742100 001122345688999999999999999999
Q ss_pred eeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 896 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 896 DVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
|||||||++|||++ |..||.+.+..++...+..+.. +..+..+++++.+||.+||..||.+||+ +.++++
T Consensus 275 DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~ 345 (382)
T 3tt0_A 275 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPT---FKQLVE 345 (382)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCSSCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 99999999999999 9999999998888888776542 2235789999999999999999999999 555554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=375.43 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=206.4
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~T---Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd 758 (1092)
..+..++|++.+.||+|+||.||+|.+..+ +..||+|+++... .....+.+.+|+.++..++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 345668999999999999999999998754 4579999886532 3445678999999999999999999999984
Q ss_pred CCeeEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 567899999999999999998654 6999999999999999999999999999999999999999999999999998753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~ 916 (1092)
... .........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+
T Consensus 167 ~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~ 220 (281)
T 1mp8_A 167 EDS--------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220 (281)
T ss_dssp --------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred Ccc--------------------------cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCc
Confidence 100 0011223467889999999999999999999999999999997 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
.+..++...+..... +..+..+++++.+||.+||..||.+||++.++
T Consensus 221 ~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 267 (281)
T 1mp8_A 221 VKNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 267 (281)
T ss_dssp CCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 888888887776542 22457899999999999999999999994433
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=381.98 Aligned_cols=255 Identities=29% Similarity=0.476 Sum_probs=208.3
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhc----CCCceEEEeee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITV----RNPFVVRFFYS 755 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk---~~ie~~l~EieIL~~L----~HPNIVkL~~s 755 (1092)
....++|++.+.||+|+||.||+|+++.+|+.||+|+++....... .....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3556789999999999999999999999999999999976443221 1233466799999988 89999999999
Q ss_pred eccCCeeEEEEee-cCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEec-CCCcEEEEecCC
Q 001360 756 FTCRDNLYLVMEY-LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGL 833 (1092)
Q Consensus 756 fqde~~LYLVMEY-m~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD-~nG~VKLsDFGL 833 (1092)
+...+..|+|||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78999999999888999999999999999999999999999999999999999 899999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCC
Q 001360 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIP 912 (1092)
Q Consensus 834 Ak~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~ 912 (1092)
++... ........||+.|+|||++.+..+ +.++|||||||++|||++|+.
T Consensus 187 ~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 237 (312)
T 2iwi_A 187 GALLH-----------------------------DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237 (312)
T ss_dssp CEECC-----------------------------SSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred hhhcc-----------------------------cCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCC
Confidence 87521 011234579999999999987666 458999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCC
Q 001360 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 913 PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgId 978 (1092)
||.... .+......++ ..++.++.+||.+||..||.+||+ +.++++||||+...
T Consensus 238 pf~~~~------~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 238 PFERDQ------EILEAELHFP---AHVSPDCCALIRRCLAPKPSSRPS---LEEILLDPWMQTPA 291 (312)
T ss_dssp SCCSHH------HHHHTCCCCC---TTSCHHHHHHHHHHTCSSTTTSCC---HHHHHHSTTTCC--
T ss_pred CCCChH------HHhhhccCCc---ccCCHHHHHHHHHHccCChhhCcC---HHHHhcChhhcCch
Confidence 997532 2344444444 688999999999999999999999 88999999998653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=367.85 Aligned_cols=252 Identities=21% Similarity=0.361 Sum_probs=217.8
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
.+..++|++.+.||+|+||.||+|.+. +++.||+|++++... ..+.+.+|+.++..++||||+++++++.+.+.+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 456689999999999999999999987 578899999976432 235688999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
|+||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~- 157 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD- 157 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc-
Confidence 9999999999999999865 56899999999999999999999999999999999999999999999999998753110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
.........||+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 158 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (267)
T 3t9t_A 158 -------------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 212 (267)
T ss_dssp -------------------------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred -------------------------cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH
Confidence 0111234567889999999999999999999999999999999 99999999988
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
+....+..+... ..+...+.++.+||.+||..||.+||+ +.++++
T Consensus 213 ~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~ 257 (267)
T 3t9t_A 213 EVVEDISTGFRL--YKPRLASTHVYQIMNHCWRERPEDRPA---FSRLLR 257 (267)
T ss_dssp HHHHHHHTTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHhcCCcC--CCCccCcHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 888887765332 234678999999999999999999999 445443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=381.22 Aligned_cols=259 Identities=21% Similarity=0.340 Sum_probs=219.0
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk-----~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~ 753 (1092)
.......++|++.+.||+|+||.||+|.+..++. .||+|+++... .......+.+|+.+|..+ +||||++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 3456778999999999999999999999987664 79999997533 334567899999999999 899999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhh--------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceE
Q 001360 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKV--------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819 (1092)
Q Consensus 754 ~sfqde~~LYLVMEYm~GGSL~dlLkk~--------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNIL 819 (1092)
+++...+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 9999999999999999999999999753 35799999999999999999999999999999999999
Q ss_pred ecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeec
Q 001360 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899 (1092)
Q Consensus 820 LD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWS 899 (1092)
++.++.+||+|||+++...... .........||+.|+|||++.+..++.++||||
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 251 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDS-------------------------NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 251 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCT-------------------------TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHH
T ss_pred ECCCCeEEECcccccccccccc-------------------------ceeecCCCCCCccccCHHHhccCCCChHHHHHH
Confidence 9999999999999987432100 011123456889999999999999999999999
Q ss_pred hhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHH
Q 001360 900 VGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (1092)
Q Consensus 900 LGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~ 966 (1092)
|||++|||++ |.+||.+.........+.......+ .+...+.++.+||.+||..||.+||++.++.
T Consensus 252 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 318 (333)
T 2i1m_A 252 YGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA-QPAFAPKNIYSIMQACWALEPTHRPTFQQIC 318 (333)
T ss_dssp HHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 9999999998 9999998776666666665544432 3567899999999999999999999944333
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=374.39 Aligned_cols=254 Identities=29% Similarity=0.493 Sum_probs=206.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++.+.||+|+||.||+|....+|+.||+|+++............+.+|+.++..++||||+++++++...+.+|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 35678999999999999999999999999999999998755555667788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 764 LVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999999864 35689999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s- 918 (1092)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 189 ---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 241 (310)
T 2wqm_A 189 ---------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241 (310)
T ss_dssp -------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C
T ss_pred ---------------------------CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 0111234579999999999999999999999999999999999999997653
Q ss_pred -hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 919 -PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 919 -~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
.......+.....+ +..+..++.++.+||.+||..||.+||++.++
T Consensus 242 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~i 288 (310)
T 2wqm_A 242 NLYSLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288 (310)
T ss_dssp CHHHHHHHHHTTCSC-CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hHHHHHHHhhcccCC-CCcccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 34555555544432 11236789999999999999999999994433
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=386.11 Aligned_cols=267 Identities=23% Similarity=0.397 Sum_probs=199.2
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCceEEEeeeecc
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTC 758 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~Eie-IL~~L~HPNIVkL~~sfqd 758 (1092)
..+.+..++|++++.||+|+||.||+|.++.+|+.||||+++... .......+..|.. +++.++||||+++++++.+
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 445677899999999999999999999999999999999997642 2334455666665 6777899999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHc-CCeeeecCCCceEecCCCcEEEEecC
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFG 832 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk-----~g~LsE~~ar~yaaQIL~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFG 832 (1092)
.+.+|+||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.+|.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999985 88887763 46799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh----cCCCCCccceeechhhhHHHHH
Q 001360 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL----LGTEHGYAADWWSVGIILFEFI 908 (1092)
Q Consensus 833 LAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL----~g~~Yt~ksDVWSLGVILYEML 908 (1092)
+++.... ........||+.|+|||++ .+..|+.++|||||||++|+|+
T Consensus 172 ~~~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~ 223 (327)
T 3aln_A 172 ISGQLVD----------------------------SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223 (327)
T ss_dssp SSCC----------------------------------------------------------CCSHHHHHHHHHHHHHHH
T ss_pred Cceeccc----------------------------ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHH
Confidence 9874210 0111234799999999999 4567899999999999999999
Q ss_pred hCCCCCCCCCh-HHHHHHHhhcCCC-CCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcc
Q 001360 909 TGIPPFTAESP-EIIFDNILNRKIP-WPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 909 TGk~PF~~~s~-~ei~~kIl~~~l~-fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd 980 (1092)
+|..||..... .+....+..+..+ ++. ....+++++.+||.+||..||.+||+ +.++++||||....+.
T Consensus 224 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 224 TGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK---YKELLKHPFILMYEER 295 (327)
T ss_dssp HSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCC---HHHHTTSHHHHHHHHS
T ss_pred HCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcC---HHHHHhChHHHHhHhh
Confidence 99999987543 2333333333221 111 12468999999999999999999999 8899999999765444
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=377.49 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=214.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--CCceEEEeeeeccCC
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRD 760 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~--HPNIVkL~~sfqde~ 760 (1092)
....++|++++.||+|+||.||+|++. +|+.||+|++.... ........+.+|+.+|.++. ||||+++++++...+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 345677999999999999999999985 58999999997543 23456788999999999997 599999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|+||| +.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+++.....
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 9999999 56889999999888999999999999999999999999999999999999996 599999999998742110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----------CCCCccceeechhhhHHHHHh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----------TEHGYAADWWSVGIILFEFIT 909 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----------~~Yt~ksDVWSLGVILYEMLT 909 (1092)
.........+||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 180 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~ 234 (313)
T 3cek_A 180 -------------------------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234 (313)
T ss_dssp -----------------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHH
T ss_pred -------------------------cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHh
Confidence 00111234679999999999976 468899999999999999999
Q ss_pred CCCCCCCCCh-HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 910 GIPPFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 910 Gk~PF~~~s~-~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
|..||..... ......+....... .++...+.++.+||.+||..||.+||+ +.++++||||+.
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~h~~~~~ 298 (313)
T 3cek_A 235 GKTPFQQIINQISKLHAIIDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQI 298 (313)
T ss_dssp SSCTTTTCCSHHHHHHHHHCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHC
T ss_pred CCCchhhHHHHHHHHHHHHhccccc-CCcccchHHHHHHHHHHccCCcccCcC---HHHHhcCccccC
Confidence 9999987543 34444444433322 234667899999999999999999999 889999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=378.65 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=214.0
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 755 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~s 755 (1092)
+....++|++.+.||+|+||+||+|++ ..+++.||+|++++.. .......+.+|+.+|.++ +||||++++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 345678999999999999999999985 3567899999997643 334567889999999999 69999999999
Q ss_pred eccCC-eeEEEEeecCCCcHHHHHHhhcC----------------CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCce
Q 001360 756 FTCRD-NLYLVMEYLNGGDLYSLLRKVGC----------------LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (1092)
Q Consensus 756 fqde~-~LYLVMEYm~GGSL~dlLkk~g~----------------LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNI 818 (1092)
+...+ .+|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 87765 49999999999999999987543 89999999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001360 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (1092)
Q Consensus 819 LLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVW 898 (1092)
|++.+|.+||+|||+++..... ..........||+.|+|||++.+..++.++|||
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~-------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 234 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKD-------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTC-------------------------TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred EECCCCCEEECCCccccccccC-------------------------ccceeccCCCcceeecCchhhccccccchhHHH
Confidence 9999999999999998742100 001122346789999999999999999999999
Q ss_pred chhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 899 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 899 SLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
||||++|||++ |..||.+..........+..... +..+..+++++.+||.+||..||.+||+ +.++++|
T Consensus 235 slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~~ 304 (316)
T 2xir_A 235 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 304 (316)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc-CCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 99999999998 99999887654444333333222 2234678999999999999999999999 5565554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=374.50 Aligned_cols=256 Identities=24% Similarity=0.379 Sum_probs=206.7
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEE----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar----~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd 758 (1092)
.+..++|++++.||+|+||+||+|+ ...+|+.||||+++.. .......+.+|+.+|.+++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3556899999999999999999999 4668999999998753 34556789999999999999999999998865
Q ss_pred C--CeeEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcc
Q 001360 759 R--DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1092)
Q Consensus 759 e--~~LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 835 (1092)
. ..+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 4 56999999999999999998754 59999999999999999999999999999999999999999999999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC
Q 001360 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 836 ~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
...... ..........||+.|+|||++.+..|+.++|||||||++|||++|..||.
T Consensus 163 ~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 163 VLPQDK------------------------EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp -------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred cccCCc------------------------ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence 531100 00111223457888999999999999999999999999999999999986
Q ss_pred CCChH----------------HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 916 AESPE----------------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 916 ~~s~~----------------ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
..... .....+. .....+ .+..+++++.+||.+||..||.+||++.++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 219 SPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLP-RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp SHHHHHHHHHCTTCCTHHHHHHHHHHHH-TTCCCC-CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CChHHHHhhhcCccccchhHHHHHHHHh-ccCcCC-CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 53221 1122222 222222 35789999999999999999999999544433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=382.08 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=214.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEE--EEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~V--AIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~ 760 (1092)
+..++|++.+.||+|+||.||+|+++.+|..+ |+|.++.. ........+.+|+.+|.++ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 56689999999999999999999999888865 99988752 2334556789999999999 8999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g----------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG 824 (1092)
.+|+||||+++|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997654 699999999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhH
Q 001360 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (1092)
Q Consensus 825 ~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVIL 904 (1092)
.+||+|||+++.... ........+|+.|+|||++.+..++.++|||||||++
T Consensus 180 ~~kL~Dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 231 (327)
T 1fvr_A 180 VAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231 (327)
T ss_dssp CEEECCTTCEESSCE----------------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred eEEEcccCcCccccc----------------------------cccccCCCCCccccChhhhccccCCchhcchHHHHHH
Confidence 999999999873110 1112234678999999999998999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 905 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 905 YEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
|||++ |.+||.+.+..++...+..+.. +..+..+++++.+||.+||..||.+||+ +.++++
T Consensus 232 ~ellt~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~ 293 (327)
T 1fvr_A 232 WEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPS---FAQILV 293 (327)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHcCCCCCCCCCcHHHHHHHhhcCCC--CCCCCCCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 99998 9999999999888888776532 2234688999999999999999999999 555554
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=384.02 Aligned_cols=255 Identities=23% Similarity=0.356 Sum_probs=206.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEE----EEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~V----AIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
+..++|++++.||+|+||+||+|++..+|+.+ |+|.++.. ........+.+|+.+|.+++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 55678999999999999999999998888765 66665432 1234457899999999999999999999999875
Q ss_pred CeeEEEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
. .++||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 4 7899999999999999987 4579999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
... .........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.
T Consensus 169 ~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 169 AEE-------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp TTC-------------------------C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCc-------------------------ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 100 0111233567889999999999999999999999999999999 99999998
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
+...+...+..+.. .+ .+..++.++.+||.+||+.||.+||+ +.+++.+
T Consensus 224 ~~~~~~~~~~~~~~-~~-~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~ 272 (327)
T 3poz_A 224 PASEISSILEKGER-LP-QPPICTIDVYMIMVKCWMIDADSRPK---FRELIIE 272 (327)
T ss_dssp CGGGHHHHHHTTCC-CC-CCTTBCHHHHHHHHHHTCSCGGGSCC---HHHHHHH
T ss_pred CHHHHHHHHHcCCC-CC-CCccCCHHHHHHHHHHcCCChhhCCC---HHHHHHH
Confidence 88777766655432 22 34778999999999999999999999 4455543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=379.96 Aligned_cols=256 Identities=23% Similarity=0.358 Sum_probs=217.7
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEEC-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEE
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKR-------TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 751 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k-------~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVk 751 (1092)
..+.+..++|++.+.||+|+||.||+|++. .++..||+|+++... .......+.+|+.+|..+ +||||++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 344566789999999999999999999986 457789999997532 345567899999999999 8999999
Q ss_pred EeeeeccCCeeEEEEeecCCCcHHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCC
Q 001360 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 815 (1092)
Q Consensus 752 L~~sfqde~~LYLVMEYm~GGSL~dlLkk~g----------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKP 815 (1092)
+++++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 9999999999999999999999999998654 389999999999999999999999999999999
Q ss_pred CceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001360 816 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (1092)
Q Consensus 816 eNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ks 895 (1092)
+|||++.+|.+||+|||+++...... .........||+.|+|||++.+..++.++
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 240 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNID-------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQS 240 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTS-------------------------SEECCSCCCCCGGGCCHHHHHHCEECHHH
T ss_pred ceEEEcCCCCEEEccccccccccccc-------------------------cccccCCCCcccceeChHHhcCCCcChHH
Confidence 99999999999999999997531100 00112334678999999999998999999
Q ss_pred eeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 896 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 896 DVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
|||||||++|||++ |..||.+.+..++...+..+.. +..+..++.++.+||.+||..||.+||++.+
T Consensus 241 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 308 (334)
T 2pvf_A 241 DVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAVPSQRPTFKQ 308 (334)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC--CCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999999999 9999999998888887766542 2235789999999999999999999999443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=389.06 Aligned_cols=254 Identities=30% Similarity=0.511 Sum_probs=185.6
Q ss_pred ccCCCeEEEE-eeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----
Q 001360 684 TSIDDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC---- 758 (1092)
Q Consensus 684 i~~~dFeilr-~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd---- 758 (1092)
...++|++++ .||+|+||+||+|+++.+|+.||||++.+.. . ........+..+.||||++++++|..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----K---ARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----H---HHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 4568999965 6999999999999999999999999996521 1 11222234567789999999999876
Q ss_pred CCeeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC---CCcEEEEecCC
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGL 833 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFGL 833 (1092)
...+|+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 456899999999999999998764 6999999999999999999999999999999999999986 45699999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCC
Q 001360 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913 (1092)
Q Consensus 834 Ak~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~P 913 (1092)
++... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..|
T Consensus 178 ~~~~~-----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (336)
T 3fhr_A 178 AKETT-----------------------------QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228 (336)
T ss_dssp CEEC---------------------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCC
T ss_pred ceecc-----------------------------ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 87421 1112346789999999999988999999999999999999999999
Q ss_pred CCCCChHHH----HHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 914 FTAESPEII----FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 914 F~~~s~~ei----~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
|........ ...+......+|. ....++.++++||.+||..||.+||+ +.++++||||++
T Consensus 229 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~ 293 (336)
T 3fhr_A 229 FYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT---ITQFMNHPWINQ 293 (336)
T ss_dssp C---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHHSHHHHT
T ss_pred CCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCccccc
Confidence 987665443 2233333333332 12578999999999999999999999 889999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=390.69 Aligned_cols=279 Identities=15% Similarity=0.193 Sum_probs=209.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCC-----CcEEEEEEeecccccchh--------HHHHHHHHHHHHHhcCCCceE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKN--------DIERILAERNILITVRNPFVV 750 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~T-----Gk~VAIKvLkK~ei~kk~--------~ie~~l~EieIL~~L~HPNIV 750 (1092)
...++|++.+.||+|+||+||+|.++.+ ++.||||++......... ....+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4566999999999999999999998765 588999998754311111 112344566677788899999
Q ss_pred EEeeeeccC----CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEec--CC
Q 001360 751 RFFYSFTCR----DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA--HD 823 (1092)
Q Consensus 751 kL~~sfqde----~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD--~n 823 (1092)
++++++... ..+||||||+ ||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+||||+ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998775 4589999999 99999999876 6799999999999999999999999999999999999999 88
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhh
Q 001360 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (1092)
Q Consensus 824 G~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVI 903 (1092)
+.+||+|||+++......... ..........+||+.|+|||++.+..|+.++|||||||+
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 250 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHK--------------------AYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYC 250 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCC--------------------CSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CeEEEEECCcceecccCCccc--------------------ccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHH
Confidence 999999999998532111000 001112245679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhh----cCC------CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH----
Q 001360 904 LFEFITGIPPFTAESPEIIFDNILN----RKI------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK---- 969 (1092)
Q Consensus 904 LYEMLTGk~PF~~~s~~ei~~kIl~----~~l------~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL---- 969 (1092)
||||++|+.||.+......+..... ..+ .++ +..++.++.+||..||..||.+||++.++.+++
T Consensus 251 l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 251 MIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp HHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 9999999999986432222111111 000 011 256789999999999999999999965544443
Q ss_pred ---cCCCCCCCCcchhhhc
Q 001360 970 ---AHPFFKGVNWDSLALQ 985 (1092)
Q Consensus 970 ---~HPFFkgIdWd~L~~~ 985 (1092)
..++...++|......
T Consensus 329 ~~~~~~~~~~~dw~~~~~~ 347 (364)
T 3op5_A 329 KAIGSKDDGKLDLSVVENG 347 (364)
T ss_dssp HHTTCCCCCCCCC------
T ss_pred HHcCCCcCCccceEeccCC
Confidence 3456667788765543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=380.69 Aligned_cols=260 Identities=21% Similarity=0.318 Sum_probs=218.1
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEE-----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar-----~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfq 757 (1092)
.+..++|++++.||+|+||.||+|+ ...++..||||++... ........+.+|+.++.+++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 3566899999999999999999999 5567889999999643 23455678899999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC---CcEE
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKVG-------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIK 827 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~g-------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n---G~VK 827 (1092)
....+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998753 48999999999999999999999999999999999999954 4699
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001360 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (1092)
Q Consensus 828 LsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEM 907 (1092)
|+|||+++...... .........||+.|+|||++.+..++.++|||||||++|+|
T Consensus 184 l~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 238 (327)
T 2yfx_A 184 IGDFGMARDIYRAS-------------------------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238 (327)
T ss_dssp ECCCHHHHHHHC-------------------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ECcccccccccccc-------------------------ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHH
Confidence 99999987431100 01122345789999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 908 LT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
++ |..||...+..+....+..+... ..+..++..+.+||.+||..||.+||+ +.++++|.++
T Consensus 239 lt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~l~~ 301 (327)
T 2yfx_A 239 FSLGYMPYPSKSNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPN---FAIILERIEY 301 (327)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHH
T ss_pred HcCCCCCCCCcCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHhcCChhhCcC---HHHHHHHHHH
Confidence 98 99999999888888877765432 235789999999999999999999999 7788888765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=397.82 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=213.9
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD- 760 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~- 760 (1092)
+.+..++|++++.||+|+||+||+|.+. |+.||||+++... ..+.+.+|+.+|++++|||||++++++...+
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 4567789999999999999999999985 7899999997532 3467899999999999999999999976655
Q ss_pred eeEEEEeecCCCcHHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~--LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+|+||||+++|+|.+++.+.+. +++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 79999999999999999987654 7999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
.......+|+.|+|||++.+..|+.++|||||||+||||++ |..||.+.
T Consensus 341 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 390 (450)
T 1k9a_A 341 ------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390 (450)
T ss_dssp ------------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS
T ss_pred ------------------------------ccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 00112367899999999999999999999999999999998 99999998
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+..++...+..+. .+ ..|..+++++.+||.+||..||.+||++.++.+.|
T Consensus 391 ~~~~~~~~i~~~~-~~-~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 391 PLKDVVPRVEKGY-KM-DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp CTTTHHHHHHTTC-CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHcCC-CC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 8888877776552 22 24578999999999999999999999955444333
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=370.24 Aligned_cols=259 Identities=22% Similarity=0.308 Sum_probs=216.2
Q ss_pred ccCCCeEEEE-eeccCCCeEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 684 TSIDDFEIIK-PISRGAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 684 i~~~dFeilr-~LGkGgFGtVyLar~--k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
+..++|++.+ .||+|+||+||+|.+ ..+++.||+|+++... ......+.+.+|+.++..++||||+++++++ ..+
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 4557899998 999999999999954 5668899999997643 2334467899999999999999999999999 567
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|+||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 78999999999999999998888999999999999999999999999999999999999999999999999998753110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~ 919 (1092)
. ..........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 171 ~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 171 E------------------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp C------------------------SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred C------------------------CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 0 00011223457899999999998889999999999999999999 9999999998
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
.++...+..+.. +..+..+++++.+||.+||..||.+||++.++.+.++
T Consensus 227 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 275 (291)
T 1xbb_A 227 SEVTAMLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275 (291)
T ss_dssp HHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 888877766542 3345789999999999999999999999655555443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=369.62 Aligned_cols=259 Identities=23% Similarity=0.340 Sum_probs=208.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRT-TGD--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~-TGk--~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.+..++|++++.||+|+||+||+|++.. ++. .||+|+++..........+.+.+|+.++..++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 3456789999999999999999998753 333 6999999765444456678899999999999999999999999876
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
. .|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 89999999999999999765 579999999999999999999999999999999999999999999999999987531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
... ..........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 173 ~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 173 QND------------------------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp C-C------------------------CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccc------------------------cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 100 00111234568889999999999889999999999999999999 99999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
+..++...+......++ .+..++.++.+||.+||..||.+||++.++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 229 NGSQILHKIDKEGERLP-RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CHHHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHccCCCCC-CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99988888877655544 35689999999999999999999999444333
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=366.82 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=211.2
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~---TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd 758 (1092)
..+..++|++.+.||+|+||+||+|++.. ++..||+|++++.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 34567899999999999999999998754 34469999987642 33456789999999999999999999999875
Q ss_pred CCeeEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
. ..|+||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4 5799999999999999997654 5999999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~ 916 (1092)
... .........||+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 164 ~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 164 EDE--------------------------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp -----------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccc--------------------------cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 100 0111233567899999999999999999999999999999998 9999998
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
.........+...... ..+..+++.+.+||.+||..||.+||++.+
T Consensus 218 ~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~e 263 (281)
T 3cc6_A 218 LENKDVIGVLEKGDRL--PKPDLCPPVLYTLMTRCWDYDPSDRPRFTE 263 (281)
T ss_dssp SCGGGHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CChHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 8877777766654321 234678999999999999999999999443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=365.00 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=217.0
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
.+.+..++|++++.||+|+||.||+|... ++..||+|+++.... ..+.+.+|+.+|..++||||+++++++.. +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 44566789999999999999999999976 567899999975432 34678999999999999999999998864 5
Q ss_pred eeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 6899999999999999997643 69999999999999999999999999999999999999999999999999997531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
.. .........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 161 ~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 161 DN--------------------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp SS--------------------------CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred Cc--------------------------ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 10 0111223567899999999998889999999999999999999 99999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
+..++...+..+.. +..+..++.++.+||.+||..||.+||++.++.+.++
T Consensus 215 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 265 (279)
T 1qpc_A 215 TNPEVIQNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (279)
T ss_dssp CHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHhcccC--CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 88888877765532 2235788999999999999999999999665555443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=370.29 Aligned_cols=253 Identities=24% Similarity=0.403 Sum_probs=199.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCceEEEeeeecc---
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTC--- 758 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~--L~HPNIVkL~~sfqd--- 758 (1092)
...++|++++.||+|+||+||+|++ +|+.||||++... ....+..|.+++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 4567899999999999999999987 5899999998642 34556778888777 789999999988544
Q ss_pred -CCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH--------HcCCeeeecCCCceEecCCCcEEEE
Q 001360 759 -RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH--------SLGIVHRDLKPDNLLIAHDGHIKLT 829 (1092)
Q Consensus 759 -e~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLH--------s~GIIHRDLKPeNILLD~nG~VKLs 829 (1092)
...+|+||||+++|+|.+++.. ..+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 4568999999999999999954 57999999999999999999999 9999999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC------CCCccceeechhhh
Q 001360 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGII 903 (1092)
Q Consensus 830 DFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~------~Yt~ksDVWSLGVI 903 (1092)
|||+++....... .........+||+.|+|||++.+. .++.++|||||||+
T Consensus 156 Dfg~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~i 212 (301)
T 3q4u_A 156 DLGLAVMHSQSTN-----------------------QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLV 212 (301)
T ss_dssp CCTTCEEEETTTT-----------------------EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHH
T ss_pred eCCCeeecccccc-----------------------cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHH
Confidence 9999975321000 001112345899999999999876 45579999999999
Q ss_pred HHHHHhC----------CCCCCCCC----hHHHHHHHhhcCCCCCCCC-----CCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 904 LFEFITG----------IPPFTAES----PEIIFDNILNRKIPWPCVP-----SDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 904 LYEMLTG----------k~PF~~~s----~~ei~~kIl~~~l~fP~ip-----~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
+|||++| .+||.... .......+.......+.++ ...+.++.+||.+||..||.+||++.+
T Consensus 213 l~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 292 (301)
T 3q4u_A 213 LWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292 (301)
T ss_dssp HHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence 9999999 89996532 2233333333222223222 235678999999999999999999544
Q ss_pred HHHH
Q 001360 965 AAEV 968 (1092)
Q Consensus 965 a~EI 968 (1092)
+.+.
T Consensus 293 i~~~ 296 (301)
T 3q4u_A 293 IKKT 296 (301)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4433
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=395.74 Aligned_cols=258 Identities=22% Similarity=0.357 Sum_probs=220.6
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
..+.+..++|++.+.||+|+||+||+|+++ ++..||||+++... ...+.+.+|+.+|+.++|||||++++++. .
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 345677889999999999999999999986 46789999997643 23577999999999999999999999986 6
Q ss_pred CeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++..
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 6799999999999999999754 36899999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~ 916 (1092)
.... ........+|+.|+|||++.+..|+.++|||||||+||||++ |.+||.+
T Consensus 335 ~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 335 EDNE--------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp CCHH--------------------------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCc--------------------------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 1100 011123457889999999998999999999999999999999 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
.+..++...+..+. .+| .+..+++++.+||.+||..||.+||++.++.+.|..
T Consensus 389 ~~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~ 441 (454)
T 1qcf_A 389 MSNPEVIRALERGY-RMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441 (454)
T ss_dssp CCHHHHHHHHHHTC-CCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCHHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 99888888876652 333 357899999999999999999999997666665643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=368.55 Aligned_cols=258 Identities=26% Similarity=0.347 Sum_probs=207.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEE----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar----~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.....|++++.||+|+||.||+|+ ...+|+.||+|+++... .......+.+|+.+|..++||||+++++++.+.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 445679999999999999999999 46689999999997543 234467889999999999999999999999887
Q ss_pred --CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 760 --DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 760 --~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
..+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 6689999999999999999554 5799999999999999999999999999999999999999999999999999975
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
..... ..........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 176 ~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 176 IETDK------------------------EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp CCTTC------------------------CEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccCCC------------------------cceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 31100 001122345789999999999999999999999999999999999988643
Q ss_pred C--------------ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 917 E--------------SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 917 ~--------------s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
. .........+......+ .+..+++++.+||.+||..||.+||++.++.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 296 (302)
T 4e5w_A 232 PMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP-CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296 (302)
T ss_dssp HHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hhhHHhhccCCcccccCHHHHHHHHhccCCCC-CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 2 11112222222222222 357899999999999999999999995544443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=364.46 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=210.2
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee-E
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL-Y 763 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk---~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L-Y 763 (1092)
.|++.+.||+|+||+||+|++..++. .||+|++.+. ......+.+.+|+.+|+.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 46778999999999999999866555 7999998752 3445678899999999999999999999999877765 9
Q ss_pred EEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
+||||+.+|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999986 45689999999999999999999999999999999999999999999999999974311100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~e 921 (1092)
..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+...
T Consensus 180 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~ 236 (298)
T 3pls_A 180 -----------------------YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236 (298)
T ss_dssp -----------------------GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG
T ss_pred -----------------------cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH
Confidence 01122334578999999999999999999999999999999999 666777777777
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 922 i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
+...+..... +..+..+++++.+||.+||..||.+||++.++
T Consensus 237 ~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 278 (298)
T 3pls_A 237 LTHFLAQGRR--LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVL 278 (298)
T ss_dssp HHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHhhcCCC--CCCCccchHHHHHHHHHHccCChhhCcCHHHH
Confidence 7766665542 22357889999999999999999999995433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=380.34 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=207.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEE----EEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAI----KVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAI----KvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
+..++|++++.||+|+||+||+|++..+++.||+ |.++.. ........+.+|+.+|..++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 5568999999999999999999999988887644 444322 2234567899999999999999999999999876
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
. .++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 88999999999999999864 569999999999999999999999999999999999999999999999999997531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
.. ..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.
T Consensus 169 ~~-------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 223 (327)
T 3lzb_A 169 AE-------------------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp ------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred Cc-------------------------cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 10 00111223457889999999999999999999999999999999 99999998
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
+..++...+..... .+ .+..++.++.+||.+||..||.+||++.++
T Consensus 224 ~~~~~~~~~~~~~~-~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~el 269 (327)
T 3lzb_A 224 PASEISSILEKGER-LP-QPPICTIDVYMIMRKCWMIDADSRPKFREL 269 (327)
T ss_dssp CGGGHHHHHHTTCC-CC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CHHHHHHHHHcCCC-CC-CCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 88887776655432 22 357799999999999999999999994433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=365.86 Aligned_cols=245 Identities=24% Similarity=0.409 Sum_probs=208.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------ 758 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd------ 758 (1092)
...+|++++.||+|+||.||+|++..+|+.||+|+++... ..+.+|+.++..++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 3467999999999999999999999999999999997532 246789999999999999999998864
Q ss_pred ----------CCeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcE
Q 001360 759 ----------RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 826 (1092)
Q Consensus 759 ----------e~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~V 826 (1092)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence 45589999999999999999754 579999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHH
Q 001360 827 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906 (1092)
Q Consensus 827 KLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYE 906 (1092)
||+|||+++.... ........||+.|+|||++.+..++.++|||||||++||
T Consensus 162 kl~Dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 213 (284)
T 2a19_B 162 KIGDFGLVTSLKN----------------------------DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213 (284)
T ss_dssp EECCCTTCEESSC----------------------------CSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHH
T ss_pred EECcchhheeccc----------------------------cccccccCCcccccChhhhccCCCcchhhhHHHHHHHHH
Confidence 9999999875210 011234579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 907 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 907 MLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
|++|..||... ......+.... ++..++.++.+||.+||..||.+||+ +.++++|+++
T Consensus 214 l~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~~l~~ 271 (284)
T 2a19_B 214 LLHVCDTAFET--SKFFTDLRDGI-----ISDIFDKKEKTLLQKLLSKKPEDRPN---TSEILRTLTV 271 (284)
T ss_dssp HHSCCSSHHHH--HHHHHHHHTTC-----CCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHH
T ss_pred HHhcCCcchhH--HHHHHHhhccc-----ccccCCHHHHHHHHHHccCChhhCcC---HHHHHHHHHH
Confidence 99999988532 23333443332 23678899999999999999999999 7788887654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=366.65 Aligned_cols=249 Identities=25% Similarity=0.405 Sum_probs=208.1
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-C
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-D 760 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde-~ 760 (1092)
+.+..++|++.+.||+|+||+||+|++. |+.||+|+++... ..+.+.+|+.++..++||||+++++++... +
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 3466789999999999999999999874 8899999987532 456789999999999999999999986554 4
Q ss_pred eeEEEEeecCCCcHHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~--LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+|+||||+++|+|.+++.+.+. +++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 79999999999999999986643 8999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
.......||+.|+|||++.+..++.++||||||+++|||++ |.+||...
T Consensus 169 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 169 ------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp -------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ------------------------------ccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 01123467899999999999999999999999999999998 99999998
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+..++...+..+.. +..+..+++++.+||.+||..||.+||++.++.+.+
T Consensus 219 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 268 (278)
T 1byg_A 219 PLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268 (278)
T ss_dssp CGGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHhcCCC--CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHH
Confidence 88887777765432 234578999999999999999999999955444433
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=390.17 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=208.8
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k---~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.+..++|++.+.||+|+||+||+|+++ .++..||||+++... .......+.+|+.+|.+++||||+++++++...
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 456678999999999999999999987 457789999997532 345567899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
..+|+||||++||+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999999998754 69999999999999999999999999999999999999999999999999997532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
... ..........||+.|+|||++.+..|+.++|||||||++|||++ |..||...
T Consensus 199 ~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 199 DDP------------------------EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp ---------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred cCC------------------------ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 100 00011122346889999999999999999999999999999998 99999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
+..++...+..+. ..+ .+..++.++.+||.+||..||.+||++.++.+.+
T Consensus 255 ~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L 304 (373)
T 2qol_A 255 SNQDVIKAVDEGY-RLP-PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304 (373)
T ss_dssp CHHHHHHHHHTTE-ECC-CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHcCC-CCC-CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHH
Confidence 9888887776542 222 2467899999999999999999999955444433
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=366.54 Aligned_cols=256 Identities=25% Similarity=0.331 Sum_probs=215.6
Q ss_pred cccCCCeEEEE-eeccCCCeEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 683 RTSIDDFEIIK-PISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 683 ~i~~~dFeilr-~LGkGgFGtVyLar~k--~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.+..++|.+.+ .||+|+||.||+|.++ .++..||+|+++... .....+.+.+|+.+|..++||||+++++++ ..
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 34567888887 9999999999999864 467889999997642 345677899999999999999999999999 45
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 6799999999999999999654 569999999999999999999999999999999999999999999999999997531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
... ..........||+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 162 ~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 162 ADD------------------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp TCS------------------------CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCc------------------------ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 100 00111234567999999999998899999999999999999998 99999998
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
+..++...+..+.. +..+..+++++.+||.+||..||.+||++.++.+
T Consensus 218 ~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 265 (287)
T 1u59_A 218 KGPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 265 (287)
T ss_dssp CTHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHhcCCc--CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 88888877766542 3345789999999999999999999999443333
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=366.54 Aligned_cols=272 Identities=22% Similarity=0.306 Sum_probs=210.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEe-eeeccCCeeE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTCRDNLY 763 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~-~sfqde~~LY 763 (1092)
..++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+.++..++|++++..+ .++...+..|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 34789999999999999999999999999999998765332 23478899999999987766555 4556777899
Q ss_pred EEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe---cCCCcEEEEecCCcccccc
Q 001360 764 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL---D~nG~VKLsDFGLAk~~~~ 839 (1092)
+||||+ +|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 9999999975 4579999999999999999999999999999999999999 7899999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
.... ............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 161 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 161 ARTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp TTTC--------------------CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccC--------------------ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 1000 00001223457899999999999999999999999999999999999999987443
Q ss_pred ---HHHHHHHhhcCCCCC--CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc-------CCCCCCCCcchh
Q 001360 920 ---EIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA-------HPFFKGVNWDSL 982 (1092)
Q Consensus 920 ---~ei~~kIl~~~l~fP--~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~-------HPFFkgIdWd~L 982 (1092)
...+..+.......| .....+++++.+||.+||..||.+||++.++.+.+. .++...++|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred hhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 233333333222211 123567899999999999999999999654444432 466666778765
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=366.61 Aligned_cols=255 Identities=21% Similarity=0.279 Sum_probs=209.8
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee-ccCCe
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF-TCRDN 761 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TG---k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sf-qde~~ 761 (1092)
...|++.+.||+|+||+||+|++..++ ..||+|.+++. ........+.+|+.++++++||||+++++++ ...+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 356999999999999999999976443 36899988752 3445667899999999999999999999984 55668
Q ss_pred eEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999999999764 46899999999999999999999999999999999999999999999999999753111
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~ 919 (1092)
.. ..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+.
T Consensus 182 ~~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 182 EY-----------------------YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238 (298)
T ss_dssp GG-----------------------CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred ch-----------------------hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence 00 01122334578999999999999999999999999999999999 7788888887
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
.+....+..+.... .+..++.++.+||.+||..||.+||++.++.+
T Consensus 239 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 239 FDITVYLLQGRRLL--QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCCC--CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 77777776655432 24778999999999999999999999544433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=380.88 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=202.1
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD- 760 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~- 760 (1092)
..+..++|++++.||+|+||+||+|++. ++.||||+++... ........|+.+|.+++|||||++++++....
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 3466789999999999999999999876 7999999996532 33445667888999999999999999998754
Q ss_pred ---eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc----------CCeeeecCCCceEecCCCcEE
Q 001360 761 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL----------GIVHRDLKPDNLLIAHDGHIK 827 (1092)
Q Consensus 761 ---~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~----------GIIHRDLKPeNILLD~nG~VK 827 (1092)
.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+|
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred CCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 47999999999999999976 4599999999999999999999999 999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-----CCCccceeechhh
Q 001360 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----EHGYAADWWSVGI 902 (1092)
Q Consensus 828 LsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-----~Yt~ksDVWSLGV 902 (1092)
|+|||+++..... .........+||+.|+|||++.+. .++.++|||||||
T Consensus 172 L~DFg~a~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 226 (322)
T 3soc_A 172 IADFGLALKFEAG-------------------------KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226 (322)
T ss_dssp ECCCTTCEEECTT-------------------------SCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHH
T ss_pred EccCCcccccccc-------------------------cCccccccCccCccccCHhhcccccccCcCCCccchhHHHHH
Confidence 9999999753210 001122346899999999999873 4567889999999
Q ss_pred hHHHHHhCCCCCCCCC----------------hHHHHHHHhhcCCCCCCCCC-----CCCHHHHHHHHHhccCCcCCCCC
Q 001360 903 ILFEFITGIPPFTAES----------------PEIIFDNILNRKIPWPCVPS-----DMSFEAQDLINRFLIHDPNQRLG 961 (1092)
Q Consensus 903 ILYEMLTGk~PF~~~s----------------~~ei~~kIl~~~l~fP~ip~-----~lS~eakDLI~kcL~kDP~KRpS 961 (1092)
++|||++|..||.+.. ...+...+..... .|.++. ..+.++.+||.+||..||.+||+
T Consensus 227 il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (322)
T 3soc_A 227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK-RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305 (322)
T ss_dssp HHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC-CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccC-CCCccccccccchHHHHHHHHHHHccCChhhCcC
Confidence 9999999999997642 2233333333322 222222 23456999999999999999999
Q ss_pred cccHHH
Q 001360 962 ANGAAE 967 (1092)
Q Consensus 962 a~ga~E 967 (1092)
+.++.+
T Consensus 306 ~~ell~ 311 (322)
T 3soc_A 306 AGCVGE 311 (322)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 554443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=364.51 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=208.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEe-eeeccCCeeE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTCRDNLY 763 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~-~sfqde~~LY 763 (1092)
..++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.++..++|++++..+ .++......|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 35789999999999999999999999999999999875432 23578999999999987755544 4556677889
Q ss_pred EEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe---cCCCcEEEEecCCcccccc
Q 001360 764 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL---D~nG~VKLsDFGLAk~~~~ 839 (1092)
+||||+ +|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 8999999974 4579999999999999999999999999999999999999 5889999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s- 918 (1092)
.... ...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 161 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 161 ARTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp TTTC--------------------CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccc--------------------cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 1000 0001112345689999999999999999999999999999999999999998743
Q ss_pred --hHHHHHHHhhcCCCCC--CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 919 --PEIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 919 --~~ei~~kIl~~~l~fP--~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
....+..+.......| ..+..+++++.+||.+||..||.+||++.++.+.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 276 (296)
T 3uzp_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred hhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence 2334444443322222 123578899999999999999999999665555544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=376.64 Aligned_cols=268 Identities=26% Similarity=0.390 Sum_probs=215.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec--
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT-- 757 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~----k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfq-- 757 (1092)
+..++|++++.||+|+||.||+|++ ..+++.||+|++.+. .....+.+.+|+.+|++++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 4567899999999999999999994 668899999999753 3445677999999999999999999999886
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
....+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 456799999999999999999874 5699999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
..... ..........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 177 ~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 177 LPLDK------------------------DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CCTTC------------------------SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccCC------------------------ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 31100 001122345689999999999999999999999999999999999999975
Q ss_pred CChH---------------HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcc
Q 001360 917 ESPE---------------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 917 ~s~~---------------ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd 980 (1092)
.... .+...+ ......+ .+..+++++.+||.+||..||.+||++.++.+.++..|.....|.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 233 PSAEFLRMMGCERDVPALSRLLELL-EEGQRLP-APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp HHHHHHHHCC----CCHHHHHHHHH-HTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred ccchhhhhcccccccccHHHHHHHh-hcccCCC-CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 4332 222222 2222222 357899999999999999999999997777777777776654443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=402.53 Aligned_cols=258 Identities=21% Similarity=0.358 Sum_probs=222.4
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
.+.+..++|++.+.||+|+||.||+|+++.++..||||+++... ...+.+.+|+.+|++++|||||++++++....
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 45567789999999999999999999999999999999997543 23567999999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+||||||+++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999999999864 458999999999999999999999999999999999999999999999999998521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
.. .........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+.
T Consensus 370 ~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 370 GD--------------------------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp TC--------------------------CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CC--------------------------ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 00 0011223457889999999999999999999999999999999 99999998
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
+..++...+..+ ...+ .+..+++++.+||.+||..||.+||++.++.+.++
T Consensus 424 ~~~~~~~~~~~~-~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~ 474 (495)
T 1opk_A 424 DLSQVYELLEKD-YRME-RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474 (495)
T ss_dssp CGGGHHHHHHTT-CCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHcC-CCCC-CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 888877766543 2222 35789999999999999999999999665655554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=374.25 Aligned_cols=257 Identities=23% Similarity=0.299 Sum_probs=212.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TG----k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd 758 (1092)
.+..++|++.+.||+|+||+||+|.++.++ ..||+|+++... .......+.+|+.++..++||||+++++++..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 466789999999999999999999987654 359999997532 34456678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
.+.+|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999999765 57999999999999999999999999999999999999999999999999998753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~ 916 (1092)
.... ..........||+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 198 ~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 198 EDDP------------------------EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp -------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccc------------------------ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 1100 00011123457889999999999999999999999999999999 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
.+..++...+..+. ..+ .+..++.++.+||.+||..||.+||++.++.+
T Consensus 254 ~~~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 254 LSNHEVMKAINDGF-RLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp CCHHHHHHHHHTTC-CCC-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHCCC-cCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99888888776653 222 34689999999999999999999999544433
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=370.62 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=207.0
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~---TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.+..++|++.+.||+|+||.||+|.... ++..||+|+++... ......+.+.+|+.++.+++||||+++++++.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3566789999999999999999998765 45689999987543 2345567899999999999999999999998876
Q ss_pred C-----eeEEEEeecCCCcHHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEE
Q 001360 760 D-----NLYLVMEYLNGGDLYSLLRK------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 828 (1092)
Q Consensus 760 ~-----~LYLVMEYm~GGSL~dlLkk------~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKL 828 (1092)
. ..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 5 35999999999999999943 356999999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHH
Q 001360 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (1092)
Q Consensus 829 sDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEML 908 (1092)
+|||+++...... .........||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 189 ~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 243 (313)
T 3brb_A 189 ADFGLSKKIYSGD-------------------------YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243 (313)
T ss_dssp CSCSCC-----------------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred eecCcceeccccc-------------------------ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHH
Confidence 9999987431100 001122346788999999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 909 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 909 T-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
+ |.+||.+.....+...+..+.. +..+..+++++.+||.+||..||.+||++.+
T Consensus 244 ~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 298 (313)
T 3brb_A 244 TRGMTPYPGVQNHEMYDYLLHGHR--LKQPEDCLDELYEIMYSCWRTDPLDRPTFSV 298 (313)
T ss_dssp TTSCCSSTTCCGGGHHHHHHTTCC--CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred hcCCCCCccCCHHHHHHHHHcCCC--CCCCccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 9 9999999988888888776542 2235789999999999999999999999443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=369.47 Aligned_cols=245 Identities=29% Similarity=0.444 Sum_probs=200.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+..++|++.+.||+|+||+||+|++. ++.||+|++... ...+.+.+|+.+|.+++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45678999999999999999999885 788999998642 345778999999999999999999998874 489
Q ss_pred EEEeecCCCcHHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHH---cCCeeeecCCCceEecCCCc-EEEEecCCccc
Q 001360 764 LVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHS---LGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKI 836 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g---~LsE~~ar~yaaQIL~ALeYLHs---~GIIHRDLKPeNILLD~nG~-VKLsDFGLAk~ 836 (1092)
+||||++||+|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.+|. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999998654 47889999999999999999999 89999999999999999886 79999999864
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 156 IQ------------------------------THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp ---------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred cc------------------------------cccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 21 011234699999999999999999999999999999999999999986
Q ss_pred CCh--HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 917 ESP--EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 917 ~s~--~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
... ..+...+..+. .+..+..++..+.+||.+||..||.+||++.++.+.+
T Consensus 206 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 258 (307)
T 2eva_A 206 IGGPAFRIMWAVHNGT--RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258 (307)
T ss_dssp TCSSHHHHHHHHHTTC--CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hCccHHHHHHHHhcCC--CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 432 23333333332 2334578999999999999999999999955444444
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=366.40 Aligned_cols=256 Identities=20% Similarity=0.321 Sum_probs=200.6
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
..+..++|++.+.||+|+||+||+|++. ..||+|+++... ......+.+.+|+.+|+.++||||+++++++ ....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 3567789999999999999999999864 359999997543 3455678899999999999999999999854 5667
Q ss_pred eEEEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
+|+||||+.||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 8999999999999999964 356999999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
..........||+.|+|||++. +..++.++|||||||++|+|++|..||.+.
T Consensus 174 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 174 -------------------------SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp -----------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred -------------------------cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 0011223467999999999997 567889999999999999999999999886
Q ss_pred ChHHHHHHHh-hcCC--CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 918 SPEIIFDNIL-NRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 918 s~~ei~~kIl-~~~l--~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
........++ .+.. .++.....+++++.+||.+||..||.+||++.++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 229 NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6544444433 3332 223344678999999999999999999999544433
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=379.90 Aligned_cols=270 Identities=19% Similarity=0.189 Sum_probs=207.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECC---CCcEEEEEEeecccccch--------hHHHHHHHHHHHHHhcCCCceEEE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK--------NDIERILAERNILITVRNPFVVRF 752 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~---TGk~VAIKvLkK~ei~kk--------~~ie~~l~EieIL~~L~HPNIVkL 752 (1092)
...++|++.+.||+|+||+||+|++.. ++..||+|++.+...... .....+.+|+.++..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 445789999999999999999999987 788999999876432111 112346778899999999999999
Q ss_pred eeeecc----CCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC--cE
Q 001360 753 FYSFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--HI 826 (1092)
Q Consensus 753 ~~sfqd----e~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG--~V 826 (1092)
++++.. ...+|+||||+ ||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999888 77899999999 999999998888999999999999999999999999999999999999999887 99
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHH
Q 001360 827 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906 (1092)
Q Consensus 827 KLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYE 906 (1092)
||+|||+++........ ...........+||+.|+|||++.+..|+.++|||||||++||
T Consensus 193 kL~Dfg~a~~~~~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 252 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNH--------------------KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLR 252 (345)
T ss_dssp EECCCTTCEESSGGGCC--------------------CCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred EEEeCCCceeccccccc--------------------ccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHH
Confidence 99999999853211100 0001122245689999999999999999999999999999999
Q ss_pred HHhCCCCCCCC--ChHHHHHHHhhcCCCCCC------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 907 FITGIPPFTAE--SPEIIFDNILNRKIPWPC------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 907 MLTGk~PF~~~--s~~ei~~kIl~~~l~fP~------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
|++|..||.+. +..............+|. .+..++.++.+||.+||..||.+||++.++.+.++...+
T Consensus 253 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 253 WLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 99999999653 332222221111111111 012788999999999999999999997777776665443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=367.89 Aligned_cols=262 Identities=26% Similarity=0.363 Sum_probs=189.3
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeee-----
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSF----- 756 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sf----- 756 (1092)
.+...+|++.+.||+|+||.||+|++..+|+.||||++.+. .......+.+|+.+|.++. ||||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 34556899999999999999999999999999999998653 2345677899999999996 99999999988
Q ss_pred ---ccCCeeEEEEeecCCCcHHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHcC--CeeeecCCCceEecCCCcEEE
Q 001360 757 ---TCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKL 828 (1092)
Q Consensus 757 ---qde~~LYLVMEYm~GGSL~dlLkk---~g~LsE~~ar~yaaQIL~ALeYLHs~G--IIHRDLKPeNILLD~nG~VKL 828 (1092)
.....+|+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.| |+||||||+||||+.++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence 44456899999996 699998865 457999999999999999999999999 999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh---cCCCCCccceeechhhhHH
Q 001360 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILF 905 (1092)
Q Consensus 829 sDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL---~g~~Yt~ksDVWSLGVILY 905 (1092)
+|||+++........ ................+||+.|+|||++ .+..++.++|||||||++|
T Consensus 180 ~Dfg~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~ 244 (337)
T 3ll6_A 180 CDFGSATTISHYPDY---------------SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244 (337)
T ss_dssp CCCTTCBCCSSCC----------------------------------------------CCTTSCSSHHHHHHHHHHHHH
T ss_pred ecCccceeccccCcc---------------cccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHH
Confidence 999999853211000 0000000011122356799999999998 5667899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 906 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 906 EMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
||++|..||.......+. ......+ .+...+..+.+||.+||..||.+||+ +.++++|
T Consensus 245 el~~g~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~~ 302 (337)
T 3ll6_A 245 LLCFRQHPFEDGAKLRIV----NGKYSIP-PHDTQYTVFHSLIRAMLQVNPEERLS---IAEVVHQ 302 (337)
T ss_dssp HHHHSSCCC----------------CCCC-TTCCSSGGGHHHHHHHSCSSGGGSCC---HHHHHHH
T ss_pred HHHhCCCCCcchhHHHhh----cCcccCC-cccccchHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 999999999876554333 3333333 23567788999999999999999999 6666655
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=388.56 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=206.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--ee
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--NL 762 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~--~L 762 (1092)
..+.|++.+.||+|+||+||+|+++.+|+.||||++++.... ...+.+.+|+.+|.+++||||+++++++.... .+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 356899999999999999999999999999999999864432 33567789999999999999999999988765 78
Q ss_pred EEEEeecCCCcHHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe----cCCCcEEEEecCCcc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGC---LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLSK 835 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~---LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL----D~nG~VKLsDFGLAk 835 (1092)
|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999999976543 9999999999999999999999999999999999999 788889999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--------CCCCccceeechhhhHHHH
Q 001360 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--------TEHGYAADWWSVGIILFEF 907 (1092)
Q Consensus 836 ~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--------~~Yt~ksDVWSLGVILYEM 907 (1092)
.... .......+||+.|+|||++.+ ..|+.++|||||||++|||
T Consensus 165 ~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el 216 (396)
T 4eut_A 165 ELED----------------------------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (396)
T ss_dssp ECCC----------------------------GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHH
T ss_pred EccC----------------------------CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHH
Confidence 5210 112234679999999999875 5678899999999999999
Q ss_pred HhCCCCCCC----CChHHHHHHHhhcCCC-------------------CC---CCCCCCCHHHHHHHHHhccCCcCCCCC
Q 001360 908 ITGIPPFTA----ESPEIIFDNILNRKIP-------------------WP---CVPSDMSFEAQDLINRFLIHDPNQRLG 961 (1092)
Q Consensus 908 LTGk~PF~~----~s~~ei~~kIl~~~l~-------------------fP---~ip~~lS~eakDLI~kcL~kDP~KRpS 961 (1092)
++|..||.. ....++..+++.+... +| .++..++..+.+||.+||..||.+||+
T Consensus 217 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s 296 (396)
T 4eut_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296 (396)
T ss_dssp HHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred HHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc
Confidence 999999964 2334555555554321 11 111335667899999999999999999
Q ss_pred cc
Q 001360 962 AN 963 (1092)
Q Consensus 962 a~ 963 (1092)
+.
T Consensus 297 ~~ 298 (396)
T 4eut_A 297 FD 298 (396)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=377.37 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=209.1
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
.....++|++.+.||+|+||.||+|+++ +|+.||+|++.... ....+.+.+|+.+|..++||||+++++++...+.
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 3456789999999999999999999964 68999999886532 3456789999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g----~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999999986543 5899999999999999999999999999999999999999999999999998752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 190 ~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 190 TEL-------------------------DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp SSS-------------------------SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred ccc-------------------------cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 100 0011223457999999999999999999999999999999999999999865
Q ss_pred ChHHHH-------HHHhhcCCC---CC----CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 918 SPEIIF-------DNILNRKIP---WP----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 918 s~~ei~-------~kIl~~~l~---fP----~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
.+.+.. .......+. -+ .++...+..+.+||.+||..||.+||+ +.++++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 309 (321)
T 2qkw_B 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS---MGDVLWK 309 (321)
T ss_dssp SSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcC---HHHHHHH
Confidence 432211 111111111 01 122335677899999999999999999 5555543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=388.76 Aligned_cols=257 Identities=24% Similarity=0.373 Sum_probs=214.7
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
..+.+..++|++.+.||+|+||+||+|.++. +..||||+++.... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 3455677899999999999999999999875 46799999976432 24578999999999999999999999876
Q ss_pred CeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++..
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 6799999999999999999753 46999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~ 916 (1092)
... .........||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+
T Consensus 331 ~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 384 (452)
T 1fmk_A 331 EDN--------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384 (452)
T ss_dssp --------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCC--------------------------ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence 110 0011123457889999999999999999999999999999999 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
....++...+..+. ..+ .+..+++++.+||.+||..||.+||++.++.+.+.
T Consensus 385 ~~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~ 436 (452)
T 1fmk_A 385 MVNREVLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436 (452)
T ss_dssp CCHHHHHHHHHTTC-CCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 99888888776542 222 35789999999999999999999999665555553
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=388.47 Aligned_cols=255 Identities=27% Similarity=0.376 Sum_probs=196.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LYLV 765 (1092)
+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+|.++ +|||||++++++.+...+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 445667899999999998754 457999999998642 235678899999876 899999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCC-------HHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC-------------Cc
Q 001360 766 MEYLNGGDLYSLLRKVGCLE-------EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-------------GH 825 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~Ls-------E~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n-------------G~ 825 (1092)
|||+. |+|.+++....... +..+..++.||+.||.|||++|||||||||+||||+.+ ++
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 69999998754332 22356799999999999999999999999999999754 48
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-------CCCCccceee
Q 001360 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWW 898 (1092)
Q Consensus 826 VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-------~~Yt~ksDVW 898 (1092)
+||+|||+++....... .........+||+.|+|||++.+ ..++.++|||
T Consensus 167 ~kL~DFG~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 223 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQS-----------------------SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223 (434)
T ss_dssp EEECCCTTCEECCC-------------------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHH
T ss_pred EEEcccccceecCCCCc-----------------------cceeeecCCCCCCCccCHHHhccccccccccCcchhhhhH
Confidence 99999999985311000 00111234689999999999976 6789999999
Q ss_pred chhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCC----CCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCC
Q 001360 899 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVP----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1092)
Q Consensus 899 SLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip----~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPF 973 (1092)
||||++|||++ |..||....... ..++.+...++..+ ..+++++.+||.+||+.||.+||+ +.++++|||
T Consensus 224 SlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eil~hp~ 298 (434)
T 2rio_A 224 SMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT---AMKVLRHPL 298 (434)
T ss_dssp HHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC---HHHHHTSGG
T ss_pred hHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCC---HHHHHhCCc
Confidence 99999999999 999998765443 34445444443321 235688999999999999999999 889999999
Q ss_pred CCCC
Q 001360 974 FKGV 977 (1092)
Q Consensus 974 FkgI 977 (1092)
|...
T Consensus 299 f~~~ 302 (434)
T 2rio_A 299 FWPK 302 (434)
T ss_dssp GSCH
T ss_pred cCCc
Confidence 9653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=375.27 Aligned_cols=243 Identities=15% Similarity=0.212 Sum_probs=199.6
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEE-----EECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEE
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLA-----RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRF 752 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLa-----r~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~---HPNIVkL 752 (1092)
......++|++.+.||+|+||+||+| ....+++.||||+++.. ....+..|+.++..++ |+||+++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 34466788999999999999999999 46778999999998753 2345778888888887 9999999
Q ss_pred eeeeccCCeeEEEEeecCCCcHHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-----
Q 001360 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH----- 822 (1092)
Q Consensus 753 ~~sfqde~~LYLVMEYm~GGSL~dlLkk-----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~----- 822 (1092)
++++...+..||||||++||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999999974 456999999999999999999999999999999999999998
Q ss_pred ------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001360 823 ------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 896 (1092)
Q Consensus 823 ------nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksD 896 (1092)
++.+||+|||+|+..... .........+||+.|||||++.+..|+.++|
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 267 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLF-------------------------PKGTIFTAKCETSGFQCVEMLSNKPWNYQID 267 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGS-------------------------CTTEEECCSSCTTSCCCHHHHTTCCBSTHHH
T ss_pred cccccccCCEEEeeCchhhhhhcc-------------------------CCCceeeeecCCCCCCChHHhcCCCCCcccc
Confidence 899999999999742100 0112234578999999999999999999999
Q ss_pred eechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC
Q 001360 897 WWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961 (1092)
Q Consensus 897 VWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpS 961 (1092)
||||||+||||++|+.||....... ......++. ...++...+++..||..+|.+|+.
T Consensus 268 iwslG~il~elltg~~pf~~~~~~~-----~~~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 268 YFGVAATVYCMLFGTYMKVKNEGGE-----CKPEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp HHHHHHHHHHHHHSSCCCEEEETTE-----EEECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred HHHHHHHHHHHHhCCCccccCCCCc-----eeechhccc--cCcHHHHHHHHHHHcCCCCCCcch
Confidence 9999999999999999996543211 011111221 234778999999999999999976
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=373.83 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=205.3
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.......++|++.+.||+|+||.||+|+.. +|+.||||+++..... .....+.+|+.++..++||||+++++++.+.
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 344567789999999999999999999854 6899999999764321 1223688999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHc---CCeeeecCCCceEecCCCcEEEEecC
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSL---GIVHRDLKPDNLLIAHDGHIKLTDFG 832 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g----~LsE~~ar~yaaQIL~ALeYLHs~---GIIHRDLKPeNILLD~nG~VKLsDFG 832 (1092)
...|+||||+.||+|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999999998653 499999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCC
Q 001360 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912 (1092)
Q Consensus 833 LAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~ 912 (1092)
+++.... .........+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 180 ~~~~~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 233 (326)
T 3uim_A 180 LAKLMDY--------------------------KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233 (326)
T ss_dssp SCEECCS--------------------------SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCC
T ss_pred cccccCc--------------------------ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCC
Confidence 9975310 01112234569999999999998889999999999999999999999
Q ss_pred CCCCC-----Ch---HHHHHHHhhcC-CC---C----CCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 913 PFTAE-----SP---EIIFDNILNRK-IP---W----PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 913 PF~~~-----s~---~ei~~kIl~~~-l~---f----P~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
||... .. ........... .. . +..+...+.++.+||.+||..||.+||+ +.++++|
T Consensus 234 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~ell~~ 305 (326)
T 3uim_A 234 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK---MSEVVRM 305 (326)
T ss_dssp SBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCC---HHHHHHH
T ss_pred cccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCC---HHHHHHH
Confidence 99521 11 11111111110 00 0 0112233478999999999999999999 4455544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=393.17 Aligned_cols=262 Identities=24% Similarity=0.317 Sum_probs=204.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~L 762 (1092)
+...+|++.+.||+|+||+|+.. ...+|+.||||++.+... ..+.+|+.+|+.+ +|||||++++++.+...+
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 44457999999999999997643 345799999999865332 2256799999999 799999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC---C--CcEEEEecCCccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---D--GHIKLTDFGLSKI 836 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~---n--G~VKLsDFGLAk~ 836 (1092)
|||||||. |+|.+++.... .+.+..+..++.||+.||.|||++|||||||||+||||+. + ..+||+|||+|+.
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99999996 59999997654 4566677889999999999999999999999999999953 2 3588999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHh-CCC
Q 001360 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFIT-GIP 912 (1092)
Q Consensus 837 ~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Yt~ksDVWSLGVILYEMLT-Gk~ 912 (1092)
..... .........+||+.|+|||++. +..++.++|||||||++|||++ |.+
T Consensus 173 ~~~~~------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~ 228 (432)
T 3p23_A 173 LAVGR------------------------HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228 (432)
T ss_dssp C------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCB
T ss_pred ccCCC------------------------cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 31100 0011224568999999999998 4567889999999999999999 999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcc
Q 001360 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 913 PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd 980 (1092)
||...........+..........+...+..+++||.+||+.||.+||+ +.++++||||.+++|.
T Consensus 229 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 229 PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS---AKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp TTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCC---HHHHHTSTTTCCHHHH
T ss_pred CcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCC---HHHHHhCccccChHHH
Confidence 9976655544433322222222222345667899999999999999999 8899999999998874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=368.14 Aligned_cols=263 Identities=22% Similarity=0.347 Sum_probs=206.8
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec----c
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT----C 758 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfq----d 758 (1092)
.+..++|++++.||+|+||.||+|+++.+|+.||||++... .......+.+|+.++..++||||+++++++. .
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 35567899999999999999999999999999999998653 3455678899999999999999999999987 3
Q ss_pred CCeeEEEEeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCc
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 834 (1092)
...+|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 4578999999999999999976 367999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC---CCccceeechhhhHHHHHhCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGI 911 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~---Yt~ksDVWSLGVILYEMLTGk 911 (1092)
+....... ...............||+.|+|||++.+.. ++.++|||||||++|||++|.
T Consensus 182 ~~~~~~~~------------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 243 (317)
T 2buj_A 182 NQACIHVE------------------GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243 (317)
T ss_dssp EESCEEEE------------------SHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSS
T ss_pred hhcccccc------------------cccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCC
Confidence 74210000 000000001112456899999999998654 688999999999999999999
Q ss_pred CCCCCCC--hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 912 PPFTAES--PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 912 ~PF~~~s--~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
.||.... ....... ......+|. +..++.++.+||.+||..||.+||+ +.++++|
T Consensus 244 ~p~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~ 300 (317)
T 2buj_A 244 GPYDMVFQKGDSVALA-VQNQLSIPQ-SPRHSSALWQLLNSMMTVDPHQRPH---IPLLLSQ 300 (317)
T ss_dssp CTTHHHHHTTSCHHHH-HHCC--CCC-CTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CChhhhhcccchhhHH-hhccCCCCc-cccCCHHHHHHHHHHhhcChhhCCC---HHHHHHH
Confidence 9995421 1111222 222333332 3578999999999999999999999 5566543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=366.61 Aligned_cols=267 Identities=25% Similarity=0.351 Sum_probs=194.9
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH--HhcCCCceEEEeeee---
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL--ITVRNPFVVRFFYSF--- 756 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL--~~L~HPNIVkL~~sf--- 756 (1092)
..+..++|++++.||+|+||.||+|+. +|+.||||+++... ...+..|.+++ ..++||||+++++.+
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 346789999999999999999999976 58999999997532 23444555554 458999999998743
Q ss_pred --ccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc---------CCeeeecCCCceEecCCCc
Q 001360 757 --TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---------GIVHRDLKPDNLLIAHDGH 825 (1092)
Q Consensus 757 --qde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~---------GIIHRDLKPeNILLD~nG~ 825 (1092)
.....+|+||||+++|+|.+++... .+++..+..++.||+.||.|||+. ||+||||||+||||+.+|.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 3344689999999999999999664 458899999999999999999999 9999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-------CCCCccceee
Q 001360 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWW 898 (1092)
Q Consensus 826 VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-------~~Yt~ksDVW 898 (1092)
+||+|||+++......... ...........+||+.|+|||++.+ ..++.++|||
T Consensus 159 ~kL~DFG~a~~~~~~~~~~-------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 219 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVR-------------------PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219 (336)
T ss_dssp EEECCCTTCEECSSSSCC----------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHH
T ss_pred EEEeeccceeecccccccC-------------------ccccccccccCCCccceeCchhhcCCcccccccccccccchH
Confidence 9999999998532110000 0001122345689999999999987 3566789999
Q ss_pred chhhhHHHHHhCCCCCCCCCh-----------------HHHHHHHhhcCCCCCCCCCC------CCHHHHHHHHHhccCC
Q 001360 899 SVGIILFEFITGIPPFTAESP-----------------EIIFDNILNRKIPWPCVPSD------MSFEAQDLINRFLIHD 955 (1092)
Q Consensus 899 SLGVILYEMLTGk~PF~~~s~-----------------~ei~~kIl~~~l~fP~ip~~------lS~eakDLI~kcL~kD 955 (1092)
||||++|||++|..||..... ......+.......|.++.. +++++.+||.+||..|
T Consensus 220 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (336)
T 3g2f_A 220 ALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299 (336)
T ss_dssp HHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCC
Confidence 999999999999766643211 11122222222222333333 4458999999999999
Q ss_pred cCCCCCcccHHHH---HcCCCCCC
Q 001360 956 PNQRLGANGAAEV---KAHPFFKG 976 (1092)
Q Consensus 956 P~KRpSa~ga~EI---L~HPFFkg 976 (1092)
|.+||++.++.+. +.++|-++
T Consensus 300 P~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 300 AEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp GGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred hhhCcchHHHHHHHHHHHHHHHhc
Confidence 9999995443332 33566543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=374.90 Aligned_cols=254 Identities=18% Similarity=0.215 Sum_probs=202.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCC--------CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEE------
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTT--------GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR------ 751 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~T--------Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVk------ 751 (1092)
.++|++.+.||+|+||.||+|+++.+ ++.||+|++.+. ..+.+|+.++.+++|||||+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47899999999999999999999874 889999998753 35788999999999999998
Q ss_pred ---------Eeeeecc-CCeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceE
Q 001360 752 ---------FFYSFTC-RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819 (1092)
Q Consensus 752 ---------L~~sfqd-e~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNIL 819 (1092)
+++++.. ...+|+||||+ +|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 4555554 67899999999 99999999876 78999999999999999999999999999999999999
Q ss_pred ecCCC--cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001360 820 IAHDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (1092)
Q Consensus 820 LD~nG--~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDV 897 (1092)
++.++ .+||+|||+++........ ...........+||+.|+|||++.+..|+.++||
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 251 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKH--------------------VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDL 251 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCC--------------------CCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred EcCCCCceEEEecCcceeeccCCCcc--------------------ccccccccccccCCccccCHHHHccCCCCchhhH
Confidence 99998 9999999999753211000 0000112234689999999999999999999999
Q ss_pred echhhhHHHHHhCCCCCCCCC--hHHHHHHHh---hcCCCCCC---CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 898 WSVGIILFEFITGIPPFTAES--PEIIFDNIL---NRKIPWPC---VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 898 WSLGVILYEMLTGk~PF~~~s--~~ei~~kIl---~~~l~fP~---ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
|||||+||||++|..||.... ...+...+. .....++. ....++.++.+||.+||..||.+||++.++.+.
T Consensus 252 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 252 QSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 999999999999999998763 333333222 22222211 012578999999999999999999995544433
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.91 Aligned_cols=253 Identities=28% Similarity=0.436 Sum_probs=197.2
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc--CCCceEEEeeeeccC-
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV--RNPFVVRFFYSFTCR- 759 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L--~HPNIVkL~~sfqde- 759 (1092)
....++|++++.||+|+||.||+|++. |+.||||++... .......|.+++..+ +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 345578999999999999999999885 899999998642 234455666666554 899999999998887
Q ss_pred ---CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeeecCCCceEecCCCcEEE
Q 001360 760 ---DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIKL 828 (1092)
Q Consensus 760 ---~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~--------GIIHRDLKPeNILLD~nG~VKL 828 (1092)
..+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+||||+.+|.+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999965 4699999999999999999999999 9999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc------ceeechhh
Q 001360 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA------ADWWSVGI 902 (1092)
Q Consensus 829 sDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~k------sDVWSLGV 902 (1092)
+|||+++....... .........+||+.|+|||++.+..++.. +|||||||
T Consensus 184 ~Dfg~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 240 (337)
T 3mdy_A 184 ADLGLAVKFISDTN-----------------------EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240 (337)
T ss_dssp CCCTTCEECC--------------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHH
T ss_pred EeCCCceeeccccc-----------------------cccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHH
Confidence 99999975311000 00111235689999999999988777655 99999999
Q ss_pred hHHHHHhC----------CCCCCCCCh----HHHHHHHhhcCCCCCCCC-----CCCCHHHHHHHHHhccCCcCCCCCcc
Q 001360 903 ILFEFITG----------IPPFTAESP----EIIFDNILNRKIPWPCVP-----SDMSFEAQDLINRFLIHDPNQRLGAN 963 (1092)
Q Consensus 903 ILYEMLTG----------k~PF~~~s~----~ei~~kIl~~~l~fP~ip-----~~lS~eakDLI~kcL~kDP~KRpSa~ 963 (1092)
++|||++| ..||....+ ......+.......+..+ ..+++++.+||.+||..||.+||+
T Consensus 241 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-- 318 (337)
T 3mdy_A 241 ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT-- 318 (337)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC--
T ss_pred HHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC--
Confidence 99999999 777765321 222222222211112222 245678999999999999999999
Q ss_pred cHHHHHc
Q 001360 964 GAAEVKA 970 (1092)
Q Consensus 964 ga~EIL~ 970 (1092)
+.++++
T Consensus 319 -~~ell~ 324 (337)
T 3mdy_A 319 -ALRVKK 324 (337)
T ss_dssp -HHHHHH
T ss_pred -HHHHHH
Confidence 555554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=404.22 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=217.6
Q ss_pred ccCCCeEEEE-eeccCCCeEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 684 TSIDDFEIIK-PISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 684 i~~~dFeilr-~LGkGgFGtVyLar~k~--TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
...+++.+.+ .||+|+||+||+|.++. ++..||||++++.. .....+.+.+|+.+|.+++|||||++++++.. +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 4556777777 89999999999998763 46679999997642 33456789999999999999999999999976 5
Q ss_pred eeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
.+||||||++||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 699999999999999999754 4699999999999999999999999999999999999999999999999999985311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s 918 (1092)
.. ..........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+.+
T Consensus 489 ~~------------------------~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 489 DD------------------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp -------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CC------------------------ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 00 00011123456799999999999999999999999999999998 999999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
..++...+..+.. +..+..+++++.+||.+||..||.+||++.++.+.|++.|+
T Consensus 545 ~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 545 GPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp SHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 8888888876542 22357899999999999999999999997777777766554
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=381.55 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=202.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec-cCCee
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT-CRDNL 762 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TG---k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfq-de~~L 762 (1092)
..|++.+.||+|+||+||+|++..++ ..||+|.++.. ......+.+.+|+.+|++++|||||++++++. ..+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 45889999999999999999976433 46899988752 33456788999999999999999999999854 45688
Q ss_pred EEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999865 458899999999999999999999999999999999999999999999999997431100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ 920 (1092)
. ..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||...+..
T Consensus 247 ~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 247 F-----------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp ----------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred c-----------------------ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 0 00111234568899999999999999999999999999999999 78999888777
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
++...+..+... ..+..++.++.+||.+||..||.+||++.++
T Consensus 304 ~~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~dp~~RPs~~el 346 (373)
T 3c1x_A 304 DITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 346 (373)
T ss_dssp CHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 777776665432 2357899999999999999999999994433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=392.37 Aligned_cols=257 Identities=24% Similarity=0.373 Sum_probs=218.6
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
..+.+..++|++.+.||+|+||+||+|.+.. +..||||+++.... ..+.+.+|+.+|++++|||||++++++.+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 3455777899999999999999999999875 46799999976432 24578999999999999999999999876
Q ss_pred CeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
+.+||||||+.+|+|.++|... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++..
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 6799999999999999999753 46999999999999999999999999999999999999999999999999999752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~ 916 (1092)
... .........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+
T Consensus 414 ~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 414 EDN--------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp CCH--------------------------HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred CCC--------------------------ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 110 0011123457889999999999999999999999999999999 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
....++...+..+. .++ .+..++.++.+||.+||..||.+||++.++.+.|.
T Consensus 468 ~~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~ 519 (535)
T 2h8h_A 468 MVNREVLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519 (535)
T ss_dssp CCHHHHHHHHHTTC-CCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 99888888776542 222 35789999999999999999999999666655554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=401.75 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=212.0
Q ss_pred CeEEE-EeeccCCCeEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 688 DFEII-KPISRGAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 688 dFeil-r~LGkGgFGtVyLar~--k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
.+.+. +.||+|+||+||+|.+ +.+++.||||+++... ......+.+.+|+.+|.+++|||||++++++.. +.+||
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 34443 4899999999999955 4567899999997643 334456789999999999999999999999864 56899
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||||++|+|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~--- 523 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--- 523 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc---
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998532100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~ 923 (1092)
..........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+.+..++.
T Consensus 524 ---------------------~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~ 582 (635)
T 4fl3_A 524 ---------------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 582 (635)
T ss_dssp --------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred ---------------------cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 00111223457899999999999999999999999999999998 99999999998888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
..+..+.. +..+..++.++.+||.+||..||.+||++.++.+.|+
T Consensus 583 ~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 627 (635)
T 4fl3_A 583 AMLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 627 (635)
T ss_dssp HHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 88776542 2345789999999999999999999999665555554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=385.66 Aligned_cols=248 Identities=19% Similarity=0.263 Sum_probs=196.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcC---------CCc-
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVR---------NPF- 748 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~-----kk~~ie~~l~EieIL~~L~---------HPN- 748 (1092)
+..++|++++.||+|+||+||+|++ +|+.||||++++.... .....+.+.+|+.+|+.++ |||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3457899999999999999999998 6899999999865321 2334577899999998886 545
Q ss_pred ----------------eEEEeeeecc-------------CCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHH
Q 001360 749 ----------------VVRFFYSFTC-------------RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799 (1092)
Q Consensus 749 ----------------IVkL~~sfqd-------------e~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~A 799 (1092)
||+++++|.+ ...+||||||+++|++.+.+.+ +.+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 4555555554 6789999999999987777654 678999999999999999
Q ss_pred HHHHH-HcCCeeeecCCCceEecCCC--------------------cEEEEecCCcccccccccccCCCCCCCCCCCCCC
Q 001360 800 LEYLH-SLGIVHRDLKPDNLLIAHDG--------------------HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858 (1092)
Q Consensus 800 LeYLH-s~GIIHRDLKPeNILLD~nG--------------------~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~ 858 (1092)
|.||| ++|||||||||+||||+.+| .+||+|||+|+...
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~-------------------- 233 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER-------------------- 233 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE--------------------
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC--------------------
Confidence 99999 99999999999999999987 99999999998521
Q ss_pred CCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhh-HHHHHhCCCCCCCCCh-HHHHHHHhhc-CCC---
Q 001360 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII-LFEFITGIPPFTAESP-EIIFDNILNR-KIP--- 932 (1092)
Q Consensus 859 ~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVI-LYEMLTGk~PF~~~s~-~ei~~kIl~~-~l~--- 932 (1092)
....+||+.|||||++.+.. +.++||||||++ .++++.|..||.+... ......+... ...
T Consensus 234 ------------~~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 300 (336)
T 2vuw_A 234 ------------DGIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC 300 (336)
T ss_dssp ------------TTEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCC
T ss_pred ------------CCcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCccc
Confidence 01358999999999998776 899999998776 7889999999954321 2233333322 111
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH-cCCCCC
Q 001360 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK-AHPFFK 975 (1092)
Q Consensus 933 fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL-~HPFFk 975 (1092)
.+..+..+++++++||.+||++| + +.+++ +||||+
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----s---a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----S---ATDLLCQHSLFK 336 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----S---HHHHHHHCGGGC
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----C---HHHHHhcCCCcC
Confidence 11112357889999999999977 5 89999 999995
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=366.81 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=213.4
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
..+.+..++|++.+.||+|+||.||+|++.. .||+|+++.... .....+.+.+|+.++..++||||+++++++.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 4456778999999999999999999999864 499999875432 223345577899999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
+.+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ +|.+||+|||+++...
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999999999998755 699999999999999999999999999999999999998 7899999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---------CCCCccceeechhhhHHHHHh
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---------TEHGYAADWWSVGIILFEFIT 909 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---------~~Yt~ksDVWSLGVILYEMLT 909 (1092)
.... ...........||+.|+|||++.+ ..|+.++|||||||++|||++
T Consensus 181 ~~~~----------------------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~ 238 (319)
T 2y4i_B 181 VLQA----------------------GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238 (319)
T ss_dssp -----------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH
T ss_pred cccc----------------------cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh
Confidence 0000 001122334579999999999975 457899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 910 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 910 Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
|..||.......+...+..+..+.. .+..++.++.+||.+||..||.+||++.++.+.+
T Consensus 239 g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 297 (319)
T 2y4i_B 239 REWPFKTQPAEAIIWQMGTGMKPNL-SQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297 (319)
T ss_dssp SSCSSSSCCHHHHHHHHHTTCCCCC-CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHhccCCCCCC-CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 9999999998888877766543322 2346889999999999999999999955555544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=365.49 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=205.2
Q ss_pred CeEEEEeeccCCCeEEEEEEEC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Ce
Q 001360 688 DFEIIKPISRGAFGRVFLARKR----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DN 761 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k----~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde--~~ 761 (1092)
.|++++.||+|+||+||++.++ .+|+.||||++++. ........+.+|+.+|+.++||||+++++++.+. ..
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 3599999999999999888653 47889999999764 2345567899999999999999999999999874 67
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+|+||||+++|+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 89999999999999999764 49999999999999999999999999999999999999999999999999998531100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 189 ------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~ 244 (318)
T 3lxp_A 189 ------------------------EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF 244 (318)
T ss_dssp ------------------------SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred ------------------------cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh
Confidence 00112234568999999999999999999999999999999999999997543210
Q ss_pred --------------HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 922 --------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 922 --------------i~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
.....+..... +..+..++.++.+||.+||..||.+||++.++.+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 305 (318)
T 3lxp_A 245 LELIGIAQGQMTVLRLTELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305 (318)
T ss_dssp HHHHCSCCHHHHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhhhcccccchhHHHHHHHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11122222222 224578999999999999999999999955444433
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=358.86 Aligned_cols=234 Identities=31% Similarity=0.548 Sum_probs=193.5
Q ss_pred cccCCCeEEE-EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhcCCCceEEEeeeecc--
Q 001360 683 RTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVRFFYSFTC-- 758 (1092)
Q Consensus 683 ~i~~~dFeil-r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL-~~L~HPNIVkL~~sfqd-- 758 (1092)
....++|.++ +.||+|+||.||+|+++.+|+.||+|+++.. ..+.+|+.++ +..+||||++++++|..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 3456789998 7899999999999999999999999998642 3466788887 56689999999999887
Q ss_pred --CCeeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC---CCcEEEEec
Q 001360 759 --RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDF 831 (1092)
Q Consensus 759 --e~~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDF 831 (1092)
...+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 678999999999999999998754 6999999999999999999999999999999999999998 789999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCC
Q 001360 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911 (1092)
Q Consensus 832 GLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk 911 (1092)
|++.... +..|+.++|||||||++|||++|.
T Consensus 165 g~a~~~~-------------------------------------------------~~~~~~~~DiwslG~il~el~tg~ 195 (299)
T 3m2w_A 165 GFAKETT-------------------------------------------------GEKYDKSCDMWSLGVIMYILLCGY 195 (299)
T ss_dssp TTCEECT-------------------------------------------------TCGGGGHHHHHHHHHHHHHHHHSS
T ss_pred ccccccc-------------------------------------------------cccCCchhhHHHHHHHHHHHHHCC
Confidence 9987410 134778999999999999999999
Q ss_pred CCCCCCChHHHHHHHhh----cCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 912 PPFTAESPEIIFDNILN----RKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 912 ~PF~~~s~~ei~~kIl~----~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
+||.+.........+.. ....+|. ....+++++.+||.+||..||.+||+ +.++++||||++
T Consensus 196 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~e~l~hp~~~~ 262 (299)
T 3m2w_A 196 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQ 262 (299)
T ss_dssp CSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHT
T ss_pred CCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCC---HHHHhcChhhcc
Confidence 99987765544322221 2222221 01468999999999999999999999 889999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=360.22 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=199.6
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 001360 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei-~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm 769 (1092)
..+.||+|+||.||+|.. +++.||+|++..... ........+.+|+.++..++||||+++++++.+.+.+|+||||+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 347899999999999986 588999999875432 23345678999999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 770 NGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 770 ~GGSL~dlLkk~---g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
+||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~------ 186 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF------ 186 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC------
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc------
Confidence 999999999743 45999999999999999999999999999999999999999999999999998752100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH----H
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI----I 922 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e----i 922 (1092)
.........+||+.|+|||++.+ .++.++|||||||++|+|++|.+||....... +
T Consensus 187 -------------------~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 187 -------------------AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp -------------------SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred -------------------cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 00111234679999999999875 48899999999999999999999998754322 2
Q ss_pred HHHHhhcCC--------CCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 923 FDNILNRKI--------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 923 ~~kIl~~~l--------~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
...+..... .++..+...+..+.+||.+||..||.+||++.++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 222221111 112223445678999999999999999999444433
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=387.96 Aligned_cols=275 Identities=22% Similarity=0.307 Sum_probs=221.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccCCeeE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H-PNIVkL~~sfqde~~LY 763 (1092)
..++|++++.||+|+||.||+|++..+|+.||||++...... ..+..|+.++..+.| ++|+.+..++...+..|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 457899999999999999999999999999999988754322 247889999999986 66667777778888999
Q ss_pred EEEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEe---cCCCcEEEEecCCcccccc
Q 001360 764 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILL---D~nG~VKLsDFGLAk~~~~ 839 (1092)
|||||+ +|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+++....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999975 4579999999999999999999999999999999999999 6889999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
.... ...........+||+.|+|||++.+..|+.++|||||||+||||++|..||.+...
T Consensus 159 ~~~~--------------------~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 159 TSTH--------------------QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp TTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred Cccc--------------------cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 1000 00001123367899999999999999999999999999999999999999987543
Q ss_pred ---HHHHHHHhhcCCC--CCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH-------HHcCCCCCCCCcchhhhc
Q 001360 920 ---EIIFDNILNRKIP--WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE-------VKAHPFFKGVNWDSLALQ 985 (1092)
Q Consensus 920 ---~ei~~kIl~~~l~--fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E-------IL~HPFFkgIdWd~L~~~ 985 (1092)
...+.++...... .+.+...++.++.+||.+||..||.+||++.++.+ .+.++|+..++|+.+...
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~ 296 (483)
T 3sv0_A 219 GTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (483)
T ss_dssp SSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-
T ss_pred hhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccc
Confidence 4444444433211 11122567899999999999999999999654433 345899999999987655
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=361.59 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=206.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~----k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd 758 (1092)
....++|++++.||+|+||.||+|+. ..+|+.||+|++... .......+.+|+.+|+.++||||+++++++..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 35567899999999999999999994 567999999998753 33456789999999999999999999998876
Q ss_pred CC--eeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcc
Q 001360 759 RD--NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1092)
Q Consensus 759 e~--~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 835 (1092)
.+ .+|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 54 789999999999999999875 469999999999999999999999999999999999999999999999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC
Q 001360 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 836 ~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
...... ..........||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 194 ~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 194 VLPQDK------------------------EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp ECCSSC------------------------SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred hccccc------------------------cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 531100 00011223467888999999999889999999999999999999999986
Q ss_pred CCCh------------HHH---HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHH
Q 001360 916 AESP------------EII---FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (1092)
Q Consensus 916 ~~s~------------~ei---~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~ 966 (1092)
.... ... ....+......+ .+..++.++.+||.+||..||.+||++.++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 314 (326)
T 2w1i_A 250 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP-RPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 314 (326)
T ss_dssp SHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCHHHHHHhhccccchhhhHHHHHHHhhcCCCCC-CCCcccHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 4311 111 111222222222 3578999999999999999999999954433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=359.52 Aligned_cols=251 Identities=23% Similarity=0.355 Sum_probs=202.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCceEEEeeeeccCC-
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRD- 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~--L~HPNIVkL~~sfqde~- 760 (1092)
...++|++.+.||+|+||.||+|++ +|+.||||++.+. ....+.+|.+++.. ++||||+++++++....
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 3457899999999999999999998 4899999998642 34567889999988 78999999999998876
Q ss_pred ---eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH--------HcCCeeeecCCCceEecCCCcEEEE
Q 001360 761 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH--------SLGIVHRDLKPDNLLIAHDGHIKLT 829 (1092)
Q Consensus 761 ---~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLH--------s~GIIHRDLKPeNILLD~nG~VKLs 829 (1092)
.+|+||||+++|+|.+++.+ ..+++..+..++.||+.||.||| +.||+||||||+||||+.+|.+||+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 79999999999999999976 46899999999999999999999 8999999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC------CCccceeechhhh
Q 001360 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGII 903 (1092)
Q Consensus 830 DFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~------Yt~ksDVWSLGVI 903 (1092)
|||+++....... .........+||+.|+|||++.+.. ++.++|||||||+
T Consensus 190 Dfg~~~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~i 246 (342)
T 1b6c_B 190 DLGLAVRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 246 (342)
T ss_dssp CCTTCEEEETTTT-----------------------EEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHH
T ss_pred ECCCceecccccc-----------------------ccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHH
Confidence 9999975321000 0001224568999999999998753 3368999999999
Q ss_pred HHHHHhC----------CCCCCCCC-----hHHHHHHHhhcCCCCCCCCC-----CCCHHHHHHHHHhccCCcCCCCCcc
Q 001360 904 LFEFITG----------IPPFTAES-----PEIIFDNILNRKIPWPCVPS-----DMSFEAQDLINRFLIHDPNQRLGAN 963 (1092)
Q Consensus 904 LYEMLTG----------k~PF~~~s-----~~ei~~kIl~~~l~fP~ip~-----~lS~eakDLI~kcL~kDP~KRpSa~ 963 (1092)
+|||++| ..||.... ...+...+...... |.++. ..+..+.+||.+||..||.+||+
T Consensus 247 l~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-- 323 (342)
T 1b6c_B 247 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLT-- 323 (342)
T ss_dssp HHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC--
T ss_pred HHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhC-CCCcccccchhHHHHHHHHHHHHhccChhhCCC--
Confidence 9999999 78997643 34445444444332 22222 34467999999999999999999
Q ss_pred cHHHHHc
Q 001360 964 GAAEVKA 970 (1092)
Q Consensus 964 ga~EIL~ 970 (1092)
+.++++
T Consensus 324 -~~~i~~ 329 (342)
T 1b6c_B 324 -ALRIKK 329 (342)
T ss_dssp -HHHHHH
T ss_pred -HHHHHH
Confidence 445544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=381.14 Aligned_cols=253 Identities=17% Similarity=0.174 Sum_probs=199.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-Cce-------------
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFV------------- 749 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H-PNI------------- 749 (1092)
.....|...+.||+|+||+||+|++..+|+.||||+++..........+.+.+|+.++..+.| +++
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 345568999999999999999999999999999999985444444456778999999999876 211
Q ss_pred --------EEEeeeecc-----CCeeEEEEeecCCCcHHHHHHh-------hcCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 001360 750 --------VRFFYSFTC-----RDNLYLVMEYLNGGDLYSLLRK-------VGCLEEDVARIYIAELVLALEYLHSLGIV 809 (1092)
Q Consensus 750 --------VkL~~sfqd-----e~~LYLVMEYm~GGSL~dlLkk-------~g~LsE~~ar~yaaQIL~ALeYLHs~GII 809 (1092)
..++..+.. ...+|++|+++ +|+|.+++.. ...+++..+..++.||+.||.|||++|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 111111121 12367777766 6799999852 23477888888889999999999999999
Q ss_pred eeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh---
Q 001360 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--- 886 (1092)
Q Consensus 810 HRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL--- 886 (1092)
||||||+||||+.+|.+||+|||+++... ......+| +.|+|||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~------------------------------~~~~~~~g-~~y~aPE~~~~~ 282 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG------------------------------ASAVSPIG-RGFAPPETTAER 282 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT------------------------------EEECCCCC-TTTCCHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecC------------------------------CccccCCC-CceeCchhhhcc
Confidence 99999999999999999999999987421 11345678 999999999
Q ss_pred -------cCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCC
Q 001360 887 -------LGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959 (1092)
Q Consensus 887 -------~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KR 959 (1092)
.+..|+.++|||||||+||||++|+.||...+.......++... ..+++++.+||.+||..||.+|
T Consensus 283 ~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC-------KNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp TSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSSC-------CCCCHHHHHHHHHHTCSSGGGS
T ss_pred ccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhhc-------ccCCHHHHHHHHHHccCChhhC
Confidence 55568889999999999999999999999887666555554432 3578999999999999999999
Q ss_pred CCcccHHHHHcCCCCCCCC
Q 001360 960 LGANGAAEVKAHPFFKGVN 978 (1092)
Q Consensus 960 pSa~ga~EIL~HPFFkgId 978 (1092)
|+ +.++++||||+.+.
T Consensus 356 pt---~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 356 LL---PLQAMETPEYEQLR 371 (413)
T ss_dssp CC---HHHHTTSHHHHHHH
T ss_pred cC---HHHHHhCHHHHHHH
Confidence 99 88999999998753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=392.31 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=212.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~T---Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.+..++|++.+.||+|+||+||+|.+..+ +..||+|+++... .....+.+.+|+.+|.+++|||||++++++. .
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 45567899999999999999999998654 4579999886532 3445678999999999999999999999985 4
Q ss_pred CeeEEEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
+.+|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 66899999999999999998654 68999999999999999999999999999999999999999999999999997521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
.. .........||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.
T Consensus 543 ~~--------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 543 DS--------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp C------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CC--------------------------cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 00 0111223467889999999999999999999999999999997 99999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHH
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~ 966 (1092)
+..++...+..+.. +..+..+++++.+||.+||..||.+||++.++.
T Consensus 597 ~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~ 643 (656)
T 2j0j_A 597 KNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 643 (656)
T ss_dssp CHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 99888888876542 223578999999999999999999999954433
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=399.14 Aligned_cols=261 Identities=28% Similarity=0.412 Sum_probs=210.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-----
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----- 758 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd----- 758 (1092)
...++|++.+.||+|+||.||+|.++.+|+.||||+++.. ........+.+|+.+|.+++||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 3458899999999999999999999999999999998753 244566789999999999999999999998766
Q ss_pred -CCeeEEEEeecCCCcHHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc---EEEEec
Q 001360 759 -RDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDF 831 (1092)
Q Consensus 759 -e~~LYLVMEYm~GGSL~dlLkk~g---~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~---VKLsDF 831 (1092)
.+..|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|. +||+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 677899999999999999998754 5999999999999999999999999999999999999997775 999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCC
Q 001360 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911 (1092)
Q Consensus 832 GLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk 911 (1092)
|+++... ........+||+.|+|||++.+..|+.++|||||||++|+|++|.
T Consensus 169 G~a~~~~----------------------------~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~ 220 (676)
T 3qa8_A 169 GYAKELD----------------------------QGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220 (676)
T ss_dssp CCCCBTT----------------------------SCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSC
T ss_pred ccccccc----------------------------cccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCC
Confidence 9987421 011223468999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHH--------------HhhcCCCCCC-------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 912 PPFTAESPEIIFDN--------------ILNRKIPWPC-------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 912 ~PF~~~s~~ei~~k--------------Il~~~l~fP~-------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
.||.+......+.. ...+...++. +...+++.+.+||.+||..||.+||+ +.++++
T Consensus 221 ~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT---a~elL~ 297 (676)
T 3qa8_A 221 RPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT---DPQNPN 297 (676)
T ss_dssp SSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C---CTTCCC
T ss_pred CCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC---HHHHhc
Confidence 99976543221110 1112222211 22346789999999999999999999 668899
Q ss_pred CCCCCCC
Q 001360 971 HPFFKGV 977 (1092)
Q Consensus 971 HPFFkgI 977 (1092)
||||+.+
T Consensus 298 hp~F~~l 304 (676)
T 3qa8_A 298 VGCFQAL 304 (676)
T ss_dssp CTTHHHH
T ss_pred CHHHHHH
Confidence 9999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=346.95 Aligned_cols=227 Identities=15% Similarity=0.157 Sum_probs=189.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+..+.|++.+.||+|+||.||+|++..+|+.||||+++............+.+|+.++..++||||+++++++.+.+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34478999999999999999999999999999999998765555566788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
+||||++||+|.+++.+ + .....+..++.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999999954 3 4556788899999999999999999999999999999999999988544
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
|++ .++.++|||||||++|||++|+.||.+.+.....
T Consensus 175 ------------------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~ 211 (286)
T 3uqc_A 175 ------------------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211 (286)
T ss_dssp ------------------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS
T ss_pred ------------------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh
Confidence 222 3788999999999999999999999887654322
Q ss_pred H---HHhhcCCCCC-CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 924 D---NILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 924 ~---kIl~~~l~fP-~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
. ++.......+ .....+++++.+||.+||..||.+| ++.++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 212 APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 1 1112221111 1235789999999999999999999 8443333
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=385.27 Aligned_cols=243 Identities=28% Similarity=0.396 Sum_probs=199.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe-
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN- 761 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~-TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~- 761 (1092)
...++|++.+.||+|+||+||+|.+.. +|+.||||++.... .......+.+|+.+|.+++|||||+++++|...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 445899999999999999999999976 78999999986532 33456778999999999999999999999987765
Q ss_pred ----eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 762 ----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 762 ----LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
+||||||++||+|.+++.. .+++..+..++.||+.||.|||++|||||||||+||||+.+ .+||+|||+++..
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999988765 79999999999999999999999999999999999999875 9999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
. .....+||+.|+|||++.+. ++.++|||||||+||+|++|.+||.+.
T Consensus 232 ~-------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 232 N-------------------------------SFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp T-------------------------------CCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred c-------------------------------cCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 1 01345799999999999765 588999999999999999999998753
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
... .++........++.+.+||.+||..||.+||+ ..+.+.|+|+.
T Consensus 280 ~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~ 325 (681)
T 2pzi_A 280 YVD---------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFT---TAEEMSAQLTG 325 (681)
T ss_dssp ECS---------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHH
T ss_pred ccc---------cccccccccccCHHHHHHHhhhccCChhhCCC---HHHHHHHHHHH
Confidence 211 11100001124578999999999999999998 45667777764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-33 Score=331.95 Aligned_cols=192 Identities=18% Similarity=0.142 Sum_probs=140.5
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeE
Q 001360 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-------RKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~-------kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~~LY 763 (1092)
....+.|++|.+..++....|+.||+|++.+.... .....+.+.+|+++|+++ .|+||++++++++++..+|
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 34578899999988888888999999999864221 223456799999999999 6999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
|||||++||+|.++|.+.+.+++. .|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~---- 391 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ---- 391 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC----
Confidence 999999999999999998888865 4789999999999999999999999999999999999999999985310
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCC
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
......+.+||+.|||||++.+. +...+|+||+|+++|+|++|..||
T Consensus 392 -----------------------~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 -----------------------DCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -------------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred -----------------------CCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 11223567999999999999764 677899999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-28 Score=280.99 Aligned_cols=194 Identities=18% Similarity=0.129 Sum_probs=146.4
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 690 eilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~k-----k~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
...+.||+|+||+||+|+. .+..+|+|.+....... ....+++.+|+++|++++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 3456899999999999943 47889999875432221 1224568999999999999999955555556777899
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
||||++||+|.+++.+ +..++.||+.||.|||++|||||||||+|||++. ++||+|||+++.......
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~-- 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED-- 484 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH--
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc--
Confidence 9999999999999876 5688999999999999999999999999999998 999999999985311000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCC
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
..........+.+||+.|||||++.. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 485 ------------------~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 ------------------KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp ------------------HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ------------------cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 00000001246789999999999987 678889999999999888888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-25 Score=239.73 Aligned_cols=135 Identities=21% Similarity=0.192 Sum_probs=110.1
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---------------hHHHHHHHHHHHHHhcCCCceEEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---------------NDIERILAERNILITVRNPFVVRF 752 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk---------------~~ie~~l~EieIL~~L~HPNIVkL 752 (1092)
-|.+.+.||+|+||.||+|++ .+|+.||||+++....... .....+.+|+.+|.+++| +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 466779999999999999999 7899999999964321111 235678999999999994 555
Q ss_pred eeeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecC
Q 001360 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832 (1092)
Q Consensus 753 ~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFG 832 (1092)
+.++. .+.+|+||||++||+|.+ +. ......++.||+.||.|||++|||||||||+||||+ +|++||+|||
T Consensus 167 ~~~~~-~~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 167 PKVYA-WEGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp CCEEE-EETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred CeEEe-ccceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 55443 356799999999999987 42 133557899999999999999999999999999999 9999999999
Q ss_pred Ccc
Q 001360 833 LSK 835 (1092)
Q Consensus 833 LAk 835 (1092)
+|+
T Consensus 238 ~a~ 240 (282)
T 1zar_A 238 QSV 240 (282)
T ss_dssp TCE
T ss_pred CCe
Confidence 986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=198.52 Aligned_cols=139 Identities=21% Similarity=0.178 Sum_probs=108.8
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcE--EEEEEeecccccc---------------------hhHHHHHHHHHHHHHhcC
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIR---------------------KNDIERILAERNILITVR 745 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~--VAIKvLkK~ei~k---------------------k~~ie~~l~EieIL~~L~ 745 (1092)
|++.+.||+|+||.||+|.+..+|+. ||||+++...... ......+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78899999999999999998778999 9999976432110 011246789999999998
Q ss_pred CCce--EEEeeeeccCCeeEEEEeecCC-C----cHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH-HcCCeeeecCCCc
Q 001360 746 NPFV--VRFFYSFTCRDNLYLVMEYLNG-G----DLYSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDN 817 (1092)
Q Consensus 746 HPNI--VkL~~sfqde~~LYLVMEYm~G-G----SL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLH-s~GIIHRDLKPeN 817 (1092)
|++| ..++.. ...||||||+.+ | +|.++... +++..+..++.||+.||.||| +.|||||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 7753 333332 357899999942 4 67665432 235567889999999999999 9999999999999
Q ss_pred eEecCCCcEEEEecCCccc
Q 001360 818 LLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 818 ILLD~nG~VKLsDFGLAk~ 836 (1092)
||++. .++|+|||+|..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99998 999999999874
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.7e-17 Score=187.06 Aligned_cols=136 Identities=13% Similarity=0.158 Sum_probs=98.3
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----------chhHHHH--------HHHHHHHHHhcCCCce
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----------RKNDIER--------ILAERNILITVRNPFV 749 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~-----------kk~~ie~--------~l~EieIL~~L~HPNI 749 (1092)
|++.+.||.|+||.||+|... +|+.||||+++..... ....... ...|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999875 6999999998642110 0001111 2345566666644332
Q ss_pred E--EEeeeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC---
Q 001360 750 V--RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--- 824 (1092)
Q Consensus 750 V--kL~~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG--- 824 (1092)
. ..+.. ...+|||||+.|++|..+. ..+.+..++.||+.+|.|||+.|||||||||.||||+.+|
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 1 11111 1237999999999886442 2234567789999999999999999999999999999877
Q ss_pred -------cEEEEecCCcc
Q 001360 825 -------HIKLTDFGLSK 835 (1092)
Q Consensus 825 -------~VKLsDFGLAk 835 (1092)
.+.|+||+-+.
T Consensus 246 d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp CTTSEEEEEEECCCTTCE
T ss_pred cccccccceEEEEeCCcc
Confidence 48999999775
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=9.9e-12 Score=129.43 Aligned_cols=143 Identities=15% Similarity=0.138 Sum_probs=113.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LY 763 (1092)
.+..|++...+|.|+++.||++... |..|++|+...... .....+.+|..+|+.+. +..+.++++++.+.+..|
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 3467999999999999999999743 68899998864221 11235788999999885 677888888888888999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-------------------------------------- 805 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs-------------------------------------- 805 (1092)
+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999999876531 222334678899999999998
Q ss_pred ---------------------cCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 806 ---------------------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 806 ---------------------~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
..++|+|++|.|||++.++.+.|+||+.+..+
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 45899999999999987656679999988753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=4e-11 Score=122.75 Aligned_cols=137 Identities=15% Similarity=0.137 Sum_probs=100.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc--eEEEeeeeccCCee
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF--VVRFFYSFTCRDNL 762 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPN--IVkL~~sfqde~~L 762 (1092)
...+|.+....+.|..+.||++.. .+|..|++|+.... ....+.+|..+|+.+.+.+ +.++++++...+..
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 345677655555667799999964 45778999987643 1234678888888886433 56688888888889
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcC-----------------------------------
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG----------------------------------- 807 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~G----------------------------------- 807 (1092)
|+||||++|.+|. . .... ...++.+++..|..||+..
T Consensus 91 ~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999999998883 1 1122 1245667777777777643
Q ss_pred -----------------------CeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 808 -----------------------IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 808 -----------------------IIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.05 E-value=3.8e-10 Score=123.58 Aligned_cols=141 Identities=17% Similarity=0.310 Sum_probs=106.1
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEee--cccccchhHHHHHHHHHHHHHhcC--CCceEEEeeeeccC---CeeE
Q 001360 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCR---DNLY 763 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~TGk~VAIKvLk--K~ei~kk~~ie~~l~EieIL~~L~--HPNIVkL~~sfqde---~~LY 763 (1092)
.++.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+|+.+. +..+.+++..+.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4678999999999998754 4678888765 32211 12346778999999887 45678888887776 4589
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-------------------------------------- 805 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs-------------------------------------- 805 (1092)
+||||++|..+.+. ....++......++.+++.+|..||+
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999877431 12346788888899999999999997
Q ss_pred --------------------cCCeeeecCCCceEecCCCc--EEEEecCCcccc
Q 001360 806 --------------------LGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIG 837 (1092)
Q Consensus 806 --------------------~GIIHRDLKPeNILLD~nG~--VKLsDFGLAk~~ 837 (1092)
.+++|+|++|.|||++.++. +.|+||+.+..+
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36899999999999997763 699999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=4e-10 Score=120.87 Aligned_cols=133 Identities=20% Similarity=0.223 Sum_probs=98.0
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CC--ceEEEeeeeccCC---eeEEEE
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NP--FVVRFFYSFTCRD---NLYLVM 766 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HP--NIVkL~~sfqde~---~LYLVM 766 (1092)
+.++.|.+..||++. ..+++|+.... .....+.+|..+|..+. +. .+.+++....... ..|+||
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 358999999999863 45888875432 34567889999998873 32 2344444443333 358999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS----------------------------------------- 805 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs----------------------------------------- 805 (1092)
++++|..|..... ..++..+...++.+++..|..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999988865432 346777778888888888888886
Q ss_pred -----------------cCCeeeecCCCceEecC--CCcEEEEecCCcccc
Q 001360 806 -----------------LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIG 837 (1092)
Q Consensus 806 -----------------~GIIHRDLKPeNILLD~--nG~VKLsDFGLAk~~ 837 (1092)
..++|+|++|.|||++. .+.+.|+||+.+..+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 13699999999999998 456899999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=3.4e-06 Score=91.40 Aligned_cols=134 Identities=17% Similarity=0.242 Sum_probs=91.1
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC---ceEEEeeeec-cCCeeEEEEe
Q 001360 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP---FVVRFFYSFT-CRDNLYLVME 767 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HP---NIVkL~~sfq-de~~LYLVME 767 (1092)
++.++.|....||++ |..+++|+-.. ......+.+|..+|..+.+. .|.+.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 455788999999988 56688887432 23456788999999998742 2445554443 4456789999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL----------------------------------------- 806 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~----------------------------------------- 806 (1092)
|++|..|..... ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988865321 1234444444444444444444432
Q ss_pred -------------------CCeeeecCCCceEecC---CCc-EEEEecCCcccc
Q 001360 807 -------------------GIVHRDLKPDNLLIAH---DGH-IKLTDFGLSKIG 837 (1092)
Q Consensus 807 -------------------GIIHRDLKPeNILLD~---nG~-VKLsDFGLAk~~ 837 (1092)
.++|+|++|.|||++. ++. +.|+||+.+..+
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999987 455 489999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=6.3e-06 Score=85.92 Aligned_cols=139 Identities=18% Similarity=0.193 Sum_probs=97.2
Q ss_pred CeEEEEeeccCCCe-EEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEE
Q 001360 688 DFEIIKPISRGAFG-RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 688 dFeilr~LGkGgFG-tVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LYLV 765 (1092)
.|+.. .+..|..| .||+......+..+.+|+-.. .....+.+|..+|..+. +--|.+++.++.+.+..|+|
T Consensus 26 g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 26 GYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp TCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred CCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 34433 34445554 799888777777899997653 23456788999998775 33366777888888899999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------------------------------------- 806 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~--------------------------------------- 806 (1092)
||+++|.++.+..... ......+..++...|.-||..
T Consensus 99 me~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp EECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred EEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 9999998877654321 112233444555555555531
Q ss_pred -------------------CCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 807 -------------------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 807 -------------------GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
.++|+|+.|.|||++.++.+-|+||+.+..+
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1789999999999998777789999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=3e-06 Score=94.12 Aligned_cols=80 Identities=26% Similarity=0.292 Sum_probs=50.6
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cch---hHHHHHHHHHHHHHhcCC--C-ceEEEeeeeccCCeeE
Q 001360 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRK---NDIERILAERNILITVRN--P-FVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei-~kk---~~ie~~l~EieIL~~L~H--P-NIVkL~~sfqde~~LY 763 (1092)
.++.||.|.++.||++....+++.|++|....... ... ....++..|.++|..+.. | .+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35689999999999997665678899998653211 000 123456778888887642 3 34455543 344568
Q ss_pred EEEeecCCC
Q 001360 764 LVMEYLNGG 772 (1092)
Q Consensus 764 LVMEYm~GG 772 (1092)
+||||++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=3.3e-05 Score=82.43 Aligned_cols=137 Identities=12% Similarity=0.110 Sum_probs=78.8
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----CCceEEEe-e--eeccCCee
Q 001360 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----NPFVVRFF-Y--SFTCRDNL 762 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-----HPNIVkL~-~--sfqde~~L 762 (1092)
-++.|+.|..+.||++... +..|++|+.... . ..+..|..++..+. .|.++... + +....+..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEET--TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeC--CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 3456777789999999764 345899988641 1 22334455554432 34444311 1 11345678
Q ss_pred EEEEeecCCCcHH-----------HH---HHhh-cCC--C-----------HH--------H------------------
Q 001360 763 YLVMEYLNGGDLY-----------SL---LRKV-GCL--E-----------ED--------V------------------ 788 (1092)
Q Consensus 763 YLVMEYm~GGSL~-----------dl---Lkk~-g~L--s-----------E~--------~------------------ 788 (1092)
|+||+|++|..+. .. ++.. ..+ + +. .
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986431 11 1111 111 1 00 0
Q ss_pred -----HHHHHHHHHHHHHHHHH-------------cCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 789 -----ARIYIAELVLALEYLHS-------------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 789 -----ar~yaaQIL~ALeYLHs-------------~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
...+..++..++.+|+. .+++|+|++|.|||++.++.+.|+||+.+..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11112234446666653 5799999999999998888999999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.83 E-value=4.4e-05 Score=83.13 Aligned_cols=82 Identities=15% Similarity=0.166 Sum_probs=53.8
Q ss_pred EEEEee-ccCCCeEEEEEEEC---C---CCcEEEEEEeeccc---ccchhHHHHHHHHHHHHHhcC-C--CceEEEeeee
Q 001360 690 EIIKPI-SRGAFGRVFLARKR---T---TGDLFAIKVLKKLD---MIRKNDIERILAERNILITVR-N--PFVVRFFYSF 756 (1092)
Q Consensus 690 eilr~L-GkGgFGtVyLar~k---~---TGk~VAIKvLkK~e---i~kk~~ie~~l~EieIL~~L~-H--PNIVkL~~sf 756 (1092)
..++.| +.|....+|++... . ++..+++|+..... ... ...+.+|..+|..+. + ..+.+++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 456778 88999999998753 1 15678889765422 111 134567787777664 2 3466677666
Q ss_pred ccC---CeeEEEEeecCCCcH
Q 001360 757 TCR---DNLYLVMEYLNGGDL 774 (1092)
Q Consensus 757 qde---~~LYLVMEYm~GGSL 774 (1092)
.+. ...|+||||++|..+
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCC
T ss_pred cCCCccCCceEEEEecCCCCh
Confidence 554 357899999998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00021 Score=80.44 Aligned_cols=32 Identities=22% Similarity=0.469 Sum_probs=28.4
Q ss_pred HcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 805 s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
...++|+|++|.|||++.++ ++|+||+.+..+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 45799999999999998877 999999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0014 Score=72.30 Aligned_cols=76 Identities=14% Similarity=0.132 Sum_probs=59.1
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCeeEEEEe
Q 001360 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~---HPNIVkL~~sfqde~~LYLVME 767 (1092)
-++.|+.|.+..+|++.. ++..|++|+.... ....+..|...|+.+. ...|.+++......+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 457799999999999874 4678889977542 2456788988888774 3567778877777788999999
Q ss_pred ecCCCcH
Q 001360 768 YLNGGDL 774 (1092)
Q Consensus 768 Ym~GGSL 774 (1092)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0016 Score=69.65 Aligned_cols=132 Identities=14% Similarity=0.078 Sum_probs=72.6
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeec-
Q 001360 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYL- 769 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LYLVMEYm- 769 (1092)
++.|+.|....+|++ ..|++|+....... .....+|..++..+. +....++++.+. +.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecC
Confidence 678999999999999 45888877542110 011235666666553 211134454433 3347899999
Q ss_pred CCCcHHH---------------HH---Hhhc-CCC-----HHHHHHHHHH--------------HHHHHHHHHH------
Q 001360 770 NGGDLYS---------------LL---RKVG-CLE-----EDVARIYIAE--------------LVLALEYLHS------ 805 (1092)
Q Consensus 770 ~GGSL~d---------------lL---kk~g-~Ls-----E~~ar~yaaQ--------------IL~ALeYLHs------ 805 (1092)
+|-+|.. .| +..+ .+. ......+... +...+..|..
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 6644421 01 1111 011 1111112111 1112222211
Q ss_pred --cCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 806 --LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 806 --~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
..++|+|+.|.||| ..++.+.|+||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 13899999999999 5677899999998875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0021 Score=68.73 Aligned_cols=141 Identities=16% Similarity=0.154 Sum_probs=79.2
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc--eEEEeee------eccCC
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF--VVRFFYS------FTCRD 760 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPN--IVkL~~s------fqde~ 760 (1092)
..-++.|+.|....||++... +| .|++|+..... ....+..|..++..+.... +.+++.. ....+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 445678888999999999764 23 68899886521 1123456777766553111 2333321 12235
Q ss_pred eeEEEEeecCCCcHH-----------HH---HHhh-cCC--------CHH-HHHH--------------HHHHHHHHHHH
Q 001360 761 NLYLVMEYLNGGDLY-----------SL---LRKV-GCL--------EED-VARI--------------YIAELVLALEY 802 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~-----------dl---Lkk~-g~L--------sE~-~ar~--------------yaaQIL~ALeY 802 (1092)
..++||+|++|..+. .. ++.. ..+ ... .... +...+...+..
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 678999999985431 11 1111 011 100 0000 00123445566
Q ss_pred HHH-------cCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 803 LHS-------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 803 LHs-------~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
++. .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 653 3699999999999998776668999998874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0034 Score=67.37 Aligned_cols=136 Identities=15% Similarity=0.171 Sum_probs=76.9
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeee-----eccCCeeEEE
Q 001360 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYS-----FTCRDNLYLV 765 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H--PNIVkL~~s-----fqde~~LYLV 765 (1092)
..|+ |....||++... +|+.|++|+.+.... ....+..|..++..+.. -.+++++.. ....+..|+|
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 3466 888899987643 466799998863211 23456667777776641 123444432 1123456889
Q ss_pred EeecCCCcHH-----------HHH---Hhh----c-----CCCHHHH----HHH---------------HHHHHHHHHHH
Q 001360 766 MEYLNGGDLY-----------SLL---RKV----G-----CLEEDVA----RIY---------------IAELVLALEYL 803 (1092)
Q Consensus 766 MEYm~GGSL~-----------dlL---kk~----g-----~LsE~~a----r~y---------------aaQIL~ALeYL 803 (1092)
|+|++|..+. ..| +.. . .++.... +.+ ...+-..+..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999885421 111 110 0 1111110 011 11111223333
Q ss_pred H-------HcCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 804 H-------SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 804 H-------s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
. ...++|+|++|.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2 23589999999999998 4 899999998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0026 Score=68.78 Aligned_cols=32 Identities=34% Similarity=0.607 Sum_probs=28.0
Q ss_pred cCCeeeecCCCceEecCC----CcEEEEecCCcccc
Q 001360 806 LGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIG 837 (1092)
Q Consensus 806 ~GIIHRDLKPeNILLD~n----G~VKLsDFGLAk~~ 837 (1092)
..++|+|+.+.|||++.+ +.+.|+||+.+..+
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 68999999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.65 E-value=0.005 Score=70.25 Aligned_cols=74 Identities=18% Similarity=0.225 Sum_probs=49.6
Q ss_pred EEEeeccCCCeEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCee
Q 001360 691 IIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~-------TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~L 762 (1092)
-++.|+.|....||++.... ++..|.+|+..... ....+..|..++..+. +....++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678889899999998753 25789999874311 1134557888888775 3333566666543
Q ss_pred EEEEeecCCCc
Q 001360 763 YLVMEYLNGGD 773 (1092)
Q Consensus 763 YLVMEYm~GGS 773 (1092)
.+||||++|-.
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38999998733
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0054 Score=67.49 Aligned_cols=74 Identities=15% Similarity=0.202 Sum_probs=42.7
Q ss_pred EEeeccCCCeEEEEEEECC--------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCee
Q 001360 692 IKPISRGAFGRVFLARKRT--------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~--------TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~L 762 (1092)
++.|+.|....+|++.... .+..|++|+...... .......|..++..+. +..+.++++.+. -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 4678888888999998653 136788998754211 1111356777777664 222345555442 2
Q ss_pred EEEEeecCCCc
Q 001360 763 YLVMEYLNGGD 773 (1092)
Q Consensus 763 YLVMEYm~GGS 773 (1092)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 78999998853
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.32 E-value=0.053 Score=57.54 Aligned_cols=78 Identities=14% Similarity=0.002 Sum_probs=53.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-C--CceEEEeeeeccCCeeEE
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-N--PFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-H--PNIVkL~~sfqde~~LYL 764 (1092)
...-++.+|.|..+.||+++.. +|+.|.+|+-...... ....+..|...|+.+. . -.+.+++.. +.-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceE
Confidence 4566788999999999999864 6889999976532211 1234678998888774 1 123444443 22479
Q ss_pred EEeecCCCc
Q 001360 765 VMEYLNGGD 773 (1092)
Q Consensus 765 VMEYm~GGS 773 (1092)
||||+.++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0066 Score=68.73 Aligned_cols=136 Identities=13% Similarity=0.216 Sum_probs=80.8
Q ss_pred EeeccCCCeEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEE
Q 001360 693 KPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~-------TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LYL 764 (1092)
+.|..|-...+|++.... +++.|.+|+..... .....+.+|..+++.+. +....++++.+.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 456667777888887642 35788898763311 12344568988887774 3333566666654 29
Q ss_pred EEeecCCCcHH--------------HHHH---hhc-----CC--CHHHHHHHHHHHHH-------------------HHH
Q 001360 765 VMEYLNGGDLY--------------SLLR---KVG-----CL--EEDVARIYIAELVL-------------------ALE 801 (1092)
Q Consensus 765 VMEYm~GGSL~--------------dlLk---k~g-----~L--sE~~ar~yaaQIL~-------------------ALe 801 (1092)
||||++|..|. ..|. ... .. -..++..|+.++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999985442 1111 111 11 13445555544422 233
Q ss_pred HHHH--------cCCeeeecCCCceEecCC----CcEEEEecCCccc
Q 001360 802 YLHS--------LGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKI 836 (1092)
Q Consensus 802 YLHs--------~GIIHRDLKPeNILLD~n----G~VKLsDFGLAk~ 836 (1092)
.|.+ ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 258999999999999876 7899999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.04 Score=63.84 Aligned_cols=75 Identities=16% Similarity=0.199 Sum_probs=47.7
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCCeeEEEEeecC
Q 001360 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYLVMEYLN 770 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPN-IVkL~~sfqde~~LYLVMEYm~ 770 (1092)
++.|+.|-...+|++.....+..|++|+...... ..+ .-.+|..+|..+...+ ..++++.+. + .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 5678889899999998764457888998753210 001 1147888888886333 356777663 2 25999998
Q ss_pred CCcH
Q 001360 771 GGDL 774 (1092)
Q Consensus 771 GGSL 774 (1092)
|-.|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 8443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.81 E-value=0.057 Score=59.32 Aligned_cols=31 Identities=19% Similarity=0.452 Sum_probs=28.0
Q ss_pred CCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 807 GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
.++|+|+.|.|||++.++.+.|+||+.+..+
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 5899999999999998889999999988753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.36 E-value=0.058 Score=57.64 Aligned_cols=122 Identities=17% Similarity=0.124 Sum_probs=80.8
Q ss_pred CcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHH-HcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCC
Q 001360 772 GDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849 (1092)
Q Consensus 772 GSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLH-s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~ 849 (1092)
-+|.++|... .+++|++++.++.|.+.+|.-+- ...-..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 3799999855 58999999999999999987762 11112333457899999999888663 2110
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhc
Q 001360 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929 (1092)
Q Consensus 850 t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kIl~~ 929 (1092)
.....+.|||.+. ...+.+.=|||||++||.-|-=..|
T Consensus 98 -------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~---------------- 135 (229)
T 2yle_A 98 -------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK---------------- 135 (229)
T ss_dssp ----------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC----------------
T ss_pred -------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC----------------
Confidence 0122355777663 3456788899999999988741111
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccC
Q 001360 930 KIPWPCVPSDMSFEAQDLINRFLIH 954 (1092)
Q Consensus 930 ~l~fP~ip~~lS~eakDLI~kcL~k 954 (1092)
+..+..+|+.+..||..|..-
T Consensus 136 ----e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 136 ----ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ----TTEEECCCHHHHHHHHHHTTC
T ss_pred ----cccchhhCHHHHHHHHHHHhc
Confidence 122467999999999999865
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.99 E-value=0.16 Score=58.31 Aligned_cols=75 Identities=12% Similarity=0.134 Sum_probs=46.4
Q ss_pred EEEeeccCCCeEEEEEEECCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCee
Q 001360 691 IIKPISRGAFGRVFLARKRTT-------GDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~T-------Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~L 762 (1092)
-++.|..|-...+|++..... +..|++++..... . ..-...+|..+++.+. +.-..++++.+. -
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---G-KFYDSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 345677788889999987521 5789999865321 0 0111246777776664 333445555443 2
Q ss_pred EEEEeecCCCc
Q 001360 763 YLVMEYLNGGD 773 (1092)
Q Consensus 763 YLVMEYm~GGS 773 (1092)
++||||++|..
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 78999999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.24 E-value=1.5 Score=49.32 Aligned_cols=29 Identities=28% Similarity=0.505 Sum_probs=25.6
Q ss_pred CeeeecCCCceEe------cCCCcEEEEecCCccc
Q 001360 808 IVHRDLKPDNLLI------AHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 808 IIHRDLKPeNILL------D~nG~VKLsDFGLAk~ 836 (1092)
++|.|+.+.|||+ +..+.++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999999875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1092 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-90 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-88 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-87 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-85 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-84 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-83 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-79 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-78 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-78 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-78 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-77 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-76 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-76 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-76 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-75 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-75 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-75 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-73 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-71 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-70 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-70 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-67 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-64 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-64 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-64 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-63 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-62 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-61 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-60 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-58 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-58 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-58 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-58 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-57 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-56 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-52 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-51 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-45 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-20 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 289 bits (740), Expect = 3e-90
Identities = 101/312 (32%), Positives = 170/312 (54%), Gaps = 31/312 (9%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ +DF+ K + G+F V LAR+ T +AIK+L+K +I++N + + ER+++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+ +PF V+ +++F + LY + Y G+L +RK+G +E R Y AE+V ALEY
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH GI+HRDLKP+N+L+ D HI++TDFG +K+
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV-------------------------L 158
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
++ +S VGT Y++PE+L ++D W++G I+++ + G+PPF A + +I
Sbjct: 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNW 979
F I+ + + P +A+DL+ + L+ D +RLG G +KAHPFF+ V W
Sbjct: 219 FQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275
Query: 980 DSLALQKAVFVP 991
++L Q +
Sbjct: 276 ENLHQQTPPKLT 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 284 bits (728), Expect = 4e-88
Identities = 116/343 (33%), Positives = 183/343 (53%), Gaps = 35/343 (10%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITV 744
I+DF + K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E+ +L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
+PF+ F +F ++NL+ VMEYLNGGDL ++ + A Y AE++L L++LH
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S GIV+RDLK DN+L+ DGHIK+ DFG+ K
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN--------------------------- 153
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
+ ++ GTPDY+APEILLG ++ ++ DWWS G++L+E + G PF + E +F
Sbjct: 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 984
+I + P + EA+DL+ + + +P +RLG +++ HP F+ +NW+ L
Sbjct: 214 SIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGV--RGDIRQHPLFREINWEELER 268
Query: 985 QK--AVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDAD 1025
++ F P+ +S D S F F L + D
Sbjct: 269 KEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMD 311
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 283 bits (724), Expect = 2e-87
Identities = 126/356 (35%), Positives = 191/356 (53%), Gaps = 35/356 (9%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ +++DF+ +K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
R+PF+ Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS +V+RD+K +NL++ DGHIK+TDFGL K G
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG------------------------- 155
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+D + GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +
Sbjct: 156 --ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 980
F+ IL +I + P +S EA+ L+ L DP QRLG + A EV H FF +NW
Sbjct: 214 FELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270
Query: 981 SLALQKAV--FVPQPESVDDTSYFLSRFSQISSGL-PDDQNGSYSDADTCDSSSNS 1033
+ +K + F PQ S DT YF F+ S + P D+ S +
Sbjct: 271 DVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQE 326
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (702), Expect = 3e-85
Identities = 92/292 (31%), Positives = 148/292 (50%), Gaps = 35/292 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+++DFEI +P+ +G FG V+LAR++ + + A+KVL K + + ++ E I +
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
R+P ++R + F +YL++EY G +Y L+K+ +E YI EL AL Y H
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S ++HRD+KP+NLL+ G +K+ DFG S
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSV----------------------------- 154
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
+ R + GT DYL PE++ G H D WS+G++ +EF+ G PPF A + + +
Sbjct: 155 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 214
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
I + + P ++ A+DLI+R L H+P+QR EV HP+
Sbjct: 215 RISRVEFTF---PDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITA 260
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 274 bits (702), Expect = 6e-84
Identities = 104/333 (31%), Positives = 163/333 (48%), Gaps = 38/333 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+++DF + + I RG FG V+ RK TG ++A+K L K + K L ER +L V
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 745 RN---PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
PF+V Y+F D L +++ +NGGDL+ L + G E R Y AE++L LE
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
++H+ +V+RDLKP N+L+ GH++++D GL+
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-------------------------- 155
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ H++VGT Y+APE+L G + +ADW+S+G +LF+ + G PF +
Sbjct: 156 ---DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVN 978
+ +P S E + L+ L D N+RLG GA EVK PFF+ ++
Sbjct: 213 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
Query: 979 WDSLALQK--AVFVPQPESVDDTSYF-LSRFSQ 1008
W + LQK +P V+ F + F +
Sbjct: 273 WQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDE 305
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 271 bits (693), Expect = 3e-83
Identities = 115/323 (35%), Positives = 180/323 (55%), Gaps = 38/323 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
S+ DF+I++ + G+FGRV L R R G +A+KVLKK ++R +E ER +L V
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
+PF++R + +F ++++M+Y+ GG+L+SLLRK VA+ Y AE+ LALEYLH
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S I++RDLKP+N+L+ +GHIK+TDFG +K
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--------------------------- 154
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
++ GTPDY+APE++ + + DWWS GI+++E + G PF + ++
Sbjct: 155 ---PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSL 982
ILN ++ + P + + +DL++R + D +QRLG NG +VK HP+FK V W+ L
Sbjct: 212 KILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268
Query: 983 ALQK--AVFVPQPE-SVDDTSYF 1002
+ + P + DTS F
Sbjct: 269 LSRNIETPYEPPIQQGQGDTSQF 291
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (659), Expect = 4e-79
Identities = 73/291 (25%), Positives = 134/291 (46%), Gaps = 31/291 (10%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+GI HRD+KP+NLL+ ++K++DFGL+ + NN
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN------------------------ 157
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
R + GT Y+APE+L E H D WS GI+L + G P+ S
Sbjct: 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ K + + L+++ L+ +P+ R+ ++K ++
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (658), Expect = 1e-78
Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 39/296 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +EII + GAFG+V+ A+ + T L A KV+ + ++E + E +IL + +
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDH 68
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
P +V+ +F +NL++++E+ GG + +++ ++ L E ++ + + AL YLH
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK N+L DG IKL DFG+S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKN---------------------------T 161
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ R S +GTP ++APE+++ + Y AD WS+GI L E PP +P
Sbjct: 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ I + P PS S +D + + L + + R +++ HPF
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQLLQHPFVTV 274
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 258 bits (660), Expect = 3e-78
Identities = 116/326 (35%), Positives = 183/326 (56%), Gaps = 37/326 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ +D F+ IK + G+FGRV L + + +G+ +A+K+L K +++ IE L E+ I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
L V PF+V+ +SF NLY+VMEY+ GG+++S LR++G E AR Y A++VL
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLHSL +++RDLKP+NLLI G+I++TDFG +K
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR------------------------ 190
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ GTP+ LAPEI+L + A DWW++G++++E G PPF A+ P
Sbjct: 191 ------VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVN 978
I++ I++ K+ + PS S + +DL+ L D +R G NG ++K H +F +
Sbjct: 245 QIYEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
Query: 979 WDSLALQK--AVFVPQPESVDDTSYF 1002
W ++ +K A F+P+ + DTS F
Sbjct: 302 WIAIYQRKVEAPFIPKFKGPGDTSNF 327
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 257 bits (657), Expect = 8e-78
Identities = 76/342 (22%), Positives = 140/342 (40%), Gaps = 38/342 (11%)
Query: 674 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 733
P K +D ++I + + GAFG V +R TG+ FA K + +D E
Sbjct: 13 YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKET 69
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIY 792
+ E + +R+P +V +F + + ++ E+++GG+L+ + + + ED A Y
Sbjct: 70 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 129
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINNTIDLSGPET 850
+ ++ L ++H VH DLKP+N++ +KL DFGL+
Sbjct: 130 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA--------------- 174
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
++ GT ++ APE+ G GY D WSVG++ + ++G
Sbjct: 175 -------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221
Query: 911 IPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969
+ PF E+ + N+ + S +S + +D I + L+ DPN R+ +
Sbjct: 222 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQAL 278
Query: 970 AHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS 1011
HP+ N Q + + + +
Sbjct: 279 EHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPP 320
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 255 bits (652), Expect = 2e-77
Identities = 124/333 (37%), Positives = 189/333 (56%), Gaps = 38/333 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRK-NDIER 733
+ H E+ I++FE++K + GA+G+VFL RK TG L+A+KVLKK +++K E
Sbjct: 15 TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 74
Query: 734 ILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 792
ER +L +R PF+V Y+F L+L+++Y+NGG+L++ L + E +IY
Sbjct: 75 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 134
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+ E+VLALE+LH LGI++RD+K +N+L+ +GH+ LTDFGLS
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS------------------ 176
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITG 910
E+ + + GT +Y+AP+I+ G + G+ A DWWS+G++++E +TG
Sbjct: 177 --------KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
Query: 911 IPPFTAESPEIIFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAE 967
PFT + + I R + P P +MS A+DLI R L+ DP +RLG A E
Sbjct: 229 ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE 288
Query: 968 VKAHPFFKGVNWDSLALQK--AVFVPQPESVDD 998
+K H FF+ +NWD LA +K A F P D
Sbjct: 289 IKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 250 bits (640), Expect = 2e-76
Identities = 82/303 (27%), Positives = 130/303 (42%), Gaps = 45/303 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR------KNDIERILAERNI 740
+++E + + RG V + T +A+K++ + E L E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 741 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
L V P +++ ++ +LV + + G+L+ L + L E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ LH L IVHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC------------------------ 158
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPP 913
Q GTP YLAPEI+ + +G D WS G+I++ + G PP
Sbjct: 159 ----QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
Query: 914 FTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
F ++ I++ + D S +DL++RFL+ P +R A E AHP
Sbjct: 215 FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHP 271
Query: 973 FFK 975
FF+
Sbjct: 272 FFQ 274
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (641), Expect = 3e-76
Identities = 90/299 (30%), Positives = 137/299 (45%), Gaps = 38/299 (12%)
Query: 681 KERTSIDD----FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 736
+ S+ D + + I +GA G V+ A TG AI+ + +K E I+
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIIN 66
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
E ++ +NP +V + S+ D L++VMEYL GG L ++ + C++E E
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCREC 125
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ ALE+LHS ++HRD+K DN+L+ DG +KLTDFG
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--------------------- 164
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
+ R + VGTP ++APE++ +G D WS+GI+ E I G PP+
Sbjct: 165 ------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
E+P I P P +S +D +NR L D +R A E+ H F K
Sbjct: 219 ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLK 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 252 bits (644), Expect = 7e-76
Identities = 74/367 (20%), Positives = 148/367 (40%), Gaps = 49/367 (13%)
Query: 674 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 733
P K+ + D ++I++ + GAFG V ++ TG +F K + + K ++
Sbjct: 16 VPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN 75
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 792
E +I+ + +P ++ +F + + L++E+L+GG+L+ + + E Y
Sbjct: 76 ---EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 132
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIA--HDGHIKLTDFGLSKIGLINNTIDLSGPET 850
+ + L+++H IVH D+KP+N++ +K+ DFGL+
Sbjct: 133 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT--------------- 177
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
+ + T ++ APEI+ G+ D W++G++ + ++G
Sbjct: 178 -------------KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224
Query: 911 IPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969
+ PF E N+ + S +S EA+D I L +P +RL +
Sbjct: 225 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDAL 281
Query: 970 AHPFFKGVNWDSLALQKAVFVPQPESVDDTSYF-----------LSRFSQISSGLPDDQN 1018
HP+ KG + + + + + Y ++ FS + P +
Sbjct: 282 EHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQ 341
Query: 1019 GSYSDAD 1025
S D
Sbjct: 342 IYDSYFD 348
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (639), Expect = 1e-75
Identities = 83/344 (24%), Positives = 136/344 (39%), Gaps = 76/344 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE I + G G VF + +G + A K++ I+ +I+ E +L +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS- 805
P++V F+ +F + + ME+++GG L +L+K G + E + ++ L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRD+KP N+L+ G IKL DFG+S Q
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----------------------------Q 154
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
+ +S VGT Y++PE L GT + +D WS+G+ L E G P + +
Sbjct: 155 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
Query: 926 ILNR----------------------------------------KIPWPCVPSD-MSFEA 944
+ P P +PS S E
Sbjct: 215 FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 274
Query: 945 QDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAV 988
QD +N+ LI +P +R ++ H F K + + + +
Sbjct: 275 QDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEEVDFAGWL 315
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (632), Expect = 2e-75
Identities = 82/298 (27%), Positives = 138/298 (46%), Gaps = 44/298 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+D+E++ I G++GR R+++ G + K L + + + + +++E N+L +++
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY-GSMTEAEKQMLVSEVNLLRELKH 62
Query: 747 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLAL 800
P +VR++ R N LY+VMEY GGDL S++ K L+E+ + +L LAL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 801 EYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ H ++HRDLKP N+ + ++KL DFGL++I
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI------------------- 163
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
D + VGTP Y++PE + + +D WS+G +L+E +PPFT
Sbjct: 164 --------LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215
Query: 916 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
A S + + I K P S E ++I R L R E+ +P
Sbjct: 216 AFSQKELAGKIREGKFRRI--PYRYSDELNEIITRMLNLKDYHRP---SVEEILENPL 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 247 bits (631), Expect = 9e-75
Identities = 91/328 (27%), Positives = 150/328 (45%), Gaps = 38/328 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D ++ + GAF V LA + T L AIK + K + + + E +L +++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +V + +LYL+M+ ++GG+L+ + + G E A I +++ A++YLH L
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
GIVHRDLKP+NLL D I ++DFGLSK+
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--------------------------- 159
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ +A GTP Y+APE+L + A D WS+G+I + + G PPF E+ +F
Sbjct: 160 -EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218
Query: 924 DNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982
+ IL + + D+S A+D I + DP +R + HP+ G
Sbjct: 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAGDTALDK 275
Query: 983 ALQKAVFVPQPESVDDTSYFLSRFSQIS 1010
+ ++V Q + S + F+ +
Sbjct: 276 NIHQSV-SEQIKKNFAKSKWKQAFNATA 302
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 241 bits (617), Expect = 9e-73
Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 38/292 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ + +LVMEY G L L+E + L YLHS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K N+L++ G +KL DFG + I
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI------------------------------ 164
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+S VGTP ++APE++L + G D WS+GI E PP +
Sbjct: 165 -MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+I + P S ++ ++ L P R + + H F
Sbjct: 224 YHIAQNESPALQ-SGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 7e-71
Identities = 70/293 (23%), Positives = 131/293 (44%), Gaps = 39/293 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I + + RG FG V + ++ + K +K + D + E +IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHS 805
++ SF + L ++ E+++G D++ + L E Y+ ++ AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 806 LGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
I H D++P+N++ IK+ +FG ++
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---------------------------- 152
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
Q N P+Y APE+ A D WS+G +++ ++GI PF AE+ + I
Sbjct: 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 924 DNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+NI+N + + ++S EA D ++R L+ + R+ A+E HP+ K
Sbjct: 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLK 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 3e-70
Identities = 81/314 (25%), Positives = 142/314 (45%), Gaps = 40/314 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---IERILAERNILIT 743
D ++ + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+++P V+ + + ++ L++E + GG+L+ L + L E+ A ++ +++ + YL
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 804 HSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
HSL I H DLKP+N+++ IK+ DFGL+
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH------------------------ 165
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
+ + GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 166 ----KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221
Query: 920 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ N+ + S+ S A+D I R L+ DP +R+ + HP+ K +
Sbjct: 222 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKD 278
Query: 979 WDSLALQKAVFVPQ 992
AL A PQ
Sbjct: 279 TQQ-ALSSAWSHPQ 291
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 6e-70
Identities = 61/301 (20%), Positives = 124/301 (41%), Gaps = 43/301 (14%)
Query: 684 TSIDD--FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
S D + I RG+F V+ T A L+ + K++ +R E +L
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEML 62
Query: 742 ITVRNPFVVRFFYSFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
+++P +VRF+ S+ + + LV E + G L + L++ ++ V R + +++
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 122
Query: 798 LALEYLHSLG--IVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
L++LH+ I+HRDLK DN+ I G +K+ D GL+ +
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL------------------ 164
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ +GTP+++APE+ ++ + D ++ G+ + E T P+
Sbjct: 165 -----------KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 212
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ + + E +++I + + ++R ++ H FF
Sbjct: 213 SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFF 269
Query: 975 K 975
+
Sbjct: 270 Q 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 224 bits (572), Expect = 5e-67
Identities = 72/289 (24%), Positives = 122/289 (42%), Gaps = 31/289 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +E+ + + G V LAR A+KVL+ + R E + +
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 747 PFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
P +V + + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
H GI+HRD+KP N++I+ +K+ DFG+++
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIAR------------------------AIA 162
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+ +GT YL+PE G +D +S+G +L+E +TG PPFT +SP +
Sbjct: 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 222
Query: 923 FDNILNRK-IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
+ IP +S + ++ + L +P R AAE++A
Sbjct: 223 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AAEMRA 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 2e-64
Identities = 70/299 (23%), Positives = 130/299 (43%), Gaps = 49/299 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE---RILAERNILIT 743
+++ + G FG V+ + + AIK ++K + ++ R+ E +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 744 VRN--PFVVRFFYSFTCRDNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLAL 800
V + V+R F D+ L++E DL+ + + G L+E++AR + +++ A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 801 EYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ H+ G++HRD+K +N+LI + G +KL DFG +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----------------------- 160
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAES 918
+ GT Y PE + HG +A WS+GI+L++ + G PF +
Sbjct: 161 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD- 213
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
+ I+ ++ + +S E Q LI L P+ R E++ HP+ + V
Sbjct: 214 -----EEIIRGQVFF---RQRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDV 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 2e-64
Identities = 82/311 (26%), Positives = 139/311 (44%), Gaps = 55/311 (17%)
Query: 681 KERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
K+ IDD+++ + + G G+V + T + FA+K+L+ R+ E
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 56
Query: 740 ILITV-RNPFVVRFFYSF----TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIY 792
+ + P +VR + R L +VME L+GG+L+S ++ G E A
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ + A++YLHS+ I HRD+KP+NLL + +KLTDFG +K
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------------- 162
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
+ T + + + TP Y+APE+L ++ + D WS+G+I++ +
Sbjct: 163 --------------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 208
Query: 910 GIPPFTAESP----EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANG 964
G PPF + + I + +P S++S E + LI L +P QR+
Sbjct: 209 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---T 265
Query: 965 AAEVKAHPFFK 975
E HP+
Sbjct: 266 ITEFMNHPWIM 276
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 3e-64
Identities = 54/280 (19%), Positives = 112/280 (40%), Gaps = 37/280 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I G+FG V+ + A+K+L ++ E +L R+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNV-TAPTPQQLQAFKNEVGVLRKTRH 63
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
++ F ++ L +V ++ G LY L + E + ++YLH+
Sbjct: 64 VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK +N+ + D +K+ DFGL+ + + +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV-------------------------KSRW 157
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEII 922
+ + G+ ++APE++ + + +D ++ GI+L+E +TG P++ +
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217
Query: 923 FDNILNRKIPWPC---VPSDMSFEAQDLINRFLIHDPNQR 959
++ R P V S+ + L+ L ++R
Sbjct: 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 4e-63
Identities = 76/314 (24%), Positives = 117/314 (37%), Gaps = 58/314 (18%)
Query: 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND--IERILAERNILITVRNP 747
E + + G F V+ AR + T + AIK +K D L E +L + +P
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
++ +F + N+ LV +++ + L + Y+ + LEYLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRDLKP+NLL+ +G +KL DFGL+K +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK---------------------------SFGSP 153
Query: 868 NRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
NR V T Y APE+L G +G D W+VG IL E + +P +S I
Sbjct: 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
Query: 927 LN-------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
IP + S + DLI + +P R+
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI- 272
Query: 962 ANGAAEVKAHPFFK 975
A + +F
Sbjct: 273 --TATQALKMKYFS 284
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 6e-63
Identities = 61/303 (20%), Positives = 119/303 (39%), Gaps = 35/303 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLA--RKRTTGDLFAIKVLKKLDMIRKNDIERILAER 738
++ +++D K + G FG V + + A+K+LK + + +LAE
Sbjct: 5 RKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEA 59
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
N++ + NP++VR ++ LVME G L L++ +++ + ++ +
Sbjct: 60 NVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL--------------------- 157
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917
+ + + + APE + + +D WS G++++E + G P+
Sbjct: 158 ---RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214
Query: 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
+ + + P+ E DL+N +D R G + ++ V
Sbjct: 215 KGSEVTAMLEKGERMGC--PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
Query: 978 NWD 980
N
Sbjct: 273 NEG 275
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 211 bits (538), Expect = 3e-62
Identities = 75/316 (23%), Positives = 128/316 (40%), Gaps = 59/316 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + ++ I G +G V+ A+ G+ FA+K ++ + + + E +IL +++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+V+ + + L LV E+L+ L G LE A+ ++ +L+ + Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRDLKP NLLI +G +K+ DFGL++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARA---------------------------FGI 152
Query: 867 DNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R + T Y AP++L+G++ + D WSVG I E + G P F S
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 926 ILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I +PW + DL+++ L DPNQR
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 960 LGANGAAEVKAHPFFK 975
+ A + H +FK
Sbjct: 273 I---TAKQALEHAYFK 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-61
Identities = 76/329 (23%), Positives = 121/329 (36%), Gaps = 65/329 (19%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+ +E + I +G FG VF AR R TG A+K + + ++ L E IL +
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKILQLL 66
Query: 745 RNPFVVRFFYSFT--------CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
++ VV C+ ++YLV ++ L + + + L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ L Y+H I+HRD+K N+LI DG +KL DFGL++
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA-------------------- 166
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 915
+ + + + V T Y PE+LLG ++G D W G I+ E T P
Sbjct: 167 ---FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
Query: 916 AESPEIIFDNILN-----------------------------RKIPWPCVPSDMSFEAQD 946
+ + I RK+ A D
Sbjct: 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 283
Query: 947 LINRFLIHDPNQRLGANGAAEVKAHPFFK 975
LI++ L+ DP QR+ + + H FF
Sbjct: 284 LIDKLLVLDPAQRI---DSDDALNHDFFW 309
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (526), Expect = 2e-60
Identities = 81/321 (25%), Positives = 136/321 (42%), Gaps = 59/321 (18%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+++F+ ++ I G +G V+ AR + TG++ A+K ++ D + + E ++L +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELN 59
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 804
+P +V+ + LYLV E+L+ + + + + Y+ +L+ L + H
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S ++HRDLKP NLLI +G IKL DFGL++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARA---------------------------F 152
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
R V T Y APEILLG ++ A D WS+G I E +T F +S
Sbjct: 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 924 DNILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPN 957
I + + V + + + L+++ L +DPN
Sbjct: 213 FRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPN 272
Query: 958 QRLGANGAAEVKAHPFFKGVN 978
+R+ A AHPFF+ V
Sbjct: 273 KRI---SAKAALAHPFFQDVT 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 4e-60
Identities = 62/291 (21%), Positives = 113/291 (38%), Gaps = 46/291 (15%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
++ + ++++ I +G FG V L R G+ A+K +K + LAE +++ +
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQL 57
Query: 745 RNPFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 801
R+ +V+ + LY+V EY+ G L LR G L D + ++ A+E
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YL VHRDL N+L++ D K++DFGL+K
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------------------------ 153
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920
+ + + + APE L + +D WS GI+L+E + G P+ +
Sbjct: 154 ------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971
+ + P +++ D R +++
Sbjct: 208 DVVPRVEKGYKMDA--PDGCPPAVYEVMKNCWHLDAAMRP---SFLQLREQ 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-59
Identities = 74/322 (22%), Positives = 127/322 (39%), Gaps = 63/322 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I GA+G V A AIK + + + +R L E IL+ R+
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRH 65
Query: 747 PFVVRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ ++ +L G DLY LL+ L D ++ +++ L+Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKY 124
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HS ++HRDLKP NLL+ +K+ DFGL+++ +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA------------------------D 160
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
V T Y APEI+L + + D WSVG IL E ++ P F +
Sbjct: 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
Query: 922 IFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFLI 953
++IL K+PW + + +A DL+++ L
Sbjct: 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 280
Query: 954 HDPNQRLGANGAAEVKAHPFFK 975
+P++R+ + AHP+ +
Sbjct: 281 FNPHKRI---EVEQALAHPYLE 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 4e-59
Identities = 67/299 (22%), Positives = 111/299 (37%), Gaps = 37/299 (12%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAER 738
++ I D E+ G FG V R AIKVLK+ K D E ++ E
Sbjct: 7 RDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQ--GTEKADTEEMMREA 60
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELV 797
I+ + NP++VR L LVME GG L+ L K + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+ ++YL VHRDL N+L+ + + K++DFGLSK
Sbjct: 120 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA--------------------- 158
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916
+ R + + APE + + +D WS G+ ++E ++ G P+
Sbjct: 159 ---LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 215
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ I K P + E L++ I+ R + ++
Sbjct: 216 MKGPEVMAFIEQGKRMEC--PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-58
Identities = 59/280 (21%), Positives = 103/280 (36%), Gaps = 31/280 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNIL 741
D +++ + G+FG V A+K LK + + ++ + E N +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLAL 800
++ + ++R + + +V E G L L + G Y ++ +
Sbjct: 66 HSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
YL S +HRDL NLL+A +K+ DFGL + + +D HY
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA----------------LPQNDDHY 168
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919
+ + APE L +A+D W G+ L+E T G P+ +
Sbjct: 169 --------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I I P P D + +++ + H P R
Sbjct: 221 SQILHKIDKEGERLPR-PEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-58
Identities = 82/328 (25%), Positives = 126/328 (38%), Gaps = 64/328 (19%)
Query: 685 SIDDFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKN--DIERILAERNIL 741
+ +E + I GA+G+VF AR + G A+K ++ R +A L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 742 ITVRNPFVVRFFYSFTC-----RDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAE 795
T +P VVR F T L LV E+++ Y + + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
L+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI------------------- 165
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
+ S V T Y APE+LL + + D WSVG I E P F
Sbjct: 166 ---------YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216
Query: 916 AESPEIIFDNILN------------------------RKIPWPCVPSDMSFEAQDLINRF 951
S IL+ P +D+ +DL+ +
Sbjct: 217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKGVNW 979
L +P +R+ A +HP+F+ +
Sbjct: 277 LTFNPAKRI---SAYSALSHPYFQDLER 301
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 4e-58
Identities = 56/304 (18%), Positives = 101/304 (33%), Gaps = 35/304 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + + + I G+FG ++L G+ AIK+ K ++ E I ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQG 61
Query: 747 P-FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ + D +VME L + +++ +EY+HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 806 LGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HRD+KPDN L+ + + DFGL+K T
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART-------------------- 161
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+Q R + GT Y + LG E D S+G +L F G P+
Sbjct: 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
Query: 923 FDNILNRK-----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK-G 976
P + E +N + + + ++ + F + G
Sbjct: 222 RQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
Query: 977 VNWD 980
++D
Sbjct: 282 FSYD 285
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 6e-58
Identities = 85/348 (24%), Positives = 135/348 (38%), Gaps = 71/348 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++P+ GA+G V A TG AIK L + + +R E +L +R+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 747 PFVVRFFYSFTCRD------NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
V+ FT + + YLVM ++ G L K L ED + + +++ L
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
Y+H+ GI+HRDLKP NL + D +K+ DFGL++
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----------------------- 171
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESP 919
+ V T Y APE++L + D WSVG I+ E ITG F
Sbjct: 172 -------DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224
Query: 920 EIIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRF 951
I+ K + + ++ S A +L+ +
Sbjct: 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDT 999
L+ D QR+ A E AHP+F+ ++ Q + + VD T
Sbjct: 285 LVLDAEQRV---TAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRT 329
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-57
Identities = 88/367 (23%), Positives = 135/367 (36%), Gaps = 77/367 (20%)
Query: 669 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK 728
++ V+TP +R + K I G+FG V+ A+ +G+L AIK + +
Sbjct: 4 TTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------ 55
Query: 729 NDIERILAERNILITVRNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLL---R 779
D E I+ + + +VR Y F L LV++Y+ R
Sbjct: 56 -DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 780 KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGL 838
L ++Y+ +L +L Y+HS GI HRD+KP NLL+ D +KL DFG +K
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--- 171
Query: 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADW 897
Q S + + Y APE++ G ++ + D
Sbjct: 172 -------------------------QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206
Query: 898 WSVGIILFEFITGIPPFTAESPEIIFDNILN-------------------------RKIP 932
WS G +L E + G P F +S I+ + P
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 933 WPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVP 991
W V EA L +R L + P RL E AH FF + ++ L P
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDELRDPNVKLPNGRDTP 323
Query: 992 QPESVDD 998
+
Sbjct: 324 ALFNFTT 330
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 197 bits (502), Expect = 8e-57
Identities = 79/339 (23%), Positives = 135/339 (39%), Gaps = 80/339 (23%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
E + DD+++++ + RG + VF A T + +K+LK ++I E IL
Sbjct: 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKIL 83
Query: 742 ITVR-NPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+R P ++ + LV E++N D L + L + R Y+ E++
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILK 140
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
AL+Y HS+GI+HRD+KP N++I H+ ++L D+GL++
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-------------------- 180
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 916
+ + V + + PE+L+ + + Y+ D WS+G +L I PF
Sbjct: 181 --------HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232
Query: 917 ESPEI----------------------------IFDNILNR-------KIPWPCVPSDMS 941
F++IL R + +S
Sbjct: 233 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 292
Query: 942 FEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980
EA D +++ L +D RL A E HP+F V D
Sbjct: 293 PEALDFLDKLLRYDHQSRL---TAREAMEHPYFYTVVKD 328
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-56
Identities = 52/275 (18%), Positives = 110/275 (40%), Gaps = 35/275 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +K + G FG V + R AIK++K+ M + + E +++ + +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSH 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHS 805
+V+ + T + ++++ EY+ G L + LR + ++ A+EYL S
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+HRDL N L+ G +K++DFGLS+
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSR--------------------------YVLD 152
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 924
+ + + + PE+L+ ++ +D W+ G++++E + G P+ + +
Sbjct: 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 212
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+I + P S + ++ ++R
Sbjct: 213 HIAQGLRLYR--PHLASEKVYTIMYSCWHEKADER 245
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 4e-56
Identities = 57/293 (19%), Positives = 114/293 (38%), Gaps = 42/293 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++++ + G FG V++ A+K LK+ + LAE N++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQ----GSMSPDAFLAEANLMKQLQH 67
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLH 804
+VR Y+ ++ +Y++ EY+ G L L+ L + A++ + ++
Sbjct: 68 QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HRDL+ N+L++ K+ DFGL+++ +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL--------------------------IE 160
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
+ R A + APE + +D WS GI+L E +T G P+ + +
Sbjct: 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--HPFF 974
N+ + P + E L+ P R +++ FF
Sbjct: 221 QNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRP---TFDYLRSVLEDFF 268
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (492), Expect = 5e-56
Identities = 71/317 (22%), Positives = 119/317 (37%), Gaps = 59/317 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+E ++ I G +G VF A+ R T ++ A+K ++ D + L E +L +++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICLLKELKH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+VR L LV E+ + G L+ ++ + ++ +L+ L + HS
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRDLKP NLLI +G +KL +FGL++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARA---------------------------FGI 153
Query: 867 DNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITG-IPPFTAESPEIIFD 924
R + V T Y P++L G + + + D WS G I E P F +
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213
Query: 925 NILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 958
I V ++ +DL+ L +P Q
Sbjct: 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
Query: 959 RLGANGAAEVKAHPFFK 975
R+ A E HP+F
Sbjct: 274 RI---SAEEALQHPYFS 287
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 5e-56
Identities = 61/303 (20%), Positives = 114/303 (37%), Gaps = 58/303 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDL-----FAIKVLKKLDMIRKNDIERILAERNIL 741
++ E K + GAFG+V A A+K+LK+ ++ E +++E ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE--KADSSEREALMSELKMM 94
Query: 742 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-------------------- 780
+ + +V + T +YL+ EY GDL + LR
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 781 ---VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
+ L + + ++ +E+L VHRDL N+L+ H +K+ DFGL++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD- 213
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897
++ R +A ++APE L + +D
Sbjct: 214 ------------------------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249
Query: 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP 956
WS GI+L+E + G+ P+ + F ++ P + E ++ D
Sbjct: 250 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDS 308
Query: 957 NQR 959
+R
Sbjct: 309 RKR 311
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-55
Identities = 61/294 (20%), Positives = 108/294 (36%), Gaps = 42/294 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + + +G FG V++ T AIK LK E L E ++ +R+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP----GTMSPEAFLQEAQVMKKLRH 71
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL--LRKVGCLEEDVARIYIAELVLALEYLH 804
+V+ Y+ + +Y+V EY++ G L L A++ + Y+
Sbjct: 72 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+ VHRDL+ N+L+ + K+ DFGL+++ +
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARL--------------------------IE 164
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
+ R A + APE L +D WS GI+L E T G P+ +
Sbjct: 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--HPFFK 975
D + P + DL+ + +P +R ++A +F
Sbjct: 225 DQVERGYRMP--CPPECPESLHDLMCQCWRKEPEERP---TFEYLQAFLEDYFT 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-55
Identities = 51/275 (18%), Positives = 102/275 (37%), Gaps = 35/275 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++ I G FG V L D AIK +++ E + E +++ + +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE----GAMSEEDFIEEAEVMMKLSH 59
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL-EEDVARIYIAELVLALEYLHS 805
P +V+ + + + LV E++ G L LR L + ++ + YL
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRDL N L+ + IK++DFG+++
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRF--------------------------VLD 153
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 924
+ + +PE+ + + +D WS G++++E + G P+ S + +
Sbjct: 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+I + P S ++N P R
Sbjct: 214 DISTGFRLYK--PRLASTHVYQIMNHCWKERPEDR 246
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-55
Identities = 59/293 (20%), Positives = 107/293 (36%), Gaps = 48/293 (16%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+D + I G FG+V AR + G + + + K+D E +L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 745 RN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------------VGCLEED 787
+ P ++ + R LYL +EY G+L LRK L
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ A++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG----------- 176
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907
Q + ++A E L + + +D WS G++L+E
Sbjct: 177 -----------------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219
Query: 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
++ G P+ + +++ + P + E DL+ + P +R
Sbjct: 220 VSLGGTPYCGMTCAELYEKLPQGYRLEK--PLNCDDEVYDLMRQCWREKPYER 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 3e-55
Identities = 60/303 (19%), Positives = 106/303 (34%), Gaps = 59/303 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ E ++ I GAFGRVF AR + A+K+LK+ + E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--EASADMQADFQREAALM 70
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------- 782
NP +V+ + L+ EY+ GDL LR +
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 783 -----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
L ++ + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN- 189
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897
Y + + ++ PE + + +D
Sbjct: 190 ------------------------IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225
Query: 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP 956
W+ G++L+E + G+ P+ + E + + + I P + E +L+ P
Sbjct: 226 WAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLP 283
Query: 957 NQR 959
R
Sbjct: 284 ADR 286
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (487), Expect = 4e-55
Identities = 61/281 (21%), Positives = 104/281 (37%), Gaps = 27/281 (9%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRKNDIERILAERNI 740
+ I +I + I G FG V + G +K L + L+E +I
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLA 799
+ +P V+ T + ++ E++ G L S LR G + +
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
++YL + VHRDL N+L+ + K++DFGLS+ + D
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR-----------------FLEDDTS 183
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918
P Y + APE + + A+D WS GI+++E ++ G P+ +
Sbjct: 184 DPTYTSALGG-----KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + + I P P D L+ D N R
Sbjct: 239 NQDVINAIEQDYRLPP--PMDCPSALHQLMLDCWQKDRNHR 277
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-54
Identities = 61/288 (21%), Positives = 112/288 (38%), Gaps = 35/288 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI-ERILAERNILITVR 745
+ E+ + I G FG V + + +K + + E+ L E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEYLH 804
+P +V+ T + ++++ME G+L S L + L+ +Y +L AL YL
Sbjct: 67 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S VHRD+ N+L++ + +KL DFGLS+ +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--------------------------ME 159
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
+ ++APE + A+D W G+ ++E + G+ PF +
Sbjct: 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971
I N + +P + L+ + +DP++R E+KA
Sbjct: 220 GRIENGERLP--MPPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-53
Identities = 58/324 (17%), Positives = 114/324 (35%), Gaps = 33/324 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKV-LKKL-DMIRKNDIERILAERNILITV 744
+F+ IK + GAFG V+ G+ I V +K+L + + IL E ++ +V
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
NP V R + G L + + + ++ + YL
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+VHRDL N+L+ H+K+TDFGL+K+
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---------------------- 166
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
+ ++A E +L + + +D WS G+ ++E +T G P+ I
Sbjct: 167 ---EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983
+ + P + + ++ + + D + R E+ +
Sbjct: 224 SILEKGERLPQ--PPICTIDVYMIMVKCWMIDADSRP---KFRELIIEFSKMARDPQRYL 278
Query: 984 LQKAVFVPQPESVDDTSYFLSRFS 1007
+ + S D++++ +
Sbjct: 279 VIQGDERMHLPSPTDSNFYRALMD 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 186 bits (473), Expect = 2e-53
Identities = 48/282 (17%), Positives = 96/282 (34%), Gaps = 36/282 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
+++ + I G+FG +F AIK + ++D ++ E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+ +Y + LV++ L L + +++ ++ +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 808 IVHRDLKPDNLLIA-----HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+V+RD+KPDN LI + I + DFG+ K T
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT-------------------- 161
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESP 919
Q R + + GT Y++ LG E D ++G + F+ G A +
Sbjct: 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
Query: 920 EIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQR 959
+ ++ I +K P + + E ++ +
Sbjct: 222 KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (463), Expect = 5e-52
Identities = 54/276 (19%), Positives = 105/276 (38%), Gaps = 35/276 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D + + G +G V+ + A+K LK+ ++E L E ++ +++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKH 72
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLH 804
P +V+ T Y++ E++ G+L LR+ + V ++ A+EYL
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HRDL N L+ + +K+ DFGLS++
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------------------------MT 166
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
A + APE L + +D W+ G++L+E T G+ P+ ++
Sbjct: 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + P + +L+ +P+ R
Sbjct: 227 ELLEKDYRMER--PEGCPEKVYELMRACWQWNPSDR 260
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-51
Identities = 81/347 (23%), Positives = 132/347 (38%), Gaps = 69/347 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++ + P+ GA+G V A TG A+K L + +R E +L +++
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 747 PFVVRFFYSFT-----CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
V+ FT N ++ +L G DL ++++ L +D + I +++ L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLK 135
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
Y+HS I+HRDLKP NL + D +K+ DFGL+
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------------------- 168
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE 920
+ + V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 169 ---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225
Query: 921 IIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFL 952
IL K+ + V + A DL+ + L
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285
Query: 953 IHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDT 999
+ D ++R+ AA+ AH +F + + ES D
Sbjct: 286 VLDSDKRI---TAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLL 329
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (461), Expect = 4e-51
Identities = 68/337 (20%), Positives = 129/337 (38%), Gaps = 80/337 (23%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 744 VRNPFVVRFFYSFTCRD------NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
V + ++ FT + ++YLVME ++ + ++ + + + +++
Sbjct: 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQML 129
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+++LHS GI+HRDLKP N+++ D +K+ DFGL++
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------------------- 168
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
+ V T Y APE++LG + D WSVG I+ E + F
Sbjct: 169 -------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 918 SPEIIFDNILN---------------------------RKIPWPCVPSD----------- 939
++ ++ + +P + D
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281
Query: 940 -MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ +A+DL+++ L+ DP +R+ + HP+
Sbjct: 282 LKASQARDLLSKMLVIDPAKRI---SVDDALQHPYIN 315
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-50
Identities = 59/311 (18%), Positives = 109/311 (35%), Gaps = 48/311 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ + + + +G+FG V+ K AIK + + +R + L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR----------KVGCLEEDVARI 791
VVR + ++ME + GDL S LR +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
E+ + YL++ VHRDL N ++A D +K+ DFG+
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM------------------ 179
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911
Y+ R + +++PE L +D WS G++L+E T
Sbjct: 180 -------TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232
Query: 912 -PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV-- 968
P+ S E + ++ + P + +L+ ++P R
Sbjct: 233 EQPYQGLSNEQVLRFVMEGGLLDK--PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
Query: 969 -KAHPFFKGVN 978
+ P F+ V+
Sbjct: 291 EEMEPGFREVS 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 3e-50
Identities = 60/298 (20%), Positives = 109/298 (36%), Gaps = 53/298 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ K + GAFG+V A K A+K+LK + E +++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVL 80
Query: 742 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----------------- 783
+ N +V + T ++ EY GDL + LR+
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 784 -LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
L+ + + ++ + +L S +HRDL N+L+ H K+ DFGL++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI----- 195
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
++ + +A ++APE + + + +D WS GI
Sbjct: 196 --------------------KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 903 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
L+E + G P+ + F ++ P E D++ DP +R
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKR 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-49
Identities = 62/298 (20%), Positives = 115/298 (38%), Gaps = 54/298 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD-------LFAIKVLKKLDMIRKNDIERILAERN 739
D + KP+ GAFG+V LA A+K+LK + D+ +++E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEME 70
Query: 740 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--------------- 783
++ + ++ ++ + T LY+++EY + G+L L+
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 784 -LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
L ++ +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----- 185
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
+ + + ++APE L + + +D WS G+
Sbjct: 186 --------------------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225
Query: 903 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+L+E T G P+ E +F + PS+ + E ++ P+QR
Sbjct: 226 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK--PSNCTNELYMMMRDCWHAVPSQR 281
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 5e-47
Identities = 56/278 (20%), Positives = 95/278 (34%), Gaps = 32/278 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILI 742
K I G FG V+ +T+ AIK LK + L E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA--GYTEKQRVDFLGEAGIMG 64
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL-LRKVGCLEEDVARIYIAELVLALE 801
+ ++R + + ++ EY+ G L K G + + ++
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YL ++ VHRDL N+L+ + K++DFGLS++
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL------------------------ 160
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
E + APE + + A+D WS GI+++E +T E
Sbjct: 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 220
Query: 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+N P P D L+ + + +R
Sbjct: 221 EVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARR 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-46
Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 55/309 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
D ++ KP+ RGAFG+V A K T A+K+LK+ ++ +++E IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKIL 70
Query: 742 ITVRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVG----------------C 783
I + + V + L +++E+ G+L + LR
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
L + Y ++ +E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD------- 183
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
Y+ D + A ++APE + + +D WS G++
Sbjct: 184 ------------------IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 225
Query: 904 LFEFITGI-PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
L+E + P+ + F L P + E + +P+QR
Sbjct: 226 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRP-- 282
Query: 963 NGAAEVKAH 971
+E+ H
Sbjct: 283 -TFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 3e-46
Identities = 55/313 (17%), Positives = 106/313 (33%), Gaps = 67/313 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I +G FG V+ + G+ A+K+ R+ AE + +R+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 747 PFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ F + + L+LV +Y G L+ L + E + ++ + L +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL-STASGLAH 115
Query: 803 LHS--------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
LH I HRDLK N+L+ +G + D GL+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV------------------- 156
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH------GYAADWWSVGIILFEFI 908
+ T + + VGT Y+APE+L + + AD +++G++ +E
Sbjct: 157 ----RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212
Query: 909 TGIPPFTAESP-------------------EIIFDNILNRKIPWPCVPSDMSFEAQDLIN 949
+++ + L IP + ++
Sbjct: 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 272
Query: 950 RFLIHDPNQRLGA 962
+ RL A
Sbjct: 273 ECWYANGAARLTA 285
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-45
Identities = 53/271 (19%), Positives = 99/271 (36%), Gaps = 33/271 (12%)
Query: 695 ISRGAFGRVFLAR---KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 751
I RG FG V+ A+K L ++ ++ + L E I+ +P V+
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 752 FF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHSLGIV 809
+ +V+ Y+ GDL + +R I ++ +++L S V
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
HRDL N ++ +K+ DFGL++ + +
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARD-----------------------MYDKEFDSVH 189
Query: 870 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 928
N+ A ++A E L + +D WS G++L+E +T G PP+ + I +L
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ P +++ + R
Sbjct: 250 GRRLLQ--PEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 145 bits (365), Expect = 3e-38
Identities = 57/348 (16%), Positives = 119/348 (34%), Gaps = 87/348 (25%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-------L 741
+ +++ + G F V+LA+ A+K+++ + + + I + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 742 ITVRNPFVVRFFYSFT--CRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIAEL 796
++ +++ F + +++VM + G + + + +L
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 797 VLALEYL-HSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIM 854
+L L+Y+ GI+H D+KP+N+L+ L ++ +G +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---------- 184
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ +++ T +Y +PE+LLG G AD WS ++FE ITG F
Sbjct: 185 ---------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
Query: 915 TAESPEIIFDNI------------------------------------LNRKIPWPC--- 935
+ + +++ WP
Sbjct: 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289
Query: 936 ------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
D + E D ++ L DP +R A + HP+ K
Sbjct: 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDT 334
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.4 bits (213), Expect = 8e-20
Identities = 27/161 (16%), Positives = 50/161 (31%), Gaps = 28/161 (17%)
Query: 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAER---- 738
I K + G VF +K K K+ R
Sbjct: 3 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 739 ----NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
L ++ V + + ++ME ++ +LY + + +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELY-------RVRVENPDEVLD 110
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
++ + + GIVH DL N+L+ + I + DF S
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1092 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.24 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.78 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.58 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.52 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.12 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.2 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-66 Score=568.05 Aligned_cols=301 Identities=41% Similarity=0.758 Sum_probs=275.3
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~L 762 (1092)
++++++|++++.||+|+||+||+|+++.+|+.||||++++..........++.+|+.+|++++|||||+++++|++.+.+
T Consensus 1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 35788999999999999999999999999999999999987666666788899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
|+|||||+||+|.+++.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~---- 156 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI---- 156 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC----
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998531
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.......+.+||+.|||||++.+.+|+.++|||||||++|||++|++||.+.+..++
T Consensus 157 -----------------------~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 213 (337)
T d1o6la_ 157 -----------------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp -----------------------CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -----------------------cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH
Confidence 012234568999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD 998 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~D 998 (1092)
++.+..+.+.+| ..+|+++++||.+||++||.+|++. .++.++++||||++++|+.+..+ .|||+|...+..|
T Consensus 214 ~~~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~ 290 (337)
T d1o6la_ 214 FELILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVD 290 (337)
T ss_dssp HHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTC
T ss_pred HHHHhcCCCCCC---ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhh
Confidence 999999987776 7899999999999999999999973 25899999999999999998765 7899999999999
Q ss_pred ccccccccccCCCCC
Q 001360 999 TSYFLSRFSQISSGL 1013 (1092)
Q Consensus 999 ts~Fds~fs~~~s~l 1013 (1092)
+++|+..+.......
T Consensus 291 ~~~f~~~~~~~~~~~ 305 (337)
T d1o6la_ 291 TRYFDDEFTAQSITI 305 (337)
T ss_dssp CTTSCHHHHTSCCC-
T ss_pred hhhcCchhhhccCCC
Confidence 999998877654443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-63 Score=532.10 Aligned_cols=280 Identities=36% Similarity=0.718 Sum_probs=251.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+++|++++|||||+++++|.+.+.+|
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 34578999999999999999999999999999999998766555666788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||||+||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~--- 161 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE--- 161 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999853110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++
T Consensus 162 ----------------------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~ 219 (288)
T d1uu3a_ 162 ----------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219 (288)
T ss_dssp ------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ----------------------CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH
Confidence 0112234578999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCccc---HHHHHcCCCCCCCCcchhhhccCCccC
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG---AAEVKAHPFFKGVNWDSLALQKAVFVP 991 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~g---a~EIL~HPFFkgIdWd~L~~~~pPfiP 991 (1092)
.+|.+..+.+| ..+++++++||.+||++||.+|||+++ ...|++||||++++|+.+..+.||-+|
T Consensus 220 ~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 220 QKIIKLEYDFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp HHHHTTCCCCC---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HHHHcCCCCCC---ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 99999887766 689999999999999999999999653 456899999999999999988877655
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-62 Score=537.38 Aligned_cols=291 Identities=39% Similarity=0.763 Sum_probs=244.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hcCCCceEEEeeeeccCCeeEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~-~L~HPNIVkL~~sfqde~~LYL 764 (1092)
+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+..|..++. .++|||||+++++|.+.+.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 478999999999999999999999999999999998765555566778888888775 6899999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||||+||+|.+++...+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~----- 155 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML----- 155 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-----
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999984210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++.
T Consensus 156 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 213 (320)
T d1xjda_ 156 ----------------------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213 (320)
T ss_dssp ----------------------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ----------------------ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1122345689999999999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccc
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 1002 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~F 1002 (1092)
+|..+.+.+| ..+|+++++||.+||++||.+||++. .++++||||++++|+.+..+ .||++|...++.|+++|
T Consensus 214 ~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~s~~--~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~f 288 (320)
T d1xjda_ 214 SIRMDNPFYP---RWLEKEAKDLLVKLFVREPEKRLGVR--GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNF 288 (320)
T ss_dssp HHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSBTTB--SCGGGSGGGTTCCHHHHHTTCSCC---------------
T ss_pred HHHcCCCCCC---ccCCHHHHHHHHHhcccCCCCCcCHH--HHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhhc
Confidence 9998876655 78999999999999999999999942 26899999999999988665 78999999999999999
Q ss_pred cccccc
Q 001360 1003 LSRFSQ 1008 (1092)
Q Consensus 1003 ds~fs~ 1008 (1092)
+..+..
T Consensus 289 ~~~~~~ 294 (320)
T d1xjda_ 289 DKEFLN 294 (320)
T ss_dssp ------
T ss_pred ChHhhh
Confidence 876544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.2e-62 Score=530.74 Aligned_cols=287 Identities=40% Similarity=0.768 Sum_probs=254.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||+++++|.+.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 46789999999999999999999999999999999987655555667889999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||||.||+|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~------ 155 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------ 155 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS------
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.
T Consensus 156 ------------------------~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 211 (316)
T d1fota_ 156 ------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211 (316)
T ss_dssp ------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred ------------------------cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH
Confidence 12235789999999999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCC-CCCc
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES-VDDT 999 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s-~~Dt 999 (1092)
+|.++...+| ..+|+++++||.+||.+||.+|++. ..+.++++||||++++|+.+..+ .+||+|.... ..|+
T Consensus 212 ~i~~~~~~~p---~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~~d~ 288 (316)
T d1fota_ 212 KILNAELRFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDT 288 (316)
T ss_dssp HHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-------
T ss_pred HHHcCCCCCC---CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCCCcchh
Confidence 9999887765 6899999999999999999999852 24889999999999999998765 7889887544 4678
Q ss_pred ccccc
Q 001360 1000 SYFLS 1004 (1092)
Q Consensus 1000 s~Fds 1004 (1092)
++|+.
T Consensus 289 ~~f~~ 293 (316)
T d1fota_ 289 SQFDK 293 (316)
T ss_dssp -----
T ss_pred hhcCC
Confidence 88765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.8e-62 Score=536.46 Aligned_cols=288 Identities=40% Similarity=0.779 Sum_probs=264.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+++|+.+|+.++|||||+++++|.+...+|+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 35799999999999999999999999999999999987655555667889999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~------ 192 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS------
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+...++.
T Consensus 193 ------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 248 (350)
T d1rdqe_ 193 ------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248 (350)
T ss_dssp ------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ------------------------cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH
Confidence 11235789999999999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcc
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTS 1000 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts 1000 (1092)
+|......+| ..+++++.+||++||++||.+|+.. ..+.++++||||++++|+.+..+ .|||+|...++.|++
T Consensus 249 ~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s 325 (350)
T d1rdqe_ 249 KIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTS 325 (350)
T ss_dssp HHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCT
T ss_pred HHhcCCCCCC---ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchhh
Confidence 9999887665 7899999999999999999999731 24889999999999999998766 789999999999999
Q ss_pred ccccc
Q 001360 1001 YFLSR 1005 (1092)
Q Consensus 1001 ~Fds~ 1005 (1092)
+|++.
T Consensus 326 ~~~~~ 330 (350)
T d1rdqe_ 326 NFDDY 330 (350)
T ss_dssp TSCCC
T ss_pred hcCCC
Confidence 98753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.2e-60 Score=525.16 Aligned_cols=288 Identities=35% Similarity=0.623 Sum_probs=240.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHH---HHHHHhcCCCceEEEeeeeccCC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---RNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~E---ieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
+++++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+| +.++..++|||||+++++|.+.+
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 357899999999999999999999999999999999987554444344445555 55666778999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
.+|||||||+||+|.++|.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~-- 158 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-- 158 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS--
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
.......+||+.|||||++.. ..|+.++|||||||+||||++|++||.+.+.
T Consensus 159 ---------------------------~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 159 ---------------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp ---------------------------SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred ---------------------------CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 112345689999999999974 6799999999999999999999999987654
Q ss_pred H---HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCc--ccHHHHHcCCCCCCCCcchhhhc--cCCccCC
Q 001360 920 E---IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQ 992 (1092)
Q Consensus 920 ~---ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa--~ga~EIL~HPFFkgIdWd~L~~~--~pPfiP~ 992 (1092)
. .+.+.+......+ +..+|+++++||.+||++||.+||+. ..|.++++||||++++|+.+..+ +||++|.
T Consensus 212 ~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~ 288 (364)
T d1omwa3 212 KDKHEIDRMTLTMAVEL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 288 (364)
T ss_dssp SCHHHHHHHSSSCCCCC---CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHHHHHhcccCCCCC---CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCC
Confidence 3 3444444444443 47899999999999999999999994 35899999999999999988766 7889998
Q ss_pred CCCCCCccccc
Q 001360 993 PESVDDTSYFL 1003 (1092)
Q Consensus 993 ~~s~~Dts~Fd 1003 (1092)
.......++|+
T Consensus 289 ~~~~~~~~~~d 299 (364)
T d1omwa3 289 RGEVNAADAFD 299 (364)
T ss_dssp CC---------
T ss_pred CCCCCcCCccc
Confidence 77665555554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-60 Score=502.88 Aligned_cols=257 Identities=36% Similarity=0.650 Sum_probs=237.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
..+++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 34689999999999999999999999999999999998766555556778999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----- 157 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----- 157 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC-----
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
.......+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++
T Consensus 158 ------------------------~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~ 213 (263)
T d2j4za1 158 ------------------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 213 (263)
T ss_dssp ------------------------CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred ------------------------CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH
Confidence 11223568999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
.++.+..+.+| ..+|+++++||.+||++||.+||| +.|+++||||.
T Consensus 214 ~~i~~~~~~~p---~~~s~~~~~li~~~L~~dp~~R~t---~~eil~hp~~~ 259 (263)
T d2j4za1 214 KRISRVEFTFP---DFVTEGARDLISRLLKHNPSQRPM---LREVLEHPWIT 259 (263)
T ss_dssp HHHHTTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTCHHHH
T ss_pred HHHHcCCCCCC---ccCCHHHHHHHHHHccCCHhHCcC---HHHHHcCcCcC
Confidence 99998887666 689999999999999999999999 88999999995
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-58 Score=491.06 Aligned_cols=266 Identities=29% Similarity=0.500 Sum_probs=234.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk---~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+.|++++.||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 569999999999999999999999999999999987544322 23678999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC----cEEEEecCCcccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGLI 839 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG----~VKLsDFGLAk~~~~ 839 (1092)
||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.+| ++||+|||+|+...
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~- 168 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 168 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT-
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC-
Confidence 9999999999999999989999999999999999999999999999999999999999877 59999999997531
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
......+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 169 ---------------------------~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 221 (293)
T d1jksa_ 169 ---------------------------FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221 (293)
T ss_dssp ---------------------------TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH
Confidence 11223456899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001360 920 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983 (1092)
Q Consensus 920 ~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L~ 983 (1092)
.+++..|......++. .+..+|+++++||++||+.||.+||| +.++++||||++.+|+...
T Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~~~~~~l 283 (293)
T d1jksa_ 222 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQAL 283 (293)
T ss_dssp HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTCC-------
T ss_pred HHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCCChhHhh
Confidence 9999999888776542 23678999999999999999999999 8899999999999998654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-58 Score=495.09 Aligned_cols=262 Identities=27% Similarity=0.471 Sum_probs=222.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..++|++++.||+|+||+||+|+++.+|+.||||++++... .+..+.+.+|+.+|++++|||||++++++.+.+.+||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 35789999999999999999999999999999999976432 2234678999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....++
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~--- 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN--- 157 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT---
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC---
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998632111
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
......+.+||+.|||||++.+..| +.++|||||||++|||++|++||...+.....
T Consensus 158 ----------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~ 215 (271)
T d1nvra_ 158 ----------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215 (271)
T ss_dssp ----------------------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH
T ss_pred ----------------------ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH
Confidence 1122346789999999999998876 67899999999999999999999876543333
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 924 ~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
..........+.....+|+++++||.+||+.||.+||| +.++++||||+.
T Consensus 216 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hpwf~~ 265 (271)
T d1nvra_ 216 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTC
T ss_pred HHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhCc
Confidence 23333322333334678999999999999999999999 889999999963
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=492.32 Aligned_cols=256 Identities=34% Similarity=0.545 Sum_probs=228.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
++|++++.||+|+||+||+|+++.+|+.||||++++.... ..+.+.+|+.+|++++|||||+++++|.+.+.+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 4699999999999999999999999999999999865432 3467899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001360 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls 846 (1092)
|||+||+|.+++.+ +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~------- 168 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------- 168 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-------
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc-------
Confidence 99999999998765 5799999999999999999999999999999999999999999999999999985310
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 847 ~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
........+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.......+
T Consensus 169 --------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 228 (293)
T d1yhwa1 169 --------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (293)
T ss_dssp --------------------TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred --------------------ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 112234568999999999999999999999999999999999999999999888877777
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 927 l~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
.....+....+..+|+++++||.+||..||.+||+ +.|+|+||||+.
T Consensus 229 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~Hp~~~~ 275 (293)
T d1yhwa1 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (293)
T ss_dssp HHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHTTCGGGGG
T ss_pred HhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhCC
Confidence 76544333346789999999999999999999999 889999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-57 Score=494.20 Aligned_cols=259 Identities=34% Similarity=0.583 Sum_probs=218.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+.... .....+.+|+.+|++++|||||+++++|.+.+.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35699999999999999999999999999999999875432 2345688999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEec---CCCcEEEEecCCccccccccc
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD---~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||+. .+|++||+|||+|+...
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~---- 161 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED---- 161 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc----
Confidence 99999999999999989999999999999999999999999999999999999995 57899999999998521
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
......+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++
T Consensus 162 ------------------------~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 217 (307)
T d1a06a_ 162 ------------------------PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217 (307)
T ss_dssp -----------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 11123457899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 923 FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 923 ~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
+..|......++. .+..+|+++++||.+||.+||.+||| +.|+++||||++.
T Consensus 218 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~ 270 (307)
T d1a06a_ 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT---CEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTTSS
T ss_pred HHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcC---HHHHhcCHhhCCC
Confidence 9999988766542 34679999999999999999999999 8899999999863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-57 Score=488.73 Aligned_cols=257 Identities=32% Similarity=0.548 Sum_probs=230.2
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVM 766 (1092)
+.|++++.||+|+||+||+|+++.+|+.||||++++.. ....+.+.+|+++|++++|||||+++++|.+.+.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 46999999999999999999999999999999997642 344567899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||+||+|.+++.+. +.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~------ 162 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR------ 162 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH------
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC------
Confidence 999999999998654 5699999999999999999999999999999999999999999999999999975311
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
......+.+||+.|||||++. +..|+.++|||||||+||||++|++||.+.++.
T Consensus 163 ---------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~ 221 (288)
T d2jfla1 163 ---------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221 (288)
T ss_dssp ---------------------HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred ---------------------CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH
Confidence 011234578999999999984 456899999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
+++.++..+..+....+..+|+++++||.+||++||.+||| +.|+++||||+.
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~ell~hp~~~~ 274 (288)
T d2jfla1 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWT---TSQLLQHPFVTV 274 (288)
T ss_dssp GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSGGGCC
T ss_pred HHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCC
Confidence 99999988766554456789999999999999999999999 889999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-58 Score=496.60 Aligned_cols=262 Identities=31% Similarity=0.521 Sum_probs=224.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
+..++|++++.||+|+||+||+|+++.+|+.||+|++++.. .......+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45679999999999999999999999999999999997632 3344578899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
||||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +|||||||||+||||+.+|++||+|||+|+...
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~---- 156 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 156 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC----
Confidence 999999999999999999999999999999999999999997 599999999999999999999999999998531
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei 922 (1092)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+....
T Consensus 157 -------------------------~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~ 211 (322)
T d1s9ja_ 157 -------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211 (322)
T ss_dssp -------------------------HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHH
T ss_pred -------------------------CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 1122457999999999999999999999999999999999999999987653322
Q ss_pred HH------------------------------------------HHhhcCCCCCCCC-CCCCHHHHHHHHHhccCCcCCC
Q 001360 923 FD------------------------------------------NILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQR 959 (1092)
Q Consensus 923 ~~------------------------------------------kIl~~~l~fP~ip-~~lS~eakDLI~kcL~kDP~KR 959 (1092)
.. .+... ..|..+ ..+|.+++|||.+||+.||.+|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R 289 (322)
T d1s9ja_ 212 ELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAER 289 (322)
T ss_dssp HHHC------------------------------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCCChhHC
Confidence 11 11111 111111 3468999999999999999999
Q ss_pred CCcccHHHHHcCCCCCCCCcch
Q 001360 960 LGANGAAEVKAHPFFKGVNWDS 981 (1092)
Q Consensus 960 pSa~ga~EIL~HPFFkgIdWd~ 981 (1092)
|| +.|+|+||||+..+|+.
T Consensus 290 ~t---a~e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 290 AD---LKQLMVHAFIKRSDAEE 308 (322)
T ss_dssp CC---HHHHHTSHHHHHHHHSC
T ss_pred cC---HHHHhhCHhhCcCCccc
Confidence 99 88999999998776654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-56 Score=495.13 Aligned_cols=264 Identities=28% Similarity=0.510 Sum_probs=236.4
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|++++|||||+++++|.+.+.+||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4679999999999999999999999999999999997643 3445778999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHH-hhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC--CCcEEEEecCCcccccccc
Q 001360 765 VMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 765 VMEYm~GGSL~dlLk-k~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~--nG~VKLsDFGLAk~~~~n~ 841 (1092)
|||||+||+|.+++. ..+.+++..++.|+.||+.||.|||++|||||||||+||||+. +|.+||+|||+|+...
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~--- 177 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 177 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC---
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc---
Confidence 999999999999995 4567999999999999999999999999999999999999964 6899999999998521
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
......+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+
T Consensus 178 -------------------------~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 232 (350)
T d1koaa2 178 -------------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232 (350)
T ss_dssp -------------------------TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 1122345789999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCcchh
Q 001360 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982 (1092)
Q Consensus 922 i~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdWd~L 982 (1092)
++..|......++. ....+|+++++||.+||++||.+||| +.|+++||||+..+|...
T Consensus 233 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 233 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp HHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCC---HHHHHHSTTTSCTTCCSC
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCCCCCCc
Confidence 99999988776553 23468999999999999999999999 889999999998877543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-57 Score=479.31 Aligned_cols=256 Identities=32% Similarity=0.546 Sum_probs=219.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCeeE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLY 763 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd--e~~LY 763 (1092)
.++|++++.||+|+||+||+|+++.+|+.||+|++++... .+...+.+.+|+++|++++|||||++++++.+ .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 4689999999999999999999999999999999987544 44567789999999999999999999999865 45689
Q ss_pred EEEeecCCCcHHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHcC-----CeeeecCCCceEecCCCcEEEEecCCc
Q 001360 764 LVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk----~g~LsE~~ar~yaaQIL~ALeYLHs~G-----IIHRDLKPeNILLD~nG~VKLsDFGLA 834 (1092)
||||||+||+|.+++.+ .+.+++..++.++.||+.||.|||+.| ||||||||+||||+.+|.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999864 357999999999999999999999976 999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
+.... ......+.+||+.|||||++.+..|+.++|||||||++|||++|++||
T Consensus 162 ~~~~~---------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 162 RILNH---------------------------DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp HHC--------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred eeccc---------------------------CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCC
Confidence 85310 111234578999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCC
Q 001360 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1092)
Q Consensus 915 ~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFF 974 (1092)
.+.+..+++.+|..+..+ .+|..+|+++++||.+||+.||.+||+ +.|+++|||.
T Consensus 215 ~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~li~~~L~~dp~~Rps---~~ell~hp~i 269 (269)
T d2java1 215 TAFSQKELAGKIREGKFR--RIPYRYSDELNEIITRMLNLKDYHRPS---VEEILENPLI 269 (269)
T ss_dssp CCSSHHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTC
T ss_pred CCCCHHHHHHHHHcCCCC--CCCcccCHHHHHHHHHHcCCChhHCcC---HHHHHhCCcC
Confidence 999999999999887653 346789999999999999999999999 8899999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-56 Score=475.36 Aligned_cols=252 Identities=24% Similarity=0.456 Sum_probs=220.1
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCeeEE
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLYL 764 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd----e~~LYL 764 (1092)
|++.+.||+|+||+||+|+++.++..||+|++.+... .....+.+.+|+++|++++|||||++|++|.+ ...+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4777899999999999999999999999999986543 34557789999999999999999999999865 356899
Q ss_pred EEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcC--CeeeecCCCceEec-CCCcEEEEecCCcccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~G--IIHRDLKPeNILLD-~nG~VKLsDFGLAk~~~~n~ 841 (1092)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| ||||||||+||||+ .+|.+||+|||+|+...
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~--- 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 166 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc---
Confidence 9999999999999999999999999999999999999999999 99999999999996 58999999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-hH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PE 920 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s-~~ 920 (1092)
.....+.+||+.|||||++.+ .|+.++|||||||++|||++|++||.+.. ..
T Consensus 167 --------------------------~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~ 219 (270)
T d1t4ha_ 167 --------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA 219 (270)
T ss_dssp --------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred --------------------------CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH
Confidence 112345789999999999876 59999999999999999999999997654 55
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
.+++.+..+..+ +.++...++++++||.+||.+||++||| +.|+++||||+
T Consensus 220 ~~~~~i~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~ell~Hp~fk 270 (270)
T d1t4ha_ 220 QIYRRVTSGVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHTTTCCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC
T ss_pred HHHHHHHcCCCC-cccCccCCHHHHHHHHHHccCCHhHCcC---HHHHhCCcccC
Confidence 666666655432 3345678999999999999999999999 88999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-56 Score=486.33 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=230.7
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
.|+.++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|++++|||||+++++|.+.+.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987666566667889999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
||.||+|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~--------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA--------- 166 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS---------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC---------
Confidence 99999998888888899999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
.....+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+.
T Consensus 167 ----------------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~ 224 (309)
T d1u5ra_ 167 ----------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (309)
T ss_dssp ----------------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ----------------------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 1234689999999999964 468999999999999999999999999999988888
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
++..+..+.+ .+..+|+++++||.+||++||.+||| +.++++||||..
T Consensus 225 ~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 225 HIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLR 272 (309)
T ss_dssp HHHHSCCCCC-SCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHS
T ss_pred HHHhCCCCCC-CCCCCCHHHHHHHHHHCcCChhHCcC---HHHHHhCHHhcC
Confidence 8887765433 24678999999999999999999999 889999999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.2e-56 Score=490.19 Aligned_cols=260 Identities=25% Similarity=0.482 Sum_probs=234.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LY 763 (1092)
...++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34578999999999999999999999999999999998643 234567889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEec--CCCcEEEEecCCccccccc
Q 001360 764 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA--HDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD--~nG~VKLsDFGLAk~~~~n 840 (1092)
||||||+||+|.+++.+.+ .+++..++.++.||+.||.|||++|||||||||+||||+ .+|++||+|||+|+...
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~-- 180 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-- 180 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC--
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC--
Confidence 9999999999999886654 699999999999999999999999999999999999998 57899999999998531
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ 920 (1092)
......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..
T Consensus 181 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 234 (352)
T d1koba_ 181 --------------------------PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234 (352)
T ss_dssp --------------------------TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred --------------------------CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 112234578999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 921 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 921 ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
+++..|......+|. .+..+|+++++||.+||++||.+||| +.|+|+||||++.
T Consensus 235 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~Hp~~~~~ 289 (352)
T d1koba_ 235 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSC
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhCCC
Confidence 999999988776653 34679999999999999999999999 8899999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.6e-55 Score=466.66 Aligned_cols=260 Identities=31% Similarity=0.510 Sum_probs=232.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc------hhHHHHHHHHHHHHHhcC-CCceEEEeeeecc
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR------KNDIERILAERNILITVR-NPFVVRFFYSFTC 758 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~k------k~~ie~~l~EieIL~~L~-HPNIVkL~~sfqd 758 (1092)
.++|++++.||+|+||+||+|+++.+|+.||||++++..... +...+.+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999998754322 223457889999999997 9999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+.+|||||||+||+|.++|...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC------CCCCccceeechhhhHHHHHhCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG------TEHGYAADWWSVGIILFEFITGIP 912 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g------~~Yt~ksDVWSLGVILYEMLTGk~ 912 (1092)
. .......+||+.|+|||++.+ ..|+.++|||||||++|||++|++
T Consensus 162 ~----------------------------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~ 213 (277)
T d1phka_ 162 P----------------------------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213 (277)
T ss_dssp T----------------------------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred C----------------------------CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCC
Confidence 0 112234689999999999863 457889999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 913 PFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 913 PF~~~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
||.+.+.......|..+...++. ....+|+++++||.+||+.||.+||+ +.++++||||+.
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s---~~eil~h~~~~~ 275 (277)
T d1phka_ 214 PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQ 275 (277)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCT
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC---HHHHHcCHHHHH
Confidence 99999999999999988766553 23479999999999999999999999 889999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-55 Score=468.40 Aligned_cols=258 Identities=29% Similarity=0.446 Sum_probs=216.9
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001360 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK--NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1092)
Q Consensus 690 eilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk--~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVME 767 (1092)
+.++.||+|+||+||+|+++.+|+.||||++++...... .....+.+|+.+|++++|||||+++++|.+.+.+|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 357899999999999999999999999999976443221 123568899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001360 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1092)
Q Consensus 768 Ym~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~ 847 (1092)
|+.||++..++.....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~--------- 151 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG--------- 151 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT---------
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccC---------
Confidence 99998888777777789999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001360 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1092)
Q Consensus 848 ~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~kI 926 (1092)
.......+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..++..+|
T Consensus 152 ------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i 213 (299)
T d1ua2a_ 152 ------------------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213 (299)
T ss_dssp ------------------SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ------------------CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH
Confidence 01122345689999999999875 46899999999999999999999999999998888777
Q ss_pred hhcCC-----CC---------------CC-----CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 927 LNRKI-----PW---------------PC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 927 l~~~l-----~f---------------P~-----ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
..... .+ +. ....+++++++||.+||++||++||| |.|+|+||||++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s---a~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQALKMKYFSNR 286 (299)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC---HHHHHTSGGGTSS
T ss_pred HHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC---HHHHhCCHhhCCC
Confidence 64200 00 10 11357899999999999999999999 8899999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-55 Score=476.20 Aligned_cols=257 Identities=27% Similarity=0.493 Sum_probs=231.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..++|++++.||+|+||+||+|+++.+|+.||||++++.. .+...+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3578999999999999999999999999999999997643 334568899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCC--CcEEEEecCCcccccccc
Q 001360 765 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~n--G~VKLsDFGLAk~~~~n~ 841 (1092)
|||||+||+|.+++.+.+ .+++.+++.|+.||+.||.|||++|||||||||+|||++.+ +.+||+|||+++...
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~--- 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---
Confidence 999999999999998765 69999999999999999999999999999999999999854 489999999997521
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
......+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 156 -------------------------~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~ 210 (321)
T d1tkia_ 156 -------------------------PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp -------------------------TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred -------------------------cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH
Confidence 1122345789999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 922 i~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
++..|.+..+.+|. .+..+|+++++||.+||++||.+||+ +.|+++||||+.
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~ 263 (321)
T d1tkia_ 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHS
T ss_pred HHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhcc
Confidence 99999998877653 22468999999999999999999999 889999999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=472.26 Aligned_cols=287 Identities=42% Similarity=0.790 Sum_probs=244.2
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEE---CCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcCC-CceEEEeeeec
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRN-PFVVRFFYSFT 757 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~---k~TGk~VAIKvLkK~ei~k-k~~ie~~l~EieIL~~L~H-PNIVkL~~sfq 757 (1092)
++.+++|++++.||+|+||+||+|++ +.+|+.||||++++..... ....+.+.+|+.+|++++| |||+++++++.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 45678999999999999999999987 4578999999997654322 2345678899999999976 89999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
+...+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC--CCCccceeechhhhHHHHHhCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFT 915 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~--~Yt~ksDVWSLGVILYEMLTGk~PF~ 915 (1092)
.. .......+..||+.|+|||++.+. .|+.++|||||||+||||++|..||.
T Consensus 180 ~~--------------------------~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 180 VA--------------------------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp CG--------------------------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cc--------------------------cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 21 112223457899999999999765 46789999999999999999999998
Q ss_pred CCChHHH----HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcc--cHHHHHcCCCCCCCCcchhhhc--cC
Q 001360 916 AESPEII----FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KA 987 (1092)
Q Consensus 916 ~~s~~ei----~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~--ga~EIL~HPFFkgIdWd~L~~~--~p 987 (1092)
+.+.... .........++ |..+|+++.+||.+||.+||.+||+.. .+.|+++||||++++|+.+..+ ++
T Consensus 234 ~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~ 310 (322)
T d1vzoa_ 234 VDGEKNSQAEISRRILKSEPPY---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA 310 (322)
T ss_dssp CTTSCCCHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred CCCHHHHHHHHHHhcccCCCCC---cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCc
Confidence 7665443 33333444443 468999999999999999999999843 5899999999999999998876 78
Q ss_pred CccCCCCCCCC
Q 001360 988 VFVPQPESVDD 998 (1092)
Q Consensus 988 PfiP~~~s~~D 998 (1092)
|++|...+..|
T Consensus 311 p~~p~~~~~~~ 321 (322)
T d1vzoa_ 311 PFKPVIRDELD 321 (322)
T ss_dssp SCCCCCCC-CC
T ss_pred CCCCCCCCCCC
Confidence 99998887665
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-54 Score=456.15 Aligned_cols=253 Identities=27% Similarity=0.443 Sum_probs=219.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchh---HHHHHHHHHHHHHhcC--CCceEEEeeeeccCC
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILITVR--NPFVVRFFYSFTCRD 760 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~---~ie~~l~EieIL~~L~--HPNIVkL~~sfqde~ 760 (1092)
.++|++.+.||+|+||+||+|+++.+|+.||||++++....... ...++.+|+.+|++++ |||||+++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36799999999999999999999999999999999875433221 2234678999999987 899999999999999
Q ss_pred eeEEEEeecCC-CcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-CCcEEEEecCCccccc
Q 001360 761 NLYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 ~LYLVMEYm~G-GSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~ 838 (1092)
.+|+||||+.+ +++.+++.+.+.+++..++.++.||+.||.|||++|||||||||+||||+. ++.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 688999988899999999999999999999999999999999999999985 4799999999997521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
.....+.+||+.|||||++.+..| +.++|||||||++|||++|++||.+.
T Consensus 163 -----------------------------~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 163 -----------------------------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp -----------------------------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred -----------------------------cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 112235789999999999987665 67899999999999999999999763
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCc
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdW 979 (1092)
..+......++ ..+|+++++||.+||..||++||| +.|+++||||+++-.
T Consensus 214 ------~~i~~~~~~~~---~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 214 ------EEIIRGQVFFR---QRVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDVLL 263 (273)
T ss_dssp ------HHHHHCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSCCC
T ss_pred ------hHHhhcccCCC---CCCCHHHHHHHHHHccCCHhHCcC---HHHHhcCHhhCCCCC
Confidence 24556665555 789999999999999999999999 889999999998643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=454.13 Aligned_cols=264 Identities=30% Similarity=0.438 Sum_probs=219.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeecc--
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTT-GDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTC-- 758 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~T-Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L---~HPNIVkL~~sfqd-- 758 (1092)
..++|++++.||+|+||+||+|++..+ ++.||||++++.... ......+.+|+.+|+.+ +|||||+++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 347899999999999999999999765 678999999764322 22233456777776655 79999999999853
Q ss_pred ---CCeeEEEEeecCCCcHHHHHH-hhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCc
Q 001360 759 ---RDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1092)
Q Consensus 759 ---e~~LYLVMEYm~GGSL~dlLk-k~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 834 (1092)
...+|++|||+.+|.+..... ....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 346899999999987765544 3456999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCC
Q 001360 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (1092)
Q Consensus 835 k~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF 914 (1092)
+... ........+||+.|||||++.+..|+.++|||||||++|||++|++||
T Consensus 164 ~~~~----------------------------~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf 215 (305)
T d1blxa_ 164 RIYS----------------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 215 (305)
T ss_dssp CCCC----------------------------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred hhhc----------------------------ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCC
Confidence 7421 112234678999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhhcC------------------------CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 915 TAESPEIIFDNILNRK------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 915 ~~~s~~ei~~kIl~~~------------------------l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
.+.+..++..+|+... .+.+..+..+++++++||.+||++||.+||| +.|+|+
T Consensus 216 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s---a~e~L~ 292 (305)
T d1blxa_ 216 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSALS 292 (305)
T ss_dssp CCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC---HHHHHT
T ss_pred CCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC---HHHHhc
Confidence 9999888887775410 0111134568999999999999999999999 889999
Q ss_pred CCCCCCCCcc
Q 001360 971 HPFFKGVNWD 980 (1092)
Q Consensus 971 HPFFkgIdWd 980 (1092)
||||+++++.
T Consensus 293 Hpff~~i~~~ 302 (305)
T d1blxa_ 293 HPYFQDLERC 302 (305)
T ss_dssp SGGGTTCCCC
T ss_pred ChhhcCchhh
Confidence 9999998753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=453.75 Aligned_cols=262 Identities=31% Similarity=0.504 Sum_probs=218.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
+++|++++.||+|+||+||+|+++.+|+.||||+++... ........+.+|+++|++++|||||+++++|.+.+.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 479999999999999999999999999999999997543 2333457889999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccccc
Q 001360 766 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~d 844 (1092)
|||+.++.+...... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~------ 153 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG------ 153 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC------
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc------
Confidence 999976544433333 4569999999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001360 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1092)
Q Consensus 845 ls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-t~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~ 923 (1092)
.........+||+.|+|||++....+ +.++|+|||||++|+|++|+.||.+.+..+..
T Consensus 154 ---------------------~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~ 212 (298)
T d1gz8a_ 154 ---------------------VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212 (298)
T ss_dssp ---------------------CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ---------------------CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH
Confidence 11223345689999999999887665 78999999999999999999999999887776
Q ss_pred HHHhhcCC-----CC-------------CC--------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 924 DNILNRKI-----PW-------------PC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 924 ~kIl~~~l-----~f-------------P~--------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.++..... .+ +. ....++++++|||.+||++||++||| +.|+++||||+++
T Consensus 213 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t---~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 213 FRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS---AKAALAHPFFQDV 289 (298)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGTTC
T ss_pred HHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcC---HHHHhCCHhhccC
Confidence 66543110 00 00 11357899999999999999999999 8899999999876
Q ss_pred C
Q 001360 978 N 978 (1092)
Q Consensus 978 d 978 (1092)
.
T Consensus 290 ~ 290 (298)
T d1gz8a_ 290 T 290 (298)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-52 Score=444.35 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=216.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----e
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----N 761 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~----~ 761 (1092)
.++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999999999999999998766555666788999999999999999999999998764 3
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~ 841 (1092)
+||||||++||+|..++...+.+++..++.++.||+.||.|||++|||||||||+||||+.++.++|+|||+++.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~- 164 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS- 164 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc-
Confidence 8999999999999999999999999999999999999999999999999999999999999999999999998743110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
........+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.++.+
T Consensus 165 -----------------------~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 221 (277)
T d1o6ya_ 165 -----------------------GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221 (277)
T ss_dssp -------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----------------------cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH
Confidence 011223456789999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCC
Q 001360 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLG 961 (1092)
Q Consensus 922 i~~kIl~~~l~fP~-ip~~lS~eakDLI~kcL~kDP~KRpS 961 (1092)
+..+++......|. ....+|+++++||.+||++||.+||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~ 262 (277)
T d1o6ya_ 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262 (277)
T ss_dssp HHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS
T ss_pred HHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHh
Confidence 88888877654432 34679999999999999999999995
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-54 Score=469.35 Aligned_cols=254 Identities=31% Similarity=0.530 Sum_probs=214.4
Q ss_pred ccCCCeEEEE-eeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc---
Q 001360 684 TSIDDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC--- 758 (1092)
Q Consensus 684 i~~~dFeilr-~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqd--- 758 (1092)
..+++|+++. +||+|+||+||+|+++.+|+.||||++++. ..+.+|+.++.++ +|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 3468999985 699999999999999999999999999753 3467899887654 79999999999876
Q ss_pred -CCeeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC---CCcEEEEecC
Q 001360 759 -RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFG 832 (1092)
Q Consensus 759 -e~~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFG 832 (1092)
...+|||||||+||+|.++|.+.+ .|++.+++.|+.||+.||+|||++|||||||||+|||++. ++++||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 467999999999999999998753 6999999999999999999999999999999999999985 5689999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCC
Q 001360 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912 (1092)
Q Consensus 833 LAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~ 912 (1092)
+|+.... .......+||+.|||||++.+..|+.++|||||||+||+|++|++
T Consensus 160 ~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~ 211 (335)
T d2ozaa1 160 FAKETTS----------------------------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211 (335)
T ss_dssp TCEECCC----------------------------CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSC
T ss_pred eeeeccC----------------------------CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCC
Confidence 9985311 112345689999999999999999999999999999999999999
Q ss_pred CCCCCChHHHH----HHHhhcCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 913 PFTAESPEIIF----DNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 913 PF~~~s~~ei~----~kIl~~~l~fP~i-p~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
||.+.+..... ..+....+.+|.. ...+|+++++||.+||++||.+||+ +.++++||||..
T Consensus 212 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 277 (335)
T d2ozaa1 212 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQ 277 (335)
T ss_dssp SCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSHHHHT
T ss_pred CCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC---HHHHHcCHHhhC
Confidence 99887654443 3444455555531 1358999999999999999999999 889999999954
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-52 Score=445.56 Aligned_cols=259 Identities=29% Similarity=0.488 Sum_probs=220.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
+++|++++.||+|+||+||+|+++ +|+.||||++++... .......+.+|+.+|++++|||||+++++|.+.+.+|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 468999999999999999999986 789999999976432 334467899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||+.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~------- 151 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG------- 151 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC-------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecc-------
Confidence 9999998888888878899999999999999999999999999999999999999999999999999987531
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~ei~~ 924 (1092)
.........+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+...
T Consensus 152 --------------------~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~ 211 (286)
T d1ob3a_ 152 --------------------IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211 (286)
T ss_dssp --------------------C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred --------------------cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH
Confidence 011223456799999999999764 56999999999999999999999999988877777
Q ss_pred HHhhcC--------------------------CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCC
Q 001360 925 NILNRK--------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1092)
Q Consensus 925 kIl~~~--------------------------l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkg 976 (1092)
++.... .+++.....++++++|||++||++||++||| +.|+++||||+.
T Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s---~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT---AKQALEHAYFKE 286 (286)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGGC
T ss_pred HHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCc
Confidence 664310 0111123568999999999999999999999 889999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-52 Score=450.27 Aligned_cols=254 Identities=21% Similarity=0.339 Sum_probs=217.4
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.++++..++|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|++++|||||+++++|.+.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 456677889999999999999999999999999999999997543 2356799999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
+.+|||||||++|+|.+++.+. ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999999999764 56899999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCC-CCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP-PFTA 916 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~-PF~~ 916 (1092)
... .........||+.|||||++.+..|+.++|||||||++|||++|.. ||.+
T Consensus 166 ~~~--------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 166 TGD--------------------------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp CSS--------------------------SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCC--------------------------CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc
Confidence 110 0111234568999999999999999999999999999999999655 5556
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
.+...+++.+..+ .. +..+..+|+++++||.+||+.||.+||++.++
T Consensus 220 ~~~~~~~~~i~~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei 266 (287)
T d1opja_ 220 IDLSQVYELLEKD-YR-MERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266 (287)
T ss_dssp CCHHHHHHHHHTT-CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred chHHHHHHHHhcC-CC-CCCCccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 6666666655443 33 33467899999999999999999999994433
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=456.24 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=219.6
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk-----~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~ 753 (1092)
.++.+..++|++.+.||+|+||+||+|+++.+++ .||+|++.+.. .......+.+|+.+|.++ +|||||+++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 3455677899999999999999999999876554 69999886532 233456789999999998 899999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhh-----------------------cCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 001360 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKV-----------------------GCLEEDVARIYIAELVLALEYLHSLGIVH 810 (1092)
Q Consensus 754 ~sfqde~~LYLVMEYm~GGSL~dlLkk~-----------------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIH 810 (1092)
++|.+.+.+|||||||+||+|.++|+.. +.+++..++.|+.||+.||.|||++||||
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 9999999999999999999999999754 24899999999999999999999999999
Q ss_pred eecCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC
Q 001360 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 890 (1092)
Q Consensus 811 RDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ 890 (1092)
|||||+|||++.+|++||+|||+|+..... .......+.+||+.|||||++.+..
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~l~~~~ 242 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSD-------------------------SNYVVRGNARLPVKWMAPESLFEGI 242 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGC-------------------------TTSEEETTEEECGGGCCHHHHHHCC
T ss_pred ccCchhccccccCCeEEEeeccccccccCC-------------------------CceeeeccccCCCccCChHHHcCCC
Confidence 999999999999999999999999853210 0111223567999999999999999
Q ss_pred CCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 891 HGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 891 Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
|+.++|||||||+||||++ |.+||.+.+....+.+++.....++ .|..+|+++++||.+||+.||++||| +.+|+
T Consensus 243 ~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~RPt---~~ei~ 318 (325)
T d1rjba_ 243 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD-QPFYATEEIYIIMQSCWAFDSRKRPS---FPNLT 318 (325)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHH
T ss_pred CCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-CCCcCCHHHHHHHHHHcCCChhHCcC---HHHHH
Confidence 9999999999999999997 8999999887777777777665543 46789999999999999999999999 55665
Q ss_pred cC
Q 001360 970 AH 971 (1092)
Q Consensus 970 ~H 971 (1092)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
Confidence 44
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=449.60 Aligned_cols=259 Identities=32% Similarity=0.480 Sum_probs=215.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~----- 760 (1092)
.+.|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 578999999999999999999999999999999997643 35556788999999999999999999999998765
Q ss_pred -eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 761 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 -~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
.+|+||||+ |++|..++ +.+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 479999999 56777766 45679999999999999999999999999999999999999999999999999998421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+
T Consensus 173 -----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 173 -----------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp -----------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----------------------------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 112356899999999999874 56899999999999999999999999887
Q ss_pred hHHHHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 919 PEIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 919 ~~ei~~kIl~~----------------------------~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
.......+... ...++.....+++++.|||.+||+.||.+||| +.|+|+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a~eiL~ 300 (346)
T d1cm8a_ 224 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---AGEALA 300 (346)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC---HHHHHH
T ss_pred hHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC---HHHHhc
Confidence 76655444321 11122234578999999999999999999999 889999
Q ss_pred CCCCCCCCcc
Q 001360 971 HPFFKGVNWD 980 (1092)
Q Consensus 971 HPFFkgIdWd 980 (1092)
||||+++.+.
T Consensus 301 Hp~f~~~~~~ 310 (346)
T d1cm8a_ 301 HPYFESLHDT 310 (346)
T ss_dssp SGGGTTTC--
T ss_pred ChhhCcCCCc
Confidence 9999987643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=445.06 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=217.1
Q ss_pred EeeccCCCeEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 001360 693 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (1092)
Q Consensus 693 r~LGkGgFGtVyLar~k~--TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLVMEYm~ 770 (1092)
+.||+|+||+||+|.++. +++.||||+++... ......+.+.+|+.+|++++|||||++++++.+ +.+|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 479999999999998653 56789999997543 334456789999999999999999999999865 46799999999
Q ss_pred CCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccCCCCCC
Q 001360 771 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (1092)
Q Consensus 771 GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t 850 (1092)
||+|.+++.+...+++..+..++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~--------- 161 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--------- 161 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC---------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc---------
Confidence 99999999998899999999999999999999999999999999999999999999999999998532100
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhc
Q 001360 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNR 929 (1092)
Q Consensus 851 ~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~ 929 (1092)
..........||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..++...+..+
T Consensus 162 ---------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~ 226 (277)
T d1xbba_ 162 ---------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 226 (277)
T ss_dssp ---------------SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred ---------------cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence 00112234679999999999999999999999999999999998 99999999998888888765
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 930 ~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.. +..|..+|+++.+||.+||..||.+||++.++.+.|+|+||.-+
T Consensus 227 ~~--~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 227 ER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp CC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CC--CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 32 33457899999999999999999999997777777888887543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=445.79 Aligned_cols=263 Identities=25% Similarity=0.329 Sum_probs=224.6
Q ss_pred ccCCCeEEEEe-eccCCCeEEEEEEECCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 684 TSIDDFEIIKP-ISRGAFGRVFLARKRTT--GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 684 i~~~dFeilr~-LGkGgFGtVyLar~k~T--Gk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
+..++|.+.+. ||+|+||+||+|.++.+ +..||||++++. ......+.+.+|+++|.+++|||||++++++.+ +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 34467888885 99999999999987644 458999999753 244567889999999999999999999999875 4
Q ss_pred eeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
.+|||||||+||+|.+++... +.+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 689999999999999998654 5799999999999999999999999999999999999999999999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s 918 (1092)
.. .........+||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+
T Consensus 162 ~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 162 DD------------------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp CS------------------------CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cc------------------------cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 10 00112234679999999999999999999999999999999998 999999998
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
..++...|..+.. +..|..+|+++.+||.+||..||++||++.++.+.|+|+|+.
T Consensus 218 ~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 218 GPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp THHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 8888888876542 334688999999999999999999999988888889998873
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=444.80 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=211.7
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~ 761 (1092)
|++..++|++.+.||+|+||+||+|+++ ..||||+++.... .....+.+.+|+.+|.+++|||||++++++. .+.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 4567789999999999999999999864 3599999976433 3456788999999999999999999998764 567
Q ss_pred eEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
+|||||||+||+|.+++... +.+++..+..++.||+.||+|||++|||||||||+||||+.++++||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 89999999999999999765 56999999999999999999999999999999999999999999999999999753110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Yt~ksDVWSLGVILYEMLTGk~PF~~~ 917 (1092)
.......+.+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.
T Consensus 158 -------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 158 -------------------------SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp ---------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred -------------------------CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 01122345689999999999975 35899999999999999999999999987
Q ss_pred ChHHHHHHHhhcCCCCC---CCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 918 SPEIIFDNILNRKIPWP---CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP---~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
+.......++......| .++..+++++++||.+||..||.+||+ +.+|++|
T Consensus 213 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~~il~~ 266 (276)
T d1uwha_ 213 NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL---FPQILAS 266 (276)
T ss_dssp CCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred ChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 76655555554433222 345789999999999999999999999 5566544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=435.41 Aligned_cols=251 Identities=21% Similarity=0.370 Sum_probs=209.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..++|++++.||+|+||+||+|+++ +++.||||++++... ..+.+.+|+.+|.+++|||||++++++...+.+|+
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 4578999999999999999999987 467899999976432 23568999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+++||||||||+||||+.++.+||+|||+++.....
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~--- 154 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--- 154 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC---
Confidence 99999999999998765 56899999999999999999999999999999999999999999999999999853110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 922 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei 922 (1092)
.........||+.|||||++.+..|+.++|||||||++|||+| |.+||...+..++
T Consensus 155 -----------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~ 211 (263)
T d1sm2a_ 155 -----------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 211 (263)
T ss_dssp ---------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH
T ss_pred -----------------------CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH
Confidence 0112234679999999999999999999999999999999999 6888888888888
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
...+..+.. +..|..+++++.+||.+||+.||.+||+ +.+|++|
T Consensus 212 ~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~Rps---~~~il~~ 255 (263)
T d1sm2a_ 212 VEDISTGFR--LYKPRLASTHVYQIMNHCWKERPEDRPA---FSRLLRQ 255 (263)
T ss_dssp HHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHhcCC--CCCccccCHHHHHHHHHHccCCHhHCcC---HHHHHHH
Confidence 888877533 2235788999999999999999999999 5566654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-51 Score=443.12 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=207.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk---~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
+..++|++.+.||+|+||+||+|+++.+|+ .||||.+.... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 345789999999999999999999987765 58888876432 3455678999999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999999999988764 5799999999999999999999999999999999999999999999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s 918 (1092)
.... ..........||+.|||||++.+..|+.++|||||||+||||+| |.+||.+.+
T Consensus 181 ~~~~----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 181 DTSD----------------------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp -------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCc----------------------ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 1000 00111223568999999999999999999999999999999998 899999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
..++...+..+.. .| .+..++.++.+||.+||..||.+||++.+
T Consensus 239 ~~~~~~~i~~~~~-~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~e 282 (299)
T d1jpaa_ 239 NQDVINAIEQDYR-LP-PPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282 (299)
T ss_dssp HHHHHHHHHTTCC-CC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHHHHcCCC-CC-CCccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 9998888876532 22 35789999999999999999999999544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=438.59 Aligned_cols=258 Identities=23% Similarity=0.377 Sum_probs=218.2
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
.+.+..++|++++.||+|+||+||+|+++ ++..||||++++... ..+.+.+|+.+|.+++|||||++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 34566789999999999999999999986 578899999976432 34579999999999999999999998754 5
Q ss_pred eeEEEEeecCCCcHHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~--g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++++||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 689999999999999987644 369999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
.+ .........||+.|||||++.+..|+.++|||||||++|||+| |.+||...
T Consensus 161 ~~--------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~ 214 (272)
T d1qpca_ 161 DN--------------------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (272)
T ss_dssp SS--------------------------CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CC--------------------------ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 10 0112234679999999999999999999999999999999999 56777788
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc--CCCCC
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--HPFFK 975 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~--HPFFk 975 (1092)
+..++...+..+.. +..|..+++++.+||.+||..||++||+ +.+|++ |+||.
T Consensus 215 ~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~Rpt---~~ei~~~L~~~ft 269 (272)
T d1qpca_ 215 TNPEVIQNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRPT---FDYLRSVLEDFFT 269 (272)
T ss_dssp CHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCC--CCCcccChHHHHHHHHHHcCCCHhHCcC---HHHHHHHhhhhhh
Confidence 88888888776532 2346789999999999999999999999 455554 56664
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=440.95 Aligned_cols=264 Identities=28% Similarity=0.383 Sum_probs=217.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-------
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------- 758 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd------- 758 (1092)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 5899999999999999999999999999999999976433 33455778999999999999999999998865
Q ss_pred -CCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 759 -RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 759 -e~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
...+|+||||+.++.+..+......+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++..
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999998877776666778999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
..... .......+.+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+
T Consensus 168 ~~~~~-----------------------~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 168 SLAKN-----------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp CC----------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccc-----------------------cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 21100 111233457899999999999865 689999999999999999999999999
Q ss_pred CChHHHHHHHhhcCCCCCC-CC----------------------------CCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 917 ESPEIIFDNILNRKIPWPC-VP----------------------------SDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~-ip----------------------------~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
.+.......+......++. .. ...+++++|||.+||++||++||| +.|
T Consensus 225 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s---a~e 301 (318)
T d3blha1 225 NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID---SDD 301 (318)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC---HHH
T ss_pred CCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC---HHH
Confidence 8887777666542111110 00 013778899999999999999999 889
Q ss_pred HHcCCCCCC
Q 001360 968 VKAHPFFKG 976 (1092)
Q Consensus 968 IL~HPFFkg 976 (1092)
+++||||+.
T Consensus 302 lL~Hpff~~ 310 (318)
T d3blha1 302 ALNHDFFWS 310 (318)
T ss_dssp HHHSGGGSS
T ss_pred HHcChhhcc
Confidence 999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=428.15 Aligned_cols=261 Identities=27% Similarity=0.445 Sum_probs=224.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYLV 765 (1092)
+++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||+++++|.+...+++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 368999999999999999999999999999999997644 3445678899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 766 MEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|+++.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+||||+.++++||+|||+|+....
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~------ 153 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI------ 153 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS------
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC------
Confidence 99999999999999889999999999999999999999999999999999999999999999999999985310
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeechhhhHHHHHhCCCCC-CCCChHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF-TAESPEIIF 923 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Yt~ksDVWSLGVILYEMLTGk~PF-~~~s~~ei~ 923 (1092)
.........+++.|+|||++.+.. ++.++|||||||++|||++|+.|| .+.+..+.+
T Consensus 154 ---------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~ 212 (292)
T d1unla_ 154 ---------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212 (292)
T ss_dssp ---------------------CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH
T ss_pred ---------------------CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH
Confidence 111223456889999999998765 689999999999999999999885 555666666
Q ss_pred HHHhhcC--------------------------CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCC
Q 001360 924 DNILNRK--------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1092)
Q Consensus 924 ~kIl~~~--------------------------l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgI 977 (1092)
.++.... .........+++++.+||.+||+.||.+||| |.|+|+||||+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s---a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS---AEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHTTSGGGSSC
T ss_pred HHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC---HHHHhcChhhcCC
Confidence 6654310 0111133567899999999999999999999 8899999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.3e-51 Score=441.71 Aligned_cols=256 Identities=30% Similarity=0.467 Sum_probs=212.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc--CCe
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC--RDN 761 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqd--e~~ 761 (1092)
..++|++++.||+|+||+||+|+++.+|+.||||++++. ..+.+.+|+++|..+. ||||++++++|.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 346899999999999999999999999999999999753 2456889999999996 9999999999874 456
Q ss_pred eEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC-cEEEEecCCccccccc
Q 001360 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~n 840 (1092)
+|+|||||.+|+|..+. +.+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+...
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~-- 181 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-- 181 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC--
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc--
Confidence 99999999999997653 4699999999999999999999999999999999999998755 69999999998531
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
........+||+.|+|||++.+. .|+.++|+|||||++|||++|..||.....
T Consensus 182 --------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 182 --------------------------PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp --------------------------TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred --------------------------CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 01123456899999999998875 579999999999999999999999976542
Q ss_pred -HHHHHHHhh-------------cCC---------------------CCCCCCCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 920 -EIIFDNILN-------------RKI---------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 920 -~ei~~kIl~-------------~~l---------------------~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
......+.. ... ........++++++|||++||++||.+|||
T Consensus 236 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t--- 312 (328)
T d3bqca1 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT--- 312 (328)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC---
T ss_pred hHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC---
Confidence 222211110 000 000112347899999999999999999999
Q ss_pred HHHHHcCCCCCCCCcc
Q 001360 965 AAEVKAHPFFKGVNWD 980 (1092)
Q Consensus 965 a~EIL~HPFFkgIdWd 980 (1092)
+.|+|+||||+++.|+
T Consensus 313 a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 313 AREAMEHPYFYTVVKD 328 (328)
T ss_dssp HHHHHTSGGGTTSCCC
T ss_pred HHHHhcCcccCCCCCC
Confidence 8899999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=444.06 Aligned_cols=252 Identities=31% Similarity=0.460 Sum_probs=210.8
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------CCe
Q 001360 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------RDN 761 (1092)
Q Consensus 688 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd------e~~ 761 (1092)
+|+.+++||+|+||+||+|+++.+|+.||||++++.... ..+|+.+|++++|||||+++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 799999999999999999999999999999999764322 2469999999999999999998843 345
Q ss_pred eEEEEeecCCCcHHHHH---HhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC-cEEEEecCCcccc
Q 001360 762 LYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIG 837 (1092)
Q Consensus 762 LYLVMEYm~GGSL~dlL---kk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~ 837 (1092)
+|||||||++|.+..+. .....+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+++..
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 89999999876443333 3445799999999999999999999999999999999999999876 8999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 916 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Yt~ksDVWSLGVILYEMLTGk~PF~~ 916 (1092)
. ......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|++||..
T Consensus 174 ~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 174 V----------------------------RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp C----------------------------TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred c----------------------------CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 1 1122345789999999999875 5789999999999999999999999999
Q ss_pred CChHHHHHHHhhc-----------------CCCCCC---------CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc
Q 001360 917 ESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1092)
Q Consensus 917 ~s~~ei~~kIl~~-----------------~l~fP~---------ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~ 970 (1092)
.+..+.+..|+.. ...++. ....+++++.+||.+||++||++||| +.|+++
T Consensus 226 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---a~e~L~ 302 (350)
T d1q5ka_ 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT---PLEACA 302 (350)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHT
T ss_pred CCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC---HHHHhc
Confidence 8887777666431 111221 12457999999999999999999999 889999
Q ss_pred CCCCCCC
Q 001360 971 HPFFKGV 977 (1092)
Q Consensus 971 HPFFkgI 977 (1092)
||||+.+
T Consensus 303 Hp~f~~~ 309 (350)
T d1q5ka_ 303 HSFFDEL 309 (350)
T ss_dssp SGGGGGG
T ss_pred CHhhccc
Confidence 9999765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-51 Score=430.12 Aligned_cols=251 Identities=21% Similarity=0.347 Sum_probs=220.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~~LYL 764 (1092)
..++|++++.||+|+||+||+|+++ +++.||||++++... ..+.+++|+.++.+++|||||++++++.+.+.+|+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 3579999999999999999999986 678999999987543 23568999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccc
Q 001360 765 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk-~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~ 843 (1092)
||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+++....
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~---- 152 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---- 152 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS----
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC----
Confidence 9999999999999764 45799999999999999999999999999999999999999999999999999975311
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHH
Q 001360 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 922 (1092)
Q Consensus 844 dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s~~ei 922 (1092)
..........||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++
T Consensus 153 ----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~ 210 (258)
T d1k2pa_ 153 ----------------------DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 210 (258)
T ss_dssp ----------------------SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred ----------------------CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH
Confidence 01112234679999999999999999999999999999999998 8999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 923 ~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
..++..+.. +..|..+++++++||.+||+.||.+||+ +.+|++|
T Consensus 211 ~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPt---~~eil~~ 254 (258)
T d1k2pa_ 211 AEHIAQGLR--LYRPHLASEKVYTIMYSCWHEKADERPT---FKILLSN 254 (258)
T ss_dssp HHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHhCCC--CCCcccccHHHHHHHHHHccCCHhHCcC---HHHHHHH
Confidence 988877532 2246889999999999999999999999 6777765
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=428.35 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=209.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~TG---k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
.+..++|++.+.||+|+||+||+|++..++ ..||||.++.. ......+.+.+|+.+|++++|||||++++++. .
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 345578999999999999999999987553 46888887643 23455678999999999999999999999996 4
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
+.+|+||||+++|+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 6789999999999999987654 579999999999999999999999999999999999999999999999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
. .........+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.
T Consensus 160 ~--------------------------~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~ 213 (273)
T d1mp8a_ 160 D--------------------------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213 (273)
T ss_dssp -------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred C--------------------------CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC
Confidence 1 01112334678999999999999999999999999999999998 99999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
+..+++.++..+.. +.++..+|+++++||.+||..||.+||+ +.+|++|
T Consensus 214 ~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~ei~~~ 262 (273)
T d1mp8a_ 214 KNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPR---FTELKAQ 262 (273)
T ss_dssp CGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 99999998887643 2346889999999999999999999999 5566654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=440.18 Aligned_cols=261 Identities=28% Similarity=0.471 Sum_probs=214.1
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----ee
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----NL 762 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~----~L 762 (1092)
+.|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+++|+.+|+.++|||||++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 46999999999999999999999999999999997643 3455678999999999999999999999987654 23
Q ss_pred EEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccccc
Q 001360 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1092)
Q Consensus 763 YLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s 842 (1092)
+++|+|+.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~- 163 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH- 163 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG-
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC-
Confidence 455566779999999965 469999999999999999999999999999999999999999999999999998532111
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 843 ~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
.........+||+.|+|||++. +..|+.++||||+||++|||++|++||.+.+..+
T Consensus 164 -----------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~ 220 (345)
T d1pmea_ 164 -----------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220 (345)
T ss_dssp -----------------------CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----------------------ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH
Confidence 0112234578999999999985 4567999999999999999999999999888766
Q ss_pred HHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCC
Q 001360 922 IFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1092)
Q Consensus 922 i~~kIl~~----------------------------~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPF 973 (1092)
....+... ..++......+++++++||.+||++||.+||+ +.++|+|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---a~e~L~hpf 297 (345)
T d1pmea_ 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---VEQALAHPY 297 (345)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGG
T ss_pred HHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHh
Confidence 55554321 01111123467899999999999999999999 889999999
Q ss_pred CCCC
Q 001360 974 FKGV 977 (1092)
Q Consensus 974 FkgI 977 (1092)
|+..
T Consensus 298 ~~~~ 301 (345)
T d1pmea_ 298 LEQY 301 (345)
T ss_dssp GTTT
T ss_pred hccC
Confidence 9754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=424.67 Aligned_cols=254 Identities=22% Similarity=0.272 Sum_probs=208.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TG----k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
+..+.|++.++||+|+||+||+|.++.++ ..||||+++... .......+++|+.+|.+++|||||++++++.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 45678999999999999999999987665 479999986532 334556799999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
+.+|+|||||.+|+|.+++... +.+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999999999988755 579999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC-CCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG-IPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTG-k~PF~~~ 917 (1092)
... ..........||+.|||||++.+..|+.++|||||||+||||++| .+||...
T Consensus 162 ~~~------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~ 217 (283)
T d1mqba_ 162 DDP------------------------EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217 (283)
T ss_dssp ------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCC------------------------ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC
Confidence 100 001112345689999999999999999999999999999999994 6666777
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
+..++++.+..+. . +..+..++.++.+||.+||..||++||++.++
T Consensus 218 ~~~~~~~~i~~~~-~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ei 263 (283)
T d1mqba_ 218 SNHEVMKAINDGF-R-LPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263 (283)
T ss_dssp CHHHHHHHHHTTC-C-CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CHHHHHHHHhccC-C-CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHH
Confidence 7777877776543 2 23457899999999999999999999995443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=437.68 Aligned_cols=257 Identities=30% Similarity=0.419 Sum_probs=216.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~----- 760 (1092)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+++|+.++|||||+++++|....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 468999999999999999999999999999999998643 34455678999999999999999999999986443
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n 840 (1092)
..++||+|+.||+|.+++.. +.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+|++|||++...
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~--- 171 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--- 171 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC---
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc---
Confidence 34677788889999999854 57999999999999999999999999999999999999999999999999998742
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 841 ~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
.....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.
T Consensus 172 ---------------------------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 172 ---------------------------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp ---------------------------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ---------------------------CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence 11234568999999999987754 58999999999999999999999999988
Q ss_pred HHHHHHHhhcCCCC-----------------------CC-----CCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 920 EIIFDNILNRKIPW-----------------------PC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 920 ~ei~~kIl~~~l~f-----------------------P~-----ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
......|....... +. ....++++++|||.+||+.||.+||| +.|+|+|
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a~elL~H 301 (348)
T d2gfsa1 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQALAH 301 (348)
T ss_dssp HHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHTS
T ss_pred HHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC---HHHHhcC
Confidence 77777765432111 10 12468999999999999999999999 8899999
Q ss_pred CCCCCC
Q 001360 972 PFFKGV 977 (1092)
Q Consensus 972 PFFkgI 977 (1092)
|||+..
T Consensus 302 p~f~~~ 307 (348)
T d2gfsa1 302 AYFAQY 307 (348)
T ss_dssp GGGTTT
T ss_pred HhhCCC
Confidence 999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=429.06 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=206.2
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 755 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~s 755 (1092)
+.+..++|++++.||+|+||+||+|++.. +++.||||++++.. .......+.+|..++.++ +|||||.++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 34556889999999999999999999754 34689999997533 344566788888888777 58999999988
Q ss_pred eccC-CeeEEEEeecCCCcHHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCce
Q 001360 756 FTCR-DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (1092)
Q Consensus 756 fqde-~~LYLVMEYm~GGSL~dlLkk~----------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNI 818 (1092)
+... ..+|+|||||+||+|.++|... ..+++..++.|+.||+.||.|||++|||||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 7654 4689999999999999999753 2488999999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001360 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (1092)
Q Consensus 819 LLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVW 898 (1092)
||+.+|++||+|||+|+..... .......+.+||+.|||||++.+..|+.++|||
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~-------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiw 220 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKD-------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 220 (299)
T ss_dssp EECGGGCEEECC------CCSC-------------------------TTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHH
T ss_pred eECCCCcEEEccCcchhhcccc-------------------------ccccccCceeeCccccchhHhhcCCCCccccee
Confidence 9999999999999999853110 011123456899999999999999999999999
Q ss_pred chhhhHHHHHhC-CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 899 SVGIILFEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 899 SLGVILYEMLTG-k~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
||||++|||++| .+||.+.+..+.+..++..... +..|..+++++++||.+||+.||.+||+ +.+|++|
T Consensus 221 S~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~eil~~ 290 (299)
T d1ywna1 221 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 290 (299)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHcCCChhHCcC---HHHHHHH
Confidence 999999999986 5789887765555555554433 3356789999999999999999999999 6666665
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-49 Score=427.96 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=220.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001360 683 RTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (1092)
Q Consensus 683 ~i~~~dFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfq 757 (1092)
+...++|++++.||+|+||+||+|+++. +++.||||++++.. .......+.+|+.+|++++||||+++++++.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 3456789999999999999999999863 56789999987532 3445678999999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhhc------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeec
Q 001360 758 CRDNLYLVMEYLNGGDLYSLLRKVG------------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDL 813 (1092)
Q Consensus 758 de~~LYLVMEYm~GGSL~dlLkk~g------------------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDL 813 (1092)
+.+.+++||||+++|+|.+++.... .+++..+..++.||+.||.|||++|||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 9999999999999999999996532 3889999999999999999999999999999
Q ss_pred CCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCc
Q 001360 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY 893 (1092)
Q Consensus 814 KPeNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ 893 (1092)
||+||||+.++++||+|||+|+..... .......+.+||+.|||||++.+..|+.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~t~ 221 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSA-------------------------DYYKADGNDAIPIRWMPPESIFYNRYTT 221 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGG-------------------------GCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred cccceEECCCCcEEEccchhheeccCC-------------------------ccccccCCCCcCcCcCCHHHHccCCCCh
Confidence 999999999999999999999853211 1112234578999999999999999999
Q ss_pred cceeechhhhHHHHHhCC-CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 894 AADWWSVGIILFEFITGI-PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 894 ksDVWSLGVILYEMLTGk-~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
++|||||||+||||++|. +||.+.+..++...+..+.. |.+|..+++++.+||.+||+.||++||++.++.+.|
T Consensus 222 ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~--~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999999999999999984 78999999999988877653 445688999999999999999999999955554443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=426.93 Aligned_cols=261 Identities=24% Similarity=0.394 Sum_probs=215.5
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde 759 (1092)
..+.+..++|++.+.||+|+||+||+|+++.+ +.||||++++... ..+.+.+|+.+|.+++|||||++|+++.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 34456778999999999999999999999765 5699999975432 24678999999999999999999999865
Q ss_pred CeeEEEEeecCCCcHHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk--~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
+.+|+||||+++|+|..++.. .+.+++.++..++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+..
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 568999999999999998864 357999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001360 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (1092)
Q Consensus 838 ~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~ 916 (1092)
.. ..........||+.|+|||++....|+.++|||||||++|||++ |.+||..
T Consensus 164 ~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 164 ED--------------------------NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp --------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cC--------------------------CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence 10 01112234679999999999999999999999999999999999 5666777
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc--CCCCCCC
Q 001360 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--HPFFKGV 977 (1092)
Q Consensus 917 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~--HPFFkgI 977 (1092)
....++...+..+. ..| ++..+++++++||.+||+.||++||+ +.+|++ |+||...
T Consensus 218 ~~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~Rps---~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 218 MVNREVLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPT---FEYLQAFLEDYFTST 275 (285)
T ss_dssp CCHHHHHHHHHTTC-CCC-CCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHTTTSCS
T ss_pred CCHHHHHHHHHhcC-CCC-CCcccCHHHHHHHHHHcccCHhHCcC---HHHHHHHHhhhhcCC
Confidence 77788887776543 223 46789999999999999999999999 555555 6788653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=430.89 Aligned_cols=254 Identities=23% Similarity=0.342 Sum_probs=210.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk----~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
..++|++++.||+|+||+||+|+++.+|+ .||+|.++.. ......+.+.+|+.+|++++|||||++++++.+.
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 34689999999999999999999998887 4777776543 2334567899999999999999999999999865
Q ss_pred eeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
..+++|||+.+|+|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+|+....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 578889999999999988764 5799999999999999999999999999999999999999999999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s 918 (1092)
. ..........||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+
T Consensus 164 ~-------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 164 E-------------------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp T-------------------------CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred c-------------------------cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 0 00112234579999999999999999999999999999999998 899999988
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
..++...+..+.. +..|..+++++.+||.+||..||.+||+ +.+|+.|
T Consensus 219 ~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs---~~eil~~ 266 (317)
T d1xkka_ 219 ASEISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRPK---FRELIIE 266 (317)
T ss_dssp GGGHHHHHHHTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHHHcCCC--CCCCcccCHHHHHHHHHhCCCChhhCcC---HHHHHHH
Confidence 8888877766542 2235789999999999999999999999 6677776
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=437.72 Aligned_cols=259 Identities=26% Similarity=0.411 Sum_probs=209.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------C
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------R 759 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd------e 759 (1092)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|++++|||||+++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 478999999999999999999999999999999998643 345567789999999999999999999999964 4
Q ss_pred CeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 760 ~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
..+|+|||||.|| +.+.+ ...+++..++.+++||+.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~- 170 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 170 (355)
T ss_dssp CEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc-
Confidence 6799999999765 44444 3569999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~ 919 (1092)
........+||+.|+|||++.+..|+.++||||+||++|||++|++||.+.+.
T Consensus 171 ---------------------------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~ 223 (355)
T d2b1pa1 171 ---------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_dssp -------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH
Confidence 11223456899999999999999999999999999999999999999999887
Q ss_pred HHHHHHHhhc----------------------CCCCCCC-----------------CCCCCHHHHHHHHHhccCCcCCCC
Q 001360 920 EIIFDNILNR----------------------KIPWPCV-----------------PSDMSFEAQDLINRFLIHDPNQRL 960 (1092)
Q Consensus 920 ~ei~~kIl~~----------------------~l~fP~i-----------------p~~lS~eakDLI~kcL~kDP~KRp 960 (1092)
.....+++.. ....... ...++++++|||++||..||++||
T Consensus 224 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 303 (355)
T d2b1pa1 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc
Confidence 7766655421 1111000 012467899999999999999999
Q ss_pred CcccHHHHHcCCCCCCCCc
Q 001360 961 GANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 961 Sa~ga~EIL~HPFFkgIdW 979 (1092)
| |.|+|+||||+..-+
T Consensus 304 t---a~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 304 S---VDDALQHPYINVWYD 319 (355)
T ss_dssp C---HHHHHTSTTTGGGCC
T ss_pred C---HHHHhcCcccCCCCC
Confidence 9 889999999986433
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-50 Score=426.77 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=211.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCC-C--cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTT-G--DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~T-G--k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqde~ 760 (1092)
+..++|++++.||+|+||+||+|++..+ + ..||||++++.........+.+.+|+.+|++++|||||++|++|.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 3457899999999999999999987533 3 3689999987666566667889999999999999999999999976 5
Q ss_pred eeEEEEeecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 839 (1092)
.+|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 789999999999999887654 5699999999999999999999999999999999999999999999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001360 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1092)
Q Consensus 840 n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~s 918 (1092)
.. ..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 164 ~~------------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 164 ND------------------------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp -C------------------------CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CC------------------------CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 10 01112334568899999999999999999999999999999998 899999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 919 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
..++..++......++ .+..+|+++++||.+||..||++||++.++.++|
T Consensus 220 ~~~~~~~i~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L 269 (273)
T d1u46a_ 220 GSQILHKIDKEGERLP-RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269 (273)
T ss_dssp HHHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCC-CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9999999988766544 4678999999999999999999999966555544
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=428.32 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=215.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001360 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 760 (1092)
Q Consensus 684 i~~~dFeilr~LGkGgFGtVyLar~k~TGk~--VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~~sfqde~ 760 (1092)
+..++|++.+.||+|+||+||+|+++.+|.. ||||.+++. ......+.+.+|+++|.++ +|||||++|+++.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 5668999999999999999999999988875 666766542 2334567799999999998 6999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCC
Q 001360 761 NLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~----------------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG 824 (1092)
.+|+||||++||+|.++|++. ..+++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999754 5699999999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhH
Q 001360 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (1092)
Q Consensus 825 ~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVIL 904 (1092)
.+||+|||+|+.... ........||+.|+|||.+.+..|+.++|||||||++
T Consensus 165 ~~kl~DfG~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil 216 (309)
T d1fvra_ 165 VAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216 (309)
T ss_dssp CEEECCTTCEESSCE----------------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred ceEEccccccccccc----------------------------cccccceecCCcccchHHhccCCCCccceeehhHHHH
Confidence 999999999974210 1122345799999999999999999999999999999
Q ss_pred HHHHhC-CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 905 FEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 905 YEMLTG-k~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
|||++| .+||.+.+..+++..+..+.. |..+..+++++++||.+||..||++||+ +.+|++|
T Consensus 217 ~ell~~~~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~eil~~ 279 (309)
T d1fvra_ 217 WEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPS---FAQILVS 279 (309)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHcCCChhHCcC---HHHHHHH
Confidence 999996 578999999999998877532 3346789999999999999999999999 6677765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=419.25 Aligned_cols=244 Identities=25% Similarity=0.422 Sum_probs=207.8
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-CC
Q 001360 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RD 760 (1092)
Q Consensus 682 ~~i~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd-e~ 760 (1092)
|.+..++|++++.||+|+||.||+|+++ |..||||++++.. ..+.+.+|+.+|++++|||||++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 4577889999999999999999999985 7899999997532 34678999999999999999999998854 46
Q ss_pred eeEEEEeecCCCcHHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCccccc
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g--~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 838 (1092)
.+||||||+++|+|.++|.+.+ .+++..++.++.||+.||.|||+.+||||||||+|||++.+|++||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 7899999999999999997653 59999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLT-Gk~PF~~~ 917 (1092)
.......||+.|+|||++.+..|+.++|||||||++|||++ |++||...
T Consensus 155 ------------------------------~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 155 ------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp -------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ------------------------------CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence 11234568999999999999999999999999999999998 89999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCccc
Q 001360 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1092)
Q Consensus 918 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~g 964 (1092)
+..++...|.++.. |.++..+++++++||.+||..||.+||++.+
T Consensus 205 ~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~ 249 (262)
T d1byga_ 205 PLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQ 249 (262)
T ss_dssp CGGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcccCHhHCcCHHH
Confidence 99999988876532 3356789999999999999999999999443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=420.06 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=216.5
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCC-------cEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEE
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTG-------DLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 751 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k~TG-------k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVk 751 (1092)
.++.+..++|++++.||+|+||.||+|+...++ ..||||++++.. .......+.+|...+.++ +|||||+
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 345567789999999999999999999986654 379999997632 345567889999999888 7999999
Q ss_pred EeeeeccCCeeEEEEeecCCCcHHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCC
Q 001360 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 815 (1092)
Q Consensus 752 L~~sfqde~~LYLVMEYm~GGSL~dlLkk~g----------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKP 815 (1092)
++++|.+++.+|+|||||.+|+|.++|.... .+++..+..++.||+.||.|||++|||||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 9999999999999999999999999997543 489999999999999999999999999999999
Q ss_pred CceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001360 816 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (1092)
Q Consensus 816 eNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ks 895 (1092)
+|||++.+|.+||+|||+++..... .........+||+.|+|||++.++.|+.++
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~ 218 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHI-------------------------DYYKKTTNGRLPVKWMAPEALFDRIYTHQS 218 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGC-------------------------CTTCCCTTSCCGGGGSCHHHHHHCCCCHHH
T ss_pred cceeecCCCCeEeccchhhcccccc-------------------------ccccccccCCCChhhhhhhHhcCCCCCchh
Confidence 9999999999999999999853210 011223456799999999999999999999
Q ss_pred eeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHH
Q 001360 896 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1092)
Q Consensus 896 DVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~E 967 (1092)
|||||||++|||++ |.+||.+.+...++..+..+. . +..|..+++++++||.+||+.||.+||++.++.+
T Consensus 219 DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~-~-~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 219 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-R-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-C-CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCC-C-CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 99999999999998 799999999998888876643 2 3356889999999999999999999999544433
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=421.62 Aligned_cols=261 Identities=23% Similarity=0.355 Sum_probs=221.6
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001360 680 HKERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (1092)
Q Consensus 680 ~~~~i~~~dFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L-~HPNIVkL~ 753 (1092)
.++.+..++|++.+.||+|+||+||+|+++ .+++.||||++++.. .......+.+|+.++.++ +|||||+++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 355677789999999999999999999873 456799999997643 344567899999999999 699999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhhc------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCC
Q 001360 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 815 (1092)
Q Consensus 754 ~sfqde~~LYLVMEYm~GGSL~dlLkk~g------------------~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKP 815 (1092)
+++.+.+.+|||||||+||+|.+++.+.. .+++..++.|+.||+.||.|||++|||||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 99999999999999999999999997543 589999999999999999999999999999999
Q ss_pred CceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001360 816 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (1092)
Q Consensus 816 eNILLD~nG~VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ks 895 (1092)
+|||++.++.+||+|||+++..... .........+||+.|+|||++.+..|+.++
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 228 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKND-------------------------SNYVVKGNARLPVKWMAPESIFNCVYTFES 228 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSC-------------------------TTSEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred ccccccccCcccccccchheeccCC-------------------------CcceEeeecccChHHcCHHHhcCCCCCCcc
Confidence 9999999999999999999853110 001122346899999999999999999999
Q ss_pred eeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHH
Q 001360 896 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1092)
Q Consensus 896 DVWSLGVILYEMLT-Gk~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EI 968 (1092)
|||||||++|||+| |.+||...+..+.+.+++..... +..+..++.++.+||.+||+.||.+||++.++.+.
T Consensus 229 DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~ 301 (311)
T d1t46a_ 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (311)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999998 77888887777777677666554 33467899999999999999999999995544433
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=421.69 Aligned_cols=268 Identities=21% Similarity=0.295 Sum_probs=227.2
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeee
Q 001360 681 KERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS 755 (1092)
Q Consensus 681 ~~~i~~~dFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~s 755 (1092)
.+.+..++|++.+.||+|+||+||+|.++. ++..||||++++.. .......+.+|+.+|++++|||||++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 456778999999999999999999998853 35789999997543 34556789999999999999999999999
Q ss_pred eccCCeeEEEEeecCCCcHHHHHHhh----------cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCc
Q 001360 756 FTCRDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 825 (1092)
Q Consensus 756 fqde~~LYLVMEYm~GGSL~dlLkk~----------g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~ 825 (1092)
+...+.+|+|||||++|+|.+++... ..+++..+..++.|++.||.|||+++||||||||+||||+.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999998643 24688899999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHH
Q 001360 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 905 (1092)
Q Consensus 826 VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILY 905 (1092)
+||+|||+|+...... ........+||+.|||||.+.+..|+.++|||||||++|
T Consensus 172 ~Kl~DFGla~~~~~~~-------------------------~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~ 226 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226 (308)
T ss_dssp EEECCTTCCCGGGGGG-------------------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred EEEeecccceeccCCc-------------------------ceeeccceecccccCCHHHHccCCCCcccccccHHHHHH
Confidence 9999999998532110 111233457999999999999999999999999999999
Q ss_pred HHHhC-CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHc---CCCCCCC
Q 001360 906 EFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA---HPFFKGV 977 (1092)
Q Consensus 906 EMLTG-k~PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~---HPFFkgI 977 (1092)
||++| .+||.+.+..+++..+.++.. +..|..+++.+.+||.+||+.||.+||++.++.+.|+ +|+|+.+
T Consensus 227 El~t~~~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 227 EIATLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp HHHHTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhCCC--CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 99998 589999999999998887653 4456889999999999999999999999544433333 6666543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-47 Score=409.53 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=207.2
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCCeeEEE
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYLV 765 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPN-IVkL~~sfqde~~LYLV 765 (1092)
+.|++++.||+|+||+||+|+++.+|+.||||++..... ...+..|+++++.++|++ |+.+++++.+.+..|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 469999999999999999999999999999999875332 234778999999998665 55666777888899999
Q ss_pred EeecCCCcHHHHHH-hhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC---CCcEEEEecCCcccccccc
Q 001360 766 MEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINN 841 (1092)
Q Consensus 766 MEYm~GGSL~dlLk-k~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFGLAk~~~~n~ 841 (1092)
|||+.+ +|.+.+. ..+.+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+......
T Consensus 82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 999955 6655554 4567999999999999999999999999999999999999864 4579999999998642111
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001360 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1092)
Q Consensus 842 s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s~~e 921 (1092)
.. .........+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.......
T Consensus 161 ~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 161 TH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp TC--------------------CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred cc--------------------cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH
Confidence 00 0011223346789999999999999999999999999999999999999998766544
Q ss_pred HHHHHh---hcC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCC
Q 001360 922 IFDNIL---NRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1092)
Q Consensus 922 i~~kIl---~~~--l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFk 975 (1092)
....+. ... .+.+.....+|+++.+||.+||..||.+||++..+.++++|+|.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 221 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ----HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 333222 111 122223467899999999999999999999988788888887653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=403.77 Aligned_cols=251 Identities=20% Similarity=0.258 Sum_probs=203.7
Q ss_pred EEEeeccCCCeEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-CCeeEEEE
Q 001360 691 IIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RDNLYLVM 766 (1092)
Q Consensus 691 ilr~LGkGgFGtVyLar~k~TG---k~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~HPNIVkL~~sfqd-e~~LYLVM 766 (1092)
+-++||+|+||+||+|++..++ ..||||++++ .......+.+.+|+++|.+++|||||++++++.. +..+|+||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECC--CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc--ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3578999999999999987654 3699999975 3345667889999999999999999999998765 56899999
Q ss_pred eecCCCcHHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCCcccccccccccC
Q 001360 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1092)
Q Consensus 767 EYm~GGSL~dlLkk~-g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~n~s~dl 845 (1092)
|||++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+||||++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~--- 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF--- 185 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC---
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc---
Confidence 999999999998754 4577888899999999999999999999999999999999999999999999985321100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC-CCChHHHHH
Q 001360 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT-AESPEIIFD 924 (1092)
Q Consensus 846 s~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~-~~s~~ei~~ 924 (1092)
..........||+.|+|||++.+..|+.++||||||++||||++|..||. ..+..++..
T Consensus 186 --------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~ 245 (311)
T d1r0pa_ 186 --------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245 (311)
T ss_dssp --------------------CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH
T ss_pred --------------------ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 00112234579999999999999999999999999999999999666665 445556666
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHHcC
Q 001360 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1092)
Q Consensus 925 kIl~~~l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~H 971 (1092)
.+..+.. |..|..+++++.+||.+||..||++||+ +.||++|
T Consensus 246 ~i~~g~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs---~~ei~~~ 287 (311)
T d1r0pa_ 246 YLLQGRR--LLQPEYCPDPLYEVMLKCWHPKAEMRPS---FSELVSR 287 (311)
T ss_dssp HHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHcCCC--CCCcccCcHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 6666542 3456889999999999999999999999 5566655
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-45 Score=395.18 Aligned_cols=258 Identities=20% Similarity=0.251 Sum_probs=209.8
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccCCeeEE
Q 001360 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 686 ~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H-PNIVkL~~sfqde~~LYL 764 (1092)
-+.|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+|++++..+.| +||+.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 3679999999999999999999999999999999865321 2346788899999975 899999999999999999
Q ss_pred EEeecCCCcHHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecC-----CCcEEEEecCCccccc
Q 001360 765 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-----DGHIKLTDFGLSKIGL 838 (1092)
Q Consensus 765 VMEYm~GGSL~dlLkk~g-~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~-----nG~VKLsDFGLAk~~~ 838 (1092)
||||+ ||+|.+++...+ .+++..+..++.|++.||.|||++|||||||||+||||+. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 689999987654 6999999999999999999999999999999999999974 5789999999998642
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001360 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1092)
Q Consensus 839 ~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVILYEMLTGk~PF~~~s 918 (1092)
..... .........+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+..
T Consensus 158 ~~~~~--------------------~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 158 DPVTK--------------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp CTTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cCccc--------------------cceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 11000 0011123446789999999999999999999999999999999999999997654
Q ss_pred ---hHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCcccHHHHH
Q 001360 919 ---PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1092)
Q Consensus 919 ---~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL 969 (1092)
....+.++.... .+.+.+...+|+++.+|+..|+..+|.+||+...+.+++
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l 273 (293)
T d1csna_ 218 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273 (293)
T ss_dssp SCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred chhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 334444443322 122223367889999999999999999999865554443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=391.04 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=189.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH--HHHhcCCCceEEEeeeeccCC----
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN--ILITVRNPFVVRFFYSFTCRD---- 760 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~Eie--IL~~L~HPNIVkL~~sfqde~---- 760 (1092)
.+|.+.+.||+|+||+||+|++ +|+.||||+++... ...+..|.+ .+..++|||||++++++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 4788999999999999999987 58999999986422 233444544 445789999999999998654
Q ss_pred eeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH--------cCCeeeecCCCceEecCCCcEEEEecC
Q 001360 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS--------LGIVHRDLKPDNLLIAHDGHIKLTDFG 832 (1092)
Q Consensus 761 ~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs--------~GIIHRDLKPeNILLD~nG~VKLsDFG 832 (1092)
.+|||||||++|+|.++|++. .+++.....++.|++.||.|||. +|||||||||+||||+.+|++||+|||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 589999999999999999764 68999999999999999999996 599999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC------CCccceeechhhhHHH
Q 001360 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFE 906 (1092)
Q Consensus 833 LAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~------Yt~ksDVWSLGVILYE 906 (1092)
+++....... .........+||+.|||||++.+.. |+.++|||||||+|||
T Consensus 154 l~~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~e 210 (303)
T d1vjya_ 154 LAVRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210 (303)
T ss_dssp TCEEEETTTT-----------------------EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccCCCc-----------------------ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHH
Confidence 9986421110 0011233578999999999997643 5678999999999999
Q ss_pred HHhCCCCCCCC---------------ChHHHHHHHhhcCCCCCCCCCC-----CCHHHHHHHHHhccCCcCCCCCcccH
Q 001360 907 FITGIPPFTAE---------------SPEIIFDNILNRKIPWPCVPSD-----MSFEAQDLINRFLIHDPNQRLGANGA 965 (1092)
Q Consensus 907 MLTGk~PF~~~---------------s~~ei~~kIl~~~l~fP~ip~~-----lS~eakDLI~kcL~kDP~KRpSa~ga 965 (1092)
|+||.+||... ........+...... |.++.. ....+.+||.+||..||.+||++.++
T Consensus 211 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 288 (303)
T d1vjya_ 211 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp HHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred HhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccC-CCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 99999887432 123333333333332 322222 23468999999999999999994433
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-44 Score=388.33 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=198.1
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----------CCceEEEeee
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----------NPFVVRFFYS 755 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-----------HPNIVkL~~s 755 (1092)
+.|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|+.++ |||||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 45999999999999999999999999999999998643 23456778888887765 5789999988
Q ss_pred eccC--CeeEEEEeecCCCcHHHHHH---hhcCCCHHHHHHHHHHHHHHHHHHHH-cCCeeeecCCCceEecCCCc----
Q 001360 756 FTCR--DNLYLVMEYLNGGDLYSLLR---KVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGH---- 825 (1092)
Q Consensus 756 fqde--~~LYLVMEYm~GGSL~dlLk---k~g~LsE~~ar~yaaQIL~ALeYLHs-~GIIHRDLKPeNILLD~nG~---- 825 (1092)
+... ...+++|+++..+....... ....+++..++.++.||+.||.|||+ .||+||||||+||||+.+|.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 7653 46777777776655433332 33579999999999999999999998 89999999999999987664
Q ss_pred --EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhh
Q 001360 826 --IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (1092)
Q Consensus 826 --VKLsDFGLAk~~~~n~s~dls~~~t~g~~p~~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Yt~ksDVWSLGVI 903 (1092)
+||+|||.++... ......+||+.|+|||++.+..|+.++|+|||||+
T Consensus 169 ~~~kl~dfg~s~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 218 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD------------------------------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACL 218 (362)
T ss_dssp EEEEECCCTTCEETT------------------------------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHH
T ss_pred ceeeEeecccccccc------------------------------cccccccccccccChhhccccCCCccccccchHHH
Confidence 9999999987421 12245689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChH------HHHHHHhh--cC------------------C----CCC---------------CCCC
Q 001360 904 LFEFITGIPPFTAESPE------IIFDNILN--RK------------------I----PWP---------------CVPS 938 (1092)
Q Consensus 904 LYEMLTGk~PF~~~s~~------ei~~kIl~--~~------------------l----~fP---------------~ip~ 938 (1092)
+++|++|+.||...... +....+.. +. . .++ ..+.
T Consensus 219 l~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (362)
T d1q8ya_ 219 IFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 298 (362)
T ss_dssp HHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCH
T ss_pred HHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCc
Confidence 99999999999754321 11111100 00 0 000 0112
Q ss_pred CCCHHHHHHHHHhccCCcCCCCCcccHHHHHcCCCCCCCCc
Q 001360 939 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1092)
Q Consensus 939 ~lS~eakDLI~kcL~kDP~KRpSa~ga~EIL~HPFFkgIdW 979 (1092)
..+++++|||.+||++||.+||| |.|+|+||||+++.+
T Consensus 299 ~~~~~~~dll~~mL~~dP~~Rpt---a~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 299 DEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDTLG 336 (362)
T ss_dssp HHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTCTT
T ss_pred ccCHHHHHHHHHHCCCChhHCcC---HHHHhcCcccCCCCC
Confidence 35678999999999999999999 889999999997643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=3.6e-24 Score=214.11 Aligned_cols=135 Identities=20% Similarity=0.159 Sum_probs=107.5
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---------------chhHHHHHHHHHHHHHhcCCCceEEEe
Q 001360 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI---------------RKNDIERILAERNILITVRNPFVVRFF 753 (1092)
Q Consensus 689 Feilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~---------------kk~~ie~~l~EieIL~~L~HPNIVkL~ 753 (1092)
+.+.+.||+|+||+||+|++. +|+.||||+++..... .......+..|...|.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 357899999999999999985 6899999987632110 011223456788899999999999887
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHcCCeeeecCCCceEecCCCcEEEEecCC
Q 001360 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1092)
Q Consensus 754 ~sfqde~~LYLVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGL 833 (1092)
++.. .+++|||++++.+. .++...+..++.|++.||.|||++||+||||||+|||++.+ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 6532 37999999986553 25666678899999999999999999999999999999865 489999999
Q ss_pred ccc
Q 001360 834 SKI 836 (1092)
Q Consensus 834 Ak~ 836 (1092)
|+.
T Consensus 149 a~~ 151 (191)
T d1zara2 149 SVE 151 (191)
T ss_dssp CEE
T ss_pred ccc
Confidence 874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.24 E-value=1.8e-06 Score=87.08 Aligned_cols=143 Identities=13% Similarity=0.103 Sum_probs=93.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeE
Q 001360 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 763 (1092)
Q Consensus 685 ~~~dFeilr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqde~~LY 763 (1092)
.+..|+..+..+.++.+.||++. ..+..+.+|+...... .....+.+|..+|..+. +--+.+++.+..+.+..|
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 34677887776666668999886 3466778887754322 12334677888877664 333556667777788899
Q ss_pred EEEeecCCCcHHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 001360 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-------------------------------------- 805 (1092)
Q Consensus 764 LVMEYm~GGSL~dlLkk~g~LsE~~ar~yaaQIL~ALeYLHs-------------------------------------- 805 (1092)
+||++++|..+....... .....++.++...|..||+
T Consensus 87 lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 999999998775443110 1111122333333333332
Q ss_pred ---------------c------CCeeeecCCCceEecCCCcEEEEecCCcccc
Q 001360 806 ---------------L------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1092)
Q Consensus 806 ---------------~------GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 837 (1092)
. .++|+|+.|.|||++.++.+-|+||+.+..+
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 1 2799999999999987766779999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.78 E-value=2.1e-05 Score=85.87 Aligned_cols=80 Identities=25% Similarity=0.270 Sum_probs=49.2
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecc-cccc---hhHHHHHHHHHHHHHhcC-C--CceEEEeeeeccCCeeEE
Q 001360 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKL-DMIR---KNDIERILAERNILITVR-N--PFVVRFFYSFTCRDNLYL 764 (1092)
Q Consensus 692 lr~LGkGgFGtVyLar~k~TGk~VAIKvLkK~-ei~k---k~~ie~~l~EieIL~~L~-H--PNIVkL~~sfqde~~LYL 764 (1092)
.+.||.|....||++....+|+.|++|.-... .... .....+...|...|..+. + ..+.++|.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 55789999999999988777888999964321 1110 112345567888777653 2 345566654 3445689
Q ss_pred EEeecCCCc
Q 001360 765 VMEYLNGGD 773 (1092)
Q Consensus 765 VMEYm~GGS 773 (1092)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.58 E-value=5.9e-05 Score=75.34 Aligned_cols=136 Identities=14% Similarity=0.104 Sum_probs=81.5
Q ss_pred eeccCC-CeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--CCceEEEeeeeccCCeeEEEEeecC
Q 001360 694 PISRGA-FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLYLVMEYLN 770 (1092)
Q Consensus 694 ~LGkGg-FGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~--HPNIVkL~~sfqde~~LYLVMEYm~ 770 (1092)
.+..|. -+.||++.. ..+..+.+|.-.... ...+..|..+|+.+. .-.+.+++....+.+..|+||+|++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 344444 468998875 346678889765432 223566777776654 2335667777788888999999999
Q ss_pred CCcHHH--------------HHHhhc-------CCC--HHHH-----HHHH---------------HHHHHHHHHHHHc-
Q 001360 771 GGDLYS--------------LLRKVG-------CLE--EDVA-----RIYI---------------AELVLALEYLHSL- 806 (1092)
Q Consensus 771 GGSL~d--------------lLkk~g-------~Ls--E~~a-----r~ya---------------aQIL~ALeYLHs~- 806 (1092)
|-++.. .+.+-. .+. .... ..+. ......+..+..+
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 865421 111100 000 0000 0000 0112223333332
Q ss_pred ------CCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 807 ------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 807 ------GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
.+||+|+.|.|||++.++.+-|+||+.+..
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 379999999999999876678999998864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.52 E-value=0.0025 Score=66.99 Aligned_cols=130 Identities=15% Similarity=0.232 Sum_probs=74.0
Q ss_pred CeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC---C--ceEEEe--eeeccCCeeEEEEeecCCC
Q 001360 700 FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---P--FVVRFF--YSFTCRDNLYLVMEYLNGG 772 (1092)
Q Consensus 700 FGtVyLar~k~TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~H---P--NIVkL~--~sfqde~~LYLVMEYm~GG 772 (1092)
--.||+++. .+|..|++|+.+.... ..+.+..|...|..+.. | ..+..- ..+......+.++++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357999976 4688899999865321 23456678877766541 1 111111 2223455678999999874
Q ss_pred cH-----H------HHH---Hh----------------------------hcCCCHHHHHHHHHHHHHHHHHHHH-----
Q 001360 773 DL-----Y------SLL---RK----------------------------VGCLEEDVARIYIAELVLALEYLHS----- 805 (1092)
Q Consensus 773 SL-----~------dlL---kk----------------------------~g~LsE~~ar~yaaQIL~ALeYLHs----- 805 (1092)
.+ . ..+ +. ...++......+...+-..++.+..
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 32 0 001 10 0111122222233333333444432
Q ss_pred --cCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 806 --LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 806 --~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
.++||+|+.|.|||++. | ..++||+-|..
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 26899999999999974 4 45899998875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.12 E-value=0.0091 Score=64.18 Aligned_cols=78 Identities=18% Similarity=0.267 Sum_probs=51.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc
Q 001360 687 DDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC 758 (1092)
Q Consensus 687 ~dFeilr~LGkGgFGtVyLar~k~-------TGk~VAIKvLkK~ei~kk~~ie~~l~EieIL~~L~-HPNIVkL~~sfqd 758 (1092)
+++++ +.|+.|-.=.+|++.... .++.|.+++.-... . .....+|..+++.+. +.-..+++++|..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 34444 578888888999998753 24567777764321 1 223457888888775 4444577777754
Q ss_pred CCeeEEEEeecCCCcH
Q 001360 759 RDNLYLVMEYLNGGDL 774 (1092)
Q Consensus 759 e~~LYLVMEYm~GGSL 774 (1092)
.+||||++|-.|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 689999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.20 E-value=0.068 Score=54.71 Aligned_cols=31 Identities=32% Similarity=0.438 Sum_probs=27.8
Q ss_pred cCCeeeecCCCceEecCCCcEEEEecCCccc
Q 001360 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1092)
Q Consensus 806 ~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 836 (1092)
.|+||+|+.++|||++.++..-|.||+.|..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3799999999999999887778999999874
|